{"WAG001977": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GOT1 (glutamic-oxaloacetic transaminase 1), GOT2 (glutamic-oxaloacetic transaminase 2), ASS1 (argininosuccinate synthase 1), GAD2 (glutamate decarboxylase 2), GAD1 (glutamate decarboxylase 1), PC (pyruvate carboxylase), ASPA (aspartoacylase), ASL (argininosuccinate lyase), GPT (glutamic--pyruvic transaminase), ABAT (4-aminobutyrate aminotransferase), AGXT (alanine--glyoxylate and serine--pyruvate aminotransferase), DARS1 (aspartyl-tRNA synthetase 1)"], "WAG001978": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), EIF2S2 (eukaryotic translation initiation factor 2 subunit beta), EIF4E (eukaryotic translation initiation factor 4E), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), EIF4B (eukaryotic translation initiation factor 4B), EIF5 (eukaryotic translation initiation factor 5), EIF3B (eukaryotic translation initiation factor 3 subunit B), EIF2S3 (eukaryotic translation initiation factor 2 subunit gamma), EIF4A1 (eukaryotic translation initiation factor 4A1), EIF3A (eukaryotic translation initiation factor 3 subunit A), EIF3I (eukaryotic translation initiation factor 3 subunit I), EIF3G (eukaryotic translation initiation factor 3 subunit G), EIF4H (eukaryotic translation initiation factor 4H), EIF4A2 (eukaryotic translation initiation factor 4A2), EIF1AY (eukaryotic translation initiation factor 1A Y-linked), EIF3C (eukaryotic translation initiation factor 3 subunit C), EIF3F (eukaryotic translation initiation factor 3 subunit F), EIF3H (eukaryotic translation initiation factor 3 subunit H), EIF5B (eukaryotic translation initiation factor 5B), EIF3E (eukaryotic translation initiation factor 3 subunit E), EEF1A1 (eukaryotic translation elongation factor 1 alpha 1), EIF3D (eukaryotic translation initiation factor 3 subunit D), EIF3J (eukaryotic translation initiation factor 3 subunit J), EIF1 (eukaryotic translation initiation factor 1), EIF2B1 (eukaryotic translation initiation factor 2B subunit alpha), EIF2B5 (eukaryotic translation initiation factor 2B subunit epsilon), EIF2B2 (eukaryotic translation initiation factor 2B subunit beta), PABPC1 (poly(A) binding protein cytoplasmic 1), EIF1AX (eukaryotic translation initiation factor 1A X-linked), EIF2B4 (eukaryotic translation initiation factor 2B subunit delta), EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma), EEF2 (eukaryotic translation elongation factor 2), EIF5A (eukaryotic translation initiation factor 5A), EIF6 (eukaryotic translation initiation factor 6), EEF1B2 (eukaryotic translation elongation factor 1 beta 2), ETF1 (eukaryotic translation termination factor 1), EIF4G3 (eukaryotic translation initiation factor 4 gamma 3), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), EEF1G (eukaryotic translation elongation factor 1 gamma), PAIP1 (poly(A) binding protein interacting protein 1), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), EEF1D (eukaryotic translation elongation factor 1 delta), EIF4EBP3 (eukaryotic translation initiation factor 4E binding protein 3), GSPT2 (G1 to S phase transition 2), EIF2AK1 (eukaryotic translation initiation factor 2 alpha kinase 1), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), EIF4EBP2 (eukaryotic translation initiation factor 4E binding protein 2), CLUH (clustered mitochondria homolog), EEF2K (eukaryotic elongation factor 2 kinase), EEF1A2 (eukaryotic translation elongation factor 1 alpha 2)"], "WAG001979": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII), UQCRC2 (ubiquinol-cytochrome c reductase core protein 2), UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X), UQCR11 (ubiquinol-cytochrome c reductase, complex III subunit XI), UQCRC1 (ubiquinol-cytochrome c reductase core protein 1), UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1), UQCRH (ubiquinol-cytochrome c reductase hinge protein), UQCRB (ubiquinol-cytochrome c reductase binding protein), NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3), NDUFA1 (NADH:ubiquinone oxidoreductase subunit A1), NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6), NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5), NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9), NDUFA2 (NADH:ubiquinone oxidoreductase subunit A2), NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8), NDUFS8 (NADH:ubiquinone oxidoreductase core subunit S8), NDUFS6 (NADH:ubiquinone oxidoreductase subunit S6), NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8), NDUFA4 (NDUFA4 mitochondrial complex associated), NDUFS4 (NADH:ubiquinone oxidoreductase subunit S4), NDUFB7 (NADH:ubiquinone oxidoreductase subunit B7), NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1), NDUFA9 (NADH:ubiquinone oxidoreductase subunit A9), NDUFS5 (NADH:ubiquinone oxidoreductase subunit S5), NDUFB2 (NADH:ubiquinone oxidoreductase subunit B2), NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5), NDUFA7 (NADH:ubiquinone oxidoreductase subunit A7), NDUFV1 (NADH:ubiquinone oxidoreductase core subunit V1), NDUFC2 (NADH:ubiquinone oxidoreductase subunit C2), NDUFB10 (NADH:ubiquinone oxidoreductase subunit B10), NDUFA12 (NADH:ubiquinone oxidoreductase subunit A12), NDUFB4 (NADH:ubiquinone oxidoreductase subunit B4), NDUFB6 (NADH:ubiquinone oxidoreductase subunit B6), NDUFB3 (NADH:ubiquinone oxidoreductase subunit B3), NDUFS7 (NADH:ubiquinone oxidoreductase core subunit S7), NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10), NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2), NDUFA3 (NADH:ubiquinone oxidoreductase subunit A3), NDUFS1 (NADH:ubiquinone oxidoreductase core subunit S1), NDUFV2 (NADH:ubiquinone oxidoreductase core subunit V2), NDUFB1 (NADH:ubiquinone oxidoreductase subunit B1), NDUFV3 (NADH:ubiquinone oxidoreductase subunit V3), NDUFC1 (NADH:ubiquinone oxidoreductase subunit C1), COX5A (cytochrome c oxidase subunit 5A), COX6B1 (cytochrome c oxidase subunit 6B1), COX5B (cytochrome c oxidase subunit 5B), COX7A2 (cytochrome c oxidase subunit 7A2), COX6C (cytochrome c oxidase subunit 6C), COX7B (cytochrome c oxidase subunit 7B), COX7C (cytochrome c oxidase subunit 7C), COX4I1 (cytochrome c oxidase subunit 4I1), COX6A1 (cytochrome c oxidase subunit 6A1), SDHB (succinate dehydrogenase complex iron sulfur subunit B), SDHC (succinate dehydrogenase complex subunit C), SDHD (succinate dehydrogenase complex subunit D), COX7A2L (cytochrome c oxidase subunit 7A2 like), COX8A (cytochrome c oxidase subunit 8A), COX6A2 (cytochrome c oxidase subunit 6A2), COX7A1 (cytochrome c oxidase subunit 7A1), SURF1 (SURF1 cytochrome c oxidase assembly factor), SDHA (succinate dehydrogenase complex flavoprotein subunit A), COX15 (cytochrome c oxidase assembly homolog COX15), COX11 (cytochrome c oxidase copper chaperone COX11), SLC25A5 (solute carrier family 25 member 5), UCP2 (uncoupling protein 2), SCO1 (synthesis of cytochrome C oxidase 1), COX17 (cytochrome c oxidase copper chaperone COX17), SLC25A14 (solute carrier family 25 member 14), SLC25A4 (solute carrier family 25 member 4), UCP3 (uncoupling protein 3), SLC25A27 (solute carrier family 25 member 27), UCP1 (uncoupling protein 1), SLC25A6 (solute carrier family 25 member 6), ATP5F1B (ATP synthase F1 subunit beta), ATP5ME (ATP synthase membrane subunit e), ATP5IF1 (ATP synthase inhibitory factor subunit 1), ATP5MF (ATP synthase membrane subunit f), ATP5PO (ATP synthase peripheral stalk subunit OSCP), ND4L (NADH dehydrogenase, subunit 4L (complex I)), ND6 (NADH dehydrogenase, subunit 6 (complex I)), ATP5PB (ATP synthase peripheral stalk-membrane subunit b), ATP5F1D (ATP synthase F1 subunit delta), ATP5MC3 (ATP synthase membrane subunit c locus 3), ATP5F1C (ATP synthase F1 subunit gamma), DMAC2L (distal membrane arm assembly complex 2 like), ND4 (NADH dehydrogenase, subunit 4 (complex I)), ATP6 (ATP synthase F0 subunit 6), COX1 (cytochrome c oxidase subunit I), ND3 (NADH dehydrogenase, subunit 3 (complex I)), ND2 (MTND2), ATP8 (ATP synthase F0 subunit 8), ND1 (NADH dehydrogenase, subunit 1 (complex I)), ATP5PD (ATP synthase peripheral stalk subunit d), COX2 (cytochrome c oxidase subunit II), ATP5MC2 (ATP synthase membrane subunit c locus 2), ATP5MG (ATP synthase membrane subunit g), CYTB (cytochrome b), COX3 (cytochrome c oxidase III), ATP5MC1 (ATP synthase membrane subunit c locus 1), ATP5F1A (ATP synthase F1 subunit alpha)"], "WAG001982": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), JAK1 (Janus kinase 1), MAPK3 (mitogen-activated protein kinase 3), GRB2 (growth factor receptor bound protein 2), JAK2 (Janus kinase 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), IL2 (interleukin 2), SYK (spleen associated tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), STAT3 (signal transducer and activator of transcription 3), SHC1 (SHC adaptor protein 1), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MYC (MYC proto-oncogene, bHLH transcription factor), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), BTK (Bruton tyrosine kinase), STAT5A (signal transducer and activator of transcription 5A), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), STAT1 (signal transducer and activator of transcription 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CSF2RB (colony stimulating factor 2 receptor subunit beta), KRAS (KRAS proto-oncogene, GTPase), LYN (LYN proto-oncogene, Src family tyrosine kinase), RPS6KB1 (ribosomal protein S6 kinase B1), STAT5B (signal transducer and activator of transcription 5B), GSK3B (glycogen synthase kinase 3 beta), RPS6KA1 (ribosomal protein S6 kinase A1), BCL2 (BCL2 apoptosis regulator), MAP2K2 (mitogen-activated protein kinase kinase 2), IL5RA (interleukin 5 receptor subunit alpha), ELK1 (ETS transcription factor ELK1), MAPT (microtubule associated protein tau), RPS6KB2 (ribosomal protein S6 kinase B2), GSK3A (glycogen synthase kinase 3 alpha), RPS6 (ribosomal protein S6), FOXO3 (forkhead box O3), SPRED1 (sprouty related EVH1 domain containing 1)"], "WAG001986": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AR (androgen receptor), HDAC1 (histone deacetylase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), EP300 (E1A binding protein p300), AKT1 (AKT serine/threonine kinase 1), CREBBP (CREB binding protein), BRCA1 (BRCA1 DNA repair associated), SMAD4 (SMAD family member 4), MDM2 (MDM2 proto-oncogene), STAT3 (signal transducer and activator of transcription 3), CCND1 (cyclin D1), SMAD3 (SMAD family member 3), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), RELA (RELA proto-oncogene, NF-kB subunit), SUMO1 (small ubiquitin like modifier 1), CTNNB1 (catenin beta 1), SP1 (Sp1 transcription factor), KAT2B (lysine acetyltransferase 2B), PTEN (phosphatase and tensin homolog), UBE2I (ubiquitin conjugating enzyme E2 I), CDKN1A (cyclin dependent kinase inhibitor 1A), RB1 (RB transcriptional corepressor 1), NCOA3 (nuclear receptor coactivator 3), EGFR (epidermal growth factor receptor), NCOA2 (nuclear receptor coactivator 2), FOXO1 (forkhead box O1), SIN3A (SIN3 transcription regulator family member A), SIRT1 (sirtuin 1), CREB1 (cAMP responsive element binding protein 1), RAC1 (Rac family small GTPase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIAS1 (protein inhibitor of activated STAT 1), FHL2 (four and a half LIM domains 2), KLK3 (kallikrein related peptidase 3), NCOR1 (nuclear receptor corepressor 1), NCOR2 (nuclear receptor corepressor 2), CARM1 (coactivator associated arginine methyltransferase 1), NCOA1 (nuclear receptor coactivator 1), GSK3B (glycogen synthase kinase 3 beta), RUNX2 (RUNX family transcription factor 2), CDC42 (cell division cycle 42), PTK2 (protein tyrosine kinase 2), KAT5 (lysine acetyltransferase 5), STUB1 (STIP1 homology and U-box containing protein 1), PIAS3 (protein inhibitor of activated STAT 3), DAXX (death domain associated protein), FLNA (filamin A), RHOA (ras homolog family member A), PIAS2 (protein inhibitor of activated STAT 2), PARK7 (Parkinsonism associated deglycase), RAN (RAN, member RAS oncogene family), SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1), NR0B2 (nuclear receptor subfamily 0 group B member 2), CAV1 (caveolin 1), PIAS4 (protein inhibitor of activated STAT 4), CCNE1 (cyclin E1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), UBE3A (ubiquitin protein ligase E3A), ROCK1 (Rho associated coiled-coil containing protein kinase 1), KDM1A (lysine demethylase 1A), TGIF1 (TGFB induced factor homeobox 1), NCOA4 (nuclear receptor coactivator 4), BAG1 (BAG cochaperone 1), RHOB (ras homolog family member B), RNF6 (ring finger protein 6), ROCK2 (Rho associated coiled-coil containing protein kinase 2), RNF4 (ring finger protein 4), TGFB1I1 (transforming growth factor beta 1 induced transcript 1), PAK6 (p21 (RAC1) activated kinase 6), RNF14 (ring finger protein 14), PRDX1 (peroxiredoxin 1), KAT7 (lysine acetyltransferase 7), LIMK2 (LIM domain kinase 2), ZMIZ1 (zinc finger MIZ-type containing 1), NR2C2 (nuclear receptor subfamily 2 group C member 2), EFCAB6 (EF-hand calcium binding domain 6), RAD9A (RAD9 checkpoint clamp component A), FKBP4 (FKBP prolyl isomerase 4), PATZ1 (POZ/BTB and AT hook containing zinc finger 1), CALR (calreticulin), ETV5 (ETS variant transcription factor 5), PSMC3IP (PSMC3 interacting protein), BMF (Bcl2 modifying factor), RLN1 (relaxin 1), ZNF318 (zinc finger protein 318), DSTN (destrin, actin depolymerizing factor), TLE5 (TLE family member 5, transcriptional modulator), PLPP1 (phospholipid phosphatase 1), BUB1B-PAK6 (BUB1B-PAK6 readthrough), RACK1 (receptor for activated C kinase 1)"], "WAG001987": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), INS-IGF2 (INS-IGF2 readthrough), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), STK11 (serine/threonine kinase 11), AKT2 (AKT serine/threonine kinase 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), LEP (leptin), RPS6KB1 (ribosomal protein S6 kinase B1), ACACB (acetyl-CoA carboxylase beta), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), SLC2A4 (solute carrier family 2 member 4), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), TP53 (tumor protein p53), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), TSC2 (TSC complex subunit 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), TSC1 (TSC complex subunit 1), INSR (insulin receptor), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), ACACA (acetyl-CoA carboxylase alpha), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2), CAMKK1 (calcium/calmodulin dependent protein kinase kinase 1), PLCB1 (phospholipase C beta 1), SREBF1 (sterol regulatory element binding transcription factor 1), CAB39 (calcium binding protein 39), RPTOR (regulatory associated protein of MTOR complex 1), CDKN1A (cyclin dependent kinase inhibitor 1A), FASN (fatty acid synthase), STRADB (STE20 related adaptor beta), CCNB1 (cyclin B1), EEF2K (eukaryotic elongation factor 2 kinase), LEPR (leptin receptor), ADIPOR2 (adiponectin receptor 2), EEF2 (eukaryotic translation elongation factor 2), ADIPOR1 (adiponectin receptor 1), RPS6KB2 (ribosomal protein S6 kinase B2), ADRA1B (adrenoceptor alpha 1B), ADIPOQ (adiponectin, C1Q and collagen domain containing), LIPE (lipase E, hormone sensitive type), CPT1A (carnitine palmitoyltransferase 1A), HNF4A (hepatocyte nuclear factor 4 alpha), GYS1 (glycogen synthase 1), CCNA2 (cyclin A2), CPT1B (carnitine palmitoyltransferase 1B), IGF2 (insulin like growth factor 2), PRKACB (protein kinase cAMP-activated catalytic subunit beta), CCNA1 (cyclin A1), PPARGC1B (PPARG coactivator 1 beta), CPT1C (carnitine palmitoyltransferase 1C), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), ELAVL1 (ELAV like RNA binding protein 1), STRADA (STE20 related adaptor alpha), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3), CRTC2 (CREB regulated transcription coactivator 2), SLC2A4RG (SLC2A4 regulator), GYS2 (glycogen synthase 2), ADRA1A (adrenoceptor alpha 1A), BORCS8-MEF2B (BORCS8-MEF2B readthrough)"], "WAG001988": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SGPP2 (sphingosine-1-phosphate phosphatase 2), ASAH2 (N-acylsphingosine amidohydrolase 2), ASAH1 (N-acylsphingosine amidohydrolase 1), GBA (glucosylceramidase beta), UGCG (UDP-glucose ceramide glucosyltransferase), UGT8 (UDP glycosyltransferase 8), ACER1 (alkaline ceramidase 1), SGMS2 (sphingomyelin synthase 2), CERK (ceramide kinase), KDSR (3-ketodihydrosphingosine reductase), SGMS1 (sphingomyelin synthase 1), SPHK1 (sphingosine kinase 1), SPHK2 (sphingosine kinase 2), SPTLC3 (serine palmitoyltransferase long chain base subunit 3), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), SPTLC2 (serine palmitoyltransferase long chain base subunit 2), SGPL1 (sphingosine-1-phosphate lyase 1), B4GALT6 (beta-1,4-galactosyltransferase 6), PPP1CA (protein phosphatase 1 catalytic subunit alpha), PPP2CA (protein phosphatase 2 catalytic subunit alpha), GAL3ST1 (galactose-3-O-sulfotransferase 1), GBA2 (glucosylceramidase beta 2), CERS6 (ceramide synthase 6), CERS5 (ceramide synthase 5), CERS4 (ceramide synthase 4), PLPP1 (phospholipid phosphatase 1), CERT1 (ceramide transporter 1), CERS3 (ceramide synthase 3), CERS2 (ceramide synthase 2), SERINC1 (serine incorporator 1)"], "WAG001990": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ST3GAL1 (ST3 beta-galactoside alpha-2,3-sialyltransferase 1), ST3GAL2 (ST3 beta-galactoside alpha-2,3-sialyltransferase 2), FUT2 (fucosyltransferase 2), FUT1 (fucosyltransferase 1 (H blood group)), ST6GALNAC2 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2), B3GALT5 (beta-1,3-galactosyltransferase 5), ST6GALNAC1 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1), GCNT1 (glucosaminyl (N-acetyl) transferase 1), ST8SIA1 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1), ST6GALNAC4 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4), ST6GALNAC5 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5), B3GALNT1 (beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)), FUT9 (fucosyltransferase 9), GBGT1 (globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)), ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1), ST6GALNAC6 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6), ST6GALNAC3 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3), ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase), GALNT2 (polypeptide N-acetylgalactosaminyltransferase 2), A4GALT (alpha 1,4-galactosyltransferase (P blood group)), ST6GAL2 (ST6 beta-galactoside alpha-2,6-sialyltransferase 2)"], "WAG001991": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD4 (SMAD family member 4), SMAD6 (SMAD family member 6), BMPR1A (bone morphogenetic protein receptor type 1A), SMAD1 (SMAD family member 1), BMP2 (bone morphogenetic protein 2), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), BMPR1B (bone morphogenetic protein receptor type 1B), BMPR2 (bone morphogenetic protein receptor type 2), RUNX2 (RUNX family transcription factor 2), NOG (noggin), TOB1 (transducer of ERBB2, 1), TOB2 (transducer of ERBB2, 2)"], "WAG001992": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ACADM (acyl-CoA dehydrogenase medium chain), CPT1A (carnitine palmitoyltransferase 1A), ACADL (acyl-CoA dehydrogenase long chain), CPT2 (carnitine palmitoyltransferase 2), ACSL1 (acyl-CoA synthetase long chain family member 1), CPT1B (carnitine palmitoyltransferase 1B), ACADVL (acyl-CoA dehydrogenase very long chain), ACSL4 (acyl-CoA synthetase long chain family member 4), HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta), ACSL3 (acyl-CoA synthetase long chain family member 3), ACSL5 (acyl-CoA synthetase long chain family member 5), CHKB (choline kinase beta), HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha), HADH (hydroxyacyl-CoA dehydrogenase), LPL (lipoprotein lipase), ECHS1 (enoyl-CoA hydratase, short chain 1), ACAT1 (acetyl-CoA acetyltransferase 1), ACSL6 (acyl-CoA synthetase long chain family member 6), LIPF (lipase F, gastric type), ACADS (acyl-CoA dehydrogenase short chain), LIPC (lipase C, hepatic type), ECI1 (enoyl-CoA delta isomerase 1), GCDH (glutaryl-CoA dehydrogenase), CRAT (carnitine O-acetyltransferase), GK2 (glycerol kinase 2), ACSS2 (acyl-CoA synthetase short chain family member 2), LIPE (lipase E, hormone sensitive type), SLC25A20 (solute carrier family 25 member 20), DLD (dihydrolipoamide dehydrogenase), DECR1 (2,4-dienoyl-CoA reductase 1), GPD2 (glycerol-3-phosphate dehydrogenase 2), GK (glycerol kinase), PNPLA2 (patatin like phospholipase domain containing 2), TPI1 (triosephosphate isomerase 1)"], "WAG001993": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP1 (caspase 1), PYCARD (PYD and CARD domain containing), NOD1 (nucleotide binding oligomerization domain containing 1), CASP8 (caspase 8), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), RIPK2 (receptor interacting serine/threonine kinase 2), HSP90AA1 (heat shock protein 90 alpha family class A member 1), RELA (RELA proto-oncogene, NF-kB subunit), NOD2 (nucleotide binding oligomerization domain containing 2), NLRP1 (NLR family pyrin domain containing 1), NLRC4 (NLR family CARD domain containing 4), NLRP2 (NLR family pyrin domain containing 2), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), NLRP3 (NLR family pyrin domain containing 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CARD8 (caspase recruitment domain family member 8), IL1B (interleukin 1 beta), XIAP (X-linked inhibitor of apoptosis), CASP9 (caspase 9), MEFV (MEFV innate immuity regulator, pyrin), SUGT1 (SGT1 homolog, MIS12 kinetochore complex assembly cochaperone), NFKBIA (NFKB inhibitor alpha), CASP7 (caspase 7), IL18 (interleukin 18), NLRP4 (NLR family pyrin domain containing 4), CARD9 (caspase recruitment domain family member 9), NLRP12 (NLR family pyrin domain containing 12), CASP5 (caspase 5), RAC1 (Rac family small GTPase 1), CARD6 (caspase recruitment domain family member 6), AIM2 (absent in melanoma 2), NAIP (NLR family apoptosis inhibitory protein), COPS6 (COP9 signalosome subunit 6), NLRP7 (NLR family pyrin domain containing 7), PRDM1 (PR/SET domain 1), ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1), DUOX2 (dual oxidase 2), NLRP10 (NLR family pyrin domain containing 10), AAMP (angio associated migratory cell protein), NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13), ERBIN (erbb2 interacting protein)"], "WAG001996": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), RELA (RELA proto-oncogene, NF-kB subunit), TNF (tumor necrosis factor), MYD88 (MYD88 innate immune signal transduction adaptor), NFKB1 (nuclear factor kappa B subunit 1), TLR3 (toll like receptor 3), IRAK1 (interleukin 1 receptor associated kinase 1), TLR4 (toll like receptor 4), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), STAT1 (signal transducer and activator of transcription 1), AKT1 (AKT serine/threonine kinase 1), IL1B (interleukin 1 beta), CD40 (CD40 molecule), MAPK1 (mitogen-activated protein kinase 1), IRF3 (interferon regulatory factor 3), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), IL6 (interleukin 6), MAPK14 (mitogen-activated protein kinase 14), NFKBIA (NFKB inhibitor alpha), RAC1 (Rac family small GTPase 1), TICAM1 (toll like receptor adaptor molecule 1), RIPK1 (receptor interacting serine/threonine kinase 1), IRF7 (interferon regulatory factor 7), SYK (spleen associated tyrosine kinase), MAPK8 (mitogen-activated protein kinase 8), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), TIRAP (TIR domain containing adaptor protein), BTK (Bruton tyrosine kinase), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), NFKB2 (nuclear factor kappa B subunit 2), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), MAPK3 (mitogen-activated protein kinase 3), TRAF3 (TNF receptor associated factor 3), TBK1 (TANK binding kinase 1), IRAK2 (interleukin 1 receptor associated kinase 2), TLR9 (toll like receptor 9), MAP2K6 (mitogen-activated protein kinase kinase 6), MAP2K4 (mitogen-activated protein kinase kinase 4), IFNB1 (interferon beta 1), IRAK4 (interleukin 1 receptor associated kinase 4), TNFAIP3 (TNF alpha induced protein 3), MAP2K1 (mitogen-activated protein kinase kinase 1), SOCS1 (suppressor of cytokine signaling 1), LY96 (lymphocyte antigen 96), MAP2K3 (mitogen-activated protein kinase kinase 3), TLR2 (toll like receptor 2), IFNA13 (interferon alpha 13), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PTPN6 (protein tyrosine phosphatase non-receptor type 6), TOLLIP (toll interacting protein), MAPK11 (mitogen-activated protein kinase 11), IFNA2 (interferon alpha 2), IRF5 (interferon regulatory factor 5), IFNAR1 (interferon alpha and beta receptor subunit 1), CD86 (CD86 molecule), CASP8 (caspase 8), CD14 (CD14 molecule), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), AKT2 (AKT serine/threonine kinase 2), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), FADD (Fas associated via death domain), SQSTM1 (sequestosome 1), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), TLR1 (toll like receptor 1), IRAK3 (interleukin 1 receptor associated kinase 3), MAP2K7 (mitogen-activated protein kinase kinase 7), IFNAR2 (interferon alpha and beta receptor subunit 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), TLR7 (toll like receptor 7), TICAM2 (toll like receptor adaptor molecule 2), AKT3 (AKT serine/threonine kinase 3), IFNA17 (interferon alpha 17), MAPK12 (mitogen-activated protein kinase 12), MAPK9 (mitogen-activated protein kinase 9), TLR5 (toll like receptor 5), TMED7 (transmembrane p24 trafficking protein 7), PELI1 (pellino E3 ubiquitin protein ligase 1), IFNA5 (interferon alpha 5), TLR6 (toll like receptor 6), IL12B (interleukin 12B), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), IFNA14 (interferon alpha 14), MAPK10 (mitogen-activated protein kinase 10), MAPK13 (mitogen-activated protein kinase 13), CXCL10 (C-X-C motif chemokine ligand 10), CCL5 (C-C motif chemokine ligand 5), TLR8 (toll like receptor 8), IFNA6 (interferon alpha 6), MAP2K2 (mitogen-activated protein kinase kinase 2), CCL3 (C-C motif chemokine ligand 3), IFNA21 (interferon alpha 21), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), CYLD (CYLD lysine 63 deubiquitinase)"], "WAG001998": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTOR (mechanistic target of rapamycin kinase), MLST8 (MTOR associated protein, LST8 homolog), RPTOR (regulatory associated protein of MTOR complex 1), RHEB (Ras homolog, mTORC1 binding), TSC1 (TSC complex subunit 1), AKT1 (AKT serine/threonine kinase 1), TSC2 (TSC complex subunit 2), RICTOR (RPTOR independent companion of MTOR complex 2), RPS6KB1 (ribosomal protein S6 kinase B1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), MAPKAP1 (MAPK associated protein 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKCA (protein kinase C alpha), AKT1S1 (AKT1 substrate 1), ULK2 (unc-51 like autophagy activating kinase 2), PRR5 (proline rich 5), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), ULK1 (unc-51 like autophagy activating kinase 1), RRAGC (Ras related GTP binding C), RRAGD (Ras related GTP binding D), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), RRAGB (Ras related GTP binding B), CDC42 (cell division cycle 42), RRAGA (Ras related GTP binding A), RAC1 (Rac family small GTPase 1), PRR5L (proline rich 5 like), DDIT4 (DNA damage inducible transcript 4), FKBP1A (FKBP prolyl isomerase 1A), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), DDIT4L (DNA damage inducible transcript 4 like), ULK3 (unc-51 like kinase 3), IDI1 (isopentenyl-diphosphate delta isomerase 1)"], "WAG002000": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), ALB (albumin), IL6 (interleukin 6), CRP (C-reactive protein), PTGS2 (prostaglandin-endoperoxide synthase 2), SOD2 (superoxide dismutase 2), APOA1 (apolipoprotein A1), TXN (thioredoxin), F2 (coagulation factor II, thrombin), ICAM1 (intercellular adhesion molecule 1), IL1B (interleukin 1 beta), APOB (apolipoprotein B), GPX1 (glutathione peroxidase 1), NFKB1 (nuclear factor kappa B subunit 1), CAT (catalase), GPX4 (glutathione peroxidase 4), PLG (plasminogen), IFNG (interferon gamma), SERPINE1 (serpin family E member 1), CCL2 (C-C motif chemokine ligand 2), ALOX5 (arachidonate 5-lipoxygenase), MPO (myeloperoxidase), PLAT (plasminogen activator, tissue type), RELA (RELA proto-oncogene, NF-kB subunit), FGA (fibrinogen alpha chain), FGG (fibrinogen gamma chain), GSR (glutathione-disulfide reductase), GGT1 (gamma-glutamyltransferase 1), SAA1 (serum amyloid A1), TXNRD1 (thioredoxin reductase 1), PTGS1 (prostaglandin-endoperoxide synthase 1), LDLR (low density lipoprotein receptor), PRDX1 (peroxiredoxin 1), SOD1 (superoxide dismutase 1), FGB (fibrinogen beta chain), PRDX5 (peroxiredoxin 5), SCARB1 (scavenger receptor class B member 1), ALOX15B (arachidonate 15-lipoxygenase type B), ABCA1 (ATP binding cassette subfamily A member 1), PRDX4 (peroxiredoxin 4), GPX3 (glutathione peroxidase 3), GPX2 (glutathione peroxidase 2), CTH (cystathionine gamma-lyase), NFKB2 (nuclear factor kappa B subunit 2), F7 (coagulation factor VII), MTHFR (methylenetetrahydrofolate reductase), PRDX2 (peroxiredoxin 2), SOD3 (superoxide dismutase 3), INSR (insulin receptor), PRDX3 (peroxiredoxin 3), GPX6 (glutathione peroxidase 6), CBS (cystathionine beta-synthase), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), TXNRD2 (thioredoxin reductase 2), SEPHS2 (selenophosphate synthetase 2), TXNRD3 (thioredoxin reductase 3), SAA2 (serum amyloid A2), XDH (xanthine dehydrogenase), DIO3 (iodothyronine deiodinase 3), KYNU (kynureninase), SERPINA3 (serpin family A member 3), INS (insulin), DIO1 (iodothyronine deiodinase 1), FLAD1 (flavin adenine dinucleotide synthetase 1), DIO2 (iodothyronine deiodinase 2), SAA4 (serum amyloid A4, constitutive), ALOX5AP (arachidonate 5-lipoxygenase activating protein), KMO (kynurenine 3-monooxygenase), RFK (riboflavin kinase), HBB (hemoglobin subunit beta), SELENOV (selenoprotein V), GGT2 (gamma-glutamyltransferase 2), PNPO (pyridoxamine 5'-phosphate oxidase), SELENOW (selenoprotein W), SAA3P (serum amyloid A3, pseudogene), SELENOI (selenoprotein I), SELENOT (selenoprotein T), SELENOP (selenoprotein P), SELENOH (selenoprotein H), SELENOO (selenoprotein O), MSRB1 (methionine sulfoxide reductase B1), CBSL (cystathionine beta-synthase like), LOC102724197 (inactive glutathione hydrolase 2), SELENOF (selenoprotein F), SELENOM (selenoprotein M), HBA1 (hemoglobin subunit alpha 1), SELENOK (selenoprotein K), SELENON (selenoprotein N), SOD2-OT1 (SOD2 overlapping transcript 1), SELENOS (selenoprotein S)"], "WAG002001": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), MAPK8 (mitogen-activated protein kinase 8), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), STAT3 (signal transducer and activator of transcription 3), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RAC1 (Rac family small GTPase 1), EDN1 (endothelin 1), MAPK11 (mitogen-activated protein kinase 11), NFATC4 (nuclear factor of activated T cells 4), MAP2K3 (mitogen-activated protein kinase kinase 3), GATA4 (GATA binding protein 4), CTF1 (cardiotrophin 1), RHOA (ras homolog family member A), LIFR (LIF receptor subunit alpha), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PRKCE (protein kinase C epsilon), IL6ST (interleukin 6 signal transducer), PPP3CB (protein phosphatase 3 catalytic subunit beta), PRKCB (protein kinase C beta), AGT (angiotensinogen), MYEF2 (myelin expression factor 2), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CALM1 (calmodulin 1)"], "WAG002002": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), CDK2 (cyclin dependent kinase 2), ATM (ATM serine/threonine kinase), MYC (MYC proto-oncogene, bHLH transcription factor), CDKN1A (cyclin dependent kinase inhibitor 1A), CCNB1 (cyclin B1), RB1 (RB transcriptional corepressor 1), CHEK1 (checkpoint kinase 1), CDK1 (cyclin dependent kinase 1), CDK4 (cyclin dependent kinase 4), MDM2 (MDM2 proto-oncogene), E2F1 (E2F transcription factor 1), CCND1 (cyclin D1), ATR (ATR serine/threonine kinase), CDC25A (cell division cycle 25A), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), RAD51 (RAD51 recombinase), CHEK2 (checkpoint kinase 2), MCM7 (minichromosome maintenance complex component 7), CCNE1 (cyclin E1), CDKN1B (cyclin dependent kinase inhibitor 1B), CASP3 (caspase 3), CDK6 (cyclin dependent kinase 6), RPA2 (replication protein A2), CCNE2 (cyclin E2), CCND3 (cyclin D3), RAD50 (RAD50 double strand break repair protein), CCNB2 (cyclin B2), ATRIP (ATR interacting protein), CDK5 (cyclin dependent kinase 5), RFC1 (replication factor C subunit 1), BAX (BCL2 associated X, apoptosis regulator), GADD45A (growth arrest and DNA damage inducible alpha), CCND2 (cyclin D2), CDC25C (cell division cycle 25C), RAD9A (RAD9 checkpoint clamp component A), RAD17 (RAD17 checkpoint clamp loader component), SFN (stratifin), NBN (nibrin), PRKDC (protein kinase, DNA-activated, catalytic subunit), BID (BH3 interacting domain death agonist), CASP9 (caspase 9), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), FANCD2 (FA complementation group D2), SMC1A (structural maintenance of chromosomes 1A), CASP8 (caspase 8), PML (PML nuclear body scaffold), APAF1 (apoptotic peptidase activating factor 1), FAS (Fas cell surface death receptor), CYCS (cytochrome c, somatic), RAD52 (RAD52 homolog, DNA repair protein), CREB1 (cAMP responsive element binding protein 1), RAD1 (RAD1 checkpoint DNA exonuclease), CCNG1 (cyclin G1), CCNB3 (cyclin B3), GADD45G (growth arrest and DNA damage inducible gamma), TNFRSF10B (TNF receptor superfamily member 10b), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), GADD45B (growth arrest and DNA damage inducible beta), DDB2 (damage specific DNA binding protein 2), BBC3 (BCL2 binding component 3), TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1), TLK2 (tousled like kinase 2), TLK1 (tousled like kinase 1), HUS1B (HUS1 checkpoint clamp component B), SESN1 (sestrin 1), CDC20B (cell division cycle 20B), MIR24-1 (microRNA 24-1), MIR15A (microRNA 15a), H2AX (H2A.X variant histone), MRE11 (MRE11 homolog, double strand break repair nuclease), MIR449B (microRNA 449b), MIR17 (microRNA 17), MIR421 (microRNA 421), MIR449A (microRNA 449a), MIR3591 (microRNA 3591), MIR181A1 (microRNA 181a-1), MIR106B (microRNA 106b), MIR29C (microRNA 29c), MIR16-1 (microRNA 16-1), MIR203A (microRNA 203a), MIR221 (microRNA 221), MIR210 (microRNA 210), MIR20A (microRNA 20a), MIR17HG (miR-17-92a-1 cluster host gene), MIR29A (microRNA 29a), PIDD1 (p53-induced death domain protein 1), MIR373 (microRNA 373), MIR34B (microRNA 34b), MIR29B1 (microRNA 29b-1), MIR21 (microRNA 21), MIR424 (microRNA 424), MIR330 (microRNA 330), MIR195 (microRNA 195), MIR223 (microRNA 223), MIR222 (microRNA 222), MIR145 (microRNA 145)"], "WAG002004": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALB (albumin), IL6 (interleukin 6), TNF (tumor necrosis factor), CRP (C-reactive protein), APOE (apolipoprotein E), APOA1 (apolipoprotein A1), ICAM1 (intercellular adhesion molecule 1), SERPINE1 (serpin family E member 1), IL1B (interleukin 1 beta), APOB (apolipoprotein B), NFKB1 (nuclear factor kappa B subunit 1), F2 (coagulation factor II, thrombin), CCL2 (C-C motif chemokine ligand 2), IFNG (interferon gamma), RELA (RELA proto-oncogene, NF-kB subunit), SOD2 (superoxide dismutase 2), LDLR (low density lipoprotein receptor), SCARB1 (scavenger receptor class B member 1), PLG (plasminogen), LRP2 (LDL receptor related protein 2), MTHFR (methylenetetrahydrofolate reductase), MPO (myeloperoxidase), SAA1 (serum amyloid A1), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), PLAT (plasminogen activator, tissue type), ABCA1 (ATP binding cassette subfamily A member 1), CCL5 (C-C motif chemokine ligand 5), F7 (coagulation factor VII), CBS (cystathionine beta-synthase), NFKB2 (nuclear factor kappa B subunit 2), INSR (insulin receptor), MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), CUBN (cubilin), SHMT2 (serine hydroxymethyltransferase 2), CTH (cystathionine gamma-lyase), SOD1 (superoxide dismutase 1), MAT1A (methionine adenosyltransferase 1A), SAA2 (serum amyloid A2), TCN2 (transcobalamin 2), INS (insulin), SERPINA3 (serpin family A member 3), SOD3 (superoxide dismutase 3), MMAB (metabolism of cobalamin associated B), TCN1 (transcobalamin 1), HBB (hemoglobin subunit beta), SAA4 (serum amyloid A4, constitutive), MCEE (methylmalonyl-CoA epimerase), CBSL (cystathionine beta-synthase like), CBLIF (cobalamin binding intrinsic factor), HBA1 (hemoglobin subunit alpha 1), SOD2-OT1 (SOD2 overlapping transcript 1), SAA3P (serum amyloid A3, pseudogene), MMUT (methylmalonyl-CoA mutase)"], "WAG002005": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), KDR (kinase insert domain receptor), FGF2 (fibroblast growth factor 2), PLCG1 (phospholipase C gamma 1), PDGFB (platelet derived growth factor subunit B), NOS3 (nitric oxide synthase 3), FLT1 (fms related receptor tyrosine kinase 1), ANGPT1 (angiopoietin 1), HIF1A (hypoxia inducible factor 1 subunit alpha), MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), PTK2 (protein tyrosine kinase 2), PDGFRA (platelet derived growth factor receptor alpha), CREBBP (CREB binding protein), MMP9 (matrix metallopeptidase 9), ARNT (aryl hydrocarbon receptor nuclear translocator), FGFR2 (fibroblast growth factor receptor 2), TEK (TEK receptor tyrosine kinase), TIMP3 (TIMP metallopeptidase inhibitor 3), TIMP2 (TIMP metallopeptidase inhibitor 2), SMAD1 (SMAD family member 1)"], "WAG002006": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EP300 (E1A binding protein p300), PPARGC1A (PPARG coactivator 1 alpha), PPARG (peroxisome proliferator activated receptor gamma), HDAC1 (histone deacetylase 1), PPARA (peroxisome proliferator activated receptor alpha), MEF2D (myocyte enhancer factor 2D), SIRT1 (sirtuin 1), MEF2A (myocyte enhancer factor 2A), RXRA (retinoid X receptor alpha), MAPK14 (mitogen-activated protein kinase 14), ESRRA (estrogen related receptor alpha), CREB1 (cAMP responsive element binding protein 1), MEF2C (myocyte enhancer factor 2C), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), NCOA1 (nuclear receptor coactivator 1), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), FOXO1 (forkhead box O1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), GSK3B (glycogen synthase kinase 3 beta), PPARD (peroxisome proliferator activated receptor delta), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), NRF1 (nuclear respiratory factor 1), PPP3CB (protein phosphatase 3 catalytic subunit beta), MEF2B (myocyte enhancer factor 2B), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), PPP3CC (protein phosphatase 3 catalytic subunit gamma), TFAM (transcription factor A, mitochondrial), FOXO3 (forkhead box O3), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), ATF2 (activating transcription factor 2), CAMK4 (calcium/calmodulin dependent protein kinase IV), UCP2 (uncoupling protein 2), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), PRMT1 (protein arginine methyltransferase 1), PPRC1 (PPARG related coactivator 1), GABPA (GA binding protein transcription factor subunit alpha), UCP3 (uncoupling protein 3), MYBBP1A (MYB binding protein 1a), TFB2M (transcription factor B2, mitochondrial), SIRT3 (sirtuin 3), PPP3R2 (protein phosphatase 3 regulatory subunit B, beta), PPARGC1B (PPARG coactivator 1 beta), TFB1M (transcription factor B1, mitochondrial), MED1 (mediator complex subunit 1)"], "WAG002007": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), MAPK3 (mitogen-activated protein kinase 3), RAC1 (Rac family small GTPase 1), MAPK14 (mitogen-activated protein kinase 14), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAPK8 (mitogen-activated protein kinase 8), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), TNF (tumor necrosis factor), STAT3 (signal transducer and activator of transcription 3), GSK3B (glycogen synthase kinase 3 beta), NFKB1 (nuclear factor kappa B subunit 1), CTNNB1 (catenin beta 1), MTOR (mechanistic target of rapamycin kinase), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), EGF (epidermal growth factor), MAP2K1 (mitogen-activated protein kinase kinase 1), IGF1 (insulin like growth factor 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K4 (mitogen-activated protein kinase kinase 4), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PLCB2 (phospholipase C beta 2), EDN1 (endothelin 1), AKT2 (AKT serine/threonine kinase 2), IGF1R (insulin like growth factor 1 receptor), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), MAP2K6 (mitogen-activated protein kinase kinase 6), TGFB1 (transforming growth factor beta 1), PDPK1 (3-phosphoinositide dependent protein kinase 1), MAP2K3 (mitogen-activated protein kinase kinase 3), PRKCB (protein kinase C beta), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K2 (mitogen-activated protein kinase kinase 2), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), MAPK7 (mitogen-activated protein kinase 7), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), RHOA (ras homolog family member A), FGF2 (fibroblast growth factor 2), FGFR2 (fibroblast growth factor receptor 2), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), DVL1 (dishevelled segment polarity protein 1), HDAC4 (histone deacetylase 4), CDK9 (cyclin dependent kinase 9), NPPA (natriuretic peptide A), NFATC4 (nuclear factor of activated T cells 4), MAP2K5 (mitogen-activated protein kinase kinase 5), ROCK1 (Rho associated coiled-coil containing protein kinase 1), LIF (LIF interleukin 6 family cytokine), MAP2K7 (mitogen-activated protein kinase kinase 7), IL6ST (interleukin 6 signal transducer), GATA4 (GATA binding protein 4), PPP3CA (protein phosphatase 3 catalytic subunit alpha), FZD1 (frizzled class receptor 1), WNT3A (Wnt family member 3A), LRP6 (LDL receptor related protein 6), FZD2 (frizzled class receptor 2), CTF1 (cardiotrophin 1), ROCK2 (Rho associated coiled-coil containing protein kinase 2), WNT5A (Wnt family member 5A), NRG1 (neuregulin 1), MAPK4 (mitogen-activated protein kinase 4), MYEF2 (myelin expression factor 2), AGT (angiotensinogen), MYLK (myosin light chain kinase), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), LRP5 (LDL receptor related protein 5), HDAC9 (histone deacetylase 9), HDAC5 (histone deacetylase 5), HDAC7 (histone deacetylase 7), PLA2G2A (phospholipase A2 group IIA), PRKG1 (protein kinase cGMP-dependent 1), CAMK2D (calcium/calmodulin dependent protein kinase II delta), RCAN1 (regulator of calcineurin 1), PPP3CB (protein phosphatase 3 catalytic subunit beta), CISH (cytokine inducible SH2 containing protein), CDK7 (cyclin dependent kinase 7), NPPB (natriuretic peptide B), EIF2B5 (eukaryotic translation initiation factor 2B subunit epsilon), MYLK3 (myosin light chain kinase 3), MIR130B (microRNA 130b), MIR30E (microRNA 30e), MIR199A2 (microRNA 199a-2), MIR125B1 (microRNA 125b-1), MIR208A (microRNA 208a), CALM1 (calmodulin 1), MIR214 (microRNA 214), MIR133B (microRNA 133b), MIR133A2 (microRNA 133a-2), MIR15B (microRNA 15b), MIR103A1 (microRNA 103a-1), MIRLET7B (microRNA let-7b), MIR27B (microRNA 27b), MIR185 (microRNA 185), MIR125B2 (microRNA 125b-2), MIR133A1 (microRNA 133a-1), MIR199A1 (microRNA 199a-1), MIR140 (microRNA 140)"], "WAG002011": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide), ALDH1A1 (aldehyde dehydrogenase 1 family member A1), MTHFR (methylenetetrahydrofolate reductase), CYP2E1 (cytochrome P450 family 2 subfamily E member 1), CBS (cystathionine beta-synthase), ALDH1L1 (aldehyde dehydrogenase 1 family member L1), CEBPB (CCAAT enhancer binding protein beta), CREB1 (cAMP responsive element binding protein 1), CBSL (cystathionine beta-synthase like)"], "WAG002014": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TYMS (thymidylate synthetase), DPYD (dihydropyrimidine dehydrogenase), UPP1 (uridine phosphorylase 1), CDA (cytidine deaminase), TYMP (thymidine phosphorylase), TK1 (thymidine kinase 1), UCK2 (uridine-cytidine kinase 2), UMPS (uridine monophosphate synthetase), TP53 (tumor protein p53), DHFR (dihydrofolate reductase), RRM2 (ribonucleotide reductase regulatory subunit M2), UPP2 (uridine phosphorylase 2), FPGS (folylpolyglutamate synthase), RRM1 (ribonucleotide reductase catalytic subunit M1), GGH (gamma-glutamyl hydrolase), UCK1 (uridine-cytidine kinase 1), MTHFR (methylenetetrahydrofolate reductase), DPYS (dihydropyrimidinase), ABCC4 (ATP binding cassette subfamily C member 4), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), ABCC3 (ATP binding cassette subfamily C member 3), ABCC5 (ATP binding cassette subfamily C member 5), ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)), UPB1 (beta-ureidopropionase 1), TDG (thymine DNA glycosylase), SMUG1 (single-strand-selective monofunctional uracil-DNA glycosylase 1), PPAT (phosphoribosyl pyrophosphate amidotransferase), XRCC3 (X-ray repair cross complementing 3), SLC29A1 (solute carrier family 29 member 1 (Augustine blood group)), SLC22A7 (solute carrier family 22 member 7), CES2 (carboxylesterase 2), CES1 (carboxylesterase 1), CYP2A6 (cytochrome P450 family 2 subfamily A member 6), MIR29C (microRNA 29c)"], "WAG002021": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL6 (interleukin 6), ALB (albumin), TNF (tumor necrosis factor), CRP (C-reactive protein), ICAM1 (intercellular adhesion molecule 1), APOA1 (apolipoprotein A1), IL1B (interleukin 1 beta), F2 (coagulation factor II, thrombin), NFKB1 (nuclear factor kappa B subunit 1), SOD2 (superoxide dismutase 2), CCL2 (C-C motif chemokine ligand 2), APOB (apolipoprotein B), SERPINE1 (serpin family E member 1), MTHFR (methylenetetrahydrofolate reductase), TP53 (tumor protein p53), IFNG (interferon gamma), IL2 (interleukin 2), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1), SHMT1 (serine hydroxymethyltransferase 1), PLAT (plasminogen activator, tissue type), PLG (plasminogen), RELA (RELA proto-oncogene, NF-kB subunit), IL4 (interleukin 4), SHMT2 (serine hydroxymethyltransferase 2), MPO (myeloperoxidase), FGA (fibrinogen alpha chain), FGG (fibrinogen gamma chain), CAT (catalase), SCARB1 (scavenger receptor class B member 1), DHFR (dihydrofolate reductase), CBS (cystathionine beta-synthase), SAA1 (serum amyloid A1), LDLR (low density lipoprotein receptor), GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase), FGB (fibrinogen beta chain), MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase), GPX1 (glutathione peroxidase 1), ABCA1 (ATP binding cassette subfamily A member 1), SOD1 (superoxide dismutase 1), CSF1 (colony stimulating factor 1), AHCY (adenosylhomocysteinase), F7 (coagulation factor VII), MAT1A (methionine adenosyltransferase 1A), NFKB2 (nuclear factor kappa B subunit 2), CTH (cystathionine gamma-lyase), GPX4 (glutathione peroxidase 4), MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), INSR (insulin receptor), SOD3 (superoxide dismutase 3), MTHFS (methenyltetrahydrofolate synthetase), FOLR1 (folate receptor alpha), SAA2 (serum amyloid A2), SLC19A1 (solute carrier family 19 member 1), SERPINA3 (serpin family A member 3), GPX2 (glutathione peroxidase 2), INS (insulin), GPX3 (glutathione peroxidase 3), FLAD1 (flavin adenine dinucleotide synthetase 1), GPX6 (glutathione peroxidase 6), SAA4 (serum amyloid A4, constitutive), RFK (riboflavin kinase), FOLR2 (folate receptor beta), HBB (hemoglobin subunit beta), SLC46A1 (solute carrier family 46 member 1), NOS1 (nitric oxide synthase 1), FOLR3 (folate receptor gamma), IZUMO1R (IZUMO1 receptor, JUNO), SAA3P (serum amyloid A3, pseudogene), CBSL (cystathionine beta-synthase like), HBA1 (hemoglobin subunit alpha 1), SOD2-OT1 (SOD2 overlapping transcript 1)"], "WAG002022": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP8 (caspase 8), CASP3 (caspase 3), BCL2 (BCL2 apoptosis regulator), FADD (Fas associated via death domain), TP53 (tumor protein p53), CASP9 (caspase 9), TNFRSF1A (TNF receptor superfamily member 1A), BIRC3 (baculoviral IAP repeat containing 3), BID (BH3 interacting domain death agonist), BCL2L1 (BCL2 like 1), BAX (BCL2 associated X, apoptosis regulator), BIRC2 (baculoviral IAP repeat containing 2), TRADD (TNFRSF1A associated via death domain), APAF1 (apoptotic peptidase activating factor 1), FASLG (Fas ligand), RIPK1 (receptor interacting serine/threonine kinase 1), CASP10 (caspase 10), FAS (Fas cell surface death receptor), CASP7 (caspase 7), DIABLO (diablo IAP-binding mitochondrial protein), CFLAR (CASP8 and FADD like apoptosis regulator), MAPK8 (mitogen-activated protein kinase 8), XIAP (X-linked inhibitor of apoptosis), TRAF6 (TNF receptor associated factor 6), CASP2 (caspase 2), TNFSF10 (TNF superfamily member 10), TNFRSF10B (TNF receptor superfamily member 10b), MCL1 (MCL1 apoptosis regulator, BCL2 family member), NFKB1 (nuclear factor kappa B subunit 1), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), CYCS (cytochrome c, somatic), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CASP1 (caspase 1), BCL2L11 (BCL2 like 11), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CASP6 (caspase 6), TNFRSF10A (TNF receptor superfamily member 10a), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), TRAF3 (TNF receptor associated factor 3), BAD (BCL2 associated agonist of cell death), IL1R1 (interleukin 1 receptor type 1), BIRC5 (baculoviral IAP repeat containing 5), NFKBIA (NFKB inhibitor alpha), MAPK3 (mitogen-activated protein kinase 3), BCL2L2 (BCL2 like 2), BCL2A1 (BCL2 related protein A1), AIFM1 (apoptosis inducing factor mitochondria associated 1), DFFA (DNA fragmentation factor subunit alpha), BAK1 (BCL2 antagonist/killer 1), DAXX (death domain associated protein), CRADD (CASP2 and RIPK1 domain containing adaptor with death domain), MYD88 (MYD88 innate immune signal transduction adaptor), IRAK1 (interleukin 1 receptor associated kinase 1), TNFRSF10D (TNF receptor superfamily member 10d), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), CASP4 (caspase 4), HTRA2 (HtrA serine peptidase 2), HRK (harakiri, BCL2 interacting protein), TNFRSF1B (TNF receptor superfamily member 1B), BBC3 (BCL2 binding component 3), BMF (Bcl2 modifying factor), IL1R2 (interleukin 1 receptor type 2), TNFRSF10C (TNF receptor superfamily member 10c), BIRC7 (baculoviral IAP repeat containing 7), BIK (BCL2 interacting killer), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), NAIP (NLR family apoptosis inhibitory protein), CDKN2A (cyclin dependent kinase inhibitor 2A), MADD (MAP kinase activating death domain), TOLLIP (toll interacting protein), ENDOG (endonuclease G), BIRC6 (baculoviral IAP repeat containing 6), BAG3 (BAG cochaperone 3), BCL2L10 (BCL2 like 10), PTPN13 (protein tyrosine phosphatase non-receptor type 13), DFFB (DNA fragmentation factor subunit beta), TNFRSF25 (TNF receptor superfamily member 25), PEA15 (proliferation and apoptosis adaptor protein 15), BNIP3 (BCL2 interacting protein 3), BOK (BCL2 family apoptosis regulator BOK), PRKD1 (protein kinase D1), TNFRSF11B (TNF receptor superfamily member 11b), BLK (BLK proto-oncogene, Src family tyrosine kinase), CAPNS1 (calpain small subunit 1), TNFRSF6B (TNF receptor superfamily member 6b), AIFM2 (apoptosis inducing factor mitochondria associated 2), PTRH2 (peptidyl-tRNA hydrolase 2), PIDD1 (p53-induced death domain protein 1), HSPA1A (heat shock protein family A (Hsp70) member 1A), MIR29B2 (microRNA 29b-2), MIR29B1 (microRNA 29b-1), SEPTIN4 (septin 4), RNR2 (RNA, ribosomal 45S cluster 2), RNR2 (l-rRNA)"], "WAG002023": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PLK1 (polo like kinase 1), CDC20 (cell division cycle 20), CDK1 (cyclin dependent kinase 1), BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B), AURKB (aurora kinase B), CDK2 (cyclin dependent kinase 2), BUB3 (BUB3 mitotic checkpoint protein), CDC6 (cell division cycle 6), UBE2C (ubiquitin conjugating enzyme E2 C), CCNB1 (cyclin B1), BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), CDC25A (cell division cycle 25A), BIRC5 (baculoviral IAP repeat containing 5), CDC27 (cell division cycle 27), NDC80 (NDC80 kinetochore complex component), KNTC1 (kinetochore associated 1), CDCA8 (cell division cycle associated 8), CDC16 (cell division cycle 16), UBB (ubiquitin B), BRCA1 (BRCA1 DNA repair associated), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CHEK1 (checkpoint kinase 1), CENPA (centromere protein A), PPP1CC (protein phosphatase 1 catalytic subunit gamma), CENPF (centromere protein F), CDC23 (cell division cycle 23), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA3 (proteasome 20S subunit alpha 3), NUF2 (NUF2 component of NDC80 kinetochore complex), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMC2 (proteasome 26S subunit, ATPase 2), XPO1 (exportin 1), KIF2C (kinesin family member 2C), MAD2L1 (mitotic arrest deficient 2 like 1), ORC1 (origin recognition complex subunit 1), SPC25 (SPC25 component of NDC80 kinetochore complex), PSMA6 (proteasome 20S subunit alpha 6), CENPE (centromere protein E), PSMC5 (proteasome 26S subunit, ATPase 5), ANAPC1 (anaphase promoting complex subunit 1), ANAPC10 (anaphase promoting complex subunit 10), PSMA2 (proteasome 20S subunit alpha 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), ANAPC4 (anaphase promoting complex subunit 4), PSMB3 (proteasome 20S subunit beta 3), ANAPC2 (anaphase promoting complex subunit 2), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA1 (proteasome 20S subunit alpha 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD1 (proteasome 26S subunit, non-ATPase 1), CENPN (centromere protein N), ZWILCH (zwilch kinetochore protein), PSMD13 (proteasome 26S subunit, non-ATPase 13), CDKN1A (cyclin dependent kinase inhibitor 1A), ANAPC5 (anaphase promoting complex subunit 5), PSMB2 (proteasome 20S subunit beta 2), PSMA5 (proteasome 20S subunit alpha 5), KIF18A (kinesin family member 18A), PSMB4 (proteasome 20S subunit beta 4), ANAPC7 (anaphase promoting complex subunit 7), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), CENPK (centromere protein K), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMB7 (proteasome 20S subunit beta 7), PSMA7 (proteasome 20S subunit alpha 7), ZWINT (ZW10 interacting kinetochore protein), PSME3 (proteasome activator subunit 3), ANAPC11 (anaphase promoting complex subunit 11), PSMB6 (proteasome 20S subunit beta 6), PSMB1 (proteasome 20S subunit beta 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), CDC26 (cell division cycle 26), TP53 (tumor protein p53), PSMB5 (proteasome 20S subunit beta 5), RFC4 (replication factor C subunit 4), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD3 (proteasome 26S subunit, non-ATPase 3), CENPH (centromere protein H), CCNA2 (cyclin A2), PSMB10 (proteasome 20S subunit beta 10), MAPRE1 (microtubule associated protein RP/EB family member 1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD7 (proteasome 26S subunit, non-ATPase 7), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), PSME1 (proteasome activator subunit 1), UBE2E1 (ubiquitin conjugating enzyme E2 E1), CKAP5 (cytoskeleton associated protein 5), PSMD5 (proteasome 26S subunit, non-ATPase 5), MCM6 (minichromosome maintenance complex component 6), PSMD9 (proteasome 26S subunit, non-ATPase 9), CENPM (centromere protein M), INCENP (inner centromere protein), PSMF1 (proteasome inhibitor subunit 1), NUP37 (nucleoporin 37), CLASP1 (cytoplasmic linker associated protein 1), PSMA8 (proteasome 20S subunit alpha 8), ERCC6L (ERCC excision repair 6 like, spindle assembly checkpoint helicase)"], "WAG002024": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA7 (proteasome 20S subunit alpha 7), PSMA2 (proteasome 20S subunit alpha 2), PSMA1 (proteasome 20S subunit alpha 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA3 (proteasome 20S subunit alpha 3), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB2 (proteasome 20S subunit beta 2), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA4 (proteasome 20S subunit alpha 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB5 (proteasome 20S subunit beta 5), PSMA6 (proteasome 20S subunit alpha 6), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB4 (proteasome 20S subunit beta 4), PSMB10 (proteasome 20S subunit beta 10), PSMB1 (proteasome 20S subunit beta 1), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB3 (proteasome 20S subunit beta 3), PSMA5 (proteasome 20S subunit alpha 5), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMB6 (proteasome 20S subunit beta 6), PSME4 (proteasome activator subunit 4), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), UBB (ubiquitin B), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), VCP (valosin containing protein), CFTR (CF transmembrane conductance regulator), ABCC4 (ATP binding cassette subfamily C member 4), ABCF1 (ATP binding cassette subfamily F member 1), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), RNF185 (ring finger protein 185), EIF2S2 (eukaryotic translation initiation factor 2 subunit beta), ABCC5 (ATP binding cassette subfamily C member 5), ABCD3 (ATP binding cassette subfamily D member 3), DERL1 (derlin 1), EIF2S3 (eukaryotic translation initiation factor 2 subunit gamma), ABCC2 (ATP binding cassette subfamily C member 2), ABCC3 (ATP binding cassette subfamily C member 3), RPS27A (ribosomal protein S27a), ABCB8 (ATP binding cassette subfamily B member 8), ABCB1 (ATP binding cassette subfamily B member 1), ABCC1 (ATP binding cassette subfamily C member 1), ABCB10 (ATP binding cassette subfamily B member 10), SEL1L (SEL1L adaptor subunit of ERAD E3 ubiquitin ligase), ABCC9 (ATP binding cassette subfamily C member 9), ABCB6 (ATP binding cassette subfamily B member 6 (Langereis blood group)), ERLIN2 (ER lipid raft associated 2), OS9 (OS9 endoplasmic reticulum lectin), PEX19 (peroxisomal biogenesis factor 19), ABCD1 (ATP binding cassette subfamily D member 1), ABCG1 (ATP binding cassette subfamily G member 1), DERL2 (derlin 2), ABCA3 (ATP binding cassette subfamily A member 3), APOA1 (apolipoprotein A1), ABCD2 (ATP binding cassette subfamily D member 2), ABCB4 (ATP binding cassette subfamily B member 4), ERLEC1 (endoplasmic reticulum lectin 1), ABCG5 (ATP binding cassette subfamily G member 5), ABCB9 (ATP binding cassette subfamily B member 9), ABCA7 (ATP binding cassette subfamily A member 7), ABCC6 (ATP binding cassette subfamily C member 6), RNF5 (ring finger protein 5), ABCG8 (ATP binding cassette subfamily G member 8), ABCB7 (ATP binding cassette subfamily B member 7), ABCA2 (ATP binding cassette subfamily A member 2), KCNJ11 (potassium inwardly rectifying channel subfamily J member 11), ABCG4 (ATP binding cassette subfamily G member 4), PEX3 (peroxisomal biogenesis factor 3), ERLIN1 (ER lipid raft associated 1), ABCA4 (ATP binding cassette subfamily A member 4), ABCA6 (ATP binding cassette subfamily A member 6), ABCA5 (ATP binding cassette subfamily A member 5), ABCC10 (ATP binding cassette subfamily C member 10), ABCB5 (ATP binding cassette subfamily B member 5), DERL3 (derlin 3), ABCA8 (ATP binding cassette subfamily A member 8), ABCA12 (ATP binding cassette subfamily A member 12), ABCA9 (ATP binding cassette subfamily A member 9)"], "WAG002027": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), VCP (valosin containing protein), DPM1 (dolichyl-phosphate mannosyltransferase subunit 1, catalytic), CANX (calnexin), RPN1 (ribophorin I), DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit), ALG5 (ALG5 dolichyl-phosphate beta-glucosyltransferase), STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A), ALG3 (ALG3 alpha-1,3- mannosyltransferase), DPAGT1 (dolichyl-phosphate N-acetylglucosaminephosphotransferase 1), AMFR (autocrine motility factor receptor), B4GALT1 (beta-1,4-galactosyltransferase 1), ALG1 (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase), DERL1 (derlin 1), GANAB (glucosidase II alpha subunit), ALG8 (ALG8 alpha-1,3-glucosyltransferase), B4GALT3 (beta-1,4-galactosyltransferase 3), PMM2 (phosphomannomutase 2), MOGS (mannosyl-oligosaccharide glucosidase), EDEM1 (ER degradation enhancing alpha-mannosidase like protein 1), RPN2 (ribophorin II), MAN1B1 (mannosidase alpha class 1B member 1), DPM2 (dolichyl-phosphate mannosyltransferase subunit 2, regulatory), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), DPM3 (dolichyl-phosphate mannosyltransferase subunit 3, regulatory), SYVN1 (synoviolin 1), SEL1L (SEL1L adaptor subunit of ERAD E3 ubiquitin ligase), GMDS (GDP-mannose 4,6-dehydratase), MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase), MAN1A1 (mannosidase alpha class 1A member 1), GMPPB (GDP-mannose pyrophosphorylase B), MAN2A1 (mannosidase alpha class 2A member 1), OS9 (OS9 endoplasmic reticulum lectin), RAD23B (RAD23 homolog B, nucleotide excision repair protein), DAD1 (defender against cell death 1), MGAT2 (alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase), FUT8 (fucosyltransferase 8), B4GALT6 (beta-1,4-galactosyltransferase 6), DERL2 (derlin 2), B4GALT4 (beta-1,4-galactosyltransferase 4), DOLK (dolichol kinase), GMPPA (GDP-mannose pyrophosphorylase A), MAN1A2 (mannosidase alpha class 1A member 2), UGGT2 (UDP-glucose glycoprotein glucosyltransferase 2), ALG6 (ALG6 alpha-1,3-glucosyltransferase), CALR (calreticulin), DOLPP1 (dolichyldiphosphatase 1), PDIA3 (protein disulfide isomerase family A member 3), NGLY1 (N-glycanase 1), TUSC3 (tumor suppressor candidate 3), PRKCSH (protein kinase C substrate 80K-H), GFPT2 (glutamine-fructose-6-phosphate transaminase 2), UBB (ubiquitin B), B4GALT2 (beta-1,4-galactosyltransferase 2), MAGT1 (magnesium transporter 1), PSMC1 (proteasome 26S subunit, ATPase 1), FUT3 (fucosyltransferase 3 (Lewis blood group)), ASGR2 (asialoglycoprotein receptor 2), ALG12 (ALG12 alpha-1,6-mannosyltransferase), ALG9 (ALG9 alpha-1,2-mannosyltransferase), MPI (mannose phosphate isomerase), PGM3 (phosphoglucomutase 3), ST8SIA3 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3), MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase), MAN1C1 (mannosidase alpha class 1C member 1), MGAT3 (beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase), ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2), MGAT4B (alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B), UBXN1 (UBX domain protein 1), ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1), RNF185 (ring finger protein 185), RPS27A (ribosomal protein S27a), GFPT1 (glutamine--fructose-6-phosphate transaminase 1), ASGR1 (asialoglycoprotein receptor 1), UGGT1 (UDP-glucose glycoprotein glucosyltransferase 1), GNPNAT1 (glucosamine-phosphate N-acetyltransferase 1), MGAT4A (alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A), PMM1 (phosphomannomutase 1), MGAT4C (MGAT4 family member C), EDEM3 (ER degradation enhancing alpha-mannosidase like protein 3), NAGK (N-acetylglucosamine kinase), AMDHD2 (amidohydrolase domain containing 2), B4GALT5 (beta-1,4-galactosyltransferase 5), ALG14 (ALG14 UDP-N-acetylglucosaminyltransferase subunit), ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4), MPDU1 (mannose-P-dolichol utilization defect 1), ALG13 (ALG13 UDP-N-acetylglucosaminyltransferase subunit), LMAN1 (lectin, mannose binding 1), RNF5 (ring finger protein 5), MLEC (malectin), EDEM2 (ER degradation enhancing alpha-mannosidase like protein 2), MAN2A2 (mannosidase alpha class 2A member 2), TRIM13 (tripartite motif containing 13), ALG2 (ALG2 alpha-1,3/1,6-mannosyltransferase), RNF103 (ring finger protein 103), ALG10 (ALG10 alpha-1,2-glucosyltransferase), SLC35C1 (solute carrier family 35 member C1), LHB (luteinizing hormone subunit beta), RFT1 (RFT1 homolog), ALG10B (ALG10 alpha-1,2-glucosyltransferase B)"], "WAG002030": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDK2 (cyclin dependent kinase 2), CDK1 (cyclin dependent kinase 1), CCNB1 (cyclin B1), CDKN1A (cyclin dependent kinase inhibitor 1A), CDC25A (cell division cycle 25A), CCNA2 (cyclin A2), PCNA (proliferating cell nuclear antigen), CDK4 (cyclin dependent kinase 4), CDC6 (cell division cycle 6), CCNE1 (cyclin E1), PLK1 (polo like kinase 1), RB1 (RB transcriptional corepressor 1), E2F1 (E2F transcription factor 1), TP53 (tumor protein p53), CCNE2 (cyclin E2), MYC (MYC proto-oncogene, bHLH transcription factor), CCND1 (cyclin D1), CDKN1B (cyclin dependent kinase inhibitor 1B), SKP2 (S-phase kinase associated protein 2), FZR1 (fizzy and cell division cycle 20 related 1), CHEK1 (checkpoint kinase 1), CCNA1 (cyclin A1), CDC20 (cell division cycle 20), CCNB2 (cyclin B2), MCM3 (minichromosome maintenance complex component 3), MCM7 (minichromosome maintenance complex component 7), CDC7 (cell division cycle 7), TFDP1 (transcription factor Dp-1), MCM2 (minichromosome maintenance complex component 2), HDAC1 (histone deacetylase 1), EP300 (E1A binding protein p300), ORC1 (origin recognition complex subunit 1), MCM4 (minichromosome maintenance complex component 4), CDC45 (cell division cycle 45), MCM6 (minichromosome maintenance complex component 6), MCM5 (minichromosome maintenance complex component 5), CDK6 (cyclin dependent kinase 6), CDC27 (cell division cycle 27), CDKN2A (cyclin dependent kinase inhibitor 2A), E2F3 (E2F transcription factor 3), CCND3 (cyclin D3), BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), CDC16 (cell division cycle 16), E2F4 (E2F transcription factor 4), CDC25C (cell division cycle 25C), CCND2 (cyclin D2), RBL1 (RB transcriptional corepressor like 1), CUL1 (cullin 1), CDC23 (cell division cycle 23), E2F5 (E2F transcription factor 5), CDK7 (cyclin dependent kinase 7), RBL2 (RB transcriptional corepressor like 2), CCNH (cyclin H), E2F2 (E2F transcription factor 2), ATM (ATM serine/threonine kinase), TFDP2 (transcription factor Dp-2), ORC4 (origin recognition complex subunit 4), ORC2 (origin recognition complex subunit 2), MDM2 (MDM2 proto-oncogene), ANAPC2 (anaphase promoting complex subunit 2), ORC3 (origin recognition complex subunit 3), ANAPC5 (anaphase promoting complex subunit 5), CHEK2 (checkpoint kinase 2), ANAPC10 (anaphase promoting complex subunit 10), WEE1 (WEE1 G2 checkpoint kinase), SMAD2 (SMAD family member 2), SKP1 (S-phase kinase associated protein 1), ATR (ATR serine/threonine kinase), ANAPC4 (anaphase promoting complex subunit 4), ORC5 (origin recognition complex subunit 5), TTK (TTK protein kinase), BUB3 (BUB3 mitotic checkpoint protein), ORC6 (origin recognition complex subunit 6), ANAPC1 (anaphase promoting complex subunit 1), SMAD3 (SMAD family member 3), ANAPC7 (anaphase promoting complex subunit 7), ESPL1 (extra spindle pole bodies like 1, separase), CDC25B (cell division cycle 25B), RBX1 (ring-box 1), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), PTTG1 (PTTG1 regulator of sister chromatid separation, securin), ANAPC11 (anaphase promoting complex subunit 11), DBF4 (DBF4 zinc finger), SMAD4 (SMAD family member 4), RAD21 (RAD21 cohesin complex component), ANAPC13 (anaphase promoting complex subunit 13), CDC14A (cell division cycle 14A), CCNB3 (cyclin B3), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), HDAC2 (histone deacetylase 2), SMC1A (structural maintenance of chromosomes 1A), CDKN1C (cyclin dependent kinase inhibitor 1C), MAD2L2 (mitotic arrest deficient 2 like 2), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), SFN (stratifin), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), SMC3 (structural maintenance of chromosomes 3), CDKN2C (cyclin dependent kinase inhibitor 2C), CDKN2B (cyclin dependent kinase inhibitor 2B)"], "WAG002031": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNA1 (catenin alpha 1), CLDN9 (claudin 9), CLDN17 (claudin 17), CLDN20 (claudin 20), CLDN15 (claudin 15), CTNND1 (catenin delta 1), CLDN14 (claudin 14), CLDN11 (claudin 11), CLDN10 (claudin 10), CLDN19 (claudin 19), CLDN3 (claudin 3), CLDN16 (claudin 16), CLDN18 (claudin 18), CLDN22 (claudin 22), CLDN1 (claudin 1), CLDN5 (claudin 5), CLDN7 (claudin 7), CLDN2 (claudin 2), CLDN6 (claudin 6), JUP (junction plakoglobin), CDH5 (cadherin 5), CLDN8 (claudin 8), CLDN4 (claudin 4), ITGB4 (integrin subunit beta 4), CDH2 (cadherin 2), CDH4 (cadherin 4), CDH6 (cadherin 6), CDH11 (cadherin 11), CDH9 (cadherin 9), ITGB1 (integrin subunit beta 1), ITGA6 (integrin subunit alpha 6), CDH10 (cadherin 10), CDH15 (cadherin 15), CDH18 (cadherin 18), CDH12 (cadherin 12), CDH24 (cadherin 24), CDH8 (cadherin 8), CDH13 (cadherin 13), CDH1 (cadherin 1), CLDN23 (claudin 23), ILK (integrin linked kinase), ACTN1 (actinin alpha 1), PARD6A (par-6 family cell polarity regulator alpha), COL17A1 (collagen type XVII alpha 1 chain), VASP (vasodilator stimulated phosphoprotein), LAMC2 (laminin subunit gamma 2), F11R (F11 receptor), LAMB3 (laminin subunit beta 3), PARD3 (par-3 family cell polarity regulator), PXN (paxillin), PARD6G (par-6 family cell polarity regulator gamma), FLNA (filamin A), PLEC (plectin), CLDN12 (claudin 12), CD151 (CD151 molecule (Raph blood group)), PARVB (parvin beta), CDH3 (cadherin 3), PARD6B (par-6 family cell polarity regulator beta), PRKCI (protein kinase C iota), CDH7 (cadherin 7), LAMA3 (laminin subunit alpha 3), FLNC (filamin C), MPP5 (membrane palmitoylated protein 5), FBLIM1 (filamin binding LIM protein 1), LIMS1 (LIM zinc finger domain containing 1), FERMT2 (fermitin family member 2), CRB3 (crumbs cell polarity complex component 3), CADM1 (cell adhesion molecule 1), DST (dystonin), RSU1 (Ras suppressor protein 1), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), CDH17 (cadherin 17), LIMS2 (LIM zinc finger domain containing 2), PVR (PVR cell adhesion molecule), CADM3 (cell adhesion molecule 3), ANG (angiogenin), NECTIN1 (nectin cell adhesion molecule 1), TESK1 (testis associated actin remodelling kinase 1), PATJ (PATJ crumbs cell polarity complex component), NECTIN2 (nectin cell adhesion molecule 2), SDK2 (sidekick cell adhesion molecule 2), NECTIN3 (nectin cell adhesion molecule 3), SDK1 (sidekick cell adhesion molecule 1), CADM2 (cell adhesion molecule 2), SLC7A14-AS1 (SLC7A14 antisense RNA 1), NECTIN4 (nectin cell adhesion molecule 4)"], "WAG002032": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FYN (FYN proto-oncogene, Src family tyrosine kinase), ITGB1 (integrin subunit beta 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), ITGB2 (integrin subunit beta 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PTPN11 (protein tyrosine phosphatase non-receptor type 11), FN1 (fibronectin 1), LCK (LCK proto-oncogene, Src family tyrosine kinase), SHC1 (SHC adaptor protein 1), CD44 (CD44 molecule (Indian blood group)), ITGAM (integrin subunit alpha M), ITGAV (integrin subunit alpha V), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), TEK (TEK receptor tyrosine kinase), ANGPT1 (angiopoietin 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), ITGB3 (integrin subunit beta 3), ITGA4 (integrin subunit alpha 4), SELE (selectin E), HRAS (HRas proto-oncogene, GTPase), ITGA5 (integrin subunit alpha 5), ITGA6 (integrin subunit alpha 6), PTPN6 (protein tyrosine phosphatase non-receptor type 6), FCER1G (Fc fragment of IgE receptor Ig), LYN (LYN proto-oncogene, Src family tyrosine kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), ITGAL (integrin subunit alpha L), INPP5D (inositol polyphosphate-5-phosphatase D), NRAS (NRAS proto-oncogene, GTPase), PLCG1 (phospholipase C gamma 1), SELL (selectin L), CD2 (CD2 molecule), ITGAX (integrin subunit alpha X), CD47 (CD47 molecule), CAV1 (caveolin 1), ITGA3 (integrin subunit alpha 3), BSG (basigin (Ok blood group)), SELP (selectin P), TGFB1 (transforming growth factor beta 1), CD58 (CD58 molecule), SLC3A2 (solute carrier family 3 member 2), SPN (sialophorin), F11R (F11 receptor), SELPLG (selectin P ligand), SLC7A5 (solute carrier family 7 member 5), F2 (coagulation factor II, thrombin), PF4 (platelet factor 4), CEACAM1 (CEA cell adhesion molecule 1), ANGPT2 (angiopoietin 2), DOK2 (docking protein 2), GP6 (glycoprotein VI platelet), JAM3 (junctional adhesion molecule 3), PROC (protein C, inactivator of coagulation factors Va and VIIIa), GRB7 (growth factor receptor bound protein 7), CD48 (CD48 molecule), GPC1 (glypican 1), APOB (apolipoprotein B), JAM2 (junctional adhesion molecule 2), THBD (thrombomodulin), PSG3 (pregnancy specific beta-1-glycoprotein 3), ESAM (endothelial cell adhesion molecule), L1CAM (L1 cell adhesion molecule), SIRPA (signal regulatory protein alpha), MERTK (MER proto-oncogene, tyrosine kinase), PSG5 (pregnancy specific beta-1-glycoprotein 5), CD74 (CD74 molecule), PSG2 (pregnancy specific beta-1-glycoprotein 2), PSG1 (pregnancy specific beta-1-glycoprotein 1), PSG9 (pregnancy specific beta-1-glycoprotein 9), GAS6 (growth arrest specific 6), PSG4 (pregnancy specific beta-1-glycoprotein 4), CEACAM8 (CEA cell adhesion molecule 8), CEACAM6 (CEA cell adhesion molecule 6), PSG8 (pregnancy specific beta-1-glycoprotein 8), CEACAM5 (CEA cell adhesion molecule 5), PROCR (protein C receptor), MMP1 (matrix metallopeptidase 1), SLC7A11 (solute carrier family 7 member 11), CEACAM3 (CEA cell adhesion molecule 3), PICK1 (protein interacting with PRKCA 1), GLG1 (golgi glycoprotein 1), PROS1 (protein S), PPIA (peptidylprolyl isomerase A), GRB14 (growth factor receptor bound protein 14), SLC16A1 (solute carrier family 16 member 1), GYPA (glycophorin A (MNS blood group)), SLC7A9 (solute carrier family 7 member 9), SLC7A8 (solute carrier family 7 member 8), TNFRSF10B (TNF receptor superfamily member 10b), SLC16A3 (solute carrier family 16 member 3), SLC16A8 (solute carrier family 16 member 8), SLC7A7 (solute carrier family 7 member 7), ANGPT4 (angiopoietin 4), MIF (macrophage migration inhibitory factor), TNFRSF10D (TNF receptor superfamily member 10d), MAG (myelin associated glycoprotein), SLC7A10 (solute carrier family 7 member 10), ATP1B2 (ATPase Na+/K+ transporting subunit beta 2), ATP1B1 (ATPase Na+/K+ transporting subunit beta 1)"], "WAG002033": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MSMO1 (methylsterol monooxygenase 1), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), SQLE (squalene epoxidase), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), IDI1 (isopentenyl-diphosphate delta isomerase 1), FDPS (farnesyl diphosphate synthase), NSDHL (NAD(P) dependent steroid dehydrogenase-like), DHCR7 (7-dehydrocholesterol reductase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), LSS (lanosterol synthase), MVD (mevalonate diphosphate decarboxylase), DHCR24 (24-dehydrocholesterol reductase), TM7SF2 (transmembrane 7 superfamily member 2), PMVK (phosphomevalonate kinase), MVK (mevalonate kinase), HSD17B7 (hydroxysteroid 17-beta dehydrogenase 7), EBP (EBP cholestenol delta-isomerase), LBR (lamin B receptor), GGPS1 (geranylgeranyl diphosphate synthase 1), ACAT2 (acetyl-CoA acetyltransferase 2), IDI2 (isopentenyl-diphosphate delta isomerase 2), PLPP6 (phospholipid phosphatase 6), SC5D (sterol-C5-desaturase), ARV1 (ARV1 homolog, fatty acid homeostasis modulator)"], "WAG002034": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), EP300 (E1A binding protein p300), ARNTL (aryl hydrocarbon receptor nuclear translocator like), HDAC3 (histone deacetylase 3), CREBBP (CREB binding protein), CLOCK (clock circadian regulator), NPAS2 (neuronal PAS domain protein 2), PPARGC1A (PPARG coactivator 1 alpha), RORA (RAR related orphan receptor A), HIF1A (hypoxia inducible factor 1 subunit alpha), RXRA (retinoid X receptor alpha), CARM1 (coactivator associated arginine methyltransferase 1), NCOA2 (nuclear receptor coactivator 2), PPARA (peroxisome proliferator activated receptor alpha), NCOA6 (nuclear receptor coactivator 6), TBL1XR1 (TBL1X receptor 1), NCOA1 (nuclear receptor coactivator 1), CRY1 (cryptochrome circadian regulator 1), NCOR1 (nuclear receptor corepressor 1), PER2 (period circadian regulator 2), CHD9 (chromodomain helicase DNA binding protein 9), CRY2 (cryptochrome circadian regulator 2), TGS1 (trimethylguanosine synthase 1), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), SIRT1 (sirtuin 1), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), SKP1 (S-phase kinase associated protein 1), CUL1 (cullin 1), NR3C1 (nuclear receptor subfamily 3 group C member 1), NR1D1 (nuclear receptor subfamily 1 group D member 1), CSNK1E (casein kinase 1 epsilon), CREB1 (cAMP responsive element binding protein 1), PER1 (period circadian regulator 1), UBB (ubiquitin B), BHLHE41 (basic helix-loop-helix family member e41), CSNK1D (casein kinase 1 delta), FBXL3 (F-box and leucine rich repeat protein 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), NRIP1 (nuclear receptor interacting protein 1), MEF2D (myocyte enhancer factor 2D), MEF2C (myocyte enhancer factor 2C), NFIL3 (nuclear factor, interleukin 3 regulated), PPP1CA (protein phosphatase 1 catalytic subunit alpha), PPP1CC (protein phosphatase 1 catalytic subunit gamma), CRTC2 (CREB regulated transcription coactivator 2), TBL1X (transducin beta like 1 X-linked), ATF2 (activating transcription factor 2), RPS27A (ribosomal protein S27a), SIK1 (salt inducible kinase 1), PPP1CB (protein phosphatase 1 catalytic subunit beta), CRTC1 (CREB regulated transcription coactivator 1), RBM4 (RNA binding motif protein 4), USP46 (ubiquitin specific peptidase 46), RAI1 (retinoic acid induced 1), CRTC3 (CREB regulated transcription coactivator 3), MED1 (mediator complex subunit 1), HELZ2 (helicase with zinc finger 2)"], "WAG002035": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "C3 (complement C3), C4A (complement C4A (Rodgers blood group)), C1R (complement C1r), C5 (complement C5), CFI (complement factor I), C2 (complement C2), C4B (complement C4B (Chido blood group)), MASP1 (mannan binding lectin serine peptidase 1), C1S (complement C1s), C7 (complement C7), MBL2 (mannose binding lectin 2), SERPING1 (serpin family G member 1), C9 (complement C9), C1QA (complement C1q A chain), CR1 (complement C3b/C4b receptor 1 (Knops blood group)), CRP (C-reactive protein), CFB (complement factor B), F2 (coagulation factor II, thrombin), C8A (complement C8 alpha chain), C1QB (complement C1q B chain), C4BPA (complement component 4 binding protein alpha), C6 (complement C6), CPB2 (carboxypeptidase B2), CD55 (CD55 molecule (Cromer blood group)), CD46 (CD46 molecule), C1QC (complement C1q C chain), C8B (complement C8 beta chain), C4BPB (complement component 4 binding protein beta), C8G (complement C8 gamma chain), CR2 (complement C3d receptor 2), CFHR1 (complement factor H related 1), CFH (complement factor H), CLU (clusterin), C5AR1 (complement C5a receptor 1), CD59 (CD59 molecule (CD59 blood group)), C3AR1 (complement C3a receptor 1), PROS1 (protein S), CPN1 (carboxypeptidase N subunit 1), CD81 (CD81 molecule), FCN2 (ficolin 2), CPN2 (carboxypeptidase N subunit 2), CD19 (CD19 molecule), CFD (complement factor D), CFHR4 (complement factor H related 4), CFHR3 (complement factor H related 3), FCN3 (ficolin 3), CFHR2 (complement factor H related 2), CFHR5 (complement factor H related 5), VTN (vitronectin), COLEC11 (collectin subfamily member 11), ELANE (elastase, neutrophil expressed), GZMM (granzyme M), COLEC10 (collectin subfamily member 10), LOC110384692 (complement C4A (Rodgers blood group)-like), C5AR2 (complement component 5a receptor 2)"], "WAG002036": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), LCK (LCK proto-oncogene, Src family tyrosine kinase), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), CD4 (CD4 molecule), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CD86 (CD86 molecule), VAV1 (vav guanine nucleotide exchange factor 1), CD3E (CD3e molecule), PTPN6 (protein tyrosine phosphatase non-receptor type 6), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), CD3D (CD3d molecule), CSK (C-terminal Src kinase), CD3G (CD3g molecule), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), RAC1 (Rac family small GTPase 1), MTOR (mechanistic target of rapamycin kinase), CDC42 (cell division cycle 42), CTLA4 (cytotoxic T-lymphocyte associated protein 4), CD28 (CD28 molecule), CD80 (CD80 molecule), GRAP2 (GRB2 related adaptor protein 2), AKT2 (AKT serine/threonine kinase 2), PDPK1 (3-phosphoinositide dependent protein kinase 1), PDCD1 (programmed cell death 1), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), LYN (LYN proto-oncogene, Src family tyrosine kinase), PPP2CA (protein phosphatase 2 catalytic subunit alpha), PAK2 (p21 (RAC1) activated kinase 2), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), PAK1 (p21 (RAC1) activated kinase 1), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), AKT3 (AKT serine/threonine kinase 3), PPP2CB (protein phosphatase 2 catalytic subunit beta), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), HLA-DRA (major histocompatibility complex, class II, DR alpha), MLST8 (MTOR associated protein, LST8 homolog), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), RICTOR (RPTOR independent companion of MTOR complex 2), MAPKAP1 (MAPK associated protein 1), PRR5 (proline rich 5), BTLA (B and T lymphocyte associated), PAK3 (p21 (RAC1) activated kinase 3), THEM4 (thioesterase superfamily member 4), TRIB3 (tribbles pseudokinase 3), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), CD274 (CD274 molecule), TNFRSF14 (TNF receptor superfamily member 14), ICOSLG (inducible T cell costimulator ligand), HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1), HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1), PDCD1LG2 (programmed cell death 1 ligand 2), HLA-DQA2 (major histocompatibility complex, class II, DQ alpha 2), HLA-DPB1 (major histocompatibility complex, class II, DP beta 1), HLA-DQB2 (major histocompatibility complex, class II, DQ beta 2)"], "WAG002037": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1), CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4), CACNG2 (calcium voltage-gated channel auxiliary subunit gamma 2), CACNB3 (calcium voltage-gated channel auxiliary subunit beta 3), CACNA1A (calcium voltage-gated channel subunit alpha1 A), CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2), CACNA1E (calcium voltage-gated channel subunit alpha1 E), CACNA1B (calcium voltage-gated channel subunit alpha1 B), CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2), CACNA2D3 (calcium voltage-gated channel auxiliary subunit alpha2delta 3), CACNG4 (calcium voltage-gated channel auxiliary subunit gamma 4)"], "WAG002038": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLG (plasminogen), PLAU (plasminogen activator, urokinase), PLAT (plasminogen activator, tissue type), PLAUR (plasminogen activator, urokinase receptor), SERPINE1 (serpin family E member 1), HRG (histidine rich glycoprotein), SERPINF2 (serpin family F member 2), SERPINB2 (serpin family B member 2), ANXA2 (annexin A2), S100A10 (S100 calcium binding protein A10), SERPINB6 (serpin family B member 6), SERPINE2 (serpin family E member 2), SERPINB8 (serpin family B member 8)"], "WAG002039": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PCNA (proliferating cell nuclear antigen), POLD1 (DNA polymerase delta 1, catalytic subunit), RPA1 (replication protein A1), POLE (DNA polymerase epsilon, catalytic subunit), RFC5 (replication factor C subunit 5), RPA2 (replication protein A2), POLD2 (DNA polymerase delta 2, accessory subunit), RFC4 (replication factor C subunit 4), POLD4 (DNA polymerase delta 4, accessory subunit), DDB1 (damage specific DNA binding protein 1), RFC2 (replication factor C subunit 2), RFC3 (replication factor C subunit 3), RFC1 (replication factor C subunit 1), POLD3 (DNA polymerase delta 3, accessory subunit), POLE2 (DNA polymerase epsilon 2, accessory subunit), REV3L (REV3 like, DNA directed polymerase zeta catalytic subunit), RPA3 (replication protein A3), RAD18 (RAD18 E3 ubiquitin protein ligase), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), POLH (DNA polymerase eta), DTL (denticleless E3 ubiquitin protein ligase homolog), REV1 (REV1 DNA directed polymerase), POLE3 (DNA polymerase epsilon 3, accessory subunit), POLI (DNA polymerase iota), RPS27A (ribosomal protein S27a), CUL4B (cullin 4B), VCP (valosin containing protein), USP1 (ubiquitin specific peptidase 1), CUL4A (cullin 4A), RBX1 (ring-box 1), TRIM25 (tripartite motif containing 25), POLK (DNA polymerase kappa), UBE2L6 (ubiquitin conjugating enzyme E2 L6), POLE4 (DNA polymerase epsilon 4, accessory subunit), MAD2L2 (mitotic arrest deficient 2 like 2), ISG15 (ISG15 ubiquitin like modifier), UBE2B (ubiquitin conjugating enzyme E2 B), WDR48 (WD repeat domain 48), NPLOC4 (NPL4 homolog, ubiquitin recognition factor), UBA7 (ubiquitin like modifier activating enzyme 7), RCHY1 (ring finger and CHY zinc finger domain containing 1), USP10 (ubiquitin specific peptidase 10), SPRTN (SprT-like N-terminal domain), UFD1 (ubiquitin recognition factor in ER associated degradation 1), PCLAF (PCNA clamp associated factor), USP43 (ubiquitin specific peptidase 43)"], "WAG002040": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ASCC3 (activating signal cointegrator 1 complex subunit 3), ASCC1 (activating signal cointegrator 1 complex subunit 1), ALKBH5 (alkB homolog 5, RNA demethylase), ALKBH2 (alkB homolog 2, alpha-ketoglutarate dependent dioxygenase), ALKBH3 (alkB homolog 3, alpha-ketoglutarate dependent dioxygenase), ASCC2 (activating signal cointegrator 1 complex subunit 2), FTO (FTO alpha-ketoglutarate dependent dioxygenase), MGMT (O-6-methylguanine-DNA methyltransferase)"], "WAG002041": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DGKD (diacylglycerol kinase delta), DGKI (diacylglycerol kinase iota), DGKG (diacylglycerol kinase gamma), DGKB (diacylglycerol kinase beta), DGKE (diacylglycerol kinase epsilon), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), DGKA (diacylglycerol kinase alpha), DGKQ (diacylglycerol kinase theta), PRKCQ (protein kinase C theta), PRKCD (protein kinase C delta), TRPC3 (transient receptor potential cation channel subfamily C member 3), RASGRP1 (RAS guanyl releasing protein 1), TRPC6 (transient receptor potential cation channel subfamily C member 6), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PRKCE (protein kinase C epsilon), PRKCH (protein kinase C eta), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), TRPC7 (transient receptor potential cation channel subfamily C member 7), MGLL (monoglyceride lipase), DGKH (diacylglycerol kinase eta), DGKZ (diacylglycerol kinase zeta), DAGLA (diacylglycerol lipase alpha), DAGLB (diacylglycerol lipase beta), ABHD12 (abhydrolase domain containing 12, lysophospholipase), ABHD6 (abhydrolase domain containing 6, acylglycerol lipase), RASGRP2 (RAS guanyl releasing protein 2), DGKK (diacylglycerol kinase kappa)"], "WAG002045": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), TP53 (tumor protein p53), RAC1 (Rac family small GTPase 1), HDAC2 (histone deacetylase 2), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), IRF1 (interferon regulatory factor 1), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), CDC42 (cell division cycle 42), IRF2 (interferon regulatory factor 2), IFNA14 (interferon alpha 14), GATA1 (GATA binding protein 1), IFNA5 (interferon alpha 5), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), IFNA2 (interferon alpha 2), ZFPM1 (zinc finger protein, FOG family member 1), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), ZFPM2 (zinc finger protein, FOG family member 2), CDK2 (cyclin dependent kinase 2), AKAP1 (A-kinase anchoring protein 1), KDM1A (lysine demethylase 1A), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), IFNA6 (interferon alpha 6), GATA2 (GATA binding protein 2), JAK2 (Janus kinase 2), IFNB1 (interferon beta 1), PRKACB (protein kinase cAMP-activated catalytic subunit beta), IFNA16 (interferon alpha 16), IFNA8 (interferon alpha 8), GATA3 (GATA binding protein 3), GATA4 (GATA binding protein 4), MYB (MYB proto-oncogene, transcription factor), MAFK (MAF bZIP transcription factor K), PHF21A (PHD finger protein 21A), SIN3A (SIN3 transcription regulator family member A), DOCK6 (dedicator of cytokinesis 6), GATA5 (GATA binding protein 5), DOCK1 (dedicator of cytokinesis 1), CDK5 (cyclin dependent kinase 5), NFE2 (nuclear factor, erythroid 2), DOCK8 (dedicator of cytokinesis 8), IFNA13 (interferon alpha 13), HBE1 (hemoglobin subunit epsilon 1), AKAP10 (A-kinase anchoring protein 10), DOCK9 (dedicator of cytokinesis 9), GATA6 (GATA binding protein 6), IFNA17 (interferon alpha 17), DOCK11 (dedicator of cytokinesis 11), RCOR1 (REST corepressor 1), HMG20B (high mobility group 20B), CABLES1 (Cdk5 and Abl enzyme substrate 1), EHD1 (EH domain containing 1), CAPZB (capping actin protein of muscle Z-line subunit beta), MAFG (MAF bZIP transcription factor G), EHD2 (EH domain containing 2), EHD3 (EH domain containing 3), RAB5A (RAB5A, member RAS oncogene family), VPS45 (vacuolar protein sorting 45 homolog), HBB (hemoglobin subunit beta), MAFF (MAF bZIP transcription factor F), IFNA21 (interferon alpha 21), IFNA10 (interferon alpha 10), CABLES2 (Cdk5 and Abl enzyme substrate 2), WEE1 (WEE1 G2 checkpoint kinase), DOCK7 (dedicator of cytokinesis 7), CBX5 (chromobox 5), HBG2 (hemoglobin subunit gamma 2), MICAL1 (microtubule associated monooxygenase, calponin and LIM domain containing 1), CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2), CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1), SH2B1 (SH2B adaptor protein 1), SH2B3 (SH2B adaptor protein 3), DOCK2 (dedicator of cytokinesis 2), HBD (hypophosphatemic bone disease), HBD (hemoglobin subunit delta), IFNA4 (interferon alpha 4), MFN1 (mitofusin 1), DOCK3 (dedicator of cytokinesis 3), DOCK10 (dedicator of cytokinesis 10), RAD51C (RAD51 paralog C), RAD51B (RAD51 paralog B), HBG1 (hemoglobin subunit gamma 1), MFN2 (mitofusin 2), DOCK5 (dedicator of cytokinesis 5), DOCK4 (dedicator of cytokinesis 4), ITPK1 (inositol-tetrakisphosphate 1-kinase), H3C10 (H3 clustered histone 10), H3C8 (H3 clustered histone 8), H3C6 (H3 clustered histone 6), RBSN (rabenosyn, RAB effector), IFNA7 (interferon alpha 7), H3C15 (H3 clustered histone 15), JMJD1C (jumonji domain containing 1C), H3C4 (H3 clustered histone 4), AK3 (adenylate kinase 3), H3C11 (H3 clustered histone 11), H3C14 (H3 clustered histone 14), H3C1 (H3 clustered histone 1), H3-3A (H3.3 histone A)"], "WAG002048": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ESR1 (estrogen receptor 1), RXRA (retinoid X receptor alpha), NCOR2 (nuclear receptor corepressor 2), CREBBP (CREB binding protein), PPARA (peroxisome proliferator activated receptor alpha), HDAC3 (histone deacetylase 3), ESR2 (estrogen receptor 2), THRA (thyroid hormone receptor alpha), RARA (retinoic acid receptor alpha), VDR (vitamin D receptor), PPARD (peroxisome proliferator activated receptor delta), HNF4A (hepatocyte nuclear factor 4 alpha), THRB (thyroid hormone receptor beta), NR0B2 (nuclear receptor subfamily 0 group B member 2), NR4A1 (nuclear receptor subfamily 4 group A member 1), NR2C1 (nuclear receptor subfamily 2 group C member 1), NR2C2 (nuclear receptor subfamily 2 group C member 2), TBL1XR1 (TBL1X receptor 1), RXRG (retinoid X receptor gamma), PPARG (peroxisome proliferator activated receptor gamma), RARG (retinoic acid receptor gamma), NR2E1 (nuclear receptor subfamily 2 group E member 1), NR1H2 (nuclear receptor subfamily 1 group H member 2), CDK8 (cyclin dependent kinase 8), NCOR1 (nuclear receptor corepressor 1), RORA (RAR related orphan receptor A), RARB (retinoic acid receptor beta), NR4A2 (nuclear receptor subfamily 4 group A member 2), HDAC1 (histone deacetylase 1), ESRRA (estrogen related receptor alpha), NR1D1 (nuclear receptor subfamily 1 group D member 1), NR1D2 (nuclear receptor subfamily 1 group D member 2), NR5A1 (nuclear receptor subfamily 5 group A member 1), ESRRG (estrogen related receptor gamma), RORC (RAR related orphan receptor C), NR2F1 (nuclear receptor subfamily 2 group F member 1), CCNC (cyclin C), TRIM28 (tripartite motif containing 28), MED17 (mediator complex subunit 17), NR2F6 (nuclear receptor subfamily 2 group F member 6), MED16 (mediator complex subunit 16), MED6 (mediator complex subunit 6), NR2C2AP (nuclear receptor 2C2 associated protein), NRBP1 (nuclear receptor binding protein 1), MED23 (mediator complex subunit 23), MED10 (mediator complex subunit 10), MED12 (mediator complex subunit 12), ESRRB (estrogen related receptor beta), HNF4G (hepatocyte nuclear factor 4 gamma), MED7 (mediator complex subunit 7), MED4 (mediator complex subunit 4), MED13 (mediator complex subunit 13), KAT2B (lysine acetyltransferase 2B), HDAC2 (histone deacetylase 2), MED8 (mediator complex subunit 8), MED26 (mediator complex subunit 26), MED20 (mediator complex subunit 20), MED15 (mediator complex subunit 15), HDAC4 (histone deacetylase 4), SNW1 (SNW domain containing 1), MED27 (mediator complex subunit 27), MED30 (mediator complex subunit 30), MED31 (mediator complex subunit 31), MED25 (mediator complex subunit 25), AR (androgen receptor), HDAC9 (histone deacetylase 9), HDAC10 (histone deacetylase 10), HDAC7 (histone deacetylase 7), MAML1 (mastermind like transcriptional coactivator 1), NOTCH1 (notch receptor 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), RXRB (retinoid X receptor beta), MAML2 (mastermind like transcriptional coactivator 2), HDAC5 (histone deacetylase 5), MAML3 (mastermind like transcriptional coactivator 3), HDAC6 (histone deacetylase 6), KAT2A (lysine acetyltransferase 2A), HDAC8 (histone deacetylase 8), HDAC11 (histone deacetylase 11), NOTCH2 (notch receptor 2), NOTCH3 (notch receptor 3), TBL1X (transducin beta like 1 X-linked), NOTCH4 (notch receptor 4), PGR (progesterone receptor), ZNF19 (zinc finger protein 19), ZNF14 (zinc finger protein 14), ZNF30 (zinc finger protein 30), ZNF197 (zinc finger protein 197), ZNF18 (zinc finger protein 18), ZNF254 (zinc finger protein 254), ZNF20 (zinc finger protein 20), ZNF28 (zinc finger protein 28), ZNF224 (zinc finger protein 224), ZNF256 (zinc finger protein 256), ZNF253 (zinc finger protein 253), ZNF133 (zinc finger protein 133), ZNF496 (zinc finger protein 496), ZNF257 (zinc finger protein 257), ZNF681 (zinc finger protein 681), ZNF675 (zinc finger protein 675)"], "WAG002050": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VAV1 (vav guanine nucleotide exchange factor 1), VAV2 (vav guanine nucleotide exchange factor 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SYK (spleen associated tyrosine kinase), FYN (FYN proto-oncogene, Src family tyrosine kinase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), LCK (LCK proto-oncogene, Src family tyrosine kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PLCG2 (phospholipase C gamma 2), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), RAC1 (Rac family small GTPase 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), FCER1G (Fc fragment of IgE receptor Ig), LAT (linker for activation of T cells), RAC2 (Rac family small GTPase 2), LCP2 (lymphocyte cytosolic protein 2), VAV3 (vav guanine nucleotide exchange factor 3), CDC42 (cell division cycle 42), PTPN6 (protein tyrosine phosphatase non-receptor type 6), LYN (LYN proto-oncogene, Src family tyrosine kinase), GP6 (glycoprotein VI platelet), PRKCZ (protein kinase C zeta), RHOG (ras homolog family member G), RHOA (ras homolog family member A), PDPK1 (3-phosphoinositide dependent protein kinase 1), RHOB (ras homolog family member B), PIK3R6 (phosphoinositide-3-kinase regulatory subunit 6), PDPN (podoplanin), CLEC1B (C-type lectin domain family 1 member B), MPIG6B (megakaryocyte and platelet inhibitory receptor G6b)"], "WAG002051": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "B2M (beta-2-microglobulin), CD8A (CD8a molecule), ITGAL (integrin subunit alpha L), ITGB2 (integrin subunit beta 2), FCGR3A (Fc fragment of IgG receptor IIIa), HLA-A (major histocompatibility complex, class I, A), TYROBP (transmembrane immune signaling adaptor TYROBP), HLA-B (major histocompatibility complex, class I, B), KLRD1 (killer cell lectin like receptor D1), LILRB2 (leukocyte immunoglobulin like receptor B2), ICAM1 (intercellular adhesion molecule 1), HLA-G (major histocompatibility complex, class I, G), HLA-C (major histocompatibility complex, class I, C), CD33 (CD33 molecule), SELL (selectin L), ITGB1 (integrin subunit beta 1), CD19 (CD19 molecule), ITGA4 (integrin subunit alpha 4), KLRC1 (killer cell lectin like receptor C1), KIR2DL3 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3), CD1A (CD1a molecule), KIR3DL1 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1), FCGR1A (Fc fragment of IgG receptor Ia), VCAM1 (vascular cell adhesion molecule 1), HLA-F (major histocompatibility complex, class I, F), KIR2DL4 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4), ICAM3 (intercellular adhesion molecule 3), KLRK1 (killer cell lectin like receptor K1), CD22 (CD22 molecule), CD8B (CD8b molecule), SIGLEC7 (sialic acid binding Ig like lectin 7), NCR1 (natural cytotoxicity triggering receptor 1), KLRB1 (killer cell lectin like receptor B1), LILRA2 (leukocyte immunoglobulin like receptor A2), ITGB7 (integrin subunit beta 7), CD3D (CD3d molecule), KIR3DL2 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2), KIR2DL1 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1), CD40LG (CD40 ligand), CD3E (CD3e molecule), CD81 (CD81 molecule), CD3G (CD3g molecule), ICAM2 (intercellular adhesion molecule 2), LILRA1 (leukocyte immunoglobulin like receptor A1), SIGLEC5 (sialic acid binding Ig like lectin 5), CD226 (CD226 molecule), LILRB4 (leukocyte immunoglobulin like receptor B4), ICAM4 (intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)), HCST (hematopoietic cell signal transducer), SH2D1A (SH2 domain containing 1A), SIGLEC8 (sialic acid binding Ig like lectin 8), CD1B (CD1b molecule), CD1D (CD1d molecule), SIGLEC9 (sialic acid binding Ig like lectin 9), C3 (complement C3), SIGLEC1 (sialic acid binding Ig like lectin 1), CD160 (CD160 molecule), LILRB5 (leukocyte immunoglobulin like receptor B5), CD1C (CD1c molecule), PVR (PVR cell adhesion molecule), SIGLEC10 (sialic acid binding Ig like lectin 10), PILRA (paired immunoglobin like type 2 receptor alpha), FCGR2B (Fc fragment of IgG receptor IIb), ULBP1 (UL16 binding protein 1), SIGLEC6 (sialic acid binding Ig like lectin 6), ULBP3 (UL16 binding protein 3), IFITM1 (interferon induced transmembrane protein 1), KLRG1 (killer cell lectin like receptor G1), ICAM5 (intercellular adhesion molecule 5), KLRF1 (killer cell lectin like receptor F1), LILRA6 (leukocyte immunoglobulin like receptor A6), CDH1 (cadherin 1), LILRB3 (leukocyte immunoglobulin like receptor B3), LILRA4 (leukocyte immunoglobulin like receptor A4), CD96 (CD96 molecule), SLAMF6 (SLAM family member 6), CLEC2B (C-type lectin domain family 2 member B), LAIR1 (leukocyte associated immunoglobulin like receptor 1), CLEC2D (C-type lectin domain family 2 member D), OSCAR (osteoclast associated Ig-like receptor), SIGLEC12 (sialic acid binding Ig like lectin 12), SLAMF7 (SLAM family member 7), CD200R1 (CD200 receptor 1), CD200 (CD200 molecule), LAIR2 (leukocyte associated immunoglobulin like receptor 2), RAET1E (retinoic acid early transcript 1E), MICB (MHC class I polypeptide-related sequence B), CRTAM (cytotoxic and regulatory T cell molecule), SH2D1B (SH2 domain containing 1B), LILRA5 (leukocyte immunoglobulin like receptor A5), COLEC12 (collectin subfamily member 12), KLRC4-KLRK1 (KLRC4-KLRK1 readthrough), NCR3LG1 (natural killer cell cytotoxicity receptor 3 ligand 1), LOC102725035 (leukocyte immunoglobulin-like receptor subfamily B member 3), LOC107987425 (leukocyte immunoglobulin-like receptor subfamily B member 3), CD8B2 (CD8b2 molecule), CD99 (CD99 molecule (Xg blood group)), SIGLEC11 (sialic acid binding Ig like lectin 11), CLEC4G (C-type lectin domain family 4 member G), CXADR (CXADR Ig-like cell adhesion molecule)"], "WAG002052": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA6 (proteasome 20S subunit alpha 6), PSMB4 (proteasome 20S subunit beta 4), PSMA2 (proteasome 20S subunit alpha 2), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMA1 (proteasome 20S subunit alpha 1), PSMB10 (proteasome 20S subunit beta 10), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA7 (proteasome 20S subunit alpha 7), PSMB2 (proteasome 20S subunit beta 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB1 (proteasome 20S subunit beta 1), PSMB3 (proteasome 20S subunit beta 3), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB6 (proteasome 20S subunit beta 6), PSMB5 (proteasome 20S subunit beta 5), PSMA3 (proteasome 20S subunit alpha 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA4 (proteasome 20S subunit alpha 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB7 (proteasome 20S subunit beta 7), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA5 (proteasome 20S subunit alpha 5), PSME3 (proteasome activator subunit 3), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME1 (proteasome activator subunit 1), UBB (ubiquitin B), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), UBE2D1 (ubiquitin conjugating enzyme E2 D1), HLA-B (major histocompatibility complex, class I, B), UBA1 (ubiquitin like modifier activating enzyme 1), UCHL3 (ubiquitin C-terminal hydrolase L3), HLA-C (major histocompatibility complex, class I, C), HLA-A (major histocompatibility complex, class I, A), NEDD4 (NEDD4 E3 ubiquitin protein ligase), HLA-F (major histocompatibility complex, class I, F), UBE2D2 (ubiquitin conjugating enzyme E2 D2), UBE2D3 (ubiquitin conjugating enzyme E2 D3), HLA-G (major histocompatibility complex, class I, G), IFNG (interferon gamma), HLA-E (major histocompatibility complex, class I, E), UCHL1 (ubiquitin C-terminal hydrolase L1), UBE2B (ubiquitin conjugating enzyme E2 B), RPN1 (ribophorin I), RPN2 (ribophorin II), UBA7 (ubiquitin like modifier activating enzyme 7), HLA-H (major histocompatibility complex, class I, H (pseudogene)), HLA-J (major histocompatibility complex, class I, J (pseudogene)), H2AX (H2A.X variant histone), H2AZ1 (H2A.Z variant histone 1), H2AC4 (H2A clustered histone 4)"], "WAG002053": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNG2 (G protein subunit gamma 2), GNAI2 (G protein subunit alpha i2), GNB1 (G protein subunit beta 1), GNAS (GNAS complex locus), ADCY2 (adenylate cyclase 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), ADCY8 (adenylate cyclase 8), ADCY1 (adenylate cyclase 1), ADCY5 (adenylate cyclase 5), ADCY9 (adenylate cyclase 9), ADCY7 (adenylate cyclase 7), ADCY4 (adenylate cyclase 4), GNAI1 (G protein subunit alpha i1), ADCY6 (adenylate cyclase 6), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PLCB1 (phospholipase C beta 1), PLCB2 (phospholipase C beta 2), PLCB3 (phospholipase C beta 3), GNGT1 (G protein subunit gamma transducin 1), GNG3 (G protein subunit gamma 3), GNB2 (G protein subunit beta 2), GNG4 (G protein subunit gamma 4), GNG13 (G protein subunit gamma 13), GNB3 (G protein subunit beta 3), GNG12 (G protein subunit gamma 12), GCG (glucagon), GNG7 (G protein subunit gamma 7), PRKACB (protein kinase cAMP-activated catalytic subunit beta), GNG8 (G protein subunit gamma 8), GNGT2 (G protein subunit gamma transducin 2), GNB5 (G protein subunit beta 5), ADCY3 (adenylate cyclase 3), GNG5 (G protein subunit gamma 5), GNB4 (G protein subunit beta 4), GNG11 (G protein subunit gamma 11), CACNA1A (calcium voltage-gated channel subunit alpha1 A), GNA15 (G protein subunit alpha 15), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), GNG10 (G protein subunit gamma 10), PRKCA (protein kinase C alpha), GNAQ (G protein subunit alpha q), GNA11 (G protein subunit alpha 11), KCNB1 (potassium voltage-gated channel subfamily B member 1), GNA14 (G protein subunit alpha 14), CACNA1C (calcium voltage-gated channel subunit alpha1 C), AKAP5 (A-kinase anchoring protein 5), CHRM3 (cholinergic receptor muscarinic 3), ADRA2A (adrenoceptor alpha 2A), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), MLXIPL (MLX interacting protein like), IQGAP1 (IQ motif containing GTPase activating protein 1), GLP1R (glucagon like peptide 1 receptor), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), FFAR1 (free fatty acid receptor 1), CYSLTR2 (cysteinyl leukotriene receptor 2), ADRA2C (adrenoceptor alpha 2C), CACNA1D (calcium voltage-gated channel subunit alpha1 D), ACACB (acetyl-CoA carboxylase beta), CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2), KCNS3 (potassium voltage-gated channel modifier subfamily S member 3), KCNG2 (potassium voltage-gated channel modifier subfamily G member 2), STX1A (syntaxin 1A), FASN (fatty acid synthase), CACNB3 (calcium voltage-gated channel auxiliary subunit beta 3), RAP1A (RAP1A, member of RAS oncogene family), PPP2CA (protein phosphatase 2 catalytic subunit alpha), SNAP25 (synaptosome associated protein 25), STK11 (serine/threonine kinase 11), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), VAMP2 (vesicle associated membrane protein 2), ABCC8 (ATP binding cassette subfamily C member 8), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), CACNA1E (calcium voltage-gated channel subunit alpha1 E), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), ACACA (acetyl-CoA carboxylase alpha), ACLY (ATP citrate lyase), RAPGEF4 (Rap guanine nucleotide exchange factor 4), KCNJ11 (potassium inwardly rectifying channel subfamily J member 11), RAPGEF3 (Rap guanine nucleotide exchange factor 3), STXBP1 (syntaxin binding protein 1), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2CB (protein phosphatase 2 catalytic subunit beta), MLX (MAX dimerization protein MLX), CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2), SLC2A2 (solute carrier family 2 member 2), SLC2A1 (solute carrier family 2 member 1), ADIPOR1 (adiponectin receptor 1), KCNC2 (potassium voltage-gated channel subfamily C member 2), ADIPOR2 (adiponectin receptor 2), ADIPOQ (adiponectin, C1Q and collagen domain containing), SYT5 (synaptotagmin 5), ACSL4 (acyl-CoA synthetase long chain family member 4), ACSL3 (acyl-CoA synthetase long chain family member 3), PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1)"], "WAG002054": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT2 (signal transducer and activator of transcription 2), ISG15 (ISG15 ubiquitin like modifier), IRF9 (interferon regulatory factor 9), IFIT1 (interferon induced protein with tetratricopeptide repeats 1), IRF1 (interferon regulatory factor 1), MX1 (MX dynamin like GTPase 1), IFIT3 (interferon induced protein with tetratricopeptide repeats 3), IRF7 (interferon regulatory factor 7), OAS2 (2'-5'-oligoadenylate synthetase 2), OAS1 (2'-5'-oligoadenylate synthetase 1), IFIT2 (interferon induced protein with tetratricopeptide repeats 2), XAF1 (XIAP associated factor 1), IFI35 (interferon induced protein 35), ISG20 (interferon stimulated exonuclease gene 20), IFI6 (interferon alpha inducible protein 6), OAS3 (2'-5'-oligoadenylate synthetase 3), MX2 (MX dynamin like GTPase 2), IFI27 (interferon alpha inducible protein 27), OASL (2'-5'-oligoadenylate synthetase like), IRF3 (interferon regulatory factor 3), IFITM1 (interferon induced transmembrane protein 1), ADAR (adenosine deaminase RNA specific), RNASEL (ribonuclease L), IRF5 (interferon regulatory factor 5), IRF2 (interferon regulatory factor 2), IRF6 (interferon regulatory factor 6), IRF4 (interferon regulatory factor 4), GBP2 (guanylate binding protein 2), IRF8 (interferon regulatory factor 8), IP6K2 (inositol hexakisphosphate kinase 2), EGR1 (early growth response 1), RSAD2 (radical S-adenosyl methionine domain containing 2), IFNB1 (interferon beta 1), JAK1 (Janus kinase 1), USP18 (ubiquitin specific peptidase 18), IFNAR1 (interferon alpha and beta receptor subunit 1), TYK2 (tyrosine kinase 2), IFIT5 (interferon induced protein with tetratricopeptide repeats 5), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SOCS1 (suppressor of cytokine signaling 1), PTPN6 (protein tyrosine phosphatase non-receptor type 6), SOCS3 (suppressor of cytokine signaling 3), BST2 (bone marrow stromal cell antigen 2), PTPN1 (protein tyrosine phosphatase non-receptor type 1), HLA-B (major histocompatibility complex, class I, B), HLA-C (major histocompatibility complex, class I, C), HLA-A (major histocompatibility complex, class I, A), HLA-F (major histocompatibility complex, class I, F), PSMB8 (proteasome 20S subunit beta 8), HLA-G (major histocompatibility complex, class I, G), SAMHD1 (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1), IFITM3 (interferon induced transmembrane protein 3), ABCE1 (ATP binding cassette subfamily E member 1), IFITM2 (interferon induced transmembrane protein 2)"], "WAG002055": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "B2M (beta-2-microglobulin), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), IRF1 (interferon regulatory factor 1), IRF9 (interferon regulatory factor 9), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), ICAM1 (intercellular adhesion molecule 1), IRF8 (interferon regulatory factor 8), IRF7 (interferon regulatory factor 7), PML (PML nuclear body scaffold), GBP1 (guanylate binding protein 1), VCAM1 (vascular cell adhesion molecule 1), SP100 (SP100 nuclear antigen), IFNG (interferon gamma), IRF3 (interferon regulatory factor 3), OAS2 (2'-5'-oligoadenylate synthetase 2), IRF2 (interferon regulatory factor 2), OAS1 (2'-5'-oligoadenylate synthetase 1), NCAM1 (neural cell adhesion molecule 1), GBP2 (guanylate binding protein 2), CD44 (CD44 molecule (Indian blood group)), PTAFR (platelet activating factor receptor), CIITA (class II major histocompatibility complex transactivator), IRF6 (interferon regulatory factor 6), OASL (2'-5'-oligoadenylate synthetase like), OAS3 (2'-5'-oligoadenylate synthetase 3), IRF5 (interferon regulatory factor 5), IFI30 (IFI30 lysosomal thiol reductase), IRF4 (interferon regulatory factor 4), JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), IFNGR1 (interferon gamma receptor 1), PTPN6 (protein tyrosine phosphatase non-receptor type 6), IFNGR2 (interferon gamma receptor 2), TRIM21 (tripartite motif containing 21), SOCS1 (suppressor of cytokine signaling 1), SUMO1 (small ubiquitin like modifier 1), PRKCD (protein kinase C delta), CAMK2D (calcium/calmodulin dependent protein kinase II delta), SOCS3 (suppressor of cytokine signaling 3), PTPN1 (protein tyrosine phosphatase non-receptor type 1), HLA-C (major histocompatibility complex, class I, C), CAMK2B (calcium/calmodulin dependent protein kinase II beta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), HLA-A (major histocompatibility complex, class I, A), HLA-B (major histocompatibility complex, class I, B), TRIM22 (tripartite motif containing 22), TRIM5 (tripartite motif containing 5), PIAS1 (protein inhibitor of activated STAT 1), HLA-G (major histocompatibility complex, class I, G), TRIM8 (tripartite motif containing 8), HLA-F (major histocompatibility complex, class I, F), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), GBP5 (guanylate binding protein 5), GBP4 (guanylate binding protein 4), HLA-DRA (major histocompatibility complex, class II, DR alpha), TRIM17 (tripartite motif containing 17), TRIM38 (tripartite motif containing 38), FCGR1A (Fc fragment of IgG receptor Ia), HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1), TRIM6 (tripartite motif containing 6), TRIM2 (tripartite motif containing 2), TRIM25 (tripartite motif containing 25), TRIM26 (tripartite motif containing 26), GBP7 (guanylate binding protein 7), MID1 (midline 1), TRIM35 (tripartite motif containing 35), HLA-DPB1 (major histocompatibility complex, class II, DP beta 1), HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1), TRIM34 (tripartite motif containing 34), HLA-DQA2 (major histocompatibility complex, class II, DQ alpha 2), GBP3 (guanylate binding protein 3), TRIM3 (tripartite motif containing 3), TRIM29 (tripartite motif containing 29), TRIM10 (tripartite motif containing 10), GBP6 (guanylate binding protein family member 6), TRIM45 (tripartite motif containing 45), TRIM14 (tripartite motif containing 14), TRIM68 (tripartite motif containing 68), TRIM48 (tripartite motif containing 48), FCGR1B (Fc fragment of IgG receptor Ib), MT2A (metallothionein 2A), TRIM62 (tripartite motif containing 62), HLA-DQB2 (major histocompatibility complex, class II, DQ beta 2), TRIM46 (tripartite motif containing 46), TRIM31 (tripartite motif containing 31)"], "WAG002057": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TRAF6 (TNF receptor associated factor 6), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CUL1 (cullin 1), UBB (ubiquitin B), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), RBX1 (ring-box 1), SKP1 (S-phase kinase associated protein 1), PSMA4 (proteasome 20S subunit alpha 4), PSMA7 (proteasome 20S subunit alpha 7), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA2 (proteasome 20S subunit alpha 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA3 (proteasome 20S subunit alpha 3), PSMA6 (proteasome 20S subunit alpha 6), PSMA1 (proteasome 20S subunit alpha 1), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMB5 (proteasome 20S subunit beta 5), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB2 (proteasome 20S subunit beta 2), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB6 (proteasome 20S subunit beta 6), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMB3 (proteasome 20S subunit beta 3), PSMB10 (proteasome 20S subunit beta 10), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB1 (proteasome 20S subunit beta 1), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA5 (proteasome 20S subunit alpha 5), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSME4 (proteasome activator subunit 4), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), PSME1 (proteasome activator subunit 1), PSMB11 (proteasome subunit beta 11), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), NFKB1 (nuclear factor kappa B subunit 1), IRAK1 (interleukin 1 receptor associated kinase 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MYD88 (MYD88 innate immune signal transduction adaptor), RELA (RELA proto-oncogene, NF-kB subunit), NFKBIA (NFKB inhibitor alpha), IL1B (interleukin 1 beta), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), IL1A (interleukin 1 alpha), IRAK2 (interleukin 1 receptor associated kinase 2), RIPK2 (receptor interacting serine/threonine kinase 2), IL1R1 (interleukin 1 receptor type 1), SQSTM1 (sequestosome 1), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PELI1 (pellino E3 ubiquitin protein ligase 1), IRAK4 (interleukin 1 receptor associated kinase 4), CASP1 (caspase 1), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), IL18 (interleukin 18), PELI3 (pellino E3 ubiquitin protein ligase family member 3), MAPK8 (mitogen-activated protein kinase 8), SMAD3 (SMAD family member 3), STAT3 (signal transducer and activator of transcription 3), PELI2 (pellino E3 ubiquitin protein ligase family member 2), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), IRAK3 (interleukin 1 receptor associated kinase 3), TOLLIP (toll interacting protein), MAP2K6 (mitogen-activated protein kinase kinase 6), TBK1 (TANK binding kinase 1), UBE2N (ubiquitin conjugating enzyme E2 N), MAP2K1 (mitogen-activated protein kinase kinase 1), MAP2K4 (mitogen-activated protein kinase kinase 4), IL1RN (interleukin 1 receptor antagonist), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), TNIP2 (TNFAIP3 interacting protein 2), IL1R2 (interleukin 1 receptor type 2), RPS27A (ribosomal protein S27a), IL18R1 (interleukin 18 receptor 1), NOD2 (nucleotide binding oligomerization domain containing 2), PTPN6 (protein tyrosine phosphatase non-receptor type 6), FBXW11 (F-box and WD repeat domain containing 11), UBE2V1 (ubiquitin conjugating enzyme E2 V1), NOD1 (nucleotide binding oligomerization domain containing 1), IL4 (interleukin 4)"], "WAG002058": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), GAB2 (GRB2 associated binding protein 2), JAK2 (Janus kinase 2), CBL (Cbl proto-oncogene), SHC1 (SHC adaptor protein 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SYK (spleen associated tyrosine kinase), FYN (FYN proto-oncogene, Src family tyrosine kinase), JAK1 (Janus kinase 1), PTPN6 (protein tyrosine phosphatase non-receptor type 6), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), INPP5D (inositol polyphosphate-5-phosphatase D), CSF2RB (colony stimulating factor 2 receptor subunit beta), JAK3 (Janus kinase 3), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), IL2RB (interleukin 2 receptor subunit beta), CRKL (CRK like proto-oncogene, adaptor protein), VAV1 (vav guanine nucleotide exchange factor 1), IL3RA (interleukin 3 receptor subunit alpha), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), IL2RG (interleukin 2 receptor subunit gamma), IL2RA (interleukin 2 receptor subunit alpha), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), LYN (LYN proto-oncogene, Src family tyrosine kinase), STAT5A (signal transducer and activator of transcription 5A), IL2 (interleukin 2), HCK (HCK proto-oncogene, Src family tyrosine kinase), IL3 (interleukin 3), STAT5B (signal transducer and activator of transcription 5B), CRK (CRK proto-oncogene, adaptor protein), CSF2 (colony stimulating factor 2), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), CSF2RA (colony stimulating factor 2 receptor subunit alpha), IL5 (interleukin 5), BLNK (B cell linker), IL5RA (interleukin 5 receptor subunit alpha), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), TEC (transient erythroblastopenia of childhood), TEC (tec protein tyrosine kinase), RAPGEF1 (Rap guanine nucleotide exchange factor 1), INPPL1 (inositol polyphosphate phosphatase like 1), PRKACA (protein kinase cAMP-activated catalytic subunit alpha)"], "WAG002059": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BCL2 (BCL2 apoptosis regulator), BCL2L1 (BCL2 like 1), BAX (BCL2 associated X, apoptosis regulator), BAD (BCL2 associated agonist of cell death), CASP3 (caspase 3), AKT1 (AKT serine/threonine kinase 1), CASP9 (caspase 9), APAF1 (apoptotic peptidase activating factor 1), MAPK8 (mitogen-activated protein kinase 8), MAPK1 (mitogen-activated protein kinase 1), BID (BH3 interacting domain death agonist), CASP8 (caspase 8), MAPK3 (mitogen-activated protein kinase 3), BCL2L11 (BCL2 like 11), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), XIAP (X-linked inhibitor of apoptosis), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), CYCS (cytochrome c, somatic), CASP7 (caspase 7), E2F1 (E2F transcription factor 1), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), DIABLO (diablo IAP-binding mitochondrial protein), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), TP53BP2 (tumor protein p53 binding protein 2), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), TP73 (tumor protein p73), SFN (stratifin), BAK1 (BCL2 antagonist/killer 1), BBC3 (BCL2 binding component 3), TFDP1 (transcription factor Dp-1), TP63 (tumor protein p63), AKT2 (AKT serine/threonine kinase 2), STAT3 (signal transducer and activator of transcription 3), AKT3 (AKT serine/threonine kinase 3), DYNLL1 (dynein light chain LC8-type 1), BMF (Bcl2 modifying factor), CDKN2A (cyclin dependent kinase inhibitor 2A), C1QBP (complement C1q binding protein), TFDP2 (transcription factor Dp-2), GZMB (granzyme B), PPP1R13B (protein phosphatase 1 regulatory subunit 13B), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), NMT1 (N-myristoyltransferase 1), DYNLL2 (dynein light chain LC8-type 2), PPP3CC (protein phosphatase 3 catalytic subunit gamma), AVEN (apoptosis and caspase activation inhibitor), UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats), CARD8 (caspase recruitment domain family member 8), APIP (APAF1 interacting protein)"], "WAG002060": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KIF11 (kinesin family member 11), KIF26A (kinesin family member 26A), KIF2C (kinesin family member 2C), KIF23 (kinesin family member 23), KIF15 (kinesin family member 15), KIF5B (kinesin family member 5B), KIF5A (kinesin family member 5A), KIF18A (kinesin family member 18A), CENPE (centromere protein E), KIF3B (kinesin family member 3B), KIF20A (kinesin family member 20A), KIFAP3 (kinesin associated protein 3), KIF3A (kinesin family member 3A), KIF2A (kinesin family member 2A), KLC2 (kinesin light chain 2), KIF3C (kinesin family member 3C), KLC1 (kinesin light chain 1), RACGAP1 (Rac GTPase activating protein 1), KIF25 (kinesin family member 25), KIF22 (kinesin family member 22), KIFC1 (kinesin family member C1), KIF20B (kinesin family member 20B), KIF2B (kinesin family member 2B), KIF1B (kinesin family member 1B), KIF18B (kinesin family member 18B), KIF1C (kinesin family member 1C), KIF13B (kinesin family member 13B), KLC3 (kinesin light chain 3), KLC4 (kinesin light chain 4), KIF1A (kinesin family member 1A), KIF9 (kinesin family member 9), KIF21B (kinesin family member 21B), KIF21A (kinesin family member 21A), KIF12 (kinesin family member 12), KIF26B (kinesin family member 26B), KIFC2 (kinesin family member C2), KIF27 (kinesin family member 27), KIF19 (kinesin family member 19), KIF16B (kinesin family member 16B), KIF6 (kinesin family member 6)"], "WAG002061": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "L1CAM (L1 cell adhesion molecule), EGFR (epidermal growth factor receptor), MAPK1 (mitogen-activated protein kinase 1), AP2A1 (adaptor related protein complex 2 subunit alpha 1), AP2A2 (adaptor related protein complex 2 subunit alpha 2), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), AP2M1 (adaptor related protein complex 2 subunit mu 1), ITGB1 (integrin subunit beta 1), NFASC (neurofascin), RAC1 (Rac family small GTPase 1), AP2S1 (adaptor related protein complex 2 subunit sigma 1), SPTAN1 (spectrin alpha, non-erythrocytic 1), AP2B1 (adaptor related protein complex 2 subunit beta 1), NRCAM (neuronal cell adhesion molecule), RPS6KA2 (ribosomal protein S6 kinase A2), MAPK3 (mitogen-activated protein kinase 3), EZR (ezrin), SPTBN4 (spectrin beta, non-erythrocytic 4), RPS6KA1 (ribosomal protein S6 kinase A1), LAMA1 (laminin subunit alpha 1), RPS6KA3 (ribosomal protein S6 kinase A3), SPTBN1 (spectrin beta, non-erythrocytic 1), RPS6KA4 (ribosomal protein S6 kinase A4), ITGAV (integrin subunit alpha V), RPS6KA6 (ribosomal protein S6 kinase A6), RPS6KA5 (ribosomal protein S6 kinase A5), ITGA1 (integrin subunit alpha 1), SCN1B (sodium voltage-gated channel beta subunit 1), NCAM1 (neural cell adhesion molecule 1), SPTA1 (spectrin alpha, erythrocytic 1), ANK2 (ankyrin 2), ITGA5 (integrin subunit alpha 5), LAMB1 (laminin subunit beta 1), ITGB3 (integrin subunit beta 3), LAMC1 (laminin subunit gamma 1), ANK1 (ankyrin 1), SPTB (spectrin beta, erythrocytic), SPTBN5 (spectrin beta, non-erythrocytic 5), SPTBN2 (spectrin beta, non-erythrocytic 2), ITGA2 (integrin subunit alpha 2), MAP2K1 (mitogen-activated protein kinase kinase 1), DLG4 (discs large MAGUK scaffold protein 4), SCN5A (sodium voltage-gated channel alpha subunit 5), PAK1 (p21 (RAC1) activated kinase 1), DNM1 (dynamin 1), ANK3 (ankyrin 3), CNTN2 (contactin 2), SCN2B (sodium voltage-gated channel beta subunit 2), CLTC (clathrin heavy chain), ITGA10 (integrin subunit alpha 10), SCN4B (sodium voltage-gated channel beta subunit 4), CLTA (clathrin light chain A), NUMB (NUMB endocytic adaptor protein), CNTN1 (contactin 1), SCN3B (sodium voltage-gated channel beta subunit 3), DLG1 (discs large MAGUK scaffold protein 1), ITGA9 (integrin subunit alpha 9), SCN3A (sodium voltage-gated channel alpha subunit 3), SCN8A (sodium voltage-gated channel alpha subunit 8), CSNK2B (casein kinase 2 beta), MSN (moesin), EPHB2 (EPH receptor B2), ITGA2B (integrin subunit alpha 2b), CSNK2A1 (casein kinase 2 alpha 1), HSPA8 (heat shock protein family A (Hsp70) member 8), MAP2K2 (mitogen-activated protein kinase kinase 2), NRP1 (neuropilin 1), CNTNAP1 (contactin associated protein 1), ALCAM (activated leukocyte cell adhesion molecule), SCN4A (sodium voltage-gated channel alpha subunit 4), CSNK2A2 (casein kinase 2 alpha 2), SCN1A (sodium voltage-gated channel alpha subunit 1), VAV2 (vav guanine nucleotide exchange factor 2), SCN2A (sodium voltage-gated channel alpha subunit 2), DNM2 (dynamin 2), DPYSL2 (dihydropyrimidinase like 2), DLG3 (discs large MAGUK scaffold protein 3), NCAN (neurocan), DCX (doublecortin), CNTN6 (contactin 6), GAP43 (growth associated protein 43), RDX (radixin), SDCBP (syndecan binding protein), SCN7A (sodium voltage-gated channel alpha subunit 7), SCN11A (sodium voltage-gated channel alpha subunit 11), SCN10A (sodium voltage-gated channel alpha subunit 10), RANBP9 (RAN binding protein 9), SCN9A (sodium voltage-gated channel alpha subunit 9), NRP2 (neuropilin 2), DNM3 (dynamin 3), CHL1 (cell adhesion molecule L1 like), KIF4A (kinesin family member 4A), KIF4B (kinesin family member 4B), SHTN1 (shootin 1), LYPLA2 (lysophospholipase 2), LOC101928143 (uncharacterized LOC101928143)"], "WAG002062": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), MAPK3 (mitogen-activated protein kinase 3), MAPK11 (mitogen-activated protein kinase 11), MAPK8 (mitogen-activated protein kinase 8), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CREB1 (cAMP responsive element binding protein 1), MAPK9 (mitogen-activated protein kinase 9), MAPK7 (mitogen-activated protein kinase 7), PPP2CA (protein phosphatase 2 catalytic subunit alpha), ATF2 (activating transcription factor 2), MAPK10 (mitogen-activated protein kinase 10), PPP2CB (protein phosphatase 2 catalytic subunit beta), RPS6KA5 (ribosomal protein S6 kinase A5), ELK1 (ETS transcription factor ELK1), RPS6KA3 (ribosomal protein S6 kinase A3), RPS6KA2 (ribosomal protein S6 kinase A2), RPS6KA1 (ribosomal protein S6 kinase A1), DUSP4 (dual specificity phosphatase 4), DUSP3 (dual specificity phosphatase 3), DUSP6 (dual specificity phosphatase 6), DUSP7 (dual specificity phosphatase 7), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), MEF2A (myocyte enhancer factor 2A), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), MAPKAPK2 (MAPK activated protein kinase 2), MEF2C (myocyte enhancer factor 2C), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), ATF1 (activating transcription factor 1), VRK3 (VRK serine/threonine kinase 3)"], "WAG002063": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTK2 (protein tyrosine kinase 2), PXN (paxillin), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), ITGB1 (integrin subunit beta 1), CRK (CRK proto-oncogene, adaptor protein), RAC1 (Rac family small GTPase 1), CSK (C-terminal Src kinase), BCAR1 (BCAR1 scaffold protein, Cas family member), MAPK1 (mitogen-activated protein kinase 1), TLN1 (talin 1), AKT1 (AKT serine/threonine kinase 1), ITGB4 (integrin subunit beta 4), FYN (FYN proto-oncogene, Src family tyrosine kinase), ITGB2 (integrin subunit beta 2), GRB2 (growth factor receptor bound protein 2), ITGB7 (integrin subunit beta 7), ITGB6 (integrin subunit beta 6), ITGB5 (integrin subunit beta 5), ITGAV (integrin subunit alpha V), ITGA1 (integrin subunit alpha 1), ITGB8 (integrin subunit beta 8), CDC42 (cell division cycle 42), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SHC1 (SHC adaptor protein 1), ITGB3 (integrin subunit beta 3), ITGA4 (integrin subunit alpha 4), ITGA5 (integrin subunit alpha 5), ITGA6 (integrin subunit alpha 6), ILK (integrin linked kinase), VASP (vasodilator stimulated phosphoprotein), ITGAL (integrin subunit alpha L), ITGA3 (integrin subunit alpha 3), ITGA2 (integrin subunit alpha 2), ITGA2B (integrin subunit alpha 2b), HRAS (HRas proto-oncogene, GTPase), PAK1 (p21 (RAC1) activated kinase 1), MAP2K1 (mitogen-activated protein kinase kinase 1), ITGAM (integrin subunit alpha M), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), ITGA8 (integrin subunit alpha 8), ITGA9 (integrin subunit alpha 9), ITGA10 (integrin subunit alpha 10), PAK2 (p21 (RAC1) activated kinase 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), ITGA11 (integrin subunit alpha 11), RAC2 (Rac family small GTPase 2), ITGAX (integrin subunit alpha X), RAC3 (Rac family small GTPase 3), VCL (vinculin), CAV1 (caveolin 1), VAV2 (vav guanine nucleotide exchange factor 2), RAP1B (RAP1B, member of RAS oncogene family), CAPN1 (calpain 1), ARHGEF7 (Rho guanine nucleotide exchange factor 7), ITGAD (integrin subunit alpha D), PAK4 (p21 (RAC1) activated kinase 4), ITGA7 (integrin subunit alpha 7), BRAF (B-Raf proto-oncogene, serine/threonine kinase), RAP1A (RAP1A, member of RAS oncogene family), TNS1 (tensin 1), ZYX (zyxin), ITGAE (integrin subunit alpha E), CAPN2 (calpain 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), VAV3 (vav guanine nucleotide exchange factor 3), MAP2K3 (mitogen-activated protein kinase kinase 3), MAPK12 (mitogen-activated protein kinase 12), PAK3 (p21 (RAC1) activated kinase 3), MAP2K2 (mitogen-activated protein kinase kinase 2), DOCK1 (dedicator of cytokinesis 1), RAPGEF1 (Rap guanine nucleotide exchange factor 1), MAP2K6 (mitogen-activated protein kinase kinase 6), PDPK1 (3-phosphoinositide dependent protein kinase 1), MAPK10 (mitogen-activated protein kinase 10), GIT2 (GIT ArfGAP 2), CAV2 (caveolin 2), PAK6 (p21 (RAC1) activated kinase 6), CAV3 (caveolin 3), SORBS1 (sorbin and SH3 domain containing 1), MAPK7 (mitogen-activated protein kinase 7), ROCK1 (Rho associated coiled-coil containing protein kinase 1), CAPNS1 (calpain small subunit 1), MAP2K5 (mitogen-activated protein kinase kinase 5), MAPK6 (mitogen-activated protein kinase 6), MYLK2 (myosin light chain kinase 2), AKT2 (AKT serine/threonine kinase 2), MAPK4 (mitogen-activated protein kinase 4), SHC3 (SHC adaptor protein 3), ROCK2 (Rho associated coiled-coil containing protein kinase 2), AKT3 (AKT serine/threonine kinase 3), CAPN3 (calpain 3), CAPN10 (calpain 10), CAPN7 (calpain 7), CAPN9 (calpain 9), RHO (rhodopsin), CAPN6 (calpain 6), CAPN11 (calpain 11), CAPN5 (calpain 5), MYPN (myopalladin), LINC02478 (long intergenic non-protein coding RNA 2478)"], "WAG002066": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PANK3 (pantothenate kinase 3), ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1), PANK4 (pantothenate kinase 4 (inactive)), COASY (Coenzyme A synthase), ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3), ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2), PANK1 (pantothenate kinase 1), ACACB (acetyl-CoA carboxylase beta), PPCDC (phosphopantothenoylcysteine decarboxylase), FASN (fatty acid synthase), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), HLCS (holocarboxylase synthetase), PPCS (phosphopantothenoylcysteine synthetase), RFK (riboflavin kinase), ACP5 (acid phosphatase 5, tartrate resistant), MCCC1 (methylcrotonoyl-CoA carboxylase 1), ACACA (acetyl-CoA carboxylase alpha), BTD (biotinidase), PC (pyruvate carboxylase), VNN2 (vanin 2), AOX1 (aldehyde oxidase 1), VNN1 (vanin 1), MMAB (metabolism of cobalamin associated B), GPHN (gephyrin), PCCA (propionyl-CoA carboxylase subunit alpha), MCCC2 (methylcrotonoyl-CoA carboxylase 2), MMACHC (metabolism of cobalamin associated C), MOCS2 (molybdenum cofactor synthesis 2), FLAD1 (flavin adenine dinucleotide synthetase 1), PCCB (propionyl-CoA carboxylase subunit beta), MMAA (metabolism of cobalamin associated A), MMADHC (metabolism of cobalamin associated D), TCN2 (transcobalamin 2), PANK2 (pantothenate kinase 2), CD320 (CD320 molecule), PNPO (pyridoxamine 5'-phosphate oxidase), MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), AASDHPPT (aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase), MOCS3 (molybdenum cofactor synthesis 3), PDXK (pyridoxal kinase), TPK1 (thiamin pyrophosphokinase 1), CYB5R3 (cytochrome b5 reductase 3), GSTO1 (glutathione S-transferase omega 1), MOCOS (molybdenum cofactor sulfurase), PRSS1 (serine protease 1), LMBRD1 (LMBR1 domain containing 1), SLC5A6 (solute carrier family 5 member 6), TCN1 (transcobalamin 1), CYB5A (cytochrome b5 type A), SLC19A3 (solute carrier family 19 member 3), GSTO2 (glutathione S-transferase omega 2), SLC23A1 (solute carrier family 23 member 1), SLC19A2 (solute carrier family 19 member 2), SLC2A3 (solute carrier family 2 member 3), SLC2A1 (solute carrier family 2 member 1), PRSS3 (serine protease 3), SLC23A2 (solute carrier family 23 member 2), CTRC (chymotrypsin C), CUBN (cubilin), CTRB1 (chymotrypsinogen B1), ABCD4 (ATP binding cassette subfamily D member 4), CTRB2 (chymotrypsinogen B2), SLC52A3 (solute carrier family 52 member 3), MMUT (methylmalonyl-CoA mutase), SLC25A16 (solute carrier family 25 member 16), AMN (amnion associated transmembrane protein), CBLIF (cobalamin binding intrinsic factor), SLC52A1 (solute carrier family 52 member 1), SLC52A2 (solute carrier family 52 member 2), PDZD11 (PDZ domain containing 11), SLC25A19 (solute carrier family 25 member 19), ABCC1 (ATP binding cassette subfamily C member 1), THTPA (thiamine triphosphatase), LOC105372824 (uncharacterized LOC105372824)"], "WAG002067": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CDK2 (cyclin dependent kinase 2), CDC6 (cell division cycle 6), CDK1 (cyclin dependent kinase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), CDC25A (cell division cycle 25A), CCND1 (cyclin D1), CDKN1B (cyclin dependent kinase inhibitor 1B), CDT1 (chromatin licensing and DNA replication factor 1), ORC1 (origin recognition complex subunit 1), GMNN (geminin DNA replication inhibitor), SKP2 (S-phase kinase associated protein 2), UBB (ubiquitin B), PCNA (proliferating cell nuclear antigen), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CUL1 (cullin 1), SKP1 (S-phase kinase associated protein 1), RB1 (RB transcriptional corepressor 1), MYC (MYC proto-oncogene, bHLH transcription factor), PSMC3 (proteasome 26S subunit, ATPase 3), CDK4 (cyclin dependent kinase 4), CCNA2 (cyclin A2), PSMA6 (proteasome 20S subunit alpha 6), PSMA1 (proteasome 20S subunit alpha 1), CCNB1 (cyclin B1), PSMA3 (proteasome 20S subunit alpha 3), PSMC1 (proteasome 26S subunit, ATPase 1), E2F1 (E2F transcription factor 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMA2 (proteasome 20S subunit alpha 2), PSMA4 (proteasome 20S subunit alpha 4), PSMA7 (proteasome 20S subunit alpha 7), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB4 (proteasome 20S subunit beta 4), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB5 (proteasome 20S subunit beta 5), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB1 (proteasome 20S subunit beta 1), PSMA5 (proteasome 20S subunit alpha 5), PSMB2 (proteasome 20S subunit beta 2), PSMB3 (proteasome 20S subunit beta 3), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB7 (proteasome 20S subunit beta 7), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD1 (proteasome 26S subunit, non-ATPase 1), POLA1 (DNA polymerase alpha 1, catalytic subunit), PSMB6 (proteasome 20S subunit beta 6), PSMD3 (proteasome 26S subunit, non-ATPase 3), CCNE1 (cyclin E1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD8 (proteasome 26S subunit, non-ATPase 8), MCM7 (minichromosome maintenance complex component 7), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMD11 (proteasome 26S subunit, non-ATPase 11), MCM3 (minichromosome maintenance complex component 3), TFDP1 (transcription factor Dp-1), CDC7 (cell division cycle 7), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMF1 (proteasome inhibitor subunit 1), MCM6 (minichromosome maintenance complex component 6), CCNA1 (cyclin A1), MCM4 (minichromosome maintenance complex component 4), PSMD4 (proteasome 26S subunit, non-ATPase 4), MCM2 (minichromosome maintenance complex component 2), CDC45 (cell division cycle 45), MCM5 (minichromosome maintenance complex component 5), RRM2 (ribonucleotide reductase regulatory subunit M2), ORC4 (origin recognition complex subunit 4), E2F3 (E2F transcription factor 3), CKS1B (CDC28 protein kinase regulatory subunit 1B), E2F4 (E2F transcription factor 4), ORC3 (origin recognition complex subunit 3), CDK6 (cyclin dependent kinase 6), RPA1 (replication protein A1), MCM10 (minichromosome maintenance 10 replication initiation factor), ORC2 (origin recognition complex subunit 2), ORC5 (origin recognition complex subunit 5), CCNE2 (cyclin E2), TOP2A (DNA topoisomerase II alpha), ORC6 (origin recognition complex subunit 6), RBL2 (RB transcriptional corepressor like 2), PSMB8 (proteasome 20S subunit beta 8), TFDP2 (transcription factor Dp-2), PSMB9 (proteasome 20S subunit beta 9), E2F5 (E2F transcription factor 5), CCND2 (cyclin D2), PSME2 (proteasome activator subunit 2), POLE2 (DNA polymerase epsilon 2, accessory subunit), RBL1 (RB transcriptional corepressor like 1), PRIM1 (DNA primase subunit 1), CCND3 (cyclin D3), POLE (DNA polymerase epsilon, catalytic subunit), RBBP4 (RB binding protein 4, chromatin remodeling factor)"], "WAG002068": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CDK1 (cyclin dependent kinase 1), PLK1 (polo like kinase 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), CDK2 (cyclin dependent kinase 2), CDC25A (cell division cycle 25A), NEK2 (NIMA related kinase 2), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), PLK4 (polo like kinase 4), MAPRE1 (microtubule associated protein RP/EB family member 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), CUL1 (cullin 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), CSNK1E (casein kinase 1 epsilon), HAUS2 (HAUS augmin like complex subunit 2), CKAP5 (cytoskeleton associated protein 5), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), PSMC3 (proteasome 26S subunit, ATPase 3), CLASP1 (cytoplasmic linker associated protein 1), SKP1 (S-phase kinase associated protein 1), PSMD1 (proteasome 26S subunit, non-ATPase 1), CCP110 (centriolar coiled-coil protein 110), PSMA6 (proteasome 20S subunit alpha 6), CDK5RAP2 (CDK5 regulatory subunit associated protein 2), CENPJ (centromere protein J), CSNK1D (casein kinase 1 delta), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA3 (proteasome 20S subunit alpha 3), CEP290 (centrosomal protein 290), NDE1 (nudE neurodevelopment protein 1), PSMD14 (proteasome 26S subunit, non-ATPase 14), PCNT (pericentrin), NEDD1 (NEDD1 gamma-tubulin ring complex targeting factor), PSMA2 (proteasome 20S subunit alpha 2), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB5 (proteasome 20S subunit beta 5), AKAP9 (A-kinase anchoring protein 9), CDKN1A (cyclin dependent kinase inhibitor 1A), PSMB4 (proteasome 20S subunit beta 4), DCTN2 (dynactin subunit 2), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), PSMA1 (proteasome 20S subunit alpha 1), PSMB2 (proteasome 20S subunit beta 2), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD2 (proteasome 26S subunit, non-ATPase 2), UBB (ubiquitin B), PSMC2 (proteasome 26S subunit, ATPase 2), NINL (ninein like), CEP250 (centrosomal protein 250), OFD1 (OFD1 centriole and centriolar satellite protein), CETN2 (centrin 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA7 (proteasome 20S subunit alpha 7), CEP135 (centrosomal protein 135), TUBG1 (tubulin gamma 1), CNTRL (centriolin), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), CEP72 (centrosomal protein 72), PSMB1 (proteasome 20S subunit beta 1), PSMB3 (proteasome 20S subunit beta 3), DCTN3 (dynactin subunit 3), PSMD4 (proteasome 26S subunit, non-ATPase 4), CEP164 (centrosomal protein 164), PSMA4 (proteasome 20S subunit alpha 4), PSMC1 (proteasome 26S subunit, ATPase 1), SSNA1 (SS nuclear autoantigen 1), ODF2 (outer dense fiber of sperm tails 2), CEP152 (centrosomal protein 152), PSMB7 (proteasome 20S subunit beta 7), PSMA5 (proteasome 20S subunit alpha 5), CEP57 (centrosomal protein 57), CEP78 (centrosomal protein 78), CEP76 (centrosomal protein 76), CEP70 (centrosomal protein 70), PSMB10 (proteasome 20S subunit beta 10), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMB6 (proteasome 20S subunit beta 6), PSMD13 (proteasome 26S subunit, non-ATPase 13), SFI1 (SFI1 centrin binding protein), PSMD7 (proteasome 26S subunit, non-ATPase 7), SDCCAG8 (SHH signaling and ciliogenesis regulator SDCCAG8), CEP41 (centrosomal protein 41), CEP63 (centrosomal protein 63), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMF1 (proteasome inhibitor subunit 1), PSME1 (proteasome activator subunit 1), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMD10 (proteasome 26S subunit, non-ATPase 10), RBX1 (ring-box 1), PSME3 (proteasome activator subunit 3), PSME4 (proteasome activator subunit 4), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), TUBGCP2 (tubulin gamma complex associated protein 2)"], "WAG002070": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLR2B (RNA polymerase II subunit B), POLR2C (RNA polymerase II subunit C), POLR2G (RNA polymerase II subunit G), POLR2I (RNA polymerase II subunit I), GTF2F2 (general transcription factor IIF subunit 2), POLR2D (RNA polymerase II subunit D), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), CDK7 (cyclin dependent kinase 7), GTF2F1 (general transcription factor IIF subunit 1), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), GTF2H1 (general transcription factor IIH subunit 1), GTF2H3 (general transcription factor IIH subunit 3), POLR2J (RNA polymerase II subunit J), CCNH (cyclin H), POLR2E (RNA polymerase II, I and III subunit E), RNGTT (RNA guanylyltransferase and 5'-phosphatase), MNAT1 (MNAT1 component of CDK activating kinase), POLR2H (RNA polymerase II, I and III subunit H), POLR2F (RNA polymerase II, I and III subunit F), NCBP2 (nuclear cap binding protein subunit 2), POLR2L (RNA polymerase II, I and III subunit L), GTF2H4 (general transcription factor IIH subunit 4), GTF2H2 (general transcription factor IIH subunit 2), RNMT (RNA guanine-7 methyltransferase), NCBP1 (nuclear cap binding protein subunit 1), POLR2K (RNA polymerase II, I and III subunit K), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), GTF2H5 (general transcription factor IIH subunit 5)"], "WAG002072": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK14 (mitogen-activated protein kinase 14), CTNNB1 (catenin beta 1), MAPK11 (mitogen-activated protein kinase 11), MEF2A (myocyte enhancer factor 2A), MEF2C (myocyte enhancer factor 2C), MAPK12 (mitogen-activated protein kinase 12), CDH2 (cadherin 2), CDON (cell adhesion associated, oncogene regulated), CTNNA1 (catenin alpha 1), CDC42 (cell division cycle 42), CDH15 (cadherin 15), SPAG9 (sperm associated antigen 9), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), BNIP2 (BCL2 interacting protein 2), CTNNA2 (catenin alpha 2), MAP2K6 (mitogen-activated protein kinase kinase 6), MYOD1 (myogenic differentiation 1), MYOG (myogenin), MYF6 (myogenic factor 6), MYF5 (myogenic factor 5), TCF3 (transcription factor 3), MEF2D (myocyte enhancer factor 2D), MEF2B (myocyte enhancer factor 2B), CDH4 (cadherin 4), TCF4 (transcription factor 4), TCF12 (transcription factor 12), NTN3 (netrin 3), NEO1 (neogenin 1)"], "WAG002073": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NCAM1 (neural cell adhesion molecule 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), HRAS (HRas proto-oncogene, GTPase), PTK2 (protein tyrosine kinase 2), FYN (FYN proto-oncogene, Src family tyrosine kinase), NRAS (NRAS proto-oncogene, GTPase), PTPRA (protein tyrosine phosphatase receptor type A), SPTB (spectrin beta, erythrocytic), SPTAN1 (spectrin alpha, non-erythrocytic 1), SPTBN2 (spectrin beta, non-erythrocytic 2), SPTBN1 (spectrin beta, non-erythrocytic 1), SPTBN4 (spectrin beta, non-erythrocytic 4), SPTA1 (spectrin alpha, erythrocytic 1), SPTBN5 (spectrin beta, non-erythrocytic 5), GDNF (glial cell derived neurotrophic factor), GFRA1 (GDNF family receptor alpha 1), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), CREB1 (cAMP responsive element binding protein 1), NRTN (neurturin), PSPN (persephin), ARTN (artemin), GFRA2 (GDNF family receptor alpha 2), GFRA4 (GDNF family receptor alpha 4), COL9A1 (collagen type IX alpha 1 chain), COL6A1 (collagen type VI alpha 1 chain), COL9A2 (collagen type IX alpha 2 chain), COL6A2 (collagen type VI alpha 2 chain), COL9A3 (collagen type IX alpha 3 chain), RPS6KA5 (ribosomal protein S6 kinase A5), CNTN2 (contactin 2), NCAN (neurocan), PRNP (prion protein), ST8SIA4 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4), ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2), AGRN (agrin)"], "WAG002074": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FYN (FYN proto-oncogene, Src family tyrosine kinase), NPHS1 (NPHS1 adhesion molecule, nephrin), CD2AP (CD2 associated protein), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), NCK1 (NCK adaptor protein 1), WASL (WASP like actin nucleation promoting factor), NCK2 (NCK adaptor protein 2), SPTBN1 (spectrin beta, non-erythrocytic 1), IQGAP1 (IQ motif containing GTPase activating protein 1), SPTAN1 (spectrin alpha, non-erythrocytic 1), MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2), KIRREL3 (kirre like nephrin family adhesion molecule 3), CASK (calcium/calmodulin dependent serine protein kinase), KIRREL2 (kirre like nephrin family adhesion molecule 2), KIRREL1 (kirre like nephrin family adhesion molecule 1)"], "WAG002075": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DCC (DCC netrin 1 receptor), RAC1 (Rac family small GTPase 1), NTN1 (netrin 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PTK2 (protein tyrosine kinase 2), NCK1 (NCK adaptor protein 1), CDC42 (cell division cycle 42), PLCG1 (phospholipase C gamma 1), DOCK1 (dedicator of cytokinesis 1), NEO1 (neogenin 1), MAPK14 (mitogen-activated protein kinase 14), DSCAM (DS cell adhesion molecule), MAPK8 (mitogen-activated protein kinase 8), ABLIM1 (actin binding LIM protein 1), UNC5C (unc-5 netrin receptor C), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK11 (mitogen-activated protein kinase 11), EZR (ezrin), PAK1 (p21 (RAC1) activated kinase 1), UNC5B (unc-5 netrin receptor B), TRPC3 (transient receptor potential cation channel subfamily C member 3), WASL (WASP like actin nucleation promoting factor), ABLIM3 (actin binding LIM protein family member 3), TRIO (trio Rho guanine nucleotide exchange factor), ABLIM2 (actin binding LIM protein family member 2), TRPC6 (transient receptor potential cation channel subfamily C member 6), ROBO1 (roundabout guidance receptor 1), MAPK12 (mitogen-activated protein kinase 12), UNC5A (unc-5 netrin receptor A), MAPK13 (mitogen-activated protein kinase 13), SLIT2 (slit guidance ligand 2), PRKCQ (protein kinase C theta), TRPC1 (transient receptor potential cation channel subfamily C member 1), UNC5D (unc-5 netrin receptor D), PITPNA (phosphatidylinositol transfer protein alpha), TRPC5 (transient receptor potential cation channel subfamily C member 5), TRPC4 (transient receptor potential cation channel subfamily C member 4), NTN4 (netrin 4), SLIT1 (slit guidance ligand 1), AGAP2 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2), MYO10 (myosin X), SIAH2 (siah E3 ubiquitin protein ligase 2), RGMA (repulsive guidance molecule BMP co-receptor a), SIAH1 (siah E3 ubiquitin protein ligase 1), RGMB (repulsive guidance molecule BMP co-receptor b), TRPC7 (transient receptor potential cation channel subfamily C member 7), DSCAML1 (DS cell adhesion molecule like 1), SLIT3 (slit guidance ligand 3), HJV (hemojuvelin BMP co-receptor)"], "WAG002076": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAOA (monoamine oxidase A), COMT (catechol-O-methyltransferase), ALDH2 (aldehyde dehydrogenase 2 family member), SLC6A4 (solute carrier family 6 member 4), SLC6A3 (solute carrier family 6 member 3), SLC22A2 (solute carrier family 22 member 2), BCHE (butyrylcholinesterase), ACHE (acetylcholinesterase (Cartwright blood group)), SLC22A1 (solute carrier family 22 member 1), LRTOMT (leucine rich transmembrane and O-methyltransferase domain containing)"], "WAG002077": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SYT1 (synaptotagmin 1), RIMS1 (regulating synaptic membrane exocytosis 1), RAB3A (RAB3A, member RAS oncogene family), VAMP2 (vesicle associated membrane protein 2), CPLX1 (complexin 1), STX1A (syntaxin 1A), CASK (calcium/calmodulin dependent serine protein kinase), SNAP25 (synaptosome associated protein 25), SLC18A3 (solute carrier family 18 member A3), UNC13B (unc-13 homolog B), SLC17A7 (solute carrier family 17 member 7), SLC18A2 (solute carrier family 18 member A2), APBA1 (amyloid beta precursor protein binding family A member 1), SLC22A2 (solute carrier family 22 member 2), CHAT (choline O-acetyltransferase), SLC1A1 (solute carrier family 1 member 1), SYN1 (synapsin I), SLC1A3 (solute carrier family 1 member 3), PPFIA3 (PTPRF interacting protein alpha 3), SLC1A6 (solute carrier family 1 member 6), SLC1A7 (solute carrier family 1 member 7), PPFIA2 (PTPRF interacting protein alpha 2), SLC1A2 (solute carrier family 1 member 2), LIN7A (lin-7 homolog A, crumbs cell polarity complex component), PPFIA1 (PTPRF interacting protein alpha 1), LIN7B (lin-7 homolog B, crumbs cell polarity complex component), LIN7C (lin-7 homolog C, crumbs cell polarity complex component), GLS2 (glutaminase 2), SYN3 (synapsin III), ARL6IP5 (ADP ribosylation factor like GTPase 6 interacting protein 5), SLC5A7 (solute carrier family 5 member 7), MAOA (monoamine oxidase A), GLS (glutaminase), PPFIA4 (PTPRF interacting protein alpha 4), SLC22A1 (solute carrier family 22 member 1), SLC38A2 (solute carrier family 38 member 2), NAAA (N-acylethanolamine acid amidase), TSPOAP1 (TSPO associated protein 1)"], "WAG002078": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GLUL (glutamate-ammonia ligase), SLC1A2 (solute carrier family 1 member 2), SLC1A3 (solute carrier family 1 member 3), SLC38A1 (solute carrier family 38 member 1)"], "WAG002079": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), NGF (nerve growth factor), SHC1 (SHC adaptor protein 1), MAPK14 (mitogen-activated protein kinase 14), HRAS (HRas proto-oncogene, GTPase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK11 (mitogen-activated protein kinase 11), MAP2K1 (mitogen-activated protein kinase kinase 1), NRAS (NRAS proto-oncogene, GTPase), NTRK1 (neurotrophic receptor tyrosine kinase 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CREB1 (cAMP responsive element binding protein 1), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), CRK (CRK proto-oncogene, adaptor protein), MAPK13 (mitogen-activated protein kinase 13), MAPK12 (mitogen-activated protein kinase 12), FRS2 (fibroblast growth factor receptor substrate 2), IRS1 (insulin receptor substrate 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), BRAF (B-Raf proto-oncogene, serine/threonine kinase), IRS2 (insulin receptor substrate 2), MAP2K2 (mitogen-activated protein kinase kinase 2), RPS6KA2 (ribosomal protein S6 kinase A2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), AP2A1 (adaptor related protein complex 2 subunit alpha 1), MAPK7 (mitogen-activated protein kinase 7), RPS6KA5 (ribosomal protein S6 kinase A5), AP2M1 (adaptor related protein complex 2 subunit mu 1), AP2A2 (adaptor related protein complex 2 subunit alpha 2), PLCG1 (phospholipase C gamma 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), RPS6KA3 (ribosomal protein S6 kinase A3), RPS6KA1 (ribosomal protein S6 kinase A1), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), PPP2CA (protein phosphatase 2 catalytic subunit alpha), AP2B1 (adaptor related protein complex 2 subunit beta 1), AP2S1 (adaptor related protein complex 2 subunit sigma 1), NTRK2 (neurotrophic receptor tyrosine kinase 2), SHC2 (SHC adaptor protein 2), CRKL (CRK like proto-oncogene, adaptor protein), STAT3 (signal transducer and activator of transcription 3), RAP1A (RAP1A, member of RAS oncogene family), DNM1 (dynamin 1), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), SHC3 (SHC adaptor protein 3), PPP2CB (protein phosphatase 2 catalytic subunit beta), MAPKAPK2 (MAPK activated protein kinase 2), RAPGEF1 (Rap guanine nucleotide exchange factor 1), RALGDS (ral guanine nucleotide dissociation stimulator), RHOA (ras homolog family member A), ELK1 (ETS transcription factor ELK1), RALA (RAS like proto-oncogene A), DUSP6 (dual specificity phosphatase 6), DNM2 (dynamin 2), DUSP3 (dual specificity phosphatase 3), MAP2K5 (mitogen-activated protein kinase kinase 5), KIDINS220 (kinase D interacting substrate 220), CLTC (clathrin heavy chain), MEF2C (myocyte enhancer factor 2C), DUSP4 (dual specificity phosphatase 4), DUSP7 (dual specificity phosphatase 7), MEF2A (myocyte enhancer factor 2A), DNAL4 (dynein axonemal light chain 4), RIT2 (Ras like without CAAX 2), CLTA (clathrin light chain A), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), MAPKAPK3 (MAPK activated protein kinase 3), ADCYAP1 (adenylate cyclase activating polypeptide 1), ATF1 (activating transcription factor 1), RIT1 (Ras like without CAAX 1), DNM3 (dynamin 3), RALB (RAS like proto-oncogene B), ADCYAP1R1 (ADCYAP receptor type I), ADORA2A (adenosine A2a receptor), VRK3 (VRK serine/threonine kinase 3)"], "WAG002085": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNG2 (G protein subunit gamma 2), GNB1 (G protein subunit beta 1), GNAS (GNAS complex locus), GNG3 (G protein subunit gamma 3), GNG4 (G protein subunit gamma 4), GNG13 (G protein subunit gamma 13), GNG7 (G protein subunit gamma 7), GNB2 (G protein subunit beta 2), GNG8 (G protein subunit gamma 8), GNGT2 (G protein subunit gamma transducin 2), GNB3 (G protein subunit beta 3), GNG12 (G protein subunit gamma 12), GNB4 (G protein subunit beta 4), GNGT1 (G protein subunit gamma transducin 1), GNG5 (G protein subunit gamma 5), GNG11 (G protein subunit gamma 11), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), PPP2CA (protein phosphatase 2 catalytic subunit alpha), PPP2CB (protein phosphatase 2 catalytic subunit beta), GNB5 (G protein subunit beta 5), MAPK14 (mitogen-activated protein kinase 14), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), GNG10 (G protein subunit gamma 10), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), TRPC3 (transient receptor potential cation channel subfamily C member 3), SLC8A1 (solute carrier family 8 member A1), NOS3 (nitric oxide synthase 3), NOS1 (nitric oxide synthase 1), FGR (FGR proto-oncogene, Src family tyrosine kinase), PTPN6 (protein tyrosine phosphatase non-receptor type 6), P2RX7 (purinergic receptor P2X 7), ATP2B1 (ATPase plasma membrane Ca2+ transporting 1), APOB (apolipoprotein B), NOS2 (nitric oxide synthase 2), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), TRPC6 (transient receptor potential cation channel subfamily C member 6), ATP2B2 (ATPase plasma membrane Ca2+ transporting 2), ATP2B4 (ATPase plasma membrane Ca2+ transporting 4), P2RX3 (purinergic receptor P2X 3), KCNMA1 (potassium calcium-activated channel subfamily M alpha 1), P2RX1 (purinergic receptor P2X 1), P2RX2 (purinergic receptor P2X 2), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), P2RX5 (purinergic receptor P2X 5), PRKG2 (protein kinase cGMP-dependent 2), P2RX6 (purinergic receptor P2X 6), ATP2B3 (ATPase plasma membrane Ca2+ transporting 3), PLA2G4A (phospholipase A2 group IVA), ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3), TRPC7 (transient receptor potential cation channel subfamily C member 7), KCNMB1 (potassium calcium-activated channel subfamily M regulatory beta subunit 1), ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1), STIM1 (stromal interaction molecule 1), KCNMB4 (potassium calcium-activated channel subfamily M regulatory beta subunit 4), SLC8A2 (solute carrier family 8 member A2), LRP8 (LDL receptor related protein 8), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), PTGIR (prostaglandin I2 receptor), SLC8A3 (solute carrier family 8 member A3), GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2), ORAI2 (ORAI calcium release-activated calcium modulator 2), SRI (sorcin), KCNMB3 (potassium calcium-activated channel subfamily M regulatory beta subunit 3), PAFAH2 (platelet activating factor acetylhydrolase 2), IRAG1 (inositol 1,4,5-triphosphate receptor associated 1), GUCY1A1 (guanylate cyclase 1 soluble subunit alpha 1), CALM1 (calmodulin 1), KCNMB2 (potassium calcium-activated channel subfamily M regulatory beta subunit 2), GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1), P2RX4 (purinergic receptor P2X 4)"], "WAG002087": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NCBP2 (nuclear cap binding protein subunit 2), SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide), SNRPF (small nuclear ribonucleoprotein polypeptide F), SF3A2 (splicing factor 3a subunit 2), SNRPD2 (small nuclear ribonucleoprotein D2 polypeptide), NCBP1 (nuclear cap binding protein subunit 1), U2AF2 (U2 small nuclear RNA auxiliary factor 2), CDC40 (cell division cycle 40), SNRPG (small nuclear ribonucleoprotein polypeptide G), DHX38 (DEAH-box helicase 38), U2AF1 (U2 small nuclear RNA auxiliary factor 1), CPSF1 (cleavage and polyadenylation specific factor 1), SNRNP200 (small nuclear ribonucleoprotein U5 subunit 200), RBM8A (RNA binding motif protein 8A), CPSF2 (cleavage and polyadenylation specific factor 2), CPSF3 (cleavage and polyadenylation specific factor 3), SRRM1 (serine and arginine repetitive matrix 1), SF3B4 (splicing factor 3b subunit 4), RNPS1 (RNA binding protein with serine rich domain 1), SF3B3 (splicing factor 3b subunit 3), PRPF4 (pre-mRNA processing factor 4), SF3A1 (splicing factor 3a subunit 1), EFTUD2 (elongation factor Tu GTP binding domain containing 2), SF3B1 (splicing factor 3b subunit 1), SF3B2 (splicing factor 3b subunit 2), PRPF8 (pre-mRNA processing factor 8), HNRNPK (heterogeneous nuclear ribonucleoprotein K), SF3A3 (splicing factor 3a subunit 3), SNRNP70 (small nuclear ribonucleoprotein U1 subunit 70), SNRPA (small nuclear ribonucleoprotein polypeptide A), HNRNPM (heterogeneous nuclear ribonucleoprotein M), HNRNPD (heterogeneous nuclear ribonucleoprotein D), SRSF2 (serine and arginine rich splicing factor 2), HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1), PCBP1 (poly(rC) binding protein 1), SRSF1 (serine and arginine rich splicing factor 1), HNRNPR (heterogeneous nuclear ribonucleoprotein R), SNRPB2 (small nuclear ribonucleoprotein polypeptide B2), PTBP1 (polypyrimidine tract binding protein 1), POLR2G (RNA polymerase II subunit G), FUS (FUS RNA binding protein), SNRPB (small nuclear ribonucleoprotein polypeptides B and B1), SRSF3 (serine and arginine rich splicing factor 3), UPF3B (UPF3B regulator of nonsense mediated mRNA decay), POLR2B (RNA polymerase II subunit B), SRSF4 (serine and arginine rich splicing factor 4), HNRNPU (heterogeneous nuclear ribonucleoprotein U), HNRNPF (heterogeneous nuclear ribonucleoprotein F), PCF11 (PCF11 cleavage and polyadenylation factor subunit), DHX9 (DExH-box helicase 9), HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1), HNRNPL (heterogeneous nuclear ribonucleoprotein L), PABPN1 (poly(A) binding protein nuclear 1), POLR2C (RNA polymerase II subunit C), CD2BP2 (CD2 cytoplasmic tail binding protein 2), POLR2D (RNA polymerase II subunit D), SNRPD1 (small nuclear ribonucleoprotein D1 polypeptide), CSTF2 (cleavage stimulation factor subunit 2), RBM5 (RNA binding motif protein 5), POLR2I (RNA polymerase II subunit I), PCBP2 (poly(rC) binding protein 2), PRPF6 (pre-mRNA processing factor 6), SRSF7 (serine and arginine rich splicing factor 7), CSTF1 (cleavage stimulation factor subunit 1), SRSF9 (serine and arginine rich splicing factor 9), SRSF5 (serine and arginine rich splicing factor 5), GTF2F2 (general transcription factor IIF subunit 2), YBX1 (Y-box binding protein 1), GTF2F1 (general transcription factor IIF subunit 1), SF3B5 (splicing factor 3b subunit 5), SRSF6 (serine and arginine rich splicing factor 6), HNRNPA0 (heterogeneous nuclear ribonucleoprotein A0), MAGOH (mago homolog, exon junction complex subunit), SRSF11 (serine and arginine rich splicing factor 11), DNAJC8 (DnaJ heat shock protein family (Hsp40) member C8), SNRPE (small nuclear ribonucleoprotein polypeptide E), LSM2 (LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated), HNRNPC (heterogeneous nuclear ribonucleoprotein C), HNRNPUL1 (heterogeneous nuclear ribonucleoprotein U like 1), DDX23 (DEAD-box helicase 23), TXNL4A (thioredoxin like 4A), HNRNPH1 (heterogeneous nuclear ribonucleoprotein H1), NUDT21 (nudix hydrolase 21), PHF5A (PHD finger protein 5A), CSTF3 (cleavage stimulation factor subunit 3), SNRNP40 (small nuclear ribonucleoprotein U5 subunit 40), POLR2E (RNA polymerase II, I and III subunit E), POLR2L (RNA polymerase II, I and III subunit L), POLR2F (RNA polymerase II, I and III subunit F), POLR2H (RNA polymerase II, I and III subunit H), HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2), CPSF7 (cleavage and polyadenylation specific factor 7), CLP1 (cleavage factor polyribonucleotide kinase subunit 1), NXF1 (nuclear RNA export factor 1), PAPOLA (poly(A) polymerase alpha), SUGP1 (SURP and G-patch domain containing 1), POLR2J (RNA polymerase II subunit J), CCAR1 (cell division cycle and apoptosis regulator 1), PRPF19 (pre-mRNA processing factor 19), RAE1 (ribonucleic acid export 1)"], "WAG002088": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CPSF2 (cleavage and polyadenylation specific factor 2), CPSF1 (cleavage and polyadenylation specific factor 1), NCBP2 (nuclear cap binding protein subunit 2), SNRPF (small nuclear ribonucleoprotein polypeptide F), SNRPG (small nuclear ribonucleoprotein polypeptide G), PCF11 (PCF11 cleavage and polyadenylation factor subunit), CPSF3 (cleavage and polyadenylation specific factor 3), SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide), CSTF2 (cleavage stimulation factor subunit 2), CSTF1 (cleavage stimulation factor subunit 1), NCBP1 (nuclear cap binding protein subunit 1), PABPN1 (poly(A) binding protein nuclear 1), CSTF3 (cleavage stimulation factor subunit 3), SNRPB (small nuclear ribonucleoprotein polypeptides B and B1), PAPOLA (poly(A) polymerase alpha), SNRPE (small nuclear ribonucleoprotein polypeptide E), NUDT21 (nudix hydrolase 21), CLP1 (cleavage factor polyribonucleotide kinase subunit 1), CPSF4 (cleavage and polyadenylation specific factor 4), CPSF7 (cleavage and polyadenylation specific factor 7), FIP1L1 (factor interacting with PAPOLA and CPSF1), SLBP (stem-loop binding protein), LSM10 (LSM10, U7 small nuclear RNA associated), SYMPK (symplekin), LSM11 (LSM11, U7 small nuclear RNA associated), ZNF473 (zinc finger protein 473), WDR33 (WD repeat domain 33), CSTF2T (cleavage stimulation factor subunit 2 tau variant)"], "WAG002089": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNB5 (G protein subunit beta 5), GNB1 (G protein subunit beta 1), GNG2 (G protein subunit gamma 2), GNAI2 (G protein subunit alpha i2), TCP1 (t-complex 1), TUBB1 (tubulin beta 1 class VI), CCT5 (chaperonin containing TCP1 subunit 5), GNB2 (G protein subunit beta 2), GNG3 (G protein subunit gamma 3), CCT2 (chaperonin containing TCP1 subunit 2), CCT3 (chaperonin containing TCP1 subunit 3), GNB4 (G protein subunit beta 4), PFDN4 (prefoldin subunit 4), GNAI1 (G protein subunit alpha i1), GNB3 (G protein subunit beta 3), GNGT1 (G protein subunit gamma transducin 1), PFDN5 (prefoldin subunit 5), GNAI3 (G protein subunit alpha i3), GNG4 (G protein subunit gamma 4), GNGT2 (G protein subunit gamma transducin 2), GNG13 (G protein subunit gamma 13), CCT7 (chaperonin containing TCP1 subunit 7), VBP1 (VHL binding protein 1), CCT4 (chaperonin containing TCP1 subunit 4), CCT6A (chaperonin containing TCP1 subunit 6A), GNG7 (G protein subunit gamma 7), CCT8 (chaperonin containing TCP1 subunit 8), GNG5 (G protein subunit gamma 5), PFDN2 (prefoldin subunit 2), GNAO1 (G protein subunit alpha o1), PFDN1 (prefoldin subunit 1), GNG8 (G protein subunit gamma 8), GNG12 (G protein subunit gamma 12), TUBA4A (tubulin alpha 4a), FBXO6 (F-box protein 6), GNAT2 (G protein subunit alpha transducin 2), ACTB (actin beta), GNG11 (G protein subunit gamma 11), TUBA1A (tubulin alpha 1a), GNAT1 (G protein subunit alpha transducin 1), RGS9 (regulator of G protein signaling 9), GNAT3 (G protein subunit alpha transducin 3), TBCE (tubulin folding cofactor E), GNG10 (G protein subunit gamma 10), RGS6 (regulator of G protein signaling 6), TBCA (tubulin folding cofactor A), SPHK1 (sphingosine kinase 1), TP53 (tumor protein p53), TUBA3E (tubulin alpha 3e), RGS7 (regulator of G protein signaling 7), TUBA1B (tubulin alpha 1b), HDAC3 (histone deacetylase 3), TBCD (tubulin folding cofactor D), CSNK2B (casein kinase 2 beta), PDCL (phosducin like), TUBB2A (tubulin beta 2A class IIa), TUBB4A (tubulin beta 4A class IVa), TUBA1C (tubulin alpha 1c), PFDN6 (prefoldin subunit 6), TBCB (tubulin folding cofactor B), TUBB2B (tubulin beta 2B class IIb), FBXL5 (F-box and leucine rich repeat protein 5), TUBB4B (tubulin beta 4B class IVb), FBXO4 (F-box protein 4), NOP56 (NOP56 ribonucleoprotein), CCT6B (chaperonin containing TCP1 subunit 6B), FBXW5 (F-box and WD repeat domain containing 5), FBXW7 (F-box and WD repeat domain containing 7), TUBB6 (tubulin beta 6 class V), TUBB3 (tubulin beta 3 class III), CSNK2A1 (casein kinase 2 alpha 1), FBXL3 (F-box and leucine rich repeat protein 3), RGS11 (regulator of G protein signaling 11), TUBAL3 (tubulin alpha like 3), FBXW4 (F-box and WD repeat domain containing 4), TBCC (tubulin folding cofactor C), CSNK2A2 (casein kinase 2 alpha 2), STAT3 (signal transducer and activator of transcription 3), DCAF7 (DDB1 and CUL4 associated factor 7), FBXW2 (F-box and WD repeat domain containing 2), SKIV2L (Ski2 like RNA helicase), GBA (glucosylceramidase beta), TUBA8 (tubulin alpha 8), ARL2 (ADP ribosylation factor like GTPase 2), USP11 (ubiquitin specific peptidase 11), ARFGEF2 (ADP ribosylation factor guanine nucleotide exchange factor 2), XRN2 (5'-3' exoribonuclease 2), TUBA4B (tubulin alpha 4b), KIF13A (kinesin family member 13A), GAPDHS (glyceraldehyde-3-phosphate dehydrogenase, spermatogenic), LONP2 (lon peptidase 2, peroxisomal), FBXW10 (F-box and WD repeat domain containing 10), WRAP53 (WD repeat containing antisense to TP53), FBXW9 (F-box and WD repeat domain containing 9), AP3M1 (adaptor related protein complex 3 subunit mu 1), FKBP9 (FKBP prolyl isomerase 9)"], "WAG002090": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAP1A (RAP1A, member of RAS oncogene family), RAP1B (RAP1B, member of RAS oncogene family), RAP1GAP (RAP1 GTPase activating protein), SIPA1 (signal-induced proliferation-associated 1), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), RAP1GAP2 (RAP1 GTPase activating protein 2), RASGRP1 (RAS guanyl releasing protein 1), RAPGEF4 (Rap guanine nucleotide exchange factor 4), RAPGEF3 (Rap guanine nucleotide exchange factor 3), RASGRP2 (RAS guanyl releasing protein 2)"], "WAG002091": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMA2 (proteasome 20S subunit alpha 2), PSMA7 (proteasome 20S subunit alpha 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMA1 (proteasome 20S subunit alpha 1), PSMB1 (proteasome 20S subunit beta 1), PSMA3 (proteasome 20S subunit alpha 3), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMA6 (proteasome 20S subunit alpha 6), PSMA4 (proteasome 20S subunit alpha 4), PSMB5 (proteasome 20S subunit beta 5), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB7 (proteasome 20S subunit beta 7), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), PSMB8 (proteasome 20S subunit beta 8), PAK2 (p21 (RAC1) activated kinase 2), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), RPS27A (ribosomal protein S27a), ARHGAP10 (Rho GTPase activating protein 10), OPA1 (OPA1 mitochondrial dynamin like GTPase), OMA1 (OMA1 zinc metallopeptidase), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002092": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII), UQCRC2 (ubiquinol-cytochrome c reductase core protein 2), UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X), NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3), CYC1 (cytochrome c1), UQCR11 (ubiquinol-cytochrome c reductase, complex III subunit XI), UQCRC1 (ubiquinol-cytochrome c reductase core protein 1), UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1), UQCRH (ubiquinol-cytochrome c reductase hinge protein), UQCRB (ubiquinol-cytochrome c reductase binding protein), NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5), NDUFS8 (NADH:ubiquinone oxidoreductase core subunit S8), NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6), NDUFA1 (NADH:ubiquinone oxidoreductase subunit A1), NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9), NDUFA2 (NADH:ubiquinone oxidoreductase subunit A2), NDUFS4 (NADH:ubiquinone oxidoreductase subunit S4), NDUFV1 (NADH:ubiquinone oxidoreductase core subunit V1), NDUFS6 (NADH:ubiquinone oxidoreductase subunit S6), NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8), NDUFA9 (NADH:ubiquinone oxidoreductase subunit A9), NDUFB7 (NADH:ubiquinone oxidoreductase subunit B7), NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8), NDUFS7 (NADH:ubiquinone oxidoreductase core subunit S7), NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2), NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1), NDUFA4 (NDUFA4 mitochondrial complex associated), NDUFS1 (NADH:ubiquinone oxidoreductase core subunit S1), NDUFS5 (NADH:ubiquinone oxidoreductase subunit S5), NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5), NDUFA7 (NADH:ubiquinone oxidoreductase subunit A7), NDUFA12 (NADH:ubiquinone oxidoreductase subunit A12), NDUFB10 (NADH:ubiquinone oxidoreductase subunit B10), NDUFB2 (NADH:ubiquinone oxidoreductase subunit B2), NDUFC2 (NADH:ubiquinone oxidoreductase subunit C2), NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10), NDUFB11 (NADH:ubiquinone oxidoreductase subunit B11), NDUFB6 (NADH:ubiquinone oxidoreductase subunit B6), NDUFA11 (NADH:ubiquinone oxidoreductase subunit A11), NDUFB4 (NADH:ubiquinone oxidoreductase subunit B4), NDUFB3 (NADH:ubiquinone oxidoreductase subunit B3), NDUFA3 (NADH:ubiquinone oxidoreductase subunit A3), NDUFV2 (NADH:ubiquinone oxidoreductase core subunit V2), NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13), NDUFB1 (NADH:ubiquinone oxidoreductase subunit B1), NDUFV3 (NADH:ubiquinone oxidoreductase subunit V3), NDUFC1 (NADH:ubiquinone oxidoreductase subunit C1), NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1), COX5A (cytochrome c oxidase subunit 5A), COX6B1 (cytochrome c oxidase subunit 6B1), COX5B (cytochrome c oxidase subunit 5B), COX4I1 (cytochrome c oxidase subunit 4I1), COX7B (cytochrome c oxidase subunit 7B), COX7C (cytochrome c oxidase subunit 7C), COX6C (cytochrome c oxidase subunit 6C), SDHB (succinate dehydrogenase complex iron sulfur subunit B), COX6A1 (cytochrome c oxidase subunit 6A1), SDHC (succinate dehydrogenase complex subunit C), SDHD (succinate dehydrogenase complex subunit D), ETFA (electron transfer flavoprotein subunit alpha), COX7A2L (cytochrome c oxidase subunit 7A2 like), COX8A (cytochrome c oxidase subunit 8A), ETFB (electron transfer flavoprotein subunit beta), CYCS (cytochrome c, somatic), SURF1 (SURF1 cytochrome c oxidase assembly factor), ETFDH (electron transfer flavoprotein dehydrogenase), NDUFAF2 (NADH:ubiquinone oxidoreductase complex assembly factor 2), NDUFAF3 (NADH:ubiquinone oxidoreductase complex assembly factor 3), NDUFAF5 (NADH:ubiquinone oxidoreductase complex assembly factor 5), NDUFAF4 (NADH:ubiquinone oxidoreductase complex assembly factor 4), SDHA (succinate dehydrogenase complex flavoprotein subunit A), NDUFAF6 (NADH:ubiquinone oxidoreductase complex assembly factor 6), NUBPL (nucleotide binding protein like), LRPPRC (leucine rich pentatricopeptide repeat containing), COX11 (cytochrome c oxidase copper chaperone COX11), SCO1 (synthesis of cytochrome C oxidase 1), TACO1 (translational activator of cytochrome c oxidase I), SCO2 (synthesis of cytochrome C oxidase 2), COX14 (cytochrome c oxidase assembly factor COX14), UCP2 (uncoupling protein 2), SLC25A14 (solute carrier family 25 member 14), UCP3 (uncoupling protein 3), UCP1 (uncoupling protein 1), SLC25A27 (solute carrier family 25 member 27), ECSIT (ECSIT signaling integrator), COX19 (cytochrome c oxidase assembly factor COX19), COX18 (cytochrome c oxidase assembly factor COX18), COX16 (cytochrome c oxidase assembly factor COX16), TMEM126B (transmembrane protein 126B), TRAP1 (TNF receptor associated protein 1), ACAD9 (acyl-CoA dehydrogenase family member 9), COX3 (cytochrome c oxidase III), ND6 (NADH dehydrogenase, subunit 6 (complex I)), ND4 (NADH dehydrogenase, subunit 4 (complex I)), DMAC2L (distal membrane arm assembly complex 2 like), ATP5F1C (ATP synthase F1 subunit gamma), ATP5MC3 (ATP synthase membrane subunit c locus 3), ATP5F1D (ATP synthase F1 subunit delta), ATP5PB (ATP synthase peripheral stalk-membrane subunit b), COX20 (cytochrome c oxidase assembly factor COX20)"], "WAG002093": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FN1 (fibronectin 1), APP (amyloid beta precursor protein), ALB (albumin), PLG (plasminogen), KNG1 (kininogen 1), F5 (coagulation factor V), SERPINF2 (serpin family F member 2), F8 (coagulation factor VIII), F13A1 (coagulation factor XIII A chain), SERPINE1 (serpin family E member 1), SERPINA1 (serpin family A member 1), PF4 (platelet factor 4), EGF (epidermal growth factor), TIMP1 (TIMP metallopeptidase inhibitor 1), SERPING1 (serpin family G member 1), CLU (clusterin), PPBP (pro-platelet basic protein), SPARC (secreted protein acidic and cysteine rich), MMRN1 (multimerin 1), SRGN (serglycin), CFD (complement factor D), ALDOA (aldolase, fructose-bisphosphate A), GAS6 (growth arrest specific 6), FGA (fibrinogen alpha chain), THBS1 (thrombospondin 1), FGG (fibrinogen gamma chain), FGB (fibrinogen beta chain), ITGB3 (integrin subunit beta 3), APOA1 (apolipoprotein A1), ITGA2B (integrin subunit alpha 2b), FLNA (filamin A), AHSG (alpha 2-HS glycoprotein), APOH (apolipoprotein H), VWF (von Willebrand factor), VCL (vinculin), HRG (histidine rich glycoprotein), PLEK (pleckstrin), PRKCA (protein kinase C alpha), TLN1 (talin 1), SELP (selectin P), HABP4 (hyaluronan binding protein 4), SOD1 (superoxide dismutase 1), TTN (titin), TF (transferrin), CD36 (CD36 molecule), ITIH3 (inter-alpha-trypsin inhibitor heavy chain 3), WDR1 (WD repeat domain 1), CD9 (CD9 molecule), CD63 (CD63 molecule), BRPF3 (bromodomain and PHD finger containing 3), PRKCB (protein kinase C beta), HGF (hepatocyte growth factor), ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4), CFL1 (cofilin 1), PFN1 (profilin 1), ORM1 (orosomucoid 1), PPIA (peptidylprolyl isomerase A), SERPINA3 (serpin family A member 3), STXBP3 (syntaxin binding protein 3), STX4 (syntaxin 4), HSPA5 (heat shock protein family A (Hsp70) member 5), PRKCG (protein kinase C gamma), CAP1 (cyclase associated actin cytoskeleton regulatory protein 1), PROS1 (protein S), ANXA5 (annexin A5), SPP2 (secreted phosphoprotein 2), CLEC3B (C-type lectin domain family 3 member B), ORM2 (orosomucoid 2), TAGLN2 (transgelin 2), LGALS3BP (galectin 3 binding protein), LAMP2 (lysosomal associated membrane protein 2), SERPINA4 (serpin family A member 4), FERMT3 (fermitin family member 3), APLP2 (amyloid beta precursor like protein 2), TIMP3 (TIMP metallopeptidase inhibitor 3), STXBP2 (syntaxin binding protein 2), ECM1 (extracellular matrix protein 1), TMSB4X (thymosin beta 4 X-linked), CALU (calumenin), TMX3 (thioredoxin related transmembrane protein 3), CHID1 (chitinase domain containing 1), VTI1B (vesicle transport through interaction with t-SNAREs 1B), RAB27B (RAB27B, member RAS oncogene family), SYTL4 (synaptotagmin like 4), OLA1 (Obg like ATPase 1), PCDH7 (protocadherin 7), GTPBP2 (GTP binding protein 2), TUBA4A (tubulin alpha 4a), PSAP (prosaposin), FAM3C (FAM3 metabolism regulating signaling molecule C), ISLR (immunoglobulin superfamily containing leucine rich repeat), MAGED2 (MAGE family member D2), SCG3 (secretogranin III), PCYOX1L (prenylcysteine oxidase 1 like), SELENOP (selenoprotein P), CYRIB (CYFIP related Rac1 interactor B), CDC37L1 (cell division cycle 37 like 1), CTSW (cathepsin W), CALM1 (calmodulin 1), RARRES2 (retinoic acid receptor responder 2)"], "WAG002094": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), MAVS (mitochondrial antiviral signaling protein), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), TRAF6 (TNF receptor associated factor 6), RELA (RELA proto-oncogene, NF-kB subunit), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), DDX58 (DExD/H-box helicase 58), NFKB1 (nuclear factor kappa B subunit 1), TRAF2 (TNF receptor associated factor 2), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), UBB (ubiquitin B), NFKBIA (NFKB inhibitor alpha), TBK1 (TANK binding kinase 1), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), RIPK1 (receptor interacting serine/threonine kinase 1), TRAF3 (TNF receptor associated factor 3), TNFAIP3 (TNF alpha induced protein 3), APP (amyloid beta precursor protein), IRF7 (interferon regulatory factor 7), IRF3 (interferon regulatory factor 3), CASP8 (caspase 8), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), NFKB2 (nuclear factor kappa B subunit 2), UBE2D3 (ubiquitin conjugating enzyme E2 D3), ITCH (itchy E3 ubiquitin protein ligase), TRIM25 (tripartite motif containing 25), FADD (Fas associated via death domain), TANK (TRAF family member associated NFKB activator), UBE2D1 (ubiquitin conjugating enzyme E2 D1), UBE2L6 (ubiquitin conjugating enzyme E2 L6), ISG15 (ISG15 ubiquitin like modifier), UBE2D2 (ubiquitin conjugating enzyme E2 D2), CREBBP (CREB binding protein), CYLD (CYLD lysine 63 deubiquitinase), IFIH1 (interferon induced with helicase C domain 1), NFKBIB (NFKB inhibitor beta), IFNB1 (interferon beta 1), UBE2K (ubiquitin conjugating enzyme E2 K), TAX1BP1 (Tax1 binding protein 1), EP300 (E1A binding protein p300), PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1), HERC5 (HECT and RLD domain containing E3 ubiquitin protein ligase 5), RPS27A (ribosomal protein S27a), NLRX1 (NLR family member X1), RNF135 (ring finger protein 135), RNF125 (ring finger protein 125), SIKE1 (suppressor of IKBKE 1), CASP10 (caspase 10), UBA7 (ubiquitin like modifier activating enzyme 7), NLRC5 (NLR family CARD domain containing 5), HMGB1 (high mobility group box 1), DHX58 (DExH-box helicase 58), ATG5 (autophagy related 5), ATG12 (autophagy related 12), OTUD5 (OTU deubiquitinase 5), AGER (advanced glycosylation end-product specific receptor), S100B (S100 calcium binding protein B), PCBP2 (poly(rC) binding protein 2), RNF216 (ring finger protein 216), NKIRAS1 (NFKB inhibitor interacting Ras like 1), NKIRAS2 (NFKB inhibitor interacting Ras like 2), S100A12 (S100 calcium binding protein A12), SAA1 (serum amyloid A1), TKFC (triokinase and FMN cyclase)"], "WAG002095": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLR2C (RNA polymerase II subunit C), POLR2B (RNA polymerase II subunit B), POLR2G (RNA polymerase II subunit G), GTF2F2 (general transcription factor IIF subunit 2), GTF2F1 (general transcription factor IIF subunit 1), POLR2I (RNA polymerase II subunit I), POLR2D (RNA polymerase II subunit D), POLR2E (RNA polymerase II, I and III subunit E), NCBP2 (nuclear cap binding protein subunit 2), POLR2F (RNA polymerase II, I and III subunit F), POLR2H (RNA polymerase II, I and III subunit H), POLR2L (RNA polymerase II, I and III subunit L), POLR2J (RNA polymerase II subunit J), NCBP1 (nuclear cap binding protein subunit 1), CPSF1 (cleavage and polyadenylation specific factor 1), CPSF2 (cleavage and polyadenylation specific factor 2), GTF2H3 (general transcription factor IIH subunit 3), GTF2H1 (general transcription factor IIH subunit 1), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), CDK7 (cyclin dependent kinase 7), SNRPF (small nuclear ribonucleoprotein polypeptide F), CPSF3 (cleavage and polyadenylation specific factor 3), CCNH (cyclin H), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), SNRPG (small nuclear ribonucleoprotein polypeptide G), PCF11 (PCF11 cleavage and polyadenylation factor subunit), SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide), MNAT1 (MNAT1 component of CDK activating kinase), CSTF2 (cleavage stimulation factor subunit 2), RBM8A (RNA binding motif protein 8A), U2AF2 (U2 small nuclear RNA auxiliary factor 2), TBP (TATA-box binding protein), DHX38 (DEAH-box helicase 38), CDK9 (cyclin dependent kinase 9), U2AF1 (U2 small nuclear RNA auxiliary factor 1), CSTF1 (cleavage stimulation factor subunit 1), GTF2H4 (general transcription factor IIH subunit 4), CDC40 (cell division cycle 40), PABPN1 (poly(A) binding protein nuclear 1), RNPS1 (RNA binding protein with serine rich domain 1), TCEA1 (transcription elongation factor A1), GTF2H2 (general transcription factor IIH subunit 2), GTF2B (general transcription factor IIB), TAF5 (TATA-box binding protein associated factor 5), TAF11 (TATA-box binding protein associated factor 11), CSTF3 (cleavage stimulation factor subunit 3), TAF6 (TATA-box binding protein associated factor 6), TAF13 (TATA-box binding protein associated factor 13), TAF12 (TATA-box binding protein associated factor 12), SRRM1 (serine and arginine repetitive matrix 1), SRSF2 (serine and arginine rich splicing factor 2), TAF7 (TATA-box binding protein associated factor 7), UPF3B (UPF3B regulator of nonsense mediated mRNA decay), TAF4 (TATA-box binding protein associated factor 4), TAF10 (TATA-box binding protein associated factor 10), NUDT21 (nudix hydrolase 21), SRSF1 (serine and arginine rich splicing factor 1), SRSF3 (serine and arginine rich splicing factor 3), TAF1 (TATA-box binding protein associated factor 1), SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), GTF2E1 (general transcription factor IIE subunit 1), CLP1 (cleavage factor polyribonucleotide kinase subunit 1), GTF2E2 (general transcription factor IIE subunit 2), SRSF4 (serine and arginine rich splicing factor 4), SRSF5 (serine and arginine rich splicing factor 5), CPSF7 (cleavage and polyadenylation specific factor 7), SRSF7 (serine and arginine rich splicing factor 7), SRSF6 (serine and arginine rich splicing factor 6), SRSF9 (serine and arginine rich splicing factor 9), GTF2A2 (general transcription factor IIA subunit 2), CCNT1 (cyclin T1), MAGOH (mago homolog, exon junction complex subunit), SRSF11 (serine and arginine rich splicing factor 11), GTF2A1 (general transcription factor IIA subunit 1), TAF9 (TATA-box binding protein associated factor 9), SNRPB (small nuclear ribonucleoprotein polypeptides B and B1), ELL (elongation factor for RNA polymerase II), TAF4B (TATA-box binding protein associated factor 4b), SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit), SNRPE (small nuclear ribonucleoprotein polypeptide E), CCNT2 (cyclin T2), PAPOLA (poly(A) polymerase alpha), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), CTDP1 (CTD phosphatase subunit 1), SSRP1 (structure specific recognition protein 1), RNGTT (RNA guanylyltransferase and 5'-phosphatase), EIF4A3 (eukaryotic translation initiation factor 4A3), RNMT (RNA guanine-7 methyltransferase), CDC73 (cell division cycle 73), SLBP (stem-loop binding protein), TAF2 (TATA-box binding protein associated factor 2), CPSF4 (cleavage and polyadenylation specific factor 4), POLR2K (RNA polymerase II, I and III subunit K), LSM10 (LSM10, U7 small nuclear RNA associated), MLLT3 (MLLT3 super elongation complex subunit), DDX39B (DExD-box helicase 39B), PAF1 (PAF1 homolog, Paf1/RNA polymerase II complex component), CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex component), TAF9B (TATA-box binding protein associated factor 9b), RTF1 (RTF1 homolog, Paf1/RNA polymerase II complex component)"], "WAG002096": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), PLXNA1 (plexin A1), PLXNA4 (plexin A4), PLXNA2 (plexin A2), SEMA3A (semaphorin 3A), RHOA (ras homolog family member A), PLXNA3 (plexin A3), CDK5 (cyclin dependent kinase 5), FES (FES proto-oncogene, tyrosine kinase), RND1 (Rho family GTPase 1), LIMK1 (LIM domain kinase 1), ROCK2 (Rho associated coiled-coil containing protein kinase 2), DPYSL2 (dihydropyrimidinase like 2), TLN1 (talin 1), PLXNB1 (plexin B1), CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1), CRMP1 (collapsin response mediator protein 1), PAK2 (p21 (RAC1) activated kinase 2), SEMA4D (semaphorin 4D), RRAS (RAS related), RHOB (ras homolog family member B), ROCK1 (Rho associated coiled-coil containing protein kinase 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), ERBB2 (erb-b2 receptor tyrosine kinase 2), ARHGEF11 (Rho guanine nucleotide exchange factor 11), DPYSL5 (dihydropyrimidinase like 5), MYH9 (myosin heavy chain 9), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), DPYSL3 (dihydropyrimidinase like 3), DPYSL4 (dihydropyrimidinase like 4), PAK1 (p21 (RAC1) activated kinase 1), MYH11 (myosin heavy chain 11), FARP2 (FERM, ARH/RhoGEF and pleckstrin domain protein 2), ARHGEF12 (Rho guanine nucleotide exchange factor 12), HSP90AB1 (heat shock protein 90 alpha family class B member 1), NRP1 (neuropilin 1), MET (MET proto-oncogene, receptor tyrosine kinase), LIMK2 (LIM domain kinase 2), ARHGAP35 (Rho GTPase activating protein 35), MYH10 (myosin heavy chain 10), ITGA1 (integrin subunit alpha 1), PLXNB3 (plexin B3), MYL6 (myosin light chain 6), MYL12B (myosin light chain 12B), MYL9 (myosin light chain 9), GSK3B (glycogen synthase kinase 3 beta), ITGB1 (integrin subunit beta 1), PAK3 (p21 (RAC1) activated kinase 3), TYROBP (transmembrane immune signaling adaptor TYROBP), TREM2 (triggering receptor expressed on myeloid cells 2), SEMA4A (semaphorin 4A), PLXND1 (plexin D1), CFL1 (cofilin 1), SEMA3E (semaphorin 3E), SEMA7A (semaphorin 7A (John Milton Hagen blood group)), SEMA6D (semaphorin 6D), MYH14 (myosin heavy chain 14), SEMA6A (semaphorin 6A), RHOC (ras homolog family member C), PLXNC1 (plexin C1), SEMA5A (semaphorin 5A), CD72 (CD72 molecule)"], "WAG002097": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNG2 (G protein subunit gamma 2), GNAI2 (G protein subunit alpha i2), GNB1 (G protein subunit beta 1), GNAI3 (G protein subunit alpha i3), GNAI1 (G protein subunit alpha i1), GNB2 (G protein subunit beta 2), GNG3 (G protein subunit gamma 3), GNB5 (G protein subunit beta 5), GNGT1 (G protein subunit gamma transducin 1), GNG13 (G protein subunit gamma 13), GNGT2 (G protein subunit gamma transducin 2), GNB4 (G protein subunit beta 4), GNG4 (G protein subunit gamma 4), GNG7 (G protein subunit gamma 7), GNA15 (G protein subunit alpha 15), GNB3 (G protein subunit beta 3), GNG5 (G protein subunit gamma 5), GNG8 (G protein subunit gamma 8), GNG12 (G protein subunit gamma 12), GNA11 (G protein subunit alpha 11), GNG11 (G protein subunit gamma 11), GNAQ (G protein subunit alpha q), TBXA2R (thromboxane A2 receptor), GNG10 (G protein subunit gamma 10), GNA13 (G protein subunit alpha 13), GNA14 (G protein subunit alpha 14), MAPK14 (mitogen-activated protein kinase 14), GNAT3 (G protein subunit alpha transducin 3), PLA2G4A (phospholipase A2 group IVA), P2RY1 (purinergic receptor P2Y1), P2RY12 (purinergic receptor P2Y12), AAMP (angio associated migratory cell protein)"], "WAG002098": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CD47 (CD47 molecule), PTK2B (protein tyrosine kinase 2 beta), PTPN6 (protein tyrosine phosphatase non-receptor type 6), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SIRPA (signal regulatory protein alpha), SIRPB1 (signal regulatory protein beta 1), TYROBP (transmembrane immune signaling adaptor TYROBP), PTK2 (protein tyrosine kinase 2), SKAP2 (src kinase associated phosphoprotein 2), SIRPG (signal regulatory protein gamma), FYB1 (FYN binding protein 1)"], "WAG002100": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "INSR (insulin receptor), ATP6V1E1 (ATPase H+ transporting V1 subunit E1), ATP6V1A (ATPase H+ transporting V1 subunit A), ATP6V0D1 (ATPase H+ transporting V0 subunit d1), ATP6V1F (ATPase H+ transporting V1 subunit F), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), ATP6V1B2 (ATPase H+ transporting V1 subunit B2), ATP6V1H (ATPase H+ transporting V1 subunit H), ATP6V0D2 (ATPase H+ transporting V0 subunit d2), ATP6V1D (ATPase H+ transporting V1 subunit D), ATP6V1G1 (ATPase H+ transporting V1 subunit G1), ATP6V0A1 (ATPase H+ transporting V0 subunit a1), ATP6V1B1 (ATPase H+ transporting V1 subunit B1), ATP6V0C (ATPase H+ transporting V0 subunit c), ATP6V0B (ATPase H+ transporting V0 subunit b), ATP6V1C2 (ATPase H+ transporting V1 subunit C2), ATP6V0A4 (ATPase H+ transporting V0 subunit a4), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), ATP6V0A2 (ATPase H+ transporting V0 subunit a2), ATP6V0E2 (ATPase H+ transporting V0 subunit e2), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), ATP6V1G3 (ATPase H+ transporting V1 subunit G3), IRS1 (insulin receptor substrate 1), IRS2 (insulin receptor substrate 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SHC1 (SHC adaptor protein 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), HRAS (HRas proto-oncogene, GTPase), ATP6AP1 (ATPase H+ transporting accessory protein 1), MAPK1 (mitogen-activated protein kinase 1), NRAS (NRAS proto-oncogene, GTPase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAPK3 (mitogen-activated protein kinase 3), INS (insulin), GRB10 (growth factor receptor bound protein 10), ATP6V1G2 (ATPase H+ transporting V1 subunit G2), ATP6V1E2 (ATPase H+ transporting V1 subunit E2)"], "WAG002101": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PDGFRB (platelet derived growth factor receptor beta), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PDGFRA (platelet derived growth factor receptor alpha), PDGFB (platelet derived growth factor subunit B), CRK (CRK proto-oncogene, adaptor protein), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), HRAS (HRas proto-oncogene, GTPase), CRKL (CRK like proto-oncogene, adaptor protein), PLCG1 (phospholipase C gamma 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), STAT3 (signal transducer and activator of transcription 3), NCK1 (NCK adaptor protein 1), NRAS (NRAS proto-oncogene, GTPase), BCAR1 (BCAR1 scaffold protein, Cas family member), STAT5A (signal transducer and activator of transcription 5A), STAT1 (signal transducer and activator of transcription 1), RASA1 (RAS p21 protein activator 1), STAT5B (signal transducer and activator of transcription 5B), KRAS (KRAS proto-oncogene, GTPase), RAPGEF1 (Rap guanine nucleotide exchange factor 1), PDGFD (platelet derived growth factor D), NCK2 (NCK adaptor protein 2), STAT6 (signal transducer and activator of transcription 6), PTPN12 (protein tyrosine phosphatase non-receptor type 12), GRB7 (growth factor receptor bound protein 7), PLAT (plasminogen activator, tissue type), FURIN (furin, paired basic amino acid cleaving enzyme), PLG (plasminogen), SPP1 (secreted phosphoprotein 1)"], "WAG002102": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC2 (Rac family small GTPase 2), RHOG (ras homolog family member G), RHOB (ras homolog family member B), ARHGAP4 (Rho GTPase activating protein 4), RAC1 (Rac family small GTPase 1), RHOQ (ras homolog family member Q), RHOH (ras homolog family member H), RHOD (ras homolog family member D), RHOU (ras homolog family member U), RHOV (ras homolog family member V), RHOA (ras homolog family member A), RHOF (ras homolog family member F, filopodia associated), VAV1 (vav guanine nucleotide exchange factor 1), ARHGDIA (Rho GDP dissociation inhibitor alpha), VAV2 (vav guanine nucleotide exchange factor 2), CDC42 (cell division cycle 42), TIAM1 (TIAM Rac1 associated GEF 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), ARHGEF11 (Rho guanine nucleotide exchange factor 11), ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2), ARHGDIB (Rho GDP dissociation inhibitor beta), ECT2 (epithelial cell transforming 2), ARHGDIG (Rho GDP dissociation inhibitor gamma), MCF2L (MCF.2 cell line derived transforming sequence like), PLEKHG2 (pleckstrin homology and RhoGEF domain containing G2), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), ARHGAP1 (Rho GTPase activating protein 1), FGD1 (FYVE, RhoGEF and PH domain containing 1), ARHGEF18 (Rho/Rac guanine nucleotide exchange factor 18), ARHGEF9 (Cdc42 guanine nucleotide exchange factor 9), RASGRF2 (Ras protein specific guanine nucleotide releasing factor 2), ARHGEF17 (Rho guanine nucleotide exchange factor 17), PLEKHG5 (pleckstrin homology and RhoGEF domain containing G5), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), RACGAP1 (Rac GTPase activating protein 1), RALBP1 (ralA binding protein 1), BCR (BCR activator of RhoGEF and GTPase), ARHGAP31 (Rho GTPase activating protein 31), STARD8 (StAR related lipid transfer domain containing 8), ARHGAP32 (Rho GTPase activating protein 32), ARHGAP35 (Rho GTPase activating protein 35), ARHGAP5 (Rho GTPase activating protein 5), OPHN1 (oligophrenin 1), ARHGAP39 (Rho GTPase activating protein 39), ARHGEF1 (Rho guanine nucleotide exchange factor 1), TRIP10 (thyroid hormone receptor interactor 10), ARHGAP33 (Rho GTPase activating protein 33), ARHGAP26 (Rho GTPase activating protein 26), ARHGAP15 (Rho GTPase activating protein 15), GMIP (GEM interacting protein), ARHGAP44 (Rho GTPase activating protein 44), ARHGAP29 (Rho GTPase activating protein 29), MYO9A (myosin IXA), ARHGAP30 (Rho GTPase activating protein 30), DEPDC1B (DEP domain containing 1B), INPP5B (inositol polyphosphate-5-phosphatase B), ARAP2 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2), ARAP3 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3), ARHGAP18 (Rho GTPase activating protein 18), ARHGAP19 (Rho GTPase activating protein 19), ARHGAP22 (Rho GTPase activating protein 22), FAM13B (family with sequence similarity 13 member B), SYDE2 (synapse defective Rho GTPase homolog 2), GNA13 (G protein subunit alpha 13), RAC3 (Rac family small GTPase 3), MCF2 (MCF.2 cell line derived transforming sequence), ARHGEF12 (Rho guanine nucleotide exchange factor 12), ARHGEF7 (Rho guanine nucleotide exchange factor 7), VAV3 (vav guanine nucleotide exchange factor 3), ARHGAP6 (Rho GTPase activating protein 6), TRIO (trio Rho guanine nucleotide exchange factor), CHN1 (chimerin 1), ITSN1 (intersectin 1), NGEF (neuronal guanine nucleotide exchange factor), ARHGAP8 (Rho GTPase activating protein 8), CHN2 (chimerin 2), STARD13 (StAR related lipid transfer domain containing 13), TIAM2 (TIAM Rac1 associated GEF 2), ARHGEF4 (Rho guanine nucleotide exchange factor 4), DLC1 (DLC1 Rho GTPase activating protein), SRGAP1 (SLIT-ROBO Rho GTPase activating protein 1), PREX1 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1), AKAP13 (A-kinase anchoring protein 13), OCRL (OCRL inositol polyphosphate-5-phosphatase), ARHGAP17 (Rho GTPase activating protein 17), NET1 (neuroepithelial cell transforming 1), ARAP1 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1), RHOC (ras homolog family member C), MYO9B (myosin IXB), ARHGAP24 (Rho GTPase activating protein 24), ARHGAP9 (Rho GTPase activating protein 9), ARHGEF3 (Rho guanine nucleotide exchange factor 3), ABR (ABR activator of RhoGEF and GTPase), ARHGEF5 (Rho guanine nucleotide exchange factor 5), ARHGAP11A (Rho GTPase activating protein 11A), RHOJ (ras homolog family member J), ARHGAP10 (Rho GTPase activating protein 10), ARHGEF19 (Rho guanine nucleotide exchange factor 19), KALRN (kalirin RhoGEF kinase)"], "WAG002103": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), RPS3 (ribosomal protein S3), RPL8 (ribosomal protein L8), RPS24 (ribosomal protein S24), RPS6 (ribosomal protein S6), RPL6 (ribosomal protein L6), RPS7 (ribosomal protein S7), RPS16 (ribosomal protein S16), RPL4 (ribosomal protein L4), RPL18A (ribosomal protein L18a), RPL11 (ribosomal protein L11), RPS5 (ribosomal protein S5), RPL23 (ribosomal protein L23), RPS18 (ribosomal protein S18), RPS13 (ribosomal protein S13), RPL30 (ribosomal protein L30), RPL3 (ribosomal protein L3), RPL35 (ribosomal protein L35), RPL19 (ribosomal protein L19), RPLP0 (ribosomal protein lateral stalk subunit P0), RPS23 (ribosomal protein S23), RPS15 (ribosomal protein S15), RPS15A (ribosomal protein S15a), RPL27A (ribosomal protein L27a), RPS20 (ribosomal protein S20), RPS14 (ribosomal protein S14), RPL7A (ribosomal protein L7a), RPS9 (ribosomal protein S9), RPL18 (ribosomal protein L18), RPL38 (ribosomal protein L38), RPS10 (ribosomal protein S10), RPS8 (ribosomal protein S8), RPS19 (ribosomal protein S19), RPL36 (ribosomal protein L36), RPL28 (ribosomal protein L28), RPS17 (ribosomal protein S17), RPL27 (ribosomal protein L27), RPS29 (ribosomal protein S29), RPL12 (ribosomal protein L12), RPS21 (ribosomal protein S21), RPL22 (ribosomal protein L22), RPL31 (ribosomal protein L31), RPL34 (ribosomal protein L34), RPLP1 (ribosomal protein lateral stalk subunit P1), RPL29 (ribosomal protein L29), RPL35A (ribosomal protein L35a), RPL37 (ribosomal protein L37), RPLP2 (ribosomal protein lateral stalk subunit P2), RPL15 (ribosomal protein L15), RPS28 (ribosomal protein S28), UBB (ubiquitin B), RPL37A (ribosomal protein L37a), RPL13 (ribosomal protein L13), RPL7 (ribosomal protein L7), RPL24 (ribosomal protein L24), FAU (FAU ubiquitin like and ribosomal protein S30 fusion), RPS3A (ribosomal protein S3A), RPL10 (ribosomal protein L10), ETF1 (eukaryotic translation termination factor 1), RPS11 (ribosomal protein S11), RPS25 (ribosomal protein S25), RPL10A (ribosomal protein L10a), RPS12 (ribosomal protein S12), RPL13A (ribosomal protein L13a), RPL26 (ribosomal protein L26), RPS2 (ribosomal protein S2), RPL14 (ribosomal protein L14), RPL21 (ribosomal protein L21), RPL3L (ribosomal protein L3 like), RPS27 (ribosomal protein S27), RPL39 (ribosomal protein L39), RPSA (ribosomal protein SA), RPL23A (ribosomal protein L23a), RPL32 (ribosomal protein L32), RPS4X (ribosomal protein S4 X-linked), RPS4Y1 (ribosomal protein S4 Y-linked 1), RPL41 (ribosomal protein L41), RPS27A (ribosomal protein S27a), RPL17 (ribosomal protein L17), NCBP1 (nuclear cap binding protein subunit 1), EIF4A3 (eukaryotic translation initiation factor 4A3), RPS26 (ribosomal protein S26), PSMD14 (proteasome 26S subunit, non-ATPase 14), RPL10L (ribosomal protein L10 like), RPL26L1 (ribosomal protein L26 like 1), PSMD2 (proteasome 26S subunit, non-ATPase 2), UPF2 (UPF2 regulator of nonsense mediated mRNA decay), PSMA7 (proteasome 20S subunit alpha 7), RBM8A (RNA binding motif protein 8A), GSPT2 (G1 to S phase transition 2), PSMC3 (proteasome 26S subunit, ATPase 3), RNPS1 (RNA binding protein with serine rich domain 1), NCBP2 (nuclear cap binding protein subunit 2), RPL39L (ribosomal protein L39 like), UPF3B (UPF3B regulator of nonsense mediated mRNA decay), RPL36A (ribosomal protein L36a), PSMA6 (proteasome 20S subunit alpha 6), UPF3A (UPF3A regulator of nonsense mediated mRNA decay)"], "WAG002104": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), AKT1 (AKT serine/threonine kinase 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), CDC42 (cell division cycle 42), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), KDR (kinase insert domain receptor), VEGFA (vascular endothelial growth factor A), PLCG1 (phospholipase C gamma 1), PTK2 (protein tyrosine kinase 2), PRKCA (protein kinase C alpha), RHOA (ras homolog family member A), CRK (CRK proto-oncogene, adaptor protein), NCK1 (NCK adaptor protein 1), PTK2B (protein tyrosine kinase 2 beta), MAPK14 (mitogen-activated protein kinase 14), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), ABI1 (abl interactor 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), HRAS (HRas proto-oncogene, GTPase), PRKCD (protein kinase C delta), PXN (paxillin), HSP90AA1 (heat shock protein 90 alpha family class A member 1), FLT1 (fms related receptor tyrosine kinase 1), PRKCB (protein kinase C beta), VAV1 (vav guanine nucleotide exchange factor 1), MTOR (mechanistic target of rapamycin kinase), PAK1 (p21 (RAC1) activated kinase 1), PRKCZ (protein kinase C zeta), BCAR1 (BCAR1 scaffold protein, Cas family member), PDPK1 (3-phosphoinositide dependent protein kinase 1), VAV2 (vav guanine nucleotide exchange factor 2), MAPK11 (mitogen-activated protein kinase 11), RASA1 (RAS p21 protein activator 1), WASF1 (WASP family member 1), NRAS (NRAS proto-oncogene, GTPase), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), FLT4 (fms related receptor tyrosine kinase 4), ITGAV (integrin subunit alpha V), AKT2 (AKT serine/threonine kinase 2), NCF1 (neutrophil cytosolic factor 1), ITGB3 (integrin subunit beta 3), PAK2 (p21 (RAC1) activated kinase 2), NOS3 (nitric oxide synthase 3), MAPK12 (mitogen-activated protein kinase 12), NCK2 (NCK adaptor protein 2), WASF2 (WASP family member 2), VAV3 (vav guanine nucleotide exchange factor 3), MAPK13 (mitogen-activated protein kinase 13), AKT3 (AKT serine/threonine kinase 3), CTNNA1 (catenin alpha 1), CAV1 (caveolin 1), NCF2 (neutrophil cytosolic factor 2), ROCK1 (Rho associated coiled-coil containing protein kinase 1), NCF4 (neutrophil cytosolic factor 4), SHC2 (SHC adaptor protein 2), DOCK1 (dedicator of cytokinesis 1), ABI2 (abl interactor 2), BAIAP2 (BAR/IMD domain containing adaptor protein 2), CYFIP2 (cytoplasmic FMR1 interacting protein 2), PGF (placental growth factor), NCKAP1 (NCK associated protein 1), VEGFC (vascular endothelial growth factor C), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), CTNND1 (catenin delta 1), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), CYBA (cytochrome b-245 alpha chain), CYBB (cytochrome b-245 beta chain), PAK3 (p21 (RAC1) activated kinase 3), CDH5 (cadherin 5), RICTOR (RPTOR independent companion of MTOR complex 2), JUP (junction plakoglobin), ROCK2 (Rho associated coiled-coil containing protein kinase 2), PRKACB (protein kinase cAMP-activated catalytic subunit beta), CYFIP1 (cytoplasmic FMR1 interacting protein 1), MLST8 (MTOR associated protein, LST8 homolog), MAPKAPK2 (MAPK activated protein kinase 2), SPHK1 (sphingosine kinase 1), VEGFB (vascular endothelial growth factor B), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), MAPKAP1 (MAPK associated protein 1), WASF3 (WASP family member 3), SHB (SH2 domain containing adaptor protein B), NRP1 (neuropilin 1), NCKAP1L (NCK associated protein 1 like), BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex), HSPB1 (heat shock protein family B (small) member 1), PRR5 (proline rich 5), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), MAPKAPK3 (MAPK activated protein kinase 3), ELMO1 (engulfment and cell motility 1), NRP2 (neuropilin 2), AXL (AXL receptor tyrosine kinase), THEM4 (thioesterase superfamily member 4), TRIB3 (tribbles pseudokinase 3), SH2D2A (SH2 domain containing 2A), ELMO2 (engulfment and cell motility 2), AHCYL1 (adenosylhomocysteinase like 1), CALM1 (calmodulin 1), VEGFD (vascular endothelial growth factor D)"], "WAG002105": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CDK2 (cyclin dependent kinase 2), CDC6 (cell division cycle 6), CDT1 (chromatin licensing and DNA replication factor 1), FZR1 (fizzy and cell division cycle 20 related 1), UBE2C (ubiquitin conjugating enzyme E2 C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA6 (proteasome 20S subunit alpha 6), UBB (ubiquitin B), PSMA1 (proteasome 20S subunit alpha 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA2 (proteasome 20S subunit alpha 2), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC2 (proteasome 26S subunit, ATPase 2), PSMA3 (proteasome 20S subunit alpha 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMB7 (proteasome 20S subunit beta 7), PSMB4 (proteasome 20S subunit beta 4), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB6 (proteasome 20S subunit beta 6), PSMA4 (proteasome 20S subunit alpha 4), PSMB5 (proteasome 20S subunit beta 5), PSMB1 (proteasome 20S subunit beta 1), SKP2 (S-phase kinase associated protein 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB3 (proteasome 20S subunit beta 3), PSMA5 (proteasome 20S subunit alpha 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA7 (proteasome 20S subunit alpha 7), PSMB10 (proteasome 20S subunit beta 10), PSMD3 (proteasome 26S subunit, non-ATPase 3), CDC23 (cell division cycle 23), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMA8 (proteasome 20S subunit alpha 8), ORC1 (origin recognition complex subunit 1), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME3 (proteasome activator subunit 3), CDC27 (cell division cycle 27), CDC16 (cell division cycle 16), PSMF1 (proteasome inhibitor subunit 1), ANAPC1 (anaphase promoting complex subunit 1), ANAPC4 (anaphase promoting complex subunit 4), PSME4 (proteasome activator subunit 4), ANAPC5 (anaphase promoting complex subunit 5), ANAPC7 (anaphase promoting complex subunit 7), ANAPC10 (anaphase promoting complex subunit 10), ANAPC2 (anaphase promoting complex subunit 2), ANAPC11 (anaphase promoting complex subunit 11), PSMB11 (proteasome subunit beta 11), CDC26 (cell division cycle 26), RBX1 (ring-box 1), CUL1 (cullin 1), UBE2E1 (ubiquitin conjugating enzyme E2 E1), PSMD4 (proteasome 26S subunit, non-ATPase 4), SKP1 (S-phase kinase associated protein 1), MCM6 (minichromosome maintenance complex component 6), POLA1 (DNA polymerase alpha 1, catalytic subunit), PSMB8 (proteasome 20S subunit beta 8), GINS1 (GINS complex subunit 1), MCM4 (minichromosome maintenance complex component 4), PSMB9 (proteasome 20S subunit beta 9), MCM7 (minichromosome maintenance complex component 7), MCM3 (minichromosome maintenance complex component 3), PCNA (proliferating cell nuclear antigen), PSME2 (proteasome activator subunit 2), MCM5 (minichromosome maintenance complex component 5), RPA1 (replication protein A1), MCM2 (minichromosome maintenance complex component 2), CDC45 (cell division cycle 45), RFC4 (replication factor C subunit 4), PRIM1 (DNA primase subunit 1), POLD1 (DNA polymerase delta 1, catalytic subunit), POLE (DNA polymerase epsilon, catalytic subunit), POLA2 (DNA polymerase alpha 2, accessory subunit), RPA3 (replication protein A3), POLE2 (DNA polymerase epsilon 2, accessory subunit), CCNA2 (cyclin A2), UBE2D1 (ubiquitin conjugating enzyme E2 D1), RFC5 (replication factor C subunit 5), RPA2 (replication protein A2), FEN1 (flap structure-specific endonuclease 1), CCNE1 (cyclin E1), RFC3 (replication factor C subunit 3), RFC2 (replication factor C subunit 2), ORC3 (origin recognition complex subunit 3), LIG1 (DNA ligase 1), ORC6 (origin recognition complex subunit 6), ORC5 (origin recognition complex subunit 5), ORC2 (origin recognition complex subunit 2)"], "WAG002107": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), CUL1 (cullin 1), CD4 (CD4 molecule), UBB (ubiquitin B), PSMB5 (proteasome 20S subunit beta 5), SKP1 (S-phase kinase associated protein 1), PSMA4 (proteasome 20S subunit alpha 4), PSMA2 (proteasome 20S subunit alpha 2), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMA1 (proteasome 20S subunit alpha 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA3 (proteasome 20S subunit alpha 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA7 (proteasome 20S subunit alpha 7), PSMC1 (proteasome 26S subunit, ATPase 1), PSMA6 (proteasome 20S subunit alpha 6), PSMB4 (proteasome 20S subunit beta 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMB10 (proteasome 20S subunit beta 10), PSMB6 (proteasome 20S subunit beta 6), PSMB3 (proteasome 20S subunit beta 3), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB1 (proteasome 20S subunit beta 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB7 (proteasome 20S subunit beta 7), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMA5 (proteasome 20S subunit alpha 5), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSME1 (proteasome activator subunit 1), PSMA8 (proteasome 20S subunit alpha 8), PSME4 (proteasome activator subunit 4), PSMF1 (proteasome inhibitor subunit 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB11 (proteasome subunit beta 11), TRAF6 (TNF receptor associated factor 6), PSME3 (proteasome activator subunit 3), PAK2 (p21 (RAC1) activated kinase 2), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), LCK (LCK proto-oncogene, Src family tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), NFKBIA (NFKB inhibitor alpha), UBE2D1 (ubiquitin conjugating enzyme E2 D1), NFKB1 (nuclear factor kappa B subunit 1), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), PLCG1 (phospholipase C gamma 1), LCP2 (lymphocyte cytosolic protein 2), RELA (RELA proto-oncogene, NF-kB subunit), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CD3E (CD3e molecule), ITK (IL2 inducible T cell kinase), PRKCQ (protein kinase C theta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), CD3D (CD3d molecule), LAT (linker for activation of T cells), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CD3G (CD3g molecule), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CSK (C-terminal Src kinase), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), MALT1 (MALT1 paracaspase), BCL10 (BCL10 immune signaling adaptor), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), GRAP2 (GRB2 related adaptor protein 2), NCK1 (NCK adaptor protein 1), CARD11 (caspase recruitment domain family member 11), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PLCG2 (phospholipase C gamma 2), WAS (WASP actin nucleation promoting factor), PDPK1 (3-phosphoinositide dependent protein kinase 1), RIPK2 (receptor interacting serine/threonine kinase 2), TRAT1 (T cell receptor associated transmembrane adaptor 1), INPP5D (inositol polyphosphate-5-phosphatase D), PTEN (phosphatase and tensin homolog), CDC34 (cell division cycle 34, ubiqiutin conjugating enzyme), UBE2D2 (ubiquitin conjugating enzyme E2 D2), PAG1 (phosphoprotein membrane anchor with glycosphingolipid microdomains 1), RPS27A (ribosomal protein S27a), UBE2N (ubiquitin conjugating enzyme E2 N), PAK1 (p21 (RAC1) activated kinase 1), HLA-DRA (major histocompatibility complex, class II, DR alpha), FBXW11 (F-box and WD repeat domain containing 11), PTPN22 (protein tyrosine phosphatase non-receptor type 22)"], "WAG002109": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNG2 (G protein subunit gamma 2), GNB1 (G protein subunit beta 1), GNGT1 (G protein subunit gamma transducin 1), GNG3 (G protein subunit gamma 3), GNB2 (G protein subunit beta 2), F2R (coagulation factor II thrombin receptor), GNA15 (G protein subunit alpha 15), GNGT2 (G protein subunit gamma transducin 2), GNB5 (G protein subunit beta 5), GNG4 (G protein subunit gamma 4), GNG13 (G protein subunit gamma 13), GNG7 (G protein subunit gamma 7), GNG5 (G protein subunit gamma 5), GNG12 (G protein subunit gamma 12), F2RL3 (F2R like thrombin or trypsin receptor 3), GNB4 (G protein subunit beta 4), GNG8 (G protein subunit gamma 8), GNB3 (G protein subunit beta 3), GNA12 (G protein subunit alpha 12), GNA11 (G protein subunit alpha 11), GNA13 (G protein subunit alpha 13), GNAQ (G protein subunit alpha q), F2RL2 (coagulation factor II thrombin receptor like 2), GNG11 (G protein subunit gamma 11), GNA14 (G protein subunit alpha 14), ARRB1 (arrestin beta 1), F2 (coagulation factor II, thrombin), GNG10 (G protein subunit gamma 10), ARRB2 (arrestin beta 2), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3)"], "WAG002111": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SLC22A6 (solute carrier family 22 member 6), SLC39A6 (solute carrier family 39 member 6), SLC6A12 (solute carrier family 6 member 12), SLC22A1 (solute carrier family 22 member 1), SLC6A13 (solute carrier family 6 member 13), SLC6A11 (solute carrier family 6 member 11), SLC11A2 (solute carrier family 11 member 2), SLC6A2 (solute carrier family 6 member 2), SLC39A1 (solute carrier family 39 member 1), SLC16A1 (solute carrier family 16 member 1), SLC22A2 (solute carrier family 22 member 2), SLC13A3 (solute carrier family 13 member 3), SLC30A1 (solute carrier family 30 member 1), SLC40A1 (solute carrier family 40 member 1), SLC6A9 (solute carrier family 6 member 9), SLC6A1 (solute carrier family 6 member 1), SLC6A5 (solute carrier family 6 member 5), SLC16A8 (solute carrier family 16 member 8), SLC18A2 (solute carrier family 18 member A2), SLC13A2 (solute carrier family 13 member 2), SLC39A2 (solute carrier family 39 member 2), BSG (basigin (Ok blood group)), SLC22A4 (solute carrier family 22 member 4), SLC6A7 (solute carrier family 6 member 7), SLC16A3 (solute carrier family 16 member 3), SLC39A4 (solute carrier family 39 member 4), SLC30A5 (solute carrier family 30 member 5), SLC6A3 (solute carrier family 6 member 3), SLC39A3 (solute carrier family 39 member 3), HEPH (hephaestin), CP (ceruloplasmin), SLC18A1 (solute carrier family 18 member A1), SLC6A6 (solute carrier family 6 member 6), SLC22A8 (solute carrier family 22 member 8), SLC6A14 (solute carrier family 6 member 14), RSC1A1 (regulator of solute carriers 1), SLC13A1 (solute carrier family 13 member 1), SLC39A14 (solute carrier family 39 member 14), SLC47A1 (solute carrier family 47 member 1), SLC13A4 (solute carrier family 13 member 4), SLC39A8 (solute carrier family 39 member 8), SLC16A7 (solute carrier family 16 member 7), SLC39A5 (solute carrier family 39 member 5), SLC22A5 (solute carrier family 22 member 5), SLC22A3 (solute carrier family 22 member 3), SLC6A15 (solute carrier family 6 member 15), SLC6A20 (solute carrier family 6 member 20), SLC22A11 (solute carrier family 22 member 11), SLC47A2 (solute carrier family 47 member 2), SLC11A1 (solute carrier family 11 member 1), RUNX1 (RUNX family transcription factor 1), SLC30A3 (solute carrier family 30 member 3), SLC6A18 (solute carrier family 6 member 18), SLC6A19 (solute carrier family 6 member 19), SLC14A1 (solute carrier family 14 member 1 (Kidd blood group)), SLC14A2 (solute carrier family 14 member 2), SLC5A3 (solute carrier family 5 member 3), SLC31A1 (solute carrier family 31 member 1), SLC5A7 (solute carrier family 5 member 7), SLC39A7 (solute carrier family 39 member 7), EMB (embigin), SLC22A7 (solute carrier family 22 member 7), SLC30A2 (solute carrier family 30 member 2), SLC30A10 (solute carrier family 30 member 10), SLC39A10 (solute carrier family 39 member 10), SLC30A7 (solute carrier family 30 member 7), SLC2A13 (solute carrier family 2 member 13), RHBG (Rh family B glycoprotein), SLC22A16 (solute carrier family 22 member 16), SLC22A18 (solute carrier family 22 member 18), SLC13A5 (solute carrier family 13 member 5), SLC44A2 (solute carrier family 44 member 2), SLC44A1 (solute carrier family 44 member 1), SLC41A1 (solute carrier family 41 member 1), SLC44A5 (solute carrier family 44 member 5), SLC5A11 (solute carrier family 5 member 11), SLC22A12 (solute carrier family 22 member 12), RHCG (Rh family C glycoprotein), SLC41A2 (solute carrier family 41 member 2), SLC30A8 (solute carrier family 30 member 8), RHAG (Rh associated glycoprotein), SLC10A6 (solute carrier family 10 member 6), SLC44A3 (solute carrier family 44 member 3), LOC100506403 (uncharacterized LOC100506403), SLC44A4 (solute carrier family 44 member 4), SLC30A6 (solute carrier family 30 member 6), SLC22A15 (solute carrier family 22 member 15)"], "WAG002112": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SLC3A2 (solute carrier family 3 member 2), SLC4A2 (solute carrier family 4 member 2), SLC3A1 (solute carrier family 3 member 1), SLC1A5 (solute carrier family 1 member 5), SLC7A5 (solute carrier family 7 member 5), SLC9A3 (solute carrier family 9 member A3), SLC1A4 (solute carrier family 1 member 4), SLC1A1 (solute carrier family 1 member 1), SLC7A8 (solute carrier family 7 member 8), SLC9A1 (solute carrier family 9 member A1), SLC1A6 (solute carrier family 1 member 6), SLC1A3 (solute carrier family 1 member 3), SLC7A9 (solute carrier family 7 member 9), SLC12A2 (solute carrier family 12 member 2), SLC8A1 (solute carrier family 8 member A1), SLC12A1 (solute carrier family 12 member 1), SLC7A11 (solute carrier family 7 member 11), SLC24A2 (solute carrier family 24 member 2), SLC1A7 (solute carrier family 1 member 7), SLC1A2 (solute carrier family 1 member 2), SLC9A2 (solute carrier family 9 member A2), SLC7A7 (solute carrier family 7 member 7), SLC12A4 (solute carrier family 12 member 4), SLC24A1 (solute carrier family 24 member 1), SLC7A10 (solute carrier family 7 member 10), SLC12A6 (solute carrier family 12 member 6), SLC4A1 (solute carrier family 4 member 1 (Diego blood group)), SLC9A6 (solute carrier family 9 member A6), SLC9A5 (solute carrier family 9 member A5), SLC36A2 (solute carrier family 36 member 2), SLC26A6 (solute carrier family 26 member 6), SLC4A4 (solute carrier family 4 member 4), SLC12A3 (solute carrier family 12 member 3), SLC26A3 (solute carrier family 26 member 3), SLC8A3 (solute carrier family 8 member A3), SLC8A2 (solute carrier family 8 member A2), SLC38A1 (solute carrier family 38 member 1), SLC12A5 (solute carrier family 12 member 5), SLC4A3 (solute carrier family 4 member 3), SLC34A1 (solute carrier family 34 member 1), SLC38A2 (solute carrier family 38 member 2), SLC6A12 (solute carrier family 6 member 12), SLC43A1 (solute carrier family 43 member 1), SLC24A3 (solute carrier family 24 member 3), SLC6A19 (solute carrier family 6 member 19), SLC24A4 (solute carrier family 24 member 4), SLC6A6 (solute carrier family 6 member 6), SLC12A7 (solute carrier family 12 member 7), SLC6A20 (solute carrier family 6 member 20), SLC26A4 (solute carrier family 26 member 4), SLC17A1 (solute carrier family 17 member 1), SLC32A1 (solute carrier family 32 member 1), SLC20A1 (solute carrier family 20 member 1), SLC6A18 (solute carrier family 6 member 18), SLC26A2 (solute carrier family 26 member 2), SLC7A6 (solute carrier family 7 member 6), SLC4A9 (solute carrier family 4 member 9), SLC7A1 (solute carrier family 7 member 1), SLC15A2 (solute carrier family 15 member 2), SLC15A1 (solute carrier family 15 member 1), SLC26A1 (solute carrier family 26 member 1), SLC20A2 (solute carrier family 20 member 2), SLC26A7 (solute carrier family 26 member 7), SLC6A14 (solute carrier family 6 member 14), SLC6A15 (solute carrier family 6 member 15), SLC34A2 (solute carrier family 34 member 2), SLC4A7 (solute carrier family 4 member 7), SLC17A7 (solute carrier family 17 member 7), SLC25A22 (solute carrier family 25 member 22), SLC25A18 (solute carrier family 25 member 18), SRI (sorcin), SLC5A5 (solute carrier family 5 member 5), SLC7A3 (solute carrier family 7 member 3), SLC38A5 (solute carrier family 38 member 5), SLC4A8 (solute carrier family 4 member 8), SLC17A6 (solute carrier family 17 member 6), SLC36A1 (solute carrier family 36 member 1), SLC15A3 (solute carrier family 15 member 3), SLC17A8 (solute carrier family 17 member 8), SLC9A7 (solute carrier family 9 member A7), SLC43A2 (solute carrier family 43 member 2), SLC16A10 (solute carrier family 16 member 10), SLC4A10 (solute carrier family 4 member 10), SLC9A8 (solute carrier family 9 member A8), SLC9A4 (solute carrier family 9 member A4), SLC26A11 (solute carrier family 26 member 11), SLC5A12 (solute carrier family 5 member 12), SLC34A3 (solute carrier family 34 member 3), SLC25A26 (solute carrier family 25 member 26), SLC8B1 (solute carrier family 8 member B1), SLC38A4 (solute carrier family 38 member 4), SLC26A9 (solute carrier family 26 member 9), SLC5A8 (solute carrier family 5 member 8), SLC36A4 (solute carrier family 36 member 4), AHCYL2 (adenosylhomocysteinase like 2), SLC25A29 (solute carrier family 25 member 29), SLC15A4 (solute carrier family 15 member 4), SLC4A5 (solute carrier family 4 member 5), CALM1 (calmodulin 1), CTNS (cystinosin, lysosomal cystine transporter)"], "WAG002115": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATF6 (activating transcription factor 6), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), CREB3L3 (cAMP responsive element binding protein 3 like 3), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), ATF4 (activating transcription factor 4), CREB3 (cAMP responsive element binding protein 3), HSPA5 (heat shock protein family A (Hsp70) member 5), ERN1 (endoplasmic reticulum to nucleus signaling 1), CREB3L1 (cAMP responsive element binding protein 3 like 1), CREB3L4 (cAMP responsive element binding protein 3 like 4), EIF2S3 (eukaryotic translation initiation factor 2 subunit gamma), EIF2S2 (eukaryotic translation initiation factor 2 subunit beta), CREB3L2 (cAMP responsive element binding protein 3 like 2), MBTPS1 (membrane bound transcription factor peptidase, site 1), MBTPS2 (membrane bound transcription factor peptidase, site 2), DCSTAMP (dendrocyte expressed seven transmembrane protein), CREBRF (CREB3 regulatory factor)"], "WAG002117": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GAPDH (glyceraldehyde-3-phosphate dehydrogenase), GPI (glucose-6-phosphate isomerase), TPI1 (triosephosphate isomerase 1), HK1 (hexokinase 1), PGK1 (phosphoglycerate kinase 1), ALDOA (aldolase, fructose-bisphosphate A), TALDO1 (transaldolase 1), SLC2A4 (solute carrier family 2 member 4), LDHA (lactate dehydrogenase A), PGAM1 (phosphoglycerate mutase 1), G6PD (glucose-6-phosphate dehydrogenase), PGK2 (phosphoglycerate kinase 2), SLC2A1 (solute carrier family 2 member 1), SLC2A2 (solute carrier family 2 member 2), GPT (glutamic--pyruvic transaminase), PFKP (phosphofructokinase, platelet), INS (insulin)"], "WAG002118": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), IRAK1 (interleukin 1 receptor associated kinase 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MAPK1 (mitogen-activated protein kinase 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAPK14 (mitogen-activated protein kinase 14), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), NFKB1 (nuclear factor kappa B subunit 1), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), MAPK3 (mitogen-activated protein kinase 3), NFKBIA (NFKB inhibitor alpha), RELA (RELA proto-oncogene, NF-kB subunit), IL1B (interleukin 1 beta), MAPK8 (mitogen-activated protein kinase 8), AKT1 (AKT serine/threonine kinase 1), MYD88 (MYD88 innate immune signal transduction adaptor), IRAK2 (interleukin 1 receptor associated kinase 2), IL1A (interleukin 1 alpha), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), MAP2K6 (mitogen-activated protein kinase kinase 6), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), IL1R1 (interleukin 1 receptor type 1), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), MAP2K4 (mitogen-activated protein kinase kinase 4), IRAK4 (interleukin 1 receptor associated kinase 4), PRKCZ (protein kinase C zeta), MAP2K1 (mitogen-activated protein kinase kinase 1), PELI1 (pellino E3 ubiquitin protein ligase 1), MAP2K3 (mitogen-activated protein kinase kinase 3), IRAK3 (interleukin 1 receptor associated kinase 3), SQSTM1 (sequestosome 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), TOLLIP (toll interacting protein), PELI2 (pellino E3 ubiquitin protein ligase family member 2), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), IL1RAP (interleukin 1 receptor accessory protein), MAP2K7 (mitogen-activated protein kinase kinase 7), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAP3K2 (mitogen-activated protein kinase kinase kinase 2), REL (REL proto-oncogene, NF-kB subunit), MAPK9 (mitogen-activated protein kinase 9), NFKBIB (NFKB inhibitor beta), MAP2K2 (mitogen-activated protein kinase kinase 2), PLCG1 (phospholipase C gamma 1), MAPKAPK2 (MAPK activated protein kinase 2), ATF2 (activating transcription factor 2), UBE2N (ubiquitin conjugating enzyme E2 N), ECSIT (ECSIT signaling integrator), CCL2 (C-C motif chemokine ligand 2), UBE2V1 (ubiquitin conjugating enzyme E2 V1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), HSPB2 (heat shock protein family B (small) member 2)"], "WAG002119": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SQLE (squalene epoxidase), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), MSMO1 (methylsterol monooxygenase 1), IDI1 (isopentenyl-diphosphate delta isomerase 1), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), FDPS (farnesyl diphosphate synthase), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), DHCR7 (7-dehydrocholesterol reductase), MVD (mevalonate diphosphate decarboxylase), NSDHL (NAD(P) dependent steroid dehydrogenase-like), LSS (lanosterol synthase), PMVK (phosphomevalonate kinase), MVK (mevalonate kinase), SC5D (sterol-C5-desaturase)"], "WAG002120": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), MYC (MYC proto-oncogene, bHLH transcription factor), CDK2 (cyclin dependent kinase 2), CDKN1A (cyclin dependent kinase inhibitor 1A), AKT1 (AKT serine/threonine kinase 1), RB1 (RB transcriptional corepressor 1), ATM (ATM serine/threonine kinase), CHEK1 (checkpoint kinase 1), MDM2 (MDM2 proto-oncogene), BCL2 (BCL2 apoptosis regulator), CDK1 (cyclin dependent kinase 1), E2F1 (E2F transcription factor 1), CDK4 (cyclin dependent kinase 4), CDC25A (cell division cycle 25A), CHEK2 (checkpoint kinase 2), CDKN1B (cyclin dependent kinase inhibitor 1B), CASP3 (caspase 3), ATR (ATR serine/threonine kinase), MSH2 (mutS homolog 2), BAX (BCL2 associated X, apoptosis regulator), BLM (BLM RecQ like helicase), RAD50 (RAD50 double strand break repair protein), MSH6 (mutS homolog 6), SMAD3 (SMAD family member 3), PTEN (phosphatase and tensin homolog), CASP8 (caspase 8), SMAD2 (SMAD family member 2), STAT1 (signal transducer and activator of transcription 1), BARD1 (BRCA1 associated RING domain 1), PLK1 (polo like kinase 1), CASP9 (caspase 9), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), BAD (BCL2 associated agonist of cell death), CDKN2B (cyclin dependent kinase inhibitor 2B), CDC25B (cell division cycle 25B), JAK1 (Janus kinase 1), BBC3 (BCL2 binding component 3), ATF1 (activating transcription factor 1), BACH1 (BTB domain and CNC homolog 1), MMP1 (matrix metallopeptidase 1), POU2F1 (POU class 2 homeobox 1), NOXA1 (NADPH oxidase activator 1), MRE11 (MRE11 homolog, double strand break repair nuclease), MIR21 (microRNA 21), MIR29C (microRNA 29c), MIR29B2 (microRNA 29b-2), GRIK1-AS2 (GRIK1 antisense RNA 2), MIR29B1 (microRNA 29b-1)"], "WAG002121": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ADCY8 (adenylate cyclase 8), ADCY2 (adenylate cyclase 2), GNAI2 (G protein subunit alpha i2), ADCY1 (adenylate cyclase 1), ADCY5 (adenylate cyclase 5), ADCY7 (adenylate cyclase 7), ADCY9 (adenylate cyclase 9), ADCY4 (adenylate cyclase 4), ADCY6 (adenylate cyclase 6), PLCB1 (phospholipase C beta 1), PLCB2 (phospholipase C beta 2), PLCB4 (phospholipase C beta 4), PLCB3 (phospholipase C beta 3), ADCY3 (adenylate cyclase 3), GNG2 (G protein subunit gamma 2), GNB1 (G protein subunit beta 1), GNAI1 (G protein subunit alpha i1), GNGT1 (G protein subunit gamma transducin 1), GNAI3 (G protein subunit alpha i3), GNAO1 (G protein subunit alpha o1), GNG3 (G protein subunit gamma 3), GNG13 (G protein subunit gamma 13), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), GNB2 (G protein subunit beta 2), GNB3 (G protein subunit beta 3), GNG4 (G protein subunit gamma 4), GNGT2 (G protein subunit gamma transducin 2), GNG7 (G protein subunit gamma 7), GNB4 (G protein subunit beta 4), MAPK1 (mitogen-activated protein kinase 1), GNG8 (G protein subunit gamma 8), GNB5 (G protein subunit beta 5), GNG12 (G protein subunit gamma 12), GNG5 (G protein subunit gamma 5), GNG11 (G protein subunit gamma 11), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PDE4D (phosphodiesterase 4D), GNG10 (G protein subunit gamma 10), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), GNAT2 (G protein subunit alpha transducin 2), PDE4A (phosphodiesterase 4A), GNAT3 (G protein subunit alpha transducin 3), PDE4B (phosphodiesterase 4B), GNAT1 (G protein subunit alpha transducin 1), PRKCA (protein kinase C alpha), PPP1CA (protein phosphatase 1 catalytic subunit alpha), GNAL (G protein subunit alpha L), CREB1 (cAMP responsive element binding protein 1), PRKX (protein kinase X-linked), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PDE1A (phosphodiesterase 1A), OPRM1 (opioid receptor mu 1), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PDE4C (phosphodiesterase 4C), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), PDYN (prodynorphin), PDE1B (phosphodiesterase 1B), PPP2CA (protein phosphatase 2 catalytic subunit alpha), POMC (proopiomelanocortin), PDE1C (phosphodiesterase 1C), CAMK2B (calcium/calmodulin dependent protein kinase II beta), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), PPP3CB (protein phosphatase 3 catalytic subunit beta), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), PRKCG (protein kinase C gamma), PPP1R1B (protein phosphatase 1 regulatory inhibitor subunit 1B), PRKCD (protein kinase C delta), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), PPP2CB (protein phosphatase 2 catalytic subunit beta), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), PPP3CC (protein phosphatase 3 catalytic subunit gamma), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PLA2G4A (phospholipase A2 group IVA), CAMK4 (calcium/calmodulin dependent protein kinase IV), CAMKK1 (calcium/calmodulin dependent protein kinase kinase 1), CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2), CDK5 (cyclin dependent kinase 5), NBEA (neurobeachin), AHCYL1 (adenosylhomocysteinase like 1), LOC729966 (uncharacterized LOC729966), CALM1 (calmodulin 1), KPNA2 (karyopherin subunit alpha 2), GRK2 (G protein-coupled receptor kinase 2)"], "WAG002122": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit), DDB1 (damage specific DNA binding protein 1), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), GTF2H1 (general transcription factor IIH subunit 1), PCNA (proliferating cell nuclear antigen), ERCC6 (ERCC excision repair 6, chromatin remodeling factor), CDK7 (cyclin dependent kinase 7), RPA1 (replication protein A1), GTF2H3 (general transcription factor IIH subunit 3), DDB2 (damage specific DNA binding protein 2), MNAT1 (MNAT1 component of CDK activating kinase), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), ERCC5 (ERCC excision repair 5, endonuclease), GTF2H2 (general transcription factor IIH subunit 2), CCNH (cyclin H), GTF2H4 (general transcription factor IIH subunit 4), RPA2 (replication protein A2), POLD1 (DNA polymerase delta 1, catalytic subunit), TCEA1 (transcription elongation factor A1), RPA3 (replication protein A3), RAD23B (RAD23 homolog B, nucleotide excision repair protein), XPC (XPC complex subunit, DNA damage recognition and repair factor), POLE (DNA polymerase epsilon, catalytic subunit), RFC5 (replication factor C subunit 5), RFC4 (replication factor C subunit 4), RFC2 (replication factor C subunit 2), POLD2 (DNA polymerase delta 2, accessory subunit), RFC1 (replication factor C subunit 1), XPA (XPA, DNA damage recognition and repair factor), POLD4 (DNA polymerase delta 4, accessory subunit), POLD3 (DNA polymerase delta 3, accessory subunit), ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit), RFC3 (replication factor C subunit 3), POLR2B (RNA polymerase II subunit B), POLE2 (DNA polymerase epsilon 2, accessory subunit), POLR2G (RNA polymerase II subunit G), SUMO2 (small ubiquitin like modifier 2), POLR2E (RNA polymerase II, I and III subunit E), POLR2C (RNA polymerase II subunit C), POLR2J (RNA polymerase II subunit J), POLR2D (RNA polymerase II subunit D), POLR2I (RNA polymerase II subunit I), POLR2H (RNA polymerase II, I and III subunit H), XAB2 (XPA binding protein 2), POLR2L (RNA polymerase II, I and III subunit L), POLR2F (RNA polymerase II, I and III subunit F), RUVBL1 (RuvB like AAA ATPase 1), PARP1 (poly(ADP-ribose) polymerase 1), COPS5 (COP9 signalosome subunit 5), ELL (elongation factor for RNA polymerase II), COPS6 (COP9 signalosome subunit 6), SUMO1 (small ubiquitin like modifier 1), CUL4A (cullin 4A), YY1 (YY1 transcription factor), LIG1 (DNA ligase 1), EP300 (E1A binding protein p300), RBX1 (ring-box 1), ACTR5 (actin related protein 5), INO80 (INO80 complex ATPase subunit), COPS3 (COP9 signalosome subunit 3), COPS4 (COP9 signalosome subunit 4), ACTL6A (actin like 6A), CUL4B (cullin 4B), COPS2 (COP9 signalosome subunit 2), ACTB (actin beta), UBB (ubiquitin B), POLR2K (RNA polymerase II, I and III subunit K), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), GPS1 (G protein pathway suppressor 1), XRCC1 (X-ray repair cross complementing 1), ACTR8 (actin related protein 8), TFPT (TCF3 fusion partner), PRPF19 (pre-mRNA processing factor 19), MCRS1 (microspherule protein 1), NFRKB (nuclear factor related to kappaB binding protein), INO80B (INO80 complex subunit B), COPS7A (COP9 signalosome subunit 7A), UBE2I (ubiquitin conjugating enzyme E2 I), COPS8 (COP9 signalosome subunit 8), INO80C (INO80 complex subunit C), SUMO3 (small ubiquitin like modifier 3), INO80E (INO80 complex subunit E), INO80D (INO80 complex subunit D), POLE3 (DNA polymerase epsilon 3, accessory subunit), COPS7B (COP9 signalosome subunit 7B), RAD23A (RAD23 homolog A, nucleotide excision repair protein), USP7 (ubiquitin specific peptidase 7), UBE2N (ubiquitin conjugating enzyme E2 N), RPS27A (ribosomal protein S27a), LIG3 (DNA ligase 3), RNF111 (ring finger protein 111), GTF2H5 (general transcription factor IIH subunit 5), CHD1L (chromodomain helicase DNA binding protein 1 like), PIAS3 (protein inhibitor of activated STAT 3), PARP2 (poly(ADP-ribose) polymerase 2), UBE2V2 (ubiquitin conjugating enzyme E2 V2), CETN2 (centrin 2), HMGN1 (high mobility group nucleosome binding domain 1)"], "WAG002124": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SREBF2 (sterol regulatory element binding transcription factor 2), SREBF1 (sterol regulatory element binding transcription factor 1), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), AKT1 (AKT serine/threonine kinase 1), SCAP (SREBF chaperone), SEC24B (SEC24 homolog B, COPII coat complex component), SEC23A (Sec23 homolog A, COPII coat complex component), ACACA (acetyl-CoA carboxylase alpha), FASN (fatty acid synthase), NFYA (nuclear transcription factor Y subunit alpha), SP1 (Sp1 transcription factor), SAR1B (secretion associated Ras related GTPase 1B), SEC24A (SEC24 homolog A, COPII coat complex component), SEC24C (SEC24 homolog C, COPII coat complex component), MBTPS1 (membrane bound transcription factor peptidase, site 1), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), SEC24D (SEC24 homolog D, COPII coat complex component), PPARG (peroxisome proliferator activated receptor gamma), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), IDI1 (isopentenyl-diphosphate delta isomerase 1), INSIG1 (insulin induced gene 1), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), SQLE (squalene epoxidase), CREB1 (cAMP responsive element binding protein 1), SEC31A (SEC31 homolog A, COPII coat complex component), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), ACLY (ATP citrate lyase), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), MTOR (mechanistic target of rapamycin kinase), FDPS (farnesyl diphosphate synthase), INSIG2 (insulin induced gene 2), SCD (stearoyl-CoA desaturase), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), SIRT1 (sirtuin 1), LPL (lipoprotein lipase), ATF6 (activating transcription factor 6), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), YY1 (YY1 transcription factor), SEC31B (SEC31 homolog B, COPII coat complex component), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), SEC23B (SEC23 homolog B, COPII coat complex component), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), MVD (mevalonate diphosphate decarboxylase), LDLR (low density lipoprotein receptor), RNF139 (ring finger protein 139), LSS (lanosterol synthase), SAR1A (secretion associated Ras related GTPase 1A), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), CDK8 (cyclin dependent kinase 8), MED15 (mediator complex subunit 15), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), NR1H2 (nuclear receptor subfamily 1 group H member 2), PPARGC1B (PPARG coactivator 1 beta), AMFR (autocrine motility factor receptor), SCARB1 (scavenger receptor class B member 1), MBTPS2 (membrane bound transcription factor peptidase, site 2), KPNB1 (karyopherin subunit beta 1), GSK3A (glycogen synthase kinase 3 alpha), FGF21 (fibroblast growth factor 21), INS (insulin), MDH1 (malate dehydrogenase 1), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), ACSS1 (acyl-CoA synthetase short chain family member 1), LPIN1 (lipin 1), DBI (diazepam binding inhibitor, acyl-CoA binding protein), CAMP (cathelicidin antimicrobial peptide), RBP4 (retinol binding protein 4), MIR33B (microRNA 33b), MIR33A (microRNA 33a)"], "WAG002125": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), MYC (MYC proto-oncogene, bHLH transcription factor), MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), ESR1 (estrogen receptor 1), EP300 (E1A binding protein p300), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CCND1 (cyclin D1), SMAD4 (SMAD family member 4), HDAC1 (histone deacetylase 1), CTNNB1 (catenin beta 1), MDM2 (MDM2 proto-oncogene), AR (androgen receptor), CDK2 (cyclin dependent kinase 2), SMAD2 (SMAD family member 2), SP1 (Sp1 transcription factor), BCL2 (BCL2 apoptosis regulator), ATM (ATM serine/threonine kinase), RB1 (RB transcriptional corepressor 1), EGFR (epidermal growth factor receptor), VEGFA (vascular endothelial growth factor A), CASP3 (caspase 3), CDK4 (cyclin dependent kinase 4), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), E2F1 (E2F transcription factor 1), SIRT1 (sirtuin 1), NFKB1 (nuclear factor kappa B subunit 1), PML (PML nuclear body scaffold), PTEN (phosphatase and tensin homolog), SMAD7 (SMAD family member 7), ATR (ATR serine/threonine kinase), STAT1 (signal transducer and activator of transcription 1), MTOR (mechanistic target of rapamycin kinase), CHEK1 (checkpoint kinase 1), PLK1 (polo like kinase 1), RAC1 (Rac family small GTPase 1), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), BRCA2 (BRCA2 DNA repair associated), RAD51 (RAD51 recombinase), BAX (BCL2 associated X, apoptosis regulator), CDC25A (cell division cycle 25A), CDH1 (cadherin 1), CASP8 (caspase 8), TGFBR1 (transforming growth factor beta receptor 1), CREB1 (cAMP responsive element binding protein 1), CDC42 (cell division cycle 42), CHEK2 (checkpoint kinase 2), NCOA3 (nuclear receptor coactivator 3), PIAS1 (protein inhibitor of activated STAT 1), FOXO1 (forkhead box O1), PAK1 (p21 (RAC1) activated kinase 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), KRAS (KRAS proto-oncogene, GTPase), MSH2 (mutS homolog 2), SMAD1 (SMAD family member 1), IRS1 (insulin receptor substrate 1), TSC2 (TSC complex subunit 2), MSH6 (mutS homolog 6), RAD50 (RAD50 double strand break repair protein), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), JAK1 (Janus kinase 1), MAX (MYC associated factor X), BLM (BLM RecQ like helicase), TGFBR2 (transforming growth factor beta receptor 2), FADD (Fas associated via death domain), GADD45A (growth arrest and DNA damage inducible alpha), STK11 (serine/threonine kinase 11), CASP9 (caspase 9), RAP1A (RAP1A, member of RAS oncogene family), BARD1 (BRCA1 associated RING domain 1), CDK7 (cyclin dependent kinase 7), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), BID (BH3 interacting domain death agonist), WEE1 (WEE1 G2 checkpoint kinase), TRADD (TNFRSF1A associated via death domain), CDC25B (cell division cycle 25B), CSNK1D (casein kinase 1 delta), AHR (aryl hydrocarbon receptor), BAD (BCL2 associated agonist of cell death), MMP1 (matrix metallopeptidase 1), FOSL1 (FOS like 1, AP-1 transcription factor subunit), RHEB (Ras homolog, mTORC1 binding), PHB (prohibitin), SMAD6 (SMAD family member 6), NF1 (neurofibromin 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), RRAS (RAS related), TSC1 (TSC complex subunit 1), HIPK2 (homeodomain interacting protein kinase 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), ATF1 (activating transcription factor 1), BMPR1A (bone morphogenetic protein receptor type 1A), PLK3 (polo like kinase 3), BMPR2 (bone morphogenetic protein receptor type 2), RAD54L (RAD54 like), FER (FER tyrosine kinase), RALA (RAS like proto-oncogene A), USP15 (ubiquitin specific peptidase 15), BACH1 (BTB domain and CNC homolog 1)"], "WAG002128": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), VEGFA (vascular endothelial growth factor A), AKT1 (AKT serine/threonine kinase 1), RAC1 (Rac family small GTPase 1), SHC1 (SHC adaptor protein 1), MAPK1 (mitogen-activated protein kinase 1), CDC42 (cell division cycle 42), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CRK (CRK proto-oncogene, adaptor protein), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK14 (mitogen-activated protein kinase 14), NCK1 (NCK adaptor protein 1), PLCG1 (phospholipase C gamma 1), MAPK8 (mitogen-activated protein kinase 8), KDR (kinase insert domain receptor), PAK1 (p21 (RAC1) activated kinase 1), PXN (paxillin), PRKCA (protein kinase C alpha), ANGPT1 (angiopoietin 1), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), FGFR1 (fibroblast growth factor receptor 1), PTK2B (protein tyrosine kinase 2 beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), FRS2 (fibroblast growth factor receptor substrate 2), TEK (TEK receptor tyrosine kinase), KRAS (KRAS proto-oncogene, GTPase), IQGAP1 (IQ motif containing GTPase activating protein 1), MAPK11 (mitogen-activated protein kinase 11), MAP2K4 (mitogen-activated protein kinase kinase 4), NOS3 (nitric oxide synthase 3), MTOR (mechanistic target of rapamycin kinase), FGF1 (fibroblast growth factor 1), MMP2 (matrix metallopeptidase 2), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MMP9 (matrix metallopeptidase 9), PDPK1 (3-phosphoinositide dependent protein kinase 1), ELK1 (ETS transcription factor ELK1), DOK2 (docking protein 2), MAP2K6 (mitogen-activated protein kinase kinase 6), SHB (SH2 domain containing adaptor protein B), GRB7 (growth factor receptor bound protein 7), BMX (BMX non-receptor tyrosine kinase), WAS (WASP actin nucleation promoting factor), BAD (BCL2 associated agonist of cell death), MMP14 (matrix metallopeptidase 14), NRP1 (neuropilin 1), GRB14 (growth factor receptor bound protein 14), ATF2 (activating transcription factor 2), DAG1 (dystroglycan 1), ROBO1 (roundabout guidance receptor 1), SLIT2 (slit guidance ligand 2), APC (APC regulator of WNT signaling pathway), TIMP2 (TIMP metallopeptidase inhibitor 2), PLA2G1B (phospholipase A2 group IB), TIMP4 (TIMP metallopeptidase inhibitor 4), F2 (coagulation factor II, thrombin), SEMA3A (semaphorin 3A), VHL (von Hippel-Lindau tumor suppressor), PLXND1 (plexin D1), NOX4 (NADPH oxidase 4), SEMA4A (semaphorin 4A), ROBO4 (roundabout guidance receptor 4)"], "WAG002131": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), CDKN2A (cyclin dependent kinase inhibitor 2A), RB1 (RB transcriptional corepressor 1), CCND1 (cyclin D1), E2F1 (E2F transcription factor 1), PLK1 (polo like kinase 1), NCL (nucleolin), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), NOTCH1 (notch receptor 1), MAPK14 (mitogen-activated protein kinase 14), DDX5 (DEAD-box helicase 5), CDKN1B (cyclin dependent kinase inhibitor 1B), DHX15 (DEAH-box helicase 15), PTBP1 (polypyrimidine tract binding protein 1), SMC1A (structural maintenance of chromosomes 1A), TUBA1A (tubulin alpha 1a), TERT (telomerase reverse transcriptase), NEDD4 (NEDD4 E3 ubiquitin protein ligase), HNRNPM (heterogeneous nuclear ribonucleoprotein M), PKM (pyruvate kinase M1/2), CDK6 (cyclin dependent kinase 6), CAND1 (cullin associated and neddylation dissociated 1), CSNK1D (casein kinase 1 delta), KRAS (KRAS proto-oncogene, GTPase), AURKB (aurora kinase B), TYMS (thymidylate synthetase), CUL4B (cullin 4B), POLR2C (RNA polymerase II subunit C), ITGB4 (integrin subunit beta 4), TMED2 (transmembrane p24 trafficking protein 2), CHAF1A (chromatin assembly factor 1 subunit A), MET (MET proto-oncogene, receptor tyrosine kinase), HDAC4 (histone deacetylase 4), TMED10 (transmembrane p24 trafficking protein 10), SRSF9 (serine and arginine rich splicing factor 9), TGFBR2 (transforming growth factor beta receptor 2), CDKN1C (cyclin dependent kinase inhibitor 1C), PGM1 (phosphoglucomutase 1), GAK (cyclin G associated kinase), C1QBP (complement C1q binding protein), STX7 (syntaxin 7), TPM1 (tropomyosin 1), ARHGDIA (Rho GDP dissociation inhibitor alpha), ARID1A (AT-rich interaction domain 1A), TRIP13 (thyroid hormone receptor interactor 13), GNAI2 (G protein subunit alpha i2), MATR3 (matrin 3), BCL6 (BCL6 transcription repressor), CEBPB (CCAAT enhancer binding protein beta), TMED7 (transmembrane p24 trafficking protein 7), ATRX (ATRX chromatin remodeler), SNX6 (sorting nexin 6), ADAR (adenosine deaminase RNA specific), CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase), HMOX1 (heme oxygenase 1), NOTCH2 (notch receptor 2), PPP5C (protein phosphatase 5 catalytic subunit), TNFRSF10B (TNF receptor superfamily member 10b), CSDE1 (cold shock domain containing E1), COL1A1 (collagen type I alpha 1 chain), MYO10 (myosin X), COL4A2 (collagen type IV alpha 2 chain), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), RAD23B (RAD23 homolog B, nucleotide excision repair protein), GJA1 (gap junction protein alpha 1), POLD2 (DNA polymerase delta 2, accessory subunit), MBNL1 (muscleblind like splicing regulator 1), ARCN1 (archain 1), COL3A1 (collagen type III alpha 1 chain), ARF4 (ADP ribosylation factor 4), G6PD (glucose-6-phosphate dehydrogenase), AP3D1 (adaptor related protein complex 3 subunit delta 1), NT5E (5'-nucleotidase ecto), IPO4 (importin 4), KIT (KIT proto-oncogene, receptor tyrosine kinase), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), PHC2 (polyhomeotic homolog 2), TPM3 (tropomyosin 3), ANXA2 (annexin A2), CEP72 (centrosomal protein 72), PNP (purine nucleoside phosphorylase), SYNE1 (spectrin repeat containing nuclear envelope protein 1), GNA13 (G protein subunit alpha 13), PURA (purine rich element binding protein A), UBE2S (ubiquitin conjugating enzyme E2 S), HES1 (hes family bHLH transcription factor 1), PPIF (peptidylprolyl isomerase F), FSTL1 (follistatin like 1), CCNG1 (cyclin G1), LMNB2 (lamin B2), VPS39 (VPS39 subunit of HOPS complex), BACE1 (beta-secretase 1), MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase), TPM4 (tropomyosin 4), CHD1 (chromodomain helicase DNA binding protein 1), TRAM1 (translocation associated membrane protein 1), CALCOCO2 (calcium binding and coiled-coil domain 2), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), RHOB (ras homolog family member B)"], "WAG002132": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), MAPK14 (mitogen-activated protein kinase 14), BCL2 (BCL2 apoptosis regulator), PKM (pyruvate kinase M1/2), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), DDX5 (DEAD-box helicase 5), GAK (cyclin G associated kinase), CDK6 (cyclin dependent kinase 6), SEC24A (SEC24 homolog A, COPII coat complex component), HNRNPM (heterogeneous nuclear ribonucleoprotein M), ANXA2 (annexin A2), CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase), RHOG (ras homolog family member G), ARCN1 (archain 1), TMED10 (transmembrane p24 trafficking protein 10), RTN4 (reticulon 4), ATP6V1F (ATPase H+ transporting V1 subunit F), ARHGDIA (Rho GDP dissociation inhibitor alpha), GNAI2 (G protein subunit alpha i2), MATR3 (matrin 3), TUBA1A (tubulin alpha 1a), GNA13 (G protein subunit alpha 13), SNAP23 (synaptosome associated protein 23), AP3D1 (adaptor related protein complex 3 subunit delta 1), HMGA1 (high mobility group AT-hook 1), CEBPB (CCAAT enhancer binding protein beta), TYMS (thymidylate synthetase), ZEB1 (zinc finger E-box binding homeobox 1), ATP6V0A1 (ATPase H+ transporting V0 subunit a1), POLR2C (RNA polymerase II subunit C), POLE4 (DNA polymerase epsilon 4, accessory subunit), PPIF (peptidylprolyl isomerase F), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), PNP (purine nucleoside phosphorylase), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), IFRD1 (interferon related developmental regulator 1), G6PD (glucose-6-phosphate dehydrogenase), MCL1 (MCL1 apoptosis regulator, BCL2 family member), CDK5RAP1 (CDK5 regulatory subunit associated protein 1), GYS1 (glycogen synthase 1), HMOX1 (heme oxygenase 1), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), SNX6 (sorting nexin 6), TMED3 (transmembrane p24 trafficking protein 3), ARF4 (ADP ribosylation factor 4), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), TXNRD1 (thioredoxin reductase 1), PPIB (peptidylprolyl isomerase B), TRAM1 (translocation associated membrane protein 1), TPM3 (tropomyosin 3), RAB5C (RAB5C, member RAS oncogene family), MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase), IDH1 (isocitrate dehydrogenase (NADP(+)) 1), CAP1 (cyclase associated actin cytoskeleton regulatory protein 1), IGF2R (insulin like growth factor 2 receptor), THBS1 (thrombospondin 1), ADAR (adenosine deaminase RNA specific), CSRP1 (cysteine and glycine rich protein 1), UNC93B1 (unc-93 homolog B1, TLR signaling regulator), SRSF10 (serine and arginine rich splicing factor 10), PHC2 (polyhomeotic homolog 2), DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1), BCL6 (BCL6 transcription repressor), ADIPOR2 (adiponectin receptor 2), ARID4B (AT-rich interaction domain 4B), USP1 (ubiquitin specific peptidase 1), TXN2 (thioredoxin 2), KCNN4 (potassium calcium-activated channel subfamily N member 4), VPS39 (VPS39 subunit of HOPS complex), ACP2 (acid phosphatase 2, lysosomal), CORO1C (coronin 1C), SERPINE2 (serpin family E member 2), CTSC (cathepsin C), LMNB2 (lamin B2), FRG1 (FSHD region gene 1), ANAPC1 (anaphase promoting complex subunit 1), RAB34 (RAB34, member RAS oncogene family), PISD (phosphatidylserine decarboxylase), CD164 (CD164 molecule), TBCA (tubulin folding cofactor A), CHORDC1 (cysteine and histidine rich domain containing 1), RAB6A (RAB6A, member RAS oncogene family), TNFAIP2 (TNF alpha induced protein 2), CDK5RAP3 (CDK5 regulatory subunit associated protein 3), RFT1 (RFT1 homolog), ACAA2 (acetyl-CoA acyltransferase 2), FMNL2 (formin like 2), MPDU1 (mannose-P-dolichol utilization defect 1), MIR34A (microRNA 34a), MIR200A (microRNA 200a), MIR30C1 (microRNA 30c-1), SLC1A4 (solute carrier family 1 member 4), MIR1-1 (microRNA 1-1), SLC25A1 (solute carrier family 25 member 1), SLC7A11 (solute carrier family 7 member 11), TUSC2 (tumor suppressor 2, mitochondrial calcium regulator), SHOC2 (SHOC2 leucine rich repeat scaffold protein), PTPA (protein phosphatase 2 phosphatase activator), MIR124-3 (microRNA 124-3), TMEM43 (transmembrane protein 43)"], "WAG002133": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), EGFR (epidermal growth factor receptor), VCAM1 (vascular cell adhesion molecule 1), CCND1 (cyclin D1), RB1 (RB transcriptional corepressor 1), CDKN1A (cyclin dependent kinase inhibitor 1A), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), CDKN2A (cyclin dependent kinase inhibitor 2A), E2F1 (E2F transcription factor 1), PLK1 (polo like kinase 1), NCL (nucleolin), BCL2 (BCL2 apoptosis regulator), MAPK14 (mitogen-activated protein kinase 14), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), DDX5 (DEAD-box helicase 5), NOTCH1 (notch receptor 1), CDKN1B (cyclin dependent kinase inhibitor 1B), DHX15 (DEAH-box helicase 15), PKM (pyruvate kinase M1/2), NEDD4 (NEDD4 E3 ubiquitin protein ligase), PTBP1 (polypyrimidine tract binding protein 1), CDK6 (cyclin dependent kinase 6), SMC1A (structural maintenance of chromosomes 1A), HNRNPM (heterogeneous nuclear ribonucleoprotein M), KRAS (KRAS proto-oncogene, GTPase), MYB (MYB proto-oncogene, transcription factor), CAND1 (cullin associated and neddylation dissociated 1), TYMS (thymidylate synthetase), FGF2 (fibroblast growth factor 2), TERT (telomerase reverse transcriptase), E2F3 (E2F transcription factor 3), TUBA1A (tubulin alpha 1a), TMED2 (transmembrane p24 trafficking protein 2), AURKB (aurora kinase B), DNMT3A (DNA methyltransferase 3 alpha), HDAC4 (histone deacetylase 4), NCOA3 (nuclear receptor coactivator 3), UHRF1 (ubiquitin like with PHD and ring finger domains 1), SEC24A (SEC24 homolog A, COPII coat complex component), CSNK1D (casein kinase 1 delta), SMAD1 (SMAD family member 1), PRIM1 (DNA primase subunit 1), HMGA1 (high mobility group AT-hook 1), DNMT3B (DNA methyltransferase 3 beta), POLR2C (RNA polymerase II subunit C), CEBPB (CCAAT enhancer binding protein beta), MET (MET proto-oncogene, receptor tyrosine kinase), PWP1 (PWP1 homolog, endonuclein), POLA2 (DNA polymerase alpha 2, accessory subunit), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), CUL4B (cullin 4B), IRS1 (insulin receptor substrate 1), TMED10 (transmembrane p24 trafficking protein 10), CHAF1A (chromatin assembly factor 1 subunit A), PPP3CA (protein phosphatase 3 catalytic subunit alpha), SEC23A (Sec23 homolog A, COPII coat complex component), TPM1 (tropomyosin 1), GNAI2 (G protein subunit alpha i2), MATR3 (matrin 3), STX7 (syntaxin 7), SNAP23 (synaptosome associated protein 23), AP2A1 (adaptor related protein complex 2 subunit alpha 1), BDNF (brain derived neurotrophic factor), TMED7 (transmembrane p24 trafficking protein 7), CXCL12 (C-X-C motif chemokine ligand 12), POLD2 (DNA polymerase delta 2, accessory subunit), TRIP13 (thyroid hormone receptor interactor 13), BET1 (Bet1 golgi vesicular membrane trafficking protein), CDKN1C (cyclin dependent kinase inhibitor 1C), SRSF9 (serine and arginine rich splicing factor 9), FXR2 (FMR1 autosomal homolog 2), EIF4E (eukaryotic translation initiation factor 4E), ARHGDIA (Rho GDP dissociation inhibitor alpha), BCL6 (BCL6 transcription repressor), HMOX1 (heme oxygenase 1), TGFBR2 (transforming growth factor beta receptor 2), RHOG (ras homolog family member G), ANXA2 (annexin A2), C1QBP (complement C1q binding protein), ANAPC1 (anaphase promoting complex subunit 1), PTPRJ (protein tyrosine phosphatase receptor type J), WDR82 (WD repeat domain 82), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), SDCBP (syndecan binding protein), GNA13 (G protein subunit alpha 13), SNX6 (sorting nexin 6), ARCN1 (archain 1), EHMT2 (euchromatic histone lysine methyltransferase 2), NF2 (neurofibromin 2), VAMP3 (vesicle associated membrane protein 3), IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1), MCL1 (MCL1 apoptosis regulator, BCL2 family member), ATP6V1F (ATPase H+ transporting V1 subunit F), KIT (KIT proto-oncogene, receptor tyrosine kinase), TRAM1 (translocation associated membrane protein 1), PPP5C (protein phosphatase 5 catalytic subunit), GAK (cyclin G associated kinase), SNAP29 (synaptosome associated protein 29), AP3D1 (adaptor related protein complex 3 subunit delta 1), RTN4 (reticulon 4)"], "WAG002134": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), ESR1 (estrogen receptor 1), EGFR (epidermal growth factor receptor), CCND1 (cyclin D1), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), CDKN1A (cyclin dependent kinase inhibitor 1A), ERBB2 (erb-b2 receptor tyrosine kinase 2), MAPK14 (mitogen-activated protein kinase 14), E2F1 (E2F transcription factor 1), RB1 (RB transcriptional corepressor 1), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), BCL2 (BCL2 apoptosis regulator), NOTCH1 (notch receptor 1), NEDD4 (NEDD4 E3 ubiquitin protein ligase), FGF2 (fibroblast growth factor 2), CDKN1B (cyclin dependent kinase inhibitor 1B), NCL (nucleolin), KRAS (KRAS proto-oncogene, GTPase), ITGB4 (integrin subunit beta 4), CDK6 (cyclin dependent kinase 6), PLK1 (polo like kinase 1), IRS1 (insulin receptor substrate 1), PKM (pyruvate kinase M1/2), HDAC4 (histone deacetylase 4), DHX15 (DEAH-box helicase 15), THBS1 (thrombospondin 1), TMED2 (transmembrane p24 trafficking protein 2), CEBPB (CCAAT enhancer binding protein beta), CAND1 (cullin associated and neddylation dissociated 1), MET (MET proto-oncogene, receptor tyrosine kinase), NCOA3 (nuclear receptor coactivator 3), ERBB3 (erb-b2 receptor tyrosine kinase 3), E2F3 (E2F transcription factor 3), TYMS (thymidylate synthetase), CSNK1D (casein kinase 1 delta), DNMT3A (DNA methyltransferase 3 alpha), TMED10 (transmembrane p24 trafficking protein 10), SEC23A (Sec23 homolog A, COPII coat complex component), SEC24A (SEC24 homolog A, COPII coat complex component), COL3A1 (collagen type III alpha 1 chain), CUL4B (cullin 4B), COL1A1 (collagen type I alpha 1 chain), ITGA2 (integrin subunit alpha 2), SRF (serum response factor), COL1A2 (collagen type I alpha 2 chain), MATR3 (matrin 3), TPM1 (tropomyosin 1), UHRF1 (ubiquitin like with PHD and ring finger domains 1), PTPRJ (protein tyrosine phosphatase receptor type J), GJA1 (gap junction protein alpha 1), ERG (ETS transcription factor ERG), ARHGDIA (Rho GDP dissociation inhibitor alpha), POLA2 (DNA polymerase alpha 2, accessory subunit), HMGA1 (high mobility group AT-hook 1), TMED7 (transmembrane p24 trafficking protein 7), TGFBR2 (transforming growth factor beta receptor 2), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), MCL1 (MCL1 apoptosis regulator, BCL2 family member), BET1 (Bet1 golgi vesicular membrane trafficking protein), EHMT2 (euchromatic histone lysine methyltransferase 2), POLD2 (DNA polymerase delta 2, accessory subunit), STX7 (syntaxin 7), SPARC (secreted protein acidic and cysteine rich), ADAR (adenosine deaminase RNA specific), CXCL12 (C-X-C motif chemokine ligand 12), SNAP23 (synaptosome associated protein 23), TRAM1 (translocation associated membrane protein 1), SDCBP (syndecan binding protein), ASH2L (ASH2 like, histone lysine methyltransferase complex subunit), LPL (lipoprotein lipase), NF2 (neurofibromin 2), GAK (cyclin G associated kinase), POLR2C (RNA polymerase II subunit C), C1QBP (complement C1q binding protein), PPP3CA (protein phosphatase 3 catalytic subunit alpha), TPM2 (tropomyosin 2), EIF4E (eukaryotic translation initiation factor 4E), AP3D1 (adaptor related protein complex 3 subunit delta 1), RAD23B (RAD23 homolog B, nucleotide excision repair protein), HMOX1 (heme oxygenase 1), SNX6 (sorting nexin 6), TNFRSF10B (TNF receptor superfamily member 10b), PTPRF (protein tyrosine phosphatase receptor type F), ARCN1 (archain 1), RHOG (ras homolog family member G), GNA13 (G protein subunit alpha 13), SHOC2 (SHOC2 leucine rich repeat scaffold protein), NOTCH2 (notch receptor 2), WDR82 (WD repeat domain 82), IPO4 (importin 4), POLE4 (DNA polymerase epsilon 4, accessory subunit), TPM3 (tropomyosin 3), HES1 (hes family bHLH transcription factor 1), FSTL1 (follistatin like 1), AP3B1 (adaptor related protein complex 3 subunit beta 1), PWP1 (PWP1 homolog, endonuclein), MAPK7 (mitogen-activated protein kinase 7), LRP1 (LDL receptor related protein 1), SRPRB (SRP receptor subunit beta)"], "WAG002135": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VCAM1 (vascular cell adhesion molecule 1), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), TMED2 (transmembrane p24 trafficking protein 2), NCL (nucleolin), FGF2 (fibroblast growth factor 2), SEC23A (Sec23 homolog A, COPII coat complex component), PKM (pyruvate kinase M1/2), TMED7 (transmembrane p24 trafficking protein 7), TMED10 (transmembrane p24 trafficking protein 10), HNRNPM (heterogeneous nuclear ribonucleoprotein M), ARCN1 (archain 1), POLR2C (RNA polymerase II subunit C), ATP6V1F (ATPase H+ transporting V1 subunit F), SMAD1 (SMAD family member 1), AP2A1 (adaptor related protein complex 2 subunit alpha 1), TPM1 (tropomyosin 1), NEDD4 (NEDD4 E3 ubiquitin protein ligase), ANXA2 (annexin A2), TRAM1 (translocation associated membrane protein 1), SRSF9 (serine and arginine rich splicing factor 9), HMGA1 (high mobility group AT-hook 1), SPCS3 (signal peptidase complex subunit 3), ARF4 (ADP ribosylation factor 4), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), NRP1 (neuropilin 1), SDCBP (syndecan binding protein), TUBA1A (tubulin alpha 1a), PICALM (phosphatidylinositol binding clathrin assembly protein), TGFBR2 (transforming growth factor beta receptor 2), MET (MET proto-oncogene, receptor tyrosine kinase), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), SRPRB (SRP receptor subunit beta), GYS1 (glycogen synthase 1), CHMP2A (charged multivesicular body protein 2A), THBS1 (thrombospondin 1), BET1 (Bet1 golgi vesicular membrane trafficking protein), PDCD4 (programmed cell death 4), FBXW11 (F-box and WD repeat domain containing 11), PWP1 (PWP1 homolog, endonuclein), IDH1 (isocitrate dehydrogenase (NADP(+)) 1), ARFIP1 (ADP ribosylation factor interacting protein 1), PPP1R7 (protein phosphatase 1 regulatory subunit 7), CSDE1 (cold shock domain containing E1), PDLIM7 (PDZ and LIM domain 7), RAI14 (retinoic acid induced 14), NF2 (neurofibromin 2), SH3BP4 (SH3 domain binding protein 4), TPM3 (tropomyosin 3), HMOX1 (heme oxygenase 1), CTDSP1 (CTD small phosphatase 1), POLD2 (DNA polymerase delta 2, accessory subunit), RTN4 (reticulon 4), ANP32B (acidic nuclear phosphoprotein 32 family member B), TBCA (tubulin folding cofactor A), GALNT1 (polypeptide N-acetylgalactosaminyltransferase 1), PNP (purine nucleoside phosphorylase), TXNRD1 (thioredoxin reductase 1), LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5), TNFRSF10B (TNF receptor superfamily member 10b), HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), PTMA (prothymosin alpha), HES1 (hes family bHLH transcription factor 1), SLC4A10 (solute carrier family 4 member 10), ACAA2 (acetyl-CoA acyltransferase 2), CBFB (core-binding factor subunit beta), GOLGA7 (golgin A7), RAB34 (RAB34, member RAS oncogene family), CUL4B (cullin 4B), AP3D1 (adaptor related protein complex 3 subunit delta 1), LAMC1 (laminin subunit gamma 1), GFPT1 (glutamine--fructose-6-phosphate transaminase 1), ANPEP (alanyl aminopeptidase, membrane), MRPS33 (mitochondrial ribosomal protein S33), SLC38A1 (solute carrier family 38 member 1), AKAP8 (A-kinase anchoring protein 8), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), ATRX (ATRX chromatin remodeler), ELOVL5 (ELOVL fatty acid elongase 5), PTMAP12 (prothymosin alpha pseudogene 12), MIR30E (microRNA 30e), TMEM43 (transmembrane protein 43), MIR126 (microRNA 126), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), ADAR (adenosine deaminase RNA specific), MIR30C2 (microRNA 30c-2), MIR30B (microRNA 30b), MIR370 (microRNA 370), MIR29C (microRNA 29c), TMEM59 (transmembrane protein 59), MIR199A2 (microRNA 199a-2), MIR16-1 (microRNA 16-1), MIR133B (microRNA 133b), MIR133A2 (microRNA 133a-2), MAGT1 (magnesium transporter 1), SH3BGRL3 (SH3 domain binding glutamate rich protein like 3), ADIPOR2 (adiponectin receptor 2), MIR124-3 (microRNA 124-3), SYNE2 (spectrin repeat containing nuclear envelope protein 2), POGLUT3 (protein O-glucosyltransferase 3)"], "WAG002139": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), NFKB1 (nuclear factor kappa B subunit 1), MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), AKT1 (AKT serine/threonine kinase 1), RELA (RELA proto-oncogene, NF-kB subunit), MAPK3 (mitogen-activated protein kinase 3), MAPK8 (mitogen-activated protein kinase 8), TRAF2 (TNF receptor associated factor 2), NFKBIA (NFKB inhibitor alpha), RAC1 (Rac family small GTPase 1), SYK (spleen associated tyrosine kinase), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), STAT1 (signal transducer and activator of transcription 1), CDC42 (cell division cycle 42), MAP2K1 (mitogen-activated protein kinase kinase 1), PTK2 (protein tyrosine kinase 2), TNFRSF11A (TNF receptor superfamily member 11a), GAB2 (GRB2 associated binding protein 2), TNFSF11 (TNF superfamily member 11), MTOR (mechanistic target of rapamycin kinase), MAP2K6 (mitogen-activated protein kinase kinase 6), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CBL (Cbl proto-oncogene), PLCG1 (phospholipase C gamma 1), ICAM1 (intercellular adhesion molecule 1), MAPK9 (mitogen-activated protein kinase 9), TRAF3 (TNF receptor associated factor 3), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), TRAF1 (TNF receptor associated factor 1), SQSTM1 (sequestosome 1), AKT2 (AKT serine/threonine kinase 2), NFATC1 (nuclear factor of activated T cells 1), NFKB2 (nuclear factor kappa B subunit 2), VCAM1 (vascular cell adhesion molecule 1), MAP2K7 (mitogen-activated protein kinase kinase 7), LYN (LYN proto-oncogene, Src family tyrosine kinase), TRAF5 (TNF receptor associated factor 5), RELB (RELB proto-oncogene, NF-kB subunit), MITF (melanocyte inducing transcription factor), SPI1 (Spi-1 proto-oncogene), FHL2 (four and a half LIM domains 2), CTSK (cathepsin K), TNFRSF11B (TNF receptor superfamily member 11b), ACP5 (acid phosphatase 5, tartrate resistant), CALCR (calcitonin receptor), PAPSS2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2)"], "WAG002142": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), HRAS (HRas proto-oncogene, GTPase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK14 (mitogen-activated protein kinase 14), GNAI2 (G protein subunit alpha i2), MYC (MYC proto-oncogene, bHLH transcription factor), STAT3 (signal transducer and activator of transcription 3), IGF1R (insulin like growth factor 1 receptor), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), GNAI1 (G protein subunit alpha i1), GNB1 (G protein subunit beta 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), GNG2 (G protein subunit gamma 2), MAP2K1 (mitogen-activated protein kinase kinase 1), GNAO1 (G protein subunit alpha o1), JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), GNAI3 (G protein subunit alpha i3), TSHR (thyroid stimulating hormone receptor), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), RB1 (RB transcriptional corepressor 1), MTOR (mechanistic target of rapamycin kinase), CDKN1B (cyclin dependent kinase inhibitor 1B), STAT1 (signal transducer and activator of transcription 1), CCND3 (cyclin D3), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PLCB1 (phospholipase C beta 1), GNAS (GNAS complex locus), RPS6KB1 (ribosomal protein S6 kinase B1), CREB1 (cAMP responsive element binding protein 1), CDK2 (cyclin dependent kinase 2), E2F1 (E2F transcription factor 1), CDK4 (cyclin dependent kinase 4), RPS6KA1 (ribosomal protein S6 kinase A1), RAP1A (RAP1A, member of RAS oncogene family), ADCY2 (adenylate cyclase 2), GNAQ (G protein subunit alpha q), GNA13 (G protein subunit alpha 13), MAP2K3 (mitogen-activated protein kinase kinase 3), CCNE1 (cyclin E1), PDPK1 (3-phosphoinositide dependent protein kinase 1), RAP1B (RAP1B, member of RAS oncogene family), EGR1 (early growth response 1), MAP2K6 (mitogen-activated protein kinase kinase 6), GNA12 (G protein subunit alpha 12), RBL2 (RB transcriptional corepressor like 2), RALGDS (ral guanine nucleotide dissociation stimulator), ADCY3 (adenylate cyclase 3), PDE4D (phosphodiesterase 4D), RPS6 (ribosomal protein S6), RAP1GAP (RAP1 GTPase activating protein), SCRIB (scribble planar cell polarity protein), CGA (glycoprotein hormones, alpha polypeptide), PAX8 (paired box 8), KCNIP3 (potassium voltage-gated channel interacting protein 3), TSHB (thyroid stimulating hormone subunit beta), APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1), MYL12B (myosin light chain 12B), PLD1 (phospholipase D1), TTF2 (transcription termination factor 2), TTF1 (transcription termination factor 1)"], "WAG002143": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), STAT3 (signal transducer and activator of transcription 3), GRB2 (growth factor receptor bound protein 2), JAK2 (Janus kinase 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK3 (mitogen-activated protein kinase 3), IRS1 (insulin receptor substrate 1), JAK1 (Janus kinase 1), MAPK14 (mitogen-activated protein kinase 14), PTPN11 (protein tyrosine phosphatase non-receptor type 11), ESR1 (estrogen receptor 1), SHC1 (SHC adaptor protein 1), MTOR (mechanistic target of rapamycin kinase), RAC1 (Rac family small GTPase 1), MAPK8 (mitogen-activated protein kinase 8), ERBB2 (erb-b2 receptor tyrosine kinase 2), PTK2 (protein tyrosine kinase 2), CCND1 (cyclin D1), HRAS (HRas proto-oncogene, GTPase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PLCG1 (phospholipase C gamma 1), NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), FYN (FYN proto-oncogene, Src family tyrosine kinase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), STAT1 (signal transducer and activator of transcription 1), MAP2K1 (mitogen-activated protein kinase kinase 1), PTEN (phosphatase and tensin homolog), SOCS3 (suppressor of cytokine signaling 3), PLCG2 (phospholipase C gamma 2), LEP (leptin), SP1 (Sp1 transcription factor), RPS6KB1 (ribosomal protein S6 kinase B1), GSK3B (glycogen synthase kinase 3 beta), PTPN1 (protein tyrosine phosphatase non-receptor type 1), CREB1 (cAMP responsive element binding protein 1), BCL2L1 (BCL2 like 1), CDC42 (cell division cycle 42), STAT5B (signal transducer and activator of transcription 5B), RPS6KA1 (ribosomal protein S6 kinase A1), RHOA (ras homolog family member A), ROCK1 (Rho associated coiled-coil containing protein kinase 1), IL1B (interleukin 1 beta), KHDRBS1 (KH RNA binding domain containing, signal transduction associated 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), NOS3 (nitric oxide synthase 3), REL (REL proto-oncogene, NF-kB subunit), LEPR (leptin receptor), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), BAX (BCL2 associated X, apoptosis regulator), FOXO1 (forkhead box O1), BAD (BCL2 associated agonist of cell death), ROCK2 (Rho associated coiled-coil containing protein kinase 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), SOCS7 (suppressor of cytokine signaling 7), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAP2K2 (mitogen-activated protein kinase kinase 2), CISH (cytokine inducible SH2 containing protein), NCOA1 (nuclear receptor coactivator 1), SOCS2 (suppressor of cytokine signaling 2), RPS6 (ribosomal protein S6), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), ELK1 (ETS transcription factor ELK1), EIF4E (eukaryotic translation initiation factor 4E), ACACA (acetyl-CoA carboxylase alpha), SH2B1 (SH2B adaptor protein 1), ACACB (acetyl-CoA carboxylase beta), KPNA4 (karyopherin subunit alpha 4), GSK3A (glycogen synthase kinase 3 alpha), PDE3B (phosphodiesterase 3B), CFL2 (cofilin 2), IL1RN (interleukin 1 receptor antagonist)"], "WAG002145": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), TNF (tumor necrosis factor), NFKBIA (NFKB inhibitor alpha), TRAF2 (TNF receptor associated factor 2), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), BIRC2 (baculoviral IAP repeat containing 2), AKT1 (AKT serine/threonine kinase 1), CASP8 (caspase 8), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CASP3 (caspase 3), MAPK14 (mitogen-activated protein kinase 14), RIPK1 (receptor interacting serine/threonine kinase 1), MAPK8 (mitogen-activated protein kinase 8), MAPK1 (mitogen-activated protein kinase 1), TRAF1 (TNF receptor associated factor 1), BIRC3 (baculoviral IAP repeat containing 3), RAC1 (Rac family small GTPase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MAPK3 (mitogen-activated protein kinase 3), NFKB2 (nuclear factor kappa B subunit 2), TRAF3 (TNF receptor associated factor 3), CTNNB1 (catenin beta 1), FADD (Fas associated via death domain), IL6 (interleukin 6), GSK3B (glycogen synthase kinase 3 beta), RELB (RELB proto-oncogene, NF-kB subunit), TRAF5 (TNF receptor associated factor 5), MMP9 (matrix metallopeptidase 9), AKT2 (AKT serine/threonine kinase 2), MAPK9 (mitogen-activated protein kinase 9), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), NFKBIB (NFKB inhibitor beta), CCL2 (C-C motif chemokine ligand 2), HDAC1 (histone deacetylase 1), TNFRSF12A (TNF receptor superfamily member 12A), CCL5 (C-C motif chemokine ligand 5), CASP7 (caspase 7), TNFSF12 (TNF superfamily member 12), TRIM63 (tripartite motif containing 63)"], "WAG002146": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), JAK2 (Janus kinase 2), GRB2 (growth factor receptor bound protein 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), STAT3 (signal transducer and activator of transcription 3), MAPK3 (mitogen-activated protein kinase 3), JAK1 (Janus kinase 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), FYN (FYN proto-oncogene, Src family tyrosine kinase), SHC1 (SHC adaptor protein 1), HRAS (HRas proto-oncogene, GTPase), IRS1 (insulin receptor substrate 1), RAC1 (Rac family small GTPase 1), MAPK14 (mitogen-activated protein kinase 14), ERBB2 (erb-b2 receptor tyrosine kinase 2), MAP2K1 (mitogen-activated protein kinase kinase 1), CBL (Cbl proto-oncogene), VAV1 (vav guanine nucleotide exchange factor 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PTK2 (protein tyrosine kinase 2), STAT1 (signal transducer and activator of transcription 1), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), IRS2 (insulin receptor substrate 2), GAB2 (GRB2 associated binding protein 2), STAT5A (signal transducer and activator of transcription 5A), MAPK8 (mitogen-activated protein kinase 8), PTPN6 (protein tyrosine phosphatase non-receptor type 6), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RELA (RELA proto-oncogene, NF-kB subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), PXN (paxillin), MTOR (mechanistic target of rapamycin kinase), MYC (MYC proto-oncogene, bHLH transcription factor), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), SOCS1 (suppressor of cytokine signaling 1), NFKB1 (nuclear factor kappa B subunit 1), VAV2 (vav guanine nucleotide exchange factor 2), PRLR (prolactin receptor), STAT5B (signal transducer and activator of transcription 5B), SOCS3 (suppressor of cytokine signaling 3), PRL (prolactin), PAK1 (p21 (RAC1) activated kinase 1), RPS6KB1 (ribosomal protein S6 kinase B1), PTPN1 (protein tyrosine phosphatase non-receptor type 1), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), MAPK9 (mitogen-activated protein kinase 9), TEC (tec protein tyrosine kinase), TEC (transient erythroblastopenia of childhood), GSK3B (glycogen synthase kinase 3 beta), NFKBIA (NFKB inhibitor alpha), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), CASP3 (caspase 3), FLNA (filamin A), MAP2K2 (mitogen-activated protein kinase kinase 2), ITGB1 (integrin subunit beta 1), IRF1 (interferon regulatory factor 1), CISH (cytokine inducible SH2 containing protein), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), SOCS2 (suppressor of cytokine signaling 2), RPS6KA2 (ribosomal protein S6 kinase A2), ELK1 (ETS transcription factor ELK1), NOS2 (nitric oxide synthase 2), PIAS3 (protein inhibitor of activated STAT 3), RPS6 (ribosomal protein S6), PPIA (peptidylprolyl isomerase A), SIRPA (signal regulatory protein alpha), NFKBIB (NFKB inhibitor beta), AGAP2 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2), NEK3 (NIMA related kinase 3), PPIB (peptidylprolyl isomerase B), CTSD (cathepsin D)"], "WAG002147": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), CDC42 (cell division cycle 42), AKT1 (AKT serine/threonine kinase 1), GSK3B (glycogen synthase kinase 3 beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PRKCA (protein kinase C alpha), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), MAPRE1 (microtubule associated protein RP/EB family member 1), TIAM1 (TIAM Rac1 associated GEF 1), CLASP1 (cytoplasmic linker associated protein 1), PARD6A (par-6 family cell polarity regulator alpha), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CLIP1 (CAP-Gly domain containing linker protein 1), CDK1 (cyclin dependent kinase 1), PAK1 (p21 (RAC1) activated kinase 1), MAPT (microtubule associated protein tau), APC (APC regulator of WNT signaling pathway), LIMK1 (LIM domain kinase 1), DVL1 (dishevelled segment polarity protein 1), F2RL2 (coagulation factor II thrombin receptor like 2), MARK2 (microtubule affinity regulating kinase 2), AURKB (aurora kinase B), STAT3 (signal transducer and activator of transcription 3), TAOK1 (TAO kinase 1), EPHB2 (EPH receptor B2), PTEN (phosphatase and tensin homolog), ROCK1 (Rho associated coiled-coil containing protein kinase 1), DIAPH1 (diaphanous related formin 1), KIF2C (kinesin family member 2C), STMN1 (stathmin 1), WNT3A (Wnt family member 3A), GNAQ (G protein subunit alpha q), PTPRA (protein tyrosine phosphatase receptor type A), MARK1 (microtubule affinity regulating kinase 1), DPYSL2 (dihydropyrimidinase like 2), RHO (rhodopsin), TRIO (trio Rho guanine nucleotide exchange factor), MAPKAPK2 (MAPK activated protein kinase 2), MAP1B (microtubule associated protein 1B), TPPP (tubulin polymerization promoting protein), CFL2 (cofilin 2), PHLDB2 (pleckstrin homology like domain family B member 2), SPRED1 (sprouty related EVH1 domain containing 1), CAMK4 (calcium/calmodulin dependent protein kinase IV), TESK2 (testis associated actin remodelling kinase 2)"], "WAG002148": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK3 (Janus kinase 3), STAT3 (signal transducer and activator of transcription 3), IL2RG (interleukin 2 receptor subunit gamma), JAK1 (Janus kinase 1), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), IL2RA (interleukin 2 receptor subunit alpha), STAT5A (signal transducer and activator of transcription 5A), MAPK3 (mitogen-activated protein kinase 3), STAT1 (signal transducer and activator of transcription 1), STAT5B (signal transducer and activator of transcription 5B), FYN (FYN proto-oncogene, Src family tyrosine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), MYC (MYC proto-oncogene, bHLH transcription factor), CCND1 (cyclin D1), IL7R (interleukin 7 receptor), IL7 (interleukin 7), PTK2B (protein tyrosine kinase 2 beta), BCL2L1 (BCL2 like 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), GSK3B (glycogen synthase kinase 3 beta), MAP2K2 (mitogen-activated protein kinase kinase 2), BAD (BCL2 associated agonist of cell death), CDKN1B (cyclin dependent kinase inhibitor 1B)"], "WAG002149": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APP (amyloid beta precursor protein), CALM3 (calmodulin 3), AKT1 (AKT serine/threonine kinase 1), CTNNB1 (catenin beta 1), AXIN1 (axin 1), MAPK1 (mitogen-activated protein kinase 1), GSK3B (glycogen synthase kinase 3 beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD2 (proteasome 26S subunit, non-ATPase 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA3 (proteasome 20S subunit alpha 3), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC3 (proteasome 26S subunit, ATPase 3), TNF (tumor necrosis factor), PSMA5 (proteasome 20S subunit alpha 5), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA7 (proteasome 20S subunit alpha 7), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA6 (proteasome 20S subunit alpha 6), PSMA4 (proteasome 20S subunit alpha 4), PSMB4 (proteasome 20S subunit beta 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMA1 (proteasome 20S subunit alpha 1), MAPK3 (mitogen-activated protein kinase 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB1 (proteasome 20S subunit beta 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), MAPK8 (mitogen-activated protein kinase 8), PSMB5 (proteasome 20S subunit beta 5), PSMA2 (proteasome 20S subunit alpha 2), SNCA (synuclein alpha), PSMB2 (proteasome 20S subunit beta 2), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMB6 (proteasome 20S subunit beta 6), PSMB7 (proteasome 20S subunit beta 7), PSMA8 (proteasome 20S subunit alpha 8), PSMB3 (proteasome 20S subunit beta 3), WNT3A (Wnt family member 3A), FZD5 (frizzled class receptor 5), NFKB1 (nuclear factor kappa B subunit 1), PLCB1 (phospholipase C beta 1), IRS1 (insulin receptor substrate 1), FZD1 (frizzled class receptor 1), ADRM1 (adhesion regulating molecule 1), TNFRSF1A (TNF receptor superfamily member 1A), CASP3 (caspase 3), FZD2 (frizzled class receptor 2), HRAS (HRas proto-oncogene, GTPase), DVL1 (dishevelled segment polarity protein 1), MTOR (mechanistic target of rapamycin kinase), PLCB2 (phospholipase C beta 2), FZD8 (frizzled class receptor 8), RELA (RELA proto-oncogene, NF-kB subunit), PLCB4 (phospholipase C beta 4), DVL2 (dishevelled segment polarity protein 2), CASP8 (caspase 8), PLCB3 (phospholipase C beta 3), FZD7 (frizzled class receptor 7), FZD6 (frizzled class receptor 6), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), FZD10 (frizzled class receptor 10), LRP6 (LDL receptor related protein 6), WNT5A (Wnt family member 5A), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), DVL3 (dishevelled segment polarity protein 3), FZD9 (frizzled class receptor 9), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), TRAF2 (TNF receptor associated factor 2), PSEN1 (presenilin 1), NOS2 (nitric oxide synthase 2), WNT1 (Wnt family member 1), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), IRS2 (insulin receptor substrate 2), IDE (insulin degrading enzyme), CSNK2A1 (casein kinase 2 alpha 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), AKT2 (AKT serine/threonine kinase 2), SFRP4 (secreted frizzled related protein 4), WNT7B (Wnt family member 7B), CASP9 (caspase 9), FZD3 (frizzled class receptor 3), PTGS2 (prostaglandin-endoperoxide synthase 2), APC (APC regulator of WNT signaling pathway), CYCS (cytochrome c, somatic), WNT2B (Wnt family member 2B), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3)"], "WAG002152": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), NOTCH1 (notch receptor 1), HDAC1 (histone deacetylase 1), GSK3B (glycogen synthase kinase 3 beta), MYC (MYC proto-oncogene, bHLH transcription factor), HDAC2 (histone deacetylase 2), HDAC3 (histone deacetylase 3), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), BMP4 (bone morphogenetic protein 4), DVL1 (dishevelled segment polarity protein 1), WNT3A (Wnt family member 3A), NOTCH3 (notch receptor 3), CDH1 (cadherin 1), DVL3 (dishevelled segment polarity protein 3), NFKB1 (nuclear factor kappa B subunit 1), NOTCH2 (notch receptor 2), AXIN1 (axin 1), HDAC9 (histone deacetylase 9), HDAC4 (histone deacetylase 4), SMAD1 (SMAD family member 1), SOX9 (SRY-box transcription factor 9), DVL2 (dishevelled segment polarity protein 2), HDAC5 (histone deacetylase 5), SOX10 (SRY-box transcription factor 10), HDAC6 (histone deacetylase 6), CDH2 (cadherin 2), HES1 (hes family bHLH transcription factor 1), HDAC7 (histone deacetylase 7), HDAC10 (histone deacetylase 10), FGFR1 (fibroblast growth factor receptor 1), AXIN2 (axin 2), TWIST1 (twist family bHLH transcription factor 1), PAX3 (paired box 3), WNT1 (Wnt family member 1), HDAC11 (histone deacetylase 11), DLL1 (delta like canonical Notch ligand 1), FGF8 (fibroblast growth factor 8), FGF2 (fibroblast growth factor 2), MSX2 (msh homeobox 2), HDAC8 (histone deacetylase 8), HEY2 (hes related family bHLH transcription factor with YRPW motif 2), FGFR3 (fibroblast growth factor receptor 3), NOTCH4 (notch receptor 4), SNAI1 (snail family transcriptional repressor 1), MITF (melanocyte inducing transcription factor), CTBP2 (C-terminal binding protein 2), FGFR2 (fibroblast growth factor receptor 2), SNAI2 (snail family transcriptional repressor 2), ASCL1 (achaete-scute family bHLH transcription factor 1), HES5 (hes family bHLH transcription factor 5), DLX5 (distal-less homeobox 5), DLL4 (delta like canonical Notch ligand 4), MSX1 (msh homeobox 1), TCF4 (transcription factor 4), BMP7 (bone morphogenetic protein 7), OLIG2 (oligodendrocyte transcription factor 2), LHX2 (LIM homeobox 2), FZD3 (frizzled class receptor 3), GFAP (glial fibrillary acidic protein), ID1 (inhibitor of DNA binding 1, HLH protein), DLL3 (delta like canonical Notch ligand 3), TCF7L1 (transcription factor 7 like 1), SOX5 (SRY-box transcription factor 5), ETS1 (ETS proto-oncogene 1, transcription factor), TFAP2A (transcription factor AP-2 alpha), NFKB2 (nuclear factor kappa B subunit 2), NEUROG1 (neurogenin 1), FGF19 (fibroblast growth factor 19), ISL1 (ISL LIM homeobox 1), PAX7 (paired box 7), CDH7 (cadherin 7), COL2A1 (collagen type II alpha 1 chain), PHOX2B (paired like homeobox 2B), MYB (MYB proto-oncogene, transcription factor), MPZ (myelin protein zero), ITGB1 (integrin subunit beta 1), COL11A2 (collagen type XI alpha 2 chain), FOXD3 (forkhead box D3), CDH6 (cadherin 6), RHOB (ras homolog family member B), LHX1 (LIM homeobox 1), HOXA1 (homeobox A1), GBX2 (gastrulation brain homeobox 2), MBP (myelin basic protein), LHX5 (LIM homeobox 5), GJB1 (gap junction protein beta 1), WNT8A (Wnt family member 8A), DCT (dopachrome tautomerase), OLIG1 (oligodendrocyte transcription factor 1), PMP22 (peripheral myelin protein 22), ZIC5 (Zic family member 5), HAND1 (heart and neural crest derivatives expressed 1), TLX2 (T cell leukemia homeobox 2), ZIC1 (Zic family member 1), HOXB1 (homeobox B1), TFAP2B (transcription factor AP-2 beta), TBX6 (T-box transcription factor 6), OLIG3 (oligodendrocyte transcription factor 3), MIA (MIA SH3 domain containing), PRTG (protogenin)"], "WAG002153": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), STAT3 (signal transducer and activator of transcription 3), TRAF6 (TNF receptor associated factor 6), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MAPK1 (mitogen-activated protein kinase 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), AKT1 (AKT serine/threonine kinase 1), MAPK3 (mitogen-activated protein kinase 3), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), JAK2 (Janus kinase 2), IL17A (interleukin 17A), CEBPB (CCAAT enhancer binding protein beta), IL17RA (interleukin 17 receptor A), SP1 (Sp1 transcription factor), GSK3B (glycogen synthase kinase 3 beta), TRAF3IP2 (TRAF3 interacting protein 2), TRAF3 (TNF receptor associated factor 3), JAK1 (Janus kinase 1), IL17RB (interleukin 17 receptor B), NFKBIB (NFKB inhibitor beta), CEBPD (CCAAT enhancer binding protein delta), IL17F (interleukin 17F), IL17RC (interleukin 17 receptor C), IL17RE (interleukin 17 receptor E), IL17C (interleukin 17C), IL17B (interleukin 17B), IL17RD (interleukin 17 receptor D), IL25 (interleukin 25), IL17D (interleukin 17D)"], "WAG002155": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ACTN2 (actinin alpha 2), ACTN1 (actinin alpha 1), ACTN4 (actinin alpha 4), ITGB1 (integrin subunit beta 1), ACTB (actin beta), ITGB7 (integrin subunit beta 7), ACTG1 (actin gamma 1), ITGB4 (integrin subunit beta 4), ITGAV (integrin subunit alpha V), ITGB6 (integrin subunit beta 6), ITGB8 (integrin subunit beta 8), ITGA3 (integrin subunit alpha 3), ITGA2 (integrin subunit alpha 2), ITGA5 (integrin subunit alpha 5), ITGB5 (integrin subunit beta 5), LAMA2 (laminin subunit alpha 2), ITGA1 (integrin subunit alpha 1), ITGA6 (integrin subunit alpha 6), CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1), ITGA4 (integrin subunit alpha 4), ACTN3 (actinin alpha 3), ITGA8 (integrin subunit alpha 8), ITGA2B (integrin subunit alpha 2b), ITGA10 (integrin subunit alpha 10), ITGA11 (integrin subunit alpha 11), ITGA9 (integrin subunit alpha 9), CTNNB1 (catenin beta 1), CACNA1D (calcium voltage-gated channel subunit alpha1 D), CACNA1C (calcium voltage-gated channel subunit alpha1 C), CACNB3 (calcium voltage-gated channel auxiliary subunit beta 3), CACNA2D1 (calcium voltage-gated channel auxiliary subunit alpha2delta 1), CACNG6 (calcium voltage-gated channel auxiliary subunit gamma 6), CACNG1 (calcium voltage-gated channel auxiliary subunit gamma 1), CACNA1S (calcium voltage-gated channel subunit alpha1 S), CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4), CACNG8 (calcium voltage-gated channel auxiliary subunit gamma 8), CACNG3 (calcium voltage-gated channel auxiliary subunit gamma 3), CACNG7 (calcium voltage-gated channel auxiliary subunit gamma 7), CACNA1F (calcium voltage-gated channel subunit alpha1 F), ITGA7 (integrin subunit alpha 7), CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2), CACNG2 (calcium voltage-gated channel auxiliary subunit gamma 2), ITGB3 (integrin subunit beta 3), JUP (junction plakoglobin), CTNNA1 (catenin alpha 1), RYR2 (ryanodine receptor 2), DMD (dystrophin), CTNNA2 (catenin alpha 2), CTNNA3 (catenin alpha 3), DAG1 (dystroglycan 1), PKP2 (plakophilin 2), CACNG4 (calcium voltage-gated channel auxiliary subunit gamma 4), CACNG5 (calcium voltage-gated channel auxiliary subunit gamma 5), SGCA (sarcoglycan alpha), SGCD (sarcoglycan delta), CDH2 (cadherin 2), DES (desmin), SGCB (sarcoglycan beta), SGCG (sarcoglycan gamma), DSP (desmoplakin), LEF1 (lymphoid enhancer binding factor 1), LMNA (lamin A/C), GJA1 (gap junction protein alpha 1), DSG2 (desmoglein 2), TCF7L2 (transcription factor 7 like 2), DSC2 (desmocollin 2), TCF7 (transcription factor 7), EMD (emerin), CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), SLC8A1 (solute carrier family 8 member A1), CACNA2D4 (calcium voltage-gated channel auxiliary subunit alpha2delta 4), TCF7L1 (transcription factor 7 like 1), CACNA2D3 (calcium voltage-gated channel auxiliary subunit alpha2delta 3), LINC02478 (long intergenic non-protein coding RNA 2478)"], "WAG002158": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT3 (signal transducer and activator of transcription 3), JAK2 (Janus kinase 2), LCK (LCK proto-oncogene, Src family tyrosine kinase), JAK1 (Janus kinase 1), MAPK1 (mitogen-activated protein kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK14 (mitogen-activated protein kinase 14), STAT1 (signal transducer and activator of transcription 1), AKT1 (AKT serine/threonine kinase 1), IL2RA (interleukin 2 receptor subunit alpha), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK3 (mitogen-activated protein kinase 3), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), GAB2 (GRB2 associated binding protein 2), STAT5A (signal transducer and activator of transcription 5A), FYN (FYN proto-oncogene, Src family tyrosine kinase), IL6 (interleukin 6), MYC (MYC proto-oncogene, bHLH transcription factor), MAP2K1 (mitogen-activated protein kinase kinase 1), LYN (LYN proto-oncogene, Src family tyrosine kinase), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), STAT5B (signal transducer and activator of transcription 5B), NFKBIA (NFKB inhibitor alpha), BTK (Bruton tyrosine kinase), IL7R (interleukin 7 receptor), MAPK8 (mitogen-activated protein kinase 8), HCK (HCK proto-oncogene, Src family tyrosine kinase), STAT6 (signal transducer and activator of transcription 6), MTOR (mechanistic target of rapamycin kinase), CISH (cytokine inducible SH2 containing protein), STAT4 (signal transducer and activator of transcription 4), MAPK9 (mitogen-activated protein kinase 9), FES (FES proto-oncogene, tyrosine kinase), MAP2K2 (mitogen-activated protein kinase kinase 2), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), TEC (tec protein tyrosine kinase), TEC (transient erythroblastopenia of childhood), NFKB2 (nuclear factor kappa B subunit 2), RELB (RELB proto-oncogene, NF-kB subunit), TSLP (thymic stromal lymphopoietin), CRLF2 (cytokine receptor like factor 2), RPS6 (ribosomal protein S6), TNFSF4 (TNF superfamily member 4), CCL11 (C-C motif chemokine ligand 11), PI4K2A (phosphatidylinositol 4-kinase type 2 alpha), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002161": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), HRAS (HRas proto-oncogene, GTPase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), GRB2 (growth factor receptor bound protein 2), EGFR (epidermal growth factor receptor), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), TP53 (tumor protein p53), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), NRAS (NRAS proto-oncogene, GTPase), PTEN (phosphatase and tensin homolog), PLCG1 (phospholipase C gamma 1), MAPK3 (mitogen-activated protein kinase 3), ERBB2 (erb-b2 receptor tyrosine kinase 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PRKCD (protein kinase C delta), CCND1 (cyclin D1), KRAS (KRAS proto-oncogene, GTPase), MDM2 (MDM2 proto-oncogene), IGF1R (insulin like growth factor 1 receptor), CDKN1B (cyclin dependent kinase inhibitor 1B), MAP2K1 (mitogen-activated protein kinase kinase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PLCG2 (phospholipase C gamma 2), CBL (Cbl proto-oncogene), IRS1 (insulin receptor substrate 1), PRKCZ (protein kinase C zeta), PRKCA (protein kinase C alpha), PDGFRB (platelet derived growth factor receptor beta), BRCA1 (BRCA1 DNA repair associated), RB1 (RB transcriptional corepressor 1), EP300 (E1A binding protein p300), AKT2 (AKT serine/threonine kinase 2), MET (MET proto-oncogene, receptor tyrosine kinase), CDK2 (cyclin dependent kinase 2), CDK4 (cyclin dependent kinase 4), CDKN2A (cyclin dependent kinase inhibitor 2A), AKT3 (AKT serine/threonine kinase 3), GAB1 (GRB2 associated binding protein 1), PDPK1 (3-phosphoinositide dependent protein kinase 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), ERBB3 (erb-b2 receptor tyrosine kinase 3), E2F1 (E2F transcription factor 1), ARAF (A-Raf proto-oncogene, serine/threonine kinase), PRKCI (protein kinase C iota), FOXO1 (forkhead box O1), FGFR1 (fibroblast growth factor receptor 1), PRKCQ (protein kinase C theta), CCND2 (cyclin D2), PDGFRA (platelet derived growth factor receptor alpha), PRKCB (protein kinase C beta), CDK6 (cyclin dependent kinase 6), FOXO3 (forkhead box O3), FGFR2 (fibroblast growth factor receptor 2), CCNE1 (cyclin E1), ATM (ATM serine/threonine kinase), TSC2 (TSC complex subunit 2), MAP2K2 (mitogen-activated protein kinase kinase 2), PIK3C2B (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta), MAP2K4 (mitogen-activated protein kinase kinase 4), PRKCH (protein kinase C eta), CDKN2B (cyclin dependent kinase inhibitor 2B), MDM4 (MDM4 regulator of p53), PRKCG (protein kinase C gamma), SPRY2 (sprouty RTK signaling antagonist 2), MAP2K3 (mitogen-activated protein kinase kinase 3), CDKN2C (cyclin dependent kinase inhibitor 2C), BRCA2 (BRCA2 DNA repair associated), FOXO4 (forkhead box O4), PIK3C2G (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma), MAP2K5 (mitogen-activated protein kinase kinase 5), TSC1 (TSC complex subunit 1), MAP2K6 (mitogen-activated protein kinase kinase 6), MSH6 (mutS homolog 6), NF1 (neurofibromin 1), MAP2K7 (mitogen-activated protein kinase kinase 7), ERRFI1 (ERBB receptor feedback inhibitor 1), PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha), MIR21 (microRNA 21)"], "WAG002162": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), BRCA1 (BRCA1 DNA repair associated), MYC (MYC proto-oncogene, bHLH transcription factor), MAPK3 (mitogen-activated protein kinase 3), MAPK8 (mitogen-activated protein kinase 8), GRB2 (growth factor receptor bound protein 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK14 (mitogen-activated protein kinase 14), AR (androgen receptor), SP1 (Sp1 transcription factor), CCND1 (cyclin D1), HRAS (HRas proto-oncogene, GTPase), RB1 (RB transcriptional corepressor 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), STAT3 (signal transducer and activator of transcription 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CDK2 (cyclin dependent kinase 2), CASP3 (caspase 3), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), BCL2 (BCL2 apoptosis regulator), MDM2 (MDM2 proto-oncogene), SMAD3 (SMAD family member 3), SMAD2 (SMAD family member 2), PTEN (phosphatase and tensin homolog), CDK1 (cyclin dependent kinase 1), ATM (ATM serine/threonine kinase), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), MAP2K1 (mitogen-activated protein kinase kinase 1), MTOR (mechanistic target of rapamycin kinase), PTPN11 (protein tyrosine phosphatase non-receptor type 11), CDC25A (cell division cycle 25A), CDK4 (cyclin dependent kinase 4), STAT1 (signal transducer and activator of transcription 1), PXN (paxillin), SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1), TSC2 (TSC complex subunit 2), E2F1 (E2F transcription factor 1), JAK1 (Janus kinase 1), CHEK1 (checkpoint kinase 1), ATR (ATR serine/threonine kinase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CRK (CRK proto-oncogene, adaptor protein), BAX (BCL2 associated X, apoptosis regulator), SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2), HGF (hepatocyte growth factor), PRKDC (protein kinase, DNA-activated, catalytic subunit), RASA1 (RAS p21 protein activator 1), PTK2B (protein tyrosine kinase 2 beta), CHEK2 (checkpoint kinase 2), CASP9 (caspase 9), PAK1 (p21 (RAC1) activated kinase 1), CASP8 (caspase 8), CRKL (CRK like proto-oncogene, adaptor protein), PLK1 (polo like kinase 1), SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1), MSH2 (mutS homolog 2), GAB1 (GRB2 associated binding protein 1), BLM (BLM RecQ like helicase), MSH6 (mutS homolog 6), TSC1 (TSC complex subunit 1), CDC25B (cell division cycle 25B), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), RAP1A (RAP1A, member of RAS oncogene family), RHEB (Ras homolog, mTORC1 binding), RAD50 (RAD50 double strand break repair protein), ARID1A (AT-rich interaction domain 1A), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), BAD (BCL2 associated agonist of cell death), ACTL6A (actin like 6A), SMARCD2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2), MAP2K2 (mitogen-activated protein kinase kinase 2), ELK1 (ETS transcription factor ELK1), RAP1B (RAP1B, member of RAS oncogene family), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), RPTOR (regulatory associated protein of MTOR complex 1), ARID1B (AT-rich interaction domain 1B), KLK3 (kallikrein related peptidase 3), RAPGEF1 (Rap guanine nucleotide exchange factor 1), BARD1 (BRCA1 associated RING domain 1), MMP1 (matrix metallopeptidase 1), HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4), RICTOR (RPTOR independent companion of MTOR complex 2), ACTL6B (actin like 6B), SPRY2 (sprouty RTK signaling antagonist 2), ERG (ETS transcription factor ERG), HSD17B3 (hydroxysteroid 17-beta dehydrogenase 3), ATF1 (activating transcription factor 1), NDRG1 (N-myc downstream regulated 1), HSD17B2 (hydroxysteroid 17-beta dehydrogenase 2), HSD17B1 (hydroxysteroid 17-beta dehydrogenase 1), SPRY1 (sprouty RTK signaling antagonist 1), DOCK1 (dedicator of cytokinesis 1), ETV4 (ETS variant transcription factor 4), CYP17A1 (cytochrome P450 family 17 subfamily A member 1), HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1), FKBP5 (FKBP prolyl isomerase 5), HSD17B7 (hydroxysteroid 17-beta dehydrogenase 7), FOXA1 (forkhead box A1)"], "WAG002163": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SNAP25 (synaptosome associated protein 25), STX1A (syntaxin 1A), SYT1 (synaptotagmin 1), VAMP2 (vesicle associated membrane protein 2), RIMS1 (regulating synaptic membrane exocytosis 1), RAB3A (RAB3A, member RAS oncogene family), STXBP1 (syntaxin binding protein 1), CPLX1 (complexin 1), UNC13B (unc-13 homolog B), SLC18A3 (solute carrier family 18 member A3), SLC18A2 (solute carrier family 18 member A2), SLC17A7 (solute carrier family 17 member 7), AP2A2 (adaptor related protein complex 2 subunit alpha 2), AP2M1 (adaptor related protein complex 2 subunit mu 1), STX3 (syntaxin 3), AP2A1 (adaptor related protein complex 2 subunit alpha 1), CLTC (clathrin heavy chain), AP2S1 (adaptor related protein complex 2 subunit sigma 1), DNM1 (dynamin 1), STX2 (syntaxin 2), SLC32A1 (solute carrier family 32 member 1), SYP (synaptophysin), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), AP2B1 (adaptor related protein complex 2 subunit beta 1), STX1B (syntaxin 1B), CLTA (clathrin light chain A), CACNA1A (calcium voltage-gated channel subunit alpha1 A), NAPA (NSF attachment protein alpha), SYN1 (synapsin I), CPLX2 (complexin 2), CLTCL1 (clathrin heavy chain like 1), CACNA1B (calcium voltage-gated channel subunit alpha1 B), ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2), SYN2 (synapsin II), UNC13A (unc-13 homolog A), SYN3 (synapsin III), DNM2 (dynamin 2), SLC6A4 (solute carrier family 6 member 4), SLC17A6 (solute carrier family 17 member 6), SLC18A1 (solute carrier family 18 member A1), CPLX3 (complexin 3), PARK7 (Parkinsonism associated deglycase), SLC17A8 (solute carrier family 17 member 8), SLC1A3 (solute carrier family 1 member 3), SLC22A3 (solute carrier family 22 member 3), UNC13C (unc-13 homolog C), DNM1L (dynamin 1 like), SLC25A4 (solute carrier family 25 member 4), SLC38A1 (solute carrier family 38 member 1), DNM3 (dynamin 3), CLN8 (CLN8 transmembrane ER and ERGIC protein)"], "WAG002164": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ACTB (actin beta), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), ACTG1 (actin gamma 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), WASL (WASP like actin nucleation promoting factor), WAS (WASP actin nucleation promoting factor), TUBA1A (tubulin alpha 1a), ARPC2 (actin related protein 2/3 complex subunit 2), ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2), NCK1 (NCK adaptor protein 1), CTTN (cortactin), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), ARPC4 (actin related protein 2/3 complex subunit 4), ARPC3 (actin related protein 2/3 complex subunit 3), PRKCA (protein kinase C alpha), CDC42 (cell division cycle 42), CTNNB1 (catenin beta 1), ARPC1B (actin related protein 2/3 complex subunit 1B), RHOA (ras homolog family member A), EZR (ezrin), ARPC1A (actin related protein 2/3 complex subunit 1A), ARPC5 (actin related protein 2/3 complex subunit 5), TUBA4A (tubulin alpha 4a), TUBA1B (tubulin alpha 1b), NCK2 (NCK adaptor protein 2), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CDH1 (cadherin 1), TUBB1 (tubulin beta 1 class VI), TUBB (tubulin beta class I), ITGB1 (integrin subunit beta 1), TUBB2A (tubulin beta 2A class IIa), ARPC5L (actin related protein 2/3 complex subunit 5 like), TUBA1C (tubulin alpha 1c), TUBB4A (tubulin beta 4A class IVa), TUBB4B (tubulin beta 4B class IVb), ROCK2 (Rho associated coiled-coil containing protein kinase 2), TUBB2B (tubulin beta 2B class IIb), TUBB6 (tubulin beta 6 class V), NCL (nucleolin), TUBAL3 (tubulin alpha like 3), HCLS1 (hematopoietic cell-specific Lyn substrate 1), TUBA3E (tubulin alpha 3e), ROCK1 (Rho associated coiled-coil containing protein kinase 1), TLR4 (toll like receptor 4), KRT18 (keratin 18), CD14 (CD14 molecule), TUBA3D (tubulin alpha 3d), LY96 (lymphocyte antigen 96), OCLN (occludin), TLR5 (toll like receptor 5), TUBB3 (tubulin beta 3 class III), TUBA8 (tubulin alpha 8), CLDN1 (claudin 1), TUBB7P (tubulin beta 7 pseudogene), TUBB8 (tubulin beta 8 class VIII), TUBA3C (tubulin alpha 3c)"], "WAG002165": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAG (myelin associated glycoprotein), MBP (myelin basic protein), PLP1 (proteolipid protein 1), CNP (2',3'-cyclic nucleotide 3' phosphodiesterase), MSN (moesin), TPPP (tubulin polymerization promoting protein), MIR206 (microRNA 206), GAP43 (growth associated protein 43)"], "WAG002170": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRB2 (growth factor receptor bound protein 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), LCK (LCK proto-oncogene, Src family tyrosine kinase), SYK (spleen associated tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), PLCG1 (phospholipase C gamma 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), VAV1 (vav guanine nucleotide exchange factor 1), PLCG2 (phospholipase C gamma 2), SHC1 (SHC adaptor protein 1), BTK (Bruton tyrosine kinase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAPK14 (mitogen-activated protein kinase 14), CBL (Cbl proto-oncogene), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), RAC1 (Rac family small GTPase 1), PRKCD (protein kinase C delta), LYN (LYN proto-oncogene, Src family tyrosine kinase), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK8 (mitogen-activated protein kinase 8), HRAS (HRas proto-oncogene, GTPase), INPP5D (inositol polyphosphate-5-phosphatase D), VAV2 (vav guanine nucleotide exchange factor 2), NCK1 (NCK adaptor protein 1), PTPN6 (protein tyrosine phosphatase non-receptor type 6), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), GAB2 (GRB2 associated binding protein 2), CD19 (CD19 molecule), PRKCB (protein kinase C beta), RELA (RELA proto-oncogene, NF-kB subunit), CD79A (CD79a molecule), NFKB1 (nuclear factor kappa B subunit 1), BLNK (B cell linker), MAP2K1 (mitogen-activated protein kinase kinase 1), RAC2 (Rac family small GTPase 2), CRK (CRK proto-oncogene, adaptor protein), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MYC (MYC proto-oncogene, bHLH transcription factor), CD79B (CD79b molecule), CRKL (CRK like proto-oncogene, adaptor protein), DAPP1 (dual adaptor of phosphotyrosine and 3-phosphoinositides 1), GAB1 (GRB2 associated binding protein 1), CDC42 (cell division cycle 42), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), TEC (transient erythroblastopenia of childhood), TEC (tec protein tyrosine kinase), NFKBIA (NFKB inhibitor alpha), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), GSK3B (glycogen synthase kinase 3 beta), MAPK9 (mitogen-activated protein kinase 9), HCLS1 (hematopoietic cell-specific Lyn substrate 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1), CREB1 (cAMP responsive element binding protein 1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), BLK (BLK proto-oncogene, Src family tyrosine kinase), PTPRC (protein tyrosine phosphatase receptor type C), RPS6KA1 (ribosomal protein S6 kinase A1), MAP2K6 (mitogen-activated protein kinase kinase 6), BCL10 (BCL10 immune signaling adaptor), MAP2K2 (mitogen-activated protein kinase kinase 2), PDPK1 (3-phosphoinositide dependent protein kinase 1), RAPGEF1 (Rap guanine nucleotide exchange factor 1), CD22 (CD22 molecule), REL (REL proto-oncogene, NF-kB subunit), SH3BP2 (SH3 domain binding protein 2), CARD11 (caspase recruitment domain family member 11), ETS1 (ETS proto-oncogene 1, transcription factor), MALT1 (MALT1 paracaspase), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta), NFATC2 (nuclear factor of activated T cells 2), BCL6 (BCL6 transcription repressor), ELK1 (ETS transcription factor ELK1), ATF2 (activating transcription factor 2), PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha), MAPK4 (mitogen-activated protein kinase 4), NFATC3 (nuclear factor of activated T cells 3), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), MEF2C (myocyte enhancer factor 2C), GSK3A (glycogen synthase kinase 3 alpha), PTPN18 (protein tyrosine phosphatase non-receptor type 18), FOXO1 (forkhead box O1), RASGRP3 (RAS guanyl releasing protein 3), IRF4 (interferon regulatory factor 4), CD81 (CD81 molecule), MEF2D (myocyte enhancer factor 2D), MAX (MYC associated factor X), E2F3 (E2F transcription factor 3), GTF2I (general transcription factor IIi), CR2 (complement C3d receptor 2), ILF2 (interleukin enhancer binding factor 2), KLF11 (Kruppel like factor 11), PDPK2P (3-phosphoinositide dependent protein kinase 2, pseudogene), LAT2 (linker for activation of T cells family member 2)"], "WAG002171": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), TNFRSF1A (TNF receptor superfamily member 1A), NFKB1 (nuclear factor kappa B subunit 1), TRAF2 (TNF receptor associated factor 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), AKT1 (AKT serine/threonine kinase 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), HSP90AA1 (heat shock protein 90 alpha family class A member 1), MAPK1 (mitogen-activated protein kinase 1), RIPK1 (receptor interacting serine/threonine kinase 1), TRADD (TNFRSF1A associated via death domain), CASP8 (caspase 8), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), NFKBIA (NFKB inhibitor alpha), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), CASP3 (caspase 3), BIRC3 (baculoviral IAP repeat containing 3), FADD (Fas associated via death domain), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), BIRC2 (baculoviral IAP repeat containing 2), MAPK8 (mitogen-activated protein kinase 8), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAPK3 (mitogen-activated protein kinase 3), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), PRKCZ (protein kinase C zeta), TRAF1 (TNF receptor associated factor 1), MAP2K4 (mitogen-activated protein kinase kinase 4), RAC1 (Rac family small GTPase 1), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), CFLAR (CASP8 and FADD like apoptosis regulator), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), NFKB2 (nuclear factor kappa B subunit 2), MAP2K7 (mitogen-activated protein kinase kinase 7), TNFAIP3 (TNF alpha induced protein 3), CASP9 (caspase 9), MAP2K6 (mitogen-activated protein kinase kinase 6), REL (REL proto-oncogene, NF-kB subunit), IL6 (interleukin 6), GRB2 (growth factor receptor bound protein 2), MAP2K3 (mitogen-activated protein kinase kinase 3), NFKBIB (NFKB inhibitor beta), RIPK3 (receptor interacting serine/threonine kinase 3), BCL2L1 (BCL2 like 1), BID (BH3 interacting domain death agonist), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), CREBBP (CREB binding protein), MAPK9 (mitogen-activated protein kinase 9), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), HRAS (HRas proto-oncogene, GTPase), BAX (BCL2 associated X, apoptosis regulator), TRAP1 (TNF receptor associated protein 1), PPP2CA (protein phosphatase 2 catalytic subunit alpha), CASP7 (caspase 7), TBK1 (TANK binding kinase 1), CDC37 (cell division cycle 37, HSP90 cochaperone), CUL1 (cullin 1), APAF1 (apoptotic peptidase activating factor 1), TANK (TRAF family member associated NFKB activator), DIABLO (diablo IAP-binding mitochondrial protein), SKP1 (S-phase kinase associated protein 1), TNFRSF1B (TNF receptor superfamily member 1B), NFKBIE (NFKB inhibitor epsilon), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), BAD (BCL2 associated agonist of cell death), KRAS (KRAS proto-oncogene, GTPase), NRAS (NRAS proto-oncogene, GTPase), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), FBXW11 (F-box and WD repeat domain containing 11), MAP4K2 (mitogen-activated protein kinase kinase kinase kinase 2), CSNK2A1 (casein kinase 2 alpha 1), PLK1 (polo like kinase 1), CCL2 (C-C motif chemokine ligand 2), TXN (thioredoxin), MADD (MAP kinase activating death domain), PSMD2 (proteasome 26S subunit, non-ATPase 2), KSR2 (kinase suppressor of ras 2), NSMAF (neutral sphingomyelinase activation associated factor), KSR1 (kinase suppressor of ras 1), NOX1 (NADPH oxidase 1), SELE (selectin E), CYBA (cytochrome b-245 alpha chain), RFFL (ring finger and FYVE like domain containing E3 ubiquitin protein ligase), NOXO1 (NADPH oxidase organizer 1), OTUD7B (OTU deubiquitinase 7B), SMPD2 (sphingomyelin phosphodiesterase 2), PYGL (glycogen phosphorylase L), GLUL (glutamate-ammonia ligase), RFK (riboflavin kinase), PTPRCAP (protein tyrosine phosphatase receptor type C associated protein), ALDH7A1P1 (aldehyde dehydrogenase 7 family member A1 pseudogene 1)"], "WAG002172": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), MAPK3 (mitogen-activated protein kinase 3), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RAC1 (Rac family small GTPase 1), PRKCZ (protein kinase C zeta), STAT3 (signal transducer and activator of transcription 3), EGFR (epidermal growth factor receptor), MAPK14 (mitogen-activated protein kinase 14), PRKCD (protein kinase C delta), PRKCA (protein kinase C alpha), RELA (RELA proto-oncogene, NF-kB subunit), MAPK8 (mitogen-activated protein kinase 8), NFKB1 (nuclear factor kappa B subunit 1), SHC1 (SHC adaptor protein 1), JAK2 (Janus kinase 2), SP1 (Sp1 transcription factor), CASP3 (caspase 3), NFKBIA (NFKB inhibitor alpha), IRS1 (insulin receptor substrate 1), MMP9 (matrix metallopeptidase 9), MAPK9 (mitogen-activated protein kinase 9), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), STAT1 (signal transducer and activator of transcription 1), CASP8 (caspase 8), SMAD3 (SMAD family member 3), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAP2K1 (mitogen-activated protein kinase kinase 1), RHOA (ras homolog family member A), SMAD2 (SMAD family member 2), INSR (insulin receptor), PRKCB (protein kinase C beta), CDC42 (cell division cycle 42), ROCK1 (Rho associated coiled-coil containing protein kinase 1), STAT5A (signal transducer and activator of transcription 5A), MMP2 (matrix metallopeptidase 2), NOS3 (nitric oxide synthase 3), NCF1 (neutrophil cytosolic factor 1), NOS2 (nitric oxide synthase 2), EZR (ezrin), HIF1A (hypoxia inducible factor 1 subunit alpha), STAT5B (signal transducer and activator of transcription 5B), MYD88 (MYD88 innate immune signal transduction adaptor), MSN (moesin), ATF2 (activating transcription factor 2), FOXO1 (forkhead box O1), CYCS (cytochrome c, somatic), CASP9 (caspase 9), MMP14 (matrix metallopeptidase 14), PLA2G4A (phospholipase A2 group IVA), FOXO4 (forkhead box O4), MMP13 (matrix metallopeptidase 13), ALPL (alkaline phosphatase, biomineralization associated), IRAK4 (interleukin 1 receptor associated kinase 4), INS (insulin), DIAPH1 (diaphanous related formin 1), TIRAP (TIR domain containing adaptor protein), MMP7 (matrix metallopeptidase 7), LGALS3 (galectin 3), DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit), SOD1 (superoxide dismutase 1), AGER (advanced glycosylation end-product specific receptor), INHBB (inhibin subunit beta B), MSR1 (macrophage scavenger receptor 1)"], "WAG002173": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IFNG (interferon gamma), IL2 (interleukin 2), TNF (tumor necrosis factor), IL10 (interleukin 10), IL4 (interleukin 4), TGFB1 (transforming growth factor beta 1), IL2RA (interleukin 2 receptor subunit alpha), CD86 (CD86 molecule), STAT1 (signal transducer and activator of transcription 1), CD40 (CD40 molecule), FASLG (Fas ligand), CD80 (CD80 molecule), C3 (complement C3), CD28 (CD28 molecule), GZMB (granzyme B), CASP3 (caspase 3), C5 (complement C5), CXCL9 (C-X-C motif chemokine ligand 9), IL1B (interleukin 1 beta), IL13 (interleukin 13), CD40LG (CD40 ligand), VEGFA (vascular endothelial growth factor A), PRF1 (perforin 1), CTLA4 (cytotoxic T-lymphocyte associated protein 4), CXCL12 (C-X-C motif chemokine ligand 12), FOXP3 (forkhead box P3), CASP8 (caspase 8), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), C4A (complement C4A (Rodgers blood group)), FAS (Fas cell surface death receptor), IL1A (interleukin 1 alpha), IL17A (interleukin 17A), IL5 (interleukin 5), HLA-C (major histocompatibility complex, class I, C), IL12B (interleukin 12B), HLA-A (major histocompatibility complex, class I, A), IL12A (interleukin 12A), PRKCZ (protein kinase C zeta), CXCL11 (C-X-C motif chemokine ligand 11), HLA-B (major histocompatibility complex, class I, B), CXCL13 (C-X-C motif chemokine ligand 13), CASP7 (caspase 7), CXCR5 (C-X-C motif chemokine receptor 5), CCL19 (C-C motif chemokine ligand 19), CCL21 (C-C motif chemokine ligand 21), CASP9 (caspase 9), C2 (complement C2), C7 (complement C7), VIM (vimentin), C6 (complement C6), HLA-G (major histocompatibility complex, class I, G), HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1), C4B (complement C4B (Chido blood group)), HLA-DRA (major histocompatibility complex, class II, DR alpha), C8A (complement C8 alpha chain), C1QB (complement C1q B chain), C9 (complement C9), HLA-E (major histocompatibility complex, class I, E), C1QA (complement C1q A chain), HLA-DMB (major histocompatibility complex, class II, DM beta), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), HLA-F (major histocompatibility complex, class I, F), C8B (complement C8 beta chain), IL21 (interleukin 21), C1QC (complement C1q C chain), HLA-DMA (major histocompatibility complex, class II, DM alpha), CD55 (CD55 molecule (Cromer blood group)), GNLY (granulysin), IL22 (interleukin 22), PDGFRA (platelet derived growth factor receptor alpha), HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1), LRRK2 (leucine rich repeat kinase 2), ABCB1 (ATP binding cassette subfamily B member 1), HLA-DQA2 (major histocompatibility complex, class II, DQ alpha 2), MICA (MHC class I polypeptide-related sequence A), GDNF (glial cell derived neurotrophic factor), HLA-DPB1 (major histocompatibility complex, class II, DP beta 1), HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1), CSNK2A2 (casein kinase 2 alpha 2), AGTR1 (angiotensin II receptor type 1), HLA-DOA (major histocompatibility complex, class II, DO alpha), HLA-DOB (major histocompatibility complex, class II, DO beta), COL5A1 (collagen type V alpha 1 chain), CXCL8 (C-X-C motif chemokine ligand 8), TRB (T cell receptor beta locus), TUBA1B (tubulin alpha 1b), TRA (T cell receptor alpha locus), LOC110384692 (complement C4A (Rodgers blood group)-like), HLA-DRB3 (major histocompatibility complex, class II, DR beta 3), HLA-DRB4 (major histocompatibility complex, class II, DR beta 4), HARS1 (histidyl-tRNA synthetase 1), GABPA (GA binding protein transcription factor subunit alpha), PECR (peroxisomal trans-2-enoyl-CoA reductase), BHMT2 (betaine--homocysteine S-methyltransferase 2)"], "WAG002174": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT3 (signal transducer and activator of transcription 3), AKT1 (AKT serine/threonine kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), GRB2 (growth factor receptor bound protein 2), STAT1 (signal transducer and activator of transcription 1), RELA (RELA proto-oncogene, NF-kB subunit), HRAS (HRas proto-oncogene, GTPase), FYN (FYN proto-oncogene, Src family tyrosine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), IL6ST (interleukin 6 signal transducer), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SOCS3 (suppressor of cytokine signaling 3), TYK2 (tyrosine kinase 2), BCL2 (BCL2 apoptosis regulator), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CREB1 (cAMP responsive element binding protein 1), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), RPS6KA1 (ribosomal protein S6 kinase A1), TGFB1 (transforming growth factor beta 1), RPS6KB1 (ribosomal protein S6 kinase B1), PIAS1 (protein inhibitor of activated STAT 1), PDPK1 (3-phosphoinositide dependent protein kinase 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), ICAM1 (intercellular adhesion molecule 1), FES (FES proto-oncogene, tyrosine kinase), IL11 (interleukin 11), RUNX2 (RUNX family transcription factor 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K2 (mitogen-activated protein kinase kinase 2), PIAS3 (protein inhibitor of activated STAT 3), IL11RA (interleukin 11 receptor subunit alpha), BIRC5 (baculoviral IAP repeat containing 5), RPS6 (ribosomal protein S6), BGLAP (bone gamma-carboxyglutamate protein), IBSP (integrin binding sialoprotein), ITGA2 (integrin subunit alpha 2), ATF1 (activating transcription factor 1), PTPA (protein phosphatase 2 phosphatase activator)"], "WAG002177": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), MAPK3 (mitogen-activated protein kinase 3), MAPK14 (mitogen-activated protein kinase 14), MAPK8 (mitogen-activated protein kinase 8), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), NFKB1 (nuclear factor kappa B subunit 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), IL2 (interleukin 2), RELA (RELA proto-oncogene, NF-kB subunit), PLCG1 (phospholipase C gamma 1), PRKCA (protein kinase C alpha), PRKCD (protein kinase C delta), BCL2 (BCL2 apoptosis regulator), CTNNB1 (catenin beta 1), MAP2K1 (mitogen-activated protein kinase kinase 1), SP1 (Sp1 transcription factor), CASP3 (caspase 3), CREB1 (cAMP responsive element binding protein 1), GNAI2 (G protein subunit alpha i2), GNAI1 (G protein subunit alpha i1), RHOA (ras homolog family member A), MAPK9 (mitogen-activated protein kinase 9), TGFB1 (transforming growth factor beta 1), GNB1 (G protein subunit beta 1), PRKCB (protein kinase C beta), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), NFKBIA (NFKB inhibitor alpha), ARRB2 (arrestin beta 2), GNAO1 (G protein subunit alpha o1), POMC (proopiomelanocortin), ARRB1 (arrestin beta 1), NR4A1 (nuclear receptor subfamily 4 group A member 1), PTK2 (protein tyrosine kinase 2), GSK3B (glycogen synthase kinase 3 beta), GNAZ (G protein subunit alpha z), GNAS (GNAS complex locus), NOS3 (nitric oxide synthase 3), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PRKCQ (protein kinase C theta), PARP1 (poly(ADP-ribose) polymerase 1), IL18 (interleukin 18), CRH (corticotropin releasing hormone), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), PLCG2 (phospholipase C gamma 2), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), GJA1 (gap junction protein alpha 1), FOSL1 (FOS like 1, AP-1 transcription factor subunit), TLR4 (toll like receptor 4), GNB2 (G protein subunit beta 2), ELK1 (ETS transcription factor ELK1), GRK6 (G protein-coupled receptor kinase 6), RAP1B (RAP1B, member of RAS oncogene family), PRKCI (protein kinase C iota), GNAQ (G protein subunit alpha q), IVL (involucrin), CRHR1 (corticotropin releasing hormone receptor 1), GNA11 (G protein subunit alpha 11), CASP9 (caspase 9), GNB5 (G protein subunit beta 5), FOSL2 (FOS like 2, AP-1 transcription factor subunit), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), NCOA2 (nuclear receptor coactivator 2), CYP11A1 (cytochrome P450 family 11 subfamily A member 1), NR4A2 (nuclear receptor subfamily 4 group A member 2), CYP11B1 (cytochrome P450 family 11 subfamily B member 1), TRIM28 (tripartite motif containing 28), TFAP2A (transcription factor AP-2 alpha), TCF4 (transcription factor 4), STAR (steroidogenic acute regulatory protein), CYP21A2 (cytochrome P450 family 21 subfamily A member 2), CRHR2 (corticotropin releasing hormone receptor 2), HSD3B2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2), RAPGEF3 (Rap guanine nucleotide exchange factor 3), SULT2A1 (sulfotransferase family 2A member 1), JUP (junction plakoglobin), GNB3 (G protein subunit beta 3), ERN1 (endoplasmic reticulum to nucleus signaling 1), KRT1 (keratin 1), ACACA (acetyl-CoA carboxylase alpha), CRHBP (corticotropin releasing hormone binding protein), KRT14 (keratin 14), TBX19 (T-box transcription factor 19), CACNA1H (calcium voltage-gated channel subunit alpha1 H), CXCL8 (C-X-C motif chemokine ligand 8), LINC02210-CRHR1 (LINC02210-CRHR1 readthrough), CASP12 (caspase 12 (gene/pseudogene)), GRK3 (G protein-coupled receptor kinase 3), ECE1 (endothelin converting enzyme 1)"], "WAG002178": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CUL1 (cullin 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD4 (proteasome 26S subunit, non-ATPase 4), HSPA8 (heat shock protein family A (Hsp70) member 8), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD9 (proteasome 26S subunit, non-ATPase 9), SNCA (synuclein alpha), HSPA4 (heat shock protein family A (Hsp70) member 4), TUBA4A (tubulin alpha 4a), SIAH1 (siah E3 ubiquitin protein ligase 1), TUBA1A (tubulin alpha 1a), STUB1 (STIP1 homology and U-box containing protein 1), TUBA1B (tubulin alpha 1b), UBA1 (ubiquitin like modifier activating enzyme 1), HSPA5 (heat shock protein family A (Hsp70) member 5), TUBB1 (tubulin beta 1 class VI), TUBB4B (tubulin beta 4B class IVb), TUBA1C (tubulin alpha 1c), UBE2L3 (ubiquitin conjugating enzyme E2 L3), UBE2L6 (ubiquitin conjugating enzyme E2 L6), TUBB4A (tubulin beta 4A class IVa), TUBB2A (tubulin beta 2A class IIa), SNCAIP (synuclein alpha interacting protein), TUBB (tubulin beta class I), HSPA1B (heat shock protein family A (Hsp70) member 1B), UBE2G2 (ubiquitin conjugating enzyme E2 G2), HSPA9 (heat shock protein family A (Hsp70) member 9), GPR37 (G protein-coupled receptor 37), CASP1 (caspase 1), CCNE1 (cyclin E1), TUBB6 (tubulin beta 6 class V), TUBB2B (tubulin beta 2B class IIb), TUBAL3 (tubulin alpha like 3), TUBA3E (tubulin alpha 3e), SIAH2 (siah E3 ubiquitin protein ligase 2), RNF19A (ring finger protein 19A, RBR E3 ubiquitin protein ligase), TUBB3 (tubulin beta 3 class III), CASP8 (caspase 8), UBE2G1 (ubiquitin conjugating enzyme E2 G1), FBXW7 (F-box and WD repeat domain containing 7), UBE2J2 (ubiquitin conjugating enzyme E2 J2), CASK (calcium/calmodulin dependent serine protein kinase), HSPA6 (heat shock protein family A (Hsp70) member 6), TUBA8 (tubulin alpha 8), TUBA3D (tubulin alpha 3d), HSPA1L (heat shock protein family A (Hsp70) member 1 like), HSPA14 (heat shock protein family A (Hsp70) member 14), UBE2J1 (ubiquitin conjugating enzyme E2 J1), HSPA2 (heat shock protein family A (Hsp70) member 2), TUBB8 (tubulin beta 8 class VIII), TUBB7P (tubulin beta 7 pseudogene), HSPA1A (heat shock protein family A (Hsp70) member 1A), PRKN (parkin RBR E3 ubiquitin protein ligase), TUBA3C (tubulin alpha 3c), SEPTIN5 (septin 5), TUBA4B (tubulin alpha 4b)"], "WAG002179": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPARG (peroxisome proliferator activated receptor gamma), RXRA (retinoid X receptor alpha), SP1 (Sp1 transcription factor), NCOA1 (nuclear receptor coactivator 1), NCOA2 (nuclear receptor coactivator 2), TNF (tumor necrosis factor), STAT3 (signal transducer and activator of transcription 3), TGFB1 (transforming growth factor beta 1), PPARGC1A (PPARG coactivator 1 alpha), IL6 (interleukin 6), PPARA (peroxisome proliferator activated receptor alpha), CEBPB (CCAAT enhancer binding protein beta), NCOR2 (nuclear receptor corepressor 2), LEP (leptin), SMAD3 (SMAD family member 3), NR3C1 (nuclear receptor subfamily 3 group C member 1), IGF1 (insulin like growth factor 1), RARA (retinoic acid receptor alpha), CDKN1A (cyclin dependent kinase inhibitor 1A), HIF1A (hypoxia inducible factor 1 subunit alpha), CTNNB1 (catenin beta 1), CEBPD (CCAAT enhancer binding protein delta), LPL (lipoprotein lipase), SOCS3 (suppressor of cytokine signaling 3), RB1 (RB transcriptional corepressor 1), ADIPOQ (adiponectin, C1Q and collagen domain containing), PPARD (peroxisome proliferator activated receptor delta), E2F1 (E2F transcription factor 1), STAT5A (signal transducer and activator of transcription 5A), STAT1 (signal transducer and activator of transcription 1), IRS1 (insulin receptor substrate 1), FOXO1 (forkhead box O1), SREBF1 (sterol regulatory element binding transcription factor 1), NRIP1 (nuclear receptor interacting protein 1), CREB1 (cAMP responsive element binding protein 1), RORA (RAR related orphan receptor A), WNT1 (Wnt family member 1), SOCS1 (suppressor of cytokine signaling 1), SERPINE1 (serpin family E member 1), NCOR1 (nuclear receptor corepressor 1), RXRG (retinoid X receptor gamma), WNT10B (Wnt family member 10B), STAT5B (signal transducer and activator of transcription 5B), EBF1 (EBF transcription factor 1), AHR (aryl hydrocarbon receptor), SLC2A4 (solute carrier family 2 member 4), KLF5 (Kruppel like factor 5), STAT6 (signal transducer and activator of transcription 6), CEBPA (CCAAT enhancer binding protein alpha), MEF2C (myocyte enhancer factor 2C), IL6ST (interleukin 6 signal transducer), EGR2 (early growth response 2), NR1H3 (nuclear receptor subfamily 1 group H member 3), OSM (oncostatin M), RETN (resistin), IRS2 (insulin receptor substrate 2), NR2F1 (nuclear receptor subfamily 2 group F member 1), LIF (LIF interleukin 6 family cytokine), BMP2 (bone morphogenetic protein 2), E2F4 (E2F transcription factor 4), EPAS1 (endothelial PAS domain protein 1), PLIN1 (perilipin 1), UCP1 (uncoupling protein 1), PRLR (prolactin receptor), GATA4 (GATA binding protein 4), RBL1 (RB transcriptional corepressor like 1), LIFR (LIF receptor subunit alpha), HNF1A (HNF1 homeobox A), PCK1 (phosphoenolpyruvate carboxykinase 1), HMGA1 (high mobility group AT-hook 1), GADD45A (growth arrest and DNA damage inducible alpha), STAT2 (signal transducer and activator of transcription 2), BMP4 (bone morphogenetic protein 4), MEF2A (myocyte enhancer factor 2A), DDIT3 (DNA damage inducible transcript 3), GADD45B (growth arrest and DNA damage inducible beta), GH1 (growth hormone 1), MEF2D (myocyte enhancer factor 2D), LMNA (lamin A/C), PLIN2 (perilipin 2), FZD1 (frizzled class receptor 1), GATA2 (GATA binding protein 2), CNTFR (ciliary neurotrophic factor receptor), WWTR1 (WW domain containing transcription regulator 1), GATA3 (GATA binding protein 3), KLF6 (Kruppel like factor 6), FAS (Fas cell surface death receptor), NDN (necdin, MAGE family member), AGT (angiotensinogen), RBL2 (RB transcriptional corepressor like 2), LIPE (lipase E, hormone sensitive type), SCD (stearoyl-CoA desaturase), TRIB3 (tribbles pseudokinase 3), DVL1 (dishevelled segment polarity protein 1), INS (insulin), LPIN1 (lipin 1), ID3 (inhibitor of DNA binding 3, HLH protein), SFRP4 (secreted frizzled related protein 4), PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial), CFD (complement factor D)"], "WAG002180": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TOP2A (DNA topoisomerase II alpha), CENPF (centromere protein F), UBE2C (ubiquitin conjugating enzyme E2 C), TPX2 (TPX2 microtubule nucleation factor), MCM4 (minichromosome maintenance complex component 4), ECT2 (epithelial cell transforming 2), KIF15 (kinesin family member 15), MYBL2 (MYB proto-oncogene like 2), RUVBL1 (RuvB like AAA ATPase 1), KIF20B (kinesin family member 20B), ACTL6A (actin like 6A), CCNA1 (cyclin A1), E2F7 (E2F transcription factor 7), INO80D (INO80 complex subunit D), LIN9 (lin-9 DREAM MuvB core complex component), NUP107 (nucleoporin 107), RNF216 (ring finger protein 216), APC (APC regulator of WNT signaling pathway), NOTCH1 (notch receptor 1), SMOC2 (SPARC related modular calcium binding 2), H4-16 (H4 histone 16), S100P (S100 calcium binding protein P), GATD3A (glutamine amidotransferase like class 1 domain containing 3A), CASTOR3 (CASTOR family member 3), ESM1 (endothelial cell specific molecule 1), CEP192 (centrosomal protein 192), ERVK-6 (endogenous retrovirus group K member 6, envelope), AURKA (aurora kinase A), H3-3A (H3.3 histone A), GATD3B (glutamine amidotransferase like class 1 domain containing 3B)"], "WAG002181": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RFC4 (replication factor C subunit 4), RFC3 (replication factor C subunit 3), MYC (MYC proto-oncogene, bHLH transcription factor), TP53 (tumor protein p53), TOP2A (DNA topoisomerase II alpha), UBE2T (ubiquitin conjugating enzyme E2 T), DSCC1 (DNA replication and sister chromatid cohesion 1), FANCI (FA complementation group I), ATAD2 (ATPase family AAA domain containing 2), CHTF18 (chromosome transmission fidelity factor 18), CTNNB1 (catenin beta 1), RAD17 (RAD17 checkpoint clamp loader component), UBE2C (ubiquitin conjugating enzyme E2 C), BRIX1 (biogenesis of ribosomes BRX1), CHTF8 (chromosome transmission fidelity factor 8), CACYBP (calcyclin binding protein), CEBPZ (CCAAT enhancer binding protein zeta), EGFR (epidermal growth factor receptor), OTUD5 (OTU deubiquitinase 5), S100A6 (S100 calcium binding protein A6), RNF144B (ring finger protein 144B), LMNB2 (lamin B2), COL9A3 (collagen type IX alpha 3 chain), SNURF (SNRPN upstream reading frame), LBR (lamin B receptor), CD48 (CD48 molecule), MTDH (metadherin), COL9A1 (collagen type IX alpha 1 chain), AHCTF1 (AT-hook containing transcription factor 1), FAM91A1 (family with sequence similarity 91 member A1), MIRLET7E (microRNA let-7e), PLAC8 (placenta associated 8)"], "WAG002185": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), STAT3 (signal transducer and activator of transcription 3), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), JAK2 (Janus kinase 2), JAK1 (Janus kinase 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK14 (mitogen-activated protein kinase 14), TP53 (tumor protein p53), SHC1 (SHC adaptor protein 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), HRAS (HRas proto-oncogene, GTPase), PRKCD (protein kinase C delta), MAPK8 (mitogen-activated protein kinase 8), GRB2 (growth factor receptor bound protein 2), VEGFA (vascular endothelial growth factor A), JAK3 (Janus kinase 3), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), STAT1 (signal transducer and activator of transcription 1), PRKCA (protein kinase C alpha), MAP2K1 (mitogen-activated protein kinase kinase 1), IRS1 (insulin receptor substrate 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PTK2B (protein tyrosine kinase 2 beta), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), RELA (RELA proto-oncogene, NF-kB subunit), TYK2 (tyrosine kinase 2), SOCS3 (suppressor of cytokine signaling 3), NFKB1 (nuclear factor kappa B subunit 1), MTOR (mechanistic target of rapamycin kinase), MAPK9 (mitogen-activated protein kinase 9), KRAS (KRAS proto-oncogene, GTPase), IL6ST (interleukin 6 signal transducer), PXN (paxillin), PRKCE (protein kinase C epsilon), NFKBIA (NFKB inhibitor alpha), OSM (oncostatin M), STAT5B (signal transducer and activator of transcription 5B), CREB1 (cAMP responsive element binding protein 1), CASP3 (caspase 3), PRKCB (protein kinase C beta), MMP1 (matrix metallopeptidase 1), HIF1A (hypoxia inducible factor 1 subunit alpha), EGR1 (early growth response 1), CEBPB (CCAAT enhancer binding protein beta), CCL2 (C-C motif chemokine ligand 2), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), MAP2K2 (mitogen-activated protein kinase kinase 2), CDKN1B (cyclin dependent kinase inhibitor 1B), PRKCH (protein kinase C eta), LIFR (LIF receptor subunit alpha), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), CDK2 (cyclin dependent kinase 2), MMP3 (matrix metallopeptidase 3), OSMR (oncostatin M receptor), SERPINE1 (serpin family E member 1), MMP13 (matrix metallopeptidase 13), PIAS3 (protein inhibitor of activated STAT 3), RPS6 (ribosomal protein S6), TIMP3 (TIMP metallopeptidase inhibitor 3), RICTOR (RPTOR independent companion of MTOR complex 2), CASP7 (caspase 7), LDLR (low density lipoprotein receptor), CCN1 (cellular communication network factor 1)"], "WAG002186": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), MAPK3 (mitogen-activated protein kinase 3), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), RAC1 (Rac family small GTPase 1), MAPK14 (mitogen-activated protein kinase 14), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), NGF (nerve growth factor), HRAS (HRas proto-oncogene, GTPase), MAPK8 (mitogen-activated protein kinase 8), SHC1 (SHC adaptor protein 1), JAK2 (Janus kinase 2), PRKCD (protein kinase C delta), CTNNB1 (catenin beta 1), TRAF6 (TNF receptor associated factor 6), PTPN11 (protein tyrosine phosphatase non-receptor type 11), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PLCG1 (phospholipase C gamma 1), IRS1 (insulin receptor substrate 1), RELA (RELA proto-oncogene, NF-kB subunit), CDC42 (cell division cycle 42), PPP2CA (protein phosphatase 2 catalytic subunit alpha), STAT3 (signal transducer and activator of transcription 3), MAP2K1 (mitogen-activated protein kinase kinase 1), MTOR (mechanistic target of rapamycin kinase), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), BDNF (brain derived neurotrophic factor), NTRK2 (neurotrophic receptor tyrosine kinase 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), NGFR (nerve growth factor receptor), NFKB1 (nuclear factor kappa B subunit 1), NTRK1 (neurotrophic receptor tyrosine kinase 1), MAPK9 (mitogen-activated protein kinase 9), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), GSK3B (glycogen synthase kinase 3 beta), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), SQSTM1 (sequestosome 1), RPS6KB1 (ribosomal protein S6 kinase B1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), CREB1 (cAMP responsive element binding protein 1), IRS2 (insulin receptor substrate 2), NTRK3 (neurotrophic receptor tyrosine kinase 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), NFKBIA (NFKB inhibitor alpha), MAPK10 (mitogen-activated protein kinase 10), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), STAT1 (signal transducer and activator of transcription 1), CASP3 (caspase 3), RPS6KA1 (ribosomal protein S6 kinase A1), CSNK2A1 (casein kinase 2 alpha 1), PTK2B (protein tyrosine kinase 2 beta), SHC2 (SHC adaptor protein 2), FRS2 (fibroblast growth factor receptor substrate 2), VAV2 (vav guanine nucleotide exchange factor 2), RPS6KA3 (ribosomal protein S6 kinase A3), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), NCK1 (NCK adaptor protein 1), MAP2K2 (mitogen-activated protein kinase kinase 2), BAD (BCL2 associated agonist of cell death), CDK5 (cyclin dependent kinase 5), MAPT (microtubule associated protein tau), NTF3 (neurotrophin 3), RAP1A (RAP1A, member of RAS oncogene family), EGR1 (early growth response 1), MAPK7 (mitogen-activated protein kinase 7), SHC3 (SHC adaptor protein 3), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), TSC2 (TSC complex subunit 2), CDH2 (cadherin 2), PDPK1 (3-phosphoinositide dependent protein kinase 1), STAT5A (signal transducer and activator of transcription 5A), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), BCL2L11 (BCL2 like 11), MAP2K5 (mitogen-activated protein kinase kinase 5), TIAM1 (TIAM Rac1 associated GEF 1), SYN1 (synapsin I), ELK1 (ETS transcription factor ELK1), RPS6KA5 (ribosomal protein S6 kinase A5), STAT5B (signal transducer and activator of transcription 5B), RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1), MEF2C (myocyte enhancer factor 2C), EIF4E (eukaryotic translation initiation factor 4E), RPS6 (ribosomal protein S6), MEF2A (myocyte enhancer factor 2A), VAV3 (vav guanine nucleotide exchange factor 3), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), NCF1 (neutrophil cytosolic factor 1), CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1), SH2B2 (SH2B adaptor protein 2), MAP3K2 (mitogen-activated protein kinase kinase kinase 2), FRS3 (fibroblast growth factor receptor substrate 3), PTPRF (protein tyrosine phosphatase receptor type F), YBX1 (Y-box binding protein 1), NFATC4 (nuclear factor of activated T cells 4), RHOG (ras homolog family member G), SH2B1 (SH2B adaptor protein 1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)"], "WAG002188": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BMP4 (bone morphogenetic protein 4), GATA4 (GATA binding protein 4), FGF2 (fibroblast growth factor 2), NOG (noggin), TGFB1 (transforming growth factor beta 1), NKX2-5 (NK2 homeobox 5), IGF1 (insulin like growth factor 1), MYL2 (myosin light chain 2), MEF2C (myocyte enhancer factor 2C), NANOG (Nanog homeobox), NOTCH1 (notch receptor 1), SOX2 (SRY-box transcription factor 2), TBX5 (T-box transcription factor 5), PDGFRA (platelet derived growth factor receptor alpha), SOX17 (SRY-box transcription factor 17), MYH6 (myosin heavy chain 6), WNT3A (Wnt family member 3A), POU5F1 (POU class 5 homeobox 1), ISL1 (ISL LIM homeobox 1), MAPK14 (mitogen-activated protein kinase 14), PAX6 (paired box 6), KDR (kinase insert domain receptor), GSK3B (glycogen synthase kinase 3 beta), TNNI3 (troponin I3, cardiac type), ACTC1 (actin alpha cardiac muscle 1), TNNT2 (troponin T2, cardiac type), CXCR4 (C-X-C motif chemokine receptor 4), KIT (KIT proto-oncogene, receptor tyrosine kinase), IGF2 (insulin like growth factor 2), TBX20 (T-box transcription factor 20), NODAL (nodal growth differentiation factor), SOX1 (SRY-box transcription factor 1), FOXA2 (forkhead box A2), NCAM1 (neural cell adhesion molecule 1), BMP1 (bone morphogenetic protein 1), INHBA (inhibin subunit beta A), SIRPA (signal regulatory protein alpha), DKK1 (dickkopf WNT signaling pathway inhibitor 1), INS (insulin), MYLK3 (myosin light chain kinase 3), ZFP42 (ZFP42 zinc finger protein), ANPEP (alanyl aminopeptidase, membrane), NRG1 (neuregulin 1), LIN28A (lin-28 homolog A), MESP2 (mesoderm posterior bHLH transcription factor 2), THY1 (Thy-1 cell surface antigen), MESP1 (mesoderm posterior bHLH transcription factor 1), ROR2 (receptor tyrosine kinase like orphan receptor 2), MIXL1 (Mix paired-like homeobox), IRX4 (iroquois homeobox 4), TBXT (T-box transcription factor T), LIN28B (lin-28 homolog B), SCN5A (sodium voltage-gated channel alpha subunit 5)"], "WAG002189": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), SHMT1 (serine hydroxymethyltransferase 1), SHMT2 (serine hydroxymethyltransferase 2), AMT (aminomethyltransferase), GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase), MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase), FTCD (formimidoyltransferase cyclodeaminase), DHFR (dihydrofolate reductase), MTHFD1L (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like), ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase), MTHFR (methylenetetrahydrofolate reductase), TYMS (thymidylate synthetase), ALDH1L1 (aldehyde dehydrogenase 1 family member L1), MAT1A (methionine adenosyltransferase 1A), AHCY (adenosylhomocysteinase), MTFMT (mitochondrial methionyl-tRNA formyltransferase), DNMT1 (DNA methyltransferase 1), AHCYL2 (adenosylhomocysteinase like 2), BHMT (betaine--homocysteine S-methyltransferase), MTHFS (methenyltetrahydrofolate synthetase), DNMT3B (DNA methyltransferase 3 beta), DNMT3A (DNA methyltransferase 3 alpha), MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), TCN2 (transcobalamin 2), CHDH (choline dehydrogenase), FOLH1 (folate hydrolase 1), GLRX (glutaredoxin), MAT2B (methionine adenosyltransferase 2B), FOLH1B (folate hydrolase 1B)"], "WAG002190": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), TP53 (tumor protein p53), TNF (tumor necrosis factor), IL6 (interleukin 6), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), MAPK3 (mitogen-activated protein kinase 3), TGFB1 (transforming growth factor beta 1), IL1B (interleukin 1 beta), EGFR (epidermal growth factor receptor), CCND1 (cyclin D1), RAC1 (Rac family small GTPase 1), PTGS2 (prostaglandin-endoperoxide synthase 2), MYC (MYC proto-oncogene, bHLH transcription factor), PRKCA (protein kinase C alpha), ICAM1 (intercellular adhesion molecule 1), IFNG (interferon gamma), MMP9 (matrix metallopeptidase 9), CASP3 (caspase 3), CDK2 (cyclin dependent kinase 2), CDC42 (cell division cycle 42), CCL2 (C-C motif chemokine ligand 2), IL4 (interleukin 4), IL2 (interleukin 2), NGFR (nerve growth factor receptor), CDK1 (cyclin dependent kinase 1), TLR4 (toll like receptor 4), NOS2 (nitric oxide synthase 2), CDKN1B (cyclin dependent kinase inhibitor 1B), BDNF (brain derived neurotrophic factor), IL1A (interleukin 1 alpha), RB1 (RB transcriptional corepressor 1), RHOA (ras homolog family member A), CDK4 (cyclin dependent kinase 4), EGR1 (early growth response 1), CXCL10 (C-X-C motif chemokine ligand 10), LEP (leptin), CXCL1 (C-X-C motif chemokine ligand 1), MBP (myelin basic protein), VIM (vimentin), E2F1 (E2F transcription factor 1), VCAN (versican), ANXA1 (annexin A1), CXCL2 (C-X-C motif chemokine ligand 2), GFAP (glial fibrillary acidic protein), GADD45A (growth arrest and DNA damage inducible alpha), GJA1 (gap junction protein alpha 1), PLA2G2A (phospholipase A2 group IIA), E2F5 (E2F transcription factor 5), PLA2G6 (phospholipase A2 group VI), MAG (myelin associated glycoprotein), ROCK2 (Rho associated coiled-coil containing protein kinase 2), PPP3CA (protein phosphatase 3 catalytic subunit alpha), NOS1 (nitric oxide synthase 1), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), LGALS3 (galectin 3), CCR2 (C-C motif chemokine receptor 2), NR4A1 (nuclear receptor subfamily 4 group A member 1), SELP (selectin P), RTN4 (reticulon 4), IL1R1 (interleukin 1 receptor type 1), BTG2 (BTG anti-proliferation factor 2), ARG1 (arginase 1), PDYN (prodynorphin), FOXO3 (forkhead box O3), NCAN (neurocan), SLIT2 (slit guidance ligand 2), BCAN (brevican), CSPG4 (chondroitin sulfate proteoglycan 4), COL2A1 (collagen type II alpha 1 chain), CCNG1 (cyclin G1), TNFSF13B (TNF superfamily member 13b), C5 (complement C5), EFNB2 (ephrin B2), PLA2G5 (phospholipase A2 group V), RTN4R (reticulon 4 receptor), ZFP36 (ZFP36 ring finger protein), RHOB (ras homolog family member B), COL4A1 (collagen type IV alpha 1 chain), PTPRZ1 (protein tyrosine phosphatase receptor type Z1), CHST11 (carbohydrate sulfotransferase 11), TACR1 (tachykinin receptor 1), MIF (macrophage migration inhibitory factor), GAP43 (growth associated protein 43), OMG (oligodendrocyte myelin glycoprotein), NTN1 (netrin 1), GDNF (glial cell derived neurotrophic factor), AQP4 (aquaporin 4), FCGR2A (Fc fragment of IgG receptor IIa), FKBP1A (FKBP prolyl isomerase 1A), NOX4 (NADPH oxidase 4), PTPRA (protein tyrosine phosphatase receptor type A), ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase), SOX9 (SRY-box transcription factor 9), EPHA4 (EPH receptor A4), APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1), SLIT1 (slit guidance ligand 1), PLXNA2 (plexin A2), LTB4R (leukotriene B4 receptor), XYLT1 (xylosyltransferase 1), RHOC (ras homolog family member C)"], "WAG002193": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), ITGB4 (integrin subunit beta 4), SHC1 (SHC adaptor protein 1), PRKCA (protein kinase C alpha), HRAS (HRas proto-oncogene, GTPase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), ITGA6 (integrin subunit alpha 6), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), PTK2 (protein tyrosine kinase 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), RAC1 (Rac family small GTPase 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), IRS1 (insulin receptor substrate 1), PRKCD (protein kinase C delta), IRS2 (insulin receptor substrate 2), MTOR (mechanistic target of rapamycin kinase), RHOA (ras homolog family member A), LAMA1 (laminin subunit alpha 1), GAB1 (GRB2 associated binding protein 1), LAMB2 (laminin subunit beta 2), LAMC1 (laminin subunit gamma 1), LAMB1 (laminin subunit beta 1), LAMA5 (laminin subunit alpha 5), LAMC2 (laminin subunit gamma 2), MAPK14 (mitogen-activated protein kinase 14), LAMB3 (laminin subunit beta 3), LAMA3 (laminin subunit alpha 3), LAMA2 (laminin subunit alpha 2), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1)"], "WAG002194": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PCNA (proliferating cell nuclear antigen), CDK2 (cyclin dependent kinase 2), CDK1 (cyclin dependent kinase 1), CCNA2 (cyclin A2), MCM3 (minichromosome maintenance complex component 3), RB1 (RB transcriptional corepressor 1), POLA1 (DNA polymerase alpha 1, catalytic subunit), CCNB1 (cyclin B1), RRM2 (ribonucleotide reductase regulatory subunit M2), MCM4 (minichromosome maintenance complex component 4), CHEK1 (checkpoint kinase 1), TP53 (tumor protein p53), MCM7 (minichromosome maintenance complex component 7), MYC (MYC proto-oncogene, bHLH transcription factor), MCM6 (minichromosome maintenance complex component 6), RFC4 (replication factor C subunit 4), CDK4 (cyclin dependent kinase 4), TOP2A (DNA topoisomerase II alpha), CDC45 (cell division cycle 45), ORC1 (origin recognition complex subunit 1), CDT1 (chromatin licensing and DNA replication factor 1), CCNE1 (cyclin E1), E2F1 (E2F transcription factor 1), CDKN1A (cyclin dependent kinase inhibitor 1A), CDC25A (cell division cycle 25A), CDC7 (cell division cycle 7), TFDP1 (transcription factor Dp-1), HDAC1 (histone deacetylase 1), PRIM1 (DNA primase subunit 1), RPA1 (replication protein A1), CCNE2 (cyclin E2), RFC5 (replication factor C subunit 5), TYMS (thymidylate synthetase), RFC3 (replication factor C subunit 3), SMC2 (structural maintenance of chromosomes 2), CCND1 (cyclin D1), RRM1 (ribonucleotide reductase catalytic subunit M1), E2F3 (E2F transcription factor 3), SKP2 (S-phase kinase associated protein 2), POLE2 (DNA polymerase epsilon 2, accessory subunit), RPA2 (replication protein A2), CCNB2 (cyclin B2), TTK (TTK protein kinase), CDKN1B (cyclin dependent kinase inhibitor 1B), RBBP4 (RB binding protein 4, chromatin remodeling factor), RPA3 (replication protein A3), POLE (DNA polymerase epsilon, catalytic subunit), E2F2 (E2F transcription factor 2), CDK6 (cyclin dependent kinase 6), TFDP2 (transcription factor Dp-2), DNMT1 (DNA methyltransferase 1), CCND3 (cyclin D3), MSH6 (mutS homolog 6), PLK4 (polo like kinase 4), MDM2 (MDM2 proto-oncogene), KIF4A (kinesin family member 4A), DHFR (dihydrofolate reductase), ANLN (anillin actin binding protein), SMC1A (structural maintenance of chromosomes 1A), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), SUV39H1 (suppressor of variegation 3-9 homolog 1), WEE1 (WEE1 G2 checkpoint kinase), PRKDC (protein kinase, DNA-activated, catalytic subunit), HMGB2 (high mobility group box 2), SMC3 (structural maintenance of chromosomes 3), CDC25B (cell division cycle 25B), POLD3 (DNA polymerase delta 3, accessory subunit), BARD1 (BRCA1 associated RING domain 1), SIN3A (SIN3 transcription regulator family member A), SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2), RBBP7 (RB binding protein 7, chromatin remodeling factor), FANCG (FA complementation group G), HMGB1 (high mobility group box 1), STMN1 (stathmin 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SAP30 (Sin3A associated protein 30), RBP1 (retinol binding protein 1), HLTF (helicase like transcription factor), MAPK13 (mitogen-activated protein kinase 13), DCK (deoxycytidine kinase), PRMT2 (protein arginine methyltransferase 2), NPAT (nuclear protein, coactivator of histone transcription), CCDC6 (coiled-coil domain containing 6), FAF1 (Fas associated factor 1), ZNF655 (zinc finger protein 655), RABIF (RAB interacting factor), MIR29B1 (microRNA 29b-1), MIR21 (microRNA 21), MIR29B2 (microRNA 29b-2), H2AZ1 (H2A.Z variant histone 1)"], "WAG002195": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP3 (caspase 3), BCL2 (BCL2 apoptosis regulator), TNF (tumor necrosis factor), TP53 (tumor protein p53), BAX (BCL2 associated X, apoptosis regulator), BID (BH3 interacting domain death agonist), SOD1 (superoxide dismutase 1), CASP9 (caspase 9), BCL2L1 (BCL2 like 1), APAF1 (apoptotic peptidase activating factor 1), BAD (BCL2 associated agonist of cell death), TNFRSF1A (TNF receptor superfamily member 1A), RAC1 (Rac family small GTPase 1), MAPK14 (mitogen-activated protein kinase 14), CASP1 (caspase 1), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PPP3CC (protein phosphatase 3 catalytic subunit gamma), MAP2K6 (mitogen-activated protein kinase kinase 6), DAXX (death domain associated protein), CAT (catalase), GPX1 (glutathione peroxidase 1), PPP3CB (protein phosphatase 3 catalytic subunit beta), NEFH (neurofilament heavy), NEFL (neurofilament light), MAP2K2 (mitogen-activated protein kinase kinase 2), NEFM (neurofilament medium), ALS2 (alsin Rho guanine nucleotide exchange factor ALS2), SLC1A2 (solute carrier family 1 member 2), PRPH (peripherin), TOMM40 (translocase of outer mitochondrial membrane 40), NOS1 (nitric oxide synthase 1), CCS (copper chaperone for superoxide dismutase), RAB5A (RAB5A, member RAS oncogene family), DERL1 (derlin 1), CASP12 (caspase 12 (gene/pseudogene)), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), CST3 (cystatin C)"], "WAG002197": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GAPDH (glyceraldehyde-3-phosphate dehydrogenase), TPI1 (triosephosphate isomerase 1), GPD1 (glycerol-3-phosphate dehydrogenase 1), LDHA (lactate dehydrogenase A), HIF1A (hypoxia inducible factor 1 subunit alpha), SLC2A1 (solute carrier family 2 member 1), PPARG (peroxisome proliferator activated receptor gamma), GPAT3 (glycerol-3-phosphate acyltransferase 3)"], "WAG002199": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KYNU (kynureninase), KMO (kynurenine 3-monooxygenase), TDO2 (tryptophan 2,3-dioxygenase), AFMID (arylformamidase), HAAO (3-hydroxyanthranilate 3,4-dioxygenase), QPRT (quinolinate phosphoribosyltransferase), NMNAT1 (nicotinamide nucleotide adenylyltransferase 1), NADSYN1 (NAD synthetase 1)"], "WAG002202": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP3 (caspase 3), CASP8 (caspase 8), BCL2 (BCL2 apoptosis regulator), APAF1 (apoptotic peptidase activating factor 1), CASP9 (caspase 9), BAX (BCL2 associated X, apoptosis regulator), CASP7 (caspase 7), DIABLO (diablo IAP-binding mitochondrial protein), BID (BH3 interacting domain death agonist), CYCS (cytochrome c, somatic), FASLG (Fas ligand), FADD (Fas associated via death domain), FAS (Fas cell surface death receptor), CFLAR (CASP8 and FADD like apoptosis regulator), CASP6 (caspase 6), AIFM1 (apoptosis inducing factor mitochondria associated 1), ENDOG (endonuclease G), BAK1 (BCL2 antagonist/killer 1), HTRA2 (HtrA serine peptidase 2), PRF1 (perforin 1)"], "WAG002203": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BECN1 (beclin 1), ATG12 (autophagy related 12), ATG5 (autophagy related 5), ATG3 (autophagy related 3), ATG7 (autophagy related 7), ULK1 (unc-51 like autophagy activating kinase 1), AMBRA1 (autophagy and beclin 1 regulator 1), ATG16L1 (autophagy related 16 like 1), UVRAG (UV radiation resistance associated), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), ATG10 (autophagy related 10), ATG14 (autophagy related 14), BCL2 (BCL2 apoptosis regulator), SH3GLB1 (SH3 domain containing GRB2 like, endophilin B1), ULK2 (unc-51 like autophagy activating kinase 2), TSC1 (TSC complex subunit 1), INSR (insulin receptor), ATG4A (autophagy related 4A cysteine peptidase), TSC2 (TSC complex subunit 2), INS (insulin), VMP1 (vacuole membrane protein 1), CHAF1A (chromatin assembly factor 1 subunit A), ATG9B (autophagy related 9B)"], "WAG002204": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CUL1 (cullin 1), CCND1 (cyclin D1), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), UBB (ubiquitin B), PSMC6 (proteasome 26S subunit, ATPase 6), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA7 (proteasome 20S subunit alpha 7), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA3 (proteasome 20S subunit alpha 3), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMC3 (proteasome 26S subunit, ATPase 3), SKP1 (S-phase kinase associated protein 1), PSMA2 (proteasome 20S subunit alpha 2), PSMA6 (proteasome 20S subunit alpha 6), PSMB4 (proteasome 20S subunit beta 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA4 (proteasome 20S subunit alpha 4), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB1 (proteasome 20S subunit beta 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMA1 (proteasome 20S subunit alpha 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB5 (proteasome 20S subunit beta 5), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA5 (proteasome 20S subunit alpha 5), PSMB10 (proteasome 20S subunit beta 10), PSME3 (proteasome activator subunit 3), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSME4 (proteasome activator subunit 4), PSMA8 (proteasome 20S subunit alpha 8), PSMB2 (proteasome 20S subunit beta 2), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMB7 (proteasome 20S subunit beta 7), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSME1 (proteasome activator subunit 1), PSMB11 (proteasome subunit beta 11), MYC (MYC proto-oncogene, bHLH transcription factor), PSMB9 (proteasome 20S subunit beta 9), AKT1 (AKT serine/threonine kinase 1), PSMB8 (proteasome 20S subunit beta 8), PSME2 (proteasome activator subunit 2), NFKB1 (nuclear factor kappa B subunit 1), MAPK1 (mitogen-activated protein kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MDM2 (MDM2 proto-oncogene), MAPK3 (mitogen-activated protein kinase 3), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RAC1 (Rac family small GTPase 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), ERBB2 (erb-b2 receptor tyrosine kinase 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), CASP3 (caspase 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), NFKB2 (nuclear factor kappa B subunit 2), JAK2 (Janus kinase 2), EGF (epidermal growth factor), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), BIRC2 (baculoviral IAP repeat containing 2), IGF1 (insulin like growth factor 1), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), MAP2K1 (mitogen-activated protein kinase kinase 1), TRAF2 (TNF receptor associated factor 2), IRS1 (insulin receptor substrate 1), CBL (Cbl proto-oncogene), BIRC3 (baculoviral IAP repeat containing 3), PAK1 (p21 (RAC1) activated kinase 1), MTOR (mechanistic target of rapamycin kinase), KDR (kinase insert domain receptor), CASP9 (caspase 9), RIPK1 (receptor interacting serine/threonine kinase 1), RELB (RELB proto-oncogene, NF-kB subunit), CRK (CRK proto-oncogene, adaptor protein), ITGAV (integrin subunit alpha V), MYD88 (MYD88 innate immune signal transduction adaptor), RAP1A (RAP1A, member of RAS oncogene family), RIPK3 (receptor interacting serine/threonine kinase 3), CSK (C-terminal Src kinase), FBXW11 (F-box and WD repeat domain containing 11), REL (REL proto-oncogene, NF-kB subunit), BRAF (B-Raf proto-oncogene, serine/threonine kinase), UBE2M (ubiquitin conjugating enzyme E2 M), FAS (Fas cell surface death receptor), MAP2K2 (mitogen-activated protein kinase kinase 2), ARF6 (ADP ribosylation factor 6), APAF1 (apoptotic peptidase activating factor 1), CASP6 (caspase 6), RPS27A (ribosomal protein S27a)"], "WAG002205": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RIPK1 (receptor interacting serine/threonine kinase 1), FADD (Fas associated via death domain), CASP8 (caspase 8), TNFRSF1A (TNF receptor superfamily member 1A), TNF (tumor necrosis factor), TRADD (TNFRSF1A associated via death domain), RIPK3 (receptor interacting serine/threonine kinase 3), MAPK8 (mitogen-activated protein kinase 8), PARP1 (poly(ADP-ribose) polymerase 1), TICAM1 (toll like receptor adaptor molecule 1), PLA2G4A (phospholipase A2 group IVA), FTL (ferritin light chain)"], "WAG002206": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATM (ATM serine/threonine kinase), TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), CHEK1 (checkpoint kinase 1), CHEK2 (checkpoint kinase 2), MDM2 (MDM2 proto-oncogene), CDK2 (cyclin dependent kinase 2), CDK1 (cyclin dependent kinase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), RAD51 (RAD51 recombinase), CCNB1 (cyclin B1), MDC1 (mediator of DNA damage checkpoint 1), TP73 (tumor protein p73), RAD50 (RAD50 double strand break repair protein), CCNE1 (cyclin E1), CDC25A (cell division cycle 25A), NBN (nibrin), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TP53BP1 (tumor protein p53 binding protein 1), CDC25C (cell division cycle 25C), MDM4 (MDM4 regulator of p53), RAD9A (RAD9 checkpoint clamp component A), FANCD2 (FA complementation group D2), SMC1A (structural maintenance of chromosomes 1A), GADD45A (growth arrest and DNA damage inducible alpha), CREB1 (cAMP responsive element binding protein 1), ATF2 (activating transcription factor 2), RIPK1 (receptor interacting serine/threonine kinase 1), NFKBIA (NFKB inhibitor alpha), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), BID (BH3 interacting domain death agonist), CASP2 (caspase 2), MAPK9 (mitogen-activated protein kinase 9), CRADD (CASP2 and RIPK1 domain containing adaptor with death domain), TLK1 (tousled like kinase 1), AP3B2 (adaptor related protein complex 3 subunit beta 2), PIDD1 (p53-induced death domain protein 1), MRE11 (MRE11 homolog, double strand break repair nuclease), H2AX (H2A.X variant histone)"], "WAG002208": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), RAC1 (Rac family small GTPase 1), MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), MAPK3 (mitogen-activated protein kinase 3), HRAS (HRas proto-oncogene, GTPase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PLCG1 (phospholipase C gamma 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), STAT3 (signal transducer and activator of transcription 3), PDGFRB (platelet derived growth factor receptor beta), PTPN11 (protein tyrosine phosphatase non-receptor type 11), VAV1 (vav guanine nucleotide exchange factor 1), SHC1 (SHC adaptor protein 1), JAK1 (Janus kinase 1), MAPK8 (mitogen-activated protein kinase 8), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), PAK1 (p21 (RAC1) activated kinase 1), PDGFB (platelet derived growth factor subunit B), CDC42 (cell division cycle 42), RASA1 (RAS p21 protein activator 1), RHOA (ras homolog family member A), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), NFKB1 (nuclear factor kappa B subunit 1), STAT1 (signal transducer and activator of transcription 1), VAV2 (vav guanine nucleotide exchange factor 2), NFKBIA (NFKB inhibitor alpha), MAP2K4 (mitogen-activated protein kinase kinase 4), ELK1 (ETS transcription factor ELK1), SRF (serum response factor), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TIAM1 (TIAM Rac1 associated GEF 1), PDGFA (platelet derived growth factor subunit A), WASL (WASP like actin nucleation promoting factor), PLA2G4A (phospholipase A2 group IVA), ARFIP2 (ADP ribosylation factor interacting protein 2), COX2 (cytochrome c oxidase subunit II)"], "WAG002209": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase), PTDSS1 (phosphatidylserine synthase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), CEPT1 (choline/ethanolamine phosphotransferase 1), CDS2 (CDP-diacylglycerol synthase 2), PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), GPD1 (glycerol-3-phosphate dehydrogenase 1), PLA2G2A (phospholipase A2 group IIA), PGS1 (phosphatidylglycerophosphate synthase 1), PCYT2 (phosphate cytidylyltransferase 2, ethanolamine), CRLS1 (cardiolipin synthase 1), CHPT1 (choline phosphotransferase 1), GNPAT (glyceronephosphate O-acyltransferase), PEMT (phosphatidylethanolamine N-methyltransferase), PI4K2A (phosphatidylinositol 4-kinase type 2 alpha), AGPS (alkylglycerone phosphate synthase), GK (glycerol kinase), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), CHKB (choline kinase beta), GPAT2 (glycerol-3-phosphate acyltransferase 2, mitochondrial), LPIN2 (lipin 2), LPIN1 (lipin 1), GPAT3 (glycerol-3-phosphate acyltransferase 3), IPMK (inositol polyphosphate multikinase), PTPMT1 (protein tyrosine phosphatase mitochondrial 1), GPAT4 (glycerol-3-phosphate acyltransferase 4), MOGAT3 (monoacylglycerol O-acyltransferase 3)"], "WAG002212": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP3 (caspase 3), CASP8 (caspase 8), TP53 (tumor protein p53), TNF (tumor necrosis factor), BCL2 (BCL2 apoptosis regulator), TNFRSF1A (TNF receptor superfamily member 1A), AKT1 (AKT serine/threonine kinase 1), BIRC3 (baculoviral IAP repeat containing 3), RELA (RELA proto-oncogene, NF-kB subunit), TRADD (TNFRSF1A associated via death domain), FADD (Fas associated via death domain), BAX (BCL2 associated X, apoptosis regulator), TRAF2 (TNF receptor associated factor 2), RIPK1 (receptor interacting serine/threonine kinase 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), NFKB1 (nuclear factor kappa B subunit 1), FASLG (Fas ligand), BID (BH3 interacting domain death agonist), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CASP9 (caspase 9), BCL2L1 (BCL2 like 1), BIRC2 (baculoviral IAP repeat containing 2), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CFLAR (CASP8 and FADD like apoptosis regulator), APAF1 (apoptotic peptidase activating factor 1), CASP10 (caspase 10), FAS (Fas cell surface death receptor), CASP7 (caspase 7), XIAP (X-linked inhibitor of apoptosis), CASP2 (caspase 2), TRAF1 (TNF receptor associated factor 1), TNFSF10 (TNF superfamily member 10), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TNFRSF10B (TNF receptor superfamily member 10b), MYC (MYC proto-oncogene, bHLH transcription factor), MCL1 (MCL1 apoptosis regulator, BCL2 family member), DIABLO (diablo IAP-binding mitochondrial protein), TRAF3 (TNF receptor associated factor 3), CYCS (cytochrome c, somatic), NFKBIA (NFKB inhibitor alpha), CASP6 (caspase 6), BIRC5 (baculoviral IAP repeat containing 5), CASP1 (caspase 1), BCL2L11 (BCL2 like 11), MDM2 (MDM2 proto-oncogene), BAD (BCL2 associated agonist of cell death), DFFA (DNA fragmentation factor subunit alpha), CRADD (CASP2 and RIPK1 domain containing adaptor with death domain), IRF3 (interferon regulatory factor 3), IRF1 (interferon regulatory factor 1), INS-IGF2 (INS-IGF2 readthrough), BCL2L2 (BCL2 like 2), IGF1 (insulin like growth factor 1), GZMB (granzyme B), MAP2K4 (mitogen-activated protein kinase kinase 4), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), TNFRSF1B (TNF receptor superfamily member 1B), BAK1 (BCL2 antagonist/killer 1), TP63 (tumor protein p63), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), CASP4 (caspase 4), CDKN2A (cyclin dependent kinase inhibitor 2A), BBC3 (BCL2 binding component 3), IRF7 (interferon regulatory factor 7), MAPK10 (mitogen-activated protein kinase 10), TP73 (tumor protein p73), NFKBIB (NFKB inhibitor beta), IGF1R (insulin like growth factor 1 receptor), IRF2 (interferon regulatory factor 2), IRF5 (interferon regulatory factor 5), HRK (harakiri, BCL2 interacting protein), NFKBIE (NFKB inhibitor epsilon), TNFRSF25 (TNF receptor superfamily member 25), IRF6 (interferon regulatory factor 6), IRF4 (interferon regulatory factor 4), DFFB (DNA fragmentation factor subunit beta), BNIP3L (BCL2 interacting protein 3 like), PRF1 (perforin 1), IGF2 (insulin like growth factor 2), LTA (lymphotoxin alpha), TNFRSF21 (TNF receptor superfamily member 21), BOK (BCL2 family apoptosis regulator BOK), HELLS (helicase, lymphoid specific), SCAF11 (SR-related CTD associated factor 11), MIR29B2 (microRNA 29b-2), MIR29B1 (microRNA 29b-1), MIR29A (microRNA 29a)"], "WAG002215": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), CCND1 (cyclin D1), MAPK3 (mitogen-activated protein kinase 3), GSK3B (glycogen synthase kinase 3 beta), MYC (MYC proto-oncogene, bHLH transcription factor), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CTNNB1 (catenin beta 1), TSC2 (TSC complex subunit 2), MTOR (mechanistic target of rapamycin kinase), EGF (epidermal growth factor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), TNF (tumor necrosis factor), IGF1 (insulin like growth factor 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), TSC1 (TSC complex subunit 1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), BRAF (B-Raf proto-oncogene, serine/threonine kinase), STK11 (serine/threonine kinase 11), RHEB (Ras homolog, mTORC1 binding), PKD1 (polycystin 1, transient receptor potential channel interacting), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), SLC12A2 (solute carrier family 12 member 2), PKD2 (polycystin 2, transient receptor potential cation channel), KCNN4 (potassium calcium-activated channel subfamily N member 4), VEGFB (vascular endothelial growth factor B), SFRP4 (secreted frizzled related protein 4)"], "WAG002216": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), ITGB1 (integrin subunit beta 1), ITGAV (integrin subunit alpha V), FYN (FYN proto-oncogene, Src family tyrosine kinase), ITGB4 (integrin subunit beta 4), ACTN4 (actinin alpha 4), TLN1 (talin 1), CTNNB1 (catenin beta 1), ITGA3 (integrin subunit alpha 3), PTK2 (protein tyrosine kinase 2), ITGB3 (integrin subunit beta 3), NPHS2 (NPHS2 stomatin family member, podocin), TGFB1 (transforming growth factor beta 1), DAG1 (dystroglycan 1), PLCG1 (phospholipase C gamma 1), NCK1 (NCK adaptor protein 1), VCL (vinculin), NPHS1 (NPHS1 adhesion molecule, nephrin), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), ILK (integrin linked kinase), CD2AP (CD2 associated protein), CDKN1A (cyclin dependent kinase inhibitor 1A), LAMA5 (laminin subunit alpha 5), VIM (vimentin), LAMB2 (laminin subunit beta 2), PARVA (parvin alpha), PLAUR (plasminogen activator, urokinase receptor), CDKN1B (cyclin dependent kinase inhibitor 1B), NOTCH1 (notch receptor 1), COL4A4 (collagen type IV alpha 4 chain), CDH2 (cadherin 2), COL4A5 (collagen type IV alpha 5 chain), CD151 (CD151 molecule (Raph blood group)), COL4A3 (collagen type IV alpha 3 chain), TRPC6 (transient receptor potential cation channel subfamily C member 6), PCNA (proliferating cell nuclear antigen), MME (membrane metalloendopeptidase), VTN (vitronectin), DNM1 (dynamin 1), WT1 (WT1 transcription factor), PLCE1 (phospholipase C epsilon 1), WNT1 (Wnt family member 1), SYNPO (synaptopodin), LIMS1 (LIM zinc finger domain containing 1), LRP5 (LDL receptor related protein 5), LRP6 (LDL receptor related protein 6), JAG1 (jagged canonical Notch ligand 1), DKK1 (dickkopf WNT signaling pathway inhibitor 1), INF2 (inverted formin 2), PTPRO (protein tyrosine phosphatase receptor type O), CDKN1C (cyclin dependent kinase inhibitor 1C), SCARB2 (scavenger receptor class B member 2), MYH9 (myosin heavy chain 9), KIRREL3 (kirre like nephrin family adhesion molecule 3), TLR4 (toll like receptor 4), CAMK2B (calcium/calmodulin dependent protein kinase II beta), KIRREL2 (kirre like nephrin family adhesion molecule 2), PAX2 (paired box 2), CD80 (CD80 molecule), MKI67 (marker of proliferation Ki-67), UTRN (utrophin), KRT8 (keratin 8), LMX1B (LIM homeobox transcription factor 1 beta), IRF6 (interferon regulatory factor 6), AGRN (agrin), FAT1 (FAT atypical cadherin 1), MYO1E (myosin IE), PODXL (podocalyxin like), CTSL (cathepsin L), CR1 (complement C3b/C4b receptor 1 (Knops blood group)), CLDN1 (claudin 1), SMARCAL1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1)"], "WAG002219": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), ESR1 (estrogen receptor 1), EP300 (E1A binding protein p300), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MYC (MYC proto-oncogene, bHLH transcription factor), HSP90AA1 (heat shock protein 90 alpha family class A member 1), VEGFA (vascular endothelial growth factor A), AHR (aryl hydrocarbon receptor), EGFR (epidermal growth factor receptor), CDKN1A (cyclin dependent kinase inhibitor 1A), NCOR2 (nuclear receptor corepressor 2), ARNT (aryl hydrocarbon receptor nuclear translocator), NFKB1 (nuclear factor kappa B subunit 1), TNF (tumor necrosis factor), HRAS (HRas proto-oncogene, GTPase), PTGS2 (prostaglandin-endoperoxide synthase 2), RB1 (RB transcriptional corepressor 1), RELA (RELA proto-oncogene, NF-kB subunit), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), E2F1 (E2F transcription factor 1), CDK2 (cyclin dependent kinase 2), NFE2L2 (nuclear factor, erythroid 2 like 2), NRAS (NRAS proto-oncogene, GTPase), KRAS (KRAS proto-oncogene, GTPase), CDKN1B (cyclin dependent kinase inhibitor 1B), RET (ret proto-oncogene), NRIP1 (nuclear receptor interacting protein 1), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), CYP1B1 (cytochrome P450 family 1 subfamily B member 1), CD36 (CD36 molecule), CDC37 (cell division cycle 37, HSP90 cochaperone), NQO1 (NAD(P)H quinone dehydrogenase 1), AIP (aryl hydrocarbon receptor interacting protein), LPL (lipoprotein lipase), NCOA7 (nuclear receptor coactivator 7), NF1 (neurofibromin 1), HPGDS (hematopoietic prostaglandin D synthase), CYP1A2 (cytochrome P450 family 1 subfamily A member 2), GCLC (glutamate-cysteine ligase catalytic subunit), AHRR (aryl-hydrocarbon receptor repressor), FGF21 (fibroblast growth factor 21), KLF6 (Kruppel like factor 6), PLAGL1 (PLAG1 like zinc finger 1), CCL1 (C-C motif chemokine ligand 1), PSRC1 (proline and serine rich coiled-coil 1)"], "WAG002221": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), STAT3 (signal transducer and activator of transcription 3), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), EGFR (epidermal growth factor receptor), JAK2 (Janus kinase 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK3 (mitogen-activated protein kinase 3), JAK1 (Janus kinase 1), IRS1 (insulin receptor substrate 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), ESR1 (estrogen receptor 1), SHC1 (SHC adaptor protein 1), IGF1 (insulin like growth factor 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), MAPK14 (mitogen-activated protein kinase 14), EGF (epidermal growth factor), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), FYN (FYN proto-oncogene, Src family tyrosine kinase), IGF1R (insulin like growth factor 1 receptor), RAC1 (Rac family small GTPase 1), MYC (MYC proto-oncogene, bHLH transcription factor), CBL (Cbl proto-oncogene), MTOR (mechanistic target of rapamycin kinase), CCND1 (cyclin D1), MAPK8 (mitogen-activated protein kinase 8), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), IRS2 (insulin receptor substrate 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PTK2 (protein tyrosine kinase 2), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), PTPN6 (protein tyrosine phosphatase non-receptor type 6), MAP2K1 (mitogen-activated protein kinase kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), VAV1 (vav guanine nucleotide exchange factor 1), NFKB1 (nuclear factor kappa B subunit 1), STAT5A (signal transducer and activator of transcription 5A), STAT1 (signal transducer and activator of transcription 1), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), CDC42 (cell division cycle 42), PXN (paxillin), PRL (prolactin), RPS6KB1 (ribosomal protein S6 kinase B1), GSK3B (glycogen synthase kinase 3 beta), PTPN1 (protein tyrosine phosphatase non-receptor type 1), VAV2 (vav guanine nucleotide exchange factor 2), STAT5B (signal transducer and activator of transcription 5B), SOCS3 (suppressor of cytokine signaling 3), RHOA (ras homolog family member A), MAPK9 (mitogen-activated protein kinase 9), BCL2L1 (BCL2 like 1), CREB1 (cAMP responsive element binding protein 1), PAK1 (p21 (RAC1) activated kinase 1), GHR (growth hormone receptor), SP1 (Sp1 transcription factor), FLNA (filamin A), MDM2 (MDM2 proto-oncogene), IL1B (interleukin 1 beta), ITGB1 (integrin subunit beta 1), TEC (transient erythroblastopenia of childhood), TEC (tec protein tyrosine kinase), FOXO1 (forkhead box O1), RPS6KA1 (ribosomal protein S6 kinase A1), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), BAX (BCL2 associated X, apoptosis regulator), NOS3 (nitric oxide synthase 3), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), LEPR (leptin receptor), KHDRBS1 (KH RNA binding domain containing, signal transduction associated 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAP2K2 (mitogen-activated protein kinase kinase 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), SOCS2 (suppressor of cytokine signaling 2), ROCK1 (Rho associated coiled-coil containing protein kinase 1), BAD (BCL2 associated agonist of cell death), NCOA1 (nuclear receptor coactivator 1), CISH (cytokine inducible SH2 containing protein), IRF1 (interferon regulatory factor 1), ELK1 (ETS transcription factor ELK1), PDK1 (pyruvate dehydrogenase kinase 1), ROCK2 (Rho associated coiled-coil containing protein kinase 2), PIAS3 (protein inhibitor of activated STAT 3), TIMP1 (TIMP metallopeptidase inhibitor 1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), IGF2 (insulin like growth factor 2), EIF4E (eukaryotic translation initiation factor 4E), SIRPA (signal regulatory protein alpha), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), ACACA (acetyl-CoA carboxylase alpha), PPIA (peptidylprolyl isomerase A), SH2B1 (SH2B adaptor protein 1), GSK3A (glycogen synthase kinase 3 alpha), ACACB (acetyl-CoA carboxylase beta), TWIST1 (twist family bHLH transcription factor 1), AGAP2 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2), NEK3 (NIMA related kinase 3)"], "WAG002226": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PRKCA (protein kinase C alpha), MAPK1 (mitogen-activated protein kinase 1), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), MAPK3 (mitogen-activated protein kinase 3), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKACB (protein kinase cAMP-activated catalytic subunit beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PRKCB (protein kinase C beta), PRKCG (protein kinase C gamma), PPP1CC (protein phosphatase 1 catalytic subunit gamma), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), CREB1 (cAMP responsive element binding protein 1), ADCY8 (adenylate cyclase 8), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), ADCY1 (adenylate cyclase 1), ARAF (A-Raf proto-oncogene, serine/threonine kinase), PPP1CA (protein phosphatase 1 catalytic subunit alpha), GRIA4 (glutamate ionotropic receptor AMPA type subunit 4), MAP2K1 (mitogen-activated protein kinase kinase 1), ACTB (actin beta), RAP1A (RAP1A, member of RAS oncogene family), GNAS (GNAS complex locus), RAP1B (RAP1B, member of RAS oncogene family), MAP2K2 (mitogen-activated protein kinase kinase 2), DRD1 (dopamine receptor D1), GNAI1 (G protein subunit alpha i1), ACTG1 (actin gamma 1), GRM1 (glutamate metabotropic receptor 1), DRD2 (dopamine receptor D2), GRM5 (glutamate metabotropic receptor 5), PPP1R1A (protein phosphatase 1 regulatory inhibitor subunit 1A), PPP1CB (protein phosphatase 1 catalytic subunit beta), GRIA3 (glutamate ionotropic receptor AMPA type subunit 3), DRD4 (dopamine receptor D4), CAMK4 (calcium/calmodulin dependent protein kinase IV), GJB1 (gap junction protein beta 1), ACTG2 (actin gamma 2, smooth muscle), CALM1 (calmodulin 1)"], "WAG002227": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), MAPK14 (mitogen-activated protein kinase 14), MAPK1 (mitogen-activated protein kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAPK3 (mitogen-activated protein kinase 3), IRAK1 (interleukin 1 receptor associated kinase 1), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAPK8 (mitogen-activated protein kinase 8), MAPK11 (mitogen-activated protein kinase 11), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K4 (mitogen-activated protein kinase kinase 4), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), MAP2K6 (mitogen-activated protein kinase kinase 6), IL1A (interleukin 1 alpha), MYD88 (MYD88 innate immune signal transduction adaptor), MAP2K1 (mitogen-activated protein kinase kinase 1), MAP2K3 (mitogen-activated protein kinase kinase 3), NFKBIA (NFKB inhibitor alpha), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IRAK2 (interleukin 1 receptor associated kinase 2), IL1R1 (interleukin 1 receptor type 1), IRAK4 (interleukin 1 receptor associated kinase 4), MAPK10 (mitogen-activated protein kinase 10), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), MAPK9 (mitogen-activated protein kinase 9), MAP2K7 (mitogen-activated protein kinase kinase 7), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), MAP2K2 (mitogen-activated protein kinase kinase 2), ATF2 (activating transcription factor 2), ELK1 (ETS transcription factor ELK1), RPS6KA5 (ribosomal protein S6 kinase A5), MBP (myelin basic protein), TOLLIP (toll interacting protein), IL1RAP (interleukin 1 receptor accessory protein), NFKBIB (NFKB inhibitor beta), MKNK1 (MAPK interacting serine/threonine kinase 1), MAPKAPK2 (MAPK activated protein kinase 2), MKNK2 (MAPK interacting serine/threonine kinase 2), IRF7 (interferon regulatory factor 7), TANK (TRAF family member associated NFKB activator), EIF4E (eukaryotic translation initiation factor 4E), SAFB (scaffold attachment factor B)"], "WAG002233": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLK1 (polo like kinase 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), MAPRE1 (microtubule associated protein RP/EB family member 1), CKAP5 (cytoskeleton associated protein 5), CLASP1 (cytoplasmic linker associated protein 1), NDE1 (nudE neurodevelopment protein 1), CDK1 (cyclin dependent kinase 1), NEK2 (NIMA related kinase 2), BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), PLK4 (polo like kinase 4), NDC80 (NDC80 kinetochore complex component), AURKB (aurora kinase B), BIRC5 (baculoviral IAP repeat containing 5), BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B), KNTC1 (kinetochore associated 1), CDC20 (cell division cycle 20), CENPF (centromere protein F), CENPE (centromere protein E), PPP1CC (protein phosphatase 1 catalytic subunit gamma), KIF18A (kinesin family member 18A), CDCA8 (cell division cycle associated 8), NUF2 (NUF2 component of NDC80 kinetochore complex), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), KIF2C (kinesin family member 2C), CENPA (centromere protein A), ZWILCH (zwilch kinetochore protein), SPC25 (SPC25 component of NDC80 kinetochore complex), CENPN (centromere protein N), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), ZWINT (ZW10 interacting kinetochore protein), CENPK (centromere protein K), CENPH (centromere protein H), SKA1 (spindle and kinetochore associated complex subunit 1), TUBG1 (tubulin gamma 1), ZW10 (zw10 kinetochore protein), INCENP (inner centromere protein), BUB3 (BUB3 mitotic checkpoint protein), DSN1 (DSN1 component of MIS12 kinetochore complex), HAUS2 (HAUS augmin like complex subunit 2), NDEL1 (nudE neurodevelopment protein 1 like 1), CENPM (centromere protein M), DCTN2 (dynactin subunit 2), CSNK1D (casein kinase 1 delta), CLASP2 (cytoplasmic linker associated protein 2), XPO1 (exportin 1), SPC24 (SPC24 component of NDC80 kinetochore complex), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), ERCC6L (ERCC excision repair 6 like, spindle assembly checkpoint helicase), CSNK1E (casein kinase 1 epsilon), CLIP1 (CAP-Gly domain containing linker protein 1), NUP37 (nucleoporin 37), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), CENPI (centromere protein I), AKAP9 (A-kinase anchoring protein 9), MIS12 (MIS12 kinetochore complex component), MAD1L1 (mitotic arrest deficient 1 like 1), KIF2A (kinesin family member 2A), CENPJ (centromere protein J), PCNT (pericentrin), CENPQ (centromere protein Q), NINL (ninein like), CDK5RAP2 (CDK5 regulatory subunit associated protein 2), NUP85 (nucleoporin 85), NEDD1 (NEDD1 gamma-tubulin ring complex targeting factor), NUP107 (nucleoporin 107), CENPP (centromere protein P), DCTN3 (dynactin subunit 3), NSL1 (NSL1 component of MIS12 kinetochore complex), RANGAP1 (Ran GTPase activating protein 1), CEP290 (centrosomal protein 290), OFD1 (OFD1 centriole and centriolar satellite protein), CEP63 (centrosomal protein 63), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), CETN2 (centrin 2), CCP110 (centriolar coiled-coil protein 110), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), CEP135 (centrosomal protein 135), CEP72 (centrosomal protein 72), CENPO (centromere protein O), CEP152 (centrosomal protein 152), NUDC (nuclear distribution C, dynein complex regulator), CEP250 (centrosomal protein 250), CENPL (centromere protein L), NUP43 (nucleoporin 43), SSNA1 (SS nuclear autoantigen 1), CENPT (centromere protein T), CNTRL (centriolin), ODF2 (outer dense fiber of sperm tails 2), SFI1 (SFI1 centrin binding protein), CEP57 (centrosomal protein 57), CEP76 (centrosomal protein 76), CEP164 (centrosomal protein 164), SDCCAG8 (SHH signaling and ciliogenesis regulator SDCCAG8), CEP78 (centrosomal protein 78), CEP70 (centrosomal protein 70), CEP41 (centrosomal protein 41), NUP133 (nucleoporin 133), NUP160 (nucleoporin 160), TAOK1 (TAO kinase 1)"], "WAG002234": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), EGFR (epidermal growth factor receptor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MAPK1 (mitogen-activated protein kinase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), MAPK3 (mitogen-activated protein kinase 3), AKT2 (AKT serine/threonine kinase 2), PDGFRB (platelet derived growth factor receptor beta), MET (MET proto-oncogene, receptor tyrosine kinase), ERBB2 (erb-b2 receptor tyrosine kinase 2), EGF (epidermal growth factor), LCK (LCK proto-oncogene, Src family tyrosine kinase), RAC1 (Rac family small GTPase 1), MTOR (mechanistic target of rapamycin kinase), ESR1 (estrogen receptor 1), PTEN (phosphatase and tensin homolog), GAB1 (GRB2 associated binding protein 1), PDGFRA (platelet derived growth factor receptor alpha), IRS1 (insulin receptor substrate 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), TRAF6 (TNF receptor associated factor 6), VAV1 (vav guanine nucleotide exchange factor 1), AKT3 (AKT serine/threonine kinase 3), FGF1 (fibroblast growth factor 1), PPP2CA (protein phosphatase 2 catalytic subunit alpha), GAB2 (GRB2 associated binding protein 2), IRS2 (insulin receptor substrate 2), FRS2 (fibroblast growth factor receptor substrate 2), INSR (insulin receptor), KIT (KIT proto-oncogene, receptor tyrosine kinase), PDPK1 (3-phosphoinositide dependent protein kinase 1), GSK3B (glycogen synthase kinase 3 beta), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), MDM2 (MDM2 proto-oncogene), FGFR4 (fibroblast growth factor receptor 4), FGF9 (fibroblast growth factor 9), FGF6 (fibroblast growth factor 6), FGF2 (fibroblast growth factor 2), TSC2 (TSC complex subunit 2), CDKN1A (cyclin dependent kinase inhibitor 1A), FOXO1 (forkhead box O1), FGF10 (fibroblast growth factor 10), FGF23 (fibroblast growth factor 23), FGF19 (fibroblast growth factor 19), FGF4 (fibroblast growth factor 4), PDGFB (platelet derived growth factor subunit B), CDKN1B (cyclin dependent kinase inhibitor 1B), FGF20 (fibroblast growth factor 20), FGF16 (fibroblast growth factor 16), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), HGF (hepatocyte growth factor), PPP2CB (protein phosphatase 2 catalytic subunit beta), FGF18 (fibroblast growth factor 18), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), CD19 (CD19 molecule), RAC2 (Rac family small GTPase 2), FOXO3 (forkhead box O3), FGF3 (fibroblast growth factor 3), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), CD86 (CD86 molecule), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta), CD28 (CD28 molecule), FGF22 (fibroblast growth factor 22), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), IRAK1 (interleukin 1 receptor associated kinase 1), CREB1 (cAMP responsive element binding protein 1), PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha), RPS6KB2 (ribosomal protein S6 kinase B2), MLST8 (MTOR associated protein, LST8 homolog), CASP9 (caspase 9), MYD88 (MYD88 innate immune signal transduction adaptor), ESR2 (estrogen receptor 2), HBEGF (heparin binding EGF like growth factor), PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha), FLT3 (fms related receptor tyrosine kinase 3), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), RICTOR (RPTOR independent companion of MTOR complex 2), PIP4K2B (phosphatidylinositol-5-phosphate 4-kinase type 2 beta), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), TGFA (transforming growth factor alpha), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), PIP4K2C (phosphatidylinositol-5-phosphate 4-kinase type 2 gamma), FOXO4 (forkhead box O4), IRAK4 (interleukin 1 receptor associated kinase 4), NRG2 (neuregulin 2), INS (insulin), PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1), TRAT1 (T cell receptor associated transmembrane adaptor 1), RHOG (ras homolog family member G), EREG (epiregulin), BAD (BCL2 associated agonist of cell death), CD80 (CD80 molecule), GSK3A (glycogen synthase kinase 3 alpha)"], "WAG002235": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP85 (nucleoporin 85), NUP155 (nucleoporin 155), NUP37 (nucleoporin 37), NUP93 (nucleoporin 93), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), RAE1 (ribonucleic acid export 1), BANF1 (BAF nuclear assembly factor 1), NUP107 (nucleoporin 107), NUP153 (nucleoporin 153), NUP210 (nucleoporin 210), NUP35 (nucleoporin 35), NUP133 (nucleoporin 133), NUP205 (nucleoporin 205), NUP214 (nucleoporin 214), NUP160 (nucleoporin 160), NUP88 (nucleoporin 88), TPR (translocated promoter region, nuclear basket protein), NUP188 (nucleoporin 188), NUP50 (nucleoporin 50), AAAS (aladin WD repeat nucleoporin), NUP54 (nucleoporin 54), CDK1 (cyclin dependent kinase 1), PLK1 (polo like kinase 1), RANBP2 (RAN binding protein 2), CCNB1 (cyclin B1), POM121 (POM121 transmembrane nucleoporin), GOLGA2 (golgin A2), PPP2CA (protein phosphatase 2 catalytic subunit alpha), SMC2 (structural maintenance of chromosomes 2), CCNB2 (cyclin B2), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), MAPK1 (mitogen-activated protein kinase 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), NCAPG2 (non-SMC condensin II complex subunit G2), SMC4 (structural maintenance of chromosomes 4), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2R2D (protein phosphatase 2 regulatory subunit Bdelta), PPP2CB (protein phosphatase 2 catalytic subunit beta), PRKCB (protein kinase C beta), USO1 (USO1 vesicle transport factor), RAB1A (RAB1A, member RAS oncogene family), GORASP1 (golgi reassembly stacking protein 1), LMNB1 (lamin B1), GORASP2 (golgi reassembly stacking protein 2), SET (SET nuclear proto-oncogene), CTDNEP1 (CTD nuclear envelope phosphatase 1), PRKCA (protein kinase C alpha), VRK1 (VRK serine/threonine kinase 1), NCAPD3 (non-SMC condensin II complex subunit D3), RB1 (RB transcriptional corepressor 1), NUMA1 (nuclear mitotic apparatus protein 1), RAB2A (RAB2A, member RAS oncogene family), NCAPH2 (non-SMC condensin II complex subunit H2), MASTL (microtubule associated serine/threonine kinase like), NEK6 (NIMA related kinase 6), NEK9 (NIMA related kinase 9), EMD (emerin), RAB1B (RAB1B, member RAS oncogene family), BLZF1 (basic leucine zipper nuclear factor 1), LPIN1 (lipin 1), LEMD3 (LEM domain containing 3), NEK7 (NIMA related kinase 7), ARPP19 (cAMP regulated phosphoprotein 19), ENSA (endosulfine alpha), LEMD2 (LEM domain nuclear envelope protein 2), LPIN2 (lipin 2), LPIN3 (lipin 3), H2BC12 (H2B clustered histone 12), H2AC8 (H2A clustered histone 8), H4C11 (H4 clustered histone 11), H4C14 (H4 clustered histone 14), H2AZ1 (H2A.Z variant histone 1), H2AC18 (H2A clustered histone 18), H2BC8 (H2B clustered histone 8), H2BC17 (H2B clustered histone 17), H4C9 (H4 clustered histone 9), H2AC14 (H2A clustered histone 14), H2BS1 (H2B.S histone 1), H2AJ (H2A.J histone), H2AC7 (H2A clustered histone 7), H2BC9 (H2B clustered histone 9), H4C8 (H4 clustered histone 8), H4C5 (H4 clustered histone 5), H4C13 (H4 clustered histone 13), H4C12 (H4 clustered histone 12), H2BC15 (H2B clustered histone 15), H2BC10 (H2B clustered histone 10), H4C2 (H4 clustered histone 2), H2BC1 (H2B clustered histone 1), H2BC4 (H2B clustered histone 4), H2BC21 (H2B clustered histone 21), H4C1 (H4 clustered histone 1), KMT5A (lysine methyltransferase 5A), H2AC19 (H2A clustered histone 19), H4C6 (H4 clustered histone 6), H2AZ2 (H2A.Z variant histone 2), H2BC6 (H2B clustered histone 6), MCPH1 (microcephalin 1), H2AC6 (H2A clustered histone 6)"], "WAG002236": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HSPA5 (heat shock protein family A (Hsp70) member 5), ATF6 (activating transcription factor 6), DDIT3 (DNA damage inducible transcript 3), NFYC (nuclear transcription factor Y subunit gamma), NFYA (nuclear transcription factor Y subunit alpha), NFYB (nuclear transcription factor Y subunit beta), XBP1 (X-box binding protein 1), HSP90B1 (heat shock protein 90 beta family member 1), CALR (calreticulin), ATF4 (activating transcription factor 4)"], "WAG002238": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GHR (growth hormone receptor), JAK2 (Janus kinase 2), STAT3 (signal transducer and activator of transcription 3), STAT5A (signal transducer and activator of transcription 5A), STAT5B (signal transducer and activator of transcription 5B), SOCS3 (suppressor of cytokine signaling 3), PRLR (prolactin receptor), MAPK1 (mitogen-activated protein kinase 1), IRS1 (insulin receptor substrate 1), PRL (prolactin), PTPN6 (protein tyrosine phosphatase non-receptor type 6), SOCS1 (suppressor of cytokine signaling 1), IRS2 (insulin receptor substrate 2), STAT1 (signal transducer and activator of transcription 1), SOCS2 (suppressor of cytokine signaling 2), MAPK3 (mitogen-activated protein kinase 3), CISH (cytokine inducible SH2 containing protein), GH1 (growth hormone 1), PTPN1 (protein tyrosine phosphatase non-receptor type 1), LYN (LYN proto-oncogene, Src family tyrosine kinase), ADAM17 (ADAM metallopeptidase domain 17), GH2 (growth hormone 2), CSH1 (chorionic somatomammotropin hormone 1)"], "WAG002239": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), POLR2B (RNA polymerase II subunit B), POLR2C (RNA polymerase II subunit C), POLR2G (RNA polymerase II subunit G), GTF2F2 (general transcription factor IIF subunit 2), POLR2D (RNA polymerase II subunit D), NCBP2 (nuclear cap binding protein subunit 2), GTF2H1 (general transcription factor IIH subunit 1), CDK7 (cyclin dependent kinase 7), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), GTF2F1 (general transcription factor IIF subunit 1), GTF2H3 (general transcription factor IIH subunit 3), POLR2I (RNA polymerase II subunit I), CCNH (cyclin H), NCBP1 (nuclear cap binding protein subunit 1), MNAT1 (MNAT1 component of CDK activating kinase), POLR2J (RNA polymerase II subunit J), POLR2E (RNA polymerase II, I and III subunit E), TBP (TATA-box binding protein), GTF2H4 (general transcription factor IIH subunit 4), GTF2H2 (general transcription factor IIH subunit 2), POLR2F (RNA polymerase II, I and III subunit F), POLR2H (RNA polymerase II, I and III subunit H), POLR2L (RNA polymerase II, I and III subunit L), GTF2B (general transcription factor IIB), TAF6 (TATA-box binding protein associated factor 6), TAF13 (TATA-box binding protein associated factor 13), TAF5 (TATA-box binding protein associated factor 5), TAF11 (TATA-box binding protein associated factor 11), TAF12 (TATA-box binding protein associated factor 12), TAF4 (TATA-box binding protein associated factor 4), TAF1 (TATA-box binding protein associated factor 1), TAF7 (TATA-box binding protein associated factor 7), TAF10 (TATA-box binding protein associated factor 10), GTF2E2 (general transcription factor IIE subunit 2), GTF2E1 (general transcription factor IIE subunit 1), TAF9 (TATA-box binding protein associated factor 9), CDK9 (cyclin dependent kinase 9), GTF2A2 (general transcription factor IIA subunit 2), GTF2A1 (general transcription factor IIA subunit 1), TCEA1 (transcription elongation factor A1), CCNT1 (cyclin T1), SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), TAF4B (TATA-box binding protein associated factor 4b), ELL (elongation factor for RNA polymerase II), CTDP1 (CTD phosphatase subunit 1), SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit), CCNT2 (cyclin T2), XPO1 (exportin 1), RAN (RAN, member RAS oncogene family), NUP85 (nucleoporin 85), SSRP1 (structure specific recognition protein 1), NUP93 (nucleoporin 93), NUP155 (nucleoporin 155), NUP153 (nucleoporin 153), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), RAE1 (ribonucleic acid export 1), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), NUP133 (nucleoporin 133), NUP35 (nucleoporin 35), NUP214 (nucleoporin 214), NUP205 (nucleoporin 205), NUP210 (nucleoporin 210), TPR (translocated promoter region, nuclear basket protein), NUP107 (nucleoporin 107), NUP88 (nucleoporin 88), NUP37 (nucleoporin 37), NUP50 (nucleoporin 50), NUP160 (nucleoporin 160), NUP188 (nucleoporin 188), RNGTT (RNA guanylyltransferase and 5'-phosphatase), AAAS (aladin WD repeat nucleoporin), NUP54 (nucleoporin 54), KPNA1 (karyopherin subunit alpha 1), RANBP2 (RAN binding protein 2), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), BANF1 (BAF nuclear assembly factor 1), UBB (ubiquitin B), RNMT (RNA guanine-7 methyltransferase), CHMP6 (charged multivesicular body protein 6), CHMP2A (charged multivesicular body protein 2A), CHMP4B (charged multivesicular body protein 4B), CHMP4C (charged multivesicular body protein 4C), CHMP3 (charged multivesicular body protein 3), VPS28 (VPS28 subunit of ESCRT-I), POLR2K (RNA polymerase II, I and III subunit K), VPS4A (vacuolar protein sorting 4 homolog A), RANGAP1 (Ran GTPase activating protein 1), TAF2 (TATA-box binding protein associated factor 2), CHMP2B (charged multivesicular body protein 2B), CHMP7 (charged multivesicular body protein 7), RCC1 (regulator of chromosome condensation 1), VPS37C (VPS37C subunit of ESCRT-I), VPS4B (vacuolar protein sorting 4 homolog B), TSG101 (tumor susceptibility 101), VPS37A (VPS37A subunit of ESCRT-I), TAF9B (TATA-box binding protein associated factor 9b), CHMP5 (charged multivesicular body protein 5)"], "WAG002240": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DCP2 (decapping mRNA 2), XRN1 (5'-3' exoribonuclease 1), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), LSM1 (LSM1 homolog, mRNA degradation associated), EIF4B (eukaryotic translation initiation factor 4B), EIF4E (eukaryotic translation initiation factor 4E), LSM7 (LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated), EXOSC4 (exosome component 4), DDX6 (DEAD-box helicase 6), EIF4A3 (eukaryotic translation initiation factor 4A3), LSM4 (LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated), CNOT6 (CCR4-NOT transcription complex subunit 6), PAIP1 (poly(A) binding protein interacting protein 1), EXOSC9 (exosome component 9), EXOSC6 (exosome component 6), EXOSC5 (exosome component 5), LSM5 (LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated), CNOT1 (CCR4-NOT transcription complex subunit 1), PARN (poly(A)-specific ribonuclease), EXOSC8 (exosome component 8), CNOT8 (CCR4-NOT transcription complex subunit 8), CNOT7 (CCR4-NOT transcription complex subunit 7), EXOSC2 (exosome component 2), PABPC1 (poly(A) binding protein cytoplasmic 1), CNOT3 (CCR4-NOT transcription complex subunit 3), CNOT2 (CCR4-NOT transcription complex subunit 2), LSM2 (LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated), LSM6 (LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated), EXOSC1 (exosome component 1), LSM3 (LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated), DIS3 (DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease), DCP1B (decapping mRNA 1B), CNOT4 (CCR4-NOT transcription complex subunit 4), CNOT6L (CCR4-NOT transcription complex subunit 6 like), EXOSC7 (exosome component 7), EXOSC3 (exosome component 3), CNOT10 (CCR4-NOT transcription complex subunit 10), EDC3 (enhancer of mRNA decapping 3), EDC4 (enhancer of mRNA decapping 4), TNKS1BP1 (tankyrase 1 binding protein 1), PATL1 (PAT1 homolog 1, processing body mRNA decay factor), TTC37 (tetratricopeptide repeat domain 37), SKIV2L (Ski2 like RNA helicase), DCPS (decapping enzyme, scavenger), EIF4A1 (eukaryotic translation initiation factor 4A1), HBS1L (HBS1 like translational GTPase), WDR61 (WD repeat domain 61), EIF4A2 (eukaryotic translation initiation factor 4A2), DCP1A (decapping mRNA 1A), PAN2 (poly(A) specific ribonuclease subunit PAN2), PAN3 (poly(A) specific ribonuclease subunit PAN3), TUT4 (terminal uridylyl transferase 4), CNOT11 (CCR4-NOT transcription complex subunit 11), CNOT9 (CCR4-NOT transcription complex subunit 9), NT5C3B (5'-nucleotidase, cytosolic IIIB), TUT7 (terminal uridylyl transferase 7)"], "WAG002241": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ADCY2 (adenylate cyclase 2), ADCY1 (adenylate cyclase 1), GNAS (GNAS complex locus), ADCY5 (adenylate cyclase 5), ADCY9 (adenylate cyclase 9), ADCY8 (adenylate cyclase 8), ADCY6 (adenylate cyclase 6), ADCY7 (adenylate cyclase 7), ADCY4 (adenylate cyclase 4), GNB1 (G protein subunit beta 1), GNG2 (G protein subunit gamma 2), ADCY3 (adenylate cyclase 3), GNGT1 (G protein subunit gamma transducin 1), GNG4 (G protein subunit gamma 4), GNG3 (G protein subunit gamma 3), GNG13 (G protein subunit gamma 13), GNG7 (G protein subunit gamma 7), GNG8 (G protein subunit gamma 8), GNB3 (G protein subunit beta 3), GNG12 (G protein subunit gamma 12), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), GNB2 (G protein subunit beta 2), GNGT2 (G protein subunit gamma transducin 2), GNB4 (G protein subunit beta 4), GNG11 (G protein subunit gamma 11), GNG5 (G protein subunit gamma 5), PRKACB (protein kinase cAMP-activated catalytic subunit beta), GNB5 (G protein subunit beta 5), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), GNG10 (G protein subunit gamma 10), AQP2 (aquaporin 2), AVPR2 (arginine vasopressin receptor 2), AVP (arginine vasopressin), RAB11FIP2 (RAB11 family interacting protein 2), MYO5B (myosin VB), AQP1 (aquaporin 1 (Colton blood group)), AQP4 (aquaporin 4), AQP3 (aquaporin 3 (Gill blood group)), RAB11A (RAB11A, member RAS oncogene family)"], "WAG002243": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SYT1 (synaptotagmin 1), STX1A (syntaxin 1A), VAMP2 (vesicle associated membrane protein 2), SNAP25 (synaptosome associated protein 25), STX1B (syntaxin 1B), VAMP1 (vesicle associated membrane protein 1), SYT2 (synaptotagmin 2), SV2B (synaptic vesicle glycoprotein 2B), SV2C (synaptic vesicle glycoprotein 2C), SV2A (synaptic vesicle glycoprotein 2A)"], "WAG002244": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FBN1 (fibrillin 1), TGFB1 (transforming growth factor beta 1), ELN (elastin), ITGAV (integrin subunit alpha V), ITGB1 (integrin subunit beta 1), LOX (lysyl oxidase), ITGB6 (integrin subunit beta 6), FBLN5 (fibulin 5), ITGA5 (integrin subunit alpha 5), VTN (vitronectin), MFAP2 (microfibril associated protein 2), TGFB3 (transforming growth factor beta 3), LOXL1 (lysyl oxidase like 1), ITGB5 (integrin subunit beta 5), ITGA8 (integrin subunit alpha 8), TGFB2 (transforming growth factor beta 2), LTBP1 (latent transforming growth factor beta binding protein 1), ITGB8 (integrin subunit beta 8), FBN2 (fibrillin 2), LTBP2 (latent transforming growth factor beta binding protein 2), ITGB3 (integrin subunit beta 3), FBLN1 (fibulin 1), EFEMP2 (EGF containing fibulin extracellular matrix protein 2), MFAP5 (microfibril associated protein 5), LTBP3 (latent transforming growth factor beta binding protein 3), BMP2 (bone morphogenetic protein 2), FBLN2 (fibulin 2), LOXL2 (lysyl oxidase like 2), MFAP4 (microfibril associated protein 4), LOXL3 (lysyl oxidase like 3), LOXL4 (lysyl oxidase like 4), BMP7 (bone morphogenetic protein 7), EFEMP1 (EGF containing fibulin extracellular matrix protein 1), LTBP4 (latent transforming growth factor beta binding protein 4), MFAP1 (microfibril associated protein 1), MFAP3 (microfibril associated protein 3), BMP4 (bone morphogenetic protein 4), GDF5 (growth differentiation factor 5), FURIN (furin, paired basic amino acid cleaving enzyme), BMP10 (bone morphogenetic protein 10), LINC02478 (long intergenic non-protein coding RNA 2478), FBN3 (fibrillin 3)"], "WAG002245": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNG2 (G protein subunit gamma 2), GNG3 (G protein subunit gamma 3), GNG4 (G protein subunit gamma 4), GNB1 (G protein subunit beta 1), GNGT2 (G protein subunit gamma transducin 2), KCNJ3 (potassium inwardly rectifying channel subfamily J member 3), GNG7 (G protein subunit gamma 7), GNG13 (G protein subunit gamma 13), KCNJ6 (potassium inwardly rectifying channel subfamily J member 6), GNG8 (G protein subunit gamma 8), GNB3 (G protein subunit beta 3), GNG12 (G protein subunit gamma 12), GNB4 (G protein subunit beta 4), GNB2 (G protein subunit beta 2), GNGT1 (G protein subunit gamma transducin 1), GNG5 (G protein subunit gamma 5), GNG11 (G protein subunit gamma 11), GNB5 (G protein subunit beta 5), GNG10 (G protein subunit gamma 10), GABBR2 (gamma-aminobutyric acid type B receptor subunit 2), KCNJ2 (potassium inwardly rectifying channel subfamily J member 2), KCNJ8 (potassium inwardly rectifying channel subfamily J member 8), KCNJ11 (potassium inwardly rectifying channel subfamily J member 11), KCNMA1 (potassium calcium-activated channel subfamily M alpha 1), KCNK3 (potassium two pore domain channel subfamily K member 3), KCNJ4 (potassium inwardly rectifying channel subfamily J member 4), KCNK2 (potassium two pore domain channel subfamily K member 2), KCNK9 (potassium two pore domain channel subfamily K member 9), KCNMB4 (potassium calcium-activated channel subfamily M regulatory beta subunit 4), KCNK4 (potassium two pore domain channel subfamily K member 4), KCNK10 (potassium two pore domain channel subfamily K member 10), KCNK1 (potassium two pore domain channel subfamily K member 1), KCNJ16 (potassium inwardly rectifying channel subfamily J member 16), KCNN3 (potassium calcium-activated channel subfamily N member 3), KCNJ12 (potassium inwardly rectifying channel subfamily J member 12), HCN4 (hyperpolarization activated cyclic nucleotide gated potassium channel 4), ABCC8 (ATP binding cassette subfamily C member 8), HCN1 (hyperpolarization activated cyclic nucleotide gated potassium channel 1), KCNK7 (potassium two pore domain channel subfamily K member 7), KCNJ14 (potassium inwardly rectifying channel subfamily J member 14), KCNN4 (potassium calcium-activated channel subfamily N member 4), KCNAB3 (potassium voltage-gated channel subfamily A regulatory beta subunit 3), KCNN2 (potassium calcium-activated channel subfamily N member 2), KCNAB2 (potassium voltage-gated channel subfamily A regulatory beta subunit 2), KCNMB1 (potassium calcium-activated channel subfamily M regulatory beta subunit 1), ABCC9 (ATP binding cassette subfamily C member 9), KCNJ9 (potassium inwardly rectifying channel subfamily J member 9), KCNF1 (potassium voltage-gated channel modifier subfamily F member 1), HCN3 (hyperpolarization activated cyclic nucleotide gated potassium channel 3), HCN2 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2), KCNN1 (potassium calcium-activated channel subfamily N member 1), KCNAB1 (potassium voltage-gated channel subfamily A member regulatory beta subunit 1), GABBR1 (gamma-aminobutyric acid type B receptor subunit 1), KCNJ5 (potassium inwardly rectifying channel subfamily J member 5), KCNK17 (potassium two pore domain channel subfamily K member 17), KCNJ15 (potassium inwardly rectifying channel subfamily J member 15), KCNJ10 (potassium inwardly rectifying channel subfamily J member 10), KCNMB3 (potassium calcium-activated channel subfamily M regulatory beta subunit 3), KCNK6 (potassium two pore domain channel subfamily K member 6), KCNJ1 (potassium inwardly rectifying channel subfamily J member 1), KCNK16 (potassium two pore domain channel subfamily K member 16), KCNK18 (potassium two pore domain channel subfamily K member 18), KCNK13 (potassium two pore domain channel subfamily K member 13), KCNMB2 (potassium calcium-activated channel subfamily M regulatory beta subunit 2)"], "WAG002246": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TFRC (transferrin receptor), TF (transferrin), ATP6V1E1 (ATPase H+ transporting V1 subunit E1), ATP6V1A (ATPase H+ transporting V1 subunit A), ATP6V1F (ATPase H+ transporting V1 subunit F), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), ATP6V1B2 (ATPase H+ transporting V1 subunit B2), ATP6V0D1 (ATPase H+ transporting V0 subunit d1), ATP6V1D (ATPase H+ transporting V1 subunit D), ATP6V1H (ATPase H+ transporting V1 subunit H), ATP6V0A1 (ATPase H+ transporting V0 subunit a1), ATP6V1G1 (ATPase H+ transporting V1 subunit G1), ATP6V0D2 (ATPase H+ transporting V0 subunit d2), ATP6V1B1 (ATPase H+ transporting V1 subunit B1), ATP6V0C (ATPase H+ transporting V0 subunit c), ATP6V0A4 (ATPase H+ transporting V0 subunit a4), ATP6V0B (ATPase H+ transporting V0 subunit b), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), ATP6V0A2 (ATPase H+ transporting V0 subunit a2), ATP6V1C2 (ATPase H+ transporting V1 subunit C2), ATP6V0E2 (ATPase H+ transporting V0 subunit e2), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), ATP6V1G3 (ATPase H+ transporting V1 subunit G3), FTL (ferritin light chain), ATP6AP1 (ATPase H+ transporting accessory protein 1), FTH1 (ferritin heavy chain 1), SKP1 (S-phase kinase associated protein 1), SLC11A2 (solute carrier family 11 member 2), SLC40A1 (solute carrier family 40 member 1), HFE (homeostatic iron regulator), CUL1 (cullin 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), TFR2 (transferrin receptor 2), CP (ceruloplasmin), RPS27A (ribosomal protein S27a), IREB2 (iron responsive element binding protein 2), ATP6V1G2 (ATPase H+ transporting V1 subunit G2), FBXL5 (F-box and leucine rich repeat protein 5), HEPH (hephaestin), NEDD8 (NEDD8 ubiquitin like modifier), ACO1 (aconitase 1), HMOX1 (heme oxygenase 1), CAND1 (cullin associated and neddylation dissociated 1), CYBRD1 (cytochrome b reductase 1), STEAP3 (STEAP3 metalloreductase), HMOX2 (heme oxygenase 2), SLC46A1 (solute carrier family 46 member 1), MCOLN1 (mucolipin 1), ATP6V1E2 (ATPase H+ transporting V1 subunit E2), ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)), GLRX3 (glutaredoxin 3), STEAP2 (STEAP2 metalloreductase), SLC22A17 (solute carrier family 22 member 17), FTMT (ferritin mitochondrial)"], "WAG002248": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), EIF4E (eukaryotic translation initiation factor 4E), ISG15 (ISG15 ubiquitin like modifier), NUP85 (nucleoporin 85), NUP153 (nucleoporin 153), NUP93 (nucleoporin 93), NUP155 (nucleoporin 155), NUP43 (nucleoporin 43), NUP62 (nucleoporin 62), KPNB1 (karyopherin subunit beta 1), NUP35 (nucleoporin 35), NUP205 (nucleoporin 205), RAE1 (ribonucleic acid export 1), NUP210 (nucleoporin 210), UBE2L6 (ubiquitin conjugating enzyme E2 L6), NUP214 (nucleoporin 214), AAAS (aladin WD repeat nucleoporin), NUP188 (nucleoporin 188), NUP107 (nucleoporin 107), NUP50 (nucleoporin 50), NUP133 (nucleoporin 133), NUP88 (nucleoporin 88), NUP160 (nucleoporin 160), TPR (translocated promoter region, nuclear basket protein), NUP37 (nucleoporin 37), NUP54 (nucleoporin 54), HERC5 (HECT and RLD domain containing E3 ubiquitin protein ligase 5), RANBP2 (RAN binding protein 2), ARIH1 (ariadne RBR E3 ubiquitin protein ligase 1), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), STAT1 (signal transducer and activator of transcription 1), POM121 (POM121 transmembrane nucleoporin), EIF4A3 (eukaryotic translation initiation factor 4A3), UBE2E1 (ubiquitin conjugating enzyme E2 E1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), IFIT1 (interferon induced protein with tetratricopeptide repeats 1), DDX58 (DExD/H-box helicase 58), EIF4G3 (eukaryotic translation initiation factor 4 gamma 3), EIF4G2 (eukaryotic translation initiation factor 4 gamma 2), PLCG1 (phospholipase C gamma 1), UBB (ubiquitin B), JAK1 (Janus kinase 1), EIF4E2 (eukaryotic translation initiation factor 4E family member 2), MAPK3 (mitogen-activated protein kinase 3), IRF3 (interferon regulatory factor 3), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), EIF4E3 (eukaryotic translation initiation factor 4E family member 3), EIF4A1 (eukaryotic translation initiation factor 4A1), TRIM25 (tripartite motif containing 25), UBE2N (ubiquitin conjugating enzyme E2 N), EIF4A2 (eukaryotic translation initiation factor 4A2), UBA7 (ubiquitin like modifier activating enzyme 7), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), USP18 (ubiquitin specific peptidase 18), PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1), NEDD4 (NEDD4 E3 ubiquitin protein ligase), FLNB (filamin B), PPM1B (protein phosphatase, Mg2+/Mn2+ dependent 1B), RPS27A (ribosomal protein S27a), NUP42 (nucleoporin 42), NDC1 (NDC1 transmembrane nucleoporin)"], "WAG002250": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NODAL (nodal growth differentiation factor), SMAD2 (SMAD family member 2), SMAD4 (SMAD family member 4), ACVR2B (activin A receptor type 2B), ACVR1B (activin A receptor type 1B), SMAD3 (SMAD family member 3), TDGF1 (teratocarcinoma-derived growth factor 1), FOXH1 (forkhead box H1), ACVR2A (activin A receptor type 2A), ACVR1C (activin A receptor type 1C), LEFTY2 (left-right determination factor 2), LEFTY1 (left-right determination factor 1), FOXO3 (forkhead box O3), DRAP1 (DR1 associated protein 1), CFC1 (cripto, FRL-1, cryptic family 1), PCSK6 (proprotein convertase subtilisin/kexin type 6), FURIN (furin, paired basic amino acid cleaving enzyme), CER1 (cerberus 1, DAN family BMP antagonist), CERS1 (ceramide synthase 1), DAND5 (DAN domain BMP antagonist family member 5)"], "WAG002253": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), CD74 (CD74 molecule), DCTN1 (dynactin subunit 1), KIF26A (kinesin family member 26A), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), DCTN2 (dynactin subunit 2), AP1S1 (adaptor related protein complex 1 subunit sigma 1), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), AP2M1 (adaptor related protein complex 2 subunit mu 1), DCTN3 (dynactin subunit 3), AP1G1 (adaptor related protein complex 1 subunit gamma 1), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), DCTN4 (dynactin subunit 4), AP2S1 (adaptor related protein complex 2 subunit sigma 1), AP2A2 (adaptor related protein complex 2 subunit alpha 2), DCTN6 (dynactin subunit 6), AP2A1 (adaptor related protein complex 2 subunit alpha 1), RAB7A (RAB7A, member RAS oncogene family), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), DCTN5 (dynactin subunit 5), AP1B1 (adaptor related protein complex 1 subunit beta 1), SEC31A (SEC31 homolog A, COPII coat complex component), AP1S2 (adaptor related protein complex 1 subunit sigma 2), SPTBN2 (spectrin beta, non-erythrocytic 2), SEC24D (SEC24 homolog D, COPII coat complex component), AP2B1 (adaptor related protein complex 2 subunit beta 1), DNM2 (dynamin 2), AP1M1 (adaptor related protein complex 1 subunit mu 1), RILP (Rab interacting lysosomal protein), SEC24A (SEC24 homolog A, COPII coat complex component), SEC24C (SEC24 homolog C, COPII coat complex component), OSBPL1A (oxysterol binding protein like 1A), KIF11 (kinesin family member 11), AP1M2 (adaptor related protein complex 1 subunit mu 2), KIF3B (kinesin family member 3B), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), ACTR1A (actin related protein 1A), CLTC (clathrin heavy chain), SEC23A (Sec23 homolog A, COPII coat complex component), KIF5B (kinesin family member 5B), DYNLL1 (dynein light chain LC8-type 1), KIF5A (kinesin family member 5A), KLC1 (kinesin light chain 1), SEC24B (SEC24 homolog B, COPII coat complex component), KIF23 (kinesin family member 23), KIF15 (kinesin family member 15), SAR1B (secretion associated Ras related GTPase 1B), CANX (calnexin), LGMN (legumain), KIFAP3 (kinesin associated protein 3), AP1S3 (adaptor related protein complex 1 subunit sigma 3), DNM1 (dynamin 1), KIF3A (kinesin family member 3A), KLC2 (kinesin light chain 2), KIF3C (kinesin family member 3C), KIF18A (kinesin family member 18A), CTSS (cathepsin S), CENPE (centromere protein E), CLTA (clathrin light chain A), CTSD (cathepsin D), ACTR10 (actin related protein 10), DYNLL2 (dynein light chain LC8-type 2), KIF20A (kinesin family member 20A), RACGAP1 (Rac GTPase activating protein 1), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), CAPZB (capping actin protein of muscle Z-line subunit beta), CTSB (cathepsin B), HLA-DRA (major histocompatibility complex, class II, DR alpha), HLA-DMB (major histocompatibility complex, class II, DM beta), ACTR1B (actin related protein 1B), IFI30 (IFI30 lysosomal thiol reductase), HLA-DMA (major histocompatibility complex, class II, DM alpha), CTSF (cathepsin F), ARF1 (ADP ribosylation factor 1), HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1), CTSH (cathepsin H), CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2), KLC3 (kinesin light chain 3), KLC4 (kinesin light chain 4), HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1), HLA-DPB1 (major histocompatibility complex, class II, DP beta 1), DNM3 (dynamin 3), CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1), HLA-DQA2 (major histocompatibility complex, class II, DQ alpha 2), CTSK (cathepsin K), CAPZA3 (capping actin protein of muscle Z-line subunit alpha 3), CTSA (cathepsin A), CTSC (cathepsin C), CTSO (cathepsin O), HLA-DOB (major histocompatibility complex, class II, DO beta), HLA-DOA (major histocompatibility complex, class II, DO alpha), HLA-DQB2 (major histocompatibility complex, class II, DQ beta 2), LAG3 (lymphocyte activating 3), CTSE (cathepsin E), CTSL (cathepsin L), CTSV (cathepsin V)"], "WAG002254": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NOTCH1 (notch receptor 1), NOTCH3 (notch receptor 3), NOTCH2 (notch receptor 2), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), NOTCH4 (notch receptor 4), DLL1 (delta like canonical Notch ligand 1), CREBBP (CREB binding protein), MAML1 (mastermind like transcriptional coactivator 1), KAT2B (lysine acetyltransferase 2B), RBPJL (recombination signal binding protein for immunoglobulin kappa J region like), JAG1 (jagged canonical Notch ligand 1), MAML3 (mastermind like transcriptional coactivator 3), APH1B (aph-1 homolog B, gamma-secretase subunit), HDAC1 (histone deacetylase 1), HES5 (hes family bHLH transcription factor 5), DLL4 (delta like canonical Notch ligand 4), APH1A (aph-1 homolog A, gamma-secretase subunit), PSEN1 (presenilin 1), CTBP1 (C-terminal binding protein 1), NCSTN (nicastrin), KAT2A (lysine acetyltransferase 2A), JAG2 (jagged canonical Notch ligand 2), NCOR2 (nuclear receptor corepressor 2), PSEN2 (presenilin 2), HDAC2 (histone deacetylase 2), HES1 (hes family bHLH transcription factor 1), DTX1 (deltex E3 ubiquitin ligase 1), CTBP2 (C-terminal binding protein 2), LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase), MFNG (MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase), DVL1 (dishevelled segment polarity protein 1), DVL2 (dishevelled segment polarity protein 2), DLL3 (delta like canonical Notch ligand 3), DVL3 (dishevelled segment polarity protein 3), DTX2 (deltex E3 ubiquitin ligase 2), DTX3 (deltex E3 ubiquitin ligase 3), ADAM17 (ADAM metallopeptidase domain 17), RFNG (RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase), DTX3L (deltex E3 ubiquitin ligase 3L), NUMB (NUMB endocytic adaptor protein), PTCRA (pre T cell antigen receptor alpha), DTX4 (deltex E3 ubiquitin ligase 4), NUMBL (NUMB like endocytic adaptor protein), INPP5K (inositol polyphosphate-5-phosphatase K), LOC101928143 (uncharacterized LOC101928143), KCNJ5 (potassium inwardly rectifying channel subfamily J member 5)"], "WAG002257": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA3 (proteasome 20S subunit alpha 3), PSMA2 (proteasome 20S subunit alpha 2), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB4 (proteasome 20S subunit beta 4), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB10 (proteasome 20S subunit beta 10), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB2 (proteasome 20S subunit beta 2), PSMA7 (proteasome 20S subunit alpha 7), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA4 (proteasome 20S subunit alpha 4), PSMA1 (proteasome 20S subunit alpha 1), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB1 (proteasome 20S subunit beta 1), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMA6 (proteasome 20S subunit alpha 6), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB6 (proteasome 20S subunit beta 6), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB3 (proteasome 20S subunit beta 3), PSMB5 (proteasome 20S subunit beta 5), PSMA5 (proteasome 20S subunit alpha 5), PSMC3 (proteasome 26S subunit, ATPase 3), PSMB7 (proteasome 20S subunit beta 7), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSME1 (proteasome activator subunit 1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME4 (proteasome activator subunit 4), PSMA8 (proteasome 20S subunit alpha 8), PSME3 (proteasome activator subunit 3), SKP1 (S-phase kinase associated protein 1), PSMB11 (proteasome subunit beta 11), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), CD4 (CD4 molecule), RBX1 (ring-box 1), UBB (ubiquitin B), CUL5 (cullin 5), PAK2 (p21 (RAC1) activated kinase 2), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), XPO1 (exportin 1), KPNB1 (karyopherin subunit beta 1), RAN (RAN, member RAS oncogene family), NUP85 (nucleoporin 85), NUP155 (nucleoporin 155), NUP93 (nucleoporin 93), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), NUP153 (nucleoporin 153), NUP37 (nucleoporin 37), NUP214 (nucleoporin 214), NUP107 (nucleoporin 107), NUP35 (nucleoporin 35), NUP50 (nucleoporin 50), RAE1 (ribonucleic acid export 1), NUP205 (nucleoporin 205), NUP210 (nucleoporin 210), NUP54 (nucleoporin 54), NUP133 (nucleoporin 133), NUP88 (nucleoporin 88), NUP160 (nucleoporin 160), TPR (translocated promoter region, nuclear basket protein), NUP188 (nucleoporin 188), KPNA1 (karyopherin subunit alpha 1), AAAS (aladin WD repeat nucleoporin), RANBP2 (RAN binding protein 2), BANF1 (BAF nuclear assembly factor 1), RANGAP1 (Ran GTPase activating protein 1), RCC1 (regulator of chromosome condensation 1), AP1G1 (adaptor related protein complex 1 subunit gamma 1), POM121 (POM121 transmembrane nucleoporin), RANBP1 (RAN binding protein 1), NPM1 (nucleophosmin 1), AP2B1 (adaptor related protein complex 2 subunit beta 1), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), AP1B1 (adaptor related protein complex 1 subunit beta 1), AP2M1 (adaptor related protein complex 2 subunit mu 1), AP1S1 (adaptor related protein complex 1 subunit sigma 1), AP2S1 (adaptor related protein complex 2 subunit sigma 1), AP1M1 (adaptor related protein complex 1 subunit mu 1), AP1S2 (adaptor related protein complex 1 subunit sigma 2), LCK (LCK proto-oncogene, Src family tyrosine kinase), AP1M2 (adaptor related protein complex 1 subunit mu 2), AP2A1 (adaptor related protein complex 2 subunit alpha 1), B2M (beta-2-microglobulin), FYN (FYN proto-oncogene, Src family tyrosine kinase), AP2A2 (adaptor related protein complex 2 subunit alpha 2)"], "WAG002258": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SYT1 (synaptotagmin 1), CPLX1 (complexin 1), VAMP2 (vesicle associated membrane protein 2), RIMS1 (regulating synaptic membrane exocytosis 1), SLC32A1 (solute carrier family 32 member 1), RAB3A (RAB3A, member RAS oncogene family), STX1A (syntaxin 1A), DNAJC5 (DnaJ heat shock protein family (Hsp40) member C5), HSPA8 (heat shock protein family A (Hsp70) member 8), SNAP25 (synaptosome associated protein 25), SLC6A1 (solute carrier family 6 member 1), ABAT (4-aminobutyrate aminotransferase), GAD2 (glutamate decarboxylase 2), GAD1 (glutamate decarboxylase 1), SLC6A13 (solute carrier family 6 member 13), SLC6A11 (solute carrier family 6 member 11), SLC6A12 (solute carrier family 6 member 12), ALDH5A1 (aldehyde dehydrogenase 5 family member A1)"], "WAG002260": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKACA (protein kinase cAMP-activated catalytic subunit alpha), ADCY8 (adenylate cyclase 8), PRKACB (protein kinase cAMP-activated catalytic subunit beta), ADCY2 (adenylate cyclase 2), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), ADCY5 (adenylate cyclase 5), ADCY1 (adenylate cyclase 1), ADCY7 (adenylate cyclase 7), ADCY9 (adenylate cyclase 9), ADCY6 (adenylate cyclase 6), ADCY4 (adenylate cyclase 4), ADCY3 (adenylate cyclase 3), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKX (protein kinase X-linked), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), CREB1 (cAMP responsive element binding protein 1), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PLCG1 (phospholipase C gamma 1), PRKCE (protein kinase C epsilon), PDE1A (phosphodiesterase 1A), PRKCA (protein kinase C alpha), PDE1C (phosphodiesterase 1C), PDE1B (phosphodiesterase 1B), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), CAMK2B (calcium/calmodulin dependent protein kinase II beta), PRKCG (protein kinase C gamma), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), CAMK2D (calcium/calmodulin dependent protein kinase II delta), PRKCD (protein kinase C delta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), CAMK4 (calcium/calmodulin dependent protein kinase IV), CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2), CAMKK1 (calcium/calmodulin dependent protein kinase kinase 1), NBEA (neurobeachin), AHCYL1 (adenosylhomocysteinase like 1), CALM1 (calmodulin 1), GRK2 (G protein-coupled receptor kinase 2), KPNA2 (karyopherin subunit alpha 2)"], "WAG002261": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MMS19 (MMS19 homolog, cytosolic iron-sulfur assembly component), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), CIAO1 (cytosolic iron-sulfur assembly component 1), NUBP2 (nucleotide binding protein 2), POLD1 (DNA polymerase delta 1, catalytic subunit), NUBP1 (nucleotide binding protein 1), BRIP1 (BRCA1 interacting protein C-terminal helicase 1), RTEL1 (regulator of telomere elongation helicase 1), CIAPIN1 (cytokine induced apoptosis inhibitor 1), NDOR1 (NADPH dependent diflavin oxidoreductase 1), ABCB7 (ATP binding cassette subfamily B member 7), CIAO3 (cytosolic iron-sulfur assembly component 3), CIAO2B (cytosolic iron-sulfur assembly component 2B)"], "WAG002263": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TYROBP (transmembrane immune signaling adaptor TYROBP), FYN (FYN proto-oncogene, Src family tyrosine kinase), LCK (LCK proto-oncogene, Src family tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SYK (spleen associated tyrosine kinase), PLCG1 (phospholipase C gamma 1), RAC1 (Rac family small GTPase 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), BTK (Bruton tyrosine kinase), VAV2 (vav guanine nucleotide exchange factor 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), VAV3 (vav guanine nucleotide exchange factor 3), LCP2 (lymphocyte cytosolic protein 2), TREM2 (triggering receptor expressed on myeloid cells 2), GRAP2 (GRB2 related adaptor protein 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PLCG2 (phospholipase C gamma 2), HRAS (HRas proto-oncogene, GTPase), NRAS (NRAS proto-oncogene, GTPase), B2M (beta-2-microglobulin), KLRD1 (killer cell lectin like receptor D1), SIRPB1 (signal regulatory protein beta 1), KLRC2 (killer cell lectin like receptor C2), KLRK1 (killer cell lectin like receptor K1), TREM1 (triggering receptor expressed on myeloid cells 1), NCR2 (natural cytotoxicity triggering receptor 2), CD300E (CD300e molecule), CD300LB (CD300 molecule like family member b), SIGLEC15 (sialic acid binding Ig like lectin 15), SIGLEC14 (sialic acid binding Ig like lectin 14), CLEC5A (C-type lectin domain containing 5A), KLRC4-KLRK1 (KLRC4-KLRK1 readthrough)"], "WAG002267": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ITGB1 (integrin subunit beta 1), ITGAV (integrin subunit alpha V), ITGA2 (integrin subunit alpha 2), ITGB6 (integrin subunit beta 6), ITGB5 (integrin subunit beta 5), ITGB4 (integrin subunit beta 4), FN1 (fibronectin 1), ITGA3 (integrin subunit alpha 3), ITGA5 (integrin subunit alpha 5), ITGA1 (integrin subunit alpha 1), ITGA6 (integrin subunit alpha 6), ITGA8 (integrin subunit alpha 8), ITGA9 (integrin subunit alpha 9), ITGA2B (integrin subunit alpha 2b), LAMC1 (laminin subunit gamma 1), ITGA7 (integrin subunit alpha 7), LAMA1 (laminin subunit alpha 1), LAMB1 (laminin subunit beta 1), LAMB2 (laminin subunit beta 2), LAMA5 (laminin subunit alpha 5), LAMC2 (laminin subunit gamma 2), LAMC3 (laminin subunit gamma 3), LAMB3 (laminin subunit beta 3), LAMA2 (laminin subunit alpha 2), ITGB3 (integrin subunit beta 3), LAMA4 (laminin subunit alpha 4), LAMA3 (laminin subunit alpha 3), COMP (cartilage oligomeric matrix protein), TNC (tenascin C), NID1 (nidogen 1), HSPG2 (heparan sulfate proteoglycan 2), TGFB1 (transforming growth factor beta 1), DAG1 (dystroglycan 1), IBSP (integrin binding sialoprotein), TNR (tenascin R), TNN (tenascin N), ADAM12 (ADAM metallopeptidase domain 12), VTN (vitronectin), FGF2 (fibroblast growth factor 2), SPARC (secreted protein acidic and cysteine rich), DCN (decorin), BGN (biglycan), TNXB (tenascin XB), SERPINE1 (serpin family E member 1), TGFB3 (transforming growth factor beta 3), MATN3 (matrilin 3), NID2 (nidogen 2), ITGAX (integrin subunit alpha X), TGFB2 (transforming growth factor beta 2), COL18A1 (collagen type XVIII alpha 1 chain), PDGFB (platelet derived growth factor subunit B), MATN1 (matrilin 1), FMOD (fibromodulin), ADAM15 (ADAM metallopeptidase domain 15), AGRN (agrin), LUM (lumican), COL9A3 (collagen type IX alpha 3 chain), COL9A2 (collagen type IX alpha 2 chain), COL9A1 (collagen type IX alpha 1 chain), PDGFA (platelet derived growth factor subunit A), ASPN (asporin), NCAM1 (neural cell adhesion molecule 1), SH3PXD2A (SH3 and PX domains 2A), DMD (dystrophin), CEACAM6 (CEA cell adhesion molecule 6), CEACAM8 (CEA cell adhesion molecule 8), CEACAM1 (CEA cell adhesion molecule 1), MATN4 (matrilin 4), TTR (transthyretin), DDR1 (discoidin domain receptor tyrosine kinase 1), DSPP (dentin sialophosphoprotein), HAPLN1 (hyaluronan and proteoglycan link protein 1), DMP1 (dentin matrix acidic phosphoprotein 1), DDR2 (discoidin domain receptor tyrosine kinase 2), MUSK (muscle associated receptor tyrosine kinase), PTPRS (protein tyrosine phosphatase receptor type S), ADAM19 (ADAM metallopeptidase domain 19), LRP4 (LDL receptor related protein 4), LINC02478 (long intergenic non-protein coding RNA 2478), NRXN1 (neurexin 1), NTN4 (netrin 4)"], "WAG002268": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SREBF2 (sterol regulatory element binding transcription factor 2), NFYB (nuclear transcription factor Y subunit beta), NFYC (nuclear transcription factor Y subunit gamma), NFYA (nuclear transcription factor Y subunit alpha), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), SP1 (Sp1 transcription factor), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), CREBBP (CREB binding protein), PPARA (peroxisome proliferator activated receptor alpha), RXRA (retinoid X receptor alpha), NCOA6 (nuclear receptor coactivator 6), TBL1XR1 (TBL1X receptor 1), NCOA2 (nuclear receptor coactivator 2), CARM1 (coactivator associated arginine methyltransferase 1), TGS1 (trimethylguanosine synthase 1), CHD9 (chromodomain helicase DNA binding protein 9), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), IDI1 (isopentenyl-diphosphate delta isomerase 1), FDPS (farnesyl diphosphate synthase), SQLE (squalene epoxidase), DHCR7 (7-dehydrocholesterol reductase), MVK (mevalonate kinase), PMVK (phosphomevalonate kinase), NCOA1 (nuclear receptor coactivator 1), MVD (mevalonate diphosphate decarboxylase), FASN (fatty acid synthase), GGPS1 (geranylgeranyl diphosphate synthase 1), SCD (stearoyl-CoA desaturase), TM7SF2 (transmembrane 7 superfamily member 2), LSS (lanosterol synthase), ACACB (acetyl-CoA carboxylase beta), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), ACACA (acetyl-CoA carboxylase alpha), ELOVL6 (ELOVL fatty acid elongase 6), MTF1 (metal regulatory transcription factor 1), TBL1X (transducin beta like 1 X-linked), MED1 (mediator complex subunit 1), SC5D (sterol-C5-desaturase), HELZ2 (helicase with zinc finger 2)"], "WAG002269": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COL18A1 (collagen type XVIII alpha 1 chain), MMP9 (matrix metallopeptidase 9), MMP1 (matrix metallopeptidase 1), MMP2 (matrix metallopeptidase 2), COL23A1 (collagen type XXIII alpha 1 chain), MMP7 (matrix metallopeptidase 7), MMP14 (matrix metallopeptidase 14), MMP13 (matrix metallopeptidase 13), COL16A1 (collagen type XVI alpha 1 chain), COL13A1 (collagen type XIII alpha 1 chain), COL9A1 (collagen type IX alpha 1 chain), COL12A1 (collagen type XII alpha 1 chain), COL25A1 (collagen type XXV alpha 1 chain), COL17A1 (collagen type XVII alpha 1 chain), COL14A1 (collagen type XIV alpha 1 chain), COL9A2 (collagen type IX alpha 2 chain), COL9A3 (collagen type IX alpha 3 chain), COL15A1 (collagen type XV alpha 1 chain), COL19A1 (collagen type XIX alpha 1 chain), MMP11 (matrix metallopeptidase 11), MMP8 (matrix metallopeptidase 8), MMP10 (matrix metallopeptidase 10), MMP12 (matrix metallopeptidase 12), MMP15 (matrix metallopeptidase 15), MMP19 (matrix metallopeptidase 19), MMP20 (matrix metallopeptidase 20), MMP3 (matrix metallopeptidase 3), FURIN (furin, paired basic amino acid cleaving enzyme), ELANE (elastase, neutrophil expressed), ADAM17 (ADAM metallopeptidase domain 17), ADAM10 (ADAM metallopeptidase domain 10), CTSB (cathepsin B), CTSK (cathepsin K), CTSD (cathepsin D), ADAM9 (ADAM metallopeptidase domain 9), PRSS2 (serine protease 2), TMPRSS6 (transmembrane serine protease 6), COL26A1 (collagen type XXVI alpha 1 chain), CTSL (cathepsin L), PHYKPL (5-phosphohydroxy-L-lysine phospho-lyase)"], "WAG002270": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TLR9 (toll like receptor 9), TLR7 (toll like receptor 7), TLR3 (toll like receptor 3), TLR8 (toll like receptor 8), CTSS (cathepsin S), LGMN (legumain), UNC93B1 (unc-93 homolog B1, TLR signaling regulator), HSP90B1 (heat shock protein 90 beta family member 1), CNPY3 (canopy FGF signaling regulator 3), CTSL (cathepsin L), CTSV (cathepsin V)"], "WAG002273": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KIT (KIT proto-oncogene, receptor tyrosine kinase), FYN (FYN proto-oncogene, Src family tyrosine kinase), LCK (LCK proto-oncogene, Src family tyrosine kinase), JAK2 (Janus kinase 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PRKCA (protein kinase C alpha), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), GAB2 (GRB2 associated binding protein 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), HRAS (HRas proto-oncogene, GTPase), VAV1 (vav guanine nucleotide exchange factor 1), STAT3 (signal transducer and activator of transcription 3), RAC1 (Rac family small GTPase 1), CBL (Cbl proto-oncogene), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PTPN6 (protein tyrosine phosphatase non-receptor type 6), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), LYN (LYN proto-oncogene, Src family tyrosine kinase), NRAS (NRAS proto-oncogene, GTPase), STAT1 (signal transducer and activator of transcription 1), SOCS1 (suppressor of cytokine signaling 1), TEC (tec protein tyrosine kinase), TEC (transient erythroblastopenia of childhood), STAT5B (signal transducer and activator of transcription 5B), STAT5A (signal transducer and activator of transcription 5A), KRAS (KRAS proto-oncogene, GTPase), GRAP2 (GRB2 related adaptor protein 2), GRB10 (growth factor receptor bound protein 10), FES (FES proto-oncogene, tyrosine kinase), GRAP (GRB2 related adaptor protein), FER (FER tyrosine kinase), GRB7 (growth factor receptor bound protein 7), SH2B3 (SH2B adaptor protein 3), CHEK1 (checkpoint kinase 1), MMP9 (matrix metallopeptidase 9), SOCS6 (suppressor of cytokine signaling 6), PTPRU (protein tyrosine phosphatase receptor type U), CMA1 (chymase 1)"], "WAG002274": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "LATS2 (large tumor suppressor kinase 2), LATS1 (large tumor suppressor kinase 1), WWTR1 (WW domain containing transcription regulator 1), SAV1 (salvador family WW domain containing protein 1), STK4 (serine/threonine kinase 4), YAP1 (Yes1 associated transcriptional regulator), AMOTL1 (angiomotin like 1), AMOTL2 (angiomotin like 2), STK3 (serine/threonine kinase 3), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), CASP3 (caspase 3), MOB1A (MOB kinase activator 1A), MOB1B (MOB kinase activator 1B), TJP2 (tight junction protein 2), DVL2 (dishevelled segment polarity protein 2), TJP1 (tight junction protein 1), WWC1 (WW and C2 domain containing 1), NPHP4 (nephrocystin 4)"], "WAG002275": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DDX20 (DEAD-box helicase 20), SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide), GEMIN6 (gem nuclear organelle associated protein 6), GEMIN5 (gem nuclear organelle associated protein 5), SNRPD2 (small nuclear ribonucleoprotein D2 polypeptide), GEMIN7 (gem nuclear organelle associated protein 7), SNRPF (small nuclear ribonucleoprotein polypeptide F), SNRPG (small nuclear ribonucleoprotein polypeptide G), GEMIN4 (gem nuclear organelle associated protein 4), NUP85 (nucleoporin 85), NUP155 (nucleoporin 155), NUP93 (nucleoporin 93), NUP35 (nucleoporin 35), NUP43 (nucleoporin 43), NUP205 (nucleoporin 205), NUP153 (nucleoporin 153), RAE1 (ribonucleic acid export 1), NCBP2 (nuclear cap binding protein subunit 2), NUP210 (nucleoporin 210), NUP214 (nucleoporin 214), NUP50 (nucleoporin 50), NUP188 (nucleoporin 188), NUP88 (nucleoporin 88), NCBP1 (nuclear cap binding protein subunit 1), TPR (translocated promoter region, nuclear basket protein), AAAS (aladin WD repeat nucleoporin), NUP62 (nucleoporin 62), NUP107 (nucleoporin 107), NUP37 (nucleoporin 37), NUP133 (nucleoporin 133), NUP160 (nucleoporin 160), NUP54 (nucleoporin 54), SNUPN (snurportin 1), PHAX (phosphorylated adaptor for RNA export), SNRPB (small nuclear ribonucleoprotein polypeptides B and B1), SNRPD1 (small nuclear ribonucleoprotein D1 polypeptide), SMN2 (survival of motor neuron 2, centromeric), SNRPE (small nuclear ribonucleoprotein polypeptide E), GEMIN2 (gem nuclear organelle associated protein 2), RANBP2 (RAN binding protein 2), POM121 (POM121 transmembrane nucleoporin), WDR77 (WD repeat domain 77), CLNS1A (chloride nucleotide-sensitive channel 1A), PRMT5 (protein arginine methyltransferase 5), TGS1 (trimethylguanosine synthase 1), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), GEMIN8 (gem nuclear organelle associated protein 8), SMN1 (survival of motor neuron 1, telomeric), NDC1 (NDC1 transmembrane nucleoporin), NUP42 (nucleoporin 42)"], "WAG002276": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TIMM23 (translocase of inner mitochondrial membrane 23), TOMM20 (translocase of outer mitochondrial membrane 20), TOMM40 (translocase of outer mitochondrial membrane 40), TOMM7 (translocase of outer mitochondrial membrane 7), HSPA9 (heat shock protein family A (Hsp70) member 9), TOMM5 (translocase of outer mitochondrial membrane 5), TIMM44 (translocase of inner mitochondrial membrane 44), TOMM22 (translocase of outer mitochondrial membrane 22), TIMM17A (translocase of inner mitochondrial membrane 17A), TOMM6 (translocase of outer mitochondrial membrane 6), TIMM50 (translocase of inner mitochondrial membrane 50), GRPEL1 (GrpE like 1, mitochondrial), TIMM17B (translocase of inner mitochondrial membrane 17B), DNAJC19 (DnaJ heat shock protein family (Hsp40) member C19), PAM16 (presequence translocase associated motor 16), TIMM10 (translocase of inner mitochondrial membrane 10), GRPEL2 (GrpE like 2, mitochondrial), TIMM9 (translocase of inner mitochondrial membrane 9), PMPCB (peptidase, mitochondrial processing subunit beta), CHCHD4 (coiled-coil-helix-coiled-coil-helix domain containing 4), SAMM50 (SAMM50 sorting and assembly machinery component), TIMM13 (translocase of inner mitochondrial membrane 13), PMPCA (peptidase, mitochondrial processing subunit alpha), MTX2 (metaxin 2), TIMM8A (translocase of inner mitochondrial membrane 8A), MTX1 (metaxin 1), HSPD1 (heat shock protein family D (Hsp60) member 1), GFER (growth factor, augmenter of liver regeneration), SLC25A6 (solute carrier family 25 member 6), ACO2 (aconitase 2), VDAC1 (voltage dependent anion channel 1), CYC1 (cytochrome c1), TIMM8B (translocase of inner mitochondrial membrane 8 homolog B), SLC25A13 (solute carrier family 25 member 13), FXN (frataxin), SLC25A12 (solute carrier family 25 member 12), CS (citrate synthase), CHCHD3 (coiled-coil-helix-coiled-coil-helix domain containing 3), IDH3G (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma), COX17 (cytochrome c oxidase copper chaperone COX17), NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8), COX19 (cytochrome c oxidase assembly factor COX19), BCS1L (BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone), SLC25A4 (solute carrier family 25 member 4), COQ2 (coenzyme Q2, polyprenyltransferase), HSCB (HscB mitochondrial iron-sulfur cluster cochaperone), OTC (ornithine carbamoyltransferase), TAZ (tafazzin), PITRM1 (pitrilysin metallopeptidase 1), CHCHD2 (coiled-coil-helix-coiled-coil-helix domain containing 2), CHCHD7 (coiled-coil-helix-coiled-coil-helix domain containing 7), LDHD (lactate dehydrogenase D), TOMM70 (translocase of outer mitochondrial membrane 70), COA4 (cytochrome c oxidase assembly factor 4 homolog), TIMM21 (translocase of inner mitochondrial membrane 21), CHCHD10 (coiled-coil-helix-coiled-coil-helix domain containing 10), COA6 (cytochrome c oxidase assembly factor 6), ATP5F1B (ATP synthase F1 subunit beta), CMC4 (C-X9-C motif containing 4), CMC2 (C-X9-C motif containing 2), ATP5F1A (ATP synthase F1 subunit alpha), TIMM10B (translocase of inner mitochondrial membrane 10B), ATP5MC1 (ATP synthase membrane subunit c locus 1), CHCHD5 (coiled-coil-helix-coiled-coil-helix domain containing 5)"], "WAG002277": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NOTCH2 (notch receptor 2), UBC (ubiquitin C), DLL1 (delta like canonical Notch ligand 1), PSENEN (presenilin enhancer, gamma-secretase subunit), APH1B (aph-1 homolog B, gamma-secretase subunit), DLL4 (delta like canonical Notch ligand 4), JAG2 (jagged canonical Notch ligand 2), JAG1 (jagged canonical Notch ligand 1), UBB (ubiquitin B), ADAM10 (ADAM metallopeptidase domain 10), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), APH1A (aph-1 homolog A, gamma-secretase subunit), PSEN1 (presenilin 1), MIB1 (mindbomb E3 ubiquitin protein ligase 1), NCSTN (nicastrin), HES5 (hes family bHLH transcription factor 5), EP300 (E1A binding protein p300), PSEN2 (presenilin 2), MAML2 (mastermind like transcriptional coactivator 2), MAML1 (mastermind like transcriptional coactivator 1), MAML3 (mastermind like transcriptional coactivator 3), HES1 (hes family bHLH transcription factor 1), CNTN1 (contactin 1), CREB1 (cAMP responsive element binding protein 1), RPS27A (ribosomal protein S27a), MIB2 (mindbomb E3 ubiquitin protein ligase 2), NEURL1B (neuralized E3 ubiquitin protein ligase 1B), FCER2 (Fc fragment of IgE receptor II), MDK (midkine), MAMLD1 (mastermind like domain containing 1), NEURL1 (neuralized E3 ubiquitin protein ligase 1), GZMB (granzyme B)"], "WAG002278": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), PLCG1 (phospholipase C gamma 1), ABI1 (abl interactor 1), NCK1 (NCK adaptor protein 1), SYK (spleen associated tyrosine kinase), ACTB (actin beta), WASF1 (WASP family member 1), WAS (WASP actin nucleation promoting factor), WASL (WASP like actin nucleation promoting factor), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), CDC42 (cell division cycle 42), HCK (HCK proto-oncogene, Src family tyrosine kinase), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CRK (CRK proto-oncogene, adaptor protein), WASF2 (WASP family member 2), VAV1 (vav guanine nucleotide exchange factor 1), ACTG1 (actin gamma 1), BTK (Bruton tyrosine kinase), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), PRKCD (protein kinase C delta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PLCG2 (phospholipase C gamma 2), PTK2 (protein tyrosine kinase 2), FGR (FGR proto-oncogene, Src family tyrosine kinase), LYN (LYN proto-oncogene, Src family tyrosine kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), VAV2 (vav guanine nucleotide exchange factor 2), ARPC3 (actin related protein 2/3 complex subunit 3), PAK1 (p21 (RAC1) activated kinase 1), ARPC1B (actin related protein 2/3 complex subunit 1B), ARPC2 (actin related protein 2/3 complex subunit 2), NCKAP1 (NCK associated protein 1), ARPC4 (actin related protein 2/3 complex subunit 4), ACTR3 (actin related protein 3), PRKCE (protein kinase C epsilon), ARPC5 (actin related protein 2/3 complex subunit 5), CYFIP2 (cytoplasmic FMR1 interacting protein 2), ACTR2 (actin related protein 2), HSP90AA1 (heat shock protein 90 alpha family class A member 1), MAPK1 (mitogen-activated protein kinase 1), ARPC1A (actin related protein 2/3 complex subunit 1A), ABI2 (abl interactor 2), WASF3 (WASP family member 3), BAIAP2 (BAR/IMD domain containing adaptor protein 2), HSP90AB1 (heat shock protein 90 alpha family class B member 1), MAPK3 (mitogen-activated protein kinase 3), VAV3 (vav guanine nucleotide exchange factor 3), PLD1 (phospholipase D1), DOCK1 (dedicator of cytokinesis 1), WIPF1 (WAS/WASL interacting protein family member 1), BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex), PLD2 (phospholipase D2), NCKIPSD (NCK interacting protein with SH3 domain), MYH9 (myosin heavy chain 9), CYFIP1 (cytoplasmic FMR1 interacting protein 1), PLA2G6 (phospholipase A2 group VI), ELMO1 (engulfment and cell motility 1), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), FCGR2A (Fc fragment of IgG receptor IIa), LIMK1 (LIM domain kinase 1), CD3G (CD3g molecule), NCKAP1L (NCK associated protein 1 like), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), CFL1 (cofilin 1), FCGR3A (Fc fragment of IgG receptor IIIa), FCGR2C (Fc fragment of IgG receptor IIc (gene/pseudogene)), MYH2 (myosin heavy chain 2), MYO1C (myosin IC), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), FCGR1A (Fc fragment of IgG receptor Ia), WIPF2 (WAS/WASL interacting protein family member 2), ELMO2 (engulfment and cell motility 2), WIPF3 (WAS/WASL interacting protein family member 3), NF2 (neurofibromin 2), AHCYL1 (adenosylhomocysteinase like 1), MYO5A (myosin VA), MYO9B (myosin IXB), MYO10 (myosin X), PLD4 (phospholipase D family member 4), PLD3 (phospholipase D family member 3), PLPP5 (phospholipid phosphatase 5), PLPP4 (phospholipid phosphatase 4)"], "WAG002280": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NOTCH1 (notch receptor 1), UBC (ubiquitin C), EP300 (E1A binding protein p300), CREBBP (CREB binding protein), KAT2B (lysine acetyltransferase 2B), HDAC1 (histone deacetylase 1), SNW1 (SNW domain containing 1), MAML1 (mastermind like transcriptional coactivator 1), HDAC3 (histone deacetylase 3), UBB (ubiquitin B), MAML2 (mastermind like transcriptional coactivator 2), MYC (MYC proto-oncogene, bHLH transcription factor), MAML3 (mastermind like transcriptional coactivator 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), NCOR2 (nuclear receptor corepressor 2), HDAC2 (histone deacetylase 2), NCOR1 (nuclear receptor corepressor 1), HIF1A (hypoxia inducible factor 1 subunit alpha), DLL1 (delta like canonical Notch ligand 1), HDAC10 (histone deacetylase 10), TBL1XR1 (TBL1X receptor 1), HDAC9 (histone deacetylase 9), CUL1 (cullin 1), PSENEN (presenilin enhancer, gamma-secretase subunit), HEY2 (hes related family bHLH transcription factor with YRPW motif 2), SKP1 (S-phase kinase associated protein 1), APH1B (aph-1 homolog B, gamma-secretase subunit), CDK8 (cyclin dependent kinase 8), HDAC7 (histone deacetylase 7), HDAC6 (histone deacetylase 6), RBX1 (ring-box 1), TLE1 (TLE family member 1, transcriptional corepressor), HDAC5 (histone deacetylase 5), DLL4 (delta like canonical Notch ligand 4), CCNC (cyclin C), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), DTX1 (deltex E3 ubiquitin ligase 1), JAG1 (jagged canonical Notch ligand 1), HDAC4 (histone deacetylase 4), JAG2 (jagged canonical Notch ligand 2), ADAM10 (ADAM metallopeptidase domain 10), HES5 (hes family bHLH transcription factor 5), APH1A (aph-1 homolog A, gamma-secretase subunit), HES1 (hes family bHLH transcription factor 1), KAT2A (lysine acetyltransferase 2A), HDAC11 (histone deacetylase 11), NCSTN (nicastrin), PSEN1 (presenilin 1), TLE2 (TLE family member 2, transcriptional corepressor), MIB1 (mindbomb E3 ubiquitin protein ligase 1), TLE4 (TLE family member 4, transcriptional corepressor), HEYL (hes related family bHLH transcription factor with YRPW motif like), HDAC8 (histone deacetylase 8), ITCH (itchy E3 ubiquitin protein ligase), ARRB2 (arrestin beta 2), ARRB1 (arrestin beta 1), PSEN2 (presenilin 2), TBL1X (transducin beta like 1 X-linked), DNER (delta/notch like EGF repeat containing), NUMB (NUMB endocytic adaptor protein), ADAM17 (ADAM metallopeptidase domain 17), CNTN1 (contactin 1), RPS27A (ribosomal protein S27a), MIB2 (mindbomb E3 ubiquitin protein ligase 2), DTX2 (deltex E3 ubiquitin ligase 2), NEURL1B (neuralized E3 ubiquitin protein ligase 1B), DLK1 (delta like non-canonical Notch ligand 1), NBEA (neurobeachin), DTX4 (deltex E3 ubiquitin ligase 4), MAMLD1 (mastermind like domain containing 1), NEURL1 (neuralized E3 ubiquitin protein ligase 1), LOC101928143 (uncharacterized LOC101928143)"], "WAG002281": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CUL1 (cullin 1), RBX1 (ring-box 1), SKP1 (S-phase kinase associated protein 1), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA5 (proteasome 20S subunit alpha 5), UBB (ubiquitin B), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB1 (proteasome 20S subunit beta 1), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB3 (proteasome 20S subunit beta 3), PSMB4 (proteasome 20S subunit beta 4), PSMA7 (proteasome 20S subunit alpha 7), PSMA2 (proteasome 20S subunit alpha 2), PSMB10 (proteasome 20S subunit beta 10), PSMB2 (proteasome 20S subunit beta 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMA3 (proteasome 20S subunit alpha 3), PSMA1 (proteasome 20S subunit alpha 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA6 (proteasome 20S subunit alpha 6), PSMB5 (proteasome 20S subunit beta 5), PSMB6 (proteasome 20S subunit beta 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMA4 (proteasome 20S subunit alpha 4), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), NOTCH1 (notch receptor 1), CREBBP (CREB binding protein), NOTCH2 (notch receptor 2), KAT2B (lysine acetyltransferase 2B), EP300 (E1A binding protein p300), MAML1 (mastermind like transcriptional coactivator 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), MAML2 (mastermind like transcriptional coactivator 2), SNW1 (SNW domain containing 1), MAML3 (mastermind like transcriptional coactivator 3), SMAD3 (SMAD family member 3), NOTCH4 (notch receptor 4), DLL4 (delta like canonical Notch ligand 4), AKT1 (AKT serine/threonine kinase 1), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), PSEN1 (presenilin 1), PSENEN (presenilin enhancer, gamma-secretase subunit), JAG1 (jagged canonical Notch ligand 1), APH1B (aph-1 homolog B, gamma-secretase subunit), HEY2 (hes related family bHLH transcription factor with YRPW motif 2), KAT2A (lysine acetyltransferase 2A), HES5 (hes family bHLH transcription factor 5), ADAM10 (ADAM metallopeptidase domain 10), APH1A (aph-1 homolog A, gamma-secretase subunit), PSEN2 (presenilin 2), NCSTN (nicastrin), HES1 (hes family bHLH transcription factor 1), RPS27A (ribosomal protein S27a), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), ACTA2 (actin alpha 2, smooth muscle), TACC3 (transforming acidic coiled-coil containing protein 3), FLT4 (fms related receptor tyrosine kinase 4), MAMLD1 (mastermind like domain containing 1), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002282": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), NOTCH1 (notch receptor 1), NOTCH3 (notch receptor 3), DLL1 (delta like canonical Notch ligand 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), KAT2B (lysine acetyltransferase 2B), CREBBP (CREB binding protein), EP300 (E1A binding protein p300), DLL4 (delta like canonical Notch ligand 4), UBB (ubiquitin B), MAML1 (mastermind like transcriptional coactivator 1), JAG1 (jagged canonical Notch ligand 1), PSENEN (presenilin enhancer, gamma-secretase subunit), JAG2 (jagged canonical Notch ligand 2), MAML2 (mastermind like transcriptional coactivator 2), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), APH1B (aph-1 homolog B, gamma-secretase subunit), MAML3 (mastermind like transcriptional coactivator 3), ADAM10 (ADAM metallopeptidase domain 10), HES5 (hes family bHLH transcription factor 5), HEY2 (hes related family bHLH transcription factor with YRPW motif 2), SNW1 (SNW domain containing 1), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), KAT2A (lysine acetyltransferase 2A), PSEN1 (presenilin 1), HEYL (hes related family bHLH transcription factor with YRPW motif like), APH1A (aph-1 homolog A, gamma-secretase subunit), NCSTN (nicastrin), MIB1 (mindbomb E3 ubiquitin protein ligase 1), EGFR (epidermal growth factor receptor), PSEN2 (presenilin 2), HES1 (hes family bHLH transcription factor 1), EGF (epidermal growth factor), STAT1 (signal transducer and activator of transcription 1), PTCRA (pre T cell antigen receptor alpha), TACC3 (transforming acidic coiled-coil containing protein 3), PBX1 (PBX homeobox 1), YBX1 (Y-box binding protein 1), RPS27A (ribosomal protein S27a), MIB2 (mindbomb E3 ubiquitin protein ligase 2), NEURL1B (neuralized E3 ubiquitin protein ligase 1B), WWP2 (WW domain containing E3 ubiquitin protein ligase 2), DLGAP5 (DLG associated protein 5), FABP7 (fatty acid binding protein 7), PLXND1 (plexin D1), WWC1 (WW and C2 domain containing 1), NEURL1 (neuralized E3 ubiquitin protein ligase 1), MAMLD1 (mastermind like domain containing 1)"], "WAG002284": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COL1A1 (collagen type I alpha 1 chain), COL5A2 (collagen type V alpha 2 chain), COL1A2 (collagen type I alpha 2 chain), COL5A1 (collagen type V alpha 1 chain), COL3A1 (collagen type III alpha 1 chain), COL16A1 (collagen type XVI alpha 1 chain), COL15A1 (collagen type XV alpha 1 chain), COL10A1 (collagen type X alpha 1 chain), COL8A1 (collagen type VIII alpha 1 chain), COL2A1 (collagen type II alpha 1 chain), COL13A1 (collagen type XIII alpha 1 chain), COL18A1 (collagen type XVIII alpha 1 chain), COL12A1 (collagen type XII alpha 1 chain), COL4A6 (collagen type IV alpha 6 chain), COL7A1 (collagen type VII alpha 1 chain), COL6A3 (collagen type VI alpha 3 chain), COL4A1 (collagen type IV alpha 1 chain), COL22A1 (collagen type XXII alpha 1 chain), COL8A2 (collagen type VIII alpha 2 chain), COL4A4 (collagen type IV alpha 4 chain), COL21A1 (collagen type XXI alpha 1 chain), COL11A1 (collagen type XI alpha 1 chain), COL27A1 (collagen type XXVII alpha 1 chain), COL6A1 (collagen type VI alpha 1 chain), COL24A1 (collagen type XXIV alpha 1 chain), COL14A1 (collagen type XIV alpha 1 chain), COL28A1 (collagen type XXVIII alpha 1 chain), COL25A1 (collagen type XXV alpha 1 chain), COL23A1 (collagen type XXIII alpha 1 chain), COL20A1 (collagen type XX alpha 1 chain), COL5A3 (collagen type V alpha 3 chain), COL6A2 (collagen type VI alpha 2 chain), COL4A3 (collagen type IV alpha 3 chain), COL4A2 (collagen type IV alpha 2 chain), COL9A2 (collagen type IX alpha 2 chain), COL9A1 (collagen type IX alpha 1 chain), COL17A1 (collagen type XVII alpha 1 chain), COL9A3 (collagen type IX alpha 3 chain), COL4A5 (collagen type IV alpha 5 chain), COL19A1 (collagen type XIX alpha 1 chain), BMP1 (bone morphogenetic protein 1), P4HB (prolyl 4-hydroxylase subunit beta), PCOLCE (procollagen C-endopeptidase enhancer), ADAMTS2 (ADAM metallopeptidase with thrombospondin type 1 motif 2), SERPINH1 (serpin family H member 1), ADAMTS3 (ADAM metallopeptidase with thrombospondin type 1 motif 3), ADAMTS14 (ADAM metallopeptidase with thrombospondin type 1 motif 14), PLOD2 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 2), TLL1 (tolloid like 1), PCOLCE2 (procollagen C-endopeptidase enhancer 2), CRTAP (cartilage associated protein), PLOD3 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 3), PLOD1 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1), P4HA2 (prolyl 4-hydroxylase subunit alpha 2), P4HA1 (prolyl 4-hydroxylase subunit alpha 1), PPIB (peptidylprolyl isomerase B), COL11A2 (collagen type XI alpha 2 chain), P4HA3 (prolyl 4-hydroxylase subunit alpha 3), P3H2 (prolyl 3-hydroxylase 2), P3H3 (prolyl 3-hydroxylase 3), P3H1 (prolyl 3-hydroxylase 1), COL6A6 (collagen type VI alpha 6 chain), TLL2 (tolloid like 2), COLGALT1 (collagen beta(1-O)galactosyltransferase 1), COL6A5 (collagen type VI alpha 5 chain), COLGALT2 (collagen beta(1-O)galactosyltransferase 2), COL26A1 (collagen type XXVI alpha 1 chain)"], "WAG002285": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), RBX1 (ring-box 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA7 (proteasome 20S subunit alpha 7), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA2 (proteasome 20S subunit alpha 2), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB5 (proteasome 20S subunit beta 5), PSMB1 (proteasome 20S subunit beta 1), PSMB2 (proteasome 20S subunit beta 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB3 (proteasome 20S subunit beta 3), PSMB10 (proteasome 20S subunit beta 10), PSMA6 (proteasome 20S subunit alpha 6), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMA1 (proteasome 20S subunit alpha 1), PSMA3 (proteasome 20S subunit alpha 3), PSMB6 (proteasome 20S subunit beta 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB7 (proteasome 20S subunit beta 7), PSMA5 (proteasome 20S subunit alpha 5), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA8 (proteasome 20S subunit alpha 8), PSME4 (proteasome activator subunit 4), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), UBB (ubiquitin B), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), UBE2D1 (ubiquitin conjugating enzyme E2 D1), VHL (von Hippel-Lindau tumor suppressor), HIF1A (hypoxia inducible factor 1 subunit alpha), EPAS1 (endothelial PAS domain protein 1), CUL2 (cullin 2), HIF3A (hypoxia inducible factor 3 subunit alpha), ARNT (aryl hydrocarbon receptor nuclear translocator), EGLN3 (egl-9 family hypoxia inducible factor 3), EP300 (E1A binding protein p300), EGLN1 (egl-9 family hypoxia inducible factor 1), CREBBP (CREB binding protein), VEGFA (vascular endothelial growth factor A), EGLN2 (egl-9 family hypoxia inducible factor 2), RPS27A (ribosomal protein S27a), HIF1AN (hypoxia inducible factor 1 subunit alpha inhibitor), EPO (erythropoietin), CA9 (carbonic anhydrase 9), CITED2 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2), UBE2D2 (ubiquitin conjugating enzyme E2 D2), UBE2D3 (ubiquitin conjugating enzyme E2 D3), LIMD1 (LIM domains containing 1), WTIP (WT1 interacting protein), HIGD1A (HIG1 hypoxia inducible domain family member 1A), ELOB (elongin B), SEM1 (SEM1 26S proteasome complex subunit), AJUBA (ajuba LIM protein), ELOC (elongin C)"], "WAG002290": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), HSPB1 (heat shock protein family B (small) member 1), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB1 (proteasome 20S subunit beta 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB4 (proteasome 20S subunit beta 4), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA2 (proteasome 20S subunit alpha 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA6 (proteasome 20S subunit alpha 6), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB3 (proteasome 20S subunit beta 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMA7 (proteasome 20S subunit alpha 7), PSMA5 (proteasome 20S subunit alpha 5), PSMA3 (proteasome 20S subunit alpha 3), PSMB2 (proteasome 20S subunit beta 2), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB5 (proteasome 20S subunit beta 5), PSMA1 (proteasome 20S subunit alpha 1), PSMA4 (proteasome 20S subunit alpha 4), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB6 (proteasome 20S subunit beta 6), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSME4 (proteasome activator subunit 4), PSMB7 (proteasome 20S subunit beta 7), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), HSPA8 (heat shock protein family A (Hsp70) member 8), UBB (ubiquitin B), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), TNPO1 (transportin 1), EXOSC8 (exosome component 8), KHSRP (KH-type splicing regulatory protein), DCP2 (decapping mRNA 2), EXOSC9 (exosome component 9), EXOSC5 (exosome component 5), EXOSC6 (exosome component 6), ZFP36L1 (ZFP36 ring finger protein like 1), EXOSC3 (exosome component 3), DIS3 (DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease), EXOSC2 (exosome component 2), AKT1 (AKT serine/threonine kinase 1), EXOSC4 (exosome component 4), EXOSC1 (exosome component 1), EXOSC7 (exosome component 7), XPO1 (exportin 1), XRN1 (5'-3' exoribonuclease 1), PARN (poly(A)-specific ribonuclease), ELAVL1 (ELAV like RNA binding protein 1), MAPK14 (mitogen-activated protein kinase 14), MAPKAPK2 (MAPK activated protein kinase 2), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), PRKCA (protein kinase C alpha), SET (SET nuclear proto-oncogene), PABPC1 (poly(A) binding protein cytoplasmic 1), PRKCD (protein kinase C delta), NUP214 (nucleoporin 214), ANP32A (acidic nuclear phosphoprotein 32 family member A), RPS27A (ribosomal protein S27a), MAPK11 (mitogen-activated protein kinase 11), TNFSF13 (TNF superfamily member 13), DCP1A (decapping mRNA 1A), HSPA1A (heat shock protein family A (Hsp70) member 1A), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002291": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), HRAS (HRas proto-oncogene, GTPase), MAPK1 (mitogen-activated protein kinase 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAPK3 (mitogen-activated protein kinase 3), NRAS (NRAS proto-oncogene, GTPase), EGFR (epidermal growth factor receptor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), SHC1 (SHC adaptor protein 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PSMA7 (proteasome 20S subunit alpha 7), PSMB5 (proteasome 20S subunit beta 5), PSMA2 (proteasome 20S subunit alpha 2), PSMA3 (proteasome 20S subunit alpha 3), PSMB1 (proteasome 20S subunit beta 1), PSMB2 (proteasome 20S subunit beta 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PSMA5 (proteasome 20S subunit alpha 5), PSMA6 (proteasome 20S subunit alpha 6), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB3 (proteasome 20S subunit beta 3), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD14 (proteasome 26S subunit, non-ATPase 14), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB4 (proteasome 20S subunit beta 4), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA1 (proteasome 20S subunit alpha 1), PSMC1 (proteasome 26S subunit, ATPase 1), PSMA4 (proteasome 20S subunit alpha 4), PSMB10 (proteasome 20S subunit beta 10), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB7 (proteasome 20S subunit beta 7), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB6 (proteasome 20S subunit beta 6), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD5 (proteasome 26S subunit, non-ATPase 5), FN1 (fibronectin 1), PSME1 (proteasome activator subunit 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSME4 (proteasome activator subunit 4), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), FYN (FYN proto-oncogene, Src family tyrosine kinase), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), RBX1 (ring-box 1), PSME3 (proteasome activator subunit 3), PTK2 (protein tyrosine kinase 2), MAP2K1 (mitogen-activated protein kinase kinase 1), JAK2 (Janus kinase 2), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), PSMB9 (proteasome 20S subunit beta 9), PSMB8 (proteasome 20S subunit beta 8), PDGFRB (platelet derived growth factor receptor beta), ERBB2 (erb-b2 receptor tyrosine kinase 2), PSME2 (proteasome activator subunit 2), SHC2 (SHC adaptor protein 2), IRS1 (insulin receptor substrate 1), JAK1 (Janus kinase 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MET (MET proto-oncogene, receptor tyrosine kinase), EGF (epidermal growth factor), PDGFRA (platelet derived growth factor receptor alpha), SHC3 (SHC adaptor protein 3), PPP2CB (protein phosphatase 2 catalytic subunit beta), FRS2 (fibroblast growth factor receptor substrate 2), PPP2CA (protein phosphatase 2 catalytic subunit alpha), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), RASA1 (RAS p21 protein activator 1), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), MAP2K2 (mitogen-activated protein kinase kinase 2), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), FGF1 (fibroblast growth factor 1), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), KIT (KIT proto-oncogene, receptor tyrosine kinase), ACTN2 (actinin alpha 2), CSK (C-terminal Src kinase), RET (ret proto-oncogene), SPTAN1 (spectrin alpha, non-erythrocytic 1), JAK3 (Janus kinase 3), IL2RB (interleukin 2 receptor subunit beta), DLG4 (discs large MAGUK scaffold protein 4), MAPK12 (mitogen-activated protein kinase 12), BRAF (B-Raf proto-oncogene, serine/threonine kinase), NCAM1 (neural cell adhesion molecule 1), IL2RG (interleukin 2 receptor subunit gamma), IL2 (interleukin 2), IRS2 (insulin receptor substrate 2)"], "WAG002292": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYO5A (myosin VA), EXOC4 (exocyst complex component 4), EXOC5 (exocyst complex component 5), EXOC6 (exocyst complex component 6), EXOC2 (exocyst complex component 2), EXOC3 (exocyst complex component 3), EXOC8 (exocyst complex component 8), EXOC7 (exocyst complex component 7), VAMP2 (vesicle associated membrane protein 2), KIF5B (kinesin family member 5B), EXOC1 (exocyst complex component 1), RAB27A (RAB27A, member RAS oncogene family), CPE (carboxypeptidase E), STX1A (syntaxin 1A), KIF5A (kinesin family member 5A), PCSK1 (proprotein convertase subtilisin/kexin type 1), MYRIP (myosin VIIA and Rab interacting protein), PCSK2 (proprotein convertase subtilisin/kexin type 2), KIF5C (kinesin family member 5C), INS (insulin), SLC30A7 (solute carrier family 30 member 7), ERO1B (endoplasmic reticulum oxidoreductase 1 beta), SLC30A8 (solute carrier family 30 member 8), SLC30A5 (solute carrier family 30 member 5), CLTRN (collectrin, amino acid transport regulator), ERO1A (endoplasmic reticulum oxidoreductase 1 alpha), SLC30A6 (solute carrier family 30 member 6)"], "WAG002295": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLD2 (phospholipase D2), LPCAT4 (lysophosphatidylcholine acyltransferase 4), PLD1 (phospholipase D1), CEPT1 (choline/ethanolamine phosphotransferase 1), LPCAT1 (lysophosphatidylcholine acyltransferase 1), PLA2G2A (phospholipase A2 group IIA), LPCAT2 (lysophosphatidylcholine acyltransferase 2), PTDSS1 (phosphatidylserine synthase 1), PLB1 (phospholipase B1), PLA2G2F (phospholipase A2 group IIF), CHPT1 (choline phosphotransferase 1), PISD (phosphatidylserine decarboxylase), PLA2G4A (phospholipase A2 group IVA), PLA2G10 (phospholipase A2 group X), PTDSS2 (phosphatidylserine synthase 2), PLA2G1B (phospholipase A2 group IB), PEMT (phosphatidylethanolamine N-methyltransferase), PLA2G5 (phospholipase A2 group V), PLA2G2D (phospholipase A2 group IID), PLA2G6 (phospholipase A2 group VI), PLA2G3 (phospholipase A2 group III), MBOAT1 (membrane bound O-acyltransferase domain containing 1), PLA2G2E (phospholipase A2 group IIE), MBOAT2 (membrane bound O-acyltransferase domain containing 2), CDS2 (CDP-diacylglycerol synthase 2), PLA2G15 (phospholipase A2 group XV), PLA2G4E (phospholipase A2 group IVE), AGPAT2 (1-acylglycerol-3-phosphate O-acyltransferase 2), PLA2G4D (phospholipase A2 group IVD), PLA2G12A (phospholipase A2 group XIIA), AGPAT3 (1-acylglycerol-3-phosphate O-acyltransferase 3), AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4), CDS1 (CDP-diacylglycerol synthase 1), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), LCLAT1 (lysocardiolipin acyltransferase 1), PLA2G4B (phospholipase A2 group IVB), GPAT2 (glycerol-3-phosphate acyltransferase 2, mitochondrial), LPCAT3 (lysophosphatidylcholine acyltransferase 3), AGPAT1 (1-acylglycerol-3-phosphate O-acyltransferase 1), LPIN1 (lipin 1), AGK (acylglycerol kinase), LPIN2 (lipin 2), ACHE (acetylcholinesterase (Cartwright blood group)), PCYT2 (phosphate cytidylyltransferase 2, ethanolamine), CHAT (choline O-acetyltransferase), AGPAT5 (1-acylglycerol-3-phosphate O-acyltransferase 5), PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), PLA2G4F (phospholipase A2 group IVF), DGAT1 (diacylglycerol O-acyltransferase 1), PLA2G4C (phospholipase A2 group IVC), PLBD1 (phospholipase B domain containing 1), PHOSPHO1 (phosphoethanolamine/phosphocholine phosphatase 1), CHKA (choline kinase alpha), PCYT1B (phosphate cytidylyltransferase 1, choline, beta), GNPAT (glyceronephosphate O-acyltransferase), MBOAT7 (membrane bound O-acyltransferase domain containing 7), CHKB (choline kinase beta), CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase), DGAT2 (diacylglycerol O-acyltransferase 2), PNPLA8 (patatin like phospholipase domain containing 8), LPGAT1 (lysophosphatidylglycerol acyltransferase 1), PGS1 (phosphatidylglycerophosphate synthase 1), PNPLA2 (patatin like phospholipase domain containing 2), GPD2 (glycerol-3-phosphate dehydrogenase 2), CRLS1 (cardiolipin synthase 1), PNPLA3 (patatin like phospholipase domain containing 3), GPCPD1 (glycerophosphocholine phosphodiesterase 1), GPD1 (glycerol-3-phosphate dehydrogenase 1), HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha), CSNK2B (casein kinase 2 beta), CSNK2A2 (casein kinase 2 alpha 2), TAZ (tafazzin), CPNE3 (copine 3), GPD1L (glycerol-3-phosphate dehydrogenase 1 like), CSNK2A1 (casein kinase 2 alpha 1), HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta), MGLL (monoglyceride lipase), ALPI (alkaline phosphatase, intestinal), PLA2R1 (phospholipase A2 receptor 1), CPNE7 (copine 7), CPNE6 (copine 6), ETNK1 (ethanolamine kinase 1), ETNK2 (ethanolamine kinase 2), SLC44A3 (solute carrier family 44 member 3), SLC44A2 (solute carrier family 44 member 2), SLC44A1 (solute carrier family 44 member 1), PLD4 (phospholipase D family member 4), PLD3 (phospholipase D family member 3), PLD6 (phospholipase D family member 6), SLC44A5 (solute carrier family 44 member 5), CPNE1 (copine 1), BCHE (butyrylcholinesterase), ABHD4 (abhydrolase domain containing 4, N-acyl phospholipase B), PITPNM2 (phosphatidylinositol transfer protein membrane associated 2), LIPH (lipase H), OSBPL5 (oxysterol binding protein like 5), PCTP (phosphatidylcholine transfer protein), STARD7 (StAR related lipid transfer domain containing 7), ABHD3 (abhydrolase domain containing 3, phospholipase), PLA1A (phospholipase A1 member A)"], "WAG002296": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IPMK (inositol polyphosphate multikinase), PLCG1 (phospholipase C gamma 1), ITPKA (inositol-trisphosphate 3-kinase A), ITPKB (inositol-trisphosphate 3-kinase B), PLCD1 (phospholipase C delta 1), PLCB1 (phospholipase C beta 1), PLCG2 (phospholipase C gamma 2), PLCB4 (phospholipase C beta 4), PLCE1 (phospholipase C epsilon 1), PLCD4 (phospholipase C delta 4), PLCD3 (phospholipase C delta 3), PLCB2 (phospholipase C beta 2), PTEN (phosphatase and tensin homolog), PLCB3 (phospholipase C beta 3), PLCZ1 (phospholipase C zeta 1), INPP5J (inositol polyphosphate-5-phosphatase J), SYNJ1 (synaptojanin 1), INPPL1 (inositol polyphosphate phosphatase like 1), MINPP1 (multiple inositol-polyphosphate phosphatase 1), ITPKC (inositol-trisphosphate 3-kinase C), INPP1 (inositol polyphosphate-1-phosphatase), INPP5B (inositol polyphosphate-5-phosphatase B), INPP5A (inositol polyphosphate-5-phosphatase A), OCRL (OCRL inositol polyphosphate-5-phosphatase), ITPK1 (inositol-tetrakisphosphate 1-kinase), IMPA1 (inositol monophosphatase 1), IMPA2 (inositol monophosphatase 2), INPP5D (inositol polyphosphate-5-phosphatase D), INPP4A (inositol polyphosphate-4-phosphatase type I A), INPP4B (inositol polyphosphate-4-phosphatase type II B), IP6K1 (inositol hexakisphosphate kinase 1), PPIP5K1 (diphosphoinositol pentakisphosphate kinase 1), IP6K2 (inositol hexakisphosphate kinase 2), PPIP5K2 (diphosphoinositol pentakisphosphate kinase 2), IP6K3 (inositol hexakisphosphate kinase 3), IPPK (inositol-pentakisphosphate 2-kinase), ISYNA1 (inositol-3-phosphate synthase 1), PLCH1 (phospholipase C eta 1), PLCH2 (phospholipase C eta 2), MIOX (myo-inositol oxygenase), MTMR9 (myotubularin related protein 9), MTMR7 (myotubularin related protein 7), NUDT11 (nudix hydrolase 11), NUDT10 (nudix hydrolase 10), NUDT3 (nudix hydrolase 3), NUDT4B (nudix hydrolase 4B), PLD4 (phospholipase D family member 4), CALM1 (calmodulin 1), NUDT4 (nudix hydrolase 4)"], "WAG002297": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TGFBR1 (transforming growth factor beta receptor 1), TGFBR2 (transforming growth factor beta receptor 2), TGFB1 (transforming growth factor beta 1), UBB (ubiquitin B), SMAD7 (SMAD family member 7), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), SMAD2 (SMAD family member 2), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), PARD3 (par-3 family cell polarity regulator), NEDD4L (NEDD4 like E3 ubiquitin protein ligase), PRKCZ (protein kinase C zeta), USP15 (ubiquitin specific peptidase 15), PARD6A (par-6 family cell polarity regulator alpha), UCHL5 (ubiquitin C-terminal hydrolase L5), ARHGEF18 (Rho/Rac guanine nucleotide exchange factor 18), F11R (F11 receptor), CGN (cingulin), RPS27A (ribosomal protein S27a), XPO1 (exportin 1), STUB1 (STIP1 homology and U-box containing protein 1), RHOA (ras homolog family member A), PPP1CC (protein phosphatase 1 catalytic subunit gamma), STRAP (serine/threonine kinase receptor associated protein), PPP1R15A (protein phosphatase 1 regulatory subunit 15A), PPP1CB (protein phosphatase 1 catalytic subunit beta), FKBP1A (FKBP prolyl isomerase 1A), CBL (Cbl proto-oncogene), PPP1CA (protein phosphatase 1 catalytic subunit alpha), NEDD8 (NEDD8 ubiquitin like modifier), BAMBI (BMP and activin membrane bound inhibitor), UBE2M (ubiquitin conjugating enzyme E2 M), MTMR4 (myotubularin related protein 4), FURIN (furin, paired basic amino acid cleaving enzyme), PMEPA1 (prostate transmembrane protein, androgen induced 1)"], "WAG002298": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DCN (decorin), BGN (biglycan), VCAN (versican), SDC2 (syndecan 2), BCAN (brevican), NCAN (neurocan), SDC4 (syndecan 4), CSPG4 (chondroitin sulfate proteoglycan 4), CSPG5 (chondroitin sulfate proteoglycan 5), SDC1 (syndecan 1), SDC3 (syndecan 3), HSPG2 (heparan sulfate proteoglycan 2), GPC2 (glypican 2), GPC3 (glypican 3), GPC5 (glypican 5), GPC4 (glypican 4), AGRN (agrin), GPC6 (glypican 6), GPC1 (glypican 1), NDST1 (N-deacetylase and N-sulfotransferase 1), NDST2 (N-deacetylase and N-sulfotransferase 2), B4GALT7 (beta-1,4-galactosyltransferase 7), B3GALT6 (beta-1,3-galactosyltransferase 6), IDUA (alpha-L-iduronidase), CSGALNACT1 (chondroitin sulfate N-acetylgalactosaminyltransferase 1), GLCE (glucuronic acid epimerase), CHSY1 (chondroitin sulfate synthase 1), HS3ST1 (heparan sulfate-glucosamine 3-sulfotransferase 1), LUM (lumican), HS3ST3A1 (heparan sulfate-glucosamine 3-sulfotransferase 3A1), CHPF (chondroitin polymerizing factor), PRELP (proline and arginine rich end leucine rich repeat protein), CHSY3 (chondroitin sulfate synthase 3), EXT2 (exostosin glycosyltransferase 2), KERA (keratocan), FMOD (fibromodulin), HS6ST1 (heparan sulfate 6-O-sulfotransferase 1), EXT1 (exostosin glycosyltransferase 1), UST (uronyl 2-sulfotransferase), OGN (osteoglycin), HS3ST2 (heparan sulfate-glucosamine 3-sulfotransferase 2), CHST11 (carbohydrate sulfotransferase 11), CHST13 (carbohydrate sulfotransferase 13), CHST12 (carbohydrate sulfotransferase 12), OMD (osteomodulin), CHST3 (carbohydrate sulfotransferase 3), ST3GAL2 (ST3 beta-galactoside alpha-2,3-sialyltransferase 2), HS2ST1 (heparan sulfate 2-O-sulfotransferase 1), ST3GAL6 (ST3 beta-galactoside alpha-2,3-sialyltransferase 6), B3GNT3 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3), CHST7 (carbohydrate sulfotransferase 7), HPSE (heparanase), DSE (dermatan sulfate epimerase), B4GALT1 (beta-1,4-galactosyltransferase 1), ARSB (arylsulfatase B), CHPF2 (chondroitin polymerizing factor 2), HS6ST2 (heparan sulfate 6-O-sulfotransferase 2), B3GNT2 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2), CD44 (CD44 molecule (Indian blood group)), HPSE2 (heparanase 2 (inactive)), B4GALT3 (beta-1,4-galactosyltransferase 3), HEXB (hexosaminidase subunit beta), HEXA (hexosaminidase subunit alpha), ST3GAL1 (ST3 beta-galactoside alpha-2,3-sialyltransferase 1), CHST6 (carbohydrate sulfotransferase 6), CHST15 (carbohydrate sulfotransferase 15), CHST5 (carbohydrate sulfotransferase 5), CHST2 (carbohydrate sulfotransferase 2), ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4), B3GNT4 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4), B4GALT4 (beta-1,4-galactosyltransferase 4), B4GALT6 (beta-1,4-galactosyltransferase 6), NDST3 (N-deacetylase and N-sulfotransferase 3), NDST4 (N-deacetylase and N-sulfotransferase 4), CHST14 (carbohydrate sulfotransferase 14), ST3GAL3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3), CHST1 (carbohydrate sulfotransferase 1), GLB1 (galactosidase beta 1), B4GALT2 (beta-1,4-galactosyltransferase 2), CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2), HYAL2 (hyaluronidase 2), IDS (iduronate 2-sulfatase), B3GAT3 (beta-1,3-glucuronyltransferase 3), GUSB (glucuronidase beta), SLC9A1 (solute carrier family 9 member A1), HMMR (hyaluronan mediated motility receptor), B3GNT7 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7), HS6ST3 (heparan sulfate 6-O-sulfotransferase 3), LYVE1 (lymphatic vessel endothelial hyaluronan receptor 1), B3GAT1 (beta-1,3-glucuronyltransferase 1), B3GAT2 (beta-1,3-glucuronyltransferase 2), GNS (glucosamine (N-acetyl)-6-sulfatase), STAB2 (stabilin 2), PAPSS2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2), HAS2 (hyaluronan synthase 2), PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1), NAGLU (N-acetyl-alpha-glucosaminidase), HYAL1 (hyaluronidase 1), SGSH (N-sulfoglucosamine sulfohydrolase), HAS3 (hyaluronan synthase 3)"], "WAG002299": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SLC4A1 (solute carrier family 4 member 1 (Diego blood group)), CA2 (carbonic anhydrase 2), CA4 (carbonic anhydrase 4), CA1 (carbonic anhydrase 1), HBA2 (hemoglobin subunit alpha 2), HBB (hemoglobin subunit beta), RHAG (Rh associated glycoprotein), CYB5R2 (cytochrome b5 reductase 2), CYB5RL (cytochrome b5 reductase like), AQP1 (aquaporin 1 (Colton blood group)), CYB5R1 (cytochrome b5 reductase 1), CYB5R4 (cytochrome b5 reductase 4), HBA1 (hemoglobin subunit alpha 1)"], "WAG002300": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CUL1 (cullin 1), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), SKP1 (S-phase kinase associated protein 1), PSMA4 (proteasome 20S subunit alpha 4), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA7 (proteasome 20S subunit alpha 7), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA2 (proteasome 20S subunit alpha 2), PSMA6 (proteasome 20S subunit alpha 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA3 (proteasome 20S subunit alpha 3), PSMB5 (proteasome 20S subunit beta 5), PSMA1 (proteasome 20S subunit alpha 1), PSMB2 (proteasome 20S subunit beta 2), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMA5 (proteasome 20S subunit alpha 5), PSMB1 (proteasome 20S subunit beta 1), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA8 (proteasome 20S subunit alpha 8), PSME4 (proteasome activator subunit 4), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMC4 (proteasome 26S subunit, ATPase 4), PSMF1 (proteasome inhibitor subunit 1), PSME1 (proteasome activator subunit 1), PSMB11 (proteasome subunit beta 11), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), SYK (spleen associated tyrosine kinase), PLCG2 (phospholipase C gamma 2), NFKB1 (nuclear factor kappa B subunit 1), NFKBIA (NFKB inhibitor alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), BTK (Bruton tyrosine kinase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CD79A (CD79a molecule), RELA (RELA proto-oncogene, NF-kB subunit), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), FYN (FYN proto-oncogene, Src family tyrosine kinase), VAV1 (vav guanine nucleotide exchange factor 1), CD79B (CD79b molecule), LYN (LYN proto-oncogene, Src family tyrosine kinase), SH3KBP1 (SH3 domain containing kinase binding protein 1), NCK1 (NCK adaptor protein 1), BLNK (B cell linker), DAPP1 (dual adaptor of phosphotyrosine and 3-phosphoinositides 1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), PRKCB (protein kinase C beta), CD19 (CD19 molecule), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MALT1 (MALT1 paracaspase), PTPN6 (protein tyrosine phosphatase non-receptor type 6), PIK3AP1 (phosphoinositide-3-kinase adaptor protein 1), HRAS (HRas proto-oncogene, GTPase), NFKBIB (NFKB inhibitor beta), PPP3CA (protein phosphatase 3 catalytic subunit alpha), NFKBIE (NFKB inhibitor epsilon), BCL10 (BCL10 immune signaling adaptor), CARD11 (caspase recruitment domain family member 11), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), REL (REL proto-oncogene, NF-kB subunit), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), RPS27A (ribosomal protein S27a), BLK (BLK proto-oncogene, Src family tyrosine kinase), FKBP1A (FKBP prolyl isomerase 1A), NRAS (NRAS proto-oncogene, GTPase), FBXW11 (F-box and WD repeat domain containing 11), NFATC1 (nuclear factor of activated T cells 1), PPIA (peptidylprolyl isomerase A), PPP3CB (protein phosphatase 3 catalytic subunit beta), CD22 (CD22 molecule), NFATC2 (nuclear factor of activated T cells 2), NFATC3 (nuclear factor of activated T cells 3), RASGRP1 (RAS guanyl releasing protein 1), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2)"], "WAG002301": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTEN (phosphatase and tensin homolog), SYNJ1 (synaptojanin 1), PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta), SYNJ2 (synaptojanin 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), INPP4A (inositol polyphosphate-4-phosphatase type I A), INPP4B (inositol polyphosphate-4-phosphatase type II B), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), OCRL (OCRL inositol polyphosphate-5-phosphatase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PI4K2A (phosphatidylinositol 4-kinase type 2 alpha), PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), PI4K2B (phosphatidylinositol 4-kinase type 2 beta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), INPP5E (inositol polyphosphate-5-phosphatase E), PI4KA (phosphatidylinositol 4-kinase alpha), PIK3C2G (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma), PIK3C2B (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta), PIKFYVE (phosphoinositide kinase, FYVE-type zinc finger containing), PI4KB (phosphatidylinositol 4-kinase beta), PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha), PIP4K2B (phosphatidylinositol-5-phosphate 4-kinase type 2 beta), INPP5D (inositol polyphosphate-5-phosphatase D), PIP4K2C (phosphatidylinositol-5-phosphate 4-kinase type 2 gamma), SACM1L (SAC1 like phosphatidylinositide phosphatase), MTM1 (myotubularin 1), MTMR2 (myotubularin related protein 2), PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha), MTMR3 (myotubularin related protein 3), MTMR6 (myotubularin related protein 6), MTMR1 (myotubularin related protein 1), MTMR14 (myotubularin related protein 14), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), FIG4 (FIG4 phosphoinositide 5-phosphatase), INPP5J (inositol polyphosphate-5-phosphatase J), VAC14 (VAC14 component of PIKFYVE complex), INPP5K (inositol polyphosphate-5-phosphatase K), INPPL1 (inositol polyphosphate phosphatase like 1), MTMR9 (myotubularin related protein 9), MTMR4 (myotubularin related protein 4), RAB5A (RAB5A, member RAS oncogene family), ARF1 (ADP ribosylation factor 1), RUFY1 (RUN and FYVE domain containing 1), SBF1 (SET binding factor 1), MTMR7 (myotubularin related protein 7), INPP5F (inositol polyphosphate-5-phosphatase F), MTMR12 (myotubularin related protein 12), RAB4A (RAB4A, member RAS oncogene family), RAB14 (RAB14, member RAS oncogene family), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), MTMR8 (myotubularin related protein 8), PTPN13 (protein tyrosine phosphatase non-receptor type 13), PIK3R6 (phosphoinositide-3-kinase regulatory subunit 6), SBF2 (SET binding factor 2), BMX (BMX non-receptor tyrosine kinase), PLEKHA6 (pleckstrin homology domain containing A6), PLEKHA5 (pleckstrin homology domain containing A5), PLEKHA1 (pleckstrin homology domain containing A1), PLEKHA8 (pleckstrin homology domain containing A8), GDPD5 (glycerophosphodiester phosphodiesterase domain containing 5), ARF3 (ADP ribosylation factor 3), GDPD1 (glycerophosphodiester phosphodiesterase domain containing 1), TPTE (transmembrane phosphatase with tensin homology), GDE1 (glycerophosphodiester phosphodiesterase 1), TNFAIP8L2 (TNF alpha induced protein 8 like 2), TNFAIP8 (TNF alpha induced protein 8), TNFAIP8L3 (TNF alpha induced protein 8 like 3), PLEKHA3 (pleckstrin homology domain containing A3), PITPNB (phosphatidylinositol transfer protein beta), GDPD3 (glycerophosphodiester phosphodiesterase domain containing 3), PNPLA7 (patatin like phospholipase domain containing 7), PNPLA6 (patatin like phospholipase domain containing 6), MTMR10 (myotubularin related protein 10), PLEKHA4 (pleckstrin homology domain containing A4), PIP4P1 (phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1), TPTE2 (transmembrane phosphoinositide 3-phosphatase and tensin homolog 2), ENPP6 (ectonucleotide pyrophosphatase/phosphodiesterase 6), TNFAIP8L1 (TNF alpha induced protein 8 like 1)"], "WAG002302": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), MTOR (mechanistic target of rapamycin kinase), STK11 (serine/threonine kinase 11), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), RHEB (Ras homolog, mTORC1 binding), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), RPTOR (regulatory associated protein of MTOR complex 1), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), CAB39 (calcium binding protein 39), TSC1 (TSC complex subunit 1), RRAGC (Ras related GTP binding C), STRADB (STE20 related adaptor beta), CAB39L (calcium binding protein 39 like), PPM1A (protein phosphatase, Mg2+/Mn2+ dependent 1A), RRAGD (Ras related GTP binding D), RRAGB (Ras related GTP binding B), TSC2 (TSC complex subunit 2), LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1), LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2), MLST8 (MTOR associated protein, LST8 homolog), RRAGA (Ras related GTP binding A), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5), STRADA (STE20 related adaptor alpha), SLC38A9 (solute carrier family 38 member 9), LAMTOR4 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 4)"], "WAG002304": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CREBBP (CREB binding protein), RXRA (retinoid X receptor alpha), EP300 (E1A binding protein p300), MED26 (mediator complex subunit 26), CDK8 (cyclin dependent kinase 8), MED29 (mediator complex subunit 29), MED6 (mediator complex subunit 6), MED17 (mediator complex subunit 17), MED23 (mediator complex subunit 23), MED15 (mediator complex subunit 15), MED19 (mediator complex subunit 19), MED8 (mediator complex subunit 8), MED18 (mediator complex subunit 18), MED10 (mediator complex subunit 10), MED4 (mediator complex subunit 4), MED12 (mediator complex subunit 12), MED9 (mediator complex subunit 9), MED7 (mediator complex subunit 7), MED13 (mediator complex subunit 13), MED16 (mediator complex subunit 16), MED22 (mediator complex subunit 22), MED30 (mediator complex subunit 30), MED11 (mediator complex subunit 11), MED20 (mediator complex subunit 20), CDK19 (cyclin dependent kinase 19), HDAC3 (histone deacetylase 3), NCOA3 (nuclear receptor coactivator 3), MED21 (mediator complex subunit 21), NCOA1 (nuclear receptor coactivator 1), MED27 (mediator complex subunit 27), MED31 (mediator complex subunit 31), NCOA2 (nuclear receptor coactivator 2), CCNC (cyclin C), PPARGC1A (PPARG coactivator 1 alpha), NCOR2 (nuclear receptor corepressor 2), MED13L (mediator complex subunit 13L), FABP4 (fatty acid binding protein 4), CEBPB (CCAAT enhancer binding protein beta), PPARA (peroxisome proliferator activated receptor alpha), NCOA6 (nuclear receptor coactivator 6), TGFB1 (transforming growth factor beta 1), EBF1 (EBF transcription factor 1), CARM1 (coactivator associated arginine methyltransferase 1), TBL1XR1 (TBL1X receptor 1), ADIPOQ (adiponectin, C1Q and collagen domain containing), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), CEBPD (CCAAT enhancer binding protein delta), TGS1 (trimethylguanosine synthase 1), CD36 (CD36 molecule), CHD9 (chromodomain helicase DNA binding protein 9), ANGPTL4 (angiopoietin like 4), LPL (lipoprotein lipase), LEP (leptin), KLF4 (Kruppel like factor 4), WNT1 (Wnt family member 1), WNT10B (Wnt family member 10B), EGR2 (early growth response 2), SLC2A4 (solute carrier family 2 member 4), CDK4 (cyclin dependent kinase 4), PLIN1 (perilipin 1), CCND3 (cyclin D3), PCK1 (phosphoenolpyruvate carboxykinase 1), PPARG (peroxisome proliferator activated receptor gamma), MED28 (mediator complex subunit 28), RELA (RELA proto-oncogene, NF-kB subunit), MED25 (mediator complex subunit 25), NFKB1 (nuclear factor kappa B subunit 1), THRAP3 (thyroid hormone receptor associated protein 3), SREBF2 (sterol regulatory element binding transcription factor 2), NCOR1 (nuclear receptor corepressor 1), TNF (tumor necrosis factor), KLF5 (Kruppel like factor 5), NR2F2 (nuclear receptor subfamily 2 group F member 2), CEBPA (CCAAT enhancer binding protein alpha), TBL1X (transducin beta like 1 X-linked), FAM120B (family with sequence similarity 120B), HELZ2 (helicase with zinc finger 2), ZNF638 (zinc finger protein 638), MED1 (mediator complex subunit 1), MED14 (mediator complex subunit 14), ZNF467 (zinc finger protein 467), ADIRF (adipogenesis regulatory factor), MED24 (mediator complex subunit 24)"], "WAG002305": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TRAF6 (TNF receptor associated factor 6), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TICAM1 (toll like receptor adaptor molecule 1), RIPK1 (receptor interacting serine/threonine kinase 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), BIRC2 (baculoviral IAP repeat containing 2), UBB (ubiquitin B), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), TRAF3 (TNF receptor associated factor 3), BIRC3 (baculoviral IAP repeat containing 3), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), TLR4 (toll like receptor 4), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TBK1 (TANK binding kinase 1), CASP8 (caspase 8), TANK (TRAF family member associated NFKB activator), IRF7 (interferon regulatory factor 7), IRF3 (interferon regulatory factor 3), UBE2N (ubiquitin conjugating enzyme E2 N), IRAK2 (interleukin 1 receptor associated kinase 2), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), FADD (Fas associated via death domain), RIPK3 (receptor interacting serine/threonine kinase 3), UBE2V1 (ubiquitin conjugating enzyme E2 V1), TICAM2 (toll like receptor adaptor molecule 2), LY96 (lymphocyte antigen 96), UBE2D3 (ubiquitin conjugating enzyme E2 D3), UBE2D2 (ubiquitin conjugating enzyme E2 D2), UBE2D1 (ubiquitin conjugating enzyme E2 D1), RPS27A (ribosomal protein S27a), PTPN11 (protein tyrosine phosphatase non-receptor type 11), CD14 (CD14 molecule)"], "WAG002306": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EXOSC3 (exosome component 3), EXOSC9 (exosome component 9), EXOSC2 (exosome component 2), EXOSC5 (exosome component 5), EXOSC6 (exosome component 6), EXOSC4 (exosome component 4), DIS3 (DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease), EXOSC8 (exosome component 8), EXOSC7 (exosome component 7), EXOSC1 (exosome component 1), KHSRP (KH-type splicing regulatory protein), DCP2 (decapping mRNA 2), PARN (poly(A)-specific ribonuclease), DDIT3 (DNA damage inducible transcript 3), ATF4 (activating transcription factor 4), ATF3 (activating transcription factor 3), CEBPB (CCAAT enhancer binding protein beta), NFYC (nuclear transcription factor Y subunit gamma), CEBPG (CCAAT enhancer binding protein gamma), NFYA (nuclear transcription factor Y subunit alpha), ATF6 (activating transcription factor 6), NFYB (nuclear transcription factor Y subunit beta), CCL2 (C-C motif chemokine ligand 2), IGFBP1 (insulin like growth factor binding protein 1), HERPUD1 (homocysteine inducible ER protein with ubiquitin like domain 1), ASNS (asparagine synthetase (glutamine-hydrolyzing)), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002308": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), SMAD4 (SMAD family member 4), SMAD2 (SMAD family member 2), SMAD3 (SMAD family member 3), MYC (MYC proto-oncogene, bHLH transcription factor), HDAC1 (histone deacetylase 1), SNW1 (SNW domain containing 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), SKIL (SKI like proto-oncogene), SMAD7 (SMAD family member 7), UBB (ubiquitin B), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), SP1 (Sp1 transcription factor), RNF111 (ring finger protein 111), RBL1 (RB transcriptional corepressor like 1), SKI (SKI proto-oncogene), E2F4 (E2F transcription factor 4), NEDD4L (NEDD4 like E3 ubiquitin protein ligase), TFDP1 (transcription factor Dp-1), CDK9 (cyclin dependent kinase 9), NCOR1 (nuclear receptor corepressor 1), TRIM33 (tripartite motif containing 33), NCOR2 (nuclear receptor corepressor 2), E2F5 (E2F transcription factor 5), CDK8 (cyclin dependent kinase 8), UBE2D3 (ubiquitin conjugating enzyme E2 D3), TFDP2 (transcription factor Dp-2), SERPINE1 (serpin family E member 1), RPS27A (ribosomal protein S27a), TGIF1 (TGFB induced factor homeobox 1), CCNT1 (cyclin T1), PARP1 (poly(ADP-ribose) polymerase 1), UBE2D1 (ubiquitin conjugating enzyme E2 D1), MEN1 (menin 1), CDKN2B (cyclin dependent kinase inhibitor 2B), WWTR1 (WW domain containing transcription regulator 1), TGIF2 (TGFB induced factor homeobox 2), USP9X (ubiquitin specific peptidase 9 X-linked), PPM1A (protein phosphatase, Mg2+/Mn2+ dependent 1A), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), CCNK (cyclin K), CCNC (cyclin C), CCNT2 (cyclin T2), ATP1B4 (ATPase Na+/K+ transporting family member beta 4)"], "WAG002309": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PLK1 (polo like kinase 1), CDC20 (cell division cycle 20), BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B), AURKB (aurora kinase B), BUB3 (BUB3 mitotic checkpoint protein), CDK1 (cyclin dependent kinase 1), UBE2C (ubiquitin conjugating enzyme E2 C), CDC16 (cell division cycle 16), CDC27 (cell division cycle 27), XPO1 (exportin 1), BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), NDC80 (NDC80 kinetochore complex component), CDC23 (cell division cycle 23), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA3 (proteasome 20S subunit alpha 3), CDCA8 (cell division cycle associated 8), CENPF (centromere protein F), BIRC5 (baculoviral IAP repeat containing 5), ANAPC1 (anaphase promoting complex subunit 1), NUP37 (nucleoporin 37), PSMC2 (proteasome 26S subunit, ATPase 2), ANAPC2 (anaphase promoting complex subunit 2), ANAPC4 (anaphase promoting complex subunit 4), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD1 (proteasome 26S subunit, non-ATPase 1), PTTG1 (PTTG1 regulator of sister chromatid separation, securin), PPP1CC (protein phosphatase 1 catalytic subunit gamma), KNTC1 (kinetochore associated 1), PSMA2 (proteasome 20S subunit alpha 2), PSMC3 (proteasome 26S subunit, ATPase 3), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), MAPRE1 (microtubule associated protein RP/EB family member 1), PSMB4 (proteasome 20S subunit beta 4), ANAPC10 (anaphase promoting complex subunit 10), NUP107 (nucleoporin 107), UBB (ubiquitin B), NUP85 (nucleoporin 85), CENPE (centromere protein E), ANAPC5 (anaphase promoting complex subunit 5), PSMB2 (proteasome 20S subunit beta 2), PSMA4 (proteasome 20S subunit alpha 4), CKAP5 (cytoskeleton associated protein 5), PSMD11 (proteasome 26S subunit, non-ATPase 11), ANAPC11 (anaphase promoting complex subunit 11), PSMA6 (proteasome 20S subunit alpha 6), ANAPC7 (anaphase promoting complex subunit 7), CDC26 (cell division cycle 26), PSMA7 (proteasome 20S subunit alpha 7), PSMB3 (proteasome 20S subunit beta 3), PSMA1 (proteasome 20S subunit alpha 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMC4 (proteasome 26S subunit, ATPase 4), ZWINT (ZW10 interacting kinetochore protein), KIF2C (kinesin family member 2C), PSMB1 (proteasome 20S subunit beta 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), NUP43 (nucleoporin 43), PSMB5 (proteasome 20S subunit beta 5), PSMB7 (proteasome 20S subunit beta 7), PSMC5 (proteasome 26S subunit, ATPase 5), NUF2 (NUF2 component of NDC80 kinetochore complex), PSMD8 (proteasome 26S subunit, non-ATPase 8), RANGAP1 (Ran GTPase activating protein 1), PSME1 (proteasome activator subunit 1), KIF18A (kinesin family member 18A), PSMA5 (proteasome 20S subunit alpha 5), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB10 (proteasome 20S subunit beta 10), CLASP1 (cytoplasmic linker associated protein 1), PSMD3 (proteasome 26S subunit, non-ATPase 3), CENPN (centromere protein N), PSMC6 (proteasome 26S subunit, ATPase 6), CENPA (centromere protein A), SPC25 (SPC25 component of NDC80 kinetochore complex), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB6 (proteasome 20S subunit beta 6), NUP160 (nucleoporin 160), NUP133 (nucleoporin 133), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSME4 (proteasome activator subunit 4), CENPH (centromere protein H), ZWILCH (zwilch kinetochore protein), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), CCNB1 (cyclin B1), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), SKA1 (spindle and kinetochore associated complex subunit 1), UBE2E1 (ubiquitin conjugating enzyme E2 E1), PSMD10 (proteasome 26S subunit, non-ATPase 10), INCENP (inner centromere protein), CENPK (centromere protein K), ZW10 (zw10 kinetochore protein), PSME3 (proteasome activator subunit 3), CENPM (centromere protein M), SPC24 (SPC24 component of NDC80 kinetochore complex), DSN1 (DSN1 component of MIS12 kinetochore complex)"], "WAG002310": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), TRAF6 (TNF receptor associated factor 6), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), CUL1 (cullin 1), SKP1 (S-phase kinase associated protein 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA2 (proteasome 20S subunit alpha 2), PSMB5 (proteasome 20S subunit beta 5), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA3 (proteasome 20S subunit alpha 3), PSMA1 (proteasome 20S subunit alpha 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA6 (proteasome 20S subunit alpha 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMA7 (proteasome 20S subunit alpha 7), PSMB2 (proteasome 20S subunit beta 2), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC5 (proteasome 26S subunit, ATPase 5), PAK2 (p21 (RAC1) activated kinase 2), PSMB4 (proteasome 20S subunit beta 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMB6 (proteasome 20S subunit beta 6), PSMB10 (proteasome 20S subunit beta 10), PSMB3 (proteasome 20S subunit beta 3), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB1 (proteasome 20S subunit beta 1), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB7 (proteasome 20S subunit beta 7), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMA8 (proteasome 20S subunit alpha 8), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSME1 (proteasome activator subunit 1), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), SYK (spleen associated tyrosine kinase), PLCG1 (phospholipase C gamma 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), NFKB1 (nuclear factor kappa B subunit 1), NFKBIA (NFKB inhibitor alpha), MAPK1 (mitogen-activated protein kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), RAC1 (Rac family small GTPase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), BTK (Bruton tyrosine kinase), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), VAV1 (vav guanine nucleotide exchange factor 1), RELA (RELA proto-oncogene, NF-kB subunit), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), UBE2D1 (ubiquitin conjugating enzyme E2 D1), MAPK3 (mitogen-activated protein kinase 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), HRAS (HRas proto-oncogene, GTPase), PLCG2 (phospholipase C gamma 2), LYN (LYN proto-oncogene, Src family tyrosine kinase), PRKCQ (protein kinase C theta), MAPK8 (mitogen-activated protein kinase 8), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), VAV2 (vav guanine nucleotide exchange factor 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), LCP2 (lymphocyte cytosolic protein 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), ITK (IL2 inducible T cell kinase), GAB2 (GRB2 associated binding protein 2), FCER1G (Fc fragment of IgE receptor Ig), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), BCL10 (BCL10 immune signaling adaptor), MALT1 (MALT1 paracaspase), NRAS (NRAS proto-oncogene, GTPase), FCER1A (Fc fragment of IgE receptor Ia), TEC (tec protein tyrosine kinase), TEC (transient erythroblastopenia of childhood), MAPK10 (mitogen-activated protein kinase 10), MAP2K4 (mitogen-activated protein kinase kinase 4), VAV3 (vav guanine nucleotide exchange factor 3), GRAP2 (GRB2 related adaptor protein 2), MAPK9 (mitogen-activated protein kinase 9), CARD11 (caspase recruitment domain family member 11)"], "WAG002312": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), UBC (ubiquitin C), IRAK1 (interleukin 1 receptor associated kinase 1), MYD88 (MYD88 innate immune signal transduction adaptor), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IRAK2 (interleukin 1 receptor associated kinase 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), TIRAP (TIR domain containing adaptor protein), TLR4 (toll like receptor 4), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IRAK4 (interleukin 1 receptor associated kinase 4), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), IRAK3 (interleukin 1 receptor associated kinase 3), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PELI1 (pellino E3 ubiquitin protein ligase 1), UBB (ubiquitin B), BTK (Bruton tyrosine kinase), LY96 (lymphocyte antigen 96), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), PELI3 (pellino E3 ubiquitin protein ligase family member 3), TLR1 (toll like receptor 1), UBE2N (ubiquitin conjugating enzyme E2 N), PELI2 (pellino E3 ubiquitin protein ligase family member 2), TLR6 (toll like receptor 6), TLR2 (toll like receptor 2), ECSIT (ECSIT signaling integrator), CD14 (CD14 molecule), UBE2V1 (ubiquitin conjugating enzyme E2 V1), SIGIRR (single Ig and TIR domain containing), RPS27A (ribosomal protein S27a), SOCS1 (suppressor of cytokine signaling 1), CD36 (CD36 molecule)"], "WAG002314": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), RIPK2 (receptor interacting serine/threonine kinase 2), CASP8 (caspase 8), NFKB1 (nuclear factor kappa B subunit 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), RELA (RELA proto-oncogene, NF-kB subunit), BIRC3 (baculoviral IAP repeat containing 3), CASP1 (caspase 1), BIRC2 (baculoviral IAP repeat containing 2), MAPK14 (mitogen-activated protein kinase 14), TNFAIP3 (TNF alpha induced protein 3), APP (amyloid beta precursor protein), IRAK1 (interleukin 1 receptor associated kinase 1), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), BCL2 (BCL2 apoptosis regulator), MAP2K6 (mitogen-activated protein kinase kinase 6), NLRP3 (NLR family pyrin domain containing 3), PYCARD (PYD and CARD domain containing), MAPK11 (mitogen-activated protein kinase 11), NOD1 (nucleotide binding oligomerization domain containing 1), NOD2 (nucleotide binding oligomerization domain containing 2), NLRP1 (NLR family pyrin domain containing 1), NFKB2 (nuclear factor kappa B subunit 2), IRAK2 (interleukin 1 receptor associated kinase 2), CASP9 (caspase 9), MAPK13 (mitogen-activated protein kinase 13), ITCH (itchy E3 ubiquitin protein ligase), CASP2 (caspase 2), CARD9 (caspase recruitment domain family member 9), BCL2L1 (BCL2 like 1), HSP90AB1 (heat shock protein 90 alpha family class B member 1), MAPK12 (mitogen-activated protein kinase 12), NLRC4 (NLR family CARD domain containing 4), UBE2V1 (ubiquitin conjugating enzyme E2 V1), UBE2N (ubiquitin conjugating enzyme E2 N), CASP4 (caspase 4), CYLD (CYLD lysine 63 deubiquitinase), MEFV (MEFV innate immuity regulator, pyrin), SUGT1 (SGT1 homolog, MIS12 kinetochore complex assembly cochaperone), TXN (thioredoxin), TXNIP (thioredoxin interacting protein), PANX1 (pannexin 1), AIM2 (absent in melanoma 2), P2RX7 (purinergic receptor P2X 7), PSTPIP1 (proline-serine-threonine phosphatase interacting protein 1), AAMP (angio associated migratory cell protein)"], "WAG002316": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DLD (dihydrolipoamide dehydrogenase), DLAT (dihydrolipoamide S-acetyltransferase), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), PDHB (pyruvate dehydrogenase E1 subunit beta), OGDH (oxoglutarate dehydrogenase), PDHX (pyruvate dehydrogenase complex component X), CS (citrate synthase), MDH2 (malate dehydrogenase 2), ME1 (malic enzyme 1), SDHB (succinate dehydrogenase complex iron sulfur subunit B), ME3 (malic enzyme 3), IDH3A (isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha), ME2 (malic enzyme 2), PDHA2 (pyruvate dehydrogenase E1 subunit alpha 2), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), IDH3G (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma), IDH3B (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta), LDHA (lactate dehydrogenase A), LDHB (lactate dehydrogenase B), SDHC (succinate dehydrogenase complex subunit C), SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha), SUCLA2 (succinate-CoA ligase ADP-forming subunit beta), LDHC (lactate dehydrogenase C), LDHAL6B (lactate dehydrogenase A like 6B), DLST (dihydrolipoamide S-succinyltransferase), ACO2 (aconitase 2), FH (fumarate hydratase), PDK2 (pyruvate dehydrogenase kinase 2), SUCLG2 (succinate-CoA ligase GDP-forming subunit beta), SDHD (succinate dehydrogenase complex subunit D), PDK4 (pyruvate dehydrogenase kinase 4), PDK3 (pyruvate dehydrogenase kinase 3), LDHAL6A (lactate dehydrogenase A like 6A), SDHA (succinate dehydrogenase complex flavoprotein subunit A), PDP1 (pyruvate dehyrogenase phosphatase catalytic subunit 1), PDK1 (pyruvate dehydrogenase kinase 1), BSG (basigin (Ok blood group)), SLC16A3 (solute carrier family 16 member 3), SLC16A1 (solute carrier family 16 member 1), SLC16A8 (solute carrier family 16 member 8), NNT (nicotinamide nucleotide transhydrogenase), PDP2 (pyruvate dehyrogenase phosphatase catalytic subunit 2), VDAC1 (voltage dependent anion channel 1), PPARD (peroxisome proliferator activated receptor delta), D2HGDH (D-2-hydroxyglutarate dehydrogenase), RXRA (retinoid X receptor alpha), L2HGDH (L-2-hydroxyglutarate dehydrogenase), GLO1 (glyoxalase I), ADHFE1 (alcohol dehydrogenase iron containing 1), MPC1 (mitochondrial pyruvate carrier 1), GSTZ1 (glutathione S-transferase zeta 1), MPC2 (mitochondrial pyruvate carrier 2), FAHD1 (fumarylacetoacetate hydrolase domain containing 1), PDPR (pyruvate dehydrogenase phosphatase regulatory subunit)"], "WAG002317": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), UBC (ubiquitin C), IRAK1 (interleukin 1 receptor associated kinase 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MYD88 (MYD88 innate immune signal transduction adaptor), IRAK2 (interleukin 1 receptor associated kinase 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IRAK4 (interleukin 1 receptor associated kinase 4), TLR4 (toll like receptor 4), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TICAM1 (toll like receptor adaptor molecule 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), PELI1 (pellino E3 ubiquitin protein ligase 1), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), UBB (ubiquitin B), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBE2N (ubiquitin conjugating enzyme E2 N), PELI3 (pellino E3 ubiquitin protein ligase family member 3), IRF7 (interferon regulatory factor 7), LY96 (lymphocyte antigen 96), PELI2 (pellino E3 ubiquitin protein ligase family member 2), TICAM2 (toll like receptor adaptor molecule 2), UBE2V1 (ubiquitin conjugating enzyme E2 V1), ECSIT (ECSIT signaling integrator), CD14 (CD14 molecule), TLR9 (toll like receptor 9), RPS27A (ribosomal protein S27a), TLR7 (toll like receptor 7)"], "WAG002320": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CDC25A (cell division cycle 25A), CDK2 (cyclin dependent kinase 2), CUL1 (cullin 1), SKP1 (S-phase kinase associated protein 1), CCND1 (cyclin D1), CDKN1A (cyclin dependent kinase inhibitor 1A), SKP2 (S-phase kinase associated protein 2), CDKN1B (cyclin dependent kinase inhibitor 1B), FZR1 (fizzy and cell division cycle 20 related 1), PSMA6 (proteasome 20S subunit alpha 6), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA7 (proteasome 20S subunit alpha 7), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMA1 (proteasome 20S subunit alpha 1), PSMA2 (proteasome 20S subunit alpha 2), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA3 (proteasome 20S subunit alpha 3), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB5 (proteasome 20S subunit beta 5), PSMB3 (proteasome 20S subunit beta 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB1 (proteasome 20S subunit beta 1), PSMB2 (proteasome 20S subunit beta 2), PSMA5 (proteasome 20S subunit alpha 5), PSMB6 (proteasome 20S subunit beta 6), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMB10 (proteasome 20S subunit beta 10), UBB (ubiquitin B), PSMB7 (proteasome 20S subunit beta 7), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD10 (proteasome 26S subunit, non-ATPase 10), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMF1 (proteasome inhibitor subunit 1), PSME4 (proteasome activator subunit 4), PSME1 (proteasome activator subunit 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSME3 (proteasome activator subunit 3), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), MYC (MYC proto-oncogene, bHLH transcription factor), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), CKS1B (CDC28 protein kinase regulatory subunit 1B), CDK4 (cyclin dependent kinase 4), RB1 (RB transcriptional corepressor 1), CCNE1 (cyclin E1), E2F1 (E2F transcription factor 1), TFDP1 (transcription factor Dp-1), CCNA2 (cyclin A2), RBL2 (RB transcriptional corepressor like 2), E2F4 (E2F transcription factor 4), CCNA1 (cyclin A1), CCNE2 (cyclin E2), E2F5 (E2F transcription factor 5), TFDP2 (transcription factor Dp-2), CCNH (cyclin H), RBBP4 (RB binding protein 4, chromatin remodeling factor), RAD21 (RAD21 cohesin complex component), CDK7 (cyclin dependent kinase 7), MNAT1 (MNAT1 component of CDK activating kinase), SMC3 (structural maintenance of chromosomes 3), AKT1 (AKT serine/threonine kinase 1), WEE1 (WEE1 G2 checkpoint kinase), SMC1A (structural maintenance of chromosomes 1A), LIN54 (lin-54 DREAM MuvB core complex component), LIN9 (lin-9 DREAM MuvB core complex component), LIN37 (lin-37 DREAM MuvB core complex component), CDC25B (cell division cycle 25B), PDS5A (PDS5 cohesin associated factor A), GSK3B (glycogen synthase kinase 3 beta), LIN52 (lin-52 DREAM MuvB core complex component), CDCA5 (cell division cycle associated 5), MAX (MYC associated factor X), STAG2 (stromal antigen 2), PDS5B (PDS5 cohesin associated factor B), RPS27A (ribosomal protein S27a), STAG1 (stromal antigen 1), ESCO2 (establishment of sister chromatid cohesion N-acetyltransferase 2), AKT2 (AKT serine/threonine kinase 2), AKT3 (AKT serine/threonine kinase 3), ESCO1 (establishment of sister chromatid cohesion N-acetyltransferase 1), CABLES1 (Cdk5 and Abl enzyme substrate 1), PTK6 (protein tyrosine kinase 6), WAPL (WAPL cohesin release factor), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002321": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), AXIN1 (axin 1), PSMA3 (proteasome 20S subunit alpha 3), PSMA2 (proteasome 20S subunit alpha 2), PSMA7 (proteasome 20S subunit alpha 7), PSMB4 (proteasome 20S subunit beta 4), PSMB1 (proteasome 20S subunit beta 1), PSMA1 (proteasome 20S subunit alpha 1), PSMB5 (proteasome 20S subunit beta 5), PSMB3 (proteasome 20S subunit beta 3), PSMA4 (proteasome 20S subunit alpha 4), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA5 (proteasome 20S subunit alpha 5), PSMB2 (proteasome 20S subunit beta 2), CUL1 (cullin 1), PSMA6 (proteasome 20S subunit alpha 6), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMB10 (proteasome 20S subunit beta 10), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB7 (proteasome 20S subunit beta 7), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB6 (proteasome 20S subunit beta 6), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC2 (proteasome 26S subunit, ATPase 2), SKP1 (S-phase kinase associated protein 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSME4 (proteasome activator subunit 4), PSMF1 (proteasome inhibitor subunit 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSME3 (proteasome activator subunit 3), UBB (ubiquitin B), RBX1 (ring-box 1), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), MYC (MYC proto-oncogene, bHLH transcription factor), PSME2 (proteasome activator subunit 2), CTNNB1 (catenin beta 1), PPP2CB (protein phosphatase 2 catalytic subunit beta), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), APC (APC regulator of WNT signaling pathway), PPP2CA (protein phosphatase 2 catalytic subunit alpha), AXIN2 (axin 2), GSK3B (glycogen synthase kinase 3 beta), TCF7L2 (transcription factor 7 like 2), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), LEF1 (lymphoid enhancer binding factor 1), HDAC1 (histone deacetylase 1), CTBP1 (C-terminal binding protein 1), TLE1 (TLE family member 1, transcriptional corepressor), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), CSNK1A1 (casein kinase 1 alpha 1), CTBP2 (C-terminal binding protein 2), TCF7 (transcription factor 7), TLE2 (TLE family member 2, transcriptional corepressor), TLE4 (TLE family member 4, transcriptional corepressor), TCF7L1 (transcription factor 7 like 1), RPS27A (ribosomal protein S27a), FRAT1 (FRAT regulator of WNT signaling pathway 1), TLE3 (TLE family member 3, transcriptional corepressor), ZRANB1 (zinc finger RANBP2-type containing 1), FRAT2 (FRAT regulator of WNT signaling pathway 2), TLE5 (TLE family member 5, transcriptional modulator), SEM1 (SEM1 26S proteasome complex subunit), AMER1 (APC membrane recruitment protein 1)"], "WAG002322": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MMP2 (matrix metallopeptidase 2), MMP1 (matrix metallopeptidase 1), MMP7 (matrix metallopeptidase 7), MMP9 (matrix metallopeptidase 9), MMP13 (matrix metallopeptidase 13), CD44 (CD44 molecule (Indian blood group)), MMP14 (matrix metallopeptidase 14), MMP8 (matrix metallopeptidase 8), MMP3 (matrix metallopeptidase 3), MMP10 (matrix metallopeptidase 10), BCAN (brevican), CASP3 (caspase 3), MMP11 (matrix metallopeptidase 11), MMP19 (matrix metallopeptidase 19), LAMC2 (laminin subunit gamma 2), MMP12 (matrix metallopeptidase 12), CAPN2 (calpain 2), LAMA3 (laminin subunit alpha 3), MMP15 (matrix metallopeptidase 15), CDH1 (cadherin 1), LAMA5 (laminin subunit alpha 5), PLG (plasminogen), DCN (decorin), MMP20 (matrix metallopeptidase 20), BMP1 (bone morphogenetic protein 1), CAST (calpastatin), HSPG2 (heparan sulfate proteoglycan 2), LAMC1 (laminin subunit gamma 1), LAMB3 (laminin subunit beta 3), CAPNS1 (calpain small subunit 1), ADAMTS5 (ADAM metallopeptidase with thrombospondin type 1 motif 5), NID1 (nidogen 1), CAPN1 (calpain 1), BSG (basigin (Ok blood group)), ADAMTS4 (ADAM metallopeptidase with thrombospondin type 1 motif 4), SPP1 (secreted phosphoprotein 1), ELANE (elastase, neutrophil expressed), LAMB1 (laminin subunit beta 1), CAPN3 (calpain 3), CTSS (cathepsin S), PSEN1 (presenilin 1), ADAM10 (ADAM metallopeptidase domain 10), ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif 1), SCUBE3 (signal peptide, CUB domain and EGF like domain containing 3), CTSG (cathepsin G), ADAMTS16 (ADAM metallopeptidase with thrombospondin type 1 motif 16), CAPN10 (calpain 10), CTSK (cathepsin K), CAPN6 (calpain 6), CAPN9 (calpain 9), ADAMTS9 (ADAM metallopeptidase with thrombospondin type 1 motif 9), NCSTN (nicastrin), CAPN11 (calpain 11), CAPN7 (calpain 7), ADAM15 (ADAM metallopeptidase domain 15), HTRA1 (HtrA serine peptidase 1), ADAM8 (ADAM metallopeptidase domain 8), TLL1 (tolloid like 1), ADAMTS8 (ADAM metallopeptidase with thrombospondin type 1 motif 8), SCUBE1 (signal peptide, CUB domain and EGF like domain containing 1), CAPNS2 (calpain small subunit 2), CAPN5 (calpain 5), CAPN12 (calpain 12), ADAMTS18 (ADAM metallopeptidase with thrombospondin type 1 motif 18), KLK7 (kallikrein related peptidase 7), TLL2 (tolloid like 2), CAPN15 (calpain 15), CAPN14 (calpain 14), OPTC (opticin), TMPRSS6 (transmembrane serine protease 6), CTSV (cathepsin V), CTSL (cathepsin L), CAPN13 (calpain 13), CAPN8 (calpain 8)"], "WAG002323": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TLR4 (toll like receptor 4), CD14 (CD14 molecule), LY96 (lymphocyte antigen 96), TLR2 (toll like receptor 2), TLR9 (toll like receptor 9), TLR1 (toll like receptor 1), TLR5 (toll like receptor 5), TLR6 (toll like receptor 6), TLR8 (toll like receptor 8), TLR7 (toll like receptor 7), TLR10 (toll like receptor 10), ITGB2 (integrin subunit beta 2), LY86 (lymphocyte antigen 86), EEA1 (early endosome antigen 1), LBP (lipopolysaccharide binding protein), PLCG2 (phospholipase C gamma 2), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), ITGAM (integrin subunit alpha M), CD180 (CD180 molecule), TICAM2 (toll like receptor adaptor molecule 2), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), CD36 (CD36 molecule), BPI (bactericidal permeability increasing protein), DNM2 (dynamin 2), DNM1 (dynamin 1), PTPN4 (protein tyrosine phosphatase non-receptor type 4), RBSN (rabenosyn, RAB effector), DNM3 (dynamin 3)"], "WAG002325": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SLC2A4 (solute carrier family 2 member 4), RALA (RAS like proto-oncogene A), VAMP2 (vesicle associated membrane protein 2), EXOC2 (exocyst complex component 2), EXOC5 (exocyst complex component 5), EXOC4 (exocyst complex component 4), RAB10 (RAB10, member RAS oncogene family), EXOC6 (exocyst complex component 6), RAB8A (RAB8A, member RAS oncogene family), RHOQ (ras homolog family member Q), EXOC8 (exocyst complex component 8), STX4 (syntaxin 4), RAB13 (RAB13, member RAS oncogene family), MYO5A (myosin VA), RAB14 (RAB14, member RAS oncogene family), RAC1 (Rac family small GTPase 1), AKT2 (AKT serine/threonine kinase 2), STXBP3 (syntaxin binding protein 3), SNAP23 (synaptosome associated protein 23), TBC1D4 (TBC1 domain family member 4), ASPSCR1 (ASPSCR1 tether for SLC2A4, UBX domain containing), LNPEP (leucyl and cystinyl aminopeptidase), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), AKT1 (AKT serine/threonine kinase 1), TBC1D1 (TBC1 domain family member 1), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), EXOC3 (exocyst complex component 3), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), EXOC7 (exocyst complex component 7), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), EXOC1 (exocyst complex component 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), RAB11A (RAB11A, member RAS oncogene family), RAB4A (RAB4A, member RAS oncogene family), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), SFN (stratifin), KIFAP3 (kinesin associated protein 3), KIF3B (kinesin family member 3B), KIF3A (kinesin family member 3A), MYH9 (myosin heavy chain 9), RALGAPA2 (Ral GTPase activating protein catalytic subunit alpha 2), RALGAPB (Ral GTPase activating protein non-catalytic subunit beta), MYO1C (myosin IC), C2CD5 (C2 calcium dependent domain containing 5), CALM1 (calmodulin 1)"], "WAG002328": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), ERBB4 (erb-b2 receptor tyrosine kinase 4), EGFR (epidermal growth factor receptor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), EGF (epidermal growth factor), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), UBB (ubiquitin B), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), ESR1 (estrogen receptor 1), SHC1 (SHC adaptor protein 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSENEN (presenilin enhancer, gamma-secretase subunit), APH1B (aph-1 homolog B, gamma-secretase subunit), PSEN1 (presenilin 1), ITCH (itchy E3 ubiquitin protein ligase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PGR (progesterone receptor), HRAS (HRas proto-oncogene, GTPase), PSEN2 (presenilin 2), NRAS (NRAS proto-oncogene, GTPase), STAT5A (signal transducer and activator of transcription 5A), WWOX (WW domain containing oxidoreductase), YAP1 (Yes1 associated transcriptional regulator), GFAP (glial fibrillary acidic protein), GABRB1 (gamma-aminobutyric acid type A receptor subunit beta1), NEDD4 (NEDD4 E3 ubiquitin protein ligase), WWP1 (WW domain containing E3 ubiquitin protein ligase 1), GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1), NCSTN (nicastrin), APH1A (aph-1 homolog A, gamma-secretase subunit), GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2), ADAM17 (ADAM metallopeptidase domain 17), GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3), NCOR1 (nuclear receptor corepressor 1), GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3), DLG4 (discs large MAGUK scaffold protein 4), RPS27A (ribosomal protein S27a), APOE (apolipoprotein E), NRG2 (neuregulin 2), S100B (S100 calcium binding protein B), CXCL12 (C-X-C motif chemokine ligand 12), ADAP1 (ArfGAP with dual PH domains 1), GABRQ (gamma-aminobutyric acid type A receptor subunit theta), SPARC (secreted protein acidic and cysteine rich), STMN1 (stathmin 1), MXD4 (MAX dimerization protein 4), CSN2 (casein beta)"], "WAG002329": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALB (albumin), APOA1 (apolipoprotein A1), APOB (apolipoprotein B), COL1A2 (collagen type I alpha 2 chain), COL1A1 (collagen type I alpha 1 chain), APOE (apolipoprotein E), CALR (calreticulin), HBA2 (hemoglobin subunit alpha 2), COL4A2 (collagen type IV alpha 2 chain), HSP90B1 (heat shock protein 90 beta family member 1), COL4A1 (collagen type IV alpha 1 chain), SPARC (secreted protein acidic and cysteine rich), HP (haptoglobin), COL3A1 (collagen type III alpha 1 chain), CD36 (CD36 molecule), AMBP (alpha-1-microglobulin/bikunin precursor), LRP1 (LDL receptor related protein 1), CD163 (CD163 molecule), FTH1 (ferritin heavy chain 1), HBB (hemoglobin subunit beta), HSP90AA1 (heat shock protein 90 alpha family class A member 1), SAA1 (serum amyloid A1), FTL (ferritin light chain), HPX (hemopexin), SCARF1 (scavenger receptor class F member 1), MARCO (macrophage receptor with collagenous structure), MSR1 (macrophage scavenger receptor 1), COLEC12 (collectin subfamily member 12), HYOU1 (hypoxia up-regulated 1), SCGB3A2 (secretoglobin family 3A member 2), APOL1 (apolipoprotein L1), MASP1 (mannan binding lectin serine peptidase 1), HSPH1 (heat shock protein family H (Hsp110) member 1), HPR (haptoglobin-related protein), STAB1 (stabilin 1), COLEC11 (collectin subfamily member 11), STAB2 (stabilin 2), HBA1 (hemoglobin subunit alpha 1), JCHAIN (joining chain of multimeric IgA and IgM), SSC5D (scavenger receptor cysteine rich family member with 5 domains), SCARA5 (scavenger receptor class A member 5)"], "WAG002331": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ITGAV (integrin subunit alpha V), THBS1 (thrombospondin 1), SDC2 (syndecan 2), TNC (tenascin C), ITGB1 (integrin subunit beta 1), SDC4 (syndecan 4), ITGA2 (integrin subunit alpha 2), ITGA6 (integrin subunit alpha 6), SDC1 (syndecan 1), ACTN1 (actinin alpha 1), ITGB5 (integrin subunit beta 5), FGF2 (fibroblast growth factor 2), ITGB4 (integrin subunit beta 4), PRKCA (protein kinase C alpha), TGFB1 (transforming growth factor beta 1), ITGB3 (integrin subunit beta 3), VTN (vitronectin), SDC3 (syndecan 3), CASK (calcium/calmodulin dependent serine protein kinase), TRAPPC4 (trafficking protein particle complex 4)"], "WAG002332": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SGPP1 (sphingosine-1-phosphate phosphatase 1), ASAH1 (N-acylsphingosine amidohydrolase 1), SGPP2 (sphingosine-1-phosphate phosphatase 2), GALC (galactosylceramidase), UGT8 (UDP glycosyltransferase 8), GBA (glucosylceramidase beta), ASAH2 (N-acylsphingosine amidohydrolase 2), UGCG (UDP-glucose ceramide glucosyltransferase), SMPD2 (sphingomyelin phosphodiesterase 2), SGMS2 (sphingomyelin synthase 2), ARSA (arylsulfatase A), SMPD3 (sphingomyelin phosphodiesterase 3), DEGS1 (delta 4-desaturase, sphingolipid 1), DEGS2 (delta 4-desaturase, sphingolipid 2), SMPD1 (sphingomyelin phosphodiesterase 1), SMPD4 (sphingomyelin phosphodiesterase 4), ACER1 (alkaline ceramidase 1), ACER2 (alkaline ceramidase 2), ENPP7 (ectonucleotide pyrophosphatase/phosphodiesterase 7), CERK (ceramide kinase), ARSD (arylsulfatase D), ARSB (arylsulfatase B), GLA (galactosidase alpha), SPHK2 (sphingosine kinase 2), ARSH (arylsulfatase family member H), SUMF1 (sulfatase modifying factor 1), GLB1 (galactosidase beta 1), ARSK (arylsulfatase family member K), ARSG (arylsulfatase G), KDSR (3-ketodihydrosphingosine reductase), ARSJ (arylsulfatase family member J), ARSI (arylsulfatase family member I), ARSF (arylsulfatase F), STS (steroid sulfatase), SPHK1 (sphingosine kinase 1), NEU1 (neuraminidase 1), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), SPTLC3 (serine palmitoyltransferase long chain base subunit 3), HEXA (hexosaminidase subunit alpha), NEU3 (neuraminidase 3), NEU2 (neuraminidase 2), ACER3 (alkaline ceramidase 3), SPTLC2 (serine palmitoyltransferase long chain base subunit 2), HEXB (hexosaminidase subunit beta), CTSA (cathepsin A), SPTSSA (serine palmitoyltransferase small subunit A), SPTSSB (serine palmitoyltransferase small subunit B), ORMDL3 (ORMDL sphingolipid biosynthesis regulator 3), PSAP (prosaposin), SGPL1 (sphingosine-1-phosphate lyase 1), GM2A (GM2 ganglioside activator), OSBP (oxysterol binding protein), VAPA (VAMP associated protein A), PRKD2 (protein kinase D2), PRKD1 (protein kinase D1), CSNK1G2 (casein kinase 1 gamma 2), PPM1L (protein phosphatase, Mg2+/Mn2+ dependent 1L), VAPB (VAMP associated protein B and C), PRKD3 (protein kinase D3), B4GALNT1 (beta-1,4-N-acetyl-galactosaminyltransferase 1), GDF1 (growth differentiation factor 1), B3GALNT1 (beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)), CERS1 (ceramide synthase 1), ALDH3B1 (aldehyde dehydrogenase 3 family member B1), ALDH3B2 (aldehyde dehydrogenase 3 family member B2), GBA2 (glucosylceramidase beta 2), CERS6 (ceramide synthase 6), GLTP (glycolipid transfer protein), CERS5 (ceramide synthase 5), CERS4 (ceramide synthase 4), SUMF2 (sulfatase modifying factor 2), ORMDL2 (ORMDL sphingolipid biosynthesis regulator 2), PLPP1 (phospholipid phosphatase 1), CPTP (ceramide-1-phosphate transfer protein), LOC100130207 (uncharacterized LOC100130207), GLB1L (galactosidase beta 1 like), SAMD8 (sterile alpha motif domain containing 8), PLPP2 (phospholipid phosphatase 2), ESYT3 (extended synaptotagmin 3), ESYT1 (extended synaptotagmin 1), SPNS2 (sphingolipid transporter 2), ORMDL1 (ORMDL sphingolipid biosynthesis regulator 1), CERS3 (ceramide synthase 3), ESYT2 (extended synaptotagmin 2), PLPP3 (phospholipid phosphatase 3), FA2H (fatty acid 2-hydroxylase), CERS2 (ceramide synthase 2), ARSL (arylsulfatase L)"], "WAG002335": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TRAF6 (TNF receptor associated factor 6), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), NFKB1 (nuclear factor kappa B subunit 1), MAPK14 (mitogen-activated protein kinase 14), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IRAK1 (interleukin 1 receptor associated kinase 1), RIPK2 (receptor interacting serine/threonine kinase 2), MAP2K6 (mitogen-activated protein kinase kinase 6), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), UBB (ubiquitin B), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), MAP2K4 (mitogen-activated protein kinase kinase 4), MAPK8 (mitogen-activated protein kinase 8), MAP2K1 (mitogen-activated protein kinase kinase 1), MAPK11 (mitogen-activated protein kinase 11), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), CUL1 (cullin 1), MAP2K3 (mitogen-activated protein kinase kinase 3), MAP2K7 (mitogen-activated protein kinase kinase 7), IRAK2 (interleukin 1 receptor associated kinase 2), MAPK10 (mitogen-activated protein kinase 10), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), SKP1 (S-phase kinase associated protein 1), UBE2N (ubiquitin conjugating enzyme E2 N), TNIP2 (TNFAIP3 interacting protein 2), MAPK9 (mitogen-activated protein kinase 9), UBE2V1 (ubiquitin conjugating enzyme E2 V1), FBXW11 (F-box and WD repeat domain containing 11), RPS27A (ribosomal protein S27a), MAPKAPK3 (MAPK activated protein kinase 3), NOD2 (nucleotide binding oligomerization domain containing 2), MAPKAPK2 (MAPK activated protein kinase 2), NOD1 (nucleotide binding oligomerization domain containing 1)"], "WAG002336": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), RELA (RELA proto-oncogene, NF-kB subunit), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), NFKB1 (nuclear factor kappa B subunit 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TBK1 (TANK binding kinase 1), NFKBIA (NFKB inhibitor alpha), POLR2E (RNA polymerase II, I and III subunit E), POLR2H (RNA polymerase II, I and III subunit H), NFKBIB (NFKB inhibitor beta), POLR3A (RNA polymerase III subunit A), POLR3B (RNA polymerase III subunit B), POLR2L (RNA polymerase II, I and III subunit L), TICAM1 (toll like receptor adaptor molecule 1), POLR1C (RNA polymerase I and III subunit C), POLR3H (RNA polymerase III subunit H), NFKB2 (nuclear factor kappa B subunit 2), POLR3F (RNA polymerase III subunit F), POLR3D (RNA polymerase III subunit D), POLR2F (RNA polymerase II, I and III subunit F), POLR3E (RNA polymerase III subunit E), POLR3C (RNA polymerase III subunit C), CREBBP (CREB binding protein), IRF3 (interferon regulatory factor 3), ZBP1 (Z-DNA binding protein 1), TLR3 (toll like receptor 3), RIPK1 (receptor interacting serine/threonine kinase 1), POLR3G (RNA polymerase III subunit G), RIPK3 (receptor interacting serine/threonine kinase 3), UBB (ubiquitin B), IRF7 (interferon regulatory factor 7), POLR3GL (RNA polymerase III subunit GL), DHX9 (DExH-box helicase 9), EP300 (E1A binding protein p300), MYD88 (MYD88 innate immune signal transduction adaptor), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), POLR2K (RNA polymerase II, I and III subunit K), PRKDC (protein kinase, DNA-activated, catalytic subunit), CRCP (CGRP receptor component), CTNNB1 (catenin beta 1), POLR3K (RNA polymerase III subunit K), XRCC5 (X-ray repair cross complementing 5), STAT6 (signal transducer and activator of transcription 6), XRCC6 (X-ray repair cross complementing 6), TRIM21 (tripartite motif containing 21), RPS27A (ribosomal protein S27a), IFI16 (interferon gamma inducible protein 16), NLRP4 (NLR family pyrin domain containing 4), LRRFIP1 (LRR binding FLII interacting protein 1), NKIRAS1 (NFKB inhibitor interacting Ras like 1), NKIRAS2 (NFKB inhibitor interacting Ras like 2), TREX1 (three prime repair exonuclease 1), DTX4 (deltex E3 ubiquitin ligase 4), DDX41 (DEAD-box helicase 41), TRIM56 (tripartite motif containing 56), TRIM32 (tripartite motif containing 32), DHX36 (DEAH-box helicase 36), NLRC3 (NLR family CARD domain containing 3), STING1 (stimulator of interferon response cGAMP interactor 1), MRE11 (MRE11 homolog, double strand break repair nuclease), CGAS (cyclic GMP-AMP synthase)"], "WAG002337": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAPK8 (mitogen-activated protein kinase 8), MAPK3 (mitogen-activated protein kinase 3), MAPK14 (mitogen-activated protein kinase 14), NFKB1 (nuclear factor kappa B subunit 1), TNF (tumor necrosis factor), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MAP2K4 (mitogen-activated protein kinase kinase 4), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RAC1 (Rac family small GTPase 1), PRKCA (protein kinase C alpha), MAP2K1 (mitogen-activated protein kinase kinase 1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K3 (mitogen-activated protein kinase kinase 3), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAP2K6 (mitogen-activated protein kinase kinase 6), TNFRSF1A (TNF receptor superfamily member 1A), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), GSK3B (glycogen synthase kinase 3 beta), EGF (epidermal growth factor), TGFB1 (transforming growth factor beta 1), MAPK7 (mitogen-activated protein kinase 7), IGF1 (insulin like growth factor 1), MTOR (mechanistic target of rapamycin kinase), MAP2K7 (mitogen-activated protein kinase kinase 7), MAP2K2 (mitogen-activated protein kinase kinase 2), AKT2 (AKT serine/threonine kinase 2), MEF2A (myocyte enhancer factor 2A), PDPK1 (3-phosphoinositide dependent protein kinase 1), HDAC4 (histone deacetylase 4), FGF2 (fibroblast growth factor 2), MAP2K5 (mitogen-activated protein kinase kinase 5), NPPA (natriuretic peptide A), PRKD1 (protein kinase D1), HDAC5 (histone deacetylase 5), CDK9 (cyclin dependent kinase 9), TGFBR1 (transforming growth factor beta receptor 1), HDAC7 (histone deacetylase 7), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), PPP3CA (protein phosphatase 3 catalytic subunit alpha), HDAC9 (histone deacetylase 9), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), NFATC2 (nuclear factor of activated T cells 2), PRKG1 (protein kinase cGMP-dependent 1), PLA2G2A (phospholipase A2 group IIA), NRG1 (neuregulin 1), FGFR2 (fibroblast growth factor receptor 2), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CDK7 (cyclin dependent kinase 7), CALM1 (calmodulin 1), GUCA1A (guanylate cyclase activator 1A)"], "WAG002338": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPARA (peroxisome proliferator activated receptor alpha), RXRA (retinoid X receptor alpha), CREBBP (CREB binding protein), NCOA6 (nuclear receptor coactivator 6), NCOA2 (nuclear receptor coactivator 2), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), TBL1XR1 (TBL1X receptor 1), CARM1 (coactivator associated arginine methyltransferase 1), TGS1 (trimethylguanosine synthase 1), CHD9 (chromodomain helicase DNA binding protein 9), EP300 (E1A binding protein p300), PPARGC1A (PPARG coactivator 1 alpha), NCOA1 (nuclear receptor coactivator 1), HDAC3 (histone deacetylase 3), NCOR2 (nuclear receptor corepressor 2), NCOA3 (nuclear receptor coactivator 3), CDK8 (cyclin dependent kinase 8), MED29 (mediator complex subunit 29), MED26 (mediator complex subunit 26), MED17 (mediator complex subunit 17), MED6 (mediator complex subunit 6), MED8 (mediator complex subunit 8), MED18 (mediator complex subunit 18), MED4 (mediator complex subunit 4), MED12 (mediator complex subunit 12), MED13 (mediator complex subunit 13), MED19 (mediator complex subunit 19), MED10 (mediator complex subunit 10), MED11 (mediator complex subunit 11), MED22 (mediator complex subunit 22), MED30 (mediator complex subunit 30), MED16 (mediator complex subunit 16), MED9 (mediator complex subunit 9), MED20 (mediator complex subunit 20), MED15 (mediator complex subunit 15), MED23 (mediator complex subunit 23), MED21 (mediator complex subunit 21), CDK19 (cyclin dependent kinase 19), MED7 (mediator complex subunit 7), MED27 (mediator complex subunit 27), MED31 (mediator complex subunit 31), CCNC (cyclin C), MED13L (mediator complex subunit 13L), CD36 (CD36 molecule), ANGPTL4 (angiopoietin like 4), PPARG (peroxisome proliferator activated receptor gamma), SP1 (Sp1 transcription factor), MED28 (mediator complex subunit 28), SREBF2 (sterol regulatory element binding transcription factor 2), MED25 (mediator complex subunit 25), RORA (RAR related orphan receptor A), PPARGC1B (PPARG coactivator 1 beta), NCOR1 (nuclear receptor corepressor 1), CPT1A (carnitine palmitoyltransferase 1A), ARNTL (aryl hydrocarbon receptor nuclear translocator like), APOA1 (apolipoprotein A1), NPAS2 (neuronal PAS domain protein 2), ABCA1 (ATP binding cassette subfamily A member 1), NFYB (nuclear transcription factor Y subunit beta), NFYA (nuclear transcription factor Y subunit alpha), SIN3A (SIN3 transcription regulator family member A), NR1H2 (nuclear receptor subfamily 1 group H member 2), CLOCK (clock circadian regulator), NFYC (nuclear transcription factor Y subunit gamma), NR1H4 (nuclear receptor subfamily 1 group H member 4), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), THRAP3 (thyroid hormone receptor associated protein 3), CYP7A1 (cytochrome P450 family 7 subfamily A member 1), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), NR1H3 (nuclear receptor subfamily 1 group H member 3), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), FABP1 (fatty acid binding protein 1), APOA2 (apolipoprotein A2), RXRB (retinoid X receptor beta), ACSL1 (acyl-CoA synthetase long chain family member 1), NR1D1 (nuclear receptor subfamily 1 group D member 1), APOA5 (apolipoprotein A5), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), CPT2 (carnitine palmitoyltransferase 2), AHR (aryl hydrocarbon receptor), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2), ACADM (acyl-CoA dehydrogenase medium chain), ESRRA (estrogen related receptor alpha), ARNT (aryl hydrocarbon receptor nuclear translocator), ALAS1 (5'-aminolevulinate synthase 1), PLIN2 (perilipin 2), FHL2 (four and a half LIM domains 2), SLC27A1 (solute carrier family 27 member 1), ABCB4 (ATP binding cassette subfamily B member 4), SULT2A1 (sulfotransferase family 2A member 1), GPS2 (G protein pathway suppressor 2), TRIB3 (tribbles pseudokinase 3), ANKRD1 (ankyrin repeat domain 1), PEX11A (peroxisomal biogenesis factor 11 alpha), FADS1 (fatty acid desaturase 1), GRHL1 (grainyhead like transcription factor 1), TXNRD1 (thioredoxin reductase 1), G0S2 (G0/G1 switch 2), TIAM2 (TIAM Rac1 associated GEF 2), GLIPR1 (GLI pathogenesis related 1)"], "WAG002340": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FN1 (fibronectin 1), ALB (albumin), F2 (coagulation factor II, thrombin), APOA1 (apolipoprotein A1), APP (amyloid beta precursor protein), PLG (plasminogen), TF (transferrin), KNG1 (kininogen 1), IGF1 (insulin like growth factor 1), IGFBP3 (insulin like growth factor binding protein 3), SERPINC1 (serpin family C member 1), IGF2 (insulin like growth factor 2), FGA (fibrinogen alpha chain), APOB (apolipoprotein B), APOA2 (apolipoprotein A2), AHSG (alpha 2-HS glycoprotein), F5 (coagulation factor V), IGFBP1 (insulin like growth factor binding protein 1), IL6 (interleukin 6), SERPINA1 (serpin family A member 1), ITIH2 (inter-alpha-trypsin inhibitor heavy chain 2), SERPIND1 (serpin family D member 1), IGFBP5 (insulin like growth factor binding protein 5), FGG (fibrinogen gamma chain), IGFALS (insulin like growth factor binding protein acid labile subunit), IGFBP2 (insulin like growth factor binding protein 2), TIMP1 (TIMP metallopeptidase inhibitor 1), IGFBP4 (insulin like growth factor binding protein 4), APOE (apolipoprotein E), C3 (complement C3), CTSG (cathepsin G), MMP2 (matrix metallopeptidase 2), SDC2 (syndecan 2), AFP (alpha fetoprotein), MMP1 (matrix metallopeptidase 1), IGFBP6 (insulin like growth factor binding protein 6), PROC (protein C, inactivator of coagulation factors Va and VIIIa), SPP1 (secreted phosphoprotein 1), PAPPA (pappalysin 1), GAS6 (growth arrest specific 6), CP (ceruloplasmin), KLK3 (kallikrein related peptidase 3), FBN1 (fibrillin 1), P4HB (prolyl 4-hydroxylase subunit beta), C4A (complement C4A (Rodgers blood group)), GPC3 (glypican 3), CST3 (cystatin C), KLK2 (kallikrein related peptidase 2), HSP90B1 (heat shock protein 90 beta family member 1), APOA5 (apolipoprotein A5), SPP2 (secreted phosphoprotein 2), MFGE8 (milk fat globule EGF and factor V/VIII domain containing), IGFBP7 (insulin like growth factor binding protein 7), FSTL1 (follistatin like 1), LAMB2 (laminin subunit beta 2), BMP4 (bone morphogenetic protein 4), CHGB (chromogranin B), PDIA6 (protein disulfide isomerase family A member 6), LAMB1 (laminin subunit beta 1), TNC (tenascin C), VCAN (versican), DMP1 (dentin matrix acidic phosphoprotein 1), CDH2 (cadherin 2), FGF23 (fibroblast growth factor 23), AMELX (amelogenin X-linked), PENK (proenkephalin), LTBP1 (latent transforming growth factor beta binding protein 1), LAMC1 (laminin subunit gamma 1), CALU (calumenin), LGALS1 (galectin 1), KLK1 (kallikrein 1), RCN1 (reticulocalbin 1), PAPPA2 (pappalysin 2), AMTN (amelotin), AMBN (ameloblastin), SERPINA10 (serpin family A member 10), CHRDL1 (chordin like 1), ENAM (enamelin), KLK13 (kallikrein related peptidase 13), SCG2 (secretogranin II), FSTL3 (follistatin like 3), ADAM10 (ADAM metallopeptidase domain 10), MEPE (matrix extracellular phosphoglycoprotein), SCG3 (secretogranin III), CSF1 (colony stimulating factor 1), MBTPS1 (membrane bound transcription factor peptidase, site 1), PRKCSH (protein kinase C substrate 80K-H), NUCB1 (nucleobindin 1), DNAJC3 (DnaJ heat shock protein family (Hsp40) member C3), PRSS23 (serine protease 23), APOL1 (apolipoprotein L1), PCSK9 (proprotein convertase subtilisin/kexin type 9), SPARCL1 (SPARC like 1), MEN1 (menin 1), APLP2 (amyloid beta precursor like protein 2), BMP15 (bone morphogenetic protein 15), KTN1 (kinectin 1), MATN3 (matrilin 3), GZMH (granzyme H), FUCA2 (alpha-L-fucosidase 2)"], "WAG002342": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), UBC (ubiquitin C), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IRAK1 (interleukin 1 receptor associated kinase 1), IRAK2 (interleukin 1 receptor associated kinase 2), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MYD88 (MYD88 innate immune signal transduction adaptor), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), IRAK4 (interleukin 1 receptor associated kinase 4), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PELI1 (pellino E3 ubiquitin protein ligase 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), UBB (ubiquitin B), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), UBE2N (ubiquitin conjugating enzyme E2 N), PELI3 (pellino E3 ubiquitin protein ligase family member 3), PELI2 (pellino E3 ubiquitin protein ligase family member 2), UBE2V1 (ubiquitin conjugating enzyme E2 V1), ECSIT (ECSIT signaling integrator), RPS27A (ribosomal protein S27a), TLR5 (toll like receptor 5), TLR10 (toll like receptor 10)"], "WAG002343": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), BMP4 (bone morphogenetic protein 4), NFKB1 (nuclear factor kappa B subunit 1), GSK3B (glycogen synthase kinase 3 beta), FZD1 (frizzled class receptor 1), SHH (sonic hedgehog signaling molecule), FGFR1 (fibroblast growth factor receptor 1), LEF1 (lymphoid enhancer binding factor 1), EGFR (epidermal growth factor receptor), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MYC (MYC proto-oncogene, bHLH transcription factor), LRP6 (LDL receptor related protein 6), FGF7 (fibroblast growth factor 7), EGF (epidermal growth factor), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), DVL1 (dishevelled segment polarity protein 1), FGFR2 (fibroblast growth factor receptor 2), TP63 (tumor protein p63), LRP5 (LDL receptor related protein 5), BMPR1A (bone morphogenetic protein receptor type 1A), DKK4 (dickkopf WNT signaling pathway inhibitor 4), FST (follistatin), PTCH1 (patched 1), FGF20 (fibroblast growth factor 20), NOG (noggin), SMO (smoothened, frizzled class receptor), WNT10B (Wnt family member 10B), NFKBIB (NFKB inhibitor beta), TCF3 (transcription factor 3), WNT10A (Wnt family member 10A), MSX2 (msh homeobox 2), EDA (ectodysplasin A), SP5 (Sp5 transcription factor), INHBA (inhibin subunit beta A), VCAN (versican), EDAR (ectodysplasin A receptor), IVL (involucrin), GJB6 (gap junction protein beta 6), CDH3 (cadherin 3), KRT10 (keratin 10), FOXI3 (forkhead box I3), CCN2 (cellular communication network factor 2)"], "WAG002345": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "C3 (complement C3), ALB (albumin), C4A (complement C4A (Rodgers blood group)), ITGB2 (integrin subunit beta 2), PLG (plasminogen), C1R (complement C1r), C5 (complement C5), FGB (fibrinogen beta chain), SERPING1 (serpin family G member 1), ICAM1 (intercellular adhesion molecule 1), ITGB3 (integrin subunit beta 3), CFI (complement factor I), ITGA2B (integrin subunit alpha 2b), ITGA2 (integrin subunit alpha 2), FGA (fibrinogen alpha chain), CRP (C-reactive protein), FGG (fibrinogen gamma chain), ITGAX (integrin subunit alpha X), CFB (complement factor B), MBL2 (mannose binding lectin 2), C2 (complement C2), C5AR1 (complement C5a receptor 1), THBS1 (thrombospondin 1), MASP2 (mannan binding lectin serine peptidase 2), C1S (complement C1s), MASP1 (mannan binding lectin serine peptidase 1), F10 (coagulation factor X), SELL (selectin L), CFH (complement factor H), C7 (complement C7), C9 (complement C9), PRKCA (protein kinase C alpha), PLAUR (plasminogen activator, urokinase receptor), CD55 (CD55 molecule (Cromer blood group)), CR1 (complement C3b/C4b receptor 1 (Knops blood group)), SELE (selectin E), FPR1 (formyl peptide receptor 1), F13A1 (coagulation factor XIII A chain), SELP (selectin P), KLKB1 (kallikrein B1), F12 (coagulation factor XII), CD40 (CD40 molecule), CFP (complement factor properdin), C6 (complement C6), VTN (vitronectin), CD19 (CD19 molecule), APOA1 (apolipoprotein A1), C8A (complement C8 alpha chain), CD46 (CD46 molecule), CD93 (CD93 molecule), C4BPA (complement component 4 binding protein alpha), APCS (amyloid P component, serum), FCGR3A (Fc fragment of IgG receptor IIIa), CR2 (complement C3d receptor 2), CALR (calreticulin), CFD (complement factor D), GNAI2 (G protein subunit alpha i2), F11 (coagulation factor XI), C3AR1 (complement C3a receptor 1), LAMA5 (laminin subunit alpha 5), ELANE (elastase, neutrophil expressed), C1QBP (complement C1q binding protein), ARRB2 (arrestin beta 2), FCER2 (Fc fragment of IgE receptor II), FCN2 (ficolin 2), LAMC1 (laminin subunit gamma 1), LAMB1 (laminin subunit beta 1), SPP1 (secreted phosphoprotein 1), SELPLG (selectin P ligand), PROS1 (protein S), CD59 (CD59 molecule (CD59 blood group)), CPN1 (carboxypeptidase N subunit 1), ICAM2 (intercellular adhesion molecule 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), GNA15 (G protein subunit alpha 15), DCN (decorin), GNAI3 (G protein subunit alpha i3), TXN (thioredoxin), PRNP (prion protein), IBSP (integrin binding sialoprotein), TLR2 (toll like receptor 2), PTX3 (pentraxin 3), RPS19 (ribosomal protein S19), SFTPA1 (surfactant protein A1), CFHR4 (complement factor H related 4), VSIG4 (V-set and immunoglobulin domain containing 4), LRP2 (LDL receptor related protein 2), SFTPA2 (surfactant protein A2), WAS (WASP actin nucleation promoting factor), CFHR2 (complement factor H related 2), ADM (adrenomedullin), ADIPOQ (adiponectin, C1Q and collagen domain containing), CLEC4M (C-type lectin domain family 4 member M), CSNK1A1 (casein kinase 1 alpha 1), LOC110384692 (complement C4A (Rodgers blood group)-like), C5AR2 (complement component 5a receptor 2), FKBP2 (FKBP prolyl isomerase 2)"], "WAG002346": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYC (MYC proto-oncogene, bHLH transcription factor), CCND1 (cyclin D1), AKT1 (AKT serine/threonine kinase 1), TGFB1 (transforming growth factor beta 1), TNF (tumor necrosis factor), CDH1 (cadherin 1), ITGB1 (integrin subunit beta 1), TERT (telomerase reverse transcriptase), ITGA6 (integrin subunit alpha 6), ALPL (alkaline phosphatase, biomineralization associated), SFRP1 (secreted frizzled related protein 1), ERBB4 (erb-b2 receptor tyrosine kinase 4), NRG3 (neuregulin 3), CLDN4 (claudin 4), MIR200A (microRNA 200a), MIR200B (microRNA 200b), ZEB2 (zinc finger E-box binding homeobox 2), MIR429 (microRNA 429)"], "WAG002347": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ESR1 (estrogen receptor 1), CCND1 (cyclin D1), EGF (epidermal growth factor), MYC (MYC proto-oncogene, bHLH transcription factor), ERBB2 (erb-b2 receptor tyrosine kinase 2), FN1 (fibronectin 1), PGR (progesterone receptor), STAT5A (signal transducer and activator of transcription 5A), VIM (vimentin), TIMP1 (TIMP metallopeptidase inhibitor 1), FOSL1 (FOS like 1, AP-1 transcription factor subunit), NRIP1 (nuclear receptor interacting protein 1), AREG (amphiregulin)"], "WAG002350": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ESR1 (estrogen receptor 1), ERBB2 (erb-b2 receptor tyrosine kinase 2), EGFR (epidermal growth factor receptor), CCND1 (cyclin D1), PRL (prolactin), JAK2 (Janus kinase 2), MYC (MYC proto-oncogene, bHLH transcription factor), PGR (progesterone receptor), CAV1 (caveolin 1), ERBB4 (erb-b2 receptor tyrosine kinase 4), CEBPB (CCAAT enhancer binding protein beta), ERBB3 (erb-b2 receptor tyrosine kinase 3), PTPN1 (protein tyrosine phosphatase non-receptor type 1), NR3C1 (nuclear receptor subfamily 3 group C member 1), CEBPA (CCAAT enhancer binding protein alpha), PRLR (prolactin receptor), ESR2 (estrogen receptor 2), CSN2 (casein beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), YY1 (YY1 transcription factor), EIF4E (eukaryotic translation initiation factor 4E), BCL2L1 (BCL2 like 1), TNFSF11 (TNF superfamily member 11), GAL (galanin and GMAP prepropeptide), TNFRSF11A (TNF receptor superfamily member 11a), GJB2 (gap junction protein beta 2), TPM3 (tropomyosin 3), TTC9 (tetratricopeptide repeat domain 9), USF2 (upstream transcription factor 2, c-fos interacting), ELF5 (E74 like ETS transcription factor 5), ATP2C2 (ATPase secretory pathway Ca2+ transporting 2), PNCK (pregnancy up-regulated nonubiquitous CaM kinase)"], "WAG002352": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TXN (thioredoxin), SOD2 (superoxide dismutase 2), CAT (catalase), SOD1 (superoxide dismutase 1), GPX1 (glutathione peroxidase 1), CYBA (cytochrome b-245 alpha chain), NCF2 (neutrophil cytosolic factor 2), NCF4 (neutrophil cytosolic factor 4), SOD3 (superoxide dismutase 3), GSTP1 (glutathione S-transferase pi 1), PRDX1 (peroxiredoxin 1), PRDX6 (peroxiredoxin 6), TXNRD1 (thioredoxin reductase 1), GPX5 (glutathione peroxidase 5), NCF1 (neutrophil cytosolic factor 1), CYBB (cytochrome b-245 beta chain), ATOX1 (antioxidant 1 copper chaperone), PRDX3 (peroxiredoxin 3), PRDX2 (peroxiredoxin 2), TXN2 (thioredoxin 2), CYCS (cytochrome c, somatic), CCS (copper chaperone for superoxide dismutase), GPX2 (glutathione peroxidase 2), GPX6 (glutathione peroxidase 6), ATP7A (ATPase copper transporting alpha), NOX4 (NADPH oxidase 4), P4HB (prolyl 4-hydroxylase subunit beta), GPX3 (glutathione peroxidase 3), TXNRD2 (thioredoxin reductase 2), GPX7 (glutathione peroxidase 7), AQP8 (aquaporin 8), NOX5 (NADPH oxidase 5), GPX8 (glutathione peroxidase 8 (putative)), ERO1A (endoplasmic reticulum oxidoreductase 1 alpha), SOD2-OT1 (SOD2 overlapping transcript 1), NUDT2 (nudix hydrolase 2)"], "WAG002354": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), HRAS (HRas proto-oncogene, GTPase), TP53 (tumor protein p53), CCND1 (cyclin D1), EGFR (epidermal growth factor receptor), NRAS (NRAS proto-oncogene, GTPase), ERBB2 (erb-b2 receptor tyrosine kinase 2), VEGFA (vascular endothelial growth factor A), MYC (MYC proto-oncogene, bHLH transcription factor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), EGF (epidermal growth factor), KRAS (KRAS proto-oncogene, GTPase), MDM2 (MDM2 proto-oncogene), CDKN2A (cyclin dependent kinase inhibitor 2A), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAP2K1 (mitogen-activated protein kinase kinase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), RB1 (RB transcriptional corepressor 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), CDH1 (cadherin 1), MMP9 (matrix metallopeptidase 9), MMP2 (matrix metallopeptidase 2), CDK4 (cyclin dependent kinase 4), HBEGF (heparin binding EGF like growth factor), E2F1 (E2F transcription factor 1), ARAF (A-Raf proto-oncogene, serine/threonine kinase), RASSF1 (Ras association domain family member 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), BRAF (B-Raf proto-oncogene, serine/threonine kinase), THBS1 (thrombospondin 1), DAPK1 (death associated protein kinase 1), MMP1 (matrix metallopeptidase 1), MAP2K2 (mitogen-activated protein kinase kinase 2), FGFR3 (fibroblast growth factor receptor 3), DAPK3 (death associated protein kinase 3), RPS6KA5 (ribosomal protein S6 kinase A5), DAPK2 (death associated protein kinase 2), TYMP (thymidine phosphorylase), CXCL8 (C-X-C motif chemokine ligand 8), UPK3A (uroplakin 3A)"], "WAG002355": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CCND1 (cyclin D1), CTNNB1 (catenin beta 1), MYC (MYC proto-oncogene, bHLH transcription factor), BMP4 (bone morphogenetic protein 4), SHH (sonic hedgehog signaling molecule), CDH1 (cadherin 1), PTCH1 (patched 1), GLI2 (GLI family zinc finger 2), GLI1 (GLI family zinc finger 1), LEF1 (lymphoid enhancer binding factor 1), RUNX2 (RUNX family transcription factor 2), WNT5A (Wnt family member 5A), FGFR2 (fibroblast growth factor receptor 2), FGF1 (fibroblast growth factor 1), CCND2 (cyclin D2), SMO (smoothened, frizzled class receptor), LRP5 (LDL receptor related protein 5), ITGB1 (integrin subunit beta 1), NFKB1 (nuclear factor kappa B subunit 1), FZD1 (frizzled class receptor 1), PDGFA (platelet derived growth factor subunit A), NCAM1 (neural cell adhesion molecule 1), PDGFRA (platelet derived growth factor receptor alpha), SNAI1 (snail family transcriptional repressor 1), LAMA5 (laminin subunit alpha 5), EDA (ectodysplasin A), TP63 (tumor protein p63), EDAR (ectodysplasin A receptor), GJB6 (gap junction protein beta 6), GTPBP4 (GTP binding protein 4), INHBA (inhibin subunit beta A), FOXI3 (forkhead box I3)"], "WAG002358": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL6 (interleukin 6), TGFB1 (transforming growth factor beta 1), VEGFA (vascular endothelial growth factor A), BMP4 (bone morphogenetic protein 4), FGF2 (fibroblast growth factor 2), IGF1 (insulin like growth factor 1), SHH (sonic hedgehog signaling molecule), EGF (epidermal growth factor), KITLG (KIT ligand), FGF1 (fibroblast growth factor 1), IL3 (interleukin 3), WNT3A (Wnt family member 3A), EPO (erythropoietin), IL11 (interleukin 11), NOG (noggin), CSF1 (colony stimulating factor 1), FGF10 (fibroblast growth factor 10), WNT1 (Wnt family member 1), CSF1R (colony stimulating factor 1 receptor), KIT (KIT proto-oncogene, receptor tyrosine kinase), IL6R (interleukin 6 receptor), HGF (hepatocyte growth factor), CNTF (ciliary neurotrophic factor), FGF4 (fibroblast growth factor 4), FGF8 (fibroblast growth factor 8), PDGFB (platelet derived growth factor subunit B), WNT2B (Wnt family member 2B), TF (transferrin), FLT3LG (fms related receptor tyrosine kinase 3 ligand), WNT7B (Wnt family member 7B), NOTCH1 (notch receptor 1), WNT5A (Wnt family member 5A), FST (follistatin), WNT2 (Wnt family member 2), TGFB3 (transforming growth factor beta 3), DKK1 (dickkopf WNT signaling pathway inhibitor 1), INHBA (inhibin subunit beta A), NODAL (nodal growth differentiation factor), PDGFA (platelet derived growth factor subunit A), LEFTY1 (left-right determination factor 1), TNFSF11 (TNF superfamily member 11), GDF5 (growth differentiation factor 5), NTF4 (neurotrophin 4), ALK (ALK receptor tyrosine kinase), INS (insulin), NT5E (5'-nucleotidase ecto), CXCR1 (C-X-C motif chemokine receptor 1), TPO (thyroid peroxidase)"], "WAG002359": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CSF2 (colony stimulating factor 2), IL3 (interleukin 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL6 (interleukin 6), GATA1 (GATA binding protein 1), KITLG (KIT ligand), SPI1 (Spi-1 proto-oncogene), CD34 (CD34 molecule), IL1B (interleukin 1 beta), GATA2 (GATA binding protein 2), EPO (erythropoietin), CXCR4 (C-X-C motif chemokine receptor 4), IL5 (interleukin 5), STAT5A (signal transducer and activator of transcription 5A), CSF1 (colony stimulating factor 1), RUNX1 (RUNX family transcription factor 1), NOTCH1 (notch receptor 1), MYB (MYB proto-oncogene, transcription factor), CSF3 (colony stimulating factor 3), VAV1 (vav guanine nucleotide exchange factor 1), ITGB3 (integrin subunit beta 3), IL1A (interleukin 1 alpha), NFATC2 (nuclear factor of activated T cells 2), KLF1 (Kruppel like factor 1), NFE2 (nuclear factor, erythroid 2), PIM1 (Pim-1 proto-oncogene, serine/threonine kinase), LMO2 (LIM domain only 2), LEF1 (lymphoid enhancer binding factor 1), FLI1 (Fli-1 proto-oncogene, ETS transcription factor), GYPA (glycophorin A (MNS blood group)), IRF5 (interferon regulatory factor 5), NCKAP1L (NCK associated protein 1 like), IKZF1 (IKAROS family zinc finger 1), ITGA2B (integrin subunit alpha 2b), KCNH2 (potassium voltage-gated channel subfamily H member 2), GP9 (glycoprotein IX platelet), RHOH (ras homolog family member H), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), CBFA2T3 (CBFA2/RUNX1 partner transcriptional co-repressor 3), CIITA (class II major histocompatibility complex transactivator), LYL1 (LYL1 basic helix-loop-helix family member), TNXB (tenascin XB), TRIM29 (tripartite motif containing 29), THRB (thyroid hormone receptor beta), HES6 (hes family bHLH transcription factor 6), LOC100506403 (uncharacterized LOC100506403), MIR15A (microRNA 15a), MIR130A (microRNA 130a), MIR128-1 (microRNA 128-1), MIR150 (microRNA 150), ZNF835 (zinc finger protein 835), TPO (thyroid peroxidase), MIR181A1 (microRNA 181a-1), RIOK3 (RIO kinase 3), HMGN5 (high mobility group nucleosome binding domain 5), MIR16-1 (microRNA 16-1), MXI1 (MAX interactor 1, dimerization protein), ACVR1B (activin A receptor type 1B), MIR221 (microRNA 221), ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase), MUC1 (mucin 1, cell surface associated), TRAF3IP3 (TRAF3 interacting protein 3), MIR223 (microRNA 223), SEC14L2 (SEC14 like lipid binding 2), MIR3074 (microRNA 3074)"], "WAG002360": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), APP (amyloid beta precursor protein), CTNNB1 (catenin beta 1), SMAD2 (SMAD family member 2), TGFB1 (transforming growth factor beta 1), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), LEF1 (lymphoid enhancer binding factor 1), GATA4 (GATA binding protein 4), SOX2 (SRY-box transcription factor 2), CDC73 (cell division cycle 73), SOX17 (SRY-box transcription factor 17), FOXO1 (forkhead box O1), FOXA2 (forkhead box A2), NOTCH1 (notch receptor 1), NANOG (Nanog homeobox), DNMT3B (DNA methyltransferase 3 beta), NOG (noggin), TCF7 (transcription factor 7), POU5F1 (POU class 5 homeobox 1), LEO1 (LEO1 homolog, Paf1/RNA polymerase II complex component), RTF1 (RTF1 homolog, Paf1/RNA polymerase II complex component), CUL4B (cullin 4B), CTBP2 (C-terminal binding protein 2), PAF1 (PAF1 homolog, Paf1/RNA polymerase II complex component), GATA6 (GATA binding protein 6), FOXH1 (forkhead box H1), JARID2 (jumonji and AT-rich interaction domain containing 2), NLK (nemo like kinase), NR3C1 (nuclear receptor subfamily 3 group C member 1), CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex component), PIAS1 (protein inhibitor of activated STAT 1), TCF4 (transcription factor 4), GLI2 (GLI family zinc finger 2), NODAL (nodal growth differentiation factor), DAB2 (DAB adaptor protein 2), ZBTB17 (zinc finger and BTB domain containing 17), TCF7L1 (transcription factor 7 like 1), NKX2-1 (NK2 homeobox 1), APC (APC regulator of WNT signaling pathway), ELP4 (elongator acetyltransferase complex subunit 4), BMP7 (bone morphogenetic protein 7), CAND1 (cullin associated and neddylation dissociated 1), FOXA1 (forkhead box A1), BMPR1A (bone morphogenetic protein receptor type 1A), CER1 (cerberus 1, DAN family BMP antagonist), LHX1 (LIM homeobox 1), HNF1B (HNF1 homeobox B), OTX2 (orthodenticle homeobox 2), RAB38 (RAB38, member RAS oncogene family), PABPC1 (poly(A) binding protein cytoplasmic 1), ONECUT1 (one cut homeobox 1), SFRP1 (secreted frizzled related protein 1), WNT3 (Wnt family member 3), PBX1 (PBX homeobox 1), WNT8A (Wnt family member 8A), UBR5 (ubiquitin protein ligase E3 component n-recognin 5), C1QBP (complement C1q binding protein), AEBP2 (AE binding protein 2), TBX21 (T-box transcription factor 21), PAX3 (paired box 3), HOXA1 (homeobox A1), MTF2 (metal response element binding transcription factor 2), ZNF281 (zinc finger protein 281), HHEX (hematopoietically expressed homeobox), SOX7 (SRY-box transcription factor 7), MAP2K3 (mitogen-activated protein kinase kinase 3), STAT1 (signal transducer and activator of transcription 1), DKK1 (dickkopf WNT signaling pathway inhibitor 1), ELAVL1 (ELAV like RNA binding protein 1), LRPPRC (leucine rich pentatricopeptide repeat containing), ZIC3 (Zic family member 3), EPB41L5 (erythrocyte membrane protein band 4.1 like 5), LAMC1 (laminin subunit gamma 1), RARG (retinoic acid receptor gamma), BPTF (bromodomain PHD finger transcription factor), TCEAL2 (transcription elongation factor A like 2), DIP2A (disco interacting protein 2 homolog A), MIXL1 (Mix paired-like homeobox), DUSP4 (dual specificity phosphatase 4), PBX3 (PBX homeobox 3), HOXC11 (homeobox C11), PTHLH (parathyroid hormone like hormone), TAF4B (TATA-box binding protein associated factor 4b), NCAPG2 (non-SMC condensin II complex subunit G2), CEBPZ (CCAAT enhancer binding protein zeta), EOMES (eomesodermin), ASCC3 (activating signal cointegrator 1 complex subunit 3), TNRC6C (trinucleotide repeat containing adaptor 6C), WDHD1 (WD repeat and HMG-box DNA binding protein 1), TAF5 (TATA-box binding protein associated factor 5), SOX21 (SRY-box transcription factor 21), ZFHX4 (zinc finger homeobox 4), WWC1 (WW and C2 domain containing 1), SIAH2 (siah E3 ubiquitin protein ligase 2), RGS10 (regulator of G protein signaling 10), AHDC1 (AT-hook DNA binding motif containing 1), CEP250 (centrosomal protein 250), GRHL2 (grainyhead like transcription factor 2), CDYL (chromodomain Y like)"], "WAG002361": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MESP2 (mesoderm posterior bHLH transcription factor 2), NOTCH1 (notch receptor 1), DLL1 (delta like canonical Notch ligand 1), LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase), HES7 (hes family bHLH transcription factor 7), TBX6 (T-box transcription factor 6), WNT3A (Wnt family member 3A), HES1 (hes family bHLH transcription factor 1), EPHA4 (EPH receptor A4), RIPPLY2 (ripply transcriptional repressor 2), FGF8 (fibroblast growth factor 8)"], "WAG002363": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), SMAD2 (SMAD family member 2), BMP4 (bone morphogenetic protein 4), SMAD1 (SMAD family member 1), SOX2 (SRY-box transcription factor 2), AXIN1 (axin 1), LEF1 (lymphoid enhancer binding factor 1), ACVR2B (activin A receptor type 2B), HNF4A (hepatocyte nuclear factor 4 alpha), ACVR1 (activin A receptor type 1), BMPR1A (bone morphogenetic protein receptor type 1A), CCND1 (cyclin D1), WNT3A (Wnt family member 3A), POU5F1 (POU class 5 homeobox 1), BMP7 (bone morphogenetic protein 7), CHRD (chordin), BMPR2 (bone morphogenetic protein receptor type 2), NODAL (nodal growth differentiation factor), PAX6 (paired box 6), SMAD6 (SMAD family member 6), ACVR2A (activin A receptor type 2A), NOG (noggin), PITX2 (paired like homeodomain 2), NANOG (Nanog homeobox), AXIN2 (axin 2), SRF (serum response factor), SOX17 (SRY-box transcription factor 17), JAK2 (Janus kinase 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), YAP1 (Yes1 associated transcriptional regulator), FOXH1 (forkhead box H1), PIAS1 (protein inhibitor of activated STAT 1), KLF5 (Kruppel like factor 5), PPP2CA (protein phosphatase 2 catalytic subunit alpha), TCF7L1 (transcription factor 7 like 1), FOXA2 (forkhead box A2), GATA6 (GATA binding protein 6), JARID2 (jumonji and AT-rich interaction domain containing 2), TCF4 (transcription factor 4), FZD5 (frizzled class receptor 5), INHBA (inhibin subunit beta A), DKK1 (dickkopf WNT signaling pathway inhibitor 1), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), HMGA2 (high mobility group AT-hook 2), FGF8 (fibroblast growth factor 8), PBX1 (PBX homeobox 1), LEFTY1 (left-right determination factor 1), TRIM28 (tripartite motif containing 28), FGFR1 (fibroblast growth factor receptor 1), AMH (anti-Mullerian hormone), FZD8 (frizzled class receptor 8), KLF4 (Kruppel like factor 4), DNMT3B (DNA methyltransferase 3 beta), WNT3 (Wnt family member 3), CTBP2 (C-terminal binding protein 2), RARG (retinoic acid receptor gamma), NLK (nemo like kinase), TBX6 (T-box transcription factor 6), ZNF281 (zinc finger protein 281), ZIC3 (Zic family member 3), RARB (retinoic acid receptor beta), FZD4 (frizzled class receptor 4), LEFTY2 (left-right determination factor 2), GATA3 (GATA binding protein 3), FOXC1 (forkhead box C1), TEAD1 (TEA domain transcription factor 1), MEIS1 (Meis homeobox 1), FOXA1 (forkhead box A1), CUL4B (cullin 4B), ZIC2 (Zic family member 2), EOMES (eomesodermin), TBX3 (T-box transcription factor 3), KDM6A (lysine demethylase 6A), TBX1 (T-box transcription factor 1), SNAI1 (snail family transcriptional repressor 1), TWSG1 (twisted gastrulation BMP signaling modulator 1), C1QBP (complement C1q binding protein), UBR5 (ubiquitin protein ligase E3 component n-recognin 5), EXT2 (exostosin glycosyltransferase 2), MTF2 (metal response element binding transcription factor 2), PBX3 (PBX homeobox 3), HTT (huntingtin), HES7 (hes family bHLH transcription factor 7), HAND1 (heart and neural crest derivatives expressed 1), RGS10 (regulator of G protein signaling 10), TEAD2 (TEA domain transcription factor 2), MIXL1 (Mix paired-like homeobox), CRTC1 (CREB regulated transcription coactivator 1), CSRP2 (cysteine and glycine rich protein 2), MACF1 (microtubule actin crosslinking factor 1), DLL1 (delta like canonical Notch ligand 1), ASCC3 (activating signal cointegrator 1 complex subunit 3), EPB41L5 (erythrocyte membrane protein band 4.1 like 5), WDHD1 (WD repeat and HMG-box DNA binding protein 1), PHF6 (PHD finger protein 6), EXT1 (exostosin glycosyltransferase 1), ZIC5 (Zic family member 5), ZFHX4 (zinc finger homeobox 4), LATS1 (large tumor suppressor kinase 1)"], "WAG002364": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), SMAD4 (SMAD family member 4), MYC (MYC proto-oncogene, bHLH transcription factor), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), BMP4 (bone morphogenetic protein 4), JUP (junction plakoglobin), CTBP1 (C-terminal binding protein 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), SHH (sonic hedgehog signaling molecule), PAX6 (paired box 6), BMPR1A (bone morphogenetic protein receptor type 1A), WNT1 (Wnt family member 1), SOX2 (SRY-box transcription factor 2), HDAC6 (histone deacetylase 6), TCF7L1 (transcription factor 7 like 1), TCF3 (transcription factor 3), ZBTB16 (zinc finger and BTB domain containing 16), FHL2 (four and a half LIM domains 2), NF2 (neurofibromin 2), GLI3 (GLI family zinc finger 3), FZD5 (frizzled class receptor 5), PAX3 (paired box 3), FGFR2 (fibroblast growth factor receptor 2), NFATC1 (nuclear factor of activated T cells 1), CDON (cell adhesion associated, oncogene regulated), OGT (O-linked N-acetylglucosamine (GlcNAc) transferase), ARHGAP15 (Rho GTPase activating protein 15), CTNND2 (catenin delta 2), CTNNA2 (catenin alpha 2), NLK (nemo like kinase), PPARD (peroxisome proliferator activated receptor delta), NUMA1 (nuclear mitotic apparatus protein 1), PTPN13 (protein tyrosine phosphatase non-receptor type 13), SKIL (SKI like proto-oncogene), LHX1 (LIM homeobox 1), BOC (BOC cell adhesion associated, oncogene regulated), ROR2 (receptor tyrosine kinase like orphan receptor 2), HDAC10 (histone deacetylase 10), FOXA2 (forkhead box A2), TRIM33 (tripartite motif containing 33), TFAP2A (transcription factor AP-2 alpha), RGMA (repulsive guidance molecule BMP co-receptor a), PIM1 (Pim-1 proto-oncogene, serine/threonine kinase), TBL1X (transducin beta like 1 X-linked), FZD4 (frizzled class receptor 4), FZD8 (frizzled class receptor 8), CDH6 (cadherin 6), CDH8 (cadherin 8), MECP2 (methyl-CpG binding protein 2), GATA6 (GATA binding protein 6), NR2F2 (nuclear receptor subfamily 2 group F member 2), EDA (ectodysplasin A), SPRY2 (sprouty RTK signaling antagonist 2), ARHGEF9 (Cdc42 guanine nucleotide exchange factor 9), SNCA (synuclein alpha), CCDC130 (coiled-coil domain containing 130), UBTF (upstream binding transcription factor), RAB8B (RAB8B, member RAS oncogene family), TFAP2C (transcription factor AP-2 gamma), RIT1 (Ras like without CAAX 1), SDCBP (syndecan binding protein), MAFB (MAF bZIP transcription factor B), AHI1 (Abelson helper integration site 1), PHF8 (PHD finger protein 8), PAN2 (poly(A) specific ribonuclease subunit PAN2), FOXL1 (forkhead box L1), PTPRB (protein tyrosine phosphatase receptor type B), HMGB2 (high mobility group box 2), SIX6 (SIX homeobox 6), TSKU (tsukushi, small leucine rich proteoglycan), POU2F2 (POU class 2 homeobox 2), SCHIP1 (schwannomin interacting protein 1), SGSM3 (small G protein signaling modulator 3), BCOR (BCL6 corepressor), ZNF219 (zinc finger protein 219), TSC22D1 (TSC22 domain family member 1), EDA2R (ectodysplasin A2 receptor), MKS1 (MKS transition zone complex subunit 1), ARX (aristaless related homeobox), ZBTB7B (zinc finger and BTB domain containing 7B), KIFC3 (kinesin family member C3), TNFRSF11B (TNF receptor superfamily member 11b), VAX2 (ventral anterior homeobox 2), ARHGDIG (Rho GDP dissociation inhibitor gamma), PLXNA2 (plexin A2), ST8SIA4 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4), LDB2 (LIM domain binding 2), BAZ1A (bromodomain adjacent to zinc finger domain 1A), DMD (dystrophin), TRPM2 (transient receptor potential cation channel subfamily M member 2), ARHGAP10 (Rho GTPase activating protein 10), CLDN11 (claudin 11), NLGN1 (neuroligin 1), HESX1 (HESX homeobox 1), ZFHX4 (zinc finger homeobox 4), CCDC88C (coiled-coil domain containing 88C), KRT6A (keratin 6A), TOX3 (TOX high mobility group box family member 3), CCL2 (C-C motif chemokine ligand 2), STX16 (syntaxin 16)"], "WAG002365": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRB2 (growth factor receptor bound protein 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), JAK2 (Janus kinase 2), GAB2 (GRB2 associated binding protein 2), SHC1 (SHC adaptor protein 1), HRAS (HRas proto-oncogene, GTPase), JAK1 (Janus kinase 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), CBL (Cbl proto-oncogene), MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), SYK (spleen associated tyrosine kinase), MAPK3 (mitogen-activated protein kinase 3), STAT3 (signal transducer and activator of transcription 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), VAV1 (vav guanine nucleotide exchange factor 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PTPN6 (protein tyrosine phosphatase non-receptor type 6), IL3 (interleukin 3), CSF2RB (colony stimulating factor 2 receptor subunit beta), INPP5D (inositol polyphosphate-5-phosphatase D), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), STAT5A (signal transducer and activator of transcription 5A), MAP2K1 (mitogen-activated protein kinase kinase 1), HCK (HCK proto-oncogene, Src family tyrosine kinase), LYN (LYN proto-oncogene, Src family tyrosine kinase), CRKL (CRK like proto-oncogene, adaptor protein), STAT5B (signal transducer and activator of transcription 5B), MAPK8 (mitogen-activated protein kinase 8), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL3RA (interleukin 3 receptor subunit alpha), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), BCL2 (BCL2 apoptosis regulator), BCL2L1 (BCL2 like 1), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), RAPGEF1 (Rap guanine nucleotide exchange factor 1), BAD (BCL2 associated agonist of cell death), IL5RA (interleukin 5 receptor subunit alpha), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CD86 (CD86 molecule), TGFB1 (transforming growth factor beta 1), CCR3 (C-C motif chemokine receptor 3), CD69 (CD69 molecule), ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002366": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APP (amyloid beta precursor protein), MAPK1 (mitogen-activated protein kinase 1), NFKB1 (nuclear factor kappa B subunit 1), AKT1 (AKT serine/threonine kinase 1), TNF (tumor necrosis factor), VIM (vimentin), SOCS3 (suppressor of cytokine signaling 3), CDKN1A (cyclin dependent kinase inhibitor 1A), CUL1 (cullin 1), HSPD1 (heat shock protein family D (Hsp60) member 1), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), PTK2B (protein tyrosine kinase 2 beta), PAK2 (p21 (RAC1) activated kinase 2), PTK2 (protein tyrosine kinase 2), SQSTM1 (sequestosome 1), HSPA5 (heat shock protein family A (Hsp70) member 5), HDAC1 (histone deacetylase 1), ERBB3 (erb-b2 receptor tyrosine kinase 3), RIPK2 (receptor interacting serine/threonine kinase 2), CASP7 (caspase 7), ETS1 (ETS proto-oncogene 1, transcription factor), RPS6KB1 (ribosomal protein S6 kinase B1), SMAD7 (SMAD family member 7), PKN1 (protein kinase N1), AXIN1 (axin 1), RNF7 (ring finger protein 7), HSPB1 (heat shock protein family B (small) member 1), BIRC5 (baculoviral IAP repeat containing 5), CDKN1B (cyclin dependent kinase inhibitor 1B), CUL5 (cullin 5), TRAF1 (TNF receptor associated factor 1), TNFRSF10B (TNF receptor superfamily member 10b), SERBP1 (SERPINE1 mRNA binding protein 1), ANXA5 (annexin A5), BCL3 (BCL3 transcription coactivator), CTNNA1 (catenin alpha 1), F2R (coagulation factor II thrombin receptor), HELLS (helicase, lymphoid specific), IER3 (immediate early response 3), NRG1 (neuregulin 1), IL7R (interleukin 7 receptor), VAV3 (vav guanine nucleotide exchange factor 3), NQO1 (NAD(P)H quinone dehydrogenase 1), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), ERN1 (endoplasmic reticulum to nucleus signaling 1), APOE (apolipoprotein E), TNFRSF21 (TNF receptor superfamily member 21), GCLC (glutamate-cysteine ligase catalytic subunit), THBS1 (thrombospondin 1), CARD14 (caspase recruitment domain family member 14), BEX3 (brain expressed X-linked 3), YBX3 (Y-box binding protein 3), NET1 (neuroepithelial cell transforming 1)"], "WAG002367": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL1B (interleukin 1 beta), IRAK1 (interleukin 1 receptor associated kinase 1), NFKB1 (nuclear factor kappa B subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MMP9 (matrix metallopeptidase 9), MYD88 (MYD88 innate immune signal transduction adaptor), IL18 (interleukin 18), IFNG (interferon gamma), IL1R1 (interleukin 1 receptor type 1), CCL2 (C-C motif chemokine ligand 2), TLR2 (toll like receptor 2), ICAM1 (intercellular adhesion molecule 1), NLRP3 (NLR family pyrin domain containing 3), S100A9 (S100 calcium binding protein A9), TLR1 (toll like receptor 1), TIMP1 (TIMP metallopeptidase inhibitor 1), CCR3 (C-C motif chemokine receptor 3), F2R (coagulation factor II thrombin receptor), F2 (coagulation factor II, thrombin), HBEGF (heparin binding EGF like growth factor), FCER1A (Fc fragment of IgE receptor Ia), TIMP2 (TIMP metallopeptidase inhibitor 2), PLA2G7 (phospholipase A2 group VII), SELENBP1 (selenium binding protein 1)"], "WAG002369": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), TGFB1 (transforming growth factor beta 1), AKT1 (AKT serine/threonine kinase 1), SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), EGFR (epidermal growth factor receptor), SMAD2 (SMAD family member 2), ERBB2 (erb-b2 receptor tyrosine kinase 2), TGFBR2 (transforming growth factor beta receptor 2), TGFBR1 (transforming growth factor beta receptor 1), AXIN1 (axin 1), HRAS (HRas proto-oncogene, GTPase), NRAS (NRAS proto-oncogene, GTPase), MET (MET proto-oncogene, receptor tyrosine kinase), TGFB2 (transforming growth factor beta 2), TGFB3 (transforming growth factor beta 3), HGF (hepatocyte growth factor), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), TGFBR3 (transforming growth factor beta receptor 3), KRAS (KRAS proto-oncogene, GTPase), MTOR (mechanistic target of rapamycin kinase), APC (APC regulator of WNT signaling pathway), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), TGFA (transforming growth factor alpha), WNT3A (Wnt family member 3A), WNT5A (Wnt family member 5A), DKK4 (dickkopf WNT signaling pathway inhibitor 4), PROM1 (prominin 1), TSPAN8 (tetraspanin 8), MFGE8 (milk fat globule EGF and factor V/VIII domain containing)"], "WAG002370": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JUN (Jun proto-oncogene, AP-1 transcription factor subunit), AHR (aryl hydrocarbon receptor), EP300 (E1A binding protein p300), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), CYP1B1 (cytochrome P450 family 1 subfamily B member 1), ARNT (aryl hydrocarbon receptor nuclear translocator), HSP90AA1 (heat shock protein 90 alpha family class A member 1), GSTA2 (glutathione S-transferase alpha 2), CYP1A2 (cytochrome P450 family 1 subfamily A member 2), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), TNF (tumor necrosis factor), IFNG (interferon gamma), TGFB1 (transforming growth factor beta 1), IL2 (interleukin 2), NFE2L2 (nuclear factor, erythroid 2 like 2), PTGES3 (prostaglandin E synthase 3), EGFR (epidermal growth factor receptor), IL1B (interleukin 1 beta), NQO1 (NAD(P)H quinone dehydrogenase 1), CDKN1B (cyclin dependent kinase inhibitor 1B), NCOA1 (nuclear receptor coactivator 1), AIP (aryl hydrocarbon receptor interacting protein), UGT1A1 (UDP glucuronosyltransferase family 1 member A1), MGST1 (microsomal glutathione S-transferase 1), UGT1A6 (UDP glucuronosyltransferase family 1 member A6), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), UGT1A4 (UDP glucuronosyltransferase family 1 member A4), IL12B (interleukin 12B), UGT1A9 (UDP glucuronosyltransferase family 1 member A9), UGT1A7 (UDP glucuronosyltransferase family 1 member A7), UGT1A3 (UDP glucuronosyltransferase family 1 member A3), IL12A (interleukin 12A), CDC37 (cell division cycle 37, HSP90 cochaperone), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), BAX (BCL2 associated X, apoptosis regulator), ALDH3A1 (aldehyde dehydrogenase 3 family member A1), HES1 (hes family bHLH transcription factor 1), IGFBP1 (insulin like growth factor binding protein 1), AHRR (aryl-hydrocarbon receptor repressor), SERPINB2 (serpin family B member 2), CES3 (carboxylesterase 3), SLC7A5 (solute carrier family 7 member 5), IL17B (interleukin 17B), CAP2 (cyclase associated actin cytoskeleton regulatory protein 2), POLK (DNA polymerase kappa), MYOF (myoferlin)"], "WAG002377": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAP3K7 (mitogen-activated protein kinase kinase kinase 7), RELA (RELA proto-oncogene, NF-kB subunit), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CD40 (CD40 molecule), MAPK8 (mitogen-activated protein kinase 8), EPHB2 (EPH receptor B2), ERBIN (erbb2 interacting protein)"], "WAG002378": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HSP90AA1 (heat shock protein 90 alpha family class A member 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PTGS2 (prostaglandin-endoperoxide synthase 2), NFKB2 (nuclear factor kappa B subunit 2), NR3C1 (nuclear receptor subfamily 3 group C member 1), RXRA (retinoid X receptor alpha), TNFAIP3 (TNF alpha induced protein 3), NR1I3 (nuclear receptor subfamily 1 group I member 3), CUL1 (cullin 1), PTGES3 (prostaglandin E synthase 3), NR1I2 (nuclear receptor subfamily 1 group I member 2), TSC22D3 (TSC22 domain family member 3), BIRC2 (baculoviral IAP repeat containing 2), BIRC3 (baculoviral IAP repeat containing 3), CCL2 (C-C motif chemokine ligand 2), GADD45B (growth arrest and DNA damage inducible beta), CCL20 (C-C motif chemokine ligand 20), CDKN1C (cyclin dependent kinase inhibitor 1C), BHLHE40 (basic helix-loop-helix family member e40), THBD (thrombomodulin), ANGPTL4 (angiopoietin like 4), IL11 (interleukin 11), RGS2 (regulator of G protein signaling 2), ANKRD1 (ankyrin repeat domain 1), EDN2 (endothelin 2), ENC1 (ectodermal-neural cortex 1), KTN1 (kinectin 1), ZIC2 (Zic family member 2), POU5F1 (POU class 5 homeobox 1), DNAJC15 (DnaJ heat shock protein family (Hsp40) member C15), ALOX5AP (arachidonate 5-lipoxygenase activating protein), SRGN (serglycin), SPRY1 (sprouty RTK signaling antagonist 1), FGD4 (FYVE, RhoGEF and PH domain containing 4), SERTAD2 (SERTA domain containing 2), ADGRF4 (adhesion G protein-coupled receptor F4), SERPINB9 (serpin family B member 9), ACKR3 (atypical chemokine receptor 3), PDE4B (phosphodiesterase 4B), SLC19A2 (solute carrier family 19 member 2), SNAI2 (snail family transcriptional repressor 2), NAV3 (neuron navigator 3), FGFBP1 (fibroblast growth factor binding protein 1), LRRC8A (leucine rich repeat containing 8 VRAC subunit A), MT1IP (metallothionein 1I, pseudogene), ETNK2 (ethanolamine kinase 2), CPEB4 (cytoplasmic polyadenylation element binding protein 4), SLC26A2 (solute carrier family 26 member 2), MFGE8 (milk fat globule EGF and factor V/VIII domain containing), TGFBR3 (transforming growth factor beta receptor 3), MGAM (maltase-glucoamylase), ABHD2 (abhydrolase domain containing 2, acylglycerol lipase), DNER (delta/notch like EGF repeat containing), CDC42EP3 (CDC42 effector protein 3), PRRG4 (proline rich and Gla domain 4), ARL5B (ADP ribosylation factor like GTPase 5B), GPR153 (G protein-coupled receptor 153), B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5), S100P (S100 calcium binding protein P), SPINK13 (serine peptidase inhibitor Kazal type 13), SEC14L1 (SEC14 like lipid binding 1), PPP1R14C (protein phosphatase 1 regulatory inhibitor subunit 14C), STOM (stomatin), AMIGO2 (adhesion molecule with Ig like domain 2), EPB41L4B (erythrocyte membrane protein band 4.1 like 4B), AKAP13 (A-kinase anchoring protein 13), PMP2 (peripheral myelin protein 2), PLK2 (polo like kinase 2), SCNN1A (sodium channel epithelial 1 subunit alpha), CAVIN2 (caveolae associated protein 2), TNS4 (tensin 4)"], "WAG002380": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PPARA (peroxisome proliferator activated receptor alpha), RXRA (retinoid X receptor alpha), ESR1 (estrogen receptor 1), EP300 (E1A binding protein p300), TNF (tumor necrosis factor), HSP90AA1 (heat shock protein 90 alpha family class A member 1), CYP3A4 (cytochrome P450 family 3 subfamily A member 4), MYC (MYC proto-oncogene, bHLH transcription factor), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), CYP2B6 (cytochrome P450 family 2 subfamily B member 6), CYP2C9 (cytochrome P450 family 2 subfamily C member 9), EGFR (epidermal growth factor receptor), GSTA2 (glutathione S-transferase alpha 2), NCOA2 (nuclear receptor coactivator 2), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), CYP3A5 (cytochrome P450 family 3 subfamily A member 5), CYP2C19 (cytochrome P450 family 2 subfamily C member 19), TGFB1 (transforming growth factor beta 1), GSTA1 (glutathione S-transferase alpha 1), GSTA3 (glutathione S-transferase alpha 3), GSTA4 (glutathione S-transferase alpha 4), SP1 (Sp1 transcription factor), CYP1A2 (cytochrome P450 family 1 subfamily A member 2), STAT3 (signal transducer and activator of transcription 3), CYP1B1 (cytochrome P450 family 1 subfamily B member 1), NR3C1 (nuclear receptor subfamily 3 group C member 1), NCOA6 (nuclear receptor coactivator 6), NCOA1 (nuclear receptor coactivator 1), PTGS2 (prostaglandin-endoperoxide synthase 2), GSTP1 (glutathione S-transferase pi 1), CYP3A7 (cytochrome P450 family 3 subfamily A member 7), CCND1 (cyclin D1), GSTM2 (glutathione S-transferase mu 2), NR1I3 (nuclear receptor subfamily 1 group I member 3), AHR (aryl hydrocarbon receptor), NCOA3 (nuclear receptor coactivator 3), MGST1 (microsomal glutathione S-transferase 1), GSTM1 (glutathione S-transferase mu 1), GSTM3 (glutathione S-transferase mu 3), MGST3 (microsomal glutathione S-transferase 3), GSTM4 (glutathione S-transferase mu 4), GSTM5 (glutathione S-transferase mu 5), MGST2 (microsomal glutathione S-transferase 2), PPARGC1A (PPARG coactivator 1 alpha), GSTA5 (glutathione S-transferase alpha 5), NR1H4 (nuclear receptor subfamily 1 group H member 4), VDR (vitamin D receptor), ABCB1 (ATP binding cassette subfamily B member 1), IL1B (interleukin 1 beta), CDK4 (cyclin dependent kinase 4), ADH7 (alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide), NR0B2 (nuclear receptor subfamily 0 group B member 2), NR1H3 (nuclear receptor subfamily 1 group H member 3), PSMC5 (proteasome 26S subunit, ATPase 5), UGT1A1 (UDP glucuronosyltransferase family 1 member A1), GGT1 (gamma-glutamyltransferase 1), HSP90AB1 (heat shock protein 90 alpha family class B member 1), ARNT (aryl hydrocarbon receptor nuclear translocator), GSR (glutathione-disulfide reductase), SLC2A4 (solute carrier family 2 member 4), NFE2L2 (nuclear factor, erythroid 2 like 2), CYP4A11 (cytochrome P450 family 4 subfamily A member 11), CYP7A1 (cytochrome P450 family 7 subfamily A member 1), NR1I2 (nuclear receptor subfamily 1 group I member 2), UGT1A6 (UDP glucuronosyltransferase family 1 member A6), FOXO1 (forkhead box O1), KAT2B (lysine acetyltransferase 2B), HMOX1 (heme oxygenase 1), IFNG (interferon gamma), NQO1 (NAD(P)H quinone dehydrogenase 1), GPX2 (glutathione peroxidase 2), UGT1A9 (UDP glucuronosyltransferase family 1 member A9), GPX3 (glutathione peroxidase 3), PPARD (peroxisome proliferator activated receptor delta), UGT1A4 (UDP glucuronosyltransferase family 1 member A4), UGT1A7 (UDP glucuronosyltransferase family 1 member A7), APOA1 (apolipoprotein A1), UGT1A3 (UDP glucuronosyltransferase family 1 member A3), IL2 (interleukin 2), ALDH3A1 (aldehyde dehydrogenase 3 family member A1), NRIP1 (nuclear receptor interacting protein 1), CDKN1B (cyclin dependent kinase inhibitor 1B), CDK1 (cyclin dependent kinase 1), EGR1 (early growth response 1), TXN (thioredoxin), FASN (fatty acid synthase), CUL1 (cullin 1), UGT2B4 (UDP glucuronosyltransferase family 2 member B4), PTGES3 (prostaglandin E synthase 3), UGT2B7 (UDP glucuronosyltransferase family 2 member B7), ABCB11 (ATP binding cassette subfamily B member 11), CPT1A (carnitine palmitoyltransferase 1A), SREBF1 (sterol regulatory element binding transcription factor 1), ABCC2 (ATP binding cassette subfamily C member 2), NFKB2 (nuclear factor kappa B subunit 2), APOA2 (apolipoprotein A2), CCL2 (C-C motif chemokine ligand 2), SLCO1B1 (solute carrier organic anion transporter family member 1B1), CES5A (carboxylesterase 5A)"], "WAG002381": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GSTA2 (glutathione S-transferase alpha 2), GSTA1 (glutathione S-transferase alpha 1), GSTA4 (glutathione S-transferase alpha 4), GSTA3 (glutathione S-transferase alpha 3), ADH7 (alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide), GSTP1 (glutathione S-transferase pi 1), GSTM2 (glutathione S-transferase mu 2), GSR (glutathione-disulfide reductase), GSTM3 (glutathione S-transferase mu 3), GSTM1 (glutathione S-transferase mu 1), GSTM4 (glutathione S-transferase mu 4), GSTM5 (glutathione S-transferase mu 5), GGT1 (gamma-glutamyltransferase 1), MGST2 (microsomal glutathione S-transferase 2), MGST3 (microsomal glutathione S-transferase 3), GSTA5 (glutathione S-transferase alpha 5), GPX2 (glutathione peroxidase 2), GPX3 (glutathione peroxidase 3), ALDH3A1 (aldehyde dehydrogenase 3 family member A1), NQO1 (NAD(P)H quinone dehydrogenase 1), NFE2L2 (nuclear factor, erythroid 2 like 2), SLC2A4 (solute carrier family 2 member 4), TGFB1 (transforming growth factor beta 1), CES5A (carboxylesterase 5A), HMOX1 (heme oxygenase 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), UGT1A1 (UDP glucuronosyltransferase family 1 member A1), UGT1A4 (UDP glucuronosyltransferase family 1 member A4), KEAP1 (kelch like ECH associated protein 1), TXN (thioredoxin), UGT1A9 (UDP glucuronosyltransferase family 1 member A9), UGT1A7 (UDP glucuronosyltransferase family 1 member A7), BLVRB (biliverdin reductase B), UGT1A6 (UDP glucuronosyltransferase family 1 member A6), UGT1A3 (UDP glucuronosyltransferase family 1 member A3), SLC39A6 (solute carrier family 39 member 6), GCLC (glutamate-cysteine ligase catalytic subunit), SLC2A1 (solute carrier family 2 member 1), CES2 (carboxylesterase 2), CYP4A11 (cytochrome P450 family 4 subfamily A member 11), SLC2A5 (solute carrier family 2 member 5), SLC2A3 (solute carrier family 2 member 3), SLC5A1 (solute carrier family 5 member 1), SLC2A2 (solute carrier family 2 member 2), RXRA (retinoid X receptor alpha), TXNRD1 (thioredoxin reductase 1), ABCC3 (ATP binding cassette subfamily C member 3), G6PD (glucose-6-phosphate dehydrogenase), SLC2A9 (solute carrier family 2 member 9), UGT2B7 (UDP glucuronosyltransferase family 2 member B7), MAFG (MAF bZIP transcription factor G), GCLM (glutamate-cysteine ligase modifier subunit), SLC6A7 (solute carrier family 6 member 7), TGFBR2 (transforming growth factor beta receptor 2), ABCC2 (ATP binding cassette subfamily C member 2), PPARD (peroxisome proliferator activated receptor delta), HSP90AB1 (heat shock protein 90 alpha family class B member 1), CES1 (carboxylesterase 1), SLC6A2 (solute carrier family 6 member 2), PRDX1 (peroxiredoxin 1), SLC6A11 (solute carrier family 6 member 11), HGF (hepatocyte growth factor), FTH1 (ferritin heavy chain 1), PRDX6 (peroxiredoxin 6), SLC6A13 (solute carrier family 6 member 13), TGFB2 (transforming growth factor beta 2), SQSTM1 (sequestosome 1), SLC6A9 (solute carrier family 6 member 9), PGD (phosphogluconate dehydrogenase), SLC6A1 (solute carrier family 6 member 1), EGR1 (early growth response 1), CES3 (carboxylesterase 3), CES4A (carboxylesterase 4A), FTL (ferritin light chain), MAFF (MAF bZIP transcription factor F), SLC39A3 (solute carrier family 39 member 3), SLC39A2 (solute carrier family 39 member 2), SLC6A5 (solute carrier family 6 member 5), EPHA2 (EPH receptor A2), ABCC4 (ATP binding cassette subfamily C member 4), SLC39A1 (solute carrier family 39 member 1), SLC2A8 (solute carrier family 2 member 8), ABCC5 (ATP binding cassette subfamily C member 5), TGFA (transforming growth factor alpha), SLC2A6 (solute carrier family 2 member 6), SLC2A11 (solute carrier family 2 member 11), SERPINA1 (serpin family A member 1), HBEGF (heparin binding EGF like growth factor), SLC6A3 (solute carrier family 6 member 3), SLC5A4 (solute carrier family 5 member 4), NRG1 (neuregulin 1), SRXN1 (sulfiredoxin 1), DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1), SLC2A13 (solute carrier family 2 member 13), SLC39A4 (solute carrier family 39 member 4), SLC6A15 (solute carrier family 6 member 15), PDGFB (platelet derived growth factor subunit B), SLC6A8 (solute carrier family 6 member 8), ME1 (malic enzyme 1), SLC6A14 (solute carrier family 6 member 14)"], "WAG002384": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CALM3 (calmodulin 3), GNG2 (G protein subunit gamma 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), GNAS (GNAS complex locus), ADCY2 (adenylate cyclase 2), PLCB3 (phospholipase C beta 3), ADCY8 (adenylate cyclase 8), ADCY5 (adenylate cyclase 5), ADCY7 (adenylate cyclase 7), ADCY1 (adenylate cyclase 1), PRKCA (protein kinase C alpha), ADCY6 (adenylate cyclase 6), ADCY9 (adenylate cyclase 9), ADCY4 (adenylate cyclase 4), PLCG1 (phospholipase C gamma 1), GNB1 (G protein subunit beta 1), PRKACB (protein kinase cAMP-activated catalytic subunit beta), ADCY3 (adenylate cyclase 3), GNGT1 (G protein subunit gamma transducin 1), PRKCE (protein kinase C epsilon), GNG3 (G protein subunit gamma 3), LPAR1 (lysophosphatidic acid receptor 1), PLCG2 (phospholipase C gamma 2), GNG4 (G protein subunit gamma 4), PRKCD (protein kinase C delta), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), GNG7 (G protein subunit gamma 7), RGS2 (regulator of G protein signaling 2), CREB1 (cAMP responsive element binding protein 1), GNB5 (G protein subunit beta 5), GNG13 (G protein subunit gamma 13), GNB3 (G protein subunit beta 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), GNG12 (G protein subunit gamma 12), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), GNB2 (G protein subunit beta 2), ARRB1 (arrestin beta 1), GNG8 (G protein subunit gamma 8), ADM (adrenomedullin), PRKCB (protein kinase C beta), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), GNG11 (G protein subunit gamma 11), GNG5 (G protein subunit gamma 5), GNB4 (G protein subunit beta 4), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), ACTB (actin beta), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), CALCA (calcitonin related polypeptide alpha), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), GNAQ (G protein subunit alpha q), ARRB2 (arrestin beta 2), PRKCG (protein kinase C gamma), PLCD1 (phospholipase C delta 1), NFKB1 (nuclear factor kappa B subunit 1), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), CRH (corticotropin releasing hormone), IL6 (interleukin 6), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), GRK5 (G protein-coupled receptor kinase 5), RGS7 (regulator of G protein signaling 7), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), PRKCZ (protein kinase C zeta), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), NOS3 (nitric oxide synthase 3), RGS19 (regulator of G protein signaling 19), CAMK2B (calcium/calmodulin dependent protein kinase II beta), RXFP1 (relaxin family peptide receptor 1), ACTG1 (actin gamma 1), RGS9 (regulator of G protein signaling 9), SP1 (Sp1 transcription factor), GRK6 (G protein-coupled receptor kinase 6), RGS6 (regulator of G protein signaling 6), PDE4D (phosphodiesterase 4D), ATF2 (activating transcription factor 2), RGS14 (regulator of G protein signaling 14), RXFP2 (relaxin family peptide receptor 2), PRKD1 (protein kinase D1), CAMK2D (calcium/calmodulin dependent protein kinase II delta), OXTR (oxytocin receptor), RGS3 (regulator of G protein signaling 3), RGS10 (regulator of G protein signaling 10), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), RGS4 (regulator of G protein signaling 4), ATF4 (activating transcription factor 4), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), ACTA1 (actin alpha 1, skeletal muscle), PDE4B (phosphodiesterase 4B), PRKCQ (protein kinase C theta), RGS18 (regulator of G protein signaling 18), RYR2 (ryanodine receptor 2), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), GRK4 (G protein-coupled receptor kinase 4), PRKCH (protein kinase C eta), RGS16 (regulator of G protein signaling 16), RGS1 (regulator of G protein signaling 1), RGS11 (regulator of G protein signaling 11), DGKZ (diacylglycerol kinase zeta)"], "WAG002386": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ITGA1 (integrin subunit alpha 1), ITGA11 (integrin subunit alpha 11), ITGB5 (integrin subunit beta 5), ITGB6 (integrin subunit beta 6), COL4A1 (collagen type IV alpha 1 chain), COL1A2 (collagen type I alpha 2 chain), COL5A1 (collagen type V alpha 1 chain), COL5A2 (collagen type V alpha 2 chain), COL4A2 (collagen type IV alpha 2 chain), COL6A3 (collagen type VI alpha 3 chain), COL3A1 (collagen type III alpha 1 chain), COL5A3 (collagen type V alpha 3 chain), COL6A2 (collagen type VI alpha 2 chain), SDC2 (syndecan 2), COL6A1 (collagen type VI alpha 1 chain), FN1 (fibronectin 1), THBS1 (thrombospondin 1), THBS2 (thrombospondin 2), LAMC1 (laminin subunit gamma 1), LAMA4 (laminin subunit alpha 4), LAMB2 (laminin subunit beta 2), TNXB (tenascin XB), MIR30C1 (microRNA 30c-1), MIR92A2 (microRNA 92a-2), MIR532 (microRNA 532), MIR30D (microRNA 30d), MIR25 (microRNA 25), MIR548AA2 (microRNA 548aa-2), MIR148B (microRNA 148b), MIR589 (microRNA 589), MIR200A (microRNA 200a), MIR141 (microRNA 141), MIR107 (microRNA 107), MIR548D1 (microRNA 548d-1), MIR30C2 (microRNA 30c-2), MIR219A1 (microRNA 219a-1), MIR548D2 (microRNA 548d-2), MIR30B (microRNA 30b), MIR200B (microRNA 200b), MIR30E (microRNA 30e), LINC02478 (long intergenic non-protein coding RNA 2478), MIR15B (microRNA 15b), MIR200C (microRNA 200c), MIR548AA1 (microRNA 548aa-1), MIR7-1 (microRNA 7-1), MIR429 (microRNA 429)"], "WAG002391": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NFE2L2 (nuclear factor, erythroid 2 like 2), HMOX1 (heme oxygenase 1), KEAP1 (kelch like ECH associated protein 1), NQO1 (NAD(P)H quinone dehydrogenase 1), GCLC (glutamate-cysteine ligase catalytic subunit), GCLM (glutamate-cysteine ligase modifier subunit), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), GSTA2 (glutathione S-transferase alpha 2), PRKCA (protein kinase C alpha), MAPK8 (mitogen-activated protein kinase 8), MAF (MAF bZIP transcription factor), EPHB2 (EPH receptor B2), AIMP2 (aminoacyl tRNA synthetase complex interacting multifunctional protein 2), SLC7A11 (solute carrier family 7 member 11), CEBPB (CCAAT enhancer binding protein beta)"], "WAG002392": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KIT (KIT proto-oncogene, receptor tyrosine kinase), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), MAPK1 (mitogen-activated protein kinase 1), SHC1 (SHC adaptor protein 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), JAK2 (Janus kinase 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK3 (mitogen-activated protein kinase 3), AKT1 (AKT serine/threonine kinase 1), HRAS (HRas proto-oncogene, GTPase), VAV1 (vav guanine nucleotide exchange factor 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), GAB2 (GRB2 associated binding protein 2), CBL (Cbl proto-oncogene), PRKCA (protein kinase C alpha), STAT3 (signal transducer and activator of transcription 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PTPN6 (protein tyrosine phosphatase non-receptor type 6), BTK (Bruton tyrosine kinase), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), LYN (LYN proto-oncogene, Src family tyrosine kinase), CRK (CRK proto-oncogene, adaptor protein), PLCG1 (phospholipase C gamma 1), MAPK8 (mitogen-activated protein kinase 8), MAPK14 (mitogen-activated protein kinase 14), MAP2K1 (mitogen-activated protein kinase kinase 1), STAT5A (signal transducer and activator of transcription 5A), INPP5D (inositol polyphosphate-5-phosphatase D), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CRKL (CRK like proto-oncogene, adaptor protein), STAT5B (signal transducer and activator of transcription 5B), KITLG (KIT ligand), STAT1 (signal transducer and activator of transcription 1), DOK1 (docking protein 1), RPS6KB1 (ribosomal protein S6 kinase B1), EP300 (E1A binding protein p300), SOCS1 (suppressor of cytokine signaling 1), TEC (tec protein tyrosine kinase), TEC (transient erythroblastopenia of childhood), GRB10 (growth factor receptor bound protein 10), PRKCB (protein kinase C beta), RPS6KA1 (ribosomal protein S6 kinase A1), BCL2 (BCL2 apoptosis regulator), SH2B2 (SH2B adaptor protein 2), BAD (BCL2 associated agonist of cell death), RPS6KA3 (ribosomal protein S6 kinase A3), MAP2K2 (mitogen-activated protein kinase kinase 2), MITF (melanocyte inducing transcription factor), GRB7 (growth factor receptor bound protein 7), MATK (megakaryocyte-associated tyrosine kinase), MAPT (microtubule associated protein tau), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), RPS6 (ribosomal protein S6), FOXO3 (forkhead box O3), SNAI2 (snail family transcriptional repressor 2), SOCS6 (suppressor of cytokine signaling 6), TBX2 (T-box transcription factor 2), SNAI1 (snail family transcriptional repressor 1)"], "WAG002393": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ITGB1 (integrin subunit beta 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), ITGB4 (integrin subunit beta 4), ITGAV (integrin subunit alpha V), AKT1 (AKT serine/threonine kinase 1), GRB2 (growth factor receptor bound protein 2), ITGB5 (integrin subunit beta 5), EGFR (epidermal growth factor receptor), RAC1 (Rac family small GTPase 1), PXN (paxillin), ITGB7 (integrin subunit beta 7), ITGB6 (integrin subunit beta 6), ITGA1 (integrin subunit alpha 1), PTK2 (protein tyrosine kinase 2), ITGB8 (integrin subunit beta 8), ITGA6 (integrin subunit alpha 6), FN1 (fibronectin 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), ITGA4 (integrin subunit alpha 4), ITGA5 (integrin subunit alpha 5), CRK (CRK proto-oncogene, adaptor protein), ITGA3 (integrin subunit alpha 3), ITGA2B (integrin subunit alpha 2b), ITGA2 (integrin subunit alpha 2), FYN (FYN proto-oncogene, Src family tyrosine kinase), ITGA9 (integrin subunit alpha 9), ITGA8 (integrin subunit alpha 8), ITGA10 (integrin subunit alpha 10), ITGA11 (integrin subunit alpha 11), MAPK1 (mitogen-activated protein kinase 1), RHOA (ras homolog family member A), BCAR1 (BCAR1 scaffold protein, Cas family member), ITGA7 (integrin subunit alpha 7), VEGFA (vascular endothelial growth factor A), ITGB3 (integrin subunit beta 3), ERBB2 (erb-b2 receptor tyrosine kinase 2), CDC42 (cell division cycle 42), EGF (epidermal growth factor), SHC1 (SHC adaptor protein 1), PRKCA (protein kinase C alpha), ACTB (actin beta), CRKL (CRK like proto-oncogene, adaptor protein), HRAS (HRas proto-oncogene, GTPase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PDGFRB (platelet derived growth factor receptor beta), TLN1 (talin 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), IGF1R (insulin like growth factor 1 receptor), MAPK3 (mitogen-activated protein kinase 3), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), FLNA (filamin A), KDR (kinase insert domain receptor), ACTN1 (actinin alpha 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MET (MET proto-oncogene, receptor tyrosine kinase), COL1A1 (collagen type I alpha 1 chain), ILK (integrin linked kinase), ACTG1 (actin gamma 1), IGF1 (insulin like growth factor 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PDGFB (platelet derived growth factor subunit B), PTEN (phosphatase and tensin homolog), CTNNB1 (catenin beta 1), VAV1 (vav guanine nucleotide exchange factor 1), MAPK8 (mitogen-activated protein kinase 8), ACTN4 (actinin alpha 4), COL1A2 (collagen type I alpha 2 chain), VAV2 (vav guanine nucleotide exchange factor 2), LAMA1 (laminin subunit alpha 1), THBS1 (thrombospondin 1), CAV1 (caveolin 1), PAK1 (p21 (RAC1) activated kinase 1), PDGFRA (platelet derived growth factor receptor alpha), RAC3 (Rac family small GTPase 3), PRKCB (protein kinase C beta), VASP (vasodilator stimulated phosphoprotein), FGR (FGR proto-oncogene, Src family tyrosine kinase), RAC2 (Rac family small GTPase 2), CCND1 (cyclin D1), COL2A1 (collagen type II alpha 1 chain), HCK (HCK proto-oncogene, Src family tyrosine kinase), COL4A1 (collagen type IV alpha 1 chain), FLT1 (fms related receptor tyrosine kinase 1), MAP2K1 (mitogen-activated protein kinase kinase 1), LAMB1 (laminin subunit beta 1), PPP1CA (protein phosphatase 1 catalytic subunit alpha), VCL (vinculin), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), LAMA5 (laminin subunit alpha 5), LAMB2 (laminin subunit beta 2), COL5A2 (collagen type V alpha 2 chain), FLNB (filamin B), LAMC1 (laminin subunit gamma 1), HGF (hepatocyte growth factor), LAMB3 (laminin subunit beta 3), LAMC2 (laminin subunit gamma 2), LAMA2 (laminin subunit alpha 2), LAMA4 (laminin subunit alpha 4)"], "WAG002395": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), MAPK3 (mitogen-activated protein kinase 3), MAPK1 (mitogen-activated protein kinase 1), PXN (paxillin), PTK2 (protein tyrosine kinase 2), MAPK8 (mitogen-activated protein kinase 8), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), HRAS (HRas proto-oncogene, GTPase), CRK (CRK proto-oncogene, adaptor protein), CRKL (CRK like proto-oncogene, adaptor protein), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PTK2B (protein tyrosine kinase 2 beta), STAT3 (signal transducer and activator of transcription 3), MET (MET proto-oncogene, receptor tyrosine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), GAB1 (GRB2 associated binding protein 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RASA1 (RAS p21 protein activator 1), HGF (hepatocyte growth factor), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), ITGB1 (integrin subunit beta 1), RAPGEF1 (Rap guanine nucleotide exchange factor 1), PTEN (phosphatase and tensin homolog), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), RAP1B (RAP1B, member of RAS oncogene family), RAP1A (RAP1A, member of RAS oncogene family), PAK1 (p21 (RAC1) activated kinase 1), MAP2K2 (mitogen-activated protein kinase kinase 2), ITGA1 (integrin subunit alpha 1), ELK1 (ETS transcription factor ELK1), DOCK1 (dedicator of cytokinesis 1), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1)"], "WAG002396": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP3 (caspase 3), CASP8 (caspase 8), CASP7 (caspase 7), CASP10 (caspase 10), TNF (tumor necrosis factor), CASP9 (caspase 9), CASP6 (caspase 6), FADD (Fas associated via death domain), MAPK8 (mitogen-activated protein kinase 8), FAS (Fas cell surface death receptor), FASLG (Fas ligand), CFLAR (CASP8 and FADD like apoptosis regulator), APAF1 (apoptotic peptidase activating factor 1), BCL2 (BCL2 apoptosis regulator), CYCS (cytochrome c, somatic), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAP2K4 (mitogen-activated protein kinase kinase 4), RB1 (RB transcriptional corepressor 1), DAXX (death domain associated protein), HSPB1 (heat shock protein family B (small) member 1), PARP1 (poly(ADP-ribose) polymerase 1), PAK1 (p21 (RAC1) activated kinase 1), RIPK2 (receptor interacting serine/threonine kinase 2), DFFA (DNA fragmentation factor subunit alpha), FAF1 (Fas associated factor 1), PAK2 (p21 (RAC1) activated kinase 2), LMNA (lamin A/C), ACTB (actin beta), ACTA1 (actin alpha 1, skeletal muscle), PRKDC (protein kinase, DNA-activated, catalytic subunit), LMNB1 (lamin B1), IL1A (interleukin 1 alpha), ACTG1 (actin gamma 1), DFFB (DNA fragmentation factor subunit beta), SPTAN1 (spectrin alpha, non-erythrocytic 1), MAPKAPK2 (MAPK activated protein kinase 2), LMNB2 (lamin B2), MAPKAPK3 (MAPK activated protein kinase 3), NFX1 (nuclear transcription factor, X-box binding 1), ARHGDIB (Rho GDP dissociation inhibitor beta), MIR34C (microRNA 34c)"], "WAG002399": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), AKT1 (AKT serine/threonine kinase 1), APP (amyloid beta precursor protein), GSK3B (glycogen synthase kinase 3 beta), MDM2 (MDM2 proto-oncogene), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CASP3 (caspase 3), CCND1 (cyclin D1), XIAP (X-linked inhibitor of apoptosis), SP1 (Sp1 transcription factor), PTEN (phosphatase and tensin homolog), MT2A (metallothionein 2A), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), ATOX1 (antioxidant 1 copper chaperone), FOXO1 (forkhead box O1), SLC31A1 (solute carrier family 31 member 1), COMMD1 (copper metabolism domain containing 1), COX17 (cytochrome c oxidase copper chaperone COX17), SOD1 (superoxide dismutase 1), ATP7A (ATPase copper transporting alpha), MT1B (metallothionein 1B), SCO2 (synthesis of cytochrome C oxidase 2), FOXO3 (forkhead box O3), MT1H (metallothionein 1H), MAPT (microtubule associated protein tau), ATP7B (ATPase copper transporting beta), MT1X (metallothionein 1X), MT1L (metallothionein 1L, pseudogene), MT1E (metallothionein 1E), CCS (copper chaperone for superoxide dismutase), MT3 (metallothionein 3), SCO1 (synthesis of cytochrome C oxidase 1), ADAM17 (ADAM metallopeptidase domain 17), APC (APC regulator of WNT signaling pathway), MT1A (metallothionein 1A), PRNP (prion protein), MT1G (metallothionein 1G), BACE1 (beta-secretase 1), COX11 (cytochrome c oxidase copper chaperone COX11), SOD3 (superoxide dismutase 3), XAF1 (XIAP associated factor 1), MT4 (metallothionein 4), ADAM10 (ADAM metallopeptidase domain 10), MT1F (metallothionein 1F), MTF2 (metal response element binding transcription factor 2), ADAM9 (ADAM metallopeptidase domain 9), SLC31A2 (solute carrier family 31 member 2), STEAP3 (STEAP3 metalloreductase), MTF1 (metal regulatory transcription factor 1), STEAP1 (STEAP family member 1), STEAP2 (STEAP2 metalloreductase), SLC11A2 (solute carrier family 11 member 2), MT1JP (metallothionein 1J, pseudogene), STEAP4 (STEAP4 metalloreductase)"], "WAG002400": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), IL6 (interleukin 6), FN1 (fibronectin 1), BAX (BCL2 associated X, apoptosis regulator), PTGS2 (prostaglandin-endoperoxide synthase 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), BCL2 (BCL2 apoptosis regulator), PTK2 (protein tyrosine kinase 2), HMOX1 (heme oxygenase 1), CRP (C-reactive protein), AKT3 (AKT serine/threonine kinase 3), PTGS1 (prostaglandin-endoperoxide synthase 1), COL4A1 (collagen type IV alpha 1 chain), ITGAD (integrin subunit alpha D), CCND3 (cyclin D3), NFRKB (nuclear factor related to kappaB binding protein), CDH3 (cadherin 3), LAMA3 (laminin subunit alpha 3), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002403": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), PRL (prolactin), CXCL12 (C-X-C motif chemokine ligand 12), ERBB4 (erb-b2 receptor tyrosine kinase 4), RGS16 (regulator of G protein signaling 16), KLF2 (Kruppel like factor 2), MYB (MYB proto-oncogene, transcription factor), MIR150 (microRNA 150), MIR143 (microRNA 143), MIR126 (microRNA 126), MIR146A (microRNA 146a)"], "WAG002404": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CSNK1E (casein kinase 1 epsilon), ARNTL (aryl hydrocarbon receptor nuclear translocator like), CRY2 (cryptochrome circadian regulator 2), PER1 (period circadian regulator 1), CLOCK (clock circadian regulator), PER2 (period circadian regulator 2), CRY1 (cryptochrome circadian regulator 1), SIRT1 (sirtuin 1), CSNK1D (casein kinase 1 delta), PER3 (period circadian regulator 3), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), CYP1B1 (cytochrome P450 family 1 subfamily B member 1), CYP1A2 (cytochrome P450 family 1 subfamily A member 2), NFKB1 (nuclear factor kappa B subunit 1), CYP2D6 (cytochrome P450 family 2 subfamily D member 6), CYP2C19 (cytochrome P450 family 2 subfamily C member 19), ASMT (acetylserotonin O-methyltransferase), FOXO1 (forkhead box O1), GSK3B (glycogen synthase kinase 3 beta), AANAT (aralkylamine N-acetyltransferase), MAOA (monoamine oxidase A), MTNR1B (melatonin receptor 1B), PRKCA (protein kinase C alpha), MTNR1A (melatonin receptor 1A), TRAF6 (TNF receptor associated factor 6), MAP2 (microtubule associated protein 2), IRAK1 (interleukin 1 receptor associated kinase 1), EDN1 (endothelin 1), SULT1A1 (sulfotransferase family 1A member 1), APOE (apolipoprotein E), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), ECE1 (endothelin converting enzyme 1), ADRB1 (adrenoceptor beta 1), ACHE (acetylcholinesterase (Cartwright blood group)), CALM1 (calmodulin 1), MIR126 (microRNA 126), MIR146A (microRNA 146a), LOC107987478 (cytochrome P450 2D6-like), LOC107987479 (cytochrome P450 2D6)"], "WAG002405": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POU5F1 (POU class 5 homeobox 1), KLF4 (Kruppel like factor 4), SOX2 (SRY-box transcription factor 2), MYC (MYC proto-oncogene, bHLH transcription factor), MIRLET7I (microRNA let-7i), MIRLET7G (microRNA let-7g), TRIM71 (tripartite motif containing 71), EGR1 (early growth response 1), MIRLET7C (microRNA let-7c), MIRLET7D (microRNA let-7d), MIRLET7F1 (microRNA let-7f-1), MIRLET7E (microRNA let-7e), MIRLET7A2 (microRNA let-7a-2), MIRLET7A1 (microRNA let-7a-1), MIRLET7F2 (microRNA let-7f-2)"], "WAG002406": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CUL5 (cullin 5), CBFB (core-binding factor subunit beta), RBX1 (ring-box 1), UBB (ubiquitin B), APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G), RUNX1 (RUNX family transcription factor 1), LOC100506403 (uncharacterized LOC100506403), ELOC (elongin C), ELOB (elongin B)"], "WAG002409": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), EGFR (epidermal growth factor receptor), RAC1 (Rac family small GTPase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK3 (mitogen-activated protein kinase 3), TEK (TEK receptor tyrosine kinase), STAT3 (signal transducer and activator of transcription 3), GRB2 (growth factor receptor bound protein 2), MAPK14 (mitogen-activated protein kinase 14), PTPN11 (protein tyrosine phosphatase non-receptor type 11), TP53 (tumor protein p53), HRAS (HRas proto-oncogene, GTPase), ANGPT1 (angiopoietin 1), ERBB2 (erb-b2 receptor tyrosine kinase 2), NFKB1 (nuclear factor kappa B subunit 1), PTK2 (protein tyrosine kinase 2), MYC (MYC proto-oncogene, bHLH transcription factor), CRK (CRK proto-oncogene, adaptor protein), NRAS (NRAS proto-oncogene, GTPase), CTNNB1 (catenin beta 1), MAPK8 (mitogen-activated protein kinase 8), RELA (RELA proto-oncogene, NF-kB subunit), RASA1 (RAS p21 protein activator 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PXN (paxillin), FN1 (fibronectin 1), PAK1 (p21 (RAC1) activated kinase 1), NCK1 (NCK adaptor protein 1), NFKBIA (NFKB inhibitor alpha), ITGB1 (integrin subunit beta 1), KRAS (KRAS proto-oncogene, GTPase), BIRC5 (baculoviral IAP repeat containing 5), STAT5A (signal transducer and activator of transcription 5A), MAPK11 (mitogen-activated protein kinase 11), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), DOK2 (docking protein 2), BAX (BCL2 associated X, apoptosis regulator), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAPK9 (mitogen-activated protein kinase 9), MMP2 (matrix metallopeptidase 2), GRB7 (growth factor receptor bound protein 7), CASP9 (caspase 9), STAT5B (signal transducer and activator of transcription 5B), MAPK12 (mitogen-activated protein kinase 12), NOS2 (nitric oxide synthase 2), FOXO1 (forkhead box O1), BAD (BCL2 associated agonist of cell death), MAPK13 (mitogen-activated protein kinase 13), CASP7 (caspase 7), TNIP2 (TNFAIP3 interacting protein 2), ANGPT2 (angiopoietin 2), TIE1 (tyrosine kinase with immunoglobulin like and EGF like domains 1), GRB14 (growth factor receptor bound protein 14), MSH2 (mutS homolog 2), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), STMN1 (stathmin 1), TNIP1 (TNFAIP3 interacting protein 1), ANGPT4 (angiopoietin 4), YAP1 (Yes1 associated transcriptional regulator), RAD51 (RAD51 recombinase), NOS1 (nitric oxide synthase 1), ANGPTL1 (angiopoietin like 1), TNIP3 (TNFAIP3 interacting protein 3), RS1 (retinoschisin 1)"], "WAG002412": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA7 (proteasome 20S subunit alpha 7), PSMA3 (proteasome 20S subunit alpha 3), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA2 (proteasome 20S subunit alpha 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMA1 (proteasome 20S subunit alpha 1), PSMB1 (proteasome 20S subunit beta 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB3 (proteasome 20S subunit beta 3), PSMA4 (proteasome 20S subunit alpha 4), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB5 (proteasome 20S subunit beta 5), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMB2 (proteasome 20S subunit beta 2), PSMA5 (proteasome 20S subunit alpha 5), PSME4 (proteasome activator subunit 4), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA6 (proteasome 20S subunit alpha 6), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB6 (proteasome 20S subunit beta 6), PSMA8 (proteasome 20S subunit alpha 8), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD9 (proteasome 26S subunit, non-ATPase 9), HSPB1 (heat shock protein family B (small) member 1), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSME3 (proteasome activator subunit 3), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), UBB (ubiquitin B), CDK1 (cyclin dependent kinase 1), PAK2 (p21 (RAC1) activated kinase 2), PSMB9 (proteasome 20S subunit beta 9), PSMB8 (proteasome 20S subunit beta 8), PSME2 (proteasome activator subunit 2), MYC (MYC proto-oncogene, bHLH transcription factor), CDC42 (cell division cycle 42), XPO1 (exportin 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RAC1 (Rac family small GTPase 1), NCOA3 (nuclear receptor coactivator 3), MAPK6 (mitogen-activated protein kinase 6), MAPKAPK5 (MAPK activated protein kinase 5), CCND3 (cyclin D3), PAK1 (p21 (RAC1) activated kinase 1), FOXO1 (forkhead box O1), RPS27A (ribosomal protein S27a), PAK3 (p21 (RAC1) activated kinase 3), FOXO3 (forkhead box O3), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), MAPK4 (mitogen-activated protein kinase 4), PRKACB (protein kinase cAMP-activated catalytic subunit beta), TNRC6B (trinucleotide repeat containing adaptor 6B), MMP2 (matrix metallopeptidase 2), TNRC6A (trinucleotide repeat containing adaptor 6A), KALRN (kalirin RhoGEF kinase), IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), ETV4 (ETS variant transcription factor 4), RAG2 (recombination activating 2), DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1), CDC14A (cell division cycle 14A), RAG1 (recombination activating 1), MOV10 (Mov10 RISC complex RNA helicase), CDC42EP5 (CDC42 effector protein 5), TNRC6C (trinucleotide repeat containing adaptor 6C), CDC42EP3 (CDC42 effector protein 3), CDC42EP2 (CDC42 effector protein 2), MMP10 (matrix metallopeptidase 10), MIR34C (microRNA 34c), AGO3 (argonaute RISC catalytic component 3), CDC14B (cell division cycle 14B), SEPTIN7 (septin 7), AGO1 (argonaute RISC component 1), SEM1 (SEM1 26S proteasome complex subunit), AGO2 (argonaute RISC catalytic component 2), AGO4 (argonaute RISC component 4), MIR34B (microRNA 34b)"], "WAG002413": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TP53 (tumor protein p53), RB1 (RB transcriptional corepressor 1), CDK4 (cyclin dependent kinase 4), CDKN2A (cyclin dependent kinase inhibitor 2A), E2F1 (E2F transcription factor 1), SP1 (Sp1 transcription factor), CDK6 (cyclin dependent kinase 6), MDM2 (MDM2 proto-oncogene), TFDP1 (transcription factor Dp-1), CDKN2C (cyclin dependent kinase inhibitor 2C), MAPK1 (mitogen-activated protein kinase 1), E2F3 (E2F transcription factor 3), E2F2 (E2F transcription factor 2), UBB (ubiquitin B), MDM4 (MDM4 regulator of p53), TFDP2 (transcription factor Dp-2), CDKN2B (cyclin dependent kinase inhibitor 2B), ETS1 (ETS proto-oncogene 1, transcription factor), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CDKN2D (cyclin dependent kinase inhibitor 2D), MAPK3 (mitogen-activated protein kinase 3), RPS27A (ribosomal protein S27a), ETS2 (ETS proto-oncogene 2, transcription factor), TNRC6B (trinucleotide repeat containing adaptor 6B), TNRC6A (trinucleotide repeat containing adaptor 6A), TNRC6C (trinucleotide repeat containing adaptor 6C), ERF (ETS2 repressor factor), ID1 (inhibitor of DNA binding 1, HLH protein), MOV10 (Mov10 RISC complex RNA helicase), AGO3 (argonaute RISC catalytic component 3), AGO4 (argonaute RISC component 4), AGO1 (argonaute RISC component 1)"], "WAG002414": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), EPHB2 (EPH receptor B2), CDC42 (cell division cycle 42), EFNB1 (ephrin B1), EPHA2 (EPH receptor A2), ACTB (actin beta), EFNA1 (ephrin A1), RASA1 (RAS p21 protein activator 1), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), RHOA (ras homolog family member A), EFNB2 (ephrin B2), EPHA4 (EPH receptor A4), WASL (WASP like actin nucleation promoting factor), NCK2 (NCK adaptor protein 2), ACTG1 (actin gamma 1), EPHA3 (EPH receptor A3), HRAS (HRas proto-oncogene, GTPase), EPHA7 (EPH receptor A7), EPHB1 (EPH receptor B1), PAK1 (p21 (RAC1) activated kinase 1), EPHA1 (EPH receptor A1), EFNB3 (ephrin B3), EPHA5 (EPH receptor A5), EPHB3 (EPH receptor B3), CLTC (clathrin heavy chain), EFNA2 (ephrin A2), PTK2 (protein tyrosine kinase 2), PAK2 (p21 (RAC1) activated kinase 2), EFNA5 (ephrin A5), ROCK2 (Rho associated coiled-coil containing protein kinase 2), EPHA6 (EPH receptor A6), EFNA3 (ephrin A3), NGEF (neuronal guanine nucleotide exchange factor), VAV2 (vav guanine nucleotide exchange factor 2), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), EFNA4 (ephrin A4), ARPC3 (actin related protein 2/3 complex subunit 3), MYH9 (myosin heavy chain 9), LYN (LYN proto-oncogene, Src family tyrosine kinase), ARPC2 (actin related protein 2/3 complex subunit 2), ITSN1 (intersectin 1), MYH10 (myosin heavy chain 10), ARPC1B (actin related protein 2/3 complex subunit 1B), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), ARPC4 (actin related protein 2/3 complex subunit 4), ROCK1 (Rho associated coiled-coil containing protein kinase 1), ACTR3 (actin related protein 3), TIAM1 (TIAM Rac1 associated GEF 1), AP2M1 (adaptor related protein complex 2 subunit mu 1), ACTR2 (actin related protein 2), ARPC1A (actin related protein 2/3 complex subunit 1A), PAK3 (p21 (RAC1) activated kinase 3), DNM1 (dynamin 1), ARPC5 (actin related protein 2/3 complex subunit 5), GIT1 (GIT ArfGAP 1), ARHGEF7 (Rho guanine nucleotide exchange factor 7), MYL12B (myosin light chain 12B), EPHB4 (EPH receptor B4), MYH11 (myosin heavy chain 11), AP2B1 (adaptor related protein complex 2 subunit beta 1), AP2S1 (adaptor related protein complex 2 subunit sigma 1), LIMK1 (LIM domain kinase 1), AP2A2 (adaptor related protein complex 2 subunit alpha 2), LIMK2 (LIM domain kinase 2), AP2A1 (adaptor related protein complex 2 subunit alpha 1), MYL9 (myosin light chain 9), VAV3 (vav guanine nucleotide exchange factor 3), CFL1 (cofilin 1), MYL12A (myosin light chain 12A), PSEN1 (presenilin 1), EPHA8 (EPH receptor A8), CLTA (clathrin light chain A), KALRN (kalirin RhoGEF kinase), ADAM10 (ADAM metallopeptidase domain 10), CLTB (clathrin light chain B), SDCBP (syndecan binding protein), SDC2 (syndecan 2), PSENEN (presenilin enhancer, gamma-secretase subunit), APH1B (aph-1 homolog B, gamma-secretase subunit), MYH14 (myosin heavy chain 14), PSEN2 (presenilin 2), MYL6 (myosin light chain 6), MMP9 (matrix metallopeptidase 9), NCSTN (nicastrin), APH1A (aph-1 homolog A, gamma-secretase subunit), CLTCL1 (clathrin heavy chain like 1), MMP2 (matrix metallopeptidase 2), EPHA10 (EPH receptor A10), ARHGEF28 (Rho guanine nucleotide exchange factor 28)"], "WAG002415": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MRPS16 (mitochondrial ribosomal protein S16), MRPL13 (mitochondrial ribosomal protein L13), MRPL17 (mitochondrial ribosomal protein L17), MRPL4 (mitochondrial ribosomal protein L4), MRPL15 (mitochondrial ribosomal protein L15), MRPL22 (mitochondrial ribosomal protein L22), MRPL2 (mitochondrial ribosomal protein L2), MRPL3 (mitochondrial ribosomal protein L3), MRPL19 (mitochondrial ribosomal protein L19), MRPL11 (mitochondrial ribosomal protein L11), MRPL16 (mitochondrial ribosomal protein L16), MRPL27 (mitochondrial ribosomal protein L27), MRPL23 (mitochondrial ribosomal protein L23), MRPL40 (mitochondrial ribosomal protein L40), MRPS7 (mitochondrial ribosomal protein S7), MRPS15 (mitochondrial ribosomal protein S15), MRPL18 (mitochondrial ribosomal protein L18), MRPL24 (mitochondrial ribosomal protein L24), MRPS9 (mitochondrial ribosomal protein S9), TUFM (Tu translation elongation factor, mitochondrial), MRPS35 (mitochondrial ribosomal protein S35), MRPS12 (mitochondrial ribosomal protein S12), MRPS33 (mitochondrial ribosomal protein S33), MRPS2 (mitochondrial ribosomal protein S2), MRPL34 (mitochondrial ribosomal protein L34), MRPS10 (mitochondrial ribosomal protein S10), MRPS34 (mitochondrial ribosomal protein S34), MRPS18A (mitochondrial ribosomal protein S18A), MRPS23 (mitochondrial ribosomal protein S23), MRPL28 (mitochondrial ribosomal protein L28), MRPL1 (mitochondrial ribosomal protein L1), MRPL9 (mitochondrial ribosomal protein L9), MRPS28 (mitochondrial ribosomal protein S28), MRPL44 (mitochondrial ribosomal protein L44), MRPL49 (mitochondrial ribosomal protein L49), MRPL47 (mitochondrial ribosomal protein L47), MRPS14 (mitochondrial ribosomal protein S14), DAP3 (death associated protein 3), MRPL14 (mitochondrial ribosomal protein L14), MRPL33 (mitochondrial ribosomal protein L33), MRPS11 (mitochondrial ribosomal protein S11), MRPL20 (mitochondrial ribosomal protein L20), MRPS5 (mitochondrial ribosomal protein S5), GFM1 (G elongation factor mitochondrial 1), MRPL48 (mitochondrial ribosomal protein L48), MRPL35 (mitochondrial ribosomal protein L35), MRPL32 (mitochondrial ribosomal protein L32), TSFM (Ts translation elongation factor, mitochondrial), CHCHD1 (coiled-coil-helix-coiled-coil-helix domain containing 1), OXA1L (OXA1L mitochondrial inner membrane protein), MRPS24 (mitochondrial ribosomal protein S24), MRPL41 (mitochondrial ribosomal protein L41), MRPL30 (mitochondrial ribosomal protein L30), GFM2 (GTP dependent ribosome recycling factor mitochondrial 2), MRPL55 (mitochondrial ribosomal protein L55), MRRF (mitochondrial ribosome recycling factor), MRPS27 (mitochondrial ribosomal protein S27), MRPS18C (mitochondrial ribosomal protein S18C), MRPL46 (mitochondrial ribosomal protein L46), MRPL54 (mitochondrial ribosomal protein L54), MRPL53 (mitochondrial ribosomal protein L53), MRPS31 (mitochondrial ribosomal protein S31), MRPL36 (mitochondrial ribosomal protein L36), MRPL38 (mitochondrial ribosomal protein L38), MRPL37 (mitochondrial ribosomal protein L37), MRPL12 (mitochondrial ribosomal protein L12), MRPS22 (mitochondrial ribosomal protein S22), MTIF2 (mitochondrial translational initiation factor 2), MRPL51 (mitochondrial ribosomal protein L51), MRPL21 (mitochondrial ribosomal protein L21), MRPS30 (mitochondrial ribosomal protein S30), MRPL43 (mitochondrial ribosomal protein L43), MRPS17 (mitochondrial ribosomal protein S17), MRPL50 (mitochondrial ribosomal protein L50), MRPS18B (mitochondrial ribosomal protein S18B), MRPS6 (mitochondrial ribosomal protein S6), MRPS26 (mitochondrial ribosomal protein S26), MRPS36 (mitochondrial ribosomal protein S36), GADD45GIP1 (GADD45G interacting protein 1), MRPS25 (mitochondrial ribosomal protein S25), PTCD3 (pentatricopeptide repeat domain 3), AURKAIP1 (aurora kinase A interacting protein 1), MTFMT (mitochondrial methionyl-tRNA formyltransferase), MRPL10 (mitochondrial ribosomal protein L10), MTIF3 (mitochondrial translational initiation factor 3), MRPL52 (mitochondrial ribosomal protein L52), MRPL57 (mitochondrial ribosomal protein L57), MTRF1L (mitochondrial translational release factor 1 like), LOC107987373 (39S ribosomal protein L23, mitochondrial), MRPL39 (mitochondrial ribosomal protein L39), MRPL42 (mitochondrial ribosomal protein L42), ERAL1 (Era like 12S mitochondrial rRNA chaperone 1), MRPL58 (mitochondrial ribosomal protein L58)"], "WAG002417": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA7 (proteasome 20S subunit alpha 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA3 (proteasome 20S subunit alpha 3), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD8 (proteasome 26S subunit, non-ATPase 8), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMA2 (proteasome 20S subunit alpha 2), PSMB2 (proteasome 20S subunit beta 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMA4 (proteasome 20S subunit alpha 4), PSMB1 (proteasome 20S subunit beta 1), PSMA1 (proteasome 20S subunit alpha 1), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMA6 (proteasome 20S subunit alpha 6), PSMB5 (proteasome 20S subunit beta 5), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA5 (proteasome 20S subunit alpha 5), UBB (ubiquitin B), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSME4 (proteasome activator subunit 4), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), PSME3 (proteasome activator subunit 3), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), RBX1 (ring-box 1), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), GLI1 (GLI family zinc finger 1), GLI2 (GLI family zinc finger 2), GLI3 (GLI family zinc finger 3), SHH (sonic hedgehog signaling molecule), SMO (smoothened, frizzled class receptor), CUL3 (cullin 3), ARRB2 (arrestin beta 2), IHH (Indian hedgehog signaling molecule), PTCH1 (patched 1), PTCH2 (patched 2), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), DHH (desert hedgehog signaling molecule), RPS27A (ribosomal protein S27a), ITCH (itchy E3 ubiquitin protein ligase), ARRB1 (arrestin beta 1), SUFU (SUFU negative regulator of hedgehog signaling), HHIP (hedgehog interacting protein), CDON (cell adhesion associated, oncogene regulated), KIF3A (kinesin family member 3A), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), NUMB (NUMB endocytic adaptor protein), GAS1 (growth arrest specific 1), CSNK1A1 (casein kinase 1 alpha 1), BOC (BOC cell adhesion associated, oncogene regulated), SPOP (speckle type BTB/POZ protein), KIF7 (kinesin family member 7), ULK3 (unc-51 like kinase 3), CDC73 (cell division cycle 73), EVC (EvC ciliary complex subunit 1), EVC2 (EvC ciliary complex subunit 2), GAS8 (growth arrest specific 8), GRK2 (G protein-coupled receptor kinase 2), SEM1 (SEM1 26S proteasome complex subunit), IQCE (IQ motif containing E), GPR161 (G protein-coupled receptor 161), SPOPL (speckle type BTB/POZ protein like), LOC101928143 (uncharacterized LOC101928143), DZIP1 (DAZ interacting zinc finger protein 1), EFCAB7 (EF-hand calcium binding domain 7)"], "WAG002418": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MUC1 (mucin 1, cell surface associated), MUC5B (mucin 5B, oligomeric mucus/gel-forming), MUC7 (mucin 7, secreted), MUC4 (mucin 4, cell surface associated), MUC13 (mucin 13, cell surface associated), MUC20 (mucin 20, cell surface associated), MUC15 (mucin 15, cell surface associated), MUC6 (mucin 6, oligomeric mucus/gel-forming), MUC17 (mucin 17, cell surface associated), MUCL1 (mucin like 1), C1GALT1C1 (C1GALT1 specific chaperone 1), GCNT1 (glucosaminyl (N-acetyl) transferase 1), C1GALT1 (core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1), GALNT1 (polypeptide N-acetylgalactosaminyltransferase 1), B3GNT3 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3), GALNT14 (polypeptide N-acetylgalactosaminyltransferase 14), GALNT12 (polypeptide N-acetylgalactosaminyltransferase 12), GALNT10 (polypeptide N-acetylgalactosaminyltransferase 10), GALNT2 (polypeptide N-acetylgalactosaminyltransferase 2), GALNT11 (polypeptide N-acetylgalactosaminyltransferase 11), GALNT3 (polypeptide N-acetylgalactosaminyltransferase 3), GALNT6 (polypeptide N-acetylgalactosaminyltransferase 6), GALNT8 (polypeptide N-acetylgalactosaminyltransferase 8), GALNT9 (polypeptide N-acetylgalactosaminyltransferase 9), GALNT5 (polypeptide N-acetylgalactosaminyltransferase 5), GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13), B3GNT2 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2), B3GNT4 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4), B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5), B3GNT7 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7), ST3GAL2 (ST3 beta-galactoside alpha-2,3-sialyltransferase 2), B3GNT6 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6), ST3GAL1 (ST3 beta-galactoside alpha-2,3-sialyltransferase 1), GCNT3 (glucosaminyl (N-acetyl) transferase 3, mucin type), ST6GALNAC4 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4), ST6GALNAC2 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2), GCNT4 (glucosaminyl (N-acetyl) transferase 4), ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4), ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1), B4GALT5 (beta-1,4-galactosyltransferase 5), ST3GAL3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3), ADAMTS15 (ADAM metallopeptidase with thrombospondin type 1 motif 15), ADAMTS2 (ADAM metallopeptidase with thrombospondin type 1 motif 2), B4GALT6 (beta-1,4-galactosyltransferase 6), ADAMTS5 (ADAM metallopeptidase with thrombospondin type 1 motif 5), ADAMTS9 (ADAM metallopeptidase with thrombospondin type 1 motif 9), ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif 1), ADAMTS14 (ADAM metallopeptidase with thrombospondin type 1 motif 14), ADAMTS16 (ADAM metallopeptidase with thrombospondin type 1 motif 16), ADAMTS3 (ADAM metallopeptidase with thrombospondin type 1 motif 3), ADAMTS6 (ADAM metallopeptidase with thrombospondin type 1 motif 6), ADAMTS7 (ADAM metallopeptidase with thrombospondin type 1 motif 7), ADAMTS12 (ADAM metallopeptidase with thrombospondin type 1 motif 12), GALNTL5 (polypeptide N-acetylgalactosaminyltransferase like 5), ADAMTS4 (ADAM metallopeptidase with thrombospondin type 1 motif 4), GALNT7 (polypeptide N-acetylgalactosaminyltransferase 7), GALNTL6 (polypeptide N-acetylgalactosaminyltransferase like 6), ADAMTS18 (ADAM metallopeptidase with thrombospondin type 1 motif 18), ADAMTS19 (ADAM metallopeptidase with thrombospondin type 1 motif 19), ADAMTS17 (ADAM metallopeptidase with thrombospondin type 1 motif 17), ADAMTS8 (ADAM metallopeptidase with thrombospondin type 1 motif 8), POMT1 (protein O-mannosyltransferase 1), POMT2 (protein O-mannosyltransferase 2), POMGNT1 (protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)), DAG1 (dystroglycan 1), ST6GALNAC3 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3), THBS1 (thrombospondin 1), MUC3A (mucin 3A, cell surface associated), MUC16 (mucin 16, cell surface associated), MUC21 (mucin 21, cell surface associated), THBS2 (thrombospondin 2), ADAMTS20 (ADAM metallopeptidase with thrombospondin type 1 motif 20), B3GALNT2 (beta-1,3-N-acetylgalactosaminyltransferase 2), SPON1 (spondin 1), POFUT2 (protein O-fucosyltransferase 2), GALNT4 (polypeptide N-acetylgalactosaminyltransferase 4), ADAMTSL2 (ADAMTS like 2), B3GNTL1 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1), LARGE1 (LARGE xylosyl- and glucuronyltransferase 1), LARGE2 (LARGE xylosyl- and glucuronyltransferase 2), THSD7B (thrombospondin type 1 domain containing 7B), GALNT15 (polypeptide N-acetylgalactosaminyltransferase 15), SEMA5A (semaphorin 5A), ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13), GALNT18 (polypeptide N-acetylgalactosaminyltransferase 18), B3GNT8 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8), CFP (complement factor properdin), SPON2 (spondin 2), ADAMTSL3 (ADAMTS like 3), MUC12 (mucin 12, cell surface associated), GALNT17 (polypeptide N-acetylgalactosaminyltransferase 17), B3GNT9 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9), POMGNT2 (protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)), GALNT16 (polypeptide N-acetylgalactosaminyltransferase 16), MUC5AC (mucin 5AC, oligomeric mucus/gel-forming), POMK (protein O-mannose kinase), KCNA6 (potassium voltage-gated channel subfamily A member 6), A4GNT (alpha-1,4-N-acetylglucosaminyltransferase), THSD1 (thrombospondin type 1 domain containing 1), THSD7A (thrombospondin type 1 domain containing 7A)"], "WAG002419": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMA2 (proteasome 20S subunit alpha 2), PSMA7 (proteasome 20S subunit alpha 7), PSMB10 (proteasome 20S subunit beta 10), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB4 (proteasome 20S subunit beta 4), PSMB1 (proteasome 20S subunit beta 1), PSMA3 (proteasome 20S subunit alpha 3), PSMA1 (proteasome 20S subunit alpha 1), PSMA6 (proteasome 20S subunit alpha 6), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMA4 (proteasome 20S subunit alpha 4), PSMB5 (proteasome 20S subunit beta 5), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA5 (proteasome 20S subunit alpha 5), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSME4 (proteasome activator subunit 4), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), CUL1 (cullin 1), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSME3 (proteasome activator subunit 3), SKP1 (S-phase kinase associated protein 1), RBX1 (ring-box 1), UBB (ubiquitin B), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), ADCY2 (adenylate cyclase 2), GNAS (GNAS complex locus), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), ADCY6 (adenylate cyclase 6), ADCY9 (adenylate cyclase 9), ADCY5 (adenylate cyclase 5), GLI2 (GLI family zinc finger 2), ADCY7 (adenylate cyclase 7), ADCY4 (adenylate cyclase 4), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), ADCY1 (adenylate cyclase 1), GLI3 (GLI family zinc finger 3), ADCY8 (adenylate cyclase 8), GLI1 (GLI family zinc finger 1), ADCY3 (adenylate cyclase 3), GSK3B (glycogen synthase kinase 3 beta), SMO (smoothened, frizzled class receptor), SUFU (SUFU negative regulator of hedgehog signaling), RPS27A (ribosomal protein S27a), NUMB (NUMB endocytic adaptor protein), IFT172 (intraflagellar transport 172), ITCH (itchy E3 ubiquitin protein ligase), PTCH1 (patched 1), KIF3A (kinesin family member 3A), CSNK1A1 (casein kinase 1 alpha 1), RPGRIP1L (RPGRIP1 like), IFT88 (intraflagellar transport 88), KIF7 (kinesin family member 7), TULP3 (TUB like protein 3), TTC21B (tetratricopeptide repeat domain 21B), OFD1 (OFD1 centriole and centriolar satellite protein), IFT52 (intraflagellar transport 52), IFT140 (intraflagellar transport 140), ADCY10 (adenylate cyclase 10), IFT57 (intraflagellar transport 57), WDR35 (WD repeat domain 35), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), GPR161 (G protein-coupled receptor 161), MKS1 (MKS transition zone complex subunit 1), FUZ (fuzzy planar cell polarity protein), INTU (inturned planar cell polarity protein), IFT122 (intraflagellar transport 122), WDR19 (WD repeat domain 19), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002421": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTOR (mechanistic target of rapamycin kinase), RPTOR (regulatory associated protein of MTOR complex 1), MLST8 (MTOR associated protein, LST8 homolog), RPS6KB1 (ribosomal protein S6 kinase B1), RHEB (Ras homolog, mTORC1 binding), AKT1 (AKT serine/threonine kinase 1), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), RRAGC (Ras related GTP binding C), RRAGD (Ras related GTP binding D), TSC2 (TSC complex subunit 2), AKT1S1 (AKT1 substrate 1), EIF4E (eukaryotic translation initiation factor 4E), RPS6 (ribosomal protein S6), TSC1 (TSC complex subunit 1), RRAGB (Ras related GTP binding B), AKT2 (AKT serine/threonine kinase 2), LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1), LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2), RRAGA (Ras related GTP binding A), EIF4B (eukaryotic translation initiation factor 4B), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), EEF2K (eukaryotic elongation factor 2 kinase), SLC38A9 (solute carrier family 38 member 9), LAMTOR4 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 4)"], "WAG002422": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ADD1 (adducin 1), ADD2 (adducin 2), AZGP1 (alpha-2-glycoprotein 1, zinc-binding), PIP (prolactin induced protein), TUSC3 (tumor suppressor candidate 3), MAGT1 (magnesium transporter 1), ADD3 (adducin 3), DMTN (dematin actin binding protein), MRS2 (magnesium transporter MRS2), LRRC8A (leucine rich repeat containing 8 VRAC subunit A), LRRC8E (leucine rich repeat containing 8 VRAC subunit E), NIPAL4 (NIPA like domain containing 4), NIPA2 (NIPA magnesium transporter 2), NIPAL2 (NIPA like domain containing 2), NIPAL1 (NIPA like domain containing 1), SLC66A1 (solute carrier family 66 member 1), MMGT1 (membrane magnesium transporter 1), LRRC8B (leucine rich repeat containing 8 VRAC subunit B), NIPAL3 (NIPA like domain containing 3), LRRC8D (leucine rich repeat containing 8 VRAC subunit D), CTNS (cystinosin, lysosomal cystine transporter), NIPA1 (NIPA magnesium transporter 1), ANKH (ANKH inorganic pyrophosphate transport regulator), LRRC8C (leucine rich repeat containing 8 VRAC subunit C)"], "WAG002424": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SUMO2 (small ubiquitin like modifier 2), SUMO1 (small ubiquitin like modifier 1), NUP153 (nucleoporin 153), UBE2I (ubiquitin conjugating enzyme E2 I), NUP85 (nucleoporin 85), NUP93 (nucleoporin 93), NUP205 (nucleoporin 205), TPR (translocated promoter region, nuclear basket protein), NUP155 (nucleoporin 155), RAE1 (ribonucleic acid export 1), NUP210 (nucleoporin 210), NUP214 (nucleoporin 214), RANBP2 (RAN binding protein 2), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), NUP133 (nucleoporin 133), NUP188 (nucleoporin 188), NUP35 (nucleoporin 35), NUP107 (nucleoporin 107), NUP88 (nucleoporin 88), AAAS (aladin WD repeat nucleoporin), NUP160 (nucleoporin 160), NUP50 (nucleoporin 50), NUP37 (nucleoporin 37), NUP54 (nucleoporin 54), BRCA1 (BRCA1 DNA repair associated), RNF2 (ring finger protein 2), CBX4 (chromobox 4), BMI1 (BMI1 proto-oncogene, polycomb ring finger), RAD21 (RAD21 cohesin complex component), SUMO3 (small ubiquitin like modifier 3), SMC1A (structural maintenance of chromosomes 1A), PARP1 (poly(ADP-ribose) polymerase 1), POM121 (POM121 transmembrane nucleoporin), PML (PML nuclear body scaffold), SMC3 (structural maintenance of chromosomes 3), PCGF2 (polycomb group ring finger 2), PHC1 (polyhomeotic homolog 1), WRN (WRN RecQ like helicase), CBX2 (chromobox 2), RPA1 (replication protein A1), PHC3 (polyhomeotic homolog 3), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), CBX8 (chromobox 8), PHC2 (polyhomeotic homolog 2), PIAS4 (protein inhibitor of activated STAT 4), BLM (BLM RecQ like helicase), RING1 (ring finger protein 1), RAD52 (RAD52 homolog, DNA repair protein), NSMCE2 (NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase), PIAS1 (protein inhibitor of activated STAT 1), SMC6 (structural maintenance of chromosomes 6), MDC1 (mediator of DNA damage checkpoint 1), CDKN2A (cyclin dependent kinase inhibitor 2A), SMC5 (structural maintenance of chromosomes 5), STAG2 (stromal antigen 2), TDG (thymine DNA glycosylase), NSMCE1 (NSE1 homolog, SMC5-SMC6 complex component), SP100 (SP100 nuclear antigen), XPC (XPC complex subunit, DNA damage recognition and repair factor), HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2), STAG1 (stromal antigen 1), NSMCE4A (NSE4 homolog A, SMC5-SMC6 complex component), RNF168 (ring finger protein 168), HDAC7 (histone deacetylase 7), CETN2 (centrin 2), EID3 (EP300 interacting inhibitor of differentiation 3), XRCC4 (X-ray repair cross complementing 4), NSMCE3 (NSE3 homolog, SMC5-SMC6 complex component), NDC1 (NDC1 transmembrane nucleoporin), NUP42 (nucleoporin 42)"], "WAG002425": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDC42 (cell division cycle 42), RAC1 (Rac family small GTPase 1), IQGAP1 (IQ motif containing GTPase activating protein 1), CTNNB1 (catenin beta 1), CDH1 (cadherin 1), CTNNA1 (catenin alpha 1), IQGAP2 (IQ motif containing GTPase activating protein 2), CLIP1 (CAP-Gly domain containing linker protein 1), MEN1 (menin 1), IQGAP3 (IQ motif containing GTPase activating protein 3), CALM1 (calmodulin 1)"], "WAG002426": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPARGC1A (PPARG coactivator 1 alpha), CREBBP (CREB binding protein), HDAC3 (histone deacetylase 3), PPARA (peroxisome proliferator activated receptor alpha), RXRA (retinoid X receptor alpha), CARM1 (coactivator associated arginine methyltransferase 1), NCOA1 (nuclear receptor coactivator 1), NCOA2 (nuclear receptor coactivator 2), NCOA6 (nuclear receptor coactivator 6), TBL1XR1 (TBL1X receptor 1), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), TGS1 (trimethylguanosine synthase 1), CHD9 (chromodomain helicase DNA binding protein 9), CREB1 (cAMP responsive element binding protein 1), ALAS1 (5'-aminolevulinate synthase 1), NCOR1 (nuclear receptor corepressor 1), MAPK14 (mitogen-activated protein kinase 14), MEF2C (myocyte enhancer factor 2C), MEF2D (myocyte enhancer factor 2D), ATF2 (activating transcription factor 2), ESRRA (estrogen related receptor alpha), MAPK11 (mitogen-activated protein kinase 11), TFAM (transcription factor A, mitochondrial), NR1D1 (nuclear receptor subfamily 1 group D member 1), CYCS (cytochrome c, somatic), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), NRF1 (nuclear respiratory factor 1), MAPK12 (mitogen-activated protein kinase 12), SIRT3 (sirtuin 3), CAMK4 (calcium/calmodulin dependent protein kinase IV), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), PPARGC1B (PPARG coactivator 1 beta), TFB2M (transcription factor B2, mitochondrial), POLRMT (RNA polymerase mitochondrial), HCFC1 (host cell factor C1), TBL1X (transducin beta like 1 X-linked), GABPA (GA binding protein transcription factor subunit alpha), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), SIRT5 (sirtuin 5), GLUD2 (glutamate dehydrogenase 2), TFB1M (transcription factor B1, mitochondrial), PPRC1 (PPARG related coactivator 1), GLUD1 (glutamate dehydrogenase 1), CRTC2 (CREB regulated transcription coactivator 2), SOD2 (superoxide dismutase 2), SIRT4 (sirtuin 4), CRTC1 (CREB regulated transcription coactivator 1), ACSS2 (acyl-CoA synthetase short chain family member 2), SSBP1 (single stranded DNA binding protein 1), CRTC3 (CREB regulated transcription coactivator 3), MTERF1 (mitochondrial transcription termination factor 1), TWNK (twinkle mtDNA helicase), SOD2-OT1 (SOD2 overlapping transcript 1), MED1 (mediator complex subunit 1), ATP5F1B (ATP synthase F1 subunit beta), PERM1 (PPARGC1 and ESRR induced regulator, muscle 1), HELZ2 (helicase with zinc finger 2), CALM1 (calmodulin 1), USP46 (ubiquitin specific peptidase 46), POLG2 (DNA polymerase gamma 2, accessory subunit)"], "WAG002427": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAP2K1 (mitogen-activated protein kinase kinase 1), JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), DUSP1 (dual specificity phosphatase 1), IL6 (interleukin 6), DUSP4 (dual specificity phosphatase 4), DUSP6 (dual specificity phosphatase 6), IL6R (interleukin 6 receptor), DUSP5 (dual specificity phosphatase 5), TYK2 (tyrosine kinase 2), DUSP8 (dual specificity phosphatase 8), DUSP9 (dual specificity phosphatase 9), MAP2K2 (mitogen-activated protein kinase kinase 2), DUSP10 (dual specificity phosphatase 10), DUSP7 (dual specificity phosphatase 7), DUSP2 (dual specificity phosphatase 2), DUSP16 (dual specificity phosphatase 16), PEA15 (proliferation and apoptosis adaptor protein 15), CDK1 (cyclin dependent kinase 1)"], "WAG002428": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NANOG (Nanog homeobox), POU5F1 (POU class 5 homeobox 1), SALL4 (spalt like transcription factor 4), SOX2 (SRY-box transcription factor 2), SALL1 (spalt like transcription factor 1), STAT3 (signal transducer and activator of transcription 3), DPPA4 (developmental pluripotency associated 4), FOXD3 (forkhead box D3), TDGF1 (teratocarcinoma-derived growth factor 1), ZIC3 (Zic family member 3), FGF2 (fibroblast growth factor 2), EPHA1 (EPH receptor A1)"], "WAG002430": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK1 (mitogen-activated protein kinase 1), FRS2 (fibroblast growth factor receptor substrate 2), FGFR1 (fibroblast growth factor receptor 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAPK3 (mitogen-activated protein kinase 3), SPRY2 (sprouty RTK signaling antagonist 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), HRAS (HRas proto-oncogene, GTPase), FGF1 (fibroblast growth factor 1), CBL (Cbl proto-oncogene), PLCG1 (phospholipase C gamma 1), GAB1 (GRB2 associated binding protein 1), STAT1 (signal transducer and activator of transcription 1), GAB2 (GRB2 associated binding protein 2), FGF6 (fibroblast growth factor 6), FGF9 (fibroblast growth factor 9), FGF10 (fibroblast growth factor 10), FGF23 (fibroblast growth factor 23), NRAS (NRAS proto-oncogene, GTPase), FGF2 (fibroblast growth factor 2), FGF4 (fibroblast growth factor 4), STAT3 (signal transducer and activator of transcription 3), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), BCR (BCR activator of RhoGEF and GTPase), PPP2CA (protein phosphatase 2 catalytic subunit alpha), STAT5A (signal transducer and activator of transcription 5A), FGF18 (fibroblast growth factor 18), FGF20 (fibroblast growth factor 20), STAT5B (signal transducer and activator of transcription 5B), FGF3 (fibroblast growth factor 3), FGF22 (fibroblast growth factor 22), BRAF (B-Raf proto-oncogene, serine/threonine kinase), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), FRS3 (fibroblast growth factor receptor substrate 3), UBB (ubiquitin B), PPP2CB (protein phosphatase 2 catalytic subunit beta), MKNK1 (MAPK interacting serine/threonine kinase 1), FGFR1OP2 (FGFR1 oncogene partner 2), RPS27A (ribosomal protein S27a), SPRED2 (sprouty related EVH1 domain containing 2), ZMYM2 (zinc finger MYM-type containing 2), FLRT3 (fibronectin leucine rich transmembrane protein 3), FLRT1 (fibronectin leucine rich transmembrane protein 1), FGFRL1 (fibroblast growth factor receptor like 1), SPRED1 (sprouty related EVH1 domain containing 1), FLRT2 (fibronectin leucine rich transmembrane protein 2), BAG4 (BAG cochaperone 4), ERLIN2 (ER lipid raft associated 2), CUX1 (cut like homeobox 1), MYO18A (myosin XVIIIA), TRIM24 (tripartite motif containing 24), CPSF6 (cleavage and polyadenylation specific factor 6), ANOS1 (anosmin 1), CEP43 (centrosomal protein 43), LRRFIP1 (LRR binding FLII interacting protein 1)"], "WAG002431": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FRS2 (fibroblast growth factor receptor substrate 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), UBC (ubiquitin C), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAPK1 (mitogen-activated protein kinase 1), SPRY2 (sprouty RTK signaling antagonist 2), MAPK3 (mitogen-activated protein kinase 3), FGFR3 (fibroblast growth factor receptor 3), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), GAB1 (GRB2 associated binding protein 1), CBL (Cbl proto-oncogene), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), HRAS (HRas proto-oncogene, GTPase), FGF1 (fibroblast growth factor 1), FGF23 (fibroblast growth factor 23), PLCG1 (phospholipase C gamma 1), NRAS (NRAS proto-oncogene, GTPase), FGF9 (fibroblast growth factor 9), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), FGF4 (fibroblast growth factor 4), FGF20 (fibroblast growth factor 20), FGF18 (fibroblast growth factor 18), FGF16 (fibroblast growth factor 16), FGF2 (fibroblast growth factor 2), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PPP2CA (protein phosphatase 2 catalytic subunit alpha), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), FRS3 (fibroblast growth factor receptor substrate 3), MKNK1 (MAPK interacting serine/threonine kinase 1), PPP2CB (protein phosphatase 2 catalytic subunit beta), RPS27A (ribosomal protein S27a), GALNT3 (polypeptide N-acetylgalactosaminyltransferase 3)"], "WAG002433": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), FRS2 (fibroblast growth factor receptor substrate 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK1 (mitogen-activated protein kinase 1), FGFR2 (fibroblast growth factor receptor 2), SPRY2 (sprouty RTK signaling antagonist 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), POLR2B (RNA polymerase II subunit B), POLR2C (RNA polymerase II subunit C), POLR2G (RNA polymerase II subunit G), NCBP1 (nuclear cap binding protein subunit 1), POLR2J (RNA polymerase II subunit J), NCBP2 (nuclear cap binding protein subunit 2), POLR2D (RNA polymerase II subunit D), GTF2F1 (general transcription factor IIF subunit 1), HNRNPM (heterogeneous nuclear ribonucleoprotein M), PTBP1 (polypyrimidine tract binding protein 1), HNRNPF (heterogeneous nuclear ribonucleoprotein F), GTF2F2 (general transcription factor IIF subunit 2), MAPK3 (mitogen-activated protein kinase 3), POLR2I (RNA polymerase II subunit I), FGF1 (fibroblast growth factor 1), POLR2H (RNA polymerase II, I and III subunit H), POLR2E (RNA polymerase II, I and III subunit E), GAB1 (GRB2 associated binding protein 1), POLR2L (RNA polymerase II, I and III subunit L), POLR2F (RNA polymerase II, I and III subunit F), HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1), FGF10 (fibroblast growth factor 10), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), HNRNPH1 (heterogeneous nuclear ribonucleoprotein H1), FGF7 (fibroblast growth factor 7), FGF6 (fibroblast growth factor 6), FGF9 (fibroblast growth factor 9), FGF23 (fibroblast growth factor 23), CBL (Cbl proto-oncogene), PLCG1 (phospholipase C gamma 1), FGF4 (fibroblast growth factor 4), HRAS (HRas proto-oncogene, GTPase), FGF20 (fibroblast growth factor 20), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), FGF18 (fibroblast growth factor 18), FGF3 (fibroblast growth factor 3), FGF16 (fibroblast growth factor 16), POLR2K (RNA polymerase II, I and III subunit K), FGF22 (fibroblast growth factor 22), NRAS (NRAS proto-oncogene, GTPase), FGF2 (fibroblast growth factor 2), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PPP2CA (protein phosphatase 2 catalytic subunit alpha), UBB (ubiquitin B), PPP2CB (protein phosphatase 2 catalytic subunit beta), TIA1 (TIA1 cytotoxic granule associated RNA binding protein), FRS3 (fibroblast growth factor receptor substrate 3), FGFBP1 (fibroblast growth factor binding protein 1), MKNK1 (MAPK interacting serine/threonine kinase 1), RPS27A (ribosomal protein S27a), TIAL1 (TIA1 cytotoxic granule associated RNA binding protein like 1), RBFOX2 (RNA binding fox-1 homolog 2), ESRP1 (epithelial splicing regulatory protein 1), ESRP2 (epithelial splicing regulatory protein 2), FGFBP2 (fibroblast growth factor binding protein 2), FGFBP3 (fibroblast growth factor binding protein 3)"], "WAG002434": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), AXIN1 (axin 1), CTNNB1 (catenin beta 1), PSMA3 (proteasome 20S subunit alpha 3), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PSMC5 (proteasome 26S subunit, ATPase 5), MYC (MYC proto-oncogene, bHLH transcription factor), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA7 (proteasome 20S subunit alpha 7), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA2 (proteasome 20S subunit alpha 2), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMA5 (proteasome 20S subunit alpha 5), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMA4 (proteasome 20S subunit alpha 4), PSMB3 (proteasome 20S subunit beta 3), PSMB1 (proteasome 20S subunit beta 1), PSMA1 (proteasome 20S subunit alpha 1), PSMB5 (proteasome 20S subunit beta 5), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMB2 (proteasome 20S subunit beta 2), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB7 (proteasome 20S subunit beta 7), PSMA6 (proteasome 20S subunit alpha 6), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB10 (proteasome 20S subunit beta 10), UBB (ubiquitin B), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD6 (proteasome 26S subunit, non-ATPase 6), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB6 (proteasome 20S subunit beta 6), RBX1 (ring-box 1), PSME4 (proteasome activator subunit 4), PSMF1 (proteasome inhibitor subunit 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), LRP6 (LDL receptor related protein 6), DVL1 (dishevelled segment polarity protein 1), GSK3B (glycogen synthase kinase 3 beta), APC (APC regulator of WNT signaling pathway), WNT3A (Wnt family member 3A), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), AXIN2 (axin 2), DVL3 (dishevelled segment polarity protein 3), PPP2CB (protein phosphatase 2 catalytic subunit beta), CREBBP (CREB binding protein), HDAC1 (histone deacetylase 1), TCF7L2 (transcription factor 7 like 2), FZD1 (frizzled class receptor 1), WNT1 (Wnt family member 1), FZD5 (frizzled class receptor 5), AKT1 (AKT serine/threonine kinase 1), EP300 (E1A binding protein p300), DVL2 (dishevelled segment polarity protein 2), PPP2CA (protein phosphatase 2 catalytic subunit alpha), LEF1 (lymphoid enhancer binding factor 1), RUVBL1 (RuvB like AAA ATPase 1), FZD8 (frizzled class receptor 8), WNT5A (Wnt family member 5A), FZD6 (frizzled class receptor 6), FZD4 (frizzled class receptor 4), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), FZD2 (frizzled class receptor 2), LRP5 (LDL receptor related protein 5), SFRP1 (secreted frizzled related protein 1), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), CSNK2A1 (casein kinase 2 alpha 1), CSNK1E (casein kinase 1 epsilon), CUL3 (cullin 3), CTBP1 (C-terminal binding protein 1), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), TLE1 (TLE family member 1, transcriptional corepressor), CSNK1A1 (casein kinase 1 alpha 1), DKK1 (dickkopf WNT signaling pathway inhibitor 1), XPO1 (exportin 1), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), SFRP2 (secreted frizzled related protein 2), WNT3 (Wnt family member 3), CSNK2B (casein kinase 2 beta), TERT (telomerase reverse transcriptase), TCF7 (transcription factor 7), WNT8B (Wnt family member 8B), WNT9A (Wnt family member 9A), CSNK2A2 (casein kinase 2 alpha 2)"], "WAG002436": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLD1 (DNA polymerase delta 1, catalytic subunit), PCNA (proliferating cell nuclear antigen), POLE (DNA polymerase epsilon, catalytic subunit), RPA1 (replication protein A1), RPA2 (replication protein A2), POLD2 (DNA polymerase delta 2, accessory subunit), RFC5 (replication factor C subunit 5), RFC4 (replication factor C subunit 4), POLD4 (DNA polymerase delta 4, accessory subunit), FEN1 (flap structure-specific endonuclease 1), RPA3 (replication protein A3), RFC2 (replication factor C subunit 2), RFC3 (replication factor C subunit 3), RFC1 (replication factor C subunit 1), POLD3 (DNA polymerase delta 3, accessory subunit), APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1), LIG1 (DNA ligase 1), PARP1 (poly(ADP-ribose) polymerase 1), POLE2 (DNA polymerase epsilon 2, accessory subunit), XRCC1 (X-ray repair cross complementing 1), POLB (DNA polymerase beta), LIG3 (DNA ligase 3), OGG1 (8-oxoguanine DNA glycosylase), POLE3 (DNA polymerase epsilon 3, accessory subunit), NTHL1 (nth like DNA glycosylase 1), PARP2 (poly(ADP-ribose) polymerase 2), NEIL1 (nei like DNA glycosylase 1), PNKP (polynucleotide kinase 3'-phosphatase), POLE4 (DNA polymerase epsilon 4, accessory subunit), TDG (thymine DNA glycosylase), MPG (N-methylpurine DNA glycosylase), NEIL2 (nei like DNA glycosylase 2), PARG (poly(ADP-ribose) glycohydrolase), MBD4 (methyl-CpG binding domain 4, DNA glycosylase), SMUG1 (single-strand-selective monofunctional uracil-DNA glycosylase 1), ADPRS (ADP-ribosylserine hydrolase)"], "WAG002437": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ULK1 (unc-51 like autophagy activating kinase 1), MTOR (mechanistic target of rapamycin kinase), GABARAP (GABA type A receptor-associated protein), BECN1 (beclin 1), ATG3 (autophagy related 3), GABARAPL2 (GABA type A receptor associated protein like 2), ATG5 (autophagy related 5), RB1CC1 (RB1 inducible coiled-coil 1), RPTOR (regulatory associated protein of MTOR complex 1), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), ATG7 (autophagy related 7), ATG12 (autophagy related 12), MAP1LC3C (microtubule associated protein 1 light chain 3 gamma), ATG4B (autophagy related 4B cysteine peptidase), RHEB (Ras homolog, mTORC1 binding), GABARAPL1 (GABA type A receptor associated protein like 1), ATG13 (autophagy related 13), ATG16L1 (autophagy related 16 like 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), TSC1 (TSC complex subunit 1), MLST8 (MTOR associated protein, LST8 homolog), RRAGC (Ras related GTP binding C), ATG10 (autophagy related 10), AMBRA1 (autophagy and beclin 1 regulator 1), RRAGD (Ras related GTP binding D), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), RRAGB (Ras related GTP binding B), TSC2 (TSC complex subunit 2), LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2), RRAGA (Ras related GTP binding A), CHMP4B (charged multivesicular body protein 4B), ATG14 (autophagy related 14), CHMP2A (charged multivesicular body protein 2A), CHMP6 (charged multivesicular body protein 6), CHMP4C (charged multivesicular body protein 4C), CHMP3 (charged multivesicular body protein 3), UVRAG (UV radiation resistance associated), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), CHMP2B (charged multivesicular body protein 2B), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5), CHMP7 (charged multivesicular body protein 7), WIPI1 (WD repeat domain, phosphoinositide interacting 1), ATG4A (autophagy related 4A cysteine peptidase), CHMP4A (charged multivesicular body protein 4A), WIPI2 (WD repeat domain, phosphoinositide interacting 2), ATG4D (autophagy related 4D cysteine peptidase), ATG9A (autophagy related 9A), ATG4C (autophagy related 4C cysteine peptidase), MTMR14 (myotubularin related protein 14), DYNLL2 (dynein light chain LC8-type 2), DYNLL1 (dynein light chain LC8-type 1), MTMR3 (myotubularin related protein 3), ATG9B (autophagy related 9B), SLC38A9 (solute carrier family 38 member 9), LAMTOR4 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 4), ATG101 (autophagy related 101), WDR45B (WD repeat domain 45B), WDR45 (WD repeat domain 45)"], "WAG002438": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTOR (mechanistic target of rapamycin kinase), TP53 (tumor protein p53), TSC2 (TSC complex subunit 2), TSC1 (TSC complex subunit 1), RPTOR (regulatory associated protein of MTOR complex 1), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), AKT1 (AKT serine/threonine kinase 1), MLST8 (MTOR associated protein, LST8 homolog), RHEB (Ras homolog, mTORC1 binding), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), COX6B1 (cytochrome c oxidase subunit 6B1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), CYCS (cytochrome c, somatic), COX5B (cytochrome c oxidase subunit 5B), RRAGC (Ras related GTP binding C), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), COX5A (cytochrome c oxidase subunit 5A), COX7C (cytochrome c oxidase subunit 7C), COX4I1 (cytochrome c oxidase subunit 4I1), RRAGD (Ras related GTP binding D), DDIT4 (DNA damage inducible transcript 4), COX6C (cytochrome c oxidase subunit 6C), COX7B (cytochrome c oxidase subunit 7B), RRAGB (Ras related GTP binding B), AKT2 (AKT serine/threonine kinase 2), LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1), LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2), PTEN (phosphatase and tensin homolog), SFN (stratifin), TXN (thioredoxin), COX8A (cytochrome c oxidase subunit 8A), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRDX1 (peroxiredoxin 1), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), RRAGA (Ras related GTP binding A), COX7A2L (cytochrome c oxidase subunit 7A2 like), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), AKT3 (AKT serine/threonine kinase 3), SURF1 (SURF1 cytochrome c oxidase assembly factor), LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), LRPPRC (leucine rich pentatricopeptide repeat containing), SCO2 (synthesis of cytochrome C oxidase 2), COX6A1 (cytochrome c oxidase subunit 6A1), SCO1 (synthesis of cytochrome C oxidase 1), NDUFA4 (NDUFA4 mitochondrial complex associated), COX11 (cytochrome c oxidase copper chaperone COX11), PRDX2 (peroxiredoxin 2), TP63 (tumor protein p63), TXNRD1 (thioredoxin reductase 1), TNRC6B (trinucleotide repeat containing adaptor 6B), COX19 (cytochrome c oxidase assembly factor COX19), TACO1 (translational activator of cytochrome c oxidase I), G6PD (glucose-6-phosphate dehydrogenase), SESN2 (sestrin 2), SESN1 (sestrin 1), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), GPX2 (glutathione peroxidase 2), TNRC6A (trinucleotide repeat containing adaptor 6A), TNRC6C (trinucleotide repeat containing adaptor 6C), COX18 (cytochrome c oxidase assembly factor COX18), GLS2 (glutaminase 2), GPI (glucose-6-phosphate isomerase), COX14 (cytochrome c oxidase assembly factor COX14), MOV10 (Mov10 RISC complex RNA helicase), SESN3 (sestrin 3), GLS (glutaminase), COX16 (cytochrome c oxidase assembly factor COX16), LAMTOR4 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 4), AGO2 (argonaute RISC catalytic component 2), COX3 (cytochrome c oxidase III), AGO1 (argonaute RISC component 1), AGO3 (argonaute RISC catalytic component 3), COX2 (cytochrome c oxidase subunit II), TIGAR (TP53 induced glycolysis regulatory phosphatase), AGO4 (argonaute RISC component 4), SLC38A9 (solute carrier family 38 member 9), COX20 (cytochrome c oxidase assembly factor COX20), COX1 (cytochrome c oxidase subunit I)"], "WAG002440": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PAK1 (p21 (RAC1) activated kinase 1), RAC1 (Rac family small GTPase 1), MYLK (myosin light chain kinase), PAK2 (p21 (RAC1) activated kinase 2), MYL9 (myosin light chain 9), MYL12B (myosin light chain 12B), CDC42 (cell division cycle 42), MYH9 (myosin heavy chain 9), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), PAK3 (p21 (RAC1) activated kinase 3), MYL6 (myosin light chain 6), MYH11 (myosin heavy chain 11), CTTN (cortactin), PPP1CB (protein phosphatase 1 catalytic subunit beta), MYH10 (myosin heavy chain 10), FLNA (filamin A), LIMK1 (LIM domain kinase 1), PPP1R12B (protein phosphatase 1 regulatory subunit 12B), NF2 (neurofibromin 2), MYH14 (myosin heavy chain 14), CALM1 (calmodulin 1)"], "WAG002441": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TRAF6 (TNF receptor associated factor 6), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TICAM1 (toll like receptor adaptor molecule 1), BIRC2 (baculoviral IAP repeat containing 2), RIPK1 (receptor interacting serine/threonine kinase 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), TRAF3 (TNF receptor associated factor 3), UBB (ubiquitin B), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), BIRC3 (baculoviral IAP repeat containing 3), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TBK1 (TANK binding kinase 1), TLR3 (toll like receptor 3), CASP8 (caspase 8), TANK (TRAF family member associated NFKB activator), UBE2N (ubiquitin conjugating enzyme E2 N), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), IRF7 (interferon regulatory factor 7), RIPK3 (receptor interacting serine/threonine kinase 3), FADD (Fas associated via death domain), IRF3 (interferon regulatory factor 3), UBE2V1 (ubiquitin conjugating enzyme E2 V1), UBE2D3 (ubiquitin conjugating enzyme E2 D3), UBE2D2 (ubiquitin conjugating enzyme E2 D2), UBE2D1 (ubiquitin conjugating enzyme E2 D1), RPS27A (ribosomal protein S27a)"], "WAG002442": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CUL1 (cullin 1), UBB (ubiquitin B), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), SKP1 (S-phase kinase associated protein 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA4 (proteasome 20S subunit alpha 4), PSMA2 (proteasome 20S subunit alpha 2), PSMA3 (proteasome 20S subunit alpha 3), PSMA6 (proteasome 20S subunit alpha 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMB5 (proteasome 20S subunit beta 5), PSMA1 (proteasome 20S subunit alpha 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA7 (proteasome 20S subunit alpha 7), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB2 (proteasome 20S subunit beta 2), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMC5 (proteasome 26S subunit, ATPase 5), TRAF6 (TNF receptor associated factor 6), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC3 (proteasome 26S subunit, ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMB10 (proteasome 20S subunit beta 10), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB6 (proteasome 20S subunit beta 6), PSMB3 (proteasome 20S subunit beta 3), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB1 (proteasome 20S subunit beta 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB7 (proteasome 20S subunit beta 7), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSME1 (proteasome activator subunit 1), PSMB11 (proteasome subunit beta 11), PSME3 (proteasome activator subunit 3), PAK2 (p21 (RAC1) activated kinase 2), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), NFKB1 (nuclear factor kappa B subunit 1), NFKBIA (NFKB inhibitor alpha), RELA (RELA proto-oncogene, NF-kB subunit), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), UBE2D1 (ubiquitin conjugating enzyme E2 D1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CASP8 (caspase 8), PRKCD (protein kinase C delta), NFKB2 (nuclear factor kappa B subunit 2), MALT1 (MALT1 paracaspase), BCL10 (BCL10 immune signaling adaptor), SYK (spleen associated tyrosine kinase), CREBBP (CREB binding protein), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MUC1 (mucin 1, cell surface associated), LYN (LYN proto-oncogene, Src family tyrosine kinase), FYN (FYN proto-oncogene, Src family tyrosine kinase), CARD11 (caspase recruitment domain family member 11), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), EP300 (E1A binding protein p300), RELB (RELB proto-oncogene, NF-kB subunit), PLCG2 (phospholipase C gamma 2), UBE2D2 (ubiquitin conjugating enzyme E2 D2), IL1B (interleukin 1 beta), RPS27A (ribosomal protein S27a), CDC34 (cell division cycle 34, ubiqiutin conjugating enzyme), PAK1 (p21 (RAC1) activated kinase 1), PYCARD (PYD and CARD domain containing), MUC5B (mucin 5B, oligomeric mucus/gel-forming), UBE2N (ubiquitin conjugating enzyme E2 N), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), PPP3CA (protein phosphatase 3 catalytic subunit alpha), MUC4 (mucin 4, cell surface associated), UBE2M (ubiquitin conjugating enzyme E2 M), MUC13 (mucin 13, cell surface associated), MUC6 (mucin 6, oligomeric mucus/gel-forming), FCER1G (Fc fragment of IgE receptor Ig), MUC7 (mucin 7, secreted), FBXW11 (F-box and WD repeat domain containing 11), MUC15 (mucin 15, cell surface associated), MUC20 (mucin 20, cell surface associated), NFATC2 (nuclear factor of activated T cells 2), MUC17 (mucin 17, cell surface associated), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha)"], "WAG002443": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CLOCK (clock circadian regulator), ARNTL (aryl hydrocarbon receptor nuclear translocator like), RXRA (retinoid X receptor alpha), NPAS2 (neuronal PAS domain protein 2), CREBBP (CREB binding protein), CARM1 (coactivator associated arginine methyltransferase 1), TBL1XR1 (TBL1X receptor 1), PPARA (peroxisome proliferator activated receptor alpha), NCOA6 (nuclear receptor coactivator 6), NCOA2 (nuclear receptor coactivator 2), TGS1 (trimethylguanosine synthase 1), CHD9 (chromodomain helicase DNA binding protein 9), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), NCOA1 (nuclear receptor coactivator 1), BHLHE40 (basic helix-loop-helix family member e40), BHLHE41 (basic helix-loop-helix family member e41), SERPINE1 (serpin family E member 1), F7 (coagulation factor VII), DBP (D-box binding PAR bZIP transcription factor), ARNTL2 (aryl hydrocarbon receptor nuclear translocator like 2), TBL1X (transducin beta like 1 X-linked), NAMPT (nicotinamide phosphoribosyltransferase), NOCT (nocturnin), HELZ2 (helicase with zinc finger 2), KLF15 (Kruppel like factor 15), AVP (arginine vasopressin), MED1 (mediator complex subunit 1)"], "WAG002444": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), RHOA (ras homolog family member A), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), CDC25C (cell division cycle 25C), MYH9 (myosin heavy chain 9), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), MYH10 (myosin heavy chain 10), MYL12B (myosin light chain 12B), MYH11 (myosin heavy chain 11), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), MYL9 (myosin light chain 9), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), PPP1CB (protein phosphatase 1 catalytic subunit beta), PAK1 (p21 (RAC1) activated kinase 1), MYL6 (myosin light chain 6), RHOB (ras homolog family member B), PKN1 (protein kinase N1), PDPK1 (3-phosphoinositide dependent protein kinase 1), SFN (stratifin), RAC1 (Rac family small GTPase 1), PPP1R12B (protein phosphatase 1 regulatory subunit 12B), PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A), PKN2 (protein kinase N2), MYH14 (myosin heavy chain 14), RHOC (ras homolog family member C), PKN3 (protein kinase N3)"], "WAG002445": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RIPK1 (receptor interacting serine/threonine kinase 1), CASP8 (caspase 8), FADD (Fas associated via death domain), TNFRSF10B (TNF receptor superfamily member 10b), TNFSF10 (TNF superfamily member 10), TRADD (TNFRSF1A associated via death domain), TRAF2 (TNF receptor associated factor 2), TNFRSF10A (TNF receptor superfamily member 10a), FAS (Fas cell surface death receptor), FASLG (Fas ligand), TICAM1 (toll like receptor adaptor molecule 1), TLR4 (toll like receptor 4), TICAM2 (toll like receptor adaptor molecule 2), LY96 (lymphocyte antigen 96), CD14 (CD14 molecule)"], "WAG002447": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HSP90AB1 (heat shock protein 90 alpha family class B member 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), EEF2 (eukaryotic translation elongation factor 2), CD9 (CD9 molecule), HBEGF (heparin binding EGF like growth factor), TXNRD1 (thioredoxin reductase 1)"], "WAG002448": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ST3GAL2 (ST3 beta-galactoside alpha-2,3-sialyltransferase 2), ST3GAL1 (ST3 beta-galactoside alpha-2,3-sialyltransferase 1), ST8SIA1 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1), ST6GALNAC4 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4), ST6GALNAC2 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2), ST8SIA5 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5), ST8SIA3 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3), ST8SIA4 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4), ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2), NEU1 (neuraminidase 1), GLB1 (galactosidase beta 1), ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4), NANS (N-acetylneuraminate synthase), ST6GALNAC3 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3), ST6GALNAC6 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6), ST6GALNAC5 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5), ST6GALNAC1 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1), ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1), CMAS (cytidine monophosphate N-acetylneuraminic acid synthetase), CTSA (cathepsin A), GNE (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase), NEU3 (neuraminidase 3), NEU2 (neuraminidase 2), ST3GAL5 (ST3 beta-galactoside alpha-2,3-sialyltransferase 5), NANP (N-acetylneuraminic acid phosphatase), NPL (N-acetylneuraminate pyruvate lyase), ST3GAL3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3), SLC17A5 (solute carrier family 17 member 5), ST3GAL6 (ST3 beta-galactoside alpha-2,3-sialyltransferase 6), ST8SIA6 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6), NEU4 (neuraminidase 4), ST6GAL2 (ST6 beta-galactoside alpha-2,6-sialyltransferase 2), SLC35A1 (solute carrier family 35 member A1)"], "WAG002450": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ROCK2 (Rho associated coiled-coil containing protein kinase 2), RHOA (ras homolog family member A), MYL9 (myosin light chain 9), ROCK1 (Rho associated coiled-coil containing protein kinase 1), MYL12B (myosin light chain 12B), MYH11 (myosin heavy chain 11), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), MYH9 (myosin heavy chain 9), MYH10 (myosin heavy chain 10), MYL6 (myosin light chain 6), RHOB (ras homolog family member B), LIMK1 (LIM domain kinase 1), PPP1CB (protein phosphatase 1 catalytic subunit beta), PPP1R12B (protein phosphatase 1 regulatory subunit 12B), LIMK2 (LIM domain kinase 2), CFL1 (cofilin 1), PAK1 (p21 (RAC1) activated kinase 1), MYH14 (myosin heavy chain 14), RHOC (ras homolog family member C)"], "WAG002452": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TDG (thymine DNA glycosylase), TET1 (tet methylcytosine dioxygenase 1), TET3 (tet methylcytosine dioxygenase 3), TET2 (tet methylcytosine dioxygenase 2)"], "WAG002454": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RHOA (ras homolog family member A), MYH9 (myosin heavy chain 9), MYL9 (myosin light chain 9), MYL12B (myosin light chain 12B), MYL6 (myosin light chain 6), MYH11 (myosin heavy chain 11), MYH10 (myosin heavy chain 10), RHOB (ras homolog family member B), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), CIT (citron rho-interacting serine/threonine kinase), PPP1CB (protein phosphatase 1 catalytic subunit beta), RAC1 (Rac family small GTPase 1), PPP1R12B (protein phosphatase 1 regulatory subunit 12B), MYH14 (myosin heavy chain 14), DLG4 (discs large MAGUK scaffold protein 4), RHOC (ras homolog family member C), KIF14 (kinesin family member 14), PRC1 (protein regulator of cytokinesis 1), CDKN1B (cyclin dependent kinase inhibitor 1B)"], "WAG002456": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), PLK1 (polo like kinase 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), PPP1CC (protein phosphatase 1 catalytic subunit gamma), NDC80 (NDC80 kinetochore complex component), CENPA (centromere protein A), CENPF (centromere protein F), AURKB (aurora kinase B), MAPRE1 (microtubule associated protein RP/EB family member 1), BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B), NUF2 (NUF2 component of NDC80 kinetochore complex), CKAP5 (cytoskeleton associated protein 5), CDCA8 (cell division cycle associated 8), BIRC5 (baculoviral IAP repeat containing 5), CENPH (centromere protein H), CENPN (centromere protein N), CLASP1 (cytoplasmic linker associated protein 1), KNTC1 (kinetochore associated 1), ZWINT (ZW10 interacting kinetochore protein), CENPE (centromere protein E), SPC25 (SPC25 component of NDC80 kinetochore complex), ZWILCH (zwilch kinetochore protein), KIF18A (kinesin family member 18A), DSN1 (DSN1 component of MIS12 kinetochore complex), CENPK (centromere protein K), CDC20 (cell division cycle 20), CLIP1 (CAP-Gly domain containing linker protein 1), KIF2C (kinesin family member 2C), ZW10 (zw10 kinetochore protein), SPC24 (SPC24 component of NDC80 kinetochore complex), NDE1 (nudE neurodevelopment protein 1), CENPI (centromere protein I), MIS12 (MIS12 kinetochore complex component), SKA1 (spindle and kinetochore associated complex subunit 1), CENPM (centromere protein M), CENPQ (centromere protein Q), NUP37 (nucleoporin 37), BUB3 (BUB3 mitotic checkpoint protein), NUP107 (nucleoporin 107), CENPP (centromere protein P), NUP85 (nucleoporin 85), XPO1 (exportin 1), NDEL1 (nudE neurodevelopment protein 1 like 1), ERCC6L (ERCC excision repair 6 like, spindle assembly checkpoint helicase), INCENP (inner centromere protein), NSL1 (NSL1 component of MIS12 kinetochore complex), CENPO (centromere protein O), CENPL (centromere protein L), MAD1L1 (mitotic arrest deficient 1 like 1), NUP43 (nucleoporin 43), KIF2A (kinesin family member 2A), CENPT (centromere protein T), RANGAP1 (Ran GTPase activating protein 1), NUP133 (nucleoporin 133), RCC2 (regulator of chromosome condensation 2), CLASP2 (cytoplasmic linker associated protein 2), NUP160 (nucleoporin 160), NUDC (nuclear distribution C, dynein complex regulator), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), TAOK1 (TAO kinase 1), AHCTF1 (AT-hook containing transcription factor 1), KIF2B (kinesin family member 2B), B9D2 (B9 domain containing 2), MAD2L1 (mitotic arrest deficient 2 like 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), DIAPH1 (diaphanous related formin 1), RAC1 (Rac family small GTPase 1), SKA2 (spindle and kinetochore associated complex subunit 2), PPP2CA (protein phosphatase 2 catalytic subunit alpha), DYNLL1 (dynein light chain LC8-type 1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), RHOA (ras homolog family member A), CDC42 (cell division cycle 42), ACTB (actin beta), ITGB3BP (integrin subunit beta 3 binding protein), PPP2CB (protein phosphatase 2 catalytic subunit beta), DAAM1 (dishevelled associated activator of morphogenesis 1), DIAPH3 (diaphanous related formin 3), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), ACTG1 (actin gamma 1), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), DVL1 (dishevelled segment polarity protein 1), ITGB1 (integrin subunit beta 1), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), PFN1 (profilin 1), PFN2 (profilin 2), DVL3 (dishevelled segment polarity protein 3), RANBP2 (RAN binding protein 2), PMF1 (polyamine modulated factor 1), RHOB (ras homolog family member B), DVL2 (dishevelled segment polarity protein 2), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), FMNL1 (formin like 1), DYNLL2 (dynein light chain LC8-type 2)"], "WAG002457": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TNFRSF1A (TNF receptor superfamily member 1A), RIPK1 (receptor interacting serine/threonine kinase 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), TRAF2 (TNF receptor associated factor 2), TNF (tumor necrosis factor), TRADD (TNFRSF1A associated via death domain), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CASP8 (caspase 8), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), TNFAIP3 (TNF alpha induced protein 3), TRAF1 (TNF receptor associated factor 1), BIRC3 (baculoviral IAP repeat containing 3), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), UBB (ubiquitin B), BIRC2 (baculoviral IAP repeat containing 2), FADD (Fas associated via death domain), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), RBCK1 (RANBP2-type and C3HC4-type zinc finger containing 1), XIAP (X-linked inhibitor of apoptosis), CYLD (CYLD lysine 63 deubiquitinase), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), RNF31 (ring finger protein 31), USP2 (ubiquitin specific peptidase 2), SHARPIN (SHANK associated RH domain interactor), BAG4 (BAG cochaperone 4), USP4 (ubiquitin specific peptidase 4), SMPD3 (sphingomyelin phosphodiesterase 3), TAX1BP1 (Tax1 binding protein 1), NSMAF (neutral sphingomyelinase activation associated factor), CLIP3 (CAP-Gly domain containing linker protein 3), RPS27A (ribosomal protein S27a), USP21 (ubiquitin specific peptidase 21), SMPD2 (sphingomyelin phosphodiesterase 2), OTUD7B (OTU deubiquitinase 7B), ADAM17 (ADAM metallopeptidase domain 17), RACK1 (receptor for activated C kinase 1), SPPL2A (signal peptide peptidase like 2A), SPPL2B (signal peptide peptidase like 2B), OTULIN (OTU deubiquitinase with linear linkage specificity)"], "WAG002458": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PCNA (proliferating cell nuclear antigen), POLD1 (DNA polymerase delta 1, catalytic subunit), RPA1 (replication protein A1), RPA2 (replication protein A2), MSH2 (mutS homolog 2), RPA3 (replication protein A3), EXO1 (exonuclease 1), MSH3 (mutS homolog 3), LIG1 (DNA ligase 1), POLD2 (DNA polymerase delta 2, accessory subunit), MSH6 (mutS homolog 6), MLH1 (mutL homolog 1), POLD3 (DNA polymerase delta 3, accessory subunit), POLD4 (DNA polymerase delta 4, accessory subunit), PMS2 (PMS1 homolog 2, mismatch repair system component)"], "WAG002461": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "WASF1 (WASP family member 1), WASL (WASP like actin nucleation promoting factor), WASF2 (WASP family member 2), WAS (WASP actin nucleation promoting factor), RAC1 (Rac family small GTPase 1), ARPC3 (actin related protein 2/3 complex subunit 3), ABI1 (abl interactor 1), ARPC2 (actin related protein 2/3 complex subunit 2), NCKAP1 (NCK associated protein 1), NCK1 (NCK adaptor protein 1), ARPC1B (actin related protein 2/3 complex subunit 1B), ARPC4 (actin related protein 2/3 complex subunit 4), ARPC5 (actin related protein 2/3 complex subunit 5), CYFIP2 (cytoplasmic FMR1 interacting protein 2), ACTR3 (actin related protein 3), ACTR2 (actin related protein 2), ACTB (actin beta), ABI2 (abl interactor 2), ARPC1A (actin related protein 2/3 complex subunit 1A), ACTG1 (actin gamma 1), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CDC42 (cell division cycle 42), BAIAP2 (BAR/IMD domain containing adaptor protein 2), WASF3 (WASP family member 3), BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex), CYFIP1 (cytoplasmic FMR1 interacting protein 1), NCKIPSD (NCK interacting protein with SH3 domain), PTK2 (protein tyrosine kinase 2), WIPF1 (WAS/WASL interacting protein family member 1), NCKAP1L (NCK associated protein 1 like), BTK (Bruton tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), WIPF2 (WAS/WASL interacting protein family member 2), WIPF3 (WAS/WASL interacting protein family member 3)"], "WAG002462": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAP2K4 (mitogen-activated protein kinase kinase 4), MAP2K1 (mitogen-activated protein kinase kinase 1), MAP2K2 (mitogen-activated protein kinase kinase 2), MAP2K7 (mitogen-activated protein kinase kinase 7), PDCD6IP (programmed cell death 6 interacting protein), CALM1 (calmodulin 1), FURIN (furin, paired basic amino acid cleaving enzyme)"], "WAG002466": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HSP90AA1 (heat shock protein 90 alpha family class A member 1), NUP85 (nucleoporin 85), NUP153 (nucleoporin 153), TPR (translocated promoter region, nuclear basket protein), NUP155 (nucleoporin 155), NUP93 (nucleoporin 93), NUP43 (nucleoporin 43), NUP35 (nucleoporin 35), NUP205 (nucleoporin 205), NUP62 (nucleoporin 62), NUP37 (nucleoporin 37), NUP107 (nucleoporin 107), NUP133 (nucleoporin 133), RAE1 (ribonucleic acid export 1), NUP210 (nucleoporin 210), NUP50 (nucleoporin 50), NUP214 (nucleoporin 214), NUP188 (nucleoporin 188), NUP160 (nucleoporin 160), NUP88 (nucleoporin 88), AAAS (aladin WD repeat nucleoporin), HSPA4 (heat shock protein family A (Hsp70) member 4), NUP54 (nucleoporin 54), HSPA8 (heat shock protein family A (Hsp70) member 8), RANBP2 (RAN binding protein 2), HSF1 (heat shock transcription factor 1), MAPK1 (mitogen-activated protein kinase 1), HSP90AB1 (heat shock protein 90 alpha family class B member 1), VCP (valosin containing protein), HDAC6 (histone deacetylase 6), HSPB1 (heat shock protein family B (small) member 1), HSPA1B (heat shock protein family A (Hsp70) member 1B), EEF1A1 (eukaryotic translation elongation factor 1 alpha 1), SIRT1 (sirtuin 1), POM121 (POM121 transmembrane nucleoporin), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), MAPK3 (mitogen-activated protein kinase 3), HSPA5 (heat shock protein family A (Hsp70) member 5), MTOR (mechanistic target of rapamycin kinase), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1), PTGES3 (prostaglandin E synthase 3), RPTOR (regulatory associated protein of MTOR complex 1), ATR (ATR serine/threonine kinase), RPA2 (replication protein A2), DNAJC7 (DnaJ heat shock protein family (Hsp40) member C7), RPA1 (replication protein A1), EP300 (E1A binding protein p300), HSPA9 (heat shock protein family A (Hsp70) member 9), GSK3B (glycogen synthase kinase 3 beta), RPA3 (replication protein A3), CAMK2B (calcium/calmodulin dependent protein kinase II beta), CAMK2D (calcium/calmodulin dependent protein kinase II delta), HSPH1 (heat shock protein family H (Hsp110) member 1), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), MLST8 (MTOR associated protein, LST8 homolog), FKBP4 (FKBP prolyl isomerase 4), UBB (ubiquitin B), ATM (ATM serine/threonine kinase), CREBBP (CREB binding protein), ST13 (ST13 Hsp70 interacting protein), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), MAPKAPK2 (MAPK activated protein kinase 2), HSPB2 (heat shock protein family B (small) member 2), DNAJC2 (DnaJ heat shock protein family (Hsp40) member C2), HSPB8 (heat shock protein family B (small) member 8), CRYAB (crystallin alpha B), AKT1S1 (AKT1 substrate 1), HSBP1 (heat shock factor binding protein 1), DNAJB6 (DnaJ heat shock protein family (Hsp40) member B6), HSPA2 (heat shock protein family A (Hsp70) member 2), HSPA6 (heat shock protein family A (Hsp70) member 6), HSPA1L (heat shock protein family A (Hsp70) member 1 like), HSPA4L (heat shock protein family A (Hsp70) member 4 like), HSPA12A (heat shock protein family A (Hsp70) member 12A), HSPA12B (heat shock protein family A (Hsp70) member 12B), HSPA14 (heat shock protein family A (Hsp70) member 14), RPS19BP1 (ribosomal protein S19 binding protein 1), TNFRSF21 (TNF receptor superfamily member 21), SERPINH1 (serpin family H member 1), CRYBA4 (crystallin beta A4), MRPL18 (mitochondrial ribosomal protein L18), GML (glycosylphosphatidylinositol anchored molecule like), HIKESHI (heat shock protein nuclear import factor hikeshi), RLN1 (relaxin 1), HSPA13 (heat shock protein family A (Hsp70) member 13), NDC1 (NDC1 transmembrane nucleoporin), COL4A6 (collagen type IV alpha 6 chain), HSPA1A (heat shock protein family A (Hsp70) member 1A), DEDD2 (death effector domain containing 2), CCAR2 (cell cycle and apoptosis regulator 2), NUP42 (nucleoporin 42)"], "WAG002469": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB10 (proteasome 20S subunit beta 10), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA7 (proteasome 20S subunit alpha 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB2 (proteasome 20S subunit beta 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA2 (proteasome 20S subunit alpha 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMA1 (proteasome 20S subunit alpha 1), PSMB1 (proteasome 20S subunit beta 1), PSMB3 (proteasome 20S subunit beta 3), PSMB5 (proteasome 20S subunit beta 5), PSMA6 (proteasome 20S subunit alpha 6), PSMA4 (proteasome 20S subunit alpha 4), PSMB6 (proteasome 20S subunit beta 6), PSMA3 (proteasome 20S subunit alpha 3), PSMF1 (proteasome inhibitor subunit 1), PSME4 (proteasome activator subunit 4), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA5 (proteasome 20S subunit alpha 5), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB7 (proteasome 20S subunit beta 7), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA8 (proteasome 20S subunit alpha 8), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMB11 (proteasome subunit beta 11), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), TRAF2 (TNF receptor associated factor 2), BIRC2 (baculoviral IAP repeat containing 2), TRAF3 (TNF receptor associated factor 3), TNF (tumor necrosis factor), BIRC3 (baculoviral IAP repeat containing 3), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), LTBR (lymphotoxin beta receptor), TNFRSF1B (TNF receptor superfamily member 1B), CD40LG (CD40 ligand), TNFSF12 (TNF superfamily member 12), TNFRSF12A (TNF receptor superfamily member 12A), TNFSF13B (TNF superfamily member 13b), TNFSF14 (TNF superfamily member 14), TNFRSF13C (TNF receptor superfamily member 13C), TNFRSF11A (TNF receptor superfamily member 11a), TNFSF11 (TNF superfamily member 11), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002473": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA2 (proteasome 20S subunit alpha 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA7 (proteasome 20S subunit alpha 7), PSMB2 (proteasome 20S subunit beta 2), PSMA1 (proteasome 20S subunit alpha 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMB4 (proteasome 20S subunit beta 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA3 (proteasome 20S subunit alpha 3), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB1 (proteasome 20S subunit beta 1), PSMC3 (proteasome 26S subunit, ATPase 3), PSMB3 (proteasome 20S subunit beta 3), PSMA4 (proteasome 20S subunit alpha 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB5 (proteasome 20S subunit beta 5), PSMB6 (proteasome 20S subunit beta 6), PSMA6 (proteasome 20S subunit alpha 6), PSMC4 (proteasome 26S subunit, ATPase 4), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), VCP (valosin containing protein), SYVN1 (synoviolin 1), SEL1L (SEL1L adaptor subunit of ERAD E3 ubiquitin ligase), SHH (sonic hedgehog signaling molecule), DERL2 (derlin 2), OS9 (OS9 endoplasmic reticulum lectin), RPS27A (ribosomal protein S27a), P4HB (prolyl 4-hydroxylase subunit beta), ERLEC1 (endoplasmic reticulum lectin 1), HHAT (hedgehog acyltransferase), DHH (desert hedgehog signaling molecule), IHH (Indian hedgehog signaling molecule), GPC5 (glypican 5), ADAM17 (ADAM metallopeptidase domain 17), NOTUM (notum, palmitoleoyl-protein carboxylesterase), DISP2 (dispatched RND transporter family member 2), SCUBE2 (signal peptide, CUB domain and EGF like domain containing 2), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002477": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NOTCH1 (notch receptor 1), JAG1 (jagged canonical Notch ligand 1), VEGFA (vascular endothelial growth factor A), DLL4 (delta like canonical Notch ligand 4), DLL1 (delta like canonical Notch ligand 1), JAG2 (jagged canonical Notch ligand 2), DLL3 (delta like canonical Notch ligand 3), MGP (matrix Gla protein), ALPL (alkaline phosphatase, biomineralization associated), PLAT (plasminogen activator, tissue type), ITGA1 (integrin subunit alpha 1), FGFR3 (fibroblast growth factor receptor 3), GJA5 (gap junction protein alpha 5), SOX6 (SRY-box transcription factor 6), LPAR1 (lysophosphatidic acid receptor 1), SAT1 (spermidine/spermine N1-acetyltransferase 1), CALU (calumenin)"], "WAG002478": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), HDAC3 (histone deacetylase 3), HDAC2 (histone deacetylase 2), NFATC1 (nuclear factor of activated T cells 1), NFKB1 (nuclear factor kappa B subunit 1), EP300 (E1A binding protein p300), CREBBP (CREB binding protein), RELA (RELA proto-oncogene, NF-kB subunit), SP1 (Sp1 transcription factor), HDAC4 (histone deacetylase 4), HDAC5 (histone deacetylase 5), HDAC7 (histone deacetylase 7), NFATC2 (nuclear factor of activated T cells 2), NFATC3 (nuclear factor of activated T cells 3), HDAC9 (histone deacetylase 9), NFKBIA (NFKB inhibitor alpha), NFATC4 (nuclear factor of activated T cells 4), PPP3CA (protein phosphatase 3 catalytic subunit alpha), CDK9 (cyclin dependent kinase 9), PPP3CB (protein phosphatase 3 catalytic subunit beta), PPP3CC (protein phosphatase 3 catalytic subunit gamma), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), HDAC8 (histone deacetylase 8), PPP3R2 (protein phosphatase 3 regulatory subunit B, beta), CCNT1 (cyclin T1), HEXIM1 (HEXIM P-TEFb complex subunit 1), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), NELFA (negative elongation factor complex member A), NELFCD (negative elongation factor complex member C/D), NELFE (negative elongation factor complex member E), NELFB (negative elongation factor complex member B)"], "WAG002481": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SSR1 (signal sequence receptor subunit 1), HYOU1 (hypoxia up-regulated 1), PDIA6 (protein disulfide isomerase family A member 6), EXTL3 (exostosin like glycosyltransferase 3), EXTL2 (exostosin like glycosyltransferase 2), DNAJC3 (DnaJ heat shock protein family (Hsp40) member C3), SRPRB (SRP receptor subunit beta), EXTL1 (exostosin like glycosyltransferase 1), EDEM1 (ER degradation enhancing alpha-mannosidase like protein 1), SYVN1 (synoviolin 1), ZBTB17 (zinc finger and BTB domain containing 17), HDGF (heparin binding growth factor), WFS1 (wolframin ER transmembrane glycoprotein), DNAJB9 (DnaJ heat shock protein family (Hsp40) member B9), ADD1 (adducin 1), SERP1 (stress associated endoplasmic reticulum protein 1), SHC1 (SHC adaptor protein 1), TLN1 (talin 1), LMNA (lamin A/C), CXXC1 (CXXC finger protein 1), PDIA5 (protein disulfide isomerase family A member 5), ACADVL (acyl-CoA dehydrogenase very long chain), PREB (prolactin regulatory element binding), MYDGF (myeloid derived growth factor), YIF1A (Yip1 interacting factor homolog A, membrane trafficking protein), TSPYL2 (TSPY like 2), PLA2G4B (phospholipase A2 group IVB), DNAJB11 (DnaJ heat shock protein family (Hsp40) member B11), KLHDC3 (kelch domain containing 3), SULT1A3 (sulfotransferase family 1A member 3), TPP1 (tripeptidyl peptidase 1), GSK3A (glycogen synthase kinase 3 alpha), SEC31A (SEC31 homolog A, COPII coat complex component), SRPRA (SRP receptor subunit alpha), ATP6V0D1 (ATPase H+ transporting V0 subunit d1), CTDSP2 (CTD small phosphatase 2), KDELR3 (KDEL endoplasmic reticulum protein retention receptor 3), WIPI1 (WD repeat domain, phosphoinositide interacting 1), FKBP14 (FKBP prolyl isomerase 14), GOSR2 (golgi SNAP receptor complex member 2), GFPT1 (glutamine--fructose-6-phosphate transaminase 1), DDX11 (DEAD/H-box helicase 11), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), DCTN1 (dynactin subunit 1), CUL7 (cullin 7), ARFGAP1 (ADP ribosylation factor GTPase activating protein 1), TATDN2 (TatD DNase domain containing 2)"], "WAG002483": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEP290 (centrosomal protein 290), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), PLK1 (polo like kinase 1), HAUS2 (HAUS augmin like complex subunit 2), MAPRE1 (microtubule associated protein RP/EB family member 1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), DCTN2 (dynactin subunit 2), CLASP1 (cytoplasmic linker associated protein 1), CCP110 (centriolar coiled-coil protein 110), CDK1 (cyclin dependent kinase 1), CEP164 (centrosomal protein 164), NDE1 (nudE neurodevelopment protein 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), CSNK1D (casein kinase 1 delta), CKAP5 (cytoskeleton associated protein 5), DCTN3 (dynactin subunit 3), CEP76 (centrosomal protein 76), CETN2 (centrin 2), OFD1 (OFD1 centriole and centriolar satellite protein), SDCCAG8 (SHH signaling and ciliogenesis regulator SDCCAG8), PCNT (pericentrin), NEK2 (NIMA related kinase 2), CENPJ (centromere protein J), PLK4 (polo like kinase 4), NEDD1 (NEDD1 gamma-tubulin ring complex targeting factor), CEP135 (centrosomal protein 135), CDK5RAP2 (CDK5 regulatory subunit associated protein 2), CSNK1E (casein kinase 1 epsilon), CEP72 (centrosomal protein 72), AKAP9 (A-kinase anchoring protein 9), SFI1 (SFI1 centrin binding protein), NINL (ninein like), CEP63 (centrosomal protein 63), CEP57 (centrosomal protein 57), CEP250 (centrosomal protein 250), CEP152 (centrosomal protein 152), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), SSNA1 (SS nuclear autoantigen 1), CNTRL (centriolin), ODF2 (outer dense fiber of sperm tails 2), CEP78 (centrosomal protein 78), CEP70 (centrosomal protein 70), CEP41 (centrosomal protein 41), TUBA1A (tubulin alpha 1a), HSP90AA1 (heat shock protein 90 alpha family class A member 1), TUBG1 (tubulin gamma 1), TUBA4A (tubulin alpha 4a), TUBB (tubulin beta class I), DYNLL1 (dynein light chain LC8-type 1), PCM1 (pericentriolar material 1), TUBB4B (tubulin beta 4B class IVb), ACTR1A (actin related protein 1A), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), TUBB4A (tubulin beta 4A class IVa), BBS7 (Bardet-Biedl syndrome 7), BBS2 (Bardet-Biedl syndrome 2), IQCB1 (IQ motif containing B1), RPGRIP1L (RPGRIP1 like), B9D2 (B9 domain containing 2), RAB8A (RAB8A, member RAS oncogene family), BBS10 (Bardet-Biedl syndrome 10), MKS1 (MKS transition zone complex subunit 1), BBS4 (Bardet-Biedl syndrome 4), NPHP4 (nephrocystin 4), BBS1 (Bardet-Biedl syndrome 1), NPHP1 (nephrocystin 1), BBS9 (Bardet-Biedl syndrome 9), BBS5 (Bardet-Biedl syndrome 5), TMEM67 (transmembrane protein 67), AHI1 (Abelson helper integration site 1), EXOC7 (exocyst complex component 7), HDAC6 (histone deacetylase 6), KIF3B (kinesin family member 3B), CCT2 (chaperonin containing TCP1 subunit 2), CC2D2A (coiled-coil and C2 domain containing 2A), EXOC5 (exocyst complex component 5), TTC8 (tetratricopeptide repeat domain 8), ARL3 (ADP ribosylation factor like GTPase 3), TCP1 (t-complex 1), ARL6 (ADP ribosylation factor like GTPase 6), TMEM216 (transmembrane protein 216), HAUS6 (HAUS augmin like complex subunit 6), KIF3A (kinesin family member 3A), EXOC4 (exocyst complex component 4), CCT3 (chaperonin containing TCP1 subunit 3), EXOC2 (exocyst complex component 2), CCT4 (chaperonin containing TCP1 subunit 4), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), IFT20 (intraflagellar transport 20), BBS12 (Bardet-Biedl syndrome 12), B9D1 (B9 domain containing 1), EXOC8 (exocyst complex component 8), KIFAP3 (kinesin associated protein 3), RAB3IP (RAB3A interacting protein), EXOC6 (exocyst complex component 6), EXOC1 (exocyst complex component 1), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1)"], "WAG002484": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ADCY2 (adenylate cyclase 2), GNAS (GNAS complex locus), ADCY5 (adenylate cyclase 5), ADCY7 (adenylate cyclase 7), ADCY1 (adenylate cyclase 1), ADCY8 (adenylate cyclase 8), GNAI2 (G protein subunit alpha i2), ADCY9 (adenylate cyclase 9), ADCY6 (adenylate cyclase 6), ADCY4 (adenylate cyclase 4), GNB1 (G protein subunit beta 1), ADCY3 (adenylate cyclase 3), GNAI1 (G protein subunit alpha i1), GNGT1 (G protein subunit gamma transducin 1), PLCB3 (phospholipase C beta 3), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), GNAI3 (G protein subunit alpha i3), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), GNAZ (G protein subunit alpha z), GNG3 (G protein subunit gamma 3), GNB2 (G protein subunit beta 2), GNB5 (G protein subunit beta 5), PDE4D (phosphodiesterase 4D), PRKACB (protein kinase cAMP-activated catalytic subunit beta), GNG4 (G protein subunit gamma 4), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), GNGT2 (G protein subunit gamma transducin 2), GNG13 (G protein subunit gamma 13), PDE4A (phosphodiesterase 4A), GNG7 (G protein subunit gamma 7), GNAO1 (G protein subunit alpha o1), GNB3 (G protein subunit beta 3), GNG5 (G protein subunit gamma 5), GNG12 (G protein subunit gamma 12), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), GNG8 (G protein subunit gamma 8), PDE4B (phosphodiesterase 4B), PDE7A (phosphodiesterase 7A), RHOA (ras homolog family member A), PDE8A (phosphodiesterase 8A), PRKCA (protein kinase C alpha), PRKCE (protein kinase C epsilon), PDE4C (phosphodiesterase 4C), GNG11 (G protein subunit gamma 11), PDE1A (phosphodiesterase 1A), PDE7B (phosphodiesterase 7B), PDE1B (phosphodiesterase 1B), PDE8B (phosphodiesterase 8B), HRAS (HRas proto-oncogene, GTPase), GNA15 (G protein subunit alpha 15), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PDE1C (phosphodiesterase 1C), GNG10 (G protein subunit gamma 10), GNA12 (G protein subunit alpha 12), GNA13 (G protein subunit alpha 13), GNAL (G protein subunit alpha L), PRKCD (protein kinase C delta), PRKCB (protein kinase C beta), GNA11 (G protein subunit alpha 11), AKAP1 (A-kinase anchoring protein 1), GNAQ (G protein subunit alpha q), KCNJ3 (potassium inwardly rectifying channel subfamily J member 3), AKAP5 (A-kinase anchoring protein 5), NRAS (NRAS proto-oncogene, GTPase), PRKCZ (protein kinase C zeta), KRAS (KRAS proto-oncogene, GTPase), AKAP13 (A-kinase anchoring protein 13), PRKCH (protein kinase C eta), PRKCG (protein kinase C gamma), ARHGEF1 (Rho guanine nucleotide exchange factor 1), GNA14 (G protein subunit alpha 14), PRKCQ (protein kinase C theta), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PRKD1 (protein kinase D1), AKAP8 (A-kinase anchoring protein 8), AKAP10 (A-kinase anchoring protein 10), RRAS (RAS related), AKAP4 (A-kinase anchoring protein 4), AKAP11 (A-kinase anchoring protein 11), AKAP9 (A-kinase anchoring protein 9), PRKD3 (protein kinase D3), AKAP3 (A-kinase anchoring protein 3), PPP3CA (protein phosphatase 3 catalytic subunit alpha), AKAP7 (A-kinase anchoring protein 7), AKAP12 (A-kinase anchoring protein 12), AKAP6 (A-kinase anchoring protein 6), PRKCI (protein kinase C iota), PPP3CC (protein phosphatase 3 catalytic subunit gamma), SLC9A1 (solute carrier family 9 member A1), LOC100505585 (uncharacterized LOC100505585), CALM1 (calmodulin 1), LOC729966 (uncharacterized LOC729966)"], "WAG002486": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POU5F1 (POU class 5 homeobox 1), KLF4 (Kruppel like factor 4), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), SOX2 (SRY-box transcription factor 2), NANOG (Nanog homeobox), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), CDH1 (cadherin 1), CDX2 (caudal type homeobox 2), HNRNPAB (heterogeneous nuclear ribonucleoprotein A/B), TPRX1 (tetrapeptide repeat homeobox 1), ZFP36 (ZFP36 ring finger protein), KHSRP (KH-type splicing regulatory protein), EGR1 (early growth response 1), DDIT3 (DNA damage inducible transcript 3), TBX3 (T-box transcription factor 3), SOX8 (SRY-box transcription factor 8), NANOGNB (NANOG neighbor homeobox), LEUTX (leucine twenty homeobox), DPRX (divergent-paired related homeobox), HMGA1 (high mobility group AT-hook 1), PBX1 (PBX homeobox 1), SIX3 (SIX homeobox 3), IRF4 (interferon regulatory factor 4), MTA3 (metastasis associated 1 family member 3), ZFP42 (ZFP42 zinc finger protein), MXD1 (MAX dimerization protein 1), ARGFX (arginine-fifty homeobox), DNMT3L (DNA methyltransferase 3 like), BATF3 (basic leucine zipper ATF-like transcription factor 3), ELAVL1 (ELAV like RNA binding protein 1), AQP3 (aquaporin 3 (Gill blood group)), TCF7L1 (transcription factor 7 like 1), NKX2-1 (NK2 homeobox 1), GATA3 (GATA binding protein 3), GATA2 (GATA binding protein 2), ZAR1 (zygote arrest 1), DPPA3 (developmental pluripotency associated 3), FOXD1 (forkhead box D1), SOX11 (SRY-box transcription factor 11), NLRP5 (NLR family pyrin domain containing 5), DLX2 (distal-less homeobox 2), ZFP36L2 (ZFP36 ring finger protein like 2), NR3C2 (nuclear receptor subfamily 3 group C member 2), TFAP2B (transcription factor AP-2 beta), ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1), FOXQ1 (forkhead box Q1), AQP9 (aquaporin 9), IRX5 (iroquois homeobox 5), MIR302A (microRNA 302a), ESRRA (estrogen related receptor alpha), CELF3 (CUGBP Elav-like family member 3), MYBL1 (MYB proto-oncogene like 1), MOS (MOS proto-oncogene, serine/threonine kinase), PADI6 (peptidyl arginine deiminase 6), ZSCAN4 (zinc finger and SCAN domain containing 4), TEAD4 (TEA domain transcription factor 4), E2F5 (E2F transcription factor 5), BARX2 (BARX homeobox 2), MACROH2A2 (macroH2A.2 histone)"], "WAG002487": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MT2A (metallothionein 2A), SLC30A1 (solute carrier family 30 member 1), MT1B (metallothionein 1B), SLC30A4 (solute carrier family 30 member 4), MT1H (metallothionein 1H), MT1L (metallothionein 1L, pseudogene), MT1X (metallothionein 1X), MT1E (metallothionein 1E), SLC39A2 (solute carrier family 39 member 2), SLC39A1 (solute carrier family 39 member 1), SLC39A4 (solute carrier family 39 member 4), MT3 (metallothionein 3), MT1G (metallothionein 1G), SLC30A5 (solute carrier family 30 member 5), MT4 (metallothionein 4), MT1A (metallothionein 1A), SLC39A5 (solute carrier family 39 member 5), MT1F (metallothionein 1F), MTF1 (metal regulatory transcription factor 1), SLC30A3 (solute carrier family 30 member 3), SLC39A14 (solute carrier family 39 member 14), SLC39A8 (solute carrier family 39 member 8), SLC39A10 (solute carrier family 39 member 10), SLC39A3 (solute carrier family 39 member 3), SLC39A6 (solute carrier family 39 member 6), SLC39A11 (solute carrier family 39 member 11), SLC39A7 (solute carrier family 39 member 7), SLC30A9 (solute carrier family 30 member 9), SLC30A2 (solute carrier family 30 member 2), SLC39A13 (solute carrier family 39 member 13), SLC30A6 (solute carrier family 30 member 6), SLC30A8 (solute carrier family 30 member 8), SLC39A12 (solute carrier family 39 member 12), SLC39A9 (solute carrier family 39 member 9), SLC30A7 (solute carrier family 30 member 7), SLC30A10 (solute carrier family 30 member 10), MT1M (metallothionein 1M)"], "WAG002490": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CUL1 (cullin 1), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA3 (proteasome 20S subunit alpha 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA7 (proteasome 20S subunit alpha 7), PSMB10 (proteasome 20S subunit beta 10), PSMA2 (proteasome 20S subunit alpha 2), PSMA6 (proteasome 20S subunit alpha 6), PSMB5 (proteasome 20S subunit beta 5), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB1 (proteasome 20S subunit beta 1), PSMA1 (proteasome 20S subunit alpha 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMA4 (proteasome 20S subunit alpha 4), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD13 (proteasome 26S subunit, non-ATPase 13), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD4 (proteasome 26S subunit, non-ATPase 4), SKP1 (S-phase kinase associated protein 1), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSMB11 (proteasome subunit beta 11), PSME1 (proteasome activator subunit 1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME3 (proteasome activator subunit 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), NFKB2 (nuclear factor kappa B subunit 2), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), UBE2M (ubiquitin conjugating enzyme E2 M), RELB (RELB proto-oncogene, NF-kB subunit), RPS27A (ribosomal protein S27a), FBXW11 (F-box and WD repeat domain containing 11), UBA3 (ubiquitin like modifier activating enzyme 3), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002493": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), SQSTM1 (sequestosome 1), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), TOMM20 (translocase of outer mitochondrial membrane 20), TOMM40 (translocase of outer mitochondrial membrane 40), TOMM22 (translocase of outer mitochondrial membrane 22), RPS27A (ribosomal protein S27a), TOMM7 (translocase of outer mitochondrial membrane 7), PINK1 (PTEN induced kinase 1), TOMM5 (translocase of outer mitochondrial membrane 5), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), VDAC1 (voltage dependent anion channel 1), TOMM6 (translocase of outer mitochondrial membrane 6), ULK1 (unc-51 like autophagy activating kinase 1), ATG5 (autophagy related 5), UBB (ubiquitin B), CSNK2A1 (casein kinase 2 alpha 1), CSNK2A2 (casein kinase 2 alpha 2), ATG12 (autophagy related 12), CSNK2B (casein kinase 2 beta), MFN1 (mitofusin 1), MFN2 (mitofusin 2), FUNDC1 (FUN14 domain containing 1), MTERF3 (mitochondrial transcription termination factor 3), TOMM70 (translocase of outer mitochondrial membrane 70), PRKN (parkin RBR E3 ubiquitin protein ligase)"], "WAG002495": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATP6V1E1 (ATPase H+ transporting V1 subunit E1), ATP6V1A (ATPase H+ transporting V1 subunit A), ATP6V1F (ATPase H+ transporting V1 subunit F), ATP6V0D1 (ATPase H+ transporting V0 subunit d1), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), ATP6V1B2 (ATPase H+ transporting V1 subunit B2), ATP6V1G1 (ATPase H+ transporting V1 subunit G1), ATP6V1D (ATPase H+ transporting V1 subunit D), ATP6V1H (ATPase H+ transporting V1 subunit H), ATP6V0D2 (ATPase H+ transporting V0 subunit d2), ATP6V0A1 (ATPase H+ transporting V0 subunit a1), ATP6V0C (ATPase H+ transporting V0 subunit c), ATP6V1B1 (ATPase H+ transporting V1 subunit B1), ATP6V1C2 (ATPase H+ transporting V1 subunit C2), ATP6V0B (ATPase H+ transporting V0 subunit b), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), ATP6V0A2 (ATPase H+ transporting V0 subunit a2), ATP6V0A4 (ATPase H+ transporting V0 subunit a4), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), ATP6V0E2 (ATPase H+ transporting V0 subunit e2), ATP6V1G3 (ATPase H+ transporting V1 subunit G3), NCF2 (neutrophil cytosolic factor 2), CYBA (cytochrome b-245 alpha chain), NCF4 (neutrophil cytosolic factor 4), RAC2 (Rac family small GTPase 2), NOS2 (nitric oxide synthase 2), CYBB (cytochrome b-245 beta chain), NCF1 (neutrophil cytosolic factor 1), ATP6V1G2 (ATPase H+ transporting V1 subunit G2), NOS3 (nitric oxide synthase 3), NOS1 (nitric oxide synthase 1), ATP6V1E2 (ATPase H+ transporting V1 subunit E2), SLC11A1 (solute carrier family 11 member 1), HVCN1 (hydrogen voltage gated channel 1)"], "WAG002496": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP85 (nucleoporin 85), NUP153 (nucleoporin 153), CPSF1 (cleavage and polyadenylation specific factor 1), NUP155 (nucleoporin 155), NUP93 (nucleoporin 93), NUP43 (nucleoporin 43), NUP35 (nucleoporin 35), NUP62 (nucleoporin 62), NUP214 (nucleoporin 214), NUP205 (nucleoporin 205), RAN (RAN, member RAS oncogene family), NUP210 (nucleoporin 210), NUP133 (nucleoporin 133), NUP188 (nucleoporin 188), RAE1 (ribonucleic acid export 1), NUP50 (nucleoporin 50), NUP107 (nucleoporin 107), NUP88 (nucleoporin 88), NUP160 (nucleoporin 160), TPR (translocated promoter region, nuclear basket protein), AAAS (aladin WD repeat nucleoporin), NUP37 (nucleoporin 37), NUP54 (nucleoporin 54), RANBP2 (RAN binding protein 2), POM121 (POM121 transmembrane nucleoporin), RPP30 (ribonuclease P/MRP subunit p30), RPP38 (ribonuclease P/MRP subunit p38), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), POP4 (POP4 homolog, ribonuclease P/MRP subunit), RPP25 (ribonuclease P and MRP subunit p25), RPP40 (ribonuclease P/MRP subunit p40), RPP14 (ribonuclease P/MRP subunit p14), POP5 (POP5 homolog, ribonuclease P/MRP subunit), POP1 (POP1 homolog, ribonuclease P/MRP subunit), TSEN2 (tRNA splicing endonuclease subunit 2), POP7 (POP7 homolog, ribonuclease P/MRP subunit), CLP1 (cleavage factor polyribonucleotide kinase subunit 1), RPP21 (ribonuclease P/MRP subunit p21), XPOT (exportin for tRNA), DDX1 (DEAD-box helicase 1), TSEN34 (tRNA splicing endonuclease subunit 34), CSTF2 (cleavage stimulation factor subunit 2), TSEN15 (tRNA splicing endonuclease subunit 15), TSEN54 (tRNA splicing endonuclease subunit 54), CPSF4 (cleavage and polyadenylation specific factor 4), FAM98B (family with sequence similarity 98 member B), C2orf49 (chromosome 2 open reading frame 49), ELAC2 (elaC ribonuclease Z 2), TRNT1 (tRNA nucleotidyl transferase 1), RTCB (RNA 2',3'-cyclic phosphate and 5'-OH ligase), TRIM39-RPP21 (TRIM39-RPP21 readthrough), ZBTB8OS (zinc finger and BTB domain containing 8 opposite strand), NDC1 (NDC1 transmembrane nucleoporin), RTRAF (RNA transcription, translation and transport factor), NUP42 (nucleoporin 42)"], "WAG002498": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB10 (proteasome 20S subunit beta 10), PSMA7 (proteasome 20S subunit alpha 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB2 (proteasome 20S subunit beta 2), PSMB4 (proteasome 20S subunit beta 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA2 (proteasome 20S subunit alpha 2), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB1 (proteasome 20S subunit beta 1), PSMB3 (proteasome 20S subunit beta 3), PSMA1 (proteasome 20S subunit alpha 1), PSMB5 (proteasome 20S subunit beta 5), PSMA6 (proteasome 20S subunit alpha 6), PSMB6 (proteasome 20S subunit beta 6), PSMA4 (proteasome 20S subunit alpha 4), PSMA3 (proteasome 20S subunit alpha 3), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB7 (proteasome 20S subunit beta 7), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA8 (proteasome 20S subunit alpha 8), PSMF1 (proteasome inhibitor subunit 1), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), PSMD4 (proteasome 26S subunit, non-ATPase 4), OAZ1 (ornithine decarboxylase antizyme 1), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), OAZ3 (ornithine decarboxylase antizyme 3), OAZ2 (ornithine decarboxylase antizyme 2), PSME2 (proteasome activator subunit 2), ODC1 (ornithine decarboxylase 1), SRM (spermidine synthase), SAT1 (spermidine/spermine N1-acetyltransferase 1), AZIN1 (antizyme inhibitor 1), AMD1 (adenosylmethionine decarboxylase 1), SMS (spermine synthase), AGMAT (agmatinase), PAOX (polyamine oxidase), NQO1 (NAD(P)H quinone dehydrogenase 1), AZIN2 (antizyme inhibitor 2), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002499": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DBT (dihydrolipoamide branched chain transacylase E2), BCKDHA (branched chain keto acid dehydrogenase E1 subunit alpha), ECHS1 (enoyl-CoA hydratase, short chain 1), BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta), DLD (dihydrolipoamide dehydrogenase), ACADSB (acyl-CoA dehydrogenase short/branched chain), IVD (isovaleryl-CoA dehydrogenase), ACAD8 (acyl-CoA dehydrogenase family member 8), BCAT1 (branched chain amino acid transaminase 1), BCAT2 (branched chain amino acid transaminase 2), MCCC1 (methylcrotonoyl-CoA carboxylase 1), ACAT1 (acetyl-CoA acetyltransferase 1), HSD17B10 (hydroxysteroid 17-beta dehydrogenase 10), MCCC2 (methylcrotonoyl-CoA carboxylase 2), HIBADH (3-hydroxyisobutyrate dehydrogenase), HIBCH (3-hydroxyisobutyryl-CoA hydrolase), BCKDK (branched chain keto acid dehydrogenase kinase), ALDH6A1 (aldehyde dehydrogenase 6 family member A1), AUH (AU RNA binding methylglutaconyl-CoA hydratase), SLC25A44 (solute carrier family 25 member 44), PPM1K (protein phosphatase, Mg2+/Mn2+ dependent 1K)"], "WAG002500": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA3 (proteasome 20S subunit alpha 3), PSMA7 (proteasome 20S subunit alpha 7), PSMA6 (proteasome 20S subunit alpha 6), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB4 (proteasome 20S subunit beta 4), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA2 (proteasome 20S subunit alpha 2), PSMA4 (proteasome 20S subunit alpha 4), PSMB1 (proteasome 20S subunit beta 1), PSMA1 (proteasome 20S subunit alpha 1), PSMB5 (proteasome 20S subunit beta 5), PSMB3 (proteasome 20S subunit beta 3), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSME4 (proteasome activator subunit 4), UBB (ubiquitin B), PSMA5 (proteasome 20S subunit alpha 5), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMB6 (proteasome 20S subunit beta 6), PSMC3 (proteasome 26S subunit, ATPase 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD9 (proteasome 26S subunit, non-ATPase 9), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMB11 (proteasome subunit beta 11), PSME3 (proteasome activator subunit 3), PSME1 (proteasome activator subunit 1), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), PLCB3 (phospholipase C beta 3), PLCB2 (phospholipase C beta 2), PLCB1 (phospholipase C beta 1), MYC (MYC proto-oncogene, bHLH transcription factor), DVL2 (dishevelled segment polarity protein 2), GNB1 (G protein subunit beta 1), GNAO1 (G protein subunit alpha o1), DVL1 (dishevelled segment polarity protein 1), DVL3 (dishevelled segment polarity protein 3), GNG2 (G protein subunit gamma 2), CTNNB1 (catenin beta 1), RAC1 (Rac family small GTPase 1), RHOA (ras homolog family member A), GNGT1 (G protein subunit gamma transducin 1), WNT5A (Wnt family member 5A), FZD2 (frizzled class receptor 2), FZD5 (frizzled class receptor 5), GNB5 (G protein subunit beta 5), FZD6 (frizzled class receptor 6), GNG3 (G protein subunit gamma 3), GNB2 (G protein subunit beta 2), FZD1 (frizzled class receptor 1), GNGT2 (G protein subunit gamma transducin 2), ARRB2 (arrestin beta 2), FZD4 (frizzled class receptor 4), GNG4 (G protein subunit gamma 4), GNG13 (G protein subunit gamma 13), PRKCA (protein kinase C alpha), GNB4 (G protein subunit beta 4), GNB3 (G protein subunit beta 3), GNG7 (G protein subunit gamma 7), WNT1 (Wnt family member 1), FZD7 (frizzled class receptor 7), FZD8 (frizzled class receptor 8), GNG5 (G protein subunit gamma 5), GNG12 (G protein subunit gamma 12), GNG8 (G protein subunit gamma 8), GNAT2 (G protein subunit alpha transducin 2), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), GNG11 (G protein subunit gamma 11), WNT11 (Wnt family member 11), PRKCB (protein kinase C beta), PARD6A (par-6 family cell polarity regulator alpha), FZD3 (frizzled class receptor 3), CLTC (clathrin heavy chain), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PPP3CA (protein phosphatase 3 catalytic subunit alpha), AP2M1 (adaptor related protein complex 2 subunit mu 1), PRKCG (protein kinase C gamma), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), GNG10 (G protein subunit gamma 10), WNT4 (Wnt family member 4)"], "WAG002501": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SEC23A (Sec23 homolog A, COPII coat complex component), SEC24B (SEC24 homolog B, COPII coat complex component), TMED2 (transmembrane p24 trafficking protein 2), SAR1B (secretion associated Ras related GTPase 1B), SEC24C (SEC24 homolog C, COPII coat complex component), LMAN1 (lectin, mannose binding 1), SEC24A (SEC24 homolog A, COPII coat complex component), SEC24D (SEC24 homolog D, COPII coat complex component), STX5 (syntaxin 5), PREB (prolactin regulatory element binding), TMED10 (transmembrane p24 trafficking protein 10), SEC22B (SEC22 homolog B, vesicle trafficking protein), F8 (coagulation factor VIII), MIA3 (MIA SH3 domain ER export factor 3), MCFD2 (multiple coagulation factor deficiency 2, ER cargo receptor complex subunit), F5 (coagulation factor V), LMAN2 (lectin, mannose binding 2), GOSR2 (golgi SNAP receptor complex member 2), LMAN2L (lectin, mannose binding 2 like), SERPINA1 (serpin family A member 1), LMAN1L (lectin, mannose binding 1 like), COL7A1 (collagen type VII alpha 1 chain), CNIH2 (cornichon family AMPA receptor auxiliary protein 2), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), CNIH3 (cornichon family AMPA receptor auxiliary protein 3), CD59 (CD59 molecule (CD59 blood group)), CTSC (cathepsin C), CTSZ (cathepsin Z), CNIH1 (cornichon family AMPA receptor auxiliary protein 1), FOLR1 (folate receptor alpha), AREG (amphiregulin), MIA2 (MIA SH3 domain ER export factor 2), TGFA (transforming growth factor alpha)"], "WAG002502": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "LAGE3 (L antigen family member 3), METTL1 (methyltransferase like 1), OSGEP (O-sialoglycoprotein endopeptidase), TP53RK (TP53 regulating kinase), TPRKB (TP53RK binding protein), TRMT11 (tRNA methyltransferase 11 homolog), TRMT61A (tRNA methyltransferase 61A), WDR4 (WD repeat domain 4), TRMT1 (tRNA methyltransferase 1), CTU1 (cytosolic thiouridylase subunit 1), FTSJ1 (FtsJ RNA 2'-O-methyltransferase 1), TRMT112 (tRNA methyltransferase subunit 11-2), URM1 (ubiquitin related modifier 1), PUS7 (pseudouridine synthase 7), CTU2 (cytosolic thiouridylase subunit 2), NSUN2 (NOP2/Sun RNA methyltransferase 2), TRMT6 (tRNA methyltransferase 6), TRIT1 (tRNA isopentenyltransferase 1), ALKBH8 (alkB homolog 8, tRNA methyltransferase), ADAT2 (adenosine deaminase tRNA specific 2), THADA (THADA armadillo repeat containing), PUS3 (pseudouridine synthase 3), ADAT1 (adenosine deaminase tRNA specific 1), NSUN6 (NOP2/Sun RNA methyltransferase 6), QTRT1 (queuine tRNA-ribosyltransferase catalytic subunit 1), CDKAL1 (CDK5 regulatory subunit associated protein 1 like 1), QTRT2 (queuine tRNA-ribosyltransferase accessory subunit 2), TRMT9B (tRNA methyltransferase 9B (putative)), TRDMT1 (tRNA aspartic acid methyltransferase 1), TRMT10A (tRNA methyltransferase 10A), THG1L (tRNA-histidine guanylyltransferase 1 like), TRMT13 (tRNA methyltransferase 13 homolog), TRMT44 (tRNA methyltransferase 44 homolog), EPRS1 (glutamyl-prolyl-tRNA synthetase 1), DUS2 (dihydrouridine synthase 2)"], "WAG002505": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PCNA (proliferating cell nuclear antigen), BRCA1 (BRCA1 DNA repair associated), RPA1 (replication protein A1), RAD51 (RAD51 recombinase), RPA2 (replication protein A2), POLD1 (DNA polymerase delta 1, catalytic subunit), RAD50 (RAD50 double strand break repair protein), CHEK1 (checkpoint kinase 1), ATM (ATM serine/threonine kinase), RFC4 (replication factor C subunit 4), ATR (ATR serine/threonine kinase), RPA3 (replication protein A3), RFC5 (replication factor C subunit 5), BLM (BLM RecQ like helicase), RFC2 (replication factor C subunit 2), RFC3 (replication factor C subunit 3), RAD17 (RAD17 checkpoint clamp loader component), TOPBP1 (DNA topoisomerase II binding protein 1), POLE (DNA polymerase epsilon, catalytic subunit), CDK2 (cyclin dependent kinase 2), EXO1 (exonuclease 1), RFC1 (replication factor C subunit 1), ATRIP (ATR interacting protein), RAD52 (RAD52 homolog, DNA repair protein), SUMO2 (small ubiquitin like modifier 2), TIPIN (TIMELESS interacting protein), RAD9A (RAD9 checkpoint clamp component A), POLE2 (DNA polymerase epsilon 2, accessory subunit), BARD1 (BRCA1 associated RING domain 1), BRCA2 (BRCA2 DNA repair associated), CLSPN (claspin), TP53BP1 (tumor protein p53 binding protein 1), MDC1 (mediator of DNA damage checkpoint 1), WRN (WRN RecQ like helicase), RAD1 (RAD1 checkpoint DNA exonuclease), NBN (nibrin), TIMELESS (timeless circadian regulator), HUS1 (HUS1 checkpoint clamp component), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), POLD2 (DNA polymerase delta 2, accessory subunit), MUS81 (MUS81 structure-specific endonuclease subunit), SUMO1 (small ubiquitin like modifier 1), CCNA2 (cyclin A2), DNA2 (DNA replication helicase/nuclease 2), UIMC1 (ubiquitin interaction motif containing 1), POLD4 (DNA polymerase delta 4, accessory subunit), RAD51C (RAD51 paralog C), TOP3A (DNA topoisomerase III alpha), POLD3 (DNA polymerase delta 3, accessory subunit), XRCC3 (X-ray repair cross complementing 3), RBBP8 (RB binding protein 8, endonuclease), UBE2N (ubiquitin conjugating enzyme E2 N), ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit), UBE2I (ubiquitin conjugating enzyme E2 I), RNF8 (ring finger protein 8), RAD51AP1 (RAD51 associated protein 1), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), POLH (DNA polymerase eta), POLE3 (DNA polymerase epsilon 3, accessory subunit), RAD51B (RAD51 paralog B), RMI1 (RecQ mediated genome instability 1), HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2), XRCC2 (X-ray repair cross complementing 2), RAD51D (RAD51 paralog D), KAT5 (lysine acetyltransferase 5), RAD9B (RAD9 checkpoint clamp component B), BRIP1 (BRCA1 interacting protein C-terminal helicase 1), BRCC3 (BRCA1/BRCA2-containing complex subunit 3), SLX4 (SLX4 structure-specific endonuclease subunit), PIAS4 (protein inhibitor of activated STAT 4), RNF168 (ring finger protein 168), UBE2V2 (ubiquitin conjugating enzyme E2 V2), CCNA1 (cyclin A1), POLE4 (DNA polymerase epsilon 4, accessory subunit), RNF4 (ring finger protein 4), PALB2 (partner and localizer of BRCA2), RPS27A (ribosomal protein S27a), GEN1 (GEN1 Holliday junction 5' flap endonuclease), EME1 (essential meiotic structure-specific endonuclease 1), BABAM1 (BRISC and BRCA1 A complex member 1), SLX1B (SLX1 homolog B, structure-specific endonuclease subunit), POLK (DNA polymerase kappa), PPP4C (protein phosphatase 4 catalytic subunit), SIRT6 (sirtuin 6), RTEL1 (regulator of telomere elongation helicase 1), PPP4R2 (protein phosphatase 4 regulatory subunit 2), EME2 (essential meiotic structure-specific endonuclease subunit 2), H2BS1 (H2B.S histone 1), H2AX (H2A.X variant histone), SPIDR (scaffold protein involved in DNA repair), H2BC4 (H2B clustered histone 4), H2BC21 (H2B clustered histone 21), RHNO1 (RAD9-HUS1-RAD1 interacting nuclear orphan 1), H4-16 (H4 histone 16), H2BC14 (H2B clustered histone 14), MRE11 (MRE11 homolog, double strand break repair nuclease), H4C15 (H4 clustered histone 15)"], "WAG002507": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), FANCD2 (FA complementation group D2), FANCG (FA complementation group G), FANCI (FA complementation group I), FANCA (FA complementation group A), FANCM (FA complementation group M), FANCL (FA complementation group L), UBE2T (ubiquitin conjugating enzyme E2 T), UBB (ubiquitin B), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), FANCB (FA complementation group B), FANCF (FA complementation group F), FANCE (FA complementation group E), FANCC (FA complementation group C), ATRIP (ATR interacting protein), ATR (ATR serine/threonine kinase), RPA1 (replication protein A1), ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), MUS81 (MUS81 structure-specific endonuclease subunit), USP1 (ubiquitin specific peptidase 1), SLX4 (SLX4 structure-specific endonuclease subunit), RPA2 (replication protein A2), RPA3 (replication protein A3), FAN1 (FANCD2 and FANCI associated nuclease 1), SLX1B (SLX1 homolog B, structure-specific endonuclease subunit), POLN (DNA polymerase nu), WDR48 (WD repeat domain 48), EME1 (essential meiotic structure-specific endonuclease 1), RPS27A (ribosomal protein S27a), EME2 (essential meiotic structure-specific endonuclease subunit 2), DCLRE1A (DNA cross-link repair 1A), DCLRE1B (DNA cross-link repair 1B), FAAP100 (FA core complex associated protein 100), CENPX (centromere protein X), FAAP24 (FA core complex associated protein 24), FAAP20 (FA core complex associated protein 20), SLX1A (SLX1 homolog A, structure-specific endonuclease subunit), CENPS (centromere protein S)"], "WAG002513": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), RBX1 (ring-box 1), CUL1 (cullin 1), SKP1 (S-phase kinase associated protein 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBE2D1 (ubiquitin conjugating enzyme E2 D1), UBE2E1 (ubiquitin conjugating enzyme E2 E1), UBB (ubiquitin B), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD14 (proteasome 26S subunit, non-ATPase 14), SKP2 (S-phase kinase associated protein 2), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA3 (proteasome 20S subunit alpha 3), PSMA2 (proteasome 20S subunit alpha 2), PSMC3 (proteasome 26S subunit, ATPase 3), PSMB5 (proteasome 20S subunit beta 5), PSMC2 (proteasome 26S subunit, ATPase 2), PSMA7 (proteasome 20S subunit alpha 7), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB2 (proteasome 20S subunit beta 2), PSMA6 (proteasome 20S subunit alpha 6), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMA4 (proteasome 20S subunit alpha 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB1 (proteasome 20S subunit beta 1), PSMB4 (proteasome 20S subunit beta 4), CUL5 (cullin 5), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB3 (proteasome 20S subunit beta 3), PSMB10 (proteasome 20S subunit beta 10), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMA1 (proteasome 20S subunit alpha 1), PSMC1 (proteasome 26S subunit, ATPase 1), PSME3 (proteasome activator subunit 3), PSMB6 (proteasome 20S subunit beta 6), PSMA5 (proteasome 20S subunit alpha 5), FZR1 (fizzy and cell division cycle 20 related 1), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMB7 (proteasome 20S subunit beta 7), UBE2D2 (ubiquitin conjugating enzyme E2 D2), PSME1 (proteasome activator subunit 1), PSMD5 (proteasome 26S subunit, non-ATPase 5), ANAPC11 (anaphase promoting complex subunit 11), CDC23 (cell division cycle 23), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME4 (proteasome activator subunit 4), CDC20 (cell division cycle 20), PSMA8 (proteasome 20S subunit alpha 8), UBE2C (ubiquitin conjugating enzyme E2 C), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB11 (proteasome subunit beta 11), ANAPC5 (anaphase promoting complex subunit 5), CDC16 (cell division cycle 16), UBE2D3 (ubiquitin conjugating enzyme E2 D3), CDC27 (cell division cycle 27), ANAPC2 (anaphase promoting complex subunit 2), ANAPC10 (anaphase promoting complex subunit 10), ANAPC1 (anaphase promoting complex subunit 1), ANAPC4 (anaphase promoting complex subunit 4), CDC26 (cell division cycle 26), ANAPC7 (anaphase promoting complex subunit 7), UBE3A (ubiquitin protein ligase E3A), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), CUL3 (cullin 3), PSME2 (proteasome activator subunit 2), TRIP12 (thyroid hormone receptor interactor 12), UBR1 (ubiquitin protein ligase E3 component n-recognin 1), UBE3C (ubiquitin protein ligase E3C), UBE2N (ubiquitin conjugating enzyme E2 N), LNPEP (leucyl and cystinyl aminopeptidase), UBE2K (ubiquitin conjugating enzyme E2 K), SEC61G (SEC61 translocon subunit gamma), BLMH (bleomycin hydrolase), TPP2 (tripeptidyl peptidase 2), SEC61B (SEC61 translocon subunit beta), UBE2L3 (ubiquitin conjugating enzyme E2 L3), UBE2E3 (ubiquitin conjugating enzyme E2 E3), RNF7 (ring finger protein 7), UBE2D4 (ubiquitin conjugating enzyme E2 D4 (putative)), UBA1 (ubiquitin like modifier activating enzyme 1), CUL2 (cullin 2), UBE2S (ubiquitin conjugating enzyme E2 S), CDC34 (cell division cycle 34, ubiqiutin conjugating enzyme), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), UBE2A (ubiquitin conjugating enzyme E2 A), CUL7 (cullin 7), FBXO6 (F-box protein 6), UBE2H (ubiquitin conjugating enzyme E2 H), NEDD4L (NEDD4 like E3 ubiquitin protein ligase), NEDD4 (NEDD4 E3 ubiquitin protein ligase), STUB1 (STIP1 homology and U-box containing protein 1), VHL (von Hippel-Lindau tumor suppressor)"], "WAG002514": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AP1G1 (adaptor related protein complex 1 subunit gamma 1), AP1B1 (adaptor related protein complex 1 subunit beta 1), AP1S1 (adaptor related protein complex 1 subunit sigma 1), AP1S2 (adaptor related protein complex 1 subunit sigma 2), ARRB1 (arrestin beta 1), HSPA8 (heat shock protein family A (Hsp70) member 8), AP1M1 (adaptor related protein complex 1 subunit mu 1), AP1M2 (adaptor related protein complex 1 subunit mu 2), DNAJC6 (DnaJ heat shock protein family (Hsp40) member C6), CLTC (clathrin heavy chain), CLINT1 (clathrin interactor 1), AP1S3 (adaptor related protein complex 1 subunit sigma 3), BLOC1S1 (biogenesis of lysosomal organelles complex 1 subunit 1), BLOC1S6 (biogenesis of lysosomal organelles complex 1 subunit 6), APP (amyloid beta precursor protein), BLOC1S3 (biogenesis of lysosomal organelles complex 1 subunit 3), DTNBP1 (dystrobrevin binding protein 1), FTH1 (ferritin heavy chain 1), TXNDC5 (thioredoxin domain containing 5), FTL (ferritin light chain), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), SH3D19 (SH3 domain containing 19), PUM1 (pumilio RNA binding family member 1), DNM2 (dynamin 2), HGS (hepatocyte growth factor-regulated tyrosine kinase substrate), AP4M1 (adaptor related protein complex 4 subunit mu 1), CLTA (clathrin light chain A), AP1G2 (adaptor related protein complex 1 subunit gamma 2), ARF1 (ADP ribosylation factor 1), CLTB (clathrin light chain B), VAMP2 (vesicle associated membrane protein 2), AP4B1 (adaptor related protein complex 4 subunit beta 1), PICALM (phosphatidylinositol binding clathrin assembly protein), TGOLN2 (trans-golgi network protein 2), SNAP23 (synaptosome associated protein 23), NAPA (NSF attachment protein alpha), SNAPIN (SNAP associated protein), AP3S1 (adaptor related protein complex 3 subunit sigma 1), STX4 (syntaxin 4), AP4E1 (adaptor related protein complex 4 subunit epsilon 1), AP3B1 (adaptor related protein complex 3 subunit beta 1), VAMP7 (vesicle associated membrane protein 7), GAK (cyclin G associated kinase), AP4S1 (adaptor related protein complex 4 subunit sigma 1), VAMP8 (vesicle associated membrane protein 8), TFRC (transferrin receptor), HIP1R (huntingtin interacting protein 1 related), SNX2 (sorting nexin 2), IGF2R (insulin like growth factor 2 receptor), M6PR (mannose-6-phosphate receptor, cation dependent), SNX5 (sorting nexin 5), OCRL (OCRL inositol polyphosphate-5-phosphatase), GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1), SNX9 (sorting nexin 9), NECAP1 (NECAP endocytosis associated 1), ACBD3 (acyl-CoA binding domain containing 3), PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha), GOLGB1 (golgin B1), RAB5C (RAB5C, member RAS oncogene family), GNS (glucosamine (N-acetyl)-6-sulfatase), TPD52L1 (TPD52 like 1), TPD52 (tumor protein D52), CHMP2A (charged multivesicular body protein 2A), YIPF6 (Yip1 domain family member 6), DNASE2 (deoxyribonuclease 2, lysosomal), TBC1D8B (TBC1 domain family member 8B), CLVS2 (clavesin 2), CLVS1 (clavesin 1), CPD (carboxypeptidase D), SORT1 (sortilin 1), CTSZ (cathepsin Z), BLOC1S4 (biogenesis of lysosomal organelles complex 1 subunit 4)"], "WAG002517": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), AKT1 (AKT serine/threonine kinase 1), SP1 (Sp1 transcription factor), CREB1 (cAMP responsive element binding protein 1), IGF1R (insulin like growth factor 1 receptor), SIN3A (SIN3 transcription regulator family member A), IGF1 (insulin like growth factor 1), MECP2 (methyl-CpG binding protein 2), YBX1 (Y-box binding protein 1), FUS (FUS RNA binding protein), E2F1 (E2F transcription factor 1), SP3 (Sp3 transcription factor), NCOR1 (nuclear receptor corepressor 1), FGF2 (fibroblast growth factor 2), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), BDNF (brain derived neurotrophic factor), MTOR (mechanistic target of rapamycin kinase), CTCF (CCCTC-binding factor), DHX9 (DExH-box helicase 9), PTEN (phosphatase and tensin homolog), HNRNPH1 (heterogeneous nuclear ribonucleoprotein H1), HNRNPF (heterogeneous nuclear ribonucleoprotein F), BCL6 (BCL6 transcription repressor), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), IGF2 (insulin like growth factor 2), CEBPD (CCAAT enhancer binding protein delta), SST (somatostatin), MEF2C (myocyte enhancer factor 2C), REST (RE1 silencing transcription factor), SMC3 (structural maintenance of chromosomes 3), RPS6 (ribosomal protein S6), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), MBP (myelin basic protein), GRIA4 (glutamate ionotropic receptor AMPA type subunit 4), NF1 (neurofibromin 1), TAF1 (TATA-box binding protein associated factor 1), TARDBP (TAR DNA binding protein), FGF3 (fibroblast growth factor 3), SGK1 (serum/glucocorticoid regulated kinase 1), MAG (myelin associated glycoprotein), FGF5 (fibroblast growth factor 5), FGF4 (fibroblast growth factor 4), GRIA3 (glutamate ionotropic receptor AMPA type subunit 3), UBE3A (ubiquitin protein ligase E3A), DLX5 (distal-less homeobox 5), MYT1 (myelin transcription factor 1), PSIP1 (PC4 and SFRS1 interacting protein 1), RBFOX1 (RNA binding fox-1 homolog 1), CNP (2',3'-cyclic nucleotide 3' phosphodiesterase), FKBP5 (FKBP prolyl isomerase 5), OPRK1 (opioid receptor kappa 1), GAD1 (glutamate decarboxylase 1), CDON (cell adhesion associated, oncogene regulated), DLX6 (distal-less homeobox 6), TET1 (tet methylcytosine dioxygenase 1), GRID1 (glutamate ionotropic receptor delta type subunit 1), TET2 (tet methylcytosine dioxygenase 2), GAMT (guanidinoacetate N-methyltransferase), PRPF38A (pre-mRNA processing factor 38A), POU4F1 (POU class 4 homeobox 1), FUT8 (fucosyltransferase 8), TAP1 (transporter 1, ATP binding cassette subfamily B member), ARHGEF26 (Rho guanine nucleotide exchange factor 26), POU3F2 (POU class 3 homeobox 2), NREP (neuronal regeneration related protein), FOXG1 (forkhead box G1), GPRIN1 (G protein regulated inducer of neurite outgrowth 1), CSRP1 (cysteine and glycine rich protein 1), GABRR2 (gamma-aminobutyric acid type A receptor subunit rho2), TET3 (tet methylcytosine dioxygenase 3), MPP1 (membrane palmitoylated protein 1), APOC2 (apolipoprotein C2)"], "WAG002518": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MBD3 (methyl-CpG binding domain protein 3), DNMT1 (DNA methyltransferase 1), IDH1 (isocitrate dehydrogenase (NADP(+)) 1), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), TET1 (tet methylcytosine dioxygenase 1), MECP2 (methyl-CpG binding protein 2), TET2 (tet methylcytosine dioxygenase 2), TET3 (tet methylcytosine dioxygenase 3), TDG (thymine DNA glycosylase)"], "WAG002522": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TP53 (tumor protein p53), EP300 (E1A binding protein p300), HDAC1 (histone deacetylase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), SIRT1 (sirtuin 1), ARNTL (aryl hydrocarbon receptor nuclear translocator like), HDAC3 (histone deacetylase 3), CLOCK (clock circadian regulator), PPARG (peroxisome proliferator activated receptor gamma), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PER2 (period circadian regulator 2), NPAS2 (neuronal PAS domain protein 2), PPARA (peroxisome proliferator activated receptor alpha), CREB1 (cAMP responsive element binding protein 1), HDAC2 (histone deacetylase 2), GSK3B (glycogen synthase kinase 3 beta), CRY1 (cryptochrome circadian regulator 1), PPARGC1A (PPARG coactivator 1 alpha), CUL1 (cullin 1), NCOA2 (nuclear receptor coactivator 2), RORA (RAR related orphan receptor A), NCOR1 (nuclear receptor corepressor 1), CDK4 (cyclin dependent kinase 4), SIN3A (SIN3 transcription regulator family member A), LEP (leptin), CRY2 (cryptochrome circadian regulator 2), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), BHLHE40 (basic helix-loop-helix family member e40), NR1D1 (nuclear receptor subfamily 1 group D member 1), MAPK8 (mitogen-activated protein kinase 8), PML (PML nuclear body scaffold), PPP1CA (protein phosphatase 1 catalytic subunit alpha), CSNK1E (casein kinase 1 epsilon), NR1D2 (nuclear receptor subfamily 1 group D member 2), SKP1 (S-phase kinase associated protein 1), PER1 (period circadian regulator 1), PER3 (period circadian regulator 3), IL6 (interleukin 6), RORC (RAR related orphan receptor C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), NMS (neuromedin S), NONO (non-POU domain containing octamer binding), ARNT (aryl hydrocarbon receptor nuclear translocator), BHLHE41 (basic helix-loop-helix family member e41), ADCY1 (adenylate cyclase 1), PPP1CC (protein phosphatase 1 catalytic subunit gamma), CSNK1D (casein kinase 1 delta), TOP1 (DNA topoisomerase I), DDX5 (DEAD-box helicase 5), NPS (neuropeptide S), SERPINE1 (serpin family E member 1), DRD4 (dopamine receptor D4), NRIP1 (nuclear receptor interacting protein 1), CRH (corticotropin releasing hormone), SREBF1 (sterol regulatory element binding transcription factor 1), SFPQ (splicing factor proline and glutamine rich), TIMELESS (timeless circadian regulator), DRD2 (dopamine receptor D2), TOP2A (DNA topoisomerase II alpha), NFIL3 (nuclear factor, interleukin 3 regulated), ADORA1 (adenosine A1 receptor), MAPK9 (mitogen-activated protein kinase 9), FBXL3 (F-box and leucine rich repeat protein 3), SUV39H1 (suppressor of variegation 3-9 homolog 1), ADORA2A (adenosine A2a receptor), PTEN (phosphatase and tensin homolog), DHX9 (DExH-box helicase 9), RELB (RELB proto-oncogene, NF-kB subunit), DRD1 (dopamine receptor D1), ATF4 (activating transcription factor 4), FBXW11 (F-box and WD repeat domain containing 11), NR1H3 (nuclear receptor subfamily 1 group H member 3), AHR (aryl hydrocarbon receptor), EGR1 (early growth response 1), CHRM1 (cholinergic receptor muscarinic 1), CREM (cAMP responsive element modulator), MTNR1A (melatonin receptor 1A), HNRNPU (heterogeneous nuclear ribonucleoprotein U), ID2 (inhibitor of DNA binding 2), NGFR (nerve growth factor receptor), MTA1 (metastasis associated 1), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), OPN4 (opsin 4), CPT1A (carnitine palmitoyltransferase 1A), TH (tyrosine hydroxylase), HNRNPD (heterogeneous nuclear ribonucleoprotein D), HEBP1 (heme binding protein 1), MTNR1B (melatonin receptor 1B), PRKDC (protein kinase, DNA-activated, catalytic subunit), PPP1CB (protein phosphatase 1 catalytic subunit beta), HCRTR1 (hypocretin receptor 1), MAPK10 (mitogen-activated protein kinase 10), GHRH (growth hormone releasing hormone), UBE3A (ubiquitin protein ligase E3A), UTS2R (urotensin 2 receptor), NOS2 (nitric oxide synthase 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), UTS2 (urotensin 2), ADIPOQ (adiponectin, C1Q and collagen domain containing)"], "WAG002524": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ID2 (inhibitor of DNA binding 2), USP1 (ubiquitin specific peptidase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), ID1 (inhibitor of DNA binding 1, HLH protein), ARCN1 (archain 1)"], "WAG002525": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPARG (peroxisome proliferator activated receptor gamma), PPARGC1A (PPARG coactivator 1 alpha), NR3C1 (nuclear receptor subfamily 3 group C member 1), CEBPB (CCAAT enhancer binding protein beta), LEP (leptin), TNF (tumor necrosis factor), IL6 (interleukin 6), RXRA (retinoid X receptor alpha), MAPK8 (mitogen-activated protein kinase 8), FOXO1 (forkhead box O1), IRS1 (insulin receptor substrate 1), CREB1 (cAMP responsive element binding protein 1), ADIPOQ (adiponectin, C1Q and collagen domain containing), IRS2 (insulin receptor substrate 2), INSR (insulin receptor), SLC2A4 (solute carrier family 2 member 4), CEBPD (CCAAT enhancer binding protein delta), CEBPA (CCAAT enhancer binding protein alpha), NRIP1 (nuclear receptor interacting protein 1), PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial), LPIN1 (lipin 1), TWIST1 (twist family bHLH transcription factor 1)"], "WAG002526": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APOB (apolipoprotein B), APOA1 (apolipoprotein A1), LPL (lipoprotein lipase), APOE (apolipoprotein E), APOC3 (apolipoprotein C3), APOA2 (apolipoprotein A2), CETP (cholesteryl ester transfer protein), APOC2 (apolipoprotein C2), LCAT (lecithin-cholesterol acyltransferase), LDLR (low density lipoprotein receptor)"], "WAG002532": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK8 (mitogen-activated protein kinase 8), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TP53 (tumor protein p53), MAPK14 (mitogen-activated protein kinase 14), TNF (tumor necrosis factor), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), BCL2 (BCL2 apoptosis regulator), CDKN1A (cyclin dependent kinase inhibitor 1A), FASLG (Fas ligand), IL6 (interleukin 6), CCND1 (cyclin D1), ATF2 (activating transcription factor 2), MAPK11 (mitogen-activated protein kinase 11), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), TRAF6 (TNF receptor associated factor 6), TNFRSF1A (TNF receptor superfamily member 1A), MAP2K6 (mitogen-activated protein kinase kinase 6), MAP2K7 (mitogen-activated protein kinase kinase 7), MAP2K3 (mitogen-activated protein kinase kinase 3), TRAF2 (TNF receptor associated factor 2), BAX (BCL2 associated X, apoptosis regulator), HSP90AA1 (heat shock protein 90 alpha family class A member 1), EGFR (epidermal growth factor receptor), BCL2L1 (BCL2 like 1), IL2 (interleukin 2), MAP2K4 (mitogen-activated protein kinase kinase 4), FAS (Fas cell surface death receptor), MAPK12 (mitogen-activated protein kinase 12), CFLAR (CASP8 and FADD like apoptosis regulator), BID (BH3 interacting domain death agonist), RB1 (RB transcriptional corepressor 1), MAPK13 (mitogen-activated protein kinase 13), BCL2L11 (BCL2 like 11), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), MMP2 (matrix metallopeptidase 2), MCL1 (MCL1 apoptosis regulator, BCL2 family member), CDKN2A (cyclin dependent kinase inhibitor 2A), IFNG (interferon gamma), CCNA2 (cyclin A2), ELK1 (ETS transcription factor ELK1), BAK1 (BCL2 antagonist/killer 1), TNFSF10 (TNF superfamily member 10), TRAF5 (TNF receptor associated factor 5), NFE2L2 (nuclear factor, erythroid 2 like 2), CCNE1 (cyclin E1), BMF (Bcl2 modifying factor), FGF7 (fibroblast growth factor 7), HBEGF (heparin binding EGF like growth factor), BCL3 (BCL3 transcription coactivator), PDGFRA (platelet derived growth factor receptor alpha)"], "WAG002533": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK14 (mitogen-activated protein kinase 14), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), NFE2L2 (nuclear factor, erythroid 2 like 2), MAPK8 (mitogen-activated protein kinase 8), NQO1 (NAD(P)H quinone dehydrogenase 1), HMOX1 (heme oxygenase 1), MAPK11 (mitogen-activated protein kinase 11), MAPK12 (mitogen-activated protein kinase 12), MAPK13 (mitogen-activated protein kinase 13), GSTP1 (glutathione S-transferase pi 1), GCLC (glutamate-cysteine ligase catalytic subunit), KEAP1 (kelch like ECH associated protein 1), GCLM (glutamate-cysteine ligase modifier subunit), ABCC3 (ATP binding cassette subfamily C member 3), ABCC2 (ATP binding cassette subfamily C member 2), ABCC4 (ATP binding cassette subfamily C member 4), ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)), EPHX1 (epoxide hydrolase 1), ABCC6 (ATP binding cassette subfamily C member 6), NQO2 (N-ribosyldihydronicotinamide:quinone reductase 2), CES1 (carboxylesterase 1), SRXN1 (sulfiredoxin 1)"], "WAG002534": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATF4 (activating transcription factor 4), HSPA5 (heat shock protein family A (Hsp70) member 5), ATF6 (activating transcription factor 6), DDIT3 (DNA damage inducible transcript 3), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), XBP1 (X-box binding protein 1), ERN1 (endoplasmic reticulum to nucleus signaling 1), HSP90B1 (heat shock protein 90 beta family member 1), CALR (calreticulin), PPP1R15A (protein phosphatase 1 regulatory subunit 15A), ATF3 (activating transcription factor 3), PDIA6 (protein disulfide isomerase family A member 6), DNAJC3 (DnaJ heat shock protein family (Hsp40) member C3), NFE2L2 (nuclear factor, erythroid 2 like 2), EDEM1 (ER degradation enhancing alpha-mannosidase like protein 1), TRIB3 (tribbles pseudokinase 3), DNAJB9 (DnaJ heat shock protein family (Hsp40) member B9), ASNS (asparagine synthetase (glutamine-hydrolyzing)), EIF2A (eukaryotic translation initiation factor 2A), ERP27 (endoplasmic reticulum protein 27), BCL2L11 (BCL2 like 11), NARS1 (asparaginyl-tRNA synthetase 1), UBE2E1 (ubiquitin conjugating enzyme E2 E1), BBC3 (BCL2 binding component 3), DNAJB11 (DnaJ heat shock protein family (Hsp40) member B11), SULT1E1 (sulfotransferase family 1E member 1), WARS1 (tryptophanyl-tRNA synthetase 1)"], "WAG002535": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HIF1A (hypoxia inducible factor 1 subunit alpha), VEGFA (vascular endothelial growth factor A), TP53 (tumor protein p53), ARNT (aryl hydrocarbon receptor nuclear translocator), BCL2L1 (BCL2 like 1), BAX (BCL2 associated X, apoptosis regulator), MCL1 (MCL1 apoptosis regulator, BCL2 family member), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), BAK1 (BCL2 antagonist/killer 1), BID (BH3 interacting domain death agonist), PKM (pyruvate kinase M1/2), PTGS2 (prostaglandin-endoperoxide synthase 2), SERPINE1 (serpin family E member 1), LDHA (lactate dehydrogenase A), BIRC5 (baculoviral IAP repeat containing 5), PGK1 (phosphoglycerate kinase 1), NOS2 (nitric oxide synthase 2), EDN1 (endothelin 1), EGLN1 (egl-9 family hypoxia inducible factor 1), IGFBP3 (insulin like growth factor binding protein 3), BCL2A1 (BCL2 related protein A1), HK1 (hexokinase 1), BNIP3L (BCL2 interacting protein 3 like), TGFA (transforming growth factor alpha), BNIP3 (BCL2 interacting protein 3), SLC2A1 (solute carrier family 2 member 1), IGFBP1 (insulin like growth factor binding protein 1), EPO (erythropoietin), TGFB3 (transforming growth factor beta 3), ANGPT1 (angiopoietin 1), ANGPT2 (angiopoietin 2), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), HIF1AN (hypoxia inducible factor 1 subunit alpha inhibitor), SLC2A3 (solute carrier family 2 member 3), IGFBP2 (insulin like growth factor binding protein 2), PFKL (phosphofructokinase, liver type), SLC16A1 (solute carrier family 16 member 1)"], "WAG002536": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NFKB1 (nuclear factor kappa B subunit 1), TNF (tumor necrosis factor), RELA (RELA proto-oncogene, NF-kB subunit), IL6 (interleukin 6), IL1B (interleukin 1 beta), VEGFA (vascular endothelial growth factor A), IL1A (interleukin 1 alpha), ICAM1 (intercellular adhesion molecule 1), CSF2 (colony stimulating factor 2), PTGS2 (prostaglandin-endoperoxide synthase 2), CD40LG (CD40 ligand), NFKB2 (nuclear factor kappa B subunit 2), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TNFRSF1A (TNF receptor superfamily member 1A), VCAM1 (vascular cell adhesion molecule 1), TRAF6 (TNF receptor associated factor 6), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), BIRC3 (baculoviral IAP repeat containing 3), MMP9 (matrix metallopeptidase 9), REL (REL proto-oncogene, NF-kB subunit), BIRC2 (baculoviral IAP repeat containing 2), IL2 (interleukin 2), SELE (selectin E), MMP1 (matrix metallopeptidase 1), RELB (RELB proto-oncogene, NF-kB subunit), MMP2 (matrix metallopeptidase 2), CCND1 (cyclin D1), BIRC5 (baculoviral IAP repeat containing 5), MMP3 (matrix metallopeptidase 3), CFLAR (CASP8 and FADD like apoptosis regulator), CXCL2 (C-X-C motif chemokine ligand 2), BCL2A1 (BCL2 related protein A1), BCL2L2 (BCL2 like 2), CXCL8 (C-X-C motif chemokine ligand 8), EGLN2 (egl-9 family hypoxia inducible factor 2)"], "WAG002537": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), TGFB1 (transforming growth factor beta 1), IL6 (interleukin 6), IL1B (interleukin 1 beta), CCL2 (C-C motif chemokine ligand 2), FGF2 (fibroblast growth factor 2), EGF (epidermal growth factor), IL4 (interleukin 4), MMP9 (matrix metallopeptidase 9), CSF2 (colony stimulating factor 2), IGF1 (insulin like growth factor 1), HGF (hepatocyte growth factor), CCL3 (C-C motif chemokine ligand 3), CCR3 (C-C motif chemokine receptor 3), MMP2 (matrix metallopeptidase 2), PLAU (plasminogen activator, urokinase), TIMP1 (TIMP metallopeptidase inhibitor 1), IL13 (interleukin 13), CCL4 (C-C motif chemokine ligand 4), EDN1 (endothelin 1), FGF1 (fibroblast growth factor 1), CCL5 (C-C motif chemokine ligand 5), CCL11 (C-C motif chemokine ligand 11), SPP1 (secreted phosphoprotein 1), FGF7 (fibroblast growth factor 7), CCR2 (C-C motif chemokine receptor 2), HMOX1 (heme oxygenase 1), IL5 (interleukin 5), CXCL2 (C-X-C motif chemokine ligand 2), CSF3 (colony stimulating factor 3), ELN (elastin), SMAD7 (SMAD family member 7), BMP7 (bone morphogenetic protein 7), TGFA (transforming growth factor alpha), PDGFB (platelet derived growth factor subunit B), IL12B (interleukin 12B), SERPINA1 (serpin family A member 1), MUC5B (mucin 5B, oligomeric mucus/gel-forming), SFTPC (surfactant protein C), CEBPB (CCAAT enhancer binding protein beta), CALCA (calcitonin related polypeptide alpha), SFTPA2 (surfactant protein A2), SFTPA1 (surfactant protein A1), PDGFA (platelet derived growth factor subunit A), NFE2L2 (nuclear factor, erythroid 2 like 2), PTX3 (pentraxin 3), CMA1 (chymase 1), GREM1 (gremlin 1, DAN family BMP antagonist), TERT (telomerase reverse transcriptase), MT2A (metallothionein 2A), CYSLTR2 (cysteinyl leukotriene receptor 2), SKIL (SKI like proto-oncogene), ELMOD2 (ELMO domain containing 2), RTEL1 (regulator of telomere elongation helicase 1), FAM13A (family with sequence similarity 13 member A), DPP9 (dipeptidyl peptidase 9), STN1 (STN1 subunit of CST complex), ATP11A (ATPase phospholipid transporting 11A), CXCL8 (C-X-C motif chemokine ligand 8), MECP2 (methyl-CpG binding protein 2), DSP (desmoplakin), PARN (poly(A)-specific ribonuclease), CCN2 (cellular communication network factor 2)"], "WAG002539": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), GSK3B (glycogen synthase kinase 3 beta), AXIN1 (axin 1), DVL2 (dishevelled segment polarity protein 2), DVL1 (dishevelled segment polarity protein 1), DVL3 (dishevelled segment polarity protein 3), APC (APC regulator of WNT signaling pathway), AKT1 (AKT serine/threonine kinase 1), MYC (MYC proto-oncogene, bHLH transcription factor), MAPK1 (mitogen-activated protein kinase 1), GSK3A (glycogen synthase kinase 3 alpha), CCND1 (cyclin D1), AXIN2 (axin 2), RAC1 (Rac family small GTPase 1), MAPK8 (mitogen-activated protein kinase 8), LRP6 (LDL receptor related protein 6), LEF1 (lymphoid enhancer binding factor 1), TCF7L2 (transcription factor 7 like 2), CSNK1A1 (casein kinase 1 alpha 1), CSNK1E (casein kinase 1 epsilon), PRKCA (protein kinase C alpha), RHOA (ras homolog family member A), CSNK1D (casein kinase 1 delta), MTOR (mechanistic target of rapamycin kinase), CTBP1 (C-terminal binding protein 1), PRKCB (protein kinase C beta), GJA1 (gap junction protein alpha 1), TSC2 (TSC complex subunit 2), TCF4 (transcription factor 4), FRAT1 (FRAT regulator of WNT signaling pathway 1), MAPK9 (mitogen-activated protein kinase 9), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CSNK1G1 (casein kinase 1 gamma 1), TCF3 (transcription factor 3), ARRB2 (arrestin beta 2), TSC1 (TSC complex subunit 1), NLK (nemo like kinase), PRKCG (protein kinase C gamma), PPARG (peroxisome proliferator activated receptor gamma), PI4K2A (phosphatidylinositol 4-kinase type 2 alpha), CDK6 (cyclin dependent kinase 6), NFATC2 (nuclear factor of activated T cells 2), ROR2 (receptor tyrosine kinase like orphan receptor 2), LRP5 (LDL receptor related protein 5), RYK (receptor like tyrosine kinase), BCL9 (BCL9 transcription coactivator), PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta), SOX1 (SRY-box transcription factor 1), ROR1 (receptor tyrosine kinase like orphan receptor 1), TEK (TEK receptor tyrosine kinase), GCKR (glucokinase regulator)"], "WAG002542": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT2 (AKT serine/threonine kinase 2), RPS6KB1 (ribosomal protein S6 kinase B1), MTOR (mechanistic target of rapamycin kinase), IRS1 (insulin receptor substrate 1), INSR (insulin receptor), SLC2A4 (solute carrier family 2 member 4), RPS6 (ribosomal protein S6), TBC1D4 (TBC1 domain family member 4)"], "WAG002543": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT2 (AKT serine/threonine kinase 2), RPS6KB1 (ribosomal protein S6 kinase B1), MTOR (mechanistic target of rapamycin kinase), IRS1 (insulin receptor substrate 1), INSR (insulin receptor), SLC2A4 (solute carrier family 2 member 4), RPS6 (ribosomal protein S6), TBC1D4 (TBC1 domain family member 4)"], "WAG002544": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT3 (signal transducer and activator of transcription 3), MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), JAK1 (Janus kinase 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), AKT1 (AKT serine/threonine kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), JAK2 (Janus kinase 2), MAPK3 (mitogen-activated protein kinase 3), IL6 (interleukin 6), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PRKCD (protein kinase C delta), SHC1 (SHC adaptor protein 1), IL6ST (interleukin 6 signal transducer), VAV1 (vav guanine nucleotide exchange factor 1), STAT1 (signal transducer and activator of transcription 1), MAP2K1 (mitogen-activated protein kinase kinase 1), RAC1 (Rac family small GTPase 1), HCK (HCK proto-oncogene, Src family tyrosine kinase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), IL6R (interleukin 6 receptor), TYK2 (tyrosine kinase 2), GAB1 (GRB2 associated binding protein 1), CREBBP (CREB binding protein), SOCS3 (suppressor of cytokine signaling 3), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), BCL2L1 (BCL2 like 1), RPS6KB1 (ribosomal protein S6 kinase B1), MAP2K2 (mitogen-activated protein kinase kinase 2), MAP2K4 (mitogen-activated protein kinase kinase 4), BAD (BCL2 associated agonist of cell death), NCOA1 (nuclear receptor coactivator 1), IRF1 (interferon regulatory factor 1), GSK3B (glycogen synthase kinase 3 beta), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), CRP (C-reactive protein), AGT (angiotensinogen), HDAC1 (histone deacetylase 1), TIMP1 (TIMP metallopeptidase inhibitor 1), NLK (nemo like kinase), VIP (vasoactive intestinal peptide), NR2F6 (nuclear receptor subfamily 2 group F member 6), PRDM1 (PR/SET domain 1)"], "WAG002545": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYC (MYC proto-oncogene, bHLH transcription factor), KIT (KIT proto-oncogene, receptor tyrosine kinase), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), PDGFRB (platelet derived growth factor receptor beta), BCR (BCR activator of RhoGEF and GTPase), SKP2 (S-phase kinase associated protein 2), CDKN1B (cyclin dependent kinase inhibitor 1B), PIM1 (Pim-1 proto-oncogene, serine/threonine kinase), FOXO3 (forkhead box O3), ABCB1 (ATP binding cassette subfamily B member 1), CSF1R (colony stimulating factor 1 receptor), GADD45A (growth arrest and DNA damage inducible alpha), PDGFRA (platelet derived growth factor receptor alpha), GAB2 (GRB2 associated binding protein 2), ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)), SPRED2 (sprouty related EVH1 domain containing 2), FLT1 (fms related receptor tyrosine kinase 1), PIM2 (Pim-2 proto-oncogene, serine/threonine kinase), LYL1 (LYL1 basic helix-loop-helix family member), NOP2 (NOP2 nucleolar protein)"], "WAG002548": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), TP53 (tumor protein p53), STAT3 (signal transducer and activator of transcription 3), MYC (MYC proto-oncogene, bHLH transcription factor), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), VEGFA (vascular endothelial growth factor A), MAPK3 (mitogen-activated protein kinase 3), CCND1 (cyclin D1), TGFB1 (transforming growth factor beta 1), IL6 (interleukin 6), MAPK8 (mitogen-activated protein kinase 8), MAPK14 (mitogen-activated protein kinase 14), RAC1 (Rac family small GTPase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), CASP3 (caspase 3), BRCA1 (BRCA1 DNA repair associated), BIRC5 (baculoviral IAP repeat containing 5), SMAD4 (SMAD family member 4), SMAD3 (SMAD family member 3), NFKB1 (nuclear factor kappa B subunit 1), CD44 (CD44 molecule (Indian blood group)), GRB2 (growth factor receptor bound protein 2), FASLG (Fas ligand), HIF1A (hypoxia inducible factor 1 subunit alpha), PTGS2 (prostaglandin-endoperoxide synthase 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), BCL2L1 (BCL2 like 1), JAK1 (Janus kinase 1), CASP9 (caspase 9), NOS2 (nitric oxide synthase 2), MMP1 (matrix metallopeptidase 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CASP7 (caspase 7), BIRC3 (baculoviral IAP repeat containing 3), TGFBR1 (transforming growth factor beta receptor 1), IL6R (interleukin 6 receptor), VAV2 (vav guanine nucleotide exchange factor 2), HNF1A (HNF1 homeobox A), LEF1 (lymphoid enhancer binding factor 1), RRM2 (ribonucleotide reductase regulatory subunit M2), CTTN (cortactin), E2F2 (E2F transcription factor 2), UCHL1 (ubiquitin C-terminal hydrolase L1), COL4A2 (collagen type IV alpha 2 chain), CXCR1 (C-X-C motif chemokine receptor 1), PODXL (podocalyxin like), MIR24-1 (microRNA 24-1), MYOF (myoferlin), MIR34A (microRNA 34a), MIR24-2 (microRNA 24-2), MIR92A2 (microRNA 92a-2), MIR744 (microRNA 744), MIR155 (microRNA 155), MIR92A1 (microRNA 92a-1), FRZB (frizzled related protein), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002549": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYC (MYC proto-oncogene, bHLH transcription factor), TP53 (tumor protein p53), CREBBP (CREB binding protein), EP300 (E1A binding protein p300), BRCA1 (BRCA1 DNA repair associated), AKT1 (AKT serine/threonine kinase 1), NOTCH1 (notch receptor 1), CTBP1 (C-terminal binding protein 1), ATM (ATM serine/threonine kinase), PTEN (phosphatase and tensin homolog), MAX (MYC associated factor X), SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MYB (MYB proto-oncogene, transcription factor), CHEK1 (checkpoint kinase 1), FOXO3 (forkhead box O3), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), ERBB2 (erb-b2 receptor tyrosine kinase 2), PRKDC (protein kinase, DNA-activated, catalytic subunit), HRAS (HRas proto-oncogene, GTPase), NCOR1 (nuclear receptor corepressor 1), SMC1A (structural maintenance of chromosomes 1A), CEBPA (CCAAT enhancer binding protein alpha), FBXW7 (F-box and WD repeat domain containing 7), CHEK2 (checkpoint kinase 2), KAT6A (lysine acetyltransferase 6A), MYCN (MYCN proto-oncogene, bHLH transcription factor), MAML3 (mastermind like transcriptional coactivator 3), ARID1A (AT-rich interaction domain 1A), SRCAP (Snf2 related CREBBP activator protein), MYBL1 (MYB proto-oncogene like 1), KANSL1 (KAT8 regulatory NSL complex subunit 1), SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1), FOXP2 (forkhead box P2), MAP2K2 (mitogen-activated protein kinase kinase 2), MGA (MAX dimerization protein MGA), ARID5B (AT-rich interaction domain 5B), TLK1 (tousled like kinase 1), FGFR4 (fibroblast growth factor receptor 4), FGF16 (fibroblast growth factor 16), UHRF1 (ubiquitin like with PHD and ring finger domains 1), ATRX (ATRX chromatin remodeler), BCORL1 (BCL6 corepressor like 1), MYCBP (MYC binding protein), MAGI2 (membrane associated guanylate kinase, WW and PDZ domain containing 2), CNTN6 (contactin 6), MAGI1 (membrane associated guanylate kinase, WW and PDZ domain containing 1), ARID4B (AT-rich interaction domain 4B), DTX4 (deltex E3 ubiquitin ligase 4), INSRR (insulin receptor related receptor), BRD1 (bromodomain containing 1), KMT2C (lysine methyltransferase 2C), NFIB (nuclear factor I B), IL17RD (interleukin 17 receptor D), CMTR2 (cap methyltransferase 2), H1-4 (H1.4 linker histone, cluster member), NSD1 (nuclear receptor binding SET domain protein 1), MORF4L1 (mortality factor 4 like 1), H2AC16 (H2A clustered histone 16), JMJD1C (jumonji domain containing 1C), ERBIN (erbb2 interacting protein), KDM6B (lysine demethylase 6B), SETD2 (SET domain containing 2, histone lysine methyltransferase), BCOR (BCL6 corepressor), KDM6A (lysine demethylase 6A)"], "WAG002553": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), LRP6 (LDL receptor related protein 6), LEF1 (lymphoid enhancer binding factor 1), GSK3B (glycogen synthase kinase 3 beta), APC (APC regulator of WNT signaling pathway), MYC (MYC proto-oncogene, bHLH transcription factor), AXIN2 (axin 2), WNT1 (Wnt family member 1), CCND1 (cyclin D1), JUP (junction plakoglobin), RARA (retinoic acid receptor alpha), DKK1 (dickkopf WNT signaling pathway inhibitor 1), LRP5 (LDL receptor related protein 5), AKT1 (AKT serine/threonine kinase 1), PML (PML nuclear body scaffold), TCF3 (transcription factor 3), CSNK1A1 (casein kinase 1 alpha 1), ZBTB16 (zinc finger and BTB domain containing 16), RUNX1T1 (RUNX1 partner transcriptional co-repressor 1), PPARD (peroxisome proliferator activated receptor delta), FZD6 (frizzled class receptor 6), WIF1 (WNT inhibitory factor 1), FLT3 (fms related receptor tyrosine kinase 3), PYGO1 (pygopus family PHD finger 1), BCL9 (BCL9 transcription coactivator), SALL4 (spalt like transcription factor 4)"], "WAG002554": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), SMAD2 (SMAD family member 2), MAPK1 (mitogen-activated protein kinase 1), EP300 (E1A binding protein p300), MYC (MYC proto-oncogene, bHLH transcription factor), TP53 (tumor protein p53), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TGFB1 (transforming growth factor beta 1), AKT1 (AKT serine/threonine kinase 1), MAPK14 (mitogen-activated protein kinase 14), SMAD7 (SMAD family member 7), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK8 (mitogen-activated protein kinase 8), HDAC1 (histone deacetylase 1), CCND1 (cyclin D1), APP (amyloid beta precursor protein), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), TGFBR1 (transforming growth factor beta receptor 1), TGFBR2 (transforming growth factor beta receptor 2), CREBBP (CREB binding protein), SP1 (Sp1 transcription factor), PML (PML nuclear body scaffold), CDKN1A (cyclin dependent kinase inhibitor 1A), FN1 (fibronectin 1), GRB2 (growth factor receptor bound protein 2), RAC1 (Rac family small GTPase 1), CDC42 (cell division cycle 42), SUMO1 (small ubiquitin like modifier 1), TRAF6 (TNF receptor associated factor 6), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CAV1 (caveolin 1), MAP2K1 (mitogen-activated protein kinase kinase 1), PTK2 (protein tyrosine kinase 2), AXIN1 (axin 1), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), ATF2 (activating transcription factor 2), SHC1 (SHC adaptor protein 1), MAPK9 (mitogen-activated protein kinase 9), UBE2I (ubiquitin conjugating enzyme E2 I), CDK1 (cyclin dependent kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), COPS5 (COP9 signalosome subunit 5), ITCH (itchy E3 ubiquitin protein ligase), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), RUNX2 (RUNX family transcription factor 2), MET (MET proto-oncogene, receptor tyrosine kinase), ITGB1 (integrin subunit beta 1), MAP2K4 (mitogen-activated protein kinase kinase 4), ETS1 (ETS proto-oncogene 1, transcription factor), ITGB4 (integrin subunit beta 4), MAP2K3 (mitogen-activated protein kinase kinase 3), RHOA (ras homolog family member A), CUL1 (cullin 1), TFDP1 (transcription factor Dp-1), SIN3A (SIN3 transcription regulator family member A), RBL2 (RB transcriptional corepressor like 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), SNW1 (SNW domain containing 1), SKP1 (S-phase kinase associated protein 1), SKI (SKI proto-oncogene), ATF3 (activating transcription factor 3), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), SKIL (SKI like proto-oncogene), RBL1 (RB transcriptional corepressor like 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), RBX1 (ring-box 1), COL1A2 (collagen type I alpha 2 chain), MAP2K6 (mitogen-activated protein kinase kinase 6), MMP1 (matrix metallopeptidase 1), PIAS2 (protein inhibitor of activated STAT 2), PAK2 (p21 (RAC1) activated kinase 2), DAB2 (DAB adaptor protein 2), PIAS1 (protein inhibitor of activated STAT 1), SPTBN1 (spectrin beta, non-erythrocytic 1), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), HGS (hepatocyte growth factor-regulated tyrosine kinase substrate), ITGB3 (integrin subunit beta 3), E2F5 (E2F transcription factor 5), BCAR1 (BCAR1 scaffold protein, Cas family member), E2F4 (E2F transcription factor 4), MEF2C (myocyte enhancer factor 2C), TERT (telomerase reverse transcriptase), YAP1 (Yes1 associated transcriptional regulator), MEF2A (myocyte enhancer factor 2A), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), ZFYVE9 (zinc finger FYVE-type containing 9), SNIP1 (Smad nuclear interacting protein 1), TGIF1 (TGFB induced factor homeobox 1), WWP1 (WW domain containing E3 ubiquitin protein ligase 1), NEDD4L (NEDD4 like E3 ubiquitin protein ligase), RNF111 (ring finger protein 111), ROCK1 (Rho associated coiled-coil containing protein kinase 1), THBS1 (thrombospondin 1), KLF10 (Kruppel like factor 10), STRAP (serine/threonine kinase receptor associated protein), CDKN2B (cyclin dependent kinase inhibitor 2B)"], "WAG002557": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), SMAD2 (SMAD family member 2), MAPK1 (mitogen-activated protein kinase 1), TGFBR1 (transforming growth factor beta receptor 1), MAPK14 (mitogen-activated protein kinase 14), TGFBR2 (transforming growth factor beta receptor 2), MAPK8 (mitogen-activated protein kinase 8), MAPK3 (mitogen-activated protein kinase 3), SHC1 (SHC adaptor protein 1), ENG (endoglin), RUNX2 (RUNX family transcription factor 2), TGFBR3 (transforming growth factor beta receptor 3), FBN1 (fibrillin 1), FBN2 (fibrillin 2), ANGPT2 (angiopoietin 2), SERPINE1 (serpin family E member 1), LTBP1 (latent transforming growth factor beta binding protein 1), FLNA (filamin A), AGTR1 (angiotensin II receptor type 1), POSTN (periostin), LTBP2 (latent transforming growth factor beta binding protein 2), NR2C2 (nuclear receptor subfamily 2 group C member 2), FBN3 (fibrillin 3), CCN2 (cellular communication network factor 2)"], "WAG002558": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COL2A1 (collagen type II alpha 1 chain), LOXL4 (lysyl oxidase like 4), FN1 (fibronectin 1), TGFB1 (transforming growth factor beta 1), PKD1 (polycystin 1, transient receptor potential channel interacting), ECSIT (ECSIT signaling integrator), CDC37 (cell division cycle 37, HSP90 cochaperone), BMP2 (bone morphogenetic protein 2), EXOC6 (exocyst complex component 6), NFE2L2 (nuclear factor, erythroid 2 like 2), ANXA5 (annexin A5), SUV39H1 (suppressor of variegation 3-9 homolog 1), NQO1 (NAD(P)H quinone dehydrogenase 1), SIRT1 (sirtuin 1), FGF7 (fibroblast growth factor 7), DDR1 (discoidin domain receptor tyrosine kinase 1), NRF1 (nuclear respiratory factor 1), IGFBP7 (insulin like growth factor binding protein 7)"], "WAG002560": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SHH (sonic hedgehog signaling molecule), SMAD2 (SMAD family member 2), GLI3 (GLI family zinc finger 3), TGIF1 (TGFB induced factor homeobox 1), NKX2-1 (NK2 homeobox 1), NODAL (nodal growth differentiation factor), FGF8 (fibroblast growth factor 8), TGIF2 (TGFB induced factor homeobox 2), FOXG1 (forkhead box G1)"], "WAG002561": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), AKT1 (AKT serine/threonine kinase 1), HRAS (HRas proto-oncogene, GTPase), SHC1 (SHC adaptor protein 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PLCG1 (phospholipase C gamma 1), MAP2K1 (mitogen-activated protein kinase kinase 1), MTOR (mechanistic target of rapamycin kinase), NRAS (NRAS proto-oncogene, GTPase), GAB2 (GRB2 associated binding protein 2), RPS6KB1 (ribosomal protein S6 kinase B1), RPS6KA1 (ribosomal protein S6 kinase A1), GAB1 (GRB2 associated binding protein 1), KRAS (KRAS proto-oncogene, GTPase), CREB1 (cAMP responsive element binding protein 1), TSC2 (TSC complex subunit 2), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), BDNF (brain derived neurotrophic factor), RHEB (Ras homolog, mTORC1 binding), TSC1 (TSC complex subunit 1), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), NTRK2 (neurotrophic receptor tyrosine kinase 2), DLG4 (discs large MAGUK scaffold protein 4), EEF2K (eukaryotic elongation factor 2 kinase), ARC (activity regulated cytoskeleton associated protein), MKNK1 (MAPK interacting serine/threonine kinase 1), TRPC3 (transient receptor potential cation channel subfamily C member 3), HOMER1 (homer scaffold protein 1), ADCY1 (adenylate cyclase 1), TRPC6 (transient receptor potential cation channel subfamily C member 6)"], "WAG002562": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), CXCR4 (C-X-C motif chemokine receptor 4), NOTCH1 (notch receptor 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), VCAM1 (vascular cell adhesion molecule 1), VHL (von Hippel-Lindau tumor suppressor), LEF1 (lymphoid enhancer binding factor 1), EPAS1 (endothelial PAS domain protein 1), TCF7L2 (transcription factor 7 like 2), TNC (tenascin C), JAG1 (jagged canonical Notch ligand 1), TCF7 (transcription factor 7), POSTN (periostin), WNT2 (Wnt family member 2), CYTIP (cytohesin 1 interacting protein), TCF7L1 (transcription factor 7 like 1)"], "WAG002563": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), RYR2 (ryanodine receptor 2), PLCB1 (phospholipase C beta 1), RYR1 (ryanodine receptor 1), RYR3 (ryanodine receptor 3), GNAQ (G protein subunit alpha q), TRPC1 (transient receptor potential cation channel subfamily C member 1), CD38 (CD38 molecule), GNAI1 (G protein subunit alpha i1), CCK (cholecystokinin), CCKBR (cholecystokinin B receptor), CNR1 (cannabinoid receptor 1), DAGLA (diacylglycerol lipase alpha)"], "WAG002565": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), EGFR (epidermal growth factor receptor), MAPK1 (mitogen-activated protein kinase 1), PLCG1 (phospholipase C gamma 1), GRB2 (growth factor receptor bound protein 2), ERBB2 (erb-b2 receptor tyrosine kinase 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CTNNB1 (catenin beta 1), DVL1 (dishevelled segment polarity protein 1), SHC1 (SHC adaptor protein 1), PTK2 (protein tyrosine kinase 2), PAK1 (p21 (RAC1) activated kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAPK8 (mitogen-activated protein kinase 8), MAP2K1 (mitogen-activated protein kinase kinase 1), FN1 (fibronectin 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CBL (Cbl proto-oncogene), RHOA (ras homolog family member A), PPP2CA (protein phosphatase 2 catalytic subunit alpha), MYC (MYC proto-oncogene, bHLH transcription factor), FZD5 (frizzled class receptor 5), ACTA1 (actin alpha 1, skeletal muscle), NCK1 (NCK adaptor protein 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), GSK3B (glycogen synthase kinase 3 beta), CDKN1A (cyclin dependent kinase inhibitor 1A), FZD1 (frizzled class receptor 1), CDKN1B (cyclin dependent kinase inhibitor 1B), FZD2 (frizzled class receptor 2), AXIN1 (axin 1), STAT5A (signal transducer and activator of transcription 5A), FZD7 (frizzled class receptor 7), WNT11 (Wnt family member 11), FZD10 (frizzled class receptor 10), FZD4 (frizzled class receptor 4), ERBB4 (erb-b2 receptor tyrosine kinase 4), FZD8 (frizzled class receptor 8), FZD6 (frizzled class receptor 6), WNT16 (Wnt family member 16), FZD9 (frizzled class receptor 9), PFN1 (profilin 1), APC (APC regulator of WNT signaling pathway), MAP2K4 (mitogen-activated protein kinase kinase 4), MYLK (myosin light chain kinase), ELK1 (ETS transcription factor ELK1), ROCK2 (Rho associated coiled-coil containing protein kinase 2), ACTR3 (actin related protein 3), FZD3 (frizzled class receptor 3), PFN4 (profilin family member 4), ACTR2 (actin related protein 2), PFN2 (profilin 2), TGFA (transforming growth factor alpha), DAAM1 (dishevelled associated activator of morphogenesis 1), NEFM (neurofilament medium), TMSB4X (thymosin beta 4 X-linked), NEFH (neurofilament heavy), CAMK1 (calcium/calmodulin dependent protein kinase I), NOS1 (nitric oxide synthase 1), MYL1 (myosin light chain 1), NEFL (neurofilament light), SOD1 (superoxide dismutase 1), PFN3 (profilin 3), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), GPX1 (glutathione peroxidase 1)"], "WAG002571": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MANBA (mannosidase beta), MAN2C1 (mannosidase alpha class 2C member 1), MAN2B1 (mannosidase alpha class 2B member 1), MAN2B2 (mannosidase alpha class 2B member 2)"], "WAG002572": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP153 (nucleoporin 153), NUP85 (nucleoporin 85), NUP93 (nucleoporin 93), NUP205 (nucleoporin 205), NUP155 (nucleoporin 155), NUP210 (nucleoporin 210), NUP214 (nucleoporin 214), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), TPR (translocated promoter region, nuclear basket protein), NUP188 (nucleoporin 188), NUP35 (nucleoporin 35), NUP107 (nucleoporin 107), NUP133 (nucleoporin 133), NUP88 (nucleoporin 88), RAE1 (ribonucleic acid export 1), AAAS (aladin WD repeat nucleoporin), NUP160 (nucleoporin 160), NUP50 (nucleoporin 50), NUP37 (nucleoporin 37), RANBP2 (RAN binding protein 2), NUP54 (nucleoporin 54), SUMO1 (small ubiquitin like modifier 1), SUMO2 (small ubiquitin like modifier 2), RNF2 (ring finger protein 2), CBX4 (chromobox 4), UBE2I (ubiquitin conjugating enzyme E2 I), POM121 (POM121 transmembrane nucleoporin), BMI1 (BMI1 proto-oncogene, polycomb ring finger), PCGF2 (polycomb group ring finger 2), PHC1 (polyhomeotic homolog 1), PHC3 (polyhomeotic homolog 3), CBX8 (chromobox 8), PHC2 (polyhomeotic homolog 2), RING1 (ring finger protein 1), CBX2 (chromobox 2), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), HNRNPK (heterogeneous nuclear ribonucleoprotein K), HNRNPC (heterogeneous nuclear ribonucleoprotein C), NOP58 (NOP58 ribonucleoprotein), NUP42 (nucleoporin 42), NDC1 (NDC1 transmembrane nucleoporin)"], "WAG002573": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TTN (titin), MYL1 (myosin light chain 1), MYL4 (myosin light chain 4), TNNT2 (troponin T2, cardiac type), ACTN2 (actinin alpha 2), NEB (nebulin), MYL3 (myosin light chain 3), MYBPC3 (myosin binding protein C3), TPM1 (tropomyosin 1), TNNI2 (troponin I2, fast skeletal type), TNNI3 (troponin I3, cardiac type), MYBPC2 (myosin binding protein C2), MYBPC1 (myosin binding protein C1), TNNT3 (troponin T3, fast skeletal type), TPM3 (tropomyosin 3), TNNT1 (troponin T1, slow skeletal type), TNNC2 (troponin C2, fast skeletal type), TNNI1 (troponin I1, slow skeletal type), MYL2 (myosin light chain 2), TMOD1 (tropomodulin 1), DES (desmin), MYH3 (myosin heavy chain 3), TCAP (titin-cap), DMD (dystrophin), TPM4 (tropomyosin 4), TPM2 (tropomyosin 2), VIM (vimentin), MYH6 (myosin heavy chain 6), TNNC1 (troponin C1, slow skeletal and cardiac type), MYH8 (myosin heavy chain 8), TMOD4 (tropomodulin 4), TMOD2 (tropomodulin 2), ACTN3 (actinin alpha 3), TMOD3 (tropomodulin 3)"], "WAG002574": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RPS7 (ribosomal protein S7), RPS15A (ribosomal protein S15a), RPL4 (ribosomal protein L4), RPS5 (ribosomal protein S5), RPS8 (ribosomal protein S8), RPS24 (ribosomal protein S24), RPS3 (ribosomal protein S3), RPL30 (ribosomal protein L30), RPL19 (ribosomal protein L19), RPLP0 (ribosomal protein lateral stalk subunit P0), RPL3 (ribosomal protein L3), RPL11 (ribosomal protein L11), RPS13 (ribosomal protein S13), RPS4X (ribosomal protein S4 X-linked), RPS9 (ribosomal protein S9), RPS3A (ribosomal protein S3A), RPL7A (ribosomal protein L7a), RPS16 (ribosomal protein S16), RPL8 (ribosomal protein L8), RPL18A (ribosomal protein L18a), RPS17 (ribosomal protein S17), RPS11 (ribosomal protein S11), RPL7 (ribosomal protein L7), RPL6 (ribosomal protein L6), RPS6 (ribosomal protein S6), RPL18 (ribosomal protein L18), RPL35 (ribosomal protein L35), RPS14 (ribosomal protein S14), RPL10A (ribosomal protein L10a), RPS18 (ribosomal protein S18), RPL27 (ribosomal protein L27), RPL27A (ribosomal protein L27a), RPL13A (ribosomal protein L13a), RPL13 (ribosomal protein L13), RPL12 (ribosomal protein L12), RPL23 (ribosomal protein L23), RPL36 (ribosomal protein L36), RPL15 (ribosomal protein L15), RPL31 (ribosomal protein L31), RPL10 (ribosomal protein L10), RPS20 (ribosomal protein S20), RPS15 (ribosomal protein S15), RPL37A (ribosomal protein L37a), RPS21 (ribosomal protein S21), RPL26 (ribosomal protein L26), RPS19 (ribosomal protein S19), RPL24 (ribosomal protein L24), RPL38 (ribosomal protein L38), RPS23 (ribosomal protein S23), RPL14 (ribosomal protein L14), RPS10 (ribosomal protein S10), RPL37 (ribosomal protein L37), RPS29 (ribosomal protein S29), RPL17 (ribosomal protein L17), RPL29 (ribosomal protein L29), RPSA (ribosomal protein SA), RPL34 (ribosomal protein L34), RPS12 (ribosomal protein S12), RPL39 (ribosomal protein L39), RPS25 (ribosomal protein S25), RPS2 (ribosomal protein S2), RPL21 (ribosomal protein L21), RPL35A (ribosomal protein L35a), RPLP2 (ribosomal protein lateral stalk subunit P2), RPL22 (ribosomal protein L22), RPL28 (ribosomal protein L28), RPS27 (ribosomal protein S27), RPL32 (ribosomal protein L32), RPLP1 (ribosomal protein lateral stalk subunit P1), RPS28 (ribosomal protein S28), RPL23A (ribosomal protein L23a), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), FAU (FAU ubiquitin like and ribosomal protein S30 fusion), RPL41 (ribosomal protein L41), RPS4Y1 (ribosomal protein S4 Y-linked 1), RPL3L (ribosomal protein L3 like), RPS27A (ribosomal protein S27a), RPS26 (ribosomal protein S26), RPL10L (ribosomal protein L10 like), NOP56 (NOP56 ribonucleoprotein), RPL26L1 (ribosomal protein L26 like 1), BYSL (bystin like), PES1 (pescadillo ribosomal biogenesis factor 1), PWP2 (PWP2 small subunit processome component), RPL36A (ribosomal protein L36a), HEATR1 (HEAT repeat containing 1), NOP58 (NOP58 ribonucleoprotein), KRR1 (KRR1 small subunit processome component homolog), UTP6 (UTP6 small subunit processome component), RPL39L (ribosomal protein L39 like), IMP4 (IMP U3 small nucleolar ribonucleoprotein 4), FBL (fibrillarin), TSR1 (TSR1 ribosome maturation factor), MPHOSPH10 (M-phase phosphoprotein 10), RPL36AL (ribosomal protein L36a like), RPS27L (ribosomal protein S27 like), RBM28 (RNA binding motif protein 28), NOL6 (nucleolar protein 6), NOC4L (nucleolar complex associated 4 homolog), PDCD11 (programmed cell death 11)"], "WAG002576": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP153 (nucleoporin 153), NUP155 (nucleoporin 155), NUP214 (nucleoporin 214), NUP93 (nucleoporin 93), RANBP2 (RAN binding protein 2), NUP210 (nucleoporin 210), NUP85 (nucleoporin 85), NUP205 (nucleoporin 205), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), NUP107 (nucleoporin 107), TPR (translocated promoter region, nuclear basket protein), NUP188 (nucleoporin 188), NUP35 (nucleoporin 35), NUP133 (nucleoporin 133), NUP88 (nucleoporin 88), RAE1 (ribonucleic acid export 1), AAAS (aladin WD repeat nucleoporin), NUP160 (nucleoporin 160), NUP50 (nucleoporin 50), SUMO2 (small ubiquitin like modifier 2), NUP54 (nucleoporin 54), NUP37 (nucleoporin 37), SUMO1 (small ubiquitin like modifier 1), UBE2I (ubiquitin conjugating enzyme E2 I), RNF2 (ring finger protein 2), HDAC2 (histone deacetylase 2), SUZ12 (SUZ12 polycomb repressive complex 2 subunit), CBX4 (chromobox 4), HDAC1 (histone deacetylase 1), BMI1 (BMI1 proto-oncogene, polycomb ring finger), PHC1 (polyhomeotic homolog 1), PCGF2 (polycomb group ring finger 2), CBX8 (chromobox 8), POM121 (POM121 transmembrane nucleoporin), PHC3 (polyhomeotic homolog 3), PHC2 (polyhomeotic homolog 2), RING1 (ring finger protein 1), CBX2 (chromobox 2), HDAC4 (histone deacetylase 4), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), CHD3 (chromodomain helicase DNA binding protein 3), SATB1 (SATB homeobox 1), PIAS1 (protein inhibitor of activated STAT 1), SUMO3 (small ubiquitin like modifier 3), CBX5 (chromobox 5), L3MBTL2 (L3MBTL histone methyl-lysine binding protein 2), SATB2 (SATB homeobox 2), ZBED1 (zinc finger BED-type containing 1), H4C1 (H4 clustered histone 1), H4C2 (H4 clustered histone 2), H4C11 (H4 clustered histone 11), H4C14 (H4 clustered histone 14), H4C9 (H4 clustered histone 9), NDC1 (NDC1 transmembrane nucleoporin), H4C15 (H4 clustered histone 15), H4C3 (H4 clustered histone 3), NUP42 (nucleoporin 42), H4C8 (H4 clustered histone 8), H4C5 (H4 clustered histone 5), H4C13 (H4 clustered histone 13), H4C12 (H4 clustered histone 12), H4-16 (H4 histone 16), H4C4 (H4 clustered histone 4), H4C6 (H4 clustered histone 6)"], "WAG002577": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MSRA (methionine sulfoxide reductase A), MSRB2 (methionine sulfoxide reductase B2), TXN (thioredoxin), MSRB3 (methionine sulfoxide reductase B3), MSRB1 (methionine sulfoxide reductase B1), PCMT1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase)"], "WAG002579": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BAX (BCL2 associated X, apoptosis regulator), BID (BH3 interacting domain death agonist), CASP10 (caspase 10), APAF1 (apoptotic peptidase activating factor 1), TNFRSF10B (TNF receptor superfamily member 10b), TP63 (tumor protein p63), CASP1 (caspase 1), FAS (Fas cell surface death receptor), TP73 (tumor protein p73), CASP2 (caspase 2), TNFRSF10A (TNF receptor superfamily member 10a), CREBBP (CREB binding protein), PPP1R13B (protein phosphatase 1 regulatory subunit 13B), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), CASP6 (caspase 6), TNFRSF10D (TNF receptor superfamily member 10d), TP53BP2 (tumor protein p53 binding protein 2), BBC3 (BCL2 binding component 3), CRADD (CASP2 and RIPK1 domain containing adaptor with death domain), TNFRSF10C (TNF receptor superfamily member 10c), ATM (ATM serine/threonine kinase), BNIP3L (BCL2 interacting protein 3 like), BIRC5 (baculoviral IAP repeat containing 5), TP53I3 (tumor protein p53 inducible protein 3), TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1), TRIAP1 (TP53 regulated inhibitor of apoptosis 1), PERP (p53 apoptosis effector related to PMP22), STEAP3 (STEAP3 metalloreductase), NLRC4 (NLR family CARD domain containing 4), RABGGTA (Rab geranylgeranyltransferase subunit alpha), BCL6 (BCL6 transcription repressor), IGFBP3 (insulin like growth factor binding protein 3), RABGGTB (Rab geranylgeranyltransferase subunit beta), CHM (CHM Rab escort protein), TP53INP1 (tumor protein p53 inducible nuclear protein 1), ZNF420 (zinc finger protein 420), NDRG1 (N-myc downstream regulated 1), AIFM2 (apoptosis inducing factor mitochondria associated 2), BCL2L14 (BCL2 like 14), PRELID1 (PRELI domain containing 1), TMEM219 (transmembrane protein 219), PIDD1 (p53-induced death domain protein 1), PRELID3A (PRELI domain containing 3A)"], "WAG002581": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), CDK1 (cyclin dependent kinase 1), CDK2 (cyclin dependent kinase 2), CDKN1A (cyclin dependent kinase inhibitor 1A), E2F1 (E2F transcription factor 1), PCNA (proliferating cell nuclear antigen), CCNA2 (cyclin A2), CCNB1 (cyclin B1), TFDP1 (transcription factor Dp-1), CCNE1 (cyclin E1), EP300 (E1A binding protein p300), CCNE2 (cyclin E2), RBL2 (RB transcriptional corepressor like 2), CDKN1B (cyclin dependent kinase inhibitor 1B), CCNA1 (cyclin A1), TFDP2 (transcription factor Dp-2), RBL1 (RB transcriptional corepressor like 1), E2F4 (E2F transcription factor 4), CNOT7 (CCR4-NOT transcription complex subunit 7), CNOT8 (CCR4-NOT transcription complex subunit 8), CNOT1 (CCR4-NOT transcription complex subunit 1), CDC25C (cell division cycle 25C), CNOT6L (CCR4-NOT transcription complex subunit 6 like), GADD45A (growth arrest and DNA damage inducible alpha), CNOT4 (CCR4-NOT transcription complex subunit 4), CNOT6 (CCR4-NOT transcription complex subunit 6), CNOT3 (CCR4-NOT transcription complex subunit 3), CNOT2 (CCR4-NOT transcription complex subunit 2), CNOT10 (CCR4-NOT transcription complex subunit 10), TNKS1BP1 (tankyrase 1 binding protein 1), PRMT1 (protein arginine methyltransferase 1), NPM1 (nucleophosmin 1), BTG2 (BTG anti-proliferation factor 2), SFN (stratifin), BAX (BCL2 associated X, apoptosis regulator), PLK2 (polo like kinase 2), E2F8 (E2F transcription factor 8), CARM1 (coactivator associated arginine methyltransferase 1), PLK3 (polo like kinase 3), E2F7 (E2F transcription factor 7), ARID3A (AT-rich interaction domain 3A), PLAGL1 (PLAG1 like zinc finger 1), ZNF385A (zinc finger protein 385A), CENPJ (centromere protein J), PCBP4 (poly(rC) binding protein 4), AURKA (aurora kinase A), CNOT11 (CCR4-NOT transcription complex subunit 11), CNOT9 (CCR4-NOT transcription complex subunit 9), RGCC (regulator of cell cycle)"], "WAG002582": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP85 (nucleoporin 85), NUP43 (nucleoporin 43), NUP107 (nucleoporin 107), NUP133 (nucleoporin 133), NUP37 (nucleoporin 37), NUP160 (nucleoporin 160), NUP153 (nucleoporin 153), NUP155 (nucleoporin 155), NUP93 (nucleoporin 93), RANBP2 (RAN binding protein 2), NUP210 (nucleoporin 210), NUP214 (nucleoporin 214), NUP62 (nucleoporin 62), NUP205 (nucleoporin 205), NUP35 (nucleoporin 35), TPR (translocated promoter region, nuclear basket protein), NUP188 (nucleoporin 188), SUMO1 (small ubiquitin like modifier 1), NUP88 (nucleoporin 88), RAE1 (ribonucleic acid export 1), AAAS (aladin WD repeat nucleoporin), NUP50 (nucleoporin 50), RANGAP1 (Ran GTPase activating protein 1), NUP54 (nucleoporin 54), SUMO2 (small ubiquitin like modifier 2), CDCA8 (cell division cycle associated 8), AURKB (aurora kinase B), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), UBE2I (ubiquitin conjugating enzyme E2 I), BIRC5 (baculoviral IAP repeat containing 5), POM121 (POM121 transmembrane nucleoporin), INCENP (inner centromere protein), TOP2A (DNA topoisomerase II alpha), SUMO3 (small ubiquitin like modifier 3), PCNA (proliferating cell nuclear antigen), TOP1 (DNA topoisomerase I), TOP2B (DNA topoisomerase II beta), PIAS3 (protein inhibitor of activated STAT 3), PIAS4 (protein inhibitor of activated STAT 4), AURKA (aurora kinase A), NUP42 (nucleoporin 42), NDC1 (NDC1 transmembrane nucleoporin)"], "WAG002584": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TP53 (tumor protein p53), MDM2 (MDM2 proto-oncogene), AKT1 (AKT serine/threonine kinase 1), CDK2 (cyclin dependent kinase 2), MTOR (mechanistic target of rapamycin kinase), PPP2CA (protein phosphatase 2 catalytic subunit alpha), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), CDK1 (cyclin dependent kinase 1), UBB (ubiquitin B), MDM4 (MDM4 regulator of p53), CDKN2A (cyclin dependent kinase inhibitor 2A), CHEK2 (checkpoint kinase 2), ATM (ATM serine/threonine kinase), SGK1 (serum/glucocorticoid regulated kinase 1), USP7 (ubiquitin specific peptidase 7), MLST8 (MTOR associated protein, LST8 homolog), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), RICTOR (RPTOR independent companion of MTOR complex 2), DAXX (death domain associated protein), PDPK1 (3-phosphoinositide dependent protein kinase 1), CCNG1 (cyclin G1), PPP2CB (protein phosphatase 2 catalytic subunit beta), RPS27A (ribosomal protein S27a), PRR5 (proline rich 5), MAPKAP1 (MAPK associated protein 1), CCNA2 (cyclin A2), AKT2 (AKT serine/threonine kinase 2), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), CCNA1 (cyclin A1), USP2 (ubiquitin specific peptidase 2), AKT3 (AKT serine/threonine kinase 3), RFFL (ring finger and FYVE like domain containing E3 ubiquitin protein ligase), PHF20 (PHD finger protein 20), RNF34 (ring finger protein 34), PRDM1 (PR/SET domain 1)"], "WAG002585": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDK9 (cyclin dependent kinase 9), GTF2F2 (general transcription factor IIF subunit 2), CDK7 (cyclin dependent kinase 7), GTF2H1 (general transcription factor IIH subunit 1), GTF2F1 (general transcription factor IIF subunit 1), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), CCNH (cyclin H), POLR2B (RNA polymerase II subunit B), POLR2G (RNA polymerase II subunit G), POLR2C (RNA polymerase II subunit C), MNAT1 (MNAT1 component of CDK activating kinase), POLR2I (RNA polymerase II subunit I), CCNT1 (cyclin T1), POLR2E (RNA polymerase II, I and III subunit E), POLR2D (RNA polymerase II subunit D), GTF2H3 (general transcription factor IIH subunit 3), SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), TCEA1 (transcription elongation factor A1), POLR2J (RNA polymerase II subunit J), GTF2H4 (general transcription factor IIH subunit 4), ELL (elongation factor for RNA polymerase II), POLR2H (RNA polymerase II, I and III subunit H), CCNT2 (cyclin T2), POLR2F (RNA polymerase II, I and III subunit F), POLR2L (RNA polymerase II, I and III subunit L), GTF2H2 (general transcription factor IIH subunit 2), CTDP1 (CTD phosphatase subunit 1), SSRP1 (structure specific recognition protein 1), SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit), TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), POLR2K (RNA polymerase II, I and III subunit K), MSH2 (mutS homolog 2), ATR (ATR serine/threonine kinase), CHEK1 (checkpoint kinase 1), DDB2 (damage specific DNA binding protein 2), ATM (ATM serine/threonine kinase), FANCD2 (FA complementation group D2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), GTF2H5 (general transcription factor IIH subunit 5), MLH1 (mutL homolog 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), MDC1 (mediator of DNA damage checkpoint 1), CCNK (cyclin K), FANCI (FA complementation group I), ATF2 (activating transcription factor 2), FANCC (FA complementation group C), CDK12 (cyclin dependent kinase 12), PMS2 (PMS1 homolog 2, mismatch repair system component), CDK13 (cyclin dependent kinase 13), RAD51D (RAD51 paralog D), ELOA3D (elongin A3 family member D), ELOA3 (elongin A3), ELOC (elongin C), ELOB (elongin B), ELOA (elongin A), NELFE (negative elongation factor complex member E), ELOA3B (elongin A3 family member B), ELOA3C (elongin A3 family member C), NELFB (negative elongation factor complex member B), ELOA2 (elongin A2), NELFA (negative elongation factor complex member A)"], "WAG002587": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKACA (protein kinase cAMP-activated catalytic subunit alpha), RYR2 (ryanodine receptor 2), CACNA1C (calcium voltage-gated channel subunit alpha1 C), KCND2 (potassium voltage-gated channel subfamily D member 2), KCNQ1 (potassium voltage-gated channel subfamily Q member 1), PLN (phospholamban), SCN1B (sodium voltage-gated channel beta subunit 1), RYR1 (ryanodine receptor 1), SCN5A (sodium voltage-gated channel alpha subunit 5), CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2), KCNH2 (potassium voltage-gated channel subfamily H member 2), NPPA (natriuretic peptide A), CACNG8 (calcium voltage-gated channel auxiliary subunit gamma 8), RYR3 (ryanodine receptor 3), ATP1A3 (ATPase Na+/K+ transporting subunit alpha 3), SCN4B (sodium voltage-gated channel beta subunit 4), CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1), FXYD2 (FXYD domain containing ion transport regulator 2), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1), SCN2B (sodium voltage-gated channel beta subunit 2), ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1), ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2), KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1), ATP1B1 (ATPase Na+/K+ transporting subunit beta 1), SCN8A (sodium voltage-gated channel alpha subunit 8), KCNJ2 (potassium inwardly rectifying channel subfamily J member 2), AKAP9 (A-kinase anchoring protein 9), KCND3 (potassium voltage-gated channel subfamily D member 3), CAMK2B (calcium/calmodulin dependent protein kinase II beta), CACNG6 (calcium voltage-gated channel auxiliary subunit gamma 6), CACNG7 (calcium voltage-gated channel auxiliary subunit gamma 7), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), FXYD1 (FXYD domain containing ion transport regulator 1), KCNE2 (potassium voltage-gated channel subfamily E regulatory subunit 2), SCN3B (sodium voltage-gated channel beta subunit 3), SLC8A1 (solute carrier family 8 member A1), SCN3A (sodium voltage-gated channel alpha subunit 3), KCNE4 (potassium voltage-gated channel subfamily E regulatory subunit 4), TRPC1 (transient receptor potential cation channel subfamily C member 1), KCNE3 (potassium voltage-gated channel subfamily E regulatory subunit 3), ATP2B1 (ATPase plasma membrane Ca2+ transporting 1), ATP1B2 (ATPase Na+/K+ transporting subunit beta 2), FKBP1B (FKBP prolyl isomerase 1B), ATP1A4 (ATPase Na+/K+ transporting subunit alpha 4), KCND1 (potassium voltage-gated channel subfamily D member 1), KCNIP2 (potassium voltage-gated channel interacting protein 2), ATP1B3 (ATPase Na+/K+ transporting subunit beta 3), NOS1 (nitric oxide synthase 1), CACNG4 (calcium voltage-gated channel auxiliary subunit gamma 4), SCN4A (sodium voltage-gated channel alpha subunit 4), SCN1A (sodium voltage-gated channel alpha subunit 1), KCNK5 (potassium two pore domain channel subfamily K member 5), ATP2B2 (ATPase plasma membrane Ca2+ transporting 2), DMPK (DM1 protein kinase), KCNK9 (potassium two pore domain channel subfamily K member 9), FXYD7 (FXYD domain containing ion transport regulator 7), KCNK3 (potassium two pore domain channel subfamily K member 3), NKX2-5 (NK2 homeobox 5), TBX5 (T-box transcription factor 5), ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3), ATP2B4 (ATPase plasma membrane Ca2+ transporting 4), SCN2A (sodium voltage-gated channel alpha subunit 2), KCNK2 (potassium two pore domain channel subfamily K member 2), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), KCNIP1 (potassium voltage-gated channel interacting protein 1), ATP2B3 (ATPase plasma membrane Ca2+ transporting 3), KCNK10 (potassium two pore domain channel subfamily K member 10), KCNK4 (potassium two pore domain channel subfamily K member 4), KCNK1 (potassium two pore domain channel subfamily K member 1), NPR2 (natriuretic peptide receptor 2), TRDN (triadin), HIPK2 (homeodomain interacting protein kinase 2), KAT2B (lysine acetyltransferase 2B), SLN (sarcolipin), KCNJ12 (potassium inwardly rectifying channel subfamily J member 12), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), SRI (sorcin), NPR1 (natriuretic peptide receptor 1), HIPK1 (homeodomain interacting protein kinase 1), KCNIP4 (potassium voltage-gated channel interacting protein 4), KCNK7 (potassium two pore domain channel subfamily K member 7), SCN7A (sodium voltage-gated channel alpha subunit 7), GATA4 (GATA binding protein 4), KCNJ4 (potassium inwardly rectifying channel subfamily J member 4), NPPC (natriuretic peptide C), KCNJ11 (potassium inwardly rectifying channel subfamily J member 11), STIM1 (stromal interaction molecule 1), ASPH (aspartate beta-hydroxylase), SCN9A (sodium voltage-gated channel alpha subunit 9), WWTR1 (WW domain containing transcription regulator 1), SLC8A2 (solute carrier family 8 member A2), KCNJ14 (potassium inwardly rectifying channel subfamily J member 14), SCN11A (sodium voltage-gated channel alpha subunit 11), TNNI3 (troponin I3, cardiac type), KCNK17 (potassium two pore domain channel subfamily K member 17), CACNA2D2 (calcium voltage-gated channel auxiliary subunit alpha2delta 2)"], "WAG002588": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYLK (myosin light chain kinase), MYH11 (myosin heavy chain 11), MYL6B (myosin light chain 6B), SORBS1 (sorbin and SH3 domain containing 1), VCL (vinculin), ITGB5 (integrin subunit beta 5), SORBS3 (sorbin and SH3 domain containing 3), TLN1 (talin 1), MYL6 (myosin light chain 6), LMOD1 (leiomodin 1), TPM1 (tropomyosin 1), ITGA1 (integrin subunit alpha 1), CALD1 (caldesmon 1), TPM2 (tropomyosin 2), TPM4 (tropomyosin 4), TPM3 (tropomyosin 3), PXN (paxillin), MYL9 (myosin light chain 9), MYLPF (myosin light chain, phosphorylatable, fast skeletal muscle), ACTA2 (actin alpha 2, smooth muscle), ANXA2 (annexin A2), MYL5 (myosin light chain 5), PAK2 (p21 (RAC1) activated kinase 2), DYSF (dysferlin), ACTG2 (actin gamma 2, smooth muscle), MYL12B (myosin light chain 12B), PAK1 (p21 (RAC1) activated kinase 1), CAV3 (caveolin 3), ANXA1 (annexin A1), MYL12A (myosin light chain 12A), TRIM72 (tripartite motif containing 72), ANXA6 (annexin A6), MYL7 (myosin light chain 7), MYL10 (myosin light chain 10), GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1), CALM1 (calmodulin 1), GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2), GUCY1A1 (guanylate cyclase 1 soluble subunit alpha 1)"], "WAG002589": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DLG4 (discs large MAGUK scaffold protein 4), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), DLG3 (discs large MAGUK scaffold protein 3), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), DLG1 (discs large MAGUK scaffold protein 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), LRFN2 (leucine rich repeat and fibronectin type III domain containing 2), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), PTPRD (protein tyrosine phosphatase receptor type D), LRFN1 (leucine rich repeat and fibronectin type III domain containing 1), PTPRF (protein tyrosine phosphatase receptor type F), PTPRS (protein tyrosine phosphatase receptor type S), FLOT2 (flotillin 2), FLOT1 (flotillin 1), LRFN5 (leucine rich repeat and fibronectin type III domain containing 5), LRFN3 (leucine rich repeat and fibronectin type III domain containing 3), LRFN4 (leucine rich repeat and fibronectin type III domain containing 4), RTN3 (reticulon 3)"], "WAG002592": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), HDAC2 (histone deacetylase 2), TP53 (tumor protein p53), CHD4 (chromodomain helicase DNA binding protein 4), EP300 (E1A binding protein p300), RBBP4 (RB binding protein 4, chromatin remodeling factor), MTA2 (metastasis associated 1 family member 2), RBBP7 (RB binding protein 7, chromatin remodeling factor), CHD3 (chromodomain helicase DNA binding protein 3), GATAD2A (GATA zinc finger domain containing 2A), MBD3 (methyl-CpG binding domain protein 3), ING2 (inhibitor of growth family member 2), GATAD2B (GATA zinc finger domain containing 2B), KAT6A (lysine acetyltransferase 6A), ING5 (inhibitor of growth family member 5), PML (PML nuclear body scaffold), MEAF6 (MYST/Esa1 associated factor 6), BRPF1 (bromodomain and PHD finger containing 1), BRPF3 (bromodomain and PHD finger containing 3), BRD1 (bromodomain containing 1), PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1), AKT1 (AKT serine/threonine kinase 1), BRD7 (bromodomain containing 7), AKT2 (AKT serine/threonine kinase 2), AKT3 (AKT serine/threonine kinase 3), PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha), MAP2K6 (mitogen-activated protein kinase kinase 6), PIP4P1 (phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1), PIP4K2B (phosphatidylinositol-5-phosphate 4-kinase type 2 beta), PIP4K2C (phosphatidylinositol-5-phosphate 4-kinase type 2 gamma)"], "WAG002596": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), MAPK14 (mitogen-activated protein kinase 14), MAPK8 (mitogen-activated protein kinase 8), AKT1 (AKT serine/threonine kinase 1), GRB2 (growth factor receptor bound protein 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), EGFR (epidermal growth factor receptor), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), RAC1 (Rac family small GTPase 1), TRAF6 (TNF receptor associated factor 6), MAPK11 (mitogen-activated protein kinase 11), NFKB1 (nuclear factor kappa B subunit 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K4 (mitogen-activated protein kinase kinase 4), MAPK10 (mitogen-activated protein kinase 10), MAPK13 (mitogen-activated protein kinase 13), TP53 (tumor protein p53), MAPK9 (mitogen-activated protein kinase 9), MAPK12 (mitogen-activated protein kinase 12), TNF (tumor necrosis factor), RELA (RELA proto-oncogene, NF-kB subunit), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), HRAS (HRas proto-oncogene, GTPase), MAP2K1 (mitogen-activated protein kinase kinase 1), CDC42 (cell division cycle 42), MAP2K3 (mitogen-activated protein kinase kinase 3), PRKCD (protein kinase C delta), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PRKCA (protein kinase C alpha), MAP2K6 (mitogen-activated protein kinase kinase 6), MYC (MYC proto-oncogene, bHLH transcription factor), RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1), PDGFRB (platelet derived growth factor receptor beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), TRAF2 (TNF receptor associated factor 2), NRAS (NRAS proto-oncogene, GTPase), MAP2K7 (mitogen-activated protein kinase kinase 7), CASP3 (caspase 3), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), FGFR1 (fibroblast growth factor receptor 1), RASGRP1 (RAS guanyl releasing protein 1), TGFB1 (transforming growth factor beta 1), NGF (nerve growth factor), FGFR2 (fibroblast growth factor receptor 2), TNFRSF1A (TNF receptor superfamily member 1A), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), FGFR3 (fibroblast growth factor receptor 3), RASGRP3 (RAS guanyl releasing protein 3), CRK (CRK proto-oncogene, adaptor protein), RASGRF2 (Ras protein specific guanine nucleotide releasing factor 2), RASGRP2 (RAS guanyl releasing protein 2), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), HSPA8 (heat shock protein family A (Hsp70) member 8), EGF (epidermal growth factor), CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1), PAK1 (p21 (RAC1) activated kinase 1), CACNA1C (calcium voltage-gated channel subunit alpha1 C), RASGRP4 (RAS guanyl releasing protein 4), BRAF (B-Raf proto-oncogene, serine/threonine kinase), FASLG (Fas ligand), CACNB3 (calcium voltage-gated channel auxiliary subunit beta 3), CACNA1D (calcium voltage-gated channel subunit alpha1 D), CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4), CACNG6 (calcium voltage-gated channel auxiliary subunit gamma 6), CACNA2D1 (calcium voltage-gated channel auxiliary subunit alpha2delta 1), CACNG8 (calcium voltage-gated channel auxiliary subunit gamma 8), CACNG7 (calcium voltage-gated channel auxiliary subunit gamma 7), CACNG1 (calcium voltage-gated channel auxiliary subunit gamma 1), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), ARRB2 (arrestin beta 2), CACNG3 (calcium voltage-gated channel auxiliary subunit gamma 3), FGFR4 (fibroblast growth factor receptor 4), CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2), CACNA1F (calcium voltage-gated channel subunit alpha1 F), CACNA1S (calcium voltage-gated channel subunit alpha1 S), ARAF (A-Raf proto-oncogene, serine/threonine kinase), FGF2 (fibroblast growth factor 2), CACNG2 (calcium voltage-gated channel auxiliary subunit gamma 2), PPM1A (protein phosphatase, Mg2+/Mn2+ dependent 1A), PAK2 (p21 (RAC1) activated kinase 2), PRKACB (protein kinase cAMP-activated catalytic subunit beta), CACNA1A (calcium voltage-gated channel subunit alpha1 A), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), RASA1 (RAS p21 protein activator 1), FGF1 (fibroblast growth factor 1), CACNA1I (calcium voltage-gated channel subunit alpha1 I), CACNA1B (calcium voltage-gated channel subunit alpha1 B), CACNA1E (calcium voltage-gated channel subunit alpha1 E), CACNA1H (calcium voltage-gated channel subunit alpha1 H), CACNA1G (calcium voltage-gated channel subunit alpha1 G), HSPA1B (heat shock protein family A (Hsp70) member 1B), RAP1A (RAP1A, member of RAS oncogene family), MAPK7 (mitogen-activated protein kinase 7), FLNA (filamin A), KRAS (KRAS proto-oncogene, GTPase), RAC3 (Rac family small GTPase 3)"], "WAG002598": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VKORC1 (vitamin K epoxide reductase complex subunit 1), VKORC1L1 (vitamin K epoxide reductase complex subunit 1 like 1), UBIAD1 (UbiA prenyltransferase domain containing 1)"], "WAG002601": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLR2H (RNA polymerase II, I and III subunit H), POLR2E (RNA polymerase II, I and III subunit E), POLR2B (RNA polymerase II subunit B), POLR2C (RNA polymerase II subunit C), POLR2L (RNA polymerase II, I and III subunit L), POLR2F (RNA polymerase II, I and III subunit F), POLR2D (RNA polymerase II subunit D), POLR2G (RNA polymerase II subunit G), POLR2J (RNA polymerase II subunit J), TBP (TATA-box binding protein), POLR2I (RNA polymerase II subunit I), GTF2F2 (general transcription factor IIF subunit 2), GTF2F1 (general transcription factor IIF subunit 1), CDK7 (cyclin dependent kinase 7), GTF2B (general transcription factor IIB), CDK9 (cyclin dependent kinase 9), TAF6 (TATA-box binding protein associated factor 6), TAF11 (TATA-box binding protein associated factor 11), TAF5 (TATA-box binding protein associated factor 5), TAF13 (TATA-box binding protein associated factor 13), GTF2E1 (general transcription factor IIE subunit 1), GTF2E2 (general transcription factor IIE subunit 2), GTF2A1 (general transcription factor IIA subunit 1), GTF2A2 (general transcription factor IIA subunit 2), SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), CCNT1 (cyclin T1), TAF9 (TATA-box binding protein associated factor 9), ELL (elongation factor for RNA polymerase II), NCBP2 (nuclear cap binding protein subunit 2), CCNT2 (cyclin T2), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), NCBP1 (nuclear cap binding protein subunit 1), INTS3 (integrator complex subunit 3), INTS6 (integrator complex subunit 6), INTS10 (integrator complex subunit 10), PCF11 (PCF11 cleavage and polyadenylation factor subunit), INTS5 (integrator complex subunit 5), POLR2K (RNA polymerase II, I and III subunit K), POU2F1 (POU class 2 homeobox 1), RPAP2 (RNA polymerase II associated protein 2), INTS1 (integrator complex subunit 1), SNAPC5 (small nuclear RNA activating complex polypeptide 5), SNAPC1 (small nuclear RNA activating complex polypeptide 1), SNAPC2 (small nuclear RNA activating complex polypeptide 2), SNAPC3 (small nuclear RNA activating complex polypeptide 3), SNAPC4 (small nuclear RNA activating complex polypeptide 4), ZNF143 (zinc finger protein 143), INTS7 (integrator complex subunit 7), INTS4 (integrator complex subunit 4), INTS8 (integrator complex subunit 8), INTS12 (integrator complex subunit 12), INTS2 (integrator complex subunit 2), INTS9 (integrator complex subunit 9), TAF8 (TATA-box binding protein associated factor 8), ELL2 (elongation factor for RNA polymerase II 2), SP1 (Sp1 transcription factor), CCNK (cyclin K), ELL3 (elongation factor for RNA polymerase II 3), SSU72 (SSU72 homolog, RNA polymerase II CTD phosphatase), POU2F2 (POU class 2 homeobox 2), NABP1 (nucleic acid binding protein 1), PHAX (phosphorylated adaptor for RNA export), RPRD1B (regulation of nuclear pre-mRNA domain containing 1B), RPRD1A (regulation of nuclear pre-mRNA domain containing 1A), RPRD2 (regulation of nuclear pre-mRNA domain containing 2), SRRT (serrate, RNA effector molecule), NABP2 (nucleic acid binding protein 2), RNU5A-1 (RNA, U5A small nuclear 1), RNU11 (RNA, U11 small nuclear), INTS11 (integrator complex subunit 11), RNU1-1 (RNA, U1 small nuclear 1), RNU4-1 (RNA, U4 small nuclear 1), RNU2-1 (RNA, U2 small nuclear 1), ZC3H8 (zinc finger CCCH-type containing 8), INTS13 (integrator complex subunit 13), ICE2 (interactor of little elongation complex ELL subunit 2), RNU12 (RNA, U12 small nuclear), INTS14 (integrator complex subunit 14), ICE1 (interactor of little elongation complex ELL subunit 1), RNU4ATAC (RNA, U4atac small nuclear (U12-dependent splicing))"], "WAG002604": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TTN (titin), ACTN2 (actinin alpha 2), MYL1 (myosin light chain 1), MYL4 (myosin light chain 4), MYL3 (myosin light chain 3), MYBPC3 (myosin binding protein C3), TNNI3 (troponin I3, cardiac type), TNNT2 (troponin T2, cardiac type), MYL2 (myosin light chain 2), TPM1 (tropomyosin 1), DMD (dystrophin), TNNC2 (troponin C2, fast skeletal type), TNNI2 (troponin I2, fast skeletal type), TNNT3 (troponin T3, fast skeletal type), TNNI1 (troponin I1, slow skeletal type), TPM3 (tropomyosin 3), NEB (nebulin), MYBPC1 (myosin binding protein C1), TPM2 (tropomyosin 2), MYBPC2 (myosin binding protein C2), TNNT1 (troponin T1, slow skeletal type), MYH3 (myosin heavy chain 3), VIM (vimentin), DES (desmin), TPM4 (tropomyosin 4), TCAP (titin-cap), TMOD1 (tropomodulin 1), ACTA1 (actin alpha 1, skeletal muscle), MYH6 (myosin heavy chain 6), MYOM1 (myomesin 1), ACTC1 (actin alpha cardiac muscle 1), TNNC1 (troponin C1, slow skeletal and cardiac type), MYH8 (myosin heavy chain 8), ACTG1 (actin gamma 1), MYL9 (myosin light chain 9), ACTN4 (actinin alpha 4), ACTA2 (actin alpha 2, smooth muscle), ACTN3 (actinin alpha 3)"], "WAG002605": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), TP53 (tumor protein p53), ATM (ATM serine/threonine kinase), BRCA1 (BRCA1 DNA repair associated), RPA1 (replication protein A1), CHEK1 (checkpoint kinase 1), MDM2 (MDM2 proto-oncogene), ATR (ATR serine/threonine kinase), RFC4 (replication factor C subunit 4), CDK2 (cyclin dependent kinase 2), RPA2 (replication protein A2), RAD50 (RAD50 double strand break repair protein), TOPBP1 (DNA topoisomerase II binding protein 1), RFC5 (replication factor C subunit 5), RFC2 (replication factor C subunit 2), ATRIP (ATR interacting protein), RFC3 (replication factor C subunit 3), BLM (BLM RecQ like helicase), RPA3 (replication protein A3), TBP (TATA-box binding protein), TAF1 (TATA-box binding protein associated factor 1), RAD9A (RAD9 checkpoint clamp component A), RAD17 (RAD17 checkpoint clamp loader component), CHEK2 (checkpoint kinase 2), HUS1 (HUS1 checkpoint clamp component), EXO1 (exonuclease 1), TAF9 (TATA-box binding protein associated factor 9), CCNA2 (cyclin A2), TAF6 (TATA-box binding protein associated factor 6), TAF5 (TATA-box binding protein associated factor 5), TAF10 (TATA-box binding protein associated factor 10), TAF13 (TATA-box binding protein associated factor 13), TAF7 (TATA-box binding protein associated factor 7), NBN (nibrin), TAF12 (TATA-box binding protein associated factor 12), TAF11 (TATA-box binding protein associated factor 11), TAF4 (TATA-box binding protein associated factor 4), TAF2 (TATA-box binding protein associated factor 2), RAD1 (RAD1 checkpoint DNA exonuclease), BARD1 (BRCA1 associated RING domain 1), AURKB (aurora kinase B), TAF9B (TATA-box binding protein associated factor 9b), WRN (WRN RecQ like helicase), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), CSNK2A1 (casein kinase 2 alpha 1), TAF3 (TATA-box binding protein associated factor 3), STK11 (serine/threonine kinase 11), DNA2 (DNA replication helicase/nuclease 2), TAF4B (TATA-box binding protein associated factor 4b), TAF15 (TATA-box binding protein associated factor 15), TOP3A (DNA topoisomerase III alpha), UBB (ubiquitin B), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), MAPK14 (mitogen-activated protein kinase 14), CSNK2B (casein kinase 2 beta), RAD9B (RAD9 checkpoint clamp component B), TPX2 (TPX2 microtubule nucleation factor), PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), KAT5 (lysine acetyltransferase 5), RBBP8 (RB binding protein 8, endonuclease), DYRK2 (dual specificity tyrosine phosphorylation regulated kinase 2), CDK5 (cyclin dependent kinase 5), TAF1L (TATA-box binding protein associated factor 1 like), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), RMI1 (RecQ mediated genome instability 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), HIPK1 (homeodomain interacting protein kinase 1), MDM4 (MDM4 regulator of p53), SSRP1 (structure specific recognition protein 1), HIPK2 (homeodomain interacting protein kinase 2), RPS27A (ribosomal protein S27a), CSNK2A2 (casein kinase 2 alpha 2), CCNA1 (cyclin A1), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), MAPKAPK5 (MAPK activated protein kinase 5), BRIP1 (BRCA1 interacting protein C-terminal helicase 1), SUPT16H (SPT16 homolog, facilitates chromatin remodeling subunit), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), NUAK1 (NUAK family kinase 1), PLK3 (polo like kinase 3), MAPK11 (mitogen-activated protein kinase 11), TAF7L (TATA-box binding protein associated factor 7 like), NOC2L (NOC2 like nucleolar associated transcriptional repressor), CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1), TP53INP1 (tumor protein p53 inducible nuclear protein 1), TP53RK (TP53 regulating kinase), MRE11 (MRE11 homolog, double strand break repair nuclease), RHNO1 (RAD9-HUS1-RAD1 interacting nuclear orphan 1), AURKA (aurora kinase A)"], "WAG002607": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP8 (caspase 8), CASP3 (caspase 3), TNFRSF1A (TNF receptor superfamily member 1A), FADD (Fas associated via death domain), CASP7 (caspase 7), BID (BH3 interacting domain death agonist), CASP9 (caspase 9), APAF1 (apoptotic peptidase activating factor 1), FASLG (Fas ligand), FAS (Fas cell surface death receptor), CASP2 (caspase 2), CYCS (cytochrome c, somatic), RIPK1 (receptor interacting serine/threonine kinase 1), CASP6 (caspase 6), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), NFKB1 (nuclear factor kappa B subunit 1), AIFM1 (apoptosis inducing factor mitochondria associated 1), MAPK10 (mitogen-activated protein kinase 10), HSPA1A (heat shock protein family A (Hsp70) member 1A)"], "WAG002608": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STX5 (syntaxin 5), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), COPA (COPI coat complex subunit alpha), ARF1 (ADP ribosylation factor 1), COPB1 (COPI coat complex subunit beta 1), KIF26A (kinesin family member 26A), DCTN1 (dynactin subunit 1), YKT6 (YKT6 v-SNARE homolog), DCTN2 (dynactin subunit 2), STX16 (syntaxin 16), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), GOSR1 (golgi SNAP receptor complex member 1), KIF11 (kinesin family member 11), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), STX6 (syntaxin 6), KIF23 (kinesin family member 23), KIF5B (kinesin family member 5B), KIF3B (kinesin family member 3B), GOSR2 (golgi SNAP receptor complex member 2), RAB6A (RAB6A, member RAS oncogene family), ARL1 (ADP ribosylation factor like GTPase 1), ARCN1 (archain 1), KIF5A (kinesin family member 5A), COPB2 (COPI coat complex subunit beta 2), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), DCTN3 (dynactin subunit 3), ACTR1A (actin related protein 1A), NAPA (NSF attachment protein alpha), COG3 (component of oligomeric golgi complex 3), KIFAP3 (kinesin associated protein 3), TMED10 (transmembrane p24 trafficking protein 10), VTI1A (vesicle transport through interaction with t-SNAREs 1A), KIF15 (kinesin family member 15), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), ZW10 (zw10 kinetochore protein), DCTN4 (dynactin subunit 4), COPZ1 (COPI coat complex subunit zeta 1), RAB1A (RAB1A, member RAS oncogene family), KIF3A (kinesin family member 3A), KIF20A (kinesin family member 20A), KLC1 (kinesin light chain 1), SEC22B (SEC22 homolog B, vesicle trafficking protein), COPG2 (COPI coat complex subunit gamma 2), DCTN6 (dynactin subunit 6), TMED2 (transmembrane p24 trafficking protein 2), DCTN5 (dynactin subunit 5), TMED7 (transmembrane p24 trafficking protein 7), KIF18A (kinesin family member 18A), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1), CENPE (centromere protein E), COPE (COPI coat complex subunit epsilon), DYNLL1 (dynein light chain LC8-type 1), VAMP4 (vesicle associated membrane protein 4), KIF3C (kinesin family member 3C), NAPB (NSF attachment protein beta), GOLGA4 (golgin A4), BNIP1 (BCL2 interacting protein 1), STX18 (syntaxin 18), VAMP3 (vesicle associated membrane protein 3), KLC2 (kinesin light chain 2), USE1 (unconventional SNARE in the ER 1), ARFGAP1 (ADP ribosylation factor GTPase activating protein 1), TMED9 (transmembrane p24 trafficking protein 9), COG6 (component of oligomeric golgi complex 6), VPS45 (vacuolar protein sorting 45 homolog), VPS52 (VPS52 subunit of GARP complex), COG1 (component of oligomeric golgi complex 1), COG8 (component of oligomeric golgi complex 8), BET1L (Bet1 golgi vesicular membrane trafficking protein like), COG4 (component of oligomeric golgi complex 4), SNAP29 (synaptosome associated protein 29), RACGAP1 (Rac GTPase activating protein 1), COG5 (component of oligomeric golgi complex 5), GCC2 (GRIP and coiled-coil domain containing 2), TGOLN2 (trans-golgi network protein 2), KIF25 (kinesin family member 25), COG2 (component of oligomeric golgi complex 2), KIFC1 (kinesin family member C1), NAPG (NSF attachment protein gamma), COG7 (component of oligomeric golgi complex 7), STX10 (syntaxin 10), VPS53 (VPS53 subunit of GARP complex), BICD2 (BICD cargo adaptor 2), COPZ2 (COPI coat complex subunit zeta 2), CYTH1 (cytohesin 1), SURF4 (surfeit 4), CAPZB (capping actin protein of muscle Z-line subunit beta), ARF4 (ADP ribosylation factor 4), GOLGA1 (golgin A1), GOLGA5 (golgin A5), KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1), KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2), VPS54 (VPS54 subunit of GARP complex), ACTR10 (actin related protein 10), BICD1 (BICD cargo adaptor 1), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), ARF5 (ADP ribosylation factor 5), DYNLL2 (dynein light chain LC8-type 2), ARF3 (ADP ribosylation factor 3)"], "WAG002609": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PTEN (phosphatase and tensin homolog), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), HRAS (HRas proto-oncogene, GTPase), RPTOR (regulatory associated protein of MTOR complex 1), TSC2 (TSC complex subunit 2), GSK3B (glycogen synthase kinase 3 beta), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), NRAS (NRAS proto-oncogene, GTPase), FOXO1 (forkhead box O1), CDKN1B (cyclin dependent kinase inhibitor 1B), PDK1 (pyruvate dehydrogenase kinase 1), KRAS (KRAS proto-oncogene, GTPase), RICTOR (RPTOR independent companion of MTOR complex 2), RHEB (Ras homolog, mTORC1 binding), FOXO3 (forkhead box O3), NOS3 (nitric oxide synthase 3), RB1CC1 (RB1 inducible coiled-coil 1), ULK1 (unc-51 like autophagy activating kinase 1), ATG13 (autophagy related 13), FOXO4 (forkhead box O4), GRB10 (growth factor receptor bound protein 10), BAD (BCL2 associated agonist of cell death), TFEB (transcription factor EB)"], "WAG002610": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NOTCH1 (notch receptor 1), NOTCH3 (notch receptor 3), NOTCH2 (notch receptor 2), NOTCH4 (notch receptor 4), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), JAG1 (jagged canonical Notch ligand 1), DLL1 (delta like canonical Notch ligand 1), DLL4 (delta like canonical Notch ligand 4), MAML1 (mastermind like transcriptional coactivator 1), MAML2 (mastermind like transcriptional coactivator 2), JAG2 (jagged canonical Notch ligand 2), MAML3 (mastermind like transcriptional coactivator 3), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), PSEN1 (presenilin 1), ADAM10 (ADAM metallopeptidase domain 10), DLL3 (delta like canonical Notch ligand 3), PSEN2 (presenilin 2), HES1 (hes family bHLH transcription factor 1), MFAP2 (microfibril associated protein 2), DNER (delta/notch like EGF repeat containing), LEF1 (lymphoid enhancer binding factor 1), DLK1 (delta like non-canonical Notch ligand 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), CNTN6 (contactin 6), MFAP1 (microfibril associated protein 1), DLK2 (delta like non-canonical Notch ligand 2), RRAS (RAS related)"], "WAG002611": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAP3K1 (mitogen-activated protein kinase kinase kinase 1), NFKB1 (nuclear factor kappa B subunit 1), TRAF6 (TNF receptor associated factor 6), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAPK1 (mitogen-activated protein kinase 1), NFKBIA (NFKB inhibitor alpha), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K6 (mitogen-activated protein kinase kinase 6), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RRAS (RAS related)"], "WAG002612": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), RPS6KB1 (ribosomal protein S6 kinase B1), RPTOR (regulatory associated protein of MTOR complex 1), MLST8 (MTOR associated protein, LST8 homolog), IRS1 (insulin receptor substrate 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), RICTOR (RPTOR independent companion of MTOR complex 2), IGF1 (insulin like growth factor 1), IGF1R (insulin like growth factor 1 receptor), DEPTOR (DEP domain containing MTOR interacting protein), GSK3B (glycogen synthase kinase 3 beta), PTEN (phosphatase and tensin homolog), AKT1S1 (AKT1 substrate 1), ILK (integrin linked kinase), MAPKAP1 (MAPK associated protein 1), EIF4E (eukaryotic translation initiation factor 4E), PDK1 (pyruvate dehydrogenase kinase 1), SMAD3 (SMAD family member 3), NFKB1 (nuclear factor kappa B subunit 1), PPARGC1A (PPARG coactivator 1 alpha), ITGB1 (integrin subunit beta 1), MSTN (myostatin), SMAD2 (SMAD family member 2), IGFBP5 (insulin like growth factor binding protein 5), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), FBXO32 (F-box protein 32), TNFRSF1A (TNF receptor superfamily member 1A), ACVR2B (activin A receptor type 2B), TRIM63 (tripartite motif containing 63), NEB (nebulin), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), EIF2B2 (eukaryotic translation initiation factor 2B subunit beta), WASL (WASP like actin nucleation promoting factor), TNFSF9 (TNF superfamily member 9), PLD1 (phospholipase D1), JKAMP (JNK1/MAPK8 associated membrane protein)"], "WAG002613": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MYD88 (MYD88 innate immune signal transduction adaptor), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TICAM1 (toll like receptor adaptor molecule 1), TLR4 (toll like receptor 4), TNF (tumor necrosis factor), TIRAP (TIR domain containing adaptor protein), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), NFKB1 (nuclear factor kappa B subunit 1), IRAK1 (interleukin 1 receptor associated kinase 1), IRF7 (interferon regulatory factor 7), NFKBIA (NFKB inhibitor alpha), TBK1 (TANK binding kinase 1), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), RIPK1 (receptor interacting serine/threonine kinase 1), TRAF3 (TNF receptor associated factor 3), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), IRAK4 (interleukin 1 receptor associated kinase 4), IRF3 (interferon regulatory factor 3), IRAK3 (interleukin 1 receptor associated kinase 3), IL6 (interleukin 6), IFNB1 (interferon beta 1), TRAM1 (translocation associated membrane protein 1), INPP5D (inositol polyphosphate-5-phosphatase D), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002614": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), HTT (huntingtin), EGFR (epidermal growth factor receptor), EGF (epidermal growth factor), CREB1 (cAMP responsive element binding protein 1), CASP3 (caspase 3), HRAS (HRas proto-oncogene, GTPase), BDNF (brain derived neurotrophic factor), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RPS6KA5 (ribosomal protein S6 kinase A5), CASP7 (caspase 7), ELK1 (ETS transcription factor ELK1), NTRK2 (neurotrophic receptor tyrosine kinase 2), GRM1 (glutamate metabotropic receptor 1), MAP2K7 (mitogen-activated protein kinase kinase 7)"], "WAG002615": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TLR4 (toll like receptor 4), TRAF6 (TNF receptor associated factor 6), MYD88 (MYD88 innate immune signal transduction adaptor), TLR3 (toll like receptor 3), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TICAM1 (toll like receptor adaptor molecule 1), IRAK1 (interleukin 1 receptor associated kinase 1), TBK1 (TANK binding kinase 1), RELA (RELA proto-oncogene, NF-kB subunit), TIRAP (TIR domain containing adaptor protein), IRF7 (interferon regulatory factor 7), TLR1 (toll like receptor 1), NFKB1 (nuclear factor kappa B subunit 1), TRAF3 (TNF receptor associated factor 3), IRF3 (interferon regulatory factor 3), TLR2 (toll like receptor 2), TLR9 (toll like receptor 9), IRAK4 (interleukin 1 receptor associated kinase 4), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), TLR6 (toll like receptor 6), NFKB2 (nuclear factor kappa B subunit 2), TICAM2 (toll like receptor adaptor molecule 2), TOLLIP (toll interacting protein), TLR7 (toll like receptor 7), TLR8 (toll like receptor 8), TLR5 (toll like receptor 5), REL (REL proto-oncogene, NF-kB subunit), RELB (RELB proto-oncogene, NF-kB subunit), MAPK1 (mitogen-activated protein kinase 1)"], "WAG002616": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TGFB1 (transforming growth factor beta 1), SMAD4 (SMAD family member 4), SMAD3 (SMAD family member 3), FN1 (fibronectin 1), AKT1 (AKT serine/threonine kinase 1), SMAD2 (SMAD family member 2), MAPK1 (mitogen-activated protein kinase 1), CDH1 (cadherin 1), MAPK3 (mitogen-activated protein kinase 3), VIM (vimentin), RUNX2 (RUNX family transcription factor 2), SNAI2 (snail family transcriptional repressor 2), TNC (tenascin C), CDH2 (cadherin 2), SNAI1 (snail family transcriptional repressor 1), ID1 (inhibitor of DNA binding 1, HLH protein), CDH6 (cadherin 6), CDH16 (cadherin 16)"], "WAG002617": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "LCK (LCK proto-oncogene, Src family tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), IL2 (interleukin 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), GRB2 (growth factor receptor bound protein 2), NFKB1 (nuclear factor kappa B subunit 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), CD4 (CD4 molecule), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TNF (tumor necrosis factor), PRKCQ (protein kinase C theta), MAPK3 (mitogen-activated protein kinase 3), PLCG1 (phospholipase C gamma 1), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), CBL (Cbl proto-oncogene), CD28 (CD28 molecule), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CD3D (CD3d molecule), PTPN6 (protein tyrosine phosphatase non-receptor type 6), LCP2 (lymphocyte cytosolic protein 2), IFNG (interferon gamma), IL4 (interleukin 4), NFKBIA (NFKB inhibitor alpha), ITK (IL2 inducible T cell kinase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CSF2 (colony stimulating factor 2), CD8A (CD8a molecule), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), LAT (linker for activation of T cells), PTPRC (protein tyrosine phosphatase receptor type C), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), GRAP2 (GRB2 related adaptor protein 2), CD40LG (CD40 ligand), MAP2K1 (mitogen-activated protein kinase kinase 1), NFATC2 (nuclear factor of activated T cells 2), MAPK9 (mitogen-activated protein kinase 9), BCL10 (BCL10 immune signaling adaptor), CTLA4 (cytotoxic T-lymphocyte associated protein 4), NCK1 (NCK adaptor protein 1), PAK1 (p21 (RAC1) activated kinase 1), IL5 (interleukin 5), IL10 (interleukin 10), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), CARD11 (caspase recruitment domain family member 11), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), MAP2K2 (mitogen-activated protein kinase kinase 2), MALT1 (MALT1 paracaspase), RRAS (RAS related), MAP2K7 (mitogen-activated protein kinase kinase 7), GSK3B (glycogen synthase kinase 3 beta), CDK4 (cyclin dependent kinase 4), PDK1 (pyruvate dehydrogenase kinase 1), PDCD1 (programmed cell death 1), ICOS (inducible T cell costimulator), DLG1 (discs large MAGUK scaffold protein 1), CHP1 (calcineurin like EF-hand protein 1), CALM1 (calmodulin 1), AHSA1 (activator of HSP90 ATPase activity 1)"], "WAG002618": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAVS (mitochondrial antiviral signaling protein), TRAF6 (TNF receptor associated factor 6), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), TRAF2 (TNF receptor associated factor 2), TNF (tumor necrosis factor), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), TBK1 (TANK binding kinase 1), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), RELA (RELA proto-oncogene, NF-kB subunit), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TRAF3 (TNF receptor associated factor 3), RIPK1 (receptor interacting serine/threonine kinase 1), NFKB1 (nuclear factor kappa B subunit 1), DDX58 (DExD/H-box helicase 58), IRF3 (interferon regulatory factor 3), TRADD (TNFRSF1A associated via death domain), CASP8 (caspase 8), IRF7 (interferon regulatory factor 7), NFKBIA (NFKB inhibitor alpha), FADD (Fas associated via death domain), TANK (TRAF family member associated NFKB activator), MAPK8 (mitogen-activated protein kinase 8), MAPK14 (mitogen-activated protein kinase 14), CYLD (CYLD lysine 63 deubiquitinase), CASP10 (caspase 10), IFNB1 (interferon beta 1), IFIH1 (interferon induced with helicase C domain 1), ISG15 (ISG15 ubiquitin like modifier), MAPK9 (mitogen-activated protein kinase 9), NLRX1 (NLR family member X1), PIN1 (peptidylprolyl cis/trans isomerase, NIMA-interacting 1), SIKE1 (suppressor of IKBKE 1), NFKBIB (NFKB inhibitor beta), IFNG (interferon gamma), MAPK11 (mitogen-activated protein kinase 11), DDX3X (DEAD-box helicase 3 X-linked), MAPK10 (mitogen-activated protein kinase 10), CXCL10 (C-X-C motif chemokine ligand 10), AZI2 (5-azacytidine induced 2), MAPK13 (mitogen-activated protein kinase 13), ATG5 (autophagy related 5), TRIM25 (tripartite motif containing 25), MAPK12 (mitogen-activated protein kinase 12), TBKBP1 (TBK1 binding protein 1), DHX58 (DExH-box helicase 58), ATG12 (autophagy related 12), RNF125 (ring finger protein 125), DDX3Y (DEAD-box helicase 3 Y-linked), OTUD5 (OTU deubiquitinase 5), CXCL12 (C-X-C motif chemokine ligand 12), DDX17 (DEAD-box helicase 17), SNW1 (SNW domain containing 1), IFNA1 (interferon alpha 1), TKFC (triokinase and FMN cyclase), CXCL8 (C-X-C motif chemokine ligand 8), IFNE (interferon epsilon), STING1 (stimulator of interferon response cGAMP interactor 1), IFNK (interferon kappa)"], "WAG002619": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK3 (mitogen-activated protein kinase 3), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), MAPK1 (mitogen-activated protein kinase 1), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), ADCY1 (adenylate cyclase 1), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), MAPK14 (mitogen-activated protein kinase 14), ADCY7 (adenylate cyclase 7), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), MAPK8 (mitogen-activated protein kinase 8), MAPK11 (mitogen-activated protein kinase 11), MAPK13 (mitogen-activated protein kinase 13), MAPK12 (mitogen-activated protein kinase 12), MAPK10 (mitogen-activated protein kinase 10), MAPK9 (mitogen-activated protein kinase 9), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), CYP3A4 (cytochrome P450 family 3 subfamily A member 4), AHR (aryl hydrocarbon receptor), CNR1 (cannabinoid receptor 1), CYP2C19 (cytochrome P450 family 2 subfamily C member 19), CYP2C9 (cytochrome P450 family 2 subfamily C member 9), ADORA2A (adenosine A2a receptor), FAAH (fatty acid amide hydrolase), CNR2 (cannabinoid receptor 2), NAPEPLD (N-acyl phosphatidylethanolamine phospholipase D), DAGLA (diacylglycerol lipase alpha), DAGLB (diacylglycerol lipase beta)"], "WAG002621": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BAX (BCL2 associated X, apoptosis regulator), BCL2 (BCL2 apoptosis regulator), MCL1 (MCL1 apoptosis regulator, BCL2 family member), BCL2L1 (BCL2 like 1), AKT1 (AKT serine/threonine kinase 1), BAK1 (BCL2 antagonist/killer 1), MYC (MYC proto-oncogene, bHLH transcription factor), BID (BH3 interacting domain death agonist), GSK3B (glycogen synthase kinase 3 beta), BCL2L2 (BCL2 like 2), BCL2A1 (BCL2 related protein A1), BCL2L10 (BCL2 like 10), GSK3A (glycogen synthase kinase 3 alpha), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), ITGB4 (integrin subunit beta 4), ITGA6 (integrin subunit alpha 6), BOK (BCL2 family apoptosis regulator BOK), BCL2L12 (BCL2 like 12), BCL2L14 (BCL2 like 14), PTHLH (parathyroid hormone like hormone), BCL2L13 (BCL2 like 13), BCL2L15 (BCL2 like 15)"], "WAG002622": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), SMAD2 (SMAD family member 2), TGFBR1 (transforming growth factor beta receptor 1), TGFB1 (transforming growth factor beta 1), MAPK8 (mitogen-activated protein kinase 8), TGFBR2 (transforming growth factor beta receptor 2), BMPR2 (bone morphogenetic protein receptor type 2), MAPK14 (mitogen-activated protein kinase 14), MAPK9 (mitogen-activated protein kinase 9), BMPR1A (bone morphogenetic protein receptor type 1A), LOXL2 (lysyl oxidase like 2), LOX (lysyl oxidase), LOXL4 (lysyl oxidase like 4), LOXL1 (lysyl oxidase like 1), GREM1 (gremlin 1, DAN family BMP antagonist), BMP1 (bone morphogenetic protein 1)"], "WAG002624": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD9 (SMAD family member 9), BMP2 (bone morphogenetic protein 2), FOXO1 (forkhead box O1), DKK1 (dickkopf WNT signaling pathway inhibitor 1), SMAD1 (SMAD family member 1), SMAD5 (SMAD family member 5), CTNNB1 (catenin beta 1), SFRP1 (secreted frizzled related protein 1), BCL2L11 (BCL2 like 11), WNT4 (Wnt family member 4), SST (somatostatin), LEFTY2 (left-right determination factor 2), DCN (decorin)"], "WAG002625": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), MYD88 (MYD88 innate immune signal transduction adaptor), TLR4 (toll like receptor 4), IRAK1 (interleukin 1 receptor associated kinase 1), TLR2 (toll like receptor 2), TLR9 (toll like receptor 9), TLR1 (toll like receptor 1), TLR5 (toll like receptor 5), TLR7 (toll like receptor 7), TLR6 (toll like receptor 6), TLR8 (toll like receptor 8), TLR10 (toll like receptor 10), IL1A (interleukin 1 alpha), NFKB1 (nuclear factor kappa B subunit 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), UBE2N (ubiquitin conjugating enzyme E2 N), UBE2V1 (ubiquitin conjugating enzyme E2 V1), TIFA (TRAF interacting protein with forkhead associated domain)"], "WAG002626": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATM (ATM serine/threonine kinase), RAD50 (RAD50 double strand break repair protein), TP53BP1 (tumor protein p53 binding protein 1), NBN (nibrin), CHEK2 (checkpoint kinase 2), CHEK1 (checkpoint kinase 1), ATR (ATR serine/threonine kinase), RNF8 (ring finger protein 8), MDC1 (mediator of DNA damage checkpoint 1), PRKDC (protein kinase, DNA-activated, catalytic subunit), KAT5 (lysine acetyltransferase 5), CDK1 (cyclin dependent kinase 1), NFKB1 (nuclear factor kappa B subunit 1), SMC1A (structural maintenance of chromosomes 1A), BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), RBBP8 (RB binding protein 8, endonuclease), DCLRE1C (DNA cross-link repair 1C), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), TRIM28 (tripartite motif containing 28), ATF2 (activating transcription factor 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), AURKB (aurora kinase B), HDAC4 (histone deacetylase 4), MTOR (mechanistic target of rapamycin kinase), CDK5 (cyclin dependent kinase 5), STK11 (serine/threonine kinase 11), TSC2 (TSC complex subunit 2), HSPB1 (heat shock protein family B (small) member 1), PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D), RNF20 (ring finger protein 20), RNF40 (ring finger protein 40), ATMIN (ATM interactor), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1), CEP63 (centrosomal protein 63), RNF168 (ring finger protein 168), PPP5C (protein phosphatase 5 catalytic subunit), LBR (lamin B receptor), G6PD (glucose-6-phosphate dehydrogenase), CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1), RIF1 (replication timing regulatory factor 1), MRE11 (MRE11 homolog, double strand break repair nuclease), PTPA (protein phosphatase 2 phosphatase activator), H2AX (H2A.X variant histone), HMGN1 (high mobility group nucleosome binding domain 1)"], "WAG002628": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), VEGFA (vascular endothelial growth factor A), FN1 (fibronectin 1), RAC1 (Rac family small GTPase 1), MAPK3 (mitogen-activated protein kinase 3), MAPK14 (mitogen-activated protein kinase 14), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CTNNB1 (catenin beta 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), PRKCA (protein kinase C alpha), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), FYN (FYN proto-oncogene, Src family tyrosine kinase), MAPK8 (mitogen-activated protein kinase 8), PXN (paxillin), MDM2 (MDM2 proto-oncogene), PRKCD (protein kinase C delta), SHC1 (SHC adaptor protein 1), CDC42 (cell division cycle 42), STAT3 (signal transducer and activator of transcription 3), PLCG1 (phospholipase C gamma 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), NFKB1 (nuclear factor kappa B subunit 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), KDR (kinase insert domain receptor), RELA (RELA proto-oncogene, NF-kB subunit), PTK2 (protein tyrosine kinase 2), CRK (CRK proto-oncogene, adaptor protein), MTOR (mechanistic target of rapamycin kinase), RHOA (ras homolog family member A), CBL (Cbl proto-oncogene), PRKCZ (protein kinase C zeta), CREBBP (CREB binding protein), HRAS (HRas proto-oncogene, GTPase), ITGB1 (integrin subunit beta 1), PPP2CA (protein phosphatase 2 catalytic subunit alpha), ARRB2 (arrestin beta 2), PRKCE (protein kinase C epsilon), ATF2 (activating transcription factor 2), PRKCB (protein kinase C beta), PTK2B (protein tyrosine kinase 2 beta), CSK (C-terminal Src kinase), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), CCND1 (cyclin D1), STAT1 (signal transducer and activator of transcription 1), MAP2K1 (mitogen-activated protein kinase kinase 1), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), CAV1 (caveolin 1), NCK1 (NCK adaptor protein 1), ACTG1 (actin gamma 1), HDAC1 (histone deacetylase 1), ICAM1 (intercellular adhesion molecule 1), RPS6KB1 (ribosomal protein S6 kinase B1), PTGS2 (prostaglandin-endoperoxide synthase 2), MAPK9 (mitogen-activated protein kinase 9), PAK1 (p21 (RAC1) activated kinase 1), GSK3B (glycogen synthase kinase 3 beta), CREB1 (cAMP responsive element binding protein 1), ITGAV (integrin subunit alpha V), BCAR1 (BCAR1 scaffold protein, Cas family member), FLT1 (fms related receptor tyrosine kinase 1), NFKBIA (NFKB inhibitor alpha), ITGB3 (integrin subunit beta 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PTPN6 (protein tyrosine phosphatase non-receptor type 6), VCL (vinculin), NOS3 (nitric oxide synthase 3), EZR (ezrin), PAK2 (p21 (RAC1) activated kinase 2), EPHA2 (EPH receptor A2), RPS6 (ribosomal protein S6), EIF4E (eukaryotic translation initiation factor 4E), PPP1CA (protein phosphatase 1 catalytic subunit alpha), ETS1 (ETS proto-oncogene 1, transcription factor), ITGB5 (integrin subunit beta 5), BCL2 (BCL2 apoptosis regulator), MAP2K4 (mitogen-activated protein kinase kinase 4), ROCK1 (Rho associated coiled-coil containing protein kinase 1), CLTC (clathrin heavy chain), PLAU (plasminogen activator, urokinase), PTPN1 (protein tyrosine phosphatase non-receptor type 1), PRKCI (protein kinase C iota), CTNNA1 (catenin alpha 1), IQGAP1 (IQ motif containing GTPase activating protein 1), MAPK12 (mitogen-activated protein kinase 12), VAV2 (vav guanine nucleotide exchange factor 2), CTNND1 (catenin delta 1), HDAC5 (histone deacetylase 5), PDPK1 (3-phosphoinositide dependent protein kinase 1), ALB (albumin), EGR1 (early growth response 1), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), NFATC1 (nuclear factor of activated T cells 1), SRF (serum response factor), RPL5 (ribosomal protein L5), NCL (nucleolin)"], "WAG002629": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL1B (interleukin 1 beta), TLR4 (toll like receptor 4), CASP1 (caspase 1), NFKB1 (nuclear factor kappa B subunit 1), PYCARD (PYD and CARD domain containing), NOX1 (NADPH oxidase 1), CTSB (cathepsin B)"], "WAG002633": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "F2 (coagulation factor II, thrombin), PLG (plasminogen), F5 (coagulation factor V), KNG1 (kininogen 1), C3 (complement C3), SERPINC1 (serpin family C member 1), F8 (coagulation factor VIII), SERPING1 (serpin family G member 1), F10 (coagulation factor X), SERPINE1 (serpin family E member 1), C1R (complement C1r), CFI (complement factor I), PROC (protein C, inactivator of coagulation factors Va and VIIIa), F3 (coagulation factor III, tissue factor), SERPINF2 (serpin family F member 2), F7 (coagulation factor VII), PLAT (plasminogen activator, tissue type), FGB (fibrinogen beta chain), A2M (alpha-2-macroglobulin), CPB2 (carboxypeptidase B2), MASP2 (mannan binding lectin serine peptidase 2), SERPIND1 (serpin family D member 1), CFB (complement factor B), F9 (coagulation factor IX), C2 (complement C2), THBD (thrombomodulin), VWF (von Willebrand factor), MASP1 (mannan binding lectin serine peptidase 1), C1S (complement C1s), CLU (clusterin), C4B (complement C4B (Chido blood group)), CFD (complement factor D), KLKB1 (kallikrein B1), F12 (coagulation factor XII), SERPINA1 (serpin family A member 1), SERPINA5 (serpin family A member 5), PROS1 (protein S), TFPI (tissue factor pathway inhibitor), C7 (complement C7), F2R (coagulation factor II thrombin receptor), PLAU (plasminogen activator, urokinase), F13B (coagulation factor XIII B chain), C9 (complement C9), CR1 (complement C3b/C4b receptor 1 (Knops blood group)), C1QB (complement C1q B chain), C1QA (complement C1q A chain), C5AR1 (complement C5a receptor 1), C6 (complement C6), PLAUR (plasminogen activator, urokinase receptor), APOA2 (apolipoprotein A2), C1QC (complement C1q C chain), CD46 (CD46 molecule), C3AR1 (complement C3a receptor 1), CFH (complement factor H), BDKRB1 (bradykinin receptor B1), C8G (complement C8 gamma chain), CD55 (CD55 molecule (Cromer blood group)), CR2 (complement C3d receptor 2), LMAN1 (lectin, mannose binding 1), CLTC (clathrin heavy chain)"], "WAG002639": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FDFT1 (farnesyl-diphosphate farnesyltransferase 1), SQLE (squalene epoxidase), IDI1 (isopentenyl-diphosphate delta isomerase 1), MSMO1 (methylsterol monooxygenase 1), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), MVD (mevalonate diphosphate decarboxylase), FDPS (farnesyl diphosphate synthase), NSDHL (NAD(P) dependent steroid dehydrogenase-like), LSS (lanosterol synthase), PMVK (phosphomevalonate kinase), MVK (mevalonate kinase), SC5D (sterol-C5-desaturase)"], "WAG002641": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MVD (mevalonate diphosphate decarboxylase), IDI1 (isopentenyl-diphosphate delta isomerase 1), SQLE (squalene epoxidase), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), FDPS (farnesyl diphosphate synthase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), MVK (mevalonate kinase), PMVK (phosphomevalonate kinase), LSS (lanosterol synthase)"], "WAG002642": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TFAM (transcription factor A, mitochondrial), HCFC1 (host cell factor C1), PPARGC1A (PPARG coactivator 1 alpha), NRF1 (nuclear respiratory factor 1), SP1 (Sp1 transcription factor), GABPB1 (GA binding protein transcription factor subunit beta 1), GABPA (GA binding protein transcription factor subunit alpha), POLRMT (RNA polymerase mitochondrial), TFB1M (transcription factor B1, mitochondrial), CREB1 (cAMP responsive element binding protein 1), TFB2M (transcription factor B2, mitochondrial), ESRRA (estrogen related receptor alpha), PPRC1 (PPARG related coactivator 1), CAMK4 (calcium/calmodulin dependent protein kinase IV), PPARGC1B (PPARG coactivator 1 beta), MYEF2 (myelin expression factor 2), PPP3CA (protein phosphatase 3 catalytic subunit alpha), MTERF3 (mitochondrial transcription termination factor 3), MTERF1 (mitochondrial transcription termination factor 1), GABPB1-IT1 (GABPB1 intronic transcript)"], "WAG002645": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), MAPK8 (mitogen-activated protein kinase 8), MTOR (mechanistic target of rapamycin kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK14 (mitogen-activated protein kinase 14), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), IRS1 (insulin receptor substrate 1), CRK (CRK proto-oncogene, adaptor protein), MAP2K4 (mitogen-activated protein kinase kinase 4), HRAS (HRas proto-oncogene, GTPase), RPS6KB1 (ribosomal protein S6 kinase B1), MAP2K1 (mitogen-activated protein kinase kinase 1), SHC1 (SHC adaptor protein 1), INSR (insulin receptor), AKT2 (AKT serine/threonine kinase 2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), GSK3B (glycogen synthase kinase 3 beta), IRS2 (insulin receptor substrate 2), TSC2 (TSC complex subunit 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MAP2K3 (mitogen-activated protein kinase kinase 3), MAP2K6 (mitogen-activated protein kinase kinase 6), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CBL (Cbl proto-oncogene), PDPK1 (3-phosphoinositide dependent protein kinase 1), TSC1 (TSC complex subunit 1), MAPK11 (mitogen-activated protein kinase 11), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), SLC2A4 (solute carrier family 2 member 4), MAP2K7 (mitogen-activated protein kinase kinase 7), RPTOR (regulatory associated protein of MTOR complex 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), MAP2K2 (mitogen-activated protein kinase kinase 2), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), RXRA (retinoid X receptor alpha), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), MAPK7 (mitogen-activated protein kinase 7), RHEB (Ras homolog, mTORC1 binding), RPS6KA1 (ribosomal protein S6 kinase A1), MAPK9 (mitogen-activated protein kinase 9), MAPK13 (mitogen-activated protein kinase 13), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), RPS6KA2 (ribosomal protein S6 kinase A2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), MAPK6 (mitogen-activated protein kinase 6), MAPK12 (mitogen-activated protein kinase 12), IRS4 (insulin receptor substrate 4), MLST8 (MTOR associated protein, LST8 homolog), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), FOXO1 (forkhead box O1), MAP3K4 (mitogen-activated protein kinase kinase kinase 4), CBLB (Cbl proto-oncogene B), MAPK10 (mitogen-activated protein kinase 10), RPS6KA5 (ribosomal protein S6 kinase A5), INS (insulin), RPS6KA3 (ribosomal protein S6 kinase A3), MAP2K5 (mitogen-activated protein kinase kinase 5), SREBF1 (sterol regulatory element binding transcription factor 1), FASN (fatty acid synthase), MAP3K11 (mitogen-activated protein kinase kinase kinase 11), RPS6KA4 (ribosomal protein S6 kinase A4), RICTOR (RPTOR independent companion of MTOR complex 2), SHC2 (SHC adaptor protein 2), PTPN1 (protein tyrosine phosphatase non-receptor type 1), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), CBLC (Cbl proto-oncogene C), MAP3K2 (mitogen-activated protein kinase kinase kinase 2), EIF4E (eukaryotic translation initiation factor 4E), MAP3K12 (mitogen-activated protein kinase kinase kinase 12), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), MAP4K2 (mitogen-activated protein kinase kinase kinase kinase 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), RHOQ (ras homolog family member Q), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), RAPGEF1 (Rap guanine nucleotide exchange factor 1), MAPKAP1 (MAPK associated protein 1), RPS6KA6 (ribosomal protein S6 kinase A6), SHC3 (SHC adaptor protein 3), TRIP10 (thyroid hormone receptor interactor 10), RPS6KB2 (ribosomal protein S6 kinase B2), MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4), PCK1 (phosphoenolpyruvate carboxykinase 1), MAPK4 (mitogen-activated protein kinase 4), G6PC (glucose-6-phosphatase catalytic subunit), MAP4K3 (mitogen-activated protein kinase kinase kinase kinase 3), FOXO3 (forkhead box O3), NR1H3 (nuclear receptor subfamily 1 group H member 3), SLC2A1 (solute carrier family 2 member 1)"], "WAG002646": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SQLE (squalene epoxidase), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), MSMO1 (methylsterol monooxygenase 1), IDI1 (isopentenyl-diphosphate delta isomerase 1), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), FDPS (farnesyl diphosphate synthase), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), DHCR7 (7-dehydrocholesterol reductase), MVD (mevalonate diphosphate decarboxylase), NSDHL (NAD(P) dependent steroid dehydrogenase-like), LSS (lanosterol synthase), PMVK (phosphomevalonate kinase), MVK (mevalonate kinase), SC5D (sterol-C5-desaturase)"], "WAG002647": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MDH2 (malate dehydrogenase 2), OGDH (oxoglutarate dehydrogenase), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), FH (fumarate hydratase), HK1 (hexokinase 1), G6PD (glucose-6-phosphate dehydrogenase), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), SUCLA2 (succinate-CoA ligase ADP-forming subunit beta), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), LDHA (lactate dehydrogenase A), SDHA (succinate dehydrogenase complex flavoprotein subunit A), FASN (fatty acid synthase), PDK1 (pyruvate dehydrogenase kinase 1)"], "WAG002650": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), FASN (fatty acid synthase), HK1 (hexokinase 1), G6PD (glucose-6-phosphate dehydrogenase), LDHA (lactate dehydrogenase A), PDK1 (pyruvate dehydrogenase kinase 1)"], "WAG002653": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GOT2 (glutamic-oxaloacetic transaminase 2), GOT1 (glutamic-oxaloacetic transaminase 1), PC (pyruvate carboxylase), GLUD1 (glutamate dehydrogenase 1), MDH2 (malate dehydrogenase 2), CS (citrate synthase), OGDH (oxoglutarate dehydrogenase), PKM (pyruvate kinase M1/2), MDH1 (malate dehydrogenase 1), ALDH7A1 (aldehyde dehydrogenase 7 family member A1), CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase), ACLY (ATP citrate lyase), DLD (dihydrolipoamide dehydrogenase), GLUL (glutamate-ammonia ligase), DDC (dopa decarboxylase), ALDH18A1 (aldehyde dehydrogenase 18 family member A1), GLS (glutaminase), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), PDHX (pyruvate dehydrogenase complex component X), LDHA (lactate dehydrogenase A), ASS1 (argininosuccinate synthase 1), PCK1 (phosphoenolpyruvate carboxykinase 1), MAOA (monoamine oxidase A), ASNS (asparagine synthetase (glutamine-hydrolyzing)), TAT (tyrosine aminotransferase), CTH (cystathionine gamma-lyase), HADH (hydroxyacyl-CoA dehydrogenase), ACO2 (aconitase 2), ALDH1A1 (aldehyde dehydrogenase 1 family member A1), CPS1 (carbamoyl-phosphate synthase 1), ACAA1 (acetyl-CoA acyltransferase 1), FTCD (formimidoyltransferase cyclodeaminase), IDH1 (isocitrate dehydrogenase (NADP(+)) 1), EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase), DLST (dihydrolipoamide S-succinyltransferase), GCLM (glutamate-cysteine ligase modifier subunit), SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha), CBS (cystathionine beta-synthase), OTC (ornithine carbamoyltransferase), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2), OAT (ornithine aminotransferase), FH (fumarate hydratase), TH (tyrosine hydroxylase), AOC3 (amine oxidase copper containing 3), ACADM (acyl-CoA dehydrogenase medium chain), HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase), ODC1 (ornithine decarboxylase 1), ACSS1 (acyl-CoA synthetase short chain family member 1), MCCC1 (methylcrotonoyl-CoA carboxylase 1), ARG1 (arginase 1), HAL (histidine ammonia-lyase), HIBCH (3-hydroxyisobutyryl-CoA hydrolase), DBH (dopamine beta-hydroxylase), SDHA (succinate dehydrogenase complex flavoprotein subunit A), TPO (thyroid peroxidase), MPST (mercaptopyruvate sulfurtransferase), ADH1C (alcohol dehydrogenase 1C (class I), gamma polypeptide), SRM (spermidine synthase), ARG2 (arginase 2), PDK4 (pyruvate dehydrogenase kinase 4), BHMT (betaine--homocysteine S-methyltransferase), HNMT (histamine N-methyltransferase), AUH (AU RNA binding methylglutaconyl-CoA hydratase), FARSB (phenylalanyl-tRNA synthetase subunit beta), HDC (histidine decarboxylase), ADH4 (alcohol dehydrogenase 4 (class II), pi polypeptide), ADH5 (alcohol dehydrogenase 5 (class III), chi polypeptide), ADH7 (alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide), TDO2 (tryptophan 2,3-dioxygenase), PNMT (phenylethanolamine N-methyltransferase), TPH1 (tryptophan hydroxylase 1), PYCR1 (pyrroline-5-carboxylate reductase 1), GPT2 (glutamic--pyruvic transaminase 2), HIBADH (3-hydroxyisobutyrate dehydrogenase), GSS (glutathione synthetase), GSR (glutathione-disulfide reductase), SDS (serine dehydratase), BCAT1 (branched chain amino acid transaminase 1), SMS (spermine synthase), FAH (fumarylacetoacetate hydrolase), P4HA2 (prolyl 4-hydroxylase subunit alpha 2), LARS2 (leucyl-tRNA synthetase 2, mitochondrial), VARS1 (valyl-tRNA synthetase 1), MMUT (methylmalonyl-CoA mutase), MARS2 (methionyl-tRNA synthetase 2, mitochondrial), CBSL (cystathionine beta-synthase like), IARS1 (isoleucyl-tRNA synthetase 1), EPRS1 (glutamyl-prolyl-tRNA synthetase 1), WARS1 (tryptophanyl-tRNA synthetase 1), PPM1L (protein phosphatase, Mg2+/Mn2+ dependent 1L), RARS1 (arginyl-tRNA synthetase 1), G6PC2 (glucose-6-phosphatase catalytic subunit 2)"], "WAG002656": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNAI2 (G protein subunit alpha i2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), GNG2 (G protein subunit gamma 2), GNAI1 (G protein subunit alpha i1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), GNAI3 (G protein subunit alpha i3), CCR3 (C-C motif chemokine receptor 3), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), AKT1 (AKT serine/threonine kinase 1), JAK2 (Janus kinase 2), CXCR4 (C-X-C motif chemokine receptor 4), RAC1 (Rac family small GTPase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), CCR1 (C-C motif chemokine receptor 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), GNB1 (G protein subunit beta 1), ADCY7 (adenylate cyclase 7), CCR6 (C-C motif chemokine receptor 6), CCR7 (C-C motif chemokine receptor 7), CXCR5 (C-X-C motif chemokine receptor 5), CCR8 (C-C motif chemokine receptor 8), CXCR6 (C-X-C motif chemokine receptor 6), CXCL12 (C-X-C motif chemokine ligand 12), CXCR2 (C-X-C motif chemokine receptor 2), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), MAPK1 (mitogen-activated protein kinase 1), CCL5 (C-C motif chemokine ligand 5), GRB2 (growth factor receptor bound protein 2), ADCY2 (adenylate cyclase 2), GNGT1 (G protein subunit gamma transducin 1), XCR1 (X-C motif chemokine receptor 1), ADCY5 (adenylate cyclase 5), ADCY1 (adenylate cyclase 1), ADCY6 (adenylate cyclase 6), CXCL10 (C-X-C motif chemokine ligand 10), ADCY4 (adenylate cyclase 4), ADCY9 (adenylate cyclase 9), ADCY8 (adenylate cyclase 8), CXCL9 (C-X-C motif chemokine ligand 9), MAPK3 (mitogen-activated protein kinase 3), PRKCD (protein kinase C delta), CCR4 (C-C motif chemokine receptor 4), PTK2 (protein tyrosine kinase 2), CXCL11 (C-X-C motif chemokine ligand 11), CX3CR1 (C-X3-C motif chemokine receptor 1), FGR (FGR proto-oncogene, Src family tyrosine kinase), JAK3 (Janus kinase 3), CCR2 (C-C motif chemokine receptor 2), CXCR3 (C-X-C motif chemokine receptor 3), CCL20 (C-C motif chemokine ligand 20), CCL19 (C-C motif chemokine ligand 19), CCL21 (C-C motif chemokine ligand 21), HRAS (HRas proto-oncogene, GTPase), PLCB2 (phospholipase C beta 2), CXCL13 (C-X-C motif chemokine ligand 13), PRKCZ (protein kinase C zeta), PLCB1 (phospholipase C beta 1), CXCL5 (C-X-C motif chemokine ligand 5), CCR10 (C-C motif chemokine receptor 10), HCK (HCK proto-oncogene, Src family tyrosine kinase), CXCL16 (C-X-C motif chemokine ligand 16), PPBP (pro-platelet basic protein), GNG4 (G protein subunit gamma 4), CXCL3 (C-X-C motif chemokine ligand 3), CCL25 (C-C motif chemokine ligand 25), ARRB1 (arrestin beta 1), GNB2 (G protein subunit beta 2), CCR9 (C-C motif chemokine receptor 9), CDC42 (cell division cycle 42), VAV1 (vav guanine nucleotide exchange factor 1), GNG7 (G protein subunit gamma 7), GNG3 (G protein subunit gamma 3), GNG13 (G protein subunit gamma 13), ARRB2 (arrestin beta 2), CCL28 (C-C motif chemokine ligand 28), PLCB3 (phospholipase C beta 3), GNG12 (G protein subunit gamma 12), GNG8 (G protein subunit gamma 8), PLCB4 (phospholipase C beta 4), PTK2B (protein tyrosine kinase 2 beta), GRK6 (G protein-coupled receptor kinase 6), GNB3 (G protein subunit beta 3), GNB4 (G protein subunit beta 4), CSK (C-terminal Src kinase), SHC1 (SHC adaptor protein 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), CCL4 (C-C motif chemokine ligand 4), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), GNGT2 (G protein subunit gamma transducin 2), STAT3 (signal transducer and activator of transcription 3), GNG5 (G protein subunit gamma 5), NRAS (NRAS proto-oncogene, GTPase), GNG11 (G protein subunit gamma 11), NFKB1 (nuclear factor kappa B subunit 1), GNB5 (G protein subunit beta 5), CRK (CRK proto-oncogene, adaptor protein), VAV2 (vav guanine nucleotide exchange factor 2), RAC2 (Rac family small GTPase 2)"], "WAG002658": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), PDGFRB (platelet derived growth factor receptor beta), FGFR2 (fibroblast growth factor receptor 2), FGFR1 (fibroblast growth factor receptor 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), AKT1 (AKT serine/threonine kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PDGFRA (platelet derived growth factor receptor alpha), FGFR3 (fibroblast growth factor receptor 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), WNT3A (Wnt family member 3A), CTNNB1 (catenin beta 1), FZD5 (frizzled class receptor 5), FGFR4 (fibroblast growth factor receptor 4), FZD1 (frizzled class receptor 1), GAB1 (GRB2 associated binding protein 1), STAT3 (signal transducer and activator of transcription 3), FGF1 (fibroblast growth factor 1), FZD2 (frizzled class receptor 2), WNT1 (Wnt family member 1), FZD7 (frizzled class receptor 7), FZD4 (frizzled class receptor 4), FZD8 (frizzled class receptor 8), HRAS (HRas proto-oncogene, GTPase), FZD6 (frizzled class receptor 6), LRP6 (LDL receptor related protein 6), EGF (epidermal growth factor), DVL1 (dishevelled segment polarity protein 1), FGF4 (fibroblast growth factor 4), FGF10 (fibroblast growth factor 10), FZD9 (frizzled class receptor 9), WNT5A (Wnt family member 5A), FGF9 (fibroblast growth factor 9), MAP2K1 (mitogen-activated protein kinase kinase 1), GSK3B (glycogen synthase kinase 3 beta), WNT7B (Wnt family member 7B), FGF6 (fibroblast growth factor 6), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), SMAD4 (SMAD family member 4), JAK1 (Janus kinase 1), WNT7A (Wnt family member 7A), FGF7 (fibroblast growth factor 7), FGF2 (fibroblast growth factor 2), WNT11 (Wnt family member 11), WNT2B (Wnt family member 2B), SMAD7 (SMAD family member 7), WNT10B (Wnt family member 10B), WNT3 (Wnt family member 3), BMP4 (bone morphogenetic protein 4), DVL3 (dishevelled segment polarity protein 3), FGF18 (fibroblast growth factor 18), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), FZD3 (frizzled class receptor 3), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), LRP5 (LDL receptor related protein 5), FGF23 (fibroblast growth factor 23), FGF8 (fibroblast growth factor 8), WNT10A (Wnt family member 10A), FGF19 (fibroblast growth factor 19), WNT2 (Wnt family member 2), DVL2 (dishevelled segment polarity protein 2), FGF16 (fibroblast growth factor 16), FGF20 (fibroblast growth factor 20), WNT5B (Wnt family member 5B), FGF3 (fibroblast growth factor 3), PTEN (phosphatase and tensin homolog), WNT9B (Wnt family member 9B), WNT6 (Wnt family member 6), PDGFB (platelet derived growth factor subunit B), AXIN1 (axin 1), WNT16 (Wnt family member 16), FGF5 (fibroblast growth factor 5), FGF22 (fibroblast growth factor 22), MAP2K6 (mitogen-activated protein kinase kinase 6), WNT4 (Wnt family member 4), MTOR (mechanistic target of rapamycin kinase), MAPK12 (mitogen-activated protein kinase 12), MDM2 (MDM2 proto-oncogene), MAP2K2 (mitogen-activated protein kinase kinase 2), FGF17 (fibroblast growth factor 17), SMAD1 (SMAD family member 1), MAP2K3 (mitogen-activated protein kinase kinase 3), APC (APC regulator of WNT signaling pathway), SMAD5 (SMAD family member 5), FGF21 (fibroblast growth factor 21), BMPR1B (bone morphogenetic protein receptor type 1B), ARAF (A-Raf proto-oncogene, serine/threonine kinase), BMPR1A (bone morphogenetic protein receptor type 1A), SMAD9 (SMAD family member 9), MAP2K5 (mitogen-activated protein kinase kinase 5), SMAD6 (SMAD family member 6), MAPK7 (mitogen-activated protein kinase 7), FGF13 (fibroblast growth factor 13), FGF12 (fibroblast growth factor 12), FGF11 (fibroblast growth factor 11), IL6ST (interleukin 6 signal transducer), BRAF (B-Raf proto-oncogene, serine/threonine kinase)"], "WAG002659": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), AKT1 (AKT serine/threonine kinase 1), GRB2 (growth factor receptor bound protein 2), EGFR (epidermal growth factor receptor), MAPK1 (mitogen-activated protein kinase 1), ITGB1 (integrin subunit beta 1), ITGAV (integrin subunit alpha V), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), MAPK3 (mitogen-activated protein kinase 3), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), VEGFA (vascular endothelial growth factor A), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), ITGB4 (integrin subunit beta 4), FN1 (fibronectin 1), IGF1R (insulin like growth factor 1 receptor), PTK2 (protein tyrosine kinase 2), JAK2 (Janus kinase 2), ITGA6 (integrin subunit alpha 6), ITGA5 (integrin subunit alpha 5), ITGA4 (integrin subunit alpha 4), PDGFRB (platelet derived growth factor receptor beta), ITGA3 (integrin subunit alpha 3), HRAS (HRas proto-oncogene, GTPase), ITGB7 (integrin subunit beta 7), ITGB6 (integrin subunit beta 6), ITGA2 (integrin subunit alpha 2), ITGB8 (integrin subunit beta 8), ITGA2B (integrin subunit alpha 2b), MTOR (mechanistic target of rapamycin kinase), HSP90AA1 (heat shock protein 90 alpha family class A member 1), ITGB5 (integrin subunit beta 5), IRS1 (insulin receptor substrate 1), EGF (epidermal growth factor), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), JAK1 (Janus kinase 1), ITGA9 (integrin subunit alpha 9), ITGA8 (integrin subunit alpha 8), IGF1 (insulin like growth factor 1), FGFR1 (fibroblast growth factor receptor 1), PDGFRA (platelet derived growth factor receptor alpha), MET (MET proto-oncogene, receptor tyrosine kinase), ITGA11 (integrin subunit alpha 11), ITGA10 (integrin subunit alpha 10), ITGA7 (integrin subunit alpha 7), AKT2 (AKT serine/threonine kinase 2), FGFR2 (fibroblast growth factor receptor 2), ITGB3 (integrin subunit beta 3), RPS6KB1 (ribosomal protein S6 kinase B1), GSK3B (glycogen synthase kinase 3 beta), IRS2 (insulin receptor substrate 2), NRAS (NRAS proto-oncogene, GTPase), PPP2CA (protein phosphatase 2 catalytic subunit alpha), FGF2 (fibroblast growth factor 2), PDGFB (platelet derived growth factor subunit B), KDR (kinase insert domain receptor), IL2 (interleukin 2), COL1A2 (collagen type I alpha 2 chain), COL1A1 (collagen type I alpha 1 chain), THBS1 (thrombospondin 1), JAK3 (Janus kinase 3), PTEN (phosphatase and tensin homolog), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), COL2A1 (collagen type II alpha 1 chain), FLT4 (fms related receptor tyrosine kinase 4), FGFR3 (fibroblast growth factor receptor 3), AKT3 (AKT serine/threonine kinase 3), KRAS (KRAS proto-oncogene, GTPase), SPP1 (secreted phosphoprotein 1), COL4A1 (collagen type IV alpha 1 chain), HIF1A (hypoxia inducible factor 1 subunit alpha), FLT1 (fms related receptor tyrosine kinase 1), KIT (KIT proto-oncogene, receptor tyrosine kinase), COL5A1 (collagen type V alpha 1 chain), MDM2 (MDM2 proto-oncogene), FGF1 (fibroblast growth factor 1), MAP2K1 (mitogen-activated protein kinase kinase 1), COL3A1 (collagen type III alpha 1 chain), HSP90AB1 (heat shock protein 90 alpha family class B member 1), CREB1 (cAMP responsive element binding protein 1), IL2RA (interleukin 2 receptor subunit alpha), HGF (hepatocyte growth factor), COL5A2 (collagen type V alpha 2 chain), INSR (insulin receptor), COL4A6 (collagen type IV alpha 6 chain), COL4A4 (collagen type IV alpha 4 chain), NOS3 (nitric oxide synthase 3), COL4A2 (collagen type IV alpha 2 chain), GNG2 (G protein subunit gamma 2), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), ITGB2 (integrin subunit beta 2), COL11A1 (collagen type XI alpha 1 chain), LAMB1 (laminin subunit beta 1), GNB1 (G protein subunit beta 1), COL5A3 (collagen type V alpha 3 chain), COL6A2 (collagen type VI alpha 2 chain), LAMB2 (laminin subunit beta 2), LAMA4 (laminin subunit alpha 4)"], "WAG002660": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEPT1 (choline/ethanolamine phosphotransferase 1), PCYT2 (phosphate cytidylyltransferase 2, ethanolamine), PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), PCYT1B (phosphate cytidylyltransferase 1, choline, beta), PISD (phosphatidylserine decarboxylase), PTDSS1 (phosphatidylserine synthase 1), PEMT (phosphatidylethanolamine N-methyltransferase), PTDSS2 (phosphatidylserine synthase 2), CHPT1 (choline phosphotransferase 1), CHKA (choline kinase alpha), CHKB (choline kinase beta), ETNK1 (ethanolamine kinase 1), ETNK2 (ethanolamine kinase 2), SGPL1 (sphingosine-1-phosphate lyase 1)"], "WAG002662": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IRS1 (insulin receptor substrate 1), INSR (insulin receptor), JAK2 (Janus kinase 2), SOCS3 (suppressor of cytokine signaling 3), IRS2 (insulin receptor substrate 2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), AKT1 (AKT serine/threonine kinase 1), SOCS1 (suppressor of cytokine signaling 1), LEPR (leptin receptor), LEP (leptin), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), STAT3 (signal transducer and activator of transcription 3), SOCS2 (suppressor of cytokine signaling 2), PDPK1 (3-phosphoinositide dependent protein kinase 1), IRS4 (insulin receptor substrate 4), INS (insulin), DGKZ (diacylglycerol kinase zeta)"], "WAG002663": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SYK (spleen associated tyrosine kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), VAV1 (vav guanine nucleotide exchange factor 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), TYROBP (transmembrane immune signaling adaptor TYROBP), VAV2 (vav guanine nucleotide exchange factor 2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), RAC1 (Rac family small GTPase 1), RAC2 (Rac family small GTPase 2), ITGB2 (integrin subunit beta 2), FCER1G (Fc fragment of IgE receptor Ig), HCK (HCK proto-oncogene, Src family tyrosine kinase), PLCG2 (phospholipase C gamma 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PTPN6 (protein tyrosine phosphatase non-receptor type 6), LAT (linker for activation of T cells), VAV3 (vav guanine nucleotide exchange factor 3), LYN (LYN proto-oncogene, Src family tyrosine kinase), NCF4 (neutrophil cytosolic factor 4), RAC3 (Rac family small GTPase 3), ITGAM (integrin subunit alpha M), NCF2 (neutrophil cytosolic factor 2), CYBB (cytochrome b-245 beta chain), TREM2 (triggering receptor expressed on myeloid cells 2), NCF1 (neutrophil cytosolic factor 1), CYBA (cytochrome b-245 alpha chain), FCGR1A (Fc fragment of IgG receptor Ia), NCKAP1L (NCK associated protein 1 like), C1QA (complement C1q A chain), C1QB (complement C1q B chain), C1QC (complement C1q C chain), SIGLEC7 (sialic acid binding Ig like lectin 7), TREM1 (triggering receptor expressed on myeloid cells 1), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), PIK3R6 (phosphoinositide-3-kinase regulatory subunit 6), PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha), ARPC1B (actin related protein 2/3 complex subunit 1B)"], "WAG002665": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GSS (glutathione synthetase), BHMT (betaine--homocysteine S-methyltransferase), SHMT1 (serine hydroxymethyltransferase 1), SHMT2 (serine hydroxymethyltransferase 2), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), GSR (glutathione-disulfide reductase), GNMT (glycine N-methyltransferase), MAT1A (methionine adenosyltransferase 1A), CTH (cystathionine gamma-lyase), PEMT (phosphatidylethanolamine N-methyltransferase), MTHFR (methylenetetrahydrofolate reductase), CEPT1 (choline/ethanolamine phosphotransferase 1), SARDH (sarcosine dehydrogenase), GCLC (glutamate-cysteine ligase catalytic subunit), MAT2A (methionine adenosyltransferase 2A), BHMT2 (betaine--homocysteine S-methyltransferase 2), SOD2 (superoxide dismutase 2), PCYT2 (phosphate cytidylyltransferase 2, ethanolamine), PCYT1B (phosphate cytidylyltransferase 1, choline, beta), PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), CDO1 (cysteine dioxygenase type 1), GCLM (glutamate-cysteine ligase modifier subunit), GAD2 (glutamate decarboxylase 2), DMGDH (dimethylglycine dehydrogenase), GAD1 (glutamate decarboxylase 1), AHCYL1 (adenosylhomocysteinase like 1), GPX4 (glutathione peroxidase 4), GPX1 (glutathione peroxidase 1), CHPT1 (choline phosphotransferase 1), AGXT2 (alanine--glyoxylate aminotransferase 2), PLD1 (phospholipase D1), CHKA (choline kinase alpha), CHDH (choline dehydrogenase), TYMS (thymidylate synthetase), SOD1 (superoxide dismutase 1), GPX5 (glutathione peroxidase 5), GPX2 (glutathione peroxidase 2), CHKB (choline kinase beta), DNMT3A (DNA methyltransferase 3 alpha), BAAT (bile acid-CoA:amino acid N-acyltransferase), SOD3 (superoxide dismutase 3), CSAD (cysteine sulfinic acid decarboxylase), GPX3 (glutathione peroxidase 3), GPX6 (glutathione peroxidase 6), GPX7 (glutathione peroxidase 7), BCAT1 (branched chain amino acid transaminase 1), ETNK1 (ethanolamine kinase 1), BCAT2 (branched chain amino acid transaminase 2), ETNK2 (ethanolamine kinase 2), DNM1 (dynamin 1), DHFR2 (dihydrofolate reductase 2), CBSL (cystathionine beta-synthase like), SOD2-OT1 (SOD2 overlapping transcript 1)"], "WAG002666": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASP3 (caspase 3), TNF (tumor necrosis factor), TRAF6 (TNF receptor associated factor 6), BCL2 (BCL2 apoptosis regulator), TRAF2 (TNF receptor associated factor 2), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), CDC42 (cell division cycle 42), NFKB1 (nuclear factor kappa B subunit 1), TRAF1 (TNF receptor associated factor 1), TRAF3 (TNF receptor associated factor 3), CDKN1A (cyclin dependent kinase inhibitor 1A), MAP2K4 (mitogen-activated protein kinase kinase 4), CYCS (cytochrome c, somatic), TNFRSF1B (TNF receptor superfamily member 1B), MAPK10 (mitogen-activated protein kinase 10), C1QB (complement C1q B chain), C4B (complement C4B (Chido blood group)), C1R (complement C1r), C1QA (complement C1q A chain), C1S (complement C1s), PCNA (proliferating cell nuclear antigen), CDKN1B (cyclin dependent kinase inhibitor 1B), CASP9 (caspase 9), TDP2 (tyrosyl-DNA phosphodiesterase 2), C2 (complement C2), C1QC (complement C1q C chain), BAD (BCL2 associated agonist of cell death), APAF1 (apoptotic peptidase activating factor 1), MAPK13 (mitogen-activated protein kinase 13), C5 (complement C5), C3AR1 (complement C3a receptor 1), GADD45A (growth arrest and DNA damage inducible alpha), C5AR1 (complement C5a receptor 1), BAG4 (BAG cochaperone 4), CDKN1C (cyclin dependent kinase inhibitor 1C), BAK1 (BCL2 antagonist/killer 1), MAP3K9 (mitogen-activated protein kinase kinase kinase 9), TNK2 (tyrosine kinase non receptor 2), NFKBIE (NFKB inhibitor epsilon), CR2 (complement C3d receptor 2)"], "WAG002668": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), VEGFA (vascular endothelial growth factor A), KDR (kinase insert domain receptor), SLIT2 (slit guidance ligand 2), ROBO4 (roundabout guidance receptor 4)"], "WAG002670": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TYROBP (transmembrane immune signaling adaptor TYROBP), ITGB2 (integrin subunit beta 2), PLEK (pleckstrin), HCLS1 (hematopoietic cell-specific Lyn substrate 1), IL10RA (interleukin 10 receptor subunit alpha), ITGAM (integrin subunit alpha M), IGSF6 (immunoglobulin superfamily member 6), SLC7A7 (solute carrier family 7 member 7), CD4 (CD4 molecule), ITGAX (integrin subunit alpha X), NCF2 (neutrophil cytosolic factor 2), C3 (complement C3), NCKAP1L (NCK associated protein 1 like), TNFRSF1B (TNF receptor superfamily member 1B), IL18 (interleukin 18), RGS1 (regulator of G protein signaling 1), PYCARD (PYD and CARD domain containing), ADAP2 (ArfGAP with dual PH domains 2), CXCL16 (C-X-C motif chemokine ligand 16), C1QC (complement C1q C chain), CD37 (CD37 molecule), RPS6KA1 (ribosomal protein S6 kinase A1), STAT5A (signal transducer and activator of transcription 5A), SLC1A5 (solute carrier family 1 member 5), SH2B3 (SH2B adaptor protein 3), TGFBR1 (transforming growth factor beta receptor 1), CD84 (CD84 molecule), RUNX3 (RUNX family transcription factor 3), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), APBB1IP (amyloid beta precursor protein binding family B member 1 interacting protein), BIN2 (bridging integrator 2), DPYD (dihydropyrimidine dehydrogenase), CAPG (capping actin protein, gelsolin like), IL13RA1 (interleukin 13 receptor subunit alpha 1), GPX1 (glutathione peroxidase 1), NPC2 (NPC intracellular cholesterol transporter 2), RNASE6 (ribonuclease A family member k6), GAPT (GRB2 binding adaptor protein, transmembrane), GAL3ST4 (galactose-3-O-sulfotransferase 4), GIMAP2 (GTPase, IMAP family member 2), PPP1R18 (protein phosphatase 1 regulatory subunit 18), LOXL3 (lysyl oxidase like 3), SFT2D2 (SFT2 domain containing 2), ELF4 (E74 like ETS transcription factor 4), SAMSN1 (SAM domain, SH3 domain and nuclear localization signals 1), KCNE3 (potassium voltage-gated channel subfamily E regulatory subunit 3), SPP1 (secreted phosphoprotein 1), LGALS9C (galectin 9C), CREB3L2 (cAMP responsive element binding protein 3 like 2), NRROS (negative regulator of reactive oxygen species), MAF (MAF bZIP transcription factor), CYTL1 (cytokine like 1), FKBP15 (FKBP prolyl isomerase 15), LHFPL2 (LHFPL tetraspan subfamily member 2), LYL1 (LYL1 basic helix-loop-helix family member), RBM47 (RNA binding motif protein 47), ABCC4 (ATP binding cassette subfamily C member 4), TMEM106A (transmembrane protein 106A), ZFP36L2 (ZFP36 ring finger protein like 2), HLX (H2.0 like homeobox)"], "WAG002671": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FOS (Fos proto-oncogene, AP-1 transcription factor subunit), HTR1A (5-hydroxytryptamine receptor 1A), POMC (proopiomelanocortin), PPP3CA (protein phosphatase 3 catalytic subunit alpha), CRH (corticotropin releasing hormone), CAMK2B (calcium/calmodulin dependent protein kinase II beta), PRKCB (protein kinase C beta), HTR2C (5-hydroxytryptamine receptor 2C), HTR2A (5-hydroxytryptamine receptor 2A), GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1), PLCD4 (phospholipase C delta 4), GRM1 (glutamate metabotropic receptor 1), TRPV1 (transient receptor potential cation channel subfamily V member 1), FMR1 (FMRP translational regulator 1), ARC (activity regulated cytoskeleton associated protein), PLEK (pleckstrin), ADRA1A (adrenoceptor alpha 1A)"], "WAG002672": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), JAK3 (Janus kinase 3), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), IL2RG (interleukin 2 receptor subunit gamma), AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PTPN11 (protein tyrosine phosphatase non-receptor type 11), STAT3 (signal transducer and activator of transcription 3), GRB2 (growth factor receptor bound protein 2), MAPK1 (mitogen-activated protein kinase 1), IRS1 (insulin receptor substrate 1), MAPK14 (mitogen-activated protein kinase 14), SHC1 (SHC adaptor protein 1), IL4 (interleukin 4), MAPK3 (mitogen-activated protein kinase 3), IRS2 (insulin receptor substrate 2), TYK2 (tyrosine kinase 2), PTPN6 (protein tyrosine phosphatase non-receptor type 6), STAT5A (signal transducer and activator of transcription 5A), IL4R (interleukin 4 receptor), STAT1 (signal transducer and activator of transcription 1), SOCS3 (suppressor of cytokine signaling 3), CBL (Cbl proto-oncogene), GAB2 (GRB2 associated binding protein 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), STAT6 (signal transducer and activator of transcription 6), RELA (RELA proto-oncogene, NF-kB subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), EP300 (E1A binding protein p300), SOCS1 (suppressor of cytokine signaling 1), STAT5B (signal transducer and activator of transcription 5B), NFKB1 (nuclear factor kappa B subunit 1), INPP5D (inositol polyphosphate-5-phosphatase D), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), NFKBIA (NFKB inhibitor alpha), CEBPB (CCAAT enhancer binding protein beta), FES (FES proto-oncogene, tyrosine kinase), MAPK11 (mitogen-activated protein kinase 11), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), SOCS5 (suppressor of cytokine signaling 5), ELK1 (ETS transcription factor ELK1), RPS6KB1 (ribosomal protein S6 kinase B1), ATF2 (activating transcription factor 2), FLNA (filamin A), DOK2 (docking protein 2), CEBPA (CCAAT enhancer binding protein alpha), GATA3 (GATA binding protein 3), BIRC5 (baculoviral IAP repeat containing 5), BAD (BCL2 associated agonist of cell death), NFIL3 (nuclear factor, interleukin 3 regulated), HRH1 (histamine receptor H1)"], "WAG002674": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLCB1 (phospholipase C beta 1), PLCB2 (phospholipase C beta 2), PLCB3 (phospholipase C beta 3), PLCG1 (phospholipase C gamma 1), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), PLCD1 (phospholipase C delta 1), PLCG2 (phospholipase C gamma 2), PLCE1 (phospholipase C epsilon 1), PLCD3 (phospholipase C delta 3), PLCZ1 (phospholipase C zeta 1), GNA11 (G protein subunit alpha 11), FFAR1 (free fatty acid receptor 1), PKD1 (polycystin 1, transient receptor potential channel interacting), PLCL1 (phospholipase C like 1 (inactive)), PLCH1 (phospholipase C eta 1)"], "WAG002675": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATM (ATM serine/threonine kinase), TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), PCNA (proliferating cell nuclear antigen), ATR (ATR serine/threonine kinase), RAD50 (RAD50 double strand break repair protein), MDM2 (MDM2 proto-oncogene), CHEK1 (checkpoint kinase 1), RAD51 (RAD51 recombinase), CHEK2 (checkpoint kinase 2), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), TP53BP1 (tumor protein p53 binding protein 1), BLM (BLM RecQ like helicase), NBN (nibrin), E2F1 (E2F transcription factor 1), PARP1 (poly(ADP-ribose) polymerase 1), FANCD2 (FA complementation group D2), PRKDC (protein kinase, DNA-activated, catalytic subunit), CASP3 (caspase 3), KAT5 (lysine acetyltransferase 5), MDC1 (mediator of DNA damage checkpoint 1), BRCA2 (BRCA2 DNA repair associated), RNF8 (ring finger protein 8), CDKN2A (cyclin dependent kinase inhibitor 2A), RAD17 (RAD17 checkpoint clamp loader component), RAD9A (RAD9 checkpoint clamp component A), SMC1A (structural maintenance of chromosomes 1A), EXO1 (exonuclease 1), TP73 (tumor protein p73), TRIM28 (tripartite motif containing 28), BAX (BCL2 associated X, apoptosis regulator), SMC3 (structural maintenance of chromosomes 3), RAD52 (RAD52 homolog, DNA repair protein), TERF2 (telomeric repeat binding factor 2), CDC25C (cell division cycle 25C), MCPH1 (microcephalin 1), CASP9 (caspase 9), BID (BH3 interacting domain death agonist), DCLRE1C (DNA cross-link repair 1C), RASSF1 (Ras association domain family member 1), CDK5 (cyclin dependent kinase 5), APAF1 (apoptotic peptidase activating factor 1), TRAF6 (TNF receptor associated factor 6), ATF2 (activating transcription factor 2), LATS1 (large tumor suppressor kinase 1), YAP1 (Yes1 associated transcriptional regulator), STK3 (serine/threonine kinase 3), BAK1 (BCL2 antagonist/killer 1), ACTL6A (actin like 6A), UPF1 (UPF1 RNA helicase and ATPase), HSF1 (heat shock transcription factor 1), RIF1 (replication timing regulatory factor 1), MRE11 (MRE11 homolog, double strand break repair nuclease), H2AX (H2A.X variant histone), NABP2 (nucleic acid binding protein 2)"], "WAG002676": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MDH2 (malate dehydrogenase 2), OGDH (oxoglutarate dehydrogenase), ACO2 (aconitase 2), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), FH (fumarate hydratase), G6PD (glucose-6-phosphate dehydrogenase), HK1 (hexokinase 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), SUCLA2 (succinate-CoA ligase ADP-forming subunit beta), SDHA (succinate dehydrogenase complex flavoprotein subunit A), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), LDHA (lactate dehydrogenase A), FASN (fatty acid synthase), PDK1 (pyruvate dehydrogenase kinase 1)"], "WAG002677": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), MVK (mevalonate kinase), MVD (mevalonate diphosphate decarboxylase), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), FDPS (farnesyl diphosphate synthase), PMVK (phosphomevalonate kinase), ACAT2 (acetyl-CoA acetyltransferase 2)"], "WAG002678": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKACA (protein kinase cAMP-activated catalytic subunit alpha), ACACA (acetyl-CoA carboxylase alpha), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), LIPE (lipase E, hormone sensitive type), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), FASN (fatty acid synthase), PLIN1 (perilipin 1), ACLY (ATP citrate lyase), AKT1 (AKT serine/threonine kinase 1), ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase), PNPLA2 (patatin like phospholipase domain containing 2), AKT3 (AKT serine/threonine kinase 3), ACSS2 (acyl-CoA synthetase short chain family member 2), AKT2 (AKT serine/threonine kinase 2), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), ACSBG1 (acyl-CoA synthetase bubblegum family member 1), HILPDA (hypoxia inducible lipid droplet associated), BCKDHA (branched chain keto acid dehydrogenase E1 subunit alpha)"], "WAG002680": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COL1A1 (collagen type I alpha 1 chain), SPARC (secreted protein acidic and cysteine rich), FN1 (fibronectin 1), YAP1 (Yes1 associated transcriptional regulator), COL3A1 (collagen type III alpha 1 chain), COL5A1 (collagen type V alpha 1 chain), TEAD1 (TEA domain transcription factor 1), TEAD4 (TEA domain transcription factor 4), TEAD3 (TEA domain transcription factor 3), TEAD2 (TEA domain transcription factor 2), BCAR1 (BCAR1 scaffold protein, Cas family member), THBS2 (thrombospondin 2), SNAI2 (snail family transcriptional repressor 2), EDNRA (endothelin receptor type A), TWIST1 (twist family bHLH transcription factor 1), PBX3 (PBX homeobox 3), GPC6 (glypican 6), MIR509-3 (microRNA 509-3)"], "WAG002683": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), MAPK3 (mitogen-activated protein kinase 3), HRAS (HRas proto-oncogene, GTPase), STAT3 (signal transducer and activator of transcription 3), SHC1 (SHC adaptor protein 1), GRB2 (growth factor receptor bound protein 2), PDGFRB (platelet derived growth factor receptor beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PRKCA (protein kinase C alpha), PLCG1 (phospholipase C gamma 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAPK8 (mitogen-activated protein kinase 8), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), STAT1 (signal transducer and activator of transcription 1), STAT5A (signal transducer and activator of transcription 5A), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), STAT5B (signal transducer and activator of transcription 5B), RASA1 (RAS p21 protein activator 1), ELK1 (ETS transcription factor ELK1), PRKCB (protein kinase C beta), MAP2K4 (mitogen-activated protein kinase kinase 4), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), STAT6 (signal transducer and activator of transcription 6), SRF (serum response factor)"], "WAG002686": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), CCND1 (cyclin D1), TP53 (tumor protein p53), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), BCL2 (BCL2 apoptosis regulator), NFKB1 (nuclear factor kappa B subunit 1), CREBBP (CREB binding protein), GSK3B (glycogen synthase kinase 3 beta), MTOR (mechanistic target of rapamycin kinase), CTNNB1 (catenin beta 1), CDKN1A (cyclin dependent kinase inhibitor 1A), AR (androgen receptor), FOXO1 (forkhead box O1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), AKT3 (AKT serine/threonine kinase 3), MDM2 (MDM2 proto-oncogene), GRB2 (growth factor receptor bound protein 2), MAP2K1 (mitogen-activated protein kinase kinase 1), KRAS (KRAS proto-oncogene, GTPase), CDKN1B (cyclin dependent kinase inhibitor 1B), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CASP9 (caspase 9), BAD (BCL2 associated agonist of cell death), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), NFKBIA (NFKB inhibitor alpha), PDGFRB (platelet derived growth factor receptor beta), KLK3 (kallikrein related peptidase 3), MAP2K2 (mitogen-activated protein kinase kinase 2), TCF7 (transcription factor 7), PDGFA (platelet derived growth factor subunit A), CREB3L1 (cAMP responsive element binding protein 3 like 1), MIR4664 (microRNA 4664), MIR3664 (microRNA 3664), MIR466 (microRNA 466), MIR363 (microRNA 363), MIR3120 (microRNA 3120), MIR4311 (microRNA 4311), MIR3149 (microRNA 3149), MIR603 (microRNA 603), MIR589 (microRNA 589), MIR30D (microRNA 30d), MIR3682 (microRNA 3682), MIR4517 (microRNA 4517), MIR200A (microRNA 200a), MIR1299 (microRNA 1299), MIR4763 (microRNA 4763), MIR4325 (microRNA 4325), MIR337 (microRNA 337), MIR3714 (microRNA 3714)"], "WAG002688": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), WNT3A (Wnt family member 3A), FZD5 (frizzled class receptor 5), FZD1 (frizzled class receptor 1), DVL2 (dishevelled segment polarity protein 2), PPP2CA (protein phosphatase 2 catalytic subunit alpha), AXIN1 (axin 1), DVL1 (dishevelled segment polarity protein 1), DVL3 (dishevelled segment polarity protein 3), WNT1 (Wnt family member 1), LRP6 (LDL receptor related protein 6), FZD2 (frizzled class receptor 2), FZD6 (frizzled class receptor 6), WNT5A (Wnt family member 5A), TP53 (tumor protein p53), GSK3B (glycogen synthase kinase 3 beta), FZD4 (frizzled class receptor 4), FZD7 (frizzled class receptor 7), FZD8 (frizzled class receptor 8), MYC (MYC proto-oncogene, bHLH transcription factor), FZD10 (frizzled class receptor 10), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CREBBP (CREB binding protein), FZD9 (frizzled class receptor 9), EP300 (E1A binding protein p300), WNT7B (Wnt family member 7B), WNT10B (Wnt family member 10B), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), WNT2B (Wnt family member 2B), WNT11 (Wnt family member 11), AXIN2 (axin 2), WNT3 (Wnt family member 3), APC (APC regulator of WNT signaling pathway), WNT7A (Wnt family member 7A), TCF7L2 (transcription factor 7 like 2), PPP2CB (protein phosphatase 2 catalytic subunit beta), WNT10A (Wnt family member 10A), WNT5B (Wnt family member 5B), LRP5 (LDL receptor related protein 5), CCND1 (cyclin D1), WNT2 (Wnt family member 2), FZD3 (frizzled class receptor 3), WNT9B (Wnt family member 9B), WNT6 (Wnt family member 6), LEF1 (lymphoid enhancer binding factor 1), WNT16 (Wnt family member 16), CTBP1 (C-terminal binding protein 1), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), RHOA (ras homolog family member A), WNT4 (Wnt family member 4), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PRKCD (protein kinase C delta), PRKCZ (protein kinase C zeta), CSNK1E (casein kinase 1 epsilon), PRKCA (protein kinase C alpha), TCF7 (transcription factor 7), FRAT1 (FRAT regulator of WNT signaling pathway 1), MAPK9 (mitogen-activated protein kinase 9), TCF7L1 (transcription factor 7 like 1), NKD1 (NKD inhibitor of WNT signaling pathway 1), PPP2R2A (protein phosphatase 2 regulatory subunit Balpha), LRRK2 (leucine rich repeat kinase 2), PRKCB (protein kinase C beta), CTNND1 (catenin delta 1), PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), CCND2 (cyclin D2), FOSL1 (FOS like 1, AP-1 transcription factor subunit), MAPK10 (mitogen-activated protein kinase 10), PRKCE (protein kinase C epsilon), PRKCI (protein kinase C iota), PPP2R2C (protein phosphatase 2 regulatory subunit Bgamma), CCND3 (cyclin D3), PRKCG (protein kinase C gamma), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CTBP2 (C-terminal binding protein 2), CD44 (CD44 molecule (Indian blood group)), PPP2R3A (protein phosphatase 2 regulatory subunit B''alpha), PPARD (peroxisome proliferator activated receptor delta), PPP2R3B (protein phosphatase 2 regulatory subunit B''beta), NLK (nemo like kinase), POU5F1 (POU class 5 homeobox 1), PRKCQ (protein kinase C theta), MMP7 (matrix metallopeptidase 7), PRKD1 (protein kinase D1), NANOG (Nanog homeobox), MAP2K4 (mitogen-activated protein kinase kinase 4), SOX2 (SRY-box transcription factor 2), NFYA (nuclear transcription factor Y subunit alpha), PLAU (plasminogen activator, urokinase), PRKCH (protein kinase C eta), ZBTB33 (zinc finger and BTB domain containing 33), RACGAP1 (Rac GTPase activating protein 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), NKD2 (NKD inhibitor of WNT signaling pathway 2), ESRRB (estrogen related receptor beta), LDLR (low density lipoprotein receptor), FOXD3 (forkhead box D3), PPM1J (protein phosphatase, Mg2+/Mn2+ dependent 1J), FBXW2 (F-box and WD repeat domain containing 2)"], "WAG002689": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), EP300 (E1A binding protein p300), STAT3 (signal transducer and activator of transcription 3), RXRA (retinoid X receptor alpha), NFKB1 (nuclear factor kappa B subunit 1), MAPK3 (mitogen-activated protein kinase 3), BCL2 (BCL2 apoptosis regulator), HSPA5 (heat shock protein family A (Hsp70) member 5), FYN (FYN proto-oncogene, Src family tyrosine kinase), SPI1 (Spi-1 proto-oncogene), PTK2 (protein tyrosine kinase 2), CASP3 (caspase 3), PAX5 (paired box 5), PRNP (prion protein), NCAM1 (neural cell adhesion molecule 1), TBP (TATA-box binding protein), POU2F2 (POU class 2 homeobox 2), CREB1 (cAMP responsive element binding protein 1), IRF4 (interferon regulatory factor 4), EBF1 (EBF transcription factor 1), SMC3 (structural maintenance of chromosomes 3), CTCF (CCCTC-binding factor), ELK1 (ETS transcription factor ELK1), RAD21 (RAD21 cohesin complex component), FGFR1 (fibroblast growth factor receptor 1), HSP90B1 (heat shock protein 90 beta family member 1), PDIA3 (protein disulfide isomerase family A member 3), MEF2C (myocyte enhancer factor 2C), BATF (basic leucine zipper ATF-like transcription factor), CASP12 (caspase 12 (gene/pseudogene)), CHD2 (chromodomain helicase DNA binding protein 2), BCL11A (BAF chromatin remodeling complex subunit BCL11A), RFX5 (regulatory factor X5)"], "WAG002690": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC3 (histone deacetylase 3), HDAC1 (histone deacetylase 1), HDAC2 (histone deacetylase 2), HDAC4 (histone deacetylase 4), HDAC9 (histone deacetylase 9), HDAC5 (histone deacetylase 5), HDAC10 (histone deacetylase 10), HDAC7 (histone deacetylase 7), HDAC6 (histone deacetylase 6), ALDH2 (aldehyde dehydrogenase 2 family member), ALDH1A1 (aldehyde dehydrogenase 1 family member A1), HDAC8 (histone deacetylase 8), ALDH1A2 (aldehyde dehydrogenase 1 family member A2), ADH1A (alcohol dehydrogenase 1A (class I), alpha polypeptide), KAT2B (lysine acetyltransferase 2B), CYP2E1 (cytochrome P450 family 2 subfamily E member 1), ADH1C (alcohol dehydrogenase 1C (class I), gamma polypeptide), ALDH1A3 (aldehyde dehydrogenase 1 family member A3), ADH1B (alcohol dehydrogenase 1B (class I), beta polypeptide), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), ACSS2 (acyl-CoA synthetase short chain family member 2), AHCY (adenosylhomocysteinase), MTHFR (methylenetetrahydrofolate reductase), TYMS (thymidylate synthetase), DHFR (dihydrofolate reductase), ATF2 (activating transcription factor 2), MAT1A (methionine adenosyltransferase 1A), EHMT2 (euchromatic histone lysine methyltransferase 2), SLC19A1 (solute carrier family 19 member 1), HAT1 (histone acetyltransferase 1), ELP3 (elongator acetyltransferase complex subunit 3)"], "WAG002692": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), E2F1 (E2F transcription factor 1), CCND1 (cyclin D1), CDKN2A (cyclin dependent kinase inhibitor 2A), RB1 (RB transcriptional corepressor 1), CDK4 (cyclin dependent kinase 4), CDK6 (cyclin dependent kinase 6), MDM2 (MDM2 proto-oncogene), CCND2 (cyclin D2), GNRH1 (gonadotropin releasing hormone 1), CDKN2C (cyclin dependent kinase inhibitor 2C), CDKN2B (cyclin dependent kinase inhibitor 2B), MDM4 (MDM4 regulator of p53), POMC (proopiomelanocortin), UBE3A (ubiquitin protein ligase E3A), NDN (necdin, MAGE family member), CDC6 (cell division cycle 6), MKRN3 (makorin ring finger protein 3), GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3), GABRA5 (gamma-aminobutyric acid type A receptor subunit alpha5), NGF (nerve growth factor), OCA2 (OCA2 melanosomal transmembrane protein), SNRPN (small nuclear ribonucleoprotein polypeptide N), PRKCZ (protein kinase C zeta), CGA (glycoprotein hormones, alpha polypeptide), MSX1 (msh homeobox 1), HTR2C (5-hydroxytryptamine receptor 2C), KISS1 (KiSS-1 metastasis suppressor), TACR3 (tachykinin receptor 3), LHB (luteinizing hormone subunit beta), OXT (oxytocin/neurophysin I prepropeptide), GHRH (growth hormone releasing hormone), ATP10A (ATPase phospholipid transporting 10A (putative)), GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3), TYR (tyrosinase), HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2), GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), FEZ1 (fasciculation and elongation protein zeta 1), BDNF (brain derived neurotrophic factor), FSHB (follicle stimulating hormone subunit beta), INS (insulin), NIPA2 (NIPA magnesium transporter 2), TUBGCP5 (tubulin gamma complex associated protein 5), FEZ2 (fasciculation and elongation protein zeta 2), GHRL (ghrelin and obestatin prepropeptide), CYFIP1 (cytoplasmic FMR1 interacting protein 1), NIPA1 (NIPA magnesium transporter 1), GABRR2 (gamma-aminobutyric acid type A receptor subunit rho2), SNURF (SNRPN upstream reading frame), GABRR1 (gamma-aminobutyric acid type A receptor subunit rho1), PCSK1 (proprotein convertase subtilisin/kexin type 1), BBS4 (Bardet-Biedl syndrome 4), PCM1 (pericentriolar material 1), GABRG1 (gamma-aminobutyric acid type A receptor subunit gamma1), DLX5 (distal-less homeobox 5), SLC45A2 (solute carrier family 45 member 2), GABRR3 (gamma-aminobutyric acid type A receptor subunit rho3), MAGEL2 (MAGE family member L2), GABRD (gamma-aminobutyric acid type A receptor subunit delta), SNORD109B (small nucleolar RNA, C/D box 109B), SNORD64 (small nucleolar RNA, C/D box 64), NHLH2 (nescient helix-loop-helix 2), SNORD109A (small nucleolar RNA, C/D box 109A), SNORD116@ (small nucleolar RNA, C/D box 116 cluster), IPW (imprinted in Prader-Willi syndrome), SNORD107 (small nucleolar RNA, C/D box 107), NPAP1 (nuclear pore associated protein 1), PWRN1 (Prader-Willi region non-protein coding RNA 1)"], "WAG002694": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK14 (mitogen-activated protein kinase 14), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MYC (MYC proto-oncogene, bHLH transcription factor), MAP2K4 (mitogen-activated protein kinase kinase 4), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), CDC42 (cell division cycle 42), GRB2 (growth factor receptor bound protein 2), RAC1 (Rac family small GTPase 1), MAP2K6 (mitogen-activated protein kinase kinase 6), CREB1 (cAMP responsive element binding protein 1), TRAF2 (TNF receptor associated factor 2), RIPK1 (receptor interacting serine/threonine kinase 1), RPS6KA5 (ribosomal protein S6 kinase A5), ATF2 (activating transcription factor 2), DAXX (death domain associated protein), HSPB1 (heat shock protein family B (small) member 1), SHC1 (SHC adaptor protein 1), TGFBR1 (transforming growth factor beta receptor 1), STAT1 (signal transducer and activator of transcription 1), HRAS (HRas proto-oncogene, GTPase), MAPKAPK2 (MAPK activated protein kinase 2), TRADD (TNFRSF1A associated via death domain), MAPKAPK5 (MAPK activated protein kinase 5), PLA2G4A (phospholipase A2 group IVA), RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1), DDIT3 (DNA damage inducible transcript 3), TGFB2 (transforming growth factor beta 2), MAX (MYC associated factor X), MAP3K9 (mitogen-activated protein kinase kinase kinase 9), MKNK1 (MAPK interacting serine/threonine kinase 1), ELK1 (ETS transcription factor ELK1), HMGN1 (high mobility group nucleosome binding domain 1), MEF2D (myocyte enhancer factor 2D)"], "WAG002696": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CAMK2A (calcium/calmodulin dependent protein kinase II alpha), ACTN2 (actinin alpha 2), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), TNF (tumor necrosis factor), CAMK2B (calcium/calmodulin dependent protein kinase II beta), CAMK2D (calcium/calmodulin dependent protein kinase II delta), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), DLG4 (discs large MAGUK scaffold protein 4), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), NOS3 (nitric oxide synthase 3), NOS2 (nitric oxide synthase 2), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), BCL2 (BCL2 apoptosis regulator), CREB1 (cAMP responsive element binding protein 1), AKAP9 (A-kinase anchoring protein 9), IFNG (interferon gamma), NPR1 (natriuretic peptide receptor 1), NOS1 (nitric oxide synthase 1), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), IL1B (interleukin 1 beta), GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2), CYCS (cytochrome c, somatic), TSPO (translocator protein), NFKBIA (NFKB inhibitor alpha), CASP9 (caspase 9), PDE2A (phosphodiesterase 2A), XIAP (X-linked inhibitor of apoptosis), PDE3A (phosphodiesterase 3A), NPPA (natriuretic peptide A), GUCY1B2 (guanylate cyclase 1 soluble subunit beta 2 (pseudogene)), NEFL (neurofilament light), BAD (BCL2 associated agonist of cell death), CNGB1 (cyclic nucleotide gated channel subunit beta 1), CNGA2 (cyclic nucleotide gated channel subunit alpha 2), CNGA1 (cyclic nucleotide gated channel subunit alpha 1), PRKG2 (protein kinase cGMP-dependent 2), CNGA3 (cyclic nucleotide gated channel subunit alpha 3), NPPB (natriuretic peptide B), PPID (peptidylprolyl isomerase D), CNGB3 (cyclic nucleotide gated channel subunit beta 3), CNGA4 (cyclic nucleotide gated channel subunit alpha 4), GUCY1A1 (guanylate cyclase 1 soluble subunit alpha 1), GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1), CALM1 (calmodulin 1)"], "WAG002698": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTOR (mechanistic target of rapamycin kinase), AKT1 (AKT serine/threonine kinase 1), SREBF1 (sterol regulatory element binding transcription factor 1), MLST8 (MTOR associated protein, LST8 homolog), RPTOR (regulatory associated protein of MTOR complex 1), DEPTOR (DEP domain containing MTOR interacting protein), NR0B2 (nuclear receptor subfamily 0 group B member 2), PPARA (peroxisome proliferator activated receptor alpha), RICTOR (RPTOR independent companion of MTOR complex 2), AKT2 (AKT serine/threonine kinase 2), PPARG (peroxisome proliferator activated receptor gamma), AKT1S1 (AKT1 substrate 1), MAPKAP1 (MAPK associated protein 1), NR1H3 (nuclear receptor subfamily 1 group H member 3), INSR (insulin receptor), SCD (stearoyl-CoA desaturase), NR1H2 (nuclear receptor subfamily 1 group H member 2), FASN (fatty acid synthase), NR1H4 (nuclear receptor subfamily 1 group H member 4), INS (insulin), TELO2 (telomere maintenance 2), NR5A2 (nuclear receptor subfamily 5 group A member 2), TTI1 (TELO2 interacting protein 1), PRKCI (protein kinase C iota), FABP1 (fatty acid binding protein 1), HSD17B4 (hydroxysteroid 17-beta dehydrogenase 4), NFE2 (nuclear factor, erythroid 2)"], "WAG002700": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATM (ATM serine/threonine kinase), BRCA1 (BRCA1 DNA repair associated), RAD51 (RAD51 recombinase), PCNA (proliferating cell nuclear antigen), ATR (ATR serine/threonine kinase), RPA1 (replication protein A1), CHEK1 (checkpoint kinase 1), TP53 (tumor protein p53), RPA2 (replication protein A2), RAD50 (RAD50 double strand break repair protein), MSH2 (mutS homolog 2), TOPBP1 (DNA topoisomerase II binding protein 1), CDK2 (cyclin dependent kinase 2), ATRIP (ATR interacting protein), CHEK2 (checkpoint kinase 2), MDM2 (MDM2 proto-oncogene), CDK1 (cyclin dependent kinase 1), BRCA2 (BRCA2 DNA repair associated), FANCD2 (FA complementation group D2), RAD17 (RAD17 checkpoint clamp loader component), RAD9A (RAD9 checkpoint clamp component A), EXO1 (exonuclease 1), MCM2 (minichromosome maintenance complex component 2), MDC1 (mediator of DNA damage checkpoint 1), WRN (WRN RecQ like helicase), TP53BP1 (tumor protein p53 binding protein 1), BARD1 (BRCA1 associated RING domain 1), PLK1 (polo like kinase 1), NBN (nibrin), FANCA (FA complementation group A), PARP1 (poly(ADP-ribose) polymerase 1), FEN1 (flap structure-specific endonuclease 1), PRKDC (protein kinase, DNA-activated, catalytic subunit), HUS1 (HUS1 checkpoint clamp component), CDC45 (cell division cycle 45), FANCI (FA complementation group I), MLH1 (mutL homolog 1), CLSPN (claspin), E2F1 (E2F transcription factor 1), RAD52 (RAD52 homolog, DNA repair protein), RAD1 (RAD1 checkpoint DNA exonuclease), XRCC5 (X-ray repair cross complementing 5), TOP3A (DNA topoisomerase III alpha), SP1 (Sp1 transcription factor), RBBP8 (RB binding protein 8, endonuclease), TRIM28 (tripartite motif containing 28), SMC1A (structural maintenance of chromosomes 1A), CDC25C (cell division cycle 25C), CEP164 (centrosomal protein 164), UIMC1 (ubiquitin interaction motif containing 1), XPA (XPA, DNA damage recognition and repair factor), FOXM1 (forkhead box M1), PML (PML nuclear body scaffold), BRIP1 (BRCA1 interacting protein C-terminal helicase 1), RECQL5 (RecQ like helicase 5), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), RMI1 (RecQ mediated genome instability 1), MCPH1 (microcephalin 1), SMARCAL1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1), PALB2 (partner and localizer of BRCA2), BRCC3 (BRCA1/BRCA2-containing complex subunit 3), UBE2D3 (ubiquitin conjugating enzyme E2 D3), HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2), RECQL (RecQ like helicase), POLB (DNA polymerase beta), CLK2 (CDC like kinase 2), USP1 (ubiquitin specific peptidase 1), RFWD3 (ring finger and WD repeat domain 3), POLN (DNA polymerase nu), SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2), BCL6 (BCL6 transcription repressor), PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D), DCLRE1A (DNA cross-link repair 1A), TDP1 (tyrosyl-DNA phosphodiesterase 1), EEF1E1 (eukaryotic translation elongation factor 1 epsilon 1), UPF1 (UPF1 RNA helicase and ATPase), H2AX (H2A.X variant histone), MRE11 (MRE11 homolog, double strand break repair nuclease), ABRAXAS1 (abraxas 1, BRCA1 A complex subunit), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002702": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), HIF1A (hypoxia inducible factor 1 subunit alpha), PKM (pyruvate kinase M1/2), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), ALDOA (aldolase, fructose-bisphosphate A), GPI (glucose-6-phosphate isomerase), VEGFA (vascular endothelial growth factor A), PKLR (pyruvate kinase L/R), ENO1 (enolase 1), PGM1 (phosphoglucomutase 1), ARNT (aryl hydrocarbon receptor nuclear translocator), MTOR (mechanistic target of rapamycin kinase), HK1 (hexokinase 1), LDHA (lactate dehydrogenase A), ALDOC (aldolase, fructose-bisphosphate C), TPI1 (triosephosphate isomerase 1), STAT3 (signal transducer and activator of transcription 3), EP300 (E1A binding protein p300), LDHB (lactate dehydrogenase B), ALDOB (aldolase, fructose-bisphosphate B), EGFR (epidermal growth factor receptor), PGK1 (phosphoglycerate kinase 1), TGFB1 (transforming growth factor beta 1), PDGFB (platelet derived growth factor subunit B), HK2 (hexokinase 2), ENO3 (enolase 3), PTEN (phosphatase and tensin homolog), MLST8 (MTOR associated protein, LST8 homolog), MDH1 (malate dehydrogenase 1), CREBBP (CREB binding protein), ENO2 (enolase 2), ME1 (malic enzyme 1), LDHC (lactate dehydrogenase C), RPTOR (regulatory associated protein of MTOR complex 1), HK3 (hexokinase 3), PDGFRB (platelet derived growth factor receptor beta), RHEB (Ras homolog, mTORC1 binding), SLC2A1 (solute carrier family 2 member 1), DEPTOR (DEP domain containing MTOR interacting protein), KDR (kinase insert domain receptor), PGM2 (phosphoglucomutase 2), ACLY (ATP citrate lyase), TSC1 (TSC complex subunit 1), VHL (von Hippel-Lindau tumor suppressor), TSC2 (TSC complex subunit 2), AKT1S1 (AKT1 substrate 1), FLT1 (fms related receptor tyrosine kinase 1), GRB10 (growth factor receptor bound protein 10), PGK2 (phosphoglycerate kinase 2), PDGFRA (platelet derived growth factor receptor alpha), FASN (fatty acid synthase), PHGDH (phosphoglycerate dehydrogenase), SQSTM1 (sequestosome 1), SHMT2 (serine hydroxymethyltransferase 2), LDHD (lactate dehydrogenase D), PSPH (phosphoserine phosphatase), ACACB (acetyl-CoA carboxylase beta), SHMT1 (serine hydroxymethyltransferase 1), TGFB2 (transforming growth factor beta 2), ACACA (acetyl-CoA carboxylase alpha), TGFB3 (transforming growth factor beta 3), BHLHE41 (basic helix-loop-helix family member e41), SDS (serine dehydratase), PSAT1 (phosphoserine aminotransferase 1), ZEB1 (zinc finger E-box binding homeobox 1), SDSL (serine dehydratase like), ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3), CDH13 (cadherin 13), CAMK1 (calcium/calmodulin dependent protein kinase I), PLOD2 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 2), BAP1 (BRCA1 associated protein 1), CEP290 (centrosomal protein 290), SSPN (sarcospan), KDM5C (lysine demethylase 5C), PFKM (phosphofructokinase, muscle), EFCAB3 (EF-hand calcium binding domain 3), KCNJ2 (potassium inwardly rectifying channel subfamily J member 2), TOX2 (TOX high mobility group box family member 2), PFKP (phosphofructokinase, platelet), RAPGEF5 (Rap guanine nucleotide exchange factor 5), PGBD5 (piggyBac transposable element derived 5), MIR21 (microRNA 21), PBRM1 (polybromo 1), KSR1 (kinase suppressor of ras 1), PFKL (phosphofructokinase, liver type), SETD2 (SET domain containing 2, histone lysine methyltransferase)"], "WAG002703": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1), ENTPD3 (ectonucleoside triphosphate diphosphohydrolase 3), NME1 (NME/NM23 nucleoside diphosphate kinase 1), NME4 (NME/NM23 nucleoside diphosphate kinase 4), NME2 (NME/NM23 nucleoside diphosphate kinase 2), NME3 (NME/NM23 nucleoside diphosphate kinase 3), NME6 (NME/NM23 nucleoside diphosphate kinase 6), NME7 (NME/NM23 family member 7), POLR2H (RNA polymerase II, I and III subunit H), POLR2E (RNA polymerase II, I and III subunit E), POLR2L (RNA polymerase II, I and III subunit L), PNPT1 (polyribonucleotide nucleotidyltransferase 1), POLR3F (RNA polymerase III subunit F), POLR3A (RNA polymerase III subunit A), POLR3B (RNA polymerase III subunit B), POLR3D (RNA polymerase III subunit D), CTPS2 (CTP synthase 2), POLR1C (RNA polymerase I and III subunit C), POLR1B (RNA polymerase I subunit B), POLR2C (RNA polymerase II subunit C), POLR2B (RNA polymerase II subunit B), POLR2D (RNA polymerase II subunit D), POLR2G (RNA polymerase II subunit G), POLR2A (RNA polymerase II subunit A), POLR2I (RNA polymerase II subunit I), POLR1A (RNA polymerase I subunit A), POLR3E (RNA polymerase III subunit E), POLR2K (RNA polymerase II, I and III subunit K), POLR3C (RNA polymerase III subunit C), POLR3H (RNA polymerase III subunit H), POLA1 (DNA polymerase alpha 1, catalytic subunit), POLR3G (RNA polymerase III subunit G), POLR2J (RNA polymerase II subunit J), CMPK1 (cytidine/uridine monophosphate kinase 1), POLD1 (DNA polymerase delta 1, catalytic subunit), POLR3K (RNA polymerase III subunit K), DTYMK (deoxythymidylate kinase), POLE (DNA polymerase epsilon, catalytic subunit), RRM2 (ribonucleotide reductase regulatory subunit M2), RRM1 (ribonucleotide reductase catalytic subunit M1), POLR3GL (RNA polymerase III subunit GL), CMPK2 (cytidine/uridine monophosphate kinase 2), POLA2 (DNA polymerase alpha 2, accessory subunit), PRIM1 (DNA primase subunit 1), POLE2 (DNA polymerase epsilon 2, accessory subunit), TYMS (thymidylate synthetase), POLR1D (RNA polymerase I and III subunit D), POLR1E (RNA polymerase I subunit E), POLD2 (DNA polymerase delta 2, accessory subunit), POLE3 (DNA polymerase epsilon 3, accessory subunit), POLD4 (DNA polymerase delta 4, accessory subunit), POLR2J2 (RNA polymerase II subunit J2), DUT (deoxyuridine triphosphatase), NT5C (5', 3'-nucleotidase, cytosolic), NT5M (5',3'-nucleotidase, mitochondrial), POLE4 (DNA polymerase epsilon 4, accessory subunit), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), UMPS (uridine monophosphate synthetase), POLD3 (DNA polymerase delta 3, accessory subunit), TK1 (thymidine kinase 1), UPRT (uracil phosphoribosyltransferase homolog), DCK (deoxycytidine kinase), UCK2 (uridine-cytidine kinase 2), CDA (cytidine deaminase), DCTD (dCMP deaminase), UCKL1 (uridine-cytidine kinase 1 like 1), UPP1 (uridine phosphorylase 1), TYMP (thymidine phosphorylase), TK2 (thymidine kinase 2), CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase), DPYD (dihydropyrimidine dehydrogenase), UCK1 (uridine-cytidine kinase 1), PRIM2 (DNA primase subunit 2), ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1), ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3), DPYS (dihydropyrimidinase), DHODH (dihydroorotate dehydrogenase (quinone)), UPB1 (beta-ureidopropionase 1), DCTPP1 (dCTP pyrophosphatase 1), POLR1H (RNA polymerase I subunit H), NME1-NME2 (NME1-NME2 readthrough), POLR2J3 (RNA polymerase II subunit J3), POLR1F (RNA polymerase I subunit F), CTPS1 (CTP synthase 1)"], "WAG002712": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLA1 (DNA polymerase alpha 1, catalytic subunit), POLD1 (DNA polymerase delta 1, catalytic subunit), RRM2 (ribonucleotide reductase regulatory subunit M2), RRM1 (ribonucleotide reductase catalytic subunit M1), NME2 (NME/NM23 nucleoside diphosphate kinase 2), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), HPRT1 (hypoxanthine phosphoribosyltransferase 1), POLG (DNA polymerase gamma, catalytic subunit), DHFR (dihydrofolate reductase), ADSL (adenylosuccinate lyase), POLB (DNA polymerase beta), PRPS2 (phosphoribosyl pyrophosphate synthetase 2), SRM (spermidine synthase), PRPS1 (phosphoribosyl pyrophosphate synthetase 1), MTHFD2 (methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase), IMPDH1 (inosine monophosphate dehydrogenase 1), SAT1 (spermidine/spermine N1-acetyltransferase 1), OAZ1 (ornithine decarboxylase antizyme 1), ADSS2 (adenylosuccinate synthase 2)"], "WAG002713": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VAMP2 (vesicle associated membrane protein 2), SNAP25 (synaptosome associated protein 25), STX1A (syntaxin 1A), STX3 (syntaxin 3), TXLNA (taxilin alpha), TYK2 (tyrosine kinase 2), CSF3 (colony stimulating factor 3), STXBP2 (syntaxin binding protein 2), STX4 (syntaxin 4), CD4 (CD4 molecule), IL10RB (interleukin 10 receptor subunit beta), JAK1 (Janus kinase 1), CSF3R (colony stimulating factor 3 receptor), CSF1R (colony stimulating factor 1 receptor), PRTN3 (proteinase 3), IL16 (interleukin 16), CSF1 (colony stimulating factor 1), IL34 (interleukin 34), CASP3 (caspase 3), PTPRZ1 (protein tyrosine phosphatase receptor type Z1), IL32 (interleukin 32), IFNL1 (interferon lambda 1), SDC1 (syndecan 1), IFNLR1 (interferon lambda receptor 1)"], "WAG002714": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NT5E (5'-nucleotidase ecto), NT5C2 (5'-nucleotidase, cytosolic II), NT5M (5',3'-nucleotidase, mitochondrial), NT5C (5', 3'-nucleotidase, cytosolic), ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1), PNP (purine nucleoside phosphorylase), ENTPD3 (ectonucleoside triphosphate diphosphohydrolase 3), ENTPD8 (ectonucleoside triphosphate diphosphohydrolase 8), TYMP (thymidine phosphorylase), ITPA (inosine triphosphatase), NT5C1A (5'-nucleotidase, cytosolic IA), NT5C1B (5'-nucleotidase, cytosolic IB), ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)), ENTPD4 (ectonucleoside triphosphate diphosphohydrolase 4), ENTPD6 (ectonucleoside triphosphate diphosphohydrolase 6), UPP1 (uridine phosphorylase 1), UPP2 (uridine phosphorylase 2), DPYD (dihydropyrimidine dehydrogenase), XDH (xanthine dehydrogenase), GDA (guanine deaminase), UPB1 (beta-ureidopropionase 1), ENTPD2 (ectonucleoside triphosphate diphosphohydrolase 2), DPYS (dihydropyrimidinase), AGXT2 (alanine--glyoxylate aminotransferase 2), NUDT16 (nudix hydrolase 16), GPX1 (glutathione peroxidase 1), NUDT15 (nudix hydrolase 15), DNPH1 (2'-deoxynucleoside 5'-phosphate N-hydrolase 1), ENTPD7 (ectonucleoside triphosphate diphosphohydrolase 7), SAMHD1 (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1), ADPRM (ADP-ribose/CDP-alcohol diphosphatase, manganese dependent), NUDT5 (nudix hydrolase 5)"], "WAG002716": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTPRD (protein tyrosine phosphatase receptor type D), IL1RAPL1 (interleukin 1 receptor accessory protein like 1), PTPRF (protein tyrosine phosphatase receptor type F), PTPRS (protein tyrosine phosphatase receptor type S), LRRC4B (leucine rich repeat containing 4B), IL1RAPL2 (interleukin 1 receptor accessory protein like 2), SLITRK2 (SLIT and NTRK like family member 2), SLITRK5 (SLIT and NTRK like family member 5), NTRK3 (neurotrophic receptor tyrosine kinase 3), SLITRK1 (SLIT and NTRK like family member 1), SLITRK3 (SLIT and NTRK like family member 3), SLITRK4 (SLIT and NTRK like family member 4), SLITRK6 (SLIT and NTRK like family member 6)"], "WAG002717": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMA3 (proteasome 20S subunit alpha 3), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), UBB (ubiquitin B), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMB6 (proteasome 20S subunit beta 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA4 (proteasome 20S subunit alpha 4), PSMA2 (proteasome 20S subunit alpha 2), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB5 (proteasome 20S subunit beta 5), PSME3 (proteasome activator subunit 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMC3 (proteasome 26S subunit, ATPase 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMA7 (proteasome 20S subunit alpha 7), PSMA5 (proteasome 20S subunit alpha 5), PSMB2 (proteasome 20S subunit beta 2), PSMB3 (proteasome 20S subunit beta 3), PSMA6 (proteasome 20S subunit alpha 6), PSMB1 (proteasome 20S subunit beta 1), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMA1 (proteasome 20S subunit alpha 1), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSME4 (proteasome activator subunit 4), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), PSME1 (proteasome activator subunit 1), PSMB11 (proteasome subunit beta 11), TP53 (tumor protein p53), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), HDAC2 (histone deacetylase 2), PSME2 (proteasome activator subunit 2), HDAC1 (histone deacetylase 1), RBBP4 (RB binding protein 4, chromatin remodeling factor), RNF2 (ring finger protein 2), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), USP7 (ubiquitin specific peptidase 7), RBBP7 (RB binding protein 7, chromatin remodeling factor), BMI1 (BMI1 proto-oncogene, polycomb ring finger), PTEN (phosphatase and tensin homolog), SUZ12 (SUZ12 polycomb repressive complex 2 subunit), EED (embryonic ectoderm development), CSNK2A1 (casein kinase 2 alpha 1), AKT1 (AKT serine/threonine kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PML (PML nuclear body scaffold), CHD4 (chromodomain helicase DNA binding protein 4), KDM1A (lysine demethylase 1A), MTOR (mechanistic target of rapamycin kinase), CBX8 (chromobox 8), RING1 (ring finger protein 1), CBX2 (chromobox 2), CBX4 (chromobox 4), MBD3 (methyl-CpG binding domain protein 3), CHD3 (chromodomain helicase DNA binding protein 3), CBX6 (chromobox 6), PHC2 (polyhomeotic homolog 2), RPTOR (regulatory associated protein of MTOR complex 1), MTA1 (metastasis associated 1), MAPK1 (mitogen-activated protein kinase 1), MTA3 (metastasis associated 1 family member 3), MTA2 (metastasis associated 1 family member 2), PHC1 (polyhomeotic homolog 1), PHC3 (polyhomeotic homolog 3), ATF2 (activating transcription factor 2), CSNK2A2 (casein kinase 2 alpha 2), PPARG (peroxisome proliferator activated receptor gamma), RRAGC (Ras related GTP binding C), EGR1 (early growth response 1), CSNK2B (casein kinase 2 beta), GATAD2B (GATA zinc finger domain containing 2B), SNAI1 (snail family transcriptional repressor 1), GATAD2A (GATA zinc finger domain containing 2A), STUB1 (STIP1 homology and U-box containing protein 1), MAPK3 (mitogen-activated protein kinase 3), MLST8 (MTOR associated protein, LST8 homolog), NEDD4 (NEDD4 E3 ubiquitin protein ligase), RRAGD (Ras related GTP binding D), SALL4 (spalt like transcription factor 4), LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2), RRAGB (Ras related GTP binding B), LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3)"], "WAG002718": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HSP90AA1 (heat shock protein 90 alpha family class A member 1), ITGB2 (integrin subunit beta 2), RAC1 (Rac family small GTPase 1), HSPA8 (heat shock protein family A (Hsp70) member 8), ITGAM (integrin subunit alpha M), MAPK1 (mitogen-activated protein kinase 1), VCP (valosin containing protein), TYROBP (transmembrane immune signaling adaptor TYROBP), PSMD2 (proteasome 26S subunit, non-ATPase 2), EEF1A1 (eukaryotic translation elongation factor 1 alpha 1), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD14 (proteasome 26S subunit, non-ATPase 14), CD14 (CD14 molecule), HLA-B (major histocompatibility complex, class I, B), CTSS (cathepsin S), FGR (FGR proto-oncogene, Src family tyrosine kinase), PSMD1 (proteasome 26S subunit, non-ATPase 1), FPR1 (formyl peptide receptor 1), PSMA2 (proteasome 20S subunit alpha 2), MAPK14 (mitogen-activated protein kinase 14), PSMC2 (proteasome 26S subunit, ATPase 2), NFKB1 (nuclear factor kappa B subunit 1), MMP9 (matrix metallopeptidase 9), PSMD3 (proteasome 26S subunit, non-ATPase 3), RHOA (ras homolog family member A), PTPN6 (protein tyrosine phosphatase non-receptor type 6), PKM (pyruvate kinase M1/2), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD6 (proteasome 26S subunit, non-ATPase 6), HSP90AB1 (heat shock protein 90 alpha family class B member 1), ELANE (elastase, neutrophil expressed), PSMD12 (proteasome 26S subunit, non-ATPase 12), ITGAL (integrin subunit alpha L), PSMB1 (proteasome 20S subunit beta 1), PSMD11 (proteasome 26S subunit, non-ATPase 11), PRKCD (protein kinase C delta), PSMD7 (proteasome 26S subunit, non-ATPase 7), CD68 (CD68 molecule), CCT2 (chaperonin containing TCP1 subunit 2), CD44 (CD44 molecule (Indian blood group)), PSMA5 (proteasome 20S subunit alpha 5), SELL (selectin L), LILRB2 (leukocyte immunoglobulin like receptor B2), ITGAX (integrin subunit alpha X), FCER1G (Fc fragment of IgE receptor Ig), VCL (vinculin), C3 (complement C3), RAB7A (RAB7A, member RAS oncogene family), PLAUR (plasminogen activator, urokinase receptor), LYZ (lysozyme), ITGAV (integrin subunit alpha V), CD33 (CD33 molecule), NME2 (NME/NM23 nucleoside diphosphate kinase 2), CTSD (cathepsin D), CTSG (cathepsin G), PSMB7 (proteasome 20S subunit beta 7), S100A9 (S100 calcium binding protein A9), CXCR2 (C-X-C motif chemokine receptor 2), MME (membrane metalloendopeptidase), HEXB (hexosaminidase subunit beta), TNFRSF1B (TNF receptor superfamily member 1B), B2M (beta-2-microglobulin), ALOX5 (arachidonate 5-lipoxygenase), MPO (myeloperoxidase), ALDOA (aldolase, fructose-bisphosphate A), PPBP (pro-platelet basic protein), ACTR2 (actin related protein 2), PGM1 (phosphoglucomutase 1), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), COPB1 (COPI coat complex subunit beta 1), LTF (lactotransferrin), FCGR2A (Fc fragment of IgG receptor IIa), DIAPH1 (diaphanous related formin 1), PLAU (plasminogen activator, urokinase), GLB1 (galactosidase beta 1), ROCK1 (Rho associated coiled-coil containing protein kinase 1), CTSB (cathepsin B), GPI (glucose-6-phosphate isomerase), NEU1 (neuraminidase 1), CD36 (CD36 molecule), HSPA1B (heat shock protein family A (Hsp70) member 1B), CAND1 (cullin associated and neddylation dissociated 1), IQGAP1 (IQ motif containing GTPase activating protein 1), FTH1 (ferritin heavy chain 1), CD63 (CD63 molecule), GDI2 (GDP dissociation inhibitor 2), C3AR1 (complement C3a receptor 1), C5AR1 (complement C5a receptor 1), FPR2 (formyl peptide receptor 2), PRTN3 (proteinase 3), DYNLL1 (dynein light chain LC8-type 1), SERPINA1 (serpin family A member 1), SDCBP (syndecan binding protein), GRN (granulin precursor), S100A8 (S100 calcium binding protein A8), CXCR1 (C-X-C motif chemokine receptor 1), CD93 (CD93 molecule), LAMP2 (lysosomal associated membrane protein 2), MNDA (myeloid cell nuclear differentiation antigen), PSAP (prosaposin)"], "WAG002719": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLR2C (RNA polymerase II subunit C), POLR2B (RNA polymerase II subunit B), TBP (TATA-box binding protein), POLR2A (RNA polymerase II subunit A), POLR2G (RNA polymerase II subunit G), POLR2I (RNA polymerase II subunit I), POLR2E (RNA polymerase II, I and III subunit E), POLR2H (RNA polymerase II, I and III subunit H), GTF2H3 (general transcription factor IIH subunit 3), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), GTF2H1 (general transcription factor IIH subunit 1), POLR3K (RNA polymerase III subunit K), POLR2F (RNA polymerase II, I and III subunit F), CDK7 (cyclin dependent kinase 7), CCNH (cyclin H), MNAT1 (MNAT1 component of CDK activating kinase), GTF2H4 (general transcription factor IIH subunit 4), GTF2F2 (general transcription factor IIF subunit 2), GTF2H2 (general transcription factor IIH subunit 2), POLR2J (RNA polymerase II subunit J), GTF2B (general transcription factor IIB), TAF13 (TATA-box binding protein associated factor 13), GTF2E1 (general transcription factor IIE subunit 1), GTF2E2 (general transcription factor IIE subunit 2), TAF6 (TATA-box binding protein associated factor 6), GTF2A2 (general transcription factor IIA subunit 2), TAF5 (TATA-box binding protein associated factor 5), TAF12 (TATA-box binding protein associated factor 12), TAF7 (TATA-box binding protein associated factor 7), TAF9 (TATA-box binding protein associated factor 9), POLR1A (RNA polymerase I subunit A), POLR1B (RNA polymerase I subunit B), POLR1D (RNA polymerase I and III subunit D), POLR2K (RNA polymerase II, I and III subunit K), POLR3B (RNA polymerase III subunit B), POLR3D (RNA polymerase III subunit D), POLR3E (RNA polymerase III subunit E), POLR3H (RNA polymerase III subunit H), POLR1E (RNA polymerase I subunit E), ILK (integrin linked kinase)"], "WAG002723": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAB5A (RAB5A, member RAS oncogene family), RABEP1 (rabaptin, RAB GTPase binding effector protein 1), OPTN (optineurin), GABARAPL2 (GABA type A receptor associated protein like 2), GABARAP (GABA type A receptor-associated protein), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), RAB4A (RAB4A, member RAS oncogene family), RAB6A (RAB6A, member RAS oncogene family), RAB7A (RAB7A, member RAS oncogene family), RABGEF1 (RAB guanine nucleotide exchange factor 1), RABGAP1 (RAB GTPase activating protein 1), RAB5B (RAB5B, member RAS oncogene family), GGA1 (golgi associated, gamma adaptin ear containing, ARF binding protein 1), RAB11A (RAB11A, member RAS oncogene family), TBC1D15 (TBC1 domain family member 15), GGA2 (golgi associated, gamma adaptin ear containing, ARF binding protein 2), GGA3 (golgi associated, gamma adaptin ear containing, ARF binding protein 3), ARF6 (ADP ribosylation factor 6), TSC2 (TSC complex subunit 2), RAB5C (RAB5C, member RAS oncogene family), TBC1D17 (TBC1 domain family member 17), RAB11B (RAB11B, member RAS oncogene family), ULK1 (unc-51 like autophagy activating kinase 1), TBC1D25 (TBC1 domain family member 25), TBC1D10A (TBC1 domain family member 10A), RAB33B (RAB33B, member RAS oncogene family), RAB6B (RAB6B, member RAS oncogene family), TSC1 (TSC complex subunit 1), TBC1D7 (TBC1 domain family member 7), RAB35 (RAB35, member RAS oncogene family), RAB8A (RAB8A, member RAS oncogene family), TBC1D24 (TBC1 domain family member 24), TBC1D10B (TBC1 domain family member 10B), RAB8B (RAB8B, member RAS oncogene family), TBC1D14 (TBC1 domain family member 14), TBC1D2 (TBC1 domain family member 2), TBC1D13 (TBC1 domain family member 13), RAB7B (RAB7B, member RAS oncogene family), TBC1D16 (TBC1 domain family member 16), TBC1D20 (TBC1 domain family member 20), TBC1D10C (TBC1 domain family member 10C), GPR21 (G protein-coupled receptor 21), RAB33A (RAB33A, member RAS oncogene family), TBC1D3 (TBC1 domain family member 3), SYTL1 (synaptotagmin like 1)"], "WAG002724": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DLG4 (discs large MAGUK scaffold protein 4), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), DLG3 (discs large MAGUK scaffold protein 3), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), DLG1 (discs large MAGUK scaffold protein 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), LRFN2 (leucine rich repeat and fibronectin type III domain containing 2), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), PTPRD (protein tyrosine phosphatase receptor type D), LRFN1 (leucine rich repeat and fibronectin type III domain containing 1), PTPRF (protein tyrosine phosphatase receptor type F), PTPRS (protein tyrosine phosphatase receptor type S), FLOT1 (flotillin 1), FLOT2 (flotillin 2), LRFN3 (leucine rich repeat and fibronectin type III domain containing 3), LRFN4 (leucine rich repeat and fibronectin type III domain containing 4), RTN3 (reticulon 3)"], "WAG002726": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HSP90AA1 (heat shock protein 90 alpha family class A member 1), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), DCTN2 (dynactin subunit 2), DCTN1 (dynactin subunit 1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), DCTN3 (dynactin subunit 3), DCTN4 (dynactin subunit 4), DYNLL1 (dynein light chain LC8-type 1), NR3C1 (nuclear receptor subfamily 3 group C member 1), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), HSPA1B (heat shock protein family A (Hsp70) member 1B), DCTN6 (dynactin subunit 6), DCTN5 (dynactin subunit 5), HSPA8 (heat shock protein family A (Hsp70) member 8), ACTR1A (actin related protein 1A), PTGES3 (prostaglandin E synthase 3), HSP90AB1 (heat shock protein 90 alpha family class B member 1), FKBP5 (FKBP prolyl isomerase 5), STIP1 (stress induced phosphoprotein 1), FKBP4 (FKBP prolyl isomerase 4), AR (androgen receptor), DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1), DNAJA1 (DnaJ heat shock protein family (Hsp40) member A1), CAPZB (capping actin protein of muscle Z-line subunit beta), NR3C2 (nuclear receptor subfamily 3 group C member 2), ACTR10 (actin related protein 10), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), DYNLL2 (dynein light chain LC8-type 2), DNAJA2 (DnaJ heat shock protein family (Hsp40) member A2), CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2), PGR (progesterone receptor), HSPA2 (heat shock protein family A (Hsp70) member 2), CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1), CAPZA3 (capping actin protein of muscle Z-line subunit alpha 3), HSPA1L (heat shock protein family A (Hsp70) member 1 like), DNAJA4 (DnaJ heat shock protein family (Hsp40) member A4), HSPA1A (heat shock protein family A (Hsp70) member 1A)"], "WAG002727": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RRM2 (ribonucleotide reductase regulatory subunit M2), RRM1 (ribonucleotide reductase catalytic subunit M1), NME1 (NME/NM23 nucleoside diphosphate kinase 1), NME2 (NME/NM23 nucleoside diphosphate kinase 2), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), NME3 (NME/NM23 nucleoside diphosphate kinase 3), NME4 (NME/NM23 nucleoside diphosphate kinase 4), AK1 (adenylate kinase 1), CMPK1 (cytidine/uridine monophosphate kinase 1), DTYMK (deoxythymidylate kinase), AK2 (adenylate kinase 2), TXN (thioredoxin), AK4 (adenylate kinase 4), GUK1 (guanylate kinase 1), AK5 (adenylate kinase 5), AK7 (adenylate kinase 7), GLRX (glutaredoxin), TYMS (thymidylate synthetase), CTPS2 (CTP synthase 2), TXNRD1 (thioredoxin reductase 1), DCTD (dCMP deaminase), DCTPP1 (dCTP pyrophosphatase 1), AK9 (adenylate kinase 9), AK6 (adenylate kinase 6), CTPS1 (CTP synthase 1), NUDT13 (nudix hydrolase 13), AK8 (adenylate kinase 8)"], "WAG002728": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CPT1A (carnitine palmitoyltransferase 1A), RXRA (retinoid X receptor alpha), SLC25A20 (solute carrier family 25 member 20), CPT2 (carnitine palmitoyltransferase 2), CPT1B (carnitine palmitoyltransferase 1B), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PPARD (peroxisome proliferator activated receptor delta), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), MID1IP1 (MID1 interacting protein 1), SLC22A5 (solute carrier family 22 member 5), THRSP (thyroid hormone responsive)"], "WAG002729": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL6 (interleukin 6), IL1B (interleukin 1 beta), CCR5 (C-C motif chemokine receptor 5), TNF (tumor necrosis factor), IL10 (interleukin 10), CCL2 (C-C motif chemokine ligand 2), CSF2 (colony stimulating factor 2), STAT3 (signal transducer and activator of transcription 3), CCR1 (C-C motif chemokine receptor 1), IL1A (interleukin 1 alpha), CXCL10 (C-X-C motif chemokine ligand 10), CCL4 (C-C motif chemokine ligand 4), CXCL1 (C-X-C motif chemokine ligand 1), CCL3 (C-C motif chemokine ligand 3), CCL5 (C-C motif chemokine ligand 5), ICAM1 (intercellular adhesion molecule 1), TYK2 (tyrosine kinase 2), CCR2 (C-C motif chemokine receptor 2), CXCL2 (C-X-C motif chemokine ligand 2), IL18 (interleukin 18), IL12B (interleukin 12B), CCL20 (C-C motif chemokine ligand 20), CD86 (CD86 molecule), CCL19 (C-C motif chemokine ligand 19), IL1R1 (interleukin 1 receptor type 1), IL1RN (interleukin 1 receptor antagonist), FPR1 (formyl peptide receptor 1), IL10RA (interleukin 10 receptor subunit alpha), JAK1 (Janus kinase 1), CSF3 (colony stimulating factor 3), CCL22 (C-C motif chemokine ligand 22), IL12A (interleukin 12A), PTGS2 (prostaglandin-endoperoxide synthase 2), TNFRSF1B (TNF receptor superfamily member 1B), TNFRSF1A (TNF receptor superfamily member 1A), LIF (LIF interleukin 6 family cytokine), IL10RB (interleukin 10 receptor subunit beta), CSF1 (colony stimulating factor 1), TIMP1 (TIMP metallopeptidase inhibitor 1), CD80 (CD80 molecule), PTAFR (platelet activating factor receptor), IL1R2 (interleukin 1 receptor type 2), CCL3L3 (C-C motif chemokine ligand 3 like 3), FCER2 (Fc fragment of IgE receptor II), CXCL8 (C-X-C motif chemokine ligand 8), CCL3L1 (C-C motif chemokine ligand 3 like 1)"], "WAG002731": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), EGFR (epidermal growth factor receptor), EPS15 (epidermal growth factor receptor pathway substrate 15), CLTC (clathrin heavy chain), AP2M1 (adaptor related protein complex 2 subunit mu 1), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), AP2A1 (adaptor related protein complex 2 subunit alpha 1), AP2A2 (adaptor related protein complex 2 subunit alpha 2), AP2B1 (adaptor related protein complex 2 subunit beta 1), SH3KBP1 (SH3 domain containing kinase binding protein 1), EGF (epidermal growth factor), AMPH (amphiphysin), DNM1 (dynamin 1), ITSN1 (intersectin 1), CBL (Cbl proto-oncogene), AP2S1 (adaptor related protein complex 2 subunit sigma 1), ARRB2 (arrestin beta 2), EPS15L1 (epidermal growth factor receptor pathway substrate 15 like 1), WASL (WASP like actin nucleation promoting factor), HGS (hepatocyte growth factor-regulated tyrosine kinase substrate), ARRB1 (arrestin beta 1), SYNJ1 (synaptojanin 1), EPN1 (epsin 1), DNM2 (dynamin 2), STAM (signal transducing adaptor molecule), HSPA8 (heat shock protein family A (Hsp70) member 8), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), CLTA (clathrin light chain A), STAM2 (signal transducing adaptor molecule 2), HIP1R (huntingtin interacting protein 1 related), HIP1 (huntingtin interacting protein 1), CTTN (cortactin), ITSN2 (intersectin 2), PICALM (phosphatidylinositol binding clathrin assembly protein), BIN1 (bridging integrator 1), DAB2 (DAB adaptor protein 2), RAB5A (RAB5A, member RAS oncogene family), EPN2 (epsin 2), SNAP91 (synaptosome associated protein 91), CLTB (clathrin light chain B), SH3GL3 (SH3 domain containing GRB2 like 3, endophilin A3), ARF6 (ADP ribosylation factor 6), ARPC3 (actin related protein 2/3 complex subunit 3), ARPC2 (actin related protein 2/3 complex subunit 2), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), SGIP1 (SH3GL interacting endocytic adaptor 1), SH3GL1 (SH3 domain containing GRB2 like 1, endophilin A2), ACTR2 (actin related protein 2), ARPC4 (actin related protein 2/3 complex subunit 4), STON2 (stonin 2), LDLRAP1 (low density lipoprotein receptor adaptor protein 1), SYNJ2 (synaptojanin 2), CLTCL1 (clathrin heavy chain like 1), ARPC1A (actin related protein 2/3 complex subunit 1A), ARPC5 (actin related protein 2/3 complex subunit 5), ACTR3 (actin related protein 3), PACSIN3 (protein kinase C and casein kinase substrate in neurons 3), VAMP2 (vesicle associated membrane protein 2), PACSIN2 (protein kinase C and casein kinase substrate in neurons 2), DVL2 (dishevelled segment polarity protein 2), FNBP1 (formin binding protein 1), DNM3 (dynamin 3), NECAP2 (NECAP endocytosis associated 2), PACSIN1 (protein kinase C and casein kinase substrate in neurons 1), SYT1 (synaptotagmin 1), NECAP1 (NECAP endocytosis associated 1), REPS1 (RALBP1 associated Eps domain containing 1), DNAJC6 (DnaJ heat shock protein family (Hsp40) member C6), PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha), AGTR1 (angiotensin II receptor type 1), SNX9 (sorting nexin 9), ADRB2 (adrenoceptor beta 2), LDLR (low density lipoprotein receptor), REPS2 (RALBP1 associated Eps domain containing 2), APOB (apolipoprotein B), OCRL (OCRL inositol polyphosphate-5-phosphatase), LRP2 (LDL receptor related protein 2), AGFG1 (ArfGAP with FG repeats 1), TRIP10 (thyroid hormone receptor interactor 10), AVPR2 (arginine vasopressin receptor 2), VAMP3 (vesicle associated membrane protein 3), FCHO2 (FCH and mu domain containing endocytic adaptor 2), RPS27A (ribosomal protein S27a), GAK (cyclin G associated kinase), FNBP1L (formin binding protein 1 like), HBEGF (heparin binding EGF like growth factor), STON1 (stonin 1), BTC (betacellulin), RAB5C (RAB5C, member RAS oncogene family), SYT2 (synaptotagmin 2), FZD4 (frizzled class receptor 4), VAMP7 (vesicle associated membrane protein 7), EREG (epiregulin), TGFA (transforming growth factor alpha), VAMP8 (vesicle associated membrane protein 8), WNT5A (Wnt family member 5A), GAPVD1 (GTPase activating protein and VPS9 domains 1), ARFGAP1 (ADP ribosylation factor GTPase activating protein 1), AAK1 (AP2 associated kinase 1)"], "WAG002732": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT3 (signal transducer and activator of transcription 3), IL6 (interleukin 6), TNF (tumor necrosis factor), IL4 (interleukin 4), AKT1 (AKT serine/threonine kinase 1), VEGFA (vascular endothelial growth factor A), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL1B (interleukin 1 beta), TGFB1 (transforming growth factor beta 1), IL10 (interleukin 10), STAT1 (signal transducer and activator of transcription 1), TP53 (tumor protein p53), JAK2 (Janus kinase 2), CCL2 (C-C motif chemokine ligand 2), STAT6 (signal transducer and activator of transcription 6), MYC (MYC proto-oncogene, bHLH transcription factor), PTGS2 (prostaglandin-endoperoxide synthase 2), VCAM1 (vascular cell adhesion molecule 1), JAK1 (Janus kinase 1), TYK2 (tyrosine kinase 2), ICAM1 (intercellular adhesion molecule 1), IL13 (interleukin 13), FN1 (fibronectin 1), FGF2 (fibroblast growth factor 2), MMP9 (matrix metallopeptidase 9), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), IL18 (interleukin 18), JAK3 (Janus kinase 3), CDKN1A (cyclin dependent kinase inhibitor 1A), HIF1A (hypoxia inducible factor 1 subunit alpha), MMP2 (matrix metallopeptidase 2), SOCS1 (suppressor of cytokine signaling 1), SOCS3 (suppressor of cytokine signaling 3), CCND1 (cyclin D1), IL12B (interleukin 12B), IL2RG (interleukin 2 receptor subunit gamma), IL1A (interleukin 1 alpha), BCL2 (BCL2 apoptosis regulator), IL4R (interleukin 4 receptor), TIMP1 (TIMP metallopeptidase inhibitor 1), FASLG (Fas ligand), HGF (hepatocyte growth factor), HSP90AA1 (heat shock protein 90 alpha family class A member 1), NOS2 (nitric oxide synthase 2), OSM (oncostatin M), MMP1 (matrix metallopeptidase 1), IL17A (interleukin 17A), IL23R (interleukin 23 receptor), IL6R (interleukin 6 receptor), IL23A (interleukin 23 subunit alpha), IL12A (interleukin 12A), LIF (LIF interleukin 6 family cytokine), BCL2L1 (BCL2 like 1), ITGB1 (integrin subunit beta 1), POMC (proopiomelanocortin), HMOX1 (heme oxygenase 1), IRF4 (interferon regulatory factor 4), BIRC5 (baculoviral IAP repeat containing 5), IL13RA1 (interleukin 13 receptor subunit alpha 1), ITGAM (integrin subunit alpha M), BCL6 (BCL6 transcription repressor), ITGB2 (integrin subunit beta 2), IL13RA2 (interleukin 13 receptor subunit alpha 2), MMP3 (matrix metallopeptidase 3), COL1A2 (collagen type I alpha 2 chain), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), FOXO1 (forkhead box O1), SOCS5 (suppressor of cytokine signaling 5), VIM (vimentin), HSPA8 (heat shock protein family A (Hsp70) member 8), CD36 (CD36 molecule), MCL1 (MCL1 apoptosis regulator, BCL2 family member), ALOX5 (arachidonate 5-lipoxygenase), CCL11 (C-C motif chemokine ligand 11), OPRM1 (opioid receptor mu 1), TNFRSF1B (TNF receptor superfamily member 1B), ANXA1 (annexin A1), FOXO3 (forkhead box O3), S1PR1 (sphingosine-1-phosphate receptor 1), ITGAX (integrin subunit alpha X), BATF (basic leucine zipper ATF-like transcription factor), RORC (RAR related orphan receptor C), FCER2 (Fc fragment of IgE receptor II), NDN (necdin, MAGE family member), GATA3 (GATA binding protein 3), F13A1 (coagulation factor XIII A chain), MUC1 (mucin 1, cell surface associated), SOX2 (SRY-box transcription factor 2), PIM1 (Pim-1 proto-oncogene, serine/threonine kinase), HSP90B1 (heat shock protein 90 beta family member 1), LBP (lipopolysaccharide binding protein), SAA1 (serum amyloid A1), TWIST1 (twist family bHLH transcription factor 1), CCL22 (C-C motif chemokine ligand 22), ALOX15 (arachidonate 15-lipoxygenase), CEBPD (CCAAT enhancer binding protein delta), IL17F (interleukin 17F), NANOG (Nanog homeobox), OPRD1 (opioid receptor delta 1), ZEB1 (zinc finger E-box binding homeobox 1)"], "WAG002735": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAB5A (RAB5A, member RAS oncogene family), RAB1A (RAB1A, member RAS oncogene family), RAB3IP (RAB3A interacting protein), TRAPPC3 (trafficking protein particle complex 3), TRAPPC2 (trafficking protein particle complex 2), RAB5B (RAB5B, member RAS oncogene family), GDI2 (GDP dissociation inhibitor 2), TRAPPC4 (trafficking protein particle complex 4), CHM (CHM Rab escort protein), TRAPPC10 (trafficking protein particle complex 10), RAB6A (RAB6A, member RAS oncogene family), RAB3A (RAB3A, member RAS oncogene family), TRAPPC9 (trafficking protein particle complex 9), TRAPPC8 (trafficking protein particle complex 8), TRAPPC5 (trafficking protein particle complex 5), GDI1 (GDP dissociation inhibitor 1), TRAPPC6B (trafficking protein particle complex 6B), TRAPPC6A (trafficking protein particle complex 6A), RAB10 (RAB10, member RAS oncogene family), TRAPPC1 (trafficking protein particle complex 1), RAB1B (RAB1B, member RAS oncogene family), TRAPPC2L (trafficking protein particle complex 2 like), RAB7A (RAB7A, member RAS oncogene family), RAB9A (RAB9A, member RAS oncogene family), RAB8A (RAB8A, member RAS oncogene family), CHML (CHM like Rab escort protein), RAB21 (RAB21, member RAS oncogene family), RAB14 (RAB14, member RAS oncogene family), RAB31 (RAB31, member RAS oncogene family), RAB13 (RAB13, member RAS oncogene family), AKT2 (AKT serine/threonine kinase 2), RAB5C (RAB5C, member RAS oncogene family), TRAPPC11 (trafficking protein particle complex 11), MON1A (MON1 homolog A, secretory trafficking associated), MON1B (MON1 homolog B, secretory trafficking associated), RABGEF1 (RAB guanine nucleotide exchange factor 1), RAB6B (RAB6B, member RAS oncogene family), RAB18 (RAB18, member RAS oncogene family), RAB8B (RAB8B, member RAS oncogene family), RIN2 (Ras and Rab interactor 2), AKT1 (AKT serine/threonine kinase 1), GAPVD1 (GTPase activating protein and VPS9 domains 1), RIN3 (Ras and Rab interactor 3), RIN1 (Ras and Rab interactor 1), CCZ1 (CCZ1 homolog, vacuolar protein trafficking and biogenesis associated), RAB35 (RAB35, member RAS oncogene family), RAB27A (RAB27A, member RAS oncogene family), AKT3 (AKT serine/threonine kinase 3), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), RAB3GAP1 (RAB3 GTPase activating protein catalytic subunit 1), ANKRD27 (ankyrin repeat domain 27), RAB3IL1 (RAB3A interacting protein like 1), ALS2 (alsin Rho guanine nucleotide exchange factor ALS2), RAB32 (RAB32, member RAS oncogene family), RAB3GAP2 (RAB3 GTPase activating non-catalytic protein subunit 2), ALS2CL (ALS2 C-terminal like), RAB39B (RAB39B, member RAS oncogene family), RAB38 (RAB38, member RAS oncogene family), DENND1B (DENN domain containing 1B), DENND5A (DENN domain containing 5A), HPS4 (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2), HPS1 (HPS1 biogenesis of lysosomal organelles complex 3 subunit 1), ULK1 (unc-51 like autophagy activating kinase 1), DENND1A (DENN domain containing 1A), RAB9B (RAB9B, member RAS oncogene family), DENND1C (DENN domain containing 1C), RAB27B (RAB27B, member RAS oncogene family), RGP1 (RGP1 homolog, RAB6A GEF complex partner 1), DENND4A (DENN domain containing 4A), DENND5B (DENN domain containing 5B), RAB12 (RAB12, member RAS oncogene family), DENND2C (DENN domain containing 2C), DENND6A (DENN domain containing 6A), RINL (Ras and Rab interactor like), SBF2 (SET binding factor 2), RIC1 (RIC1 homolog, RAB6A GEF complex partner 1), RAB39A (RAB39A, member RAS oncogene family), DENND2B (DENN domain containing 2B), SBF1 (SET binding factor 1), DENND4C (DENN domain containing 4C), DENND3 (DENN domain containing 3), CCZ1B (CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated), DENND6B (DENN domain containing 6B), DENND4B (DENN domain containing 4B), TRAPPC2B (trafficking protein particle complex 2B), RAB7B (RAB7B, member RAS oncogene family), DENND2A (DENN domain containing 2A), TRAPPC13 (trafficking protein particle complex 13), DENND2D (DENN domain containing 2D), TRAPPC12 (trafficking protein particle complex 12)"], "WAG002736": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CHM (CHM Rab escort protein), RAB1A (RAB1A, member RAS oncogene family), RAB5A (RAB5A, member RAS oncogene family), RAB6A (RAB6A, member RAS oncogene family), RAB4A (RAB4A, member RAS oncogene family), RABGGTB (Rab geranylgeranyltransferase subunit beta), RAB10 (RAB10, member RAS oncogene family), RAB7A (RAB7A, member RAS oncogene family), RAB3A (RAB3A, member RAS oncogene family), RAB31 (RAB31, member RAS oncogene family), RAB11A (RAB11A, member RAS oncogene family), RAB1B (RAB1B, member RAS oncogene family), RAB5B (RAB5B, member RAS oncogene family), CHML (CHM like Rab escort protein), RAB14 (RAB14, member RAS oncogene family), RAB9A (RAB9A, member RAS oncogene family), RAB2A (RAB2A, member RAS oncogene family), RAB4B (RAB4B, member RAS oncogene family), RAB21 (RAB21, member RAS oncogene family), RAB13 (RAB13, member RAS oncogene family), RAB3B (RAB3B, member RAS oncogene family), RAB18 (RAB18, member RAS oncogene family), RABGGTA (Rab geranylgeranyltransferase subunit alpha), RAB25 (RAB25, member RAS oncogene family), RAB17 (RAB17, member RAS oncogene family), RAB8A (RAB8A, member RAS oncogene family), RAB11B (RAB11B, member RAS oncogene family), RAB30 (RAB30, member RAS oncogene family), RAB15 (RAB15, member RAS oncogene family), RAB3D (RAB3D, member RAS oncogene family), RAB5C (RAB5C, member RAS oncogene family), RAB24 (RAB24, member RAS oncogene family), RAB6B (RAB6B, member RAS oncogene family), RAB27A (RAB27A, member RAS oncogene family), RAB22A (RAB22A, member RAS oncogene family), RAB3C (RAB3C, member RAS oncogene family), RAB2B (RAB2B, member RAS oncogene family), RAB32 (RAB32, member RAS oncogene family), RAB8B (RAB8B, member RAS oncogene family), RAB37 (RAB37, member RAS oncogene family), RAB40C (RAB40C, member RAS oncogene family), RAB40A (RAB40A, member RAS oncogene family), RAB40B (RAB40B, member RAS oncogene family), PTP4A2 (protein tyrosine phosphatase 4A2), RAB33B (RAB33B, member RAS oncogene family), RAB27B (RAB27B, member RAS oncogene family), RAB23 (RAB23, member RAS oncogene family), RAB35 (RAB35, member RAS oncogene family), RAB12 (RAB12, member RAS oncogene family), RAB39B (RAB39B, member RAS oncogene family), RAB29 (RAB29, member RAS oncogene family), RAB9B (RAB9B, member RAS oncogene family), RAB7B (RAB7B, member RAS oncogene family), RAB43 (RAB43, member RAS oncogene family), RAB26 (RAB26, member RAS oncogene family), RAB33A (RAB33A, member RAS oncogene family), RAB42 (RAB42, member RAS oncogene family), RAB36 (RAB36, member RAS oncogene family), RAB20 (RAB20, member RAS oncogene family), RAB38 (RAB38, member RAS oncogene family), RAB39A (RAB39A, member RAS oncogene family), RAB34 (RAB34, member RAS oncogene family), RAB44 (RAB44, member RAS oncogene family), RAB19 (RAB19, member RAS oncogene family), RAB41 (RAB41, member RAS oncogene family)"], "WAG002740": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TUBA1A (tubulin alpha 1a), TUBA1B (tubulin alpha 1b), TUBA1C (tubulin alpha 1c), TUBA3E (tubulin alpha 3e), TUBB4B (tubulin beta 4B class IVb), TUBB1 (tubulin beta 1 class VI), TUBB4A (tubulin beta 4A class IVa), TUBB2A (tubulin beta 2A class IIa), TUBB6 (tubulin beta 6 class V), TUBB2B (tubulin beta 2B class IIb), TTLL4 (tubulin tyrosine ligase like 4), TTLL12 (tubulin tyrosine ligase like 12), TTLL1 (tubulin tyrosine ligase like 1), TTL (tubulin tyrosine ligase), TUBB3 (tubulin beta 3 class III), TTLL9 (tubulin tyrosine ligase like 9), TTLL6 (tubulin tyrosine ligase like 6), TTLL10 (tubulin tyrosine ligase like 10), AGBL2 (ATP/GTP binding protein like 2), AGBL5 (ATP/GTP binding protein like 5), TPGS2 (tubulin polyglutamylase complex subunit 2), AGBL3 (ATP/GTP binding protein like 3), AGBL1 (ATP/GTP binding protein like 1), AGBL4 (ATP/GTP binding protein like 4), TUBB8 (tubulin beta 8 class VIII), TPGS1 (tubulin polyglutamylase complex subunit 1), VASH2 (vasohibin 2), TTLL13P (tubulin tyrosine ligase like 13, pseudogene), TTLL5 (tubulin tyrosine ligase like 5), TTLL2 (tubulin tyrosine ligase like 2), SVBP (small vasohibin binding protein), TTLL3 (tubulin tyrosine ligase like 3), VASH1 (vasohibin 1), TTLL7 (tubulin tyrosine ligase like 7), NICN1 (nicolin 1), LRRC49 (leucine rich repeat containing 49), TTLL11 (tubulin tyrosine ligase like 11), AGTPBP1 (ATP/GTP binding protein 1)"], "WAG002742": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SOD2 (superoxide dismutase 2), MAPK14 (mitogen-activated protein kinase 14), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CAT (catalase), GPX1 (glutathione peroxidase 1), HMOX1 (heme oxygenase 1), GSR (glutathione-disulfide reductase), NFE2L2 (nuclear factor, erythroid 2 like 2), SP1 (Sp1 transcription factor), NQO1 (NAD(P)H quinone dehydrogenase 1), GCLC (glutamate-cysteine ligase catalytic subunit), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), NFKB1 (nuclear factor kappa B subunit 1), SOD1 (superoxide dismutase 1), MGST1 (microsomal glutathione S-transferase 1), NOX1 (NADPH oxidase 1), SOD3 (superoxide dismutase 3), TXNRD1 (thioredoxin reductase 1), MAPK10 (mitogen-activated protein kinase 10), CYBB (cytochrome b-245 beta chain), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), NOX3 (NADPH oxidase 3), GPX3 (glutathione peroxidase 3), UGT1A6 (UDP glucuronosyltransferase family 1 member A6), TXN2 (thioredoxin 2), XDH (xanthine dehydrogenase), MAOA (monoamine oxidase A), NOX4 (NADPH oxidase 4), TXNRD2 (thioredoxin reductase 2), MT1X (metallothionein 1X), NOX5 (NADPH oxidase 5), GSTT2 (glutathione S-transferase theta 2 (gene/pseudogene)), NFIX (nuclear factor I X), SOD2-OT1 (SOD2 overlapping transcript 1)"], "WAG002744": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DAB1 (DAB adaptor protein 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), RELN (reelin), VLDLR (very low density lipoprotein receptor), SH3KBP1 (SH3 domain containing kinase binding protein 1)"], "WAG002747": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ESR1 (estrogen receptor 1), MYC (MYC proto-oncogene, bHLH transcription factor), TFAP2A (transcription factor AP-2 alpha), EP300 (E1A binding protein p300), CREBBP (CREB binding protein), TFAP2C (transcription factor AP-2 gamma), TFAP2B (transcription factor AP-2 beta), ERBB2 (erb-b2 receptor tyrosine kinase 2), SUMO1 (small ubiquitin like modifier 1), NPM1 (nucleophosmin 1), VEGFA (vascular endothelial growth factor A), CDKN1A (cyclin dependent kinase inhibitor 1A), UBE2I (ubiquitin conjugating enzyme E2 I), CITED1 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1), YY1 (YY1 transcription factor), CITED2 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2), EGFR (epidermal growth factor receptor), CITED4 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4), DEK (DEK proto-oncogene), KCTD1 (potassium channel tetramerization domain containing 1), NOP2 (NOP2 nucleolar protein), HSPD1 (heat shock protein family D (Hsp60) member 1), PITX2 (paired like homeodomain 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), MYBL2 (MYB proto-oncogene like 2), TGFA (transforming growth factor alpha), KDM5B (lysine demethylase 5B), ATAD2 (ATPase family AAA domain containing 2), YEATS4 (YEATS domain containing 4), TFAP2E (transcription factor AP-2 epsilon), CGB8 (chorionic gonadotropin subunit beta 8), CGA (glycoprotein hormones, alpha polypeptide), TFAP2D (transcription factor AP-2 delta), KCTD15 (potassium channel tetramerization domain containing 15), WWOX (WW domain containing oxidoreductase), APOE (apolipoprotein E), CGB3 (chorionic gonadotropin subunit beta 3), CGB5 (chorionic gonadotropin subunit beta 5)"], "WAG002752": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP85 (nucleoporin 85), GPI (glucose-6-phosphate isomerase), NUP153 (nucleoporin 153), NUP93 (nucleoporin 93), NUP155 (nucleoporin 155), NUP43 (nucleoporin 43), NUP35 (nucleoporin 35), RAE1 (ribonucleic acid export 1), NUP205 (nucleoporin 205), NUP62 (nucleoporin 62), NUP210 (nucleoporin 210), NUP214 (nucleoporin 214), NUP188 (nucleoporin 188), NUP50 (nucleoporin 50), NUP88 (nucleoporin 88), TPR (translocated promoter region, nuclear basket protein), AAAS (aladin WD repeat nucleoporin), NUP107 (nucleoporin 107), NUP133 (nucleoporin 133), NUP160 (nucleoporin 160), NUP37 (nucleoporin 37), GCK (glucokinase), HK1 (hexokinase 1), NUP54 (nucleoporin 54), ALDOA (aldolase, fructose-bisphosphate A), ALDOC (aldolase, fructose-bisphosphate C), RANBP2 (RAN binding protein 2), ALDOB (aldolase, fructose-bisphosphate B), HK3 (hexokinase 3), FBP1 (fructose-bisphosphatase 1), HK2 (hexokinase 2), TPI1 (triosephosphate isomerase 1), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), PGK1 (phosphoglycerate kinase 1), PGAM2 (phosphoglycerate mutase 2), MDH2 (malate dehydrogenase 2), ENO1 (enolase 1), MDH1 (malate dehydrogenase 1), BPGM (bisphosphoglycerate mutase), POM121 (POM121 transmembrane nucleoporin), FBP2 (fructose-bisphosphatase 2), ENO3 (enolase 3), ENO2 (enolase 2), PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1), GAPDHS (glyceraldehyde-3-phosphate dehydrogenase, spermatogenic), GOT2 (glutamic-oxaloacetic transaminase 2), PFKFB2 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2), PGAM1 (phosphoglycerate mutase 1), GCKR (glucokinase regulator), PGK2 (phosphoglycerate kinase 2), PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3), PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4), PC (pyruvate carboxylase), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), PCK1 (phosphoenolpyruvate carboxykinase 1), GOT1 (glutamic-oxaloacetic transaminase 1), G6PC (glucose-6-phosphatase catalytic subunit), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PPP2CB (protein phosphatase 2 catalytic subunit beta), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), PPP2CA (protein phosphatase 2 catalytic subunit alpha), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), ADPGK (ADP dependent glucokinase), GNPDA1 (glucosamine-6-phosphate deaminase 1), GNPDA2 (glucosamine-6-phosphate deaminase 2), PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), SLC25A10 (solute carrier family 25 member 10), SLC25A11 (solute carrier family 25 member 11), PRKACB (protein kinase cAMP-activated catalytic subunit beta), SLC25A13 (solute carrier family 25 member 13), SLC25A12 (solute carrier family 25 member 12), SLC25A1 (solute carrier family 25 member 1), PGP (phosphoglycolate phosphatase), PFKL (phosphofructokinase, liver type), G6PC3 (glucose-6-phosphatase catalytic subunit 3), G6PC2 (glucose-6-phosphatase catalytic subunit 2), NUP42 (nucleoporin 42), PFKP (phosphofructokinase, platelet), PGM2L1 (phosphoglucomutase 2 like 1), NDC1 (NDC1 transmembrane nucleoporin), SLC37A1 (solute carrier family 37 member 1), PFKM (phosphofructokinase, muscle)"], "WAG002753": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COL5A2 (collagen type V alpha 2 chain), COL16A1 (collagen type XVI alpha 1 chain), COL15A1 (collagen type XV alpha 1 chain), COL8A1 (collagen type VIII alpha 1 chain), COL12A1 (collagen type XII alpha 1 chain), COL18A1 (collagen type XVIII alpha 1 chain), COL4A6 (collagen type IV alpha 6 chain), COL13A1 (collagen type XIII alpha 1 chain), COL10A1 (collagen type X alpha 1 chain), COL5A1 (collagen type V alpha 1 chain), COL22A1 (collagen type XXII alpha 1 chain), COL8A2 (collagen type VIII alpha 2 chain), COL4A4 (collagen type IV alpha 4 chain), COL21A1 (collagen type XXI alpha 1 chain), COL2A1 (collagen type II alpha 1 chain), COL27A1 (collagen type XXVII alpha 1 chain), COL28A1 (collagen type XXVIII alpha 1 chain), COL24A1 (collagen type XXIV alpha 1 chain), COL14A1 (collagen type XIV alpha 1 chain), COL25A1 (collagen type XXV alpha 1 chain), COL11A1 (collagen type XI alpha 1 chain), COL23A1 (collagen type XXIII alpha 1 chain), COL20A1 (collagen type XX alpha 1 chain), COL4A1 (collagen type IV alpha 1 chain), COL4A3 (collagen type IV alpha 3 chain), COL6A1 (collagen type VI alpha 1 chain), COL7A1 (collagen type VII alpha 1 chain), COL4A2 (collagen type IV alpha 2 chain), COL1A1 (collagen type I alpha 1 chain), COL9A2 (collagen type IX alpha 2 chain), COL1A2 (collagen type I alpha 2 chain), COL3A1 (collagen type III alpha 1 chain), COL9A1 (collagen type IX alpha 1 chain), COL17A1 (collagen type XVII alpha 1 chain), COL5A3 (collagen type V alpha 3 chain), COL6A2 (collagen type VI alpha 2 chain), COL9A3 (collagen type IX alpha 3 chain), COL4A5 (collagen type IV alpha 5 chain), COL19A1 (collagen type XIX alpha 1 chain), COL11A2 (collagen type XI alpha 2 chain), COL26A1 (collagen type XXVI alpha 1 chain)"], "WAG002754": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RET (ret proto-oncogene), GDNF (glial cell derived neurotrophic factor), GFRA1 (GDNF family receptor alpha 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SHC1 (SHC adaptor protein 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PLCG1 (phospholipase C gamma 1), PRKCA (protein kinase C alpha), GAB1 (GRB2 associated binding protein 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), GAB2 (GRB2 associated binding protein 2), DOK1 (docking protein 1), IRS2 (insulin receptor substrate 2), FRS2 (fibroblast growth factor receptor substrate 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), GRB10 (growth factor receptor bound protein 10), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), SHC3 (SHC adaptor protein 3), NRTN (neurturin), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PSPN (persephin), ARTN (artemin), GRB7 (growth factor receptor bound protein 7), GFRA3 (GDNF family receptor alpha 3), GFRA2 (GDNF family receptor alpha 2), GFRA4 (GDNF family receptor alpha 4), DOK5 (docking protein 5), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PDLIM7 (PDZ and LIM domain 7), DOK4 (docking protein 4), DOK2 (docking protein 2), DOK6 (docking protein 6), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), MAPK7 (mitogen-activated protein kinase 7), RAP1GAP (RAP1 GTPase activating protein)"], "WAG002755": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), HDAC2 (histone deacetylase 2), HDAC3 (histone deacetylase 3), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), CREBBP (CREB binding protein), KAT2B (lysine acetyltransferase 2B), RBBP4 (RB binding protein 4, chromatin remodeling factor), EP300 (E1A binding protein p300), RBBP7 (RB binding protein 7, chromatin remodeling factor), TRRAP (transformation/transcription domain associated protein), RUVBL2 (RuvB like AAA ATPase 2), TAF9 (TATA-box binding protein associated factor 9), RUVBL1 (RuvB like AAA ATPase 1), ACTL6A (actin like 6A), RELA (RELA proto-oncogene, NF-kB subunit), SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2), WDR5 (WD repeat domain 5), KAT2A (lysine acetyltransferase 2A), SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2), CHD4 (chromodomain helicase DNA binding protein 4), NCOR1 (nuclear receptor corepressor 1), SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1), SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1), TAF6L (TATA-box binding protein associated factor 6 like), TADA3 (transcriptional adaptor 3), SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1), PRMT5 (protein arginine methyltransferase 5), KDM1A (lysine demethylase 1A), KAT5 (lysine acetyltransferase 5), SUPT3H (SPT3 homolog, SAGA and STAGA complex component), EED (embryonic ectoderm development), CDK4 (cyclin dependent kinase 4), SUV39H1 (suppressor of variegation 3-9 homolog 1), HCFC1 (host cell factor C1), TAF10 (TATA-box binding protein associated factor 10), CARM1 (coactivator associated arginine methyltransferase 1), ACTB (actin beta), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), MTA2 (metastasis associated 1 family member 2), CHD3 (chromodomain helicase DNA binding protein 3), MBD3 (methyl-CpG binding domain protein 3), MEAF6 (MYST/Esa1 associated factor 6), SAP30 (Sin3A associated protein 30), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), HDAC10 (histone deacetylase 10), SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1), TAF12 (TATA-box binding protein associated factor 12), USP22 (ubiquitin specific peptidase 22), GATAD2A (GATA zinc finger domain containing 2A), YEATS4 (YEATS domain containing 4), SAP130 (Sin3A associated protein 130), TADA2B (transcriptional adaptor 2B), ING3 (inhibitor of growth family member 3), NCOR2 (nuclear receptor corepressor 2), NCOA1 (nuclear receptor coactivator 1), RBBP5 (RB binding protein 5, histone lysine methyltransferase complex subunit), ATXN7L3 (ataxin 7 like 3), CCND1 (cyclin D1), TBL1XR1 (TBL1X receptor 1), PHF21A (PHD finger protein 21A), TAF5L (TATA-box binding protein associated factor 5 like), EPC1 (enhancer of polycomb homolog 1), SUZ12 (SUZ12 polycomb repressive complex 2 subunit), DMAP1 (DNA methyltransferase 1 associated protein 1), NFKB1 (nuclear factor kappa B subunit 1), HDAC8 (histone deacetylase 8), EP400 (E1A binding protein p400), ASH2L (ASH2 like, histone lysine methyltransferase complex subunit), ENY2 (ENY2 transcription and export complex 2 subunit), SUPT7L (SPT7 like, STAGA complex subunit gamma), KAT8 (lysine acetyltransferase 8), SAP18 (Sin3A associated protein 18), NCOA2 (nuclear receptor coactivator 2), TADA1 (transcriptional adaptor 1), SUDS3 (SDS3 homolog, SIN3A corepressor complex component), ARID1A (AT-rich interaction domain 1A), BRD8 (bromodomain containing 8), MORF4L2 (mortality factor 4 like 2), MTA3 (metastasis associated 1 family member 3), KDM5B (lysine demethylase 5B), GATAD2B (GATA zinc finger domain containing 2B), ARID1B (AT-rich interaction domain 1B), SETDB1 (SET domain bifurcated histone lysine methyltransferase 1), MTA1 (metastasis associated 1), EHMT2 (euchromatic histone lysine methyltransferase 2), PRMT1 (protein arginine methyltransferase 1), VPS72 (vacuolar protein sorting 72 homolog), ATXN7 (ataxin 7), MCRS1 (microspherule protein 1), SMARCD2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2), WDR77 (WD repeat domain 77), RCOR1 (REST corepressor 1), KAT6A (lysine acetyltransferase 6A), BRMS1 (BRMS1 transcriptional repressor and anoikis regulator), ARID4A (AT-rich interaction domain 4A), PBRM1 (polybromo 1), ING5 (inhibitor of growth family member 5), GPS2 (G protein pathway suppressor 2), DNMT3A (DNA methyltransferase 3 alpha), CLOCK (clock circadian regulator)"], "WAG002757": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), ATP6V1A (ATPase H+ transporting V1 subunit A), ATP6V1E1 (ATPase H+ transporting V1 subunit E1), ATP6V0A1 (ATPase H+ transporting V0 subunit a1), ATP6V1F (ATPase H+ transporting V1 subunit F), ATP6V1H (ATPase H+ transporting V1 subunit H), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), ATP6V1D (ATPase H+ transporting V1 subunit D), ATP6V0D1 (ATPase H+ transporting V0 subunit d1), ATP6V1B2 (ATPase H+ transporting V1 subunit B2), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), ATP6V1B1 (ATPase H+ transporting V1 subunit B1), ATP6V0A2 (ATPase H+ transporting V0 subunit a2), ATP6V0C (ATPase H+ transporting V0 subunit c), ATP6V0A4 (ATPase H+ transporting V0 subunit a4), ATP6V1G1 (ATPase H+ transporting V1 subunit G1), ATP6V0D2 (ATPase H+ transporting V0 subunit d2), ATP6V0B (ATPase H+ transporting V0 subunit b), ATP6V0E2 (ATPase H+ transporting V0 subunit e2), ATP6V1C2 (ATPase H+ transporting V1 subunit C2), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), ATP6V1G3 (ATPase H+ transporting V1 subunit G3), NEDD4L (NEDD4 like E3 ubiquitin protein ligase), ATP6AP1 (ATPase H+ transporting accessory protein 1), SGK1 (serum/glucocorticoid regulated kinase 1), ATP1B1 (ATPase Na+/K+ transporting subunit beta 1), ATP4A (ATPase H+/K+ transporting subunit alpha), ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1), RYR2 (ryanodine receptor 2), TRPC1 (transient receptor potential cation channel subfamily C member 1), ATP12A (ATPase H+/K+ transporting non-gastric alpha2 subunit), RYR1 (ryanodine receptor 1), TRPC3 (transient receptor potential cation channel subfamily C member 3), TRPC4 (transient receptor potential cation channel subfamily C member 4), FXYD2 (FXYD domain containing ion transport regulator 2), ATP1A3 (ATPase Na+/K+ transporting subunit alpha 3), SCNN1B (sodium channel epithelial 1 subunit beta), PLN (phospholamban), CLCN5 (chloride voltage-gated channel 5), ATP2B3 (ATPase plasma membrane Ca2+ transporting 3), CLCN7 (chloride voltage-gated channel 7), TRPC6 (transient receptor potential cation channel subfamily C member 6), TRPC5 (transient receptor potential cation channel subfamily C member 5), ATP1B2 (ATPase Na+/K+ transporting subunit beta 2), ATP1A2 (ATPase Na+/K+ transporting subunit alpha 2), ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1), SCNN1A (sodium channel epithelial 1 subunit alpha), ATP2B2 (ATPase plasma membrane Ca2+ transporting 2), ATP2A3 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3), RYR3 (ryanodine receptor 3), ATP1A4 (ATPase Na+/K+ transporting subunit alpha 4), ATP1B3 (ATPase Na+/K+ transporting subunit beta 3), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2), CLCN2 (chloride voltage-gated channel 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SCNN1G (sodium channel epithelial 1 subunit gamma), CAMK2B (calcium/calmodulin dependent protein kinase II beta), ATP11A (ATPase phospholipid transporting 11A), TRPV4 (transient receptor potential cation channel subfamily V member 4), CLCN6 (chloride voltage-gated channel 6), CLCN3 (chloride voltage-gated channel 3), ATP2B1 (ATPase plasma membrane Ca2+ transporting 1), ATP2C1 (ATPase secretory pathway Ca2+ transporting 1), WWP1 (WW domain containing E3 ubiquitin protein ligase 1), ATP6V1G2 (ATPase H+ transporting V1 subunit G2), UBB (ubiquitin B), WNK1 (WNK lysine deficient protein kinase 1), FXYD1 (FXYD domain containing ion transport regulator 1), TRPM4 (transient receptor potential cation channel subfamily M member 4), TRPV1 (transient receptor potential cation channel subfamily V member 1), TSC22D3 (TSC22 domain family member 3), TRPV6 (transient receptor potential cation channel subfamily V member 6), RPS27A (ribosomal protein S27a), CLCN1 (chloride voltage-gated channel 1), TRPV2 (transient receptor potential cation channel subfamily V member 2), ATP8A1 (ATPase phospholipid transporting 8A1), FXYD7 (FXYD domain containing ion transport regulator 7), CAMK2D (calcium/calmodulin dependent protein kinase II delta), WNK4 (WNK lysine deficient protein kinase 4), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), FKBP1B (FKBP prolyl isomerase 1B), CLCNKA (chloride voltage-gated channel Ka), CLCN4 (chloride voltage-gated channel 4), ATP2B4 (ATPase plasma membrane Ca2+ transporting 4), TRPV5 (transient receptor potential cation channel subfamily V member 5), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), TRDN (triadin), TRPM2 (transient receptor potential cation channel subfamily M member 2), TRPC4AP (transient receptor potential cation channel subfamily C member 4 associated protein), SLN (sarcolipin), CLCNKB (chloride voltage-gated channel Kb), BSND (barttin CLCNK type accessory subunit beta), TRPM8 (transient receptor potential cation channel subfamily M member 8), SCNN1D (sodium channel epithelial 1 subunit delta), ATP4B (ATPase H+/K+ transporting subunit beta), TRPA1 (transient receptor potential cation channel subfamily A member 1), ASPH (aspartate beta-hydroxylase), SRI (sorcin), OSTM1 (osteoclastogenesis associated transmembrane protein 1)"], "WAG002759": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ARNTL (aryl hydrocarbon receptor nuclear translocator like), SUMO1 (small ubiquitin like modifier 1), CRY1 (cryptochrome circadian regulator 1), CRY2 (cryptochrome circadian regulator 2), PER2 (period circadian regulator 2), CLOCK (clock circadian regulator), HSPA8 (heat shock protein family A (Hsp70) member 8), PER1 (period circadian regulator 1), DNAJA1 (DnaJ heat shock protein family (Hsp40) member A1), PPP2CB (protein phosphatase 2 catalytic subunit beta), NR1D2 (nuclear receptor subfamily 1 group D member 2), PSMA4 (proteasome 20S subunit alpha 4), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), RBPMS (RNA binding protein, mRNA processing factor), SUMO3 (small ubiquitin like modifier 3), BTG1 (BTG anti-proliferation factor 1), QKI (QKI, KH domain containing RNA binding), DAZAP2 (DAZ associated protein 2), IDI1 (isopentenyl-diphosphate delta isomerase 1), GSTP1 (glutathione S-transferase pi 1), GSTM3 (glutathione S-transferase mu 3), CEBPB (CCAAT enhancer binding protein beta), ETV6 (ETS variant transcription factor 6), TOB1 (transducer of ERBB2, 1), VAPA (VAMP associated protein A), TUBB3 (tubulin beta 3 class III), NCKAP1 (NCK associated protein 1), HERPUD1 (homocysteine inducible ER protein with ubiquitin like domain 1), CBX3 (chromobox 3), MYF6 (myogenic factor 6), ZFR (zinc finger RNA binding protein), G0S2 (G0/G1 switch 2), UCP3 (uncoupling protein 3), SF3A3 (splicing factor 3a subunit 3), CLDN5 (claudin 5), AZIN1 (antizyme inhibitor 1), STBD1 (starch binding domain 1), PURA (purine rich element binding protein A), PPP1R3C (protein phosphatase 1 regulatory subunit 3C), GFRA1 (GDNF family receptor alpha 1), EIF4G2 (eukaryotic translation initiation factor 4 gamma 2), HLA-DMA (major histocompatibility complex, class II, DM alpha), H2BC15 (H2B clustered histone 15), KLF9 (Kruppel like factor 9), NCOA4 (nuclear receptor coactivator 4), UGP2 (UDP-glucose pyrophosphorylase 2), PIGF (phosphatidylinositol glycan anchor biosynthesis class F), ERC2 (ELKS/RAB6-interacting/CAST family member 2)"], "WAG002760": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDC42 (cell division cycle 42), PAK2 (p21 (RAC1) activated kinase 2), IFNG (interferon gamma), SOD2 (superoxide dismutase 2), RPLP0 (ribosomal protein lateral stalk subunit P0), SOD1 (superoxide dismutase 1), RAP1B (RAP1B, member of RAS oncogene family), ANXA2 (annexin A2), PPIA (peptidylprolyl isomerase A), HSPA9 (heat shock protein family A (Hsp70) member 9), GSTA2 (glutathione S-transferase alpha 2), ARF1 (ADP ribosylation factor 1), TCP1 (t-complex 1), RALA (RAS like proto-oncogene A), HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1), MSN (moesin), CNN2 (calponin 2), HNRNPF (heterogeneous nuclear ribonucleoprotein F), STAT4 (signal transducer and activator of transcription 4), CFL1 (cofilin 1), GSTO1 (glutathione S-transferase omega 1), IL10 (interleukin 10), MIF (macrophage migration inhibitory factor), PSME2 (proteasome activator subunit 2), CA1 (carbonic anhydrase 1), MTAP (methylthioadenosine phosphorylase), PDCD4 (programmed cell death 4), BOLA2 (bolA family member 2), SOD2-OT1 (SOD2 overlapping transcript 1), TALDO1 (transaldolase 1), LMNB1 (lamin B1), AIP (aryl hydrocarbon receptor interacting protein), HNRNPDL (heterogeneous nuclear ribonucleoprotein D like), LCP1 (lymphocyte cytosolic protein 1), SERPINB2 (serpin family B member 2), BOLA2B (bolA family member 2B), CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1), PITPNA (phosphatidylinositol transfer protein alpha)"], "WAG002762": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), UCHL5 (ubiquitin C-terminal hydrolase L5), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD2 (proteasome 26S subunit, non-ATPase 2), TRAF6 (TNF receptor associated factor 6), PSMA3 (proteasome 20S subunit alpha 3), PSMD11 (proteasome 26S subunit, non-ATPase 11), TP53 (tumor protein p53), PSMA2 (proteasome 20S subunit alpha 2), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMA7 (proteasome 20S subunit alpha 7), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMC4 (proteasome 26S subunit, ATPase 4), PSMA1 (proteasome 20S subunit alpha 1), PSMA6 (proteasome 20S subunit alpha 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB5 (proteasome 20S subunit beta 5), PSMB4 (proteasome 20S subunit beta 4), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMA5 (proteasome 20S subunit alpha 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB2 (proteasome 20S subunit beta 2), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB3 (proteasome 20S subunit beta 3), CDC20 (cell division cycle 20), PSMB1 (proteasome 20S subunit beta 1), MYC (MYC proto-oncogene, bHLH transcription factor), PSMB6 (proteasome 20S subunit beta 6), CDK1 (cyclin dependent kinase 1), PSMB7 (proteasome 20S subunit beta 7), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMD9 (proteasome 26S subunit, non-ATPase 9), SKP2 (S-phase kinase associated protein 2), PSME4 (proteasome activator subunit 4), CDC25A (cell division cycle 25A), PSMB10 (proteasome 20S subunit beta 10), PSME3 (proteasome activator subunit 3), PSMA8 (proteasome 20S subunit alpha 8), PSMD5 (proteasome 26S subunit, non-ATPase 5), AXIN1 (axin 1), RAD23B (RAD23 homolog B, nucleotide excision repair protein), PSMF1 (proteasome inhibitor subunit 1), PSME1 (proteasome activator subunit 1), PSMB11 (proteasome subunit beta 11), MDM2 (MDM2 proto-oncogene), ADRM1 (adhesion regulating molecule 1), PSMB8 (proteasome 20S subunit beta 8), UBE2D1 (ubiquitin conjugating enzyme E2 D1), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), USP14 (ubiquitin specific peptidase 14), BRCA1 (BRCA1 DNA repair associated), RAD23A (RAD23 homolog A, nucleotide excision repair protein), SMAD3 (SMAD family member 3), SMAD2 (SMAD family member 2), NEDD8 (NEDD8 ubiquitin like modifier), SMAD4 (SMAD family member 4), IDE (insulin degrading enzyme), USP7 (ubiquitin specific peptidase 7), VCP (valosin containing protein), YY1 (YY1 transcription factor), EP300 (E1A binding protein p300), RUVBL1 (RuvB like AAA ATPase 1), ESR1 (estrogen receptor 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), ACTB (actin beta), AR (androgen receptor), TRAF2 (TNF receptor associated factor 2), KAT2B (lysine acetyltransferase 2B), RPS27A (ribosomal protein S27a), SMAD1 (SMAD family member 1), TGFBR1 (transforming growth factor beta receptor 1), FKBP8 (FKBP prolyl isomerase 8), USP15 (ubiquitin specific peptidase 15), SMAD7 (SMAD family member 7), HIF1A (hypoxia inducible factor 1 subunit alpha), TGFB1 (transforming growth factor beta 1), MAVS (mitochondrial antiviral signaling protein), NFKBIA (NFKB inhibitor alpha), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), TGFBR2 (transforming growth factor beta receptor 2), OTUB1 (OTU deubiquitinase, ubiquitin aldehyde binding 1), BIRC2 (baculoviral IAP repeat containing 2), KAT2A (lysine acetyltransferase 2A), UCHL3 (ubiquitin C-terminal hydrolase L3), RIPK1 (receptor interacting serine/threonine kinase 1), RIPK2 (receptor interacting serine/threonine kinase 2), ACTL6A (actin like 6A), TRAF3 (TNF receptor associated factor 3)"], "WAG002765": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA1 (proteasome 20S subunit alpha 1), PSMA4 (proteasome 20S subunit alpha 4), PSMA7 (proteasome 20S subunit alpha 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB10 (proteasome 20S subunit beta 10), PSMA3 (proteasome 20S subunit alpha 3), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA6 (proteasome 20S subunit alpha 6), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB2 (proteasome 20S subunit beta 2), PSMA2 (proteasome 20S subunit alpha 2), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB4 (proteasome 20S subunit beta 4), PSMB5 (proteasome 20S subunit beta 5), PSMB1 (proteasome 20S subunit beta 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB3 (proteasome 20S subunit beta 3), PSMC2 (proteasome 26S subunit, ATPase 2), PSMB6 (proteasome 20S subunit beta 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSME4 (proteasome activator subunit 4), PSMA5 (proteasome 20S subunit alpha 5), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMF1 (proteasome inhibitor subunit 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMC3 (proteasome 26S subunit, ATPase 3), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME3 (proteasome activator subunit 3), UBB (ubiquitin B), PSME1 (proteasome activator subunit 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), AXIN1 (axin 1), PSMB9 (proteasome 20S subunit beta 9), PSMB8 (proteasome 20S subunit beta 8), PSME2 (proteasome activator subunit 2), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), CREBBP (CREB binding protein), BMI1 (BMI1 proto-oncogene, polycomb ring finger), SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1), SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2), EP300 (E1A binding protein p300), RNF2 (ring finger protein 2), ESR1 (estrogen receptor 1), SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1), SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2), SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1), SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1), GATA1 (GATA binding protein 1), RUNX1 (RUNX family transcription factor 1), CBX4 (chromobox 4), CSNK2A1 (casein kinase 2 alpha 1), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), ARID1A (AT-rich interaction domain 1A), ACTL6A (actin like 6A), SMARCD2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2), RING1 (ring finger protein 1), CBX2 (chromobox 2), TCF3 (transcription factor 3), CBX8 (chromobox 8), PCGF5 (polycomb group ring finger 5), CSNK2A2 (casein kinase 2 alpha 2), ARID1B (AT-rich interaction domain 1B), CSNK2B (casein kinase 2 beta), PHC2 (polyhomeotic homolog 2), MYB (MYB proto-oncogene, transcription factor), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), GATA3 (GATA binding protein 3), TAL1 (TAL bHLH transcription factor 1, erythroid differentiation factor), ITCH (itchy E3 ubiquitin protein ligase), PHC1 (polyhomeotic homolog 1), CBX6 (chromobox 6), ACTL6B (actin like 6B), PHC3 (polyhomeotic homolog 3), LMO2 (LIM domain only 2), PBRM1 (polybromo 1), GATA2 (GATA binding protein 2), LDB1 (LIM domain binding 1), SPI1 (Spi-1 proto-oncogene), TP73 (tumor protein p73), HIPK2 (homeodomain interacting protein kinase 2), YAP1 (Yes1 associated transcriptional regulator), ARID2 (AT-rich interaction domain 2), PAX5 (paired box 5), OCLN (occludin), CCNH (cyclin H), CDK7 (cyclin dependent kinase 7), TCF12 (transcription factor 12)"], "WAG002767": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CCND1 (cyclin D1), PSMC5 (proteasome 26S subunit, ATPase 5), CDKN1A (cyclin dependent kinase inhibitor 1A), UBB (ubiquitin B), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), MYC (MYC proto-oncogene, bHLH transcription factor), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA3 (proteasome 20S subunit alpha 3), PSMA7 (proteasome 20S subunit alpha 7), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMA2 (proteasome 20S subunit alpha 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSME3 (proteasome activator subunit 3), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB6 (proteasome 20S subunit beta 6), PSMB1 (proteasome 20S subunit beta 1), PSMA1 (proteasome 20S subunit alpha 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMB3 (proteasome 20S subunit beta 3), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB4 (proteasome 20S subunit beta 4), PSMA6 (proteasome 20S subunit alpha 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMB5 (proteasome 20S subunit beta 5), PSMB2 (proteasome 20S subunit beta 2), PSMA5 (proteasome 20S subunit alpha 5), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB10 (proteasome 20S subunit beta 10), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMF1 (proteasome inhibitor subunit 1), PSME1 (proteasome activator subunit 1), PSMB9 (proteasome 20S subunit beta 9), PSMB8 (proteasome 20S subunit beta 8), PSME2 (proteasome activator subunit 2), CREBBP (CREB binding protein), MDM2 (MDM2 proto-oncogene), TP53 (tumor protein p53), SMAD4 (SMAD family member 4), EP300 (E1A binding protein p300), SMAD3 (SMAD family member 3), NOTCH1 (notch receptor 1), CTNNB1 (catenin beta 1), KAT2B (lysine acetyltransferase 2B), RUNX3 (RUNX family transcription factor 3), TGFB1 (transforming growth factor beta 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), KAT2A (lysine acetyltransferase 2A), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), SNW1 (SNW domain containing 1), RUNX1 (RUNX family transcription factor 1), FOXO3 (forkhead box O3), MAML1 (mastermind like transcriptional coactivator 1), YAP1 (Yes1 associated transcriptional regulator), LEF1 (lymphoid enhancer binding factor 1), CDKN2A (cyclin dependent kinase inhibitor 2A), TCF7L2 (transcription factor 7 like 2), RPS27A (ribosomal protein S27a), MAML2 (mastermind like transcriptional coactivator 2), MAML3 (mastermind like transcriptional coactivator 3), WWTR1 (WW domain containing transcription regulator 1), ITGA4 (integrin subunit alpha 4), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), TCF7 (transcription factor 7), HDAC4 (histone deacetylase 4), TCF7L1 (transcription factor 7 like 1), JAG1 (jagged canonical Notch ligand 1), TEAD1 (TEA domain transcription factor 1), TEAD3 (TEA domain transcription factor 3), KRAS (KRAS proto-oncogene, GTPase), TEAD4 (TEA domain transcription factor 4), TEAD2 (TEA domain transcription factor 2), CBFB (core-binding factor subunit beta), HES1 (hes family bHLH transcription factor 1), BCL2L11 (BCL2 like 11), ZFHX3 (zinc finger homeobox 3), SPP1 (secreted phosphoprotein 1), ITGAL (integrin subunit alpha L), RORC (RAR related orphan receptor C), BRD2 (bromodomain containing 2), CCN2 (cellular communication network factor 2), MAMLD1 (mastermind like domain containing 1), SEM1 (SEM1 26S proteasome complex subunit), LOC100506403 (uncharacterized LOC100506403)"], "WAG002769": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CDC20 (cell division cycle 20), FZR1 (fizzy and cell division cycle 20 related 1), CDC27 (cell division cycle 27), CDC16 (cell division cycle 16), PSMD14 (proteasome 26S subunit, non-ATPase 14), ANAPC4 (anaphase promoting complex subunit 4), ANAPC2 (anaphase promoting complex subunit 2), CDC23 (cell division cycle 23), PSMA6 (proteasome 20S subunit alpha 6), ANAPC1 (anaphase promoting complex subunit 1), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA7 (proteasome 20S subunit alpha 7), UBE2C (ubiquitin conjugating enzyme E2 C), PSMA2 (proteasome 20S subunit alpha 2), ANAPC5 (anaphase promoting complex subunit 5), PSMB2 (proteasome 20S subunit beta 2), ANAPC11 (anaphase promoting complex subunit 11), PSMC3 (proteasome 26S subunit, ATPase 3), CDC26 (cell division cycle 26), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD2 (proteasome 26S subunit, non-ATPase 2), ANAPC7 (anaphase promoting complex subunit 7), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMB10 (proteasome 20S subunit beta 10), PSMA3 (proteasome 20S subunit alpha 3), PSMB4 (proteasome 20S subunit beta 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB5 (proteasome 20S subunit beta 5), PSMA1 (proteasome 20S subunit alpha 1), PSMB1 (proteasome 20S subunit beta 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMA4 (proteasome 20S subunit alpha 4), PSMB6 (proteasome 20S subunit beta 6), PSMB3 (proteasome 20S subunit beta 3), ANAPC10 (anaphase promoting complex subunit 10), PSMB7 (proteasome 20S subunit beta 7), PSMA5 (proteasome 20S subunit alpha 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC4 (proteasome 26S subunit, ATPase 4), PSMC5 (proteasome 26S subunit, ATPase 5), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME4 (proteasome activator subunit 4), PSMD10 (proteasome 26S subunit, non-ATPase 10), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMF1 (proteasome inhibitor subunit 1), PSMA8 (proteasome 20S subunit alpha 8), PSMB11 (proteasome subunit beta 11), PSME1 (proteasome activator subunit 1), PSME3 (proteasome activator subunit 3), CDK1 (cyclin dependent kinase 1), CDK2 (cyclin dependent kinase 2), UBE2E1 (ubiquitin conjugating enzyme E2 E1), UBB (ubiquitin B), PLK1 (polo like kinase 1), BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B), PTTG1 (PTTG1 regulator of sister chromatid separation, securin), SKP2 (S-phase kinase associated protein 2), AURKB (aurora kinase B), BUB3 (BUB3 mitotic checkpoint protein), PSMD4 (proteasome 26S subunit, non-ATPase 4), CUL1 (cullin 1), SKP1 (S-phase kinase associated protein 1), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), CCNB1 (cyclin B1), UBE2D1 (ubiquitin conjugating enzyme E2 D1), FBXO5 (F-box protein 5), NEK2 (NIMA related kinase 2), MAD2L1 (mitotic arrest deficient 2 like 1), UBE2S (ubiquitin conjugating enzyme E2 S), CCNA2 (cyclin A2), ANAPC16 (anaphase promoting complex subunit 16), CDC14A (cell division cycle 14A), RB1 (RB transcriptional corepressor 1), CCNA1 (cyclin A1), RPS27A (ribosomal protein S27a), AURKA (aurora kinase A), ANAPC15 (anaphase promoting complex subunit 15), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002770": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HNRNPK (heterogeneous nuclear ribonucleoprotein K), SNRNP70 (small nuclear ribonucleoprotein U1 subunit 70), SF3A2 (splicing factor 3a subunit 2), U2AF1 (U2 small nuclear RNA auxiliary factor 1), U2AF2 (U2 small nuclear RNA auxiliary factor 2), NCBP2 (nuclear cap binding protein subunit 2), HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1), SNRPA (small nuclear ribonucleoprotein polypeptide A), PTBP1 (polypyrimidine tract binding protein 1), HNRNPD (heterogeneous nuclear ribonucleoprotein D), HNRNPR (heterogeneous nuclear ribonucleoprotein R), SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide), HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1), DHX9 (DExH-box helicase 9), FUS (FUS RNA binding protein), SNRPG (small nuclear ribonucleoprotein polypeptide G), SNRPF (small nuclear ribonucleoprotein polypeptide F), HNRNPM (heterogeneous nuclear ribonucleoprotein M), SNRPB2 (small nuclear ribonucleoprotein polypeptide B2), SF3A1 (splicing factor 3a subunit 1), HNRNPU (heterogeneous nuclear ribonucleoprotein U), SF3B4 (splicing factor 3b subunit 4), SNRPD2 (small nuclear ribonucleoprotein D2 polypeptide), EFTUD2 (elongation factor Tu GTP binding domain containing 2), POLR2A (RNA polymerase II subunit A), PRPF4 (pre-mRNA processing factor 4), SF3B1 (splicing factor 3b subunit 1), DHX38 (DEAH-box helicase 38), CDC40 (cell division cycle 40), SF3B3 (splicing factor 3b subunit 3), CPSF1 (cleavage and polyadenylation specific factor 1), CPSF2 (cleavage and polyadenylation specific factor 2), SNRPA1 (small nuclear ribonucleoprotein polypeptide A'), CSTF2 (cleavage stimulation factor subunit 2), YBX1 (Y-box binding protein 1), SF3A3 (splicing factor 3a subunit 3), SF3B2 (splicing factor 3b subunit 2), PABPN1 (poly(A) binding protein nuclear 1), CPSF3 (cleavage and polyadenylation specific factor 3), CD2BP2 (CD2 cytoplasmic tail binding protein 2), CSTF1 (cleavage stimulation factor subunit 1), HNRNPL (heterogeneous nuclear ribonucleoprotein L), PCBP2 (poly(rC) binding protein 2), RBM5 (RNA binding motif protein 5), NCBP1 (nuclear cap binding protein subunit 1), PRPF8 (pre-mRNA processing factor 8), SMC1A (structural maintenance of chromosomes 1A), DNAJC8 (DnaJ heat shock protein family (Hsp40) member C8), SF3B5 (splicing factor 3b subunit 5), SRRM1 (serine and arginine repetitive matrix 1), SNRPB (small nuclear ribonucleoprotein polypeptides B and B1), SRSF1 (serine and arginine rich splicing factor 1), RNPS1 (RNA binding protein with serine rich domain 1), HNRNPC (heterogeneous nuclear ribonucleoprotein C), SRSF2 (serine and arginine rich splicing factor 2), PRPF6 (pre-mRNA processing factor 6), SNRPD1 (small nuclear ribonucleoprotein D1 polypeptide), HNRNPH1 (heterogeneous nuclear ribonucleoprotein H1), SRSF3 (serine and arginine rich splicing factor 3), SRSF7 (serine and arginine rich splicing factor 7), SNRPE (small nuclear ribonucleoprotein polypeptide E), SRSF6 (serine and arginine rich splicing factor 6), SRSF4 (serine and arginine rich splicing factor 4), NUDT21 (nudix hydrolase 21), SRSF5 (serine and arginine rich splicing factor 5), LSM2 (LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated), PAPOLA (poly(A) polymerase alpha), SRSF9 (serine and arginine rich splicing factor 9), CSTF3 (cleavage stimulation factor subunit 3), TXNL4A (thioredoxin like 4A), SNRNP40 (small nuclear ribonucleoprotein U5 subunit 40), HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2), PHF5A (PHD finger protein 5A), SUGP1 (SURP and G-patch domain containing 1), CLP1 (cleavage factor polyribonucleotide kinase subunit 1), DHX15 (DEAH-box helicase 15), NXF1 (nuclear RNA export factor 1), PRPF3 (pre-mRNA processing factor 3), TRA2B (transformer 2 beta homolog), SREK1 (splicing regulatory glutamic acid and lysine rich protein 1), CPSF4 (cleavage and polyadenylation specific factor 4), HNRNPAB (heterogeneous nuclear ribonucleoprotein A/B), SRPK1 (SRSF protein kinase 1), LSM7 (LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated), SNRPN (small nuclear ribonucleoprotein polypeptide N), SFPQ (splicing factor proline and glutamine rich), SRPK2 (SRSF protein kinase 2), DHX8 (DEAH-box helicase 8), RBM39 (RNA binding motif protein 39), DHX16 (DEAH-box helicase 16), CLK2 (CDC like kinase 2), NONO (non-POU domain containing octamer binding), PRPF4B (pre-mRNA processing factor 4B), DDX20 (DEAD-box helicase 20), CELF1 (CUGBP Elav-like family member 1), METTL3 (methyltransferase like 3), SRP54 (signal recognition particle 54), DDX1 (DEAD-box helicase 1), PRMT1 (protein arginine methyltransferase 1), CLK1 (CDC like kinase 1)"], "WAG002771": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FN1 (fibronectin 1), APOA1 (apolipoprotein A1), ALB (albumin), APP (amyloid beta precursor protein), KNG1 (kininogen 1), TF (transferrin), APOA2 (apolipoprotein A2), FGA (fibrinogen alpha chain), SERPINC1 (serpin family C member 1), APOB (apolipoprotein B), ITIH2 (inter-alpha-trypsin inhibitor heavy chain 2), AHSG (alpha 2-HS glycoprotein), F5 (coagulation factor V), SERPIND1 (serpin family D member 1), FGG (fibrinogen gamma chain), SERPINA1 (serpin family A member 1), IL6 (interleukin 6), IGFBP1 (insulin like growth factor binding protein 1), SDC2 (syndecan 2), APOE (apolipoprotein E), AFP (alpha fetoprotein), TIMP1 (TIMP metallopeptidase inhibitor 1), PROC (protein C, inactivator of coagulation factors Va and VIIIa), IGFBP3 (insulin like growth factor binding protein 3), C3 (complement C3), GAS6 (growth arrest specific 6), SPP1 (secreted phosphoprotein 1), IGFBP4 (insulin like growth factor binding protein 4), P4HB (prolyl 4-hydroxylase subunit beta), CP (ceruloplasmin), IGFBP5 (insulin like growth factor binding protein 5), C4A (complement C4A (Rodgers blood group)), CST3 (cystatin C), HSP90B1 (heat shock protein 90 beta family member 1), FBN1 (fibrillin 1), APOA5 (apolipoprotein A5), MFGE8 (milk fat globule EGF and factor V/VIII domain containing), LAMB2 (laminin subunit beta 2), CHGB (chromogranin B), SPP2 (secreted phosphoprotein 2), GPC3 (glypican 3), FSTL1 (follistatin like 1), BMP4 (bone morphogenetic protein 4), PDIA6 (protein disulfide isomerase family A member 6), LAMB1 (laminin subunit beta 1), VCAN (versican), FGF23 (fibroblast growth factor 23), AMELX (amelogenin X-linked), DMP1 (dentin matrix acidic phosphoprotein 1), PENK (proenkephalin), LTBP1 (latent transforming growth factor beta binding protein 1), LAMC1 (laminin subunit gamma 1), TNC (tenascin C), CALU (calumenin), LGALS1 (galectin 1), CDH2 (cadherin 2), RCN1 (reticulocalbin 1), IGFBP7 (insulin like growth factor binding protein 7), AMTN (amelotin), AMBN (ameloblastin), CHRDL1 (chordin like 1), ENAM (enamelin), SCG2 (secretogranin II), ADAM10 (ADAM metallopeptidase domain 10), MEPE (matrix extracellular phosphoglycoprotein), SCG3 (secretogranin III), SERPINA10 (serpin family A member 10), CSF1 (colony stimulating factor 1), PRKCSH (protein kinase C substrate 80K-H), FSTL3 (follistatin like 3), DNAJC3 (DnaJ heat shock protein family (Hsp40) member C3), PRSS23 (serine protease 23), APOL1 (apolipoprotein L1), PCSK9 (proprotein convertase subtilisin/kexin type 9), SPARCL1 (SPARC like 1), APLP2 (amyloid beta precursor like protein 2), KTN1 (kinectin 1), MATN3 (matrilin 3), MBTPS1 (membrane bound transcription factor peptidase, site 1), NUCB1 (nucleobindin 1), BMP15 (bone morphogenetic protein 15), VGF (VGF nerve growth factor inducible), MSLN (mesothelin), TGOLN2 (trans-golgi network protein 2), STC2 (stanniocalcin 2), QSOX1 (quiescin sulfhydryl oxidase 1), ANO8 (anoctamin 8), CKAP4 (cytoskeleton associated protein 4), FAM20C (FAM20C golgi associated secretory pathway kinase), GOLM1 (golgi membrane protein 1), HRC (histidine rich calcium binding protein), PNPLA2 (patatin like phospholipase domain containing 2), MGAT4A (alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A), FUCA2 (alpha-L-fucosidase 2), FAM20A (FAM20A golgi associated secretory pathway pseudokinase), TMEM132A (transmembrane protein 132A), CCN1 (cellular communication network factor 1), SHISA5 (shisa family member 5), NOTUM (notum, palmitoleoyl-protein carboxylesterase), MEN1 (menin 1)"], "WAG002775": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ELOVL1 (ELOVL fatty acid elongase 1), ELOVL6 (ELOVL fatty acid elongase 6), FASN (fatty acid synthase), ACSL1 (acyl-CoA synthetase long chain family member 1), ACSL4 (acyl-CoA synthetase long chain family member 4), ACSL3 (acyl-CoA synthetase long chain family member 3), ACSL5 (acyl-CoA synthetase long chain family member 5), PPT1 (palmitoyl-protein thioesterase 1), SCD (stearoyl-CoA desaturase), ACLY (ATP citrate lyase), HSD17B12 (hydroxysteroid 17-beta dehydrogenase 12), ACACA (acetyl-CoA carboxylase alpha), ACSBG1 (acyl-CoA synthetase bubblegum family member 1), ELOVL5 (ELOVL fatty acid elongase 5), ACSBG2 (acyl-CoA synthetase bubblegum family member 2), ELOVL2 (ELOVL fatty acid elongase 2), TECR (trans-2,3-enoyl-CoA reductase), ACSL6 (acyl-CoA synthetase long chain family member 6), HSD17B8 (hydroxysteroid 17-beta dehydrogenase 8), OLAH (oleoyl-ACP hydrolase), SLC25A1 (solute carrier family 25 member 1), HSD17B3 (hydroxysteroid 17-beta dehydrogenase 3), ELOVL3 (ELOVL fatty acid elongase 3), PPT2 (palmitoyl-protein thioesterase 2), TECRL (trans-2,3-enoyl-CoA reductase like), CBR4 (carbonyl reductase 4), ELOVL7 (ELOVL fatty acid elongase 7), HTD2 (hydroxyacyl-thioester dehydratase type 2), SLC27A3 (solute carrier family 27 member 3), HACD4 (3-hydroxyacyl-CoA dehydratase 4), MORC2 (MORC family CW-type zinc finger 2), ELOVL4 (ELOVL fatty acid elongase 4), ACSF3 (acyl-CoA synthetase family member 3), SCD5 (stearoyl-CoA desaturase 5), HACD1 (3-hydroxyacyl-CoA dehydratase 1), HACD3 (3-hydroxyacyl-CoA dehydratase 3), HACD2 (3-hydroxyacyl-CoA dehydratase 2)"], "WAG002776": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APP (amyloid beta precursor protein), CDK5 (cyclin dependent kinase 5), CAPN1 (calpain 1), CAPN2 (calpain 2), FOXO3 (forkhead box O3), CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), CDC25A (cell division cycle 25A), CAPNS1 (calpain small subunit 1), CDC25B (cell division cycle 25B), BCL2L11 (BCL2 like 11), CAST (calpastatin), CDC25C (cell division cycle 25C), SOD2 (superoxide dismutase 2), PRDX2 (peroxiredoxin 2), FASLG (Fas ligand), CAPNS2 (calpain small subunit 2), PRDX1 (peroxiredoxin 1), GOLGA2 (golgin A2), SOD2-OT1 (SOD2 overlapping transcript 1), LMNB1 (lamin B1)"], "WAG002778": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RUNX1 (RUNX family transcription factor 1), CCND3 (cyclin D3), CCND1 (cyclin D1), CDK6 (cyclin dependent kinase 6), CCND2 (cyclin D2), TNRC6B (trinucleotide repeat containing adaptor 6B), PML (PML nuclear body scaffold), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), CBFB (core-binding factor subunit beta), TNRC6A (trinucleotide repeat containing adaptor 6A), TNRC6C (trinucleotide repeat containing adaptor 6C), MOV10 (Mov10 RISC complex RNA helicase), AGO3 (argonaute RISC catalytic component 3), AGO1 (argonaute RISC component 1), LOC100506403 (uncharacterized LOC100506403), AGO4 (argonaute RISC component 4), AGO2 (argonaute RISC catalytic component 2)"], "WAG002779": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), SH3KBP1 (SH3 domain containing kinase binding protein 1), CBL (Cbl proto-oncogene), HGS (hepatocyte growth factor-regulated tyrosine kinase substrate), MET (MET proto-oncogene, receptor tyrosine kinase), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), EPS15 (epidermal growth factor receptor pathway substrate 15), CTNNB1 (catenin beta 1), STAM2 (signal transducing adaptor molecule 2), STAM (signal transducing adaptor molecule), CDH1 (cadherin 1), SH3GL1 (SH3 domain containing GRB2 like 1, endophilin A2), SH3GL3 (SH3 domain containing GRB2 like 3, endophilin A3), CTNND1 (catenin delta 1), RPS27A (ribosomal protein S27a), CBLL1 (Cbl proto-oncogene like 1)"], "WAG002781": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), RBX1 (ring-box 1), CUL1 (cullin 1), SKP1 (S-phase kinase associated protein 1), CUL5 (cullin 5), BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase), SKP2 (S-phase kinase associated protein 2), COPS5 (COP9 signalosome subunit 5), PSMD2 (proteasome 26S subunit, non-ATPase 2), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSMA6 (proteasome 20S subunit alpha 6), PSMA2 (proteasome 20S subunit alpha 2), UBB (ubiquitin B), PSMC3 (proteasome 26S subunit, ATPase 3), CUL4A (cullin 4A), PSMD14 (proteasome 26S subunit, non-ATPase 14), NEDD8 (NEDD8 ubiquitin like modifier), PSMA7 (proteasome 20S subunit alpha 7), PSMA3 (proteasome 20S subunit alpha 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMA4 (proteasome 20S subunit alpha 4), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC5 (proteasome 26S subunit, ATPase 5), CUL3 (cullin 3), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC2 (proteasome 26S subunit, ATPase 2), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB4 (proteasome 20S subunit beta 4), PSMA5 (proteasome 20S subunit alpha 5), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMA1 (proteasome 20S subunit alpha 1), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB5 (proteasome 20S subunit beta 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB1 (proteasome 20S subunit beta 1), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB3 (proteasome 20S subunit beta 3), PSMB10 (proteasome 20S subunit beta 10), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMB6 (proteasome 20S subunit beta 6), PSMB7 (proteasome 20S subunit beta 7), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMF1 (proteasome inhibitor subunit 1), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME4 (proteasome activator subunit 4), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSMA8 (proteasome 20S subunit alpha 8), PSME1 (proteasome activator subunit 1), COPS6 (COP9 signalosome subunit 6), PSME3 (proteasome activator subunit 3), PSMB11 (proteasome subunit beta 11), CUL2 (cullin 2), DDB1 (damage specific DNA binding protein 1), CUL4B (cullin 4B), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), UBE2D1 (ubiquitin conjugating enzyme E2 D1), COPS2 (COP9 signalosome subunit 2), COPS4 (COP9 signalosome subunit 4), FBXW5 (F-box and WD repeat domain containing 5), FBXO6 (F-box protein 6), COPS3 (COP9 signalosome subunit 3), DCUN1D1 (defective in cullin neddylation 1 domain containing 1), GPS1 (G protein pathway suppressor 1), VHL (von Hippel-Lindau tumor suppressor), ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit), RNF7 (ring finger protein 7), FBXW11 (F-box and WD repeat domain containing 11), DTL (denticleless E3 ubiquitin protein ligase homolog), FBXW7 (F-box and WD repeat domain containing 7), DCAF11 (DDB1 and CUL4 associated factor 11), UBE2M (ubiquitin conjugating enzyme E2 M), CCNF (cyclin F), FBXL3 (F-box and leucine rich repeat protein 3), COMMD1 (copper metabolism domain containing 1), COPS7A (COP9 signalosome subunit 7A), HIF1A (hypoxia inducible factor 1 subunit alpha), CAND1 (cullin associated and neddylation dissociated 1), FBXO17 (F-box protein 17), FBXO4 (F-box protein 4), DCAF8 (DDB1 and CUL4 associated factor 8), FBXL5 (F-box and leucine rich repeat protein 5), UBE2D2 (ubiquitin conjugating enzyme E2 D2), FBXO44 (F-box protein 44), UBE2D3 (ubiquitin conjugating enzyme E2 D3), COPS8 (COP9 signalosome subunit 8), UBD (ubiquitin D), FBXO31 (F-box protein 31), DDA1 (DET1 and DDB1 associated 1), UBXN7 (UBX domain protein 7), DCAF13 (DDB1 and CUL4 associated factor 13), FBXL15 (F-box and leucine rich repeat protein 15), DCAF4 (DDB1 and CUL4 associated factor 4), DDB2 (damage specific DNA binding protein 2), DCAF7 (DDB1 and CUL4 associated factor 7)"], "WAG002783": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEP290 (centrosomal protein 290), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), PLK1 (polo like kinase 1), HAUS2 (HAUS augmin like complex subunit 2), MAPRE1 (microtubule associated protein RP/EB family member 1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), DCTN2 (dynactin subunit 2), CLASP1 (cytoplasmic linker associated protein 1), CCP110 (centriolar coiled-coil protein 110), CDK1 (cyclin dependent kinase 1), CEP164 (centrosomal protein 164), NDE1 (nudE neurodevelopment protein 1), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), CSNK1D (casein kinase 1 delta), CKAP5 (cytoskeleton associated protein 5), DCTN3 (dynactin subunit 3), CEP76 (centrosomal protein 76), CETN2 (centrin 2), OFD1 (OFD1 centriole and centriolar satellite protein), SDCCAG8 (SHH signaling and ciliogenesis regulator SDCCAG8), PCNT (pericentrin), NEK2 (NIMA related kinase 2), CENPJ (centromere protein J), PLK4 (polo like kinase 4), NEDD1 (NEDD1 gamma-tubulin ring complex targeting factor), CEP135 (centrosomal protein 135), CDK5RAP2 (CDK5 regulatory subunit associated protein 2), CSNK1E (casein kinase 1 epsilon), CEP72 (centrosomal protein 72), AKAP9 (A-kinase anchoring protein 9), SFI1 (SFI1 centrin binding protein), NINL (ninein like), CEP63 (centrosomal protein 63), CEP57 (centrosomal protein 57), CEP250 (centrosomal protein 250), CEP152 (centrosomal protein 152), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), SSNA1 (SS nuclear autoantigen 1), CNTRL (centriolin), ODF2 (outer dense fiber of sperm tails 2), CEP78 (centrosomal protein 78), CEP70 (centrosomal protein 70), CEP41 (centrosomal protein 41), TUBA1A (tubulin alpha 1a), HSP90AA1 (heat shock protein 90 alpha family class A member 1), TUBG1 (tubulin gamma 1), TUBA4A (tubulin alpha 4a), TUBB (tubulin beta class I), DYNLL1 (dynein light chain LC8-type 1), PCM1 (pericentriolar material 1), TUBB4B (tubulin beta 4B class IVb), ACTR1A (actin related protein 1A), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), TUBB4A (tubulin beta 4A class IVa), BBS7 (Bardet-Biedl syndrome 7), BBS2 (Bardet-Biedl syndrome 2), IQCB1 (IQ motif containing B1), RPGRIP1L (RPGRIP1 like), B9D2 (B9 domain containing 2), RAB8A (RAB8A, member RAS oncogene family), BBS10 (Bardet-Biedl syndrome 10), MKS1 (MKS transition zone complex subunit 1), BBS4 (Bardet-Biedl syndrome 4), NPHP4 (nephrocystin 4), BBS1 (Bardet-Biedl syndrome 1), NPHP1 (nephrocystin 1), BBS9 (Bardet-Biedl syndrome 9), BBS5 (Bardet-Biedl syndrome 5), TMEM67 (transmembrane protein 67), AHI1 (Abelson helper integration site 1), EXOC7 (exocyst complex component 7), HDAC6 (histone deacetylase 6), KIF3B (kinesin family member 3B), CCT2 (chaperonin containing TCP1 subunit 2), CC2D2A (coiled-coil and C2 domain containing 2A), EXOC5 (exocyst complex component 5), TTC8 (tetratricopeptide repeat domain 8), ARL3 (ADP ribosylation factor like GTPase 3), TCP1 (t-complex 1), ARL6 (ADP ribosylation factor like GTPase 6), TMEM216 (transmembrane protein 216), HAUS6 (HAUS augmin like complex subunit 6), KIF3A (kinesin family member 3A), EXOC4 (exocyst complex component 4), CCT3 (chaperonin containing TCP1 subunit 3), EXOC2 (exocyst complex component 2), CCT4 (chaperonin containing TCP1 subunit 4), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), IFT20 (intraflagellar transport 20), BBS12 (Bardet-Biedl syndrome 12), B9D1 (B9 domain containing 1), EXOC8 (exocyst complex component 8), KIFAP3 (kinesin associated protein 3), RAB3IP (RAB3A interacting protein), EXOC6 (exocyst complex component 6), EXOC1 (exocyst complex component 1), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1)"], "WAG002786": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APOA1 (apolipoprotein A1), APOB (apolipoprotein B), LPL (lipoprotein lipase), APOE (apolipoprotein E), APOA2 (apolipoprotein A2), APOC3 (apolipoprotein C3), LIPC (lipase C, hepatic type), ABCA1 (ATP binding cassette subfamily A member 1), APOC2 (apolipoprotein C2), CETP (cholesteryl ester transfer protein), ALB (albumin), LDLR (low density lipoprotein receptor), LCAT (lecithin-cholesterol acyltransferase), APOA5 (apolipoprotein A5), LDLRAP1 (low density lipoprotein receptor adaptor protein 1), MTTP (microsomal triglyceride transfer protein), SAR1B (secretion associated Ras related GTPase 1B), APOC1 (apolipoprotein C1), CLTC (clathrin heavy chain), AP2M1 (adaptor related protein complex 2 subunit mu 1), AP2S1 (adaptor related protein complex 2 subunit sigma 1), AP2B1 (adaptor related protein complex 2 subunit beta 1), AP2A2 (adaptor related protein complex 2 subunit alpha 2), AP2A1 (adaptor related protein complex 2 subunit alpha 1), CLTA (clathrin light chain A), ABCG1 (ATP binding cassette subfamily G member 1), APOA4 (apolipoprotein A4), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), P4HB (prolyl 4-hydroxylase subunit beta), VLDLR (very low density lipoprotein receptor), APOC4 (apolipoprotein C4), PCSK9 (proprotein convertase subtilisin/kexin type 9), APOF (apolipoprotein F), FURIN (furin, paired basic amino acid cleaving enzyme), LIPG (lipase G, endothelial type), CREB3L3 (cAMP responsive element binding protein 3 like 3), SOAT1 (sterol O-acyltransferase 1), HDLBP (high density lipoprotein binding protein), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), LMF1 (lipase maturation factor 1), MBTPS1 (membrane bound transcription factor peptidase, site 1), NR1H3 (nuclear receptor subfamily 1 group H member 3), GPIHBP1 (glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1), PRKACB (protein kinase cAMP-activated catalytic subunit beta), ANGPTL3 (angiopoietin like 3), SOAT2 (sterol O-acyltransferase 2), LIPA (lipase A, lysosomal acid type), NR1H2 (nuclear receptor subfamily 1 group H member 2), PCSK5 (proprotein convertase subtilisin/kexin type 5), CUBN (cubilin), MYLIP (myosin regulatory light chain interacting protein), PCSK6 (proprotein convertase subtilisin/kexin type 6), NPC1 (NPC intracellular cholesterol transporter 1), MBTPS2 (membrane bound transcription factor peptidase, site 2), NPC2 (NPC intracellular cholesterol transporter 2), ANGPTL4 (angiopoietin like 4), LSR (lipolysis stimulated lipoprotein receptor), CIDEC (cell death inducing DFFA like effector c), LPA (lipoprotein(a)), AMN (amnion associated transmembrane protein), CES3 (carboxylesterase 3), NCEH1 (neutral cholesterol ester hydrolase 1), LMF2 (lipase maturation factor 2), APOBR (apolipoprotein B receptor), FGF21 (fibroblast growth factor 21), ANGPTL8 (angiopoietin like 8), ZDHHC8 (zinc finger DHHC-type palmitoyltransferase 8)"], "WAG002787": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "LIPE (lipase E, hormone sensitive type), PLIN1 (perilipin 1), CAV1 (caveolin 1), DGAT1 (diacylglycerol O-acyltransferase 1), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), DGAT2 (diacylglycerol O-acyltransferase 2), PPP1CB (protein phosphatase 1 catalytic subunit beta), PPP1CC (protein phosphatase 1 catalytic subunit gamma), ABHD5 (abhydrolase domain containing 5, lysophosphatidic acid acyltransferase), GPD2 (glycerol-3-phosphate dehydrogenase 2), FABP4 (fatty acid binding protein 4), PPP1CA (protein phosphatase 1 catalytic subunit alpha), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), LPIN2 (lipin 2), GK2 (glycerol kinase 2), GPAT2 (glycerol-3-phosphate acyltransferase 2, mitochondrial), PRKACB (protein kinase cAMP-activated catalytic subunit beta), LPIN1 (lipin 1), FABP1 (fatty acid binding protein 1), MOGAT2 (monoacylglycerol O-acyltransferase 2), MOGAT3 (monoacylglycerol O-acyltransferase 3), MGLL (monoglyceride lipase), FABP2 (fatty acid binding protein 2), FABP3 (fatty acid binding protein 3), MOGAT1 (monoacylglycerol O-acyltransferase 1), PNPLA4 (patatin like phospholipase domain containing 4), GK (glycerol kinase), FABP9 (fatty acid binding protein 9), PLIN3 (perilipin 3), FABP6 (fatty acid binding protein 6), LPIN3 (lipin 3), PNPLA5 (patatin like phospholipase domain containing 5), FABP7 (fatty acid binding protein 7), FABP5 (fatty acid binding protein 5), FABP12 (fatty acid binding protein 12), AGMO (alkylglycerol monooxygenase)"], "WAG002789": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DLG4 (discs large MAGUK scaffold protein 4), CASK (calcium/calmodulin dependent serine protein kinase), NRXN1 (neurexin 1), DLG2 (discs large MAGUK scaffold protein 2), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), DLG3 (discs large MAGUK scaffold protein 3), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), DLGAP1 (DLG associated protein 1), APBA1 (amyloid beta precursor protein binding family A member 1), SHANK1 (SH3 and multiple ankyrin repeat domains 1), NRXN2 (neurexin 2), SHANK2 (SH3 and multiple ankyrin repeat domains 2), NLGN1 (neuroligin 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), STX1A (syntaxin 1A), NLGN2 (neuroligin 2), HOMER1 (homer scaffold protein 1), NRXN3 (neurexin 3), SYT1 (synaptotagmin 1), APBA2 (amyloid beta precursor protein binding family A member 2), LIN7A (lin-7 homolog A, crumbs cell polarity complex component), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), NLGN3 (neuroligin 3), DLGAP4 (DLG associated protein 4), GRM1 (glutamate metabotropic receptor 1), DLGAP2 (DLG associated protein 2), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), STXBP1 (syntaxin binding protein 1), DLGAP3 (DLG associated protein 3), EPB41L1 (erythrocyte membrane protein band 4.1 like 1), NLGN4X (neuroligin 4 X-linked), HOMER3 (homer scaffold protein 3), GRM5 (glutamate metabotropic receptor 5), LIN7B (lin-7 homolog B, crumbs cell polarity complex component), SIPA1L1 (signal induced proliferation associated 1 like 1), HOMER2 (homer scaffold protein 2), EPB41L3 (erythrocyte membrane protein band 4.1 like 3), EPB41 (erythrocyte membrane protein band 4.1), EPB41L2 (erythrocyte membrane protein band 4.1 like 2), SYT7 (synaptotagmin 7), SHARPIN (SHANK associated RH domain interactor), LIN7C (lin-7 homolog C, crumbs cell polarity complex component), SYT2 (synaptotagmin 2), SYT9 (synaptotagmin 9), NLGN4Y (neuroligin 4 Y-linked), APBA3 (amyloid beta precursor protein binding family A member 3), BEGAIN (brain enriched guanylate kinase associated), LRRTM2 (leucine rich repeat transmembrane neuronal 2), SYT10 (synaptotagmin 10), SYT12 (synaptotagmin 12), LRRTM1 (leucine rich repeat transmembrane neuronal 1), EPB41L5 (erythrocyte membrane protein band 4.1 like 5), LRRTM4 (leucine rich repeat transmembrane neuronal 4), PDLIM5 (PDZ and LIM domain 5), LRRTM3 (leucine rich repeat transmembrane neuronal 3), DBNL (drebrin like)"], "WAG002791": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLR3F (RNA polymerase III subunit F), POLR3A (RNA polymerase III subunit A), POLR3D (RNA polymerase III subunit D), POLR3H (RNA polymerase III subunit H), POLR3E (RNA polymerase III subunit E), POLR3B (RNA polymerase III subunit B), POLR2E (RNA polymerase II, I and III subunit E), POLR2H (RNA polymerase II, I and III subunit H), POLR2F (RNA polymerase II, I and III subunit F), TBP (TATA-box binding protein), POLR3C (RNA polymerase III subunit C), POLR2L (RNA polymerase II, I and III subunit L), POLR1C (RNA polymerase I and III subunit C), POLR3G (RNA polymerase III subunit G), POLR3GL (RNA polymerase III subunit GL), POU2F1 (POU class 2 homeobox 1), SNAPC2 (small nuclear RNA activating complex polypeptide 2), SNAPC5 (small nuclear RNA activating complex polypeptide 5), GTF3C1 (general transcription factor IIIC subunit 1), SNAPC1 (small nuclear RNA activating complex polypeptide 1), SNAPC3 (small nuclear RNA activating complex polypeptide 3), GTF3C3 (general transcription factor IIIC subunit 3), ZNF143 (zinc finger protein 143), GTF3A (general transcription factor IIIA), GTF3C5 (general transcription factor IIIC subunit 5), GTF3C4 (general transcription factor IIIC subunit 4), SNAPC4 (small nuclear RNA activating complex polypeptide 4), GTF3C2 (general transcription factor IIIC subunit 2), NFIC (nuclear factor I C), NFIX (nuclear factor I X), POLR3K (RNA polymerase III subunit K), NFIA (nuclear factor I A), BRF1 (BRF1 RNA polymerase III transcription initiation factor subunit), SSB (small RNA binding exonuclease protection factor La), POLR2K (RNA polymerase II, I and III subunit K), CRCP (CGRP receptor component), BDP1 (B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB), NFIB (nuclear factor I B), GTF3C6 (general transcription factor IIIC subunit 6), BRF2 (BRF2 RNA polymerase III transcription initiation factor subunit)"], "WAG002792": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TLR4 (toll like receptor 4), NFKB1 (nuclear factor kappa B subunit 1), TRAF6 (TNF receptor associated factor 6), RELA (RELA proto-oncogene, NF-kB subunit), TNF (tumor necrosis factor), MYD88 (MYD88 innate immune signal transduction adaptor), TLR3 (toll like receptor 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), IRAK1 (interleukin 1 receptor associated kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), TICAM1 (toll like receptor adaptor molecule 1), IL6 (interleukin 6), AKT1 (AKT serine/threonine kinase 1), LY96 (lymphocyte antigen 96), TIRAP (TIR domain containing adaptor protein), ITGAM (integrin subunit alpha M), ITGB2 (integrin subunit beta 2), SYK (spleen associated tyrosine kinase), CD14 (CD14 molecule), IRF3 (interferon regulatory factor 3), IRAK4 (interleukin 1 receptor associated kinase 4), TICAM2 (toll like receptor adaptor molecule 2), IRAK2 (interleukin 1 receptor associated kinase 2), CBLB (Cbl proto-oncogene B), NOS2 (nitric oxide synthase 2), IFNB1 (interferon beta 1), PLAT (plasminogen activator, tissue type), CCL2 (C-C motif chemokine ligand 2), PLG (plasminogen), REL (REL proto-oncogene, NF-kB subunit), IL12B (interleukin 12B), FGA (fibrinogen alpha chain), FGG (fibrinogen gamma chain), FGB (fibrinogen beta chain), TYROBP (transmembrane immune signaling adaptor TYROBP), RHOA (ras homolog family member A), CXCL10 (C-X-C motif chemokine ligand 10), LBP (lipopolysaccharide binding protein), RASSF5 (Ras association domain family member 5), CXCL3 (C-X-C motif chemokine ligand 3)"], "WAG002793": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), GSK3B (glycogen synthase kinase 3 beta), MTOR (mechanistic target of rapamycin kinase), RELA (RELA proto-oncogene, NF-kB subunit), MYC (MYC proto-oncogene, bHLH transcription factor), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), TSC2 (TSC complex subunit 2), TSC1 (TSC complex subunit 1), CD86 (CD86 molecule), RXRA (retinoid X receptor alpha), CD80 (CD80 molecule), VDR (vitamin D receptor), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), IL10 (interleukin 10), LDHA (lactate dehydrogenase A), PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4), HK3 (hexokinase 3), IL12A (interleukin 12A), HLA-DRA (major histocompatibility complex, class II, DR alpha), CYP24A1 (cytochrome P450 family 24 subfamily A member 1), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), SLC2A3 (solute carrier family 2 member 3)"], "WAG002795": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CD68 (CD68 molecule), CD14 (CD14 molecule), CD86 (CD86 molecule), CD83 (CD83 molecule), CD163 (CD163 molecule), CD74 (CD74 molecule), LYZ (lysozyme), RAC2 (Rac family small GTPase 2), F3 (coagulation factor III, tissue factor)"], "WAG002797": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CASK (calcium/calmodulin dependent serine protein kinase), EPB41L3 (erythrocyte membrane protein band 4.1 like 3), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), CDH2 (cadherin 2), PLCB4 (phospholipase C beta 4), EPB41L2 (erythrocyte membrane protein band 4.1 like 2), CADM1 (cell adhesion molecule 1), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), GRIK2 (glutamate ionotropic receptor kainate type subunit 2), EPB41L1 (erythrocyte membrane protein band 4.1 like 1), EPB41 (erythrocyte membrane protein band 4.1), KCNMA1 (potassium calcium-activated channel subfamily M alpha 1), ANK3 (ankyrin 3), DAB1 (DAB adaptor protein 1), PRKCZ (protein kinase C zeta), CADM3 (cell adhesion molecule 3), APLP2 (amyloid beta precursor like protein 2), GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), KCNQ2 (potassium voltage-gated channel subfamily Q member 2), ATP2B1 (ATPase plasma membrane Ca2+ transporting 1), NEO1 (neogenin 1), MAPK9 (mitogen-activated protein kinase 9), STXBP2 (syntaxin binding protein 2), STX2 (syntaxin 2), CAV2 (caveolin 2), CLASP1 (cytoplasmic linker associated protein 1), MAP4 (microtubule associated protein 4), CSN3 (casein kappa), GPHN (gephyrin), TERF2IP (TERF2 interacting protein), RAP1GAP (RAP1 GTPase activating protein), CLSTN1 (calsyntenin 1), NCDN (neurochondrin), KCNJ6 (potassium inwardly rectifying channel subfamily J member 6), EFNA5 (ephrin A5), SNW1 (SNW domain containing 1), GABBR2 (gamma-aminobutyric acid type B receptor subunit 2), CHL1 (cell adhesion molecule L1 like), MAPK4 (mitogen-activated protein kinase 4), AGRN (agrin), NTNG1 (netrin G1)"], "WAG002798": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEBPB (CCAAT enhancer binding protein beta), PPARG (peroxisome proliferator activated receptor gamma), CEBPD (CCAAT enhancer binding protein delta), NR3C1 (nuclear receptor subfamily 3 group C member 1), RARA (retinoic acid receptor alpha), SREBF1 (sterol regulatory element binding transcription factor 1), EBF1 (EBF transcription factor 1), KLF5 (Kruppel like factor 5), KLF4 (Kruppel like factor 4), NR2F2 (nuclear receptor subfamily 2 group F member 2), CREB1 (cAMP responsive element binding protein 1), EGR2 (early growth response 2), RORA (RAR related orphan receptor A), CEBPA (CCAAT enhancer binding protein alpha), FOXO1 (forkhead box O1), STAT5A (signal transducer and activator of transcription 5A), GATA2 (GATA binding protein 2), STAT5B (signal transducer and activator of transcription 5B), NR1H3 (nuclear receptor subfamily 1 group H member 3), WNT10B (Wnt family member 10B), KLF2 (Kruppel like factor 2), DDIT3 (DNA damage inducible transcript 3), ZNF423 (zinc finger protein 423), IRF3 (interferon regulatory factor 3), GATA3 (GATA binding protein 3), IRF4 (interferon regulatory factor 4), MECOM (MDS1 and EVI1 complex locus), TCF7L1 (transcription factor 7 like 1), TLE3 (TLE family member 3, transcriptional corepressor), INS (insulin), CTNNA1 (catenin alpha 1), KLF15 (Kruppel like factor 15)"], "WAG002799": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FZD5 (frizzled class receptor 5), FZD1 (frizzled class receptor 1), FZD2 (frizzled class receptor 2), WNT3A (Wnt family member 3A), FZD7 (frizzled class receptor 7), FZD4 (frizzled class receptor 4), FZD8 (frizzled class receptor 8), FZD6 (frizzled class receptor 6), WNT5A (Wnt family member 5A), FZD9 (frizzled class receptor 9), WNT1 (Wnt family member 1), WNT7B (Wnt family member 7B), LRP6 (LDL receptor related protein 6), WNT3 (Wnt family member 3), WNT11 (Wnt family member 11), WNT2B (Wnt family member 2B), FZD3 (frizzled class receptor 3), WNT7A (Wnt family member 7A), WNT10B (Wnt family member 10B), WNT10A (Wnt family member 10A), WNT5B (Wnt family member 5B), WNT2 (Wnt family member 2), DVL1 (dishevelled segment polarity protein 1), WNT9B (Wnt family member 9B), WNT6 (Wnt family member 6), LRP5 (LDL receptor related protein 5), DVL2 (dishevelled segment polarity protein 2), DVL3 (dishevelled segment polarity protein 3), WNT16 (Wnt family member 16), CTNNB1 (catenin beta 1), WNT4 (Wnt family member 4), RHOA (ras homolog family member A), MAPK9 (mitogen-activated protein kinase 9), MAPK8 (mitogen-activated protein kinase 8), MAPK10 (mitogen-activated protein kinase 10), INVS (inversin), LOC101929777 (uncharacterized LOC101929777)"], "WAG002801": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK1 (mitogen-activated protein kinase 1), CCND1 (cyclin D1), HRAS (HRas proto-oncogene, GTPase), EGFR (epidermal growth factor receptor), CTNNB1 (catenin beta 1), GRB2 (growth factor receptor bound protein 2), TP53 (tumor protein p53), EGF (epidermal growth factor), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), NRAS (NRAS proto-oncogene, GTPase), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MYC (MYC proto-oncogene, bHLH transcription factor), ERBB2 (erb-b2 receptor tyrosine kinase 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAPK3 (mitogen-activated protein kinase 3), MAP2K1 (mitogen-activated protein kinase kinase 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), GSK3B (glycogen synthase kinase 3 beta), KRAS (KRAS proto-oncogene, GTPase), FGFR1 (fibroblast growth factor receptor 1), ILK (integrin linked kinase), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PTEN (phosphatase and tensin homolog), CDKN1A (cyclin dependent kinase inhibitor 1A), CDH1 (cadherin 1), AKT2 (AKT serine/threonine kinase 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), FGFR2 (fibroblast growth factor receptor 2), CASP9 (caspase 9), AKT3 (AKT serine/threonine kinase 3), BAX (BCL2 associated X, apoptosis regulator), FGF2 (fibroblast growth factor 2), BAD (BCL2 associated agonist of cell death), CTNNA1 (catenin alpha 1), FGFR3 (fibroblast growth factor receptor 3), AXIN1 (axin 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), FGF1 (fibroblast growth factor 1), APC (APC regulator of WNT signaling pathway), PDPK1 (3-phosphoinositide dependent protein kinase 1), MAP2K2 (mitogen-activated protein kinase kinase 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), FOXO3 (forkhead box O3), GADD45A (growth arrest and DNA damage inducible alpha), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), TCF7L2 (transcription factor 7 like 2), LEF1 (lymphoid enhancer binding factor 1), AXIN2 (axin 2), ELK1 (ETS transcription factor ELK1), APC2 (APC regulator of WNT signaling pathway 2), TCF7 (transcription factor 7), GADD45B (growth arrest and DNA damage inducible beta), TCF7L1 (transcription factor 7 like 1), GADD45G (growth arrest and DNA damage inducible gamma), BAK1 (BCL2 antagonist/killer 1), CTNNA2 (catenin alpha 2), CTNNA3 (catenin alpha 3), DDB2 (damage specific DNA binding protein 2), POLK (DNA polymerase kappa)"], "WAG002804": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), GABRA5 (gamma-aminobutyric acid type A receptor subunit alpha5), GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1), GABRB1 (gamma-aminobutyric acid type A receptor subunit beta1), GABRA2 (gamma-aminobutyric acid type A receptor subunit alpha2), GABRA4 (gamma-aminobutyric acid type A receptor subunit alpha4), GABRA3 (gamma-aminobutyric acid type A receptor subunit alpha3), GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2), GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3), GABRA6 (gamma-aminobutyric acid type A receptor subunit alpha6), GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3), AP2A2 (adaptor related protein complex 2 subunit alpha 2), GAD1 (glutamate decarboxylase 1), AP2A1 (adaptor related protein complex 2 subunit alpha 1), AP2M1 (adaptor related protein complex 2 subunit mu 1), ABAT (4-aminobutyrate aminotransferase), AP2S1 (adaptor related protein complex 2 subunit sigma 1), GAD2 (glutamate decarboxylase 2), AP2B1 (adaptor related protein complex 2 subunit beta 1), SLC6A1 (solute carrier family 6 member 1), ALDH9A1 (aldehyde dehydrogenase 9 family member A1), GABBR1 (gamma-aminobutyric acid type B receptor subunit 1), SLC32A1 (solute carrier family 32 member 1), GABRQ (gamma-aminobutyric acid type A receptor subunit theta), GABRG1 (gamma-aminobutyric acid type A receptor subunit gamma1), GPHN (gephyrin), GABBR2 (gamma-aminobutyric acid type B receptor subunit 2), GABRD (gamma-aminobutyric acid type A receptor subunit delta), SLC6A11 (solute carrier family 6 member 11), GABRE (gamma-aminobutyric acid type A receptor subunit epsilon), GABRP (gamma-aminobutyric acid type A receptor subunit pi)"], "WAG002805": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), AKT1 (AKT serine/threonine kinase 1), GRB2 (growth factor receptor bound protein 2), EGFR (epidermal growth factor receptor), MAPK1 (mitogen-activated protein kinase 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), ITGB1 (integrin subunit beta 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAPK3 (mitogen-activated protein kinase 3), VEGFA (vascular endothelial growth factor A), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), ITGAV (integrin subunit alpha V), JAK2 (Janus kinase 2), HRAS (HRas proto-oncogene, GTPase), FN1 (fibronectin 1), IGF1R (insulin like growth factor 1 receptor), ITGB4 (integrin subunit beta 4), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), IL6 (interleukin 6), MYC (MYC proto-oncogene, bHLH transcription factor), PTK2 (protein tyrosine kinase 2), TP53 (tumor protein p53), JAK1 (Janus kinase 1), MTOR (mechanistic target of rapamycin kinase), EGF (epidermal growth factor), PDGFRB (platelet derived growth factor receptor beta), RAC1 (Rac family small GTPase 1), ITGA6 (integrin subunit alpha 6), ITGA1 (integrin subunit alpha 1), HSP90AA1 (heat shock protein 90 alpha family class A member 1), PRKCA (protein kinase C alpha), ITGA4 (integrin subunit alpha 4), ITGA5 (integrin subunit alpha 5), IRS1 (insulin receptor substrate 1), NFKB1 (nuclear factor kappa B subunit 1), IGF1 (insulin like growth factor 1), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), RELA (RELA proto-oncogene, NF-kB subunit), ITGB5 (integrin subunit beta 5), ITGB6 (integrin subunit beta 6), ITGA2 (integrin subunit alpha 2), ITGB8 (integrin subunit beta 8), MET (MET proto-oncogene, receptor tyrosine kinase), ITGB7 (integrin subunit beta 7), PDGFRA (platelet derived growth factor receptor alpha), CCND1 (cyclin D1), ITGA2B (integrin subunit alpha 2b), ITGA3 (integrin subunit alpha 3), FGFR1 (fibroblast growth factor receptor 1), IL2 (interleukin 2), GSK3B (glycogen synthase kinase 3 beta), PPP2CA (protein phosphatase 2 catalytic subunit alpha), NRAS (NRAS proto-oncogene, GTPase), RPS6KB1 (ribosomal protein S6 kinase B1), ITGA9 (integrin subunit alpha 9), FGFR2 (fibroblast growth factor receptor 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), ITGA8 (integrin subunit alpha 8), ITGA11 (integrin subunit alpha 11), BCL2 (BCL2 apoptosis regulator), ITGA10 (integrin subunit alpha 10), ITGB3 (integrin subunit beta 3), SYK (spleen associated tyrosine kinase), FGF2 (fibroblast growth factor 2), AKT2 (AKT serine/threonine kinase 2), ITGA7 (integrin subunit alpha 7), JAK3 (Janus kinase 3), KRAS (KRAS proto-oncogene, GTPase), CDKN1A (cyclin dependent kinase inhibitor 1A), COL1A2 (collagen type I alpha 2 chain), PTEN (phosphatase and tensin homolog), COL1A1 (collagen type I alpha 1 chain), KDR (kinase insert domain receptor), HSP90AB1 (heat shock protein 90 alpha family class B member 1), KIT (KIT proto-oncogene, receptor tyrosine kinase), PDGFB (platelet derived growth factor subunit B), IL2RA (interleukin 2 receptor subunit alpha), COL2A1 (collagen type II alpha 1 chain), THBS1 (thrombospondin 1), MAP2K1 (mitogen-activated protein kinase kinase 1), FGFR3 (fibroblast growth factor receptor 3), MDM2 (MDM2 proto-oncogene), FLT4 (fms related receptor tyrosine kinase 4), SPP1 (secreted phosphoprotein 1), CREB1 (cAMP responsive element binding protein 1), AKT3 (AKT serine/threonine kinase 3), COL4A1 (collagen type IV alpha 1 chain), FGF1 (fibroblast growth factor 1), NGF (nerve growth factor), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), COL6A1 (collagen type VI alpha 1 chain), HGF (hepatocyte growth factor), PDPK1 (3-phosphoinositide dependent protein kinase 1), CDKN1B (cyclin dependent kinase inhibitor 1B), IL2RG (interleukin 2 receptor subunit gamma), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), COL4A6 (collagen type IV alpha 6 chain)"], "WAG002808": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MVD (mevalonate diphosphate decarboxylase), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase)"], "WAG002809": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FDPS (farnesyl diphosphate synthase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), MVD (mevalonate diphosphate decarboxylase), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), IDI1 (isopentenyl-diphosphate delta isomerase 1), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), MVK (mevalonate kinase), GGPS1 (geranylgeranyl diphosphate synthase 1), PMVK (phosphomevalonate kinase), ACAT2 (acetyl-CoA acetyltransferase 2), ACAT1 (acetyl-CoA acetyltransferase 1), IDI2 (isopentenyl-diphosphate delta isomerase 2), HMGCL (3-hydroxy-3-methylglutaryl-CoA lyase)"], "WAG002813": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT1 (signal transducer and activator of transcription 1), STAT2 (signal transducer and activator of transcription 2), IRF9 (interferon regulatory factor 9), JAK1 (Janus kinase 1), IRF1 (interferon regulatory factor 1), MX1 (MX dynamin like GTPase 1), TYK2 (tyrosine kinase 2), JAK2 (Janus kinase 2), SOCS1 (suppressor of cytokine signaling 1), IFNAR1 (interferon alpha and beta receptor subunit 1), IFIT1 (interferon induced protein with tetratricopeptide repeats 1), IFIT3 (interferon induced protein with tetratricopeptide repeats 3), OAS1 (2'-5'-oligoadenylate synthetase 1), IFI35 (interferon induced protein 35), IFNAR2 (interferon alpha and beta receptor subunit 2), IFITM1 (interferon induced transmembrane protein 1), IFNGR2 (interferon gamma receptor 2), IFNGR1 (interferon gamma receptor 1), TAP1 (transporter 1, ATP binding cassette subfamily B member), PIAS1 (protein inhibitor of activated STAT 1), PSMB8 (proteasome 20S subunit beta 8), PTPN2 (protein tyrosine phosphatase non-receptor type 2), MED14 (mediator complex subunit 14)"], "WAG002814": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1), SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1), SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2), SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1), ARID1A (AT-rich interaction domain 1A), SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1), ACTL6A (actin like 6A), RB1 (RB transcriptional corepressor 1), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), ARID1B (AT-rich interaction domain 1B), SMARCD2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2), DPF1 (double PHD fingers 1), DPF3 (double PHD fingers 3), ACTL6B (actin like 6B), DPF2 (double PHD fingers 2), RBBP4 (RB binding protein 4, chromatin remodeling factor), CDKN2A (cyclin dependent kinase inhibitor 2A), EED (embryonic ectoderm development), GLI1 (GLI family zinc finger 1), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), GLI3 (GLI family zinc finger 3), CDK6 (cyclin dependent kinase 6), CDK4 (cyclin dependent kinase 4), SUZ12 (SUZ12 polycomb repressive complex 2 subunit), SMO (smoothened, frizzled class receptor), PTCH1 (patched 1), GLI2 (GLI family zinc finger 2), H3-3B (H3.3 histone B), H3-3A (H3.3 histone A), GLI4 (GLI family zinc finger 4)"], "WAG002815": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), AKT1 (AKT serine/threonine kinase 1), RAC1 (Rac family small GTPase 1), HRAS (HRas proto-oncogene, GTPase), MAPK1 (mitogen-activated protein kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAPK3 (mitogen-activated protein kinase 3), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MET (MET proto-oncogene, receptor tyrosine kinase), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PTK2 (protein tyrosine kinase 2), CDC42 (cell division cycle 42), NRAS (NRAS proto-oncogene, GTPase), MAPK8 (mitogen-activated protein kinase 8), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), CBL (Cbl proto-oncogene), CRK (CRK proto-oncogene, adaptor protein), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PLCG1 (phospholipase C gamma 1), STAT3 (signal transducer and activator of transcription 3), CRKL (CRK like proto-oncogene, adaptor protein), GAB1 (GRB2 associated binding protein 1), JAK3 (Janus kinase 3), KRAS (KRAS proto-oncogene, GTPase), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PAK1 (p21 (RAC1) activated kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), HGF (hepatocyte growth factor), RAP1B (RAP1B, member of RAS oncogene family), PAK2 (p21 (RAC1) activated kinase 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), MAP2K2 (mitogen-activated protein kinase kinase 2), RAPGEF1 (Rap guanine nucleotide exchange factor 1), RAP1A (RAP1A, member of RAS oncogene family), AKT2 (AKT serine/threonine kinase 2), CDKN1A (cyclin dependent kinase inhibitor 1A), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), PAK4 (p21 (RAC1) activated kinase 4), BAD (BCL2 associated agonist of cell death), AKT3 (AKT serine/threonine kinase 3), PAK3 (p21 (RAC1) activated kinase 3), PAK6 (p21 (RAC1) activated kinase 6), ETS1 (ETS proto-oncogene 1, transcription factor), ALK (ALK receptor tyrosine kinase), PRCC (proline rich mitotic checkpoint control factor), RPL11 (ribosomal protein L11), TFE3 (transcription factor binding to IGHM enhancer 3), STRN (striatin), INSL3 (insulin like 3), PAK5 (p21 (RAC1) activated kinase 5), C8orf34 (chromosome 8 open reading frame 34), ELOA (elongin A), BUB1B-PAK6 (BUB1B-PAK6 readthrough)"], "WAG002817": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KYNU (kynureninase), KMO (kynurenine 3-monooxygenase), AFMID (arylformamidase), QPRT (quinolinate phosphoribosyltransferase), TDO2 (tryptophan 2,3-dioxygenase), NMNAT1 (nicotinamide nucleotide adenylyltransferase 1), AADAT (aminoadipate aminotransferase), IDO1 (indoleamine 2,3-dioxygenase 1), HAAO (3-hydroxyanthranilate 3,4-dioxygenase), NADSYN1 (NAD synthetase 1), NMNAT2 (nicotinamide nucleotide adenylyltransferase 2), NMNAT3 (nicotinamide nucleotide adenylyltransferase 3), NAMPT (nicotinamide phosphoribosyltransferase), NAPRT (nicotinate phosphoribosyltransferase), NMRK2 (nicotinamide riboside kinase 2), NMRK1 (nicotinamide riboside kinase 1)"], "WAG002818": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEBPB (CCAAT enhancer binding protein beta), CEBPD (CCAAT enhancer binding protein delta), CEBPA (CCAAT enhancer binding protein alpha), CEBPG (CCAAT enhancer binding protein gamma), DDIT3 (DNA damage inducible transcript 3), KLF5 (Kruppel like factor 5), SREBF1 (sterol regulatory element binding transcription factor 1), EGR2 (early growth response 2), PPARG (peroxisome proliferator activated receptor gamma), GATA2 (GATA binding protein 2), KLF2 (Kruppel like factor 2), GATA3 (GATA binding protein 3), KLF15 (Kruppel like factor 15)"], "WAG002819": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), AKT1 (AKT serine/threonine kinase 1), MYC (MYC proto-oncogene, bHLH transcription factor), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK1 (mitogen-activated protein kinase 1), MAPK8 (mitogen-activated protein kinase 8), CCND1 (cyclin D1), CTNNB1 (catenin beta 1), SMAD4 (SMAD family member 4), SMAD3 (SMAD family member 3), CDKN1A (cyclin dependent kinase inhibitor 1A), SMAD2 (SMAD family member 2), CASP3 (caspase 3), BCL2 (BCL2 apoptosis regulator), MAPK3 (mitogen-activated protein kinase 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), RAC1 (Rac family small GTPase 1), TGFB1 (transforming growth factor beta 1), BAX (BCL2 associated X, apoptosis regulator), MAPK9 (mitogen-activated protein kinase 9), GSK3B (glycogen synthase kinase 3 beta), AXIN1 (axin 1), MAP2K1 (mitogen-activated protein kinase kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), BAD (BCL2 associated agonist of cell death), CASP9 (caspase 9), RHOA (ras homolog family member A), BCL2L11 (BCL2 like 11), APC (APC regulator of WNT signaling pathway), BIRC5 (baculoviral IAP repeat containing 5), MAPK10 (mitogen-activated protein kinase 10), PTGS2 (prostaglandin-endoperoxide synthase 2), TGFBR2 (transforming growth factor beta receptor 2), KRAS (KRAS proto-oncogene, GTPase), AKT2 (AKT serine/threonine kinase 2), LEF1 (lymphoid enhancer binding factor 1), DCC (DCC netrin 1 receptor), TGFBR1 (transforming growth factor beta receptor 1), AXIN2 (axin 2), TCF7L2 (transcription factor 7 like 2), RALA (RAS like proto-oncogene A), CYCS (cytochrome c, somatic), ARAF (A-Raf proto-oncogene, serine/threonine kinase), BRAF (B-Raf proto-oncogene, serine/threonine kinase), RAC2 (Rac family small GTPase 2), GADD45A (growth arrest and DNA damage inducible alpha), RAC3 (Rac family small GTPase 3), TGFB2 (transforming growth factor beta 2), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), AKT3 (AKT serine/threonine kinase 3), RALGDS (ral guanine nucleotide dissociation stimulator), MSH2 (mutS homolog 2), MLH1 (mutL homolog 1), MSH6 (mutS homolog 6), TCF7 (transcription factor 7), CSNK1A1 (casein kinase 1 alpha 1), TGFB3 (transforming growth factor beta 3), REL (REL proto-oncogene, NF-kB subunit), RALB (RAS like proto-oncogene B), TCF7L1 (transcription factor 7 like 1), GADD45B (growth arrest and DNA damage inducible beta), APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1), BAK1 (BCL2 antagonist/killer 1), APC2 (APC regulator of WNT signaling pathway 2), EXOC2 (exocyst complex component 2), BBC3 (BCL2 binding component 3), MSH3 (mutS homolog 3), NTN1 (netrin 1), GADD45G (growth arrest and DNA damage inducible gamma), CSNK1A1L (casein kinase 1 alpha 1 like), TBK1 (TANK binding kinase 1), DDB2 (damage specific DNA binding protein 2), POLK (DNA polymerase kappa)"], "WAG002820": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), RAC1 (Rac family small GTPase 1), AKT1 (AKT serine/threonine kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), ITGB1 (integrin subunit beta 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAPK1 (mitogen-activated protein kinase 1), NFKB1 (nuclear factor kappa B subunit 1), ITGAV (integrin subunit alpha V), RELA (RELA proto-oncogene, NF-kB subunit), ACTB (actin beta), ITGA4 (integrin subunit alpha 4), RHOA (ras homolog family member A), FLNA (filamin A), ITGB3 (integrin subunit beta 3), STAT1 (signal transducer and activator of transcription 1), ITGA1 (integrin subunit alpha 1), CDC42 (cell division cycle 42), ITGA6 (integrin subunit alpha 6), ACTG1 (actin gamma 1), ACTN4 (actinin alpha 4), IGF1R (insulin like growth factor 1 receptor), ITGA5 (integrin subunit alpha 5), EP300 (E1A binding protein p300), MAPK3 (mitogen-activated protein kinase 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), ACTN1 (actinin alpha 1), CAV1 (caveolin 1), VAV2 (vav guanine nucleotide exchange factor 2), ITGA3 (integrin subunit alpha 3), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), CLTC (clathrin heavy chain), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), ITGA2 (integrin subunit alpha 2), TLR4 (toll like receptor 4), FLNB (filamin B), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), REL (REL proto-oncogene, NF-kB subunit), PAK1 (p21 (RAC1) activated kinase 1), IQGAP1 (IQ motif containing GTPase activating protein 1), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), IRF3 (interferon regulatory factor 3), CREBBP (CREB binding protein), TIAM1 (TIAM Rac1 associated GEF 1), FLNC (filamin C), TBK1 (TANK binding kinase 1), IRF7 (interferon regulatory factor 7), NFKB2 (nuclear factor kappa B subunit 2), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), SOCS3 (suppressor of cytokine signaling 3), RAB7A (RAB7A, member RAS oncogene family), GSN (gelsolin), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), IL4 (interleukin 4), RELB (RELB proto-oncogene, NF-kB subunit), TSG101 (tumor susceptibility 101), NEDD4 (NEDD4 E3 ubiquitin protein ligase), VPS18 (VPS18 core subunit of CORVET and HOPS complexes), ICAM3 (intercellular adhesion molecule 3), HLA-B (major histocompatibility complex, class I, B), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), DDX58 (DExD/H-box helicase 58), GAS6 (growth arrest specific 6), RAB5A (RAB5A, member RAS oncogene family), VPS41 (VPS41 subunit of HOPS complex), EPS15 (epidermal growth factor receptor pathway substrate 15), VPS16 (VPS16 core subunit of CORVET and HOPS complexes), VPS11 (VPS11 core subunit of CORVET and HOPS complexes), ICAM2 (intercellular adhesion molecule 2), AXL (AXL receptor tyrosine kinase), RHOB (ras homolog family member B), HLA-C (major histocompatibility complex, class I, C), VPS33A (VPS33A core subunit of CORVET and HOPS complexes), CD209 (CD209 molecule), VPS39 (VPS39 subunit of HOPS complex), MERTK (MER proto-oncogene, tyrosine kinase), CAV3 (caveolin 3), HLA-G (major histocompatibility complex, class I, G), HLA-DMB (major histocompatibility complex, class II, DM beta), HLA-DRA (major histocompatibility complex, class II, DR alpha), CAV2 (caveolin 2), C1QBP (complement C1q binding protein), KPNA1 (karyopherin subunit alpha 1), CLTA (clathrin light chain A), TFAP2A (transcription factor AP-2 alpha), HLA-F (major histocompatibility complex, class I, F), HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1), HLA-A (major histocompatibility complex, class I, A), HLA-DMA (major histocompatibility complex, class II, DM alpha), TYRO3 (TYRO3 protein tyrosine kinase), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), CLTCL1 (clathrin heavy chain like 1), CLEC4M (C-type lectin domain family 4 member M), HLA-E (major histocompatibility complex, class I, E), ADAM17 (ADAM metallopeptidase domain 17), HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1), VPS4A (vacuolar protein sorting 4 homolog A), MFGE8 (milk fat globule EGF and factor V/VIII domain containing), DAB2IP (DAB2 interacting protein), TOP1 (DNA topoisomerase I)"], "WAG002821": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), MAP2K1 (mitogen-activated protein kinase kinase 1), MAPK3 (mitogen-activated protein kinase 3), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), GRB2 (growth factor receptor bound protein 2), BRAF (B-Raf proto-oncogene, serine/threonine kinase), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), HRAS (HRas proto-oncogene, GTPase), MAP2K3 (mitogen-activated protein kinase kinase 3), MAP2K4 (mitogen-activated protein kinase kinase 4), MAPK12 (mitogen-activated protein kinase 12), ARAF (A-Raf proto-oncogene, serine/threonine kinase), NRAS (NRAS proto-oncogene, GTPase), MAP2K6 (mitogen-activated protein kinase kinase 6), MAP2K2 (mitogen-activated protein kinase kinase 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAP2K7 (mitogen-activated protein kinase kinase 7), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), KRAS (KRAS proto-oncogene, GTPase), MAPK10 (mitogen-activated protein kinase 10), ELK1 (ETS transcription factor ELK1), RRAS (RAS related), MAP3K2 (mitogen-activated protein kinase kinase kinase 2), MBP (myelin basic protein), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), MAP3K12 (mitogen-activated protein kinase kinase kinase 12), SIPA1 (signal-induced proliferation-associated 1), MAP2 (microtubule associated protein 2), RASA3 (RAS p21 protein activator 3), PLCB3 (phospholipase C beta 3)"], "WAG002823": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PDE4C (phosphodiesterase 4C), PDE4B (phosphodiesterase 4B), PDE4A (phosphodiesterase 4A), ADCY8 (adenylate cyclase 8), PDE4D (phosphodiesterase 4D), ADCY2 (adenylate cyclase 2), ADCY6 (adenylate cyclase 6), PDE7A (phosphodiesterase 7A), PDE8A (phosphodiesterase 8A), ADCY1 (adenylate cyclase 1), PDE3A (phosphodiesterase 3A), PDE1A (phosphodiesterase 1A), PDE1C (phosphodiesterase 1C), PDE2A (phosphodiesterase 2A), PDE5A (phosphodiesterase 5A), PDE1B (phosphodiesterase 1B), PDE7B (phosphodiesterase 7B), PDE10A (phosphodiesterase 10A), PDE9A (phosphodiesterase 9A), ADCY9 (adenylate cyclase 9), ADCY5 (adenylate cyclase 5), ADCY7 (adenylate cyclase 7), ADCY4 (adenylate cyclase 4), PDE6B (phosphodiesterase 6B), PDE3B (phosphodiesterase 3B), PDE6A (phosphodiesterase 6A), PDE6G (phosphodiesterase 6G), PDE6D (phosphodiesterase 6D), PDE6H (phosphodiesterase 6H), PDE6C (phosphodiesterase 6C), PDE8B (phosphodiesterase 8B), ADCY3 (adenylate cyclase 3), GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2), ADCY10 (adenylate cyclase 10), GUCY1B2 (guanylate cyclase 1 soluble subunit beta 2 (pseudogene)), DRD1 (dopamine receptor D1), PDE11A (phosphodiesterase 11A), ADORA2A (adenosine A2a receptor), DRD2 (dopamine receptor D2), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), PPP1R1B (protein phosphatase 1 regulatory inhibitor subunit 1B), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), CREB1 (cAMP responsive element binding protein 1), NOS1 (nitric oxide synthase 1), CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit), GUCY1A1 (guanylate cyclase 1 soluble subunit alpha 1), LOC729966 (uncharacterized LOC729966), GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1), PDE12 (phosphodiesterase 12)"], "WAG002824": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PLCG1 (phospholipase C gamma 1), HRAS (HRas proto-oncogene, GTPase), GRB2 (growth factor receptor bound protein 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MAPK1 (mitogen-activated protein kinase 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAPK3 (mitogen-activated protein kinase 3), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), AKT1 (AKT serine/threonine kinase 1), RAC1 (Rac family small GTPase 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PRKCA (protein kinase C alpha), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), NRAS (NRAS proto-oncogene, GTPase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), EGFR (epidermal growth factor receptor), SHC1 (SHC adaptor protein 1), PLCG2 (phospholipase C gamma 2), PRKCB (protein kinase C beta), KRAS (KRAS proto-oncogene, GTPase), RASA1 (RAS p21 protein activator 1), CALM3 (calmodulin 3), CDC42 (cell division cycle 42), MAP2K1 (mitogen-activated protein kinase kinase 1), PRKCG (protein kinase C gamma), RHOA (ras homolog family member A), PDGFRB (platelet derived growth factor receptor beta), GNB1 (G protein subunit beta 1), MET (MET proto-oncogene, receptor tyrosine kinase), GAB1 (GRB2 associated binding protein 1), SHC2 (SHC adaptor protein 2), MAPK8 (mitogen-activated protein kinase 8), RAC2 (Rac family small GTPase 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), GAB2 (GRB2 associated binding protein 2), IGF1R (insulin like growth factor 1 receptor), KDR (kinase insert domain receptor), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), RRAS (RAS related), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), PLD2 (phospholipase D2), RAC3 (Rac family small GTPase 3), GNGT1 (G protein subunit gamma transducin 1), NFKB1 (nuclear factor kappa B subunit 1), SHC3 (SHC adaptor protein 3), PLD1 (phospholipase D1), RAP1A (RAP1A, member of RAS oncogene family), GNG2 (G protein subunit gamma 2), PAK1 (p21 (RAC1) activated kinase 1), RELA (RELA proto-oncogene, NF-kB subunit), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), NGFR (nerve growth factor receptor), RRAS2 (RAS related 2), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), TIAM1 (TIAM Rac1 associated GEF 1), INSR (insulin receptor), NTRK1 (neurotrophic receptor tyrosine kinase 1), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), MRAS (muscle RAS oncogene homolog), FLT1 (fms related receptor tyrosine kinase 1), GNG12 (G protein subunit gamma 12), AKT2 (AKT serine/threonine kinase 2), PLA2G4A (phospholipase A2 group IVA), MAPK9 (mitogen-activated protein kinase 9), PDGFRA (platelet derived growth factor receptor alpha), GNG3 (G protein subunit gamma 3), RALA (RAS like proto-oncogene A), RAP1B (RAP1B, member of RAS oncogene family), FGFR1 (fibroblast growth factor receptor 1), GNG4 (G protein subunit gamma 4), RALGDS (ral guanine nucleotide dissociation stimulator), GNB2 (G protein subunit beta 2), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), ARF6 (ADP ribosylation factor 6), TEK (TEK receptor tyrosine kinase), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1), GNG13 (G protein subunit gamma 13), MAPK10 (mitogen-activated protein kinase 10), NTRK2 (neurotrophic receptor tyrosine kinase 2), CSF1R (colony stimulating factor 1 receptor), GNB4 (G protein subunit beta 4), PAK2 (p21 (RAC1) activated kinase 2), GNG7 (G protein subunit gamma 7), FLT4 (fms related receptor tyrosine kinase 4), GNG8 (G protein subunit gamma 8), GNGT2 (G protein subunit gamma transducin 2), PLA2G1B (phospholipase A2 group IB), PLA2G2A (phospholipase A2 group IIA), GNB3 (G protein subunit beta 3), PLA2G5 (phospholipase A2 group V), FGFR2 (fibroblast growth factor receptor 2), RALBP1 (ralA binding protein 1), PLA2G10 (phospholipase A2 group X), GNB5 (G protein subunit beta 5), PLA2G2D (phospholipase A2 group IID), FASLG (Fas ligand)"], "WAG002826": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DPYD (dihydropyrimidine dehydrogenase), UMPS (uridine monophosphate synthetase), CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase), TYMS (thymidylate synthetase), CPS1 (carbamoyl-phosphate synthase 1), TYMP (thymidine phosphorylase), RRM2 (ribonucleotide reductase regulatory subunit M2), DPYS (dihydropyrimidinase), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), RRM1 (ribonucleotide reductase catalytic subunit M1), UPB1 (beta-ureidopropionase 1), TK2 (thymidine kinase 2), NT5C (5', 3'-nucleotidase, cytosolic), DHODH (dihydroorotate dehydrogenase (quinone)), OTC (ornithine carbamoyltransferase), GLS2 (glutaminase 2), NT5C3A (5'-nucleotidase, cytosolic IIIA)"], "WAG002832": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), AKT1 (AKT serine/threonine kinase 1), TP53 (tumor protein p53), MAPK1 (mitogen-activated protein kinase 1), SMAD3 (SMAD family member 3), FZD1 (frizzled class receptor 1), SMAD4 (SMAD family member 4), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), FZD5 (frizzled class receptor 5), FZD2 (frizzled class receptor 2), WNT3A (Wnt family member 3A), MAPK14 (mitogen-activated protein kinase 14), CDH1 (cadherin 1), FN1 (fibronectin 1), NOTCH1 (notch receptor 1), FZD4 (frizzled class receptor 4), FZD7 (frizzled class receptor 7), FZD6 (frizzled class receptor 6), FZD8 (frizzled class receptor 8), FZD10 (frizzled class receptor 10), GSK3B (glycogen synthase kinase 3 beta), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK8 (mitogen-activated protein kinase 8), HRAS (HRas proto-oncogene, GTPase), TGFB1 (transforming growth factor beta 1), TJP1 (tight junction protein 1), MAPK3 (mitogen-activated protein kinase 3), FZD9 (frizzled class receptor 9), WNT1 (Wnt family member 1), SMAD2 (SMAD family member 2), WNT7B (Wnt family member 7B), WNT2B (Wnt family member 2B), WNT3 (Wnt family member 3), WNT11 (Wnt family member 11), WNT10B (Wnt family member 10B), WNT5A (Wnt family member 5A), WNT10A (Wnt family member 10A), SHC1 (SHC adaptor protein 1), WNT8B (Wnt family member 8B), WNT7A (Wnt family member 7A), WNT5B (Wnt family member 5B), CLDN9 (claudin 9), MAP2K1 (mitogen-activated protein kinase kinase 1), WNT8A (Wnt family member 8A), CLDN15 (claudin 15), CLDN17 (claudin 17), CLDN20 (claudin 20), GRB2 (growth factor receptor bound protein 2), WNT2 (Wnt family member 2), LRP6 (LDL receptor related protein 6), CLDN1 (claudin 1), WNT9A (Wnt family member 9A), CLDN19 (claudin 19), CLDN10 (claudin 10), CLDN16 (claudin 16), WNT9B (Wnt family member 9B), OCLN (occludin), WNT6 (Wnt family member 6), CLDN14 (claudin 14), CLDN3 (claudin 3), CLDN22 (claudin 22), TRAF6 (TNF receptor associated factor 6), CLDN18 (claudin 18), FZD3 (frizzled class receptor 3), CLDN11 (claudin 11), CLDN2 (claudin 2), TGFBR2 (transforming growth factor beta receptor 2), CLDN7 (claudin 7), CLDN6 (claudin 6), MMP9 (matrix metallopeptidase 9), CLDN5 (claudin 5), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CLDN8 (claudin 8), LRP5 (LDL receptor related protein 5), CLDN4 (claudin 4), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), WNT16 (Wnt family member 16), TGFBR1 (transforming growth factor beta receptor 1), CDH2 (cadherin 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), HIF1A (hypoxia inducible factor 1 subunit alpha), MAPK11 (mitogen-activated protein kinase 11), WNT4 (Wnt family member 4), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PAK1 (p21 (RAC1) activated kinase 1), MAP2K4 (mitogen-activated protein kinase kinase 4), MAPK12 (mitogen-activated protein kinase 12), MAP2K6 (mitogen-activated protein kinase kinase 6), MAP2K3 (mitogen-activated protein kinase kinase 3), KRAS (KRAS proto-oncogene, GTPase), MAP2K2 (mitogen-activated protein kinase kinase 2), NOTCH2 (notch receptor 2), TGFB2 (transforming growth factor beta 2), CLDN23 (claudin 23), TGFB3 (transforming growth factor beta 3), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), NOTCH3 (notch receptor 3), NOTCH4 (notch receptor 4), MAPK13 (mitogen-activated protein kinase 13)"], "WAG002833": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B), MAD2L1 (mitotic arrest deficient 2 like 1), CDC20 (cell division cycle 20), BUB3 (BUB3 mitotic checkpoint protein), ESPL1 (extra spindle pole bodies like 1, separase), BUB1 (BUB1 mitotic checkpoint serine/threonine kinase), PTTG1 (PTTG1 regulator of sister chromatid separation, securin), CENPE (centromere protein E), MAD1L1 (mitotic arrest deficient 1 like 1), RAD21 (RAD21 cohesin complex component), ANAPC2 (anaphase promoting complex subunit 2), SMC3 (structural maintenance of chromosomes 3), ANAPC11 (anaphase promoting complex subunit 11), SMC1A (structural maintenance of chromosomes 1A), STAG1 (stromal antigen 1)"], "WAG002834": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HIF1A (hypoxia inducible factor 1 subunit alpha), EPAS1 (endothelial PAS domain protein 1), VHL (von Hippel-Lindau tumor suppressor), ARNT (aryl hydrocarbon receptor nuclear translocator), VEGFA (vascular endothelial growth factor A), EP300 (E1A binding protein p300), CREBBP (CREB binding protein), RBX1 (ring-box 1), CUL2 (cullin 2), TGFB1 (transforming growth factor beta 1), EGLN1 (egl-9 family hypoxia inducible factor 1), EGLN3 (egl-9 family hypoxia inducible factor 3), EGLN2 (egl-9 family hypoxia inducible factor 2), SLC2A1 (solute carrier family 2 member 1), CDKN1A (cyclin dependent kinase inhibitor 1A), PDGFB (platelet derived growth factor subunit B), ARNT2 (aryl hydrocarbon receptor nuclear translocator 2), TGFB3 (transforming growth factor beta 3), TGFB2 (transforming growth factor beta 2), TGFA (transforming growth factor alpha), TFE3 (transcription factor binding to IGHM enhancer 3), TFEB (transcription factor EB), PRCC (proline rich mitotic checkpoint control factor), CTSK (cathepsin K), DVL2 (dishevelled segment polarity protein 2), DIAPH1 (diaphanous related formin 1), CADM2 (cell adhesion molecule 2), SFPQ (splicing factor proline and glutamine rich), FH (fumarate hydratase), ELOB (elongin B), BIRC7 (baculoviral IAP repeat containing 7), ELOC (elongin C), COL21A1 (collagen type XXI alpha 1 chain), SETD2 (SET domain containing 2, histone lysine methyltransferase)"], "WAG002835": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GLI2 (GLI family zinc finger 2), GLI3 (GLI family zinc finger 3), GLI1 (GLI family zinc finger 1), SHH (sonic hedgehog signaling molecule), SMO (smoothened, frizzled class receptor), IHH (Indian hedgehog signaling molecule), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), DHH (desert hedgehog signaling molecule), PTCH2 (patched 2), PTCH1 (patched 1), SUFU (SUFU negative regulator of hedgehog signaling), ARRB2 (arrestin beta 2), CSNK1D (casein kinase 1 delta), HHIP (hedgehog interacting protein), CDON (cell adhesion associated, oncogene regulated), CSNK1E (casein kinase 1 epsilon), CCND1 (cyclin D1), KIF3A (kinesin family member 3A), CUL3 (cullin 3), CSNK1A1 (casein kinase 1 alpha 1), PRKACB (protein kinase cAMP-activated catalytic subunit beta), CSNK1G3 (casein kinase 1 gamma 3), CSNK1G2 (casein kinase 1 gamma 2), CSNK1G1 (casein kinase 1 gamma 1), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), BOC (BOC cell adhesion associated, oncogene regulated), GAS1 (growth arrest specific 1), BCL2 (BCL2 apoptosis regulator), CSNK1A1L (casein kinase 1 alpha 1 like), ARRB1 (arrestin beta 1), KIF7 (kinesin family member 7), SPOP (speckle type BTB/POZ protein), LRP2 (LDL receptor related protein 2), CCND2 (cyclin D2), FBXL17 (F-box and leucine rich repeat protein 17), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), SMURF2 (SMAD specific E3 ubiquitin protein ligase 2), GPR161 (G protein-coupled receptor 161), EVC2 (EvC ciliary complex subunit 2), EVC (EvC ciliary complex subunit 1), SPOPL (speckle type BTB/POZ protein like), GRK3 (G protein-coupled receptor kinase 3), GRK2 (G protein-coupled receptor kinase 2)"], "WAG002836": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GOT1 (glutamic-oxaloacetic transaminase 1), GOT2 (glutamic-oxaloacetic transaminase 2), CTH (cystathionine gamma-lyase), LDHB (lactate dehydrogenase B), LDHC (lactate dehydrogenase C), AHCY (adenosylhomocysteinase), GCLM (glutamate-cysteine ligase modifier subunit), LDHAL6B (lactate dehydrogenase A like 6B), GCLC (glutamate-cysteine ligase catalytic subunit), GGT5 (gamma-glutamyltransferase 5), GAD2 (glutamate decarboxylase 2), AHCYL2 (adenosylhomocysteinase like 2), AHCYL1 (adenosylhomocysteinase like 1), LDHA (lactate dehydrogenase A), GAD1 (glutamate decarboxylase 1), GGT1 (gamma-glutamyltransferase 1), GGT6 (gamma-glutamyltransferase 6), CBS (cystathionine beta-synthase), CKMT1B (creatine kinase, mitochondrial 1B), MAT1A (methionine adenosyltransferase 1A), MAT2A (methionine adenosyltransferase 2A), MPST (mercaptopyruvate sulfurtransferase), DLD (dihydrolipoamide dehydrogenase), GGT7 (gamma-glutamyltransferase 7), DNMT3B (DNA methyltransferase 3 beta), CDO1 (cysteine dioxygenase type 1), DNMT3A (DNA methyltransferase 3 alpha), LDHAL6A (lactate dehydrogenase A like 6A), BHMT (betaine--homocysteine S-methyltransferase), CSAD (cysteine sulfinic acid decarboxylase), DNMT1 (DNA methyltransferase 1), DNMT3L (DNA methyltransferase 3 like), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), GSS (glutathione synthetase), CKMT2 (creatine kinase, mitochondrial 2), CKB (creatine kinase B), BAAT (bile acid-CoA:amino acid N-acyltransferase), MDH2 (malate dehydrogenase 2), CKM (creatine kinase, M-type), MDH1 (malate dehydrogenase 1), DBT (dihydrolipoamide branched chain transacylase E2), BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta), BCKDHA (branched chain keto acid dehydrogenase E1 subunit alpha), GGT2 (gamma-glutamyltransferase 2), SUOX (sulfite oxidase), CKMT1A (creatine kinase, mitochondrial 1A), LOC102724197 (inactive glutathione hydrolase 2), MAT2B (methionine adenosyltransferase 2B), GADL1 (glutamate decarboxylase like 1), CRAT (carnitine O-acetyltransferase), CBSL (cystathionine beta-synthase like)"], "WAG002837": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), TP53 (tumor protein p53), HRAS (HRas proto-oncogene, GTPase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), EGFR (epidermal growth factor receptor), CCND1 (cyclin D1), NRAS (NRAS proto-oncogene, GTPase), MAPK3 (mitogen-activated protein kinase 3), CDKN1A (cyclin dependent kinase inhibitor 1A), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), GRB2 (growth factor receptor bound protein 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PRKCA (protein kinase C alpha), KRAS (KRAS proto-oncogene, GTPase), ERBB2 (erb-b2 receptor tyrosine kinase 2), STAT3 (signal transducer and activator of transcription 3), MAP2K1 (mitogen-activated protein kinase kinase 1), EGF (epidermal growth factor), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PLCG1 (phospholipase C gamma 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), CASP9 (caspase 9), RB1 (RB transcriptional corepressor 1), CASP3 (caspase 3), JAK3 (Janus kinase 3), BAX (BCL2 associated X, apoptosis regulator), CDKN2A (cyclin dependent kinase inhibitor 2A), PRKCB (protein kinase C beta), AKT2 (AKT serine/threonine kinase 2), BRAF (B-Raf proto-oncogene, serine/threonine kinase), BAD (BCL2 associated agonist of cell death), CDK4 (cyclin dependent kinase 4), ARAF (A-Raf proto-oncogene, serine/threonine kinase), PLCG2 (phospholipase C gamma 2), AKT3 (AKT serine/threonine kinase 3), STK4 (serine/threonine kinase 4), CDK6 (cyclin dependent kinase 6), STAT5A (signal transducer and activator of transcription 5A), RASSF1 (Ras association domain family member 1), MAP2K2 (mitogen-activated protein kinase kinase 2), CASP8 (caspase 8), RXRA (retinoid X receptor alpha), PRKCG (protein kinase C gamma), PDK1 (pyruvate dehydrogenase kinase 1), E2F1 (E2F transcription factor 1), GADD45A (growth arrest and DNA damage inducible alpha), STAT5B (signal transducer and activator of transcription 5B), FOXO3 (forkhead box O3), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), BID (BH3 interacting domain death agonist), E2F3 (E2F transcription factor 3), CYCS (cytochrome c, somatic), ALK (ALK receptor tyrosine kinase), RXRG (retinoid X receptor gamma), E2F2 (E2F transcription factor 2), RARB (retinoic acid receptor beta), RASSF5 (Ras association domain family member 5), RXRB (retinoid X receptor beta), TGFA (transforming growth factor alpha), GADD45G (growth arrest and DNA damage inducible gamma), GADD45B (growth arrest and DNA damage inducible beta), BAK1 (BCL2 antagonist/killer 1), FHIT (fragile histidine triad diadenosine triphosphatase), DDB2 (damage specific DNA binding protein 2), CRABP2 (cellular retinoic acid binding protein 2), CRABP1 (cellular retinoic acid binding protein 1), EML4 (EMAP like 4), POLK (DNA polymerase kappa)"], "WAG002838": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), WNT3A (Wnt family member 3A), WNT1 (Wnt family member 1), FZD1 (frizzled class receptor 1), WNT5A (Wnt family member 5A), FZD5 (frizzled class receptor 5), DVL1 (dishevelled segment polarity protein 1), LRP6 (LDL receptor related protein 6), FZD2 (frizzled class receptor 2), FZD8 (frizzled class receptor 8), DVL3 (dishevelled segment polarity protein 3), DVL2 (dishevelled segment polarity protein 2), FZD6 (frizzled class receptor 6), SFRP1 (secreted frizzled related protein 1), WNT7B (Wnt family member 7B), FZD7 (frizzled class receptor 7), MYC (MYC proto-oncogene, bHLH transcription factor), FZD10 (frizzled class receptor 10), WNT2B (Wnt family member 2B), WNT10B (Wnt family member 10B), WNT3 (Wnt family member 3), WNT11 (Wnt family member 11), WNT7A (Wnt family member 7A), AXIN1 (axin 1), FZD9 (frizzled class receptor 9), GSK3B (glycogen synthase kinase 3 beta), SFRP2 (secreted frizzled related protein 2), WNT10A (Wnt family member 10A), WNT6 (Wnt family member 6), WNT5B (Wnt family member 5B), SFRP4 (secreted frizzled related protein 4), WNT2 (Wnt family member 2), SFRP5 (secreted frizzled related protein 5), LRP5 (LDL receptor related protein 5), APC (APC regulator of WNT signaling pathway), FZD3 (frizzled class receptor 3), TCF7L2 (transcription factor 7 like 2), WNT16 (Wnt family member 16), WNT4 (Wnt family member 4), AXIN2 (axin 2), DKK1 (dickkopf WNT signaling pathway inhibitor 1), WIF1 (WNT inhibitory factor 1), LEF1 (lymphoid enhancer binding factor 1), CCND1 (cyclin D1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PORCN (porcupine O-acyltransferase), CSNK1A1 (casein kinase 1 alpha 1), CER1 (cerberus 1, DAN family BMP antagonist), TCF7 (transcription factor 7), FRAT1 (FRAT regulator of WNT signaling pathway 1), CSNK2A1 (casein kinase 2 alpha 1), FRAT2 (FRAT regulator of WNT signaling pathway 2), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), TCF7L1 (transcription factor 7 like 1), CTBP1 (C-terminal binding protein 1), TCF3 (transcription factor 3), CSNK1E (casein kinase 1 epsilon), DKK2 (dickkopf WNT signaling pathway inhibitor 2), SOX17 (SRY-box transcription factor 17), CSNK2A2 (casein kinase 2 alpha 2), RYK (receptor like tyrosine kinase), CCND2 (cyclin D2), RUVBL1 (RuvB like AAA ATPase 1), ROR2 (receptor tyrosine kinase like orphan receptor 2), DKK4 (dickkopf WNT signaling pathway inhibitor 4), CCND3 (cyclin D3), NKD1 (NKD inhibitor of WNT signaling pathway 1), CDK6 (cyclin dependent kinase 6), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), CSNK2B (casein kinase 2 beta), APC2 (APC regulator of WNT signaling pathway 2), NLK (nemo like kinase), FOSL1 (FOS like 1, AP-1 transcription factor subunit), ATF3 (activating transcription factor 3), CTBP2 (C-terminal binding protein 2), HNRNPK (heterogeneous nuclear ribonucleoprotein K), SENP2 (SUMO specific peptidase 2), CTNNBIP1 (catenin beta interacting protein 1), TFAP2A (transcription factor AP-2 alpha), NKD2 (NKD inhibitor of WNT signaling pathway 2), KREMEN1 (kringle containing transmembrane protein 1), SOST (sclerostin), CDK8 (cyclin dependent kinase 8), PLAU (plasminogen activator, urokinase), CSNK1A1L (casein kinase 1 alpha 1 like), HNRNPU (heterogeneous nuclear ribonucleoprotein U), CHD8 (chromodomain helicase DNA binding protein 8), ROR1 (receptor tyrosine kinase like orphan receptor 1), SERPINF1 (serpin family F member 1), CXXC4 (CXXC finger protein 4), NOTUM (notum, palmitoleoyl-protein carboxylesterase), LOC101929777 (uncharacterized LOC101929777), MACROH2A2 (macroH2A.2 histone), MIR16-2 (microRNA 16-2), CSNK2A3 (casein kinase 2 alpha 3), MIR34AHG (MIR34A host gene), MIR16-1 (microRNA 16-1), H19 (H19 imprinted maternally expressed transcript), LOC102724852 (uncharacterized LOC102724852)"], "WAG002840": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), TP53 (tumor protein p53), MAPK1 (mitogen-activated protein kinase 1), CTNNB1 (catenin beta 1), AKT1 (AKT serine/threonine kinase 1), CCND1 (cyclin D1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), IGF1R (insulin like growth factor 1 receptor), MYC (MYC proto-oncogene, bHLH transcription factor), GRB2 (growth factor receptor bound protein 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), ESR1 (estrogen receptor 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), GSK3B (glycogen synthase kinase 3 beta), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), NOTCH1 (notch receptor 1), MAPK3 (mitogen-activated protein kinase 3), SHC1 (SHC adaptor protein 1), ERBB2 (erb-b2 receptor tyrosine kinase 2), FGFR1 (fibroblast growth factor receptor 1), IGF1 (insulin like growth factor 1), WNT3A (Wnt family member 3A), CDKN1A (cyclin dependent kinase inhibitor 1A), HRAS (HRas proto-oncogene, GTPase), DVL1 (dishevelled segment polarity protein 1), BRCA1 (BRCA1 DNA repair associated), EGF (epidermal growth factor), PTEN (phosphatase and tensin homolog), FZD5 (frizzled class receptor 5), FZD1 (frizzled class receptor 1), SP1 (Sp1 transcription factor), DVL2 (dishevelled segment polarity protein 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), DVL3 (dishevelled segment polarity protein 3), WNT1 (Wnt family member 1), FGF1 (fibroblast growth factor 1), NRAS (NRAS proto-oncogene, GTPase), SHC2 (SHC adaptor protein 2), MTOR (mechanistic target of rapamycin kinase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), FZD2 (frizzled class receptor 2), E2F1 (E2F transcription factor 1), FZD6 (frizzled class receptor 6), AXIN1 (axin 1), FZD7 (frizzled class receptor 7), WNT5A (Wnt family member 5A), CDK4 (cyclin dependent kinase 4), FZD10 (frizzled class receptor 10), LRP6 (LDL receptor related protein 6), FZD8 (frizzled class receptor 8), KRAS (KRAS proto-oncogene, GTPase), SHC3 (SHC adaptor protein 3), APC (APC regulator of WNT signaling pathway), PGR (progesterone receptor), SFRP4 (secreted frizzled related protein 4), CSNK2A1 (casein kinase 2 alpha 1), FZD9 (frizzled class receptor 9), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), FGF2 (fibroblast growth factor 2), WNT2B (Wnt family member 2B), WNT7B (Wnt family member 7B), WNT10B (Wnt family member 10B), WNT7A (Wnt family member 7A), FGF4 (fibroblast growth factor 4), RB1 (RB transcriptional corepressor 1), RPS6KB1 (ribosomal protein S6 kinase B1), MAP2K1 (mitogen-activated protein kinase kinase 1), PARP1 (poly(ADP-ribose) polymerase 1), FGF10 (fibroblast growth factor 10), WNT11 (Wnt family member 11), FGF7 (fibroblast growth factor 7), WNT3 (Wnt family member 3), FGF9 (fibroblast growth factor 9), WNT10A (Wnt family member 10A), FZD3 (frizzled class receptor 3), FGF3 (fibroblast growth factor 3), FGF6 (fibroblast growth factor 6), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), WNT5B (Wnt family member 5B), WNT2 (Wnt family member 2), NCOA3 (nuclear receptor coactivator 3), TCF7L2 (transcription factor 7 like 2), ATM (ATM serine/threonine kinase), WNT6 (Wnt family member 6), LRP5 (LDL receptor related protein 5), AXIN2 (axin 2), FGF18 (fibroblast growth factor 18), FGF23 (fibroblast growth factor 23), FGF19 (fibroblast growth factor 19), FGF16 (fibroblast growth factor 16), ATR (ATR serine/threonine kinase), CSNK2B (casein kinase 2 beta), FGF20 (fibroblast growth factor 20), WNT4 (Wnt family member 4), NCOA1 (nuclear receptor coactivator 1), AKT2 (AKT serine/threonine kinase 2), CSNK1A1 (casein kinase 1 alpha 1), FGF8 (fibroblast growth factor 8), KIT (KIT proto-oncogene, receptor tyrosine kinase)"], "WAG002841": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), TP53 (tumor protein p53), RAC1 (Rac family small GTPase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), CCND1 (cyclin D1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK8 (mitogen-activated protein kinase 8), CDC42 (cell division cycle 42), MAPK3 (mitogen-activated protein kinase 3), PRKCD (protein kinase C delta), CDKN1A (cyclin dependent kinase inhibitor 1A), VEGFA (vascular endothelial growth factor A), EGFR (epidermal growth factor receptor), MAP2K1 (mitogen-activated protein kinase kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), STAT3 (signal transducer and activator of transcription 3), MTOR (mechanistic target of rapamycin kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PAK1 (p21 (RAC1) activated kinase 1), RAC3 (Rac family small GTPase 3), EGF (epidermal growth factor), ERBB2 (erb-b2 receptor tyrosine kinase 2), NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), RAC2 (Rac family small GTPase 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), SMAD2 (SMAD family member 2), TGFB1 (transforming growth factor beta 1), BCL2L1 (BCL2 like 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), AKT2 (AKT serine/threonine kinase 2), SMAD4 (SMAD family member 4), RPS6KB1 (ribosomal protein S6 kinase B1), MAPK9 (mitogen-activated protein kinase 9), SMAD3 (SMAD family member 3), RHOA (ras homolog family member A), AKT3 (AKT serine/threonine kinase 3), RB1 (RB transcriptional corepressor 1), KRAS (KRAS proto-oncogene, GTPase), CDK4 (cyclin dependent kinase 4), CASP9 (caspase 9), TGFBR1 (transforming growth factor beta receptor 1), JAK1 (Janus kinase 1), STAT1 (signal transducer and activator of transcription 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), BAX (BCL2 associated X, apoptosis regulator), TGFBR2 (transforming growth factor beta receptor 2), CDKN2A (cyclin dependent kinase inhibitor 2A), BAD (BCL2 associated agonist of cell death), PAK2 (p21 (RAC1) activated kinase 2), MAPK10 (mitogen-activated protein kinase 10), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), BRAF (B-Raf proto-oncogene, serine/threonine kinase), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAP2K2 (mitogen-activated protein kinase kinase 2), E2F1 (E2F transcription factor 1), TIAM1 (TIAM Rac1 associated GEF 1), ARAF (A-Raf proto-oncogene, serine/threonine kinase), RALA (RAS like proto-oncogene A), TGFB2 (transforming growth factor beta 2), PAK4 (p21 (RAC1) activated kinase 4), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CDK6 (cyclin dependent kinase 6), PAK3 (p21 (RAC1) activated kinase 3), PAK6 (p21 (RAC1) activated kinase 6), RALBP1 (ralA binding protein 1), RALGDS (ral guanine nucleotide dissociation stimulator), GADD45A (growth arrest and DNA damage inducible alpha), E2F3 (E2F transcription factor 3), PEBP1 (phosphatidylethanolamine binding protein 1), TGFB3 (transforming growth factor beta 3), RALB (RAS like proto-oncogene B), RPS6KB2 (ribosomal protein S6 kinase B2), BRCA2 (BRCA2 DNA repair associated), PLD1 (phospholipase D1), E2F2 (E2F transcription factor 2), RAD51 (RAD51 recombinase), TGFA (transforming growth factor alpha), GADD45B (growth arrest and DNA damage inducible beta), DUSP6 (dual specificity phosphatase 6), GADD45G (growth arrest and DNA damage inducible gamma), BAK1 (BCL2 antagonist/killer 1), DDB2 (damage specific DNA binding protein 2), RIPK4 (receptor interacting serine/threonine kinase 4), POLK (DNA polymerase kappa), PAK5 (p21 (RAC1) activated kinase 5), BUB1B-PAK6 (BUB1B-PAK6 readthrough)"], "WAG002844": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALDOA (aldolase, fructose-bisphosphate A), ALDOC (aldolase, fructose-bisphosphate C), ALDOB (aldolase, fructose-bisphosphate B), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), PGAM2 (phosphoglycerate mutase 2), PGK1 (phosphoglycerate kinase 1), ENO1 (enolase 1), HK1 (hexokinase 1), ENO3 (enolase 3), ENO2 (enolase 2), LDHB (lactate dehydrogenase B), GAPDHS (glyceraldehyde-3-phosphate dehydrogenase, spermatogenic), LDHA (lactate dehydrogenase A), PGAM1 (phosphoglycerate mutase 1), HK2 (hexokinase 2), PGK2 (phosphoglycerate kinase 2), LDHC (lactate dehydrogenase C), LDHAL6B (lactate dehydrogenase A like 6B), HK3 (hexokinase 3), GCK (glucokinase), PFKM (phosphofructokinase, muscle), PFKL (phosphofructokinase, liver type), PFKP (phosphofructokinase, platelet)"], "WAG002845": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BCL2 (BCL2 apoptosis regulator), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), NFE2L2 (nuclear factor, erythroid 2 like 2), MAPK8 (mitogen-activated protein kinase 8), ATF6 (activating transcription factor 6), ERN1 (endoplasmic reticulum to nucleus signaling 1), SOD1 (superoxide dismutase 1), TP53TG3E (TP53 target 3 family member E), LOC102723655 (TP53-target gene 3 protein), TP53TG3F (TP53 target 3 family member F), TP53TG3C (TP53 target 3C), LOC102723713 (TP53-target gene 3 protein)"], "WAG002846": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), WNT3A (Wnt family member 3A), DVL2 (dishevelled segment polarity protein 2), DVL1 (dishevelled segment polarity protein 1), FZD1 (frizzled class receptor 1), WNT1 (Wnt family member 1), DVL3 (dishevelled segment polarity protein 3), FZD5 (frizzled class receptor 5), WNT5A (Wnt family member 5A), FZD2 (frizzled class receptor 2), FZD6 (frizzled class receptor 6), FZD8 (frizzled class receptor 8), FZD7 (frizzled class receptor 7), FZD10 (frizzled class receptor 10), LRP6 (LDL receptor related protein 6), SFRP1 (secreted frizzled related protein 1), WNT11 (Wnt family member 11), WNT7B (Wnt family member 7B), FZD9 (frizzled class receptor 9), WNT2B (Wnt family member 2B), WNT3 (Wnt family member 3), WNT7A (Wnt family member 7A), GSK3B (glycogen synthase kinase 3 beta), WNT10B (Wnt family member 10B), WNT6 (Wnt family member 6), WNT10A (Wnt family member 10A), WNT5B (Wnt family member 5B), FZD3 (frizzled class receptor 3), MYC (MYC proto-oncogene, bHLH transcription factor), WNT2 (Wnt family member 2), SFRP2 (secreted frizzled related protein 2), AXIN1 (axin 1), SFRP4 (secreted frizzled related protein 4), SFRP5 (secreted frizzled related protein 5), LRP5 (LDL receptor related protein 5), APC (APC regulator of WNT signaling pathway), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PLCB2 (phospholipase C beta 2), WNT4 (Wnt family member 4), WNT16 (Wnt family member 16), PLCB1 (phospholipase C beta 1), PLCB4 (phospholipase C beta 4), PLCB3 (phospholipase C beta 3), TCF7L2 (transcription factor 7 like 2), WIF1 (WNT inhibitory factor 1), DKK1 (dickkopf WNT signaling pathway inhibitor 1), CCND1 (cyclin D1), RAC1 (Rac family small GTPase 1), LEF1 (lymphoid enhancer binding factor 1), CSNK1A1 (casein kinase 1 alpha 1), NFATC1 (nuclear factor of activated T cells 1), PORCN (porcupine O-acyltransferase), NFATC2 (nuclear factor of activated T cells 2), CER1 (cerberus 1, DAN family BMP antagonist), VANGL1 (VANGL planar cell polarity protein 1), FRAT1 (FRAT regulator of WNT signaling pathway 1), MAPK8 (mitogen-activated protein kinase 8), PPP3CA (protein phosphatase 3 catalytic subunit alpha), CSNK2A1 (casein kinase 2 alpha 1), NFATC3 (nuclear factor of activated T cells 3), PPP3CB (protein phosphatase 3 catalytic subunit beta), PRKCA (protein kinase C alpha), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), PRKCB (protein kinase C beta), PPP3CC (protein phosphatase 3 catalytic subunit gamma), FRAT2 (FRAT regulator of WNT signaling pathway 2), TCF7 (transcription factor 7), RHOA (ras homolog family member A), MAPK9 (mitogen-activated protein kinase 9), CSNK2A2 (casein kinase 2 alpha 2), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), CTBP1 (C-terminal binding protein 1), NFATC4 (nuclear factor of activated T cells 4), DKK2 (dickkopf WNT signaling pathway inhibitor 2), SOX17 (SRY-box transcription factor 17), CSNK1E (casein kinase 1 epsilon), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), ROR2 (receptor tyrosine kinase like orphan receptor 2), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), RYK (receptor like tyrosine kinase), FOSL1 (FOS like 1, AP-1 transcription factor subunit), PPP3R2 (protein phosphatase 3 regulatory subunit B, beta), CAMK2B (calcium/calmodulin dependent protein kinase II beta), DKK4 (dickkopf WNT signaling pathway inhibitor 4), TCF7L1 (transcription factor 7 like 1), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CSNK2B (casein kinase 2 beta), NKD1 (NKD inhibitor of WNT signaling pathway 1), CCND2 (cyclin D2), PRKCG (protein kinase C gamma), VANGL2 (VANGL planar cell polarity protein 2), NLK (nemo like kinase), CCND3 (cyclin D3), PRICKLE2 (prickle planar cell polarity protein 2), DAAM1 (dishevelled associated activator of morphogenesis 1), CTBP2 (C-terminal binding protein 2), PRICKLE1 (prickle planar cell polarity protein 1), SENP2 (SUMO specific peptidase 2), CTNNBIP1 (catenin beta interacting protein 1), DAAM2 (dishevelled associated activator of morphogenesis 2)"], "WAG002847": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SQLE (squalene epoxidase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), FDPS (farnesyl diphosphate synthase), MVD (mevalonate diphosphate decarboxylase), IDI1 (isopentenyl-diphosphate delta isomerase 1), DHCR7 (7-dehydrocholesterol reductase), PMVK (phosphomevalonate kinase), MVK (mevalonate kinase), LSS (lanosterol synthase), ACAT2 (acetyl-CoA acetyltransferase 2)"], "WAG002849": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MDM2 (MDM2 proto-oncogene), CDKN1A (cyclin dependent kinase inhibitor 1A), GADD45A (growth arrest and DNA damage inducible alpha), EI24 (EI24 autophagy associated transmembrane protein), RPS27 (ribosomal protein S27), RPS27L (ribosomal protein S27 like), DDB2 (damage specific DNA binding protein 2), E2F8 (E2F transcription factor 8), BTG2 (BTG anti-proliferation factor 2), ID2 (inhibitor of DNA binding 2), PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), E2F7 (E2F transcription factor 7), TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase), TP53I3 (tumor protein p53 inducible protein 3), CBLB (Cbl proto-oncogene B), TRIM22 (tripartite motif containing 22), SMAD5 (SMAD family member 5), CEBPD (CCAAT enhancer binding protein delta), CENPE (centromere protein E), IKBIP (IKBKB interacting protein), TRIAP1 (TP53 regulated inhibitor of apoptosis 1), H2BC8 (H2B clustered histone 8), DAAM1 (dishevelled associated activator of morphogenesis 1), ITPKC (inositol-trisphosphate 3-kinase C), H2BC14 (H2B clustered histone 14), PLK3 (polo like kinase 3), H3C4 (H3 clustered histone 4), SEL1L (SEL1L adaptor subunit of ERAD E3 ubiquitin ligase), BLOC1S2 (biogenesis of lysosomal organelles complex 1 subunit 2), TIGAR (TP53 induced glycolysis regulatory phosphatase), PHLDA3 (pleckstrin homology like domain family A member 3), RAPGEF2 (Rap guanine nucleotide exchange factor 2), H2BC4 (H2B clustered histone 4), PCDH8 (protocadherin 8), RBM12B (RNA binding motif protein 12B), NLRX1 (NLR family member X1), LRRFIP2 (LRR binding FLII interacting protein 2), H1-4 (H1.4 linker histone, cluster member), BRMS1L (BRMS1 like transcriptional repressor), TM7SF3 (transmembrane 7 superfamily member 3), LCE1E (late cornified envelope 1E), ARRDC4 (arrestin domain containing 4), GXYLT1 (glucoside xylosyltransferase 1), SEMG2 (semenogelin 2), H2BC3 (H2B clustered histone 3), TNFRSF17 (TNF receptor superfamily member 17), AEN (apoptosis enhancing nuclease), FBXO22 (F-box protein 22), DUSP14 (dual specificity phosphatase 14), CCP110 (centriolar coiled-coil protein 110), H2BC10 (H2B clustered histone 10), H2BC15 (H2B clustered histone 15), MEX3B (mex-3 RNA binding family member B), DCP1B (decapping mRNA 1B), SERTAD1 (SERTA domain containing 1), ACTA2 (actin alpha 2, smooth muscle), USP41 (ubiquitin specific peptidase 41), AMER1 (APC membrane recruitment protein 1), B3GNT2 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2), PTGER4 (prostaglandin E receptor 4), COIL (coilin), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1)"], "WAG002850": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DNMT3A (DNA methyltransferase 3 alpha), DNMT1 (DNA methyltransferase 1), EHMT2 (euchromatic histone lysine methyltransferase 2), ALDH7A1 (aldehyde dehydrogenase 7 family member A1), BHMT (betaine--homocysteine S-methyltransferase), PEMT (phosphatidylethanolamine N-methyltransferase), CHDH (choline dehydrogenase), DNMT3B (DNA methyltransferase 3 beta), PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), CASP9 (caspase 9), EHMT1 (euchromatic histone lysine methyltransferase 1), CASP3 (caspase 3), CYCS (cytochrome c, somatic), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), CHKA (choline kinase alpha), MTHFR (methylenetetrahydrofolate reductase), CHPT1 (choline phosphotransferase 1), COMT (catechol-O-methyltransferase), ASMT (acetylserotonin O-methyltransferase), HNMT (histamine N-methyltransferase), NDUFAF7 (NADH:ubiquinone oxidoreductase complex assembly factor 7), MARS1 (methionyl-tRNA synthetase 1), SGMS1 (sphingomyelin synthase 1)"], "WAG002851": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PKM (pyruvate kinase M1/2), MDH2 (malate dehydrogenase 2), GPI (glucose-6-phosphate isomerase), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), TKT (transketolase), PGD (phosphogluconate dehydrogenase), TALDO1 (transaldolase 1), GOT2 (glutamic-oxaloacetic transaminase 2), ACLY (ATP citrate lyase), LDHA (lactate dehydrogenase A), PDHB (pyruvate dehydrogenase E1 subunit beta), G6PD (glucose-6-phosphate dehydrogenase), PGK1 (phosphoglycerate kinase 1), ENO1 (enolase 1), IDH3A (isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), ACO2 (aconitase 2), ALDOB (aldolase, fructose-bisphosphate B), GLUD1 (glutamate dehydrogenase 1), PGAM1 (phosphoglycerate mutase 1), HK3 (hexokinase 3), DLST (dihydrolipoamide S-succinyltransferase), FH (fumarate hydratase), SDHB (succinate dehydrogenase complex iron sulfur subunit B), PAICS (phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase), SHMT2 (serine hydroxymethyltransferase 2), GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase), PPAT (phosphoribosyl pyrophosphate amidotransferase), SUCLG2 (succinate-CoA ligase GDP-forming subunit beta), RPIA (ribose 5-phosphate isomerase A), PSAT1 (phosphoserine aminotransferase 1), GLS (glutaminase), FASN (fatty acid synthase), PSPH (phosphoserine phosphatase), SLC2A1 (solute carrier family 2 member 1), SLC1A5 (solute carrier family 1 member 5), SLC16A3 (solute carrier family 16 member 3), TIGAR (TP53 induced glycolysis regulatory phosphatase), PYCR1 (pyrroline-5-carboxylate reductase 1), PYCR2 (pyrroline-5-carboxylate reductase 2), PFKL (phosphofructokinase, liver type)"], "WAG002854": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), TNF (tumor necrosis factor), MAPK1 (mitogen-activated protein kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), BCL2 (BCL2 apoptosis regulator), CASP3 (caspase 3), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), STAT3 (signal transducer and activator of transcription 3), IL6 (interleukin 6), IL2 (interleukin 2), CASP8 (caspase 8), STAT1 (signal transducer and activator of transcription 1), CD4 (CD4 molecule), IFNG (interferon gamma), FYN (FYN proto-oncogene, Src family tyrosine kinase), BCL2L1 (BCL2 like 1), TGFB1 (transforming growth factor beta 1), MAPK3 (mitogen-activated protein kinase 3), CASP9 (caspase 9), CCND1 (cyclin D1), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), JAK1 (Janus kinase 1), CASP1 (caspase 1), IL10 (interleukin 10), CCR5 (C-C motif chemokine receptor 5), CAV1 (caveolin 1), CXCR4 (C-X-C motif chemokine receptor 4), BAX (BCL2 associated X, apoptosis regulator), CASP7 (caspase 7), TLR4 (toll like receptor 4), CYCS (cytochrome c, somatic), CREB1 (cAMP responsive element binding protein 1), SOCS1 (suppressor of cytokine signaling 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PARP1 (poly(ADP-ribose) polymerase 1), RAC3 (Rac family small GTPase 3), ITGB2 (integrin subunit beta 2), RASA1 (RAS p21 protein activator 1), BID (BH3 interacting domain death agonist), MMP9 (matrix metallopeptidase 9), EDN1 (endothelin 1), ILK (integrin linked kinase), CASP2 (caspase 2), IL12B (interleukin 12B), CD40LG (CD40 ligand), NFKB2 (nuclear factor kappa B subunit 2), RAC2 (Rac family small GTPase 2), TLR3 (toll like receptor 3), CASP6 (caspase 6), DAG1 (dystroglycan 1), ACTB (actin beta), CD80 (CD80 molecule), GSK3B (glycogen synthase kinase 3 beta), DFFA (DNA fragmentation factor subunit alpha), DMD (dystrophin), ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase), IL12A (interleukin 12A), NOD2 (nucleotide binding oligomerization domain containing 2), PYCARD (PYD and CARD domain containing), EIF4G2 (eukaryotic translation initiation factor 4 gamma 2), SGCB (sarcoglycan beta), ITGAL (integrin subunit alpha L), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), CCR3 (C-C motif chemokine receptor 3), SGCA (sarcoglycan alpha), SGCD (sarcoglycan delta), DFFB (DNA fragmentation factor subunit beta), SGCG (sarcoglycan gamma), TLR5 (toll like receptor 5), CD55 (CD55 molecule (Cromer blood group)), KRT8 (keratin 8), TICAM1 (toll like receptor adaptor molecule 1), LAMA2 (laminin subunit alpha 2), ENDOG (endonuclease G), PABPC1 (poly(A) binding protein cytoplasmic 1), MICA (MHC class I polypeptide-related sequence A), BNIP2 (BCL2 interacting protein 2), NOS1 (nitric oxide synthase 1), AIF1 (allograft inflammatory factor 1), MYH6 (myosin heavy chain 6), CXADR (CXADR Ig-like cell adhesion molecule), HLA-DMA (major histocompatibility complex, class II, DM alpha), PTCRA (pre T cell antigen receptor alpha), JKAMP (JNK1/MAPK8 associated membrane protein), CAAP1 (caspase activity and apoptosis inhibitor 1), CHRAC1 (chromatin accessibility complex subunit 1)"], "WAG002858": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), IGF1 (insulin like growth factor 1), EGF (epidermal growth factor), IL6 (interleukin 6), STAT3 (signal transducer and activator of transcription 3), MMP9 (matrix metallopeptidase 9), BIRC5 (baculoviral IAP repeat containing 5), KDR (kinase insert domain receptor), TLR4 (toll like receptor 4), PTEN (phosphatase and tensin homolog), SPP1 (secreted phosphoprotein 1), CD81 (CD81 molecule), CD63 (CD63 molecule), HSPB1 (heat shock protein family B (small) member 1), SORBS2 (sorbin and SH3 domain containing 2), ETS2 (ETS proto-oncogene 2, transcription factor), SOD1 (superoxide dismutase 1), MIR455 (microRNA 455), PDLIM5 (PDZ and LIM domain 5), GATA4 (GATA binding protein 4), MIR19A (microRNA 19a), MIR320A (microRNA 320a)"], "WAG002860": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FGF2 (fibroblast growth factor 2), SHH (sonic hedgehog signaling molecule), OLIG2 (oligodendrocyte transcription factor 2), TNF (tumor necrosis factor), SOX9 (SRY-box transcription factor 9), IGF1 (insulin like growth factor 1), BMP2 (bone morphogenetic protein 2), SOX10 (SRY-box transcription factor 10), LIF (LIF interleukin 6 family cytokine), IL1B (interleukin 1 beta), MAG (myelin associated glycoprotein), BMP4 (bone morphogenetic protein 4), MBP (myelin basic protein), SOX8 (SRY-box transcription factor 8), ASCL1 (achaete-scute family bHLH transcription factor 1), GLI2 (GLI family zinc finger 2), NKX2-2 (NK2 homeobox 2), PLP1 (proteolipid protein 1), SOX5 (SRY-box transcription factor 5), MOG (myelin oligodendrocyte glycoprotein), CNTF (ciliary neurotrophic factor), CXCL1 (C-X-C motif chemokine ligand 1), OLIG1 (oligodendrocyte transcription factor 1), PDGFB (platelet derived growth factor subunit B), SOX6 (SRY-box transcription factor 6), CXCL2 (C-X-C motif chemokine ligand 2), CNP (2',3'-cyclic nucleotide 3' phosphodiesterase), MYT1 (myelin transcription factor 1), OMG (oligodendrocyte myelin glycoprotein), NKX2-6 (NK2 homeobox 6), LOC101927057 (uncharacterized LOC101927057)"], "WAG002861": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), NCOR1 (nuclear receptor corepressor 1), HDAC5 (histone deacetylase 5), NCOR2 (nuclear receptor corepressor 2), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), GPS2 (G protein pathway suppressor 2), TBL1XR1 (TBL1X receptor 1), SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2), TBL1X (transducin beta like 1 X-linked), KDM5B (lysine demethylase 5B), MECP2 (methyl-CpG binding protein 2), HDAC8 (histone deacetylase 8), CHD4 (chromodomain helicase DNA binding protein 4), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), HTT (huntingtin), ACTL6B (actin like 6B), SMC1A (structural maintenance of chromosomes 1A), MEF2C (myocyte enhancer factor 2C), TCF4 (transcription factor 4), CDKL5 (cyclin dependent kinase like 5), SMARCA1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1), SCN2A (sodium voltage-gated channel alpha subunit 2), HAP1 (huntingtin associated protein 1), EIF2B2 (eukaryotic translation initiation factor 2B subunit beta), XAB2 (XPA binding protein 2), SATB2 (SATB homeobox 2), CRK (CRK proto-oncogene, adaptor protein), SHANK3 (SH3 and multiple ankyrin repeat domains 3), SCN8A (sodium voltage-gated channel alpha subunit 8), GNAO1 (G protein subunit alpha o1), SYNGAP1 (synaptic Ras GTPase activating protein 1), HIVEP2 (HIVEP zinc finger 2), TAF1B (TATA-box binding protein associated factor, RNA polymerase I subunit B), STXBP1 (syntaxin binding protein 1), CECR2 (CECR2 histone acetyl-lysine reader), SCN1A (sodium voltage-gated channel alpha subunit 1), TRRAP (transformation/transcription domain associated protein), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), SYNE2 (spectrin repeat containing nuclear envelope protein 2), RHOBTB2 (Rho related BTB domain containing 2), IMPDH2 (inosine monophosphate dehydrogenase 2), GABRA3 (gamma-aminobutyric acid type A receptor subunit alpha3), GABRD (gamma-aminobutyric acid type A receptor subunit delta), BRAF (B-Raf proto-oncogene, serine/threonine kinase), FOXG1 (forkhead box G1), SRRM3 (serine/arginine repetitive matrix 3), GABBR2 (gamma-aminobutyric acid type B receptor subunit 2), KCNJ10 (potassium inwardly rectifying channel subfamily J member 10)"], "WAG002862": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FTL (ferritin light chain), FTH1 (ferritin heavy chain 1), TF (transferrin), TFRC (transferrin receptor), TP53 (tumor protein p53), SLC40A1 (solute carrier family 40 member 1), CP (ceruloplasmin), SLC11A2 (solute carrier family 11 member 2), HMOX1 (heme oxygenase 1), ATG7 (autophagy related 7), ACSL1 (acyl-CoA synthetase long chain family member 1), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), ATG5 (autophagy related 5), GPX4 (glutathione peroxidase 4), SAT1 (spermidine/spermine N1-acetyltransferase 1), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), GCLM (glutamate-cysteine ligase modifier subunit), GCLC (glutamate-cysteine ligase catalytic subunit), IREB2 (iron responsive element binding protein 2), GSS (glutathione synthetase), STEAP3 (STEAP3 metalloreductase), ACSL4 (acyl-CoA synthetase long chain family member 4), ACSL3 (acyl-CoA synthetase long chain family member 3), BACH1 (BTB domain and CNC homolog 1), ACSL5 (acyl-CoA synthetase long chain family member 5), HSPB1 (heat shock protein family B (small) member 1), TXNRD1 (thioredoxin reductase 1), SLC3A2 (solute carrier family 3 member 2), MAP1LC3C (microtubule associated protein 1 light chain 3 gamma), PRNP (prion protein), PCBP1 (poly(rC) binding protein 1), VDAC2 (voltage dependent anion channel 2), PCBP2 (poly(rC) binding protein 2), SLC7A11 (solute carrier family 7 member 11), SAT2 (spermidine/spermine N1-acetyltransferase family member 2), PHKG2 (phosphorylase kinase catalytic subunit gamma 2), ACSL6 (acyl-CoA synthetase long chain family member 6), SLC1A5 (solute carrier family 1 member 5), SLC38A1 (solute carrier family 38 member 1), VDAC3 (voltage dependent anion channel 3), SLC39A14 (solute carrier family 39 member 14), SLC39A8 (solute carrier family 39 member 8), FTMT (ferritin mitochondrial), LPCAT3 (lysophosphatidylcholine acyltransferase 3), GRIK1-AS2 (GRIK1 antisense RNA 2), NCOA4 (nuclear receptor coactivator 4), ALOX15 (arachidonate 15-lipoxygenase), CISD1 (CDGSH iron sulfur domain 1), CYBB (cytochrome b-245 beta chain)"], "WAG002864": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EXOSC4 (exosome component 4), XRN1 (5'-3' exoribonuclease 1), PNPT1 (polyribonucleotide nucleotidyltransferase 1)"], "WAG002868": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKACA (protein kinase cAMP-activated catalytic subunit alpha), GRB2 (growth factor receptor bound protein 2), CREB1 (cAMP responsive element binding protein 1), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), SMARCD3 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3), MTOR (mechanistic target of rapamycin kinase), TSC2 (TSC complex subunit 2), MAPK14 (mitogen-activated protein kinase 14), RHEB (Ras homolog, mTORC1 binding), SMARCC2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2), TSC1 (TSC complex subunit 1), SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2), SMARCD1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1), SMARCC1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1), PPARG (peroxisome proliferator activated receptor gamma), ADCY2 (adenylate cyclase 2), SMARCE1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1), ACTL6A (actin like 6A), HRAS (HRas proto-oncogene, GTPase), ADCY1 (adenylate cyclase 1), RPS6KA1 (ribosomal protein S6 kinase A1), ADCY7 (adenylate cyclase 7), SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1), ADCY8 (adenylate cyclase 8), SMARCD2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2), ARID1A (AT-rich interaction domain 1A), ADCY6 (adenylate cyclase 6), ARID1B (AT-rich interaction domain 1B), ADCY5 (adenylate cyclase 5), GNAS (GNAS complex locus), ADCY4 (adenylate cyclase 4), ADCY9 (adenylate cyclase 9), NRAS (NRAS proto-oncogene, GTPase), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), RPS6KB1 (ribosomal protein S6 kinase B1), ADCY3 (adenylate cyclase 3), CPT1A (carnitine palmitoyltransferase 1A), PPARGC1A (PPARG coactivator 1 alpha), RPS6 (ribosomal protein S6), ADRB3 (adrenoceptor beta 3), FGFR1 (fibroblast growth factor receptor 1), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), DPF3 (double PHD fingers 3), DPF1 (double PHD fingers 1), ACSL1 (acyl-CoA synthetase long chain family member 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), ACTL6B (actin like 6B), RPS6KA3 (ribosomal protein S6 kinase A3), GCG (glucagon), RPTOR (regulatory associated protein of MTOR complex 1), MAPK11 (mitogen-activated protein kinase 11), CPT1B (carnitine palmitoyltransferase 1B), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), MLST8 (MTOR associated protein, LST8 homolog), CREB3 (cAMP responsive element binding protein 3), LIPE (lipase E, hormone sensitive type), ACSL5 (acyl-CoA synthetase long chain family member 5), RPS6KA2 (ribosomal protein S6 kinase A2), ACSL4 (acyl-CoA synthetase long chain family member 4), ATF2 (activating transcription factor 2), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), ACSL3 (acyl-CoA synthetase long chain family member 3), MAPK12 (mitogen-activated protein kinase 12), FRS2 (fibroblast growth factor receptor substrate 2), CPT2 (carnitine palmitoyltransferase 2), ACTB (actin beta), CPT1C (carnitine palmitoyltransferase 1C), MAPK13 (mitogen-activated protein kinase 13), CREB3L3 (cAMP responsive element binding protein 3 like 3), KRAS (KRAS proto-oncogene, GTPase), CREB3L1 (cAMP responsive element binding protein 3 like 1), RPS6KA6 (ribosomal protein S6 kinase A6), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), CREB3L4 (cAMP responsive element binding protein 3 like 4), CREB3L2 (cAMP responsive element binding protein 3 like 2), MAP2K3 (mitogen-activated protein kinase kinase 3), MGLL (monoglyceride lipase), PLIN1 (perilipin 1), RPS6KB2 (ribosomal protein S6 kinase B2), ACSL6 (acyl-CoA synthetase long chain family member 6), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), PRKG1 (protein kinase cGMP-dependent 1), FGF21 (fibroblast growth factor 21), UCP1 (uncoupling protein 1), AKT1S1 (AKT1 substrate 1), SLC25A20 (solute carrier family 25 member 20), ACTG1 (actin gamma 1), PNPLA2 (patatin like phospholipase domain containing 2), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), KDM1A (lysine demethylase 1A), CREB5 (cAMP responsive element binding protein 5), KLB (klotho beta), ADCY10 (adenylate cyclase 10), CNR1 (cannabinoid receptor 1), NPR1 (natriuretic peptide receptor 1), PRKG2 (protein kinase cGMP-dependent 2)"], "WAG002869": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3), NDUFA2 (NADH:ubiquinone oxidoreductase subunit A2), NDUFS4 (NADH:ubiquinone oxidoreductase subunit S4), NDUFA1 (NADH:ubiquinone oxidoreductase subunit A1), NDUFV2 (NADH:ubiquinone oxidoreductase core subunit V2), NDUFS6 (NADH:ubiquinone oxidoreductase subunit S6), NDUFS1 (NADH:ubiquinone oxidoreductase core subunit S1), NDUFV1 (NADH:ubiquinone oxidoreductase core subunit V1), NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2), NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1), NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6), NDUFA12 (NADH:ubiquinone oxidoreductase subunit A12), NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9), NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5), NDUFB2 (NADH:ubiquinone oxidoreductase subunit B2), NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1), NDUFB7 (NADH:ubiquinone oxidoreductase subunit B7), NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5), NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8), NDUFB4 (NADH:ubiquinone oxidoreductase subunit B4), NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8), NDUFB10 (NADH:ubiquinone oxidoreductase subunit B10), NDUFS5 (NADH:ubiquinone oxidoreductase subunit S5), NDUFC2 (NADH:ubiquinone oxidoreductase subunit C2), NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10), NDUFA7 (NADH:ubiquinone oxidoreductase subunit A7), NDUFA3 (NADH:ubiquinone oxidoreductase subunit A3), NDUFC1 (NADH:ubiquinone oxidoreductase subunit C1), NDUFB6 (NADH:ubiquinone oxidoreductase subunit B6), NDUFB11 (NADH:ubiquinone oxidoreductase subunit B11), NDUFB3 (NADH:ubiquinone oxidoreductase subunit B3), NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13), NDUFB1 (NADH:ubiquinone oxidoreductase subunit B1), NDUFV3 (NADH:ubiquinone oxidoreductase subunit V3), NDUFAF3 (NADH:ubiquinone oxidoreductase complex assembly factor 3), NDUFAF2 (NADH:ubiquinone oxidoreductase complex assembly factor 2), NDUFAF4 (NADH:ubiquinone oxidoreductase complex assembly factor 4), NUBPL (nucleotide binding protein like), FOXRED1 (FAD dependent oxidoreductase domain containing 1), NDUFAF6 (NADH:ubiquinone oxidoreductase complex assembly factor 6), ECSIT (ECSIT signaling integrator), DMAC2 (distal membrane arm assembly complex 2), ND2 (MTND2), ACAD9 (acyl-CoA dehydrogenase family member 9), TIMMDC1 (translocase of inner mitochondrial membrane domain containing 1), ND1 (NADH dehydrogenase, subunit 1 (complex I)), ND4 (NADH dehydrogenase, subunit 4 (complex I)), TMEM186 (transmembrane protein 186), ND6 (NADH dehydrogenase, subunit 6 (complex I)), ND4L (NADH dehydrogenase, subunit 4L (complex I)), TMEM70 (transmembrane protein 70), TMEM126B (transmembrane protein 126B), NDUFAF7 (NADH:ubiquinone oxidoreductase complex assembly factor 7), DMAC1 (distal membrane arm assembly complex 1), ND5 (NADH dehydrogenase, subunit 5 (complex I)), COA1 (cytochrome c oxidase assembly factor 1 homolog)"], "WAG002871": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TGFB1 (transforming growth factor beta 1), SMAD3 (SMAD family member 3), AKT1 (AKT serine/threonine kinase 1), RELA (RELA proto-oncogene, NF-kB subunit), NOTCH1 (notch receptor 1), SMAD2 (SMAD family member 2), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), HIF1A (hypoxia inducible factor 1 subunit alpha), NFKB1 (nuclear factor kappa B subunit 1), SMAD5 (SMAD family member 5), SMAD9 (SMAD family member 9), SMAD1 (SMAD family member 1), MMP9 (matrix metallopeptidase 9), ANGPT1 (angiopoietin 1), TGFBR1 (transforming growth factor beta receptor 1), TGFB3 (transforming growth factor beta 3), TGFB2 (transforming growth factor beta 2), MAPK8 (mitogen-activated protein kinase 8), CXCR4 (C-X-C motif chemokine receptor 4), NOTCH4 (notch receptor 4), DLL4 (delta like canonical Notch ligand 4), REL (REL proto-oncogene, NF-kB subunit), ACVRL1 (activin A receptor like type 1), CXCL12 (C-X-C motif chemokine ligand 12), KDR (kinase insert domain receptor), PDGFB (platelet derived growth factor subunit B), JAG1 (jagged canonical Notch ligand 1), FLT4 (fms related receptor tyrosine kinase 4), NFKB2 (nuclear factor kappa B subunit 2), KITLG (KIT ligand), NOTCH3 (notch receptor 3), MAPK9 (mitogen-activated protein kinase 9), RELB (RELB proto-oncogene, NF-kB subunit), EPHB2 (EPH receptor B2), EPHB4 (EPH receptor B4), KIT (KIT proto-oncogene, receptor tyrosine kinase)"], "WAG002872": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), WNT3A (Wnt family member 3A), WNT1 (Wnt family member 1), FZD1 (frizzled class receptor 1), WNT5A (Wnt family member 5A), FZD5 (frizzled class receptor 5), DVL1 (dishevelled segment polarity protein 1), LRP6 (LDL receptor related protein 6), FZD8 (frizzled class receptor 8), FZD2 (frizzled class receptor 2), FZD6 (frizzled class receptor 6), SFRP1 (secreted frizzled related protein 1), DVL3 (dishevelled segment polarity protein 3), FZD7 (frizzled class receptor 7), WNT7B (Wnt family member 7B), DVL2 (dishevelled segment polarity protein 2), FZD10 (frizzled class receptor 10), WNT2B (Wnt family member 2B), WNT3 (Wnt family member 3), WNT11 (Wnt family member 11), WNT10B (Wnt family member 10B), WNT7A (Wnt family member 7A), FZD9 (frizzled class receptor 9), SFRP2 (secreted frizzled related protein 2), WNT10A (Wnt family member 10A), WNT6 (Wnt family member 6), WNT5B (Wnt family member 5B), SFRP4 (secreted frizzled related protein 4), WNT2 (Wnt family member 2), SFRP5 (secreted frizzled related protein 5), AXIN1 (axin 1), MYC (MYC proto-oncogene, bHLH transcription factor), LRP5 (LDL receptor related protein 5), FZD3 (frizzled class receptor 3), GSK3B (glycogen synthase kinase 3 beta), WNT16 (Wnt family member 16), WNT4 (Wnt family member 4), TCF7L2 (transcription factor 7 like 2), APC (APC regulator of WNT signaling pathway), DKK1 (dickkopf WNT signaling pathway inhibitor 1), WIF1 (WNT inhibitory factor 1), LEF1 (lymphoid enhancer binding factor 1), CCND1 (cyclin D1), PORCN (porcupine O-acyltransferase), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CER1 (cerberus 1, DAN family BMP antagonist), FRAT1 (FRAT regulator of WNT signaling pathway 1), CSNK2A1 (casein kinase 2 alpha 1), CSNK1A1 (casein kinase 1 alpha 1), CTBP1 (C-terminal binding protein 1), TCF7 (transcription factor 7), FRAT2 (FRAT regulator of WNT signaling pathway 2), SOX17 (SRY-box transcription factor 17), DKK2 (dickkopf WNT signaling pathway inhibitor 2), CSNK2A2 (casein kinase 2 alpha 2), RYK (receptor like tyrosine kinase), CSNK1E (casein kinase 1 epsilon), DKK4 (dickkopf WNT signaling pathway inhibitor 4), CCND2 (cyclin D2), TCF7L1 (transcription factor 7 like 1), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), NKD1 (NKD inhibitor of WNT signaling pathway 1), CSNK2B (casein kinase 2 beta), ROR2 (receptor tyrosine kinase like orphan receptor 2), CCND3 (cyclin D3), CTBP2 (C-terminal binding protein 2), FOSL1 (FOS like 1, AP-1 transcription factor subunit), NLK (nemo like kinase), KLF4 (Kruppel like factor 4), CTNNBIP1 (catenin beta interacting protein 1), NKD2 (NKD inhibitor of WNT signaling pathway 2), SENP2 (SUMO specific peptidase 2), KREMEN1 (kringle containing transmembrane protein 1), SOST (sclerostin), PLAU (plasminogen activator, urokinase), ELAVL1 (ELAV like RNA binding protein 1), CSNK1A1L (casein kinase 1 alpha 1 like), MTDH (metadherin), ROR1 (receptor tyrosine kinase like orphan receptor 1), SERPINF1 (serpin family F member 1), CXXC4 (CXXC finger protein 4), CHD8 (chromodomain helicase DNA binding protein 8), SOX7 (SRY-box transcription factor 7), NOTUM (notum, palmitoleoyl-protein carboxylesterase), LOC101929777 (uncharacterized LOC101929777), MIR18A (microRNA 18a), DANCR (differentiation antagonizing non-protein coding RNA), CSNK2A3 (casein kinase 2 alpha 3), MIR320A (microRNA 320a), MIR214 (microRNA 214), MIR452 (microRNA 452)"], "WAG002873": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT3 (signal transducer and activator of transcription 3), JAK2 (Janus kinase 2), IL6ST (interleukin 6 signal transducer), IL6 (interleukin 6), JAK1 (Janus kinase 1), IL6R (interleukin 6 receptor), JAK3 (Janus kinase 3), IL11 (interleukin 11), IL11RA (interleukin 11 receptor subunit alpha), NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), ZEB1 (zinc finger E-box binding homeobox 1), MIR200B (microRNA 200b), UCA1 (urothelial cancer associated 1), MIR21 (microRNA 21), SOX4 (SRY-box transcription factor 4), MIR200C (microRNA 200c), MIR200A (microRNA 200a)"], "WAG002874": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), STAT1 (signal transducer and activator of transcription 1), JAK1 (Janus kinase 1), HRAS (HRas proto-oncogene, GTPase), PRKCD (protein kinase C delta), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK14 (mitogen-activated protein kinase 14), PRKCA (protein kinase C alpha), TNF (tumor necrosis factor), NFKB1 (nuclear factor kappa B subunit 1), PRKCZ (protein kinase C zeta), IL6 (interleukin 6), PLCB1 (phospholipase C beta 1), IFNG (interferon gamma), NRAS (NRAS proto-oncogene, GTPase), PLCG2 (phospholipase C gamma 2), CAMK2B (calcium/calmodulin dependent protein kinase II beta), SP1 (Sp1 transcription factor), PRKCB (protein kinase C beta), MAPK8 (mitogen-activated protein kinase 8), PLCB2 (phospholipase C beta 2), CD40 (CD40 molecule), PRKCE (protein kinase C epsilon), PLCB3 (phospholipase C beta 3), PLCB4 (phospholipase C beta 4), PRKCQ (protein kinase C theta), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), MAPK11 (mitogen-activated protein kinase 11), TNFRSF1A (TNF receptor superfamily member 1A), MAPK9 (mitogen-activated protein kinase 9), PRKCG (protein kinase C gamma), TLR4 (toll like receptor 4), ETS1 (ETS proto-oncogene 1, transcription factor), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), RXRA (retinoid X receptor alpha), PLCD1 (phospholipase C delta 1), VDR (vitamin D receptor), TYK2 (tyrosine kinase 2), PRKCH (protein kinase C eta), PLCE1 (phospholipase C epsilon 1), CCL2 (C-C motif chemokine ligand 2), MAPK7 (mitogen-activated protein kinase 7), CD40LG (CD40 ligand), KRAS (KRAS proto-oncogene, GTPase), IFNA2 (interferon alpha 2), RXRG (retinoid X receptor gamma), CAV1 (caveolin 1), MAPK12 (mitogen-activated protein kinase 12), MAPK13 (mitogen-activated protein kinase 13), STAT2 (signal transducer and activator of transcription 2), NFKB2 (nuclear factor kappa B subunit 2), ISG15 (ISG15 ubiquitin like modifier), RELB (RELB proto-oncogene, NF-kB subunit), TLR2 (toll like receptor 2), RSAD2 (radical S-adenosyl methionine domain containing 2), CAMP (cathelicidin antimicrobial peptide), RXRB (retinoid X receptor beta), OAS2 (2'-5'-oligoadenylate synthetase 2), TLR8 (toll like receptor 8), IFI44L (interferon induced protein 44 like), NOD2 (nucleotide binding oligomerization domain containing 2), CYP24A1 (cytochrome P450 family 24 subfamily A member 1), CYP27B1 (cytochrome P450 family 27 subfamily B member 1), SP3 (Sp3 transcription factor), DEFB4A (defensin beta 4A), MED1 (mediator complex subunit 1), CXCL8 (C-X-C motif chemokine ligand 8), IFI27L2 (interferon alpha inducible protein 27 like 2)"], "WAG002876": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COPS5 (COP9 signalosome subunit 5), CTNNB1 (catenin beta 1), RAC1 (Rac family small GTPase 1), PAFAH1B1 (platelet activating factor acetylhydrolase 1b regulatory subunit 1), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), RAB8A (RAB8A, member RAS oncogene family), DYNLL1 (dynein light chain LC8-type 1), COPS6 (COP9 signalosome subunit 6), EXOC7 (exocyst complex component 7), CEP290 (centrosomal protein 290), EXOC2 (exocyst complex component 2), APC (APC regulator of WNT signaling pathway), EXOC4 (exocyst complex component 4), EXOC8 (exocyst complex component 8), EXOC5 (exocyst complex component 5), MCM6 (minichromosome maintenance complex component 6), IQCB1 (IQ motif containing B1), HDAC1 (histone deacetylase 1), BBS7 (Bardet-Biedl syndrome 7), BBS2 (Bardet-Biedl syndrome 2), MCM7 (minichromosome maintenance complex component 7), SMC4 (structural maintenance of chromosomes 4), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), MCM5 (minichromosome maintenance complex component 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), MCM4 (minichromosome maintenance complex component 4), RB1 (RB transcriptional corepressor 1), MCM3 (minichromosome maintenance complex component 3), PSMC6 (proteasome 26S subunit, ATPase 6), COPS2 (COP9 signalosome subunit 2), PSMD13 (proteasome 26S subunit, non-ATPase 13), EXOC6 (exocyst complex component 6), COPS3 (COP9 signalosome subunit 3), EXOC6B (exocyst complex component 6B), CREBBP (CREB binding protein), IQGAP1 (IQ motif containing GTPase activating protein 1), BBS4 (Bardet-Biedl syndrome 4), MCM2 (minichromosome maintenance complex component 2), BBS5 (Bardet-Biedl syndrome 5), EXOC3 (exocyst complex component 3), BBS9 (Bardet-Biedl syndrome 9), NFKB1 (nuclear factor kappa B subunit 1), BBS1 (Bardet-Biedl syndrome 1), COPS8 (COP9 signalosome subunit 8), EXOC1 (exocyst complex component 1), RAB14 (RAB14, member RAS oncogene family), HDAC2 (histone deacetylase 2), MCM10 (minichromosome maintenance 10 replication initiation factor), DDX5 (DEAD-box helicase 5), COPS4 (COP9 signalosome subunit 4), PSMC4 (proteasome 26S subunit, ATPase 4), MSH2 (mutS homolog 2), COPS7A (COP9 signalosome subunit 7A), RANBP9 (RAN binding protein 9), TTC8 (tetratricopeptide repeat domain 8), VIM (vimentin), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), COPS7B (COP9 signalosome subunit 7B), NINL (ninein like), DYNLT3 (dynein light chain Tctex-type 3), DYNLT1 (dynein light chain Tctex-type 1), MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), IFT81 (intraflagellar transport 81), IFT20 (intraflagellar transport 20), TFAP2A (transcription factor AP-2 alpha), DYNLRB1 (dynein light chain roadblock-type 1), DCAF11 (DDB1 and CUL4 associated factor 11), MCM8 (minichromosome maintenance 8 homologous recombination repair factor), DYNLL2 (dynein light chain LC8-type 2), RMND5A (required for meiotic nuclear division 5 homolog A), SSNA1 (SS nuclear autoantigen 1), DYNLRB2 (dynein light chain roadblock-type 2), ARMC8 (armadillo repeat containing 8), IFT74 (intraflagellar transport 74), IFT52 (intraflagellar transport 52), IFT88 (intraflagellar transport 88), MKLN1 (muskelin 1), EXOSC9 (exosome component 9), IFT172 (intraflagellar transport 172), IFT27 (intraflagellar transport 27), BBIP1 (BBSome interacting protein 1), NUP133 (nucleoporin 133), TRAF3IP1 (TRAF3 interacting protein 1), WDR26 (WD repeat domain 26), RPGR (retinitis pigmentosa GTPase regulator), DVL3 (dishevelled segment polarity protein 3), EFTUD2 (elongation factor Tu GTP binding domain containing 2), NUDC (nuclear distribution C, dynein complex regulator), IQGAP2 (IQ motif containing GTPase activating protein 2), IFT140 (intraflagellar transport 140), SNRPB2 (small nuclear ribonucleoprotein polypeptide B2), NEFM (neurofilament medium), HSPB11 (heat shock protein family B (small) member 11), MKS1 (MKS transition zone complex subunit 1), TBC1D4 (TBC1 domain family member 4), EXOSC2 (exosome component 2), HTRA2 (HtrA serine peptidase 2), CNOT6L (CCR4-NOT transcription complex subunit 6 like)"], "WAG002877": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NFE2L2 (nuclear factor, erythroid 2 like 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), KEAP1 (kelch like ECH associated protein 1), PRKCA (protein kinase C alpha), FYN (FYN proto-oncogene, Src family tyrosine kinase), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), CUL3 (cullin 3), HMOX1 (heme oxygenase 1), NQO1 (NAD(P)H quinone dehydrogenase 1), EPHB2 (EPH receptor B2), PGAM5 (PGAM family member 5, mitochondrial serine/threonine protein phosphatase), GCLC (glutamate-cysteine ligase catalytic subunit), GSK3B (glycogen synthase kinase 3 beta), GCLM (glutamate-cysteine ligase modifier subunit), GSTA2 (glutathione S-transferase alpha 2), INSR (insulin receptor), MAPK8 (mitogen-activated protein kinase 8), RBX1 (ring-box 1), MAF (MAF bZIP transcription factor), CEBPB (CCAAT enhancer binding protein beta), SLC7A11 (solute carrier family 7 member 11), AIMP2 (aminoacyl tRNA synthetase complex interacting multifunctional protein 2)"], "WAG002878": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GPI (glucose-6-phosphate isomerase), PKM (pyruvate kinase M1/2), PKLR (pyruvate kinase L/R), ALDOA (aldolase, fructose-bisphosphate A), ALDOC (aldolase, fructose-bisphosphate C), ALDOB (aldolase, fructose-bisphosphate B), HK1 (hexokinase 1), TPI1 (triosephosphate isomerase 1), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), ENO1 (enolase 1), ENO3 (enolase 3), LDHB (lactate dehydrogenase B), HK2 (hexokinase 2), PGK1 (phosphoglycerate kinase 1), LDHA (lactate dehydrogenase A), PGAM2 (phosphoglycerate mutase 2), ENO2 (enolase 2), GCK (glucokinase), FBP1 (fructose-bisphosphatase 1), PGAM1 (phosphoglycerate mutase 1), MDH1 (malate dehydrogenase 1), HK3 (hexokinase 3), SLC2A4 (solute carrier family 2 member 4), LDHC (lactate dehydrogenase C), LDHAL6B (lactate dehydrogenase A like 6B), FBP2 (fructose-bisphosphatase 2), PGK2 (phosphoglycerate kinase 2), GOT1 (glutamic-oxaloacetic transaminase 1), PCK1 (phosphoenolpyruvate carboxykinase 1), SLC2A1 (solute carrier family 2 member 1), G6PC (glucose-6-phosphatase catalytic subunit), SLC2A2 (solute carrier family 2 member 2), SLC2A3 (solute carrier family 2 member 3), SLC2A5 (solute carrier family 2 member 5), PFKL (phosphofructokinase, liver type), MPC1 (mitochondrial pyruvate carrier 1), MPC2 (mitochondrial pyruvate carrier 2), PFKM (phosphofructokinase, muscle), PFKP (phosphofructokinase, platelet)"], "WAG002879": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), MAPK1 (mitogen-activated protein kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SHC1 (SHC adaptor protein 1), AKT1 (AKT serine/threonine kinase 1), EGF (epidermal growth factor), RAC1 (Rac family small GTPase 1), CBL (Cbl proto-oncogene), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), HRAS (HRas proto-oncogene, GTPase), PLCG1 (phospholipase C gamma 1), PRKCA (protein kinase C alpha), CRK (CRK proto-oncogene, adaptor protein), JAK2 (Janus kinase 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAPK14 (mitogen-activated protein kinase 14), ERBB2 (erb-b2 receptor tyrosine kinase 2), JAK1 (Janus kinase 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK8 (mitogen-activated protein kinase 8), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CDC42 (cell division cycle 42), NCK1 (NCK adaptor protein 1), STAT3 (signal transducer and activator of transcription 3), PRKCD (protein kinase C delta), SH3KBP1 (SH3 domain containing kinase binding protein 1), MAP2K1 (mitogen-activated protein kinase kinase 1), PTK2B (protein tyrosine kinase 2 beta), PTK2 (protein tyrosine kinase 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), GAB2 (GRB2 associated binding protein 2), VAV1 (vav guanine nucleotide exchange factor 1), RASA1 (RAS p21 protein activator 1), CRKL (CRK like proto-oncogene, adaptor protein), PRKCZ (protein kinase C zeta), PTEN (phosphatase and tensin homolog), PRKCB (protein kinase C beta), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), EPS15 (epidermal growth factor receptor pathway substrate 15), CBLB (Cbl proto-oncogene B), VAV2 (vav guanine nucleotide exchange factor 2), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), BCAR1 (BCAR1 scaffold protein, Cas family member), PAK1 (p21 (RAC1) activated kinase 1), ABI1 (abl interactor 1), CSK (C-terminal Src kinase), STAT1 (signal transducer and activator of transcription 1), MTOR (mechanistic target of rapamycin kinase), INPP5D (inositol polyphosphate-5-phosphatase D), MAPK9 (mitogen-activated protein kinase 9), KRAS (KRAS proto-oncogene, GTPase), GAB1 (GRB2 associated binding protein 1), HGS (hepatocyte growth factor-regulated tyrosine kinase substrate), CAV1 (caveolin 1), SH3GL2 (SH3 domain containing GRB2 like 2, endophilin A1), AP2M1 (adaptor related protein complex 2 subunit mu 1), RPS6KB1 (ribosomal protein S6 kinase B1), SPRY2 (sprouty RTK signaling antagonist 2), AP2A1 (adaptor related protein complex 2 subunit alpha 1), RPS6KA1 (ribosomal protein S6 kinase A1), CREB1 (cAMP responsive element binding protein 1), AP2B1 (adaptor related protein complex 2 subunit beta 1), MAPK7 (mitogen-activated protein kinase 7), SP1 (Sp1 transcription factor), STAT5A (signal transducer and activator of transcription 5A), STAT5B (signal transducer and activator of transcription 5B), STAM2 (signal transducing adaptor molecule 2), RPS6KA2 (ribosomal protein S6 kinase A2), PDPK1 (3-phosphoinositide dependent protein kinase 1), STAM (signal transducing adaptor molecule), AP2S1 (adaptor related protein complex 2 subunit sigma 1), DNM1 (dynamin 1), NEDD4 (NEDD4 E3 ubiquitin protein ligase), PLD2 (phospholipase D2), RPS6KA3 (ribosomal protein S6 kinase A3), ARHGEF1 (Rho guanine nucleotide exchange factor 1), NCK2 (NCK adaptor protein 2), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), IQGAP1 (IQ motif containing GTPase activating protein 1), PTPN12 (protein tyrosine phosphatase non-receptor type 12), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), ROCK1 (Rho associated coiled-coil containing protein kinase 1), INPPL1 (inositol polyphosphate phosphatase like 1), GRB10 (growth factor receptor bound protein 10), SYNJ1 (synaptojanin 1), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), MAP2K2 (mitogen-activated protein kinase kinase 2), VAV3 (vav guanine nucleotide exchange factor 3), ASAP1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 1), EPN1 (epsin 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), ARF6 (ADP ribosylation factor 6), RALBP1 (ralA binding protein 1), RPS6KA5 (ribosomal protein S6 kinase A5), RAP1A (RAP1A, member of RAS oncogene family), GJA1 (gap junction protein alpha 1), PRKCI (protein kinase C iota)"], "WAG002882": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII), UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X), UQCRC2 (ubiquinol-cytochrome c reductase core protein 2), UQCR11 (ubiquinol-cytochrome c reductase, complex III subunit XI), UQCRH (ubiquinol-cytochrome c reductase hinge protein), CYC1 (cytochrome c1), UQCRC1 (ubiquinol-cytochrome c reductase core protein 1), UQCRB (ubiquinol-cytochrome c reductase binding protein), UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1), NDUFS3 (NADH:ubiquinone oxidoreductase core subunit S3), NDUFA2 (NADH:ubiquinone oxidoreductase subunit A2), NDUFA6 (NADH:ubiquinone oxidoreductase subunit A6), NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5), NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9), NDUFA1 (NADH:ubiquinone oxidoreductase subunit A1), NDUFA8 (NADH:ubiquinone oxidoreductase subunit A8), NDUFS6 (NADH:ubiquinone oxidoreductase subunit S6), NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8), NDUFS8 (NADH:ubiquinone oxidoreductase core subunit S8), NDUFA4 (NDUFA4 mitochondrial complex associated), NDUFAB1 (NADH:ubiquinone oxidoreductase subunit AB1), NDUFB7 (NADH:ubiquinone oxidoreductase subunit B7), NDUFA7 (NADH:ubiquinone oxidoreductase subunit A7), NDUFA9 (NADH:ubiquinone oxidoreductase subunit A9), NDUFA5 (NADH:ubiquinone oxidoreductase subunit A5), NDUFS5 (NADH:ubiquinone oxidoreductase subunit S5), NDUFS4 (NADH:ubiquinone oxidoreductase subunit S4), NDUFB2 (NADH:ubiquinone oxidoreductase subunit B2), NDUFS1 (NADH:ubiquinone oxidoreductase core subunit S1), NDUFC2 (NADH:ubiquinone oxidoreductase subunit C2), NDUFB10 (NADH:ubiquinone oxidoreductase subunit B10), NDUFA12 (NADH:ubiquinone oxidoreductase subunit A12), NDUFV1 (NADH:ubiquinone oxidoreductase core subunit V1), NDUFB4 (NADH:ubiquinone oxidoreductase subunit B4), NDUFB6 (NADH:ubiquinone oxidoreductase subunit B6), NDUFB11 (NADH:ubiquinone oxidoreductase subunit B11), NDUFB3 (NADH:ubiquinone oxidoreductase subunit B3), NDUFS7 (NADH:ubiquinone oxidoreductase core subunit S7), NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10), NDUFA3 (NADH:ubiquinone oxidoreductase subunit A3), NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2), NDUFA11 (NADH:ubiquinone oxidoreductase subunit A11), NDUFV2 (NADH:ubiquinone oxidoreductase core subunit V2), NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13), NDUFB1 (NADH:ubiquinone oxidoreductase subunit B1), NDUFV3 (NADH:ubiquinone oxidoreductase subunit V3), NDUFC1 (NADH:ubiquinone oxidoreductase subunit C1), COX5A (cytochrome c oxidase subunit 5A), COX5B (cytochrome c oxidase subunit 5B), AKT1 (AKT serine/threonine kinase 1), COX6B1 (cytochrome c oxidase subunit 6B1), TNF (tumor necrosis factor), COX7A2 (cytochrome c oxidase subunit 7A2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), COX6C (cytochrome c oxidase subunit 6C), COX7B (cytochrome c oxidase subunit 7B), COX7C (cytochrome c oxidase subunit 7C), COX4I1 (cytochrome c oxidase subunit 4I1), MAPK8 (mitogen-activated protein kinase 8), RELA (RELA proto-oncogene, NF-kB subunit), CYCS (cytochrome c, somatic), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), CASP3 (caspase 3), SDHB (succinate dehydrogenase complex iron sulfur subunit B), COX6A1 (cytochrome c oxidase subunit 6A1), GSK3B (glycogen synthase kinase 3 beta), IL6 (interleukin 6), RAC1 (Rac family small GTPase 1), NFKB1 (nuclear factor kappa B subunit 1), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), IRS1 (insulin receptor substrate 1), LEP (leptin), FASLG (Fas ligand), BAX (BCL2 associated X, apoptosis regulator), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), SDHC (succinate dehydrogenase complex subunit C), VCAM1 (vascular cell adhesion molecule 1), TNFRSF1A (TNF receptor superfamily member 1A), TGFB1 (transforming growth factor beta 1), AKT2 (AKT serine/threonine kinase 2), CASP8 (caspase 8), COX8A (cytochrome c oxidase subunit 8A), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), SDHD (succinate dehydrogenase complex subunit D), IL1B (interleukin 1 beta), IRS2 (insulin receptor substrate 2), COX7A2L (cytochrome c oxidase subunit 7A2 like), TRAF2 (TNF receptor associated factor 2), CDC42 (cell division cycle 42), AKT3 (AKT serine/threonine kinase 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), COX6A2 (cytochrome c oxidase subunit 6A2), PPARA (peroxisome proliferator activated receptor alpha), BID (BH3 interacting domain death agonist), INSR (insulin receptor), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), RXRA (retinoid X receptor alpha), SOCS3 (suppressor of cytokine signaling 3)"], "WAG002888": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "E2F6 (E2F transcription factor 6), RNF2 (ring finger protein 2), RBBP4 (RB binding protein 4, chromatin remodeling factor), PCGF6 (polycomb group ring finger 6), RING1 (ring finger protein 1), EED (embryonic ectoderm development), BMI1 (BMI1 proto-oncogene, polycomb ring finger), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), RBBP7 (RB binding protein 7, chromatin remodeling factor), SUZ12 (SUZ12 polycomb repressive complex 2 subunit), TFDP1 (transcription factor Dp-1), PCGF2 (polycomb group ring finger 2), CBX3 (chromobox 3), PHC1 (polyhomeotic homolog 1), BRCA1 (BRCA1 DNA repair associated), PHC3 (polyhomeotic homolog 3), TFDP2 (transcription factor Dp-2), E2F1 (E2F transcription factor 1), YAF2 (YY1 associated factor 2), CBX5 (chromobox 5), MAX (MYC associated factor X), EHMT1 (euchromatic histone lysine methyltransferase 1), MGA (MAX dimerization protein MGA), RRM2 (ribonucleotide reductase regulatory subunit M2), EHMT2 (euchromatic histone lysine methyltransferase 2), L3MBTL2 (L3MBTL histone methyl-lysine binding protein 2), RAD51 (RAD51 recombinase), RBBP8 (RB binding protein 8, endonuclease), CHEK1 (checkpoint kinase 1), EPC1 (enhancer of polycomb homolog 1), UXT (ubiquitously expressed prefoldin like chaperone), CDC7 (cell division cycle 7), APAF1 (apoptotic peptidase activating factor 1)"], "WAG002889": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA3 (proteasome 20S subunit alpha 3), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMB10 (proteasome 20S subunit beta 10), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMA2 (proteasome 20S subunit alpha 2), PSMA7 (proteasome 20S subunit alpha 7), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMB2 (proteasome 20S subunit beta 2), PSMB4 (proteasome 20S subunit beta 4), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMA4 (proteasome 20S subunit alpha 4), PSMA1 (proteasome 20S subunit alpha 1), PSMC3 (proteasome 26S subunit, ATPase 3), PSMB1 (proteasome 20S subunit beta 1), PSMA6 (proteasome 20S subunit alpha 6), PSMB3 (proteasome 20S subunit beta 3), PSMB6 (proteasome 20S subunit beta 6), PSMB5 (proteasome 20S subunit beta 5), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMA5 (proteasome 20S subunit alpha 5), PSMB7 (proteasome 20S subunit beta 7), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC6 (proteasome 26S subunit, ATPase 6), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME4 (proteasome activator subunit 4), PSMF1 (proteasome inhibitor subunit 1), UBB (ubiquitin B), PSMA8 (proteasome 20S subunit alpha 8), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PSME3 (proteasome activator subunit 3), CUL1 (cullin 1), PSMB11 (proteasome subunit beta 11), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), SKP1 (S-phase kinase associated protein 1), RBX1 (ring-box 1), SKP2 (S-phase kinase associated protein 2), PSMB9 (proteasome 20S subunit beta 9), PSMB8 (proteasome 20S subunit beta 8), PSME2 (proteasome activator subunit 2), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), ESR1 (estrogen receptor 1), STUB1 (STIP1 homology and U-box containing protein 1), RUNX2 (RUNX family transcription factor 2), RPS27A (ribosomal protein S27a), NR3C1 (nuclear receptor subfamily 3 group C member 1), PPARGC1A (PPARG coactivator 1 alpha), WWP1 (WW domain containing E3 ubiquitin protein ligase 1), MSX2 (msh homeobox 2), STAT1 (signal transducer and activator of transcription 1), ESRRA (estrogen related receptor alpha), BMP2 (bone morphogenetic protein 2), GSK3B (glycogen synthase kinase 3 beta), HIVEP3 (HIVEP zinc finger 3), DLX5 (distal-less homeobox 5), TWIST1 (twist family bHLH transcription factor 1), CBFB (core-binding factor subunit beta), PPARGC1B (PPARG coactivator 1 beta), DLX6 (distal-less homeobox 6), NKX3-2 (NK3 homeobox 2), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002890": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD4 (SMAD family member 4), AKT1 (AKT serine/threonine kinase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), CCND1 (cyclin D1), AR (androgen receptor), MAPK1 (mitogen-activated protein kinase 1), HDAC3 (histone deacetylase 3), RB1 (RB transcriptional corepressor 1), RUNX1 (RUNX family transcription factor 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), SMAD1 (SMAD family member 1), BMP2 (bone morphogenetic protein 2), CDK1 (cyclin dependent kinase 1), YAP1 (Yes1 associated transcriptional regulator), CDK4 (cyclin dependent kinase 4), MAPK3 (mitogen-activated protein kinase 3), HDAC4 (histone deacetylase 4), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), BAX (BCL2 associated X, apoptosis regulator), CCNB1 (cyclin B1), GLI3 (GLI family zinc finger 3), HDAC6 (histone deacetylase 6), SMAD6 (SMAD family member 6), TWIST1 (twist family bHLH transcription factor 1), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), SOX9 (SRY-box transcription factor 9), SP7 (Sp7 transcription factor), HES1 (hes family bHLH transcription factor 1), HAND2 (heart and neural crest derivatives expressed 2), AKT3 (AKT serine/threonine kinase 3), HEY2 (hes related family bHLH transcription factor with YRPW motif 2), BGLAP (bone gamma-carboxyglutamate protein), AKT2 (AKT serine/threonine kinase 2), IHH (Indian hedgehog signaling molecule), GLI2 (GLI family zinc finger 2), WWTR1 (WW domain containing transcription regulator 1), COL1A1 (collagen type I alpha 1 chain), ZNF521 (zinc finger protein 521), CBFB (core-binding factor subunit beta), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), MMP13 (matrix metallopeptidase 13), MAF (MAF bZIP transcription factor), TWIST2 (twist family bHLH transcription factor 2), RBM14 (RNA binding motif protein 14), ITGA5 (integrin subunit alpha 5), SATB2 (SATB homeobox 2), LGALS3 (galectin 3), PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D), UCMA (upper zone of growth plate and cartilage matrix associated), ITGBL1 (integrin subunit beta like 1), LOC100506403 (uncharacterized LOC100506403)"], "WAG002894": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALDH1A1 (aldehyde dehydrogenase 1 family member A1), ALDH1A2 (aldehyde dehydrogenase 1 family member A2), CYP26A1 (cytochrome P450 family 26 subfamily A member 1), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), DLAT (dihydrolipoamide S-acetyltransferase), PDHB (pyruvate dehydrogenase E1 subunit beta), DLD (dihydrolipoamide dehydrogenase), PDHX (pyruvate dehydrogenase complex component X), RARB (retinoic acid receptor beta), RARA (retinoic acid receptor alpha), PDK2 (pyruvate dehydrogenase kinase 2), PDK4 (pyruvate dehydrogenase kinase 4), PPARD (peroxisome proliferator activated receptor delta), RXRA (retinoid X receptor alpha), PDK3 (pyruvate dehydrogenase kinase 3), RARG (retinoic acid receptor gamma), RXRG (retinoid X receptor gamma), ADH1C (alcohol dehydrogenase 1C (class I), gamma polypeptide), RXRB (retinoid X receptor beta), ADH1A (alcohol dehydrogenase 1A (class I), alpha polypeptide), ALDH1A3 (aldehyde dehydrogenase 1 family member A3), CPT1A (carnitine palmitoyltransferase 1A), PDHA2 (pyruvate dehydrogenase E1 subunit alpha 2), PDK1 (pyruvate dehydrogenase kinase 1), RDH16 (retinol dehydrogenase 16), DHRS4 (dehydrogenase/reductase 4), ADH4 (alcohol dehydrogenase 4 (class II), pi polypeptide), CRABP2 (cellular retinoic acid binding protein 2), DHRS9 (dehydrogenase/reductase 9), CPT1B (carnitine palmitoyltransferase 1B), RDH10 (retinol dehydrogenase 10), DHRS3 (dehydrogenase/reductase 3), RDH11 (retinol dehydrogenase 11), CYP26B1 (cytochrome P450 family 26 subfamily B member 1), SDR16C5 (short chain dehydrogenase/reductase family 16C member 5), RDH5 (retinol dehydrogenase 5), CRABP1 (cellular retinoic acid binding protein 1), CYP26C1 (cytochrome P450 family 26 subfamily C member 1), RDH14 (retinol dehydrogenase 14), AKR1C3 (aldo-keto reductase family 1 member C3), RDH13 (retinol dehydrogenase 13), ALDH8A1 (aldehyde dehydrogenase 8 family member A1), DHRS4L1 (dehydrogenase/reductase 4 like 1), FABP5 (fatty acid binding protein 5)"], "WAG002895": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNAI2 (G protein subunit alpha i2), GNG2 (G protein subunit gamma 2), GNAI1 (G protein subunit alpha i1), ADCY7 (adenylate cyclase 7), ADCY2 (adenylate cyclase 2), ADCY1 (adenylate cyclase 1), ADCY5 (adenylate cyclase 5), GNAI3 (G protein subunit alpha i3), ADCY9 (adenylate cyclase 9), ADCY4 (adenylate cyclase 4), ADCY8 (adenylate cyclase 8), ADCY6 (adenylate cyclase 6), GNB1 (G protein subunit beta 1), GNG3 (G protein subunit gamma 3), GNAS (GNAS complex locus), GNG13 (G protein subunit gamma 13), GNG4 (G protein subunit gamma 4), GNB3 (G protein subunit beta 3), GNG7 (G protein subunit gamma 7), GNG8 (G protein subunit gamma 8), GNB2 (G protein subunit beta 2), ADCY3 (adenylate cyclase 3), GNG12 (G protein subunit gamma 12), GNB4 (G protein subunit beta 4), GNGT2 (G protein subunit gamma transducin 2), GNGT1 (G protein subunit gamma transducin 1), GNG11 (G protein subunit gamma 11), GNG5 (G protein subunit gamma 5), GNB5 (G protein subunit beta 5), ADRA2A (adrenoceptor alpha 2A), GNG10 (G protein subunit gamma 10), ADRA2C (adrenoceptor alpha 2C), ADRA2B (adrenoceptor alpha 2B), PRKCE (protein kinase C epsilon), RGS19 (regulator of G protein signaling 19), RGS20 (regulator of G protein signaling 20), RGS4 (regulator of G protein signaling 4), GNAT3 (G protein subunit alpha transducin 3), RGS16 (regulator of G protein signaling 16), RGS17 (regulator of G protein signaling 17), PRKCD (protein kinase C delta), PRKCH (protein kinase C eta), PRKCQ (protein kinase C theta), RGSL1 (regulator of G protein signaling like 1)"], "WAG002896": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNAI2 (G protein subunit alpha i2), GNG2 (G protein subunit gamma 2), CCR5 (C-C motif chemokine receptor 5), CCR3 (C-C motif chemokine receptor 3), CHRM2 (cholinergic receptor muscarinic 2), ADCY2 (adenylate cyclase 2), CCR1 (C-C motif chemokine receptor 1), CXCL10 (C-X-C motif chemokine ligand 10), CCR6 (C-C motif chemokine receptor 6), CXCR2 (C-X-C motif chemokine receptor 2), CXCL9 (C-X-C motif chemokine ligand 9), CXCL11 (C-X-C motif chemokine ligand 11), CHRM4 (cholinergic receptor muscarinic 4), CCR7 (C-C motif chemokine receptor 7), CCL5 (C-C motif chemokine ligand 5), CCR8 (C-C motif chemokine receptor 8), CXCR1 (C-X-C motif chemokine receptor 1), CXCL13 (C-X-C motif chemokine ligand 13), CXCR5 (C-X-C motif chemokine receptor 5), CXCR6 (C-X-C motif chemokine receptor 6), CXCL5 (C-X-C motif chemokine ligand 5), CXCL2 (C-X-C motif chemokine ligand 2), CXCL1 (C-X-C motif chemokine ligand 1), CXCL16 (C-X-C motif chemokine ligand 16), PPBP (pro-platelet basic protein), CCL20 (C-C motif chemokine ligand 20), CXCL3 (C-X-C motif chemokine ligand 3), CCL19 (C-C motif chemokine ligand 19), ADCY5 (adenylate cyclase 5), ADCY1 (adenylate cyclase 1), ADCY8 (adenylate cyclase 8), CXCL6 (C-X-C motif chemokine ligand 6), ADCY7 (adenylate cyclase 7), CCL21 (C-C motif chemokine ligand 21), CCL16 (C-C motif chemokine ligand 16), ADCY4 (adenylate cyclase 4), CCL25 (C-C motif chemokine ligand 25), APP (amyloid beta precursor protein), ADCY9 (adenylate cyclase 9), ADCY6 (adenylate cyclase 6), CCL28 (C-C motif chemokine ligand 28), FPR1 (formyl peptide receptor 1), OPRM1 (opioid receptor mu 1), POMC (proopiomelanocortin), MTNR1B (melatonin receptor 1B), KNG1 (kininogen 1), AGTR2 (angiotensin II receptor type 2), S1PR4 (sphingosine-1-phosphate receptor 4), MTNR1A (melatonin receptor 1A), NPY (neuropeptide Y), S1PR3 (sphingosine-1-phosphate receptor 3), SSTR2 (somatostatin receptor 2), LPAR1 (lysophosphatidic acid receptor 1), OPRD1 (opioid receptor delta 1), C5AR1 (complement C5a receptor 1), S1PR2 (sphingosine-1-phosphate receptor 2), LPAR3 (lysophosphatidic acid receptor 3), FPR2 (formyl peptide receptor 2), SSTR3 (somatostatin receptor 3), ADRA2A (adrenoceptor alpha 2A), NPY2R (neuropeptide Y receptor Y2), LPAR2 (lysophosphatidic acid receptor 2), RXFP4 (relaxin family peptide/INSL5 receptor 4), S1PR5 (sphingosine-1-phosphate receptor 5), BDKRB1 (bradykinin receptor B1), BDKRB2 (bradykinin receptor B2), ANXA1 (annexin A1), OPRL1 (opioid related nociceptin receptor 1), DRD4 (dopamine receptor D4), ADORA1 (adenosine A1 receptor), GAL (galanin and GMAP prepropeptide), RXFP3 (relaxin family peptide receptor 3), SSTR5 (somatostatin receptor 5), ADRA2C (adrenoceptor alpha 2C), C3AR1 (complement C3a receptor 1), C5 (complement C5), GPR18 (G protein-coupled receptor 18), NMU (neuromedin U), P2RY14 (purinergic receptor P2Y14), NPY1R (neuropeptide Y receptor Y1), SSTR4 (somatostatin receptor 4), GPR55 (G protein-coupled receptor 55), APLN (apelin), OPRK1 (opioid receptor kappa 1), HRH4 (histamine receptor H4), PYY (peptide YY), PPY (pancreatic polypeptide), PENK (proenkephalin), PNOC (prepronociceptin), HTR1E (5-hydroxytryptamine receptor 1E), SSTR1 (somatostatin receptor 1), FPR3 (formyl peptide receptor 3), ADORA3 (adenosine A3 receptor), C3 (complement C3), NPBWR1 (neuropeptides B and W receptor 1), NPY5R (neuropeptide Y receptor Y5), GALR3 (galanin receptor 3), NPW (neuropeptide W), PTGDR2 (prostaglandin D2 receptor 2), HTR5A (5-hydroxytryptamine receptor 5A)"], "WAG002898": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RHOA (ras homolog family member A), GNA13 (G protein subunit alpha 13), ARHGEF1 (Rho guanine nucleotide exchange factor 1), GNB1 (G protein subunit beta 1), RHOB (ras homolog family member B), GNG2 (G protein subunit gamma 2), ROCK2 (Rho associated coiled-coil containing protein kinase 2), GNGT1 (G protein subunit gamma transducin 1), GNA12 (G protein subunit alpha 12), PREX1 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1), GNG12 (G protein subunit gamma 12), GNG3 (G protein subunit gamma 3), GNG4 (G protein subunit gamma 4), GNB2 (G protein subunit beta 2), GNG13 (G protein subunit gamma 13), GNG7 (G protein subunit gamma 7), GNB4 (G protein subunit beta 4), GNGT2 (G protein subunit gamma transducin 2), GNG8 (G protein subunit gamma 8), GNB3 (G protein subunit beta 3), GNB5 (G protein subunit beta 5), GNG5 (G protein subunit gamma 5), VAV1 (vav guanine nucleotide exchange factor 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), GNG11 (G protein subunit gamma 11), ARHGEF12 (Rho guanine nucleotide exchange factor 12), ARHGEF11 (Rho guanine nucleotide exchange factor 11), VAV2 (vav guanine nucleotide exchange factor 2), MCF2 (MCF.2 cell line derived transforming sequence), ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2), TBXA2R (thromboxane A2 receptor), TIAM1 (TIAM Rac1 associated GEF 1), GNG10 (G protein subunit gamma 10), BTK (Bruton tyrosine kinase), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), ADRA1B (adrenoceptor alpha 1B), PLEKHG2 (pleckstrin homology and RhoGEF domain containing G2), ADRA1D (adrenoceptor alpha 1D), ARHGEF18 (Rho/Rac guanine nucleotide exchange factor 18), ECT2 (epithelial cell transforming 2), FGD1 (FYVE, RhoGEF and PH domain containing 1), MCF2L (MCF.2 cell line derived transforming sequence like), ARHGEF7 (Rho guanine nucleotide exchange factor 7), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), VAV3 (vav guanine nucleotide exchange factor 3), TRIO (trio Rho guanine nucleotide exchange factor), AKAP13 (A-kinase anchoring protein 13), ARHGEF17 (Rho guanine nucleotide exchange factor 17), ADRA1A (adrenoceptor alpha 1A), ARHGEF9 (Cdc42 guanine nucleotide exchange factor 9), RASGRF2 (Ras protein specific guanine nucleotide releasing factor 2), PLEKHG5 (pleckstrin homology and RhoGEF domain containing G5), NET1 (neuroepithelial cell transforming 1), PLXNB1 (plexin B1), ITSN1 (intersectin 1), ROCK1 (Rho associated coiled-coil containing protein kinase 1), ARHGEF5 (Rho guanine nucleotide exchange factor 5), ARHGEF4 (Rho guanine nucleotide exchange factor 4), ARHGEF3 (Rho guanine nucleotide exchange factor 3), NGEF (neuronal guanine nucleotide exchange factor), RHOC (ras homolog family member C), ABR (ABR activator of RhoGEF and GTPase), ARHGEF10 (Rho guanine nucleotide exchange factor 10), KALRN (kalirin RhoGEF kinase), ARHGEF19 (Rho guanine nucleotide exchange factor 19), FGD3 (FYVE, RhoGEF and PH domain containing 3), ARHGEF15 (Rho guanine nucleotide exchange factor 15), ARHGEF10L (Rho guanine nucleotide exchange factor 10 like), OBSCN (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF), FGD2 (FYVE, RhoGEF and PH domain containing 2), ARHGEF40 (Rho guanine nucleotide exchange factor 40), ARHGEF16 (Rho guanine nucleotide exchange factor 16), ARHGEF37 (Rho guanine nucleotide exchange factor 37), TIAM2 (TIAM Rac1 associated GEF 2), ARHGEF39 (Rho guanine nucleotide exchange factor 39), LOC100505585 (uncharacterized LOC100505585), ARHGEF26 (Rho guanine nucleotide exchange factor 26), FGD4 (FYVE, RhoGEF and PH domain containing 4), ARHGEF35 (Rho guanine nucleotide exchange factor 35), ARHGEF38 (Rho guanine nucleotide exchange factor 38), ARHGEF33 (Rho guanine nucleotide exchange factor 33)"], "WAG002900": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), GNB1 (G protein subunit beta 1), GNG2 (G protein subunit gamma 2), PLCB2 (phospholipase C beta 2), PLCB1 (phospholipase C beta 1), PLCB3 (phospholipase C beta 3), GNG4 (G protein subunit gamma 4), GNG3 (G protein subunit gamma 3), GNG13 (G protein subunit gamma 13), GNGT1 (G protein subunit gamma transducin 1), GNB2 (G protein subunit beta 2), GNG12 (G protein subunit gamma 12), GNB4 (G protein subunit beta 4), GNG7 (G protein subunit gamma 7), GNG8 (G protein subunit gamma 8), GNGT2 (G protein subunit gamma transducin 2), GNB3 (G protein subunit beta 3), GNG5 (G protein subunit gamma 5), GNB5 (G protein subunit beta 5), GNG11 (G protein subunit gamma 11), GNG10 (G protein subunit gamma 10), AKT1 (AKT serine/threonine kinase 1), PAK1 (p21 (RAC1) activated kinase 1), CDC42 (cell division cycle 42), PDPK1 (3-phosphoinositide dependent protein kinase 1), AKT2 (AKT serine/threonine kinase 2), AKT3 (AKT serine/threonine kinase 3), RHOA (ras homolog family member A), BTK (Bruton tyrosine kinase), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), PIK3R6 (phosphoinositide-3-kinase regulatory subunit 6)"], "WAG002902": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STX5 (syntaxin 5), SEC24B (SEC24 homolog B, COPII coat complex component), SEC23A (Sec23 homolog A, COPII coat complex component), BET1 (Bet1 golgi vesicular membrane trafficking protein), USO1 (USO1 vesicle transport factor), TRAPPC3 (trafficking protein particle complex 3), SEC31A (SEC31 homolog A, COPII coat complex component), TMED2 (transmembrane p24 trafficking protein 2), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), RAB1A (RAB1A, member RAS oncogene family), SAR1B (secretion associated Ras related GTPase 1B), YKT6 (YKT6 v-SNARE homolog), SEC24C (SEC24 homolog C, COPII coat complex component), SCFD1 (sec1 family domain containing 1), LMAN1 (lectin, mannose binding 1), SEC24D (SEC24 homolog D, COPII coat complex component), SEC24A (SEC24 homolog A, COPII coat complex component), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), GOSR2 (golgi SNAP receptor complex member 2), TRAPPC2 (trafficking protein particle complex 2), TRAPPC4 (trafficking protein particle complex 4), SEC22B (SEC22 homolog B, vesicle trafficking protein), TRAPPC10 (trafficking protein particle complex 10), TRAPPC6A (trafficking protein particle complex 6A), TMED10 (transmembrane p24 trafficking protein 10), TRAPPC5 (trafficking protein particle complex 5), TRAPPC9 (trafficking protein particle complex 9), NAPA (NSF attachment protein alpha), TRAPPC6B (trafficking protein particle complex 6B), GOLGA2 (golgin A2), SEC16A (SEC16 homolog A, endoplasmic reticulum export factor), PREB (prolactin regulatory element binding), TRAPPC1 (trafficking protein particle complex 1), NAPB (NSF attachment protein beta), SEC22A (SEC22 homolog A, vesicle trafficking protein), GORASP1 (golgi reassembly stacking protein 1), SEC16B (SEC16 homolog B, endoplasmic reticulum export factor), NAPG (NSF attachment protein gamma), TRAPPC2L (trafficking protein particle complex 2 like), F8 (coagulation factor VIII), RAB1B (RAB1B, member RAS oncogene family), SEC22C (SEC22 homolog C, vesicle trafficking protein), ANKRD28 (ankyrin repeat domain 28), MCFD2 (multiple coagulation factor deficiency 2, ER cargo receptor complex subunit), STX17 (syntaxin 17), F5 (coagulation factor V), PPP6R3 (protein phosphatase 6 regulatory subunit 3), PPP6R1 (protein phosphatase 6 regulatory subunit 1), PPP6C (protein phosphatase 6 catalytic subunit), LMAN2 (lectin, mannose binding 2), LMAN2L (lectin, mannose binding 2 like), SERPINA1 (serpin family A member 1), LMAN1L (lectin, mannose binding 1 like), TGFA (transforming growth factor alpha), CNIH2 (cornichon family AMPA receptor auxiliary protein 2), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), TFG (trafficking from ER to golgi regulator), CNIH3 (cornichon family AMPA receptor auxiliary protein 3), CD59 (CD59 molecule (CD59 blood group)), TBC1D20 (TBC1 domain family member 20), COL7A1 (collagen type VII alpha 1 chain), SEC23IP (SEC23 interacting protein), CTSC (cathepsin C), CTSZ (cathepsin Z), CSNK1D (casein kinase 1 delta), CNIH1 (cornichon family AMPA receptor auxiliary protein 1), TRAPPC2B (trafficking protein particle complex 2B), FOLR1 (folate receptor alpha), AREG (amphiregulin)"], "WAG002903": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FN1 (fibronectin 1), ITGA2B (integrin subunit alpha 2b), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), ITGB3 (integrin subunit beta 3), PTK2 (protein tyrosine kinase 2), APBB1IP (amyloid beta precursor protein binding family B member 1 interacting protein), AKT1 (AKT serine/threonine kinase 1), TLN1 (talin 1), SHC1 (SHC adaptor protein 1), PTPN1 (protein tyrosine phosphatase non-receptor type 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CSK (C-terminal Src kinase), BCAR1 (BCAR1 scaffold protein, Cas family member), SYK (spleen associated tyrosine kinase), CRK (CRK proto-oncogene, adaptor protein), RAP1B (RAP1B, member of RAS oncogene family), RAP1A (RAP1A, member of RAS oncogene family), FGA (fibrinogen alpha chain), FGB (fibrinogen beta chain), FGG (fibrinogen gamma chain), PDPK1 (3-phosphoinositide dependent protein kinase 1), RAPGEF4 (Rap guanine nucleotide exchange factor 4), RASGRP1 (RAS guanyl releasing protein 1), VWF (von Willebrand factor), RAPGEF3 (Rap guanine nucleotide exchange factor 3), RASGRP2 (RAS guanyl releasing protein 2)"], "WAG002904": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ESR1 (estrogen receptor 1), EP300 (E1A binding protein p300), MYC (MYC proto-oncogene, bHLH transcription factor), TBP (TATA-box binding protein), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CREBBP (CREB binding protein), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), POLR2B (RNA polymerase II subunit B), MAPK1 (mitogen-activated protein kinase 1), CDK9 (cyclin dependent kinase 9), HSP90AA1 (heat shock protein 90 alpha family class A member 1), SP1 (Sp1 transcription factor), CCND1 (cyclin D1), GTF2F1 (general transcription factor IIF subunit 1), NCOA3 (nuclear receptor coactivator 3), POLR2E (RNA polymerase II, I and III subunit E), GTF2F2 (general transcription factor IIF subunit 2), HDAC1 (histone deacetylase 1), POLR2D (RNA polymerase II subunit D), POLR2J (RNA polymerase II subunit J), POLR2C (RNA polymerase II subunit C), POLR2G (RNA polymerase II subunit G), NCOA1 (nuclear receptor coactivator 1), POLR2I (RNA polymerase II subunit I), POLR2F (RNA polymerase II, I and III subunit F), POLR2L (RNA polymerase II, I and III subunit L), POLR2H (RNA polymerase II, I and III subunit H), CCNT1 (cyclin T1), ESR2 (estrogen receptor 2), SMC1A (structural maintenance of chromosomes 1A), NCOA2 (nuclear receptor coactivator 2), NRIP1 (nuclear receptor interacting protein 1), PGR (progesterone receptor), KAT2B (lysine acetyltransferase 2B), ATF2 (activating transcription factor 2), DDX5 (DEAD-box helicase 5), KAT5 (lysine acetyltransferase 5), GTF2A2 (general transcription factor IIA subunit 2), GTF2A1 (general transcription factor IIA subunit 1), MAPK3 (mitogen-activated protein kinase 3), YY1 (YY1 transcription factor), CARM1 (coactivator associated arginine methyltransferase 1), PRMT1 (protein arginine methyltransferase 1), MYB (MYB proto-oncogene, transcription factor), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), POLR2K (RNA polymerase II, I and III subunit K), RUNX1 (RUNX family transcription factor 1), POU2F1 (POU class 2 homeobox 1), HSP90AB1 (heat shock protein 90 alpha family class B member 1), BCL2 (BCL2 apoptosis regulator), RAD21 (RAD21 cohesin complex component), FKBP5 (FKBP prolyl isomerase 5), PPID (peptidylprolyl isomerase D), USF1 (upstream transcription factor 1), SMC3 (structural maintenance of chromosomes 3), PPP5C (protein phosphatase 5 catalytic subunit), TFF1 (trefoil factor 1), NR5A2 (nuclear receptor subfamily 5 group A member 2), PTGES3 (prostaglandin E synthase 3), FKBP4 (FKBP prolyl isomerase 4), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), ZNF217 (zinc finger protein 217), KPNA2 (karyopherin subunit alpha 2), KDM1A (lysine demethylase 1A), FOXA1 (forkhead box A1), CITED1 (Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1), CBFB (core-binding factor subunit beta), STAG2 (stromal antigen 2), AXIN1 (axin 1), STAG1 (stromal antigen 1), USF2 (upstream transcription factor 2, c-fos interacting), GATA3 (GATA binding protein 3), CTSD (cathepsin D), TGFA (transforming growth factor alpha), GREB1 (growth regulating estrogen receptor binding 1), CHD1 (chromodomain helicase DNA binding protein 1), EBAG9 (estrogen receptor binding site associated antigen 9), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), CXCL12 (C-X-C motif chemokine ligand 12), TFF3 (trefoil factor 3), KDM4B (lysine demethylase 4B), TLE3 (TLE family member 3, transcriptional corepressor), H2AC4 (H2A clustered histone 4), H2BC12 (H2B clustered histone 12), H3C14 (H3 clustered histone 14), H2AC19 (H2A clustered histone 19), H2AC6 (H2A clustered histone 6), H3C11 (H3 clustered histone 11), H4-16 (H4 histone 16), H2AX (H2A.X variant histone), KANK1 (KN motif and ankyrin repeat domains 1), H2BC7 (H2B clustered histone 7), H3C8 (H3 clustered histone 8), H2BC5 (H2B clustered histone 5), H2BC3 (H2B clustered histone 3), LOC102724334 (histone H2B type F-S-like), H2BC13 (H2B clustered histone 13), H3C12 (H3 clustered histone 12), H2AZ2 (H2A.Z variant histone 2), H4C1 (H4 clustered histone 1)"], "WAG002906": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALOX5 (arachidonate 5-lipoxygenase), ALOX5AP (arachidonate 5-lipoxygenase activating protein), LTC4S (leukotriene C4 synthase), ALOX12 (arachidonate 12-lipoxygenase, 12S type), HPGD (15-hydroxyprostaglandin dehydrogenase), PTGR1 (prostaglandin reductase 1)"], "WAG002909": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), EGFR (epidermal growth factor receptor), RAC1 (Rac family small GTPase 1), AKT1 (AKT serine/threonine kinase 1), STAT3 (signal transducer and activator of transcription 3), UBB (ubiquitin B), CCND1 (cyclin D1), HRAS (HRas proto-oncogene, GTPase), RHOA (ras homolog family member A), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CRK (CRK proto-oncogene, adaptor protein), RASA1 (RAS p21 protein activator 1), PXN (paxillin), CBL (Cbl proto-oncogene), BCAR1 (BCAR1 scaffold protein, Cas family member), PTK6 (protein tyrosine kinase 6), CDKN1B (cyclin dependent kinase inhibitor 1B), CDK2 (cyclin dependent kinase 2), KHDRBS1 (KH RNA binding domain containing, signal transduction associated 1), NRAS (NRAS proto-oncogene, GTPase), SOCS3 (suppressor of cytokine signaling 3), HIF1A (hypoxia inducible factor 1 subunit alpha), NR3C1 (nuclear receptor subfamily 3 group C member 1), DOCK1 (dedicator of cytokinesis 1), CDK4 (cyclin dependent kinase 4), PELP1 (proline, glutamate and leucine rich protein 1), CCNE1 (cyclin E1), PTPN1 (protein tyrosine phosphatase non-receptor type 1), ARHGAP35 (Rho GTPase activating protein 35), SFPQ (splicing factor proline and glutamine rich), ELMO1 (engulfment and cell motility 1), RPS27A (ribosomal protein S27a), LRRK2 (leucine rich repeat kinase 2), EPAS1 (endothelial PAS domain protein 1), DOK1 (docking protein 1), STAP2 (signal transducing adaptor family member 2), HBEGF (heparin binding EGF like growth factor), ELMO2 (engulfment and cell motility 2), ARAP1 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1), KHDRBS3 (KH RNA binding domain containing, signal transduction associated 3), KHDRBS2 (KH RNA binding domain containing, signal transduction associated 2), GPNMB (glycoprotein nmb), SRMS (src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites)"], "WAG002913": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COPA (COPI coat complex subunit alpha), COPB1 (COPI coat complex subunit beta 1), STX5 (syntaxin 5), SPTBN2 (spectrin beta, non-erythrocytic 2), USO1 (USO1 vesicle transport factor), ARF1 (ADP ribosylation factor 1), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), DCTN1 (dynactin subunit 1), DCTN4 (dynactin subunit 4), DCTN2 (dynactin subunit 2), GOSR2 (golgi SNAP receptor complex member 2), COPB2 (COPI coat complex subunit beta 2), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), TMED2 (transmembrane p24 trafficking protein 2), ARCN1 (archain 1), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), GOSR1 (golgi SNAP receptor complex member 1), COPZ1 (COPI coat complex subunit zeta 1), TMED10 (transmembrane p24 trafficking protein 10), COG3 (component of oligomeric golgi complex 3), DCTN3 (dynactin subunit 3), YKT6 (YKT6 v-SNARE homolog), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), ACTR1A (actin related protein 1A), DCTN6 (dynactin subunit 6), COPE (COPI coat complex subunit epsilon), RAB1A (RAB1A, member RAS oncogene family), GBF1 (golgi brefeldin A resistant guanine nucleotide exchange factor 1), DCTN5 (dynactin subunit 5), BET1 (Bet1 golgi vesicular membrane trafficking protein), TMED7 (transmembrane p24 trafficking protein 7), SPTBN1 (spectrin beta, non-erythrocytic 1), GOLGA2 (golgin A2), COPG2 (COPI coat complex subunit gamma 2), ANK2 (ankyrin 2), DYNLL1 (dynein light chain LC8-type 1), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), TMED9 (transmembrane p24 trafficking protein 9), SPTBN4 (spectrin beta, non-erythrocytic 4), COG4 (component of oligomeric golgi complex 4), COG1 (component of oligomeric golgi complex 1), SPTAN1 (spectrin alpha, non-erythrocytic 1), ANK1 (ankyrin 1), SPTA1 (spectrin alpha, erythrocytic 1), NAPA (NSF attachment protein alpha), SPTB (spectrin beta, erythrocytic), COG5 (component of oligomeric golgi complex 5), BET1L (Bet1 golgi vesicular membrane trafficking protein like), SPTBN5 (spectrin beta, non-erythrocytic 5), COG7 (component of oligomeric golgi complex 7), COG2 (component of oligomeric golgi complex 2), COPZ2 (COPI coat complex subunit zeta 2), COG6 (component of oligomeric golgi complex 6), COG8 (component of oligomeric golgi complex 8), ARFGAP1 (ADP ribosylation factor GTPase activating protein 1), KDELR1 (KDEL endoplasmic reticulum protein retention receptor 1), ACTR10 (actin related protein 10), TMED3 (transmembrane p24 trafficking protein 3), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), GORASP1 (golgi reassembly stacking protein 1), KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2), DYNLL2 (dynein light chain LC8-type 2), ARF4 (ADP ribosylation factor 4), CAPZB (capping actin protein of muscle Z-line subunit beta), ARFGAP3 (ADP ribosylation factor GTPase activating protein 3), NAPB (NSF attachment protein beta), NAPG (NSF attachment protein gamma), ARFGAP2 (ADP ribosylation factor GTPase activating protein 2), GOLGB1 (golgin B1), RAB1B (RAB1B, member RAS oncogene family), CAPZA2 (capping actin protein of muscle Z-line subunit alpha 2), ARF5 (ADP ribosylation factor 5), ARF3 (ADP ribosylation factor 3), CAPZA1 (capping actin protein of muscle Z-line subunit alpha 1), ANK3 (ankyrin 3), CD59 (CD59 molecule (CD59 blood group)), CAPZA3 (capping actin protein of muscle Z-line subunit alpha 3), KDELR3 (KDEL endoplasmic reticulum protein retention receptor 3), CD55 (CD55 molecule (Cromer blood group)), COPG1 (COPI coat complex subunit gamma 1), FOLR1 (folate receptor alpha), INS (insulin), TMEM115 (transmembrane protein 115)"], "WAG002915": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), RAC1 (Rac family small GTPase 1), NGFR (nerve growth factor receptor), RHOA (ras homolog family member A), NGF (nerve growth factor), ARHGEF1 (Rho guanine nucleotide exchange factor 1), TRAF6 (TNF receptor associated factor 6), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), GNA13 (G protein subunit alpha 13), NFKBIA (NFKB inhibitor alpha), UBB (ubiquitin B), PRKCI (protein kinase C iota), SQSTM1 (sequestosome 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CASP3 (caspase 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), VAV1 (vav guanine nucleotide exchange factor 1), PSENEN (presenilin enhancer, gamma-secretase subunit), APH1B (aph-1 homolog B, gamma-secretase subunit), ARHGDIA (Rho GDP dissociation inhibitor alpha), MAPK8 (mitogen-activated protein kinase 8), RIPK2 (receptor interacting serine/threonine kinase 2), IRAK1 (interleukin 1 receptor associated kinase 1), MCF2 (MCF.2 cell line derived transforming sequence), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), HDAC1 (histone deacetylase 1), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), MYD88 (MYD88 innate immune signal transduction adaptor), ARHGEF7 (Rho guanine nucleotide exchange factor 7), VAV2 (vav guanine nucleotide exchange factor 2), PSEN1 (presenilin 1), ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2), TIAM1 (TIAM Rac1 associated GEF 1), ARHGEF12 (Rho guanine nucleotide exchange factor 12), HDAC2 (histone deacetylase 2), ARHGEF11 (Rho guanine nucleotide exchange factor 11), PSEN2 (presenilin 2), HDAC3 (histone deacetylase 3), BAD (BCL2 associated agonist of cell death), NCSTN (nicastrin), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), APH1A (aph-1 homolog A, gamma-secretase subunit), RTN4 (reticulon 4), MAGED1 (MAGE family member D1), BCL2L11 (BCL2 like 11), AATF (apoptosis antagonizing transcription factor), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), ARHGEF18 (Rho/Rac guanine nucleotide exchange factor 18), ECT2 (epithelial cell transforming 2), OMG (oligodendrocyte myelin glycoprotein), PRDM4 (PR/SET domain 4), AKAP13 (A-kinase anchoring protein 13), VAV3 (vav guanine nucleotide exchange factor 3), TRIO (trio Rho guanine nucleotide exchange factor), RPS27A (ribosomal protein S27a), FGD1 (FYVE, RhoGEF and PH domain containing 1), ADAM17 (ADAM metallopeptidase domain 17), NET1 (neuroepithelial cell transforming 1), MCF2L (MCF.2 cell line derived transforming sequence like), LINGO1 (leucine rich repeat and Ig domain containing 1), RASGRF2 (Ras protein specific guanine nucleotide releasing factor 2), ITSN1 (intersectin 1), PLEKHG2 (pleckstrin homology and RhoGEF domain containing G2), ITGB3BP (integrin subunit beta 3 binding protein), SMPD2 (sphingomyelin phosphodiesterase 2), ARHGEF17 (Rho guanine nucleotide exchange factor 17), ARHGEF9 (Cdc42 guanine nucleotide exchange factor 9), ABR (ABR activator of RhoGEF and GTPase), ARHGEF4 (Rho guanine nucleotide exchange factor 4), MAG (myelin associated glycoprotein), ARHGEF5 (Rho guanine nucleotide exchange factor 5), ARHGEF19 (Rho guanine nucleotide exchange factor 19), NGEF (neuronal guanine nucleotide exchange factor), PREX1 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1), CASP2 (caspase 2), PLEKHG5 (pleckstrin homology and RhoGEF domain containing G5), KALRN (kalirin RhoGEF kinase), ARHGEF3 (Rho guanine nucleotide exchange factor 3), ARHGEF10 (Rho guanine nucleotide exchange factor 10), TIAM2 (TIAM Rac1 associated GEF 2), FGD3 (FYVE, RhoGEF and PH domain containing 3), ARHGEF15 (Rho guanine nucleotide exchange factor 15), ARHGEF40 (Rho guanine nucleotide exchange factor 40), ARHGEF10L (Rho guanine nucleotide exchange factor 10 like), FGD2 (FYVE, RhoGEF and PH domain containing 2), ARHGEF35 (Rho guanine nucleotide exchange factor 35), OBSCN (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF), LOC100505585 (uncharacterized LOC100505585), ARHGEF38 (Rho guanine nucleotide exchange factor 38), ARHGEF37 (Rho guanine nucleotide exchange factor 37), BEX3 (brain expressed X-linked 3), ARHGEF33 (Rho guanine nucleotide exchange factor 33), FGD4 (FYVE, RhoGEF and PH domain containing 4), ARHGEF16 (Rho guanine nucleotide exchange factor 16), LOC101927057 (uncharacterized LOC101927057), ARHGEF39 (Rho guanine nucleotide exchange factor 39), ARHGEF26 (Rho guanine nucleotide exchange factor 26)"], "WAG002916": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALOX5 (arachidonate 5-lipoxygenase), PTGS2 (prostaglandin-endoperoxide synthase 2)"], "WAG002922": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP85 (nucleoporin 85), NUP153 (nucleoporin 153), NUP155 (nucleoporin 155), NUP214 (nucleoporin 214), NUP62 (nucleoporin 62), NUP210 (nucleoporin 210), NUP205 (nucleoporin 205), NUP93 (nucleoporin 93), NUP43 (nucleoporin 43), NUP188 (nucleoporin 188), TPR (translocated promoter region, nuclear basket protein), NUP35 (nucleoporin 35), NUP107 (nucleoporin 107), RAE1 (ribonucleic acid export 1), NUP88 (nucleoporin 88), AAAS (aladin WD repeat nucleoporin), NUP133 (nucleoporin 133), NUP160 (nucleoporin 160), NUP50 (nucleoporin 50), NUP37 (nucleoporin 37), RANBP2 (RAN binding protein 2), NUP54 (nucleoporin 54), SUMO1 (small ubiquitin like modifier 1), POM121 (POM121 transmembrane nucleoporin), UBE2I (ubiquitin conjugating enzyme E2 I), MDM2 (MDM2 proto-oncogene), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), PIAS1 (protein inhibitor of activated STAT 1), PML (PML nuclear body scaffold), TRIM27 (tripartite motif containing 27), PIAS4 (protein inhibitor of activated STAT 4), VHL (von Hippel-Lindau tumor suppressor), NUP42 (nucleoporin 42), NDC1 (NDC1 transmembrane nucleoporin)"], "WAG002923": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP153 (nucleoporin 153), NUP85 (nucleoporin 85), NUP93 (nucleoporin 93), NUP155 (nucleoporin 155), NUP205 (nucleoporin 205), NUP210 (nucleoporin 210), NUP214 (nucleoporin 214), NUP62 (nucleoporin 62), NUP43 (nucleoporin 43), TPR (translocated promoter region, nuclear basket protein), NUP188 (nucleoporin 188), NUP35 (nucleoporin 35), NUP107 (nucleoporin 107), NUP133 (nucleoporin 133), RAE1 (ribonucleic acid export 1), NUP88 (nucleoporin 88), AAAS (aladin WD repeat nucleoporin), NUP160 (nucleoporin 160), NUP50 (nucleoporin 50), NUP37 (nucleoporin 37), NUP54 (nucleoporin 54), RANBP2 (RAN binding protein 2), SUMO1 (small ubiquitin like modifier 1), POM121 (POM121 transmembrane nucleoporin), SUMO2 (small ubiquitin like modifier 2), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), UBE2I (ubiquitin conjugating enzyme E2 I), PIAS4 (protein inhibitor of activated STAT 4), TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase), NUP42 (nucleoporin 42), NDC1 (NDC1 transmembrane nucleoporin)"], "WAG002925": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HDAC1 (histone deacetylase 1), CREB1 (cAMP responsive element binding protein 1), HDAC3 (histone deacetylase 3), NCOR1 (nuclear receptor corepressor 1), NCOR2 (nuclear receptor corepressor 2), SIN3A (SIN3 transcription regulator family member A), CAMK2B (calcium/calmodulin dependent protein kinase II beta), TBL1XR1 (TBL1X receptor 1), HDAC2 (histone deacetylase 2), NOTCH1 (notch receptor 1), GPS2 (G protein pathway suppressor 2), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), CAMK2D (calcium/calmodulin dependent protein kinase II delta), PPARG (peroxisome proliferator activated receptor gamma), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), TBL1X (transducin beta like 1 X-linked), BDNF (brain derived neurotrophic factor), SOX2 (SRY-box transcription factor 2), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), HTT (huntingtin), SST (somatostatin), MEF2C (myocyte enhancer factor 2C), CAMK4 (calcium/calmodulin dependent protein kinase IV), GAD2 (glutamate decarboxylase 2), MET (MET proto-oncogene, receptor tyrosine kinase), PVALB (parvalbumin), SGK1 (serum/glucocorticoid regulated kinase 1), GAD1 (glutamate decarboxylase 1), TNRC6B (trinucleotide repeat containing adaptor 6B), PTEN (phosphatase and tensin homolog), CRH (corticotropin releasing hormone), OPRM1 (opioid receptor mu 1), TNRC6A (trinucleotide repeat containing adaptor 6A), TNRC6C (trinucleotide repeat containing adaptor 6C), PTPN1 (protein tyrosine phosphatase non-receptor type 1), OPRK1 (opioid receptor kappa 1), DLL1 (delta like canonical Notch ligand 1), PTPN4 (protein tyrosine phosphatase non-receptor type 4), AURKB (aurora kinase B), HIPK2 (homeodomain interacting protein kinase 2), IRAK1 (interleukin 1 receptor associated kinase 1), MOV10 (Mov10 RISC complex RNA helicase), SLC2A3 (solute carrier family 2 member 3), AGO3 (argonaute RISC catalytic component 3), FKBP5 (FKBP prolyl isomerase 5), MOBP (myelin associated oligodendrocyte basic protein), MIR132 (microRNA 132), AGO2 (argonaute RISC catalytic component 2), RBFOX1 (RNA binding fox-1 homolog 1), MIR137 (microRNA 137), TRPC3 (transient receptor potential cation channel subfamily C member 3), AGO4 (argonaute RISC component 4), DGCR8 (DGCR8 microprocessor complex subunit), LBR (lamin B receptor), GAMT (guanidinoacetate N-methyltransferase), FOXG1 (forkhead box G1), GPRIN1 (G protein regulated inducer of neurite outgrowth 1), CALM1 (calmodulin 1), AGO1 (argonaute RISC component 1)"], "WAG002927": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLCB2 (phospholipase C beta 2), GNG13 (G protein subunit gamma 13), PLCB1 (phospholipase C beta 1), PLCB3 (phospholipase C beta 3), GNB1 (G protein subunit beta 1), GNG2 (G protein subunit gamma 2), GNB4 (G protein subunit beta 4), GNG4 (G protein subunit gamma 4), GNG3 (G protein subunit gamma 3), GNG7 (G protein subunit gamma 7), GNB3 (G protein subunit beta 3), GNB2 (G protein subunit beta 2), GNGT2 (G protein subunit gamma transducin 2), GNG8 (G protein subunit gamma 8), GNG12 (G protein subunit gamma 12), GNGT1 (G protein subunit gamma transducin 1), GNG5 (G protein subunit gamma 5), GNG11 (G protein subunit gamma 11), GNB5 (G protein subunit beta 5), GNG10 (G protein subunit gamma 10), GRIK2 (glutamate ionotropic receptor kainate type subunit 2), DLG4 (discs large MAGUK scaffold protein 4), GRIK3 (glutamate ionotropic receptor kainate type subunit 3), GRIK5 (glutamate ionotropic receptor kainate type subunit 5), GRIK1 (glutamate ionotropic receptor kainate type subunit 1), DLG1 (discs large MAGUK scaffold protein 1), DLG3 (discs large MAGUK scaffold protein 3), GRIK4 (glutamate ionotropic receptor kainate type subunit 4), NCALD (neurocalcin delta), CALM1 (calmodulin 1)"], "WAG002928": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNG2 (G protein subunit gamma 2), GNAI2 (G protein subunit alpha i2), GNG3 (G protein subunit gamma 3), GNG4 (G protein subunit gamma 4), GNB1 (G protein subunit beta 1), GNG13 (G protein subunit gamma 13), GNAI1 (G protein subunit alpha i1), GNG7 (G protein subunit gamma 7), GNAI3 (G protein subunit alpha i3), ADCY1 (adenylate cyclase 1), GNB3 (G protein subunit beta 3), ADCY2 (adenylate cyclase 2), GNGT2 (G protein subunit gamma transducin 2), ADCY5 (adenylate cyclase 5), GNG8 (G protein subunit gamma 8), ADCY9 (adenylate cyclase 9), ADCY4 (adenylate cyclase 4), ADCY8 (adenylate cyclase 8), ADCY7 (adenylate cyclase 7), ADCY6 (adenylate cyclase 6), GNG12 (G protein subunit gamma 12), GNGT1 (G protein subunit gamma transducin 1), GNB2 (G protein subunit beta 2), GNB4 (G protein subunit beta 4), ADCY3 (adenylate cyclase 3), GNG5 (G protein subunit gamma 5), GNG11 (G protein subunit gamma 11), GNB5 (G protein subunit beta 5), KCNJ3 (potassium inwardly rectifying channel subfamily J member 3), GNG10 (G protein subunit gamma 10), KCNJ6 (potassium inwardly rectifying channel subfamily J member 6), GNAL (G protein subunit alpha L), GABRA5 (gamma-aminobutyric acid type A receptor subunit alpha5), GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1), GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), GABRA2 (gamma-aminobutyric acid type A receptor subunit alpha2), GABRB1 (gamma-aminobutyric acid type A receptor subunit beta1), GABBR2 (gamma-aminobutyric acid type B receptor subunit 2), GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2), GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3), GABRA6 (gamma-aminobutyric acid type A receptor subunit alpha6), GABRA3 (gamma-aminobutyric acid type A receptor subunit alpha3), GABRA4 (gamma-aminobutyric acid type A receptor subunit alpha4), GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3), GNAT3 (G protein subunit alpha transducin 3), KCNJ16 (potassium inwardly rectifying channel subfamily J member 16), KCNJ4 (potassium inwardly rectifying channel subfamily J member 4), KCNJ2 (potassium inwardly rectifying channel subfamily J member 2), GABBR1 (gamma-aminobutyric acid type B receptor subunit 1), GABRQ (gamma-aminobutyric acid type A receptor subunit theta), KCNJ9 (potassium inwardly rectifying channel subfamily J member 9), KCNJ12 (potassium inwardly rectifying channel subfamily J member 12), KCNJ5 (potassium inwardly rectifying channel subfamily J member 5), KCNJ15 (potassium inwardly rectifying channel subfamily J member 15), KCNJ10 (potassium inwardly rectifying channel subfamily J member 10), GABRR1 (gamma-aminobutyric acid type A receptor subunit rho1), ARHGEF9 (Cdc42 guanine nucleotide exchange factor 9), GABRR2 (gamma-aminobutyric acid type A receptor subunit rho2), GABRR3 (gamma-aminobutyric acid type A receptor subunit rho3), NPTN (neuroplastin)"], "WAG002929": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK2 (Janus kinase 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SHC1 (SHC adaptor protein 1), PLCG1 (phospholipase C gamma 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), CRKL (CRK like proto-oncogene, adaptor protein), EPOR (erythropoietin receptor), GAB1 (GRB2 associated binding protein 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PLCG2 (phospholipase C gamma 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), VAV1 (vav guanine nucleotide exchange factor 1), HRAS (HRas proto-oncogene, GTPase), IRS2 (insulin receptor substrate 2), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), NRAS (NRAS proto-oncogene, GTPase), LYN (LYN proto-oncogene, Src family tyrosine kinase), STAT5A (signal transducer and activator of transcription 5A), STAT5B (signal transducer and activator of transcription 5B), EPO (erythropoietin), RAPGEF1 (Rap guanine nucleotide exchange factor 1)"], "WAG002930": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), CACNG2 (calcium voltage-gated channel auxiliary subunit gamma 2), GRIA4 (glutamate ionotropic receptor AMPA type subunit 4), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CACNG8 (calcium voltage-gated channel auxiliary subunit gamma 8), AKAP5 (A-kinase anchoring protein 5), EPB41L1 (erythrocyte membrane protein band 4.1 like 1), CAMK2B (calcium/calmodulin dependent protein kinase II beta), DLG4 (discs large MAGUK scaffold protein 4), CACNG3 (calcium voltage-gated channel auxiliary subunit gamma 3), CACNG4 (calcium voltage-gated channel auxiliary subunit gamma 4), PICK1 (protein interacting with PRKCA 1), MDM2 (MDM2 proto-oncogene), GRIA3 (glutamate ionotropic receptor AMPA type subunit 3), DLG1 (discs large MAGUK scaffold protein 1), PRKCA (protein kinase C alpha), GRIP1 (glutamate receptor interacting protein 1), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), PRKCG (protein kinase C gamma), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), AP2A1 (adaptor related protein complex 2 subunit alpha 1), PRKCB (protein kinase C beta), MYO6 (myosin VI), TSPAN7 (tetraspanin 7)"], "WAG002931": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RNASEL (ribonuclease L), OASL (2'-5'-oligoadenylate synthetase like), OAS2 (2'-5'-oligoadenylate synthetase 2), OAS3 (2'-5'-oligoadenylate synthetase 3), OAS1 (2'-5'-oligoadenylate synthetase 1), DDX58 (DExD/H-box helicase 58), ABCE1 (ATP binding cassette subfamily E member 1), PDE12 (phosphodiesterase 12), FLNA (filamin A)"], "WAG002932": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), CDK2 (cyclin dependent kinase 2), CDC6 (cell division cycle 6), GMNN (geminin DNA replication inhibitor), CDT1 (chromatin licensing and DNA replication factor 1), ORC1 (origin recognition complex subunit 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), PSMA1 (proteasome 20S subunit alpha 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), PSMC2 (proteasome 26S subunit, ATPase 2), PSMA2 (proteasome 20S subunit alpha 2), PSMA3 (proteasome 20S subunit alpha 3), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC1 (proteasome 26S subunit, ATPase 1), PSMB2 (proteasome 20S subunit beta 2), PSMB7 (proteasome 20S subunit beta 7), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMC3 (proteasome 26S subunit, ATPase 3), PSMD2 (proteasome 26S subunit, non-ATPase 2), PSMB4 (proteasome 20S subunit beta 4), PSMC5 (proteasome 26S subunit, ATPase 5), PSMB6 (proteasome 20S subunit beta 6), PSMB1 (proteasome 20S subunit beta 1), PSMA6 (proteasome 20S subunit alpha 6), PSMB3 (proteasome 20S subunit beta 3), PSMC4 (proteasome 26S subunit, ATPase 4), PSMB5 (proteasome 20S subunit beta 5), PSMA4 (proteasome 20S subunit alpha 4), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMA5 (proteasome 20S subunit alpha 5), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMB10 (proteasome 20S subunit beta 10), PSMA7 (proteasome 20S subunit alpha 7), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMD11 (proteasome 26S subunit, non-ATPase 11), PSMD5 (proteasome 26S subunit, non-ATPase 5), PSMA8 (proteasome 20S subunit alpha 8), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSME4 (proteasome activator subunit 4), PSMD10 (proteasome 26S subunit, non-ATPase 10), PSME1 (proteasome activator subunit 1), PSMF1 (proteasome inhibitor subunit 1), PSME3 (proteasome activator subunit 3), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMB11 (proteasome subunit beta 11), PSMB8 (proteasome 20S subunit beta 8), PSMB9 (proteasome 20S subunit beta 9), PSME2 (proteasome activator subunit 2), MCM6 (minichromosome maintenance complex component 6), CDC7 (cell division cycle 7), POLA1 (DNA polymerase alpha 1, catalytic subunit), MCM3 (minichromosome maintenance complex component 3), ORC2 (origin recognition complex subunit 2), MCM4 (minichromosome maintenance complex component 4), ORC3 (origin recognition complex subunit 3), ORC4 (origin recognition complex subunit 4), ORC6 (origin recognition complex subunit 6), ORC5 (origin recognition complex subunit 5), MCM5 (minichromosome maintenance complex component 5), MCM7 (minichromosome maintenance complex component 7), MCM2 (minichromosome maintenance complex component 2), RPA1 (replication protein A1), POLE (DNA polymerase epsilon, catalytic subunit), CDC45 (cell division cycle 45), PRIM1 (DNA primase subunit 1), POLA2 (DNA polymerase alpha 2, accessory subunit), POLE2 (DNA polymerase epsilon 2, accessory subunit), RPA3 (replication protein A3), MCM10 (minichromosome maintenance 10 replication initiation factor), DBF4 (DBF4 zinc finger), RPA4 (replication protein A4), RPA2 (replication protein A2), E2F1 (E2F transcription factor 1), E2F3 (E2F transcription factor 3), POLE3 (DNA polymerase epsilon 3, accessory subunit), E2F2 (E2F transcription factor 2), MCM8 (minichromosome maintenance 8 homologous recombination repair factor), RPS27A (ribosomal protein S27a), PRIM2 (DNA primase subunit 2), POLE4 (DNA polymerase epsilon 4, accessory subunit), SEM1 (SEM1 26S proteasome complex subunit)"], "WAG002933": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ICAM1 (intercellular adhesion molecule 1), TGFB1 (transforming growth factor beta 1), SELE (selectin E), VCAM1 (vascular cell adhesion molecule 1), CCL2 (C-C motif chemokine ligand 2), IL1B (interleukin 1 beta), CD40LG (CD40 ligand), CD40 (CD40 molecule), PF4 (platelet factor 4), TLR4 (toll like receptor 4), SELP (selectin P), TGFB2 (transforming growth factor beta 2), CCL5 (C-C motif chemokine ligand 5), TLR2 (toll like receptor 2), TGFB3 (transforming growth factor beta 3), SELPLG (selectin P ligand), TLR7 (toll like receptor 7)"], "WAG002936": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TLR4 (toll like receptor 4), IL1B (interleukin 1 beta), MYD88 (MYD88 innate immune signal transduction adaptor), IL1A (interleukin 1 alpha), IL6 (interleukin 6), NFKB1 (nuclear factor kappa B subunit 1), TRAF6 (TNF receptor associated factor 6), TNF (tumor necrosis factor), IRAK1 (interleukin 1 receptor associated kinase 1), CD14 (CD14 molecule), MAPK1 (mitogen-activated protein kinase 1), IRAK4 (interleukin 1 receptor associated kinase 4), IFNB1 (interferon beta 1), TLR2 (toll like receptor 2), LTF (lactotransferrin), AGER (advanced glycosylation end-product specific receptor), TREM1 (triggering receptor expressed on myeloid cells 1), CXCL8 (C-X-C motif chemokine ligand 8), IFNA1 (interferon alpha 1)"], "WAG002938": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), NFKB1 (nuclear factor kappa B subunit 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), RELA (RELA proto-oncogene, NF-kB subunit), NFKBIA (NFKB inhibitor alpha), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IL6 (interleukin 6), MUC1 (mucin 1, cell surface associated)"], "WAG002939": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), AKT1 (AKT serine/threonine kinase 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PLCB1 (phospholipase C beta 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), NFKB1 (nuclear factor kappa B subunit 1), PLCG1 (phospholipase C gamma 1), RELA (RELA proto-oncogene, NF-kB subunit), TNF (tumor necrosis factor), NFKBIA (NFKB inhibitor alpha), PLCB2 (phospholipase C beta 2), PLCG2 (phospholipase C gamma 2), PLCB3 (phospholipase C beta 3), PLCE1 (phospholipase C epsilon 1), PLCD1 (phospholipase C delta 1), MAPK14 (mitogen-activated protein kinase 14), PLCD3 (phospholipase C delta 3), PLCD4 (phospholipase C delta 4), PLCB4 (phospholipase C beta 4), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), AKT2 (AKT serine/threonine kinase 2), MAPK1 (mitogen-activated protein kinase 1), AKT3 (AKT serine/threonine kinase 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), MAPK3 (mitogen-activated protein kinase 3), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IL6 (interleukin 6), IL12B (interleukin 12B), IL12A (interleukin 12A), RETN (resistin), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002940": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), MAPK14 (mitogen-activated protein kinase 14), TNF (tumor necrosis factor), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), NFKBIA (NFKB inhibitor alpha), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), NR3C1 (nuclear receptor subfamily 3 group C member 1), DUSP1 (dual specificity phosphatase 1), MAP2K6 (mitogen-activated protein kinase kinase 6), SMAD3 (SMAD family member 3), IL6 (interleukin 6), SMAD4 (SMAD family member 4), NFATC1 (nuclear factor of activated T cells 1), MAP2K3 (mitogen-activated protein kinase kinase 3), RXRA (retinoid X receptor alpha), VDR (vitamin D receptor), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), MED14 (mediator complex subunit 14)"], "WAG002946": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ITGB2 (integrin subunit beta 2), VCAM1 (vascular cell adhesion molecule 1), ICAM1 (intercellular adhesion molecule 1), SELP (selectin P), ITGA4 (integrin subunit alpha 4), TNF (tumor necrosis factor), ITGAL (integrin subunit alpha L), IL6 (interleukin 6), C3 (complement C3), KNG1 (kininogen 1), ITGB1 (integrin subunit beta 1), IL1A (interleukin 1 alpha), C5 (complement C5), SELPLG (selectin P ligand), C6 (complement C6), C7 (complement C7), CXCL8 (C-X-C motif chemokine ligand 8)"], "WAG002948": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL6 (interleukin 6), STAT3 (signal transducer and activator of transcription 3), IL10 (interleukin 10), JAK1 (Janus kinase 1), STAT1 (signal transducer and activator of transcription 1), IL10RA (interleukin 10 receptor subunit alpha), HMOX1 (heme oxygenase 1), IL10RB (interleukin 10 receptor subunit beta), STAT2 (signal transducer and activator of transcription 2), BLVRA (biliverdin reductase A), BLVRB (biliverdin reductase B), IL1A (interleukin 1 alpha), TRN-GTT2-7 (tRNA-Asn (anticodon GTT) 2-7)"], "WAG002949": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), IRAK1 (interleukin 1 receptor associated kinase 1), TNF (tumor necrosis factor), IL1A (interleukin 1 alpha), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), MYD88 (MYD88 innate immune signal transduction adaptor), IL1B (interleukin 1 beta), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), IL1R1 (interleukin 1 receptor type 1), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), MAPK14 (mitogen-activated protein kinase 14), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), IRAK2 (interleukin 1 receptor associated kinase 2), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), NFKBIA (NFKB inhibitor alpha), IL6 (interleukin 6), IRAK3 (interleukin 1 receptor associated kinase 3), MAP2K6 (mitogen-activated protein kinase kinase 6), TGFB1 (transforming growth factor beta 1), MAPK8 (mitogen-activated protein kinase 8), TOLLIP (toll interacting protein), IL1RAP (interleukin 1 receptor accessory protein), IL1RN (interleukin 1 receptor antagonist), MAP2K3 (mitogen-activated protein kinase kinase 3), TGFB2 (transforming growth factor beta 2), IFNB1 (interferon beta 1), ECSIT (ECSIT signaling integrator), TGFB3 (transforming growth factor beta 3), IFNA1 (interferon alpha 1)"], "WAG002950": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDK2 (cyclin dependent kinase 2), PCNA (proliferating cell nuclear antigen), CDK1 (cyclin dependent kinase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), RB1 (RB transcriptional corepressor 1), CDK4 (cyclin dependent kinase 4), CCND1 (cyclin D1), CCNB1 (cyclin B1), E2F1 (E2F transcription factor 1), MCM3 (minichromosome maintenance complex component 3), CDKN1B (cyclin dependent kinase inhibitor 1B), MCM7 (minichromosome maintenance complex component 7), CDC25A (cell division cycle 25A), CCNA1 (cyclin A1), ORC1 (origin recognition complex subunit 1), MCM2 (minichromosome maintenance complex component 2), ORC4 (origin recognition complex subunit 4), MCM4 (minichromosome maintenance complex component 4), ORC3 (origin recognition complex subunit 3), CDC45 (cell division cycle 45), E2F3 (E2F transcription factor 3), RPA1 (replication protein A1), TFDP1 (transcription factor Dp-1), CDK6 (cyclin dependent kinase 6), CCNE1 (cyclin E1), MCM6 (minichromosome maintenance complex component 6), MCM5 (minichromosome maintenance complex component 5), ORC5 (origin recognition complex subunit 5), CCNH (cyclin H), ORC2 (origin recognition complex subunit 2), ORC6 (origin recognition complex subunit 6), TP53 (tumor protein p53), CDKN2A (cyclin dependent kinase inhibitor 2A), CDK7 (cyclin dependent kinase 7), CCNE2 (cyclin E2), MYC (MYC proto-oncogene, bHLH transcription factor), MNAT1 (MNAT1 component of CDK activating kinase), CCND3 (cyclin D3), E2F2 (E2F transcription factor 2), RPA2 (replication protein A2), RPA3 (replication protein A3), POLE (DNA polymerase epsilon, catalytic subunit), CCND2 (cyclin D2), PRIM1 (DNA primase subunit 1), POLE2 (DNA polymerase epsilon 2, accessory subunit), POLA2 (DNA polymerase alpha 2, accessory subunit), ATM (ATM serine/threonine kinase), TFDP2 (transcription factor Dp-2), MDM2 (MDM2 proto-oncogene), CDKN2C (cyclin dependent kinase inhibitor 2C), CDKN1C (cyclin dependent kinase inhibitor 1C), WEE1 (WEE1 G2 checkpoint kinase), CDKN2D (cyclin dependent kinase inhibitor 2D), CDKN2B (cyclin dependent kinase inhibitor 2B), GADD45A (growth arrest and DNA damage inducible alpha), CREB1 (cAMP responsive element binding protein 1), PRIM2 (DNA primase subunit 2), CREB3 (cAMP responsive element binding protein 3), CCNG2 (cyclin G2), CREB3L3 (cAMP responsive element binding protein 3 like 3), CREB3L1 (cAMP responsive element binding protein 3 like 1), CREB3L4 (cAMP responsive element binding protein 3 like 4), MYT1 (myelin transcription factor 1), ATF6B (activating transcription factor 6 beta)"], "WAG002955": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IDH2 (isocitrate dehydrogenase (NADP(+)) 2), D2HGDH (D-2-hydroxyglutarate dehydrogenase), L2HGDH (L-2-hydroxyglutarate dehydrogenase), MDH2 (malate dehydrogenase 2), ACY1 (aminoacylase 1), GCDH (glutaryl-CoA dehydrogenase), ALDH7A1 (aldehyde dehydrogenase 7 family member A1), ADHFE1 (alcohol dehydrogenase iron containing 1)"], "WAG002956": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALG3 (ALG3 alpha-1,3- mannosyltransferase), DPAGT1 (dolichyl-phosphate N-acetylglucosaminephosphotransferase 1), ALG1 (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase), DPM1 (dolichyl-phosphate mannosyltransferase subunit 1, catalytic), DPM2 (dolichyl-phosphate mannosyltransferase subunit 2, regulatory), PMM2 (phosphomannomutase 2), DPM3 (dolichyl-phosphate mannosyltransferase subunit 3, regulatory), ALG6 (ALG6 alpha-1,3-glucosyltransferase), DOLK (dolichol kinase), ALG9 (ALG9 alpha-1,2-mannosyltransferase), GMPPB (GDP-mannose pyrophosphorylase B), ALG8 (ALG8 alpha-1,3-glucosyltransferase), ALG12 (ALG12 alpha-1,6-mannosyltransferase), ALG14 (ALG14 UDP-N-acetylglucosaminyltransferase subunit), ALG13 (ALG13 UDP-N-acetylglucosaminyltransferase subunit), MPDU1 (mannose-P-dolichol utilization defect 1), MOGS (mannosyl-oligosaccharide glucosidase), ALG2 (ALG2 alpha-1,3/1,6-mannosyltransferase), MPI (mannose phosphate isomerase), TUSC3 (tumor suppressor candidate 3), MGAT2 (alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase), ALG11 (ALG11 alpha-1,2-mannosyltransferase), MAGT1 (magnesium transporter 1), SRD5A3 (steroid 5 alpha-reductase 3), B4GALT1 (beta-1,4-galactosyltransferase 1)"], "WAG002957": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APOB (apolipoprotein B), APOA1 (apolipoprotein A1), APOE (apolipoprotein E), LIPC (lipase C, hepatic type), LPL (lipoprotein lipase), CETP (cholesteryl ester transfer protein), APOA2 (apolipoprotein A2), LDLR (low density lipoprotein receptor), LCAT (lecithin-cholesterol acyltransferase), ABCA1 (ATP binding cassette subfamily A member 1), SCARB1 (scavenger receptor class B member 1), APOC2 (apolipoprotein C2), MTTP (microsomal triglyceride transfer protein), LDLRAP1 (low density lipoprotein receptor adaptor protein 1), LIPG (lipase G, endothelial type), PCSK9 (proprotein convertase subtilisin/kexin type 9), ANXA2 (annexin A2)"], "WAG002960": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL2 (interleukin 2), IL2RA (interleukin 2 receptor subunit alpha), IL4 (interleukin 4), IFNG (interferon gamma), CD86 (CD86 molecule), IL5 (interleukin 5), CD40 (CD40 molecule), CD80 (CD80 molecule), CD28 (CD28 molecule), LCK (LCK proto-oncogene, Src family tyrosine kinase), IL4R (interleukin 4 receptor), IL2RG (interleukin 2 receptor subunit gamma), CD40LG (CD40 ligand), IL2RB (interleukin 2 receptor subunit beta), FN1 (fibronectin 1), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), TNFRSF1A (TNF receptor superfamily member 1A), LAMA5 (laminin subunit alpha 5), THBS1 (thrombospondin 1), COL1A1 (collagen type I alpha 1 chain), IL5RA (interleukin 5 receptor subunit alpha), LAMB2 (laminin subunit beta 2), LAMB1 (laminin subunit beta 1), TNFRSF1B (TNF receptor superfamily member 1B), COL1A2 (collagen type I alpha 2 chain), LAMC1 (laminin subunit gamma 1), COL3A1 (collagen type III alpha 1 chain), LAMC2 (laminin subunit gamma 2), THBS3 (thrombospondin 3), IGHM (immunoglobulin heavy constant mu), VTN (vitronectin)"], "WAG002961": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), DYNLL1 (dynein light chain LC8-type 1), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), DYNLT3 (dynein light chain Tctex-type 3), DYNLT1 (dynein light chain Tctex-type 1), DYNLRB1 (dynein light chain roadblock-type 1), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), DYNLRB2 (dynein light chain roadblock-type 2), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), DYNLL2 (dynein light chain LC8-type 2), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1), IFT81 (intraflagellar transport 81), IFT27 (intraflagellar transport 27), IFT140 (intraflagellar transport 140), IFT80 (intraflagellar transport 80), HSPB11 (heat shock protein family B (small) member 11), IFT46 (intraflagellar transport 46), WDR35 (WD repeat domain 35), IFT43 (intraflagellar transport 43), IFT122 (intraflagellar transport 122), DYNC2I2 (dynein 2 intermediate chain 2), IFT22 (intraflagellar transport 22), DYNC2I1 (dynein 2 intermediate chain 1), WDR19 (WD repeat domain 19), TCTEX1D2 (Tctex1 domain containing 2)"], "WAG002963": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), ITGB1 (integrin subunit beta 1), ACTG1 (actin gamma 1), ACTB (actin beta), CTNNB1 (catenin beta 1), ITGB7 (integrin subunit beta 7), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), PAK1 (p21 (RAC1) activated kinase 1), ITGB4 (integrin subunit beta 4), CTNNA1 (catenin alpha 1), CDH1 (cadherin 1), PAK4 (p21 (RAC1) activated kinase 4), ACTA1 (actin alpha 1, skeletal muscle), ITGB6 (integrin subunit beta 6), ITGB5 (integrin subunit beta 5), ITGB8 (integrin subunit beta 8), STK3 (serine/threonine kinase 3), PAK2 (p21 (RAC1) activated kinase 2), ITGB2 (integrin subunit beta 2), MAPK8 (mitogen-activated protein kinase 8), NF2 (neurofibromin 2), PAK6 (p21 (RAC1) activated kinase 6), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), LATS1 (large tumor suppressor kinase 1), PAK3 (p21 (RAC1) activated kinase 3), ACTC1 (actin alpha cardiac muscle 1), MAPK10 (mitogen-activated protein kinase 10), MAPK9 (mitogen-activated protein kinase 9), TEAD4 (TEA domain transcription factor 4), SAV1 (salvador family WW domain containing protein 1), TAZ (tafazzin), MST1 (macrophage stimulating 1), MAP4K2 (mitogen-activated protein kinase kinase kinase kinase 2), TEAD1 (TEA domain transcription factor 1), MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5), ACTA2 (actin alpha 2, smooth muscle), MAP4K3 (mitogen-activated protein kinase kinase kinase kinase 3), ITGB3 (integrin subunit beta 3), TEAD3 (TEA domain transcription factor 3), MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4), TEAD2 (TEA domain transcription factor 2), ACTG2 (actin gamma 2, smooth muscle), LIMD1 (LIM domains containing 1), BUB1B-PAK6 (BUB1B-PAK6 readthrough), YY1AP1 (YY1 associated protein 1), SGMS1 (sphingomyelin synthase 1), PAK5 (p21 (RAC1) activated kinase 5), LINC02478 (long intergenic non-protein coding RNA 2478)"], "WAG002964": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), MAPK3 (mitogen-activated protein kinase 3), SMAD2 (SMAD family member 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), SMAD4 (SMAD family member 4), HRAS (HRas proto-oncogene, GTPase), NRAS (NRAS proto-oncogene, GTPase), MAP2K1 (mitogen-activated protein kinase kinase 1), ADCY2 (adenylate cyclase 2), SMAD3 (SMAD family member 3), ADCY1 (adenylate cyclase 1), ADCY7 (adenylate cyclase 7), TGFB1 (transforming growth factor beta 1), ADCY6 (adenylate cyclase 6), ADCY9 (adenylate cyclase 9), ADCY5 (adenylate cyclase 5), ADCY4 (adenylate cyclase 4), ADCY8 (adenylate cyclase 8), ADCY3 (adenylate cyclase 3), KRAS (KRAS proto-oncogene, GTPase), EMD (emerin), LEMD3 (LEM domain containing 3), RHOA (ras homolog family member A), TGFB2 (transforming growth factor beta 2), TGFB3 (transforming growth factor beta 3), SYNE2 (spectrin repeat containing nuclear envelope protein 2), TMPO (thymopoietin), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), MAP2K2 (mitogen-activated protein kinase kinase 2), SYNE1 (spectrin repeat containing nuclear envelope protein 1), SRF (serum response factor), BANF1 (BAF nuclear assembly factor 1), SUN1 (Sad1 and UNC84 domain containing 1), LBR (lamin B receptor), CFL1 (cofilin 1), ADCY10 (adenylate cyclase 10), PLEC (plectin), KIF5B (kinesin family member 5B), TMEM43 (transmembrane protein 43), TAZ (tafazzin), MAP3K9 (mitogen-activated protein kinase kinase kinase 9), CCN2 (cellular communication network factor 2), SYNE4 (spectrin repeat containing nuclear envelope family member 4), YY1AP1 (YY1 associated protein 1), SYNE3 (spectrin repeat containing nuclear envelope family member 3)"], "WAG002965": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MKS1 (MKS transition zone complex subunit 1), BBS7 (Bardet-Biedl syndrome 7), BBS9 (Bardet-Biedl syndrome 9), TMEM67 (transmembrane protein 67), BBS2 (Bardet-Biedl syndrome 2), BBS5 (Bardet-Biedl syndrome 5), CC2D2A (coiled-coil and C2 domain containing 2A), ARL6 (ADP ribosylation factor like GTPase 6), BBS12 (Bardet-Biedl syndrome 12), BBS1 (Bardet-Biedl syndrome 1), BBS4 (Bardet-Biedl syndrome 4), TTC8 (tetratricopeptide repeat domain 8), TMEM216 (transmembrane protein 216), BBS10 (Bardet-Biedl syndrome 10), B9D1 (B9 domain containing 1), IFT81 (intraflagellar transport 81), IFT20 (intraflagellar transport 20), IFT172 (intraflagellar transport 172), TCTN1 (tectonic family member 1), TMEM231 (transmembrane protein 231), IFT74 (intraflagellar transport 74), TCTN2 (tectonic family member 2), IFT52 (intraflagellar transport 52), TMEM17 (transmembrane protein 17), IFT88 (intraflagellar transport 88), KIF3A (kinesin family member 3A), IFT27 (intraflagellar transport 27), IFT80 (intraflagellar transport 80), KIF3B (kinesin family member 3B), IFT140 (intraflagellar transport 140), DYNLL1 (dynein light chain LC8-type 1), HSPB11 (heat shock protein family B (small) member 11), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1), OFD1 (OFD1 centriole and centriolar satellite protein), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), RPGRIP1L (RPGRIP1 like), LZTFL1 (leucine zipper transcription factor like 1), ARL13B (ADP ribosylation factor like GTPase 13B), WDPCP (WD repeat containing planar cell polarity effector), CEP76 (centrosomal protein 76), IFT46 (intraflagellar transport 46), KIFAP3 (kinesin associated protein 3), TTC21B (tetratricopeptide repeat domain 21B), ARL3 (ADP ribosylation factor like GTPase 3), TTC26 (tetratricopeptide repeat domain 26), RAB23 (RAB23, member RAS oncogene family), TULP3 (TUB like protein 3), DYNLT1 (dynein light chain Tctex-type 1), IFT57 (intraflagellar transport 57), WDR35 (WD repeat domain 35), RABL2B (RAB, member of RAS oncogene family like 2B), CEP19 (centrosomal protein 19), CEP97 (centrosomal protein 97), FBF1 (Fas binding factor 1), WDR19 (WD repeat domain 19), TCTN3 (tectonic family member 3), TRAF3IP1 (TRAF3 interacting protein 1), EVC (EvC ciliary complex subunit 1), EVC2 (EvC ciliary complex subunit 2), CLUAP1 (clusterin associated protein 1), IFT43 (intraflagellar transport 43), INPP5E (inositol polyphosphate-5-phosphatase E), TUBE1 (tubulin epsilon 1), TUBD1 (tubulin delta 1), IFT122 (intraflagellar transport 122), CEP120 (centrosomal protein 120), KATNB1 (katanin regulatory subunit B1), TTBK2 (tau tubulin kinase 2), CEP104 (centrosomal protein 104), RABL2A (RAB, member of RAS oncogene family like 2A), MIB1 (mindbomb E3 ubiquitin protein ligase 1), TMEM107 (transmembrane protein 107), TTC30B (tetratricopeptide repeat domain 30B), EFCAB7 (EF-hand calcium binding domain 7), CDK20 (cyclin dependent kinase 20), CEP44 (centrosomal protein 44), TXNDC15 (thioredoxin domain containing 15), CEP20 (centrosomal protein 20), IQCE (IQ motif containing E), CPLANE2 (ciliogenesis and planar polarity effector 2), SCLT1 (sodium channel and clathrin linker 1), CILK1 (ciliogenesis associated kinase 1), C2CD3 (C2 domain containing 3 centriole elongation regulator), CIBAR1 (CBY1 interacting BAR domain containing 1), SASS6 (SAS-6 centriolar assembly protein), CPLANE1 (ciliogenesis and planar polarity effector 1), FUZ (fuzzy planar cell polarity protein), CEP295 (centrosomal protein 295), TTC23 (tetratricopeptide repeat domain 23), TCTEX1D2 (Tctex1 domain containing 2), ARMC9 (armadillo repeat containing 9), CEP162 (centrosomal protein 162), KIAA0753 (KIAA0753), CEP192 (centrosomal protein 192), MKKS (McKusick-Kaufman syndrome), TEDC2 (tubulin epsilon and delta complex 2), CEP83 (centrosomal protein 83), DYNC2I1 (dynein 2 intermediate chain 1), CBY1 (chibby family member 1, beta catenin antagonist), PIBF1 (progesterone immunomodulatory binding factor 1)"], "WAG002967": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK1 (Janus kinase 1), JAK2 (Janus kinase 2), STAT3 (signal transducer and activator of transcription 3), JAK3 (Janus kinase 3), SOCS3 (suppressor of cytokine signaling 3), TYK2 (tyrosine kinase 2), MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), MAPK14 (mitogen-activated protein kinase 14), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), IL2RG (interleukin 2 receptor subunit gamma), IL6ST (interleukin 6 signal transducer), IL2RA (interleukin 2 receptor subunit alpha), MAPK8 (mitogen-activated protein kinase 8), IL2RB (interleukin 2 receptor subunit beta), EGFR (epidermal growth factor receptor), IL6R (interleukin 6 receptor), MAPK11 (mitogen-activated protein kinase 11), IL7R (interleukin 7 receptor), MAPK9 (mitogen-activated protein kinase 9), CSF2RB (colony stimulating factor 2 receptor subunit beta), PRKCB (protein kinase C beta), CNTFR (ciliary neurotrophic factor receptor), MTOR (mechanistic target of rapamycin kinase), IFNAR1 (interferon alpha and beta receptor subunit 1), IFNAR2 (interferon alpha and beta receptor subunit 2), LIFR (LIF receptor subunit alpha), CREBBP (CREB binding protein), CSF2RA (colony stimulating factor 2 receptor subunit alpha), PTPRC (protein tyrosine phosphatase receptor type C), DUSP2 (dual specificity phosphatase 2), IL10RA (interleukin 10 receptor subunit alpha), RPTOR (regulatory associated protein of MTOR complex 1), IFNGR2 (interferon gamma receptor 2), IL5RA (interleukin 5 receptor subunit alpha), IL3RA (interleukin 3 receptor subunit alpha), GHR (growth hormone receptor), PDGFRB (platelet derived growth factor receptor beta), CSF3R (colony stimulating factor 3 receptor), IL10RB (interleukin 10 receptor subunit beta), IL12RB2 (interleukin 12 receptor subunit beta 2), OSMR (oncostatin M receptor), MAPK6 (mitogen-activated protein kinase 6), MAPK13 (mitogen-activated protein kinase 13), IL22RA1 (interleukin 22 receptor subunit alpha 1), IL15RA (interleukin 15 receptor subunit alpha), MAPK12 (mitogen-activated protein kinase 12), MAPKAP1 (MAPK associated protein 1), AGTR1 (angiotensin II receptor type 1), IL20RB (interleukin 20 receptor subunit beta), IL27RA (interleukin 27 receptor subunit alpha), IL21R (interleukin 21 receptor), MPL (MPL proto-oncogene, thrombopoietin receptor), IL9R (interleukin 9 receptor), IFNGR1 (interferon gamma receptor 1), MAPK10 (mitogen-activated protein kinase 10), MLST8 (MTOR associated protein, LST8 homolog), IL11RA (interleukin 11 receptor subunit alpha), MAPK7 (mitogen-activated protein kinase 7), RICTOR (RPTOR independent companion of MTOR complex 2), DEPTOR (DEP domain containing MTOR interacting protein), PIAS3 (protein inhibitor of activated STAT 3), F2R (coagulation factor II thrombin receptor), IL20RA (interleukin 20 receptor subunit alpha), AKT1S1 (AKT1 substrate 1), STMN1 (stathmin 1), CTF1 (cardiotrophin 1), PDGFRA (platelet derived growth factor receptor alpha), F2RL2 (coagulation factor II thrombin receptor like 2), TRIM28 (tripartite motif containing 28), MAPK4 (mitogen-activated protein kinase 4), PTPRD (protein tyrosine phosphatase receptor type D), F2RL3 (F2R like thrombin or trypsin receptor 3), MAPK15 (mitogen-activated protein kinase 15), SETD7 (SET domain containing 7, histone lysine methyltransferase), AGTR2 (angiotensin II receptor type 2), PTPRT (protein tyrosine phosphatase receptor type T), IFNLR1 (interferon lambda receptor 1)"], "WAG002968": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTOR (mechanistic target of rapamycin kinase), AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), HRAS (HRas proto-oncogene, GTPase), MAPK1 (mitogen-activated protein kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), TSC2 (TSC complex subunit 2), TSC1 (TSC complex subunit 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), AKT2 (AKT serine/threonine kinase 2), GSK3B (glycogen synthase kinase 3 beta), RPS6KB1 (ribosomal protein S6 kinase B1), RHEB (Ras homolog, mTORC1 binding), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MAPK3 (mitogen-activated protein kinase 3), PTEN (phosphatase and tensin homolog), AKT3 (AKT serine/threonine kinase 3), NRAS (NRAS proto-oncogene, GTPase), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), DLG4 (discs large MAGUK scaffold protein 4), RPTOR (regulatory associated protein of MTOR complex 1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), KRAS (KRAS proto-oncogene, GTPase), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), CAMK2B (calcium/calmodulin dependent protein kinase II beta), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), BDNF (brain derived neurotrophic factor), NF1 (neurofibromin 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), SYNGAP1 (synaptic Ras GTPase activating protein 1), GRIN3A (glutamate ionotropic receptor NMDA type subunit 3A), GRIN3B (glutamate ionotropic receptor NMDA type subunit 3B), ARC (activity regulated cytoskeleton associated protein), NTRK2 (neurotrophic receptor tyrosine kinase 2), GRM1 (glutamate metabotropic receptor 1), HOMER1 (homer scaffold protein 1), UBE3A (ubiquitin protein ligase E3A), SHANK3 (SH3 and multiple ankyrin repeat domains 3), CAMK4 (calcium/calmodulin dependent protein kinase IV), CACNA1C (calcium voltage-gated channel subunit alpha1 C)"], "WAG002969": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), CDH2 (cadherin 2), RAC1 (Rac family small GTPase 1), PRKCA (protein kinase C alpha), EGFR (epidermal growth factor receptor), RHOA (ras homolog family member A), CDC42 (cell division cycle 42), PRKCD (protein kinase C delta), PLCB2 (phospholipase C beta 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CDH5 (cadherin 5), PLCB1 (phospholipase C beta 1), IGF1R (insulin like growth factor 1 receptor), PLCB4 (phospholipase C beta 4), PRKCZ (protein kinase C zeta), PLCB3 (phospholipase C beta 3), CDH6 (cadherin 6), KDR (kinase insert domain receptor), CDH1 (cadherin 1), CDH4 (cadherin 4), PRKCB (protein kinase C beta), CDH15 (cadherin 15), MTOR (mechanistic target of rapamycin kinase), CDH9 (cadherin 9), PRKCE (protein kinase C epsilon), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), CDH10 (cadherin 10), CDH18 (cadherin 18), PRKACB (protein kinase cAMP-activated catalytic subunit beta), GNAI2 (G protein subunit alpha i2), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), CDH24 (cadherin 24), CDH11 (cadherin 11), CDH8 (cadherin 8), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), CDH12 (cadherin 12), GNAS (GNAS complex locus), CDH13 (cadherin 13), PRKCG (protein kinase C gamma), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), MET (MET proto-oncogene, receptor tyrosine kinase), GNAI3 (G protein subunit alpha i3), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKCI (protein kinase C iota), SMAD3 (SMAD family member 3), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), KIT (KIT proto-oncogene, receptor tyrosine kinase), PRKCQ (protein kinase C theta), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), FGFR1 (fibroblast growth factor receptor 1), CDH7 (cadherin 7), INSR (insulin receptor), GNA11 (G protein subunit alpha 11), FLT1 (fms related receptor tyrosine kinase 1), NGFR (nerve growth factor receptor), SMAD2 (SMAD family member 2), GNAQ (G protein subunit alpha q), PDGFRB (platelet derived growth factor receptor beta), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKCH (protein kinase C eta), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), FLT4 (fms related receptor tyrosine kinase 4), EPHA2 (EPH receptor A2), NTRK2 (neurotrophic receptor tyrosine kinase 2), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), CDH3 (cadherin 3), LEF1 (lymphoid enhancer binding factor 1), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), CSF1R (colony stimulating factor 1 receptor), FLT3 (fms related receptor tyrosine kinase 3), STK3 (serine/threonine kinase 3), LATS1 (large tumor suppressor kinase 1), FGFR2 (fibroblast growth factor receptor 2), TCF7L2 (transcription factor 7 like 2), NF2 (neurofibromin 2), FGFR3 (fibroblast growth factor receptor 3), PDGFRA (platelet derived growth factor receptor alpha), TEAD4 (TEA domain transcription factor 4), FGFR4 (fibroblast growth factor receptor 4), TAZ (tafazzin), LATS2 (large tumor suppressor kinase 2), PRKD3 (protein kinase D3), NTRK1 (neurotrophic receptor tyrosine kinase 1), TCF7 (transcription factor 7), CDH16 (cadherin 16), TEAD1 (TEA domain transcription factor 1), TEK (TEK receptor tyrosine kinase), CDH17 (cadherin 17), CDH19 (cadherin 19), GNAL (G protein subunit alpha L), TEAD3 (TEA domain transcription factor 3), TEAD2 (TEA domain transcription factor 2), TCF7L1 (transcription factor 7 like 1), CDH20 (cadherin 20), MST1 (macrophage stimulating 1), YY1AP1 (YY1 associated protein 1), CDH22 (cadherin 22)"], "WAG002970": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTK2 (protein tyrosine kinase 2), CTNNB1 (catenin beta 1), ITGB1 (integrin subunit beta 1), ITGAV (integrin subunit alpha V), ITGA1 (integrin subunit alpha 1), ITGA5 (integrin subunit alpha 5), ITGB4 (integrin subunit beta 4), CTNNA1 (catenin alpha 1), EGFR (epidermal growth factor receptor), ITGB7 (integrin subunit beta 7), CDH2 (cadherin 2), ITGB2 (integrin subunit beta 2), ITGA3 (integrin subunit alpha 3), MYC (MYC proto-oncogene, bHLH transcription factor), ITGA4 (integrin subunit alpha 4), HRAS (HRas proto-oncogene, GTPase), ITGA6 (integrin subunit alpha 6), ITGB3 (integrin subunit beta 3), ITGA2 (integrin subunit alpha 2), ITGB6 (integrin subunit beta 6), ITGB8 (integrin subunit beta 8), ITGB5 (integrin subunit beta 5), ITGAL (integrin subunit alpha L), CDH1 (cadherin 1), ITGAM (integrin subunit alpha M), CCND1 (cyclin D1), ITGA10 (integrin subunit alpha 10), KDR (kinase insert domain receptor), ITGA8 (integrin subunit alpha 8), IGF1R (insulin like growth factor 1 receptor), ITGAX (integrin subunit alpha X), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CDH6 (cadherin 6), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), CDH4 (cadherin 4), ITGA11 (integrin subunit alpha 11), ITGA9 (integrin subunit alpha 9), CDH5 (cadherin 5), CD44 (CD44 molecule (Indian blood group)), MET (MET proto-oncogene, receptor tyrosine kinase), ITGAE (integrin subunit alpha E), ITGA2B (integrin subunit alpha 2b), NF2 (neurofibromin 2), CDH9 (cadherin 9), NRAS (NRAS proto-oncogene, GTPase), CDH15 (cadherin 15), CDH10 (cadherin 10), CDH18 (cadherin 18), ITGAD (integrin subunit alpha D), CDH24 (cadherin 24), FGFR1 (fibroblast growth factor receptor 1), CDH11 (cadherin 11), CDH8 (cadherin 8), CDH12 (cadherin 12), PDGFRB (platelet derived growth factor receptor beta), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), KIT (KIT proto-oncogene, receptor tyrosine kinase), EPHA2 (EPH receptor A2), ITGA7 (integrin subunit alpha 7), CDH13 (cadherin 13), KRAS (KRAS proto-oncogene, GTPase), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), FLT4 (fms related receptor tyrosine kinase 4), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), CSF1R (colony stimulating factor 1 receptor), PPP1CB (protein phosphatase 1 catalytic subunit beta), PPP1CA (protein phosphatase 1 catalytic subunit alpha), PDGFRA (platelet derived growth factor receptor alpha), CDH7 (cadherin 7), FLT1 (fms related receptor tyrosine kinase 1), PAK1 (p21 (RAC1) activated kinase 1), LATS1 (large tumor suppressor kinase 1), PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A), PPP1CC (protein phosphatase 1 catalytic subunit gamma), TEK (TEK receptor tyrosine kinase), PAK4 (p21 (RAC1) activated kinase 4), LATS2 (large tumor suppressor kinase 2), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), NTRK2 (neurotrophic receptor tyrosine kinase 2), FGFR2 (fibroblast growth factor receptor 2), CDH3 (cadherin 3), PAK2 (p21 (RAC1) activated kinase 2), FLT3 (fms related receptor tyrosine kinase 3), CUL4A (cullin 4A), FGFR3 (fibroblast growth factor receptor 3), STK3 (serine/threonine kinase 3), DDB1 (damage specific DNA binding protein 1), INSR (insulin receptor), SAV1 (salvador family WW domain containing protein 1), NGFR (nerve growth factor receptor), NTRK1 (neurotrophic receptor tyrosine kinase 1), TEAD1 (TEA domain transcription factor 1), RBX1 (ring-box 1), PAK6 (p21 (RAC1) activated kinase 6), FOXM1 (forkhead box M1), TEAD4 (TEA domain transcription factor 4), PAK3 (p21 (RAC1) activated kinase 3), FGFR4 (fibroblast growth factor receptor 4)"], "WAG002971": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "YAP1 (Yes1 associated transcriptional regulator), LATS1 (large tumor suppressor kinase 1), STK3 (serine/threonine kinase 3), MOB1A (MOB kinase activator 1A), SAV1 (salvador family WW domain containing protein 1), LATS2 (large tumor suppressor kinase 2), RAC1 (Rac family small GTPase 1), RASSF5 (Ras association domain family member 5), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), MST1 (macrophage stimulating 1), FOXO1 (forkhead box O1), TEAD1 (TEA domain transcription factor 1), RAP1A (RAP1A, member of RAS oncogene family), TEAD4 (TEA domain transcription factor 4), TEAD2 (TEA domain transcription factor 2), TEAD3 (TEA domain transcription factor 3), FOXO3 (forkhead box O3), TAZ (tafazzin), ITGAL (integrin subunit alpha L), FOXO4 (forkhead box O4), STK38L (serine/threonine kinase 38 like), RHOA (ras homolog family member A), CD19 (CD19 molecule), CCR7 (C-C motif chemokine receptor 7), MAPK14 (mitogen-activated protein kinase 14), LPL (lipoprotein lipase), RAB13 (RAB13, member RAS oncogene family), NDRG1 (N-myc downstream regulated 1), FOXP3 (forkhead box P3), FERMT3 (fermitin family member 3), PRDM1 (PR/SET domain 1), MIR21 (microRNA 21), FOXO6 (forkhead box O6), KNSTRN (kinetochore localized astrin (SPAG5) binding protein), FYB1 (FYN binding protein 1)"], "WAG002973": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), AKT1 (AKT serine/threonine kinase 1), PLCG1 (phospholipase C gamma 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PRKCA (protein kinase C alpha), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), FYN (FYN proto-oncogene, Src family tyrosine kinase), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), SHC1 (SHC adaptor protein 1), MTOR (mechanistic target of rapamycin kinase), DLG4 (discs large MAGUK scaffold protein 4), APP (amyloid beta precursor protein), RPS6KB1 (ribosomal protein S6 kinase B1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), DNM1 (dynamin 1), KRAS (KRAS proto-oncogene, GTPase), PPP3CA (protein phosphatase 3 catalytic subunit alpha), CLTC (clathrin heavy chain), MAP2K1 (mitogen-activated protein kinase kinase 1), PPP1CA (protein phosphatase 1 catalytic subunit alpha), CREB1 (cAMP responsive element binding protein 1), EIF4E (eukaryotic translation initiation factor 4E), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), PTEN (phosphatase and tensin homolog), GAB1 (GRB2 associated binding protein 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), CAMK2B (calcium/calmodulin dependent protein kinase II beta), TSC2 (TSC complex subunit 2), RPTOR (regulatory associated protein of MTOR complex 1), MLST8 (MTOR associated protein, LST8 homolog), PLCB1 (phospholipase C beta 1), AP2A1 (adaptor related protein complex 2 subunit alpha 1), AP2M1 (adaptor related protein complex 2 subunit mu 1), RHEB (Ras homolog, mTORC1 binding), MAP2K2 (mitogen-activated protein kinase kinase 2), BDNF (brain derived neurotrophic factor), TSC1 (TSC complex subunit 1), BRAF (B-Raf proto-oncogene, serine/threonine kinase), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), ARHGAP32 (Rho GTPase activating protein 32), EEF1A1 (eukaryotic translation elongation factor 1 alpha 1), DEPTOR (DEP domain containing MTOR interacting protein), AP2S1 (adaptor related protein complex 2 subunit sigma 1), GRM1 (glutamate metabotropic receptor 1), AP2B1 (adaptor related protein complex 2 subunit beta 1), DNM2 (dynamin 2), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), HOMER1 (homer scaffold protein 1), NTRK2 (neurotrophic receptor tyrosine kinase 2), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), FMR1 (FMRP translational regulator 1), CLTA (clathrin light chain A), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), MKNK1 (MAPK interacting serine/threonine kinase 1), PICK1 (protein interacting with PRKCA 1), SH3GL1 (SH3 domain containing GRB2 like 1, endophilin A2), AKAP5 (A-kinase anchoring protein 5), GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1), AKT1S1 (AKT1 substrate 1), GRIP1 (glutamate receptor interacting protein 1), ARAF (A-Raf proto-oncogene, serine/threonine kinase), ARC (activity regulated cytoskeleton associated protein), DAG1 (dystroglycan 1), NF1 (neurofibromin 1), PDK1 (pyruvate dehydrogenase kinase 1), GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), EIF4A1 (eukaryotic translation initiation factor 4A1), GAD1 (glutamate decarboxylase 1), SHANK1 (SH3 and multiple ankyrin repeat domains 1), DLGAP3 (DLG associated protein 3), GRM5 (glutamate metabotropic receptor 5), CLTB (clathrin light chain B), CAMK4 (calcium/calmodulin dependent protein kinase IV), CLTCL1 (clathrin heavy chain like 1), EIF4EBP2 (eukaryotic translation initiation factor 4E binding protein 2), SYNGAP1 (synaptic Ras GTPase activating protein 1), PTPN5 (protein tyrosine phosphatase non-receptor type 5), CAMK1 (calcium/calmodulin dependent protein kinase I), KCND2 (potassium voltage-gated channel subfamily D member 2), GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2), ABAT (4-aminobutyrate aminotransferase), TBC1D7 (TBC1 domain family member 7), CYFIP2 (cytoplasmic FMR1 interacting protein 2), CYFIP1 (cytoplasmic FMR1 interacting protein 1), DUSP3 (dual specificity phosphatase 3), CDKN2A (cyclin dependent kinase inhibitor 2A), EPHA4 (EPH receptor A4), RAP1GAP (RAP1 GTPase activating protein), AGAP2 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2), KCNC1 (potassium voltage-gated channel subfamily C member 1), MMP9 (matrix metallopeptidase 9), SH3GL3 (SH3 domain containing GRB2 like 3, endophilin A3), GRIP2 (glutamate receptor interacting protein 2), ALDH5A1 (aldehyde dehydrogenase 5 family member A1)"], "WAG002978": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK3 (mitogen-activated protein kinase 3), MAPK1 (mitogen-activated protein kinase 1), PTK2 (protein tyrosine kinase 2), ACTN1 (actinin alpha 1), PXN (paxillin), VCL (vinculin), ITGAV (integrin subunit alpha V), MYLK (myosin light chain kinase), ITGB3 (integrin subunit beta 3), PLCG1 (phospholipase C gamma 1), PRKCQ (protein kinase C theta), CREB1 (cAMP responsive element binding protein 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TJP1 (tight junction protein 1), LPP (LIM domain containing preferred translocation partner in lipoma), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), MYL2 (myosin light chain 2), MFAP5 (microfibril associated protein 5)"], "WAG002979": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), AKT1 (AKT serine/threonine kinase 1), RHOA (ras homolog family member A), EFNB1 (ephrin B1), STAT3 (signal transducer and activator of transcription 3), TIAM1 (TIAM Rac1 associated GEF 1), EFNA1 (ephrin A1), MMP9 (matrix metallopeptidase 9), BDNF (brain derived neurotrophic factor), PAK1 (p21 (RAC1) activated kinase 1), NGFR (nerve growth factor receptor), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), EFNA2 (ephrin A2), EFNB2 (ephrin B2), MMP2 (matrix metallopeptidase 2), EFNB3 (ephrin B3), EFNA3 (ephrin A3), AKT2 (AKT serine/threonine kinase 2), NTRK2 (neurotrophic receptor tyrosine kinase 2), EFNA4 (ephrin A4), TRIO (trio Rho guanine nucleotide exchange factor), KIDINS220 (kinase D interacting substrate 220), MMP8 (matrix metallopeptidase 8), EFNA5 (ephrin A5), AKT3 (AKT serine/threonine kinase 3), ARF1 (ADP ribosylation factor 1), TWIST1 (twist family bHLH transcription factor 1), PARD3 (par-3 family cell polarity regulator), CDH11 (cadherin 11), ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1 motif 13)"], "WAG002981": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), TIAM1 (TIAM Rac1 associated GEF 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), RHOA (ras homolog family member A), AKT2 (AKT serine/threonine kinase 2), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), EPHB2 (EPH receptor B2), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), STAT3 (signal transducer and activator of transcription 3), MMP9 (matrix metallopeptidase 9), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PAK1 (p21 (RAC1) activated kinase 1), NGFR (nerve growth factor receptor), AKT3 (AKT serine/threonine kinase 3), MMP2 (matrix metallopeptidase 2), BDNF (brain derived neurotrophic factor), EPHB4 (EPH receptor B4), PAK2 (p21 (RAC1) activated kinase 2), EPHB1 (EPH receptor B1), PAK4 (p21 (RAC1) activated kinase 4), PAK3 (p21 (RAC1) activated kinase 3), F2RL2 (coagulation factor II thrombin receptor like 2), PAK6 (p21 (RAC1) activated kinase 6), EPHB3 (EPH receptor B3), TRIO (trio Rho guanine nucleotide exchange factor), NGEF (neuronal guanine nucleotide exchange factor), EPHB6 (EPH receptor B6), ARF1 (ADP ribosylation factor 1), MMP8 (matrix metallopeptidase 8), TWIST1 (twist family bHLH transcription factor 1), PIK3R6 (phosphoinositide-3-kinase regulatory subunit 6), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), PAK5 (p21 (RAC1) activated kinase 5), BUB1B-PAK6 (BUB1B-PAK6 readthrough), CDH11 (cadherin 11)"], "WAG002982": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), TIAM1 (TIAM Rac1 associated GEF 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), NGFR (nerve growth factor receptor), RHOA (ras homolog family member A), AKT2 (AKT serine/threonine kinase 2), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), EPHB2 (EPH receptor B2), BDNF (brain derived neurotrophic factor), STAT3 (signal transducer and activator of transcription 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), MMP9 (matrix metallopeptidase 9), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), NTRK2 (neurotrophic receptor tyrosine kinase 2), PAK1 (p21 (RAC1) activated kinase 1), AKT3 (AKT serine/threonine kinase 3), MMP2 (matrix metallopeptidase 2), EPHB4 (EPH receptor B4), PAK2 (p21 (RAC1) activated kinase 2), EPHB1 (EPH receptor B1), PAK3 (p21 (RAC1) activated kinase 3), PAK4 (p21 (RAC1) activated kinase 4), F2RL2 (coagulation factor II thrombin receptor like 2), PAK6 (p21 (RAC1) activated kinase 6), EPHB3 (EPH receptor B3), TRIO (trio Rho guanine nucleotide exchange factor), NGEF (neuronal guanine nucleotide exchange factor), EPHB6 (EPH receptor B6), KIDINS220 (kinase D interacting substrate 220), SORT1 (sortilin 1), ARF1 (ADP ribosylation factor 1), MMP8 (matrix metallopeptidase 8), TWIST1 (twist family bHLH transcription factor 1), PIK3R6 (phosphoinositide-3-kinase regulatory subunit 6), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), PAK5 (p21 (RAC1) activated kinase 5), CDH11 (cadherin 11), BUB1B-PAK6 (BUB1B-PAK6 readthrough)"], "WAG002983": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RPS6KB1 (ribosomal protein S6 kinase B1), MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), MAPK3 (mitogen-activated protein kinase 3), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAP2K1 (mitogen-activated protein kinase kinase 1), MAPK14 (mitogen-activated protein kinase 14), MAPK8 (mitogen-activated protein kinase 8), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PRKCD (protein kinase C delta), MAP2K4 (mitogen-activated protein kinase kinase 4), EIF4E (eukaryotic translation initiation factor 4E), RPS6 (ribosomal protein S6), AKT2 (AKT serine/threonine kinase 2), PRKCA (protein kinase C alpha), RPTOR (regulatory associated protein of MTOR complex 1), AKT3 (AKT serine/threonine kinase 3), PDK1 (pyruvate dehydrogenase kinase 1), RPS6KA1 (ribosomal protein S6 kinase A1), EIF4B (eukaryotic translation initiation factor 4B), MAP2K2 (mitogen-activated protein kinase kinase 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), RPS6KA2 (ribosomal protein S6 kinase A2), EIF4G1 (eukaryotic translation initiation factor 4 gamma 1), EIF4A1 (eukaryotic translation initiation factor 4A1), MAP2K3 (mitogen-activated protein kinase kinase 3), EIF4A2 (eukaryotic translation initiation factor 4A2), RPS6KA5 (ribosomal protein S6 kinase A5), MAPK9 (mitogen-activated protein kinase 9), MAP2K7 (mitogen-activated protein kinase kinase 7), RPS6KB2 (ribosomal protein S6 kinase B2), MAP2K6 (mitogen-activated protein kinase kinase 6), RPS6KA4 (ribosomal protein S6 kinase A4), MAPK10 (mitogen-activated protein kinase 10), PDCD4 (programmed cell death 4), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), MAP2K5 (mitogen-activated protein kinase kinase 5), CSNK2A1 (casein kinase 2 alpha 1), EIF4G3 (eukaryotic translation initiation factor 4 gamma 3), PIM1 (Pim-1 proto-oncogene, serine/threonine kinase), PIM2 (Pim-2 proto-oncogene, serine/threonine kinase)"], "WAG002984": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "OTC (ornithine carbamoyltransferase), ASS1 (argininosuccinate synthase 1), ASL (argininosuccinate lyase), CPS1 (carbamoyl-phosphate synthase 1), ARG1 (arginase 1), NAGS (N-acetylglutamate synthase), SLC25A15 (solute carrier family 25 member 15), GLS2 (glutaminase 2), SLC25A13 (solute carrier family 25 member 13)"], "WAG002985": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MTOR (mechanistic target of rapamycin kinase), ULK1 (unc-51 like autophagy activating kinase 1), BECN1 (beclin 1), MLST8 (MTOR associated protein, LST8 homolog), RB1CC1 (RB1 inducible coiled-coil 1), ATG12 (autophagy related 12), RPTOR (regulatory associated protein of MTOR complex 1), ATG5 (autophagy related 5), ATG7 (autophagy related 7), RHEB (Ras homolog, mTORC1 binding), ATG3 (autophagy related 3), TSC2 (TSC complex subunit 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), TSC1 (TSC complex subunit 1), DEPTOR (DEP domain containing MTOR interacting protein), ATG16L1 (autophagy related 16 like 1), ATG14 (autophagy related 14), ATG13 (autophagy related 13), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), WIPI1 (WD repeat domain, phosphoinositide interacting 1), AKT1S1 (AKT1 substrate 1), ATG10 (autophagy related 10), WIPI2 (WD repeat domain, phosphoinositide interacting 2), STK11 (serine/threonine kinase 11), ATG2A (autophagy related 2A), ATG4A (autophagy related 4A cysteine peptidase), FTL (ferritin light chain), PLA2G6 (phospholipase A2 group VI), ATP13A2 (ATPase cation transporting 13A2), PANK2 (pantothenate kinase 2), ACACA (acetyl-CoA carboxylase alpha), WDR45 (WD repeat domain 45), CP (ceruloplasmin), COASY (Coenzyme A synthase), MECP2 (methyl-CpG binding protein 2), FA2H (fatty acid 2-hydroxylase), ATG101 (autophagy related 101), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), GTPBP2 (GTP binding protein 2), C19orf12 (chromosome 19 open reading frame 12), SCP2 (sterol carrier protein 2), DCAF17 (DDB1 and CUL4 associated factor 17)"], "WAG002989": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TYMS (thymidylate synthetase), TYMP (thymidine phosphorylase), DPYD (dihydropyrimidine dehydrogenase), UMPS (uridine monophosphate synthetase), RRM2 (ribonucleotide reductase regulatory subunit M2), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), RRM1 (ribonucleotide reductase catalytic subunit M1), TK2 (thymidine kinase 2), NT5C (5', 3'-nucleotidase, cytosolic), DPYS (dihydropyrimidinase), UPB1 (beta-ureidopropionase 1), DHODH (dihydroorotate dehydrogenase (quinone)), PUS1 (pseudouridine synthase 1), NT5C3A (5'-nucleotidase, cytosolic IIIA), CKB (creatine kinase B)"], "WAG002994": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GAPDH (glyceraldehyde-3-phosphate dehydrogenase), ENO1 (enolase 1), GPI (glucose-6-phosphate isomerase), PKM (pyruvate kinase M1/2), PGK1 (phosphoglycerate kinase 1), TPI1 (triosephosphate isomerase 1), ALDOA (aldolase, fructose-bisphosphate A), PGAM2 (phosphoglycerate mutase 2), HK1 (hexokinase 1), LDHA (lactate dehydrogenase A), SLC2A1 (solute carrier family 2 member 1), PFKM (phosphofructokinase, muscle)"], "WAG002995": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GAPDH (glyceraldehyde-3-phosphate dehydrogenase), ENO1 (enolase 1), GPI (glucose-6-phosphate isomerase), PKM (pyruvate kinase M1/2), PGK1 (phosphoglycerate kinase 1), TPI1 (triosephosphate isomerase 1), ALDOA (aldolase, fructose-bisphosphate A), PGAM2 (phosphoglycerate mutase 2), HK1 (hexokinase 1), LDHA (lactate dehydrogenase A), SLC2A1 (solute carrier family 2 member 1), PFKM (phosphofructokinase, muscle)"], "WAG002996": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), STAT1 (signal transducer and activator of transcription 1), TP53 (tumor protein p53), STAT3 (signal transducer and activator of transcription 3), TRAF6 (TNF receptor associated factor 6), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TYK2 (tyrosine kinase 2), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), NFKBIA (NFKB inhibitor alpha), JAK1 (Janus kinase 1), IL6 (interleukin 6), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAPK8 (mitogen-activated protein kinase 8), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IRF7 (interferon regulatory factor 7), IRF3 (interferon regulatory factor 3), BCL2 (BCL2 apoptosis regulator), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL2 (interleukin 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), CASP8 (caspase 8), BCL2L1 (BCL2 like 1), IL2RA (interleukin 2 receptor subunit alpha), IRF9 (interferon regulatory factor 9), IRAK1 (interleukin 1 receptor associated kinase 1), MYD88 (MYD88 innate immune signal transduction adaptor), CCND1 (cyclin D1), FASLG (Fas ligand), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), IFNB1 (interferon beta 1), JAK3 (Janus kinase 3), NFKB2 (nuclear factor kappa B subunit 2), STAT2 (signal transducer and activator of transcription 2), CASP3 (caspase 3), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IFNAR1 (interferon alpha and beta receptor subunit 1), TLR4 (toll like receptor 4), IL1B (interleukin 1 beta), IL2RB (interleukin 2 receptor subunit beta), IL2RG (interleukin 2 receptor subunit gamma), IFNAR2 (interferon alpha and beta receptor subunit 2), HSPA8 (heat shock protein family A (Hsp70) member 8), FADD (Fas associated via death domain), IFNA13 (interferon alpha 13), BAX (BCL2 associated X, apoptosis regulator), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), MAVS (mitochondrial antiviral signaling protein), TBK1 (TANK binding kinase 1), IFNA2 (interferon alpha 2), MAPK9 (mitogen-activated protein kinase 9), STAT5A (signal transducer and activator of transcription 5A), TRAF3 (TNF receptor associated factor 3), CCND3 (cyclin D3), CBLB (Cbl proto-oncogene B), CDKN1B (cyclin dependent kinase inhibitor 1B), TRADD (TNFRSF1A associated via death domain), BID (BH3 interacting domain death agonist), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), FAS (Fas cell surface death receptor), STAT5B (signal transducer and activator of transcription 5B), DDX58 (DExD/H-box helicase 58), CASP9 (caspase 9), IL12B (interleukin 12B), CD3E (CD3e molecule), TNFAIP3 (TNF alpha induced protein 3), IFNA5 (interferon alpha 5), CYCS (cytochrome c, somatic), IL1A (interleukin 1 alpha), IFNA14 (interferon alpha 14), CDK2 (cyclin dependent kinase 2), IFNA6 (interferon alpha 6), CDK4 (cyclin dependent kinase 4), MAPK10 (mitogen-activated protein kinase 10), HSPA1B (heat shock protein family A (Hsp70) member 1B), CD28 (CD28 molecule), IFNA17 (interferon alpha 17), CD3D (CD3d molecule), IFNA8 (interferon alpha 8), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), TLR9 (toll like receptor 9), NFKBIB (NFKB inhibitor beta), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), CD3G (CD3g molecule), IL12A (interleukin 12A), CSNK2A1 (casein kinase 2 alpha 1), MX1 (MX dynamin like GTPase 1), IRAK4 (interleukin 1 receptor associated kinase 4), CCND2 (cyclin D2), APAF1 (apoptotic peptidase activating factor 1), TLR7 (toll like receptor 7), IFNA21 (interferon alpha 21), MSN (moesin), TP73 (tumor protein p73), CCNE1 (cyclin E1), IFNA16 (interferon alpha 16), OAS3 (2'-5'-oligoadenylate synthetase 3)"], "WAG002998": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), IRF3 (interferon regulatory factor 3), MAVS (mitochondrial antiviral signaling protein), IRF7 (interferon regulatory factor 7), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), POLR2H (RNA polymerase II, I and III subunit H), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), POLR3A (RNA polymerase III subunit A), DDX58 (DExD/H-box helicase 58), POLR2L (RNA polymerase II, I and III subunit L), POLR3F (RNA polymerase III subunit F), POLR2E (RNA polymerase II, I and III subunit E), POLR3B (RNA polymerase III subunit B), POLR3H (RNA polymerase III subunit H), POLR3D (RNA polymerase III subunit D), POLR3E (RNA polymerase III subunit E), POLR1D (RNA polymerase I and III subunit D), TBK1 (TANK binding kinase 1), POLR2F (RNA polymerase II, I and III subunit F), POLR1C (RNA polymerase I and III subunit C), CASP8 (caspase 8), RIPK1 (receptor interacting serine/threonine kinase 1), POLR3C (RNA polymerase III subunit C), NFKBIA (NFKB inhibitor alpha), POLR3G (RNA polymerase III subunit G), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), ZBP1 (Z-DNA binding protein 1), IFNB1 (interferon beta 1), NFKBIB (NFKB inhibitor beta), IL1B (interleukin 1 beta), FADD (Fas associated via death domain), POLR3GL (RNA polymerase III subunit GL), TRADD (TNFRSF1A associated via death domain), IFNA5 (interferon alpha 5), RIPK3 (receptor interacting serine/threonine kinase 3), IFNA14 (interferon alpha 14), IFNA13 (interferon alpha 13), IL6 (interleukin 6), IFNA2 (interferon alpha 2), IFNA6 (interferon alpha 6), POLR2K (RNA polymerase II, I and III subunit K), CASP1 (caspase 1), ISG15 (ISG15 ubiquitin like modifier), IFNA17 (interferon alpha 17), IFNA8 (interferon alpha 8), CASP10 (caspase 10), CYLD (CYLD lysine 63 deubiquitinase), PYCARD (PYD and CARD domain containing), CXCL10 (C-X-C motif chemokine ligand 10), IL18 (interleukin 18), POLR3K (RNA polymerase III subunit K), NLRX1 (NLR family member X1), CCL5 (C-C motif chemokine ligand 5), IFNA10 (interferon alpha 10), IFNA16 (interferon alpha 16), CCL4 (C-C motif chemokine ligand 4), ATG5 (autophagy related 5), IFNA21 (interferon alpha 21), IFNA4 (interferon alpha 4), ADAR (adenosine deaminase RNA specific), TRIM25 (tripartite motif containing 25), ATG12 (autophagy related 12), IL33 (interleukin 33), AIM2 (absent in melanoma 2), RNF125 (ring finger protein 125), CCL4L2 (C-C motif chemokine ligand 4 like 2), TREX1 (three prime repair exonuclease 1), IFNA7 (interferon alpha 7), IFNA1 (interferon alpha 1), CCL4L1 (C-C motif chemokine ligand 4 like 1), STING1 (stimulator of interferon response cGAMP interactor 1), CGAS (cyclic GMP-AMP synthase)"], "WAG002999": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEP290 (centrosomal protein 290), MKS1 (MKS transition zone complex subunit 1), CC2D2A (coiled-coil and C2 domain containing 2A), TMEM67 (transmembrane protein 67), CEP164 (centrosomal protein 164), AHI1 (Abelson helper integration site 1), TMEM216 (transmembrane protein 216), B9D2 (B9 domain containing 2), B9D1 (B9 domain containing 1), NPHP1 (nephrocystin 1), CCP110 (centriolar coiled-coil protein 110), NPHP4 (nephrocystin 4), PCM1 (pericentriolar material 1), BBS2 (Bardet-Biedl syndrome 2), PDE6D (phosphodiesterase 6D), RAB8A (RAB8A, member RAS oncogene family), INVS (inversin), OFD1 (OFD1 centriole and centriolar satellite protein), BBS4 (Bardet-Biedl syndrome 4), BBS1 (Bardet-Biedl syndrome 1), BBS5 (Bardet-Biedl syndrome 5), BBS7 (Bardet-Biedl syndrome 7), TCTN1 (tectonic family member 1), TTC8 (tetratricopeptide repeat domain 8), TCTN2 (tectonic family member 2), BBS9 (Bardet-Biedl syndrome 9), TMEM231 (transmembrane protein 231), TMEM17 (transmembrane protein 17), CETN2 (centrin 2), PCNT (pericentrin), NPHP3 (nephrocystin 3), CEP41 (centrosomal protein 41), RPGRIP1L (RPGRIP1 like), RAB3IP (RAB3A interacting protein), ATM (ATM serine/threonine kinase), ARL13B (ADP ribosylation factor like GTPase 13B), PARP1 (poly(ADP-ribose) polymerase 1), RHOA (ras homolog family member A), ARL3 (ADP ribosylation factor like GTPase 3), PDE6B (phosphodiesterase 6B), KAT5 (lysine acetyltransferase 5), RHEB (Ras homolog, mTORC1 binding), PDE6A (phosphodiesterase 6A), PDE6G (phosphodiesterase 6G), DVL3 (dishevelled segment polarity protein 3), RAD50 (RAD50 double strand break repair protein), NEK8 (NIMA related kinase 8), RP2 (RP2 activator of ARL3 GTPase), ARL2 (ADP ribosylation factor like GTPase 2), FLNA (filamin A), UNC119 (unc-119 lipid binding chaperone), DVL1 (dishevelled segment polarity protein 1), CEP97 (centrosomal protein 97), ZNF423 (zinc finger protein 423), MTOR (mechanistic target of rapamycin kinase), CETN1 (centrin 1), TMEM237 (transmembrane protein 237), INPP5E (inositol polyphosphate-5-phosphatase E), MYO5A (myosin VA), SHH (sonic hedgehog signaling molecule), TCTN3 (tectonic family member 3), MYO6 (myosin VI), SUFU (SUFU negative regulator of hedgehog signaling), NIN (ninein), KIAA0586 (KIAA0586), ATF4 (activating transcription factor 4), ARR3 (arrestin 3), ANKS6 (ankyrin repeat and sterile alpha motif domain containing 6), MRE11 (MRE11 homolog, double strand break repair nuclease), CPLANE1 (ciliogenesis and planar polarity effector 1), ARMC9 (armadillo repeat containing 9), CEP120 (centrosomal protein 120), CSPP1 (centrosome and spindle pole associated protein 1), TMEM138 (transmembrane protein 138), PIBF1 (progesterone immunomodulatory binding factor 1), CEP104 (centrosomal protein 104)"], "WAG003000": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), HDAC3 (histone deacetylase 3), EGFR (epidermal growth factor receptor), RAN (RAN, member RAS oncogene family), KPNB1 (karyopherin subunit beta 1), PLK1 (polo like kinase 1), RANBP1 (RAN binding protein 1), CUL3 (cullin 3), XPO1 (exportin 1), SHH (sonic hedgehog signaling molecule), NCOR1 (nuclear receptor corepressor 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), TBX1 (T-box transcription factor 1), RCC1 (regulator of chromosome condensation 1), SREBF2 (sterol regulatory element binding transcription factor 2), FGF8 (fibroblast growth factor 8), GP1BB (glycoprotein Ib platelet subunit beta), RANGAP1 (Ran GTPase activating protein 1), BCL2 (BCL2 apoptosis regulator), PPP1CB (protein phosphatase 1 catalytic subunit beta), HIRA (histone cell cycle regulator), SLC2A4 (solute carrier family 2 member 4), GP9 (glycoprotein IX platelet), GP5 (glycoprotein V platelet), GP1BA (glycoprotein Ib platelet subunit alpha), FGFR2 (fibroblast growth factor receptor 2), VWF (von Willebrand factor), FGFR1 (fibroblast growth factor receptor 1), PAK4 (p21 (RAC1) activated kinase 4), SRF (serum response factor), FGF10 (fibroblast growth factor 10), MED15 (mediator complex subunit 15), CDC42 (cell division cycle 42), GNB1L (G protein subunit beta 1 like), CRKL (CRK like proto-oncogene, adaptor protein), CLDN5 (claudin 5), ALDH1A2 (aldehyde dehydrogenase 1 family member A2), DGCR8 (DGCR8 microprocessor complex subunit), GSC2 (goosecoid homeobox 2), RBX1 (ring-box 1), CHRD (chordin), ACTA2 (actin alpha 2, smooth muscle), TNPO1 (transportin 1), DROSHA (drosha ribonuclease III), RTN4 (reticulon 4), ARVCF (ARVCF delta catenin family member), ASF1A (anti-silencing function 1A histone chaperone), SREBF1 (sterol regulatory element binding transcription factor 1), KLHL22 (kelch like family member 22), FOXA2 (forkhead box A2), ALDH4A1 (aldehyde dehydrogenase 4 family member A1), PRODH (proline dehydrogenase 1), NKX2-5 (NK2 homeobox 5), COMT (catechol-O-methyltransferase), PITX2 (paired like homeodomain 2), CLTCL1 (clathrin heavy chain like 1), CDC45 (cell division cycle 45), CBX5 (chromobox 5), DGCR2 (DiGeorge syndrome critical region gene 2), ZNF74 (zinc finger protein 74), SLC25A1 (solute carrier family 25 member 1), CLDN3 (claudin 3), NPRL3 (NPR3 like, GATOR1 complex subunit), PAX3 (paired box 3), CLDN1 (claudin 1), SHOC2 (SHOC2 leucine rich repeat scaffold protein), LZTR1 (leucine zipper like transcription regulator 1), RELN (reelin), RTN4R (reticulon 4 receptor), TXNRD2 (thioredoxin reductase 2), THAP7 (THAP domain containing 7), CDH15 (cadherin 15), CYP26A1 (cytochrome P450 family 26 subfamily A member 1), GLUD1 (glutamate dehydrogenase 1), OAT (ornithine aminotransferase), NPRL2 (NPR2 like, GATOR1 complex subunit), HAND2 (heart and neural crest derivatives expressed 2), CYP26B1 (cytochrome P450 family 26 subfamily B member 1), HIRIP3 (HIRA interacting protein 3), TRMT2A (tRNA methyltransferase 2 homolog A), MAG (myelin associated glycoprotein), ARNTL (aryl hydrocarbon receptor nuclear translocator like), ZDHHC8 (zinc finger DHHC-type palmitoyltransferase 8), RORC (RAR related orphan receptor C), GBX2 (gastrulation brain homeobox 2), FOXC2 (forkhead box C2), FOXC1 (forkhead box C1), HES1 (hes family bHLH transcription factor 1), DGCR6L (DiGeorge syndrome critical region gene 6 like), TSKS (testis specific serine kinase substrate), TSSK2 (testis specific serine kinase 2), CYP26C1 (cytochrome P450 family 26 subfamily C member 1), SERPIND1 (serpin family D member 1), DEPDC5 (DEP domain containing 5, GATOR1 subcomplex subunit), C22orf39 (chromosome 22 open reading frame 39), DRD2 (dopamine receptor D2), SNAP29 (synaptosome associated protein 29), P2RX6 (purinergic receptor P2X 6), MRPL40 (mitochondrial ribosomal protein L40), ACTC1 (actin alpha cardiac muscle 1)"], "WAG003001": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), TP53 (tumor protein p53), CASP3 (caspase 3), ITGA6 (integrin subunit alpha 6), BCL2 (BCL2 apoptosis regulator), CCND1 (cyclin D1), ITGB1 (integrin subunit beta 1), CDKN1A (cyclin dependent kinase inhibitor 1A), MYC (MYC proto-oncogene, bHLH transcription factor), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), ITGAV (integrin subunit alpha V), CDKN1B (cyclin dependent kinase inhibitor 1B), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), CASP8 (caspase 8), ITGA2 (integrin subunit alpha 2), CDK2 (cyclin dependent kinase 2), ITGA3 (integrin subunit alpha 3), ITGA2B (integrin subunit alpha 2b), CASP9 (caspase 9), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), RB1 (RB transcriptional corepressor 1), NFKBIA (NFKB inhibitor alpha), CDK4 (cyclin dependent kinase 4), AKT2 (AKT serine/threonine kinase 2), TRAF6 (TNF receptor associated factor 6), BAX (BCL2 associated X, apoptosis regulator), AKT3 (AKT serine/threonine kinase 3), BCL2L1 (BCL2 like 1), E2F1 (E2F transcription factor 1), PTEN (phosphatase and tensin homolog), BIRC2 (baculoviral IAP repeat containing 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), SKP1 (S-phase kinase associated protein 1), FN1 (fibronectin 1), BIRC3 (baculoviral IAP repeat containing 3), PTK2 (protein tyrosine kinase 2), CDK6 (cyclin dependent kinase 6), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), LAMC1 (laminin subunit gamma 1), TRAF2 (TNF receptor associated factor 2), LAMB2 (laminin subunit beta 2), LAMB1 (laminin subunit beta 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), LAMA4 (laminin subunit alpha 4), CCNE1 (cyclin E1), LAMA5 (laminin subunit alpha 5), LAMA1 (laminin subunit alpha 1), LAMC2 (laminin subunit gamma 2), CCNE2 (cyclin E2), LAMC3 (laminin subunit gamma 3), LAMA2 (laminin subunit alpha 2), MAX (MYC associated factor X), LAMB3 (laminin subunit beta 3), LAMA3 (laminin subunit alpha 3), TRAF1 (TNF receptor associated factor 1), RXRA (retinoid X receptor alpha), CYCS (cytochrome c, somatic), APAF1 (apoptotic peptidase activating factor 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), E2F3 (E2F transcription factor 3), COL4A1 (collagen type IV alpha 1 chain), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), LAMB4 (laminin subunit beta 4), GADD45A (growth arrest and DNA damage inducible alpha), COL4A6 (collagen type IV alpha 6 chain), NFKBIB (NFKB inhibitor beta), COL4A4 (collagen type IV alpha 4 chain), PTGS2 (prostaglandin-endoperoxide synthase 2), BID (BH3 interacting domain death agonist), TRAF3 (TNF receptor associated factor 3), E2F2 (E2F transcription factor 2), COL4A5 (collagen type IV alpha 5 chain), COL4A2 (collagen type IV alpha 2 chain), CDKN1C (cyclin dependent kinase inhibitor 1C), CDKN2B (cyclin dependent kinase inhibitor 2B), ZBTB17 (zinc finger and BTB domain containing 17), COL4A3 (collagen type IV alpha 3 chain), TRAF5 (TNF receptor associated factor 5), CKS1B (CDC28 protein kinase regulatory subunit 1B), RXRG (retinoid X receptor gamma), BAK1 (BCL2 antagonist/killer 1), GADD45G (growth arrest and DNA damage inducible gamma), RARB (retinoic acid receptor beta), TRAF4 (TNF receptor associated factor 4), BIRC7 (baculoviral IAP repeat containing 7), NOS2 (nitric oxide synthase 2), CKS2 (CDC28 protein kinase regulatory subunit 2), RXRB (retinoid X receptor beta), GADD45B (growth arrest and DNA damage inducible beta), DDB2 (damage specific DNA binding protein 2), FHIT (fragile histidine triad diadenosine triphosphatase), BIRC8 (baculoviral IAP repeat containing 8), POLK (DNA polymerase kappa)"], "WAG003002": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), EGFR (epidermal growth factor receptor), MAPK3 (mitogen-activated protein kinase 3), VEGFA (vascular endothelial growth factor A), RAC1 (Rac family small GTPase 1), GRB2 (growth factor receptor bound protein 2), PRKCA (protein kinase C alpha), STAT3 (signal transducer and activator of transcription 3), MAPK14 (mitogen-activated protein kinase 14), FYN (FYN proto-oncogene, Src family tyrosine kinase), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK8 (mitogen-activated protein kinase 8), HRAS (HRas proto-oncogene, GTPase), CTNNB1 (catenin beta 1), PRKCD (protein kinase C delta), CCND1 (cyclin D1), CDC42 (cell division cycle 42), IRS1 (insulin receptor substrate 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SHC1 (SHC adaptor protein 1), RELA (RELA proto-oncogene, NF-kB subunit), MYC (MYC proto-oncogene, bHLH transcription factor), JAK2 (Janus kinase 2), NFKB1 (nuclear factor kappa B subunit 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL2 (interleukin 2), RHOA (ras homolog family member A), PTK2 (protein tyrosine kinase 2), MAP2K1 (mitogen-activated protein kinase kinase 1), MTOR (mechanistic target of rapamycin kinase), PLCG1 (phospholipase C gamma 1), CASP3 (caspase 3), SP1 (Sp1 transcription factor), CRK (CRK proto-oncogene, adaptor protein), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PXN (paxillin), PRKCE (protein kinase C epsilon), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), KRAS (KRAS proto-oncogene, GTPase), GSK3B (glycogen synthase kinase 3 beta), MAPK9 (mitogen-activated protein kinase 9), PTGS2 (prostaglandin-endoperoxide synthase 2), RPS6KB1 (ribosomal protein S6 kinase B1), CDKN1A (cyclin dependent kinase inhibitor 1A), BCAR1 (BCAR1 scaffold protein, Cas family member), ITGB1 (integrin subunit beta 1), CREB1 (cAMP responsive element binding protein 1), PRKCQ (protein kinase C theta), CDH1 (cadherin 1), KIT (KIT proto-oncogene, receptor tyrosine kinase), PAK1 (p21 (RAC1) activated kinase 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), NFKBIA (NFKB inhibitor alpha), BCL2L1 (BCL2 like 1), EGR1 (early growth response 1), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), PRKD1 (protein kinase D1), CDKN2A (cyclin dependent kinase inhibitor 2A), ARRB1 (arrestin beta 1), CDKN1B (cyclin dependent kinase inhibitor 1B), PPARG (peroxisome proliferator activated receptor gamma), ARRB2 (arrestin beta 2), ATF2 (activating transcription factor 2), ROCK1 (Rho associated coiled-coil containing protein kinase 1), PRKCH (protein kinase C eta), FOXO1 (forkhead box O1), ELK1 (ETS transcription factor ELK1), BIRC5 (baculoviral IAP repeat containing 5), KLF4 (Kruppel like factor 4), CD44 (CD44 molecule (Indian blood group)), KAT5 (lysine acetyltransferase 5), BAD (BCL2 associated agonist of cell death), BIRC2 (baculoviral IAP repeat containing 2), TJP1 (tight junction protein 1), GAST (gastrin), ANXA2 (annexin A2), BIRC3 (baculoviral IAP repeat containing 3), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), FOXO3 (forkhead box O3), MEF2C (myocyte enhancer factor 2C), ELAVL1 (ELAV like RNA binding protein 1), MAP3K11 (mitogen-activated protein kinase kinase kinase 11), CCKBR (cholecystokinin B receptor), RHOB (ras homolog family member B), HDAC7 (histone deacetylase 7), BMP2 (bone morphogenetic protein 2), PRKD2 (protein kinase D2), RPS6 (ribosomal protein S6), SLC9A1 (solute carrier family 9 member A1), MMP7 (matrix metallopeptidase 7), SERPINE1 (serpin family E member 1), MEF2D (myocyte enhancer factor 2D)"], "WAG003003": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLA1 (DNA polymerase alpha 1, catalytic subunit), PRIM1 (DNA primase subunit 1), RPA3 (replication protein A3), MCM7 (minichromosome maintenance complex component 7), MCM4 (minichromosome maintenance complex component 4), POLA2 (DNA polymerase alpha 2, accessory subunit), MCM3 (minichromosome maintenance complex component 3), RPA1 (replication protein A1), MCM5 (minichromosome maintenance complex component 5), MCM2 (minichromosome maintenance complex component 2), CDC6 (cell division cycle 6), MCM6 (minichromosome maintenance complex component 6), POLE (DNA polymerase epsilon, catalytic subunit), CDK2 (cyclin dependent kinase 2), RPA2 (replication protein A2), UBC (ubiquitin C), PCNA (proliferating cell nuclear antigen), POLE2 (DNA polymerase epsilon 2, accessory subunit), RFC4 (replication factor C subunit 4), ORC1 (origin recognition complex subunit 1), CDC45 (cell division cycle 45), CDC7 (cell division cycle 7), ORC5 (origin recognition complex subunit 5), CDT1 (chromatin licensing and DNA replication factor 1), ORC3 (origin recognition complex subunit 3), ORC6 (origin recognition complex subunit 6), MCM10 (minichromosome maintenance 10 replication initiation factor), ORC2 (origin recognition complex subunit 2), RFC5 (replication factor C subunit 5), RFC3 (replication factor C subunit 3), ORC4 (origin recognition complex subunit 4), POLD1 (DNA polymerase delta 1, catalytic subunit), RFC2 (replication factor C subunit 2), DBF4 (DBF4 zinc finger), RPA4 (replication protein A4), GMNN (geminin DNA replication inhibitor), POLD2 (DNA polymerase delta 2, accessory subunit), RFC1 (replication factor C subunit 1), POLD4 (DNA polymerase delta 4, accessory subunit), POLD3 (DNA polymerase delta 3, accessory subunit), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), PRIM2 (DNA primase subunit 2)"], "WAG003005": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), RELA (RELA proto-oncogene, NF-kB subunit), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), NFKB1 (nuclear factor kappa B subunit 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK3 (mitogen-activated protein kinase 3), MAPK8 (mitogen-activated protein kinase 8), MAPK14 (mitogen-activated protein kinase 14), TNF (tumor necrosis factor), TRAF6 (TNF receptor associated factor 6), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), EP300 (E1A binding protein p300), STAT3 (signal transducer and activator of transcription 3), CREBBP (CREB binding protein), MYC (MYC proto-oncogene, bHLH transcription factor), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), JAK1 (Janus kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), STAT1 (signal transducer and activator of transcription 1), JAK2 (Janus kinase 2), MAP2K1 (mitogen-activated protein kinase kinase 1), HRAS (HRas proto-oncogene, GTPase), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), BCL2 (BCL2 apoptosis regulator), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), GRB2 (growth factor receptor bound protein 2), IL6 (interleukin 6), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IRF3 (interferon regulatory factor 3), PRKCA (protein kinase C alpha), FASLG (Fas ligand), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), IRF7 (interferon regulatory factor 7), TGFB1 (transforming growth factor beta 1), TLR3 (toll like receptor 3), NRAS (NRAS proto-oncogene, GTPase), IRAK1 (interleukin 1 receptor associated kinase 1), JAK3 (Janus kinase 3), MAPK11 (mitogen-activated protein kinase 11), CASP3 (caspase 3), MAPK9 (mitogen-activated protein kinase 9), CASP8 (caspase 8), SMAD4 (SMAD family member 4), TYK2 (tyrosine kinase 2), SMAD3 (SMAD family member 3), TLR4 (toll like receptor 4), CREB1 (cAMP responsive element binding protein 1), CDKN1A (cyclin dependent kinase inhibitor 1A), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), MYD88 (MYD88 innate immune signal transduction adaptor), ATF2 (activating transcription factor 2), IFNB1 (interferon beta 1), MAP2K6 (mitogen-activated protein kinase kinase 6), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), MAP2K4 (mitogen-activated protein kinase kinase 4), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), BAX (BCL2 associated X, apoptosis regulator), MAP2K3 (mitogen-activated protein kinase kinase 3), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), MAPK13 (mitogen-activated protein kinase 13), FADD (Fas associated via death domain), MAPK12 (mitogen-activated protein kinase 12), SMAD2 (SMAD family member 2), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), BRAF (B-Raf proto-oncogene, serine/threonine kinase), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), KRAS (KRAS proto-oncogene, GTPase), MAVS (mitochondrial antiviral signaling protein), CASP9 (caspase 9), IFNAR1 (interferon alpha and beta receptor subunit 1), TRAF3 (TNF receptor associated factor 3), TIRAP (TIR domain containing adaptor protein), TBK1 (TANK binding kinase 1), STAT2 (signal transducer and activator of transcription 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), TICAM1 (toll like receptor adaptor molecule 1), STAT5A (signal transducer and activator of transcription 5A), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), MAPK10 (mitogen-activated protein kinase 10), MAP2K2 (mitogen-activated protein kinase kinase 2), PRKCB (protein kinase C beta), STAT6 (signal transducer and activator of transcription 6), BAD (BCL2 associated agonist of cell death), NFATC1 (nuclear factor of activated T cells 1), DDX58 (DExD/H-box helicase 58), TGFBR1 (transforming growth factor beta receptor 1), MAP2K7 (mitogen-activated protein kinase kinase 7), CYCS (cytochrome c, somatic), FAS (Fas cell surface death receptor), NFATC2 (nuclear factor of activated T cells 2), AKT2 (AKT serine/threonine kinase 2), PTK2B (protein tyrosine kinase 2 beta), AKT3 (AKT serine/threonine kinase 3), ELK1 (ETS transcription factor ELK1)"], "WAG003006": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ESR1 (estrogen receptor 1), ATM (ATM serine/threonine kinase), TNF (tumor necrosis factor), AR (androgen receptor), MDM2 (MDM2 proto-oncogene), PARP1 (poly(ADP-ribose) polymerase 1), EP300 (E1A binding protein p300), CREBBP (CREB binding protein), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), NOS3 (nitric oxide synthase 3), LIG4 (DNA ligase 4), BRCA2 (BRCA2 DNA repair associated), SOD2 (superoxide dismutase 2), XRCC5 (X-ray repair cross complementing 5), CCNT1 (cyclin T1), CDK9 (cyclin dependent kinase 9), MLH1 (mutL homolog 1), CYP1A1 (cytochrome P450 family 1 subfamily A member 1), BCL2 (BCL2 apoptosis regulator), AHR (aryl hydrocarbon receptor), ESR2 (estrogen receptor 2), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), MSH4 (mutS homolog 4), NQO1 (NAD(P)H quinone dehydrogenase 1), CAT (catalase), XPC (XPC complex subunit, DNA damage recognition and repair factor), RFC1 (replication factor C subunit 1), MTHFR (methylenetetrahydrofolate reductase), MLH3 (mutL homolog 3), PUM2 (pumilio RNA binding family member 2), DAZL (deleted in azoospermia like), XRCC3 (X-ray repair cross complementing 3), MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1), MTR (5-methyltetrahydrofolate-homocysteine methyltransferase), SPO11 (SPO11 initiator of meiotic double stranded breaks), HMGA1 (high mobility group AT-hook 1), MSH5 (mutS homolog 5), XRCC4 (X-ray repair cross complementing 4), ARNTL (aryl hydrocarbon receptor nuclear translocator like), MMP2 (matrix metallopeptidase 2), NOS2 (nitric oxide synthase 2), MMP9 (matrix metallopeptidase 9), CCNA1 (cyclin A1), SHMT1 (serine hydroxymethyltransferase 1), PON1 (paraoxonase 1), XRCC2 (X-ray repair cross complementing 2), FAS (Fas cell surface death receptor), POLB (DNA polymerase beta), CCNT2 (cyclin T2), CLOCK (clock circadian regulator), CLU (clusterin), MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase), PMS2 (PMS1 homolog 2, mismatch repair system component), DDX4 (DEAD-box helicase 4), GPX1 (glutathione peroxidase 1), FASLG (Fas ligand), DAZ1 (deleted in azoospermia 1), GNAO1 (G protein subunit alpha o1), NFE2L2 (nuclear factor, erythroid 2 like 2), CYP26B1 (cytochrome P450 family 26 subfamily B member 1), KDM3A (lysine demethylase 3A), BHMT (betaine--homocysteine S-methyltransferase), LTF (lactotransferrin), TEX15 (testis expressed 15, meiosis and synapsis associated), INSR (insulin receptor), PON2 (paraoxonase 2), UBD (ubiquitin D), THBS1 (thrombospondin 1), KLK2 (kallikrein related peptidase 2), SOD3 (superoxide dismutase 3), UBE2B (ubiquitin conjugating enzyme E2 B), TRIP13 (thyroid hormone receptor interactor 13), CCNK (cyclin K), AHRR (aryl-hydrocarbon receptor repressor), DAZ4 (deleted in azoospermia 4), PRM1 (protamine 1), BRDT (bromodomain testis associated), PIWIL1 (piwi like RNA-mediated gene silencing 1), NOS1 (nitric oxide synthase 1), PIWIL2 (piwi like RNA-mediated gene silencing 2), PRMT6 (protein arginine methyltransferase 6), MOV10L1 (Mov10 like RISC complex RNA helicase 1), SEMG1 (semenogelin 1), TCN2 (transcobalamin 2), APOB (apolipoprotein B), PRM2 (protamine 2), STRA8 (stimulated by retinoic acid 8), NANOS1 (nanos C2HC-type zinc finger 1), PEMT (phosphatidylethanolamine N-methyltransferase), CYP17A1 (cytochrome P450 family 17 subfamily A member 1), ABCB1 (ATP binding cassette subfamily B member 1), UBR2 (ubiquitin protein ligase E3 component n-recognin 2), PSAT1 (phosphoserine aminotransferase 1), POLG (DNA polymerase gamma, catalytic subunit), ETV5 (ETS variant transcription factor 5), RAG1 (recombination activating 1), DAZ3 (deleted in azoospermia 3), USP26 (ubiquitin specific peptidase 26), RGS9 (regulator of G protein signaling 9), DAZ2 (deleted in azoospermia 2)"], "WAG003007": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MTOR (mechanistic target of rapamycin kinase), TP53 (tumor protein p53), CCND1 (cyclin D1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PTEN (phosphatase and tensin homolog), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), VEGFA (vascular endothelial growth factor A), EGFR (epidermal growth factor receptor), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), NFKB1 (nuclear factor kappa B subunit 1), HRAS (HRas proto-oncogene, GTPase), AKT2 (AKT serine/threonine kinase 2), NOTCH1 (notch receptor 1), CTNNB1 (catenin beta 1), ERBB2 (erb-b2 receptor tyrosine kinase 2), CDKN1A (cyclin dependent kinase inhibitor 1A), TSC2 (TSC complex subunit 2), NRAS (NRAS proto-oncogene, GTPase), RELA (RELA proto-oncogene, NF-kB subunit), IGF1R (insulin like growth factor 1 receptor), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), AKT3 (AKT serine/threonine kinase 3), KRAS (KRAS proto-oncogene, GTPase), CDKN2A (cyclin dependent kinase inhibitor 2A), PDPK1 (3-phosphoinositide dependent protein kinase 1), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), TSC1 (TSC complex subunit 1), SMAD4 (SMAD family member 4), RPTOR (regulatory associated protein of MTOR complex 1), RHEB (Ras homolog, mTORC1 binding), E2F1 (E2F transcription factor 1), MLST8 (MTOR associated protein, LST8 homolog), FGFR1 (fibroblast growth factor receptor 1), RB1 (RB transcriptional corepressor 1), GAB1 (GRB2 associated binding protein 1), TERT (telomerase reverse transcriptase), CASP8 (caspase 8), RPS6 (ribosomal protein S6), STK11 (serine/threonine kinase 11), RICTOR (RPTOR independent companion of MTOR complex 2), FGFR2 (fibroblast growth factor receptor 2), CDK4 (cyclin dependent kinase 4), EIF4E (eukaryotic translation initiation factor 4E), REL (REL proto-oncogene, NF-kB subunit), CDK6 (cyclin dependent kinase 6), MAPKAP1 (MAPK associated protein 1), BIRC2 (baculoviral IAP repeat containing 2), CUL3 (cullin 3), TGFBR2 (transforming growth factor beta receptor 2), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), NFKB2 (nuclear factor kappa B subunit 2), FGFR3 (fibroblast growth factor receptor 3), TP63 (tumor protein p63), RPS6KB2 (ribosomal protein S6 kinase B2), NFE2L2 (nuclear factor, erythroid 2 like 2), FKBP1A (FKBP prolyl isomerase 1A), NOTCH2 (notch receptor 2), DDIT4 (DNA damage inducible transcript 4), KEAP1 (kelch like ECH associated protein 1), NUMB (NUMB endocytic adaptor protein), FADD (Fas associated via death domain), TRAF3 (TNF receptor associated factor 3), MAML1 (mastermind like transcriptional coactivator 1), SESN1 (sestrin 1), FAT1 (FAT atypical cadherin 1), SESN2 (sestrin 2), IRF6 (interferon regulatory factor 6), LOC101928143 (uncharacterized LOC101928143), MIRLET7C (microRNA let-7c), AJUBA (ajuba LIM protein), CSMD3 (CUB and Sushi multiple domains 3)"], "WAG003008": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "HRAS (HRas proto-oncogene, GTPase), AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), NRAS (NRAS proto-oncogene, GTPase), TP53 (tumor protein p53), CCND1 (cyclin D1), GRB2 (growth factor receptor bound protein 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), RAC1 (Rac family small GTPase 1), CDKN1A (cyclin dependent kinase inhibitor 1A), MAPK3 (mitogen-activated protein kinase 3), KRAS (KRAS proto-oncogene, GTPase), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PTEN (phosphatase and tensin homolog), MDM2 (MDM2 proto-oncogene), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RB1 (RB transcriptional corepressor 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), CALM3 (calmodulin 3), CDKN2A (cyclin dependent kinase inhibitor 2A), KIT (KIT proto-oncogene, receptor tyrosine kinase), CDK4 (cyclin dependent kinase 4), AKT2 (AKT serine/threonine kinase 2), CREB1 (cAMP responsive element binding protein 1), ERBB4 (erb-b2 receptor tyrosine kinase 4), MAP2K2 (mitogen-activated protein kinase kinase 2), KDR (kinase insert domain receptor), BRAF (B-Raf proto-oncogene, serine/threonine kinase), BAD (BCL2 associated agonist of cell death), SHC2 (SHC adaptor protein 2), BAX (BCL2 associated X, apoptosis regulator), E2F1 (E2F transcription factor 1), CDK6 (cyclin dependent kinase 6), AKT3 (AKT serine/threonine kinase 3), PAK1 (p21 (RAC1) activated kinase 1), CDH1 (cadherin 1), ARAF (A-Raf proto-oncogene, serine/threonine kinase), GADD45A (growth arrest and DNA damage inducible alpha), ETS1 (ETS proto-oncogene 1, transcription factor), ELK1 (ETS transcription factor ELK1), E2F3 (E2F transcription factor 3), MITF (melanocyte inducing transcription factor), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), E2F2 (E2F transcription factor 2), VCL (vinculin), NF1 (neurofibromin 1), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), GADD45B (growth arrest and DNA damage inducible beta), GADD45G (growth arrest and DNA damage inducible gamma), CALML5 (calmodulin like 5), BAK1 (BCL2 antagonist/killer 1), CALML3 (calmodulin like 3), DDB2 (damage specific DNA binding protein 2), CALML6 (calmodulin like 6), GRM3 (glutamate metabotropic receptor 3), PREX2 (phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2), CALM2 (calmodulin 2), STK19 (serine/threonine kinase 19), CALML4 (calmodulin like 4), POLK (DNA polymerase kappa), CALM1 (calmodulin 1)"], "WAG003009": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DBT (dihydrolipoamide branched chain transacylase E2), DLD (dihydrolipoamide dehydrogenase), BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta), BCKDHA (branched chain keto acid dehydrogenase E1 subunit alpha), IVD (isovaleryl-CoA dehydrogenase), ACADSB (acyl-CoA dehydrogenase short/branched chain), ACAD8 (acyl-CoA dehydrogenase family member 8), MCCC1 (methylcrotonoyl-CoA carboxylase 1), MCCC2 (methylcrotonoyl-CoA carboxylase 2), AUH (AU RNA binding methylglutaconyl-CoA hydratase), HSD17B10 (hydroxysteroid 17-beta dehydrogenase 10), ALDH6A1 (aldehyde dehydrogenase 6 family member A1), HMGCLL1 (3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1), MLYCD (malonyl-CoA decarboxylase), HIBCH (3-hydroxyisobutyryl-CoA hydrolase), MMUT (methylmalonyl-CoA mutase)"], "WAG003011": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), ATP2B2 (ATPase plasma membrane Ca2+ transporting 2), GSR (glutathione-disulfide reductase), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), ATP2B1 (ATPase plasma membrane Ca2+ transporting 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), GPX4 (glutathione peroxidase 4), ATP2B3 (ATPase plasma membrane Ca2+ transporting 3), GGT1 (gamma-glutamyltransferase 1), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), RXRA (retinoid X receptor alpha), ATP2B4 (ATPase plasma membrane Ca2+ transporting 4), GCLC (glutamate-cysteine ligase catalytic subunit), VDR (vitamin D receptor), BCL2 (BCL2 apoptosis regulator), SLC8A1 (solute carrier family 8 member A1), NFE2L2 (nuclear factor, erythroid 2 like 2), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), G6PD (glucose-6-phosphate dehydrogenase), KCNQ2 (potassium voltage-gated channel subfamily Q member 2), KCNQ3 (potassium voltage-gated channel subfamily Q member 3), CYP27B1 (cytochrome P450 family 27 subfamily B member 1), CALB1 (calbindin 1), CYP27A1 (cytochrome P450 family 27 subfamily A member 1), PVALB (parvalbumin), TPH2 (tryptophan hydroxylase 2), TPH1 (tryptophan hydroxylase 1), GRM5 (glutamate metabotropic receptor 5), CACNA1C (calcium voltage-gated channel subunit alpha1 C), KDM3A (lysine demethylase 3A), KDM1A (lysine demethylase 1A), GGT2 (gamma-glutamyltransferase 2), KDM6B (lysine demethylase 6B), LOC102724197 (inactive glutathione hydrolase 2), KDM1B (lysine demethylase 1B), CHRM1 (cholinergic receptor muscarinic 1)"], "WAG003013": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IRF3 (interferon regulatory factor 3), DDX58 (DExD/H-box helicase 58), IFIH1 (interferon induced with helicase C domain 1), OAS1 (2'-5'-oligoadenylate synthetase 1), MAVS (mitochondrial antiviral signaling protein), RNASEL (ribonuclease L), ADAR (adenosine deaminase RNA specific), RNASEH2B (ribonuclease H2 subunit B), RNASEH2C (ribonuclease H2 subunit C), IFNB1 (interferon beta 1), RNASEH2A (ribonuclease H2 subunit A), SAMHD1 (SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1), TREX1 (three prime repair exonuclease 1), RNASET2 (ribonuclease T2), CGAS (cyclic GMP-AMP synthase), STING1 (stimulator of interferon response cGAMP interactor 1)"], "WAG003014": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTGS2 (prostaglandin-endoperoxide synthase 2), VEGFA (vascular endothelial growth factor A), NOS3 (nitric oxide synthase 3), NFKB1 (nuclear factor kappa B subunit 1), PTGS1 (prostaglandin-endoperoxide synthase 1), PPARA (peroxisome proliferator activated receptor alpha), PDK1 (pyruvate dehydrogenase kinase 1), WNT1 (Wnt family member 1), MIR15B (microRNA 15b), H19 (H19 imprinted maternally expressed transcript), ABCC4 (ATP binding cassette subfamily C member 4), MIR32 (microRNA 32), MIR98 (microRNA 98), LOC102724852 (uncharacterized LOC102724852), MIR26B (microRNA 26b), MIR126 (microRNA 126), MIR1-1 (microRNA 1-1), MIR155 (microRNA 155), MVD (mevalonate diphosphate decarboxylase)"], "WAG003015": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DHCR7 (7-dehydrocholesterol reductase), SREBF2 (sterol regulatory element binding transcription factor 2), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), SQLE (squalene epoxidase), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), FDFT1 (farnesyl-diphosphate farnesyltransferase 1), MSMO1 (methylsterol monooxygenase 1), DHCR24 (24-dehydrocholesterol reductase), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), FDPS (farnesyl diphosphate synthase), IDI1 (isopentenyl-diphosphate delta isomerase 1), NSDHL (NAD(P) dependent steroid dehydrogenase-like), LSS (lanosterol synthase), MVD (mevalonate diphosphate decarboxylase), FASN (fatty acid synthase), PMVK (phosphomevalonate kinase), MVK (mevalonate kinase), TM7SF2 (transmembrane 7 superfamily member 2), SCD (stearoyl-CoA desaturase), FADS2 (fatty acid desaturase 2), HSD17B7 (hydroxysteroid 17-beta dehydrogenase 7), ACAT2 (acetyl-CoA acetyltransferase 2), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2), SREBF1 (sterol regulatory element binding transcription factor 1), CH25H (cholesterol 25-hydroxylase), EBP (EBP cholestenol delta-isomerase), CYP27A1 (cytochrome P450 family 27 subfamily A member 1), LBR (lamin B receptor), ABCA1 (ATP binding cassette subfamily A member 1), GGPS1 (geranylgeranyl diphosphate synthase 1), CYP46A1 (cytochrome P450 family 46 subfamily A member 1), SOAT1 (sterol O-acyltransferase 1), SOAT2 (sterol O-acyltransferase 2), FADS1 (fatty acid desaturase 1), NR1H3 (nuclear receptor subfamily 1 group H member 3), ELOVL5 (ELOVL fatty acid elongase 5), ACSL4 (acyl-CoA synthetase long chain family member 4), ACSL3 (acyl-CoA synthetase long chain family member 3), ACSL1 (acyl-CoA synthetase long chain family member 1), ELOVL2 (ELOVL fatty acid elongase 2), NR1H2 (nuclear receptor subfamily 1 group H member 2), ABCG1 (ATP binding cassette subfamily G member 1), ELOVL3 (ELOVL fatty acid elongase 3), ACOT2 (acyl-CoA thioesterase 2), MYLIP (myosin regulatory light chain interacting protein), ELOVL4 (ELOVL fatty acid elongase 4), SC5D (sterol-C5-desaturase)"], "WAG003018": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ALOX5 (arachidonate 5-lipoxygenase), CYP4F2 (cytochrome P450 family 4 subfamily F member 2), CYP4A11 (cytochrome P450 family 4 subfamily A member 11), CYP4A22 (cytochrome P450 family 4 subfamily A member 22), ALOX12 (arachidonate 12-lipoxygenase, 12S type), ALOX15B (arachidonate 15-lipoxygenase type B), ALOX15 (arachidonate 15-lipoxygenase), ACOX1 (acyl-CoA oxidase 1), PPARA (peroxisome proliferator activated receptor alpha), CYSLTR1 (cysteinyl leukotriene receptor 1), ACOX3 (acyl-CoA oxidase 3, pristanoyl), ACOX2 (acyl-CoA oxidase 2), EHHADH (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase), ACAA1 (acetyl-CoA acyltransferase 1), CYSLTR2 (cysteinyl leukotriene receptor 2), LTB4R (leukotriene B4 receptor), LTC4S (leukotriene C4 synthase), LTB4R2 (leukotriene B4 receptor 2), FPR2 (formyl peptide receptor 2), LTA4H (leukotriene A4 hydrolase), PPARD (peroxisome proliferator activated receptor delta), CYP4F12 (cytochrome P450 family 4 subfamily F member 12), GGT5 (gamma-glutamyltransferase 5), TRPA1 (transient receptor potential cation channel subfamily A member 1), TRPV1 (transient receptor potential cation channel subfamily V member 1), DPEP1 (dipeptidase 1), PTGR2 (prostaglandin reductase 2), HPGD (15-hydroxyprostaglandin dehydrogenase), PTGR1 (prostaglandin reductase 1)"], "WAG003019": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLD1 (phospholipase D1), PTDSS1 (phosphatidylserine synthase 1), PISD (phosphatidylserine decarboxylase), DGKZ (diacylglycerol kinase zeta), CDS1 (CDP-diacylglycerol synthase 1), PLA2G1B (phospholipase A2 group IB), PTDSS2 (phosphatidylserine synthase 2), CHPT1 (choline phosphotransferase 1), PCYT2 (phosphate cytidylyltransferase 2, ethanolamine), PEMT (phosphatidylethanolamine N-methyltransferase), DGAT2 (diacylglycerol O-acyltransferase 2), AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4), PNPLA3 (patatin like phospholipase domain containing 3), CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase), DGAT1 (diacylglycerol O-acyltransferase 1), PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), CRLS1 (cardiolipin synthase 1), PNPLA2 (patatin like phospholipase domain containing 2), CHKB (choline kinase beta), GPAM (glycerol-3-phosphate acyltransferase, mitochondrial), ETNK1 (ethanolamine kinase 1), GPAT4 (glycerol-3-phosphate acyltransferase 4)"], "WAG003021": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FADS2 (fatty acid desaturase 2), ACSL1 (acyl-CoA synthetase long chain family member 1), ACSL4 (acyl-CoA synthetase long chain family member 4), ACSL3 (acyl-CoA synthetase long chain family member 3), ELOVL2 (ELOVL fatty acid elongase 2), ELOVL6 (ELOVL fatty acid elongase 6), ELOVL5 (ELOVL fatty acid elongase 5), SCD (stearoyl-CoA desaturase), FASN (fatty acid synthase), ELOVL1 (ELOVL fatty acid elongase 1), FADS1 (fatty acid desaturase 1), ELOVL3 (ELOVL fatty acid elongase 3), ACOT2 (acyl-CoA thioesterase 2), SCD5 (stearoyl-CoA desaturase 5)"], "WAG003022": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SGPP1 (sphingosine-1-phosphate phosphatase 1), ASAH1 (N-acylsphingosine amidohydrolase 1), SGPP2 (sphingosine-1-phosphate phosphatase 2), UGCG (UDP-glucose ceramide glucosyltransferase), UGT8 (UDP glycosyltransferase 8), SMPD1 (sphingomyelin phosphodiesterase 1), SGMS2 (sphingomyelin synthase 2), DEGS1 (delta 4-desaturase, sphingolipid 1), SGMS1 (sphingomyelin synthase 1), DEGS2 (delta 4-desaturase, sphingolipid 2), CERK (ceramide kinase), KDSR (3-ketodihydrosphingosine reductase), SPHK2 (sphingosine kinase 2), SPHK1 (sphingosine kinase 1), SGPL1 (sphingosine-1-phosphate lyase 1), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), SPTLC2 (serine palmitoyltransferase long chain base subunit 2), CERS1 (ceramide synthase 1), GDF1 (growth differentiation factor 1), CERS6 (ceramide synthase 6), CERS4 (ceramide synthase 4), CERS2 (ceramide synthase 2), CERS3 (ceramide synthase 3), PLPP3 (phospholipid phosphatase 3)"], "WAG003024": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), IGF1 (insulin like growth factor 1), FGF2 (fibroblast growth factor 2), RUNX2 (RUNX family transcription factor 2), TGFB1 (transforming growth factor beta 1), INS-IGF2 (INS-IGF2 readthrough), AKT1 (AKT serine/threonine kinase 1), PTHLH (parathyroid hormone like hormone), MMP9 (matrix metallopeptidase 9), MMP13 (matrix metallopeptidase 13), IHH (Indian hedgehog signaling molecule), PTH (parathyroid hormone), IGF1R (insulin like growth factor 1 receptor), STAT1 (signal transducer and activator of transcription 1), SPP1 (secreted phosphoprotein 1), FGFR3 (fibroblast growth factor receptor 3), FGFR1 (fibroblast growth factor receptor 1), GLI3 (GLI family zinc finger 3), PLAU (plasminogen activator, urokinase), SOX9 (SRY-box transcription factor 9), ALPL (alkaline phosphatase, biomineralization associated), COL2A1 (collagen type II alpha 1 chain), BMP7 (bone morphogenetic protein 7), COL10A1 (collagen type X alpha 1 chain), TGFB2 (transforming growth factor beta 2), HDAC4 (histone deacetylase 4), STAT5B (signal transducer and activator of transcription 5B), ADAMTS5 (ADAM metallopeptidase with thrombospondin type 1 motif 5), IGF2 (insulin like growth factor 2), BMP6 (bone morphogenetic protein 6), PTCH1 (patched 1), GHR (growth hormone receptor), PLAT (plasminogen activator, tissue type), TIMP3 (TIMP metallopeptidase inhibitor 3), BMPR1A (bone morphogenetic protein receptor type 1A), ADAMTS4 (ADAM metallopeptidase with thrombospondin type 1 motif 4), MEF2C (myocyte enhancer factor 2C), FGF18 (fibroblast growth factor 18), ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif 1), RUNX3 (RUNX family transcription factor 3), PTH1R (parathyroid hormone 1 receptor), SOX5 (SRY-box transcription factor 5), MGP (matrix Gla protein), GH1 (growth hormone 1), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), SOX6 (SRY-box transcription factor 6), ACAN (aggrecan), THRA (thyroid hormone receptor alpha), SERPINH1 (serpin family H member 1), CDKN1C (cyclin dependent kinase inhibitor 1C), KIF3A (kinesin family member 3A), DDR2 (discoidin domain receptor tyrosine kinase 2), IFT88 (intraflagellar transport 88), NKX3-2 (NK3 homeobox 2), FRZB (frizzled related protein), CAB39 (calcium binding protein 39), ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), SLC38A2 (solute carrier family 38 member 2), SCIN (scinderin), CTSV (cathepsin V), CHST11 (carbohydrate sulfotransferase 11), CALM1 (calmodulin 1), CST5 (cystatin D)"], "WAG003026": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MTOR (mechanistic target of rapamycin kinase), MAPK14 (mitogen-activated protein kinase 14), GSK3B (glycogen synthase kinase 3 beta), RPS6KB1 (ribosomal protein S6 kinase B1), GRB2 (growth factor receptor bound protein 2), HRAS (HRas proto-oncogene, GTPase), TP53 (tumor protein p53), PPARG (peroxisome proliferator activated receptor gamma), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), FOXO1 (forkhead box O1), TSC2 (TSC complex subunit 2), RXRA (retinoid X receptor alpha), PPARGC1A (PPARG coactivator 1 alpha), CTNNB1 (catenin beta 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), RHEB (Ras homolog, mTORC1 binding), MAP2K1 (mitogen-activated protein kinase kinase 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), AKT3 (AKT serine/threonine kinase 3), FGFR1 (fibroblast growth factor receptor 1), MDM2 (MDM2 proto-oncogene), TSC1 (TSC complex subunit 1), RPTOR (regulatory associated protein of MTOR complex 1), THRB (thyroid hormone receptor beta), POMC (proopiomelanocortin), NOTCH1 (notch receptor 1), TRH (thyrotropin releasing hormone), FRS2 (fibroblast growth factor receptor substrate 2), MLST8 (MTOR associated protein, LST8 homolog), MC4R (melanocortin 4 receptor), TSHR (thyroid stimulating hormone receptor), RPS6 (ribosomal protein S6), ATF2 (activating transcription factor 2), BAD (BCL2 associated agonist of cell death), NPY (neuropeptide Y), ADCY8 (adenylate cyclase 8), ADRB3 (adrenoceptor beta 3), TPO (thyroid peroxidase), FGF21 (fibroblast growth factor 21), UCP1 (uncoupling protein 1), PLCB1 (phospholipase C beta 1), THRA (thyroid hormone receptor alpha), PAX8 (paired box 8), CASP9 (caspase 9), RPS6KA6 (ribosomal protein S6 kinase A6), AGRP (agouti related neuropeptide), NPPA (natriuretic peptide A), PLIN1 (perilipin 1), PRKCQ (protein kinase C theta), SLC5A5 (solute carrier family 5 member 5), AKT1S1 (AKT1 substrate 1), TG (thyroglobulin), ITGB3 (integrin subunit beta 3), CREB3 (cAMP responsive element binding protein 3), ITGAV (integrin subunit alpha V), SHH (sonic hedgehog signaling molecule), KDM1A (lysine demethylase 1A), PNPLA2 (patatin like phospholipase domain containing 2), SLC26A4 (solute carrier family 26 member 4), TSHB (thyroid stimulating hormone subunit beta), DIO3 (iodothyronine deiodinase 3), DUOXA2 (dual oxidase maturation factor 2), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), IYD (iodotyrosine deiodinase), ADCY3 (adenylate cyclase 3), DUOX2 (dual oxidase 2), MAFA (MAF bZIP transcription factor A), NPR1 (natriuretic peptide receptor 1), KLB (klotho beta), DIO2 (iodothyronine deiodinase 2), NPPB (natriuretic peptide B), MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5), MAPKAPK3 (MAPK activated protein kinase 3), SLC16A2 (solute carrier family 16 member 2), DIO1 (iodothyronine deiodinase 1), TTF1 (transcription termination factor 1), ACTL6B (actin like 6B), PFKFB2 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2), ZNF516 (zinc finger protein 516), PRDM16 (PR/SET domain 16), AQP7 (aquaporin 7), MGLL (monoglyceride lipase), PRKG2 (protein kinase cGMP-dependent 2), SLCO1C1 (solute carrier organic anion transporter family member 1C1), TTF2 (transcription termination factor 2), WNT4 (Wnt family member 4), SLC16A10 (solute carrier family 16 member 10), KDM3B (lysine demethylase 3B), TBC1D4 (TBC1 domain family member 4), SIRT6 (sirtuin 6), NHSL1 (NHS like 1), SECISBP2L (SECIS binding protein 2 like)"], "WAG003027": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), AKT1 (AKT serine/threonine kinase 1), RAC1 (Rac family small GTPase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PTK2 (protein tyrosine kinase 2), MAPK3 (mitogen-activated protein kinase 3), FYN (FYN proto-oncogene, Src family tyrosine kinase), PRKCA (protein kinase C alpha), TNF (tumor necrosis factor), PTPN11 (protein tyrosine phosphatase non-receptor type 11), MAPK14 (mitogen-activated protein kinase 14), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TP53 (tumor protein p53), VCAM1 (vascular cell adhesion molecule 1), MAP2K1 (mitogen-activated protein kinase kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), ICAM1 (intercellular adhesion molecule 1), CASP3 (caspase 3), NTN1 (netrin 1), RHOA (ras homolog family member A), PTK2B (protein tyrosine kinase 2 beta), KDR (kinase insert domain receptor), PPP1CA (protein phosphatase 1 catalytic subunit alpha), CCL2 (C-C motif chemokine ligand 2), SELE (selectin E), ITGB4 (integrin subunit beta 4), UNC5B (unc-5 netrin receptor B), MAP2K2 (mitogen-activated protein kinase kinase 2), NEO1 (neogenin 1), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), IL10 (interleukin 10), CDH5 (cadherin 5), IL1A (interleukin 1 alpha), DAPK1 (death associated protein kinase 1), INPP5D (inositol polyphosphate-5-phosphatase D), ARHGEF12 (Rho guanine nucleotide exchange factor 12), COL1A1 (collagen type I alpha 1 chain), YAP1 (Yes1 associated transcriptional regulator), ALPL (alkaline phosphatase, biomineralization associated), AGAP2 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 2), RGMA (repulsive guidance molecule BMP co-receptor a), NTN3 (netrin 3), NTN4 (netrin 4), MYF5 (myogenic factor 5), ROBO4 (roundabout guidance receptor 4), RLF (RLF zinc finger), CCN2 (cellular communication network factor 2), CIP2A (cellular inhibitor of PP2A), DCSTAMP (dendrocyte expressed seven transmembrane protein), PTPA (protein phosphatase 2 phosphatase activator), PLEKHH1 (pleckstrin homology, MyTH4 and FERM domain containing H1)"], "WAG003029": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "POLD1 (DNA polymerase delta 1, catalytic subunit), PCNA (proliferating cell nuclear antigen), APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1), POLE (DNA polymerase epsilon, catalytic subunit), POLB (DNA polymerase beta), XRCC1 (X-ray repair cross complementing 1), FEN1 (flap structure-specific endonuclease 1), POLD2 (DNA polymerase delta 2, accessory subunit), POLD4 (DNA polymerase delta 4, accessory subunit), LIG1 (DNA ligase 1), PARP1 (poly(ADP-ribose) polymerase 1), OGG1 (8-oxoguanine DNA glycosylase), POLD3 (DNA polymerase delta 3, accessory subunit), POLE2 (DNA polymerase epsilon 2, accessory subunit), UNG (uracil DNA glycosylase), LIG3 (DNA ligase 3), MUTYH (mutY DNA glycosylase), POLE3 (DNA polymerase epsilon 3, accessory subunit), NTHL1 (nth like DNA glycosylase 1), PNKP (polynucleotide kinase 3'-phosphatase), POLE4 (DNA polymerase epsilon 4, accessory subunit), TDG (thymine DNA glycosylase), APEX2 (apurinic/apyrimidinic endodeoxyribonuclease 2), PARP2 (poly(ADP-ribose) polymerase 2), NEIL3 (nei like DNA glycosylase 3), POLL (DNA polymerase lambda), MPG (N-methylpurine DNA glycosylase), NEIL2 (nei like DNA glycosylase 2), MBD4 (methyl-CpG binding domain 4, DNA glycosylase), SMUG1 (single-strand-selective monofunctional uracil-DNA glycosylase 1), HMGB1 (high mobility group box 1)"], "WAG003030": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RPA1 (replication protein A1), DDB1 (damage specific DNA binding protein 1), POLD1 (DNA polymerase delta 1, catalytic subunit), RPA3 (replication protein A3), GTF2H1 (general transcription factor IIH subunit 1), XPC (XPC complex subunit, DNA damage recognition and repair factor), RPA2 (replication protein A2), PCNA (proliferating cell nuclear antigen), DDB2 (damage specific DNA binding protein 2), ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), CDK7 (cyclin dependent kinase 7), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), RAD23B (RAD23 homolog B, nucleotide excision repair protein), GTF2H3 (general transcription factor IIH subunit 3), GTF2H2 (general transcription factor IIH subunit 2), ERCC5 (ERCC excision repair 5, endonuclease), GTF2H4 (general transcription factor IIH subunit 4), CCNH (cyclin H), MNAT1 (MNAT1 component of CDK activating kinase), POLD2 (DNA polymerase delta 2, accessory subunit), POLD4 (DNA polymerase delta 4, accessory subunit), XPA (XPA, DNA damage recognition and repair factor), ERCC6 (ERCC excision repair 6, chromatin remodeling factor), RFC5 (replication factor C subunit 5), POLE (DNA polymerase epsilon, catalytic subunit), RFC1 (replication factor C subunit 1), RFC3 (replication factor C subunit 3), RFC2 (replication factor C subunit 2), RFC4 (replication factor C subunit 4), POLE2 (DNA polymerase epsilon 2, accessory subunit), POLD3 (DNA polymerase delta 3, accessory subunit), ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit), LIG1 (DNA ligase 1), POLE3 (DNA polymerase epsilon 3, accessory subunit), GTF2H5 (general transcription factor IIH subunit 5), CUL4A (cullin 4A), CUL4B (cullin 4B), RAD23A (RAD23 homolog A, nucleotide excision repair protein), CETN2 (centrin 2), POLE4 (DNA polymerase epsilon 4, accessory subunit), RBX1 (ring-box 1), PGBD3 (piggyBac transposable element derived 3)"], "WAG003031": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), MAPK1 (mitogen-activated protein kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RELA (RELA proto-oncogene, NF-kB subunit), TP53 (tumor protein p53), NFKB1 (nuclear factor kappa B subunit 1), IL6 (interleukin 6), MAPK3 (mitogen-activated protein kinase 3), IL1B (interleukin 1 beta), VEGFA (vascular endothelial growth factor A), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IFNG (interferon gamma), FN1 (fibronectin 1), NFKBIA (NFKB inhibitor alpha), CASP3 (caspase 3), PRKCA (protein kinase C alpha), PTGS2 (prostaglandin-endoperoxide synthase 2), SP1 (Sp1 transcription factor), TRAF6 (TNF receptor associated factor 6), IL18 (interleukin 18), CASP8 (caspase 8), TNFRSF1A (TNF receptor superfamily member 1A), PRKCD (protein kinase C delta), MMP9 (matrix metallopeptidase 9), CCL2 (C-C motif chemokine ligand 2), ICAM1 (intercellular adhesion molecule 1), FASLG (Fas ligand), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), BCL2 (BCL2 apoptosis regulator), MMP2 (matrix metallopeptidase 2), CTNNB1 (catenin beta 1), IL10 (interleukin 10), MAPK9 (mitogen-activated protein kinase 9), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PARP1 (poly(ADP-ribose) polymerase 1), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), BAX (BCL2 associated X, apoptosis regulator), FADD (Fas associated via death domain), NFKB2 (nuclear factor kappa B subunit 2), BIRC3 (baculoviral IAP repeat containing 3), NOS2 (nitric oxide synthase 2), TIMP1 (TIMP metallopeptidase inhibitor 1), BCL2L1 (BCL2 like 1), CCL5 (C-C motif chemokine ligand 5), IL2RA (interleukin 2 receptor subunit alpha), IL13 (interleukin 13), HDAC3 (histone deacetylase 3), MMP1 (matrix metallopeptidase 1), TNFAIP3 (TNF alpha induced protein 3), GSK3B (glycogen synthase kinase 3 beta), LCK (LCK proto-oncogene, Src family tyrosine kinase), MYD88 (MYD88 innate immune signal transduction adaptor), REL (REL proto-oncogene, NF-kB subunit), TRAF1 (TNF receptor associated factor 1), IRAK1 (interleukin 1 receptor associated kinase 1), FAS (Fas cell surface death receptor), CYCS (cytochrome c, somatic), PRKCB (protein kinase C beta), CEBPB (CCAAT enhancer binding protein beta), CCL4 (C-C motif chemokine ligand 4), PTEN (phosphatase and tensin homolog), MMP3 (matrix metallopeptidase 3), IL12B (interleukin 12B), MMP13 (matrix metallopeptidase 13), IRF1 (interferon regulatory factor 1), TNFSF11 (TNF superfamily member 11), CCL3 (C-C motif chemokine ligand 3), RPS6KB1 (ribosomal protein S6 kinase B1), MMP14 (matrix metallopeptidase 14), ACTA1 (actin alpha 1, skeletal muscle), CFLAR (CASP8 and FADD like apoptosis regulator), PLCG1 (phospholipase C gamma 1), ATF3 (activating transcription factor 3), HSPB1 (heat shock protein family B (small) member 1), RUNX2 (RUNX family transcription factor 2), SOCS3 (suppressor of cytokine signaling 3), CXCL2 (C-X-C motif chemokine ligand 2), SPP1 (secreted phosphoprotein 1), BID (BH3 interacting domain death agonist), MAP2K7 (mitogen-activated protein kinase kinase 7), NR4A1 (nuclear receptor subfamily 4 group A member 1), BMP2 (bone morphogenetic protein 2), SDC4 (syndecan 4), CCL20 (C-C motif chemokine ligand 20), HMOX1 (heme oxygenase 1), COL1A2 (collagen type I alpha 2 chain), PKN1 (protein kinase N1), NR0B2 (nuclear receptor subfamily 0 group B member 2), NCF1 (neutrophil cytosolic factor 1), TGM2 (transglutaminase 2), ELAVL1 (ELAV like RNA binding protein 1), COL1A1 (collagen type I alpha 1 chain), TIMP3 (TIMP metallopeptidase inhibitor 3), S1PR4 (sphingosine-1-phosphate receptor 4), IL18R1 (interleukin 18 receptor 1), BAD (BCL2 associated agonist of cell death), CD83 (CD83 molecule), CD36 (CD36 molecule), B2M (beta-2-microglobulin)"], "WAG003032": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), AKT1 (AKT serine/threonine kinase 1), CTNNB1 (catenin beta 1), RAC1 (Rac family small GTPase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), VEGFA (vascular endothelial growth factor A), CDC42 (cell division cycle 42), FYN (FYN proto-oncogene, Src family tyrosine kinase), ACTB (actin beta), PTK2 (protein tyrosine kinase 2), ITGB1 (integrin subunit beta 1), PRKCA (protein kinase C alpha), PXN (paxillin), ITGAV (integrin subunit alpha V), CBL (Cbl proto-oncogene), PLCG1 (phospholipase C gamma 1), SHC1 (SHC adaptor protein 1), NCK1 (NCK adaptor protein 1), RHOA (ras homolog family member A), CRK (CRK proto-oncogene, adaptor protein), TGFB1 (transforming growth factor beta 1), CTTN (cortactin), ACTN4 (actinin alpha 4), ITGB4 (integrin subunit beta 4), KDR (kinase insert domain receptor), SMAD3 (SMAD family member 3), BCAR1 (BCAR1 scaffold protein, Cas family member), IGF1R (insulin like growth factor 1 receptor), CSK (C-terminal Src kinase), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), CTNNA1 (catenin alpha 1), MET (MET proto-oncogene, receptor tyrosine kinase), ITGB5 (integrin subunit beta 5), PAK1 (p21 (RAC1) activated kinase 1), ITGA6 (integrin subunit alpha 6), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), VCL (vinculin), IGF1 (insulin like growth factor 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), NCK2 (NCK adaptor protein 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), SMAD2 (SMAD family member 2), CD2AP (CD2 associated protein), CCND1 (cyclin D1), PRKCE (protein kinase C epsilon), TLN1 (talin 1), ARRB2 (arrestin beta 2), NOTCH1 (notch receptor 1), WASL (WASP like actin nucleation promoting factor), SH3KBP1 (SH3 domain containing kinase binding protein 1), TGFBR1 (transforming growth factor beta receptor 1), EZR (ezrin), SP1 (Sp1 transcription factor), CDKN1A (cyclin dependent kinase inhibitor 1A), TGFBR2 (transforming growth factor beta receptor 2), ITGA2 (integrin subunit alpha 2), VASP (vasodilator stimulated phosphoprotein), IQGAP1 (IQ motif containing GTPase activating protein 1), NPHS1 (NPHS1 adhesion molecule, nephrin), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), ILK (integrin linked kinase), HIF1A (hypoxia inducible factor 1 subunit alpha), ITGA3 (integrin subunit alpha 3), SMURF1 (SMAD specific E3 ubiquitin protein ligase 1), DAG1 (dystroglycan 1), INSR (insulin receptor), CDK5 (cyclin dependent kinase 5), DNM2 (dynamin 2), TJP1 (tight junction protein 1), PRKCI (protein kinase C iota), PSEN1 (presenilin 1), DNM1 (dynamin 1), VAV2 (vav guanine nucleotide exchange factor 2), PAK2 (p21 (RAC1) activated kinase 2), LAMA5 (laminin subunit alpha 5), RXRA (retinoid X receptor alpha), PTGS2 (prostaglandin-endoperoxide synthase 2), PARD6A (par-6 family cell polarity regulator alpha), CDKN1B (cyclin dependent kinase inhibitor 1B), DVL2 (dishevelled segment polarity protein 2), SMAD7 (SMAD family member 7), JUP (junction plakoglobin), NPHS2 (NPHS2 stomatin family member, podocin), SPTAN1 (spectrin alpha, non-erythrocytic 1), SPTBN1 (spectrin beta, non-erythrocytic 1), SPP1 (secreted phosphoprotein 1), F11R (F11 receptor), PARD3 (par-3 family cell polarity regulator), CXCL12 (C-X-C motif chemokine ligand 12), LAMC1 (laminin subunit gamma 1), ACTR3 (actin related protein 3), NOTCH2 (notch receptor 2), LAMB2 (laminin subunit beta 2), MYH9 (myosin heavy chain 9), BMP4 (bone morphogenetic protein 4), ARHGDIA (Rho GDP dissociation inhibitor alpha), ADAM10 (ADAM metallopeptidase domain 10), ACTR2 (actin related protein 2)"], "WAG003033": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CALM3 (calmodulin 3), CREB1 (cAMP responsive element binding protein 1), CAMK2B (calcium/calmodulin dependent protein kinase II beta), PLCB2 (phospholipase C beta 2), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), CAMK2D (calcium/calmodulin dependent protein kinase II delta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), CALML3 (calmodulin like 3), CALML5 (calmodulin like 5), CALML6 (calmodulin like 6), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), CAMK4 (calcium/calmodulin dependent protein kinase IV), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), AGT (angiotensinogen), ITPR2 (inositol 1,4,5-trisphosphate receptor type 2), ATF4 (activating transcription factor 4), AGTR1 (angiotensin II receptor type 1), REN (renin), CYP11B2 (cytochrome P450 family 11 subfamily B member 2), ACE (angiotensin I converting enzyme), CREB3 (cAMP responsive element binding protein 3), ATF1 (activating transcription factor 1), CYP11A1 (cytochrome P450 family 11 subfamily A member 1), CAMK1D (calcium/calmodulin dependent protein kinase ID), CAMK1 (calcium/calmodulin dependent protein kinase I), CREB3L3 (cAMP responsive element binding protein 3 like 3), CREB3L1 (cAMP responsive element binding protein 3 like 1), ATF2 (activating transcription factor 2), CREB3L4 (cAMP responsive element binding protein 3 like 4), CREB3L2 (cAMP responsive element binding protein 3 like 2), GNAQ (G protein subunit alpha q), AGTR2 (angiotensin II receptor type 2), HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1), STAR (steroidogenic acute regulatory protein), CYP21A2 (cytochrome P450 family 21 subfamily A member 2), CMA1 (chymase 1), HSD3B2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2), CAMK1G (calcium/calmodulin dependent protein kinase IG), CREB5 (cAMP responsive element binding protein 5), CTSG (cathepsin G), ATF6B (activating transcription factor 6 beta), CALM1 (calmodulin 1), CALML4 (calmodulin like 4), CALM2 (calmodulin 2)"], "WAG003034": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NPHS1 (NPHS1 adhesion molecule, nephrin), NPHS2 (NPHS2 stomatin family member, podocin), CD2AP (CD2 associated protein), ACTN4 (actinin alpha 4), ITGA3 (integrin subunit alpha 3), ITGB4 (integrin subunit beta 4), COL4A4 (collagen type IV alpha 4 chain), TRPC6 (transient receptor potential cation channel subfamily C member 6), WT1 (WT1 transcription factor), SYNPO (synaptopodin), INF2 (inverted formin 2), COL4A5 (collagen type IV alpha 5 chain), PLCE1 (phospholipase C epsilon 1), LAMB2 (laminin subunit beta 2), CD151 (CD151 molecule (Raph blood group)), COL4A3 (collagen type IV alpha 3 chain), PTPRO (protein tyrosine phosphatase receptor type O), COQ2 (coenzyme Q2, polyprenyltransferase), PDSS2 (decaprenyl diphosphate synthase subunit 2), COQ6 (coenzyme Q6, monooxygenase), PAX2 (paired box 2), LMX1B (LIM homeobox transcription factor 1 beta), LMNA (lamin A/C), MYH9 (myosin heavy chain 9), ZMPSTE24 (zinc metallopeptidase STE24), ANLN (anillin actin binding protein), APOL1 (apolipoprotein L1), PODXL (podocalyxin like), ARHGDIA (Rho GDP dissociation inhibitor alpha), ALG1 (ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase), COQ8B (coenzyme Q8B), SCARB2 (scavenger receptor class B member 2), PMM2 (phosphomannomutase 2), GPC5 (glypican 5), CUBN (cubilin), TTC21B (tetratricopeptide repeat domain 21B), E2F3 (E2F transcription factor 3), TRNL1 (tRNA), TRNI (tRNA), MYO1E (myosin IE), TRN-GTT4-1 (tRNA-Asn (anticodon GTT) 4-1), EMP2 (epithelial membrane protein 2), WDR73 (WD repeat domain 73), ARHGAP24 (Rho GTPase activating protein 24), CTLA4 (cytotoxic T-lymphocyte associated protein 4), CYP11B2 (cytochrome P450 family 11 subfamily B member 2), SMARCAL1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1), YARS1 (tyrosyl-tRNA synthetase 1)"], "WAG003035": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PLCB1 (phospholipase C beta 1), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PLCB2 (phospholipase C beta 2), PLCB3 (phospholipase C beta 3), PLCB4 (phospholipase C beta 4), GNA11 (G protein subunit alpha 11), GNAQ (G protein subunit alpha q), GNA15 (G protein subunit alpha 15), GRM1 (glutamate metabotropic receptor 1), GNA14 (G protein subunit alpha 14), PRKCG (protein kinase C gamma), TRPC3 (transient receptor potential cation channel subfamily C member 3), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), GRIA4 (glutamate ionotropic receptor AMPA type subunit 4), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), GRIA3 (glutamate ionotropic receptor AMPA type subunit 3), RYR3 (ryanodine receptor 3), HOMER3 (homer scaffold protein 3), CACNA1A (calcium voltage-gated channel subunit alpha1 A), ATP2B2 (ATPase plasma membrane Ca2+ transporting 2), CA8 (carbonic anhydrase 8), PDK1 (pyruvate dehydrogenase kinase 1)"], "WAG003036": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), PPP2CA (protein phosphatase 2 catalytic subunit alpha), MAPK14 (mitogen-activated protein kinase 14), MAPK3 (mitogen-activated protein kinase 3), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), STAT1 (signal transducer and activator of transcription 1), MAP2K2 (mitogen-activated protein kinase kinase 2), MAPK11 (mitogen-activated protein kinase 11), MAPK12 (mitogen-activated protein kinase 12), FGFR3 (fibroblast growth factor receptor 3), MAPK13 (mitogen-activated protein kinase 13), BMP2 (bone morphogenetic protein 2), SOX9 (SRY-box transcription factor 9), FGF9 (fibroblast growth factor 9), BMP4 (bone morphogenetic protein 4), CDKN1A (cyclin dependent kinase inhibitor 1A), IHH (Indian hedgehog signaling molecule), PTHLH (parathyroid hormone like hormone), FGF18 (fibroblast growth factor 18), RBL1 (RB transcriptional corepressor like 1), PTH1R (parathyroid hormone 1 receptor), NPR2 (natriuretic peptide receptor 2), CNP (2',3'-cyclic nucleotide 3' phosphodiesterase), THRA (thyroid hormone receptor alpha), SNAI1 (snail family transcriptional repressor 1), ATG5 (autophagy related 5)"], "WAG003038": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EXTL3 (exostosin like glycosyltransferase 3), B4GALT7 (beta-1,4-galactosyltransferase 7), CSGALNACT1 (chondroitin sulfate N-acetylgalactosaminyltransferase 1), B3GAT3 (beta-1,3-glucuronyltransferase 3), CHSY1 (chondroitin sulfate synthase 1), EXT2 (exostosin glycosyltransferase 2), EXT1 (exostosin glycosyltransferase 1), B3GALT6 (beta-1,3-galactosyltransferase 6), CHST3 (carbohydrate sulfotransferase 3), XYLT2 (xylosyltransferase 2), SLC26A2 (solute carrier family 26 member 2), XYLT1 (xylosyltransferase 1), CANT1 (calcium activated nucleotidase 1), PAPSS2 (3'-phosphoadenosine 5'-phosphosulfate synthase 2), SLC35B2 (solute carrier family 35 member B2), SLC35B3 (solute carrier family 35 member B3), BPNT2 (3'(2'), 5'-bisphosphate nucleotidase 2), CHST14 (carbohydrate sulfotransferase 14)"], "WAG003039": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MESP2 (mesoderm posterior bHLH transcription factor 2), DLL1 (delta like canonical Notch ligand 1), NOTCH1 (notch receptor 1), HES7 (hes family bHLH transcription factor 7), LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase), DLL3 (delta like canonical Notch ligand 3), TBX6 (T-box transcription factor 6), EPHA4 (EPH receptor A4), RIPPLY2 (ripply transcriptional repressor 2)"], "WAG003040": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COL1A1 (collagen type I alpha 1 chain), P4HB (prolyl 4-hydroxylase subunit beta), COL1A2 (collagen type I alpha 2 chain), SERPINH1 (serpin family H member 1), PPIB (peptidylprolyl isomerase B), FKBP10 (FKBP prolyl isomerase 10), CRTAP (cartilage associated protein), WNT1 (Wnt family member 1), FZD1 (frizzled class receptor 1), TNFSF11 (TNF superfamily member 11), P4HA2 (prolyl 4-hydroxylase subunit alpha 2), PLOD2 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 2), P4HA1 (prolyl 4-hydroxylase subunit alpha 1), PLOD1 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1), LRP5 (LDL receptor related protein 5), MBTPS1 (membrane bound transcription factor peptidase, site 1), BMP1 (bone morphogenetic protein 1), LOX (lysyl oxidase), TNFRSF11B (TNF receptor superfamily member 11b), LRP6 (LDL receptor related protein 6), ADAMTS2 (ADAM metallopeptidase with thrombospondin type 1 motif 2), TNFRSF11A (TNF receptor superfamily member 11a), SP7 (Sp7 transcription factor), MBTPS2 (membrane bound transcription factor peptidase, site 2), P3H2 (prolyl 3-hydroxylase 2), MIA3 (MIA SH3 domain ER export factor 3), SERPINF1 (serpin family F member 1), COLGALT1 (collagen beta(1-O)galactosyltransferase 1), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), IFITM5 (interferon induced transmembrane protein 5), CREB3L1 (cAMP responsive element binding protein 3 like 1), TMEM38B (transmembrane protein 38B), P3H1 (prolyl 3-hydroxylase 1)"], "WAG003041": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), WNT3A (Wnt family member 3A), FZD2 (frizzled class receptor 2), FZD5 (frizzled class receptor 5), FZD1 (frizzled class receptor 1), FZD4 (frizzled class receptor 4), FZD6 (frizzled class receptor 6), FZD7 (frizzled class receptor 7), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), FGFR1 (fibroblast growth factor receptor 1), WNT7B (Wnt family member 7B), FZD8 (frizzled class receptor 8), FZD10 (frizzled class receptor 10), WNT1 (Wnt family member 1), CTNNB1 (catenin beta 1), WNT2B (Wnt family member 2B), WNT5A (Wnt family member 5A), WNT7A (Wnt family member 7A), NOTCH1 (notch receptor 1), MAPK3 (mitogen-activated protein kinase 3), FZD9 (frizzled class receptor 9), FGFR2 (fibroblast growth factor receptor 2), WNT11 (Wnt family member 11), WNT3 (Wnt family member 3), WNT10B (Wnt family member 10B), WNT8B (Wnt family member 8B), BMP4 (bone morphogenetic protein 4), WNT5B (Wnt family member 5B), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), WNT10A (Wnt family member 10A), WNT2 (Wnt family member 2), WNT9A (Wnt family member 9A), WNT8A (Wnt family member 8A), WNT9B (Wnt family member 9B), WNT6 (Wnt family member 6), SMAD4 (SMAD family member 4), GLI3 (GLI family zinc finger 3), FZD3 (frizzled class receptor 3), FGFR3 (fibroblast growth factor receptor 3), LRP6 (LDL receptor related protein 6), BMP2 (bone morphogenetic protein 2), PRKCD (protein kinase C delta), FGF10 (fibroblast growth factor 10), LRP5 (LDL receptor related protein 5), WNT16 (Wnt family member 16), RUNX2 (RUNX family transcription factor 2), WNT4 (Wnt family member 4), MAPK8 (mitogen-activated protein kinase 8), FGFR4 (fibroblast growth factor receptor 4), FGF1 (fibroblast growth factor 1), GLI2 (GLI family zinc finger 2), FGF4 (fibroblast growth factor 4), STAT1 (signal transducer and activator of transcription 1), PRKCZ (protein kinase C zeta), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), MAPK14 (mitogen-activated protein kinase 14), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), FGF2 (fibroblast growth factor 2), FGF9 (fibroblast growth factor 9), FGF8 (fibroblast growth factor 8), PRKCA (protein kinase C alpha), FGF3 (fibroblast growth factor 3), FGF6 (fibroblast growth factor 6), MAPK9 (mitogen-activated protein kinase 9), NOTCH2 (notch receptor 2), FGF7 (fibroblast growth factor 7), SMAD1 (SMAD family member 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), MYOD1 (myogenic differentiation 1), PRKCE (protein kinase C epsilon), SMAD9 (SMAD family member 9), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), FGF18 (fibroblast growth factor 18), JAG1 (jagged canonical Notch ligand 1), PRKCI (protein kinase C iota), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), BMPR1A (bone morphogenetic protein receptor type 1A), SMAD5 (SMAD family member 5), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), NOTCH3 (notch receptor 3), BMPR1B (bone morphogenetic protein receptor type 1B), DLL1 (delta like canonical Notch ligand 1), BMPR2 (bone morphogenetic protein receptor type 2), FGF5 (fibroblast growth factor 5), MAPK11 (mitogen-activated protein kinase 11), IHH (Indian hedgehog signaling molecule), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), NOTCH4 (notch receptor 4), DLL4 (delta like canonical Notch ligand 4), PTCH1 (patched 1), PRKCB (protein kinase C beta), SOX9 (SRY-box transcription factor 9), PRKCQ (protein kinase C theta), MAPK7 (mitogen-activated protein kinase 7), MAPK10 (mitogen-activated protein kinase 10), MAPK12 (mitogen-activated protein kinase 12), MAPK13 (mitogen-activated protein kinase 13), JAG2 (jagged canonical Notch ligand 2), HEY2 (hes related family bHLH transcription factor with YRPW motif 2)"], "WAG003042": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), TNFSF11 (TNF superfamily member 11), NFKB1 (nuclear factor kappa B subunit 1), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), TNFRSF11A (TNF receptor superfamily member 11a), OSTM1 (osteoclastogenesis associated transmembrane protein 1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CLCN7 (chloride voltage-gated channel 7), RAB7A (RAB7A, member RAS oncogene family), PLEKHM1 (pleckstrin homology and RUN domain containing M1), SNX10 (sorting nexin 10)"], "WAG003044": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FGF23 (fibroblast growth factor 23), PTH (parathyroid hormone), PHEX (phosphate regulating endopeptidase homolog X-linked), CCND1 (cyclin D1), CYP27B1 (cytochrome P450 family 27 subfamily B member 1), ALPL (alkaline phosphatase, biomineralization associated), SPP1 (secreted phosphoprotein 1), KL (klotho), FGFR3 (fibroblast growth factor receptor 3), DMP1 (dentin matrix acidic phosphoprotein 1), FGFR2 (fibroblast growth factor receptor 2), CYP24A1 (cytochrome P450 family 24 subfamily A member 1), SLC34A3 (solute carrier family 34 member 3), ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1), GALNT3 (polypeptide N-acetylgalactosaminyltransferase 3), NFKB1 (nuclear factor kappa B subunit 1), SLC34A1 (solute carrier family 34 member 1), NFKB2 (nuclear factor kappa B subunit 2), CDKN1A (cyclin dependent kinase inhibitor 1A), CYP11B2 (cytochrome P450 family 11 subfamily B member 2), ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase), FAM20C (FAM20C golgi associated secretory pathway kinase)"], "WAG003047": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CEP290 (centrosomal protein 290), MKS1 (MKS transition zone complex subunit 1), TMEM67 (transmembrane protein 67), CC2D2A (coiled-coil and C2 domain containing 2A), NPHP1 (nephrocystin 1), BBS7 (Bardet-Biedl syndrome 7), NPHP4 (nephrocystin 4), CEP164 (centrosomal protein 164), BBS2 (Bardet-Biedl syndrome 2), B9D2 (B9 domain containing 2), AHI1 (Abelson helper integration site 1), TMEM216 (transmembrane protein 216), BBS9 (Bardet-Biedl syndrome 9), OFD1 (OFD1 centriole and centriolar satellite protein), BBS5 (Bardet-Biedl syndrome 5), INVS (inversin), NEK2 (NIMA related kinase 2), B9D1 (B9 domain containing 1), BBS1 (Bardet-Biedl syndrome 1), ARL6 (ADP ribosylation factor like GTPase 6), SDCCAG8 (SHH signaling and ciliogenesis regulator SDCCAG8), BBS4 (Bardet-Biedl syndrome 4), BBS12 (Bardet-Biedl syndrome 12), ALMS1 (ALMS1 centrosome and basal body associated protein), BBS10 (Bardet-Biedl syndrome 10), TTC8 (tetratricopeptide repeat domain 8), PLK4 (polo like kinase 4), NPHP3 (nephrocystin 3), TCTN1 (tectonic family member 1), CEP78 (centrosomal protein 78), CEP41 (centrosomal protein 41), TCTN2 (tectonic family member 2), IQCB1 (IQ motif containing B1), TMEM231 (transmembrane protein 231), TMEM17 (transmembrane protein 17), RPGRIP1L (RPGRIP1 like), GLI2 (GLI family zinc finger 2), GLI3 (GLI family zinc finger 3), PKD2 (polycystin 2, transient receptor potential cation channel), IFT172 (intraflagellar transport 172), ARL13B (ADP ribosylation factor like GTPase 13B), BBIP1 (BBSome interacting protein 1), SMO (smoothened, frizzled class receptor), DNAAF1 (dynein axonemal assembly factor 1), DNAH11 (dynein axonemal heavy chain 11), TRIM32 (tripartite motif containing 32), GLIS2 (GLIS family zinc finger 2), ARL3 (ADP ribosylation factor like GTPase 3), DNAI2 (dynein axonemal intermediate chain 2), DNAI1 (dynein axonemal intermediate chain 1), NEK8 (NIMA related kinase 8), RAB23 (RAB23, member RAS oncogene family), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), CCDC28B (coiled-coil domain containing 28B), PKD1 (polycystin 1, transient receptor potential channel interacting), IFT140 (intraflagellar transport 140), RSPH9 (radial spoke head component 9), SUFU (SUFU negative regulator of hedgehog signaling), RSPH4A (radial spoke head component 4A), IFT81 (intraflagellar transport 81), WDPCP (WD repeat containing planar cell polarity effector), PDE6D (phosphodiesterase 6D), DNAAF2 (dynein axonemal assembly factor 2), RPGRIP1 (RPGR interacting protein 1), IFT52 (intraflagellar transport 52), TTC21B (tetratricopeptide repeat domain 21B), IFT80 (intraflagellar transport 80), PKHD1 (PKHD1 ciliary IPT domain containing fibrocystin/polyductin), RP2 (RP2 activator of ARL3 GTPase), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1), LZTFL1 (leucine zipper transcription factor like 1), CENPF (centromere protein F), KIF7 (kinesin family member 7), NME7 (NME/NM23 family member 7), LCA5 (lebercilin LCA5), IFT27 (intraflagellar transport 27), ZIC2 (Zic family member 2), XPNPEP3 (X-prolyl aminopeptidase 3), NEK9 (NIMA related kinase 9), ADCY6 (adenylate cyclase 6), ZNF423 (zinc finger protein 423), UNC119 (unc-119 lipid binding chaperone), TULP1 (TUB like protein 1), DNAH6 (dynein axonemal heavy chain 6), ATXN10 (ataxin 10), WDR35 (WD repeat domain 35), TMEM237 (transmembrane protein 237), CNGA1 (cyclic nucleotide gated channel subunit alpha 1), IFT122 (intraflagellar transport 122), INPP5E (inositol polyphosphate-5-phosphatase E), NEK1 (NIMA related kinase 1), TTBK2 (tau tubulin kinase 2), ARL2BP (ADP ribosylation factor like GTPase 2 binding protein), ZMYND10 (zinc finger MYND-type containing 10), LRRC6 (leucine rich repeat containing 6), CNGB1 (cyclic nucleotide gated channel subunit beta 1), GAS8 (growth arrest specific 8), POC1A (POC1 centriolar protein A), AK7 (adenylate kinase 7), TCTN3 (tectonic family member 3)"], "WAG003049": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), EGFR (epidermal growth factor receptor), AKT1 (AKT serine/threonine kinase 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), HRAS (HRas proto-oncogene, GTPase), ERBB2 (erb-b2 receptor tyrosine kinase 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAPK1 (mitogen-activated protein kinase 1), EGF (epidermal growth factor), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PDGFRB (platelet derived growth factor receptor beta), IGF1R (insulin like growth factor 1 receptor), VEGFA (vascular endothelial growth factor A), SHC1 (SHC adaptor protein 1), NRAS (NRAS proto-oncogene, GTPase), PLCG1 (phospholipase C gamma 1), IGF1 (insulin like growth factor 1), MAPK3 (mitogen-activated protein kinase 3), STAT3 (signal transducer and activator of transcription 3), MET (MET proto-oncogene, receptor tyrosine kinase), JAK2 (Janus kinase 2), JAK1 (Janus kinase 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), MTOR (mechanistic target of rapamycin kinase), PRKCA (protein kinase C alpha), PDGFRA (platelet derived growth factor receptor alpha), KRAS (KRAS proto-oncogene, GTPase), GAB1 (GRB2 associated binding protein 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), PTEN (phosphatase and tensin homolog), MAP2K1 (mitogen-activated protein kinase kinase 1), KDR (kinase insert domain receptor), SHC2 (SHC adaptor protein 2), ERBB3 (erb-b2 receptor tyrosine kinase 3), CCND1 (cyclin D1), PDGFB (platelet derived growth factor subunit B), IL6 (interleukin 6), FGFR2 (fibroblast growth factor receptor 2), FGF2 (fibroblast growth factor 2), PLCG2 (phospholipase C gamma 2), RPS6KB1 (ribosomal protein S6 kinase B1), SHC3 (SHC adaptor protein 3), HGF (hepatocyte growth factor), BCL2 (BCL2 apoptosis regulator), MYC (MYC proto-oncogene, bHLH transcription factor), RRAS (RAS related), PRKCB (protein kinase C beta), BCL2L1 (BCL2 like 1), AKT3 (AKT serine/threonine kinase 3), BRAF (B-Raf proto-oncogene, serine/threonine kinase), AKT2 (AKT serine/threonine kinase 2), GSK3B (glycogen synthase kinase 3 beta), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), BAX (BCL2 associated X, apoptosis regulator), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), PDPK1 (3-phosphoinositide dependent protein kinase 1), FGFR3 (fibroblast growth factor receptor 3), PDGFA (platelet derived growth factor subunit A), MRAS (muscle RAS oncogene homolog), PDGFD (platelet derived growth factor D), RRAS2 (RAS related 2), BCL2L11 (BCL2 like 11), PRKCG (protein kinase C gamma), BAD (BCL2 associated agonist of cell death), NRG1 (neuregulin 1), EIF4E (eukaryotic translation initiation factor 4E), MAP2K2 (mitogen-activated protein kinase kinase 2), PDGFC (platelet derived growth factor C), TGFA (transforming growth factor alpha), RPS6KB2 (ribosomal protein S6 kinase B2), SHC4 (SHC adaptor protein 4), AXL (AXL receptor tyrosine kinase), NRG2 (neuregulin 2), FOXO3 (forkhead box O3), IL6R (interleukin 6 receptor), RPS6 (ribosomal protein S6), NF1 (neurofibromin 1), GAS6 (growth arrest specific 6), EIF4E2 (eukaryotic translation initiation factor 4E family member 2)"], "WAG003050": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), IGF1 (insulin like growth factor 1), FGF2 (fibroblast growth factor 2), RUNX2 (RUNX family transcription factor 2), TGFB1 (transforming growth factor beta 1), INS-IGF2 (INS-IGF2 readthrough), AKT1 (AKT serine/threonine kinase 1), PTHLH (parathyroid hormone like hormone), MMP9 (matrix metallopeptidase 9), MMP13 (matrix metallopeptidase 13), IHH (Indian hedgehog signaling molecule), PTH (parathyroid hormone), IGF1R (insulin like growth factor 1 receptor), STAT1 (signal transducer and activator of transcription 1), SPP1 (secreted phosphoprotein 1), FGFR3 (fibroblast growth factor receptor 3), FGFR1 (fibroblast growth factor receptor 1), GLI3 (GLI family zinc finger 3), PLAU (plasminogen activator, urokinase), SOX9 (SRY-box transcription factor 9), ALPL (alkaline phosphatase, biomineralization associated), COL2A1 (collagen type II alpha 1 chain), BMP7 (bone morphogenetic protein 7), COL10A1 (collagen type X alpha 1 chain), TGFB2 (transforming growth factor beta 2), HDAC4 (histone deacetylase 4), STAT5B (signal transducer and activator of transcription 5B), ADAMTS5 (ADAM metallopeptidase with thrombospondin type 1 motif 5), IGF2 (insulin like growth factor 2), BMP6 (bone morphogenetic protein 6), PTCH1 (patched 1), GHR (growth hormone receptor), PLAT (plasminogen activator, tissue type), TIMP3 (TIMP metallopeptidase inhibitor 3), BMPR1A (bone morphogenetic protein receptor type 1A), ADAMTS4 (ADAM metallopeptidase with thrombospondin type 1 motif 4), MEF2C (myocyte enhancer factor 2C), FGF18 (fibroblast growth factor 18), ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif 1), RUNX3 (RUNX family transcription factor 3), PTH1R (parathyroid hormone 1 receptor), SOX5 (SRY-box transcription factor 5), MGP (matrix Gla protein), GH1 (growth hormone 1), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), SOX6 (SRY-box transcription factor 6), ACAN (aggrecan), THRA (thyroid hormone receptor alpha), SERPINH1 (serpin family H member 1), CDKN1C (cyclin dependent kinase inhibitor 1C), KIF3A (kinesin family member 3A), DDR2 (discoidin domain receptor tyrosine kinase 2), IFT88 (intraflagellar transport 88), NKX3-2 (NK3 homeobox 2), FRZB (frizzled related protein), CAB39 (calcium binding protein 39), ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1), CALM1 (calmodulin 1), CHST11 (carbohydrate sulfotransferase 11), HMGCS1 (3-hydroxy-3-methylglutaryl-CoA synthase 1), SLC38A2 (solute carrier family 38 member 2), SCIN (scinderin), CTSV (cathepsin V), CST5 (cystatin D)"], "WAG003051": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), GRB2 (growth factor receptor bound protein 2), MAPK3 (mitogen-activated protein kinase 3), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), INSR (insulin receptor), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), RAC1 (Rac family small GTPase 1), HRAS (HRas proto-oncogene, GTPase), CRK (CRK proto-oncogene, adaptor protein), MAPK8 (mitogen-activated protein kinase 8), IRS1 (insulin receptor substrate 1), PRKCA (protein kinase C alpha), MAPK14 (mitogen-activated protein kinase 14), MAP2K1 (mitogen-activated protein kinase kinase 1), SHC1 (SHC adaptor protein 1), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), IGF1R (insulin like growth factor 1 receptor), MTOR (mechanistic target of rapamycin kinase), MAP2K4 (mitogen-activated protein kinase kinase 4), PTPN11 (protein tyrosine phosphatase non-receptor type 11), PRKCD (protein kinase C delta), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PRKCZ (protein kinase C zeta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), CBL (Cbl proto-oncogene), AKT2 (AKT serine/threonine kinase 2), RPS6KB1 (ribosomal protein S6 kinase B1), IRS2 (insulin receptor substrate 2), GSK3B (glycogen synthase kinase 3 beta), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PDPK1 (3-phosphoinositide dependent protein kinase 1), PTEN (phosphatase and tensin homolog), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), MAPK11 (mitogen-activated protein kinase 11), MAP2K3 (mitogen-activated protein kinase kinase 3), MAP2K6 (mitogen-activated protein kinase kinase 6), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), SLC2A4 (solute carrier family 2 member 4), MAPK9 (mitogen-activated protein kinase 9), MAP3K3 (mitogen-activated protein kinase kinase kinase 3), IRS4 (insulin receptor substrate 4), MAP2K7 (mitogen-activated protein kinase kinase 7), GAB1 (GRB2 associated binding protein 1), PRKCB (protein kinase C beta), TSC2 (TSC complex subunit 2), RPS6KA1 (ribosomal protein S6 kinase A1), RAC2 (Rac family small GTPase 2), MAP2K2 (mitogen-activated protein kinase kinase 2), PRKCI (protein kinase C iota), MAPK7 (mitogen-activated protein kinase 7), ELK1 (ETS transcription factor ELK1), MAPK10 (mitogen-activated protein kinase 10), MAPK12 (mitogen-activated protein kinase 12), MAPK13 (mitogen-activated protein kinase 13), CBLB (Cbl proto-oncogene B), RPS6KA2 (ribosomal protein S6 kinase A2), MAP3K4 (mitogen-activated protein kinase kinase kinase 4), PRKCQ (protein kinase C theta), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), GRB10 (growth factor receptor bound protein 10), RHOQ (ras homolog family member Q), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), MAPK6 (mitogen-activated protein kinase 6), SHC2 (SHC adaptor protein 2), TSC1 (TSC complex subunit 1), RPS6KA3 (ribosomal protein S6 kinase A3), SGK1 (serum/glucocorticoid regulated kinase 1), MAP2K5 (mitogen-activated protein kinase kinase 5), MAP3K11 (mitogen-activated protein kinase kinase kinase 11), RPS6KA5 (ribosomal protein S6 kinase A5), SOCS3 (suppressor of cytokine signaling 3), SHC3 (SHC adaptor protein 3), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PTPN1 (protein tyrosine phosphatase non-receptor type 1), RAPGEF1 (Rap guanine nucleotide exchange factor 1), MAP3K2 (mitogen-activated protein kinase kinase kinase 2), STX4 (syntaxin 4), SOCS1 (suppressor of cytokine signaling 1), VAMP2 (vesicle associated membrane protein 2), CBLC (Cbl proto-oncogene C), RPS6KA4 (ribosomal protein S6 kinase A4), INPPL1 (inositol polyphosphate phosphatase like 1), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), RHEB (Ras homolog, mTORC1 binding), MAP3K12 (mitogen-activated protein kinase kinase kinase 12), SH2B2 (SH2B adaptor protein 2), SORBS1 (sorbin and SH3 domain containing 1), SNAP23 (synaptosome associated protein 23), MAP4K2 (mitogen-activated protein kinase kinase kinase kinase 2), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), EIF4E (eukaryotic translation initiation factor 4E)"], "WAG003052": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SOX9 (SRY-box transcription factor 9), NR5A1 (nuclear receptor subfamily 5 group A member 1), SRY (sex determining region Y), DMRT1 (doublesex and mab-3 related transcription factor 1), FOXL2 (forkhead box L2), AMH (anti-Mullerian hormone), GATA4 (GATA binding protein 4), WNT4 (Wnt family member 4), SOX8 (SRY-box transcription factor 8), RSPO1 (R-spondin 1), WT1 (WT1 transcription factor), FGF9 (fibroblast growth factor 9), PTGDS (prostaglandin D2 synthase), DHH (desert hedgehog signaling molecule)"], "WAG003054": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TGFB1 (transforming growth factor beta 1), SMAD4 (SMAD family member 4), SMAD3 (SMAD family member 3), SMAD2 (SMAD family member 2), SMAD7 (SMAD family member 7), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), EP300 (E1A binding protein p300), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), SMAD1 (SMAD family member 1), TGFBR1 (transforming growth factor beta receptor 1), CTNNB1 (catenin beta 1), MAPK3 (mitogen-activated protein kinase 3), STAT3 (signal transducer and activator of transcription 3), RUNX2 (RUNX family transcription factor 2), SMAD5 (SMAD family member 5), CREBBP (CREB binding protein), TGFBR2 (transforming growth factor beta receptor 2), IFNG (interferon gamma), EGF (epidermal growth factor), TNF (tumor necrosis factor), BMP4 (bone morphogenetic protein 4), SMAD6 (SMAD family member 6), STAT1 (signal transducer and activator of transcription 1), SMAD9 (SMAD family member 9), LEF1 (lymphoid enhancer binding factor 1), MAPK9 (mitogen-activated protein kinase 9), ZFYVE9 (zinc finger FYVE-type containing 9), TGFBR3 (transforming growth factor beta receptor 3), NFKB1 (nuclear factor kappa B subunit 1), BAMBI (BMP and activin membrane bound inhibitor), SKI (SKI proto-oncogene), TGIF1 (TGFB induced factor homeobox 1), RUNX3 (RUNX family transcription factor 3), ENG (endoglin), SERPINE1 (serpin family E member 1), JAK1 (Janus kinase 1), SKIL (SKI like proto-oncogene), HRAS (HRas proto-oncogene, GTPase), FOXH1 (forkhead box H1), FST (follistatin), LIF (LIF interleukin 6 family cytokine), NOG (noggin), INHBA (inhibin subunit beta A), FBN1 (fibrillin 1), THBS1 (thrombospondin 1), FKBP1A (FKBP prolyl isomerase 1A), SPP1 (secreted phosphoprotein 1), WNT1 (Wnt family member 1), TFE3 (transcription factor binding to IGHM enhancer 3), ITGB6 (integrin subunit beta 6), LTBP1 (latent transforming growth factor beta binding protein 1), LEFTY1 (left-right determination factor 1), ZNF423 (zinc finger protein 423), LTBP3 (latent transforming growth factor beta binding protein 3), LEFTY2 (left-right determination factor 2), ADAMTSL2 (ADAMTS like 2), ADAMTS10 (ADAM metallopeptidase with thrombospondin type 1 motif 10), MIR302A (microRNA 302a), LINC02478 (long intergenic non-protein coding RNA 2478), ZEB2 (zinc finger E-box binding homeobox 2)"], "WAG003056": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), NCK1 (NCK adaptor protein 1), NCK2 (NCK adaptor protein 2), PAX2 (paired box 2), ITGB1 (integrin subunit beta 1), KDR (kinase insert domain receptor), SHH (sonic hedgehog signaling molecule), PDGFRB (platelet derived growth factor receptor beta), NPHS1 (NPHS1 adhesion molecule, nephrin), PDGFB (platelet derived growth factor subunit B), NPHS2 (NPHS2 stomatin family member, podocin), CTNNB1 (catenin beta 1), GDNF (glial cell derived neurotrophic factor), RET (ret proto-oncogene), FGF8 (fibroblast growth factor 8), ILK (integrin linked kinase), CD2AP (CD2 associated protein), HOXA11 (homeobox A11), SLIT2 (slit guidance ligand 2), WNT4 (Wnt family member 4), LMX1B (LIM homeobox transcription factor 1 beta), CXCR4 (C-X-C motif chemokine receptor 4), LAMB2 (laminin subunit beta 2), WT1 (WT1 transcription factor), ITGA3 (integrin subunit alpha 3), EMX2 (empty spiracles homeobox 2), GLI3 (GLI family zinc finger 3), FGFR2 (fibroblast growth factor receptor 2), LHX1 (LIM homeobox 1), ITGA8 (integrin subunit alpha 8), FOXC2 (forkhead box C2), ETV4 (ETS variant transcription factor 4), CXCL12 (C-X-C motif chemokine ligand 12), SIX1 (SIX homeobox 1), EYA1 (EYA transcriptional coactivator and phosphatase 1), CD36 (CD36 molecule), HOXD11 (homeobox D11), NOTCH2 (notch receptor 2), ROBO2 (roundabout guidance receptor 2), FOXC1 (forkhead box C1), FOXD1 (forkhead box D1), HNF1B (HNF1 homeobox B), TCF21 (transcription factor 21), KIRREL1 (kirre like nephrin family adhesion molecule 1)"], "WAG003057": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PLCG1 (phospholipase C gamma 1), SHC1 (SHC adaptor protein 1), GABRB1 (gamma-aminobutyric acid type A receptor subunit beta1), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), GABRA1 (gamma-aminobutyric acid type A receptor subunit alpha1), GABRA5 (gamma-aminobutyric acid type A receptor subunit alpha5), NGFR (nerve growth factor receptor), GABRG2 (gamma-aminobutyric acid type A receptor subunit gamma2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), GABRA2 (gamma-aminobutyric acid type A receptor subunit alpha2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), GABRA3 (gamma-aminobutyric acid type A receptor subunit alpha3), PTEN (phosphatase and tensin homolog), GABRA4 (gamma-aminobutyric acid type A receptor subunit alpha4), JAK2 (Janus kinase 2), GABRB2 (gamma-aminobutyric acid type A receptor subunit beta2), GABRB3 (gamma-aminobutyric acid type A receptor subunit beta3), GABRA6 (gamma-aminobutyric acid type A receptor subunit alpha6), GABRG3 (gamma-aminobutyric acid type A receptor subunit gamma3), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), NTRK2 (neurotrophic receptor tyrosine kinase 2), CREB1 (cAMP responsive element binding protein 1), BDNF (brain derived neurotrophic factor), STAT3 (signal transducer and activator of transcription 3), RHOA (ras homolog family member A), AP2A2 (adaptor related protein complex 2 subunit alpha 2), AP2A1 (adaptor related protein complex 2 subunit alpha 1), AP2B1 (adaptor related protein complex 2 subunit beta 1), ROCK1 (Rho associated coiled-coil containing protein kinase 1), GABRQ (gamma-aminobutyric acid type A receptor subunit theta), GABRG1 (gamma-aminobutyric acid type A receptor subunit gamma1), SLC12A5 (solute carrier family 12 member 5), CREM (cAMP responsive element modulator), GABRD (gamma-aminobutyric acid type A receptor subunit delta), GABRP (gamma-aminobutyric acid type A receptor subunit pi), GABRE (gamma-aminobutyric acid type A receptor subunit epsilon)"], "WAG003058": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), GDNF (glial cell derived neurotrophic factor), BMP4 (bone morphogenetic protein 4), RET (ret proto-oncogene), PAX2 (paired box 2), GFRA1 (GDNF family receptor alpha 1), ROBO2 (roundabout guidance receptor 2), SOX17 (SRY-box transcription factor 17), EYA1 (EYA transcriptional coactivator and phosphatase 1), SALL1 (spalt like transcription factor 1), GLI3 (GLI family zinc finger 3), GREM1 (gremlin 1, DAN family BMP antagonist), HSPB11 (heat shock protein family B (small) member 11), IFT27 (intraflagellar transport 27), SLIT2 (slit guidance ligand 2), SPRY1 (sprouty RTK signaling antagonist 1), LHX1 (LIM homeobox 1), FOXC2 (forkhead box C2), FOXC1 (forkhead box C1), GATA3 (GATA binding protein 3), SOX11 (SRY-box transcription factor 11), AGTR2 (angiotensin II receptor type 2), FAT4 (FAT atypical cadherin 4)"], "WAG003059": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), CASP3 (caspase 3), TGFB1 (transforming growth factor beta 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), RELA (RELA proto-oncogene, NF-kB subunit), BAX (BCL2 associated X, apoptosis regulator), CASP8 (caspase 8), CASP9 (caspase 9), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), TNFRSF1A (TNF receptor superfamily member 1A), SMAD4 (SMAD family member 4), SMAD2 (SMAD family member 2), APAF1 (apoptotic peptidase activating factor 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MTOR (mechanistic target of rapamycin kinase), PRKCQ (protein kinase C theta), BRAF (B-Raf proto-oncogene, serine/threonine kinase), TNFSF11 (TNF superfamily member 11), TGFBR1 (transforming growth factor beta receptor 1), PTH (parathyroid hormone), ACTA2 (actin alpha 2, smooth muscle), CALCA (calcitonin related polypeptide alpha), PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha), BAK1 (BCL2 antagonist/killer 1), SEC16B (SEC16 homolog B, endoplasmic reticulum export factor), RGN (regucalcin), TRPV5 (transient receptor potential cation channel subfamily V member 5), NOS1 (nitric oxide synthase 1), PDE1B (phosphodiesterase 1B), FFAR3 (free fatty acid receptor 3), G3BP1 (G3BP stress granule assembly factor 1), MCU (mitochondrial calcium uniporter)"], "WAG003061": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CTNNB1 (catenin beta 1), GSK3B (glycogen synthase kinase 3 beta), CCND1 (cyclin D1), LEF1 (lymphoid enhancer binding factor 1), AXIN1 (axin 1), CEBPB (CCAAT enhancer binding protein beta), TLE1 (TLE family member 1, transcriptional corepressor), APC (APC regulator of WNT signaling pathway), PPARG (peroxisome proliferator activated receptor gamma), RUNX2 (RUNX family transcription factor 2), TCF7L2 (transcription factor 7 like 2), LMNA (lamin A/C), SREBF1 (sterol regulatory element binding transcription factor 1), CEBPA (CCAAT enhancer binding protein alpha), TCF7 (transcription factor 7), CSNK1A1 (casein kinase 1 alpha 1), WNT10B (Wnt family member 10B), CEBPD (CCAAT enhancer binding protein delta), CDK6 (cyclin dependent kinase 6), ADIPOQ (adiponectin, C1Q and collagen domain containing), SLC2A4 (solute carrier family 2 member 4), HES1 (hes family bHLH transcription factor 1), TCF7L1 (transcription factor 7 like 1), EMD (emerin), CSNK1A1L (casein kinase 1 alpha 1 like), ZMPSTE24 (zinc metallopeptidase STE24), SPP1 (secreted phosphoprotein 1), ICMT (isoprenylcysteine carboxyl methyltransferase), DICER1 (dicer 1, ribonuclease III), TARBP2 (TARBP2 subunit of RISC loading complex), TOR1AIP1 (torsin 1A interacting protein 1), FNTA (farnesyltransferase, CAAX box, alpha), HMGA2 (high mobility group AT-hook 2), AGO2 (argonaute RISC catalytic component 2), MIR33B (microRNA 33b), MIRLET7B (microRNA let-7b), HES5 (hes family bHLH transcription factor 5)"], "WAG003063": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), VEGFA (vascular endothelial growth factor A), TGFB1 (transforming growth factor beta 1), FN1 (fibronectin 1), RELA (RELA proto-oncogene, NF-kB subunit), CTNNB1 (catenin beta 1), MYC (MYC proto-oncogene, bHLH transcription factor), STAT3 (signal transducer and activator of transcription 3), CCND1 (cyclin D1), IL1B (interleukin 1 beta), NFKB1 (nuclear factor kappa B subunit 1), CDKN1A (cyclin dependent kinase inhibitor 1A), BCL2 (BCL2 apoptosis regulator), CASP3 (caspase 3), MMP9 (matrix metallopeptidase 9), MMP2 (matrix metallopeptidase 2), PARP1 (poly(ADP-ribose) polymerase 1), VIM (vimentin), IL18 (interleukin 18), PPARG (peroxisome proliferator activated receptor gamma), CCL2 (C-C motif chemokine ligand 2), VCAM1 (vascular cell adhesion molecule 1), CAV1 (caveolin 1), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CDKN2A (cyclin dependent kinase inhibitor 2A), TIMP1 (TIMP metallopeptidase inhibitor 1), TGFB2 (transforming growth factor beta 2), IRS1 (insulin receptor substrate 1), CDK4 (cyclin dependent kinase 4), FOXO1 (forkhead box O1), LEF1 (lymphoid enhancer binding factor 1), CDK6 (cyclin dependent kinase 6), SPARC (secreted protein acidic and cysteine rich), KDR (kinase insert domain receptor), AKT3 (AKT serine/threonine kinase 3), ACTA1 (actin alpha 1, skeletal muscle), COL1A1 (collagen type I alpha 1 chain), TGFBR2 (transforming growth factor beta receptor 2), GLI1 (GLI family zinc finger 1), MAP2K1 (mitogen-activated protein kinase kinase 1), GLI2 (GLI family zinc finger 2), SOCS1 (suppressor of cytokine signaling 1), GLI3 (GLI family zinc finger 3), FLT1 (fms related receptor tyrosine kinase 1), MET (MET proto-oncogene, receptor tyrosine kinase), BMP7 (bone morphogenetic protein 7), SOCS3 (suppressor of cytokine signaling 3), GAS6 (growth arrest specific 6), SNAI2 (snail family transcriptional repressor 2), ACTA2 (actin alpha 2, smooth muscle), MITF (melanocyte inducing transcription factor), ZEB1 (zinc finger E-box binding homeobox 1), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), ANGPT2 (angiopoietin 2), TWIST1 (twist family bHLH transcription factor 1), BECN1 (beclin 1), FOXP3 (forkhead box P3), BMP6 (bone morphogenetic protein 6), CD36 (CD36 molecule), SNAI1 (snail family transcriptional repressor 1), TCF4 (transcription factor 4), CPT1A (carnitine palmitoyltransferase 1A), COL3A1 (collagen type III alpha 1 chain), ATG5 (autophagy related 5), CHEK1 (checkpoint kinase 1), SMO (smoothened, frizzled class receptor), MSN (moesin), CXCL16 (C-X-C motif chemokine ligand 16), CALD1 (caldesmon 1), CCR2 (C-C motif chemokine receptor 2), SCD (stearoyl-CoA desaturase), NLRP3 (NLR family pyrin domain containing 3), NRG1 (neuregulin 1), BMP8B (bone morphogenetic protein 8b), DAPK1 (death associated protein kinase 1), CXCR6 (C-X-C motif chemokine receptor 6), LTB (lymphotoxin beta), ACOX1 (acyl-CoA oxidase 1), MAP2K2 (mitogen-activated protein kinase kinase 2), ELMO1 (engulfment and cell motility 1), MERTK (MER proto-oncogene, tyrosine kinase), BMP8A (bone morphogenetic protein 8a), AHNAK2 (AHNAK nucleoprotein 2), TGFB1I1 (transforming growth factor beta 1 induced transcript 1), CAV2 (caveolin 2), TNFSF14 (TNF superfamily member 14), DKK3 (dickkopf WNT signaling pathway inhibitor 3), ADAM11 (ADAM metallopeptidase domain 11), CIP2A (cellular inhibitor of PP2A), TMEFF1 (transmembrane protein with EGF like and two follistatin like domains 1), CD274 (CD274 molecule), CCN1 (cellular communication network factor 1), LINC00526 (long intergenic non-protein coding RNA 526), TMEM132A (transmembrane protein 132A), SNAI3 (snail family transcriptional repressor 3)"], "WAG003065": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MPZ (myelin protein zero), MTMR2 (myotubularin related protein 2), GDAP1 (ganglioside induced differentiation associated protein 1), RAB7A (RAB7A, member RAS oncogene family), PMP22 (peripheral myelin protein 22), RABAC1 (Rab acceptor 1), KIF1B (kinesin family member 1B), EGR2 (early growth response 2), RAB4A (RAB4A, member RAS oncogene family), RAB11A (RAB11A, member RAS oncogene family), SBF2 (SET binding factor 2), NEFL (neurofilament light), NDRG1 (N-myc downstream regulated 1), RAB3A (RAB3A, member RAS oncogene family), RAB4B (RAB4B, member RAS oncogene family), HSPB8 (heat shock protein family B (small) member 8), SH3TC2 (SH3 domain and tetratricopeptide repeats 2), RAB25 (RAB25, member RAS oncogene family), MFN2 (mitofusin 2), RAB11B (RAB11B, member RAS oncogene family), RAB3B (RAB3B, member RAS oncogene family), DNM2 (dynamin 2), FIG4 (FIG4 phosphoinositide 5-phosphatase), HSPB1 (heat shock protein family B (small) member 1), FGD4 (FYVE, RhoGEF and PH domain containing 4), LITAF (lipopolysaccharide induced TNF factor), LRSAM1 (leucine rich repeat and sterile alpha motif containing 1)"], "WAG003066": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SRC (SRC proto-oncogene, non-receptor tyrosine kinase), MAPK1 (mitogen-activated protein kinase 1), EGFR (epidermal growth factor receptor), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), RAC1 (Rac family small GTPase 1), MAPK3 (mitogen-activated protein kinase 3), VEGFA (vascular endothelial growth factor A), PRKCA (protein kinase C alpha), GRB2 (growth factor receptor bound protein 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TNF (tumor necrosis factor), CTNNB1 (catenin beta 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CCND1 (cyclin D1), PXN (paxillin), EDN1 (endothelin 1), VCAM1 (vascular cell adhesion molecule 1), CDC42 (cell division cycle 42), IL6 (interleukin 6), ITGB1 (integrin subunit beta 1), NFKB1 (nuclear factor kappa B subunit 1), RELA (RELA proto-oncogene, NF-kB subunit), PTGS2 (prostaglandin-endoperoxide synthase 2), RHOA (ras homolog family member A), CDH1 (cadherin 1), IL1B (interleukin 1 beta), VIM (vimentin), MMP9 (matrix metallopeptidase 9), PAK1 (p21 (RAC1) activated kinase 1), ILK (integrin linked kinase), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PTK2B (protein tyrosine kinase 2 beta), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), BCL2 (BCL2 apoptosis regulator), ARRB1 (arrestin beta 1), EZR (ezrin), SHC1 (SHC adaptor protein 1), CSF2 (colony stimulating factor 2), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), ITGB3 (integrin subunit beta 3), GSK3B (glycogen synthase kinase 3 beta), HIF1A (hypoxia inducible factor 1 subunit alpha), CASP8 (caspase 8), BCAR1 (BCAR1 scaffold protein, Cas family member), NFKBIA (NFKB inhibitor alpha), MAP2K1 (mitogen-activated protein kinase kinase 1), MMP2 (matrix metallopeptidase 2), CDK2 (cyclin dependent kinase 2), NOS3 (nitric oxide synthase 3), EDNRA (endothelin receptor type A), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), KRAS (KRAS proto-oncogene, GTPase), MYLK (myosin light chain kinase), CDH2 (cadherin 2), COL1A2 (collagen type I alpha 2 chain), CTNND1 (catenin delta 1), ROCK1 (Rho associated coiled-coil containing protein kinase 1), COL1A1 (collagen type I alpha 1 chain), EPHA2 (EPH receptor A2), ARF6 (ADP ribosylation factor 6), FHL2 (four and a half LIM domains 2), CCL2 (C-C motif chemokine ligand 2), EGR1 (early growth response 1), GNA13 (G protein subunit alpha 13), GSN (gelsolin), ARHGEF7 (Rho guanine nucleotide exchange factor 7), MYH11 (myosin heavy chain 11), GNA12 (G protein subunit alpha 12), MMP14 (matrix metallopeptidase 14), TPM1 (tropomyosin 1), NPPA (natriuretic peptide A), YAP1 (Yes1 associated transcriptional regulator), MSN (moesin), CALD1 (caldesmon 1), EDNRB (endothelin receptor type B), ITGA2 (integrin subunit alpha 2), PLA2G1B (phospholipase A2 group IB), MMP13 (matrix metallopeptidase 13), GATA4 (GATA binding protein 4), PLCB1 (phospholipase C beta 1), RUNX1 (RUNX family transcription factor 1), GNAS (GNAS complex locus), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), ACTR3 (actin related protein 3), ACTA2 (actin alpha 2, smooth muscle), MEF2A (myocyte enhancer factor 2A), FLNC (filamin C), EDN3 (endothelin 3), FLNB (filamin B), ADAM17 (ADAM metallopeptidase domain 17), TNS1 (tensin 1), PPP3CA (protein phosphatase 3 catalytic subunit alpha), AXIN1 (axin 1), COL2A1 (collagen type II alpha 1 chain), TPM4 (tropomyosin 4), CAPZB (capping actin protein of muscle Z-line subunit beta), ACTR2 (actin related protein 2), SMAD5 (SMAD family member 5), RDX (radixin), HDAC5 (histone deacetylase 5)"], "WAG003068": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPP1CA (protein phosphatase 1 catalytic subunit alpha), PPP1CC (protein phosphatase 1 catalytic subunit gamma), PPP1CB (protein phosphatase 1 catalytic subunit beta), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), PPP1R15A (protein phosphatase 1 regulatory subunit 15A), HSPA5 (heat shock protein family A (Hsp70) member 5), ATF6 (activating transcription factor 6), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), PPP1R2 (protein phosphatase 1 regulatory inhibitor subunit 2), ATF4 (activating transcription factor 4), DDIT3 (DNA damage inducible transcript 3), BCL2 (BCL2 apoptosis regulator), PPP1R9B (protein phosphatase 1 regulatory subunit 9B), PPP1R1A (protein phosphatase 1 regulatory inhibitor subunit 1A), ERN1 (endoplasmic reticulum to nucleus signaling 1), PPP1R12A (protein phosphatase 1 regulatory subunit 12A), PPP1R8 (protein phosphatase 1 regulatory subunit 8), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), XBP1 (X-box binding protein 1), PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A), PPP1R7 (protein phosphatase 1 regulatory subunit 7), PPP1R9A (protein phosphatase 1 regulatory subunit 9A), PPP1R10 (protein phosphatase 1 regulatory subunit 10), PPP1R16A (protein phosphatase 1 regulatory subunit 16A), PPP1R12B (protein phosphatase 1 regulatory subunit 12B), PPP1R1B (protein phosphatase 1 regulatory inhibitor subunit 1B), PPP1R11 (protein phosphatase 1 regulatory inhibitor subunit 11), MBTPS1 (membrane bound transcription factor peptidase, site 1), PPP1R3C (protein phosphatase 1 regulatory subunit 3C), PPP1R3D (protein phosphatase 1 regulatory subunit 3D), PPP1R14B (protein phosphatase 1 regulatory inhibitor subunit 14B), PPP1R3B (protein phosphatase 1 regulatory subunit 3B), MBTPS2 (membrane bound transcription factor peptidase, site 2), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), PPP1R3A (protein phosphatase 1 regulatory subunit 3A), PPP1R14D (protein phosphatase 1 regulatory inhibitor subunit 14D), EIF2AK1 (eukaryotic translation initiation factor 2 alpha kinase 1), PPP1R13B (protein phosphatase 1 regulatory subunit 13B), PPP1R14C (protein phosphatase 1 regulatory inhibitor subunit 14C), MAPK8 (mitogen-activated protein kinase 8), PPP1R12C (protein phosphatase 1 regulatory subunit 12C), PPP1R15B (protein phosphatase 1 regulatory subunit 15B), PPP1R1C (protein phosphatase 1 regulatory inhibitor subunit 1C), PPP1R3G (protein phosphatase 1 regulatory subunit 3G), PPP1R3E (protein phosphatase 1 regulatory subunit 3E), PPP1R16B (protein phosphatase 1 regulatory subunit 16B), PPP1R3F (protein phosphatase 1 regulatory subunit 3F)"], "WAG003069": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BECN1 (beclin 1), ATG5 (autophagy related 5), ULK1 (unc-51 like autophagy activating kinase 1), ATG12 (autophagy related 12), ATG3 (autophagy related 3), ATG7 (autophagy related 7), RB1CC1 (RB1 inducible coiled-coil 1), ATG16L1 (autophagy related 16 like 1), MTOR (mechanistic target of rapamycin kinase), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), ATG13 (autophagy related 13), ULK2 (unc-51 like autophagy activating kinase 2), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), ATG10 (autophagy related 10), WIPI1 (WD repeat domain, phosphoinositide interacting 1), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), ATG4A (autophagy related 4A cysteine peptidase), ATG16L2 (autophagy related 16 like 2), ZFYVE1 (zinc finger FYVE-type containing 1)"], "WAG003070": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BCL2 (BCL2 apoptosis regulator), CASP3 (caspase 3), BAX (BCL2 associated X, apoptosis regulator), BCL2L1 (BCL2 like 1), CASP8 (caspase 8), BID (BH3 interacting domain death agonist), AKT1 (AKT serine/threonine kinase 1), MCL1 (MCL1 apoptosis regulator, BCL2 family member), CASP9 (caspase 9), APAF1 (apoptotic peptidase activating factor 1), TNF (tumor necrosis factor), BAD (BCL2 associated agonist of cell death), BCL2L11 (BCL2 like 11), CASP7 (caspase 7), FASLG (Fas ligand), FADD (Fas associated via death domain), MAPK14 (mitogen-activated protein kinase 14), BBC3 (BCL2 binding component 3), MAPK11 (mitogen-activated protein kinase 11), MAPK13 (mitogen-activated protein kinase 13), MAPK12 (mitogen-activated protein kinase 12)"], "WAG003071": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IRF7 (interferon regulatory factor 7), STAT1 (signal transducer and activator of transcription 1), IRF3 (interferon regulatory factor 3), MYD88 (MYD88 innate immune signal transduction adaptor), DDX58 (DExD/H-box helicase 58), TLR3 (toll like receptor 3), TRAF6 (TNF receptor associated factor 6), IRF9 (interferon regulatory factor 9), MAVS (mitochondrial antiviral signaling protein), TBK1 (TANK binding kinase 1), STAT2 (signal transducer and activator of transcription 2), TLR4 (toll like receptor 4), TLR9 (toll like receptor 9), TRAF3 (TNF receptor associated factor 3), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), OAS3 (2'-5'-oligoadenylate synthetase 3), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), OAS2 (2'-5'-oligoadenylate synthetase 2), TLR7 (toll like receptor 7), OAS1 (2'-5'-oligoadenylate synthetase 1), JAK1 (Janus kinase 1), TYK2 (tyrosine kinase 2), IFIH1 (interferon induced with helicase C domain 1), IFNAR2 (interferon alpha and beta receptor subunit 2), IFNAR1 (interferon alpha and beta receptor subunit 1), TLR2 (toll like receptor 2), IRAK4 (interleukin 1 receptor associated kinase 4), TLR6 (toll like receptor 6), ACE2 (angiotensin I converting enzyme 2), TREML4 (triggering receptor expressed on myeloid cells like 4), TMPRSS2 (transmembrane serine protease 2)"], "WAG003073": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GSK3B (glycogen synthase kinase 3 beta), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAPK1 (mitogen-activated protein kinase 1), AXIN1 (axin 1), CTNNB1 (catenin beta 1), SOX9 (SRY-box transcription factor 9), MAP3K4 (mitogen-activated protein kinase kinase kinase 4), FRAT1 (FRAT regulator of WNT signaling pathway 1), RHOA (ras homolog family member A), MAPK11 (mitogen-activated protein kinase 11), FGF9 (fibroblast growth factor 9), ROCK1 (Rho associated coiled-coil containing protein kinase 1), SRY (sex determining region Y), FGFR2 (fibroblast growth factor receptor 2), WNT4 (Wnt family member 4), FOXL2 (forkhead box L2), GADD45G (growth arrest and DNA damage inducible gamma)"], "WAG003075": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), RELA (RELA proto-oncogene, NF-kB subunit), CAMK4 (calcium/calmodulin dependent protein kinase IV), EP300 (E1A binding protein p300), RAC1 (Rac family small GTPase 1), CREB1 (cAMP responsive element binding protein 1), SQSTM1 (sequestosome 1), MTOR (mechanistic target of rapamycin kinase), SIRT1 (sirtuin 1), RPTOR (regulatory associated protein of MTOR complex 1), CAMK1 (calcium/calmodulin dependent protein kinase I), HDAC4 (histone deacetylase 4), ICAM1 (intercellular adhesion molecule 1), HMOX1 (heme oxygenase 1), NFE2L2 (nuclear factor, erythroid 2 like 2), VCAM1 (vascular cell adhesion molecule 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), TSC1 (TSC complex subunit 1), ARHGEF7 (Rho guanine nucleotide exchange factor 7), NOS1 (nitric oxide synthase 1), GIT1 (GIT ArfGAP 1), CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2), MAF (MAF bZIP transcription factor), NFATC2 (nuclear factor of activated T cells 2), FIS1 (fission, mitochondrial 1), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), DNM1L (dynamin 1 like), SMC1A (structural maintenance of chromosomes 1A), WFS1 (wolframin ER transmembrane glycoprotein), STIM1 (stromal interaction molecule 1), CHRM3 (cholinergic receptor muscarinic 3), CALM1 (calmodulin 1)"], "WAG003076": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), DLG2 (discs large MAGUK scaffold protein 2), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), CAMK2D (calcium/calmodulin dependent protein kinase II delta), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), CAMK2B (calcium/calmodulin dependent protein kinase II beta), DLGAP1 (DLG associated protein 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), DLG1 (discs large MAGUK scaffold protein 1), MAPK1 (mitogen-activated protein kinase 1), GRM1 (glutamate metabotropic receptor 1), MAPK3 (mitogen-activated protein kinase 3), NRXN1 (neurexin 1), HOMER1 (homer scaffold protein 1), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), NLGN1 (neuroligin 1), NLGN2 (neuroligin 2), NRXN2 (neurexin 2), NRXN3 (neurexin 3), SHANK1 (SH3 and multiple ankyrin repeat domains 1), SYNGAP1 (synaptic Ras GTPase activating protein 1), NLGN3 (neuroligin 3), RYR2 (ryanodine receptor 2), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), TJP1 (tight junction protein 1), ARC (activity regulated cytoskeleton associated protein), NLGN4X (neuroligin 4 X-linked), STX1A (syntaxin 1A), CYFIP1 (cytoplasmic FMR1 interacting protein 1), RPH3A (rabphilin 3A), FMR1 (FMRP translational regulator 1)"], "WAG003077": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL1B (interleukin 1 beta), NLRP3 (NLR family pyrin domain containing 3), NFKB1 (nuclear factor kappa B subunit 1), PYCARD (PYD and CARD domain containing), CASP1 (caspase 1), RELA (RELA proto-oncogene, NF-kB subunit), TRAF3 (TNF receptor associated factor 3)"], "WAG003078": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK14 (mitogen-activated protein kinase 14), MAPK1 (mitogen-activated protein kinase 1), MAPK8 (mitogen-activated protein kinase 8), MAP2K4 (mitogen-activated protein kinase kinase 4), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK3 (mitogen-activated protein kinase 3), MAP2K6 (mitogen-activated protein kinase kinase 6), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), MAPK11 (mitogen-activated protein kinase 11), MAP2K1 (mitogen-activated protein kinase kinase 1), MAP2K3 (mitogen-activated protein kinase kinase 3), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAPK13 (mitogen-activated protein kinase 13), MAPK12 (mitogen-activated protein kinase 12), ATF2 (activating transcription factor 2), MAP2K7 (mitogen-activated protein kinase kinase 7), MAPK9 (mitogen-activated protein kinase 9), MAPK10 (mitogen-activated protein kinase 10), MAP2K2 (mitogen-activated protein kinase kinase 2), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), MAP3K4 (mitogen-activated protein kinase kinase kinase 4), DDIT3 (DNA damage inducible transcript 3), BCL2 (BCL2 apoptosis regulator), RPS6KA1 (ribosomal protein S6 kinase A1), RPS6KA2 (ribosomal protein S6 kinase A2), RPS6KA3 (ribosomal protein S6 kinase A3), MAP3K11 (mitogen-activated protein kinase kinase kinase 11), MAP3K10 (mitogen-activated protein kinase kinase kinase 10), EIF4E (eukaryotic translation initiation factor 4E), MAP3K9 (mitogen-activated protein kinase kinase kinase 9), IFITM1 (interferon induced transmembrane protein 1), IFITM3 (interferon induced transmembrane protein 3), IFI27 (interferon alpha inducible protein 27), IFITM2 (interferon induced transmembrane protein 2), BST2 (bone marrow stromal cell antigen 2)"], "WAG003079": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CREBBP (CREB binding protein), SMAD3 (SMAD family member 3), CTNNB1 (catenin beta 1), HDAC1 (histone deacetylase 1), RB1 (RB transcriptional corepressor 1), SMAD2 (SMAD family member 2), CDKN1A (cyclin dependent kinase inhibitor 1A), RUNX2 (RUNX family transcription factor 2), NOTCH1 (notch receptor 1), TGFB1 (transforming growth factor beta 1), CEBPB (CCAAT enhancer binding protein beta), E2F1 (E2F transcription factor 1), LEF1 (lymphoid enhancer binding factor 1), KAT2B (lysine acetyltransferase 2B), GSK3B (glycogen synthase kinase 3 beta), CDK4 (cyclin dependent kinase 4), AXIN1 (axin 1), PPARG (peroxisome proliferator activated receptor gamma), TLE1 (TLE family member 1, transcriptional corepressor), CEBPA (CCAAT enhancer binding protein alpha), CEBPD (CCAAT enhancer binding protein delta), APC (APC regulator of WNT signaling pathway), MYOD1 (myogenic differentiation 1), LMNA (lamin A/C), TCF7L2 (transcription factor 7 like 2), BMP2 (bone morphogenetic protein 2), CSNK1A1 (casein kinase 1 alpha 1), TGFB2 (transforming growth factor beta 2), ACTB (actin beta), HES1 (hes family bHLH transcription factor 1), SREBF1 (sterol regulatory element binding transcription factor 1), EMD (emerin), TCF7 (transcription factor 7), TMPO (thymopoietin), LEMD3 (LEM domain containing 3), TNFRSF11B (TNF receptor superfamily member 11b), WNT10B (Wnt family member 10B), HES5 (hes family bHLH transcription factor 5), TCF7L1 (transcription factor 7 like 1), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), SPP1 (secreted phosphoprotein 1), HMGA2 (high mobility group AT-hook 2), CSNK1A1L (casein kinase 1 alpha 1 like), NAP1L1 (nucleosome assembly protein 1 like 1), FNTA (farnesyltransferase, CAAX box, alpha), ZMPSTE24 (zinc metallopeptidase STE24), MSTN (myostatin), WNT7B (Wnt family member 7B), CTSK (cathepsin K), ICMT (isoprenylcysteine carboxyl methyltransferase), TARBP2 (TARBP2 subunit of RISC loading complex), DICER1 (dicer 1, ribonuclease III), MAOB (monoamine oxidase B), MAOA (monoamine oxidase A), MIR33B (microRNA 33b), MIRLET7B (microRNA let-7b), AGO2 (argonaute RISC catalytic component 2)"], "WAG003080": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT1 (signal transducer and activator of transcription 1), TRAF6 (TNF receptor associated factor 6), MAVS (mitochondrial antiviral signaling protein), IRF3 (interferon regulatory factor 3), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), NFKB1 (nuclear factor kappa B subunit 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), NFKBIA (NFKB inhibitor alpha), IRF9 (interferon regulatory factor 9), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), MYD88 (MYD88 innate immune signal transduction adaptor), TICAM1 (toll like receptor adaptor molecule 1), DDX58 (DExD/H-box helicase 58), TBK1 (TANK binding kinase 1), RIPK1 (receptor interacting serine/threonine kinase 1), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), TRAF3 (TNF receptor associated factor 3), MAPK14 (mitogen-activated protein kinase 14), TYK2 (tyrosine kinase 2), JAK1 (Janus kinase 1), STAT2 (signal transducer and activator of transcription 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), OAS3 (2'-5'-oligoadenylate synthetase 3), OAS2 (2'-5'-oligoadenylate synthetase 2), OAS1 (2'-5'-oligoadenylate synthetase 1), MAPK8 (mitogen-activated protein kinase 8), IFNAR2 (interferon alpha and beta receptor subunit 2), IFNAR1 (interferon alpha and beta receptor subunit 1), IFIH1 (interferon induced with helicase C domain 1), TLR7 (toll like receptor 7)"], "WAG003083": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL6 (interleukin 6), IL10 (interleukin 10), TNF (tumor necrosis factor), IL2 (interleukin 2), CCL2 (C-C motif chemokine ligand 2), IL1B (interleukin 1 beta), IL2RA (interleukin 2 receptor subunit alpha), CSF3 (colony stimulating factor 3), CXCL10 (C-X-C motif chemokine ligand 10), IL7 (interleukin 7), CCL3 (C-C motif chemokine ligand 3), AGT (angiotensinogen), ACE2 (angiotensin I converting enzyme 2), CXCL8 (C-X-C motif chemokine ligand 8), TMPRSS2 (transmembrane serine protease 2)"], "WAG003084": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL2 (interleukin 2), JAK1 (Janus kinase 1), MAPK1 (mitogen-activated protein kinase 1), IL2RA (interleukin 2 receptor subunit alpha), IL2RB (interleukin 2 receptor subunit beta), JAK3 (Janus kinase 3), PTPN11 (protein tyrosine phosphatase non-receptor type 11), LCK (LCK proto-oncogene, Src family tyrosine kinase), STAT3 (signal transducer and activator of transcription 3), IL2RG (interleukin 2 receptor subunit gamma), AKT1 (AKT serine/threonine kinase 1), MAPK3 (mitogen-activated protein kinase 3), SYK (spleen associated tyrosine kinase), GRB2 (growth factor receptor bound protein 2), HRAS (HRas proto-oncogene, GTPase), SHC1 (SHC adaptor protein 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), FYN (FYN proto-oncogene, Src family tyrosine kinase), GAB2 (GRB2 associated binding protein 2), STAT1 (signal transducer and activator of transcription 1), STAT5A (signal transducer and activator of transcription 5A), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), MAP2K1 (mitogen-activated protein kinase kinase 1), STAT5B (signal transducer and activator of transcription 5B), MYC (MYC proto-oncogene, bHLH transcription factor), PTK2B (protein tyrosine kinase 2 beta), CBL (Cbl proto-oncogene), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SOCS3 (suppressor of cytokine signaling 3), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CRKL (CRK like proto-oncogene, adaptor protein), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CISH (cytokine inducible SH2 containing protein), BCL2 (BCL2 apoptosis regulator), RPS6KB1 (ribosomal protein S6 kinase B1), MAP2K2 (mitogen-activated protein kinase kinase 2), NMI (N-myc and STAT interactor), CCND2 (cyclin D2), MAPT (microtubule associated protein tau), FOXO3 (forkhead box O3), RPS6KB2 (ribosomal protein S6 kinase B2), RPS6 (ribosomal protein S6)"], "WAG003085": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "P2RY2 (purinergic receptor P2Y2), P2RY4 (pyrimidinergic receptor P2Y4), GNAI2 (G protein subunit alpha i2), P2RY1 (purinergic receptor P2Y1), ADORA1 (adenosine A1 receptor), P2RY6 (pyrimidinergic receptor P2Y6), P2RX1 (purinergic receptor P2X 1), P2RX7 (purinergic receptor P2X 7), P2RY12 (purinergic receptor P2Y12), P2RX5 (purinergic receptor P2X 5), P2RY13 (purinergic receptor P2Y13), P2RX3 (purinergic receptor P2X 3), P2RY11 (purinergic receptor P2Y11), GNAS (GNAS complex locus), P2RY14 (purinergic receptor P2Y14), GNAO1 (G protein subunit alpha o1), ADORA3 (adenosine A3 receptor), P2RY10 (P2Y receptor family member 10), P2RX2 (purinergic receptor P2X 2), LPAR4 (lysophosphatidic acid receptor 4), GNAT2 (G protein subunit alpha transducin 2), GNAI3 (G protein subunit alpha i3), LPAR6 (lysophosphatidic acid receptor 6), P2RX6 (purinergic receptor P2X 6), GNAI1 (G protein subunit alpha i1), GNAT3 (G protein subunit alpha transducin 3), GNAT1 (G protein subunit alpha transducin 1), ADORA2A (adenosine A2a receptor), ADORA2B (adenosine A2b receptor), P2RX4 (purinergic receptor P2X 4), PANX1 (pannexin 1), P2RY8 (P2Y receptor family member 8)"], "WAG003086": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD2 (SMAD family member 2), TGFBR1 (transforming growth factor beta receptor 1), TGFBR2 (transforming growth factor beta receptor 2), NEDD4 (NEDD4 E3 ubiquitin protein ligase), PMEPA1 (prostate transmembrane protein, androgen induced 1), LDLRAD4-AS1 (LDLRAD4 antisense RNA 1), LDLRAD4 (low density lipoprotein receptor class A domain containing 4), ATG16L1 (autophagy related 16 like 1)"], "WAG003088": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYC (MYC proto-oncogene, bHLH transcription factor), AKT1 (AKT serine/threonine kinase 1), HIF1A (hypoxia inducible factor 1 subunit alpha), TF (transferrin), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), TFRC (transferrin receptor), DYNLL1 (dynein light chain LC8-type 1), DYNLRB1 (dynein light chain roadblock-type 1), TGFB1 (transforming growth factor beta 1), DYNLL2 (dynein light chain LC8-type 2), SIRT1 (sirtuin 1), DYNLT1 (dynein light chain Tctex-type 1), DYNLT3 (dynein light chain Tctex-type 3), DYNLRB2 (dynein light chain roadblock-type 2), PAK2 (p21 (RAC1) activated kinase 2), HFE (homeostatic iron regulator), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1), HAMP (hepcidin antimicrobial peptide), FBXW7 (F-box and WD repeat domain containing 7), SLC40A1 (solute carrier family 40 member 1), NF2 (neurofibromin 2), MYCBP2 (MYC binding protein 2), STAT5A (signal transducer and activator of transcription 5A), ADAM10 (ADAM metallopeptidase domain 10), UBE2N (ubiquitin conjugating enzyme E2 N), DLG1 (discs large MAGUK scaffold protein 1), PXN (paxillin), CASP7 (caspase 7), PIGM (phosphatidylinositol glycan anchor biosynthesis class M), NCBP2 (nuclear cap binding protein subunit 2), RNF168 (ring finger protein 168), CEP19 (centrosomal protein 19), RNF8 (ring finger protein 8), RABL2B (RAB, member of RAS oncogene family like 2B), NCBP1 (nuclear cap binding protein subunit 1), PIGX (phosphatidylinositol glycan anchor biosynthesis class X), UBXN7 (UBX domain protein 7), STAT5B (signal transducer and activator of transcription 5B), FBXO45 (F-box protein 45), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PIGZ (phosphatidylinositol glycan anchor biosynthesis class Z), TCTEX1D2 (Tctex1 domain containing 2), FNDC8 (fibronectin type III domain containing 8), CEP350 (centrosomal protein 350), NRROS (negative regulator of reactive oxygen species), PCYT1A (phosphate cytidylyltransferase 1, choline, alpha), ZNF76 (zinc finger protein 76), CEP43 (centrosomal protein 43), DYNC2I2 (dynein 2 intermediate chain 2), WDR53 (WD repeat domain 53), DYNC2I1 (dynein 2 intermediate chain 1), LINC00885 (long intergenic non-protein coding RNA 885), SLC51B (solute carrier family 51 subunit beta), MELTF-AS1 (MELTF antisense RNA 1), NCBP2AS2 (NCBP2 antisense 2 (head to head)), ZDHHC19 (zinc finger DHHC-type palmitoyltransferase 19), SENP5 (SUMO specific peptidase 5), LINC01063 (long intergenic non-protein coding RNA 1063), SLC51A (solute carrier family 51 subunit alpha), BRINP1 (BMP/retinoic acid inducible neural specific 1), SDHAP1 (succinate dehydrogenase complex flavoprotein subunit A pseudogene 1), TM4SF19 (transmembrane 4 L six family member 19), MAD2L1BP (MAD2L1 binding protein), NCBP2-AS1 (NCBP2 antisense RNA 1), MIR4797 (microRNA 4797), DLG1-AS1 (DLG1 antisense RNA 1), MCRS1 (microspherule protein 1), TM4SF19-AS1 (TM4SF19 antisense RNA 1), RABL2A (RAB, member of RAS oncogene family like 2A), MELTF (melanotransferrin), SMCO1 (single-pass membrane protein with coiled-coil domains 1)"], "WAG003091": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATP6V1H (ATPase H+ transporting V1 subunit H), ATP6V1E1 (ATPase H+ transporting V1 subunit E1), ATP6V1A (ATPase H+ transporting V1 subunit A), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), ATP6V1F (ATPase H+ transporting V1 subunit F), ATP6V1B1 (ATPase H+ transporting V1 subunit B1), ATP6V1D (ATPase H+ transporting V1 subunit D), ATP6V1G1 (ATPase H+ transporting V1 subunit G1), ATP6V0D2 (ATPase H+ transporting V0 subunit d2), ATP6V0C (ATPase H+ transporting V0 subunit c), ATP6V0A4 (ATPase H+ transporting V0 subunit a4), ATP6V0B (ATPase H+ transporting V0 subunit b), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), CA2 (carbonic anhydrase 2), ABCB1 (ATP binding cassette subfamily B member 1), SLC22A2 (solute carrier family 22 member 2), ABCC4 (ATP binding cassette subfamily C member 4), ABCC2 (ATP binding cassette subfamily C member 2), SLC3A1 (solute carrier family 3 member 1), SLC22A8 (solute carrier family 22 member 8), SLC3A2 (solute carrier family 3 member 2), ATP1A1 (ATPase Na+/K+ transporting subunit alpha 1), ABCG2 (ATP binding cassette subfamily G member 2 (Junior blood group)), SLC22A6 (solute carrier family 22 member 6), SLC34A1 (solute carrier family 34 member 1), SLC7A8 (solute carrier family 7 member 8), SLC4A4 (solute carrier family 4 member 4), SLC7A7 (solute carrier family 7 member 7), SLC4A2 (solute carrier family 4 member 2), SLC26A6 (solute carrier family 26 member 6), ATP1B1 (ATPase Na+/K+ transporting subunit beta 1), SLC7A9 (solute carrier family 7 member 9), SLC5A1 (solute carrier family 5 member 1), CA4 (carbonic anhydrase 4), FXYD2 (FXYD domain containing ion transport regulator 2), SLC9A3 (solute carrier family 9 member A3), SLC36A2 (solute carrier family 36 member 2), SLC13A3 (solute carrier family 13 member 3), SLC5A2 (solute carrier family 5 member 2), SLC2A1 (solute carrier family 2 member 1), SLC2A2 (solute carrier family 2 member 2), SLC22A11 (solute carrier family 22 member 11), SLC47A1 (solute carrier family 47 member 1), SLC6A19 (solute carrier family 6 member 19), AQP1 (aquaporin 1 (Colton blood group)), SLC6A20 (solute carrier family 6 member 20), SLC6A18 (solute carrier family 6 member 18), SLC1A1 (solute carrier family 1 member 1), SLC22A7 (solute carrier family 22 member 7), SLC20A2 (solute carrier family 20 member 2), SLC47A2 (solute carrier family 47 member 2), SLC5A5 (solute carrier family 5 member 5), SLC16A10 (solute carrier family 16 member 10), SLC12A4 (solute carrier family 12 member 4), SLC34A3 (solute carrier family 34 member 3), SLC5A8 (solute carrier family 5 member 8), CLTRN (collectrin, amino acid transport regulator)"], "WAG003095": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1), UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII), UQCRB (ubiquinol-cytochrome c reductase binding protein), UQCRH (ubiquinol-cytochrome c reductase hinge protein), UQCR10 (ubiquinol-cytochrome c reductase, complex III subunit X), CYC1 (cytochrome c1), UQCRC1 (ubiquinol-cytochrome c reductase core protein 1), UQCRC2 (ubiquinol-cytochrome c reductase core protein 2), UQCR11 (ubiquinol-cytochrome c reductase, complex III subunit XI), BCS1L (BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone), LYRM7 (LYR motif containing 7), UQCC3 (ubiquinol-cytochrome c reductase complex assembly factor 3), CYTB (cytochrome b), TTC19 (tetratricopeptide repeat domain 19), UQCC2 (ubiquinol-cytochrome c reductase complex assembly factor 2), UQCC1 (ubiquinol-cytochrome c reductase complex assembly factor 1)"], "WAG003096": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "COX6B1 (cytochrome c oxidase subunit 6B1), COX5B (cytochrome c oxidase subunit 5B), COX5A (cytochrome c oxidase subunit 5A), COX7C (cytochrome c oxidase subunit 7C), COX6C (cytochrome c oxidase subunit 6C), COX4I1 (cytochrome c oxidase subunit 4I1), COX7B (cytochrome c oxidase subunit 7B), COX7A2 (cytochrome c oxidase subunit 7A2), COX8A (cytochrome c oxidase subunit 8A), SURF1 (SURF1 cytochrome c oxidase assembly factor), COX10 (cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10), COX6A1 (cytochrome c oxidase subunit 6A1), NDUFA4 (NDUFA4 mitochondrial complex associated), COX15 (cytochrome c oxidase assembly homolog COX15), COX11 (cytochrome c oxidase copper chaperone COX11), SCO2 (synthesis of cytochrome C oxidase 2), COX17 (cytochrome c oxidase copper chaperone COX17), COX19 (cytochrome c oxidase assembly factor COX19), TACO1 (translational activator of cytochrome c oxidase I), COX14 (cytochrome c oxidase assembly factor COX14), COX18 (cytochrome c oxidase assembly factor COX18), COX16 (cytochrome c oxidase assembly factor COX16), COX20 (cytochrome c oxidase assembly factor COX20), COX3 (cytochrome c oxidase III), PNKD (PNKD metallo-beta-lactamase domain containing), COX1 (cytochrome c oxidase subunit I), PET117 (PET117 cytochrome c oxidase chaperone), COA3 (cytochrome c oxidase assembly factor 3), TMEM177 (transmembrane protein 177), HIGD1A (HIG1 hypoxia inducible domain family member 1A), COA6 (cytochrome c oxidase assembly factor 6), COX2 (cytochrome c oxidase subunit II), CMC1 (C-X9-C motif containing 1), SMIM20 (small integral membrane protein 20), PET100 (PET100 cytochrome c oxidase chaperone)"], "WAG003097": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ULK1 (unc-51 like autophagy activating kinase 1), BECN1 (beclin 1), MTOR (mechanistic target of rapamycin kinase), RB1CC1 (RB1 inducible coiled-coil 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), ATG12 (autophagy related 12), ATG5 (autophagy related 5), RPTOR (regulatory associated protein of MTOR complex 1), AMBRA1 (autophagy and beclin 1 regulator 1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), ATG16L1 (autophagy related 16 like 1), ATG3 (autophagy related 3), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), ATG7 (autophagy related 7), MLST8 (MTOR associated protein, LST8 homolog), ATG13 (autophagy related 13), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), ATG14 (autophagy related 14), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), UVRAG (UV radiation resistance associated), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), DEPTOR (DEP domain containing MTOR interacting protein), AKT1S1 (AKT1 substrate 1), WIPI2 (WD repeat domain, phosphoinositide interacting 2), ATG9A (autophagy related 9A), ATG101 (autophagy related 101)"], "WAG003098": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BCL2 (BCL2 apoptosis regulator), DDIT3 (DNA damage inducible transcript 3), BID (BH3 interacting domain death agonist), HSPA5 (heat shock protein family A (Hsp70) member 5), CASP8 (caspase 8), ATF4 (activating transcription factor 4), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), ATF6 (activating transcription factor 6), CASP1 (caspase 1), ERN1 (endoplasmic reticulum to nucleus signaling 1), XBP1 (X-box binding protein 1), TNFRSF10B (TNF receptor superfamily member 10b), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), CASP2 (caspase 2), NFE2L2 (nuclear factor, erythroid 2 like 2), BBC3 (BCL2 binding component 3), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), PPP1R15A (protein phosphatase 1 regulatory subunit 15A), BCL2L11 (BCL2 like 11), MBTPS1 (membrane bound transcription factor peptidase, site 1), MBTPS2 (membrane bound transcription factor peptidase, site 2), IL1B (interleukin 1 beta), TXNIP (thioredoxin interacting protein), RTCB (RNA 2',3'-cyclic phosphate and 5'-OH ligase)"], "WAG003100": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK3 (mitogen-activated protein kinase 3), MAP2K1 (mitogen-activated protein kinase kinase 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SHC1 (SHC adaptor protein 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), KRAS (KRAS proto-oncogene, GTPase), BRAF (B-Raf proto-oncogene, serine/threonine kinase), MAP2K2 (mitogen-activated protein kinase kinase 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MYC (MYC proto-oncogene, bHLH transcription factor), KSR1 (kinase suppressor of ras 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), ELK1 (ETS transcription factor ELK1), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), ALK (ALK receptor tyrosine kinase), GAREM2 (GRB2 associated regulator of MAPK1 subtype 2)"], "WAG003101": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MGMT (O-6-methylguanine-DNA methyltransferase), ALKBH3 (alkB homolog 3, alpha-ketoglutarate dependent dioxygenase), ALKBH2 (alkB homolog 2, alpha-ketoglutarate dependent dioxygenase)"], "WAG003102": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MYC (MYC proto-oncogene, bHLH transcription factor), PCNA (proliferating cell nuclear antigen), GRB2 (growth factor receptor bound protein 2), HDAC2 (histone deacetylase 2), BAZ1B (bromodomain adjacent to zinc finger domain 1B), SMARCA5 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5), GTF2I (general transcription factor IIi), MAPK3 (mitogen-activated protein kinase 3), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), HDAC3 (histone deacetylase 3), RFC2 (replication factor C subunit 2), RB1 (RB transcriptional corepressor 1), HDAC6 (histone deacetylase 6), LIMK1 (LIM domain kinase 1), TSG101 (tumor susceptibility 101), RFC5 (replication factor C subunit 5), CTNNB1 (catenin beta 1), VPS28 (VPS28 subunit of ESCRT-I), TRIM50 (tripartite motif containing 50), VPS37A (VPS37A subunit of ESCRT-I), SQSTM1 (sequestosome 1), MYBBP1A (MYB binding protein 1a), ELN (elastin), VPS37C (VPS37C subunit of ESCRT-I), VPS37B (VPS37B subunit of ESCRT-I), VPS37D (VPS37D subunit of ESCRT-I), DLD (dihydrolipoamide dehydrogenase), BTK (Bruton tyrosine kinase), BRD4 (bromodomain containing 4), CHTF18 (chromosome transmission fidelity factor 18), MLXIPL (MLX interacting protein like), FZD9 (frizzled class receptor 9), TBL2 (transducin beta like 2), HMGA1 (high mobility group AT-hook 1), CLDN1 (claudin 1), UBE2E1 (ubiquitin conjugating enzyme E2 E1), ACACB (acetyl-CoA carboxylase beta), ERCC6 (ERCC excision repair 6, chromatin remodeling factor), CLASP2 (cytoplasmic linker associated protein 2), DEK (DEK proto-oncogene), PKLR (pyruvate kinase L/R), ATF4 (activating transcription factor 4), STX1A (syntaxin 1A), BCL7B (BAF chromatin remodeling complex subunit BCL7B), USF1 (upstream transcription factor 1), SF3B1 (splicing factor 3b subunit 1), FBN1 (fibrillin 1), CDKN1C (cyclin dependent kinase inhibitor 1C), CLDN3 (claudin 3), SNAP25 (synaptosome associated protein 25), CLASP1 (cytoplasmic linker associated protein 1), CFL1 (cofilin 1), CLDN5 (claudin 5), DLST (dihydrolipoamide S-succinyltransferase), MYO1C (myosin IC), FAS (Fas cell surface death receptor), EIF4H (eukaryotic translation initiation factor 4H), CLDN4 (claudin 4), FKBP6 (FKBP prolyl isomerase 6), OGDH (oxoglutarate dehydrogenase), DDX21 (DExD-box helicase 21), VAMP2 (vesicle associated membrane protein 2), CLIP2 (CAP-Gly domain containing linker protein 2), PRKG1 (protein kinase cGMP-dependent 1), NRG1 (neuregulin 1), WNT2 (Wnt family member 2), FBLN2 (fibulin 2), FBLN5 (fibulin 5), BECN1 (beclin 1), CLTC (clathrin heavy chain), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), ACACA (acetyl-CoA carboxylase alpha), UBE2L6 (ubiquitin conjugating enzyme E2 L6), NUP62 (nucleoporin 62), HOXC8 (homeobox C8), GRIP1 (glutamate receptor interacting protein 1), ATPAF2 (ATP synthase mitochondrial F1 complex assembly factor 2), EIF2A (eukaryotic translation initiation factor 2A), ULK1 (unc-51 like autophagy activating kinase 1), UBE2E3 (ubiquitin conjugating enzyme E2 E3), ATPAF1 (ATP synthase mitochondrial F1 complex assembly factor 1), HSPA2 (heat shock protein family A (Hsp70) member 2), PGBD3 (piggyBac transposable element derived 3), ATP5F1D (ATP synthase F1 subunit delta), BUD23 (BUD23 rRNA methyltransferase and ribosome maturation factor), MVB12A (multivesicular body subunit 12A), UBIAD1 (UbiA prenyltransferase domain containing 1), ATP5MC1 (ATP synthase membrane subunit c locus 1), H2AX (H2A.X variant histone), ATP5PO (ATP synthase peripheral stalk subunit OSCP), MIR590 (microRNA 590), ATP5F1A (ATP synthase F1 subunit alpha), ATP5PB (ATP synthase peripheral stalk-membrane subunit b), METTL27 (methyltransferase like 27), ATP5MC3 (ATP synthase membrane subunit c locus 3), VPS9D1 (VPS9 domain containing 1), GTF2IRD1 (GTF2I repeat domain containing 1), ATP6 (ATP synthase F0 subunit 6), ABHD11 (abhydrolase domain containing 11), MIR4284 (microRNA 4284)"], "WAG003103": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MED26 (mediator complex subunit 26), CDK9 (cyclin dependent kinase 9), GTF2F1 (general transcription factor IIF subunit 1), CDK7 (cyclin dependent kinase 7), TBP (TATA-box binding protein), CCNH (cyclin H), TAF7 (TATA-box binding protein associated factor 7), TAF10 (TATA-box binding protein associated factor 10), TAF5 (TATA-box binding protein associated factor 5), CDK8 (cyclin dependent kinase 8), GTF2B (general transcription factor IIB), GTF2F2 (general transcription factor IIF subunit 2), TAF6 (TATA-box binding protein associated factor 6), TAF13 (TATA-box binding protein associated factor 13), MED21 (mediator complex subunit 21), TAF12 (TATA-box binding protein associated factor 12), TAF1 (TATA-box binding protein associated factor 1), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), GTF2H4 (general transcription factor IIH subunit 4), TAF4 (TATA-box binding protein associated factor 4), GTF2H1 (general transcription factor IIH subunit 1), TAF11 (TATA-box binding protein associated factor 11), GTF2H3 (general transcription factor IIH subunit 3), GTF2H2 (general transcription factor IIH subunit 2), TAF9 (TATA-box binding protein associated factor 9), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), MNAT1 (MNAT1 component of CDK activating kinase), TAF4B (TATA-box binding protein associated factor 4b), MED10 (mediator complex subunit 10), MED19 (mediator complex subunit 19), GTF2A1 (general transcription factor IIA subunit 1), MED12 (mediator complex subunit 12), GTF2E1 (general transcription factor IIE subunit 1), MED17 (mediator complex subunit 17), MED6 (mediator complex subunit 6), MED7 (mediator complex subunit 7), MED29 (mediator complex subunit 29), CCNC (cyclin C), MED4 (mediator complex subunit 4), GTF2E2 (general transcription factor IIE subunit 2), MED23 (mediator complex subunit 23), GTF2A2 (general transcription factor IIA subunit 2), MED9 (mediator complex subunit 9), MED16 (mediator complex subunit 16), MED8 (mediator complex subunit 8), MED18 (mediator complex subunit 18), CDK19 (cyclin dependent kinase 19), MED30 (mediator complex subunit 30), MED11 (mediator complex subunit 11), MED15 (mediator complex subunit 15), MED22 (mediator complex subunit 22), MED31 (mediator complex subunit 31), MED13 (mediator complex subunit 13), MED20 (mediator complex subunit 20), MED27 (mediator complex subunit 27), CCNT1 (cyclin T1), MED28 (mediator complex subunit 28), MYC (MYC proto-oncogene, bHLH transcription factor), TAF2 (TATA-box binding protein associated factor 2), MED25 (mediator complex subunit 25), SUPT4H1 (SPT4 homolog, DSIF elongation factor subunit), SUPT5H (SPT5 homolog, DSIF elongation factor subunit), TAF8 (TATA-box binding protein associated factor 8), TAF3 (TATA-box binding protein associated factor 3), TAF9B (TATA-box binding protein associated factor 9b), ELL2 (elongation factor for RNA polymerase II 2), PAF1 (PAF1 homolog, Paf1/RNA polymerase II complex component), CTR9 (CTR9 homolog, Paf1/RNA polymerase II complex component), AFF4 (AF4/FMR2 family member 4), RTF1 (RTF1 homolog, Paf1/RNA polymerase II complex component), LEO1 (LEO1 homolog, Paf1/RNA polymerase II complex component), WDR61 (WD repeat domain 61), MLLT1 (MLLT1 super elongation complex subunit), BRD4 (bromodomain containing 4), GTF2H5 (general transcription factor IIH subunit 5), HEXIM1 (HEXIM P-TEFb complex subunit 1), MEPCE (methylphosphate capping enzyme), LARP7 (La ribonucleoprotein 7, transcriptional regulator), EAF1 (ELL associated factor 1), MCL1 (MCL1 apoptosis regulator, BCL2 family member), NELFCD (negative elongation factor complex member C/D), GCOM1 (GRINL1A complex locus 1), MED24 (mediator complex subunit 24), MED14 (mediator complex subunit 14), NELFB (negative elongation factor complex member B), NELFA (negative elongation factor complex member A), NELFE (negative elongation factor complex member E), MED1 (mediator complex subunit 1)"], "WAG003105": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TUBGCP5 (tubulin gamma complex associated protein 5), TUBGCP6 (tubulin gamma complex associated protein 6), TUBGCP3 (tubulin gamma complex associated protein 3), TUBGCP2 (tubulin gamma complex associated protein 2), TUBGCP4 (tubulin gamma complex associated protein 4), CYFIP1 (cytoplasmic FMR1 interacting protein 1), NIPA2 (NIPA magnesium transporter 2), NIPA1 (NIPA magnesium transporter 1), FMR1 (FMRP translational regulator 1)"], "WAG003106": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ADCY2 (adenylate cyclase 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PRKCB (protein kinase C beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), GNAS (GNAS complex locus), PRKACB (protein kinase cAMP-activated catalytic subunit beta), GNA15 (G protein subunit alpha 15), PLCB1 (phospholipase C beta 1), ADCY4 (adenylate cyclase 4), POMC (proopiomelanocortin), ADCY9 (adenylate cyclase 9), TYR (tyrosinase), PLCB2 (phospholipase C beta 2), PLCB4 (phospholipase C beta 4), PLCB3 (phospholipase C beta 3), GNAQ (G protein subunit alpha q), TYRP1 (tyrosinase related protein 1), CREB1 (cAMP responsive element binding protein 1), MLANA (melan-A), MITF (melanocyte inducing transcription factor), VEGFA (vascular endothelial growth factor A), PMEL (premelanosome protein), DCT (dopachrome tautomerase), MC1R (melanocortin 1 receptor), ARRB2 (arrestin beta 2), ARRB1 (arrestin beta 1), GPR143 (G protein-coupled receptor 143), ASIP (agouti signaling protein), SERPINF1 (serpin family F member 1)"], "WAG003107": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KLF13 (Kruppel like factor 13), CREBBP (CREB binding protein), KAT2B (lysine acetyltransferase 2B), FAN1 (FANCD2 and FANCI associated nuclease 1), TRPM1 (transient receptor potential cation channel subfamily M member 1), CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit), MTMR10 (myotubularin related protein 10), SERPINH1 (serpin family H member 1), FANCD2 (FA complementation group D2), FYN (FYN proto-oncogene, Src family tyrosine kinase), OTUD7A (OTU deubiquitinase 7A), GRM6 (glutamate metabotropic receptor 6), CHRFAM7A (CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion), GOLGA8H (golgin A8 family member H), GOLGA8R (golgin A8 family member R), GPR75 (G protein-coupled receptor 75), MIR211 (microRNA 211), ULK4P2 (ULK4 pseudogene 2), GOLGA8Q (golgin A8 family member Q), CCL5 (C-C motif chemokine ligand 5), GOLGA8O (golgin A8 family member O)"], "WAG003110": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PCNA (proliferating cell nuclear antigen), RPA1 (replication protein A1), POLD1 (DNA polymerase delta 1, catalytic subunit), RFC4 (replication factor C subunit 4), RFC5 (replication factor C subunit 5), RPA2 (replication protein A2), BRCA1 (BRCA1 DNA repair associated), POLE (DNA polymerase epsilon, catalytic subunit), RFC2 (replication factor C subunit 2), RPA3 (replication protein A3), RFC3 (replication factor C subunit 3), XPA (XPA, DNA damage recognition and repair factor), MSH2 (mutS homolog 2), RAD23B (RAD23 homolog B, nucleotide excision repair protein), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), RFC1 (replication factor C subunit 1), RAD50 (RAD50 double strand break repair protein), CHEK1 (checkpoint kinase 1), RAD51 (RAD51 recombinase), XPC (XPC complex subunit, DNA damage recognition and repair factor), DDB1 (damage specific DNA binding protein 1), ERCC5 (ERCC excision repair 5, endonuclease), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), POLD2 (DNA polymerase delta 2, accessory subunit), ATR (ATR serine/threonine kinase), POLE2 (DNA polymerase epsilon 2, accessory subunit), GTF2H1 (general transcription factor IIH subunit 1), FEN1 (flap structure-specific endonuclease 1), DDB2 (damage specific DNA binding protein 2), REV3L (REV3 like, DNA directed polymerase zeta catalytic subunit), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), CDK7 (cyclin dependent kinase 7), POLD4 (DNA polymerase delta 4, accessory subunit), ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit), ERCC6 (ERCC excision repair 6, chromatin remodeling factor), ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit), ATM (ATM serine/threonine kinase), MSH6 (mutS homolog 6), CCNH (cyclin H), MNAT1 (MNAT1 component of CDK activating kinase), GTF2H4 (general transcription factor IIH subunit 4), POLD3 (DNA polymerase delta 3, accessory subunit), GTF2H2 (general transcription factor IIH subunit 2), GTF2H3 (general transcription factor IIH subunit 3), XRCC5 (X-ray repair cross complementing 5), PARP1 (poly(ADP-ribose) polymerase 1), XRCC6 (X-ray repair cross complementing 6), FANCD2 (FA complementation group D2), LIG1 (DNA ligase 1), EXO1 (exonuclease 1), MLH1 (mutL homolog 1), RAD52 (RAD52 homolog, DNA repair protein), WRN (WRN RecQ like helicase), LIG4 (DNA ligase 4), BRCA2 (BRCA2 DNA repair associated), FANCI (FA complementation group I), MSH3 (mutS homolog 3), XRCC1 (X-ray repair cross complementing 1), APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1), FANCA (FA complementation group A), FANCG (FA complementation group G), OGG1 (8-oxoguanine DNA glycosylase), PRKDC (protein kinase, DNA-activated, catalytic subunit), NBN (nibrin), REV1 (REV1 DNA directed polymerase), FANCL (FA complementation group L), FANCE (FA complementation group E), POLB (DNA polymerase beta), POLH (DNA polymerase eta), FANCM (FA complementation group M), FANCC (FA complementation group C), FANCB (FA complementation group B), FANCF (FA complementation group F), LIG3 (DNA ligase 3), UNG (uracil DNA glycosylase), DCLRE1C (DNA cross-link repair 1C), RAD51C (RAD51 paralog C), XRCC4 (X-ray repair cross complementing 4), PNKP (polynucleotide kinase 3'-phosphatase), PMS2 (PMS1 homolog 2, mismatch repair system component), RAD23A (RAD23 homolog A, nucleotide excision repair protein), TERF2 (telomeric repeat binding factor 2), MUTYH (mutY DNA glycosylase), RAD54B (RAD54 homolog B), BRIP1 (BRCA1 interacting protein C-terminal helicase 1), POLL (DNA polymerase lambda), POLM (DNA polymerase mu), NTHL1 (nth like DNA glycosylase 1), PARP2 (poly(ADP-ribose) polymerase 2), POLI (DNA polymerase iota), POLE3 (DNA polymerase epsilon 3, accessory subunit), MGMT (O-6-methylguanine-DNA methyltransferase), TDG (thymine DNA glycosylase), PALB2 (partner and localizer of BRCA2), CUL4B (cullin 4B), NEIL3 (nei like DNA glycosylase 3), USP1 (ubiquitin specific peptidase 1), CUL4A (cullin 4A), GTF2H5 (general transcription factor IIH subunit 5), FAN1 (FANCD2 and FANCI associated nuclease 1)"], "WAG003111": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRMT1 (protein arginine methyltransferase 1), NOS3 (nitric oxide synthase 3), PRMT5 (protein arginine methyltransferase 5), PRMT2 (protein arginine methyltransferase 2), PRMT6 (protein arginine methyltransferase 6), NOS1 (nitric oxide synthase 1), NOS2 (nitric oxide synthase 2), PRMT3 (protein arginine methyltransferase 3), DDAH1 (dimethylarginine dimethylaminohydrolase 1), PRMT8 (protein arginine methyltransferase 8), CARM1 (coactivator associated arginine methyltransferase 1), PRMT7 (protein arginine methyltransferase 7), DDAH2 (dimethylarginine dimethylaminohydrolase 2)"], "WAG003113": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPP4C (protein phosphatase 4 catalytic subunit), PPP2CA (protein phosphatase 2 catalytic subunit alpha), PPP2CB (protein phosphatase 2 catalytic subunit beta), TP53 (tumor protein p53), CCT5 (chaperonin containing TCP1 subunit 5), TCP1 (t-complex 1), CCT4 (chaperonin containing TCP1 subunit 4), CCT6A (chaperonin containing TCP1 subunit 6A), CCT2 (chaperonin containing TCP1 subunit 2), CCT7 (chaperonin containing TCP1 subunit 7), CCT3 (chaperonin containing TCP1 subunit 3), NFKB1 (nuclear factor kappa B subunit 1), HDAC3 (histone deacetylase 3), TRAF6 (TNF receptor associated factor 6), IGBP1 (immunoglobulin binding protein 1), CCT8 (chaperonin containing TCP1 subunit 8), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), MAPK3 (mitogen-activated protein kinase 3), ESR1 (estrogen receptor 1), PCNA (proliferating cell nuclear antigen), CASP8 (caspase 8), NR3C1 (nuclear receptor subfamily 3 group C member 1), PPARG (peroxisome proliferator activated receptor gamma), PTEN (phosphatase and tensin homolog), CCT6B (chaperonin containing TCP1 subunit 6B), PPP4R1 (protein phosphatase 4 regulatory subunit 1), PPP4R2 (protein phosphatase 4 regulatory subunit 2), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), PPP4R4 (protein phosphatase 4 regulatory subunit 4), TRAF2 (TNF receptor associated factor 2), MAP2K6 (mitogen-activated protein kinase kinase 6), MAP2K3 (mitogen-activated protein kinase kinase 3), EZR (ezrin), MSN (moesin), MVP (major vault protein), REL (REL proto-oncogene, NF-kB subunit), PARP4 (poly(ADP-ribose) polymerase family member 4), IGFBP3 (insulin like growth factor binding protein 3), HIRA (histone cell cycle regulator), CCDC6 (coiled-coil domain containing 6), TAOK2 (TAO kinase 2), KCTD13 (potassium channel tetramerization domain containing 13), DOC2A (double C2 domain alpha), SPN (sialophorin), SIAH1 (siah E3 ubiquitin protein ligase 1), ALDOA (aldolase, fructose-bisphosphate A), KIF22 (kinesin family member 22), ASPHD1 (aspartate beta-hydroxylase domain containing 1), MAZ (MYC associated zinc finger protein), PAXIP1 (PAX interacting protein 1), HIRIP3 (HIRA interacting protein 3), BPTF (bromodomain PHD finger transcription factor), UNC13B (unc-13 homolog B), CORO1A (coronin 1A), CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase), TMEM219 (transmembrane protein 219), SEZ6L2 (seizure related 6 homolog like 2), ZG16 (zymogen granule protein 16), UNC13A (unc-13 homolog A), PPP4R3B (protein phosphatase 4 regulatory subunit 3B), TBX6 (T-box transcription factor 6), YPEL3 (yippee like 3), C16orf92 (chromosome 16 open reading frame 92), PRRT2 (proline rich transmembrane protein 2), QPRT (quinolinate phosphoribosyltransferase), GDPD3 (glycerophosphodiester phosphodiesterase domain containing 3), C16orf54 (chromosome 16 open reading frame 54), KMT2D (lysine methyltransferase 2D), CDIPTOSP (CDIP transferase opposite strand, pseudogene), KMT2C (lysine methyltransferase 2C), PAGR1 (PAXIP1 associated glutamate rich protein 1), MIR3680-2 (microRNA 3680-2), TLCD3B (TLC domain containing 3B), MIR3680-1 (microRNA 3680-1), PPP4R3C (protein phosphatase 4 regulatory subunit 3C), PPP4R3A (protein phosphatase 4 regulatory subunit 3A), INO80E (INO80 complex subunit E)"], "WAG003114": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRB2 (growth factor receptor bound protein 2), CD19 (CD19 molecule), JAK2 (Janus kinase 2), CD81 (CD81 molecule), CR2 (complement C3d receptor 2), VAV2 (vav guanine nucleotide exchange factor 2), IFITM1 (interferon induced transmembrane protein 1), IL4 (interleukin 4), C3 (complement C3), INSR (insulin receptor), NFATC2IP (nuclear factor of activated T cells 2 interacting protein), SH2B1 (SH2B adaptor protein 1), RAB5A (RAB5A, member RAS oncogene family), MPL (MPL proto-oncogene, thrombopoietin receptor), RAB4A (RAB4A, member RAS oncogene family), LAT (linker for activation of T cells), PLN (phospholamban), RABGEF1 (RAB guanine nucleotide exchange factor 1), SLN (sarcolipin), NFATC2 (nuclear factor of activated T cells 2), ATP2A1 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1), TRAF1 (TNF receptor associated factor 1), TRAF2 (TNF receptor associated factor 2), CD82 (CD82 molecule), RABEP2 (rabaptin, RAB GTPase binding effector protein 2), TUFM (Tu translation elongation factor, mitochondrial), ATXN2L (ataxin 2 like), KDR (kinase insert domain receptor), PRMT1 (protein arginine methyltransferase 1), MIR4721 (microRNA 4721), SDCCAG8 (SHH signaling and ciliogenesis regulator SDCCAG8), ATP2A1-AS1 (ATP2A1 antisense RNA 1), SPNS1 (sphingolipid transporter 1 (putative))"], "WAG003116": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), NFKBIA (NFKB inhibitor alpha), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), TBK1 (TANK binding kinase 1), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), REL (REL proto-oncogene, NF-kB subunit), NFKBIE (NFKB inhibitor epsilon), IRF3 (interferon regulatory factor 3), IL1B (interleukin 1 beta), IFNB1 (interferon beta 1), NLRX1 (NLR family member X1), NLRP3 (NLR family pyrin domain containing 3), F3 (coagulation factor III, tissue factor), STING1 (stimulator of interferon response cGAMP interactor 1), FCGR2A (Fc fragment of IgG receptor IIa), CGAS (cyclic GMP-AMP synthase), FCGR2C (Fc fragment of IgG receptor IIc (gene/pseudogene)), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), GSDMD (gasdermin D)"], "WAG003117": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A), RHOA (ras homolog family member A), ROCK1 (Rho associated coiled-coil containing protein kinase 1), ROCK2 (Rho associated coiled-coil containing protein kinase 2), PLCB1 (phospholipase C beta 1), PPP1CB (protein phosphatase 1 catalytic subunit beta), IL13 (interleukin 13), MYLK (myosin light chain kinase), ADRB2 (adrenoceptor beta 2), GNAQ (G protein subunit alpha q), CD38 (CD38 molecule), GDI1 (GDP dissociation inhibitor 1), MYL1 (myosin light chain 1), RYR1 (ryanodine receptor 1), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), CALM1 (calmodulin 1)"], "WAG003118": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BAX (BCL2 associated X, apoptosis regulator), CDKN1A (cyclin dependent kinase inhibitor 1A), MSH2 (mutS homolog 2), FAS (Fas cell surface death receptor), ICAM1 (intercellular adhesion molecule 1), PTEN (phosphatase and tensin homolog), GADD45A (growth arrest and DNA damage inducible alpha), MLH1 (mutL homolog 1), MGMT (O-6-methylguanine-DNA methyltransferase), ISG15 (ISG15 ubiquitin like modifier), IRF9 (interferon regulatory factor 9), PML (PML nuclear body scaffold), ERCC5 (ERCC excision repair 5, endonuclease), IRF5 (interferon regulatory factor 5), XPC (XPC complex subunit, DNA damage recognition and repair factor), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), DDB2 (damage specific DNA binding protein 2), CCL2 (C-C motif chemokine ligand 2), APAF1 (apoptotic peptidase activating factor 1), ULK2 (unc-51 like autophagy activating kinase 2), XRCC5 (X-ray repair cross complementing 5), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), BBC3 (BCL2 binding component 3), TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1), POLH (DNA polymerase eta), NOTCH1 (notch receptor 1), THBS1 (thrombospondin 1), LIF (LIF interleukin 6 family cytokine), ULK1 (unc-51 like autophagy activating kinase 1), SERPINE1 (serpin family E member 1), SLC2A1 (solute carrier family 2 member 1), POLK (DNA polymerase kappa), NANOG (Nanog homeobox), CCNG1 (cyclin G1), BTG2 (BTG anti-proliferation factor 2), TRAF4 (TNF receptor associated factor 4), NCF2 (neutrophil cytosolic factor 2), SERPINB5 (serpin family B member 5), GPX1 (glutathione peroxidase 1), ALDH4A1 (aldehyde dehydrogenase 4 family member A1), GLS2 (glutaminase 2), SESN2 (sestrin 2), CX3CL1 (C-X3-C motif chemokine ligand 1), SLC7A11 (solute carrier family 7 member 11), TNFRSF10D (TNF receptor superfamily member 10d), SIVA1 (SIVA1 apoptosis inducing factor), SMR3B (submaxillary gland androgen regulated protein 3B), PERP (p53 apoptosis effector related to PMP22), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), TP53INP1 (tumor protein p53 inducible nuclear protein 1), TP53I3 (tumor protein p53 inducible protein 3), CPT1C (carnitine palmitoyltransferase 1C), PIDD1 (p53-induced death domain protein 1), ADORA2B (adenosine A2b receptor), ADGRB1 (adhesion G protein-coupled receptor B1), ZMAT3 (zinc finger matrin-type 3), SESN1 (sestrin 1), MIR200C (microRNA 200c), RPRM (reprimo, TP53 dependent G2 arrest mediator homolog), FANCC (FA complementation group C), ACAD11 (acyl-CoA dehydrogenase family member 11), DRAM1 (DNA damage regulated autophagy modulator 1), MIR34B (microRNA 34b), SAT1 (spermidine/spermine N1-acetyltransferase 1), MIR145 (microRNA 145), MIR34C (microRNA 34c), ULBP1 (UL16 binding protein 1), FUCA1 (alpha-L-fucosidase 1), MIR34A (microRNA 34a), ULBP2 (UL16 binding protein 2), TIGAR (TP53 induced glycolysis regulatory phosphatase)"], "WAG003120": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KNG1 (kininogen 1), ACE (angiotensin I converting enzyme), REN (renin), NOS3 (nitric oxide synthase 3), AGTR1 (angiotensin II receptor type 1), TNF (tumor necrosis factor), AGT (angiotensinogen), BDKRB2 (bradykinin receptor B2), MAPK1 (mitogen-activated protein kinase 1), AGTR2 (angiotensin II receptor type 2), IL1B (interleukin 1 beta), SERPINE1 (serpin family E member 1), NFKB1 (nuclear factor kappa B subunit 1), BDKRB1 (bradykinin receptor B1), SERPING1 (serpin family G member 1), KLKB1 (kallikrein B1), IL1A (interleukin 1 alpha), VDR (vitamin D receptor), NPR1 (natriuretic peptide receptor 1), ACE2 (angiotensin I converting enzyme 2), F12 (coagulation factor XII), RHOA (ras homolog family member A), NOS1 (nitric oxide synthase 1), KLK1 (kallikrein 1), PRKG1 (protein kinase cGMP-dependent 1), ROCK1 (Rho associated coiled-coil containing protein kinase 1), CYP3A4 (cytochrome P450 family 3 subfamily A member 4), CPN1 (carboxypeptidase N subunit 1), CYP24A1 (cytochrome P450 family 24 subfamily A member 1)"], "WAG003121": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "OTC (ornithine carbamoyltransferase), OAT (ornithine aminotransferase), ASS1 (argininosuccinate synthase 1), ASL (argininosuccinate lyase), ARG1 (arginase 1), ODC1 (ornithine decarboxylase 1), ARG2 (arginase 2), NAGS (N-acetylglutamate synthase), GATM (glycine amidinotransferase), ACY1 (aminoacylase 1), ALDH18A1 (aldehyde dehydrogenase 18 family member A1), CPS1 (carbamoyl-phosphate synthase 1), GLUD1 (glutamate dehydrogenase 1), GAMT (guanidinoacetate N-methyltransferase), SRM (spermidine synthase), CKM (creatine kinase, M-type), CKB (creatine kinase B), SMS (spermine synthase), PYCR1 (pyrroline-5-carboxylate reductase 1), SARDH (sarcosine dehydrogenase), PYCR3 (pyrroline-5-carboxylate reductase 3)"], "WAG003122": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPARG (peroxisome proliferator activated receptor gamma), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL6 (interleukin 6), VEGFA (vascular endothelial growth factor A), CREB1 (cAMP responsive element binding protein 1), PPARGC1A (PPARG coactivator 1 alpha), CRP (C-reactive protein), CDKN1A (cyclin dependent kinase inhibitor 1A), ADIPOQ (adiponectin, C1Q and collagen domain containing), POMC (proopiomelanocortin), CDKN1B (cyclin dependent kinase inhibitor 1B), SLC2A4 (solute carrier family 2 member 4), UCP1 (uncoupling protein 1), TFAP2A (transcription factor AP-2 alpha), YAP1 (Yes1 associated transcriptional regulator), VAMP2 (vesicle associated membrane protein 2), BCL2L11 (BCL2 like 11), CDKN1C (cyclin dependent kinase inhibitor 1C), INS (insulin), PRKCD (protein kinase C delta), KRT19 (keratin 19)"], "WAG003123": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta), PTEN (phosphatase and tensin homolog), PLCG1 (phospholipase C gamma 1), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), OCRL (OCRL inositol polyphosphate-5-phosphatase), PLCD1 (phospholipase C delta 1), PLCG2 (phospholipase C gamma 2), PLCB1 (phospholipase C beta 1), PLCB2 (phospholipase C beta 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PLCE1 (phospholipase C epsilon 1), PLCB4 (phospholipase C beta 4), PLCD4 (phospholipase C delta 4), PLCZ1 (phospholipase C zeta 1), PLCD3 (phospholipase C delta 3), PLCB3 (phospholipase C beta 3), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha), PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha), PIP4K2C (phosphatidylinositol-5-phosphate 4-kinase type 2 gamma), PIP4K2B (phosphatidylinositol-5-phosphate 4-kinase type 2 beta), PIK3C2B (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta), PIK3C2G (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma), PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), INPP5D (inositol polyphosphate-5-phosphatase D), PIKFYVE (phosphoinositide kinase, FYVE-type zinc finger containing), MTMR2 (myotubularin related protein 2), MTMR3 (myotubularin related protein 3), MTM1 (myotubularin 1), MTMR6 (myotubularin related protein 6), MTMR1 (myotubularin related protein 1), MTMR9 (myotubularin related protein 9), PLCH1 (phospholipase C eta 1), PLCH2 (phospholipase C eta 2), SBF1 (SET binding factor 1), SACM1L (SAC1 like phosphatidylinositide phosphatase), MTMR12 (myotubularin related protein 12), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), MTMR7 (myotubularin related protein 7), MTMR8 (myotubularin related protein 8), MTMR4 (myotubularin related protein 4), SBF2 (SET binding factor 2), MTMR10 (myotubularin related protein 10), PIP4P1 (phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1), MTMR11 (myotubularin related protein 11), PIP4P2 (phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2)"], "WAG003125": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "OTC (ornithine carbamoyltransferase), ASS1 (argininosuccinate synthase 1), ASL (argininosuccinate lyase), ARG1 (arginase 1), SLC25A15 (solute carrier family 25 member 15), NAGS (N-acetylglutamate synthase), CPS1 (carbamoyl-phosphate synthase 1), ARG2 (arginase 2), SLC25A2 (solute carrier family 25 member 2), NMRAL1 (NmrA like redox sensor 1)"], "WAG003129": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), AKT1 (AKT serine/threonine kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), ESR1 (estrogen receptor 1), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), GNAI2 (G protein subunit alpha i2), GNAI1 (G protein subunit alpha i1), GNB1 (G protein subunit beta 1), EGFR (epidermal growth factor receptor), GNAI3 (G protein subunit alpha i3), GNG2 (G protein subunit gamma 2), HRAS (HRas proto-oncogene, GTPase), MAPK1 (mitogen-activated protein kinase 1), EGF (epidermal growth factor), GNGT1 (G protein subunit gamma transducin 1), MAPK3 (mitogen-activated protein kinase 3), GNB2 (G protein subunit beta 2), IGF1R (insulin like growth factor 1 receptor), GNB4 (G protein subunit beta 4), GNG13 (G protein subunit gamma 13), GNG3 (G protein subunit gamma 3), GNB3 (G protein subunit beta 3), NRAS (NRAS proto-oncogene, GTPase), GNG4 (G protein subunit gamma 4), GNG7 (G protein subunit gamma 7), GNGT2 (G protein subunit gamma transducin 2), GNG8 (G protein subunit gamma 8), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), GNG12 (G protein subunit gamma 12), HSP90AA1 (heat shock protein 90 alpha family class A member 1), NOS3 (nitric oxide synthase 3), GNG5 (G protein subunit gamma 5), CCND1 (cyclin D1), PTK2 (protein tyrosine kinase 2), GNB5 (G protein subunit beta 5), GNG11 (G protein subunit gamma 11), PRKCZ (protein kinase C zeta), CAV1 (caveolin 1), AKT3 (AKT serine/threonine kinase 3), GNG10 (G protein subunit gamma 10), AKT2 (AKT serine/threonine kinase 2), HBEGF (heparin binding EGF like growth factor), CDKN1B (cyclin dependent kinase inhibitor 1B), MMP9 (matrix metallopeptidase 9), CREB1 (cAMP responsive element binding protein 1), PDPK1 (3-phosphoinositide dependent protein kinase 1), ESR2 (estrogen receptor 2), MMP2 (matrix metallopeptidase 2), BCL2 (BCL2 apoptosis regulator), S1PR3 (sphingosine-1-phosphate receptor 3), FOXO3 (forkhead box O3), GNAT3 (G protein subunit alpha transducin 3), TGFA (transforming growth factor alpha), SPHK1 (sphingosine kinase 1), XPO1 (exportin 1), ELK1 (ETS transcription factor ELK1), MMP7 (matrix metallopeptidase 7), BTC (betacellulin), SRF (serum response factor), STRN (striatin), CAV2 (caveolin 2), EREG (epiregulin), MMP3 (matrix metallopeptidase 3), PRMT1 (protein arginine methyltransferase 1), UHMK1 (U2AF homology motif kinase 1), ZDHHC21 (zinc finger DHHC-type palmitoyltransferase 21), ZDHHC7 (zinc finger DHHC-type palmitoyltransferase 7), AREG (amphiregulin), CALM1 (calmodulin 1), EPGN (epithelial mitogen)"], "WAG003130": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATF4 (activating transcription factor 4), DDIT3 (DNA damage inducible transcript 3), EIF2S1 (eukaryotic translation initiation factor 2 subunit alpha), CEBPG (CCAAT enhancer binding protein gamma), ATF3 (activating transcription factor 3), CEBPB (CCAAT enhancer binding protein beta), PPP1R15A (protein phosphatase 1 regulatory subunit 15A), TRIB3 (tribbles pseudokinase 3), ATF5 (activating transcription factor 5), EIF2S3 (eukaryotic translation initiation factor 2 subunit gamma), EIF2S2 (eukaryotic translation initiation factor 2 subunit beta), EIF2AK1 (eukaryotic translation initiation factor 2 alpha kinase 1), ASNS (asparagine synthetase (glutamine-hydrolyzing)), GRB10 (growth factor receptor bound protein 10), CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1)"], "WAG003131": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GOT2 (glutamic-oxaloacetic transaminase 2), GOT1 (glutamic-oxaloacetic transaminase 1), ASPA (aspartoacylase), ASNS (asparagine synthetase (glutamine-hydrolyzing)), SLC25A12 (solute carrier family 25 member 12), SLC25A13 (solute carrier family 25 member 13), FOLH1 (folate hydrolase 1), NAALAD2 (N-acetylated alpha-linked acidic dipeptidase 2), GADL1 (glutamate decarboxylase like 1), FOLH1B (folate hydrolase 1B), ASPG (asparaginase), NAT8L (N-acetyltransferase 8 like)"], "WAG003134": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EP300 (E1A binding protein p300), EGR1 (early growth response 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), CREB1 (cAMP responsive element binding protein 1), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), ELK1 (ETS transcription factor ELK1), ATF2 (activating transcription factor 2), EGR2 (early growth response 2), SRF (serum response factor), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), FOSL1 (FOS like 1, AP-1 transcription factor subunit), ID3 (inhibitor of DNA binding 3, HLH protein), ID2 (inhibitor of DNA binding 2), EGR3 (early growth response 3), NAB2 (NGFI-A binding protein 2), ID1 (inhibitor of DNA binding 1, HLH protein), CDK5 (cyclin dependent kinase 5), NAB1 (NGFI-A binding protein 1), TCF12 (transcription factor 12), EGR4 (early growth response 4), SGK1 (serum/glucocorticoid regulated kinase 1), CHD4 (chromodomain helicase DNA binding protein 4), ID4 (inhibitor of DNA binding 4, HLH protein), MEF2D (myocyte enhancer factor 2D), CDK5R1 (cyclin dependent kinase 5 regulatory subunit 1), ASCL1 (achaete-scute family bHLH transcription factor 1), ATF1 (activating transcription factor 1), F3 (coagulation factor III, tissue factor), CDK5R2 (cyclin dependent kinase 5 regulatory subunit 2), TRIB1 (tribbles pseudokinase 1), LYL1 (LYL1 basic helix-loop-helix family member), REST (RE1 silencing transcription factor), SH3GL3 (SH3 domain containing GRB2 like 3, endophilin A3), VGF (VGF nerve growth factor inducible), TPH1 (tryptophan hydroxylase 1), DNM2 (dynamin 2), ARC (activity regulated cytoskeleton associated protein), RRAD (RRAD, Ras related glycolysis inhibitor and calcium channel regulator)"], "WAG003137": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKAB2 (protein kinase AMP-activated non-catalytic subunit beta 2), PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1), PRKAG2 (protein kinase AMP-activated non-catalytic subunit gamma 2), PRKAG1 (protein kinase AMP-activated non-catalytic subunit gamma 1), PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2), PRKAG3 (protein kinase AMP-activated non-catalytic subunit gamma 3), PLIN2 (perilipin 2), HSPA8 (heat shock protein family A (Hsp70) member 8), PLIN3 (perilipin 3)"], "WAG003141": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDKN1A (cyclin dependent kinase inhibitor 1A), FOXO3 (forkhead box O3), SMAD2 (SMAD family member 2), SMAD4 (SMAD family member 4), FOXO4 (forkhead box O4), SMAD3 (SMAD family member 3), FOXO1 (forkhead box O1), CDKN1B (cyclin dependent kinase inhibitor 1B), RBL2 (RB transcriptional corepressor like 2), CCNG2 (cyclin G2), GADD45A (growth arrest and DNA damage inducible alpha), MSTN (myostatin), BTG1 (BTG anti-proliferation factor 1), KLF4 (Kruppel like factor 4), CAV1 (caveolin 1), FOXG1 (forkhead box G1), PCBP4 (poly(rC) binding protein 4)"], "WAG003145": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GNAS (GNAS complex locus), ADCY2 (adenylate cyclase 2), ADCY7 (adenylate cyclase 7), ADCY1 (adenylate cyclase 1), ADCY8 (adenylate cyclase 8), ADCY5 (adenylate cyclase 5), GNG2 (G protein subunit gamma 2), ADCY9 (adenylate cyclase 9), ADCY6 (adenylate cyclase 6), ADCY4 (adenylate cyclase 4), GCG (glucagon), ADRB2 (adrenoceptor beta 2), POMC (proopiomelanocortin), CALCA (calcitonin related polypeptide alpha), TSHR (thyroid stimulating hormone receptor), PTH (parathyroid hormone), CRH (corticotropin releasing hormone), VIPR1 (vasoactive intestinal peptide receptor 1), ADM (adrenomedullin), ADCYAP1 (adenylate cyclase activating polypeptide 1), LHCGR (luteinizing hormone/choriogonadotropin receptor), CALCR (calcitonin receptor), CALCB (calcitonin related polypeptide beta), FSHR (follicle stimulating hormone receptor), IAPP (islet amyloid polypeptide), ADM2 (adrenomedullin 2), SCT (secretin), PTH1R (parathyroid hormone 1 receptor), RXFP1 (relaxin family peptide receptor 1), RXFP2 (relaxin family peptide receptor 2), PTHLH (parathyroid hormone like hormone), GHRH (growth hormone releasing hormone), AVPR2 (arginine vasopressin receptor 2), NPSR1 (neuropeptide S receptor 1), MC4R (melanocortin 4 receptor), GLP1R (glucagon like peptide 1 receptor), NPS (neuropeptide S), GIPR (gastric inhibitory polypeptide receptor), PTH2R (parathyroid hormone 2 receptor), CRHR2 (corticotropin releasing hormone receptor 2), ADRB1 (adrenoceptor beta 1), ADCYAP1R1 (ADCYAP receptor type I), ADORA2A (adenosine A2a receptor), HTR6 (5-hydroxytryptamine receptor 6), GHRHR (growth hormone releasing hormone receptor), MC5R (melanocortin 5 receptor), PTGDR (prostaglandin D2 receptor), SCTR (secretin receptor), MC3R (melanocortin 3 receptor), VIPR2 (vasoactive intestinal peptide receptor 2), ADRB3 (adrenoceptor beta 3), ADORA2B (adenosine A2b receptor), TAAR1 (trace amine associated receptor 1), DRD1 (dopamine receptor D1), PTGIR (prostaglandin I2 receptor), GLP2R (glucagon like peptide 2 receptor), GPBAR1 (G protein-coupled bile acid receptor 1), MC2R (melanocortin 2 receptor), PTGER4 (prostaglandin E receptor 4), HTR4 (5-hydroxytryptamine receptor 4), PTGER2 (prostaglandin E receptor 2), DRD5 (dopamine receptor D5), HTR7 (5-hydroxytryptamine receptor 7), GNAI2 (G protein subunit alpha i2), GNB1 (G protein subunit beta 1), GNAI1 (G protein subunit alpha i1), GNAI3 (G protein subunit alpha i3), ADCY3 (adenylate cyclase 3), GNGT1 (G protein subunit gamma transducin 1), GNG13 (G protein subunit gamma 13), GNG3 (G protein subunit gamma 3), GNG4 (G protein subunit gamma 4), GNB3 (G protein subunit beta 3), GNG7 (G protein subunit gamma 7), GNG8 (G protein subunit gamma 8), GNB2 (G protein subunit beta 2), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), GNG12 (G protein subunit gamma 12), GNB4 (G protein subunit beta 4), GNGT2 (G protein subunit gamma transducin 2), GNG11 (G protein subunit gamma 11), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), GNG5 (G protein subunit gamma 5), GNB5 (G protein subunit beta 5), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), PLCG1 (phospholipase C gamma 1), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), CREB1 (cAMP responsive element binding protein 1), GNG10 (G protein subunit gamma 10), FYN (FYN proto-oncogene, Src family tyrosine kinase), SYK (spleen associated tyrosine kinase), HCK (HCK proto-oncogene, Src family tyrosine kinase), IL6 (interleukin 6), PRKX (protein kinase X-linked), MAPK14 (mitogen-activated protein kinase 14), FGR (FGR proto-oncogene, Src family tyrosine kinase), VIP (vasoactive intestinal peptide)"], "WAG003147": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CDC27 (cell division cycle 27), UBE2D1 (ubiquitin conjugating enzyme E2 D1), ANAPC1 (anaphase promoting complex subunit 1), ANAPC4 (anaphase promoting complex subunit 4), ANAPC5 (anaphase promoting complex subunit 5), CDC26 (cell division cycle 26), ANAPC7 (anaphase promoting complex subunit 7), CDC16 (cell division cycle 16), CDC23 (cell division cycle 23), ANAPC10 (anaphase promoting complex subunit 10), ANAPC2 (anaphase promoting complex subunit 2), UBE2C (ubiquitin conjugating enzyme E2 C), ANAPC11 (anaphase promoting complex subunit 11), FZR1 (fizzy and cell division cycle 20 related 1), UBE2S (ubiquitin conjugating enzyme E2 S), UBE2E1 (ubiquitin conjugating enzyme E2 E1), ANAPC16 (anaphase promoting complex subunit 16), CCND1 (cyclin D1), CTNNB1 (catenin beta 1), TP53 (tumor protein p53), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), CEBPB (CCAAT enhancer binding protein beta), IL6 (interleukin 6), TNRC6B (trinucleotide repeat containing adaptor 6B), CDKN2A (cyclin dependent kinase inhibitor 2A), LEF1 (lymphoid enhancer binding factor 1), EHMT1 (euchromatic histone lysine methyltransferase 1), TCF7L2 (transcription factor 7 like 2), EHMT2 (euchromatic histone lysine methyltransferase 2), TNRC6A (trinucleotide repeat containing adaptor 6A), TNRC6C (trinucleotide repeat containing adaptor 6C), CSF1R (colony stimulating factor 1 receptor), MOV10 (Mov10 RISC complex RNA helicase), VENTX (VENT homeobox), AGO3 (argonaute RISC catalytic component 3), AGO1 (argonaute RISC component 1), ANAPC15 (anaphase promoting complex subunit 15), AGO4 (argonaute RISC component 4)"], "WAG003150": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NLRP3 (NLR family pyrin domain containing 3), IL1B (interleukin 1 beta), NFKB1 (nuclear factor kappa B subunit 1), IL18 (interleukin 18), CASP1 (caspase 1), PYCARD (PYD and CARD domain containing), IL1A (interleukin 1 alpha), RELA (RELA proto-oncogene, NF-kB subunit), MEFV (MEFV innate immuity regulator, pyrin), NFKB2 (nuclear factor kappa B subunit 2), C3 (complement C3), TXN (thioredoxin), HSP90AB1 (heat shock protein 90 alpha family class B member 1), ENTPD1 (ectonucleoside triphosphate diphosphohydrolase 1), PSTPIP1 (proline-serine-threonine phosphatase interacting protein 1), P2RX7 (purinergic receptor P2X 7), SUGT1 (SGT1 homolog, MIS12 kinetochore complex assembly cochaperone), TXNIP (thioredoxin interacting protein), NT5E (5'-nucleotidase ecto), ENTPD5 (ectonucleoside triphosphate diphosphohydrolase 5 (inactive)), C3AR1 (complement C3a receptor 1), CTSG (cathepsin G), P2RX4 (purinergic receptor P2X 4)"], "WAG003151": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FOXO1 (forkhead box O1), SMAD4 (SMAD family member 4), FOXO3 (forkhead box O3), SMAD3 (SMAD family member 3), SMAD2 (SMAD family member 2), FOXO4 (forkhead box O4), NR3C1 (nuclear receptor subfamily 3 group C member 1), HDAC1 (histone deacetylase 1), HDAC2 (histone deacetylase 2), SIN3A (SIN3 transcription regulator family member A), PPARGC1A (PPARG coactivator 1 alpha), SOD2 (superoxide dismutase 2), POMC (proopiomelanocortin), IGFBP1 (insulin like growth factor binding protein 1), NPY (neuropeptide Y), AGRP (agouti related neuropeptide), GCK (glucokinase), SREBF1 (sterol regulatory element binding transcription factor 1), CAT (catalase), FBXO32 (F-box protein 32), G6PC (glucose-6-phosphatase catalytic subunit), PCK1 (phosphoenolpyruvate carboxykinase 1), INS (insulin), RETN (resistin), ATXN3 (ataxin 3), SIRT3 (sirtuin 3), TRIM63 (tripartite motif containing 63), SOD2-OT1 (SOD2 overlapping transcript 1), PLXNA4 (plexin A4), ABCA6 (ATP binding cassette subfamily A member 6)"], "WAG003152": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PPP2CA (protein phosphatase 2 catalytic subunit alpha), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), PPP2CB (protein phosphatase 2 catalytic subunit beta), PYGB (glycogen phosphorylase B), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), PYGL (glycogen phosphorylase L), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), GYG1 (glycogenin 1), CALM3 (calmodulin 3), PYGM (glycogen phosphorylase, muscle associated), PGM1 (phosphoglucomutase 1), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), GBE1 (1,4-alpha-glucan branching enzyme 1), GYS1 (glycogen synthase 1), PPP2R2A (protein phosphatase 2 regulatory subunit Balpha), GYS2 (glycogen synthase 2), PHKB (phosphorylase kinase regulatory subunit beta), PPP2R2C (protein phosphatase 2 regulatory subunit Bgamma), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), PHKG1 (phosphorylase kinase catalytic subunit gamma 1), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), PHKA1 (phosphorylase kinase regulatory subunit alpha 1), PPP2R3A (protein phosphatase 2 regulatory subunit B''alpha), PPP2R3B (protein phosphatase 2 regulatory subunit B''beta), AGL (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase), PHKG2 (phosphorylase kinase catalytic subunit gamma 2), PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta), PHKA2 (phosphorylase kinase regulatory subunit alpha 2), UGP2 (UDP-glucose pyrophosphorylase 2), GYG2 (glycogenin 2), HK1 (hexokinase 1), GSK3B (glycogen synthase kinase 3 beta), HK3 (hexokinase 3), HK2 (hexokinase 2), HKDC1 (hexokinase domain containing 1), GSK3A (glycogen synthase kinase 3 alpha), PTPA (protein phosphatase 2 phosphatase activator), CALM1 (calmodulin 1), CALM2 (calmodulin 2)"], "WAG003153": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), WASF1 (WASP family member 1), WAS (WASP actin nucleation promoting factor), ABI1 (abl interactor 1), WASL (WASP like actin nucleation promoting factor), FYN (FYN proto-oncogene, Src family tyrosine kinase), WASF2 (WASP family member 2), NCK1 (NCK adaptor protein 1), ACTB (actin beta), ARPC3 (actin related protein 2/3 complex subunit 3), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CDC42 (cell division cycle 42), ARPC2 (actin related protein 2/3 complex subunit 2), NCKAP1 (NCK associated protein 1), ARPC1B (actin related protein 2/3 complex subunit 1B), ARPC4 (actin related protein 2/3 complex subunit 4), ARPC5 (actin related protein 2/3 complex subunit 5), CYFIP2 (cytoplasmic FMR1 interacting protein 2), ACTR3 (actin related protein 3), ACTG1 (actin gamma 1), CRK (CRK proto-oncogene, adaptor protein), ACTR2 (actin related protein 2), VAV1 (vav guanine nucleotide exchange factor 1), SYK (spleen associated tyrosine kinase), YES1 (YES proto-oncogene 1, Src family tyrosine kinase), ABI2 (abl interactor 2), ARPC1A (actin related protein 2/3 complex subunit 1A), PTK2 (protein tyrosine kinase 2), HCK (HCK proto-oncogene, Src family tyrosine kinase), BTK (Bruton tyrosine kinase), FGR (FGR proto-oncogene, Src family tyrosine kinase), VAV2 (vav guanine nucleotide exchange factor 2), BAIAP2 (BAR/IMD domain containing adaptor protein 2), WASF3 (WASP family member 3), LYN (LYN proto-oncogene, Src family tyrosine kinase), DOCK1 (dedicator of cytokinesis 1), BRK1 (BRICK1 subunit of SCAR/WAVE actin nucleating complex), MAPK1 (mitogen-activated protein kinase 1), WIPF1 (WAS/WASL interacting protein family member 1), NCKIPSD (NCK interacting protein with SH3 domain), CYFIP1 (cytoplasmic FMR1 interacting protein 1), VAV3 (vav guanine nucleotide exchange factor 3), ELMO1 (engulfment and cell motility 1), MAPK3 (mitogen-activated protein kinase 3), NCKAP1L (NCK associated protein 1 like), MYH9 (myosin heavy chain 9), MYO1C (myosin IC), MYH2 (myosin heavy chain 2), FCGR3A (Fc fragment of IgG receptor IIIa), CD3G (CD3g molecule), WIPF2 (WAS/WASL interacting protein family member 2), ELMO2 (engulfment and cell motility 2), WIPF3 (WAS/WASL interacting protein family member 3), MYO5A (myosin VA), MYO9B (myosin IXB), MYO10 (myosin X)"], "WAG003155": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GAMT (guanidinoacetate N-methyltransferase), CKB (creatine kinase B), CKMT1B (creatine kinase, mitochondrial 1B), CKMT2 (creatine kinase, mitochondrial 2), CKM (creatine kinase, M-type), SLC6A8 (solute carrier family 6 member 8), GATM (glycine amidinotransferase), SLC6A11 (solute carrier family 6 member 11), SLC6A12 (solute carrier family 6 member 12), SLC6A7 (solute carrier family 6 member 7), CKMT1A (creatine kinase, mitochondrial 1A)"], "WAG003160": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), DLG4 (discs large MAGUK scaffold protein 4), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), DLG1 (discs large MAGUK scaffold protein 1), ACTN2 (actinin alpha 2), CASK (calcium/calmodulin dependent serine protein kinase), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), DLG3 (discs large MAGUK scaffold protein 3), DLG2 (discs large MAGUK scaffold protein 2), CAMK2D (calcium/calmodulin dependent protein kinase II delta), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), CAMK2B (calcium/calmodulin dependent protein kinase II beta), LIN7A (lin-7 homolog A, crumbs cell polarity complex component), APBA1 (amyloid beta precursor protein binding family A member 1), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), GRIN3A (glutamate ionotropic receptor NMDA type subunit 3A), GRIN3B (glutamate ionotropic receptor NMDA type subunit 3B), LRRC7 (leucine rich repeat containing 7), LIN7B (lin-7 homolog B, crumbs cell polarity complex component), LIN7C (lin-7 homolog C, crumbs cell polarity complex component), NEFL (neurofilament light), KIF17 (kinesin family member 17), NBEA (neurobeachin)"], "WAG003161": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "FOXO3 (forkhead box O3), AKT1 (AKT serine/threonine kinase 1), FOXO1 (forkhead box O1), FOXO4 (forkhead box O4), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), EP300 (E1A binding protein p300), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), SIRT1 (sirtuin 1), CREBBP (CREB binding protein), KAT2B (lysine acetyltransferase 2B), SFN (stratifin), AKT2 (AKT serine/threonine kinase 2), AKT3 (AKT serine/threonine kinase 3), TXN (thioredoxin), SIRT3 (sirtuin 3), TXNIP (thioredoxin interacting protein)"], "WAG003163": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GRM4 (glutamate metabotropic receptor 4), GRM2 (glutamate metabotropic receptor 2), GRM8 (glutamate metabotropic receptor 8), GRM1 (glutamate metabotropic receptor 1), GRM7 (glutamate metabotropic receptor 7), GRM3 (glutamate metabotropic receptor 3), GRM6 (glutamate metabotropic receptor 6), GABBR1 (gamma-aminobutyric acid type B receptor subunit 1), GABBR2 (gamma-aminobutyric acid type B receptor subunit 2), GRM5 (glutamate metabotropic receptor 5), GPRC5C (G protein-coupled receptor class C group 5 member C), GPRC5D (G protein-coupled receptor class C group 5 member D), CASR (calcium sensing receptor), GPRC5B (G protein-coupled receptor class C group 5 member B), GPRC5A (G protein-coupled receptor class C group 5 member A)"], "WAG003165": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGR2 (early growth response 2), DAG1 (dystroglycan 1), MPZ (myelin protein zero), PRX (periaxin), PMP22 (peripheral myelin protein 22), SOX10 (SRY-box transcription factor 10), GJB1 (gap junction protein beta 1), LAMA2 (laminin subunit alpha 2), LAMC1 (laminin subunit gamma 1), DRP2 (dystrophin related protein 2), LAMB1 (laminin subunit beta 1), POU3F1 (POU class 3 homeobox 1), MAG (myelin associated glycoprotein), UTRN (utrophin), SREBF2 (sterol regulatory element binding transcription factor 2), YAP1 (Yes1 associated transcriptional regulator), TEAD1 (TEA domain transcription factor 1), WWTR1 (WW domain containing transcription regulator 1), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4), HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase), POU3F2 (POU class 3 homeobox 2), CYP51A1 (cytochrome P450 family 51 subfamily A member 1), NAB2 (NGFI-A binding protein 2), MBP (myelin basic protein), NAB1 (NGFI-A binding protein 1), HDAC2 (histone deacetylase 2), ADGRV1 (adhesion G protein-coupled receptor V1), SCD5 (stearoyl-CoA desaturase 5), ADGRG6 (adhesion G protein-coupled receptor G6)"], "WAG003166": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RXRA (retinoid X receptor alpha), EP300 (E1A binding protein p300), HDAC3 (histone deacetylase 3), NCOR1 (nuclear receptor corepressor 1), NCOR2 (nuclear receptor corepressor 2), NR1H3 (nuclear receptor subfamily 1 group H member 3), NCOA1 (nuclear receptor coactivator 1), NR1H2 (nuclear receptor subfamily 1 group H member 2), ABCA1 (ATP binding cassette subfamily A member 1), TBL1XR1 (TBL1X receptor 1), NRIP1 (nuclear receptor interacting protein 1), RXRB (retinoid X receptor beta), APOE (apolipoprotein E), GPS2 (G protein pathway suppressor 2), PCK1 (phosphoenolpyruvate carboxykinase 1), KDM1A (lysine demethylase 1A), SREBF1 (sterol regulatory element binding transcription factor 1), PLIN1 (perilipin 1), TBL1X (transducin beta like 1 X-linked), PLTP (phospholipid transfer protein), ABCG1 (ATP binding cassette subfamily G member 1), ABCG8 (ATP binding cassette subfamily G member 8), FASN (fatty acid synthase), ABCG5 (ATP binding cassette subfamily G member 5), CETP (cholesteryl ester transfer protein), APOC2 (apolipoprotein C2), APOC1 (apolipoprotein C1), TNRC6B (trinucleotide repeat containing adaptor 6B), SCD (stearoyl-CoA desaturase), KDM4A (lysine demethylase 4A), TNRC6A (trinucleotide repeat containing adaptor 6A), TNRC6C (trinucleotide repeat containing adaptor 6C), APOC4 (apolipoprotein C4), APOD (apolipoprotein D), KDM3A (lysine demethylase 3A), MOV10 (Mov10 RISC complex RNA helicase), MYLIP (myosin regulatory light chain interacting protein), FABP6 (fatty acid binding protein 6), ANGPTL3 (angiopoietin like 3), EEPD1 (endonuclease/exonuclease/phosphatase family domain containing 1), AGO4 (argonaute RISC component 4), ARL4C (ADP ribosylation factor like GTPase 4C), AGO1 (argonaute RISC component 1), AGO3 (argonaute RISC catalytic component 3), UGT1A3 (UDP glucuronosyltransferase family 1 member A3), KDM1B (lysine demethylase 1B), AGO2 (argonaute RISC catalytic component 2)"], "WAG003167": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BAG6 (BAG cochaperone 6), SEC61B (SEC61 translocon subunit beta), UBL4A (ubiquitin like 4A), APP (amyloid beta precursor protein), SGTA (small glutamine rich tetratricopeptide repeat containing alpha), VAMP2 (vesicle associated membrane protein 2), GET4 (guided entry of tail-anchored proteins factor 4), SERP1 (stress associated endoplasmic reticulum protein 1), VAPA (VAMP associated protein A), PRNP (prion protein), STX5 (syntaxin 5), STX1A (syntaxin 1A), SEC61G (SEC61 translocon subunit gamma), HMOX1 (heme oxygenase 1), EMD (emerin), GET1 (guided entry of tail-anchored proteins factor 1), CAMLG (calcium modulating ligand), GET3 (guided entry of tail-anchored proteins factor 3, ATPase), OTOF (otoferlin)"], "WAG003168": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NUP85 (nucleoporin 85), NUP93 (nucleoporin 93), NUP155 (nucleoporin 155), NUP43 (nucleoporin 43), TPR (translocated promoter region, nuclear basket protein), NUP107 (nucleoporin 107), NUP35 (nucleoporin 35), RAE1 (ribonucleic acid export 1), NUP153 (nucleoporin 153), NUP205 (nucleoporin 205), NUP210 (nucleoporin 210), NUP62 (nucleoporin 62), NUP188 (nucleoporin 188), NUP160 (nucleoporin 160), NUP133 (nucleoporin 133), NUP214 (nucleoporin 214), NUP88 (nucleoporin 88), NUP50 (nucleoporin 50), NUP54 (nucleoporin 54), NUP37 (nucleoporin 37), AAAS (aladin WD repeat nucleoporin), CHMP2A (charged multivesicular body protein 2A), RANBP2 (RAN binding protein 2), VPS28 (VPS28 subunit of ESCRT-I), CHMP3 (charged multivesicular body protein 3), CHMP6 (charged multivesicular body protein 6), SNF8 (SNF8 subunit of ESCRT-II), CHMP4B (charged multivesicular body protein 4B), VPS4A (vacuolar protein sorting 4 homolog A), CHMP4C (charged multivesicular body protein 4C), VPS36 (vacuolar protein sorting 36 homolog), VPS25 (vacuolar protein sorting 25 homolog), VPS37A (VPS37A subunit of ESCRT-I), VPS37C (VPS37C subunit of ESCRT-I), TSG101 (tumor susceptibility 101), CHMP2B (charged multivesicular body protein 2B), HDAC3 (histone deacetylase 3), VPS37B (VPS37B subunit of ESCRT-I), CHMP7 (charged multivesicular body protein 7), VPS37D (VPS37D subunit of ESCRT-I), EED (embryonic ectoderm development), POM121 (POM121 transmembrane nucleoporin), NCOR1 (nuclear receptor corepressor 1), SUZ12 (SUZ12 polycomb repressive complex 2 subunit), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), CHMP4A (charged multivesicular body protein 4A), PML (PML nuclear body scaffold), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), EGFR (epidermal growth factor receptor), DYNLL1 (dynein light chain LC8-type 1), NFKB1 (nuclear factor kappa B subunit 1), CHMP1A (charged multivesicular body protein 1A), RBBP4 (RB binding protein 4, chromatin remodeling factor), NCOR2 (nuclear receptor corepressor 2), EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit), RBBP7 (RB binding protein 7, chromatin remodeling factor), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), TBL1X (transducin beta like 1 X-linked), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), TBL1XR1 (TBL1X receptor 1), GPS2 (G protein pathway suppressor 2), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), DYNLL2 (dynein light chain LC8-type 2), CREB1 (cAMP responsive element binding protein 1), TRIM28 (tripartite motif containing 28), UBAP1 (ubiquitin associated protein 1), DAXX (death domain associated protein), CEBPD (CCAAT enhancer binding protein delta), HNRNPK (heterogeneous nuclear ribonucleoprotein K), CBX1 (chromobox 1), ITGB1 (integrin subunit beta 1), H2AW (H2A.W histone), H4-16 (H4 histone 16), H3C1 (H3 clustered histone 1), H2BC18 (H2B clustered histone 18), H2BC21 (H2B clustered histone 21), H3C14 (H3 clustered histone 14), H3C11 (H3 clustered histone 11), NDC1 (NDC1 transmembrane nucleoporin), H4C15 (H4 clustered histone 15), H3C8 (H3 clustered histone 8), H3C6 (H3 clustered histone 6), H4C3 (H4 clustered histone 3), H4C6 (H4 clustered histone 6), H3C4 (H3 clustered histone 4), H2BU1 (H2B.U histone 1), H3C15 (H3 clustered histone 15), H4C2 (H4 clustered histone 2), H4C12 (H4 clustered histone 12), H4C13 (H4 clustered histone 13), H4C5 (H4 clustered histone 5), H4C8 (H4 clustered histone 8), ELK1 (ETS transcription factor ELK1), H3C13 (H3 clustered histone 13), H4C9 (H4 clustered histone 9), H3C2 (H3 clustered histone 2), H3C7 (H3 clustered histone 7), H4C14 (H4 clustered histone 14), H4C11 (H4 clustered histone 11)"], "WAG003169": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATP6V1B2 (ATPase H+ transporting V1 subunit B2), ATP6V1A (ATPase H+ transporting V1 subunit A), ATP6V1E1 (ATPase H+ transporting V1 subunit E1), ATP6V1D (ATPase H+ transporting V1 subunit D), ATP6V1F (ATPase H+ transporting V1 subunit F), ATP6V0D1 (ATPase H+ transporting V0 subunit d1), ATP6V1C1 (ATPase H+ transporting V1 subunit C1), ATP6V1G1 (ATPase H+ transporting V1 subunit G1), ATP6V1B1 (ATPase H+ transporting V1 subunit B1), ATP6V1H (ATPase H+ transporting V1 subunit H), ATP6V0D2 (ATPase H+ transporting V0 subunit d2), ATP6V0C (ATPase H+ transporting V0 subunit c), ATP6V1C2 (ATPase H+ transporting V1 subunit C2), TCIRG1 (T cell immune regulator 1, ATPase H+ transporting V0 subunit a3), ATP6V0B (ATPase H+ transporting V0 subunit b), ATP6V0E1 (ATPase H+ transporting V0 subunit e1), ATP6V0E2 (ATPase H+ transporting V0 subunit e2), ATP6V1G3 (ATPase H+ transporting V1 subunit G3), RRAGC (Ras related GTP binding C), LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1), MTOR (mechanistic target of rapamycin kinase), RRAGA (Ras related GTP binding A), RPTOR (regulatory associated protein of MTOR complex 1), RRAGD (Ras related GTP binding D), RRAGB (Ras related GTP binding B), LAMTOR2 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 2), MLST8 (MTOR associated protein, LST8 homolog), LAMTOR3 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 3), LAMTOR5 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 5), SEH1L (SEH1 like nucleoporin), SEC13 (SEC13 homolog, nuclear pore and COPII coat complex component), RHEB (Ras homolog, mTORC1 binding), NPRL2 (NPR2 like, GATOR1 complex subunit), WDR59 (WD repeat domain 59), MIOS (meiosis regulator for oocyte development), ATP6V1G2 (ATPase H+ transporting V1 subunit G2), DEPDC5 (DEP domain containing 5, GATOR1 subcomplex subunit), WDR24 (WD repeat domain 24), FLCN (folliculin), FNIP1 (folliculin interacting protein 1), NPRL3 (NPR3 like, GATOR1 complex subunit), FNIP2 (folliculin interacting protein 2), ITFG2 (integrin alpha FG-GAP repeat containing 2), KPTN (kaptin, actin binding protein), ATP6V1E2 (ATPase H+ transporting V1 subunit E2), CASTOR1 (cytosolic arginine sensor for mTORC1 subunit 1), LAMTOR4 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 4), SZT2 (SZT2 subunit of KICSTOR complex), BMT2 (base methyltransferase of 25S rRNA 2 homolog), CASTOR2 (cytosolic arginine sensor for mTORC1 subunit 2), SLC38A9 (solute carrier family 38 member 9), SH3BP4 (SH3 domain binding protein 4), SESN1 (sestrin 1), C12orf66 (chromosome 12 open reading frame 66), SESN2 (sestrin 2)"], "WAG003170": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), GRB2 (growth factor receptor bound protein 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), LCK (LCK proto-oncogene, Src family tyrosine kinase), CBL (Cbl proto-oncogene), AKT1 (AKT serine/threonine kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), FYN (FYN proto-oncogene, Src family tyrosine kinase), PTPN11 (protein tyrosine phosphatase non-receptor type 11), SYK (spleen associated tyrosine kinase), HRAS (HRas proto-oncogene, GTPase), GAB2 (GRB2 associated binding protein 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), HCK (HCK proto-oncogene, Src family tyrosine kinase), FLT3 (fms related receptor tyrosine kinase 3), NRAS (NRAS proto-oncogene, GTPase), CSK (C-terminal Src kinase), CDKN1B (cyclin dependent kinase inhibitor 1B), STAT5A (signal transducer and activator of transcription 5A), STAT5B (signal transducer and activator of transcription 5B), CDKN1A (cyclin dependent kinase inhibitor 1A), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), AKT2 (AKT serine/threonine kinase 2), GRAP2 (GRB2 related adaptor protein 2), BCL2L1 (BCL2 like 1), AKT3 (AKT serine/threonine kinase 3), GRB10 (growth factor receptor bound protein 10), BCL2L11 (BCL2 like 11), FOXO3 (forkhead box O3), SPTBN1 (spectrin beta, non-erythrocytic 1), ETV6 (ETS variant transcription factor 6), SLA (Src like adaptor), ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase), PIM1 (Pim-1 proto-oncogene, serine/threonine kinase), SOCS2 (suppressor of cytokine signaling 2), PTPRJ (protein tyrosine phosphatase receptor type J), RPS27A (ribosomal protein S27a), SH2B3 (SH2B adaptor protein 3), SLA2 (Src like adaptor 2), SOCS6 (suppressor of cytokine signaling 6), MYO18A (myosin XVIIIA), FLT3LG (fms related receptor tyrosine kinase 3 ligand), NOX4 (NADPH oxidase 4), TRIP11 (thyroid hormone receptor interactor 11), GOLGB1 (golgin B1), ZMYM2 (zinc finger MYM-type containing 2)"], "WAG003171": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), CHMP4B (charged multivesicular body protein 4B), CHMP2B (charged multivesicular body protein 2B), CHMP2A (charged multivesicular body protein 2A), CHMP6 (charged multivesicular body protein 6), CHMP4C (charged multivesicular body protein 4C), CHMP3 (charged multivesicular body protein 3), SUMO1 (small ubiquitin like modifier 1), CHMP7 (charged multivesicular body protein 7), VHL (von Hippel-Lindau tumor suppressor), CHMP4A (charged multivesicular body protein 4A), BECN1 (beclin 1), RB1 (RB transcriptional corepressor 1), VCP (valosin containing protein), ST3GAL2 (ST3 beta-galactoside alpha-2,3-sialyltransferase 2), ST3GAL1 (ST3 beta-galactoside alpha-2,3-sialyltransferase 1), CANX (calnexin), RPS27A (ribosomal protein S27a), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), UBE2I (ubiquitin conjugating enzyme E2 I), DDX5 (DEAD-box helicase 5), ST6GALNAC4 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), GANAB (glucosidase II alpha subunit), ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4), UVRAG (UV radiation resistance associated), GSK3B (glycogen synthase kinase 3 beta), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), PRKCSH (protein kinase C substrate 80K-H), MOGS (mannosyl-oligosaccharide glucosidase), ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1), ST6GALNAC2 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2), PARP14 (poly(ADP-ribose) polymerase family member 14), PARP9 (poly(ADP-ribose) polymerase family member 9), ST6GALNAC3 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3), PARP10 (poly(ADP-ribose) polymerase family member 10), GSK3A (glycogen synthase kinase 3 alpha), PARP16 (poly(ADP-ribose) polymerase family member 16), ST3GAL3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3), GALNT1 (polypeptide N-acetylgalactosaminyltransferase 1), PARP8 (poly(ADP-ribose) polymerase family member 8), MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase), PARP4 (poly(ADP-ribose) polymerase family member 4), PARP6 (poly(ADP-ribose) polymerase family member 6), ZCRB1 (zinc finger CCHC-type and RNA binding motif containing 1), TMPRSS2 (transmembrane serine protease 2), CTSL (cathepsin L), ACE2 (angiotensin I converting enzyme 2)"], "WAG003172": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), UBB (ubiquitin B), CHMP4B (charged multivesicular body protein 4B), DDOST (dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit), CHMP2B (charged multivesicular body protein 2B), RPN1 (ribophorin I), CHMP2A (charged multivesicular body protein 2A), CHMP6 (charged multivesicular body protein 6), CHMP4C (charged multivesicular body protein 4C), CHMP3 (charged multivesicular body protein 3), SUMO1 (small ubiquitin like modifier 1), RPN2 (ribophorin II), CHMP7 (charged multivesicular body protein 7), MOGS (mannosyl-oligosaccharide glucosidase), STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A), DAD1 (defender against cell death 1), VCP (valosin containing protein), TUSC3 (tumor suppressor candidate 3), VHL (von Hippel-Lindau tumor suppressor), CANX (calnexin), MAGT1 (magnesium transporter 1), CHMP4A (charged multivesicular body protein 4A), GANAB (glucosidase II alpha subunit), BECN1 (beclin 1), MGAT2 (alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase), RB1 (RB transcriptional corepressor 1), ST3GAL1 (ST3 beta-galactoside alpha-2,3-sialyltransferase 1), ST3GAL2 (ST3 beta-galactoside alpha-2,3-sialyltransferase 2), RPS27A (ribosomal protein S27a), MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase), UBE2I (ubiquitin conjugating enzyme E2 I), MAN1B1 (mannosidase alpha class 1B member 1), DDX5 (DEAD-box helicase 5), ST6GALNAC4 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4), MAN2A1 (mannosidase alpha class 2A member 1), PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4), ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4), FUT8 (fucosyltransferase 8), PRKCSH (protein kinase C substrate 80K-H), MGAT4B (alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B), UVRAG (UV radiation resistance associated), GSK3B (glycogen synthase kinase 3 beta), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), MGAT4A (alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A), ST6GAL1 (ST6 beta-galactoside alpha-2,6-sialyltransferase 1), ST6GALNAC2 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2), EDEM2 (ER degradation enhancing alpha-mannosidase like protein 2), PARP14 (poly(ADP-ribose) polymerase family member 14), PARP9 (poly(ADP-ribose) polymerase family member 9), GALNT1 (polypeptide N-acetylgalactosaminyltransferase 1), ST6GALNAC3 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3), PARP10 (poly(ADP-ribose) polymerase family member 10), GSK3A (glycogen synthase kinase 3 alpha), PARP16 (poly(ADP-ribose) polymerase family member 16), ST3GAL3 (ST3 beta-galactoside alpha-2,3-sialyltransferase 3), MGAT4C (MGAT4 family member C), PARP8 (poly(ADP-ribose) polymerase family member 8), PARP4 (poly(ADP-ribose) polymerase family member 4), FURIN (furin, paired basic amino acid cleaving enzyme), PARP6 (poly(ADP-ribose) polymerase family member 6), ZCRB1 (zinc finger CCHC-type and RNA binding motif containing 1), TMPRSS2 (transmembrane serine protease 2), CTSL (cathepsin L), MMP24-AS1-EDEM2 (MMP24-AS1-EDEM2 readthrough), ACE2 (angiotensin I converting enzyme 2)"], "WAG003173": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "UBC (ubiquitin C), RIPK1 (receptor interacting serine/threonine kinase 1), CASP8 (caspase 8), TRAF2 (TNF receptor associated factor 2), FADD (Fas associated via death domain), TRADD (TNFRSF1A associated via death domain), BIRC2 (baculoviral IAP repeat containing 2), BIRC3 (baculoviral IAP repeat containing 3), RIPK3 (receptor interacting serine/threonine kinase 3), XIAP (X-linked inhibitor of apoptosis), TNFRSF10B (TNF receptor superfamily member 10b), UBB (ubiquitin B), TNFSF10 (TNF superfamily member 10), FASLG (Fas ligand), TNFRSF10A (TNF receptor superfamily member 10a), FAS (Fas cell surface death receptor), HSP90AA1 (heat shock protein 90 alpha family class A member 1), STUB1 (STIP1 homology and U-box containing protein 1), UBA52 (ubiquitin A-52 residue ribosomal protein fusion product 1), CDC37 (cell division cycle 37, HSP90 cochaperone), RPS27A (ribosomal protein S27a), PELI1 (pellino E3 ubiquitin protein ligase 1), FLOT2 (flotillin 2), PDCD6IP (programmed cell death 6 interacting protein), MLKL (mixed lineage kinase domain like pseudokinase), FLOT1 (flotillin 1), SDCBP (syndecan binding protein), OGT (O-linked N-acetylglucosamine (GlcNAc) transferase)"], "WAG003176": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DLD (dihydrolipoamide dehydrogenase), GLDC (glycine decarboxylase), GCSH (glycine cleavage system protein H), AMT (aminomethyltransferase), ISCU (iron-sulfur cluster assembly enzyme), LIAS (lipoic acid synthetase), NFU1 (NFU1 iron-sulfur cluster scaffold), BOLA3 (bolA family member 3), PNPO (pyridoxamine 5'-phosphate oxidase)"], "WAG003177": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SLC3A1 (solute carrier family 3 member 1), SLC36A2 (solute carrier family 36 member 2), SLC7A9 (solute carrier family 7 member 9), SLC6A19 (solute carrier family 6 member 19), SLC7A7 (solute carrier family 7 member 7), SLC6A20 (solute carrier family 6 member 20), SLC1A1 (solute carrier family 1 member 1), CLTRN (collectrin, amino acid transport regulator)"], "WAG003178": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ETHE1 (ETHE1 persulfide dioxygenase), TST (thiosulfate sulfurtransferase), SUOX (sulfite oxidase)"], "WAG003179": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ACACB (acetyl-CoA carboxylase beta), HLCS (holocarboxylase synthetase), MCCC1 (methylcrotonoyl-CoA carboxylase 1), BTD (biotinidase), ACACA (acetyl-CoA carboxylase alpha), MCCC2 (methylcrotonoyl-CoA carboxylase 2), PCCA (propionyl-CoA carboxylase subunit alpha), PC (pyruvate carboxylase), PCCB (propionyl-CoA carboxylase subunit beta)"], "WAG003183": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), TGFB1 (transforming growth factor beta 1), SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), SP1 (Sp1 transcription factor), HIF1A (hypoxia inducible factor 1 subunit alpha), AGT (angiotensinogen), COL1A2 (collagen type I alpha 2 chain), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), TGFBR1 (transforming growth factor beta receptor 1), TGFBR2 (transforming growth factor beta receptor 2), IL6ST (interleukin 6 signal transducer), AGTR1 (angiotensin II receptor type 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K6 (mitogen-activated protein kinase kinase 6), IL11 (interleukin 11), COL1A1 (collagen type I alpha 1 chain), ACE2 (angiotensin I converting enzyme 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), IL11RA (interleukin 11 receptor subunit alpha), RRAS (RAS related), ACTA2 (actin alpha 2, smooth muscle), MAS1 (MAS1 proto-oncogene, G protein-coupled receptor), F12 (coagulation factor XII), NOX4 (NADPH oxidase 4), CCN2 (cellular communication network factor 2), RACK1 (receptor for activated C kinase 1), PDGFD (platelet derived growth factor D)"], "WAG003185": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAVS (mitochondrial antiviral signaling protein), TRAF6 (TNF receptor associated factor 6), TRAF3 (TNF receptor associated factor 3), TBK1 (TANK binding kinase 1), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), TLR3 (toll like receptor 3), TICAM1 (toll like receptor adaptor molecule 1), IRF7 (interferon regulatory factor 7), DDX58 (DExD/H-box helicase 58), IRF3 (interferon regulatory factor 3), NFKB1 (nuclear factor kappa B subunit 1), NFKB2 (nuclear factor kappa B subunit 2), NLRX1 (NLR family member X1), IFIH1 (interferon induced with helicase C domain 1), TLR7 (toll like receptor 7), AGTR1 (angiotensin II receptor type 1), ACE (angiotensin I converting enzyme), ECSIT (ECSIT signaling integrator), REN (renin), PHB2 (prohibitin 2), AGTR2 (angiotensin II receptor type 2), ACE2 (angiotensin I converting enzyme 2), NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1), PHB (prohibitin), NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9), BCS1L (BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone), NOX1 (NADPH oxidase 1), STING1 (stimulator of interferon response cGAMP interactor 1), TMPRSS2 (transmembrane serine protease 2), CTSL (cathepsin L), ACAD9 (acyl-CoA dehydrogenase family member 9), CGAS (cyclic GMP-AMP synthase), IFN1@ (interferon, type 1, cluster), TOMM70 (translocase of outer mitochondrial membrane 70)"], "WAG003186": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), STAT1 (signal transducer and activator of transcription 1), CXCL10 (C-X-C motif chemokine ligand 10), IRF7 (interferon regulatory factor 7), IL6 (interleukin 6), CCL5 (C-C motif chemokine ligand 5), NFKB1 (nuclear factor kappa B subunit 1), MAVS (mitochondrial antiviral signaling protein), EP300 (E1A binding protein p300), CXCL9 (C-X-C motif chemokine ligand 9), CXCL11 (C-X-C motif chemokine ligand 11), CXCR2 (C-X-C motif chemokine receptor 2), CXCL1 (C-X-C motif chemokine ligand 1), TRAF6 (TNF receptor associated factor 6), IRF3 (interferon regulatory factor 3), TRAF2 (TNF receptor associated factor 2), IFNB1 (interferon beta 1), CCL2 (C-C motif chemokine ligand 2), CXCL2 (C-X-C motif chemokine ligand 2), CCL4 (C-C motif chemokine ligand 4), DDX58 (DExD/H-box helicase 58), CXCL5 (C-X-C motif chemokine ligand 5), STAT2 (signal transducer and activator of transcription 2), RIPK1 (receptor interacting serine/threonine kinase 1), PPBP (pro-platelet basic protein), CXCL13 (C-X-C motif chemokine ligand 13), TGFB1 (transforming growth factor beta 1), TRAF3 (TNF receptor associated factor 3), TRADD (TNFRSF1A associated via death domain), CSF2 (colony stimulating factor 2), CXCL12 (C-X-C motif chemokine ligand 12), CXCL3 (C-X-C motif chemokine ligand 3), TBK1 (TANK binding kinase 1), CCL3 (C-C motif chemokine ligand 3), IL10 (interleukin 10), CXCL6 (C-X-C motif chemokine ligand 6), FADD (Fas associated via death domain), CASP8 (caspase 8), MX1 (MX dynamin like GTPase 1), TANK (TRAF family member associated NFKB activator), JAK1 (Janus kinase 1), PF4 (platelet factor 4), IFIT2 (interferon induced protein with tetratricopeptide repeats 2), IFNAR1 (interferon alpha and beta receptor subunit 1), IFNAR2 (interferon alpha and beta receptor subunit 2), TRAF5 (TNF receptor associated factor 5), TLR7 (toll like receptor 7), SMAD3 (SMAD family member 3), IL6R (interleukin 6 receptor), DHX58 (DExH-box helicase 58), IFITM1 (interferon induced transmembrane protein 1), TRIM25 (tripartite motif containing 25), HDAC2 (histone deacetylase 2), NUP98 (nucleoporin 98 and 96 precursor), TFAP2A (transcription factor AP-2 alpha), RAE1 (ribonucleic acid export 1), CXCL17 (C-X-C motif chemokine ligand 17), ACE2 (angiotensin I converting enzyme 2), AP1G1 (adaptor related protein complex 1 subunit gamma 1), CD160 (CD160 molecule), HAVCR2 (hepatitis A virus cellular receptor 2), LARP1 (La ribonucleoprotein 1, translational regulator), IFN1@ (interferon, type 1, cluster), LAG3 (lymphocyte activating 3), CXCL8 (C-X-C motif chemokine ligand 8), BSG (basigin (Ok blood group)), TP53I3 (tumor protein p53 inducible protein 3)"], "WAG003188": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "KYNU (kynureninase), KMO (kynurenine 3-monooxygenase), IDO1 (indoleamine 2,3-dioxygenase 1), TNF (tumor necrosis factor), AFMID (arylformamidase), TDO2 (tryptophan 2,3-dioxygenase), HAAO (3-hydroxyanthranilate 3,4-dioxygenase), IFNG (interferon gamma), ACMSD (aminocarboxymuconate semialdehyde decarboxylase), CDKN1A (cyclin dependent kinase inhibitor 1A), AADAT (aminoadipate aminotransferase), TP53 (tumor protein p53), FOXO1 (forkhead box O1), IFNB1 (interferon beta 1), QPRT (quinolinate phosphoribosyltransferase), TLR4 (toll like receptor 4), KLF5 (Kruppel like factor 5), AHR (aryl hydrocarbon receptor), EIF2AK4 (eukaryotic translation initiation factor 2 alpha kinase 4), EIF2AK1 (eukaryotic translation initiation factor 2 alpha kinase 1), IDO2 (indoleamine 2,3-dioxygenase 2), IL1R2 (interleukin 1 receptor type 2), NOS1 (nitric oxide synthase 1)"], "WAG003190": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RHOBTB3 (Rho related BTB domain containing 3), CUL3 (cullin 3), HSP90AA1 (heat shock protein 90 alpha family class A member 1), RHOBTB2 (Rho related BTB domain containing 2), HSP90AB1 (heat shock protein 90 alpha family class B member 1), RHOBTB1 (Rho related BTB domain containing 1), CDC37 (cell division cycle 37, HSP90 cochaperone), PLIN3 (perilipin 3), RAB9A (RAB9A, member RAS oncogene family), CCNE1 (cyclin E1), HGS (hepatocyte growth factor-regulated tyrosine kinase substrate), ROCK1 (Rho associated coiled-coil containing protein kinase 1), RAB9B (RAB9B, member RAS oncogene family), VHL (von Hippel-Lindau tumor suppressor), LRRC41 (leucine rich repeat containing 41), ROCK2 (Rho associated coiled-coil containing protein kinase 2)"], "WAG003191": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SOX9 (SRY-box transcription factor 9), NR5A1 (nuclear receptor subfamily 5 group A member 1), AMH (anti-Mullerian hormone), SRY (sex determining region Y), GATA4 (GATA binding protein 4), DMRT1 (doublesex and mab-3 related transcription factor 1), FOXL2 (forkhead box L2), WNT4 (Wnt family member 4), ZFPM2 (zinc finger protein, FOG family member 2), WT1 (WT1 transcription factor), FGF9 (fibroblast growth factor 9), PTGDS (prostaglandin D2 synthase), DHH (desert hedgehog signaling molecule)"], "WAG003192": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "GAPDH (glyceraldehyde-3-phosphate dehydrogenase), PKM (pyruvate kinase M1/2), PGK1 (phosphoglycerate kinase 1), ENO1 (enolase 1), LDHA (lactate dehydrogenase A), HK1 (hexokinase 1), ALDOC (aldolase, fructose-bisphosphate C), G6PD (glucose-6-phosphate dehydrogenase), TP53 (tumor protein p53), RB1 (RB transcriptional corepressor 1), PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)"], "WAG003195": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BMP4 (bone morphogenetic protein 4), BMP2 (bone morphogenetic protein 2), SHH (sonic hedgehog signaling molecule), CTNNB1 (catenin beta 1), BMP7 (bone morphogenetic protein 7), PAX2 (paired box 2), GDNF (glial cell derived neurotrophic factor), GLI2 (GLI family zinc finger 2), BMPR2 (bone morphogenetic protein receptor type 2), GLI3 (GLI family zinc finger 3), BMPR1A (bone morphogenetic protein receptor type 1A), BMP5 (bone morphogenetic protein 5), FST (follistatin), CCND1 (cyclin D1), GLI1 (GLI family zinc finger 1), SMAD1 (SMAD family member 1), SIX1 (SIX homeobox 1), RET (ret proto-oncogene), SMO (smoothened, frizzled class receptor), WNT11 (Wnt family member 11), SLIT2 (slit guidance ligand 2), EYA1 (EYA transcriptional coactivator and phosphatase 1), ITGB1 (integrin subunit beta 1), SIX2 (SIX homeobox 2), GRIP1 (glutamate receptor interacting protein 1), ROBO1 (roundabout guidance receptor 1), GFRA1 (GDNF family receptor alpha 1), RARB (retinoic acid receptor beta), ILK (integrin linked kinase), SALL1 (spalt like transcription factor 1), TGFB2 (transforming growth factor beta 2), WT1 (WT1 transcription factor), RARA (retinoic acid receptor alpha), ROBO2 (roundabout guidance receptor 2), HOXA11 (homeobox A11), BMPER (BMP binding endothelial regulator), SPRY1 (sprouty RTK signaling antagonist 1), RARG (retinoic acid receptor gamma), HOXD11 (homeobox D11), VANGL2 (VANGL planar cell polarity protein 2), MYCN (MYCN proto-oncogene, bHLH transcription factor), PBX1 (PBX homeobox 1), LHX1 (LIM homeobox 1), GATA3 (GATA binding protein 3), GPC3 (glypican 3), FGFR2 (fibroblast growth factor receptor 2), ITGA8 (integrin subunit alpha 8), CRIM1 (cysteine rich transmembrane BMP regulator 1), FRAS1 (Fraser extracellular matrix complex subunit 1), CTDNEP1 (CTD nuclear envelope phosphatase 1), FREM2 (FRAS1 related extracellular matrix 2), CELSR1 (cadherin EGF LAG seven-pass G-type receptor 1), FOXC1 (forkhead box C1), ETV4 (ETS variant transcription factor 4), GDF11 (growth differentiation factor 11), FREM1 (FRAS1 related extracellular matrix 1), FAT4 (FAT atypical cadherin 4), HNF1B (HNF1 homeobox B), GREB1L (GREB1 like retinoic acid receptor coactivator), ANOS1 (anosmin 1)"], "WAG003196": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TGFB1 (transforming growth factor beta 1), TNF (tumor necrosis factor), FN1 (fibronectin 1), IL6 (interleukin 6), VEGFA (vascular endothelial growth factor A), MMP9 (matrix metallopeptidase 9), AKT1 (AKT serine/threonine kinase 1), IL1B (interleukin 1 beta), TP53 (tumor protein p53), EGF (epidermal growth factor), MMP2 (matrix metallopeptidase 2), NFKB1 (nuclear factor kappa B subunit 1), TLR4 (toll like receptor 4), TIMP1 (TIMP metallopeptidase inhibitor 1), MYD88 (MYD88 innate immune signal transduction adaptor), MMP1 (matrix metallopeptidase 1), CCL2 (C-C motif chemokine ligand 2), ICAM1 (intercellular adhesion molecule 1), IL1A (interleukin 1 alpha), DCN (decorin), TGFB2 (transforming growth factor beta 2), IFNB1 (interferon beta 1), TLR2 (toll like receptor 2), HGF (hepatocyte growth factor), VIM (vimentin), COL1A2 (collagen type I alpha 2 chain), CXCL12 (C-X-C motif chemokine ligand 12), CXCR4 (C-X-C motif chemokine receptor 4), TLR3 (toll like receptor 3), MMP3 (matrix metallopeptidase 3), TLR9 (toll like receptor 9), SPARC (secreted protein acidic and cysteine rich), CASP3 (caspase 3), MMP13 (matrix metallopeptidase 13), NFKBIA (NFKB inhibitor alpha), COL1A1 (collagen type I alpha 1 chain), HMGB1 (high mobility group box 1), FGFR1 (fibroblast growth factor receptor 1), SMAD3 (SMAD family member 3), ACTA1 (actin alpha 1, skeletal muscle), TLR5 (toll like receptor 5), ELN (elastin), TLR7 (toll like receptor 7), TLR1 (toll like receptor 1), TGFB3 (transforming growth factor beta 3), TLR6 (toll like receptor 6), TNFAIP3 (TNF alpha induced protein 3), S100A9 (S100 calcium binding protein A9), BCL2 (BCL2 apoptosis regulator), LY96 (lymphocyte antigen 96), CXCL1 (C-X-C motif chemokine ligand 1), KDR (kinase insert domain receptor), TLR8 (toll like receptor 8), NOD2 (nucleotide binding oligomerization domain containing 2), TNC (tenascin C), FBN1 (fibrillin 1), F13A1 (coagulation factor XIII A chain), TIMP2 (TIMP metallopeptidase inhibitor 2), IFNA2 (interferon alpha 2), PDGFRB (platelet derived growth factor receptor beta), NOD1 (nucleotide binding oligomerization domain containing 1), CXCR2 (C-X-C motif chemokine receptor 2), IL15 (interleukin 15), FGFR3 (fibroblast growth factor receptor 3), SERPINH1 (serpin family H member 1), FGFR2 (fibroblast growth factor receptor 2), INHBA (inhibin subunit beta A), FST (follistatin), NOX4 (NADPH oxidase 4), KLF4 (Kruppel like factor 4), TAGLN (transgelin), S100A6 (S100 calcium binding protein A6), FGFR4 (fibroblast growth factor receptor 4), SNAI2 (snail family transcriptional repressor 2), NFKBIZ (NFKB inhibitor zeta), FLG (filaggrin), S100A11 (S100 calcium binding protein A11), PFN1 (profilin 1), CHRNA7 (cholinergic receptor nicotinic alpha 7 subunit), AMBP (alpha-1-microglobulin/bikunin precursor), CD248 (CD248 molecule), ACHE (acetylcholinesterase (Cartwright blood group)), ADAM12 (ADAM metallopeptidase domain 12), MMP28 (matrix metallopeptidase 28), CNN2 (calponin 2), SLURP1 (secreted LY6/PLAUR domain containing 1), SCEL (sciellin), LIN28A (lin-28 homolog A), CD3E (CD3e molecule), BRD4 (bromodomain containing 4), SFRP2 (secreted frizzled related protein 2), HOTAIR (HOX transcript antisense RNA), KRT6A (keratin 6A), FOXE1 (forkhead box E1), MIAT (myocardial infarction associated transcript), MIR145 (microRNA 145), MIR126 (microRNA 126), KRT222 (keratin 222), SNHG20 (small nucleolar RNA host gene 20), MIR29A (microRNA 29a)"], "WAG003197": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ACSL3 (acyl-CoA synthetase long chain family member 3), ACSL4 (acyl-CoA synthetase long chain family member 4), ACSL1 (acyl-CoA synthetase long chain family member 1), ACSL5 (acyl-CoA synthetase long chain family member 5), FABP1 (fatty acid binding protein 1), FABP4 (fatty acid binding protein 4), FABP2 (fatty acid binding protein 2), CD36 (CD36 molecule), FABP3 (fatty acid binding protein 3), ACSL6 (acyl-CoA synthetase long chain family member 6), DBI (diazepam binding inhibitor, acyl-CoA binding protein), ACSBG1 (acyl-CoA synthetase bubblegum family member 1), SLC27A4 (solute carrier family 27 member 4), FABP9 (fatty acid binding protein 9), ACSBG2 (acyl-CoA synthetase bubblegum family member 2), FABP5 (fatty acid binding protein 5), FABP6 (fatty acid binding protein 6), FABP7 (fatty acid binding protein 7)"], "WAG003198": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL2 (interleukin 2), IL2RA (interleukin 2 receptor subunit alpha), STAT3 (signal transducer and activator of transcription 3), IL6 (interleukin 6), IL7R (interleukin 7 receptor), STAT5A (signal transducer and activator of transcription 5A), STAT5B (signal transducer and activator of transcription 5B), IL2RG (interleukin 2 receptor subunit gamma), FOXP3 (forkhead box P3), IL2RB (interleukin 2 receptor subunit beta), IL6R (interleukin 6 receptor), CD86 (CD86 molecule), IL6ST (interleukin 6 signal transducer), CD28 (CD28 molecule), CD80 (CD80 molecule)"], "WAG003200": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), KDR (kinase insert domain receptor), NRP1 (neuropilin 1), FURIN (furin, paired basic amino acid cleaving enzyme), ACE2 (angiotensin I converting enzyme 2)"], "WAG003202": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EP300 (E1A binding protein p300), CREBBP (CREB binding protein), PPARG (peroxisome proliferator activated receptor gamma), RXRA (retinoid X receptor alpha), NCOA1 (nuclear receptor coactivator 1), CEBPB (CCAAT enhancer binding protein beta), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), TNF (tumor necrosis factor), FABP4 (fatty acid binding protein 4), LPL (lipoprotein lipase), CEBPD (CCAAT enhancer binding protein delta), ADIPOQ (adiponectin, C1Q and collagen domain containing), IL1B (interleukin 1 beta), CD36 (CD36 molecule), RXRG (retinoid X receptor gamma), PTGS2 (prostaglandin-endoperoxide synthase 2), RXRB (retinoid X receptor beta), PCK1 (phosphoenolpyruvate carboxykinase 1), IL1A (interleukin 1 alpha), REL (REL proto-oncogene, NF-kB subunit), CEBPA (CCAAT enhancer binding protein alpha), PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial), PLIN2 (perilipin 2), CEBPG (CCAAT enhancer binding protein gamma)"], "WAG003203": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "LCK (LCK proto-oncogene, Src family tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), VAV1 (vav guanine nucleotide exchange factor 1), AKT1 (AKT serine/threonine kinase 1), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), GRB2 (growth factor receptor bound protein 2), PLCG1 (phospholipase C gamma 1), PRKCQ (protein kinase C theta), ITK (IL2 inducible T cell kinase), CD247 (CD247 molecule), LCP2 (lymphocyte cytosolic protein 2), TRAF6 (TNF receptor associated factor 6), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PTPN6 (protein tyrosine phosphatase non-receptor type 6), LAT (linker for activation of T cells), CD3D (CD3d molecule), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), NFKB1 (nuclear factor kappa B subunit 1), CD28 (CD28 molecule), CD3E (CD3e molecule), RELA (RELA proto-oncogene, NF-kB subunit), GRAP2 (GRB2 related adaptor protein 2), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), CD3G (CD3g molecule), NFKBIA (NFKB inhibitor alpha), CBLB (Cbl proto-oncogene B), CARD11 (caspase recruitment domain family member 11), CD8A (CD8a molecule), BCL10 (BCL10 immune signaling adaptor), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), MALT1 (MALT1 paracaspase), PDPK1 (3-phosphoinositide dependent protein kinase 1), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), TNFAIP3 (TNF alpha induced protein 3), SOCS1 (suppressor of cytokine signaling 1), REL (REL proto-oncogene, NF-kB subunit), CD5 (CD5 molecule), SH2D1A (SH2 domain containing 1A), SH2B3 (SH2B adaptor protein 3), RNF7 (ring finger protein 7), CUL5 (cullin 5), RASA2 (RAS p21 protein activator 2), GNA13 (G protein subunit alpha 13), DGKZ (diacylglycerol kinase zeta), SMARCB1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1), CDKN1B (cyclin dependent kinase inhibitor 1B), RHOH (ras homolog family member H), UBASH3A (ubiquitin associated and SH3 domain containing A), DGKA (diacylglycerol kinase alpha), ARIH2 (ariadne RBR E3 ubiquitin protein ligase 2), ZFP36L1 (ZFP36 ring finger protein like 1), PCBP2 (poly(rC) binding protein 2), MEF2D (myocyte enhancer factor 2D), NDUFB10 (NADH:ubiquinone oxidoreductase subunit B10), FIBP (FGF1 intracellular binding protein), RPRD1B (regulation of nuclear pre-mRNA domain containing 1B), TRA (T cell receptor alpha locus), ELOB (elongin B), TRB (T cell receptor beta locus), TMEM222 (transmembrane protein 222), AGO1 (argonaute RISC component 1)"], "WAG003204": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), CREBBP (CREB binding protein), EP300 (E1A binding protein p300), RELA (RELA proto-oncogene, NF-kB subunit), RXRA (retinoid X receptor alpha), NFKB1 (nuclear factor kappa B subunit 1), IL1B (interleukin 1 beta), PPARD (peroxisome proliferator activated receptor delta), LPL (lipoprotein lipase), IL1A (interleukin 1 alpha), PTGS2 (prostaglandin-endoperoxide synthase 2), NCOA1 (nuclear receptor coactivator 1), CPT1A (carnitine palmitoyltransferase 1A), MMP9 (matrix metallopeptidase 9), CCL2 (C-C motif chemokine ligand 2), REL (REL proto-oncogene, NF-kB subunit), RXRG (retinoid X receptor gamma), VCAM1 (vascular cell adhesion molecule 1), RXRB (retinoid X receptor beta), UCP1 (uncoupling protein 1), IL1RN (interleukin 1 receptor antagonist), PLIN2 (perilipin 2), BCL6 (BCL6 transcription repressor), UCP3 (uncoupling protein 3), UCP2 (uncoupling protein 2), PDK4 (pyruvate dehydrogenase kinase 4)"], "WAG003210": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), IL6 (interleukin 6), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), TNF (tumor necrosis factor), IFNG (interferon gamma), STAT1 (signal transducer and activator of transcription 1), AKT1 (AKT serine/threonine kinase 1), PRKCA (protein kinase C alpha), MAPK3 (mitogen-activated protein kinase 3), STAT3 (signal transducer and activator of transcription 3), JAK1 (Janus kinase 1), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), TGFB1 (transforming growth factor beta 1), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), NFKB1 (nuclear factor kappa B subunit 1), CAMK2B (calcium/calmodulin dependent protein kinase II beta), IL10 (interleukin 10), IL1B (interleukin 1 beta), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), IL4 (interleukin 4), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), SOCS3 (suppressor of cytokine signaling 3), CAMK2D (calcium/calmodulin dependent protein kinase II delta), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CREB1 (cAMP responsive element binding protein 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), BCL2 (BCL2 apoptosis regulator), IRS1 (insulin receptor substrate 1), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), IL12B (interleukin 12B), SMAD7 (SMAD family member 7), GRIK1 (glutamate ionotropic receptor kainate type subunit 1), FGF2 (fibroblast growth factor 2), SMAD4 (SMAD family member 4), IGF1 (insulin like growth factor 1), IL12A (interleukin 12A), IL13 (interleukin 13), SMAD2 (SMAD family member 2), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), PRKCB (protein kinase C beta), SMAD3 (SMAD family member 3), PPP1CA (protein phosphatase 1 catalytic subunit alpha), IL6R (interleukin 6 receptor), TNFRSF1A (TNF receptor superfamily member 1A), IL1A (interleukin 1 alpha), STAT6 (signal transducer and activator of transcription 6), PPP1CC (protein phosphatase 1 catalytic subunit gamma), TGFB2 (transforming growth factor beta 2), NGF (nerve growth factor), BDNF (brain derived neurotrophic factor), GRIA4 (glutamate ionotropic receptor AMPA type subunit 4), LIF (LIF interleukin 6 family cytokine), PLCB1 (phospholipase C beta 1), GRIN2D (glutamate ionotropic receptor NMDA type subunit 2D), IL4R (interleukin 4 receptor), GFAP (glial fibrillary acidic protein), IFNGR1 (interferon gamma receptor 1), TGFBR2 (transforming growth factor beta receptor 2), IL6ST (interleukin 6 signal transducer), PRKCG (protein kinase C gamma), INSR (insulin receptor), TGFBR1 (transforming growth factor beta receptor 1), IL1R1 (interleukin 1 receptor type 1), GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C), GRM1 (glutamate metabotropic receptor 1), GRIK3 (glutamate ionotropic receptor kainate type subunit 3), GRIK2 (glutamate ionotropic receptor kainate type subunit 2), IL10RA (interleukin 10 receptor subunit alpha), CNTF (ciliary neurotrophic factor), PPP1CB (protein phosphatase 1 catalytic subunit beta), TGFB3 (transforming growth factor beta 3), PLCB2 (phospholipase C beta 2), IFNGR2 (interferon gamma receptor 2), IL13RA1 (interleukin 13 receptor subunit alpha 1), PLCB4 (phospholipase C beta 4), PLCB3 (phospholipase C beta 3), IL10RB (interleukin 10 receptor subunit beta), GRIA3 (glutamate ionotropic receptor AMPA type subunit 3), TNFRSF1B (TNF receptor superfamily member 1B), GRIK5 (glutamate ionotropic receptor kainate type subunit 5), LTA (lymphotoxin alpha), GLUL (glutamate-ammonia ligase), NOS1 (nitric oxide synthase 1), TGFBR3 (transforming growth factor beta receptor 3), NFKB2 (nuclear factor kappa B subunit 2), SLC1A2 (solute carrier family 1 member 2), ADCY8 (adenylate cyclase 8), GRIK4 (glutamate ionotropic receptor kainate type subunit 4), GRM7 (glutamate metabotropic receptor 7), GRM5 (glutamate metabotropic receptor 5), SLC1A3 (solute carrier family 1 member 3), GRIN3A (glutamate ionotropic receptor NMDA type subunit 3A), CAMK4 (calcium/calmodulin dependent protein kinase IV), GRIN3B (glutamate ionotropic receptor NMDA type subunit 3B), ADCY3 (adenylate cyclase 3), GRM2 (glutamate metabotropic receptor 2), PHGDH (phosphoglycerate dehydrogenase), SLC1A1 (solute carrier family 1 member 1), GRM4 (glutamate metabotropic receptor 4), SLC2A1 (solute carrier family 2 member 1)"], "WAG003211": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PRKACA (protein kinase cAMP-activated catalytic subunit alpha), PRKACB (protein kinase cAMP-activated catalytic subunit beta), PRKACG (protein kinase cAMP-activated catalytic subunit gamma), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), DYNC1I2 (dynein cytoplasmic 1 intermediate chain 2), DYNC1I1 (dynein cytoplasmic 1 intermediate chain 1), DCTN2 (dynactin subunit 2), DCTN1 (dynactin subunit 1), DYNC1LI2 (dynein cytoplasmic 1 light intermediate chain 2), DYNC2LI1 (dynein cytoplasmic 2 light intermediate chain 1), DYNLL1 (dynein light chain LC8-type 1), DCTN4 (dynactin subunit 4), DYNC2H1 (dynein cytoplasmic 2 heavy chain 1), DCTN6 (dynactin subunit 6), DCTN5 (dynactin subunit 5), CREB1 (cAMP responsive element binding protein 1), CREB3 (cAMP responsive element binding protein 3), CREB3L3 (cAMP responsive element binding protein 3 like 3), AQP2 (aquaporin 2), CREB3L1 (cAMP responsive element binding protein 3 like 1), ADCY6 (adenylate cyclase 6), ADCY9 (adenylate cyclase 9), CREB3L4 (cAMP responsive element binding protein 3 like 4), DYNC1LI1 (dynein cytoplasmic 1 light intermediate chain 1), DYNLL2 (dynein light chain LC8-type 2), CREB3L2 (cAMP responsive element binding protein 3 like 2), ADCY3 (adenylate cyclase 3), GNAS (GNAS complex locus), STX4 (syntaxin 4), AVPR2 (arginine vasopressin receptor 2), VAMP2 (vesicle associated membrane protein 2), ARHGDIB (Rho GDP dissociation inhibitor beta), ARHGDIA (Rho GDP dissociation inhibitor alpha), RAB5A (RAB5A, member RAS oncogene family), AQP3 (aquaporin 3 (Gill blood group)), RAB11A (RAB11A, member RAS oncogene family), AVP (arginine vasopressin), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), CREB5 (cAMP responsive element binding protein 5), AQP4 (aquaporin 4), ARHGDIG (Rho GDP dissociation inhibitor gamma), RAB5C (RAB5C, member RAS oncogene family), RAB5B (RAB5B, member RAS oncogene family), RAB11B (RAB11B, member RAS oncogene family)"], "WAG003212": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), CTNNB1 (catenin beta 1), EGFR (epidermal growth factor receptor), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAPK1 (mitogen-activated protein kinase 1), TP53 (tumor protein p53), GRB2 (growth factor receptor bound protein 2), MYC (MYC proto-oncogene, bHLH transcription factor), VEGFA (vascular endothelial growth factor A), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK3 (mitogen-activated protein kinase 3), SHC1 (SHC adaptor protein 1), MAPK14 (mitogen-activated protein kinase 14), CCND1 (cyclin D1), HRAS (HRas proto-oncogene, GTPase), IGF1R (insulin like growth factor 1 receptor), FN1 (fibronectin 1), EGF (epidermal growth factor), IL6 (interleukin 6), MTOR (mechanistic target of rapamycin kinase), TGFB1 (transforming growth factor beta 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), IGF1 (insulin like growth factor 1), ITGB1 (integrin subunit beta 1), MAPK8 (mitogen-activated protein kinase 8), MDM2 (MDM2 proto-oncogene), GSK3B (glycogen synthase kinase 3 beta), FGF2 (fibroblast growth factor 2), PDGFRB (platelet derived growth factor receptor beta), MET (MET proto-oncogene, receptor tyrosine kinase), FGFR1 (fibroblast growth factor receptor 1), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), PDGFRA (platelet derived growth factor receptor alpha), CDKN1A (cyclin dependent kinase inhibitor 1A), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), SP1 (Sp1 transcription factor), STAT1 (signal transducer and activator of transcription 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), CD44 (CD44 molecule (Indian blood group)), ITGAV (integrin subunit alpha V), NFKB1 (nuclear factor kappa B subunit 1), PTEN (phosphatase and tensin homolog), PTK2 (protein tyrosine kinase 2), RPS6KB1 (ribosomal protein S6 kinase B1), MMP9 (matrix metallopeptidase 9), CREB1 (cAMP responsive element binding protein 1), FGFR2 (fibroblast growth factor receptor 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), BRCA1 (BRCA1 DNA repair associated), MAP2K1 (mitogen-activated protein kinase kinase 1), CDH1 (cadherin 1), KDR (kinase insert domain receptor), CTNNA1 (catenin alpha 1), ITGB4 (integrin subunit beta 4), WNT3A (Wnt family member 3A), HIF1A (hypoxia inducible factor 1 subunit alpha), BCL2 (BCL2 apoptosis regulator), FGF1 (fibroblast growth factor 1), HGF (hepatocyte growth factor), ITGA6 (integrin subunit alpha 6), ITGA4 (integrin subunit alpha 4), CSNK2A1 (casein kinase 2 alpha 1), IL1B (interleukin 1 beta), WNT1 (Wnt family member 1), MAX (MYC associated factor X), CDKN2A (cyclin dependent kinase inhibitor 2A), JAK1 (Janus kinase 1), FGFR3 (fibroblast growth factor receptor 3), E2F1 (E2F transcription factor 1), MMP2 (matrix metallopeptidase 2), NGF (nerve growth factor), DVL1 (dishevelled segment polarity protein 1), WNT5A (Wnt family member 5A), CDH2 (cadherin 2), PLAU (plasminogen activator, urokinase), ITGA1 (integrin subunit alpha 1), CDK2 (cyclin dependent kinase 2), FZD5 (frizzled class receptor 5), AXIN1 (axin 1), MAP2K4 (mitogen-activated protein kinase kinase 4), FZD1 (frizzled class receptor 1), TSC2 (TSC complex subunit 2), CDK4 (cyclin dependent kinase 4), FLT1 (fms related receptor tyrosine kinase 1), DVL2 (dishevelled segment polarity protein 2), SFRP1 (secreted frizzled related protein 1), PAK1 (p21 (RAC1) activated kinase 1), ATF2 (activating transcription factor 2), ITGA2 (integrin subunit alpha 2), CSF2 (colony stimulating factor 2), LRP6 (LDL receptor related protein 6), FZD2 (frizzled class receptor 2), TSC1 (TSC complex subunit 1), FZD6 (frizzled class receptor 6), FZD8 (frizzled class receptor 8), ACTG1 (actin gamma 1), APC (APC regulator of WNT signaling pathway)"], "WAG003213": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL1B (interleukin 1 beta), TNF (tumor necrosis factor), IL6 (interleukin 6), IFNG (interferon gamma), CCL2 (C-C motif chemokine ligand 2), TGFB1 (transforming growth factor beta 1), IL1A (interleukin 1 alpha), NFKB1 (nuclear factor kappa B subunit 1), MMP9 (matrix metallopeptidase 9), CXCL10 (C-X-C motif chemokine ligand 10), VEGFA (vascular endothelial growth factor A), CCL3 (C-C motif chemokine ligand 3), IL17A (interleukin 17A), CXCL1 (C-X-C motif chemokine ligand 1), CXCL9 (C-X-C motif chemokine ligand 9), CSF1 (colony stimulating factor 1), CCR2 (C-C motif chemokine receptor 2), CASP1 (caspase 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), IL12A (interleukin 12A), CD28 (CD28 molecule), PYCARD (PYD and CARD domain containing), NLRP3 (NLR family pyrin domain containing 3), PTGES (prostaglandin E synthase), AHR (aryl hydrocarbon receptor), PTGER2 (prostaglandin E receptor 2), IRF7 (interferon regulatory factor 7), PTGER4 (prostaglandin E receptor 4), IL17F (interleukin 17F), KLRD1 (killer cell lectin like receptor D1), CXCL8 (C-X-C motif chemokine ligand 8), AREG (amphiregulin), IFNA1 (interferon alpha 1)"], "WAG003215": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "C3 (complement C3), C4A (complement C4A (Rodgers blood group)), TGFB1 (transforming growth factor beta 1), CASP8 (caspase 8), C1R (complement C1r), CASP3 (caspase 3), C5 (complement C5), C4B (complement C4B (Chido blood group)), C2 (complement C2), MASP2 (mannan binding lectin serine peptidase 2), SERPING1 (serpin family G member 1), CASP9 (caspase 9), CASP7 (caspase 7), MASP1 (mannan binding lectin serine peptidase 1), C1S (complement C1s), CFI (complement factor I), C7 (complement C7), PRKCZ (protein kinase C zeta), APAF1 (apoptotic peptidase activating factor 1), C9 (complement C9), BAX (BCL2 associated X, apoptosis regulator), MBL2 (mannose binding lectin 2), CR1 (complement C3b/C4b receptor 1 (Knops blood group)), BID (BH3 interacting domain death agonist), CASP10 (caspase 10), CFB (complement factor B), CLU (clusterin), DIABLO (diablo IAP-binding mitochondrial protein), FASLG (Fas ligand), C1QA (complement C1q A chain), PARD6A (par-6 family cell polarity regulator alpha), CYCS (cytochrome c, somatic), PRKCI (protein kinase C iota), XIAP (X-linked inhibitor of apoptosis), C8A (complement C8 alpha chain), C1QB (complement C1q B chain), C6 (complement C6), GAS6 (growth arrest specific 6), CD55 (CD55 molecule (Cromer blood group)), CFP (complement factor properdin), ITGAV (integrin subunit alpha V), FAS (Fas cell surface death receptor), PARD6G (par-6 family cell polarity regulator gamma), PARD6B (par-6 family cell polarity regulator beta), CD46 (CD46 molecule), C4BPA (complement component 4 binding protein alpha), C8G (complement C8 gamma chain), CFD (complement factor D), C8B (complement C8 beta chain), PARD3 (par-3 family cell polarity regulator), ITGAM (integrin subunit alpha M), TGFB2 (transforming growth factor beta 2), C1QC (complement C1q C chain), IFNG (interferon gamma), C5AR1 (complement C5a receptor 1), C4BPB (complement component 4 binding protein beta), MARK2 (microtubule affinity regulating kinase 2), TGFB3 (transforming growth factor beta 3), CFH (complement factor H), PROS1 (protein S), ITGB2 (integrin subunit beta 2), C3AR1 (complement C3a receptor 1), CD59 (CD59 molecule (CD59 blood group)), VTN (vitronectin), FCN2 (ficolin 2), FCN1 (ficolin 1), CR2 (complement C3d receptor 2), LLGL2 (LLGL scribble cell polarity complex component 2), FCN3 (ficolin 3), MPP5 (membrane palmitoylated protein 5), ITGAX (integrin subunit alpha X), HTRA2 (HtrA serine peptidase 2), ITGB3 (integrin subunit beta 3), DEDD (death effector domain containing), MBP (myelin basic protein), TYRO3 (TYRO3 protein tyrosine kinase), CX3CL1 (C-X3-C motif chemokine ligand 1), AXL (AXL receptor tyrosine kinase), MERTK (MER proto-oncogene, tyrosine kinase), BAK1 (BCL2 antagonist/killer 1), MARK3 (microtubule affinity regulating kinase 3), CRB1 (crumbs cell polarity complex component 1), PLSCR1 (phospholipid scramblase 1), MFGE8 (milk fat globule EGF and factor V/VIII domain containing), COLEC11 (collectin subfamily member 11), CRB2 (crumbs cell polarity complex component 2), CX3CR1 (C-X3-C motif chemokine receptor 1), PLSCR4 (phospholipid scramblase 4), ATP8B2 (ATPase phospholipid transporting 8B2), ATP8B3 (ATPase phospholipid transporting 8B3), MARK1 (microtubule affinity regulating kinase 1), PLSCR3 (phospholipid scramblase 3), ATP8B1 (ATPase phospholipid transporting 8B1), CAP1 (cyclase associated actin cytoskeleton regulatory protein 1), COLEC10 (collectin subfamily member 10), ATP11A (ATPase phospholipid transporting 11A), SCRIB (scribble planar cell polarity protein), DLGAP5 (DLG associated protein 5), CSMD1 (CUB and Sushi multiple domains 1), COLEC12 (collectin subfamily member 12)"], "WAG003217": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), CCL5 (C-C motif chemokine ligand 5), IFNG (interferon gamma), CCL2 (C-C motif chemokine ligand 2), CCL4 (C-C motif chemokine ligand 4), CSF2 (colony stimulating factor 2), CCL3 (C-C motif chemokine ligand 3), KLRK1 (killer cell lectin like receptor K1), GZMB (granzyme B), PRF1 (perforin 1), PVR (PVR cell adhesion molecule), MYC (MYC proto-oncogene, bHLH transcription factor), CCL1 (C-C motif chemokine ligand 1), NCR1 (natural cytotoxicity triggering receptor 1), CD96 (CD96 molecule), CD226 (CD226 molecule), ADAM17 (ADAM metallopeptidase domain 17), TIGIT (T cell immunoreceptor with Ig and ITIM domains), BMI1 (BMI1 proto-oncogene, polycomb ring finger), FCGR3A (Fc fragment of IgG receptor IIIa), MICA (MHC class I polypeptide-related sequence A), MICB (MHC class I polypeptide-related sequence B), ADAM10 (ADAM metallopeptidase domain 10), FOXO1 (forkhead box O1), GATA2 (GATA binding protein 2), NCR3 (natural cytotoxicity triggering receptor 3), NCR3LG1 (natural killer cell cytotoxicity receptor 3 ligand 1), KLRC4-KLRK1 (KLRC4-KLRK1 readthrough)"], "WAG003218": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), GNAI2 (G protein subunit alpha i2), TNF (tumor necrosis factor), RELA (RELA proto-oncogene, NF-kB subunit), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), NOS2 (nitric oxide synthase 2), TLR4 (toll like receptor 4), PRKCE (protein kinase C epsilon), ADCY8 (adenylate cyclase 8), HDAC1 (histone deacetylase 1), ADCY1 (adenylate cyclase 1), HMOX1 (heme oxygenase 1), CACNA1B (calcium voltage-gated channel subunit alpha1 B), BDNF (brain derived neurotrophic factor), SQSTM1 (sequestosome 1), HSPA8 (heat shock protein family A (Hsp70) member 8), OPRL1 (opioid related nociceptin receptor 1), RGS4 (regulator of G protein signaling 4), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), GNA12 (G protein subunit alpha 12), MBP (myelin basic protein), JUP (junction plakoglobin), RPLP2 (ribosomal protein lateral stalk subunit P2), CAP1 (cyclase associated actin cytoskeleton regulatory protein 1), RGS9 (regulator of G protein signaling 9), TUBB (tubulin beta class I), E2F1 (E2F transcription factor 1), DNMT3A (DNA methyltransferase 3 alpha), CACNB2 (calcium voltage-gated channel auxiliary subunit beta 2), ARC (activity regulated cytoskeleton associated protein), PRKCG (protein kinase C gamma), HPCA (hippocalcin), NEU2 (neuraminidase 2), FTH1P3 (ferritin heavy chain 1 pseudogene 3), ALDH9A1 (aldehyde dehydrogenase 9 family member A1), SLC9A1 (solute carrier family 9 member A1), CCK (cholecystokinin), CELF2 (CUGBP Elav-like family member 2), PGM1 (phosphoglucomutase 1), GATA4 (GATA binding protein 4), PLEKHG1 (pleckstrin homology and RhoGEF domain containing G1)"], "WAG003219": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "VEGFA (vascular endothelial growth factor A), TNF (tumor necrosis factor), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL1B (interleukin 1 beta), IL6 (interleukin 6), MAPK1 (mitogen-activated protein kinase 1), MYC (MYC proto-oncogene, bHLH transcription factor), PRKCA (protein kinase C alpha), PPARG (peroxisome proliferator activated receptor gamma), LEP (leptin), VCAM1 (vascular cell adhesion molecule 1), MAPK3 (mitogen-activated protein kinase 3), RUNX2 (RUNX family transcription factor 2), HIF1A (hypoxia inducible factor 1 subunit alpha), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), EGR1 (early growth response 1), GNRH1 (gonadotropin releasing hormone 1), CDKN1A (cyclin dependent kinase inhibitor 1A), NR4A1 (nuclear receptor subfamily 4 group A member 1), ICAM1 (intercellular adhesion molecule 1), NOS3 (nitric oxide synthase 3), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), FOSB (FosB proto-oncogene, AP-1 transcription factor subunit), IL4 (interleukin 4), IL10 (interleukin 10), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), ALPP (alkaline phosphatase, placental), MMP3 (matrix metallopeptidase 3), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), SPP1 (secreted phosphoprotein 1), NFE2L2 (nuclear factor, erythroid 2 like 2), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), SRF (serum response factor), VHL (von Hippel-Lindau tumor suppressor), ADIPOQ (adiponectin, C1Q and collagen domain containing), HCRT (hypocretin neuropeptide precursor), CRH (corticotropin releasing hormone), HES1 (hes family bHLH transcription factor 1), MMP13 (matrix metallopeptidase 13), RARA (retinoic acid receptor alpha), LDLR (low density lipoprotein receptor), LIPE (lipase E, hormone sensitive type), SLC2A4 (solute carrier family 2 member 4), LPL (lipoprotein lipase), SELE (selectin E), BMP7 (bone morphogenetic protein 7), EGR3 (early growth response 3), GRIA1 (glutamate ionotropic receptor AMPA type subunit 1), KLF4 (Kruppel like factor 4), EGR2 (early growth response 2), HBEGF (heparin binding EGF like growth factor), RUNX1 (RUNX family transcription factor 1), CEBPA (CCAAT enhancer binding protein alpha), HMGA1 (high mobility group AT-hook 1), LDHA (lactate dehydrogenase A), IRF5 (interferon regulatory factor 5), FOSL2 (FOS like 2, AP-1 transcription factor subunit), BGLAP (bone gamma-carboxyglutamate protein), DUSP4 (dual specificity phosphatase 4), GRIA2 (glutamate ionotropic receptor AMPA type subunit 2), GADD45B (growth arrest and DNA damage inducible beta), HSPA5 (heat shock protein family A (Hsp70) member 5), ID1 (inhibitor of DNA binding 1, HLH protein), AVP (arginine vasopressin), CYP11A1 (cytochrome P450 family 11 subfamily A member 1), ID3 (inhibitor of DNA binding 3, HLH protein), HCRTR1 (hypocretin receptor 1), NPFFR1 (neuropeptide FF receptor 1), SLC2A1 (solute carrier family 2 member 1), SP7 (Sp7 transcription factor), STAR (steroidogenic acute regulatory protein), NOG (noggin), UCP1 (uncoupling protein 1), GRIN2A (glutamate ionotropic receptor NMDA type subunit 2A), MAFF (MAF bZIP transcription factor F), CXCL2 (C-X-C motif chemokine ligand 2), GH1 (growth hormone 1), CALCA (calcitonin related polypeptide alpha), HSD3B2 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2), RUNX1T1 (RUNX1 partner transcriptional co-repressor 1), NR4A3 (nuclear receptor subfamily 4 group A member 3), ID4 (inhibitor of DNA binding 4, HLH protein), BMPR1A (bone morphogenetic protein receptor type 1A), CYP11B1 (cytochrome P450 family 11 subfamily B member 1), SGK1 (serum/glucocorticoid regulated kinase 1), HOMER1 (homer scaffold protein 1), CYP11B2 (cytochrome P450 family 11 subfamily B member 2), PDK1 (pyruvate dehydrogenase kinase 1), PDHB (pyruvate dehydrogenase E1 subunit beta), PLD1 (phospholipase D1), PAPPA (pappalysin 1), FLT4 (fms related receptor tyrosine kinase 4), IL9 (interleukin 9), KLF10 (Kruppel like factor 10), TNC (tenascin C), CYP21A2 (cytochrome P450 family 21 subfamily A member 2), LHB (luteinizing hormone subunit beta), FSHB (follicle stimulating hormone subunit beta), TFAM (transcription factor A, mitochondrial), DCLK1 (doublecortin like kinase 1)"], "WAG003221": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "BRCA1 (BRCA1 DNA repair associated), RAD51 (RAD51 recombinase), RAD50 (RAD50 double strand break repair protein), BARD1 (BRCA1 associated RING domain 1), ATM (ATM serine/threonine kinase), BRCA2 (BRCA2 DNA repair associated), BLM (BLM RecQ like helicase), RPA1 (replication protein A1), TOPBP1 (DNA topoisomerase II binding protein 1), RBBP8 (RB binding protein 8, endonuclease), UIMC1 (ubiquitin interaction motif containing 1), POLD1 (DNA polymerase delta 1, catalytic subunit), TOP3A (DNA topoisomerase III alpha), BRIP1 (BRCA1 interacting protein C-terminal helicase 1), NBN (nibrin), RAD52 (RAD52 homolog, DNA repair protein), RAD54L (RAD54 like), MUS81 (MUS81 structure-specific endonuclease subunit), BRCC3 (BRCA1/BRCA2-containing complex subunit 3), PALB2 (partner and localizer of BRCA2), BABAM1 (BRISC and BRCA1 A complex member 1), SSB (small RNA binding exonuclease protection factor La), EME1 (essential meiotic structure-specific endonuclease 1), SYCP3 (synaptonemal complex protein 3), BABAM2 (BRISC and BRCA1 A complex member 2), ABRAXAS1 (abraxas 1, BRCA1 A complex subunit), SEM1 (SEM1 26S proteasome complex subunit), MRE11 (MRE11 homolog, double strand break repair nuclease)"], "WAG003223": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), LCK (LCK proto-oncogene, Src family tyrosine kinase), IL2 (interleukin 2), NFKB1 (nuclear factor kappa B subunit 1), JAK2 (Janus kinase 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), RELA (RELA proto-oncogene, NF-kB subunit), IFNG (interferon gamma), TNF (tumor necrosis factor), MAPK1 (mitogen-activated protein kinase 1), CD4 (CD4 molecule), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), FYN (FYN proto-oncogene, Src family tyrosine kinase), PRKCQ (protein kinase C theta), CD3E (CD3e molecule), MAPK3 (mitogen-activated protein kinase 3), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), GRB2 (growth factor receptor bound protein 2), NFKBIA (NFKB inhibitor alpha), TYK2 (tyrosine kinase 2), PLCG1 (phospholipase C gamma 1), MTOR (mechanistic target of rapamycin kinase), CD28 (CD28 molecule), HRAS (HRas proto-oncogene, GTPase), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), CD86 (CD86 molecule), TP53 (tumor protein p53), CD247 (CD247 molecule), IL4 (interleukin 4), CCND1 (cyclin D1), CD3D (CD3d molecule), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), CD3G (CD3g molecule), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IL12B (interleukin 12B), IL12RB1 (interleukin 12 receptor subunit beta 1), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), IL23A (interleukin 23 subunit alpha), CD80 (CD80 molecule), PTEN (phosphatase and tensin homolog), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), GRAP2 (GRB2 related adaptor protein 2), STAT4 (signal transducer and activator of transcription 4), LCP2 (lymphocyte cytosolic protein 2), GSK3B (glycogen synthase kinase 3 beta), CTLA4 (cytotoxic T-lymphocyte associated protein 4), TSC2 (TSC complex subunit 2), LAT (linker for activation of T cells), MAP2K1 (mitogen-activated protein kinase kinase 1), IL23R (interleukin 23 receptor), IL12A (interleukin 12A), BCL2L1 (BCL2 like 1), BCL10 (BCL10 immune signaling adaptor), CDKN1A (cyclin dependent kinase inhibitor 1A), TSC1 (TSC complex subunit 1), IL12RB2 (interleukin 12 receptor subunit beta 2), CARD11 (caspase recruitment domain family member 11), PDPK1 (3-phosphoinositide dependent protein kinase 1), IFNB1 (interferon beta 1), BAX (BCL2 associated X, apoptosis regulator), MALT1 (MALT1 paracaspase), NFATC1 (nuclear factor of activated T cells 1), IL17A (interleukin 17A), RHEB (Ras homolog, mTORC1 binding), IFNAR1 (interferon alpha and beta receptor subunit 1), RPTOR (regulatory associated protein of MTOR complex 1), MLST8 (MTOR associated protein, LST8 homolog), MYD88 (MYD88 innate immune signal transduction adaptor), HLA-DRA (major histocompatibility complex, class II, DR alpha), RICTOR (RPTOR independent companion of MTOR complex 2), DEPTOR (DEP domain containing MTOR interacting protein), CDKN2A (cyclin dependent kinase inhibitor 2A), MAP2K2 (mitogen-activated protein kinase kinase 2), FOXO3 (forkhead box O3), IFNAR2 (interferon alpha and beta receptor subunit 2), IL18R1 (interleukin 18 receptor 1), RASGRP1 (RAS guanyl releasing protein 1), ICOS (inducible T cell costimulator), LTA (lymphotoxin alpha), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), PPP3CC (protein phosphatase 3 catalytic subunit gamma), CCL19 (C-C motif chemokine ligand 19), IRF2BPL (interferon regulatory factor 2 binding protein like), CCL28 (C-C motif chemokine ligand 28)"], "WAG003224": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), EGFR (epidermal growth factor receptor), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PDGFRB (platelet derived growth factor receptor beta), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CDC42 (cell division cycle 42), MAPK1 (mitogen-activated protein kinase 1), FGFR1 (fibroblast growth factor receptor 1), FGFR2 (fibroblast growth factor receptor 2), RAC2 (Rac family small GTPase 2), PTK2 (protein tyrosine kinase 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), RHOA (ras homolog family member A), PDGFRA (platelet derived growth factor receptor alpha), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), RAC3 (Rac family small GTPase 3), MAPK3 (mitogen-activated protein kinase 3), PXN (paxillin), ACTB (actin beta), CRK (CRK proto-oncogene, adaptor protein), FN1 (fibronectin 1), FGFR3 (fibroblast growth factor receptor 3), EGF (epidermal growth factor), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), VAV1 (vav guanine nucleotide exchange factor 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), FGFR4 (fibroblast growth factor receptor 4), NRAS (NRAS proto-oncogene, GTPase), PIP5K1C (phosphatidylinositol-4-phosphate 5-kinase type 1 gamma), PAK1 (p21 (RAC1) activated kinase 1), ROCK2 (Rho associated coiled-coil containing protein kinase 2), MAP2K1 (mitogen-activated protein kinase kinase 1), ACTG1 (actin gamma 1), FGF1 (fibroblast growth factor 1), VCL (vinculin), CSK (C-terminal Src kinase), PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta), EZR (ezrin), PAK2 (p21 (RAC1) activated kinase 2), KRAS (KRAS proto-oncogene, GTPase), IQGAP1 (IQ motif containing GTPase activating protein 1), PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha), ACTN1 (actinin alpha 1), GSN (gelsolin), FGF6 (fibroblast growth factor 6), GNG12 (G protein subunit gamma 12), FGF7 (fibroblast growth factor 7), ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6), FGF9 (fibroblast growth factor 9), ROCK1 (Rho associated coiled-coil containing protein kinase 1), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), FGF4 (fibroblast growth factor 4), WAS (WASP actin nucleation promoting factor), BCAR1 (BCAR1 scaffold protein, Cas family member), FGF10 (fibroblast growth factor 10), PAK4 (p21 (RAC1) activated kinase 4), ARHGEF7 (Rho guanine nucleotide exchange factor 7), ARHGEF1 (Rho guanine nucleotide exchange factor 1), PDGFB (platelet derived growth factor subunit B), FGF18 (fibroblast growth factor 18), WASF1 (WASP family member 1), FGF23 (fibroblast growth factor 23), WASF2 (WASP family member 2), PAK3 (p21 (RAC1) activated kinase 3), FGF20 (fibroblast growth factor 20), FGF19 (fibroblast growth factor 19), RRAS (RAS related), FGF16 (fibroblast growth factor 16), FGF3 (fibroblast growth factor 3), PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha), LIMK1 (LIM domain kinase 1), BAIAP2 (BAR/IMD domain containing adaptor protein 2), F2R (coagulation factor II thrombin receptor), ITGA1 (integrin subunit alpha 1), FGF2 (fibroblast growth factor 2), PIP4K2B (phosphatidylinositol-5-phosphate 4-kinase type 2 beta), GNA13 (G protein subunit alpha 13), PFN1 (profilin 1), MAP2K2 (mitogen-activated protein kinase kinase 2), MSN (moesin), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PIP4K2C (phosphatidylinositol-5-phosphate 4-kinase type 2 gamma), FGF8 (fibroblast growth factor 8), CFL1 (cofilin 1), DIAPH1 (diaphanous related formin 1), MRAS (muscle RAS oncogene homolog), ABI2 (abl interactor 2), RRAS2 (RAS related 2), FGF5 (fibroblast growth factor 5), FGF22 (fibroblast growth factor 22), GIT1 (GIT ArfGAP 1), MYLK (myosin light chain kinase), PIP5KL1 (phosphatidylinositol-4-phosphate 5-kinase like 1), NCKAP1 (NCK associated protein 1), CYFIP2 (cytoplasmic FMR1 interacting protein 2), PAK6 (p21 (RAC1) activated kinase 6)"], "WAG003228": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PARP1 (poly(ADP-ribose) polymerase 1), LMNA (lamin A/C), TGFB1 (transforming growth factor beta 1), SMAD2 (SMAD family member 2), SMAD3 (SMAD family member 3), BANF1 (BAF nuclear assembly factor 1), SMAD4 (SMAD family member 4), LMNB2 (lamin B2), POLD1 (DNA polymerase delta 1, catalytic subunit), WRN (WRN RecQ like helicase), LMNB1 (lamin B1), RECQL (RecQ like helicase), PPARG (peroxisome proliferator activated receptor gamma), ZMPSTE24 (zinc metallopeptidase STE24), FNTA (farnesyltransferase, CAAX box, alpha), ICMT (isoprenylcysteine carboxyl methyltransferase), FBN1 (fibrillin 1), INS (insulin), MUCL3 (mucin like 3), FFAR3 (free fatty acid receptor 3), SPRTN (SprT-like N-terminal domain), KCNJ6 (potassium inwardly rectifying channel subfamily J member 6)"], "WAG003233": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APOE (apolipoprotein E), APOA1 (apolipoprotein A1), LPL (lipoprotein lipase), LIPC (lipase C, hepatic type), APOA2 (apolipoprotein A2), CETP (cholesteryl ester transfer protein), LCAT (lecithin-cholesterol acyltransferase), LDLR (low density lipoprotein receptor), SCARB1 (scavenger receptor class B member 1), PLTP (phospholipid transfer protein), LRP1 (LDL receptor related protein 1), VLDLR (very low density lipoprotein receptor), APOA4 (apolipoprotein A4)"], "WAG003236": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), IL1B (interleukin 1 beta), NFKBIA (NFKB inhibitor alpha), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IL6 (interleukin 6), CCL2 (C-C motif chemokine ligand 2), KEAP1 (kelch like ECH associated protein 1), HMOX1 (heme oxygenase 1), NFE2L2 (nuclear factor, erythroid 2 like 2), MMP1 (matrix metallopeptidase 1), IRF3 (interferon regulatory factor 3), NQO1 (NAD(P)H quinone dehydrogenase 1), GCLC (glutamate-cysteine ligase catalytic subunit), MMP3 (matrix metallopeptidase 3), RXRA (retinoid X receptor alpha), GCLM (glutamate-cysteine ligase modifier subunit), IL12A (interleukin 12A), GSTA2 (glutathione S-transferase alpha 2), GUCY1A2 (guanylate cyclase 1 soluble subunit alpha 2), NOX1 (NADPH oxidase 1), PRKG2 (protein kinase cGMP-dependent 2), GUCY1B2 (guanylate cyclase 1 soluble subunit beta 2 (pseudogene)), ACE2 (angiotensin I converting enzyme 2), CXCL8 (C-X-C motif chemokine ligand 8), GUCY1B1 (guanylate cyclase 1 soluble subunit beta 1), GUCY1A1 (guanylate cyclase 1 soluble subunit alpha 1), TMPRSS2 (transmembrane serine protease 2), SLC7A11 (solute carrier family 7 member 11)"], "WAG003237": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PCNA (proliferating cell nuclear antigen), RPA1 (replication protein A1), POLD1 (DNA polymerase delta 1, catalytic subunit), DDB1 (damage specific DNA binding protein 1), ERCC8 (ERCC excision repair 8, CSA ubiquitin ligase complex subunit), RPA2 (replication protein A2), RPA3 (replication protein A3), ERCC1 (ERCC excision repair 1, endonuclease non-catalytic subunit), CDK7 (cyclin dependent kinase 7), ERCC6 (ERCC excision repair 6, chromatin remodeling factor), ERCC2 (ERCC excision repair 2, TFIIH core complex helicase subunit), POLE (DNA polymerase epsilon, catalytic subunit), GTF2H1 (general transcription factor IIH subunit 1), XPC (XPC complex subunit, DNA damage recognition and repair factor), ERCC3 (ERCC excision repair 3, TFIIH core complex helicase subunit), DDB2 (damage specific DNA binding protein 2), RAD23B (RAD23 homolog B, nucleotide excision repair protein), MNAT1 (MNAT1 component of CDK activating kinase), CCNH (cyclin H), RFC5 (replication factor C subunit 5), XPA (XPA, DNA damage recognition and repair factor), GTF2H3 (general transcription factor IIH subunit 3), RFC2 (replication factor C subunit 2), GTF2H4 (general transcription factor IIH subunit 4), GTF2H2 (general transcription factor IIH subunit 2), POLD2 (DNA polymerase delta 2, accessory subunit), RFC4 (replication factor C subunit 4), RFC1 (replication factor C subunit 1), POLD4 (DNA polymerase delta 4, accessory subunit), RFC3 (replication factor C subunit 3), POLE2 (DNA polymerase epsilon 2, accessory subunit), POLD3 (DNA polymerase delta 3, accessory subunit), ERCC4 (ERCC excision repair 4, endonuclease catalytic subunit), BRCA1 (BRCA1 DNA repair associated), PARP1 (poly(ADP-ribose) polymerase 1), LIG1 (DNA ligase 1), XRCC1 (X-ray repair cross complementing 1), XAB2 (XPA binding protein 2), RAD18 (RAD18 E3 ubiquitin protein ligase), CUL4A (cullin 4A), POLE3 (DNA polymerase epsilon 3, accessory subunit), CUL4B (cullin 4B), POLH (DNA polymerase eta), GTF2H5 (general transcription factor IIH subunit 5), LIG3 (DNA ligase 3), RBX1 (ring-box 1), RAD23A (RAD23 homolog A, nucleotide excision repair protein), CETN2 (centrin 2), CHD1L (chromodomain helicase DNA binding protein 1 like), POLE4 (DNA polymerase epsilon 4, accessory subunit), GPS1 (G protein pathway suppressor 1), POLK (DNA polymerase kappa), UVSSA (UV stimulated scaffold protein A), USP7 (ubiquitin specific peptidase 7), HMGN1 (high mobility group nucleosome binding domain 1), SLX4 (SLX4 structure-specific endonuclease subunit), H4C4 (H4 clustered histone 4), H4C5 (H4 clustered histone 5), H4C6 (H4 clustered histone 6), H4C15 (H4 clustered histone 15), SLX4IP (SLX4 interacting protein), H4-16 (H4 histone 16), H2AC6 (H2A clustered histone 6), H3-3A (H3.3 histone A), H4C13 (H4 clustered histone 13), H4C8 (H4 clustered histone 8), H3-3B (H3.3 histone B), H4C3 (H4 clustered histone 3), H4C2 (H4 clustered histone 2), H4C12 (H4 clustered histone 12), H4C9 (H4 clustered histone 9), H4C14 (H4 clustered histone 14), H4C11 (H4 clustered histone 11), H4C1 (H4 clustered histone 1), PGBD3 (piggyBac transposable element derived 3)"], "WAG003238": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TNF (tumor necrosis factor), IL6 (interleukin 6), CD4 (CD4 molecule), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), AKT1 (AKT serine/threonine kinase 1), CCR5 (C-C motif chemokine receptor 5), IFNG (interferon gamma), FN1 (fibronectin 1), STAT1 (signal transducer and activator of transcription 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), IL1B (interleukin 1 beta), CCL2 (C-C motif chemokine ligand 2), ALB (albumin), CXCL10 (C-X-C motif chemokine ligand 10), TRAF6 (TNF receptor associated factor 6), JAK2 (Janus kinase 2), IL4 (interleukin 4), CXCL12 (C-X-C motif chemokine ligand 12), FYN (FYN proto-oncogene, Src family tyrosine kinase), CCL5 (C-C motif chemokine ligand 5), CCR6 (C-C motif chemokine receptor 6), CXCR2 (C-X-C motif chemokine receptor 2), IL18 (interleukin 18), IL10 (interleukin 10), CXCL9 (C-X-C motif chemokine ligand 9), CCL4 (C-C motif chemokine ligand 4), LCK (LCK proto-oncogene, Src family tyrosine kinase), CXCR1 (C-X-C motif chemokine receptor 1), CCL3 (C-C motif chemokine ligand 3), CASP8 (caspase 8), PTGS2 (prostaglandin-endoperoxide synthase 2), MAPK8 (mitogen-activated protein kinase 8), CASP3 (caspase 3), CXCL1 (C-X-C motif chemokine ligand 1), CCL20 (C-C motif chemokine ligand 20), MTOR (mechanistic target of rapamycin kinase), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), PTPN6 (protein tyrosine phosphatase non-receptor type 6), IRF3 (interferon regulatory factor 3), IL1A (interleukin 1 alpha), IL13 (interleukin 13), EGR1 (early growth response 1), FGF2 (fibroblast growth factor 2), MYD88 (MYD88 innate immune signal transduction adaptor), IRF9 (interferon regulatory factor 9), APOA1 (apolipoprotein A1), RAC1 (Rac family small GTPase 1), CXCL2 (C-X-C motif chemokine ligand 2), HSPA8 (heat shock protein family A (Hsp70) member 8), PRKCQ (protein kinase C theta), CCL21 (C-C motif chemokine ligand 21), CRP (C-reactive protein), IFNB1 (interferon beta 1), CD3E (CD3e molecule), CXCL13 (C-X-C motif chemokine ligand 13), CD8A (CD8a molecule), TRAF2 (TNF receptor associated factor 2), HIF1A (hypoxia inducible factor 1 subunit alpha), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), CXCL5 (C-X-C motif chemokine ligand 5), JAK1 (Janus kinase 1), IL5 (interleukin 5), CCL11 (C-C motif chemokine ligand 11), CD3G (CD3g molecule), CD247 (CD247 molecule), RPTOR (regulatory associated protein of MTOR complex 1), DDX58 (DExD/H-box helicase 58), IL17A (interleukin 17A), CXCL16 (C-X-C motif chemokine ligand 16), CXCL3 (C-X-C motif chemokine ligand 3), CCL22 (C-C motif chemokine ligand 22), IL7 (interleukin 7), CXCL6 (C-X-C motif chemokine ligand 6), TF (transferrin), CDK1 (cyclin dependent kinase 1), MX1 (MX dynamin like GTPase 1), BIRC5 (baculoviral IAP repeat containing 5), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), PF4 (platelet factor 4), OAS2 (2'-5'-oligoadenylate synthetase 2), IFIT1 (interferon induced protein with tetratricopeptide repeats 1), TBK1 (TANK binding kinase 1), ACTB (actin beta), IRAK1 (interleukin 1 receptor associated kinase 1), MAVS (mitochondrial antiviral signaling protein), FGA (fibrinogen alpha chain), CCL8 (C-C motif chemokine ligand 8), CD14 (CD14 molecule), SERPINE1 (serpin family E member 1), AGT (angiotensinogen), HLA-DRB5 (major histocompatibility complex, class II, DR beta 5), NFKB2 (nuclear factor kappa B subunit 2), CD2 (CD2 molecule), CCL1 (C-C motif chemokine ligand 1), ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4), TRAF3 (TNF receptor associated factor 3), IL16 (interleukin 16), IL12A (interleukin 12A), APOH (apolipoprotein H), IFI6 (interferon alpha inducible protein 6)"], "WAG003240": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMC3 (structural maintenance of chromosomes 3), REC8 (REC8 meiotic recombination protein), RAD21 (RAD21 cohesin complex component), PLK1 (polo like kinase 1), SMC1A (structural maintenance of chromosomes 1A), PPP2R1A (protein phosphatase 2 scaffold subunit Aalpha), PPP2CA (protein phosphatase 2 catalytic subunit alpha), ESPL1 (extra spindle pole bodies like 1, separase), PPP2R5D (protein phosphatase 2 regulatory subunit B'delta), CDCA5 (cell division cycle associated 5), STAG2 (stromal antigen 2), PPP2R1B (protein phosphatase 2 scaffold subunit Abeta), PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha), PDS5A (PDS5 cohesin associated factor A), PPP2CB (protein phosphatase 2 catalytic subunit beta), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), PPP2R5B (protein phosphatase 2 regulatory subunit B'beta), PPP2R5E (protein phosphatase 2 regulatory subunit B'epsilon), AURKB (aurora kinase B), NIPBL (NIPBL cohesin loading factor), CDK1 (cyclin dependent kinase 1), PDS5B (PDS5 cohesin associated factor B), ESCO2 (establishment of sister chromatid cohesion N-acetyltransferase 2), ESCO1 (establishment of sister chromatid cohesion N-acetyltransferase 1), PTTG1 (PTTG1 regulator of sister chromatid separation, securin), STAG3 (stromal antigen 3), APC (APC regulator of WNT signaling pathway), HDAC8 (histone deacetylase 8), SMC1B (structural maintenance of chromosomes 1B), MAU2 (MAU2 sister chromatid cohesion factor), SGO1 (shugoshin 1), PTPA (protein phosphatase 2 phosphatase activator), SGO2 (shugoshin 2), WAPL (WAPL cohesin release factor)"], "WAG003243": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APP (amyloid beta precursor protein), PSEN1 (presenilin 1), NCSTN (nicastrin), PSENEN (presenilin enhancer, gamma-secretase subunit), PSEN2 (presenilin 2), BACE1 (beta-secretase 1), MAPT (microtubule associated protein tau), NFKB1 (nuclear factor kappa B subunit 1), NFKB2 (nuclear factor kappa B subunit 2), SIRT1 (sirtuin 1), MSTN (myostatin)"], "WAG003244": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), SGPP1 (sphingosine-1-phosphate phosphatase 1), ASAH1 (N-acylsphingosine amidohydrolase 1), RB1 (RB transcriptional corepressor 1), SPHK1 (sphingosine kinase 1), UGCG (UDP-glucose ceramide glucosyltransferase), GBA (glucosylceramidase beta), PRKCA (protein kinase C alpha), E2F1 (E2F transcription factor 1), SGMS2 (sphingomyelin synthase 2), DEGS1 (delta 4-desaturase, sphingolipid 1), SMPD3 (sphingomyelin phosphodiesterase 3), CDKN1A (cyclin dependent kinase inhibitor 1A), CDK2 (cyclin dependent kinase 2), PRKCB (protein kinase C beta), CDK4 (cyclin dependent kinase 4), TERT (telomerase reverse transcriptase), S1PR1 (sphingosine-1-phosphate receptor 1), S1PR2 (sphingosine-1-phosphate receptor 2), KDSR (3-ketodihydrosphingosine reductase), MTOR (mechanistic target of rapamycin kinase), S1PR5 (sphingosine-1-phosphate receptor 5), PLCB1 (phospholipase C beta 1), GLB1 (galactosidase beta 1), SPTLC1 (serine palmitoyltransferase long chain base subunit 1), CERS2 (ceramide synthase 2), RPP38 (ribonuclease P/MRP subunit p38), CERS4 (ceramide synthase 4)"], "WAG003245": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTGS2 (prostaglandin-endoperoxide synthase 2), PTGS1 (prostaglandin-endoperoxide synthase 1), ALOX5 (arachidonate 5-lipoxygenase), PLA2G4A (phospholipase A2 group IVA), PTGER1 (prostaglandin E receptor 1), PTGDS (prostaglandin D2 synthase), PTGES (prostaglandin E synthase), GNAQ (G protein subunit alpha q), GNAI1 (G protein subunit alpha i1), ALOX12 (arachidonate 12-lipoxygenase, 12S type), ALOX15B (arachidonate 15-lipoxygenase type B), ALOX15 (arachidonate 15-lipoxygenase), GNAS (GNAS complex locus), PTGER4 (prostaglandin E receptor 4), TBXAS1 (thromboxane A synthase 1), PTGIS (prostaglandin I2 synthase), CYSLTR1 (cysteinyl leukotriene receptor 1), HRAS (HRas proto-oncogene, GTPase), LTC4S (leukotriene C4 synthase), CDKN1A (cyclin dependent kinase inhibitor 1A), PTGER2 (prostaglandin E receptor 2), PTGER3 (prostaglandin E receptor 3), PLCB1 (phospholipase C beta 1), ALOX5AP (arachidonate 5-lipoxygenase activating protein), MAPK11 (mitogen-activated protein kinase 11), LTA4H (leukotriene A4 hydrolase), SIRT1 (sirtuin 1), RB1 (RB transcriptional corepressor 1), ADCY3 (adenylate cyclase 3), PRXL2B (peroxiredoxin like 2B), IGFBP5 (insulin like growth factor binding protein 5)"], "WAG003247": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "APP (amyloid beta precursor protein), CALM3 (calmodulin 3), AKT1 (AKT serine/threonine kinase 1), CTNNB1 (catenin beta 1), AXIN1 (axin 1), MAPK1 (mitogen-activated protein kinase 1), GSK3B (glycogen synthase kinase 3 beta), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PSMD14 (proteasome 26S subunit, non-ATPase 14), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMD2 (proteasome 26S subunit, non-ATPase 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PSMC5 (proteasome 26S subunit, ATPase 5), PSMA3 (proteasome 20S subunit alpha 3), PSMC1 (proteasome 26S subunit, ATPase 1), PSMC6 (proteasome 26S subunit, ATPase 6), PSMC2 (proteasome 26S subunit, ATPase 2), PSMC3 (proteasome 26S subunit, ATPase 3), TNF (tumor necrosis factor), PSMA5 (proteasome 20S subunit alpha 5), PSMC4 (proteasome 26S subunit, ATPase 4), PSMD1 (proteasome 26S subunit, non-ATPase 1), PSMA7 (proteasome 20S subunit alpha 7), PSMD6 (proteasome 26S subunit, non-ATPase 6), PSMA6 (proteasome 20S subunit alpha 6), PSMA4 (proteasome 20S subunit alpha 4), PSMB4 (proteasome 20S subunit beta 4), PSMD12 (proteasome 26S subunit, non-ATPase 12), PSMD8 (proteasome 26S subunit, non-ATPase 8), PSMA1 (proteasome 20S subunit alpha 1), MAPK3 (mitogen-activated protein kinase 3), PSMD7 (proteasome 26S subunit, non-ATPase 7), PSMD3 (proteasome 26S subunit, non-ATPase 3), PSMB1 (proteasome 20S subunit beta 1), PSMD13 (proteasome 26S subunit, non-ATPase 13), MAPK8 (mitogen-activated protein kinase 8), PSMB5 (proteasome 20S subunit beta 5), PSMA2 (proteasome 20S subunit alpha 2), SNCA (synuclein alpha), PSMB2 (proteasome 20S subunit beta 2), PSMD9 (proteasome 26S subunit, non-ATPase 9), PSMB6 (proteasome 20S subunit beta 6), PSMB7 (proteasome 20S subunit beta 7), PSMA8 (proteasome 20S subunit alpha 8), PSMB3 (proteasome 20S subunit beta 3), WNT3A (Wnt family member 3A), FZD5 (frizzled class receptor 5), NFKB1 (nuclear factor kappa B subunit 1), PLCB1 (phospholipase C beta 1), IRS1 (insulin receptor substrate 1), FZD1 (frizzled class receptor 1), ADRM1 (adhesion regulating molecule 1), TNFRSF1A (TNF receptor superfamily member 1A), CASP3 (caspase 3), FZD2 (frizzled class receptor 2), HRAS (HRas proto-oncogene, GTPase), DVL1 (dishevelled segment polarity protein 1), MTOR (mechanistic target of rapamycin kinase), PLCB2 (phospholipase C beta 2), FZD8 (frizzled class receptor 8), RELA (RELA proto-oncogene, NF-kB subunit), PLCB4 (phospholipase C beta 4), DVL2 (dishevelled segment polarity protein 2), CASP8 (caspase 8), PLCB3 (phospholipase C beta 3), FZD7 (frizzled class receptor 7), FZD6 (frizzled class receptor 6), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAP3K5 (mitogen-activated protein kinase kinase kinase 5), FZD10 (frizzled class receptor 10), LRP6 (LDL receptor related protein 6), WNT5A (Wnt family member 5A), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), DVL3 (dishevelled segment polarity protein 3), FZD9 (frizzled class receptor 9), GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B), TRAF2 (TNF receptor associated factor 2), PSEN1 (presenilin 1), NOS2 (nitric oxide synthase 2), WNT1 (Wnt family member 1), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), IRS2 (insulin receptor substrate 2), IDE (insulin degrading enzyme), CSNK2A1 (casein kinase 2 alpha 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), AKT2 (AKT serine/threonine kinase 2), SFRP4 (secreted frizzled related protein 4), WNT7B (Wnt family member 7B), CASP9 (caspase 9), FZD3 (frizzled class receptor 3), PTGS2 (prostaglandin-endoperoxide synthase 2), APC (APC regulator of WNT signaling pathway), CYCS (cytochrome c, somatic), WNT2B (Wnt family member 2B), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3)"], "WAG003248": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT3 (signal transducer and activator of transcription 3), IL2 (interleukin 2), STAT1 (signal transducer and activator of transcription 1), IFNG (interferon gamma), JAK2 (Janus kinase 2), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), CD4 (CD4 molecule), TYK2 (tyrosine kinase 2), IL6 (interleukin 6), NFKB1 (nuclear factor kappa B subunit 1), IL4 (interleukin 4), IL2RA (interleukin 2 receptor subunit alpha), MAPK1 (mitogen-activated protein kinase 1), JAK1 (Janus kinase 1), MAPK14 (mitogen-activated protein kinase 14), LCK (LCK proto-oncogene, Src family tyrosine kinase), TGFB1 (transforming growth factor beta 1), FOXP3 (forkhead box P3), IL23A (interleukin 23 subunit alpha), IL1B (interleukin 1 beta), HSP90AA1 (heat shock protein 90 alpha family class A member 1), CD3E (CD3e molecule), STAT5A (signal transducer and activator of transcription 5A), IL23R (interleukin 23 receptor), STAT6 (signal transducer and activator of transcription 6), NFKBIA (NFKB inhibitor alpha), IL17A (interleukin 17A), MAPK8 (mitogen-activated protein kinase 8), CD247 (CD247 molecule), RXRA (retinoid X receptor alpha), CD3D (CD3d molecule), HIF1A (hypoxia inducible factor 1 subunit alpha), IL4R (interleukin 4 receptor), CD3G (CD3g molecule), PRKCQ (protein kinase C theta), PLCG1 (phospholipase C gamma 1), ARNTL (aryl hydrocarbon receptor nuclear translocator like), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), MTOR (mechanistic target of rapamycin kinase), RORC (RAR related orphan receptor C), NFATC1 (nuclear factor of activated T cells 1), RARA (retinoic acid receptor alpha), IL27RA (interleukin 27 receptor subunit alpha), TBX21 (T-box transcription factor 21), SMAD2 (SMAD family member 2), IL6R (interleukin 6 receptor), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IL27 (interleukin 27), IFNGR1 (interferon gamma receptor 1), IL22 (interleukin 22), IL21R (interleukin 21 receptor), IRF4 (interferon regulatory factor 4), CLOCK (clock circadian regulator), AHR (aryl hydrocarbon receptor), NR1D1 (nuclear receptor subfamily 1 group D member 1), RORA (RAR related orphan receptor A), RUNX1 (RUNX family transcription factor 1), GATA3 (GATA binding protein 3), LAT (linker for activation of T cells), IL21 (interleukin 21), CRY1 (cryptochrome circadian regulator 1), TGFBR1 (transforming growth factor beta receptor 1), NFIL3 (nuclear factor, interleukin 3 regulated), PPP3CA (protein phosphatase 3 catalytic subunit alpha), PER1 (period circadian regulator 1), IL17F (interleukin 17F), HLA-DMA (major histocompatibility complex, class II, DM alpha), LOC100506403 (uncharacterized LOC100506403)"], "WAG003257": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ATF3 (activating transcription factor 3), IL18 (interleukin 18), VEGFA (vascular endothelial growth factor A), IFNG (interferon gamma), IL1A (interleukin 1 alpha), NR4A3 (nuclear receptor subfamily 4 group A member 3), IL1R1 (interleukin 1 receptor type 1), HBEGF (heparin binding EGF like growth factor), MSTN (myostatin), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), EIF4E (eukaryotic translation initiation factor 4E), ADAM10 (ADAM metallopeptidase domain 10), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), ZEB1 (zinc finger E-box binding homeobox 1), MYOG (myogenin), CCN1 (cellular communication network factor 1), DUSP14 (dual specificity phosphatase 14), WDR1 (WD repeat domain 1), ANKRD1 (ankyrin repeat domain 1), IFRD1 (interferon related developmental regulator 1)"], "WAG003259": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "RAC1 (Rac family small GTPase 1), CDC42 (cell division cycle 42), RHOA (ras homolog family member A), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), ROCK1 (Rho associated coiled-coil containing protein kinase 1), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), ROCK2 (Rho associated coiled-coil containing protein kinase 2), LIMK1 (LIM domain kinase 1), WASL (WASP like actin nucleation promoting factor), ARHGEF1 (Rho guanine nucleotide exchange factor 1), RPS6KB1 (ribosomal protein S6 kinase B1), IQGAP1 (IQ motif containing GTPase activating protein 1), DIAPH1 (diaphanous related formin 1), PIP4K2A (phosphatidylinositol-5-phosphate 4-kinase type 2 alpha), PFN1 (profilin 1), ARHGDIB (Rho GDP dissociation inhibitor beta), WAS (WASP actin nucleation promoting factor), CFL1 (cofilin 1), ARHGDIG (Rho GDP dissociation inhibitor gamma), PKN1 (protein kinase N1), PAK3 (p21 (RAC1) activated kinase 3), GNA13 (G protein subunit alpha 13), MAP3K4 (mitogen-activated protein kinase kinase kinase 4), RTKN (rhotekin), IQGAP2 (IQ motif containing GTPase activating protein 2), CIT (citron rho-interacting serine/threonine kinase), CFL2 (cofilin 2), MAPK10 (mitogen-activated protein kinase 10), TNK2 (tyrosine kinase non receptor 2), PPP1CB (protein phosphatase 1 catalytic subunit beta), CYFIP1 (cytoplasmic FMR1 interacting protein 1), SH3RF1 (SH3 domain containing ring finger 1), RHPN2 (rhophilin Rho GTPase binding protein 2), MYL1 (myosin light chain 1), MYBPH (myosin binding protein H), LOC100505585 (uncharacterized LOC100505585), CALM1 (calmodulin 1)"], "WAG003261": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "ID2 (inhibitor of DNA binding 2), RB1 (RB transcriptional corepressor 1), ID3 (inhibitor of DNA binding 3, HLH protein), CDK2 (cyclin dependent kinase 2), MYOD1 (myogenic differentiation 1), RBL2 (RB transcriptional corepressor like 2), RBL1 (RB transcriptional corepressor like 1), ELK1 (ETS transcription factor ELK1), ID1 (inhibitor of DNA binding 1, HLH protein), ELK4 (ETS transcription factor ELK4), CCNE1 (cyclin E1), PAX5 (paired box 5), PAX2 (paired box 2), PAX8 (paired box 8), ELK3 (ETS transcription factor ELK3), SREBF1 (sterol regulatory element binding transcription factor 1)"], "WAG003262": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "IL6 (interleukin 6), IFNG (interferon gamma), IL10 (interleukin 10), TNF (tumor necrosis factor), IL4 (interleukin 4), IL1A (interleukin 1 alpha), CSF2 (colony stimulating factor 2), IL2 (interleukin 2), IL1B (interleukin 1 beta), CD4 (CD4 molecule), IL3 (interleukin 3), IL7 (interleukin 7), IL5 (interleukin 5), TGFB1 (transforming growth factor beta 1), IL15 (interleukin 15), IL13 (interleukin 13), IL11 (interleukin 11), CSF1 (colony stimulating factor 1), CSF3 (colony stimulating factor 3), IL12B (interleukin 12B), CXCL1 (C-X-C motif chemokine ligand 1), IFNB1 (interferon beta 1), HLA-DRB1 (major histocompatibility complex, class II, DR beta 1), CXCL2 (C-X-C motif chemokine ligand 2), HLA-DRA (major histocompatibility complex, class II, DR alpha), PDGFA (platelet derived growth factor subunit A), TRB (T cell receptor beta locus), IFN1@ (interferon, type 1, cluster), TRA (T cell receptor alpha locus)"], "WAG003263": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PCNA (proliferating cell nuclear antigen), POLD1 (DNA polymerase delta 1, catalytic subunit), RFC5 (replication factor C subunit 5), RPA1 (replication protein A1), POLE (DNA polymerase epsilon, catalytic subunit), RFC4 (replication factor C subunit 4), RFC2 (replication factor C subunit 2), RFC1 (replication factor C subunit 1), RFC3 (replication factor C subunit 3), POLD2 (DNA polymerase delta 2, accessory subunit), RPA2 (replication protein A2), RPA3 (replication protein A3), POLD4 (DNA polymerase delta 4, accessory subunit), POLE2 (DNA polymerase epsilon 2, accessory subunit), LIG1 (DNA ligase 1), MSH2 (mutS homolog 2), POLD3 (DNA polymerase delta 3, accessory subunit), EXO1 (exonuclease 1), MSH6 (mutS homolog 6), MLH1 (mutL homolog 1), POLE3 (DNA polymerase epsilon 3, accessory subunit), PMS2 (PMS1 homolog 2, mismatch repair system component), POLE4 (DNA polymerase epsilon 4, accessory subunit)"], "WAG003264": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PKM (pyruvate kinase M1/2), GPI (glucose-6-phosphate isomerase), PKLR (pyruvate kinase L/R), ALDOA (aldolase, fructose-bisphosphate A), ALDOC (aldolase, fructose-bisphosphate C), HK1 (hexokinase 1), ALDOB (aldolase, fructose-bisphosphate B), LDHB (lactate dehydrogenase B), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), TPI1 (triosephosphate isomerase 1), LDHA (lactate dehydrogenase A), ENO1 (enolase 1), PC (pyruvate carboxylase), PGK1 (phosphoglycerate kinase 1), MDH1 (malate dehydrogenase 1), MDH2 (malate dehydrogenase 2), PDHA1 (pyruvate dehydrogenase E1 subunit alpha 1), LDHC (lactate dehydrogenase C), LDHAL6B (lactate dehydrogenase A like 6B), ENO3 (enolase 3), PGAM2 (phosphoglycerate mutase 2), ENO2 (enolase 2), HK2 (hexokinase 2), GOT2 (glutamic-oxaloacetic transaminase 2), SLC2A4 (solute carrier family 2 member 4), FBP1 (fructose-bisphosphatase 1), GCK (glucokinase), PGAM1 (phosphoglycerate mutase 1), DLAT (dihydrolipoamide S-acetyltransferase), DLD (dihydrolipoamide dehydrogenase), PCK1 (phosphoenolpyruvate carboxykinase 1), HK3 (hexokinase 3), GOT1 (glutamic-oxaloacetic transaminase 1), FBP2 (fructose-bisphosphatase 2), PGK2 (phosphoglycerate kinase 2), G6PC (glucose-6-phosphatase catalytic subunit), SLC2A1 (solute carrier family 2 member 1), SLC2A2 (solute carrier family 2 member 2), SLC2A3 (solute carrier family 2 member 3), SLC2A5 (solute carrier family 2 member 5), MPC2 (mitochondrial pyruvate carrier 2), PFKL (phosphofructokinase, liver type), PFKP (phosphofructokinase, platelet), PFKM (phosphofructokinase, muscle), MPC1 (mitochondrial pyruvate carrier 1)"], "WAG003265": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "CALM3 (calmodulin 3), GNG2 (G protein subunit gamma 2), GNAI2 (G protein subunit alpha i2), GNAI3 (G protein subunit alpha i3), GNAS (GNAS complex locus), GNB1 (G protein subunit beta 1), GNAI1 (G protein subunit alpha i1), PLCB3 (phospholipase C beta 3), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), ADCY2 (adenylate cyclase 2), ADCY5 (adenylate cyclase 5), ADCY7 (adenylate cyclase 7), ADCY8 (adenylate cyclase 8), ADCY1 (adenylate cyclase 1), ADCY6 (adenylate cyclase 6), ADCY9 (adenylate cyclase 9), ADRB2 (adrenoceptor beta 2), GNAO1 (G protein subunit alpha o1), CHRM2 (cholinergic receptor muscarinic 2), ADCY4 (adenylate cyclase 4), GNGT1 (G protein subunit gamma transducin 1), PRKCA (protein kinase C alpha), GNG3 (G protein subunit gamma 3), GNB2 (G protein subunit beta 2), ADCY3 (adenylate cyclase 3), PRKACB (protein kinase cAMP-activated catalytic subunit beta), GNB5 (G protein subunit beta 5), GNG12 (G protein subunit gamma 12), GNG4 (G protein subunit gamma 4), CHRM4 (cholinergic receptor muscarinic 4), GNG7 (G protein subunit gamma 7), GNG13 (G protein subunit gamma 13), GNB3 (G protein subunit beta 3), RGS2 (regulator of G protein signaling 2), GNB4 (G protein subunit beta 4), CACNA1A (calcium voltage-gated channel subunit alpha1 A), GNG8 (G protein subunit gamma 8), GNG5 (G protein subunit gamma 5), CACNA1B (calcium voltage-gated channel subunit alpha1 B), GNAQ (G protein subunit alpha q), GNAZ (G protein subunit alpha z), GNG11 (G protein subunit gamma 11), GNA11 (G protein subunit alpha 11), RGS19 (regulator of G protein signaling 19), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), RGS7 (regulator of G protein signaling 7), GRK5 (G protein-coupled receptor kinase 5), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), RGS4 (regulator of G protein signaling 4), RGS10 (regulator of G protein signaling 10), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), PRKCE (protein kinase C epsilon), PRKCB (protein kinase C beta), RYR2 (ryanodine receptor 2), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), RGS14 (regulator of G protein signaling 14), RGS18 (regulator of G protein signaling 18), ARRB1 (arrestin beta 1), ADRB1 (adrenoceptor beta 1), RGS9 (regulator of G protein signaling 9), PRKCD (protein kinase C delta), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), KCNJ3 (potassium inwardly rectifying channel subfamily J member 3), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), PRKCG (protein kinase C gamma), RGS3 (regulator of G protein signaling 3), ADRB3 (adrenoceptor beta 3), CHRM3 (cholinergic receptor muscarinic 3), RGS1 (regulator of G protein signaling 1), ADRA1B (adrenoceptor alpha 1B), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), CHRM1 (cholinergic receptor muscarinic 1), ARRB2 (arrestin beta 2), RGS6 (regulator of G protein signaling 6), RYR1 (ryanodine receptor 1), CACNA1C (calcium voltage-gated channel subunit alpha1 C), GJA1 (gap junction protein alpha 1), CACNA1S (calcium voltage-gated channel subunit alpha1 S), GRK6 (G protein-coupled receptor kinase 6), RGS20 (regulator of G protein signaling 20), RGS16 (regulator of G protein signaling 16), RGS5 (regulator of G protein signaling 5), ITPR3 (inositol 1,4,5-trisphosphate receptor type 3), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), CHRM5 (cholinergic receptor muscarinic 5), PRKCZ (protein kinase C zeta), ADRA1D (adrenoceptor alpha 1D), RGS11 (regulator of G protein signaling 11), CACNA1D (calcium voltage-gated channel subunit alpha1 D), RYR3 (ryanodine receptor 3), PLN (phospholamban), CACNB1 (calcium voltage-gated channel auxiliary subunit beta 1), GRK4 (G protein-coupled receptor kinase 4), CACNB3 (calcium voltage-gated channel auxiliary subunit beta 3), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), CAMK2B (calcium/calmodulin dependent protein kinase II beta), SLC8A1 (solute carrier family 8 member A1)"], "WAG003266": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "C4A (complement C4A (Rodgers blood group)), C3 (complement C3), C2 (complement C2), C5 (complement C5), C1R (complement C1r), C4B (complement C4B (Chido blood group)), C1S (complement C1s), C7 (complement C7), CFB (complement factor B), MASP2 (mannan binding lectin serine peptidase 2), C6 (complement C6), C9 (complement C9), C8A (complement C8 alpha chain), MASP1 (mannan binding lectin serine peptidase 1), C1QB (complement C1q B chain), C1QA (complement C1q A chain), CFP (complement factor properdin), C8G (complement C8 gamma chain), C1QC (complement C1q C chain), C8B (complement C8 beta chain), CD55 (CD55 molecule (Cromer blood group)), CFD (complement factor D), LOC110384692 (complement C4A (Rodgers blood group)-like)"], "WAG003267": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "DDC (dopa decarboxylase), TH (tyrosine hydroxylase), MAOA (monoamine oxidase A), DBH (dopamine beta-hydroxylase), COMT (catechol-O-methyltransferase), TPH1 (tryptophan hydroxylase 1), PNMT (phenylethanolamine N-methyltransferase), AANAT (aralkylamine N-acetyltransferase), CHAT (choline O-acetyltransferase), GAD2 (glutamate decarboxylase 2), PAH (phenylalanine hydroxylase), ACHE (acetylcholinesterase (Cartwright blood group)), GAD1 (glutamate decarboxylase 1), ASMT (acetylserotonin O-methyltransferase), HDC (histidine decarboxylase)"], "WAG003269": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "F2 (coagulation factor II, thrombin), F5 (coagulation factor V), PLG (plasminogen), KNG1 (kininogen 1), C3 (complement C3), F8 (coagulation factor VIII), SERPINC1 (serpin family C member 1), SERPING1 (serpin family G member 1), F10 (coagulation factor X), SERPINE1 (serpin family E member 1), C1R (complement C1r), CFI (complement factor I), F3 (coagulation factor III, tissue factor), PROC (protein C, inactivator of coagulation factors Va and VIIIa), F7 (coagulation factor VII), PLAT (plasminogen activator, tissue type), SERPINF2 (serpin family F member 2), A2M (alpha-2-macroglobulin), FGB (fibrinogen beta chain), CPB2 (carboxypeptidase B2), MASP2 (mannan binding lectin serine peptidase 2), CFB (complement factor B), F9 (coagulation factor IX), SERPIND1 (serpin family D member 1), C2 (complement C2), THBD (thrombomodulin), VWF (von Willebrand factor), MASP1 (mannan binding lectin serine peptidase 1), C1S (complement C1s), CLU (clusterin), C4B (complement C4B (Chido blood group)), CFD (complement factor D), KLKB1 (kallikrein B1), F12 (coagulation factor XII), SERPINA5 (serpin family A member 5), PROS1 (protein S), TFPI (tissue factor pathway inhibitor), SERPINA1 (serpin family A member 1), C7 (complement C7), F2R (coagulation factor II thrombin receptor), PLAU (plasminogen activator, urokinase), F13B (coagulation factor XIII B chain), C9 (complement C9), CR1 (complement C3b/C4b receptor 1 (Knops blood group)), C1QB (complement C1q B chain), C1QA (complement C1q A chain), C5AR1 (complement C5a receptor 1), C6 (complement C6), PLAUR (plasminogen activator, urokinase receptor), C1QC (complement C1q C chain), CD46 (CD46 molecule), C3AR1 (complement C3a receptor 1), CFH (complement factor H), BDKRB1 (bradykinin receptor B1), C8G (complement C8 gamma chain), CD55 (CD55 molecule (Cromer blood group)), CR2 (complement C3d receptor 2), LMAN1 (lectin, mannose binding 1), CLTC (clathrin heavy chain)"], "WAG003270": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "SMAD4 (SMAD family member 4), TGFB1 (transforming growth factor beta 1), SMAD3 (SMAD family member 3), SMAD2 (SMAD family member 2), SMAD7 (SMAD family member 7), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), EP300 (E1A binding protein p300), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), SMAD1 (SMAD family member 1), TGFBR1 (transforming growth factor beta receptor 1), CTNNB1 (catenin beta 1), MAPK3 (mitogen-activated protein kinase 3), STAT3 (signal transducer and activator of transcription 3), RUNX2 (RUNX family transcription factor 2), SMAD5 (SMAD family member 5), CREBBP (CREB binding protein), TGFBR2 (transforming growth factor beta receptor 2), IFNG (interferon gamma), EGF (epidermal growth factor), TNF (tumor necrosis factor), BMP4 (bone morphogenetic protein 4), SMAD6 (SMAD family member 6), STAT1 (signal transducer and activator of transcription 1), SMAD9 (SMAD family member 9), LEF1 (lymphoid enhancer binding factor 1), MAPK9 (mitogen-activated protein kinase 9), ZFYVE9 (zinc finger FYVE-type containing 9), TGFBR3 (transforming growth factor beta receptor 3), NFKB1 (nuclear factor kappa B subunit 1), BAMBI (BMP and activin membrane bound inhibitor), SKI (SKI proto-oncogene), RUNX3 (RUNX family transcription factor 3), ENG (endoglin), SERPINE1 (serpin family E member 1), TGIF1 (TGFB induced factor homeobox 1), JAK1 (Janus kinase 1), SKIL (SKI like proto-oncogene), HRAS (HRas proto-oncogene, GTPase), FOXH1 (forkhead box H1), FST (follistatin), LIF (LIF interleukin 6 family cytokine), NOG (noggin), THBS1 (thrombospondin 1), FKBP1A (FKBP prolyl isomerase 1A), INHBA (inhibin subunit beta A), SPP1 (secreted phosphoprotein 1), WNT1 (Wnt family member 1), TFE3 (transcription factor binding to IGHM enhancer 3), ITGB6 (integrin subunit beta 6), LEFTY1 (left-right determination factor 1), ZNF423 (zinc finger protein 423), LTBP1 (latent transforming growth factor beta binding protein 1), LEFTY2 (left-right determination factor 2), ZEB2 (zinc finger E-box binding homeobox 2), MIR302A (microRNA 302a), LINC02478 (long intergenic non-protein coding RNA 2478)"], "WAG003273": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK2 (Janus kinase 2), MAPK1 (mitogen-activated protein kinase 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), GRB2 (growth factor receptor bound protein 2), MAPK3 (mitogen-activated protein kinase 3), EPOR (erythropoietin receptor), STAT3 (signal transducer and activator of transcription 3), SHC1 (SHC adaptor protein 1), AKT1 (AKT serine/threonine kinase 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), STAT5A (signal transducer and activator of transcription 5A), IRS1 (insulin receptor substrate 1), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), STAT1 (signal transducer and activator of transcription 1), IRS2 (insulin receptor substrate 2), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), STAT5B (signal transducer and activator of transcription 5B), SOCS1 (suppressor of cytokine signaling 1), EPO (erythropoietin), RASA1 (RAS p21 protein activator 1), CISH (cytokine inducible SH2 containing protein), PTPRC (protein tyrosine phosphatase receptor type C), MAP2K2 (mitogen-activated protein kinase kinase 2), PDK1 (pyruvate dehydrogenase kinase 1), PTPRU (protein tyrosine phosphatase receptor type U)"], "WAG003274": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "JAK1 (Janus kinase 1), LCK (LCK proto-oncogene, Src family tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), STAT3 (signal transducer and activator of transcription 3), FYN (FYN proto-oncogene, Src family tyrosine kinase), TYK2 (tyrosine kinase 2), PTPN11 (protein tyrosine phosphatase non-receptor type 11), STAT1 (signal transducer and activator of transcription 1), CBL (Cbl proto-oncogene), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), IRS1 (insulin receptor substrate 1), PTPN6 (protein tyrosine phosphatase non-receptor type 6), MAPK14 (mitogen-activated protein kinase 14), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), SOCS1 (suppressor of cytokine signaling 1), CRK (CRK proto-oncogene, adaptor protein), STAT5A (signal transducer and activator of transcription 5A), CRKL (CRK like proto-oncogene, adaptor protein), IFNAR1 (interferon alpha and beta receptor subunit 1), SOCS3 (suppressor of cytokine signaling 3), GAB2 (GRB2 associated binding protein 2), VAV1 (vav guanine nucleotide exchange factor 1), RAC1 (Rac family small GTPase 1), MTOR (mechanistic target of rapamycin kinase), IRS2 (insulin receptor substrate 2), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), STAT2 (signal transducer and activator of transcription 2), RPS6KB1 (ribosomal protein S6 kinase B1), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), IFNAR2 (interferon alpha and beta receptor subunit 2), EIF4E (eukaryotic translation initiation factor 4E), STAT4 (signal transducer and activator of transcription 4), RPTOR (regulatory associated protein of MTOR complex 1), RPS6 (ribosomal protein S6), PTPRC (protein tyrosine phosphatase receptor type C), IRF9 (interferon regulatory factor 9), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), RAPGEF1 (Rap guanine nucleotide exchange factor 1), PIAS1 (protein inhibitor of activated STAT 1), MLST8 (MTOR associated protein, LST8 homolog), RPS6KA5 (ribosomal protein S6 kinase A5), PIAS3 (protein inhibitor of activated STAT 3), CREB1 (cAMP responsive element binding protein 1), EIF4A1 (eukaryotic translation initiation factor 4A1), EIF4B (eukaryotic translation initiation factor 4B), MAP2K6 (mitogen-activated protein kinase kinase 6), PRMT1 (protein arginine methyltransferase 1), RAP1A (RAP1A, member of RAS oncogene family), MAPKAP1 (MAPK associated protein 1), RPS6KA4 (ribosomal protein S6 kinase A4), MAP2K3 (mitogen-activated protein kinase kinase 3), REL (REL proto-oncogene, NF-kB subunit), PDCD4 (programmed cell death 4), RACK1 (receptor for activated C kinase 1)"], "WAG003275": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "NOTCH1 (notch receptor 1), RBPJ (recombination signal binding protein for immunoglobulin kappa J region), EP300 (E1A binding protein p300), NOTCH3 (notch receptor 3), NOTCH2 (notch receptor 2), HDAC1 (histone deacetylase 1), MYC (MYC proto-oncogene, bHLH transcription factor), SNW1 (SNW domain containing 1), MAML1 (mastermind like transcriptional coactivator 1), NFKB1 (nuclear factor kappa B subunit 1), MAML2 (mastermind like transcriptional coactivator 2), NOTCH4 (notch receptor 4), DLL1 (delta like canonical Notch ligand 1), HDAC2 (histone deacetylase 2), STAT3 (signal transducer and activator of transcription 3), CCND1 (cyclin D1), MAML3 (mastermind like transcriptional coactivator 3), AKT1 (AKT serine/threonine kinase 1), HES1 (hes family bHLH transcription factor 1), CDKN1A (cyclin dependent kinase inhibitor 1A), NCOR2 (nuclear receptor corepressor 2), PSEN1 (presenilin 1), PSENEN (presenilin enhancer, gamma-secretase subunit), HEY1 (hes related family bHLH transcription factor with YRPW motif 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), GSK3B (glycogen synthase kinase 3 beta), HEY2 (hes related family bHLH transcription factor with YRPW motif 2), HES5 (hes family bHLH transcription factor 5), APH1B (aph-1 homolog B, gamma-secretase subunit), CUL1 (cullin 1), TLE1 (TLE family member 1, transcriptional corepressor), DLL4 (delta like canonical Notch ligand 4), SKP1 (S-phase kinase associated protein 1), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), JAG1 (jagged canonical Notch ligand 1), APH1A (aph-1 homolog A, gamma-secretase subunit), NCOR1 (nuclear receptor corepressor 1), HIF1A (hypoxia inducible factor 1 subunit alpha), JAK2 (Janus kinase 2), FBXW7 (F-box and WD repeat domain containing 7), SPEN (spen family transcriptional repressor), NCSTN (nicastrin), JAG2 (jagged canonical Notch ligand 2), PSEN2 (presenilin 2), LCK (LCK proto-oncogene, Src family tyrosine kinase), DTX1 (deltex E3 ubiquitin ligase 1), CIR1 (corepressor interacting with RBPJ, CIR1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), NUMB (NUMB endocytic adaptor protein), ADAM17 (ADAM metallopeptidase domain 17), DLL3 (delta like canonical Notch ligand 3), SAP30 (Sin3A associated protein 30), GATA3 (GATA binding protein 3), MAPT (microtubule associated protein tau), ITCH (itchy E3 ubiquitin protein ligase), HES6 (hes family bHLH transcription factor 6), RING1 (ring finger protein 1), FHL1 (four and a half LIM domains 1), NUMBL (NUMB like endocytic adaptor protein), PTCRA (pre T cell antigen receptor alpha), MAGEA1 (MAGE family member A1), LOC101928143 (uncharacterized LOC101928143)"], "WAG003276": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK1 (mitogen-activated protein kinase 1), TGFB1 (transforming growth factor beta 1), FN1 (fibronectin 1), IL6 (interleukin 6), MAPK14 (mitogen-activated protein kinase 14), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), HRAS (HRas proto-oncogene, GTPase), MTOR (mechanistic target of rapamycin kinase), CDKN1A (cyclin dependent kinase inhibitor 1A), SQSTM1 (sequestosome 1), IGF1 (insulin like growth factor 1), RB1 (RB transcriptional corepressor 1), SMAD3 (SMAD family member 3), SMAD4 (SMAD family member 4), BCL2 (BCL2 apoptosis regulator), ULK1 (unc-51 like autophagy activating kinase 1), GABARAP (GABA type A receptor-associated protein), MDM2 (MDM2 proto-oncogene), IL1B (interleukin 1 beta), ATG5 (autophagy related 5), IFNG (interferon gamma), PTEN (phosphatase and tensin homolog), PCNA (proliferating cell nuclear antigen), PLAU (plasminogen activator, urokinase), BECN1 (beclin 1), CD44 (CD44 molecule (Indian blood group)), ATG3 (autophagy related 3), CDKN1B (cyclin dependent kinase inhibitor 1B), ATG7 (autophagy related 7), IGF1R (insulin like growth factor 1 receptor), GABARAPL2 (GABA type A receptor associated protein like 2), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), SERPINE1 (serpin family E member 1), GABARAPL1 (GABA type A receptor associated protein like 1), E2F1 (E2F transcription factor 1), MAP1LC3B (microtubule associated protein 1 light chain 3 beta), CEBPB (CCAAT enhancer binding protein beta), CDKN2A (cyclin dependent kinase inhibitor 2A), ATG12 (autophagy related 12), MAP1LC3C (microtubule associated protein 1 light chain 3 gamma), RB1CC1 (RB1 inducible coiled-coil 1), ATG16L1 (autophagy related 16 like 1), IGFBP3 (insulin like growth factor binding protein 3), THBS1 (thrombospondin 1), ATG13 (autophagy related 13), IRF1 (interferon regulatory factor 1), IL3 (interleukin 3), IL1A (interleukin 1 alpha), MAP2K1 (mitogen-activated protein kinase kinase 1), MAP1LC3A (microtubule associated protein 1 light chain 3 alpha), IGFBP5 (insulin like growth factor binding protein 5), GSK3B (glycogen synthase kinase 3 beta), PLAT (plasminogen activator, tissue type), ATG10 (autophagy related 10), COL1A1 (collagen type I alpha 1 chain), SPARC (secreted protein acidic and cysteine rich), AMBRA1 (autophagy and beclin 1 regulator 1), IFNB1 (interferon beta 1), IRF5 (interferon regulatory factor 5), BMP2 (bone morphogenetic protein 2), CCL3 (C-C motif chemokine ligand 3), PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3), MAP2K3 (mitogen-activated protein kinase kinase 3), IRF7 (interferon regulatory factor 7), HMGA1 (high mobility group AT-hook 1), MMP14 (matrix metallopeptidase 14), UVRAG (UV radiation resistance associated), BRAF (B-Raf proto-oncogene, serine/threonine kinase), IGFBP7 (insulin like growth factor binding protein 7), IL6R (interleukin 6 receptor), SH3GLB1 (SH3 domain containing GRB2 like, endophilin B1), MLST8 (MTOR associated protein, LST8 homolog), ATG14 (autophagy related 14), IL6ST (interleukin 6 signal transducer), VTN (vitronectin), COL3A1 (collagen type III alpha 1 chain), BMI1 (BMI1 proto-oncogene, polycomb ring finger), ING1 (inhibitor of growth family member 1), CDC25B (cell division cycle 25B), INS (insulin), GSN (gelsolin), CXCL1 (C-X-C motif chemokine ligand 1), RSL1D1 (ribosomal L1 domain containing 1), LAMP2 (lysosomal associated membrane protein 2), SERPINB2 (serpin family B member 2), AKT1S1 (AKT1 substrate 1), FKBP8 (FKBP prolyl isomerase 8), ING2 (inhibitor of growth family member 2), RNASEL (ribonuclease L), INHBA (inhibin subunit beta A), COL10A1 (collagen type X alpha 1 chain), IFI16 (interferon gamma inducible protein 16), IL24 (interleukin 24), SLC39A4 (solute carrier family 39 member 4), SLC39A2 (solute carrier family 39 member 2), LAMP1 (lysosomal associated membrane protein 1), SLC39A1 (solute carrier family 39 member 1), CREG1 (cellular repressor of E1A stimulated genes 1)"], "WAG003277": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "STAT1 (signal transducer and activator of transcription 1), IFNG (interferon gamma), IRF1 (interferon regulatory factor 1), IRF9 (interferon regulatory factor 9), STAT2 (signal transducer and activator of transcription 2), JAK1 (Janus kinase 1), IRF2 (interferon regulatory factor 2), JAK2 (Janus kinase 2), ISG15 (ISG15 ubiquitin like modifier), IRF8 (interferon regulatory factor 8), IFNB1 (interferon beta 1), OAS1 (2'-5'-oligoadenylate synthetase 1), IFNA2 (interferon alpha 2), GBP1 (guanylate binding protein 1), IRF4 (interferon regulatory factor 4), ICAM1 (intercellular adhesion molecule 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), IFIT2 (interferon induced protein with tetratricopeptide repeats 2), IFNGR1 (interferon gamma receptor 1), SOCS3 (suppressor of cytokine signaling 3), IFNGR2 (interferon gamma receptor 2), SOCS1 (suppressor of cytokine signaling 1), IFI6 (interferon alpha inducible protein 6), CIITA (class II major histocompatibility complex transactivator), CXCL10 (C-X-C motif chemokine ligand 10), PRKCD (protein kinase C delta), IL1B (interleukin 1 beta), EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2), TAP1 (transporter 1, ATP binding cassette subfamily B member), NOS2 (nitric oxide synthase 2), CXCL9 (C-X-C motif chemokine ligand 9), SPI1 (Spi-1 proto-oncogene), HLA-B (major histocompatibility complex, class I, B), PSMB9 (proteasome 20S subunit beta 9), CYBB (cytochrome b-245 beta chain), H4C14 (H4 clustered histone 14), REG1A (regenerating family member 1 alpha)"], "WAG003280": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EGFR (epidermal growth factor receptor), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), AKT1 (AKT serine/threonine kinase 1), GRB2 (growth factor receptor bound protein 2), ERBB2 (erb-b2 receptor tyrosine kinase 2), MAPK1 (mitogen-activated protein kinase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), HRAS (HRas proto-oncogene, GTPase), MAPK3 (mitogen-activated protein kinase 3), ERBB4 (erb-b2 receptor tyrosine kinase 4), SHC1 (SHC adaptor protein 1), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), EGF (epidermal growth factor), ERBB3 (erb-b2 receptor tyrosine kinase 3), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAP2K1 (mitogen-activated protein kinase kinase 1), PLCG1 (phospholipase C gamma 1), NRAS (NRAS proto-oncogene, GTPase), CRK (CRK proto-oncogene, adaptor protein), PRKCA (protein kinase C alpha), PTK2 (protein tyrosine kinase 2), MAPK8 (mitogen-activated protein kinase 8), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CBL (Cbl proto-oncogene), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MTOR (mechanistic target of rapamycin kinase), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), CRKL (CRK like proto-oncogene, adaptor protein), NCK1 (NCK adaptor protein 1), KRAS (KRAS proto-oncogene, GTPase), TP53 (tumor protein p53), CCND1 (cyclin D1), PLCG2 (phospholipase C gamma 2), GAB1 (GRB2 associated binding protein 1), PAK1 (p21 (RAC1) activated kinase 1), MDM2 (MDM2 proto-oncogene), MYC (MYC proto-oncogene, bHLH transcription factor), CBLB (Cbl proto-oncogene B), RPS6KB1 (ribosomal protein S6 kinase B1), GSK3B (glycogen synthase kinase 3 beta), SHC2 (SHC adaptor protein 2), AKT2 (AKT serine/threonine kinase 2), BRAF (B-Raf proto-oncogene, serine/threonine kinase), PRKCB (protein kinase C beta), CDKN1B (cyclin dependent kinase inhibitor 1B), AKT3 (AKT serine/threonine kinase 3), NRG1 (neuregulin 1), HBEGF (heparin binding EGF like growth factor), MAPK9 (mitogen-activated protein kinase 9), CDKN1A (cyclin dependent kinase inhibitor 1A), PDPK1 (3-phosphoinositide dependent protein kinase 1), MAPK10 (mitogen-activated protein kinase 10), PAK2 (p21 (RAC1) activated kinase 2), STAT5A (signal transducer and activator of transcription 5A), NCK2 (NCK adaptor protein 2), ARAF (A-Raf proto-oncogene, serine/threonine kinase), MAP2K4 (mitogen-activated protein kinase kinase 4), SHC3 (SHC adaptor protein 3), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), STAT5B (signal transducer and activator of transcription 5B), FOXO1 (forkhead box O1), MAP2K2 (mitogen-activated protein kinase kinase 2), BCL2L11 (BCL2 like 11), BAD (BCL2 associated agonist of cell death), NRG2 (neuregulin 2), ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase), PAK6 (p21 (RAC1) activated kinase 6), PAK4 (p21 (RAC1) activated kinase 4), ELK1 (ETS transcription factor ELK1), PRKCG (protein kinase C gamma), EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1), CAMK2D (calcium/calmodulin dependent protein kinase II delta), BTC (betacellulin), PAK3 (p21 (RAC1) activated kinase 3), EREG (epiregulin), MAP2K7 (mitogen-activated protein kinase kinase 7), CAMK2B (calcium/calmodulin dependent protein kinase II beta), CAMK2A (calcium/calmodulin dependent protein kinase II alpha), TGFA (transforming growth factor alpha), NRG4 (neuregulin 4), CAMK2G (calcium/calmodulin dependent protein kinase II gamma), RPS6KB2 (ribosomal protein S6 kinase B2), SHC4 (SHC adaptor protein 4), NRG3 (neuregulin 3), MIR21 (microRNA 21), PAK5 (p21 (RAC1) activated kinase 5), AREG (amphiregulin), BUB1B-PAK6 (BUB1B-PAK6 readthrough)"], "WAG003283": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "LCK (LCK proto-oncogene, Src family tyrosine kinase), GRB2 (growth factor receptor bound protein 2), FYN (FYN proto-oncogene, Src family tyrosine kinase), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), AKT1 (AKT serine/threonine kinase 1), SHC1 (SHC adaptor protein 1), VAV1 (vav guanine nucleotide exchange factor 1), CBL (Cbl proto-oncogene), MAPK1 (mitogen-activated protein kinase 1), PLCG1 (phospholipase C gamma 1), MAPK3 (mitogen-activated protein kinase 3), PRKCQ (protein kinase C theta), ZAP70 (zeta chain of T cell receptor associated protein kinase 70), MAPK14 (mitogen-activated protein kinase 14), PTPN11 (protein tyrosine phosphatase non-receptor type 11), TRAF6 (TNF receptor associated factor 6), NFKB1 (nuclear factor kappa B subunit 1), MAPK8 (mitogen-activated protein kinase 8), LCP2 (lymphocyte cytosolic protein 2), CD4 (CD4 molecule), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), GRAP2 (GRB2 related adaptor protein 2), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), RELA (RELA proto-oncogene, NF-kB subunit), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), CRK (CRK proto-oncogene, adaptor protein), LAT (linker for activation of T cells), GAB2 (GRB2 associated binding protein 2), CD247 (CD247 molecule), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), HRAS (HRas proto-oncogene, GTPase), NCK1 (NCK adaptor protein 1), PRKCD (protein kinase C delta), CD3E (CD3e molecule), ITK (IL2 inducible T cell kinase), PTK2B (protein tyrosine kinase 2 beta), MAP4K1 (mitogen-activated protein kinase kinase kinase kinase 1), CD28 (CD28 molecule), NFKBIA (NFKB inhibitor alpha), CD3D (CD3d molecule), CDC42 (cell division cycle 42), CBLB (Cbl proto-oncogene B), IL6 (interleukin 6), RAF1 (Raf-1 proto-oncogene, serine/threonine kinase), MAP2K1 (mitogen-activated protein kinase kinase 1), CRKL (CRK like proto-oncogene, adaptor protein), CD3G (CD3g molecule), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), PAK1 (p21 (RAC1) activated kinase 1), TGFB1 (transforming growth factor beta 1), CD8A (CD8a molecule), MAPK9 (mitogen-activated protein kinase 9), WAS (WASP actin nucleation promoting factor), RIPK2 (receptor interacting serine/threonine kinase 2), BCL10 (BCL10 immune signaling adaptor), VAV3 (vav guanine nucleotide exchange factor 3), IL1B (interleukin 1 beta), CARD11 (caspase recruitment domain family member 11), CREB1 (cAMP responsive element binding protein 1), REL (REL proto-oncogene, NF-kB subunit), PDPK1 (3-phosphoinositide dependent protein kinase 1), MAP3K14 (mitogen-activated protein kinase kinase kinase 14), DBNL (drebrin like), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), VIM (vimentin), IL1A (interleukin 1 alpha), MAP2K2 (mitogen-activated protein kinase kinase 2), MALT1 (MALT1 paracaspase), NFATC2 (nuclear factor of activated T cells 2), CCR5 (C-C motif chemokine receptor 5), FAS (Fas cell surface death receptor), IL17A (interleukin 17A), ATF2 (activating transcription factor 2), NFATC1 (nuclear factor of activated T cells 1), SH2B3 (SH2B adaptor protein 3), SKAP1 (src kinase associated phosphoprotein 1), IRF4 (interferon regulatory factor 4), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), CD83 (CD83 molecule), IL15RA (interleukin 15 receptor subunit alpha), OPRM1 (opioid receptor mu 1), GATA3 (GATA binding protein 3), ICOS (inducible T cell costimulator), IL9 (interleukin 9), PSTPIP1 (proline-serine-threonine phosphatase interacting protein 1), TNFRSF9 (TNF receptor superfamily member 9), FYB1 (FYN binding protein 1), TRA (T cell receptor alpha locus), TRB (T cell receptor beta locus)"], "WAG003294": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "EP300 (E1A binding protein p300), CREBBP (CREB binding protein), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), HDAC1 (histone deacetylase 1), SP1 (Sp1 transcription factor), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CTNNB1 (catenin beta 1), CREB1 (cAMP responsive element binding protein 1), AR (androgen receptor), VEGFA (vascular endothelial growth factor A), IL6 (interleukin 6), TNF (tumor necrosis factor), NR3C1 (nuclear receptor subfamily 3 group C member 1), NFKB1 (nuclear factor kappa B subunit 1), IL1B (interleukin 1 beta), CEBPB (CCAAT enhancer binding protein beta), HIF1A (hypoxia inducible factor 1 subunit alpha), NGF (nerve growth factor), GAPDH (glyceraldehyde-3-phosphate dehydrogenase), YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta), BDNF (brain derived neurotrophic factor), YWHAE (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon), HDAC9 (histone deacetylase 9), TH (tyrosine hydroxylase), PRKACB (protein kinase cAMP-activated catalytic subunit beta), ESR2 (estrogen receptor 2), YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta), CASP3 (caspase 3), IL10 (interleukin 10), EGR1 (early growth response 1), YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta), YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma), MEF2C (myocyte enhancer factor 2C), SST (somatostatin), PPARGC1A (PPARG coactivator 1 alpha), HSPD1 (heat shock protein family D (Hsp60) member 1), PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha), SP3 (Sp3 transcription factor), PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta), RORA (RAR related orphan receptor A), ADCYAP1 (adenylate cyclase activating polypeptide 1), GRIN1 (glutamate ionotropic receptor NMDA type subunit 1), TPH1 (tryptophan hydroxylase 1), PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha), TCF3 (transcription factor 3), HTR1A (5-hydroxytryptamine receptor 1A), YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta), CREM (cAMP responsive element modulator), YBX1 (Y-box binding protein 1), TAC1 (tachykinin precursor 1), THRB (thyroid hormone receptor beta), IL1A (interleukin 1 alpha), NFKB2 (nuclear factor kappa B subunit 2), VAMP2 (vesicle associated membrane protein 2), POU5F1 (POU class 5 homeobox 1), SOX2 (SRY-box transcription factor 2), CPT1A (carnitine palmitoyltransferase 1A), ASCL1 (achaete-scute family bHLH transcription factor 1), IL13 (interleukin 13), MYB (MYB proto-oncogene, transcription factor), SPTBN1 (spectrin beta, non-erythrocytic 1), GATA3 (GATA binding protein 3), HES1 (hes family bHLH transcription factor 1), POU2F2 (POU class 2 homeobox 2), MECP2 (methyl-CpG binding protein 2), PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta), SNTA1 (syntrophin alpha 1), KCNH2 (potassium voltage-gated channel subfamily H member 2), PHOX2A (paired like homeobox 2A), NANOG (Nanog homeobox), RET (ret proto-oncogene), NFYA (nuclear transcription factor Y subunit alpha), CHAT (choline O-acetyltransferase), RYR2 (ryanodine receptor 2), IL1RN (interleukin 1 receptor antagonist), SCN5A (sodium voltage-gated channel alpha subunit 5), CHRNA4 (cholinergic receptor nicotinic alpha 4 subunit), DDC (dopa decarboxylase), HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha), RUNX3 (RUNX family transcription factor 3), GJA1 (gap junction protein alpha 1), PBX1 (PBX homeobox 1), MAOA (monoamine oxidase A), CHRM2 (cholinergic receptor muscarinic 2), GATA2 (GATA binding protein 2), KCNQ1 (potassium voltage-gated channel subfamily Q member 1), MAP2 (microtubule associated protein 2), PHOX2B (paired like homeobox 2B), IL6R (interleukin 6 receptor), HTR2A (5-hydroxytryptamine receptor 2A), ACADM (acyl-CoA dehydrogenase medium chain), AVP (arginine vasopressin), TACR1 (tachykinin receptor 1), SLC6A4 (solute carrier family 6 member 4), GCK (glucokinase), NKX2-2 (NK2 homeobox 2), TP73 (tumor protein p73), HTR3A (5-hydroxytryptamine receptor 3A), HADHB (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta), MAZ (MYC associated zinc finger protein)"], "WAG003295": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TP53 (tumor protein p53), BRCA1 (BRCA1 DNA repair associated), ATM (ATM serine/threonine kinase), CDK2 (cyclin dependent kinase 2), CDKN1A (cyclin dependent kinase inhibitor 1A), MYC (MYC proto-oncogene, bHLH transcription factor), RB1 (RB transcriptional corepressor 1), CCNB1 (cyclin B1), CHEK1 (checkpoint kinase 1), CDK1 (cyclin dependent kinase 1), E2F1 (E2F transcription factor 1), CDK4 (cyclin dependent kinase 4), MDM2 (MDM2 proto-oncogene), CCND1 (cyclin D1), ATR (ATR serine/threonine kinase), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), CDC25A (cell division cycle 25A), RAD51 (RAD51 recombinase), CHEK2 (checkpoint kinase 2), CASP3 (caspase 3), CCNE1 (cyclin E1), CDKN1B (cyclin dependent kinase inhibitor 1B), CDK6 (cyclin dependent kinase 6), RPA2 (replication protein A2), CCND3 (cyclin D3), RAD50 (RAD50 double strand break repair protein), CCNE2 (cyclin E2), CCNB2 (cyclin B2), ATRIP (ATR interacting protein), CDK5 (cyclin dependent kinase 5), BAX (BCL2 associated X, apoptosis regulator), RFC1 (replication factor C subunit 1), CCND2 (cyclin D2), GADD45A (growth arrest and DNA damage inducible alpha), RAD9A (RAD9 checkpoint clamp component A), CDC25C (cell division cycle 25C), SFN (stratifin), RAD17 (RAD17 checkpoint clamp loader component), NBN (nibrin), PRKDC (protein kinase, DNA-activated, catalytic subunit), BID (BH3 interacting domain death agonist), CASP9 (caspase 9), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), FANCD2 (FA complementation group D2), CASP8 (caspase 8), PML (PML nuclear body scaffold), SMC1A (structural maintenance of chromosomes 1A), APAF1 (apoptotic peptidase activating factor 1), FAS (Fas cell surface death receptor), CYCS (cytochrome c, somatic), RAD52 (RAD52 homolog, DNA repair protein), CREB1 (cAMP responsive element binding protein 1), RAD1 (RAD1 checkpoint DNA exonuclease), GADD45G (growth arrest and DNA damage inducible gamma), TNFRSF10B (TNF receptor superfamily member 10b), CCNB3 (cyclin B3), GADD45B (growth arrest and DNA damage inducible beta), RRM2B (ribonucleotide reductase regulatory TP53 inducible subunit M2B), DDB2 (damage specific DNA binding protein 2), BBC3 (BCL2 binding component 3), TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1), TLK1 (tousled like kinase 1), TLK2 (tousled like kinase 2), HUS1B (HUS1 checkpoint clamp component B), SESN1 (sestrin 1), H2AX (H2A.X variant histone), PIDD1 (p53-induced death domain protein 1), MRE11 (MRE11 homolog, double strand break repair nuclease)"], "WAG003296": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), TP53 (tumor protein p53), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MYC (MYC proto-oncogene, bHLH transcription factor), MAPK1 (mitogen-activated protein kinase 1), CCND1 (cyclin D1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), CTNNB1 (catenin beta 1), RAC1 (Rac family small GTPase 1), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAPK8 (mitogen-activated protein kinase 8), HRAS (HRas proto-oncogene, GTPase), ERBB2 (erb-b2 receptor tyrosine kinase 2), GSK3B (glycogen synthase kinase 3 beta), PTEN (phosphatase and tensin homolog), GRB2 (growth factor receptor bound protein 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), SMAD3 (SMAD family member 3), CDKN1A (cyclin dependent kinase inhibitor 1A), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), BCL2 (BCL2 apoptosis regulator), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), SMAD4 (SMAD family member 4), IRS1 (insulin receptor substrate 1), CDC42 (cell division cycle 42), CDKN1B (cyclin dependent kinase inhibitor 1B), NRAS (NRAS proto-oncogene, GTPase), RAC3 (Rac family small GTPase 3), NFKB1 (nuclear factor kappa B subunit 1), AKT2 (AKT serine/threonine kinase 2), SHC1 (SHC adaptor protein 1), ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase), BAX (BCL2 associated X, apoptosis regulator), RAC2 (Rac family small GTPase 2), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), AKT3 (AKT serine/threonine kinase 3), KRAS (KRAS proto-oncogene, GTPase), MDM2 (MDM2 proto-oncogene), FOXO3 (forkhead box O3), SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1), AXIN1 (axin 1), WNT3A (Wnt family member 3A), CDKN2A (cyclin dependent kinase inhibitor 2A), MAPK9 (mitogen-activated protein kinase 9), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), TGFB1 (transforming growth factor beta 1), DVL1 (dishevelled segment polarity protein 1), CCND3 (cyclin D3), DVL3 (dishevelled segment polarity protein 3), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), APC (APC regulator of WNT signaling pathway), RHOA (ras homolog family member A), DVL2 (dishevelled segment polarity protein 2), FASLG (Fas ligand), WNT5A (Wnt family member 5A), BCL2L11 (BCL2 like 11), CCND2 (cyclin D2), WNT1 (Wnt family member 1), ATM (ATM serine/threonine kinase), MAPK10 (mitogen-activated protein kinase 10), INSR (insulin receptor), BAD (BCL2 associated agonist of cell death), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), TCF7L2 (transcription factor 7 like 2), LEF1 (lymphoid enhancer binding factor 1), PDK1 (pyruvate dehydrogenase kinase 1), TP73 (tumor protein p73), PLAU (plasminogen activator, urokinase), PIK3C2B (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta), BCL6 (BCL6 transcription repressor), WNT7B (Wnt family member 7B), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), SOS2 (SOS Ras/Rho guanine nucleotide exchange factor 2), WNT11 (Wnt family member 11), WNT2B (Wnt family member 2B), WNT10B (Wnt family member 10B), SOD2 (superoxide dismutase 2), WNT10A (Wnt family member 10A), WNT7A (Wnt family member 7A), WNT5B (Wnt family member 5B), WNT3 (Wnt family member 3), FRAT1 (FRAT regulator of WNT signaling pathway 1), RBL2 (RB transcriptional corepressor like 2), WNT2 (Wnt family member 2), TCF7 (transcription factor 7), WNT6 (Wnt family member 6), FOSL1 (FOS like 1, AP-1 transcription factor subunit), PIK3C2G (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma), CAT (catalase), MAP3K4 (mitogen-activated protein kinase kinase kinase 4), WNT16 (Wnt family member 16), PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma), WNT4 (Wnt family member 4), BAK1 (BCL2 antagonist/killer 1), TCF7L1 (transcription factor 7 like 1), BBC3 (BCL2 binding component 3), NFKB2 (nuclear factor kappa B subunit 2), CCNG2 (cyclin G2), HMGB1 (high mobility group box 1)"], "WAG003297": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "AKT1 (AKT serine/threonine kinase 1), MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), NFKB1 (nuclear factor kappa B subunit 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), ESR1 (estrogen receptor 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), BCL2 (BCL2 apoptosis regulator), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAP2K1 (mitogen-activated protein kinase kinase 1), CREB1 (cAMP responsive element binding protein 1), SP1 (Sp1 transcription factor), PRKACA (protein kinase cAMP-activated catalytic subunit alpha), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), ELK1 (ETS transcription factor ELK1), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), GNB1 (G protein subunit beta 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), GNGT1 (G protein subunit gamma transducin 1), MAPK9 (mitogen-activated protein kinase 9), BRAF (B-Raf proto-oncogene, serine/threonine kinase), GNAS (GNAS complex locus), GPER1 (G protein-coupled estrogen receptor 1)"], "WAG003300": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK14 (mitogen-activated protein kinase 14), MAPK3 (mitogen-activated protein kinase 3), GNAI2 (G protein subunit alpha i2), MAP2K1 (mitogen-activated protein kinase kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), MAP3K1 (mitogen-activated protein kinase kinase kinase 1), MAP2K3 (mitogen-activated protein kinase kinase 3), CREB1 (cAMP responsive element binding protein 1), RHOA (ras homolog family member A), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), BRAF (B-Raf proto-oncogene, serine/threonine kinase), MAP2K6 (mitogen-activated protein kinase kinase 6), ELK1 (ETS transcription factor ELK1), MAPKAPK2 (MAPK activated protein kinase 2), MAP2K2 (mitogen-activated protein kinase kinase 2), GNAI1 (G protein subunit alpha i1), SRF (serum response factor), GNAI3 (G protein subunit alpha i3), HTR1A (5-hydroxytryptamine receptor 1A), GNAO1 (G protein subunit alpha o1), ELK4 (ETS transcription factor ELK4), RAP1A (RAP1A, member of RAS oncogene family), HTR1B (5-hydroxytryptamine receptor 1B), HTR1D (5-hydroxytryptamine receptor 1D), MAPKAPK3 (MAPK activated protein kinase 3), RPS6KA5 (ribosomal protein S6 kinase A5), HTR1E (5-hydroxytryptamine receptor 1E), HTR1F (5-hydroxytryptamine receptor 1F), RASGRF1 (Ras protein specific guanine nucleotide releasing factor 1), PDPK1 (3-phosphoinositide dependent protein kinase 1), ITPR1 (inositol 1,4,5-trisphosphate receptor type 1), RASGRP1 (RAS guanyl releasing protein 1)"], "WAG003301": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK14 (mitogen-activated protein kinase 14), STX1A (syntaxin 1A), TH (tyrosine hydroxylase), SLC6A3 (solute carrier family 6 member 3), TNF (tumor necrosis factor), IL1B (interleukin 1 beta), SLC6A4 (solute carrier family 6 member 4), SYN1 (synapsin I), SLC6A2 (solute carrier family 6 member 2), DBH (dopamine beta-hydroxylase), IL1R1 (interleukin 1 receptor type 1), TPH2 (tryptophan hydroxylase 2), TGFB1I1 (transforming growth factor beta 1 induced transcript 1), NOS1 (nitric oxide synthase 1), SLC6A1 (solute carrier family 6 member 1), UNC13B (unc-13 homolog B), AMPH (amphiphysin), TSC2 (TSC complex subunit 2), CDC25C (cell division cycle 25C), TNFRSF11B (TNF receptor superfamily member 11b), TDO2 (tryptophan 2,3-dioxygenase), PPP2CB (protein phosphatase 2 catalytic subunit beta), SCAMP2 (secretory carrier membrane protein 2), ACHE (acetylcholinesterase (Cartwright blood group)), AGT (angiotensinogen), ADORA2A (adenosine A2a receptor), SLC5A7 (solute carrier family 5 member 7), RBL2 (RB transcriptional corepressor like 2), NECTIN2 (nectin cell adhesion molecule 2), FBXO32 (F-box protein 32), ITGB3 (integrin subunit beta 3), HRH3 (histamine receptor H3)"], "WAG003304": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "MAPK1 (mitogen-activated protein kinase 1), MAPK3 (mitogen-activated protein kinase 3), CREB1 (cAMP responsive element binding protein 1), MAP2K1 (mitogen-activated protein kinase kinase 1), ELK1 (ETS transcription factor ELK1), EGR1 (early growth response 1), SRF (serum response factor), BRAF (B-Raf proto-oncogene, serine/threonine kinase), RPS6KA5 (ribosomal protein S6 kinase A5), MAP2K2 (mitogen-activated protein kinase kinase 2), MAPKAPK2 (MAPK activated protein kinase 2), NR3C1 (nuclear receptor subfamily 3 group C member 1), ELK4 (ETS transcription factor ELK4), GNAS (GNAS complex locus), RAP1A (RAP1A, member of RAS oncogene family), HTR6 (5-hydroxytryptamine receptor 6), HTR7 (5-hydroxytryptamine receptor 7), HTR4 (5-hydroxytryptamine receptor 4), ATF1 (activating transcription factor 1)"], "WAG003305": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "TRAF6 (TNF receptor associated factor 6), RELA (RELA proto-oncogene, NF-kB subunit), NFKB1 (nuclear factor kappa B subunit 1), TLR3 (toll like receptor 3), TNF (tumor necrosis factor), MYD88 (MYD88 innate immune signal transduction adaptor), TLR4 (toll like receptor 4), AKT1 (AKT serine/threonine kinase 1), IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma), CD40 (CD40 molecule), MAP3K7 (mitogen-activated protein kinase kinase kinase 7), IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta), STAT1 (signal transducer and activator of transcription 1), CHUK (component of inhibitor of nuclear factor kappa B kinase complex), IRF3 (interferon regulatory factor 3), MAPK1 (mitogen-activated protein kinase 1), JUN (Jun proto-oncogene, AP-1 transcription factor subunit), MAPK14 (mitogen-activated protein kinase 14), IRAK1 (interleukin 1 receptor associated kinase 1), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), IL6 (interleukin 6), RAC1 (Rac family small GTPase 1), IRF7 (interferon regulatory factor 7), MAPK8 (mitogen-activated protein kinase 8), NFKBIA (NFKB inhibitor alpha), IL1B (interleukin 1 beta), TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1), TICAM1 (toll like receptor adaptor molecule 1), FOS (Fos proto-oncogene, AP-1 transcription factor subunit), TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2), PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1), MAP2K6 (mitogen-activated protein kinase kinase 6), RIPK1 (receptor interacting serine/threonine kinase 1), MAP2K4 (mitogen-activated protein kinase kinase 4), MAPK3 (mitogen-activated protein kinase 3), TIRAP (TIR domain containing adaptor protein), MAP2K1 (mitogen-activated protein kinase kinase 1), MAP2K3 (mitogen-activated protein kinase kinase 3), TBK1 (TANK binding kinase 1), IFNB1 (interferon beta 1), TLR9 (toll like receptor 9), TLR2 (toll like receptor 2), TRAF3 (TNF receptor associated factor 3), IRF5 (interferon regulatory factor 5), IFNA13 (interferon alpha 13), MAPK11 (mitogen-activated protein kinase 11), CD86 (CD86 molecule), LY96 (lymphocyte antigen 96), IKBKE (inhibitor of nuclear factor kappa B kinase subunit epsilon), AKT2 (AKT serine/threonine kinase 2), PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), MAP2K7 (mitogen-activated protein kinase kinase 7), IFNA2 (interferon alpha 2), PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma), IFNAR1 (interferon alpha and beta receptor subunit 1), CASP8 (caspase 8), PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta), MAP3K8 (mitogen-activated protein kinase kinase kinase 8), AKT3 (AKT serine/threonine kinase 3), CD14 (CD14 molecule), TLR1 (toll like receptor 1), IRAK4 (interleukin 1 receptor associated kinase 4), TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3), TLR7 (toll like receptor 7), FADD (Fas associated via death domain), IFNA17 (interferon alpha 17), IFNAR2 (interferon alpha and beta receptor subunit 2), MAPK9 (mitogen-activated protein kinase 9), MAPK12 (mitogen-activated protein kinase 12), TOLLIP (toll interacting protein), MAPK10 (mitogen-activated protein kinase 10), TICAM2 (toll like receptor adaptor molecule 2), MAPK13 (mitogen-activated protein kinase 13), PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2), CXCL10 (C-X-C motif chemokine ligand 10), MAP2K2 (mitogen-activated protein kinase kinase 2), CCL5 (C-C motif chemokine ligand 5), TLR6 (toll like receptor 6), TLR5 (toll like receptor 5), IL12B (interleukin 12B), NFKBIB (NFKB inhibitor beta), PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3), CCL3 (C-C motif chemokine ligand 3), IFNA5 (interferon alpha 5), IFNA21 (interferon alpha 21), IFNA14 (interferon alpha 14), TLR8 (toll like receptor 8), CCL4 (C-C motif chemokine ligand 4), IFNA6 (interferon alpha 6), PIK3R5 (phosphoinositide-3-kinase regulatory subunit 5), CD80 (CD80 molecule), CXCL9 (C-X-C motif chemokine ligand 9), IFNA8 (interferon alpha 8), IFNA10 (interferon alpha 10), IFNA16 (interferon alpha 16), IL12A (interleukin 12A), CXCL11 (C-X-C motif chemokine ligand 11), LBP (lipopolysaccharide binding protein), IFNA4 (interferon alpha 4), SPP1 (secreted phosphoprotein 1)"], "WAG003306": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "OGDH (oxoglutarate dehydrogenase), SDHB (succinate dehydrogenase complex iron sulfur subunit B), SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha), DLD (dihydrolipoamide dehydrogenase), IDH3G (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma), MDH2 (malate dehydrogenase 2), IDH3B (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta), SDHC (succinate dehydrogenase complex subunit C), SUCLA2 (succinate-CoA ligase ADP-forming subunit beta), IDH3A (isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha), DLST (dihydrolipoamide S-succinyltransferase), ACO2 (aconitase 2), CS (citrate synthase), SDHD (succinate dehydrogenase complex subunit D), FH (fumarate hydratase), SUCLG2 (succinate-CoA ligase GDP-forming subunit beta), IDH2 (isocitrate dehydrogenase (NADP(+)) 2), SDHA (succinate dehydrogenase complex flavoprotein subunit A)"], "WAG003307": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "P2RY1 (purinergic receptor P2Y1), P2RY2 (purinergic receptor P2Y2), P2RY6 (pyrimidinergic receptor P2Y6), LPAR4 (lysophosphatidic acid receptor 4), LPAR6 (lysophosphatidic acid receptor 6), ADORA1 (adenosine A1 receptor), P2RY4 (pyrimidinergic receptor P2Y4), LTB4R (leukotriene B4 receptor), ADORA3 (adenosine A3 receptor), ADORA2A (adenosine A2a receptor), ADORA2B (adenosine A2b receptor)"], "WAG003308": ["Given a list of gene symbols and its description, encode the collective biological significance and pathway associations of these genes:", "PTGS2 (prostaglandin-endoperoxide synthase 2), ANXA1 (annexin A1), PTGDS (prostaglandin D2 synthase), PTGER1 (prostaglandin E receptor 1), PTGS1 (prostaglandin-endoperoxide synthase 1), PTGES (prostaglandin E synthase), PTGFR (prostaglandin F receptor), EDN1 (endothelin 1), HPGDS (hematopoietic prostaglandin D synthase), TBXA2R (thromboxane A2 receptor), TBXAS1 (thromboxane A synthase 1), AKR1C3 (aldo-keto reductase family 1 member C3), PTGIS (prostaglandin I2 synthase), PTGIR (prostaglandin I2 receptor), EDNRB (endothelin receptor type B), ANXA2 (annexin A2), PTGER2 (prostaglandin E receptor 2), PTGER4 (prostaglandin E receptor 4), PTGER3 (prostaglandin E receptor 3), EDNRA (endothelin receptor type A), ANXA5 (annexin A5), PTGDR (prostaglandin D2 receptor), ANXA6 (annexin A6), PLA2G4A (phospholipase A2 group IVA), ANXA4 (annexin A4), S100A10 (S100 calcium binding protein A10), ANXA3 (annexin A3), PPARG (peroxisome proliferator activated receptor gamma), HSD11B1 (hydroxysteroid 11-beta dehydrogenase 1), S100A6 (S100 calcium binding protein A6), HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2), MITF (melanocyte inducing transcription factor), HPGD (15-hydroxyprostaglandin dehydrogenase), PRL (prolactin), AKR1C1 (aldo-keto reductase family 1 member C1), AKR1C2 (aldo-keto reductase family 1 member C2), AKR1B1 (aldo-keto reductase family 1 member B), CBR1 (carbonyl reductase 1), SCGB1A1 (secretoglobin family 1A member 1), SOX9 (SRY-box transcription factor 9), PPARGC1A (PPARG coactivator 1 alpha), PTGFRN (prostaglandin F2 receptor inhibitor), CYP11A1 (cytochrome P450 family 11 subfamily A member 1), PPARGC1B (PPARG coactivator 1 beta), ABCC4 (ATP binding cassette subfamily C member 4)"]}